

<!DOCTYPE HTML PUBLIC "-//NAACCR//DTD XMTML-withtarget//EN" "http://www.naaccr.org/DTD/xhtml-target.dtd">

<html>	
	<head id="Head1"><title>
	NAACCR
</title><meta http-equiv="Content-Type" content="text/html; charset=utf-8" /><meta http-equiv="Content-Language" content="en-us" /><meta name="robots" content="all" /><meta name="audience" content="all" /><meta name="rating" content="general" /><meta name="distribution" content="global" /><link rel="Stylesheet" type="text/css" href="Styles/ContentReader.css" media="all" /><link rel="Stylesheet" type="text/css" href="Styles/ContentReaderPrint.css" media="print" />
        
        <script type="text/javascript" src="../js/jquery-1.6.1.js"></script>
        <script type="text/javascript" src="../js/jquery.tipTip.js"></script>
        <script type="text/javascript" src="../js/jquery.floatheader.min.js"></script>

        <script type="text/javascript">
            $(document).ready(function() {
                $(".HighlightToolTip").tipTip();
                $("table.chapterTable").floatHeader();
            });
        </script>
        <style>
            .queryBuilderLink {
            background-color: lightgray;
            border-radius: .5em;
            padding: .2em;
            text-decoration: none;
            }
        </style>
    </head>
    <body>
        <form method="post" action="./default.aspx?c=10&amp;Version=21" id="ctl00">
<div class="aspNetHidden">
<input type="hidden" name="__EVENTTARGET" id="__EVENTTARGET" value="" />
<input type="hidden" name="__EVENTARGUMENT" id="__EVENTARGUMENT" value="" />
<input type="hidden" name="__LASTFOCUS" id="__LASTFOCUS" value="" />
<input type="hidden" name="__VIEWSTATE" id="__VIEWSTATE" value="oOyr7UKxSosiZsIDLPcWq5xgTJZr7LJgUI8UWBSSm/kSU4Jf7BRpdeztKWCyy/NfCdPR7NK9WZtQjGgdtXS+dtnNgaIuv7/ti6lun/WSJ1I=" />
</div>

<script type="text/javascript">
//<![CDATA[
var theForm = document.forms['ctl00'];
if (!theForm) {
    theForm = document.ctl00;
}
function __doPostBack(eventTarget, eventArgument) {
    if (!theForm.onsubmit || (theForm.onsubmit() != false)) {
        theForm.__EVENTTARGET.value = eventTarget;
        theForm.__EVENTARGUMENT.value = eventArgument;
        theForm.submit();
    }
}
//]]>
</script>


<div class="aspNetHidden">

	<input type="hidden" name="__VIEWSTATEGENERATOR" id="__VIEWSTATEGENERATOR" value="CA0B0334" />
	<input type="hidden" name="__EVENTVALIDATION" id="__EVENTVALIDATION" value="lA06Dy+glz31Q45qSnsZrw90f4x8F96IO4UDR7g2yF8AD1x8H+Ser+HeJCGR470KIml6G8xZ7bKN6xC0YWTJxcyLpAJxpycX9+dFyJWq5geHx7JcwtNKE2hsRLBmHJOzNkCh/9z3cSnhOcvqpcEkA4/5m5bekkdc3EQJoAEbQu4EZSyCOvGrSy+XQJUccsPDwjUS42NI/na8w7ZAXfHARJJZzU/sPvFfuwoCnkdS5M31KtzdzFi+/EZqTqcLLYrTvLmtwQ+Of/X0C7rTjGEZ9g==" />
</div>
            <div id="pnlSearch">
	
                <span id="lblVersionNum">Version:</span> 
                <select name="versionDropDown" onchange="javascript:setTimeout(&#39;__doPostBack(\&#39;versionDropDown\&#39;,\&#39;\&#39;)&#39;, 0)" id="versionDropDown">
		<option value="22">22</option>
		<option selected="selected" value="21">21</option>
		<option value="18">18</option>
		<option value="16">16</option>
		<option value="15">15</option>

	</select>
                <a href="http://applications.naaccr.org/querybuilder/default.aspx?Version=21" id="queryBuilderLink" class="queryBuilderLink" target="_blank">Click here to use the Query Builder for Version 21.</a>
                <br />
                <br />
                <span id="lblSearch">Item Search:</span>
                <input name="txtSearch" type="text" id="txtSearch" /> 
                <input type="submit" name="btnSearch" value="Search" id="btnSearch" />
            
                
            
</div>

            <div id="Menu">
	
            <div id="menuWrapper">
		        <div class="chapterColumn">
                <a href="?c=1"><div class="chapter">Chapter I: Problem Statement, Goals, and Scope of this Document</div></a>
		        <a href="?c=2"><div class="chapter">Chapter II: Historical Background and Status of North American Standards</div></a>
		        <a href="?c=3"><div class="chapter">Chapter III: Standards for Tumor Inclusion and Reportability</div></a>
                <a href="?c=4"><div class="chapter">Chapter IV: Recommended Data Editors and Software Coordination of Standards</div></a>
                <a href="?c=5"><div class="chapter">Chapter V: Unresolved Issues</div></a>
                <a href="?c=6"><div class="chapter">Chapter VI: References</div></a>
                <a href="?c=7"><div class="chapter">Chapter VII: Record Layout Table (Alphabetical within Section Type)</div></a>
                <a href="?c=8"><div class="chapter">Chapter VIII: Required Status Table (Item # Order)</div></a>
                <a href="?c=9"><div class="chapter">Chapter IX: Data Descriptor Table (Item # Order)</div></a>
                <a href="?c=10"><div class="chapter">Chapter X: Data Dictionary</div></a>
        </div>
                <div class="chapterColumn">

                <a href="?c=11"><div class="chapter">Appendix A: FIPS Codes for Counties and Equivalent Entities</div></a>
                <a href="?c=12"><div class="chapter">Appendix B: Edits Tables for Selected Data Items</div></a>
                <a href="?c=13"><div class="chapter">Appendix C: Abbreviations and Acronyms Used</div></a>
                <a href="?c=14"><div class="chapter">Appendix D: Alternate Names</div></a>
                <a href="?c=15"><div class="chapter">Appendix E: Grouped Data Items</div></a>
                <a href="?c=16"><div class="chapter">Appendix F: Tables and Data Dictionary Revisions</div></a>
                <a href="?c=17"><div class="chapter">Appendix G: Recommended Abbreviations for Abstractors</div></a>
                <a href="?c=18"><div class="chapter">Appendix H: HL7 Flavors of Null Table</div></a>
        </div>
            </div>
            
</div>
         
    
    
    <div id="Panel1" style="width:950px; padding-top:20px; border-top:1px solid black;">
	
    
    
</div>
    
    <div id="Panel2" style="width:950px; padding-top:20px;">
	
    
    <h1 style="text-align: center; ">CHAPTER X:</h1><h2 style="text-align: center">DATA DICTIONARY</h2><p>In this chapter, data items are presented in alphabetical order by item names. For each item, a general description, specific codes and definitions are provided. For many items, the document provides a brief rationale for collecting the data item or for using the codes listed. The at-a-glance header for each data item has alternate name(s), XML NAACCR ID, item number, length, source of standard, and year and version implemented (and retired, if appropriate). (For a discussion of NAACCR&#8217;s standard naming conventions, see Chapter I.&nbsp;</p><p>Differences from Version 18 are marked &#8220;Revised&#8221; or &#8220;New&#8221; following the item name. Changes are highlighted in the table or indicated by black vertical lines in the outside margins of the text portion of a data item. Text of previous versions is revealed by hovering over a highlighted cell. Revised and new items are summarized in Appendix F.</p><p>Alternate names by which the same item is called under NAACCR&#8217;s naming convention are listed alphabetically in Appendix D.</p><p>The Source of Standard designates the reference for detailed coding instructions for many of the data items. References can be found in Chapter VI. A list of reference manuals for Version 21 (and prior versions) is provided in Chapter II, Table 1. Websites for the standard setting organizations:</p><p>SEER:<a name="sources">&nbsp;</a><a href="http://seer.cancer.gov/registrars/">http://seer.cancer.gov/registrars/</a><br /><span style="background-color: #ffffff;">CoC: </span><a href="https://www.facs.org/quality-programs/cancer/ncdb/call-for-data/cocmanuals" target="_blank"><span style="background-color: #ffffff;"></span><span style="background-color: #ffffff;"></span>https://www.facs.org/quality-programs/cancer/ncdb/call-for-data/cocmanuals</a><span style="background-color: #ffffff;"></span><br />NPCR: <a href="http://www.cdc.gov/cancer/npcr/">http://www.cdc.gov/cancer/npcr/</a><br />CCCR: <a target="_blank" href="http://www23.statcan.gc.ca/imdb/p2SV.pl?Function=getSurvey&SDDS=3207&lang=en&db=imdb&adm=8&dis=2">http://www23.statcan.gc.ca/imdb/p2SV.pl?Function=getSurvey&SDDS=3207&lang=en&db=imdb&adm=8&dis=2</a></p><p>The Collaborative Staging website serves as the main repository for CS-related items including publications, software, educational activities, etc., for cancer registrars and cancer registry software vendors: <a href="https://cancerstaging.org/cstage/Pages/default.aspx" target="_blank">https://cancerstaging.org/cstage/Pages/default.aspx</a>.</p><p>The date format (YYYYMMDD) specifically addresses the NAACCR standard data transmission format; not how the data should be stored in an individual registry&#8217;s database or viewed on the screen. Only valid portions of the date should be transmitted. Below are the common formats to handle the situation where only certain components of date are known.</p><ul class="nobullets notspaced">    <li>YYYYMMDD &#8211; when complete date is known and valid</li>    <li>YYYYMM &#8211; when year and month are known and valid, and day is unknown</li>    <li>YYYY &#8211; when year is known and valid, and month and day are unknown</li>    <li>Blank &#8211; when no known date applies</li>  </ul><p>The field is fixed-length and left-justified. Any missing component should be replaced by spaces. If there are no known date components, the fixed-length variable will be completely blank.</p><blockquote style="font-size: 11pt">For unknown values and codes that have meanings other than dates the HL7 Flavors of Null Table (Appendix H) has been adopted for flagging each non-system-generated missing date as a way to eliminate the ambiguity of missing values. A date flag field, to serve as a flag or indicator, is used for each date field for which an &#8220;unknown&#8221; or &#8220;not applicable&#8221; value is appropriate. This item would be blank if a valid date is transmitted in its associated date item. The only date fields that would not have a flag are system-generated dates (e.g., Date Case Completed [2090]), for which &#8220;unknown&#8221; would never be a legitimate value.</blockquote><a name='570'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>ABSTRACTED BY</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">570</td><td style="text-align:center;">3</td><td style="text-align:center;"><a href='#sources'>CoC</a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">756 - 758</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>abstractedBy</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>An alphanumeric code assigned by the reporting facility that identifies the individual abstracting the case. </div><a name='550'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>ACCESSION NUMBER--HOSP</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">550</td><td style="text-align:center;">9</td><td style="text-align:center;"><a href='#sources'>CoC</a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">745 - 753</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>Accession Number (CoC)<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>accessionNumberHosp</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'><p>Provides a unique identifier for the patient consisting of the year in which the patient was first seen at the reporting facility and the consecutive order in which the patient was abstracted.</p>  <p>  </p>The first four numbers specify the year and the last five numbers are the numeric order in which the patient was entered into the registry database. Within a registry, all primaries for an individual must have the same accession number. The first four digits must be greater than or equal to 1944. </div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>This data item protects the identity of the patient and allows cases to be identified on a local, state, and national level. If the central registry preserves this number, they can refer to it when communicating with the reporting facilities. It also provides a way to link computerized follow-up reports from reporting facilities into the central database. </div><a name='70'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>ADDR AT DX--CITY</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">70</td><td style="text-align:center;">50</td><td style="text-align:center;"><a href='#sources'>CoC</a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">74 - 123</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>City or Town (pre-96 CoC)<br />City/Town at Diagnosis (CoC)<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>addrAtDxCity</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Name of the city in which the patient resides at the time the reportable tumor was diagnosed. If the patient resides in a rural area, record the name of the city used in the mailing address. If the patient has multiple primaries, the city of residence may be different for each primary.</div><div class='content chap10-para'><strong>Codes (in addition to valid City) </strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>UNKNOWN</td><td class='code-desc'>City at diagnosis unknown</td></tr></table></div><a name='102'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>ADDR AT DX--COUNTRY</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">102</td><td style="text-align:center;">3</td><td style="text-align:center;"><a href='#sources'>NAACCR</a></td><td style="text-align:center;">2013</td><td style="text-align:center;">13</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">464 - 466</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>addrAtDxCountry</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Country code for the address of the patient's residence at the time the reportable tumor is diagnosed. If the patient has multiple tumors, the country of residence may be different for each tumor. This data item became part of the NAACCR transmission record effective with Volume II, Version 13 in order to include country and state for each geographic item and to use interoperable codes. It supplements the item Addr at Dx--State [80].</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Country of patient's residence at the time of diagnosis is an important element of the patient&#8217;s residential history profile and might be useful for understanding risk factors, assessment of patient prognosis, and chances for survival.</div><div class='content chap10-para'><strong>Codes </strong>Use the International Standards Organization (ISO) 3166-1 Country Three Character Codes, whenever possible, augmented by custom codes. See Appendix B for complete list of country names and corresponding three character alpha codes.</div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'></td><td class='code-desc'> </td></tr><tr class='code-row'><td class='code-nbr'>ZZN</td><td class='code-desc'>North America NOS</td></tr><tr class='code-row'><td class='code-nbr'>ZZC</td><td class='code-desc'>Central America NOS</td></tr><tr class='code-row'><td class='code-nbr'>ZZS</td><td class='code-desc'>South America NOS</td></tr><tr class='code-row'><td class='code-nbr'>ZZP</td><td class='code-desc'>Pacific NOS</td></tr><tr class='code-row'><td class='code-nbr'>ZZE</td><td class='code-desc'>Europe NOS</td></tr><tr class='code-row'><td class='code-nbr'>ZZF</td><td class='code-desc'>Africa NOS</td></tr><tr class='code-row'><td class='code-nbr'>ZZA</td><td class='code-desc'>Asia NOS</td></tr><tr class='code-row'><td class='code-nbr'>ZZX</td><td class='code-desc'>Non-US NOS</td></tr><tr class='code-row'><td class='code-nbr'>ZZU</td><td class='code-desc'>Unknown</td></tr><tr class='code-row'><td class='code-nbr' colspan='2'>Custom codes for historic use only </td></tr><tr class='code-row'><td class='code-nbr'>XNI</td><td class='code-desc'>North American Islands</td></tr><tr class='code-row'><td class='code-nbr'>XCB</td><td class='code-desc'>Other Caribbean Islands</td></tr><tr class='code-row'><td class='code-nbr'>XEN</td><td class='code-desc'>England, Channel islands, Isle of Man</td></tr><tr class='code-row'><td class='code-nbr'>XSC</td><td class='code-desc'>Scandinavia
</td></tr><tr class='code-row'><td class='code-nbr'>XGR</td><td class='code-desc'>Germanic Countries</td></tr><tr class='code-row'><td class='code-nbr'>XSL</td><td class='code-desc'>Slavic Countries</td></tr><tr class='code-row'><td class='code-nbr'>CSK</td><td class='code-desc'>Czechoslovakia (former)</td></tr><tr class='code-row'><td class='code-nbr'>YUG</td><td class='code-desc'>Yugoslavia</td></tr><tr class='code-row'><td class='code-nbr'>XUM</td><td class='code-desc'>Ukraine and Moldova</td></tr><tr class='code-row'><td class='code-nbr'>XNF</td><td class='code-desc'>North Africa</td></tr><tr class='code-row'><td class='code-nbr'>XSD</td><td class='code-desc'>Sudanese Countries</td></tr><tr class='code-row'><td class='code-nbr'>XWF</td><td class='code-desc'>West Africa</td></tr><tr class='code-row'><td class='code-nbr'>XSF</td><td class='code-desc'>South Africa</td></tr><tr class='code-row'><td class='code-nbr'>XEF</td><td class='code-desc'>East Africa</td></tr><tr class='code-row'><td class='code-nbr'>XIF</td><td class='code-desc'>African Islands</td></tr><tr class='code-row'><td class='code-nbr'>XET</td><td class='code-desc'>Ethiopia and Eritrea</td></tr><tr class='code-row'><td class='code-nbr'>XAP</td><td class='code-desc'>Arabian Peninsula
</td></tr><tr class='code-row'><td class='code-nbr'>XIS</td><td class='code-desc'>Israel and Palestine
</td></tr><tr class='code-row'><td class='code-nbr'>XCR</td><td class='code-desc'>Caucasian Republics of former USSR</td></tr><tr class='code-row'><td class='code-nbr'>XOR</td><td class='code-desc'>Other Asian Republics of former USSR</td></tr><tr class='code-row'><td class='code-nbr'>XSE</td><td class='code-desc'>Southeast Asia</td></tr><tr class='code-row'><td class='code-nbr'>XMS</td><td class='code-desc'>Malaysia, Singapore, Brunei</td></tr><tr class='code-row'><td class='code-nbr'>XCH</td><td class='code-desc'>China, NOS</td></tr><tr class='code-row'><td class='code-nbr'>XML</td><td class='code-desc'>Melanesian Islands</td></tr><tr class='code-row'><td class='code-nbr'>XMC</td><td class='code-desc'>Micronesian Islands</td></tr><tr class='code-row'><td class='code-nbr'>XPL</td><td class='code-desc'>Polynesian Islands</td></tr><tr class='code-row'><td class='code-nbr'></td><td class='code-desc'> </td></tr></table></div><a name='2330'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>ADDR AT DX--NO & STREET</strong></td><td style="text-align:right;font-weight:bold;"><strong>Revised</strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">2330</td><td style="text-align:center;">60</td><td title="V: 22: SEER
V: 18: CoC
V: 16: CoC
V: 15: CoC
" class=" HighlightToolTip" style="text-align:center;"><a href='#sources'>SEER</a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">4348 - 4407</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>Patient Address (Number and Street) at Diagnosis (CoC)<br />Number and Street (pre-96 CoC)<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>addrAtDxNoStreet</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>The number and street address or rural mailing address of the patient's residence at the time the reportable tumor was diagnosed. Residential street address should not include PO Boxes. For consolidated records, street address may be based on reported or corrected residential address information.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>The address is part of the patient's demographic data and has multiple uses. It can be used to evaluate referral patterns, allows for the analysis of cancer cluster concerns, and supports epidemiological studies that use area-based social measures. <br /><br /><div><strong>Coding Instructions and Summary of USPS Guidelines. </strong></div><div><ul><li>This field is intended to store street address information for the patient&#8217;s physical, residential address. All efforts should be made to find the patient&#8217;s true street address and postal code, including reviewing relevant sources outside the medical record if available. A PO Box mailing address should only be recorded when no other address information is available in the medical record and no other information sources are available.</li><li>If the patient has multiple tumors, address at diagnosis may be different for each tumor. </li><li>Do not update this item if the patient&#8217;s residential address changes. Store updated address information in the affiliated current address data items. Only update based on improved information on the residential address at time of diagnosis. For instance, it is appropriate to correct an address during the geocoding or consolidation process.  </li><li>Refer to FORDS for residency rules.</li><li>Additional address information such as facility, nursing home, name of apartment complex, or a PO Box used for mailing purposes, should be entered in Addr At Dx--Supplementl [2335]. </li><li>U.S. addresses should conform to the U.S. Postal Service (USPS) Postal Addressing Standards. These standards are referenced in USPS Publication 28, Postal Addressing Standards. The current USPS Pub. 28 may be found and downloaded here: <a href="http://pe.usps.gov/cpim/ftp/pubs/Pub28/pub28.pdf">http://pe.usps.gov/cpim/ftp/pubs/Pub28/pub28.pdf</a>.</li><li>The address should be fully spelled out with standardized use of abbreviations and punctuation per USPS postal addressing standards (USPS Pub. 28, available at link above). Mixed case allowed.</li><li>Canadian addresses should conform to the Canada Postal Guide. The current Canadian Postal Address Standards may be found here: <a href="https://www.canadapost.ca/tools/pg/manual/PGaddress-e.pdf">https://www.canadapost.ca/tools/pg/manual/PGaddress-e.pdf</a>. </li><li>Punctuation marks should be avoided, except when punctuation is necessary to convey the meaning. Punctuation normally is limited to periods when the period carries meaning (e.g., 39.2 RD), slashes for fractional addresses (e.g., 101 1/2 Main St), and hyphens when the hyphen carries meaning (e.g., 289-01 Montgomery Ave). Use of the pound sign (#) to designate address units should be avoided whenever possible. The preferred notation is as follows: 102 Main St Apt 101. If a pound sign is used, there must be a space between the pound sign and the secondary number (e.g., 425 Flower Blvd # 72).</li><li>Abbreviations should be limited to those recognized by USPS standard abbreviations, these include, but are not limited, to the list below: (A complete list of recognized street abbreviations is provided in Appendix C of USPS Pub. 28 available at link above): </li></ul></div><br /><table style="border-collapse:collapse;border:none;" cellspacing="0" cellpadding="0" border="1"><tbody><tr><td style="width:119.7pt;border:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt" width="160" valign="top"><p style="margin-bottom:0in;margin-bottom:.0001pt;line-height:   normal">APT</p></td><td style="width:119.7pt;border:solid windowtext 1.0pt;   border-left:none;padding:0in 5.4pt 0in 5.4pt" width="160" valign="top"><p style="margin-bottom:0in;margin-bottom:.0001pt;line-height:   normal">apartment</p></td><td style="width:119.7pt;border:solid windowtext 1.0pt;   border-left:none;padding:0in 5.4pt 0in 5.4pt" width="160" valign="top"><p style="margin-bottom:0in;margin-bottom:.0001pt;line-height:   normal">N</p></td><td style="width:119.7pt;border:solid windowtext 1.0pt;   border-left:none;padding:0in 5.4pt 0in 5.4pt" width="160" valign="top"><p style="margin-bottom:0in;margin-bottom:.0001pt;line-height:   normal">north</p></td></tr><tr><td style="width:119.7pt;border:solid windowtext 1.0pt;   border-top:none;   padding:0in 5.4pt 0in 5.4pt" width="160" valign="top"><p style="margin-bottom:0in;margin-bottom:.0001pt;line-height:   normal">BLDG</p></td><td style="width:119.7pt;border-top:none;border-left:   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt" width="160" valign="top"><p style="margin-bottom:0in;margin-bottom:.0001pt;line-height:   normal">building</p></td><td style="width:119.7pt;border-top:none;border-left:   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt" width="160" valign="top"><p style="margin-bottom:0in;margin-bottom:.0001pt;line-height:   normal">NE</p></td><td style="width:119.7pt;border-top:none;border-left:   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt" width="160" valign="top"><p style="margin-bottom:0in;margin-bottom:.0001pt;line-height:   normal">northeast</p></td></tr><tr><td style="width:119.7pt;border:solid windowtext 1.0pt;   border-top:none;   padding:0in 5.4pt 0in 5.4pt" width="160" valign="top"><p style="margin-bottom:0in;margin-bottom:.0001pt;line-height:   normal">FL</p></td><td style="width:119.7pt;border-top:none;border-left:   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt" width="160" valign="top"><p style="margin-bottom:0in;margin-bottom:.0001pt;line-height:   normal">floor</p></td><td style="width:119.7pt;border-top:none;border-left:   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt" width="160" valign="top"><p style="margin-bottom:0in;margin-bottom:.0001pt;line-height:   normal">NW</p></td><td style="width:119.7pt;border-top:none;border-left:   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt" width="160" valign="top"><p style="margin-bottom:0in;margin-bottom:.0001pt;line-height:   normal">northwest</p></td></tr><tr><td style="width:119.7pt;border:solid windowtext 1.0pt;   border-top:none;   padding:0in 5.4pt 0in 5.4pt" width="160" valign="top"><p style="margin-bottom:0in;margin-bottom:.0001pt;line-height:   normal">STE</p></td><td style="width:119.7pt;border-top:none;border-left:   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt" width="160" valign="top"><p style="margin-bottom:0in;margin-bottom:.0001pt;line-height:   normal">suite</p></td><td style="width:119.7pt;border-top:none;border-left:   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt" width="160" valign="top"><p style="margin-bottom:0in;margin-bottom:.0001pt;line-height:   normal">S</p></td><td style="width:119.7pt;border-top:none;border-left:   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt" width="160" valign="top"><p style="margin-bottom:0in;margin-bottom:.0001pt;line-height:   normal">south</p></td></tr><tr><td style="width:119.7pt;border:solid windowtext 1.0pt;   border-top:none;   padding:0in 5.4pt 0in 5.4pt" width="160" valign="top"><p style="margin-bottom:0in;margin-bottom:.0001pt;line-height:   normal">UNIT</p></td><td style="width:119.7pt;border-top:none;border-left:   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt" width="160" valign="top"><p style="margin-bottom:0in;margin-bottom:.0001pt;line-height:   normal">unit</p></td><td style="width:119.7pt;border-top:none;border-left:   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt" width="160" valign="top"><p style="margin-bottom:0in;margin-bottom:.0001pt;line-height:   normal">SE</p></td><td style="width:119.7pt;border-top:none;border-left:   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt" width="160" valign="top"><p style="margin-bottom:0in;margin-bottom:.0001pt;line-height:   normal">Southeast</p></td></tr><tr><td style="width:119.7pt;border:solid windowtext 1.0pt;   border-top:none;   padding:0in 5.4pt 0in 5.4pt" width="160" valign="top"><p style="margin-bottom:0in;margin-bottom:.0001pt;line-height:   normal">RM</p></td><td style="width:119.7pt;border-top:none;border-left:   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt" width="160" valign="top"><p style="margin-bottom:0in;margin-bottom:.0001pt;line-height:   normal">room</p></td><td style="width:119.7pt;border-top:none;border-left:   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt" width="160" valign="top"><p style="margin-bottom:0in;margin-bottom:.0001pt;line-height:   normal">SW</p></td><td style="width:119.7pt;border-top:none;border-left:   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt" width="160" valign="top"><p style="margin-bottom:0in;margin-bottom:.0001pt;line-height:   normal">southwest</p></td></tr><tr><td style="width:119.7pt;border:solid windowtext 1.0pt;   border-top:none;   padding:0in 5.4pt 0in 5.4pt" width="160" valign="top"><p style="margin-bottom:0in;margin-bottom:.0001pt;line-height:   normal">DEPT</p></td><td style="width:119.7pt;border-top:none;border-left:   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt" width="160" valign="top"><p style="margin-bottom:0in;margin-bottom:.0001pt;line-height:   normal">department</p></td><td style="width:119.7pt;border-top:none;border-left:   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt" width="160" valign="top"><p style="margin-bottom:0in;margin-bottom:.0001pt;line-height:   normal">E</p></td><td style="width:119.7pt;border-top:none;border-left:   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt" width="160" valign="top"><p style="margin-bottom:0in;margin-bottom:.0001pt;line-height:   normal">east</p></td></tr><tr><td style="width:119.7pt;border:solid windowtext 1.0pt;   border-top:none;   padding:0in 5.4pt 0in 5.4pt" width="160" valign="top"><p style="margin-bottom:0in;margin-bottom:.0001pt;line-height:   normal"> &nbsp;</p></td><td style="width:119.7pt;border-top:none;border-left:   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt" width="160" valign="top"><p style="margin-bottom:0in;margin-bottom:.0001pt;line-height:   normal"> &nbsp;</p></td><td style="width:119.7pt;border-top:none;border-left:   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt" width="160" valign="top"><p style="margin-bottom:0in;margin-bottom:.0001pt;line-height:   normal">W</p></td><td style="width:119.7pt;border-top:none;border-left:   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt" width="160" valign="top"><p style="margin-bottom:0in;margin-bottom:.0001pt;line-height:   normal">west</p></td></tr></tbody></table><span style="font-size:11.0pt;font-family:&quot;Times New Roman&quot;,&quot;serif&quot;;"></span></div><div class='content chap10-para'><strong>
  <span style="font-size:11.0pt;font-family:&quot;Times New Roman&quot;,&quot;serif&quot;;">Codes (in addition to valid street address)</span>
</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>UNKNOWN</td><td class='code-desc'>Patient's address is unknown</td></tr></table></div><a name='100'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>ADDR AT DX--POSTAL CODE</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">100</td><td style="text-align:center;">9</td><td style="text-align:center;"><a href='#sources'>CoC</a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">126 - 134</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>Zip Code (pre-CoC)<br />Postal Code (CCCR)<br />Postal Code at Diagnosis (CoC)<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>addrAtDxPostalCode</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Identifies the postal code of the patient&#8217;s address at diagnosis. For consolidated records, postal code may be based on reported or corrected residential address information. </div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'><div> The postal code is part of the patient&#8217;s demographic data and has multiple uses. It can be used to evaluate referral patterns, allows for the analysis of cancer cluster concerns, and supports epidemiological studies that use area-based social measures.</div><div>&nbsp;</div><div><strong>Instructions for Coding</strong></div><div><ul><li>This field is intended to store ZIP Code or other postal code for the patient's physical, residential address. The postal code for PO Box mailing address should not be entered into this data item except in the infrequent case when no other address information is available.</li><li>If the patient has multiple tumors, the postal code at diagnosis may be different for each tumor. </li><li>Do not update this item if the patient's residential address changes. Store address update information in the affiliated current address data items. Only update based on improved information on the residential address at time of diagnosis. For instance, it is appropriate to correct a ZIP Code during the geocoding or consolidation process.  </li><li>For U.S. residents, use either the 5-digit or the extended 9-digit ZIP code. Blanks follow the 5-digit code if the 4-digit extension is not collected.</li><li>For Canadian residents, use the 6-character alphanumeric postal code.</li><li>When available, enter the postal code for other countries for out-of-country addresses.<br /></li></ul></div> </div><div class='content chap10-para'><strong>Codes (in addition to known US and Canadian or other postal codes) </strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>888888888</td><td class='code-desc'>Resident of country other than the United States, U.S. possessions or territories, or Canada and the postal code is unknown</td></tr><tr class='code-row'><td class='code-nbr'>999999999</td><td class='code-desc'>Resident of the United States (including its possessions, etc.) and the postal code is unknown</td></tr><tr class='code-row'><td class='code-nbr'>999999</td><td class='code-desc'>Resident of Canada and postal code is unknown</td></tr></table></div><a name='80'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>ADDR AT DX--STATE</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">80</td><td style="text-align:center;">2</td><td style="text-align:center;"><a href='#sources'>CoC</a></td><td style="text-align:center;">2011</td><td style="text-align:center;">12.2</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">124 - 125</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>State at Diagnosis (CoC)<br />State (pre-96 CoC)<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>addrAtDxState</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Identifies the patient&#8217;s state or province of residence at the time of diagnosis as identified by the Reporting Source. For consolidated records, the state may be based on reported or corrected residential address information.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'><div> The state of residence is part of the patient's demographic data and has multiple uses. It can be used to evaluate referral patterns, allows for the analysis of cancer cluster concerns, and supports epidemiological studies that use area-based social measures.</div><div>&nbsp;</div><div><strong>Instructions for Coding </strong></div><div><ul><li>This field is intended to store residential state for the patient's physical, residential address. The state for PO Box mailing address should not be entered into this data item except in the infrequent case when no other address information is available.</li><li>If the patient has multiple tumors, state at diagnosis may be different for each tumor. </li><li>Do not update this item if the patient's residential address changes. Store address update information in the affiliated current address data items. Only update based on improved information on the residential address at time of diagnosis. For instance, it is appropriate to correct a state during the geocoding or consolidation process.</li><li>Use the U.S. Postal Service abbreviation (for the state, territory, commonwealth, U.S. possession) or Canada Post abbreviation (for the Canadian province/territory) in which the patient resides at the time the reportable tumor is diagnosed. </li><li>If the patient is a foreign resident, then code either XX or YY depending on the circumstance.<br /></li></ul></div></div><div class='content chap10-para'>Codes (in addition to USPS abbreviations)</div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>CD</td><td class='code-desc'>Resident of Canada, NOS (province/territory unknown)</td></tr><tr class='code-row'><td class='code-nbr'>US</td><td class='code-desc'>Resident of United States, NOS (state/commonwealth/territory/possession unknown)</td></tr><tr class='code-row'><td class='code-nbr'>XX</td><td class='code-desc'>Resident of country other than the United States (including its territories, commonwealths, or possessions) or Canada, and country is known</td></tr><tr class='code-row'><td class='code-nbr'>YY</td><td class='code-desc'>Resident of country other than the United States (including its territories, commonwealths, or possessions) or Canada, and country is unknown</td></tr><tr class='code-row'><td class='code-nbr'>ZZ</td><td class='code-desc'>Residence unknown</td></tr></table></div><a name='2335'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>ADDR AT DX--SUPPLEMENTL</strong></td><td style="text-align:right;font-weight:bold;"><strong>Revised</strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">2335</td><td style="text-align:center;">60</td><td title="V: 22: SEER
V: 18: CoC
V: 16: CoC
V: 15: CoC
" class=" HighlightToolTip" style="text-align:center;"><a href='#sources'>SEER</a></td><td style="text-align:center;">2003</td><td style="text-align:center;">10</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">4408 - 4467</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>Patient Address (Number and Street) at Diagnosis--Supplemental (CoC)<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>addrAtDxSupplementl</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Provides the ability to store additional address information such as the name of a place or facility (for example a nursing home, apartment complex, jail or PO Box residential or other mailing address) at the time of diagnosis.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Sometimes the registry receives the name of a facility instead of a proper street address containing the street number, name, direction, and other elements necessary to locate an address on a street file for the purpose of geocoding. By having a second street address field to hold address information, the registry can look up and store the street address and not lose the facility name due to a shortage of space. <br /><br />The presence of a second street address field to hold additional address information also aids in follow-up. For instance, Addr At DX--No &amp; Street [2330] should contain a street address only. However, it is important to retain any known PO Box information when linking for cohort studies or patient contact studies. Retaining facility name can also help correct errors in Addr At DX--No &amp; Street [2330] or assist with geocoding or consolidation. Additionally, researchers can use this field to verify if geographic areas of high risk are driven by location of facilities, such as jails, nursing homes, or homeless shelters.<br /><div>&nbsp;</div><div><strong>Instructions for Coding </strong></div><div><ul><li>Record the name of the place or facility (for example nursing home, apartment complex, prison/jail or group home) of the patient&#8217;s residence when the tumor was diagnosed. Do not use this item for information stored in other address items such as Addr At DX--NO &amp; Street [2330].</li><li>Record a full residential PO Box here (including city &amp; zip code) or other non-physical, residential mailing address here.</li><li>Record HOMELESS here when the street address used is a shelter or diagnosing facility for persons with no usual residence.</li><li>If the patient has multiple tumors, address at diagnosis supplemental may be different for each tumor. </li><li>Do not update this item if the patient&#8217;s residential address changes. Store updated address information in the affiliated current address data items. Only update based on improved information on the residential address at time of diagnosis. For instance, it is appropriate to correct supplemental address during the geocoding or consolidation process.</li><li>Refer to <em>STORE </em>for residency rules. <br /></li></ul></div></div><a name='1810'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>ADDR CURRENT--CITY</strong></td><td style="text-align:right;font-weight:bold;"><strong>Revised</strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">1810</td><td style="text-align:center;">50</td><td title="V: 22: SEER
V: 18: CoC
V: 16: CoC
V: 15: CoC
" class=" HighlightToolTip" style="text-align:center;"><a href='#sources'>SEER</a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">2803 - 2852</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>City/Town--Current (CoC)<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>addrCurrentCity</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Patient</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para mark-changed'>Name of city of the patient&#8217;s current usual residence. If the patient has multiple tumors, the current city of residence should be the same for all tumors.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para mark-changed'>"Current address" can be used to measure the regional "cancer burden" (cost, medical care needs), especially in major retirement regions. Sometimes central registries carry out follow-up by contacting the patients by a letter or telephone calls to ascertain their vital status. The most current reported address and telephone number are needed. This information is also useful for conducting interview studies.</div><a name='1832'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>ADDR CURRENT--COUNTRY</strong></td><td style="text-align:right;font-weight:bold;"><strong>Revised</strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">1832</td><td style="text-align:center;">3</td><td style="text-align:center;"><a href='#sources'>NAACCR</a></td><td style="text-align:center;">2013</td><td style="text-align:center;">13</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">467 - 469</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>addrCurrentCountry</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Patient</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para mark-changed'>Country code for the address of patient&#8217;s current usual residence. If the patient has multiple tumors, the current country of residence should be the same for all tumors. This data item became part of the NAACCR transmission record effective with Volume II, Version 13 in order to include country and state for each geographic item and to use interoperable codes. It supplements the item Addr Current--State [1820].</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para mark-changed'>Country of patient&#8217;s current residence is an important element of the patient&#8217;s residential history profile and is useful for understanding risk factors, assessment of patient prognosis, and chances for survival.</div><div class='content chap10-para'><strong>Codes </strong>Use the International Standards Organization (ISO) 3166-1 Country Three Character Codes, whenever possible, augmented by custom codes, see below. See Appendix B for complete list of country names and corresponding three character alpha codes.</div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr' colspan='2'>Custom codes for historic use only </td></tr><tr class='code-row'><td class='code-nbr'>ZZN</td><td class='code-desc'>North America NOS </td></tr><tr class='code-row'><td class='code-nbr'>ZZC</td><td class='code-desc'>Central America NOS
</td></tr><tr class='code-row'><td class='code-nbr'>ZZS</td><td class='code-desc'>South America NOS</td></tr><tr class='code-row'><td class='code-nbr'>ZZP</td><td class='code-desc'>Pacific NOS</td></tr><tr class='code-row'><td class='code-nbr'>ZZE</td><td class='code-desc'>Europe NOS</td></tr><tr class='code-row'><td class='code-nbr'>ZZF </td><td class='code-desc'>Africa NOS</td></tr><tr class='code-row'><td class='code-nbr'>ZZA</td><td class='code-desc'>Asia NOS</td></tr><tr class='code-row'><td class='code-nbr'>ZZX</td><td class='code-desc'>Non-US NOS</td></tr><tr class='code-row'><td class='code-nbr'>ZZU</td><td class='code-desc'>Unknown
</td></tr><tr class='code-row'><td class='code-nbr' colspan='2'>Custom codes for historic use only </td></tr><tr class='code-row'><td class='code-nbr'>XNI</td><td class='code-desc'>North American Islands</td></tr><tr class='code-row'><td class='code-nbr'>SCB</td><td class='code-desc'>Other Caribbean Islands</td></tr><tr class='code-row'><td class='code-nbr'>XEN</td><td class='code-desc'>England, Channel Island, Isle of Man</td></tr><tr class='code-row'><td class='code-nbr'>XSC</td><td class='code-desc'>Scandinavia</td></tr><tr class='code-row'><td class='code-nbr'>XGR</td><td class='code-desc'>Germanic Countries</td></tr><tr class='code-row'><td class='code-nbr'>XSL </td><td class='code-desc'>Slavic Countries</td></tr><tr class='code-row'><td class='code-nbr'>CSK</td><td class='code-desc'>Czechoslovakia (former)</td></tr><tr class='code-row'><td class='code-nbr'>YUG</td><td class='code-desc'>Yugoslavia (former)</td></tr><tr class='code-row'><td class='code-nbr'>XUM</td><td class='code-desc'>Ukraine and Moldova</td></tr><tr class='code-row'><td class='code-nbr'>XNF</td><td class='code-desc'>North Africa</td></tr><tr class='code-row'><td class='code-nbr'>XSD</td><td class='code-desc'>Sudanese Countries</td></tr><tr class='code-row'><td class='code-nbr'>XWF </td><td class='code-desc'>West Africa</td></tr><tr class='code-row'><td class='code-nbr'>XSF</td><td class='code-desc'>South Africa</td></tr><tr class='code-row'><td class='code-nbr'>XEF</td><td class='code-desc'>East Africa</td></tr><tr class='code-row'><td class='code-nbr'>XIF</td><td class='code-desc'>African Islands</td></tr><tr class='code-row'><td class='code-nbr'>XET</td><td class='code-desc'>Ethiopia and Eritrea</td></tr><tr class='code-row'><td class='code-nbr'>XAP</td><td class='code-desc'>Arabian Peninsula</td></tr><tr class='code-row'><td class='code-nbr'>XIS</td><td class='code-desc'>Israel and Palestine</td></tr><tr class='code-row'><td class='code-nbr'>XCR</td><td class='code-desc'>Caucasian Republics of former USSR</td></tr><tr class='code-row'><td class='code-nbr'>XOR</td><td class='code-desc'>Other Asian Republics of former USSR</td></tr><tr class='code-row'><td class='code-nbr'>XSE</td><td class='code-desc'>Southeast Asia</td></tr><tr class='code-row'><td class='code-nbr'>XMS</td><td class='code-desc'>Malaysia, Singapore, Brunei</td></tr><tr class='code-row'><td class='code-nbr'>XCH</td><td class='code-desc'>China, NOS</td></tr><tr class='code-row'><td class='code-nbr'>XML</td><td class='code-desc'>Melanesian Islands</td></tr><tr class='code-row'><td class='code-nbr'>XMC</td><td class='code-desc'>Micronesian Islands</td></tr><tr class='code-row'><td class='code-nbr'>XPL</td><td class='code-desc'>Polynesian Islands</td></tr><tr class='code-row'><td class='code-nbr'></td><td class='code-desc'> </td></tr></table></div><a name='2350'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>ADDR CURRENT--NO & STREET</strong></td><td style="text-align:right;font-weight:bold;"><strong>Revised</strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">2350</td><td style="text-align:center;">60</td><td title="V: 22: SEER
V: 18: CoC
V: 16: CoC
V: 15: CoC
" class=" HighlightToolTip" style="text-align:center;"><a href='#sources'>SEER</a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">4468 - 4527</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>Patient Address (Number and Street)-Current (CoC)<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>addrCurrentNoStreet</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Patient</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para mark-changed'>The number and street address or the rural mailing address of the patient&#8217;s current usual residence. This can be used to generate a follow-up inquiry, and must correspond to other fields in the current address. If the patient has multiple tumors, the current address should be the same. Additional address information such as facility, nursing home, or name of apartment complex should be entered in item Addr Current--Supplemental [2335].<br /><br />U.S. addresses should conform to the USPS <em>Postal Addressing Standards</em>. These standards are referenced in USPS Pub. 28, July, 2008, <em>Postal Addressing Standards</em>. The current USPS Pub. 28 may be found and downloaded from the following website: <a href="http://pe.usps.gov/cpim/ftp/pubs/Pub28/pub28.pdf">http://pe.usps.gov/cpim/ftp/pubs/Pub28/pub28.pdf</a>.<br /><br />Canadian addresses should conform to the <em>Canada Postal Guide</em>. The current Canadian Postal Address standards may be found at the following website: <span><a target="_blank" href="http://www.canadapost.ca">http://www.canadapost.ca</a>.</span></div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para mark-changed'>&#8220;Current address&#8221; can be used to measure the regional &#8220;cancer burden&#8221; (cost, medical care needs), especially in major retirement regions. Sometimes central registries carry out follow-up by contacting the patients via letter or telephone calls to ascertain their vital status. The most current reported address and telephone number are needed. This information also is useful for conducting interview studies.<br /><br />Addresses that are formatted to conform to USPS <em>Postal Addressing Standards</em> can be more properly geocoded by GIS software and vendors to the correct census tract. The USPS Standards also address a number of issues that are problematic in producing precise addresses, including the use of punctuation, abbreviations, and proper placement of address elements, such as street direction, apartment and suite numbers, and unusual addressing situations. Spanish-language addresses also are covered by the USPS Standard.<strong><br /><br />Coding Instructions (summary of USPS guidelines)</strong><br />The address should be fully spelled out with standardized use of abbreviations and punctuation per USPS postal addressing standards (USPS Postal Addressing Standards, Pub. 28, July 2008). Upper case recommended. Mixed case allowed.<br /><br />Abbreviations should be limited to those recognized by USPS standard abbreviations, these include but are not limited to (a complete list of recognized street abbreviations is provided in Appendix C of USPS Pub. 28.):<br /><br /><table style="border-collapse:collapse;border:none;" cellspacing="0" cellpadding="0" border="1"><tbody><tr><td style="width:119.7pt;border:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt" width="160" valign="top"><p style="margin-bottom:0in;margin-bottom:.0001pt;line-height:   normal">APT</p></td><td style="width:119.7pt;border:solid windowtext 1.0pt;   border-left:none;padding:0in 5.4pt 0in 5.4pt" width="160" valign="top"><p style="margin-bottom:0in;margin-bottom:.0001pt;line-height:   normal">apartment</p></td><td style="width:119.7pt;border:solid windowtext 1.0pt;   border-left:none;padding:0in 5.4pt 0in 5.4pt" width="160" valign="top"><p style="margin-bottom:0in;margin-bottom:.0001pt;line-height:   normal">N</p></td><td style="width:119.7pt;border:solid windowtext 1.0pt;   border-left:none;padding:0in 5.4pt 0in 5.4pt" width="160" valign="top"><p style="margin-bottom:0in;margin-bottom:.0001pt;line-height:   normal">north</p></td></tr><tr><td style="width:119.7pt;border:solid windowtext 1.0pt;   border-top:none;   padding:0in 5.4pt 0in 5.4pt" width="160" valign="top"><p style="margin-bottom:0in;margin-bottom:.0001pt;line-height:   normal">BLDG</p></td><td style="width:119.7pt;border-top:none;border-left:   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt" width="160" valign="top"><p style="margin-bottom:0in;margin-bottom:.0001pt;line-height:   normal">building</p></td><td style="width:119.7pt;border-top:none;border-left:   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt" width="160" valign="top"><p style="margin-bottom:0in;margin-bottom:.0001pt;line-height:   normal">NE</p></td><td style="width:119.7pt;border-top:none;border-left:   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt" width="160" valign="top"><p style="margin-bottom:0in;margin-bottom:.0001pt;line-height:   normal">northeast</p></td></tr><tr><td style="width:119.7pt;border:solid windowtext 1.0pt;   border-top:none;   padding:0in 5.4pt 0in 5.4pt" width="160" valign="top"><p style="margin-bottom:0in;margin-bottom:.0001pt;line-height:   normal">FL</p></td><td style="width:119.7pt;border-top:none;border-left:   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt" width="160" valign="top"><p style="margin-bottom:0in;margin-bottom:.0001pt;line-height:   normal">floor</p></td><td style="width:119.7pt;border-top:none;border-left:   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt" width="160" valign="top"><p style="margin-bottom:0in;margin-bottom:.0001pt;line-height:   normal">NW</p></td><td style="width:119.7pt;border-top:none;border-left:   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt" width="160" valign="top"><p style="margin-bottom:0in;margin-bottom:.0001pt;line-height:   normal">northwest</p></td></tr><tr><td style="width:119.7pt;border:solid windowtext 1.0pt;   border-top:none;   padding:0in 5.4pt 0in 5.4pt" width="160" valign="top"><p style="margin-bottom:0in;margin-bottom:.0001pt;line-height:   normal">STE</p></td><td style="width:119.7pt;border-top:none;border-left:   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt" width="160" valign="top"><p style="margin-bottom:0in;margin-bottom:.0001pt;line-height:   normal">suite</p></td><td style="width:119.7pt;border-top:none;border-left:   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt" width="160" valign="top"><p style="margin-bottom:0in;margin-bottom:.0001pt;line-height:   normal">S</p></td><td style="width:119.7pt;border-top:none;border-left:   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt" width="160" valign="top"><p style="margin-bottom:0in;margin-bottom:.0001pt;line-height:   normal">south</p></td></tr><tr><td style="width:119.7pt;border:solid windowtext 1.0pt;   border-top:none;   padding:0in 5.4pt 0in 5.4pt" width="160" valign="top"><p style="margin-bottom:0in;margin-bottom:.0001pt;line-height:   normal">UNIT</p></td><td style="width:119.7pt;border-top:none;border-left:   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt" width="160" valign="top"><p style="margin-bottom:0in;margin-bottom:.0001pt;line-height:   normal">unit</p></td><td style="width:119.7pt;border-top:none;border-left:   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt" width="160" valign="top"><p style="margin-bottom:0in;margin-bottom:.0001pt;line-height:   normal">SE</p></td><td style="width:119.7pt;border-top:none;border-left:   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt" width="160" valign="top"><p style="margin-bottom:0in;margin-bottom:.0001pt;line-height:   normal">Southeast</p></td></tr><tr><td style="width:119.7pt;border:solid windowtext 1.0pt;   border-top:none;   padding:0in 5.4pt 0in 5.4pt" width="160" valign="top"><p style="margin-bottom:0in;margin-bottom:.0001pt;line-height:   normal">RM</p></td><td style="width:119.7pt;border-top:none;border-left:   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt" width="160" valign="top"><p style="margin-bottom:0in;margin-bottom:.0001pt;line-height:   normal">room</p></td><td style="width:119.7pt;border-top:none;border-left:   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt" width="160" valign="top"><p style="margin-bottom:0in;margin-bottom:.0001pt;line-height:   normal">SW</p></td><td style="width:119.7pt;border-top:none;border-left:   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt" width="160" valign="top"><p style="margin-bottom:0in;margin-bottom:.0001pt;line-height:   normal">southwest</p></td></tr><tr><td style="width:119.7pt;border:solid windowtext 1.0pt;   border-top:none;   padding:0in 5.4pt 0in 5.4pt" width="160" valign="top"><p style="margin-bottom:0in;margin-bottom:.0001pt;line-height:   normal">DEPT</p></td><td style="width:119.7pt;border-top:none;border-left:   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt" width="160" valign="top"><p style="margin-bottom:0in;margin-bottom:.0001pt;line-height:   normal">department</p></td><td style="width:119.7pt;border-top:none;border-left:   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt" width="160" valign="top"><p style="margin-bottom:0in;margin-bottom:.0001pt;line-height:   normal">E</p></td><td style="width:119.7pt;border-top:none;border-left:   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt" width="160" valign="top"><p style="margin-bottom:0in;margin-bottom:.0001pt;line-height:   normal">east</p></td></tr><tr><td style="width:119.7pt;border:solid windowtext 1.0pt;   border-top:none;   padding:0in 5.4pt 0in 5.4pt" width="160" valign="top"><p style="margin-bottom:0in;margin-bottom:.0001pt;line-height:   normal"> &nbsp;</p></td><td style="width:119.7pt;border-top:none;border-left:   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt" width="160" valign="top"><p style="margin-bottom:0in;margin-bottom:.0001pt;line-height:   normal"> &nbsp;</p></td><td style="width:119.7pt;border-top:none;border-left:   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt" width="160" valign="top"><p style="margin-bottom:0in;margin-bottom:.0001pt;line-height:   normal">W</p></td><td style="width:119.7pt;border-top:none;border-left:   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt" width="160" valign="top"><p style="margin-bottom:0in;margin-bottom:.0001pt;line-height:   normal">west</p></td></tr></tbody></table><br /><span style="font-size:11.0pt;font-family:&quot;Times New Roman&quot;,&quot;serif&quot;;">Punctuation marks should be avoided, except when punctuation is necessary to convey the meaning. Punctuation normally is limited to periods when the period carries meaning (e.g., 39.2 RD), slashes for fractional addresses (e.g., 101 &#189; MAIN ST), and hyphens when the hyphen carries meaning (e.g., 289-01 MONTGOMERY AVE). Use of the pound sign (#) to designate address units should be avoided whenever possible. The preferred notation is as follows: 102 MAIN ST APT 101. If a pound sign is used, there must be a space between the pound sign and the secondary number (e.g., 425 FLOWER BLVD # 72).</span></div><a name='1830'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>ADDR CURRENT--POSTAL CODE</strong></td><td style="text-align:right;font-weight:bold;"><strong>Revised</strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">1830</td><td style="text-align:center;">9</td><td title="V: 22: SEER
V: 18: CoC
V: 16: CoC
V: 15: CoC
" class=" HighlightToolTip" style="text-align:center;"><a href='#sources'>SEER</a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">2855 - 2863</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>Postal Code--Current (CoC)<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>addrCurrentPostalCode</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Patient</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para mark-changed'>Postal code for the address of the patient&#8217;s current usual residence. If the patient has multiple tumors, the postal codes should be the same. For U.S. residents, use either the 5-digit or the extended 9-digit ZIP code. Blanks follow the 5-digit code. For Canadian residents, use the 6-character alphanumeric postal code. Blanks follow the 6-character code. When available, enter postal code for other countries.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para mark-changed'>&#8220;Current address&#8221; can be used to measure the regional &#8220;cancer burden&#8221; (cost, medical care needs), especially in major retirement regions. Sometimes central registries carry out follow-up by contacting the patients by a letter or telephone calls to ascertain their vital status. The most current reported address and telephone number are needed. This information also is useful for conducting interview studies.</div><div class='content chap10-para'><strong>Codes (in addition to U.S., Canadian, and Foreign postal codes) </strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>999999</td><td class='code-desc'>Resident of Canada and postal code unknown</td></tr><tr class='code-row'><td class='code-nbr'>888888888</td><td class='code-desc'>Resident of country other than the United States (including its possessions, etc.) or Canada, and postal code unknown</td></tr><tr class='code-row'><td class='code-nbr'>999999999</td><td class='code-desc'>Resident of the United States (including its possessions, etc.) and postal code unknown</td></tr></table></div><a name='1820'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>ADDR CURRENT--STATE</strong></td><td style="text-align:right;font-weight:bold;"><strong>Revised</strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">1820</td><td style="text-align:center;">2</td><td title="V: 22: SEER
V: 18: CoC
V: 16: CoC
V: 15: CoC
" class=" HighlightToolTip" style="text-align:center;"><a href='#sources'>SEER</a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">2853 - 2854</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>State--Current (CoC)<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>addrCurrentState</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Patient</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para mark-changed'>USPS abbreviation for the state, territory, commonwealth, U.S. possession, or CanadaPost abbreviation for the Canadian province/territory of the patient&#8217;s current usual residence. If the patient has multiple tumors, the current state of residence should be the same for all tumors. Effective with NAACCR Volume II, Version 13 a new data item, Addr Current--Country [1832] was added to the standard transmission record layout. The UDS Committee expects the new items to supplement the use of Addr Current--State [80].</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para mark-changed'>"Current address" can be used to measure the regional "cancer burden" (cost, medical care needs), especially in major retirement regions. Sometimes central registries carry out follow-up by contacting the patients via letter or telephone calls to ascertain vital status. The most current reported address and telephone number are needed. This information also is useful for conducting interview studies.</div><div class='content chap10-para'><strong>Codes (in addition to the U.S. and Canadian postal service abbreviations) </strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>CD</td><td class='code-desc'>Resident of Canada, NOS (province/territory unknown)</td></tr><tr class='code-row'><td class='code-nbr'>US</td><td class='code-desc'>Resident of United States, NOS (state/commonwealth/territory/possession unknown)</td></tr><tr class='code-row'><td class='code-nbr'>XX</td><td class='code-desc'>Resident of country other than the United States (including its territories, commonwealths, or possessions) or Canada, and country is known</td></tr><tr class='code-row'><td class='code-nbr'>YY</td><td class='code-desc'>Resident of country other than the United States (including its territories, commonwealths, or possessions) or Canada, and country is unknown</td></tr><tr class='code-row'><td class='code-nbr'>ZZ</td><td class='code-desc'>Residence unknown</td></tr></table></div><a name='2355'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>ADDR CURRENT--SUPPLEMENTL</strong></td><td style="text-align:right;font-weight:bold;"><strong>Revised</strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">2355</td><td style="text-align:center;">60</td><td title="V: 22: SEER
V: 18: CoC
V: 16: CoC
V: 15: CoC
" class=" HighlightToolTip" style="text-align:center;"><a href='#sources'>SEER</a></td><td style="text-align:center;">2003</td><td style="text-align:center;">10</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">4528 - 4587</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>Patient Address (Number and Street) Current--Supplemental (CoC)<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>addrCurrentSupplementl</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Patient</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para mark-changed'>This data item provides the ability to store additional address information such as the name of a place or facility, a nursing home, or the name of an apartment complex. This can be used to generate a follow-up inquiry, and must correspond to other fields in the current address. If the patient has multiple tumors, the current address should be the same.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para mark-changed'>Sometimes the registry receives the name of a facility instead of a proper street address containing the street number, name, direction, and other elements necessary to locate an address on a street file for the purpose of geocoding. By having a second street address field to hold address information, the registry can look up and store the street address and not lose the facility name due to a shortage of space. The presence of a second street address field to hold additional address information also aids in follow-up.</div><a name='3803'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>ADENOID CYSTIC BASALOID PATTERN</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">3803</td><td style="text-align:center;">5</td><td style="text-align:center;"><a href='#sources'>NAACCR</a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1839 - 1843</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>adenoidCysticBasaloidPattern</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'><!--[if gte mso 10]>  <![endif]-->Adenoid Cystic Basaloid Pattern, the presence of a basaloid pattern on pathological examination, is a prognostic factor for adenoid cystic carcinoma of the lacrimal gland. </div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Adenoid Cystic Basaloid Pattern is a Registry Data Collection Variable in AJCC 8.  This data item was previously collected as Lacrimal Gland, CS SSF# 6.   </div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>0.0-100.0</td><td class='code-desc'>0.0 to 100.0 percent basaloid pattern</td></tr><tr class='code-row'><td class='code-nbr'>XXX.5</td><td class='code-desc'>Basaloid pattern present, percentage not stated</td></tr><tr class='code-row'><td class='code-nbr'>XXX.8</td><td class='code-desc'>Not applicable: Information not collected for this case<br/> 
(If this item is required by your standard setter, use of code XXX.8 will result in an edit error.)
</td></tr><tr class='code-row'><td class='code-nbr'>XXX.9</td><td class='code-desc'>Not documented in medical record<br/>
Adenoid Cystic Basaloid Pattern not assessed or unknown if assessed
</td></tr><tr class='code-row'><td class='code-nbr'></td><td class='code-desc'> </td></tr></table></div><div class='content chap10-para'>Each Site-Specific Data Item (SSDI) applies only to selected primary sites, histologies, and years of diagnosis. Depending on applicability and standard-setter requirements, SSDIs may be left blank. </div><a name='3804'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>ADENOPATHY</strong></td><td style="text-align:right;font-weight:bold;"><strong>Revised</strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">3804</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>NAACCR</a></td><td style="text-align:center;">2018</td><td style="text-align:center;">18</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1910 - 1910</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>RAI Classification: Adenopathy<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>adenopathy</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Adenopathy is defined as the presence of lymph nodes greater than 1.5 cm on physical examination (PE) and is part of the staging criteria for Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL).</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para mark-changed'><!--[if gte mso 10]> <![endif]-->Adenopathy is a prognostic factor required for staging of Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) in AJCC 8th edition, Chapter 79










<em>Hodgkin and Non-Hodgkin Lymphomas</em>. It is a new data item for cases diagnosed 1/1/2018+.</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>0</td><td class='code-desc'>Adenopathy not identified/not present<br/> 
No lymph nodes >1.5 cm
 </td></tr><tr class='code-row'><td class='code-nbr'>1</td><td class='code-desc'>Adenopathy present<br/> 
Presence of lymph nodes >1.5 cm
</td></tr><tr class='code-row'><td class='code-nbr'>9</td><td class='code-desc'>Not documented in medical record<br/>
Adenopathy not assessed or unknown if assessed
</td></tr><tr class='code-row'><td class='code-nbr'></td><td class='code-desc'> </td></tr></table></div><div class='content chap10-para'>Each Site-Specific Data Item (SSDI) applies only to selected primary sites, histologies, and years of diagnosis. Depending on applicability and standard-setter requirements, SSDIs may be left blank. </div><a name='3805'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>AFP POST-ORCHIECTOMY LAB VALUE</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">3805</td><td style="text-align:center;">7</td><td style="text-align:center;"><a href='#sources'>NAACCR</a></td><td style="text-align:center;">2018</td><td style="text-align:center;">18</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1959 - 1965</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>Testis Serum Markers: AFP (Alpha Fetoprotein) Post-Orchiectomy Lab Value<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>afpPostOrchiectomyLabValue</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>AFP (Alpha Fetoprotein) Post-Orchiectomy Lab Value refers to the lowest AFP value measured post-orchiectomy. AFP is a serum tumor marker that is often elevated in patients with nonseminomatous germ cell tumors of the testis. The Post-Orchiectomy lab value is used to monitor response to therapy.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>AFP (Alpha Fetoprotein) Post-Orchiectomy Lab Value is a Registry Data Collection Variable in AJCC. It was previously collected as Testis CS SSF# 12.</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>0.0</td><td class='code-desc'>0.0 nanograms/milliliter (ng/mL)</td></tr><tr class='code-row'><td class='code-nbr'>0.1-99999.9</td><td class='code-desc'>0.199,999.9 ng/mL</td></tr><tr class='code-row'><td class='code-nbr'>XXXXX.1</td><td class='code-desc'>100,000 ng/mL or greater</td></tr><tr class='code-row'><td class='code-nbr'>XXXXX.7</td><td class='code-desc'>Test ordered, results not in chart</td></tr><tr class='code-row'><td class='code-nbr'>XXXXX.8</td><td class='code-desc'>Not applicable: Information not collected for this case<br/>
(If this information is required by your standard setter, use of code XXXXX.8 may result in an edit error.)
</td></tr><tr class='code-row'><td class='code-nbr'>XXXXX.9</td><td class='code-desc'>Not documented in medical record<br/>
No orchiectomy performed<br/>
AFP (Alpha Fetoprotein) Post-Orchiectomy Lab Value not assessed or unknown if assessed
</td></tr><tr class='code-row'><td class='code-nbr'></td><td class='code-desc'> </td></tr></table></div><div class='content chap10-para'>Each Site-Specific Data Item (SSDI) applies only to selected primary sites, histologies, and years of diagnosis. Depending on applicability and standard-setter requirements, SSDIs may be left blank. </div><a name='3806'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>AFP POST-ORCHIECTOMY RANGE</strong></td><td style="text-align:right;font-weight:bold;"><strong>Revised</strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">3806</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>NAACCR</a></td><td style="text-align:center;">2018</td><td style="text-align:center;">18</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1966 - 1966</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>Testis Serum Markers: AFP (Alpha Fetoprotein) Post-Orchiectomy Range<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>afpPostOrchiectomyRange</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>AFP (Alpha Fetoprotein) Post-Orchiectomy Range identifies the range category of the lowest AFP value measured post-orchiectomy.  AFP is a serum tumor marker that is often elevated in patients with nonseminomatous germ cell tumors of the testis. The Post-Orchiectomy lab value is used to monitor response to therapy.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>AFP (Alpha Fetoprotein) Post-Orchiectomy Range is a Registry Data Collection Variable in AJCC.  AFP (Alpha Fetoprotein) Post-Orchiectomy Range is used to assign the S Category Pathological and was previously collected as Testis CS SSF# 13.</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para mark-changed'><table><tr class='code-row'><td class='code-nbr'>0</td><td class='code-desc'>Within normal limits </td></tr><tr class='code-row'><td class='code-nbr'>1</td><td class='code-desc'>Above normal and less than 1,000 nanograms/milliliter (ng/mL)</td></tr><tr class='code-row'><td class='code-nbr'>2</td><td class='code-desc'>1,000 -10,000 ng/mL</td></tr><tr class='code-row'><td class='code-nbr'>3</td><td class='code-desc'>Greater than 10,000 ng/mL</td></tr><tr class='code-row'><td class='code-nbr'>4</td><td class='code-desc'>Post-Orchiectomy alpha fetoprotein (AFP) stated to be elevated</td></tr><tr class='code-row'><td class='code-nbr'>5</td><td class='code-desc'>Post-Orchiectomy alpha fetoprotein (AFP) unknown or not done but pre-orchiectomy AFP was normal </td></tr><tr class='code-row'><td class='code-nbr'>7</td><td class='code-desc'>Test ordered, results not in chart</td></tr><tr class='code-row'><td class='code-nbr'>8</td><td class='code-desc'>Not applicable: Information not collected for this case<br/>
(If this information is required by your standard setter, use of code 8 may result in an edit error.)
</td></tr><tr class='code-row'><td class='code-nbr'>9</td><td class='code-desc'>Not documented in medical record<br/>
No orchiectomy performed<br/>
AFP (Alpha Fetoprotein) Post-Orchiectomy Range not assessed or unknown if assessed 
</td></tr><tr class='code-row'><td class='code-nbr'></td><td class='code-desc'> </td></tr></table></div><div class='content chap10-para mark-changed'>Each Site-Specific Data Item (SSDI) applies only to selected primary sites, histologies, and years of diagnosis. Depending on applicability and standard-setter requirements, SSDIs may be left blank.</div><a name='3807'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>AFP PRE-ORCHIECTOMY LAB VALUE</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">3807</td><td style="text-align:center;">7</td><td style="text-align:center;"><a href='#sources'>NAACCR</a></td><td style="text-align:center;">2018</td><td style="text-align:center;">18</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1951 - 1957</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>Testis Serum Markers: AFP (Alpha Fetoprotein) Pre-Orchiectomy Lab Value<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>afpPreOrchiectomyLabValue</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>AFP (Alpha Fetoprotein) Pre-Orchiectomy Lab Value refers to the AFP value measured prior to treatment. AFP is a tumor marker that is often elevated in patients with nonseminomatous germ cell tumors of the testis.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>AFP (Alpha Fetoprotein) Pre-Orchiectomy Lab Value is a Registry Data Collection Variable in AJCC. It was previously collected as Testis CS SSF# 6</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>0.0</td><td class='code-desc'>0.0 nanograms/milliliter (ng/mL)</td></tr><tr class='code-row'><td class='code-nbr'>0.1-99999.9</td><td class='code-desc'>0.199,999.9 ng/mL</td></tr><tr class='code-row'><td class='code-nbr'>XXXXX.1</td><td class='code-desc'>100,000 ng/mL or greater</td></tr><tr class='code-row'><td class='code-nbr'>XXXXX.7</td><td class='code-desc'>Test ordered, results not in chart</td></tr><tr class='code-row'><td class='code-nbr'>XXXXX.8</td><td class='code-desc'>Not applicable: Information not collected for this case<br/>
(If this information is required by your standard setter, use of code XXXXX.8 may result in an edit error.)
</td></tr><tr class='code-row'><td class='code-nbr'>XXXXX.9</td><td class='code-desc'>Not documented in medical record<br/>
AFP (Alpha Fetoprotein) Pre-Orchiectomy Lab Value not assessed or unknown if assessed
</td></tr><tr class='code-row'><td class='code-nbr'></td><td class='code-desc'> </td></tr></table></div><div class='content chap10-para'>Each Site-Specific Data Item (SSDI) applies only to selected primary sites, histologies, and years of diagnosis. Depending on applicability and standard-setter requirements, SSDIs may be left blank. </div><a name='3808'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>AFP PRE-ORCHIECTOMY RANGE</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">3808</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>NAACCR</a></td><td style="text-align:center;">2018</td><td style="text-align:center;">18</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1958 - 1958</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>Testis Serum Markers: AFP (Alpha Fetoprotein) Pre-Orchiectomy Range<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>afpPreOrchiectomyRange</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>AFP (Alpha Fetoprotein) Pre-Orchiectomy Range identifies the range category of the highest AFP value measured prior to treatment.  AFP is a serum tumor marker that is often elevated in patients with nonseminomatous germ cell tumors of the testis.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>AFP (Alpha Fetoprotein) Pre-Orchiectomy Range is a Registry Data Collection Variable in AJCC.  AFP (Alpha Fetoprotein) Pre-Orchiectomy Range is used to assign the S Category Clinical and was previously collected as Testis CS SSF# 7.</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>0</td><td class='code-desc'>Within normal limits         </td></tr><tr class='code-row'><td class='code-nbr'>1</td><td class='code-desc'>Above normal and less than 1,000 nanograms/milliliter (ng/mL)</td></tr><tr class='code-row'><td class='code-nbr'>2</td><td class='code-desc'>1,000 -10,000 ng/mL</td></tr><tr class='code-row'><td class='code-nbr'>3</td><td class='code-desc'>Greater than 10,000 ng/mL</td></tr><tr class='code-row'><td class='code-nbr'>4</td><td class='code-desc'>Pre-Orchiectomy alpha fetoprotein (AFP) stated to be elevated</td></tr><tr class='code-row'><td class='code-nbr'>7</td><td class='code-desc'>Test ordered, results not in chart</td></tr><tr class='code-row'><td class='code-nbr'>8</td><td class='code-desc'>Not applicable: Information not collected for this case<br/>
(If this information is required by your standard setter, use of code 8 may result in an edit error.)
</td></tr><tr class='code-row'><td class='code-nbr'>9</td><td class='code-desc'>Not documented in medical record<br/>
AFP (Alpha Fetoprotein) Pre-Orchiectomy Range not assessed or unknown if assessed 
</td></tr><tr class='code-row'><td class='code-nbr'></td><td class='code-desc'> </td></tr></table></div><div class='content chap10-para'>Each Site-Specific Data Item (SSDI) applies only to selected primary sites, histologies, and years of diagnosis. Depending on applicability and standard-setter requirements, SSDIs may be left blank. </div><a name='3809'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>AFP PRETREATMENT INTERPRETATION</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">3809</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>NAACCR</a></td><td style="text-align:center;">2018</td><td style="text-align:center;">18</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1844 - 1844</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>AFP (Alpha Fetoprotein) Pretreatment Interpretation <br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>afpPretreatmentInterpretation</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>AFP (Alpha Fetoprotein) Pretreatment Interpretation, a nonspecific serum protein that generally is elevated in the setting of hepatocellular carcinoma (HCC), is a prognostic factor for liver cancer.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>AFP (Alpha Fetoprotein) Pretreatment Interpretation is a Registry Data Collection Variable in AJCC. This data item was previously collected for Liver, CS SSF# 1.</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>0</td><td class='code-desc'>Negative/normal; within normal limits</td></tr><tr class='code-row'><td class='code-nbr'>1</td><td class='code-desc'>Positive/elevated</td></tr><tr class='code-row'><td class='code-nbr'>2</td><td class='code-desc'>Borderline; undetermined if positive or negative</td></tr><tr class='code-row'><td class='code-nbr'>7</td><td class='code-desc'>Test ordered, results not in chart</td></tr><tr class='code-row'><td class='code-nbr'>8</td><td class='code-desc'>Not applicable: Information not collected for this case<br/>
(If this item is required by your standard setter, use of code 8 will result in an edit error.)
</td></tr><tr class='code-row'><td class='code-nbr'>9</td><td class='code-desc'>Not documented in medical record<br/>
AFP pretreatment interpretation not assessed or unknown if assessed
</td></tr><tr class='code-row'><td class='code-nbr'></td><td class='code-desc'> </td></tr></table></div><div class='content chap10-para'>Each Site-Specific Data Item (SSDI) applies only to selected primary sites, histologies, and years of diagnosis. Depending on applicability and standard-setter requirements, SSDIs may be left blank.</div><a name='3810'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>AFP PRETREATMENT LAB VALUE</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">3810</td><td style="text-align:center;">6</td><td style="text-align:center;"><a href='#sources'>NAACCR</a></td><td style="text-align:center;">2018</td><td style="text-align:center;">18</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1845 - 1850</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>AFP (Alpha Fetoprotein) Pretreatment Lab Value<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>afpPretreatmentLabValue</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>AFP (Alpha Fetoprotein) Pretreatment Lab Value is a nonspecific serum protein that generally is elevated in the setting of hepatocellular carcinoma (HCC). This data item pertains to the pre-treatment lab value.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>AFP (Alpha Fetoprotein) Pretreatment Lab Value is a Registry Data Collection Variable in AJCC. This data item was previously collected for Liver, CS SSF# 3.</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>0.0</td><td class='code-desc'>0.0 nanograms/milliliter (ng/ml); not detected </td></tr><tr class='code-row'><td class='code-nbr'>0.1-9999.9</td><td class='code-desc'>0.1-9999.9 ng/ml<br/>
(Exact value to nearest tenth of ng/ml)
</td></tr><tr class='code-row'><td class='code-nbr'>XXXX.1</td><td class='code-desc'>10,000.0 ng/ml or greater</td></tr><tr class='code-row'><td class='code-nbr'>XXXX.7</td><td class='code-desc'>Test ordered, results not in chart</td></tr><tr class='code-row'><td class='code-nbr'>XXXX.8</td><td class='code-desc'>Not applicable: Information not collected for this case<br/>
(If this item is required by your standard setter, use of code XXXX.8 will result in an edit error.)
</td></tr><tr class='code-row'><td class='code-nbr'>XXXX.9</td><td class='code-desc'>Not documented in medical record<br/>
AFP (Alpha Fetoprotein) Pretreatment Lab Value not assessed or unknown if assessed
</td></tr><tr class='code-row'><td class='code-nbr'></td><td class='code-desc'> </td></tr></table></div><div class='content chap10-para'>Each Site-Specific Data Item (SSDI) applies only to selected primary sites, histologies, and years of diagnosis. Depending on applicability and standard-setter requirements, SSDIs may be left blank. </div><a name='230'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>AGE AT DIAGNOSIS</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">230</td><td style="text-align:center;">3</td><td style="text-align:center;"><a href='#sources'>SEER/CoC</a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">223 - 225</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>ageAtDiagnosis</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Age of the patient at diagnosis in complete years. Different tumors for the same patient may have different values.</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>000</td><td class='code-desc'>Less than 1 year old; diagnosed in utero</td></tr><tr class='code-row'><td class='code-nbr'>001</td><td class='code-desc'>1 year old, but less than 2 years</td></tr><tr class='code-row'><td class='code-nbr'>002</td><td class='code-desc'>2 years old</td></tr><tr class='code-row'><td class='code-nbr' colspan='2'>...</td></tr><tr class='code-row'><td class='code-nbr'>101</td><td class='code-desc'>101 years old</td></tr><tr class='code-row'><td class='code-nbr' colspan='2'>...</td></tr><tr class='code-row'><td class='code-nbr'>120</td><td class='code-desc'>120 years old</td></tr><tr class='code-row'><td class='code-nbr'>999</td><td class='code-desc'>Unknown age</td></tr></table></div><a name='2156'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>AJCC API VERSION CURRENT</strong></td><td style="text-align:right;font-weight:bold;"><strong>New</strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">2156</td><td style="text-align:center;">8</td><td style="text-align:center;"><a href='#sources'>AJCC</a></td><td style="text-align:center;">2021</td><td style="text-align:center;">21</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1 - 8</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>ajccApiVersionCurrent</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'><div> This item indicates the version of the AJCC TNM API incorporated into the cancer registry software that created the record with TNM staging data in the 8th and later versions. It should be recorded the first time the AJCC Release ID (including a value of 08.01.00) is determined and should be updated each time the related input fields listed below are modified. If the registry software incorporates the AJCC API directly, the value is obtained from AJCC&#8217;s API.&nbsp; If the software instead incorporates AJCC&#8217;s Cancer Surveillance API, the value can be returned from there. The value indicates the most recent time at least one of the related input items listed below was modified.</div><div>&nbsp;</div>A valid value is required for all cases diagnosed 2018 or later that have values entered in the AJCC or related data items. Cases abstracted prior to implementation of this data item will be assigned a value <span style="background-color: #ffffff;">of</span><span style="background-color: #ffffff;"> 08.XX.XX</span><span style="background-color: #ffffff;"> d</span>uring the conversion to v21.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Over time the definitions and other content contained in the AJCC&#8217;s API may change. This value indicates the most recent release used to modify at least one of the related input items listed below.</div><div class='content chap10-para'>Codes</div><div class='content chap10-para'><em>Note:</em> This data item will be generated by registry software. Blank is allowable in the case that no AJCC or related input items are coded.</div><a name='2157'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>AJCC API VERSION ORIGINAL</strong></td><td style="text-align:right;font-weight:bold;"><strong>New</strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">2157</td><td style="text-align:center;">8</td><td style="text-align:center;"><a href='#sources'>AJCC</a></td><td style="text-align:center;">2021</td><td style="text-align:center;">21</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1 - 8</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>ajccApiVersionOriginal</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'><p class="MsoNormal" style="line-height: normal; margin-bottom: 0pt;"><span style="font-size:12.0pt;mso-ascii-font-family:Calibri;mso-fareast-font-family:
&quot;Times New Roman&quot;;mso-hansi-font-family:Calibri;mso-bidi-font-family:Calibri">This
item indicates the version of the AJCC API incorporated into the cancer
registry software that created the record with TNM stage data in the 8<sup>th</sup>
and later versions. It should be recorded the first time the AJCC ID (including
a value of 8) is determined. If the registry software incorporates the APCC API
directly, the value is obtained from AJCC&#8217;s API. If the software instead
incorporates AJCC&#8217;s Cancer Surveillance API, the value can be returned from
there. </span></p>



<p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal"><span style="font-size:12.0pt;mso-ascii-font-family:Calibri;mso-fareast-font-family:
&quot;Times New Roman&quot;;mso-hansi-font-family:Calibri;mso-bidi-font-family:Calibri">A
valid value is required for all cases diagnosed 2018 or later that have values
entered in the AJCC or related data items. Cases abstracted prior to
implementation of this data item will be assigned a value of 08.XX.XX during
the conversion to v21.</span></p>

<!--[if gte mso 9]><xml>
 <o:OfficeDocumentSettings>
  <o:AllowPNG/>
 </o:OfficeDocumentSettings>
</xml><![endif]--><!--[if gte mso 9]><xml>
 <w:WordDocument>
  <w:View>Normal</w:View>
  <w:Zoom>0</w:Zoom>
  <w:TrackMoves/>
  <w:TrackFormatting/>
  <w:DoNotShowComments/>
  <w:DoNotShowPropertyChanges/>
  <w:PunctuationKerning/>
  <w:ValidateAgainstSchemas/>
  <w:SaveIfXMLInvalid>false</w:SaveIfXMLInvalid>
  <w:IgnoreMixedContent>false</w:IgnoreMixedContent>
  <w:AlwaysShowPlaceholderText>false</w:AlwaysShowPlaceholderText>
  <w:DoNotPromoteQF/>
  <w:LidThemeOther>EN-US</w:LidThemeOther>
  <w:LidThemeAsian>X-NONE</w:LidThemeAsian>
  <w:LidThemeComplexScript>X-NONE</w:LidThemeComplexScript>
  <w:Compatibility>
   <w:BreakWrappedTables/>
   <w:SnapToGridInCell/>
   <w:WrapTextWithPunct/>
   <w:UseAsianBreakRules/>
   <w:DontGrowAutofit/>
   <w:SplitPgBreakAndParaMark/>
   <w:EnableOpenTypeKerning/>
   <w:DontFlipMirrorIndents/>
   <w:OverrideTableStyleHps/>
  </w:Compatibility>
  <m:mathPr>
   <m:mathFont m:val="Cambria Math" />
   <m:brkBin m:val="before" />
   <m:brkBinSub m:val="&#45;-" />
   <m:smallFrac m:val="off" />
   <m:dispDef/>
   <m:lMargin m:val="0" />
   <m:rMargin m:val="0" />
   <m:defJc m:val="centerGroup" />
   <m:wrapIndent m:val="1440" />
   <m:intLim m:val="subSup" />
   <m:naryLim m:val="undOvr" />
  </m:mathPr></w:WordDocument>
</xml><![endif]--><!--[if gte mso 9]><xml>
 <w:LatentStyles deflockedstate="false" defunhidewhenused="false" defsemihidden="false" defqformat="false" defpriority="99" latentstylecount="371">
  <w:LsdException locked="false" priority="0" qformat="true" name="Normal" />
  <w:LsdException locked="false" priority="9" qformat="true" name="heading 1" />
  <w:LsdException locked="false" priority="9" semihidden="true" unhidewhenused="true" qformat="true" name="heading 2" />
  <w:LsdException locked="false" priority="9" semihidden="true" unhidewhenused="true" qformat="true" name="heading 3" />
  <w:LsdException locked="false" priority="9" semihidden="true" unhidewhenused="true" qformat="true" name="heading 4" />
  <w:LsdException locked="false" priority="9" semihidden="true" unhidewhenused="true" qformat="true" name="heading 5" />
  <w:LsdException locked="false" priority="9" semihidden="true" unhidewhenused="true" qformat="true" name="heading 6" />
  <w:LsdException locked="false" priority="9" semihidden="true" unhidewhenused="true" qformat="true" name="heading 7" />
  <w:LsdException locked="false" priority="9" semihidden="true" unhidewhenused="true" qformat="true" name="heading 8" />
  <w:LsdException locked="false" priority="9" semihidden="true" unhidewhenused="true" qformat="true" name="heading 9" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="index 1" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="index 2" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="index 3" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="index 4" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="index 5" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="index 6" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="index 7" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="index 8" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="index 9" />
  <w:LsdException locked="false" priority="39" semihidden="true" unhidewhenused="true" name="toc 1" />
  <w:LsdException locked="false" priority="39" semihidden="true" unhidewhenused="true" name="toc 2" />
  <w:LsdException locked="false" priority="39" semihidden="true" unhidewhenused="true" name="toc 3" />
  <w:LsdException locked="false" priority="39" semihidden="true" unhidewhenused="true" name="toc 4" />
  <w:LsdException locked="false" priority="39" semihidden="true" unhidewhenused="true" name="toc 5" />
  <w:LsdException locked="false" priority="39" semihidden="true" unhidewhenused="true" name="toc 6" />
  <w:LsdException locked="false" priority="39" semihidden="true" unhidewhenused="true" name="toc 7" />
  <w:LsdException locked="false" priority="39" semihidden="true" unhidewhenused="true" name="toc 8" />
  <w:LsdException locked="false" priority="39" semihidden="true" unhidewhenused="true" name="toc 9" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="Normal Indent" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="footnote text" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="annotation text" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="header" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="footer" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="index heading" />
  <w:LsdException locked="false" priority="35" semihidden="true" unhidewhenused="true" qformat="true" name="caption" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="table of figures" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="envelope address" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="envelope return" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="footnote reference" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="annotation reference" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="line number" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="page number" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="endnote reference" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="endnote text" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="table of authorities" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="macro" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="toa heading" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="List" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="List Bullet" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="List Number" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="List 2" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="List 3" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="List 4" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="List 5" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="List Bullet 2" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="List Bullet 3" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="List Bullet 4" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="List Bullet 5" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="List Number 2" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="List Number 3" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="List Number 4" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="List Number 5" />
  <w:LsdException locked="false" priority="10" qformat="true" name="Title" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="Closing" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="Signature" />
  <w:LsdException locked="false" priority="1" semihidden="true" unhidewhenused="true" name="Default Paragraph Font" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="Body Text" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="Body Text Indent" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="List Continue" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="List Continue 2" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="List Continue 3" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="List Continue 4" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="List Continue 5" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="Message Header" />
  <w:LsdException locked="false" priority="11" qformat="true" name="Subtitle" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="Salutation" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="Date" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="Body Text First Indent" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="Body Text First Indent 2" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="Note Heading" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="Body Text 2" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="Body Text 3" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="Body Text Indent 2" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="Body Text Indent 3" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="Block Text" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="Hyperlink" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="FollowedHyperlink" />
  <w:LsdException locked="false" priority="22" qformat="true" name="Strong" />
  <w:LsdException locked="false" priority="20" qformat="true" name="Emphasis" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="Document Map" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="Plain Text" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="E-mail Signature" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="HTML Top of Form" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="HTML Bottom of Form" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="Normal (Web)" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="HTML Acronym" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="HTML Address" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="HTML Cite" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="HTML Code" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="HTML Definition" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="HTML Keyboard" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="HTML Preformatted" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="HTML Sample" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="HTML Typewriter" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="HTML Variable" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="Normal Table" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="annotation subject" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="No List" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="Outline List 1" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="Outline List 2" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="Outline List 3" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="Table Simple 1" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="Table Simple 2" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="Table Simple 3" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="Table Classic 1" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="Table Classic 2" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="Table Classic 3" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="Table Classic 4" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="Table Colorful 1" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="Table Colorful 2" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="Table Colorful 3" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="Table Columns 1" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="Table Columns 2" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="Table Columns 3" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="Table Columns 4" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="Table Columns 5" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="Table Grid 1" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="Table Grid 2" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="Table Grid 3" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="Table Grid 4" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="Table Grid 5" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="Table Grid 6" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="Table Grid 7" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="Table Grid 8" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="Table List 1" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="Table List 2" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="Table List 3" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="Table List 4" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="Table List 5" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="Table List 6" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="Table List 7" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="Table List 8" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="Table 3D effects 1" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="Table 3D effects 2" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="Table 3D effects 3" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="Table Contemporary" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="Table Elegant" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="Table Professional" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="Table Subtle 1" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="Table Subtle 2" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="Table Web 1" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="Table Web 2" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="Table Web 3" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="Balloon Text" />
  <w:LsdException locked="false" priority="39" name="Table Grid" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="Table Theme" />
  <w:LsdException locked="false" semihidden="true" name="Placeholder Text" />
  <w:LsdException locked="false" priority="1" qformat="true" name="No Spacing" />
  <w:LsdException locked="false" priority="60" name="Light Shading" />
  <w:LsdException locked="false" priority="61" name="Light List" />
  <w:LsdException locked="false" priority="62" name="Light Grid" />
  <w:LsdException locked="false" priority="63" name="Medium Shading 1" />
  <w:LsdException locked="false" priority="64" name="Medium Shading 2" />
  <w:LsdException locked="false" priority="65" name="Medium List 1" />
  <w:LsdException locked="false" priority="66" name="Medium List 2" />
  <w:LsdException locked="false" priority="67" name="Medium Grid 1" />
  <w:LsdException locked="false" priority="68" name="Medium Grid 2" />
  <w:LsdException locked="false" priority="69" name="Medium Grid 3" />
  <w:LsdException locked="false" priority="70" name="Dark List" />
  <w:LsdException locked="false" priority="71" name="Colorful Shading" />
  <w:LsdException locked="false" priority="72" name="Colorful List" />
  <w:LsdException locked="false" priority="73" name="Colorful Grid" />
  <w:LsdException locked="false" priority="60" name="Light Shading Accent 1" />
  <w:LsdException locked="false" priority="61" name="Light List Accent 1" />
  <w:LsdException locked="false" priority="62" name="Light Grid Accent 1" />
  <w:LsdException locked="false" priority="63" name="Medium Shading 1 Accent 1" />
  <w:LsdException locked="false" priority="64" name="Medium Shading 2 Accent 1" />
  <w:LsdException locked="false" priority="65" name="Medium List 1 Accent 1" />
  <w:LsdException locked="false" semihidden="true" name="Revision" />
  <w:LsdException locked="false" priority="34" qformat="true" name="List Paragraph" />
  <w:LsdException locked="false" priority="29" qformat="true" name="Quote" />
  <w:LsdException locked="false" priority="30" qformat="true" name="Intense Quote" />
  <w:LsdException locked="false" priority="66" name="Medium List 2 Accent 1" />
  <w:LsdException locked="false" priority="67" name="Medium Grid 1 Accent 1" />
  <w:LsdException locked="false" priority="68" name="Medium Grid 2 Accent 1" />
  <w:LsdException locked="false" priority="69" name="Medium Grid 3 Accent 1" />
  <w:LsdException locked="false" priority="70" name="Dark List Accent 1" />
  <w:LsdException locked="false" priority="71" name="Colorful Shading Accent 1" />
  <w:LsdException locked="false" priority="72" name="Colorful List Accent 1" />
  <w:LsdException locked="false" priority="73" name="Colorful Grid Accent 1" />
  <w:LsdException locked="false" priority="60" name="Light Shading Accent 2" />
  <w:LsdException locked="false" priority="61" name="Light List Accent 2" />
  <w:LsdException locked="false" priority="62" name="Light Grid Accent 2" />
  <w:LsdException locked="false" priority="63" name="Medium Shading 1 Accent 2" />
  <w:LsdException locked="false" priority="64" name="Medium Shading 2 Accent 2" />
  <w:LsdException locked="false" priority="65" name="Medium List 1 Accent 2" />
  <w:LsdException locked="false" priority="66" name="Medium List 2 Accent 2" />
  <w:LsdException locked="false" priority="67" name="Medium Grid 1 Accent 2" />
  <w:LsdException locked="false" priority="68" name="Medium Grid 2 Accent 2" />
  <w:LsdException locked="false" priority="69" name="Medium Grid 3 Accent 2" />
  <w:LsdException locked="false" priority="70" name="Dark List Accent 2" />
  <w:LsdException locked="false" priority="71" name="Colorful Shading Accent 2" />
  <w:LsdException locked="false" priority="72" name="Colorful List Accent 2" />
  <w:LsdException locked="false" priority="73" name="Colorful Grid Accent 2" />
  <w:LsdException locked="false" priority="60" name="Light Shading Accent 3" />
  <w:LsdException locked="false" priority="61" name="Light List Accent 3" />
  <w:LsdException locked="false" priority="62" name="Light Grid Accent 3" />
  <w:LsdException locked="false" priority="63" name="Medium Shading 1 Accent 3" />
  <w:LsdException locked="false" priority="64" name="Medium Shading 2 Accent 3" />
  <w:LsdException locked="false" priority="65" name="Medium List 1 Accent 3" />
  <w:LsdException locked="false" priority="66" name="Medium List 2 Accent 3" />
  <w:LsdException locked="false" priority="67" name="Medium Grid 1 Accent 3" />
  <w:LsdException locked="false" priority="68" name="Medium Grid 2 Accent 3" />
  <w:LsdException locked="false" priority="69" name="Medium Grid 3 Accent 3" />
  <w:LsdException locked="false" priority="70" name="Dark List Accent 3" />
  <w:LsdException locked="false" priority="71" name="Colorful Shading Accent 3" />
  <w:LsdException locked="false" priority="72" name="Colorful List Accent 3" />
  <w:LsdException locked="false" priority="73" name="Colorful Grid Accent 3" />
  <w:LsdException locked="false" priority="60" name="Light Shading Accent 4" />
  <w:LsdException locked="false" priority="61" name="Light List Accent 4" />
  <w:LsdException locked="false" priority="62" name="Light Grid Accent 4" />
  <w:LsdException locked="false" priority="63" name="Medium Shading 1 Accent 4" />
  <w:LsdException locked="false" priority="64" name="Medium Shading 2 Accent 4" />
  <w:LsdException locked="false" priority="65" name="Medium List 1 Accent 4" />
  <w:LsdException locked="false" priority="66" name="Medium List 2 Accent 4" />
  <w:LsdException locked="false" priority="67" name="Medium Grid 1 Accent 4" />
  <w:LsdException locked="false" priority="68" name="Medium Grid 2 Accent 4" />
  <w:LsdException locked="false" priority="69" name="Medium Grid 3 Accent 4" />
  <w:LsdException locked="false" priority="70" name="Dark List Accent 4" />
  <w:LsdException locked="false" priority="71" name="Colorful Shading Accent 4" />
  <w:LsdException locked="false" priority="72" name="Colorful List Accent 4" />
  <w:LsdException locked="false" priority="73" name="Colorful Grid Accent 4" />
  <w:LsdException locked="false" priority="60" name="Light Shading Accent 5" />
  <w:LsdException locked="false" priority="61" name="Light List Accent 5" />
  <w:LsdException locked="false" priority="62" name="Light Grid Accent 5" />
  <w:LsdException locked="false" priority="63" name="Medium Shading 1 Accent 5" />
  <w:LsdException locked="false" priority="64" name="Medium Shading 2 Accent 5" />
  <w:LsdException locked="false" priority="65" name="Medium List 1 Accent 5" />
  <w:LsdException locked="false" priority="66" name="Medium List 2 Accent 5" />
  <w:LsdException locked="false" priority="67" name="Medium Grid 1 Accent 5" />
  <w:LsdException locked="false" priority="68" name="Medium Grid 2 Accent 5" />
  <w:LsdException locked="false" priority="69" name="Medium Grid 3 Accent 5" />
  <w:LsdException locked="false" priority="70" name="Dark List Accent 5" />
  <w:LsdException locked="false" priority="71" name="Colorful Shading Accent 5" />
  <w:LsdException locked="false" priority="72" name="Colorful List Accent 5" />
  <w:LsdException locked="false" priority="73" name="Colorful Grid Accent 5" />
  <w:LsdException locked="false" priority="60" name="Light Shading Accent 6" />
  <w:LsdException locked="false" priority="61" name="Light List Accent 6" />
  <w:LsdException locked="false" priority="62" name="Light Grid Accent 6" />
  <w:LsdException locked="false" priority="63" name="Medium Shading 1 Accent 6" />
  <w:LsdException locked="false" priority="64" name="Medium Shading 2 Accent 6" />
  <w:LsdException locked="false" priority="65" name="Medium List 1 Accent 6" />
  <w:LsdException locked="false" priority="66" name="Medium List 2 Accent 6" />
  <w:LsdException locked="false" priority="67" name="Medium Grid 1 Accent 6" />
  <w:LsdException locked="false" priority="68" name="Medium Grid 2 Accent 6" />
  <w:LsdException locked="false" priority="69" name="Medium Grid 3 Accent 6" />
  <w:LsdException locked="false" priority="70" name="Dark List Accent 6" />
  <w:LsdException locked="false" priority="71" name="Colorful Shading Accent 6" />
  <w:LsdException locked="false" priority="72" name="Colorful List Accent 6" />
  <w:LsdException locked="false" priority="73" name="Colorful Grid Accent 6" />
  <w:LsdException locked="false" priority="19" qformat="true" name="Subtle Emphasis" />
  <w:LsdException locked="false" priority="21" qformat="true" name="Intense Emphasis" />
  <w:LsdException locked="false" priority="31" qformat="true" name="Subtle Reference" />
  <w:LsdException locked="false" priority="32" qformat="true" name="Intense Reference" />
  <w:LsdException locked="false" priority="33" qformat="true" name="Book Title" />
  <w:LsdException locked="false" priority="37" semihidden="true" unhidewhenused="true" name="Bibliography" />
  <w:LsdException locked="false" priority="39" semihidden="true" unhidewhenused="true" qformat="true" name="TOC Heading" />
  <w:LsdException locked="false" priority="41" name="Plain Table 1" />
  <w:LsdException locked="false" priority="42" name="Plain Table 2" />
  <w:LsdException locked="false" priority="43" name="Plain Table 3" />
  <w:LsdException locked="false" priority="44" name="Plain Table 4" />
  <w:LsdException locked="false" priority="45" name="Plain Table 5" />
  <w:LsdException locked="false" priority="40" name="Grid Table Light" />
  <w:LsdException locked="false" priority="46" name="Grid Table 1 Light" />
  <w:LsdException locked="false" priority="47" name="Grid Table 2" />
  <w:LsdException locked="false" priority="48" name="Grid Table 3" />
  <w:LsdException locked="false" priority="49" name="Grid Table 4" />
  <w:LsdException locked="false" priority="50" name="Grid Table 5 Dark" />
  <w:LsdException locked="false" priority="51" name="Grid Table 6 Colorful" />
  <w:LsdException locked="false" priority="52" name="Grid Table 7 Colorful" />
  <w:LsdException locked="false" priority="46" name="Grid Table 1 Light Accent 1" />
  <w:LsdException locked="false" priority="47" name="Grid Table 2 Accent 1" />
  <w:LsdException locked="false" priority="48" name="Grid Table 3 Accent 1" />
  <w:LsdException locked="false" priority="49" name="Grid Table 4 Accent 1" />
  <w:LsdException locked="false" priority="50" name="Grid Table 5 Dark Accent 1" />
  <w:LsdException locked="false" priority="51" name="Grid Table 6 Colorful Accent 1" />
  <w:LsdException locked="false" priority="52" name="Grid Table 7 Colorful Accent 1" />
  <w:LsdException locked="false" priority="46" name="Grid Table 1 Light Accent 2" />
  <w:LsdException locked="false" priority="47" name="Grid Table 2 Accent 2" />
  <w:LsdException locked="false" priority="48" name="Grid Table 3 Accent 2" />
  <w:LsdException locked="false" priority="49" name="Grid Table 4 Accent 2" />
  <w:LsdException locked="false" priority="50" name="Grid Table 5 Dark Accent 2" />
  <w:LsdException locked="false" priority="51" name="Grid Table 6 Colorful Accent 2" />
  <w:LsdException locked="false" priority="52" name="Grid Table 7 Colorful Accent 2" />
  <w:LsdException locked="false" priority="46" name="Grid Table 1 Light Accent 3" />
  <w:LsdException locked="false" priority="47" name="Grid Table 2 Accent 3" />
  <w:LsdException locked="false" priority="48" name="Grid Table 3 Accent 3" />
  <w:LsdException locked="false" priority="49" name="Grid Table 4 Accent 3" />
  <w:LsdException locked="false" priority="50" name="Grid Table 5 Dark Accent 3" />
  <w:LsdException locked="false" priority="51" name="Grid Table 6 Colorful Accent 3" />
  <w:LsdException locked="false" priority="52" name="Grid Table 7 Colorful Accent 3" />
  <w:LsdException locked="false" priority="46" name="Grid Table 1 Light Accent 4" />
  <w:LsdException locked="false" priority="47" name="Grid Table 2 Accent 4" />
  <w:LsdException locked="false" priority="48" name="Grid Table 3 Accent 4" />
  <w:LsdException locked="false" priority="49" name="Grid Table 4 Accent 4" />
  <w:LsdException locked="false" priority="50" name="Grid Table 5 Dark Accent 4" />
  <w:LsdException locked="false" priority="51" name="Grid Table 6 Colorful Accent 4" />
  <w:LsdException locked="false" priority="52" name="Grid Table 7 Colorful Accent 4" />
  <w:LsdException locked="false" priority="46" name="Grid Table 1 Light Accent 5" />
  <w:LsdException locked="false" priority="47" name="Grid Table 2 Accent 5" />
  <w:LsdException locked="false" priority="48" name="Grid Table 3 Accent 5" />
  <w:LsdException locked="false" priority="49" name="Grid Table 4 Accent 5" />
  <w:LsdException locked="false" priority="50" name="Grid Table 5 Dark Accent 5" />
  <w:LsdException locked="false" priority="51" name="Grid Table 6 Colorful Accent 5" />
  <w:LsdException locked="false" priority="52" name="Grid Table 7 Colorful Accent 5" />
  <w:LsdException locked="false" priority="46" name="Grid Table 1 Light Accent 6" />
  <w:LsdException locked="false" priority="47" name="Grid Table 2 Accent 6" />
  <w:LsdException locked="false" priority="48" name="Grid Table 3 Accent 6" />
  <w:LsdException locked="false" priority="49" name="Grid Table 4 Accent 6" />
  <w:LsdException locked="false" priority="50" name="Grid Table 5 Dark Accent 6" />
  <w:LsdException locked="false" priority="51" name="Grid Table 6 Colorful Accent 6" />
  <w:LsdException locked="false" priority="52" name="Grid Table 7 Colorful Accent 6" />
  <w:LsdException locked="false" priority="46" name="List Table 1 Light" />
  <w:LsdException locked="false" priority="47" name="List Table 2" />
  <w:LsdException locked="false" priority="48" name="List Table 3" />
  <w:LsdException locked="false" priority="49" name="List Table 4" />
  <w:LsdException locked="false" priority="50" name="List Table 5 Dark" />
  <w:LsdException locked="false" priority="51" name="List Table 6 Colorful" />
  <w:LsdException locked="false" priority="52" name="List Table 7 Colorful" />
  <w:LsdException locked="false" priority="46" name="List Table 1 Light Accent 1" />
  <w:LsdException locked="false" priority="47" name="List Table 2 Accent 1" />
  <w:LsdException locked="false" priority="48" name="List Table 3 Accent 1" />
  <w:LsdException locked="false" priority="49" name="List Table 4 Accent 1" />
  <w:LsdException locked="false" priority="50" name="List Table 5 Dark Accent 1" />
  <w:LsdException locked="false" priority="51" name="List Table 6 Colorful Accent 1" />
  <w:LsdException locked="false" priority="52" name="List Table 7 Colorful Accent 1" />
  <w:LsdException locked="false" priority="46" name="List Table 1 Light Accent 2" />
  <w:LsdException locked="false" priority="47" name="List Table 2 Accent 2" />
  <w:LsdException locked="false" priority="48" name="List Table 3 Accent 2" />
  <w:LsdException locked="false" priority="49" name="List Table 4 Accent 2" />
  <w:LsdException locked="false" priority="50" name="List Table 5 Dark Accent 2" />
  <w:LsdException locked="false" priority="51" name="List Table 6 Colorful Accent 2" />
  <w:LsdException locked="false" priority="52" name="List Table 7 Colorful Accent 2" />
  <w:LsdException locked="false" priority="46" name="List Table 1 Light Accent 3" />
  <w:LsdException locked="false" priority="47" name="List Table 2 Accent 3" />
  <w:LsdException locked="false" priority="48" name="List Table 3 Accent 3" />
  <w:LsdException locked="false" priority="49" name="List Table 4 Accent 3" />
  <w:LsdException locked="false" priority="50" name="List Table 5 Dark Accent 3" />
  <w:LsdException locked="false" priority="51" name="List Table 6 Colorful Accent 3" />
  <w:LsdException locked="false" priority="52" name="List Table 7 Colorful Accent 3" />
  <w:LsdException locked="false" priority="46" name="List Table 1 Light Accent 4" />
  <w:LsdException locked="false" priority="47" name="List Table 2 Accent 4" />
  <w:LsdException locked="false" priority="48" name="List Table 3 Accent 4" />
  <w:LsdException locked="false" priority="49" name="List Table 4 Accent 4" />
  <w:LsdException locked="false" priority="50" name="List Table 5 Dark Accent 4" />
  <w:LsdException locked="false" priority="51" name="List Table 6 Colorful Accent 4" />
  <w:LsdException locked="false" priority="52" name="List Table 7 Colorful Accent 4" />
  <w:LsdException locked="false" priority="46" name="List Table 1 Light Accent 5" />
  <w:LsdException locked="false" priority="47" name="List Table 2 Accent 5" />
  <w:LsdException locked="false" priority="48" name="List Table 3 Accent 5" />
  <w:LsdException locked="false" priority="49" name="List Table 4 Accent 5" />
  <w:LsdException locked="false" priority="50" name="List Table 5 Dark Accent 5" />
  <w:LsdException locked="false" priority="51" name="List Table 6 Colorful Accent 5" />
  <w:LsdException locked="false" priority="52" name="List Table 7 Colorful Accent 5" />
  <w:LsdException locked="false" priority="46" name="List Table 1 Light Accent 6" />
  <w:LsdException locked="false" priority="47" name="List Table 2 Accent 6" />
  <w:LsdException locked="false" priority="48" name="List Table 3 Accent 6" />
  <w:LsdException locked="false" priority="49" name="List Table 4 Accent 6" />
  <w:LsdException locked="false" priority="50" name="List Table 5 Dark Accent 6" />
  <w:LsdException locked="false" priority="51" name="List Table 6 Colorful Accent 6" />
  <w:LsdException locked="false" priority="52" name="List Table 7 Colorful Accent 6" />
 </w:LatentStyles>
</xml><![endif]--><!--[if gte mso 10]>

 /* Style Definitions */
 table.MsoNormalTable
	{mso-style-name:"Table Normal";
	mso-tstyle-rowband-size:0;
	mso-tstyle-colband-size:0;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-parent:"";
	mso-padding-alt:0in 5.4pt 0in 5.4pt;
	mso-para-margin-top:0in;
	mso-para-margin-right:0in;
	mso-para-margin-bottom:8.0pt;
	mso-para-margin-left:0in;
	line-height:107%;
	mso-pagination:widow-orphan;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:minor-latin;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:minor-bidi;}

<![endif]--></div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Over time the definitions and other content contained in the AJCC&#8217;s API may change. This item identifies the original API content used to code the TNM data.</div><div class='content chap10-para'>Codes</div><div class='content chap10-para'>Blank
is allowable in the case that no AJCC or related input items are coded.








<!--[if gte mso 9]><xml>
 <o:OfficeDocumentSettings>
  <o:AllowPNG/>
 </o:OfficeDocumentSettings>
</xml><![endif]-->
<!--[if gte mso 9]><xml>
 <w:WordDocument>
  <w:View>Normal</w:View>
  <w:Zoom>0</w:Zoom>
  <w:TrackMoves/>
  <w:TrackFormatting/>
  <w:DoNotShowComments/>
  <w:DoNotShowPropertyChanges/>
  <w:PunctuationKerning/>
  <w:ValidateAgainstSchemas/>
  <w:SaveIfXMLInvalid>false</w:SaveIfXMLInvalid>
  <w:IgnoreMixedContent>false</w:IgnoreMixedContent>
  <w:AlwaysShowPlaceholderText>false</w:AlwaysShowPlaceholderText>
  <w:DoNotPromoteQF/>
  <w:LidThemeOther>EN-US</w:LidThemeOther>
  <w:LidThemeAsian>X-NONE</w:LidThemeAsian>
  <w:LidThemeComplexScript>X-NONE</w:LidThemeComplexScript>
  <w:Compatibility>
   <w:BreakWrappedTables/>
   <w:SnapToGridInCell/>
   <w:WrapTextWithPunct/>
   <w:UseAsianBreakRules/>
   <w:DontGrowAutofit/>
   <w:SplitPgBreakAndParaMark/>
   <w:EnableOpenTypeKerning/>
   <w:DontFlipMirrorIndents/>
   <w:OverrideTableStyleHps/>
  </w:Compatibility>
  <m:mathPr>
   <m:mathFont m:val="Cambria Math" />
   <m:brkBin m:val="before" />
   <m:brkBinSub m:val="&#45;-" />
   <m:smallFrac m:val="off" />
   <m:dispDef/>
   <m:lMargin m:val="0" />
   <m:rMargin m:val="0" />
   <m:defJc m:val="centerGroup" />
   <m:wrapIndent m:val="1440" />
   <m:intLim m:val="subSup" />
   <m:naryLim m:val="undOvr" />
  </m:mathPr></w:WordDocument>
</xml><![endif]-->
<!--[if gte mso 9]><xml>
 <w:LatentStyles deflockedstate="false" defunhidewhenused="false" defsemihidden="false" defqformat="false" defpriority="99" latentstylecount="371">
  <w:LsdException locked="false" priority="0" qformat="true" name="Normal" />
  <w:LsdException locked="false" priority="9" qformat="true" name="heading 1" />
  <w:LsdException locked="false" priority="9" semihidden="true" unhidewhenused="true" qformat="true" name="heading 2" />
  <w:LsdException locked="false" priority="9" semihidden="true" unhidewhenused="true" qformat="true" name="heading 3" />
  <w:LsdException locked="false" priority="9" semihidden="true" unhidewhenused="true" qformat="true" name="heading 4" />
  <w:LsdException locked="false" priority="9" semihidden="true" unhidewhenused="true" qformat="true" name="heading 5" />
  <w:LsdException locked="false" priority="9" semihidden="true" unhidewhenused="true" qformat="true" name="heading 6" />
  <w:LsdException locked="false" priority="9" semihidden="true" unhidewhenused="true" qformat="true" name="heading 7" />
  <w:LsdException locked="false" priority="9" semihidden="true" unhidewhenused="true" qformat="true" name="heading 8" />
  <w:LsdException locked="false" priority="9" semihidden="true" unhidewhenused="true" qformat="true" name="heading 9" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="index 1" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="index 2" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="index 3" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="index 4" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="index 5" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="index 6" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="index 7" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="index 8" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="index 9" />
  <w:LsdException locked="false" priority="39" semihidden="true" unhidewhenused="true" name="toc 1" />
  <w:LsdException locked="false" priority="39" semihidden="true" unhidewhenused="true" name="toc 2" />
  <w:LsdException locked="false" priority="39" semihidden="true" unhidewhenused="true" name="toc 3" />
  <w:LsdException locked="false" priority="39" semihidden="true" unhidewhenused="true" name="toc 4" />
  <w:LsdException locked="false" priority="39" semihidden="true" unhidewhenused="true" name="toc 5" />
  <w:LsdException locked="false" priority="39" semihidden="true" unhidewhenused="true" name="toc 6" />
  <w:LsdException locked="false" priority="39" semihidden="true" unhidewhenused="true" name="toc 7" />
  <w:LsdException locked="false" priority="39" semihidden="true" unhidewhenused="true" name="toc 8" />
  <w:LsdException locked="false" priority="39" semihidden="true" unhidewhenused="true" name="toc 9" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="Normal Indent" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="footnote text" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="annotation text" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="header" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="footer" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="index heading" />
  <w:LsdException locked="false" priority="35" semihidden="true" unhidewhenused="true" qformat="true" name="caption" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="table of figures" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="envelope address" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="envelope return" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="footnote reference" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="annotation reference" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="line number" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="page number" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="endnote reference" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="endnote text" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="table of authorities" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="macro" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="toa heading" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="List" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="List Bullet" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="List Number" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="List 2" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="List 3" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="List 4" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="List 5" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="List Bullet 2" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="List Bullet 3" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="List Bullet 4" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="List Bullet 5" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="List Number 2" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="List Number 3" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="List Number 4" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="List Number 5" />
  <w:LsdException locked="false" priority="10" qformat="true" name="Title" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="Closing" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="Signature" />
  <w:LsdException locked="false" priority="1" semihidden="true" unhidewhenused="true" name="Default Paragraph Font" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="Body Text" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="Body Text Indent" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="List Continue" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="List Continue 2" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="List Continue 3" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="List Continue 4" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="List Continue 5" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="Message Header" />
  <w:LsdException locked="false" priority="11" qformat="true" name="Subtitle" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="Salutation" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="Date" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="Body Text First Indent" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="Body Text First Indent 2" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="Note Heading" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="Body Text 2" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="Body Text 3" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="Body Text Indent 2" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="Body Text Indent 3" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="Block Text" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="Hyperlink" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="FollowedHyperlink" />
  <w:LsdException locked="false" priority="22" qformat="true" name="Strong" />
  <w:LsdException locked="false" priority="20" qformat="true" name="Emphasis" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="Document Map" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="Plain Text" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="E-mail Signature" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="HTML Top of Form" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="HTML Bottom of Form" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="Normal (Web)" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="HTML Acronym" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="HTML Address" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="HTML Cite" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="HTML Code" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="HTML Definition" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="HTML Keyboard" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="HTML Preformatted" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="HTML Sample" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="HTML Typewriter" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="HTML Variable" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="Normal Table" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="annotation subject" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="No List" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="Outline List 1" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="Outline List 2" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="Outline List 3" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="Table Simple 1" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="Table Simple 2" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="Table Simple 3" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="Table Classic 1" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="Table Classic 2" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="Table Classic 3" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="Table Classic 4" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="Table Colorful 1" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="Table Colorful 2" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="Table Colorful 3" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="Table Columns 1" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="Table Columns 2" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="Table Columns 3" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="Table Columns 4" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="Table Columns 5" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="Table Grid 1" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="Table Grid 2" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="Table Grid 3" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="Table Grid 4" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="Table Grid 5" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="Table Grid 6" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="Table Grid 7" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="Table Grid 8" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="Table List 1" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="Table List 2" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="Table List 3" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="Table List 4" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="Table List 5" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="Table List 6" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="Table List 7" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="Table List 8" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="Table 3D effects 1" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="Table 3D effects 2" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="Table 3D effects 3" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="Table Contemporary" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="Table Elegant" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="Table Professional" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="Table Subtle 1" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="Table Subtle 2" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="Table Web 1" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="Table Web 2" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="Table Web 3" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="Balloon Text" />
  <w:LsdException locked="false" priority="39" name="Table Grid" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="Table Theme" />
  <w:LsdException locked="false" semihidden="true" name="Placeholder Text" />
  <w:LsdException locked="false" priority="1" qformat="true" name="No Spacing" />
  <w:LsdException locked="false" priority="60" name="Light Shading" />
  <w:LsdException locked="false" priority="61" name="Light List" />
  <w:LsdException locked="false" priority="62" name="Light Grid" />
  <w:LsdException locked="false" priority="63" name="Medium Shading 1" />
  <w:LsdException locked="false" priority="64" name="Medium Shading 2" />
  <w:LsdException locked="false" priority="65" name="Medium List 1" />
  <w:LsdException locked="false" priority="66" name="Medium List 2" />
  <w:LsdException locked="false" priority="67" name="Medium Grid 1" />
  <w:LsdException locked="false" priority="68" name="Medium Grid 2" />
  <w:LsdException locked="false" priority="69" name="Medium Grid 3" />
  <w:LsdException locked="false" priority="70" name="Dark List" />
  <w:LsdException locked="false" priority="71" name="Colorful Shading" />
  <w:LsdException locked="false" priority="72" name="Colorful List" />
  <w:LsdException locked="false" priority="73" name="Colorful Grid" />
  <w:LsdException locked="false" priority="60" name="Light Shading Accent 1" />
  <w:LsdException locked="false" priority="61" name="Light List Accent 1" />
  <w:LsdException locked="false" priority="62" name="Light Grid Accent 1" />
  <w:LsdException locked="false" priority="63" name="Medium Shading 1 Accent 1" />
  <w:LsdException locked="false" priority="64" name="Medium Shading 2 Accent 1" />
  <w:LsdException locked="false" priority="65" name="Medium List 1 Accent 1" />
  <w:LsdException locked="false" semihidden="true" name="Revision" />
  <w:LsdException locked="false" priority="34" qformat="true" name="List Paragraph" />
  <w:LsdException locked="false" priority="29" qformat="true" name="Quote" />
  <w:LsdException locked="false" priority="30" qformat="true" name="Intense Quote" />
  <w:LsdException locked="false" priority="66" name="Medium List 2 Accent 1" />
  <w:LsdException locked="false" priority="67" name="Medium Grid 1 Accent 1" />
  <w:LsdException locked="false" priority="68" name="Medium Grid 2 Accent 1" />
  <w:LsdException locked="false" priority="69" name="Medium Grid 3 Accent 1" />
  <w:LsdException locked="false" priority="70" name="Dark List Accent 1" />
  <w:LsdException locked="false" priority="71" name="Colorful Shading Accent 1" />
  <w:LsdException locked="false" priority="72" name="Colorful List Accent 1" />
  <w:LsdException locked="false" priority="73" name="Colorful Grid Accent 1" />
  <w:LsdException locked="false" priority="60" name="Light Shading Accent 2" />
  <w:LsdException locked="false" priority="61" name="Light List Accent 2" />
  <w:LsdException locked="false" priority="62" name="Light Grid Accent 2" />
  <w:LsdException locked="false" priority="63" name="Medium Shading 1 Accent 2" />
  <w:LsdException locked="false" priority="64" name="Medium Shading 2 Accent 2" />
  <w:LsdException locked="false" priority="65" name="Medium List 1 Accent 2" />
  <w:LsdException locked="false" priority="66" name="Medium List 2 Accent 2" />
  <w:LsdException locked="false" priority="67" name="Medium Grid 1 Accent 2" />
  <w:LsdException locked="false" priority="68" name="Medium Grid 2 Accent 2" />
  <w:LsdException locked="false" priority="69" name="Medium Grid 3 Accent 2" />
  <w:LsdException locked="false" priority="70" name="Dark List Accent 2" />
  <w:LsdException locked="false" priority="71" name="Colorful Shading Accent 2" />
  <w:LsdException locked="false" priority="72" name="Colorful List Accent 2" />
  <w:LsdException locked="false" priority="73" name="Colorful Grid Accent 2" />
  <w:LsdException locked="false" priority="60" name="Light Shading Accent 3" />
  <w:LsdException locked="false" priority="61" name="Light List Accent 3" />
  <w:LsdException locked="false" priority="62" name="Light Grid Accent 3" />
  <w:LsdException locked="false" priority="63" name="Medium Shading 1 Accent 3" />
  <w:LsdException locked="false" priority="64" name="Medium Shading 2 Accent 3" />
  <w:LsdException locked="false" priority="65" name="Medium List 1 Accent 3" />
  <w:LsdException locked="false" priority="66" name="Medium List 2 Accent 3" />
  <w:LsdException locked="false" priority="67" name="Medium Grid 1 Accent 3" />
  <w:LsdException locked="false" priority="68" name="Medium Grid 2 Accent 3" />
  <w:LsdException locked="false" priority="69" name="Medium Grid 3 Accent 3" />
  <w:LsdException locked="false" priority="70" name="Dark List Accent 3" />
  <w:LsdException locked="false" priority="71" name="Colorful Shading Accent 3" />
  <w:LsdException locked="false" priority="72" name="Colorful List Accent 3" />
  <w:LsdException locked="false" priority="73" name="Colorful Grid Accent 3" />
  <w:LsdException locked="false" priority="60" name="Light Shading Accent 4" />
  <w:LsdException locked="false" priority="61" name="Light List Accent 4" />
  <w:LsdException locked="false" priority="62" name="Light Grid Accent 4" />
  <w:LsdException locked="false" priority="63" name="Medium Shading 1 Accent 4" />
  <w:LsdException locked="false" priority="64" name="Medium Shading 2 Accent 4" />
  <w:LsdException locked="false" priority="65" name="Medium List 1 Accent 4" />
  <w:LsdException locked="false" priority="66" name="Medium List 2 Accent 4" />
  <w:LsdException locked="false" priority="67" name="Medium Grid 1 Accent 4" />
  <w:LsdException locked="false" priority="68" name="Medium Grid 2 Accent 4" />
  <w:LsdException locked="false" priority="69" name="Medium Grid 3 Accent 4" />
  <w:LsdException locked="false" priority="70" name="Dark List Accent 4" />
  <w:LsdException locked="false" priority="71" name="Colorful Shading Accent 4" />
  <w:LsdException locked="false" priority="72" name="Colorful List Accent 4" />
  <w:LsdException locked="false" priority="73" name="Colorful Grid Accent 4" />
  <w:LsdException locked="false" priority="60" name="Light Shading Accent 5" />
  <w:LsdException locked="false" priority="61" name="Light List Accent 5" />
  <w:LsdException locked="false" priority="62" name="Light Grid Accent 5" />
  <w:LsdException locked="false" priority="63" name="Medium Shading 1 Accent 5" />
  <w:LsdException locked="false" priority="64" name="Medium Shading 2 Accent 5" />
  <w:LsdException locked="false" priority="65" name="Medium List 1 Accent 5" />
  <w:LsdException locked="false" priority="66" name="Medium List 2 Accent 5" />
  <w:LsdException locked="false" priority="67" name="Medium Grid 1 Accent 5" />
  <w:LsdException locked="false" priority="68" name="Medium Grid 2 Accent 5" />
  <w:LsdException locked="false" priority="69" name="Medium Grid 3 Accent 5" />
  <w:LsdException locked="false" priority="70" name="Dark List Accent 5" />
  <w:LsdException locked="false" priority="71" name="Colorful Shading Accent 5" />
  <w:LsdException locked="false" priority="72" name="Colorful List Accent 5" />
  <w:LsdException locked="false" priority="73" name="Colorful Grid Accent 5" />
  <w:LsdException locked="false" priority="60" name="Light Shading Accent 6" />
  <w:LsdException locked="false" priority="61" name="Light List Accent 6" />
  <w:LsdException locked="false" priority="62" name="Light Grid Accent 6" />
  <w:LsdException locked="false" priority="63" name="Medium Shading 1 Accent 6" />
  <w:LsdException locked="false" priority="64" name="Medium Shading 2 Accent 6" />
  <w:LsdException locked="false" priority="65" name="Medium List 1 Accent 6" />
  <w:LsdException locked="false" priority="66" name="Medium List 2 Accent 6" />
  <w:LsdException locked="false" priority="67" name="Medium Grid 1 Accent 6" />
  <w:LsdException locked="false" priority="68" name="Medium Grid 2 Accent 6" />
  <w:LsdException locked="false" priority="69" name="Medium Grid 3 Accent 6" />
  <w:LsdException locked="false" priority="70" name="Dark List Accent 6" />
  <w:LsdException locked="false" priority="71" name="Colorful Shading Accent 6" />
  <w:LsdException locked="false" priority="72" name="Colorful List Accent 6" />
  <w:LsdException locked="false" priority="73" name="Colorful Grid Accent 6" />
  <w:LsdException locked="false" priority="19" qformat="true" name="Subtle Emphasis" />
  <w:LsdException locked="false" priority="21" qformat="true" name="Intense Emphasis" />
  <w:LsdException locked="false" priority="31" qformat="true" name="Subtle Reference" />
  <w:LsdException locked="false" priority="32" qformat="true" name="Intense Reference" />
  <w:LsdException locked="false" priority="33" qformat="true" name="Book Title" />
  <w:LsdException locked="false" priority="37" semihidden="true" unhidewhenused="true" name="Bibliography" />
  <w:LsdException locked="false" priority="39" semihidden="true" unhidewhenused="true" qformat="true" name="TOC Heading" />
  <w:LsdException locked="false" priority="41" name="Plain Table 1" />
  <w:LsdException locked="false" priority="42" name="Plain Table 2" />
  <w:LsdException locked="false" priority="43" name="Plain Table 3" />
  <w:LsdException locked="false" priority="44" name="Plain Table 4" />
  <w:LsdException locked="false" priority="45" name="Plain Table 5" />
  <w:LsdException locked="false" priority="40" name="Grid Table Light" />
  <w:LsdException locked="false" priority="46" name="Grid Table 1 Light" />
  <w:LsdException locked="false" priority="47" name="Grid Table 2" />
  <w:LsdException locked="false" priority="48" name="Grid Table 3" />
  <w:LsdException locked="false" priority="49" name="Grid Table 4" />
  <w:LsdException locked="false" priority="50" name="Grid Table 5 Dark" />
  <w:LsdException locked="false" priority="51" name="Grid Table 6 Colorful" />
  <w:LsdException locked="false" priority="52" name="Grid Table 7 Colorful" />
  <w:LsdException locked="false" priority="46" name="Grid Table 1 Light Accent 1" />
  <w:LsdException locked="false" priority="47" name="Grid Table 2 Accent 1" />
  <w:LsdException locked="false" priority="48" name="Grid Table 3 Accent 1" />
  <w:LsdException locked="false" priority="49" name="Grid Table 4 Accent 1" />
  <w:LsdException locked="false" priority="50" name="Grid Table 5 Dark Accent 1" />
  <w:LsdException locked="false" priority="51" name="Grid Table 6 Colorful Accent 1" />
  <w:LsdException locked="false" priority="52" name="Grid Table 7 Colorful Accent 1" />
  <w:LsdException locked="false" priority="46" name="Grid Table 1 Light Accent 2" />
  <w:LsdException locked="false" priority="47" name="Grid Table 2 Accent 2" />
  <w:LsdException locked="false" priority="48" name="Grid Table 3 Accent 2" />
  <w:LsdException locked="false" priority="49" name="Grid Table 4 Accent 2" />
  <w:LsdException locked="false" priority="50" name="Grid Table 5 Dark Accent 2" />
  <w:LsdException locked="false" priority="51" name="Grid Table 6 Colorful Accent 2" />
  <w:LsdException locked="false" priority="52" name="Grid Table 7 Colorful Accent 2" />
  <w:LsdException locked="false" priority="46" name="Grid Table 1 Light Accent 3" />
  <w:LsdException locked="false" priority="47" name="Grid Table 2 Accent 3" />
  <w:LsdException locked="false" priority="48" name="Grid Table 3 Accent 3" />
  <w:LsdException locked="false" priority="49" name="Grid Table 4 Accent 3" />
  <w:LsdException locked="false" priority="50" name="Grid Table 5 Dark Accent 3" />
  <w:LsdException locked="false" priority="51" name="Grid Table 6 Colorful Accent 3" />
  <w:LsdException locked="false" priority="52" name="Grid Table 7 Colorful Accent 3" />
  <w:LsdException locked="false" priority="46" name="Grid Table 1 Light Accent 4" />
  <w:LsdException locked="false" priority="47" name="Grid Table 2 Accent 4" />
  <w:LsdException locked="false" priority="48" name="Grid Table 3 Accent 4" />
  <w:LsdException locked="false" priority="49" name="Grid Table 4 Accent 4" />
  <w:LsdException locked="false" priority="50" name="Grid Table 5 Dark Accent 4" />
  <w:LsdException locked="false" priority="51" name="Grid Table 6 Colorful Accent 4" />
  <w:LsdException locked="false" priority="52" name="Grid Table 7 Colorful Accent 4" />
  <w:LsdException locked="false" priority="46" name="Grid Table 1 Light Accent 5" />
  <w:LsdException locked="false" priority="47" name="Grid Table 2 Accent 5" />
  <w:LsdException locked="false" priority="48" name="Grid Table 3 Accent 5" />
  <w:LsdException locked="false" priority="49" name="Grid Table 4 Accent 5" />
  <w:LsdException locked="false" priority="50" name="Grid Table 5 Dark Accent 5" />
  <w:LsdException locked="false" priority="51" name="Grid Table 6 Colorful Accent 5" />
  <w:LsdException locked="false" priority="52" name="Grid Table 7 Colorful Accent 5" />
  <w:LsdException locked="false" priority="46" name="Grid Table 1 Light Accent 6" />
  <w:LsdException locked="false" priority="47" name="Grid Table 2 Accent 6" />
  <w:LsdException locked="false" priority="48" name="Grid Table 3 Accent 6" />
  <w:LsdException locked="false" priority="49" name="Grid Table 4 Accent 6" />
  <w:LsdException locked="false" priority="50" name="Grid Table 5 Dark Accent 6" />
  <w:LsdException locked="false" priority="51" name="Grid Table 6 Colorful Accent 6" />
  <w:LsdException locked="false" priority="52" name="Grid Table 7 Colorful Accent 6" />
  <w:LsdException locked="false" priority="46" name="List Table 1 Light" />
  <w:LsdException locked="false" priority="47" name="List Table 2" />
  <w:LsdException locked="false" priority="48" name="List Table 3" />
  <w:LsdException locked="false" priority="49" name="List Table 4" />
  <w:LsdException locked="false" priority="50" name="List Table 5 Dark" />
  <w:LsdException locked="false" priority="51" name="List Table 6 Colorful" />
  <w:LsdException locked="false" priority="52" name="List Table 7 Colorful" />
  <w:LsdException locked="false" priority="46" name="List Table 1 Light Accent 1" />
  <w:LsdException locked="false" priority="47" name="List Table 2 Accent 1" />
  <w:LsdException locked="false" priority="48" name="List Table 3 Accent 1" />
  <w:LsdException locked="false" priority="49" name="List Table 4 Accent 1" />
  <w:LsdException locked="false" priority="50" name="List Table 5 Dark Accent 1" />
  <w:LsdException locked="false" priority="51" name="List Table 6 Colorful Accent 1" />
  <w:LsdException locked="false" priority="52" name="List Table 7 Colorful Accent 1" />
  <w:LsdException locked="false" priority="46" name="List Table 1 Light Accent 2" />
  <w:LsdException locked="false" priority="47" name="List Table 2 Accent 2" />
  <w:LsdException locked="false" priority="48" name="List Table 3 Accent 2" />
  <w:LsdException locked="false" priority="49" name="List Table 4 Accent 2" />
  <w:LsdException locked="false" priority="50" name="List Table 5 Dark Accent 2" />
  <w:LsdException locked="false" priority="51" name="List Table 6 Colorful Accent 2" />
  <w:LsdException locked="false" priority="52" name="List Table 7 Colorful Accent 2" />
  <w:LsdException locked="false" priority="46" name="List Table 1 Light Accent 3" />
  <w:LsdException locked="false" priority="47" name="List Table 2 Accent 3" />
  <w:LsdException locked="false" priority="48" name="List Table 3 Accent 3" />
  <w:LsdException locked="false" priority="49" name="List Table 4 Accent 3" />
  <w:LsdException locked="false" priority="50" name="List Table 5 Dark Accent 3" />
  <w:LsdException locked="false" priority="51" name="List Table 6 Colorful Accent 3" />
  <w:LsdException locked="false" priority="52" name="List Table 7 Colorful Accent 3" />
  <w:LsdException locked="false" priority="46" name="List Table 1 Light Accent 4" />
  <w:LsdException locked="false" priority="47" name="List Table 2 Accent 4" />
  <w:LsdException locked="false" priority="48" name="List Table 3 Accent 4" />
  <w:LsdException locked="false" priority="49" name="List Table 4 Accent 4" />
  <w:LsdException locked="false" priority="50" name="List Table 5 Dark Accent 4" />
  <w:LsdException locked="false" priority="51" name="List Table 6 Colorful Accent 4" />
  <w:LsdException locked="false" priority="52" name="List Table 7 Colorful Accent 4" />
  <w:LsdException locked="false" priority="46" name="List Table 1 Light Accent 5" />
  <w:LsdException locked="false" priority="47" name="List Table 2 Accent 5" />
  <w:LsdException locked="false" priority="48" name="List Table 3 Accent 5" />
  <w:LsdException locked="false" priority="49" name="List Table 4 Accent 5" />
  <w:LsdException locked="false" priority="50" name="List Table 5 Dark Accent 5" />
  <w:LsdException locked="false" priority="51" name="List Table 6 Colorful Accent 5" />
  <w:LsdException locked="false" priority="52" name="List Table 7 Colorful Accent 5" />
  <w:LsdException locked="false" priority="46" name="List Table 1 Light Accent 6" />
  <w:LsdException locked="false" priority="47" name="List Table 2 Accent 6" />
  <w:LsdException locked="false" priority="48" name="List Table 3 Accent 6" />
  <w:LsdException locked="false" priority="49" name="List Table 4 Accent 6" />
  <w:LsdException locked="false" priority="50" name="List Table 5 Dark Accent 6" />
  <w:LsdException locked="false" priority="51" name="List Table 6 Colorful Accent 6" />
  <w:LsdException locked="false" priority="52" name="List Table 7 Colorful Accent 6" />
 </w:LatentStyles>
</xml><![endif]-->
<!--[if gte mso 10]>

 /* Style Definitions */
 table.MsoNormalTable
	{mso-style-name:"Table Normal";
	mso-tstyle-rowband-size:0;
	mso-tstyle-colband-size:0;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-parent:"";
	mso-padding-alt:0in 5.4pt 0in 5.4pt;
	mso-para-margin-top:0in;
	mso-para-margin-right:0in;
	mso-para-margin-bottom:8.0pt;
	mso-para-margin-left:0in;
	line-height:107%;
	mso-pagination:widow-orphan;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:minor-latin;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:minor-bidi;}

<![endif]--></div><a name='2158'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>AJCC CANCER SURVEILLANCE API VERSION CURRENT</strong></td><td style="text-align:right;font-weight:bold;"><strong>New</strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">2158</td><td style="text-align:center;">13</td><td style="text-align:center;"><a href='#sources'>AJCC</a></td><td style="text-align:center;">2021</td><td style="text-align:center;">21</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1 - 13</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>ajccCancerSurvApiVersionCurrent</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'><div> This item indicates the most recently accessed version of the Cancer Surveillance .dll incorporated into the cancer registry software that created the record with stage data diagnosed 2018 and later. AJCC Cancer Surveillance API Version Current will be assigned based on the version of the AJCC Cancer Surveillance API in use in the registry software system. It must be updated every time a new version is incorporated into your system and all relevant cases should be updated to reflect the same value.</div><ul><li>For cases diagnosed prior to 2018, this field should remain blank.</li><li>For cases diagnosed in 2018-2020, this field should be set to the AJCC Cancer Surveillance API version in use at the time of implementation.</li><li>For cases diagnosed in 2018 and later abstracted after implementation, use the AJCC Cancer Surveillance API version in use at the time the case is being abstracted.</li></ul>The value is obtained from the .dll.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Over time, the definitions and other content contained in the .dll may change. This item identifies the current API content used to code the items.</div><div class='content chap10-para'>Codes</div><div class='content chap10-para'><div> This data item will be generated by registry software.</div>
<div>&nbsp;</div>
<div>
The AJCC Cancer Surveillance API contains contents to support collection of AJCC's TNM, EOD, SSDI's, and directly entered Summary Stage 2018. The underlying contents are loaded from AJCC's API and SEER's web service. The API is versioned independently from the imported contents. </div>
<div>&nbsp;</div>
<div>The value indicates the version of the Cancer Surveillance API used most recently to code the items listed below and is obtained from the API. It should be recorded the first time the AJCC ID (including a value of XX) and/or Schema ID is determined and should be updated each time an updated AJCC Cancer Surveillance API is implemented.</div>
<div>&nbsp; <br />
<blockquote><strong>Related Input Fields</strong><br />
AJCC TNM Clin T (also Path and Post Therapy T) [1001, 1011, 1021]<br />
AJCC TNM Clin N (also Path and Post Therapy N) [1002, 1012, 1022]<br />
AJCC TNM Clin M (also Path and Post Therapy M) [1003, 1013, 1023]<br />
AJCC TNM Clin Stage Group (also Path and Post Therapy Stage Group [1004, 1014, 1024])<br />
<br />
Summary Stage 2018 [764]<br />
<br />
EOD Primary Tumor [772]<br />
EOD Regional Nodes [774]<br />
EOD Mets [776]<br /><br />
All SSDIs (see SSDI manual for complete list)<br />
</blockquote></div></div><a name='2159'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>AJCC CANCER SURVEILLANCE API VERSION ORIGINAL</strong></td><td style="text-align:right;font-weight:bold;"><strong>New</strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">2159</td><td style="text-align:center;">13</td><td style="text-align:center;"><a href='#sources'>AJCC</a></td><td style="text-align:center;">2021</td><td style="text-align:center;">21</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1 - 13</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>ajccCancerSurvApiVersionOriginal</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'><p>This item indicates the version of the AJCC Cancer Surveillance .dll incorporated into the cancer registry software that created the record with stage data diagnosed 2018 and later. It should be recorded the first time the AJCC ID (including a value of XX) and/or Schema ID are determined using the .dll. The value is obtained from the .dll.</p></div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Over time, the definitions and other content contained in the .dll may change. This item identifies the original content used to code the items.</div><div class='content chap10-para'>Codes</div><div class='content chap10-para'><div> This data item will be generated by registry software.</div>
<div>&nbsp;</div><div>The AJCC Cancer Surveillance API contains contents to support collection of AJCC&#8217;s TNM, EOD, and directly entered Summary Stage 2018. The underlying contents are loaded from AJCC&#8217;s API and SEER&#8217;s web service. The API is versioned independently from the imported contents.</div><div>&nbsp;</div>The value indicates the version of the AJCC Cancer Surveillance API originally used to code the items listed below and is obtained from the API. It should be recorded the first time the AJCC ID (including a value of XX) and/or Schema ID is determined and should not be updated each time the related input fields are modified.&nbsp; However, if changes made to the diagnosis and/or date of diagnosis result in a different AJCC ID and/or Schema ID, the value for Cancer Surveillance API Version Original should be reset.<br />&nbsp; <br />
<strong>Related Input Fields</strong><br />
AJCC TNM Clin T (also Path and Post Therapy T) [1001, 1011, 1021]<br />
AJCC TNM Clin N (also Path and Post Therapy N) [1002, 1012, 1022]<br />
AJCC TNM Clin M (also Path and Post Therapy M) [1003, 1013, 1023]<br />
AJCC TNM Clin Stage Group (also Path and Post Therapy Stage Group [1004, 1014, 1024])<br />
<br />
Summary Stage 2018 [764]<br />
<br />
EOD Primary Tumor [772]<br />
EOD Regional Nodes [774]<br />
EOD Mets [776]<br /><br />
All SSDIs (see SSDI manual for complete list).</div><a name='995'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>AJCC ID</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">995</td><td style="text-align:center;">4</td><td style="text-align:center;"><a href='#sources'>NAACCR</a></td><td style="text-align:center;">2018</td><td style="text-align:center;">18</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1722 - 1725</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>ajccId</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>The values for this data item are based on the chapters of the AJCC manual and will be derived primarily from the site/histology fields and other data items as required.  IDs are assigned to cases for which AJCC staging is applicable. When staging is not applicable, code &#8216;XX&#8217; is used.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>This data item will be used to create an efficient process for running TNM Edits.</div><div class='content chap10-para'>Each Site-Specific Data Item (SSDI) applies only to selected primary sites, histologies, and years of diagnosis. Depending on applicability and standard-setter requirements, SSDIs may be left blank. </div><a name='1003'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>AJCC TNM CLIN M</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">1003</td><td style="text-align:center;">15</td><td style="text-align:center;"><a href='#sources'>AJCC</a></td><td style="text-align:center;">2018</td><td style="text-align:center;">18</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1120 - 1134</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>ajccTnmClinM</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Detailed site-specific codes for the clinical metastases (M) as defined by the current AJCC edition.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>CoC requires that AJCC TNM staging be used in its approved cancer programs. AJCC developed its staging system for evaluating trends in the treatment and control of cancer. This staging is used by physicians to estimate prognosis, to plan treatment, to evaluate new types of therapy, to analyze outcome, to design follow-up strategies, and to assess early detection results.</div><div class='content chap10-para'><strong>Codes (in addition to those published in the AJCC Cancer Staging Manual)</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>88</td><td class='code-desc'>Not applicable, no code assigned for this case in the current AJCC Staging Manual. </td></tr><tr class='code-row'><td class='code-nbr'>Blank</td><td class='code-desc'>Information not available to code this item.</td></tr><tr class='code-row'><td class='code-nbr' colspan='2'></td></tr></table></div><div class='content chap10-para'><em>Note</em>: See the AJCC Cancer Staging Manual, 8th edition for site-specific categories for the TNM elements and stage groups. See the CURRENT <em>STORE </em>manual for specifications for codes and data entry rules.</div><a name='1002'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>AJCC TNM CLIN N</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">1002</td><td style="text-align:center;">15</td><td style="text-align:center;"><a href='#sources'>AJCC</a></td><td style="text-align:center;">2018</td><td style="text-align:center;">18</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1101 - 1115</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>ajccTnmClinN</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Detailed site-specific codes for the clinical nodes (N) as defined by the current AJCC edition.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>CoC requires that AJCC TNM staging be used in its approved cancer programs. AJCC developed its staging system for evaluating trends in the treatment and control of cancer. This staging is used by physicians to estimate prognosis, to plan treatment, to evaluate new types of therapy, to analyze outcome, to design follow-up strategies, and to assess early detection results.</div><div class='content chap10-para'><strong>Codes (in addition to those published in the AJCC Cancer Staging Manual)</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>88</td><td class='code-desc'>Not applicable, no code assigned for this case in the current AJCC Staging Manual. </td></tr><tr class='code-row'><td class='code-nbr'>Blank</td><td class='code-desc'>Information not available to code this item.</td></tr><tr class='code-row'><td class='code-nbr' colspan='2'></td></tr></table></div><div class='content chap10-para'><em>Note</em>: See the AJCC Cancer Staging Manual, 8th edition for site-specific categories for the TNM elements and stage groups. See the CURRENT <em>STORE </em>manual for specifications for codes and data entry rules.</div><a name='1034'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>AJCC TNM CLIN N SUFFIX</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">1034</td><td style="text-align:center;">4</td><td style="text-align:center;"><a href='#sources'>AJCC</a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1116 - 1119</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>ajccTnmClinNSuffix</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Detailed site-specific codes for the clinical N category suffix as defined by AJCC.<br /><br />Clinical, pathological, and postneoadjuvant therapy stage data are given three separate areas in the NAACCR Data Exchange Record Layout.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>CoC requires that AJCC TNM staging be used in its approved cancer programs. AJCC developed its staging system for evaluating trends in the treatment and control of cancer. This staging is used by physicians to estimate prognosis, to plan treatment, to evaluate new types of therapy, to analyze outcome, to design follow-up strategies, and to assess early detection results.</div><div class='content chap10-para'><strong>Codes&nbsp;</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>(sn)</td><td class='code-desc'>Sentinel node procedure with or without FNA or core needle biopsy </td></tr><tr class='code-row'><td class='code-nbr'>(f)</td><td class='code-desc'>FNA or core needle biopsy only</td></tr><tr class='code-row'><td class='code-nbr'>Blank</td><td class='code-desc'>No suffix needed or appropriate; not recorded</td></tr><tr class='code-row'><td class='code-nbr' colspan='2'></td></tr></table></div><div class='content chap10-para'><em>Note</em>: Refer to the current AJCC Cancer Staging Manual for staging rules.</div><a name='1004'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>AJCC TNM CLIN STAGE GROUP</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">1004</td><td style="text-align:center;">15</td><td style="text-align:center;"><a href='#sources'>AJCC</a></td><td style="text-align:center;">2018</td><td style="text-align:center;">18</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1135 - 1149</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>ajccTnmClinStageGroup</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Detailed site-specific codes for the clinical stage group as defined by the current AJCC edition.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>CoC requires that AJCC TNM staging be used in its approved cancer programs. AJCC developed its staging system for evaluating trends in the treatment and control of cancer. This staging is used by physicians to estimate prognosis, to plan treatment, to evaluate new types of therapy, to analyze outcome, to design follow-up strategies, and to assess early detection results.</div><div class='content chap10-para'><strong>Codes&nbsp;<!--[if gte mso 10]>  <![endif]-->(in addition to those published in the AJCC Cancer Staging Manual)</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>88</td><td class='code-desc'>Not applicable, no code assigned for this case in the current AJCC Staging Manual. </td></tr><tr class='code-row'><td class='code-nbr'>99</td><td class='code-desc'>Unknown, not staged</td></tr><tr class='code-row'><td class='code-nbr' colspan='2'></td></tr></table></div><div class='content chap10-para'><em>Note</em>: See the AJCC Cancer Staging Manual, 8th edition for site-specific categories for the TNM elements and stage groups. See the CURRENT <em>STORE </em>manual for specifications for codes and data entry rules.</div><a name='1001'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>AJCC TNM CLIN T</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">1001</td><td style="text-align:center;">15</td><td style="text-align:center;"><a href='#sources'>AJCC</a></td><td style="text-align:center;">2018</td><td style="text-align:center;">18</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1082 - 1096</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>ajccTnmClinT</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Detailed site-specific codes for the clinical tumor (T) as defined by the current AJCC edition.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>CoC requires that AJCC TNM staging be used in its approved cancer programs. AJCC developed its staging system for evaluating trends in the treatment and control of cancer. This staging is used by physicians to estimate prognosis, to plan treatment, to evaluate new types of therapy, to analyze outcome, to design follow-up strategies, and to assess early detection results.</div><div class='content chap10-para'><strong>Codes (in addition to those published in the AJCC Cancer Staging Manual)</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>88</td><td class='code-desc'>Not applicable, no code assigned for this case in the current AJCC Staging Manual. </td></tr><tr class='code-row'><td class='code-nbr'>Blank</td><td class='code-desc'>Information not available to code this item.</td></tr><tr class='code-row'><td class='code-nbr' colspan='2'></td></tr></table></div><div class='content chap10-para'><em>Note</em>: See the AJCC Cancer Staging Manual, 8th edition for site-specific categories for the TNM elements and stage groups. See the CURRENT <em>STORE </em>manual for specifications for codes and data entry rules.</div><a name='1031'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>AJCC TNM CLIN T SUFFIX</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">1031</td><td style="text-align:center;">4</td><td style="text-align:center;"><a href='#sources'>AJCC</a></td><td style="text-align:center;">2018</td><td style="text-align:center;">18</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1097 - 1100</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>ajccTnmClinTSuffix</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Detailed site-specific codes for the clinical T category suffix as defined by AJCC.<br /><br />Clinical, pathological, and postneoadjuvant therapy stage data are given three separate areas in the NAACCR Data Exchange Record Layout.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>CoC requires that AJCC TNM staging be used in its approved cancer programs. AJCC developed its staging system for evaluating trends in the treatment and control of cancer. This staging is used by physicians to estimate prognosis, to plan treatment, to evaluate new types of therapy, to analyze outcome, to design follow-up strategies, and to assess early detection results</div><div class='content chap10-para'><strong>Codes (as published in the AJCC Cancer Staging Manual)</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>(m)</td><td class='code-desc'>Multiple synchronous tumors
OR
For thyroid differentiated and anaplastic only, Multifocal tumor
 </td></tr><tr class='code-row'><td class='code-nbr'>(s)</td><td class='code-desc'>For thyroid differentiated and anaplastic only, Solitary tumor</td></tr><tr class='code-row'><td class='code-nbr'>Blank</td><td class='code-desc'>No information available; not recorded</td></tr><tr class='code-row'><td class='code-nbr' colspan='2'></td></tr></table></div><div class='content chap10-para'><em>Note</em>: Refer to the current AJCC Cancer Staging Manual for staging rules.</div><a name='1013'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>AJCC TNM PATH M</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">1013</td><td style="text-align:center;">15</td><td style="text-align:center;"><a href='#sources'>AJCC</a></td><td style="text-align:center;">2018</td><td style="text-align:center;">18</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1188 - 1202</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>ajccTnmPathM</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Detailed site-specific codes for the clinical path (M) as defined by the current AJCC edition.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>CoC requires that AJCC TNM staging be used in its approved cancer programs. AJCC developed its staging system for evaluating trends in the treatment and control of cancer. This staging is used by physicians to estimate prognosis, to plan treatment, to evaluate new types of therapy, to analyze outcome, to design follow-up strategies, and to assess early detection results.</div><div class='content chap10-para'><strong>Codes (in addition to those published in the AJCC Cancer Staging Manual)</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>88</td><td class='code-desc'>Not applicable, no code assigned for this case in the current AJCC Staging Manual. </td></tr><tr class='code-row'><td class='code-nbr'>Blank</td><td class='code-desc'>Information not available to code this item.</td></tr><tr class='code-row'><td class='code-nbr' colspan='2'></td></tr></table></div><div class='content chap10-para'><em>Note</em>: See the AJCC Cancer Staging Manual, 8th edition for site-specific categories for the TNM elements and stage groups. See the CURRENT <em>STORE </em>manual for specifications for codes and data entry rules.</div><a name='1012'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>AJCC TNM PATH N</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">1012</td><td style="text-align:center;">15</td><td style="text-align:center;"><a href='#sources'>AJCC</a></td><td style="text-align:center;">2018</td><td style="text-align:center;">18</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1169 - 1183</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>ajccTnmPathN</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Detailed site-specific codes for the pathologic nodes (N) as defined by the current AJCC edition.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>CoC requires that AJCC TNM staging be used in its approved cancer programs. AJCC developed its staging system for evaluating trends in the treatment and control of cancer. This staging is used by physicians to estimate prognosis, to plan treatment, to evaluate new types of therapy, to analyze outcome, to design follow-up strategies, and to assess early detection results.</div><div class='content chap10-para'><strong>Codes (in addition to those published in the AJCC Cancer Staging Manual)</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>88</td><td class='code-desc'>Not applicable, no code assigned for this case in the current AJCC Staging Manual. </td></tr><tr class='code-row'><td class='code-nbr'>Blank</td><td class='code-desc'>Information not available to code this item.</td></tr><tr class='code-row'><td class='code-nbr' colspan='2'></td></tr></table></div><div class='content chap10-para'><em>Note</em>: See the AJCC Cancer Staging Manual, 8th edition for site-specific categories for the TNM elements and stage groups. See the CURRENT <em>STORE </em>manual for specifications for codes and data entry rules.</div><a name='1035'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>AJCC TNM PATH N SUFFIX</strong></td><td style="text-align:right;font-weight:bold;"><strong>Revised</strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">1035</td><td style="text-align:center;">4</td><td style="text-align:center;"><a href='#sources'>AJCC</a></td><td style="text-align:center;">2018</td><td style="text-align:center;">18</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1184 - 1187</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>ajccTnmPathNSuffix</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Detailed site-specific codes for the pathological N category suffix as defined by AJCC.<br /><br />Clinical, pathological, and postneoadjuvant therapy stage data are given three separate areas in the NAACCR Data Exchange Record Layout.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>CoC requires that AJCC TNM staging be used in its approved cancer programs. AJCC developed its staging system for evaluating trends in the treatment and control of cancer. This staging is used by physicians to estimate prognosis, to plan treatment, to evaluate new types of therapy, to analyze outcome, to design follow-up strategies, and to assess early detection results.</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para mark-changed'><table><tr class='code-row'><td class='code-nbr'>(sn)</td><td class='code-desc'>Sentinel node procedure without resection of nodal basin</td></tr><tr class='code-row'><td class='code-nbr'>(f)</td><td class='code-desc'>FNA or core needle biopsy only</td></tr><tr class='code-row'><td class='code-nbr'>Blank</td><td class='code-desc'>No suffix needed or appropriate; not recorded</td></tr><tr class='code-row'><td class='code-nbr'></td><td class='code-desc'> </td></tr></table></div><a name='1014'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>AJCC TNM PATH STAGE GROUP</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">1014</td><td style="text-align:center;">15</td><td style="text-align:center;"><a href='#sources'>AJCC</a></td><td style="text-align:center;">2018</td><td style="text-align:center;">18</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1203 - 1217</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>ajccTnmPathStageGroup</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Detailed site-specific codes for the pathologic stage group as defined by the current AJCC edition.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>CoC requires that AJCC TNM staging be used in its approved cancer programs. AJCC developed its staging system for evaluating trends in the treatment and control of cancer. This staging is used by physicians to estimate prognosis, to plan treatment, to evaluate new types of therapy, to analyze outcome, to design follow-up strategies, and to assess early detection results.</div><div class='content chap10-para'><strong>Codes (in addition to those published in the AJCC Cancer Staging Manual)</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>88</td><td class='code-desc'>Not applicable, no code assigned for this case in the current AJCC Staging Manual. </td></tr><tr class='code-row'><td class='code-nbr'>99</td><td class='code-desc'>Unknown, not staged</td></tr><tr class='code-row'><td class='code-nbr' colspan='2'></td></tr></table></div><div class='content chap10-para'><em>Note</em>: See the AJCC Cancer Staging Manual, 8th edition for site-specific categories for the TNM elements and stage groups. See the CURRENT <em>STORE </em>manual for specifications for codes and data entry rules.</div><a name='1011'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>AJCC TNM PATH T</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">1011</td><td style="text-align:center;">15</td><td style="text-align:center;"><a href='#sources'>AJCC</a></td><td style="text-align:center;">2018</td><td style="text-align:center;">18</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1150 - 1164</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>ajccTnmPathT</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Detailed site-specific codes for the pathologic tumor (T) as defined by the current AJCC edition.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>CoC requires that AJCC TNM staging be used in its approved cancer programs. AJCC developed its staging system for evaluating trends in the treatment and control of cancer. This staging is used by physicians to estimate prognosis, to plan treatment, to evaluate new types of therapy, to analyze outcome, to design follow-up strategies, and to assess early detection results.</div><div class='content chap10-para'><strong>Codes (in addition to those published in the AJCC Cancer Staging Manual)</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>88</td><td class='code-desc'>Not applicable, no code assigned for this case in the current AJCC Staging Manual. </td></tr><tr class='code-row'><td class='code-nbr'>Blank</td><td class='code-desc'>Information not available to code this item.</td></tr><tr class='code-row'><td class='code-nbr' colspan='2'></td></tr></table></div><div class='content chap10-para'><em>Note</em>: See the AJCC Cancer Staging Manual, 8th edition for site-specific categories for the TNM elements and stage groups. See the CURRENT <em>STORE </em>manual for specifications for codes and data entry rules.</div><a name='1032'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>AJCC TNM PATH T SUFFIX</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">1032</td><td style="text-align:center;">4</td><td style="text-align:center;"><a href='#sources'>AJCC</a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1165 - 1168</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>ajccTnmPathTSuffix</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Detailed site-specific codes for the pathological T category suffix as defined by AJCC.<br /><br />Clinical, pathological, and postneoadjuvant therapy stage data are given three separate areas in the NAACCR Data Exchange Record Layout.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>CoC requires that AJCC TNM staging be used in its approved cancer programs. AJCC developed its staging system for evaluating trends in the treatment and control of cancer. This staging is used by physicians to estimate prognosis, to plan treatment, to evaluate new types of therapy, to analyze outcome, to design follow-up strategies, and to assess early detection results.</div><div class='content chap10-para'><strong>Codes (as published in the AJCC Cancer Staging Manual)</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>(m)</td><td class='code-desc'>Multiple synchronous tumors
OR
For thyroid differentiated and anaplastic only, Multifocal tumor
 </td></tr><tr class='code-row'><td class='code-nbr'>(s)</td><td class='code-desc'>For thyroid differentiated and anaplastic only, Solitary tumor</td></tr><tr class='code-row'><td class='code-nbr'>Blank</td><td class='code-desc'>No information available; not recorded</td></tr><tr class='code-row'><td class='code-nbr' colspan='2'></td></tr></table></div><div class='content chap10-para'><em>Note</em>: Refer to the current AJCC Cancer Staging Manual for staging rules.</div><a name='1066'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>AJCC TNM POST THERAPY CLIN (YC) M</strong></td><td style="text-align:right;font-weight:bold;"><strong>New</strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">1066</td><td style="text-align:center;">15</td><td style="text-align:center;"><a href='#sources'>AJCC</a></td><td style="text-align:center;">2021</td><td style="text-align:center;">21</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1 - 15</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>ajccTnmPostTherapyClinM</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Detailed site-specific codes for the post therapy clinical (yc) metastases (M) as defined by AJCC.<br /><br />Clinical, pathological, and post therapy yc and yp stage data are given four separate areas in the NAACCR Data Exchange Record Layout.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>CoC requires that AJCC TNM staging be used in its approved cancer programs. AJCC developed its staging system for evaluating trends in the treatment and control of cancer. This staging is used by physicians to estimate prognosis, to plan treatment, to evaluate new types of therapy, to analyze outcome, to design follow-up strategies, and to assess early detection results.<br /><br />M category for post neoadjuvant therapy staging remains the same as that assigned in the clinical stage before initiation of neoadjuvant therapy or primary systemic/radiation therapy, cM or pM.</div><div class='content chap10-para'><strong>Codes (in addition to those published in the AJCC Cancer Staging Manual)</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>88</td><td class='code-desc'>Not applicable, no code assigned for this case in the current AJCC Staging Manual.  </td></tr><tr class='code-row'><td class='code-nbr'>Blank</td><td class='code-desc'>This field is left blank if no information at all is available to code this item.</td></tr><tr class='code-row'><td class='code-nbr' colspan='2'></td></tr></table></div><div class='content chap10-para'><em>Note</em>: See the <em>AJCC Cancer Staging Manual</em>, current edition for site-specific categories for the TNM categories and stage groups. See the CURRENT <em>STORE </em>manual for specifications for codes and data entry rules.</div><a name='1064'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>AJCC TNM POST THERAPY CLIN (YC) N</strong></td><td style="text-align:right;font-weight:bold;"><strong>New</strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">1064</td><td style="text-align:center;">15</td><td style="text-align:center;"><a href='#sources'>AJCC</a></td><td style="text-align:center;">2021</td><td style="text-align:center;">21</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1 - 15</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>ajccTnmPostTherapyClinN</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Detailed site-specific codes for the post therapy clinical (yc) nodes (N) as defined by AJCC.<br /><br />Clinical, pathological, and post therapy yc and yp stage data are given four separate areas in the NAACCR Data Exchange Record Layout.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>CoC requires that AJCC TNM staging be used in its approved cancer programs. AJCC developed its staging system for evaluating trends in the treatment and control of cancer. This staging is used by physicians to estimate prognosis, to plan treatment, to evaluate new types of therapy, to analyze outcome, to design follow-up strategies, and to assess early detection results.<br /><br />Identifies the absence or presence of regional lymph node (N) metastasis and describes the extent of lymph node metastasis of the tumor known following the completion of neoadjuvant therapy (satisfying the definition for that disease site) before planned surgical resection or primary treatment consisting of systemic and/or radiation therapy.</div><div class='content chap10-para'><strong>Codes (in addition to those published in the AJCC Cancer Staging Manual)</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>88</td><td class='code-desc'>Not applicable, no code assigned for this case in the current AJCC Staging Manual.  </td></tr><tr class='code-row'><td class='code-nbr'>Blank</td><td class='code-desc'>This field is left blank if no information at all is available to code this item.</td></tr><tr class='code-row'><td class='code-nbr' colspan='2'></td></tr></table></div><div class='content chap10-para'><em>Note</em>: See the <em>AJCC Cancer Staging Manual</em>, current edition for site-specific categories for the TNM categories and stage groups. See the CURRENT <em>STORE </em>manual for specifications for codes and data entry rules.</div><a name='1065'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>AJCC TNM POST THERAPY CLIN (YC) N SUFFIX</strong></td><td style="text-align:right;font-weight:bold;"><strong>New</strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">1065</td><td style="text-align:center;">4</td><td style="text-align:center;"><a href='#sources'>AJCC</a></td><td style="text-align:center;">2021</td><td style="text-align:center;">21</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1 - 4</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>ajccTnmPostTherapyClinNSuffix</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Detailed site-specific codes for the post therapy clinical (yc) N category suffix as defined by AJCC.<br /><br />Clinical, pathological, and post therapy yc and yp stage data are given four separate areas in the NAACCR Data Exchange Record Layout.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>CoC requires that AJCC TNM staging be used in its approved cancer programs. AJCC developed its staging system for evaluating trends in the treatment and control of cancer. This staging is used by physicians to estimate prognosis, to plan treatment, to evaluate new types of therapy, to analyze outcome, to design follow-up strategies, and to assess early detection results.</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>(sn)</td><td class='code-desc'>Sentinel node procedure with or without FNA or core needle biopsy</td></tr><tr class='code-row'><td class='code-nbr'>(f)</td><td class='code-desc'>FNA or core needle biopsy only</td></tr><tr class='code-row'><td class='code-nbr'>Blank</td><td class='code-desc'>No suffix needed or appropriate; not recorded</td></tr><tr class='code-row'><td class='code-nbr'></td><td class='code-desc'> </td></tr></table></div><a name='1067'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>AJCC TNM POST THERAPY CLIN (YC) STAGE GROUP</strong></td><td style="text-align:right;font-weight:bold;"><strong>New</strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">1067</td><td style="text-align:center;">15</td><td style="text-align:center;"><a href='#sources'>AJCC</a></td><td style="text-align:center;">2021</td><td style="text-align:center;">21</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1 - 15</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>ajccTnmPostTherapyClinStageGrp</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Detailed site-specific codes for the post therapy clinical (yc) stage group as defined by AJCC.<br /><br />Clinical, pathological, and post therapy yc and yp stage data are given four separate areas in the NAACCR Data Exchange Record Layout.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>CoC requires that AJCC TNM staging be used in its approved cancer programs. AJCC developed its staging system for evaluating trends in the treatment and control of cancer. This staging is used by physicians to estimate prognosis, to plan treatment, to evaluate new types of therapy, to analyze outcome, to design follow-up strategies, and to assess early detection results.<br /><br />Identifies the remaining anatomic extent of disease based on the T and N following the completion of neoadjuvant therapy (satisfying the definition for that disease site) before planned surgical resection or primary treatment consisting of systemic and/or radiation therapy, and the M status defined during the diagnostic workup.</div><div class='content chap10-para'><strong>Codes (in addition to those published in the AJCC Cancer Staging Manual)</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>88</td><td class='code-desc'>Not applicable, no code assigned for this case in the current AJCC Staging Manual. </td></tr><tr class='code-row'><td class='code-nbr'>99</td><td class='code-desc'>Unknown, not staged</td></tr><tr class='code-row'><td class='code-nbr' colspan='2'></td></tr></table></div><div class='content chap10-para'><em>Note</em>: See the <em>AJCC Cancer Staging Manual</em>, current edition for site-specific categories for the TNM categories and stage groups. See the CURRENT <em>STORE </em>manual for specifications for codes and data entry rules.</div><a name='1062'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>AJCC TNM POST THERAPY CLIN (YC) T</strong></td><td style="text-align:right;font-weight:bold;"><strong>New</strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">1062</td><td style="text-align:center;">15</td><td style="text-align:center;"><a href='#sources'>AJCC</a></td><td style="text-align:center;">2021</td><td style="text-align:center;">21</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1 - 15</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>ajccTnmPostTherapyClinT</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'><div>Detailed site-specific codes for the post therapy clinical (yc) tumor (T) as defined by AJCC.<br /><br />Clinical, pathological, and post therapy yc and yp stage data are given four separate areas in the NAACCR Data Exchange Record Layout.</div><div>&nbsp;</div><div></div><div>&nbsp;</div></div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>CoC requires that AJCC TNM staging be used in its approved cancer programs. AJCC developed its staging system for evaluating trends in the treatment and control of cancer. This staging is used by physicians to estimate prognosis, to plan treatment, to evaluate new types of therapy, to analyze outcome, to design follow-up strategies, and to assess early detection results.<br /><br />Evaluates the primary tumor (T) and reflects the tumor size and/or extension of the tumor known following the completion of neoadjuvant therapy (satisfying the definition for that disease site) before planned surgical resection or primary treatment consisting of systemic and/or radiation therapy.</div><div class='content chap10-para'><strong>Codes (in addition to those published in the AJCC Cancer Staging Manual)<br /><br /></strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>88</td><td class='code-desc'>Not applicable, no code assigned for this case in the current AJCC Staging Manual.  </td></tr><tr class='code-row'><td class='code-nbr'>Blank</td><td class='code-desc'>This field is left blank if no information at all is available to code this item.</td></tr><tr class='code-row'><td class='code-nbr' colspan='2'></td></tr></table></div><div class='content chap10-para'><em>Note</em>: See the <em>AJCC Cancer Staging Manual</em>, current edition for site-specific categories for the TNM categories and stage groups. See the CURRENT <em>STORE </em>manual for specifications for codes and data entry rules.</div><a name='1063'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>AJCC TNM POST THERAPY CLIN (YC) T SUFFIX</strong></td><td style="text-align:right;font-weight:bold;"><strong>New</strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">1063</td><td style="text-align:center;">4</td><td style="text-align:center;"><a href='#sources'>AJCC</a></td><td style="text-align:center;">2021</td><td style="text-align:center;">21</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1 - 4</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>ajccTnmPostTherapyClinTSuffix</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Detailed site-specific codes for the post therapy clinical (yc) tumor T category suffix as defined by AJCC.<br /><br />Clinical, pathological, and post therapy yc and yp stage data are given four separate areas in the NAACCR Data Exchange Record Layout.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>CoC requires that AJCC TNM staging be used in its approved cancer programs. AJCC developed its staging system for evaluating trends in the treatment and control of cancer. This staging is used by physicians to estimate prognosis, to plan treatment, to evaluate new types of therapy, to analyze outcome, to design follow-up strategies, and to assess early detection results.</div><div class='content chap10-para'><strong>Codes (as published in the AJCC Cancer Staging Manual)</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>(m)</td><td class='code-desc'>Multiple synchronous tumors OR for thyroid differentiated and anaplastic only, Multifocal tumor </td></tr><tr class='code-row'><td class='code-nbr'>(s)</td><td class='code-desc'>For thyroid differentiated and anaplastic only, Solitary tumor</td></tr><tr class='code-row'><td class='code-nbr'>Blank</td><td class='code-desc'>No information available; not recorded</td></tr><tr class='code-row'><td class='code-nbr'></td><td class='code-desc'> </td></tr></table></div><div class='content chap10-para'><em>Note</em>: Refer to the current <em>AJCC Cancer Staging Manual</em> for staging rules.</div><a name='1023'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>AJCC TNM POST THERAPY PATH (YP) M</strong></td><td style="text-align:right;font-weight:bold;"><strong>Revised</strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">1023</td><td style="text-align:center;">15</td><td style="text-align:center;"><a href='#sources'>AJCC</a></td><td style="text-align:center;">2018</td><td style="text-align:center;">18</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1256 - 1270</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>ajccTnmPostTherapyM</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para mark-changed'>Detailed site-specific codes for the postneoadjuvant therapy category metastases (M) as defined by AJCC.<br /><br />Clinical, pathological, and post therapy yc and yp stage data are given four separate areas in the NAACCR Data Exchange Record Layout.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>CoC requires that AJCC TNM staging be used in its approved cancer programs. AJCC developed its staging system for evaluating trends in the treatment and control of cancer. This staging is used by physicians to estimate prognosis, to plan treatment, to evaluate new types of therapy, to analyze outcome, to design follow-up strategies, and to assess early detection results.<br /><br />M category for postneoadjuvant therapy staging remains the same as that assigned in the clinical stage before initiation of neoadjuvant therapy, cM or pM.</div><div class='content chap10-para'><strong>Codes (in addition to those published in the AJCC Cancer Staging Manual)</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>88</td><td class='code-desc'>Not applicable, no code assigned for this case in the current AJCC Staging Manual. </td></tr><tr class='code-row'><td class='code-nbr'>Blank</td><td class='code-desc'>This field is left blank if no information at all is available to code this item.</td></tr><tr class='code-row'><td class='code-nbr' colspan='2'></td></tr></table></div><div class='content chap10-para mark-changed'><em>Note</em>: See the AJCC Cancer Staging Manual, current edition for site-specific categories for the TNM categories and stage groups. See the CURRENT <em>STORE </em>manual for specifications for codes and data entry rules.</div><a name='1022'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>AJCC TNM POST THERAPY PATH (YP) N</strong></td><td style="text-align:right;font-weight:bold;"><strong>Revised</strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">1022</td><td style="text-align:center;">15</td><td style="text-align:center;"><a href='#sources'>AJCC</a></td><td style="text-align:center;">2018</td><td style="text-align:center;">18</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1237 - 1251</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>ajccTnmPostTherapyN</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para mark-changed'>Detailed site-specific codes for the postneoadjuvant therapy Path nodes (N) as defined by AJCC.<br /><br />Clinical, pathological, and post therapy yc and yp stage data are given four separate areas in the NAACCR Data Exchange Record Layout..</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>CoC requires that AJCC TNM staging be used in its approved cancer programs. AJCC developed its staging system for evaluating trends in the treatment and control of cancer. This staging is used by physicians to estimate prognosis, to plan treatment, to evaluate new types of therapy, to analyze outcome, to design follow-up strategies, and to assess early detection results.<br /><br />Identifies the absence or presence of regional lymph node (N) metastasis and describes the extent of lymph node metastasis of the tumor known known following the completion of neoadjuvant therapy (satisfying the definition for that disease site) and planned postneoadjuvant therapy surgical resection.</div><div class='content chap10-para'><strong>Codes (in addition to those published in the AJCC Cancer Staging Manual)</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>88</td><td class='code-desc'>Not applicable, no code assigned for this case in the current AJCC Staging Manual. </td></tr><tr class='code-row'><td class='code-nbr'>Blank</td><td class='code-desc'>This field is left blank if no information at all is available to code this item.</td></tr><tr class='code-row'><td class='code-nbr' colspan='2'></td></tr></table></div><div class='content chap10-para'><em>Note</em>: See the AJCC Cancer Staging Manual, current edition for site-specific categories for the TNM categories and stage groups. See the CURRENT <em>STORE </em>manual for specifications for codes and data entry rules.</div><a name='1036'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>AJCC TNM POST THERAPY PATH (YP) N SUFFIX</strong></td><td style="text-align:right;font-weight:bold;"><strong>Revised</strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">1036</td><td style="text-align:center;">4</td><td style="text-align:center;"><a href='#sources'>AJCC</a></td><td style="text-align:center;">2018</td><td style="text-align:center;">18</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1252 - 1255</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>ajccTnmPostTherapyNSuffix</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para mark-changed'>Detailed site-specific codes for the postneoadjuvant therapy Path N category suffix as defined by AJCC.<br /><br />Clinical, pathological, and post therapy yc and yp stage data are given four separate areas in the NAACCR Data Exchange Record Layout.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>CoC requires that AJCC TNM staging be used in its approved cancer programs. AJCC developed its staging system for evaluating trends in the treatment and control of cancer. This staging is used by physicians to estimate prognosis, to plan treatment, to evaluate new types of therapy, to analyze outcome, to design follow-up strategies, and to assess early detection results.</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para mark-changed'><table><tr class='code-row'><td class='code-nbr'>(sn)</td><td class='code-desc'>Sentinel node procedure without resection of nodal basin</td></tr><tr class='code-row'><td class='code-nbr'>(f)</td><td class='code-desc'>FNA or core needle biopsy only</td></tr><tr class='code-row'><td class='code-nbr'>Blank</td><td class='code-desc'>No suffix needed or appropriate; not recorded</td></tr><tr class='code-row'><td class='code-nbr'></td><td class='code-desc'> </td></tr></table></div><a name='1024'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>AJCC TNM POST THERAPY PATH (YP) STAGE GROUP</strong></td><td style="text-align:right;font-weight:bold;"><strong>Revised</strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">1024</td><td style="text-align:center;">15</td><td style="text-align:center;"><a href='#sources'>AJCC</a></td><td style="text-align:center;">2018</td><td style="text-align:center;">18</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1271 - 1285</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>ajccTnmPostTherapyStageGroup</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para mark-changed'>Detailed site-specific codes for the postneoadjuvant therapy Path stage group as defined by AJCC.<br /><br />Clinical, pathological, and post therapy yc and yp stage data are given four separate areas in the NAACCR Data Exchange Record Layout.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>CoC requires that AJCC TNM staging be used in its approved cancer programs. AJCC developed its staging system for evaluating trends in the treatment and control of cancer. This staging is used by physicians to estimate prognosis, to plan treatment, to evaluate new types of therapy, to analyze outcome, to design follow-up strategies, and to assess early detection results.<br /><br />Identifies the remaining anatomic extent of disease based on the T and N following the completion of neoadjuvant therapy (satisfying the definition for that disease site) and planned postneoadjuvant therapy surgical resection, and the M status defined during the diagnostic workup.</div><div class='content chap10-para'><strong>Codes (in addition to those published in the AJCC Cancer Staging Manual)</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>88</td><td class='code-desc'>Not applicable, no code assigned for this case in the current AJCC Staging Manual. </td></tr><tr class='code-row'><td class='code-nbr'>99</td><td class='code-desc'>Unknown, not staged</td></tr><tr class='code-row'><td class='code-nbr' colspan='2'></td></tr></table></div><div class='content chap10-para'><em>Note</em>: See the AJCC Cancer Staging Manual, current edition for site-specific categories for the TNM categories and stage groups. See the CURRENT <em>STORE </em>manual for specifications for codes and data entry rules. </div><a name='1021'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>AJCC TNM POST THERAPY PATH (YP) T</strong></td><td style="text-align:right;font-weight:bold;"><strong>Revised</strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">1021</td><td style="text-align:center;">15</td><td style="text-align:center;"><a href='#sources'>AJCC</a></td><td style="text-align:center;">2018</td><td style="text-align:center;">18</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1218 - 1232</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>ajccTnmPostTherapyT</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para mark-changed'>Detailed site-specific codes for the postneoadjuvant therapy Path tumor (T) as defined by AJCC.<br /><br />Clinical, pathological, and post therapy yc and yp stage data are given four separate areas in the NAACCR Data Exchange Record Layout.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>CoC requires that AJCC TNM staging be used in its approved cancer programs. AJCC developed its staging system for evaluating trends in the treatment and control of cancer. This staging is used by physicians to estimate prognosis, to plan treatment, to evaluate new types of therapy, to analyze outcome, to design follow-up strategies, and to assess early detection results.<br /><br />Evaluates the primary tumor (T) and reflects the tumor size and/or extension of the tumor known following the completion of neoadjuvant therapy (satisfying the definition for that disease site) and planned postneoadjuvant therapy surgical resection.</div><div class='content chap10-para'><strong>Codes (in addition to those published in the AJCC Cancer Staging Manual)</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>88</td><td class='code-desc'>Not applicable, no code assigned for this case in the current AJCC Staging Manual. </td></tr><tr class='code-row'><td class='code-nbr'>Blank</td><td class='code-desc'>This field is left blank if no information at all is available to code this item.</td></tr><tr class='code-row'><td class='code-nbr' colspan='2'></td></tr></table></div><div class='content chap10-para'><em>Note</em>: See the AJCC Cancer Staging Manual, current edition for site-specific categories for the TNM categories and stage groups. See the CURRENT <em>STORE </em>manual for specifications for codes and data entry rules.</div><a name='1033'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>AJCC TNM POST THERAPY PATH (YP) T SUFFIX</strong></td><td style="text-align:right;font-weight:bold;"><strong>Revised</strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">1033</td><td style="text-align:center;">4</td><td style="text-align:center;"><a href='#sources'>AJCC</a></td><td style="text-align:center;">2018</td><td style="text-align:center;">18</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1233 - 1236</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>ajccTnmPostTherapyTSuffix</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para mark-changed'>Detailed site-specific codes for the postneoadjuvant therapy Path T category suffix as defined by AJCC.<br /><br />Clinical, pathological, and post therapy yc and yp stage data are given four separate areas in the NAACCR Data Exchange Record Layout.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>CoC requires that AJCC TNM staging be used in its approved cancer programs. AJCC developed its staging system for evaluating trends in the treatment and control of cancer. This staging is used by physicians to estimate prognosis, to plan treatment, to evaluate new types of therapy, to analyze outcome, to design follow-up strategies, and to assess early detection results.</div><div class='content chap10-para'><strong>Codes (as published in the AJCC Cancer Staging Manual)</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>(m)</td><td class='code-desc'>Multiple synchronous tumors
OR
For thyroid differentiated and anaplastic only, Multifocal tumor
 </td></tr><tr class='code-row'><td class='code-nbr'>(s)</td><td class='code-desc'>For thyroid differentiated and anaplastic only, Solitary tumor</td></tr><tr class='code-row'><td class='code-nbr'>Blank</td><td class='code-desc'>No information available; not recorded</td></tr><tr class='code-row'><td class='code-nbr' colspan='2'></td></tr></table></div><div class='content chap10-para'><em>Note</em>: Refer to the current AJCC Cancer Staging Manual for staging rules.</div><a name='350'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>ALCOHOL HISTORY</strong></td><td style="text-align:right;font-weight:bold;"><strong>Retired</strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">350</td><td style="text-align:center;"></td><td style="text-align:center;"><a href='#sources'></a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;">2010</td><td style="text-align:center;">12</td><td class="cross-out" style="text-align:center;"></td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td></td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td></td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>The NAACCR UDSC retired this data item in Version 12, as of January 1, 2010.</div><a name='3938'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>ALK REARRANGEMENT</strong></td><td style="text-align:right;font-weight:bold;"><strong>New</strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">3938</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>NAACCR</a></td><td style="text-align:center;">2021</td><td style="text-align:center;">21</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1 - 1</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>alkRearrangement</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Testing for ALK rearrangement is performed for patients with advanced non-small cell lung cancer (NSCLC) to identify tumors which are sensitive to small-molecule ALK kinase inhibitors.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>ALK rearrangement is recommended by treatment guidelines for patients with advanced lung cancer as a prognostic marker and factor in determining appropriate therapy. It is a new data item for cases diagnosed 01/01/2021+.</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>0</td><td class='code-desc'>Normal<br/>
ALK negative<br/>
Negative for rearrangement, no rearrangement identified, no mutations (somatic) identified, not present, not detected


</td></tr><tr class='code-row'><td class='code-nbr'>1</td><td class='code-desc'>Abnormal Rearrangement identified/detected: EML4-ALK, KIF5B-ALK, TFG-ALK, and/or KLC1-ALK </td></tr><tr class='code-row'><td class='code-nbr'>2</td><td class='code-desc'>Rearrangement identified/detected: Other ALK Rearrangement not listed in code 1</td></tr><tr class='code-row'><td class='code-nbr'>4</td><td class='code-desc'>Rearrangement, NOS</td></tr><tr class='code-row'><td class='code-nbr'>7</td><td class='code-desc'>Test ordered, results not in chart</td></tr><tr class='code-row'><td class='code-nbr'>8</td><td class='code-desc'>Not applicable: Information not collected for this case<br/>
If this information is required by your standard setter, use of code 8 may result in an edit error.
</td></tr><tr class='code-row'><td class='code-nbr'>9</td><td class='code-desc'>Not documented in medical record<br/>
ALK Rearrangement not assessed or unknown if assessed
</td></tr><tr class='code-row'><td class='code-nbr'></td><td class='code-desc'> </td></tr></table></div><div class='content chap10-para'>Each Site-Specific Data Item (SSDI) applies only to selected primary 
sites, histologies, and years of diagnosis. Depending on applicability 
and standard-setter requirements, SSDIs may be left blank.</div><a name='442'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>AMBIGUOUS TERMINOLOGY DX</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">442</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>SEER</a></td><td style="text-align:center;">2006</td><td style="text-align:center;">11</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">580 - 580</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>Ambiguous Terminology<br />Ambiguous Terminology as Basis for Diagnosis<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>ambiguousTerminologyDx</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Identifies all cases, including death certificate only and autopsy only, for which an ambiguous term is the most definitive word or phrase used to establish a cancer diagnosis (i.e., to determine whether or not the case is reportable). Ambiguous terminology may originate from any source document, such as pathology report, radiology report, or from a clinical report. This data item is used only when ambiguous terminology is used to establish diagnosis. It is not used when ambiguous terminology is used to clarify a primary site, specific histology, histologic group, or stage of disease. </div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Cases with a reportable cancer diagnosis that has been established based only on reports that contain ambiguous terminology to describe final diagnostic findings cannot currently be identified. Multiple surveys have identified a lack of consensus in the interpretation and use of ambiguous terms across physician specialties. These cases may or may not have an actual cancer diagnosis based on clinician, radiologist, and pathologist review. Furthermore, the historical interpretation and use of ambiguous terms by cancer registrars and registries has not been consistent or compatible with physician use of these terms. <br /><br />This data item will identify specific primary sites where the ambiguous terminology is commonly used to describe or establish a cancer diagnosis. Data collected will be used as the basis for modifications to case inclusion and reportable rules following complete analysis and impact assessment. This data item will allow cases to be identified within an analysis file and be excluded from patient contact studies. </div><div class='content chap10-para'><strong>Codes (refer to <a target="_blank" href="http://seer.cancer.gov/tools/mphrules/index.html">http://seer.cancer.gov/tools/mphrules/index.html</a> for additional instructions.) </strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>0</td><td class='code-desc'>Conclusive term</td></tr><tr class='code-row'><td class='code-nbr'>1</td><td class='code-desc'>Ambiguous term only</td></tr><tr class='code-row'><td class='code-nbr'>2</td><td class='code-desc'>Ambiguous term followed by conclusive term</td></tr><tr class='code-row'><td class='code-nbr'>9</td><td class='code-desc'>Unknown term</td></tr></table></div><div class='content chap10-para'>Refer to Table 2 in Chapter III for a list of ambiguous terms.</div><a name='3811'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>ANEMIA</strong></td><td style="text-align:right;font-weight:bold;"><strong>Revised</strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">3811</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>NAACCR</a></td><td style="text-align:center;">2018</td><td style="text-align:center;">18</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1911 - 1911</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>RAI Classification: Anemia<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>anemia</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Anemia is defined by a deficiency of red blood cells or of hemoglobin in the blood. In staging of Chronic Lymphocytic Leukemia/Small Lymphocytic Leukemia (CLL/SLL), anemia is defined as Hgb less than 11.0 g/dL.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para mark-changed'>Anemia is a prognostic factor required for staging of Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) in AJCC 8th edition, Chapter 79 


















<em>Hodgkin and Non-Hodgkin Lymphomas</em>.  It is a new data item for cases diagnosed 1/1/2018+.</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>0</td><td class='code-desc'>Anemia not present<br/> 
Hgb >=11.0 g/dL
 </td></tr><tr class='code-row'><td class='code-nbr'>1</td><td class='code-desc'>Anemia present<br/> 
Hgb <11.0 g/dL
</td></tr><tr class='code-row'><td class='code-nbr'>6</td><td class='code-desc'>Lab value unknown, physician states patient is anemic</td></tr><tr class='code-row'><td class='code-nbr'>7</td><td class='code-desc'>Test ordered, results not in chart</td></tr><tr class='code-row'><td class='code-nbr'>9</td><td class='code-desc'>Not documented in medical record<br/>
Anemia not assessed or unknown if assessed
</td></tr><tr class='code-row'><td class='code-nbr'></td><td class='code-desc'> </td></tr></table></div><div class='content chap10-para'>Each Site-Specific Data Item (SSDI) applies only to selected primary sites, histologies, and years of diagnosis. Depending on applicability and standard-setter requirements, SSDIs may be left blank.</div><a name='3100'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>ARCHIVE FIN</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">3100</td><td style="text-align:center;">10</td><td style="text-align:center;"><a href='#sources'>CoC</a></td><td style="text-align:center;">2003</td><td style="text-align:center;">10</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">735 - 744</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>archiveFin</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>This field identifies the CoC Facility Identification Number (FIN) of the facility at the time it originally accessioned the tumor. </div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>When CoC accredited facilities merge or join networks, their unique CoC Facility Identification Number (FIN) [540] may change. Archive FIN preserves the identity of the facility at the time the case was originally accessioned so that records resubmitted subsequent to such a reorganization can be recognized as belonging to the same facility<strong><br /><br />Instructions for Coding</strong><br />CoC maintains the codes, including those for non-hospital sources of reporting.<br /><br />For facilities with 7-digit FINs in the range of 6020009-6953290 that were assigned by CoC before January 1, 2001, the coded FIN will consist of three leading zeroes followed by the full 7-digit number.<br /><br />For facilities with FINs greater than or equal to 10000000 that were assigned by CoC after January 1, 2001, enter FIN codes of this type as two zeroes followed by the full 8-digit code. These sometimes are called CoC FIN 10-digit codes. </div><a name='1930'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>AUTOPSY</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">1930</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>NAACCR</a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">2947 - 2947</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>autopsy</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Patient</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Code indicating whether or not an autopsy was performed.</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>0</td><td class='code-desc'>Not applicable; patient alive</td></tr><tr class='code-row'><td class='code-nbr'>1</td><td class='code-desc'>Autopsy performed</td></tr><tr class='code-row'><td class='code-nbr'>2</td><td class='code-desc'>No autopsy performed</td></tr><tr class='code-row'><td class='code-nbr'>9</td><td class='code-desc'>Patient expired, unknown if autopsy performed</td></tr><tr class='code-row'><td class='code-nbr'>This data item is no longer supported by CoC (As of January 1, 2003).</td><td class='code-desc'> </td></tr></table></div><a name='3812'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>B SYMPTOMS</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">3812</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>NAACCR</a></td><td style="text-align:center;">2018</td><td style="text-align:center;">18</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1868 - 1868</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>bSymptoms</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>B symptoms refer to systemic symptoms of fever, night sweats, and weight loss which can be associated with both Hodgkin lymphoma and some non-Hodgkin lymphomas. The presence of B symptoms is a prognostic factor for some lymphomas.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>B symptoms is a Registry Data Collection Variable in AJCC. This data item was previously collected for Lymphomas, SSF# 2.</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>0</td><td class='code-desc'>No B symptoms (asymptomatic)<br/> 
Classified as "A" by physician when asymptomatic
 
</td></tr><tr class='code-row'><td class='code-nbr'>1</td><td class='code-desc'>Any B symptom(s)<br/>
Night sweats (drenching)<br/>
Unexplained fever (above 38 degrees C)<br/>
Unexplained weight loss (generally greater than 10% of body weight in the six months before admission)<br/>
B symptoms, NOS<br/>
Classified as "B" by physician when symptomatic
</td></tr><tr class='code-row'><td class='code-nbr'>8</td><td class='code-desc'>Not applicable: Information not collected for this case<br/>
(If this item is required by your standard setter, use of code 8 will result in an edit error.)
</td></tr><tr class='code-row'><td class='code-nbr'>9</td><td class='code-desc'>Not documented in medical record<br/>
B symptoms not assessed or unknown if assessed
</td></tr><tr class='code-row'><td class='code-nbr'></td><td class='code-desc'> </td></tr></table></div><div class='content chap10-para'>Each Site-Specific Data Item (SSDI) applies only to selected primary sites, histologies, and years of diagnosis. Depending on applicability and standard-setter requirements, SSDIs may be left blank.</div><a name='1972'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>BEHAVIOR (73-91) ICD-O-1</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">1972</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>SEER</a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">2604 - 2604</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>behaviorIcdO1</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Area for retaining behavior portion (1 digit) of the ICD-O-1 or field trial morphology codes entered before a conversion to ICD-O-2. See grouped data item Morph (73-91) ICD-O-1 [1970] in Appendix E. The item name includes years 73-91. However, some states may have used the codes for cases before 1973. It is a subfield of the morphology code. </div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'>For tumors diagnosed before 1992, contains the ICD-O-1 or field trial 1-digit behavior code as originally coded, if available. Blank for tumors coded directly into a later version of ICD-O.</div><a name='430'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>BEHAVIOR (92-00) ICD-O-2</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">430</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>SEER/CoC</a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">563 - 563</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>ICD-O-2 Behaviour (CCCR)<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>behaviorIcdO2</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Code for the behavior of the tumor being reported using ICD-O-2. NAACCR adopted ICD-O-2 as the standard coding system for tumors diagnosed from January 1, 1992, through December 31, 2000. In addition, NAACCR recommended that cases diagnosed prior to 1992 be converted to ICD-O-2. See Behavior (73-91) ICD-O-1 [1972], for ICD-O-1 and field trial codes. </div><div class='content chap10-para'><strong>Clarification of Required Status</strong> This data item was required by all standard-setting organizations for tumors diagnosed from January 1, 1992, through December 31, 2000, and recommended for tumors diagnosed before 1992.<br /><br />When the histologic type is coded according to the ICD-O-2, the histology code must be reported in Histology (92-00) ICD-O-2 [420], with behavior coded in Behavior (92-00) ICD-O-2 [430].<br /><br />For information on required status for related data items for histologic type and behavior when coded according to ICD-O-3, see Histologic Type ICD-O-3 [522] and Behavior Code ICD-O-3 [523]. </div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><p>Valid codes are 0-3. See ICD-O-2,<sup>15</sup> page 22, for behavior codes and definitions.</p></div><a name='523'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>BEHAVIOR CODE ICD-O-3</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">523</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>SEER/CoC</a></td><td style="text-align:center;">2001</td><td style="text-align:center;">9</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">568 - 568</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>Behavior Code (CoC)<br />ICD-O-3 Behaviour (CCCR)<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>behaviorCodeIcdO3</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Code for the behavior of the tumor being reported using ICD-O-3. NAACCR adopted ICD-O-3 as the standard coding system for tumors diagnosed beginning January 1, 2001, and later recommended that prior cases be converted from ICD-O-2. See Behavior (92-00) ICD-O-2 [430], for ICD-O-2 codes.<br /><br />Juvenile astrocytoma is coded as borderline in ICD-O-3; North American registries report as 9421/3. </div><div class='content chap10-para'><div><strong>Clarification of Required Status</strong></div><div>Behavior is required by all standard-setting organizations for tumors diagnosed on or after January 1, 2001, and recommended (by conversion from ICD-O-2 codes) for tumors diagnosed before 2001.</div><br />When the histologic type is coded according to the ICD-O-3, the histology code must be reported in Histologic Type ICD-O-3 [522], with behavior coded in Behavior Code ICD-O-3 [523].<br /><br />For information on required status for related data items for histologic type and behavior when coded according to ICD-O-2, see Histology (92-00) ICD-O-2 [420] and Behavior (92-00) ICD-O-2 [430]. </div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><p>Valid codes are 0-3. See ICD-O-3,<sup>14 </sup>page 66, for behavior codes and definitions.</p></div><a name='3813'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>BILIRUBIN PRETREATMENT TOTAL LAB VALUE</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">3813</td><td style="text-align:center;">5</td><td style="text-align:center;"><a href='#sources'>NAACCR</a></td><td style="text-align:center;">2018</td><td style="text-align:center;">18</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1851 - 1855</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>bilirubinPretxTotalLabValue</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Bilirubin Pretreatment Total Lab Value records the bilirubin value prior to treatment. Bilirubin level is an indicator of how effectively the liver excretes bile and is required to calculate the Model for End-Stage Liver Disease (MELD) score used to assign priority for liver transplant.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Bilirubin Pretreatment Total Lab Value is a Registry Data Collection Variable in AJCC. This data item was previously collected as Liver, CS SSF# 6.</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>0.0</td><td class='code-desc'>0.0 milligram/deciliter (mg/dL)<br/>
0.0 micromole/liter (umol/L)
</td></tr><tr class='code-row'><td class='code-nbr'>0.1-999.9</td><td class='code-desc'>0.1-999.9 milligram/deciliter (mg/dL)<br/>
0.1-999.9 micromole/liter (umol/L)
</td></tr><tr class='code-row'><td class='code-nbr'>XXX.1</td><td class='code-desc'>1000 milligram/deciliter (mg/dL) or greater<br/>
1000 micromole/liter (umol/L) or greater
</td></tr><tr class='code-row'><td class='code-nbr'>XXX.7</td><td class='code-desc'>Test ordered, results not in chart</td></tr><tr class='code-row'><td class='code-nbr'>XXX.8</td><td class='code-desc'>Not applicable:  Information not collected for this case<br/>
(If this item is required by your standard setter, use of code XXX.8 will result in an edit error.)
</td></tr><tr class='code-row'><td class='code-nbr'>XXX.9</td><td class='code-desc'>Not documented in medical record<br/>
Bilirubin Pretreatment Total Lab Value not assessed or unknown if assessed
</td></tr><tr class='code-row'><td class='code-nbr'></td><td class='code-desc'> </td></tr></table></div><div class='content chap10-para'>Each Site-Specific Data Item (SSDI) applies only to selected primary sites, histologies, and years of diagnosis. Depending on applicability and standard-setter requirements, SSDIs may be left blank. </div><a name='3814'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>BILIRUBIN PRETREATMENT UNIT OF MEASURE</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">3814</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>NAACCR</a></td><td style="text-align:center;">2018</td><td style="text-align:center;">18</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1856 - 1856</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>bilirubinPretxUnitOfMeasure</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Bilirubin Pretreatment Unit of Measure identifies the unit of measure for the bilirubin value measured prior to treatment. Bilirubin is commonly measured in units of Milligrams/deciliter (mg/dL) in the United States and Micromoles/liter (umol/L) in Canada and Europe.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Bilirubin Pretreatment is a Registry Data Collection Variable in AJCC. Bilirubin Pretreatment Unit of Measure is needed to identify the unit in which bilirubin is measured and was previously collected as Liver, CS SSF# 7.</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>1</td><td class='code-desc'>Milligrams per deciliter (mg/dL)</td></tr><tr class='code-row'><td class='code-nbr'>2</td><td class='code-desc'>Micromoles/liter (umol/L)</td></tr><tr class='code-row'><td class='code-nbr'>7</td><td class='code-desc'>Test ordered, results not in chart </td></tr><tr class='code-row'><td class='code-nbr'>8</td><td class='code-desc'>Not applicable: Information not collected for this case<br/>
(If this item is required by your standard setter, use of code 8 will result in an edit error.)
</td></tr><tr class='code-row'><td class='code-nbr'>9</td><td class='code-desc'>Not documented in medical record<br/>
Bilirubin unit of measure not assessed or unknown if assessed
</td></tr><tr class='code-row'><td class='code-nbr'></td><td class='code-desc'> </td></tr></table></div><div class='content chap10-para'>Each Site-Specific Data Item (SSDI) applies only to selected primary sites, histologies, and years of diagnosis. Depending on applicability and standard-setter requirements, SSDIs may be left blank. </div><a name='250'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>BIRTHPLACE</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">250</td><td style="text-align:center;">3</td><td style="text-align:center;"><a href='#sources'>SEER/CoC</a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">236 - 238</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>Place of Birth (SEER/CoC)<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>birthplace</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Patient</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Code for place of birth of the patient. If a patient has multiple tumors, all records should contain the same code. </div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Place of Birth is helpful for patient matching and can be used when reviewing race and ethnicity. In addition, adding birthplace data to race and ethnicity allows for a more specific definition of the population being reported. Careful descriptions of ancestry, birthplace, and immigration history of populations studied are needed to make the basis for classification into ethnic groups clear. Birthplace has been associated with variation in genetic, socioeconomic, cultural, and nutritional characteristics that affect patterns of disease. A better understanding of the differences within racial and ethnic categories also can help states develop effective, culturally sensitive public health prevention programs to decrease the prevalence of high-risk behaviors and increase the use of preventive services. </div><div class='content chap10-para'><em>Note</em>: For cases diagnosed January 1, 2013, and later, Birthplace--State [252] and Birthplace--Country [254] replace Birthplace [250]. </div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'>See Appendix B&#160; for numeric and alphabetic lists of places and codes (also see Appendix B of the <em>SEER Program Code Manual</em> at <a href="http://seer.cancer.gov/tools/codingmanuals/index.html">seer.cancer.gov/tools/codingmanuals/index.html</a>).</div><a name='254'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>BIRTHPLACE--COUNTRY</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">254</td><td style="text-align:center;">3</td><td style="text-align:center;"><a href='#sources'>NAACCR</a></td><td style="text-align:center;">2013</td><td style="text-align:center;">13</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">472 - 474</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>birthplaceCountry</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Patient</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Code for the country in which the patient was born. If the patient has multiple tumors, all records should contain the same code. This data item became part of the NAACCR transmission record effective with Volume II, Version 13 in order to include country and state for each geographic item and to use interoperable codes. It supplements the item BIRTHPLACE--STATE [252].  These two data items are intended to replace the use of BIRTHPLACE [250]. </div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Place of Birth is helpful for patient matching and can be used when reviewing race and ethnicity. It is an important item in algorithms for imputing race and ethnicity. In addition, adding birthplace data to race and ethnicity allows for a more specific definition of the population being reported. Careful descriptions of ancestry, birthplace, and immigration history of populations studied are needed to make the basis for classification into ethnic groups clear. Birthplace has been associated with variation in genetic, socioeconomic, cultural, and nutritional characteristics that affect patterns of disease. A better understanding of the differences within racial and ethnic categories also can help states develop effective, culturally-sensitive public health prevention programs to decrease the prevalence of high-risk behaviors and increase the use of preventive services. </div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr' colspan='2'>Custom codes for historic use only </td></tr><tr class='code-row'><td class='code-nbr'>ZZN</td><td class='code-desc'>North America NOS</td></tr><tr class='code-row'><td class='code-nbr'>ZZC</td><td class='code-desc'>Central American NOS</td></tr><tr class='code-row'><td class='code-nbr'>ZZS</td><td class='code-desc'>South America NOS</td></tr><tr class='code-row'><td class='code-nbr'>ZZP</td><td class='code-desc'>Pacific NOS</td></tr><tr class='code-row'><td class='code-nbr'>ZZE</td><td class='code-desc'>Europe NOS</td></tr><tr class='code-row'><td class='code-nbr'>ZZF</td><td class='code-desc'>Africa NOS</td></tr><tr class='code-row'><td class='code-nbr'>ZZA</td><td class='code-desc'>Asia NOS</td></tr><tr class='code-row'><td class='code-nbr'>ZZX</td><td class='code-desc'>Non-US NOS</td></tr><tr class='code-row'><td class='code-nbr'>ZZU</td><td class='code-desc'>Unknown</td></tr><tr class='code-row'><td class='code-nbr' colspan='2'>Custom codes for historic use only </td></tr><tr class='code-row'><td class='code-nbr'>XNI</td><td class='code-desc'>North American Islands</td></tr><tr class='code-row'><td class='code-nbr'>XCB</td><td class='code-desc'>Other Caribbean Islands</td></tr><tr class='code-row'><td class='code-nbr'>XEN</td><td class='code-desc'>England, Channel Islands, Isle of Man</td></tr><tr class='code-row'><td class='code-nbr'>XSC</td><td class='code-desc'>Scandinavia</td></tr><tr class='code-row'><td class='code-nbr'>XGR</td><td class='code-desc'>Germanic Countries</td></tr><tr class='code-row'><td class='code-nbr'>XSL</td><td class='code-desc'>Slavic Countries</td></tr><tr class='code-row'><td class='code-nbr'>CSK</td><td class='code-desc'>Czechoslovakia (former)</td></tr><tr class='code-row'><td class='code-nbr'>YUG</td><td class='code-desc'>Yugoslavia (former)</td></tr><tr class='code-row'><td class='code-nbr'>XUM</td><td class='code-desc'>Ukraine and Moldova</td></tr><tr class='code-row'><td class='code-nbr'>XNF</td><td class='code-desc'>North Africa</td></tr><tr class='code-row'><td class='code-nbr'>XSD</td><td class='code-desc'>Sudanese Countries</td></tr><tr class='code-row'><td class='code-nbr'>XWF</td><td class='code-desc'>West Africa</td></tr><tr class='code-row'><td class='code-nbr'>XSF</td><td class='code-desc'>South Africa</td></tr><tr class='code-row'><td class='code-nbr'>XEF</td><td class='code-desc'>East Africa</td></tr><tr class='code-row'><td class='code-nbr'>XIF</td><td class='code-desc'>African Islands</td></tr><tr class='code-row'><td class='code-nbr'>XET</td><td class='code-desc'>Ethiopia and Eritrea</td></tr><tr class='code-row'><td class='code-nbr'>XAP</td><td class='code-desc'>Arabian Peninsula</td></tr><tr class='code-row'><td class='code-nbr'>XIS</td><td class='code-desc'>Israel and Palestine</td></tr><tr class='code-row'><td class='code-nbr'>XCR</td><td class='code-desc'>Caucasian Republics of former USSR</td></tr><tr class='code-row'><td class='code-nbr'>XOR</td><td class='code-desc'>Other Asian Republics of former USSR</td></tr><tr class='code-row'><td class='code-nbr'>XSE</td><td class='code-desc'>Southeast Asia</td></tr><tr class='code-row'><td class='code-nbr'>XMS </td><td class='code-desc'>Malaysia, Singapore, Brunei</td></tr><tr class='code-row'><td class='code-nbr'>XCH</td><td class='code-desc'>China, NOS</td></tr><tr class='code-row'><td class='code-nbr'>XML</td><td class='code-desc'>Melanesian Islands</td></tr><tr class='code-row'><td class='code-nbr'>XMC</td><td class='code-desc'>Micronesian Islands</td></tr><tr class='code-row'><td class='code-nbr'>XPL</td><td class='code-desc'>Polynesian Islands</td></tr><tr class='code-row'><td class='code-nbr'></td><td class='code-desc'> </td></tr></table></div><div class='content chap10-para'>See Appendix B for numeric and alphabetic lists of places and codes (also see Appendix B of the <em>SEER Program Code Manual</em> at <a href="http://seer.cancer.gov/tools/codingmanuals/index.html">seer.cancer.gov/tools/codingmanuals/index.html</a>).</div><a name='252'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>BIRTHPLACE--STATE</strong></td><td style="text-align:right;font-weight:bold;"><strong>Revised</strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">252</td><td style="text-align:center;">2</td><td style="text-align:center;"><a href='#sources'>NAACCR</a></td><td style="text-align:center;">2013</td><td style="text-align:center;">13</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">470 - 471</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>birthplaceState</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Patient</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para mark-changed'>USPS abbreviation for the state, commonwealth, U.S. possession; or CanadaPost abbreviation for the Canadian province/territory in which the patient was born. If the patient has multiple primaries, the state of birth is the same for each tumor. This data item became part of the NAACCR transmission record effective with Volume II, Version 13 in order to include country and state for each geographic item and to use interoperable codes. It supplements the item BIRTHPLACE--COUNTRY [254].  These two data items are intended to replace the item BIRTHPLACE [250].</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para mark-changed'>This is a modification of the current item Birthplace [250] item in order to make use of standard codes, rather than using geographic codes that are only used by cancer registries. The intention is that item 250 be converted to populate the new corresponding, more standard, data items.</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'>See Appendix B  for numeric and alphabetic lists of places and codes (also see Appendix B of the <em>SEER Program Code Manual</em> at <a href="http://seer.cancer.gov/tools/codingmanuals/index.html">seer.cancer.gov/tools/codingmanuals/index.html</a>).</div><a name='3815'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>BONE INVASION</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">3815</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>NAACCR</a></td><td style="text-align:center;">2018</td><td style="text-align:center;">18</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1950 - 1950</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>boneInvasion</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Bone invasion, the presence or absence of bone invasion based on imaging, is a prognostic factor for soft tissue sarcomas.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Bone Invasion is a Registry Data Collection Variable in AJCC. This data item was previously collected for Soft Tissue, SSF# 3.</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>0</td><td class='code-desc'>Bone invasion not present/not identified on imaging </td></tr><tr class='code-row'><td class='code-nbr'>1</td><td class='code-desc'>Bone invasion present/identified on imaging</td></tr><tr class='code-row'><td class='code-nbr'>8</td><td class='code-desc'>Not applicable: Information not collected for this case<br/>
(If this information is required by your standard setter, use of code 8 may result in an edit error.)
</td></tr><tr class='code-row'><td class='code-nbr'>9</td><td class='code-desc'>Not documented in medical record<br/>
Bone invasion not assessed or unknown if assessed
</td></tr><tr class='code-row'><td class='code-nbr'></td><td class='code-desc'> </td></tr></table></div><div class='content chap10-para'>Each Site-Specific Data Item (SSDI) applies only to selected primary sites, histologies, and years of diagnosis. Depending on applicability and standard-setter requirements, SSDIs may be left blank. </div><a name='3940'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>BRAF MUTATIONAL ANALYSIS</strong></td><td style="text-align:right;font-weight:bold;"><strong>New</strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">3940</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>NAACCR</a></td><td style="text-align:center;">2021</td><td style="text-align:center;">21</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1 - 1</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>brafMutationalAnalysis</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>The BRAF oncoprotein is involved in transmitting cell growth and proliferation signals from KRAS and NRAS. The BRAF V600E mutation is associated with poorer prognosis and predicts lack of response to anti-EGFR therapies.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>BRAF mutational analysis is recommended in clinical guidelines for patients with advanced colorectal cancer as a prognostic marker and factor in determining appropriate therapy.&nbsp; It is a new data item for cases diagnosed 1/1/2021+.</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>0</td><td class='code-desc'>Normal<br/>
BRAF negative, BRAF wild type<br/>
Negative for (somatic) mutations, no alterations, no (somatic) mutations identified, not present, not detected
</td></tr><tr class='code-row'><td class='code-nbr'>1</td><td class='code-desc'>Abnormal (mutated)/detected: BRAF V600E (c.1799T>A) mutation</td></tr><tr class='code-row'><td class='code-nbr'>2</td><td class='code-desc'>Abnormal (mutated)/detected, but not BRAF V600E (c.1799T>A) mutation</td></tr><tr class='code-row'><td class='code-nbr'>4</td><td class='code-desc'>Abnormal (mutated), NOS</td></tr><tr class='code-row'><td class='code-nbr'>7</td><td class='code-desc'>Test ordered, results not in chart</td></tr><tr class='code-row'><td class='code-nbr'>8</td><td class='code-desc'>Not applicable: Information not collected for this case<br/>
If this information is required by your standard setter, use of code 8 may result in an edit error.)
</td></tr><tr class='code-row'><td class='code-nbr'>9</td><td class='code-desc'>Not documented in medical record<br/>
BRAF not assessed or unknown if assessed
</td></tr><tr class='code-row'><td class='code-nbr' colspan='2'></td></tr></table></div><div class='content chap10-para'>Each Site-Specific Data Item (SSDI) applies only to selected primary 
sites, histologies, and years of diagnosis. Depending on applicability 
and standard-setter requirements, SSDIs may be left blank.</div><a name='3816'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>BRAIN MOLECULAR MARKERS</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">3816</td><td style="text-align:center;">2</td><td style="text-align:center;"><a href='#sources'>NAACCR</a></td><td style="text-align:center;">2018</td><td style="text-align:center;">18</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1994 - 1995</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>brainMolecularMarkers</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Multiple brain molecular markers have become standard pathology components necessary for diagnosis. This data item captures clinically important brain cancer subtypes identified by molecular markers that are not distinguishable by ICD-O-3 codes.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Collection of these clinically important brain cancer subtypes has been recommended by CBTRUS.</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>01</td><td class='code-desc'>Diffuse astrocytoma, IDH-mutant (9400/3) </td></tr><tr class='code-row'><td class='code-nbr'>02</td><td class='code-desc'>Diffuse astrocytoma, IDH-wildtype (9400/3)</td></tr><tr class='code-row'><td class='code-nbr'>03</td><td class='code-desc'>Anaplastic astrocytoma, IDH-mutant (9401/3)</td></tr><tr class='code-row'><td class='code-nbr'>04</td><td class='code-desc'>Anaplastic astrocytoma, IDH-wildtype (9401/3)</td></tr><tr class='code-row'><td class='code-nbr'>05</td><td class='code-desc'>Glioblastoma, IDH-wildtype (9440/3)</td></tr><tr class='code-row'><td class='code-nbr'>06</td><td class='code-desc'>Oligodendroglioma, IDH-mutant and 1 p/19q co-deleted (9450/3)</td></tr><tr class='code-row'><td class='code-nbr'>07</td><td class='code-desc'>Anaplastic oligodendroglioma, IDH-mutant and 1 p/19q co-deleted (9451/3)</td></tr><tr class='code-row'><td class='code-nbr'>08</td><td class='code-desc'>Medulloblastoma, SHH-activated and TP53-wildtype (9471/3)</td></tr><tr class='code-row'><td class='code-nbr'>09</td><td class='code-desc'>Embryonal tumor with multilayered rosettes, C19MC-altered (9478/3)</td></tr><tr class='code-row'><td class='code-nbr'>85</td><td class='code-desc'>Not applicable: Histology not 9400/3, 9401/3, 9440/3, 9450/3, 9451/3, 9471/3, 9478/3 </td></tr><tr class='code-row'><td class='code-nbr'>86</td><td class='code-desc'>Benign or borderline tumor</td></tr><tr class='code-row'><td class='code-nbr'>87</td><td class='code-desc'>Test ordered, results not in chart</td></tr><tr class='code-row'><td class='code-nbr'>88</td><td class='code-desc'>Not applicable: Information not collected for this case<br/>
(If this item is required by your standard setter, use of code 88 will result in an edit error.)

</td></tr><tr class='code-row'><td class='code-nbr'>99</td><td class='code-desc'>Not documented in patient record<br/>
No microscopic confirmation<br/>
Brain molecular markers not assessed or unknown if assessed

</td></tr><tr class='code-row'><td class='code-nbr'></td><td class='code-desc'> </td></tr></table></div><div class='content chap10-para'>Each Site-Specific Data Item (SSDI) applies only to selected primary sites, histologies, and years of diagnosis. Depending on applicability and standard-setter requirements, SSDIs may be left blank. </div><a name='3817'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>BRESLOW TUMOR THICKNESS </strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">3817</td><td style="text-align:center;">4</td><td style="text-align:center;"><a href='#sources'>NAACCR</a></td><td style="text-align:center;">2018</td><td style="text-align:center;">18</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1891 - 1894</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>breslowTumorThickness</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Breslow Tumor Thickness, the measurement of the thickness of a melanoma as defined by Dr. Alexander Breslow, is a prognostic factor for Melanoma of the Skin.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Breslow Tumor Thickness is a Registry Data Collection Variable in AJCC.  It was previously collected as Melanoma Skin, CS SSF# 1.</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>0.0</td><td class='code-desc'>No mass/tumor found</td></tr><tr class='code-row'><td class='code-nbr'>0.1</td><td class='code-desc'>Greater than 0.0 and less than or equal to 0.1 </td></tr><tr class='code-row'><td class='code-nbr'>0.2-99.9</td><td class='code-desc'>0.2 - 99.9 millimeters</td></tr><tr class='code-row'><td class='code-nbr'>XX.1</td><td class='code-desc'>100 millimeters or larger </td></tr><tr class='code-row'><td class='code-nbr'>A0.1-A9.9</td><td class='code-desc'>Stated as "at least" some measured value of 0.1 to 9.9</td></tr><tr class='code-row'><td class='code-nbr'>AX.0</td><td class='code-desc'>Stated as greater than 9.9 mm</td></tr><tr class='code-row'><td class='code-nbr'>XX.8</td><td class='code-desc'>Not applicable: Information not collected for this schema<br/>
(If this item is required by your standard setter, use of code XX.8 will result in an edit error)
</td></tr><tr class='code-row'><td class='code-nbr'>XX.9</td><td class='code-desc'>Not documented in medical record<br/>
Microinvasion; microscopic focus or foci only and no depth given<br/>
Cannot be determined by pathologist<br/>
In situ melanoma<br/>
Breslow Tumor Thickness not assessed or unknown if assessed
</td></tr><tr class='code-row'><td class='code-nbr' colspan='2'></td></tr></table></div><div class='content chap10-para'>Each Site-Specific Data Item (SSDI) applies only to selected primary sites, histologies, and years of diagnosis. Depending on applicability and standard-setter requirements, SSDIs may be left blank.</div><a name='3942'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>CA 19-9 PRETX LAB VALUE</strong></td><td style="text-align:right;font-weight:bold;"><strong>New</strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">3942</td><td style="text-align:center;">6</td><td style="text-align:center;"><a href='#sources'>NAACCR</a></td><td style="text-align:center;">2021</td><td style="text-align:center;">21</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1 - 6</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>Carbohydrate Antigen 19-9 Pretreatment Lab Value<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>ca199PretxLabValue</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Carbohydrate Antigen (CA) 19-9 Pretreatment Lab Value records the CA 19-9 value prior to treatment. CA 19-9 is a tumor marker that has prognostic significance for pancreatic cancer.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>CA 19-9 Pretreatment Lab Value is a strong predictor of resectability in the absence of metastatic disease. It is a new data item for cases diagnosed 01/01/2021+.</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>0.0</td><td class='code-desc'>0.0 Units/milliliter (U/ml) exactly </td></tr><tr class='code-row'><td class='code-nbr'>0.1-9999.9</td><td class='code-desc'>0.1-9999.9 U/ml<br/>
Exact value to nearest tenth in U/ml)
</td></tr><tr class='code-row'><td class='code-nbr'>XXXX.1</td><td class='code-desc'>10,000 U/ml or greater</td></tr><tr class='code-row'><td class='code-nbr'>XXXX.7</td><td class='code-desc'>Test ordered, results not in chart</td></tr><tr class='code-row'><td class='code-nbr'>XXXX.8</td><td class='code-desc'>Not applicable: Information not collected for this case<br/>
If this information is required by your standard setter, use of code XXXX.8 may result in an edit error.
</td></tr><tr class='code-row'><td class='code-nbr'>XXXX.9</td><td class='code-desc'>Not documented in medical record<br/>
CA (Carbohydrate Antigen) 19-9 Pretreatment Lab Value not assessed or unknown if assessed
</td></tr><tr class='code-row'><td class='code-nbr'></td><td class='code-desc'> </td></tr></table></div><div class='content chap10-para'>Each Site-Specific Data Item (SSDI) applies only to selected primary 
sites, histologies, and years of diagnosis. Depending on applicability 
and standard-setter requirements, SSDIs may be left blank.</div><a name='3818'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>CA-125 PRETREATMENT INTERPRETATION</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">3818</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>NAACCR</a></td><td style="text-align:center;">2018</td><td style="text-align:center;">18</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1919 - 1919</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>: CA-125 (Carbohydrate Antigen 125) Pretreatment Interpretation<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>ca125PretreatmentInterpretation</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Carbohydrate Antigen 125 (CA-125) is a tumor marker that is useful for following the response to therapy in patients with ovarian cancer, who may have elevated levels of this marker.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Preoperative CA-125 is a Registry Data Collection Variable listed in AJCC. It was previously collected as Ovary, CS SSF# 1.</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>0</td><td class='code-desc'>Negative/normal; within normal limits</td></tr><tr class='code-row'><td class='code-nbr'>1</td><td class='code-desc'>Positive/elevated</td></tr><tr class='code-row'><td class='code-nbr'>2</td><td class='code-desc'>Stated as borderline; undetermined whether positive or negative</td></tr><tr class='code-row'><td class='code-nbr'>7</td><td class='code-desc'>Test ordered, results not in chart</td></tr><tr class='code-row'><td class='code-nbr'>8</td><td class='code-desc'>Not applicable: Information not collected for this case<br/>
(If this item is required by your standard setter, use of code 8 will result in an edit error)
</td></tr><tr class='code-row'><td class='code-nbr'>9</td><td class='code-desc'>Not documented in medical record<br/>
CA-125 not assessed or unknown if assessed
</td></tr><tr class='code-row'><td class='code-nbr'></td><td class='code-desc'> </td></tr></table></div><div class='content chap10-para'>Each Site-Specific Data Item (SSDI) applies only to selected primary sites, histologies, and years of diagnosis. Depending on applicability and standard-setter requirements, SSDIs may be left blank.</div><a name='1770'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>CANCER STATUS</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">1770</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>CoC</a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">2787 - 2787</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>cancerStatus</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'><p style="0in;0in; .5in;.0001pt;normal">Records the presence or absence of clinical evidence of the patient's malignant or non-malignant tumor as of the Date of Last Cancer (tumor) Status [1772]. If the patient has multiple primaries, the values may be different for each primary.</p>
<!--[if gte mso 10]>  <![endif]--></div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>This item can be used to compute disease-free survival. By maintaining this data item, central registries can assist hospital registries by sharing this information with other hospital registries that serve the same patients, if the state&#8217;s privacy laws so permit.</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>1</td><td class='code-desc'>No evidence of this tumor</td></tr><tr class='code-row'><td class='code-nbr'>2</td><td class='code-desc'>Evidence of this tumor</td></tr><tr class='code-row'><td class='code-nbr'>9</td><td class='code-desc'>Unknown, indeterminate whether this tumor is present, not stated in patient record</td></tr></table></div><a name='501'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>CASEFINDING SOURCE</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">501</td><td style="text-align:center;">2</td><td style="text-align:center;"><a href='#sources'>NAACCR</a></td><td style="text-align:center;">2006</td><td style="text-align:center;">11</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">578 - 579</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>casefindingSource</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>This variable codes the earliest source of identifying information. For cases identified by a source other than reporting facilities (such as through death clearance or as a result of an audit), this variable codes the type of source through which the tumor was first identified. This data item cannot be used by itself as a data quality indicator. The timing of the casefinding processes (e.g., death linkage) varies from registry to registry, and the coded value of this variable is a function of that timing. </div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>This data item will help reporting facilities as well as regional and central registries in prioritizing their casefinding activities. It will identify reportable tumors that were first found through death clearance or sources other than traditional reporting facilities. It provides more detail than "Type of Reporting Source."<br /><br /><strong>Coding Instructions<strong><br /></strong></strong>This variable is intended to code the source that first identified the tumor. Determine where the case was first identified and enter the appropriate code. At the regional or central level, if a hospital and a non-hospital source identified the case independently of each other, enter the code for the non-hospital source (i.e., codes 30-95 have priority over codes 10-29). If the case was first identified at a reporting facility (codes 10-29), code the earliest source (based on patient or specimen contact at the facility) of identifying information.<br /><br />If a death certificate, independent pathology laboratory report, consultation-only report from a hospital, or other report was used to identify a case that was then abstracted from a different source, enter the code for the source that first identified the case, not the source from which it was subsequently abstracted. If a regional or central registry identifies a case and asks a reporting facility to abstract it, enter the code that corresponds to the initial source, not the code that corresponds to the eventual reporting facility. </div><div class='content chap10-para'><strong>
  <span style="background-color: #ffffff;">Codes&#160;</span>
</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>10</td><td class='code-desc'>Reporting Hospital, NOS</td></tr><tr class='code-row'><td class='code-nbr'>20</td><td class='code-desc'>Pathology Department Review (surgical pathology reports, autopsies, or cytology reports)</td></tr><tr class='code-row'><td class='code-nbr'>21</td><td class='code-desc'>Daily Discharge Review (daily screening of charts of discharged patients in the medical records department)</td></tr><tr class='code-row'><td class='code-nbr'>22</td><td class='code-desc'>Disease Index Review (review of disease index in the medical records department)</td></tr><tr class='code-row'><td class='code-nbr'>23</td><td class='code-desc'>Radiation Therapy Department/Center</td></tr><tr class='code-row'><td class='code-nbr'>24</td><td class='code-desc'>Laboratory Reports (other than pathology reports, code 20)</td></tr><tr class='code-row'><td class='code-nbr'>25</td><td class='code-desc'>Outpatient Chemotherapy</td></tr><tr class='code-row'><td class='code-nbr'>26</td><td class='code-desc'>Diagnostic Imaging/Radiology (other than radiation therapy, codes 23; includes nuclear medicine)</td></tr><tr class='code-row'><td class='code-nbr'>27</td><td class='code-desc'>Tumor Board</td></tr><tr class='code-row'><td class='code-nbr'>28</td><td class='code-desc'>Hospital Rehabilitation Service or Clinic</td></tr><tr class='code-row'><td class='code-nbr'>29</td><td class='code-desc'>Other Hospital Source (including clinic, NOS or outpatient department, NOS)</td></tr><tr class='code-row'><td class='code-nbr'>30</td><td class='code-desc'>Physician-Initiated Case</td></tr><tr class='code-row'><td class='code-nbr'>40</td><td class='code-desc'>Consultation-only or Pathology-only Report (not abstracted by reporting hospital)</td></tr><tr class='code-row'><td class='code-nbr'>50</td><td class='code-desc'>Independent (non-hospital) Pathology-Laboratory Report</td></tr><tr class='code-row'><td class='code-nbr'>60</td><td class='code-desc'>Nursing Home-Initiated Case</td></tr><tr class='code-row'><td class='code-nbr'>70</td><td class='code-desc'>Coroner's Office Records Review</td></tr><tr class='code-row'><td class='code-nbr'>75</td><td class='code-desc'>Managed Care Organization (MCO) or Insurance Records</td></tr><tr class='code-row'><td class='code-nbr'>80</td><td class='code-desc'>Death Certificate (case identified through death clearance)</td></tr><tr class='code-row'><td class='code-nbr'>85</td><td class='code-desc'>Out-of-State Case Sharing</td></tr><tr class='code-row'><td class='code-nbr'>90</td><td class='code-desc'>Other Non-Reporting Hospital Source</td></tr><tr class='code-row'><td class='code-nbr'>95</td><td class='code-desc'>Quality Control Review (case initially identified through quality control activities such as casefinding audit of a regional or central registry)</td></tr><tr class='code-row'><td class='code-nbr'>99</td><td class='code-desc'>Unknown</td></tr></table></div><a name='1910'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>CAUSE OF DEATH</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">1910</td><td style="text-align:center;">4</td><td style="text-align:center;"><a href='#sources'>SEER</a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">2940 - 2943</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>Underlying Cause of Death (SEER)<br />Underlying Cause of Death (ICD Code) (pre-96 CoC)<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>causeOfDeath</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Patient</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Official cause of death as coded from the death certificate in valid ICD-7, ICD-8, ICD-9, and ICD-10 codes. </div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Cause of death is used for calculation of adjusted survival rates by the life table method. The adjustment corrects for deaths other than from the diagnosed cancer. </div><div class='content chap10-para'><em>Note:</em> This data item is no longer supported by CoC (as of January 1, 2003). </div><div class='content chap10-para'><strong>Special codes in addition to ICD-7, ICD-8, ICD-9, and ICD-10</strong> (refer to <em><a target="_blank" href="http://seer.cancer.gov/tools/codingmanuals/">SEER Program Code Manual</a></em> for additional instructions.)</div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>0000</td><td class='code-desc'>Patient alive at last contact</td></tr><tr class='code-row'><td class='code-nbr'>7777</td><td class='code-desc'>State death certificate not available</td></tr><tr class='code-row'><td class='code-nbr'>7797</td><td class='code-desc'>State death certificate available but underlying cause of death is not coded</td></tr></table></div><a name='3819'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>CEA PRETREATMENT INTERPRETATION</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">3819</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>NAACCR</a></td><td style="text-align:center;">2018</td><td style="text-align:center;">18</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1789 - 1789</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>ceaPretreatmentInterpretation</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>CEA (Carcinoembryonic Antigen) Pretreatment Interpretation refers to the interpretation of the CEA value prior to treatment. CEA is a glycoprotein that is produced by adenocarcinomas from all sites as well as many squamous cell carcinomas of the lung and other sites. CEA may be measured in blood, plasma or serum. CEA is a prognostic marker for adenocarcinomas of the appendix, colon and rectum and is used to monitor response to treatment</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>CEA (Carcinoembryonic Antigen) is a Registry Data Collection Variable for AJCC 8. CEA (Carcinoembryonic Antigen) Pretreatment Interpretation was previously collected as Colon and Rectum, CS SSF #1.</div><div class='content chap10-para'><div><strong>Codes</strong></div>
<div>&nbsp;</div></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>0</td><td class='code-desc'>CEA negative/normal; within normal limits</td></tr><tr class='code-row'><td class='code-nbr'>1</td><td class='code-desc'>CEA positive/elevated</td></tr><tr class='code-row'><td class='code-nbr'>2</td><td class='code-desc'>Borderline</td></tr><tr class='code-row'><td class='code-nbr'>3</td><td class='code-desc'>Undetermined if positive or negative (normal values not available)<br/>
AND no MD interpretation
</td></tr><tr class='code-row'><td class='code-nbr'>7</td><td class='code-desc'>Test ordered, results not in chart</td></tr><tr class='code-row'><td class='code-nbr'>8</td><td class='code-desc'>Not applicable: Information not collected for this case<br/>
(If this data item is required by your standard setter, use of code 8 will result in an edit error.)
</td></tr><tr class='code-row'><td class='code-nbr'>9</td><td class='code-desc'>Not documented in medical record<br/>
CEA (Carcinoembryonic Antigen) Pretreatment Interpretation not assessed or unknown if assessed
</td></tr><tr class='code-row'><td class='code-nbr'></td><td class='code-desc'> </td></tr></table></div><div class='content chap10-para'>Each Site-Specific Data Item (SSDI) applies only to selected primary sites, histologies, and years of diagnosis. Depending on applicability and standard-setter requirements, SSDIs may be left blank. </div><a name='3820'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>CEA PRETREATMENT LAB VALUE</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">3820</td><td style="text-align:center;">6</td><td style="text-align:center;"><a href='#sources'>NAACCR</a></td><td style="text-align:center;">2018</td><td style="text-align:center;">18</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1790 - 1795</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>ceaPretreatmentLabValue</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>CEA (Carcinoembryonic Antigen) Pretreatment Lab Value records the CEA value prior to treatment. CEA is a nonspecific tumor marker that has prognostic significance for colon and rectum cancer.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>CEA (Carcinoembryonic Antigen) Pretreatment Lab Value is a Registry Data Collection Variable in AJCC. It was previously collected as Colon and Rectum, CS SSF# 3.</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>0.0</td><td class='code-desc'>0.0 nanograms/milliliter (ng/m) exactly</td></tr><tr class='code-row'><td class='code-nbr'>0.1-9999.9</td><td class='code-desc'>0.1-9999.9 ng/ml<br/>
(Exact value to nearest tenth in ng/ml)
</td></tr><tr class='code-row'><td class='code-nbr'>XXXX.1</td><td class='code-desc'>10,000 ng/ml or greater</td></tr><tr class='code-row'><td class='code-nbr'>XXXX.7</td><td class='code-desc'>Test ordered, results not in chart</td></tr><tr class='code-row'><td class='code-nbr'>XXXX.8</td><td class='code-desc'>Not applicable: Information not collected for this case<br/> 
(If this information is required by your standard setter, use of code XXXX.8 may result in an edit error.)
</td></tr><tr class='code-row'><td class='code-nbr'>XXXX.9</td><td class='code-desc'>Not documented in medical record<br/>
CEA (Carcinoembryonic Antigen) Pretreatment Lab Value not assessed or unknown if assessed
</td></tr><tr class='code-row'><td class='code-nbr'></td><td class='code-desc'> </td></tr></table></div><div class='content chap10-para'>Each Site-Specific Data Item (SSDI) applies only to selected primary sites, histologies, and years of diagnosis. Depending on applicability and standard-setter requirements, SSDIs may be left blank.</div><a name='362'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>CENSUS BLOCK GROUP 2000</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">362</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>Census</a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">178 - 178</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>censusBlockGroup2000</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>This field is provided for coding the block group of patient&#8217;s residence at time of diagnosis, as defined by the 2000 Census.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>A block group is a subdivision of a census tract designed to have an average of 1500 people, versus a census tract&#8217;s average of 4500 people. All land area in the United States is described by a census block group in the 2000 Census. The Census Bureau publishes detailed population and socioeconomic data at this level. <br /><br />Block groups thus offer a high level of specificity for geographical and socioeconomic analyses. A block group has no meaning in the absence of a census tract. Refer to Census Tr Certainty 2000 [365] to ascertain basis of assignment of Census Block Group 2000.</div><div class='content chap10-para'><strong>Comment</strong>  <br />Numerous registries find the distinction between &#8220;attempted, could not be determined&#8221; (zero) and &#8220;not coded&#8221; (blank) to be useful for geocoding planning purposes.</div><div class='content chap10-para'><em>Note:</em> The values 1 through 9 are nominal, with no hierarchy of values. This number determines the first digit of all the blocks which comprise the block group; for instance, census block group 3 would contain blocks numbered 3000 to 3999.</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>0</td><td class='code-desc'>Census block group assignment was attempted, but the value could not be determined</td></tr><tr class='code-row'><td class='code-nbr'>1-9</td><td class='code-desc'>Census block group values as defined by the Census Bureau</td></tr><tr class='code-row'><td class='code-nbr'>Blank</td><td class='code-desc'>Census Block Group 2000 not coded</td></tr></table></div><a name='363'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>CENSUS BLOCK GROUP 2010</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">363</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>Census</a></td><td style="text-align:center;">2011</td><td style="text-align:center;">12.1</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">191 - 191</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>censusBlockGroup2010</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>This field is provided for coding the block group of patient&#8217;s residence at time of diagnosis, as defined by the 2010 Census.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>A block group is a subdivision of a census tract designed to have an average of 1500 people, versus a census tract's average of 4500 people. All land area in the United States is described by a census block group in the 2010 Census. The Census Bureau publishes detailed population and socioeconomic data at this level. Block groups thus offer a high level of specificity for geographical and socioeconomic analyses.<br /><br />A block group has no meaning in the absence of a census tract. Refer to Census Tr Certainty 2010 [367] to ascertain basis of assignment of Census Block Group 2010.</div><div class='content chap10-para'><strong>Comment</strong>  <br />Numerous registries find the distinction between &#8220;attempted, could not be determined&#8221; (zero) and &#8220;not coded&#8221; (blank) to be useful for geocoding planning purposes.</div><div class='content chap10-para'><em>Note:</em> The values 1 through 9 are nominal, with no hierarchy of values. This number determines the first digit of all the blocks which comprise the block group; for instance, census block group 3 would contain blocks numbered 3000 to 3999.</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>0</td><td class='code-desc'>Census block group assignment was attempted, but the value could not be determined</td></tr><tr class='code-row'><td class='code-nbr'>1-9</td><td class='code-desc'>Census block group values as defined by the Census Bureau</td></tr><tr class='code-row'><td class='code-nbr'>Blank</td><td class='code-desc'>Census Block Group 2010 not coded</td></tr></table></div><a name='361'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>CENSUS BLOCK GROUP 2020</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">361</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>Census</a></td><td style="text-align:center;">2018</td><td style="text-align:center;">18</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">204 - 204</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>censusBlockGroup2020</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>This field is provided for coding the block group of patient's residence at time of diagnosis, as defined by the 2020 Census.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>A block group is a subdivision of a census tract designed to have approximately 1500, socially homogeneous people, versus census tracts which are designed to have approximately 4000 people. All land area in the United States is described by a census block group in the 2020 Census. The Census Bureau publishes detailed population and socioeconomic data at this level. Block groups thus offer a high level of specificity for geographical and socioeconomic analyses.<br /><br />A block group has no meaning in the absence of a census tract. Refer to Census Tr Certainty 2020 [369] to ascertain basis of assignment of Census Block Group 2020.</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>0-9</td><td class='code-desc'>Census block group values as defined by the Census Bureau  </td></tr><tr class='code-row'><td class='code-nbr'>Blank</td><td class='code-desc'>Census Block Group 2020 not coded</td></tr><tr class='code-row'><td class='code-nbr'></td><td class='code-desc'> </td></tr></table></div><div class='content chap10-para'><div> <strong>Comment</strong>: </div><div>Historically, some registries made the distinction between "attempted, could not be determined" and "not coded" by using a 0 for "attempted." However, 0 is a valid block group value. </div><br /><em>Note</em>: The values 0 through 9 are nominal, with no hierarchy of values. This number determines the first digit of all the blocks which comprise the block group; for instance, census block group 3 would contain blocks numbered 3000 to 3999.</div><a name='368'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>CENSUS BLOCK GRP 1970/80/90</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">368</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>Census</a></td><td style="text-align:center;">2008</td><td style="text-align:center;">11.2</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">164 - 164</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>Census Block Grp 1970-90<br />CensusBlockGroup 70/80/90<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>censusBlockGrp197090</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>This field is provided for coding the block group of patient's residence at time of diagnosis, as defined by the 1970, 1980, or 1990 Census.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>A block group is a subdivision of a census tract or block numbering area (BNA). Not all of the United States was described by a census block group or BNA prior to the 2000 Census, but for areas assigned to block groups or BNAs, the Census Bureau published detailed population and socioeconomic data. Block groups thus offer a high level of specificity for geographical and socioeconomic analyses, where available.<br /><br />A block group has no meaning in the absence of a census tract. Refer to Census Tr Cert 1970/80/90 [364] to ascertain the basis of assignment of Census Block Grp 1970/80/90 [368]. Refer to Census Cod Sys 1970/80/90 [120] to ascertain the decade of reference.</div><div class='content chap10-para'><strong>Comment: </strong>Numerous registries find the distinction between &#8220;attempted, could not be determined&#8221; (zero) and &#8220;not coded&#8221; (blank) to be useful for geocoding planning purposes.</div><div class='content chap10-para'><em>Note:</em> The values 1 through 9 are nominal, with no hierarchy of values. This number determines the first digit of all the blocks which comprise the block group; for instance, census block group 3 would contain blocks numbered 3000 to 3999</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>0</td><td class='code-desc'>Census block group assignment was attempted, but the value could not be determined</td></tr><tr class='code-row'><td class='code-nbr'>1-9</td><td class='code-desc'>Census block group values as defined by the Census Bureau</td></tr><tr class='code-row'><td class='code-nbr'>Blank</td><td class='code-desc'>Census Block Grp 1970/80/90 [368] not coded</td></tr><tr class='code-row'><td class='code-nbr'></td><td class='code-desc'> </td></tr></table></div><a name='120'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>CENSUS COD SYS 1970/80/90</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">120</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>SEER</a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">165 - 165</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>Coding System for Census Tract (pre-96 SEER/CoC)<br />Census Coding System (CoC)<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>censusCodSys19708090</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Identified the set of Census Bureau census tract definitions (boundaries) that were used to code the census tract in Census Tract 1970/80/90 [110] for a specific record.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Allows for changes in census tracts over time. The census tract definition used to code the case must be recorded so that data are correctly grouped and analyzed. If the coding system were not recorded, the census codes would have to be converted or recoded every time the census tracts were changed.</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>0</td><td class='code-desc'>Not tracted</td></tr><tr class='code-row'><td class='code-nbr'>1</td><td class='code-desc'>1970 Census Tract Definitions</td></tr><tr class='code-row'><td class='code-nbr'>2</td><td class='code-desc'>1980 Census Tract Definitions</td></tr><tr class='code-row'><td class='code-nbr'>3</td><td class='code-desc'>1990 Census Tract Definitions</td></tr><tr class='code-row'><td class='code-nbr'>Blank</td><td class='code-desc'>Census Tract 1970/80/90 not coded</td></tr></table></div><div class='content chap10-para'><table style="border-collapse:collapse;" cellspacing="0" cellpadding="0" border="0">  <tbody><tr>   <td style="width:239.4pt;padding:0in 5.4pt 0in 5.4pt" width="319" valign="top">   <p style="margin-bottom:0in;   margin-bottom:.0001pt;line-height:normal"><strong><span style="font-size:12.0pt;   font-family:&quot;Times New Roman&quot;,&quot;serif&quot;;Times New Roman&quot;">Clarification   of NPCR Required Status</span></strong> </p>   </td>   <td style="width:239.4pt;padding:0in 5.4pt 0in 5.4pt" width="319" valign="top">   <p style="margin-bottom:0in;   margin-bottom:.0001pt;line-height:normal"> &nbsp;</p>   </td>  </tr>  <tr>   <td style="width:239.4pt;padding:0in 5.4pt 0in 5.4pt" width="319" valign="top">   <p style="margin-bottom:0in;   margin-bottom:.0001pt;line-height:normal"><u><span style="font-size:12.0pt;   font-family:&quot;Times New Roman&quot;,&quot;serif&quot;;Times New Roman&quot;">Census-1990   data items:</span></u> </p>   </td>   <td style="width:239.4pt;padding:0in 5.4pt 0in 5.4pt" width="319" valign="top">   <p style="margin-bottom:0in;   margin-bottom:.0001pt;line-height:normal"><u><span style="font-size:12.0pt;   font-family:&quot;Times New Roman&quot;,&quot;serif&quot;;Times New Roman&quot;">Census-2000   data items:</span></u> </p>   </td>  </tr>  <tr>   <td style="width:239.4pt;padding:0in 5.4pt 0in 5.4pt" width="319" valign="top">   <p style="margin-bottom:0in;   margin-bottom:.0001pt;line-height:normal"><span style="font-size:12.0pt;   font-family:&quot;Times New Roman&quot;,&quot;serif&quot;;Times New Roman&quot;">Census   Tract &nbsp;1970/80/90 &nbsp;[110]</span></p>   </td>   <td style="width:239.4pt;padding:0in 5.4pt 0in 5.4pt" width="319" valign="top">   <p style="margin-bottom:0in;   margin-bottom:.0001pt;line-height:normal"><span style="font-size:12.0pt;   font-family:&quot;Times New Roman&quot;,&quot;serif&quot;;Times New Roman&quot;">Census   Tract &nbsp;2000 &nbsp;[130]</span></p>   </td>  </tr>  <tr>   <td style="width:239.4pt;padding:0in 5.4pt 0in 5.4pt" width="319" valign="top">   <p style="margin-bottom:0in;   margin-bottom:.0001pt;line-height:normal"><span style="font-size:12.0pt;   font-family:&quot;Times New Roman&quot;,&quot;serif&quot;;Times New Roman&quot;">Census   Tr Cert 1970/80/90 &nbsp;[364]</span></p>   </td>   <td style="width:239.4pt;padding:0in 5.4pt 0in 5.4pt" width="319" valign="top">   <p style="margin-bottom:0in;   margin-bottom:.0001pt;line-height:normal"><span style="font-size:12.0pt;   font-family:&quot;Times New Roman&quot;,&quot;serif&quot;;Times New Roman&quot;">Census   Tr Certainty 2000 &nbsp;[365]</span></p>   </td>  </tr>  <tr>   <td style="width:239.4pt;padding:0in 5.4pt 0in 5.4pt" width="319" valign="top">   <p style="margin-bottom:0in;   margin-bottom:.0001pt;line-height:normal"><span style="font-size:12.0pt;   font-family:&quot;Times New Roman&quot;,&quot;serif&quot;;Times New Roman&quot;">Census   Tract &nbsp;Cod Sys--1970/80/90 [120]</span></p>   </td>   <td style="width:239.4pt;padding:0in 5.4pt 0in 5.4pt" width="319" valign="top">   <p style="margin-bottom:0in;   margin-bottom:.0001pt;line-height:normal"> &nbsp;</p>   </td>  </tr> </tbody></table>  <br />Information on census tract, census tract certainty, and census tract coding system is required. For tumors diagnosed in or after 2003, Census Tract &nbsp;2000 &nbsp;[130] and Census Tr Certainty 2000&nbsp; [365] (Census-2000 data items) are required. For tumors diagnosed in or before 2002, the requirement can be met by collecting either the Census-1990 data items [110, 364, 120] or the Census-2000 data items, although the Census-2000 data items [130 and 365] are recommended for tumors diagnosed in 1998 through 2002.</div><a name='280'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>CENSUS IND CODE 1970-2000</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">280</td><td style="text-align:center;">3</td><td style="text-align:center;"><a href='#sources'>Census/NPCR</a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">242 - 244</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>Industry Code--Census<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>censusIndCode19702000</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Code for the patient&#8217;s usual industry, using U.S. Census Bureau codes (2000 Census<sup>26</sup> is preferable) according to coding procedures recommended for death certificates.<sup>25</sup> This data item applies only to patients who are age 14 years or older at the time of diagnosis.<br /><br /><em>Note:</em> Occupation/industry coding should NOT be performed by reporting facilities. This is a central cancer registry data item. Specially trained and qualified personnel should perform coding.<em><br /></em><div></div><div>Formerly Industry Code--Census. </div><em>Note:</em> 2000 Census codes for occupation and industry are recommended for tumors diagnosed on or after January 1, 2003.<sup>26</sup> The 1990 Census codes are recommended for tumors diagnosed before January 1, 2003.<sup>24</sup> For more information, see the U.S. Census Bureau website at: <a href="http://www.census.gov/hhes/www/ioindex/ioindex.html">http://www.census.gov/hhes/www/ioindex/ioindex.html</a>. </div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Use of the Census Bureau classification system improves consistency of data collected from multiple sources. The Census Bureau industrial classification system is used for coding industry information from death certificates and from the U.S. Census of Population. The system includes specific coding rules.



<sup>22-27</sup></div><div class='content chap10-para'><strong>Codes </strong>
<p> <span style="Times New Roman&quot;;color:black;letter-spacing:-.1pt; layout-grid-mode:line;">Software for automated coding of industry and occupation to 1990 Census classifications is available from the Division of Safety Research, National Institute for Occupational Safety and Health, CDC </span> <span style="Times New Roman&quot;; color:black">(</span><a href="http://www.cdc.gov/niosh/SOIC/"><span style="Times New Roman&quot;"></span></a><a target="_blank" href="http://www.cdc.gov/niosh/SOIC/">http://www.cdc.gov/niosh/SOIC/</a><span>). As of press time, NIOSH is developing new web-based software for automated coding of industry and occupation to appropriate year Census (1990, 2000, or 2010) classifications. The contact person for this software (which will be available after October 2012) is Sue Nowlin, who can be contacted at sxn1@cdc.gov or (513) 841-4467. <br />
<br />
<span style="font-size: 11pt; font-family: &quot;Times New Roman&quot;,&quot;serif&quot;;">Registries may want to wait to code industry and occupation until<em> NAACCR Standards Volume II, Version 13 </em>is released and the NIOSH autocoding software is available.</span></span><br />
</p>
</div><a name='272'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>CENSUS IND CODE 2010 CDC</strong></td><td style="text-align:right;font-weight:bold;"><strong>Revised</strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">272</td><td style="text-align:center;">4</td><td style="text-align:center;"><a href='#sources'>Census/NPCR</a></td><td style="text-align:center;">2013</td><td style="text-align:center;">13</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">483 - 486</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>Census Industry Code--2010<br />Census Ind Code 2010<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>censusIndCode2010</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Code for the patient's usual industry, using U.S. Census Bureau codes and NIOSH non-paid worker codes. This data item applies only to patients who are age 14 years or older at the time of diagnosis. Usual industry refers to the type of activity at the patient's place of work for most of his or her working life. Formerly Census Ind Code 2010.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Use of a standard industry
classification system and associated codes improves the consistency of data
collected from multiple sources and facilitates the use of data by researchers.</div><div class='content chap10-para'><strong> Coding Instructions</strong><br /><div>Occupation/industry coding should NOT be performed by reporting facilities. This is a central cancer registry data item. Specially trained and qualified personnel should perform coding.</div><div>&nbsp;</div><div>Codes for industry are routinely updated to include new or more detailed codes. The 4-digit 2010 industry codes from the U.S. Census Bureau and NIOSH are the most recent codes for industry. When assigning industry codes, central registries should use the most recent code set available. The industry codes for 2010 may be used for earlier diagnosis years. Cases already coded with older industry codes do not have to be recoded to the 2010 codes. </div></div><div class='content chap10-para'><strong>Codes</strong><br />
Valid codes for industry include the U.S. Census codes and the NIOSH non-paid worker codes (listed below). CDC has combined these two sets of codes into a PHIN-VADS value set located here: <a target="_blank" href="http://phinvads.cdc.gov/vads/SearchAllVocab_search.action?searchOptions.searchText=2.16.840.1.114222.4.11.7187">http://phinvads.cdc.gov/vads/SearchAllVocab_search.action?searchOptions.searchText=2.16.840.1.114222.4.11.7187</a>. <br /><br /><strong></strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'><B>2010 NIOSH Codes for Non-Paid Worker Titles:</B></td><td class='code-desc'> </td></tr><tr class='code-row'><td class='code-nbr'>9880</td><td class='code-desc'>Retired </td></tr><tr class='code-row'><td class='code-nbr'>9890</td><td class='code-desc'>Housewife, homemaker, volunteers, student, child or infant, patient, disabled, inmate, or individual who did not work</td></tr><tr class='code-row'><td class='code-nbr'>9990</td><td class='code-desc'>Blank text, unknown, don't know, not applicable, refused, or information is inadequate to select a code</td></tr><tr class='code-row'><td class='code-nbr'>Blank</td><td class='code-desc'>Coding of Census Ind Code 2010 CDC not attempted</td></tr><tr class='code-row'><td class='code-nbr' colspan='2'></td></tr></table></div><div class='content chap10-para mark-changed'>The Division of Safety Research at CDC&#8217;s National Institute for Occupational Safety and Health (NIOSH) has developed new web-based software for automated coding of industry and occupation to appropriate year Census (1990, 2000, or 2010) classifications. This system also includes the NIOSH non-paid worker codes. See the following website for the NIOSH Industry and Occupation Computerized Coding System (NIOCCS) to look up a single industry and occupation code, crosswalk a single record, or create an account to perform batch processing: <a href="https://www.cdc.gov/niosh/topics/coding/code.html" target="_blank">https://www.cdc.gov/niosh/topics/coding/code.html</a>. <br />For more information related to the U.S. Census Bureau codes, see the following websites:<br /><ul><li>Overview: <a href="https://www.census.gov/topics/employment/industry-occupation/guidance.html" target="_blank">https://www.census.gov/topics/employment/industry-occupation/guidance.html</a></li></ul><ul><li>Crosswalk: <a href="https://www.census.gov/topics/employment/industry-occupation/guidance/code-lists.html" target="_blank">https://www.census.gov/topics/employment/industry-occupation/guidance/code-lists.html</a></li></ul><ul><li>Index: <a href=" https://www.census.gov/topics/employment/industry-occupation/guidance/indexes.html" target="_blank"> https://www.census.gov/topics/employment/industry-occupation/guidance/indexes.html</a></li></ul></div><a name='270'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>CENSUS OCC CODE 1970-2000</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">270</td><td style="text-align:center;">3</td><td style="text-align:center;"><a href='#sources'>Census/NPCR</a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">239 - 241</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>Occupation Code--Census<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>censusOccCode19702000</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'><span>Code for the patient&#8217;s usual occupation, using U.S. Census Bureau codes (see note below) according to coding procedures recommended for death certificates.<sup>22</sup></span>  <span style="Times New Roman&quot;; color:black"> This data item applies only to patients who are age 14 years or older at the time of diagnosis. Usual occupation is defined as type of job the patient was engaged in for most of his or her working life.</span>  <em>    <br />  </em>  <p style="text-autospace:none; border:none;padding:0in;">    <em>      <span style="Times New Roman&quot;; color:black">Note</span></em><span style="Times New Roman&quot;; color:black;">:</span>    <span style="Times New Roman&quot;;color:black"> Occupation/industry coding should NOT be performed by reporting facilities. This is a central registry data item. Specially trained and qualified personnel should perform coding.</span>    <em>      <br />    </em>  </p>  <p style="border: medium none; padding: 0in;">    <em>      <span style="Times New Roman&quot;; color:black">Note</span></em><span style="Times New Roman&quot;; color:black;">: The 3-digit 2000 Census codes for occupation are recommended for tumors diagnosed on or after January 1, 2003, and prior to January 1, 2013.<sup>23, 25</sup> The 3 digit 1990 Census codes for occupation are recommended for tumors diagnosed before January 1, 2003.<sup>24</sup></span><span style="Times New Roman&quot;;color:black"><sup>, 26 </sup>The 4-digit Census occupation codes are recommended for tumors diagnosed on or after January 1, 2013, and should be reported in NAACCR data item Census Occ Code 2010 CDC [282]. For more information, see the U.S. Bureau of the Census website at:</span>    <a href="http://www.census.gov/hhes/www/ioindex/ioindex.html">      <span style="Times New Roman&quot;">http://www.census.gov/hhes/www/ioindex/ioindex.html</span>    </a>    <span style="Times New Roman&quot;;color:black">.</span>  </p>  <div>Formerly Occupation Code--Census.</div></div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Use of the Census Bureau classification system improves consistency of data collected from multiple sources. The Census Bureau occupation classification system is used for coding occupation information from death certificates and from the U.S. Census of Population. The system includes specific coding rules.








<sup>22-26, 40<br /></sup></div><div class='content chap10-para'><p>    <strong>Codes</strong>    <br />    <span>Software for automated coding of industry and occupation to 1990 Census classifications is available from the Division of Safety Research, National Institute for Occupational Safety and Health, CDC (</span>    <a href="http://www.cdc.gov/niosh/SOIC/">      <span>http://www.cdc.gov/niosh/SOIC/</span>    </a>    <span style="Times New Roman&quot;;color:#1F497D">)</span>    <span style="Times New Roman&quot;;color:black">. As of press time, NIOSH is developing new web-based software for automated coding of industry and occupation to appropriate year Census (1990, 2000, or 2010) classifications. The contact person for this software (which will be available after October 2012) is Sue Nowlin, who can be contacted at</span>    <span style="Times New Roman&quot;;color:blue">sxn1@cdc.gov</span>    <span style="Times New Roman&quot;;color:black">or (513) 841-4467.</span>  </p>  <p>    <span>    </span>  </p>  <span style="Times New Roman&quot;; color:black">Registries may want to wait to code industry and occupation until</span>  <em>    <span style="Times New Roman&quot;; color:black;letter-spacing:-.1pt;layout-grid-mode:line;">NAACCR Standards Volume II, Version 13 </span>  </em>is released and the NIOSH autocoding software is available.</div><a name='282'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>CENSUS OCC CODE 2010 CDC</strong></td><td style="text-align:right;font-weight:bold;"><strong>Revised</strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">282</td><td style="text-align:center;">4</td><td style="text-align:center;"><a href='#sources'>Census/NPCR</a></td><td style="text-align:center;">2013</td><td style="text-align:center;">13</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">487 - 490</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>Census Occ Code 2010<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>censusOccCode2010</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Code for the patient's usual occupation, using U.S. Census Bureau codes and NIOSH non-paid worker codes. This data item applies only to patients who are age 14 years or older at the time of diagnosis. Usual occupation is defined as the type of job the patient was engaged in for most of his or her working life. Formerly Census Occ Code 2010.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Use of a standard occupation classification system and associated codes improves the consistency of data collected from multiple sources and facilitates the use of data by researchers.<br /><br /><strong>Coding Instructions</strong><br />Occupation/industry coding should NOT be performed by reporting facilities. This is a central registry data item. Specially trained and qualified personnel should perform coding. <br /><br />Codes for occupation are routinely updated to include new or more detailed codes. The 4-digit 2010 occupation codes from the U.S. Census Bureau and NIOSH are the most recent codes for occupation. When assigning occupation codes, central registries should use the most recent code set available. The occupation codes for 2010 may be used for earlier diagnosis years. Cases already coded with older occupation codes do not have to be recoded to the 2010 codes.</div><div class='content chap10-para'><div>Valid codes for occupation include the U.S. Census codes and the NIOSH non-paid worker codes (listed below). CDC has combined these two sets of codes into a PHIN-VADS value set located here: <a target="_blank" href="http://phinvads.cdc.gov/vads/ViewValueSet.action?id=1445D71C-F37F-4504-8B6C-BA48C5A3F4CA">http://phinvads.cdc.gov/vads/ViewValueSet.action?id=1445D71C-F37F-4504-8B6C-BA48C5A3F4CA</a></div><div>&nbsp;</div><div><strong>2010 NIOSH Occupation Codes for Non-Paid Worker Titles:</strong></div></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>9010</td><td class='code-desc'> Housewife, homemaker</td></tr><tr class='code-row'><td class='code-nbr'>9020</td><td class='code-desc'>Volunteers</td></tr><tr class='code-row'><td class='code-nbr'>9050</td><td class='code-desc'>Student</td></tr><tr class='code-row'><td class='code-nbr'>9060</td><td class='code-desc'>Retired</td></tr><tr class='code-row'><td class='code-nbr'>9100</td><td class='code-desc'>Child or infant, patient, disabled, inmate, or individual who did not work</td></tr><tr class='code-row'><td class='code-nbr'>9900</td><td class='code-desc'>Blank text, unknown, don't know, not applicable, refused or information is inadequate to select a code</td></tr><tr class='code-row'><td class='code-nbr'>Blank</td><td class='code-desc'>Coding of Census Occ Code 2010 CDC not attempted</td></tr><tr class='code-row'><td class='code-nbr' colspan='2'></td></tr></table></div><div class='content chap10-para mark-changed'><div>Note: The Division of Safety Research at CDC&#8217;s National Institute for Occupational Safety and Health (NIOSH) has developed new web-based software for automated coding of industry and occupation to appropriate year Census (1990, 2000, or 2010) classifications. This system also includes the NIOSH non-paid worker codes. The contact person for this software is Sue Nowlin, who can be contacted at <a href="mailto:sxn1@cdc.gov">sxn1@cdc.gov</a> or (513) 841-4467.</div><div>&nbsp;</div><div>For more information related to the U.S. Census Bureau codes, see the following websites:<br /><ul><li>Overview: <a href="https://www.census.gov/topics/employment/industry-occupation/guidance.html" target="_blank">https://www.census.gov/topics/employment/industry-occupation/guidance.html</a></li></ul><ul><li>Crosswalk: <a href="https://www.census.gov/topics/employment/industry-occupation/guidance/code-lists.html" target="_blank">https://www.census.gov/topics/employment/industry-occupation/guidance/code-lists.html</a>. The 2002 Census codes are the same as the 2000 codes with a &#8220;0&#8221; added to the end of the number due to the change from a 3-digit to 4-digit field.</li></ul><ul><li>Index: <a href="https://www.census.gov/topics/employment/industry-occupation/guidance/indexes.html" target="_blank"> https://www.census.gov/topics/employment/industry-occupation/guidance/indexes.html</a> <br /></li></ul></div></div><a name='330'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>CENSUS OCC/IND SYS 70-00</strong></td><td style="text-align:right;font-weight:bold;"><strong>Revised</strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">330</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>NPCR</a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">447 - 447</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>Occup/Ind Coding System<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>censusOccIndSys7000</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para mark-changed'><div>Code that identifies coding system used for occupation and industry. This is a central cancer registry data item (i.e., codes should be applied by a central or regional registry rather than collected from reporting facilities). </div>  <div>&nbsp;</div>  <div>Formerly Occup/Ind Coding System. </div></div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>1</td><td class='code-desc'>1970 Census</td></tr><tr class='code-row'><td class='code-nbr'>2</td><td class='code-desc'>1980 Census</td></tr><tr class='code-row'><td class='code-nbr'>3</td><td class='code-desc'>1990 Census</td></tr><tr class='code-row'><td class='code-nbr'>4</td><td class='code-desc'>2000 Census</td></tr><tr class='code-row'><td class='code-nbr'>5</td><td class='code-desc'>2010 Census</td></tr><tr class='code-row'><td class='code-nbr'>7</td><td class='code-desc'>Other coding system</td></tr><tr class='code-row'><td class='code-nbr'>9</td><td class='code-desc'>Unknown coding system</td></tr><tr class='code-row'><td class='code-nbr'>Blank</td><td class='code-desc'>Not collected</td></tr></table></div><div class='content chap10-para mark-changed'><em>Note:</em> 2000 Census codes for occupation and industry are recommended for tumors diagnosed on or after January 1, 2003.<sup>26 </sup>The 1990 Census codes are recommended for tumors diagnosed before January 1, 2003.<sup>24 </sup>For more information, see the U.S. Bureau of the Census website at: at:  <a href="at:  https://www.census.gov/topics/employment/industry-occupation/guidance.html" target="_blank">https://www.census.gov/topics/employment/industry-occupation/guidance.html</a>.</div><a name='364'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>CENSUS TR CERT 1970/80/90</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">364</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>SEER</a></td><td style="text-align:center;">1997</td><td style="text-align:center;">5.1</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">166 - 166</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>Census Tract Certainty<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>censusTrCert19708090</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'><p style="text-autospace:none">Code indicating basis of assignment of census tract or block numbering area (BNA) for an individual record.<span style="font-family:TimesNewRomanPSMT;">Helpful in identifying cases tracted from incomplete information or P.O. Box. This item is not coded by the hospital. Central registry staff manually assign the code.</span></p></div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>1</td><td class='code-desc'>Census tract/BNA based on complete and valid street address of residence</td></tr><tr class='code-row'><td class='code-nbr'>2</td><td class='code-desc'>Census tract/BNA based on residence ZIP + 4</td></tr><tr class='code-row'><td class='code-nbr'>3</td><td class='code-desc'>Census tract/BNA based on residence ZIP + 2</td></tr><tr class='code-row'><td class='code-nbr'>4</td><td class='code-desc'>Census tract/BNA based on residence ZIP code only</td></tr><tr class='code-row'><td class='code-nbr'>5</td><td class='code-desc'>Census tract/BNA based on ZIP code of P.O. Box</td></tr><tr class='code-row'><td class='code-nbr'>6</td><td class='code-desc'>Census tract/BNA based on residence city where city has only one census tract, or based on residence ZIP code where ZIP code has only one census tract</td></tr><tr class='code-row'><td class='code-nbr'>9</td><td class='code-desc'>Not assigned, geocoding attempted</td></tr><tr class='code-row'><td class='code-nbr'>Blank</td><td class='code-desc'>Not assigned, geocoding not attempted</td></tr></table></div><div class='content chap10-para'><table style="border-collapse: collapse;" border="0" cellpadding="0" cellspacing="0">
     <tbody>
         <tr>
             <td style="width: 239.4pt; padding: 0in 5.4pt;" valign="top" width="319">
             <strong>Clarification of NPCR Required Status</strong>
             </td>
             <td style="width:239.4pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="319">
             <p style="margin-bottom:0in; margin-bottom:.0001pt;line-height:normal"> &#160;</p>
             </td>
         </tr>
         <tr>
             <td style="width:239.4pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="319">
             <p style="margin-bottom:0in; margin-bottom:.0001pt;line-height:normal"><u><span style="font-size:12.0pt; font-family:&quot;Times New Roman&quot;,&quot;serif&quot;;Times New Roman&quot;">Census-1990 data items:</span></u> </p>
             </td>
             <td style="width:239.4pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="319">
             <p style="margin-bottom:0in; margin-bottom:.0001pt;line-height:normal"><u><span style="font-size:12.0pt; font-family:&quot;Times New Roman&quot;,&quot;serif&quot;;Times New Roman&quot;">Census-2000 data items:</span></u> </p>
             </td>
         </tr>
         <tr>
             <td style="width:239.4pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="319">
             <p style="margin-bottom:0in; margin-bottom:.0001pt;line-height:normal"><span style="font-size:12.0pt; font-family:&quot;Times New Roman&quot;,&quot;serif&quot;;Times New Roman&quot;">Census Tract &#160;1970/80/90 &#160;[110]</span></p>
             </td>
             <td style="width:239.4pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="319">
             <p style="margin-bottom:0in; margin-bottom:.0001pt;line-height:normal"><span style="font-size:12.0pt; font-family:&quot;Times New Roman&quot;,&quot;serif&quot;;Times New Roman&quot;">Census Tract &#160;2000 &#160;[130]</span></p>
             </td>
         </tr>
         <tr>
             <td style="width:239.4pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="319">
             <p style="margin-bottom:0in; margin-bottom:.0001pt;line-height:normal"><span style="font-size:12.0pt; font-family:&quot;Times New Roman&quot;,&quot;serif&quot;;Times New Roman&quot;">Census Tr Cert 1970/80/90 &#160;[364]</span></p>
             </td>
             <td style="width:239.4pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="319">
             <p style="margin-bottom:0in; margin-bottom:.0001pt;line-height:normal"><span style="font-size:12.0pt; font-family:&quot;Times New Roman&quot;,&quot;serif&quot;;Times New Roman&quot;">Census Tr Certainty 2000 &#160;[365]</span></p>
             </td>
         </tr>
         <tr>
             <td style="width:239.4pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="319">
             <p style="margin-bottom:0in; margin-bottom:.0001pt;line-height:normal"><span style="font-size:12.0pt; font-family:&quot;Times New Roman&quot;,&quot;serif&quot;;Times New Roman&quot;">Census Tract &#160;Cod Sys--1970/80/90 [120]</span></p>
             </td>
             <td style="width:239.4pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="319">
             <p style="margin-bottom:0in; margin-bottom:.0001pt;line-height:normal"> &#160;</p>
             </td>
         </tr>
     </tbody>
</table>
<br />
Information on census tract, census tract certainty, and census tract coding system is required. For tumors diagnosed in or after 2003, Census Tract 2000 [130] and Census Tr Certainty 2000 [365] (Census-2000 data items) are required. For tumors diagnosed in or before 2002, the requirement can be met by collecting either the Census-1990 data items [110, 364, 120] or the Census-2000 data items, although the Census-2000 data items [130 and 365] are recommended for tumors diagnosed in 1998 through 2002.
</div><a name='365'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>CENSUS TR CERTAINTY 2000</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">365</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>NAACCR</a></td><td style="text-align:center;">2003</td><td style="text-align:center;">10</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">179 - 179</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>censusTrCertainty2000</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Code indicating basis of assignment of census tract for an individual record. Helpful in identifying cases tracted from incomplete information or P.O. Box. This item is not coded by the hospital. Central registry staff assign the code.</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>1</td><td class='code-desc'>Census tract based on complete and valid street address of residence</td></tr><tr class='code-row'><td class='code-nbr'>2</td><td class='code-desc'>Census tract based on residence ZIP + 4</td></tr><tr class='code-row'><td class='code-nbr'>3</td><td class='code-desc'>Census tract based on residence ZIP + 2</td></tr><tr class='code-row'><td class='code-nbr'>4</td><td class='code-desc'>Census tract based on residence ZIP code only</td></tr><tr class='code-row'><td class='code-nbr'>5</td><td class='code-desc'>Census tract based on ZIP code of P.O. Box</td></tr><tr class='code-row'><td class='code-nbr'>6</td><td class='code-desc'>Census tract/BNA based on residence city where city has only one census tract, or based on residence ZIP code where ZIP code has only one census tract</td></tr><tr class='code-row'><td class='code-nbr'>9</td><td class='code-desc'>Not assigned, geocoding attempted</td></tr><tr class='code-row'><td class='code-nbr'>Blank</td><td class='code-desc'>Not assigned, geocoding not attempted</td></tr></table></div><div class='content chap10-para'><table style="border-collapse:collapse;" border="0" cellpadding="0" cellspacing="0">
     <tbody>
         <tr>
             <td style="width:239.4pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="319">
             <strong>Clarification of NPCR Required Status</strong>
             </td>
             <td style="width:239.4pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="319">
             <p style="margin-bottom:0in; margin-bottom:.0001pt;line-height:normal"> &#160;</p>
             </td>
         </tr>
         <tr>
             <td style="width:239.4pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="319">
             <p style="margin-bottom:0in; margin-bottom:.0001pt;line-height:normal"><u><span style="font-size:12.0pt; font-family:&quot;Times New Roman&quot;,&quot;serif&quot;;Times New Roman&quot;">Census-1990 data items:</span></u> </p>
             </td>
             <td style="width:239.4pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="319">
             <p style="margin-bottom:0in; margin-bottom:.0001pt;line-height:normal"><u><span style="font-size:12.0pt; font-family:&quot;Times New Roman&quot;,&quot;serif&quot;;Times New Roman&quot;">Census-2000 data items:</span></u> </p>
             </td>
         </tr>
         <tr>
             <td style="width:239.4pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="319">
             <p style="margin-bottom:0in; margin-bottom:.0001pt;line-height:normal"><span style="font-size:12.0pt; font-family:&quot;Times New Roman&quot;,&quot;serif&quot;;Times New Roman&quot;">Census Tract &#160;1970/80/90 &#160;[110]</span></p>
             </td>
             <td style="width:239.4pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="319">
             <p style="margin-bottom:0in; margin-bottom:.0001pt;line-height:normal"><span style="font-size:12.0pt; font-family:&quot;Times New Roman&quot;,&quot;serif&quot;;Times New Roman&quot;">Census Tract &#160;2000 &#160;[130]</span></p>
             </td>
         </tr>
         <tr>
             <td style="width:239.4pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="319">
             <p style="margin-bottom:0in; margin-bottom:.0001pt;line-height:normal"><span style="font-size:12.0pt; font-family:&quot;Times New Roman&quot;,&quot;serif&quot;;Times New Roman&quot;">Census Tr Cert 1970/80/90 &#160;[364]</span></p>
             </td>
             <td style="width:239.4pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="319">
             <p style="margin-bottom:0in; margin-bottom:.0001pt;line-height:normal"><span style="font-size:12.0pt; font-family:&quot;Times New Roman&quot;,&quot;serif&quot;;Times New Roman&quot;">Census Tr Certainty 2000 &#160;[365]</span></p>
             </td>
         </tr>
         <tr>
             <td style="width:239.4pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="319">
             <p style="margin-bottom:0in; margin-bottom:.0001pt;line-height:normal"><span style="font-size:12.0pt; font-family:&quot;Times New Roman&quot;,&quot;serif&quot;;Times New Roman&quot;">Census Tract &#160;Cod Sys--1970/80/90 [120]</span></p>
             </td>
             <td style="width:239.4pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="319">
             <p style="margin-bottom:0in; margin-bottom:.0001pt;line-height:normal"> &#160;</p>
             </td>
         </tr>
     </tbody>
</table>
<br />
Information on census tract, census tract certainty, and census tract coding system is required. For tumors diagnosed in or after 2003, Census Tract 2000 [130] and Census Tr Certainty 2000 [365] (Census-2000 data items) are required. For tumors diagnosed in or before 2002, the requirement can be met by collecting either the Census-1990 data items [110, 364, 120] or the Census-2000 data items, although the Census-2000 data items [130 and 365] are recommended for tumors diagnosed in 1998 through 2002.
</div><a name='367'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>CENSUS TR CERTAINTY 2010</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">367</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>NAACCR</a></td><td style="text-align:center;">2011</td><td style="text-align:center;">12.1</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">192 - 192</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>censusTrCertainty2010</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'><p style="text-autospace:none">
  <span style="font-family: TimesNewRomanPSMT;">Code indicating basis of assignment of census tract for an individual record. Helpful in identifying cases tracted from incomplete information or P.O. Box. This item is not coded by the hospital. Central registry staff assign the code.</span>
</p></div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>1</td><td class='code-desc'>Census tract based on complete and valid street address of residence</td></tr><tr class='code-row'><td class='code-nbr'>2</td><td class='code-desc'>Census tract based on residence ZIP + 4</td></tr><tr class='code-row'><td class='code-nbr'>3</td><td class='code-desc'>Census tract based on residence ZIP + 2</td></tr><tr class='code-row'><td class='code-nbr'>4</td><td class='code-desc'>Census tract based on residence ZIP code only</td></tr><tr class='code-row'><td class='code-nbr'>5</td><td class='code-desc'>Census tract based on ZIP code of P.O. Box</td></tr><tr class='code-row'><td class='code-nbr'>6</td><td class='code-desc'>Census tract/BNA based on residence city where city has only one census tract, or based on residence ZIP code where ZIP code has only one census tract</td></tr><tr class='code-row'><td class='code-nbr'>9</td><td class='code-desc'>Not assigned, geocoding attempted</td></tr><tr class='code-row'><td class='code-nbr'>Blank</td><td class='code-desc'>Not assigned, geocoding not attempted</td></tr></table></div><div class='content chap10-para'><strong>Clarification of NPCR Status</strong>
<strong>
     </strong><strong>
         </strong><strong>
             </strong><table style="border-collapse: collapse;" width="720" cellspacing="0" cellpadding="0" border="0">
     
     <tbody>
         
         <tr>
             
             <td style="width:211.5pt;padding:0in 5.4pt 0in 5.4pt" width="282" valign="top">
             <u>Census-1990 data items:</u>
             </td>
             <td style="width:166.5pt;padding:0in 5.4pt 0in 5.4pt" width="222" valign="top">
             <u>Census-2000 data items:</u>
             </td>
             <td style="width:2.25in;padding:0in 0in 0in 2.9pt" width="216" valign="top">
             <u>Census-2010 data items:</u>
             </td>
         </tr>
         <tr>
             <td style="width:211.5pt;padding:0in 5.4pt 0in 5.4pt" width="282" valign="top">
             Census Tract &nbsp;1970/80/90 &nbsp;[110]
             </td>
             <td style="width:166.5pt;padding:0in 5.4pt 0in 5.4pt" width="222" valign="top">
             Census Tract &nbsp;2000 &nbsp;[130]
             </td>
             <td style="width:2.25in;padding:0in 0in 0in 2.9pt" width="216" valign="top">
             Census Tract &nbsp;2010 &nbsp;[135]
             </td>
         </tr>
         <tr>
             <td style="width: 211.5pt; padding: 0in 5.4pt;" width="282" valign="top">
             Census Tr Cert 1970/80/90 &nbsp;[364]
             </td>
             <td style="width: 166.5pt; padding: 0in 5.4pt;" width="222" valign="top">
             Census Tr Certainty 2000 &nbsp;[365]
             </td>
             <td style="width: 222px; padding: 0in 0in 0in 2.9pt;" width="216" valign="top">
             Census Tr Certainty 2010 &nbsp;[367]
             </td>
         </tr>
         <tr>
             <td style="width:211.5pt;padding:0in 5.4pt 0in 5.4pt" width="282" valign="top">
             Census Tract &nbsp;Cod Sys--1970/80/90 [120]
             </td>
             <td style="width: 166.5pt; padding: 0in 5.4pt;" width="222" valign="top">
             <p style="margin-bottom:0in; margin-bottom:.0001pt;line-height:normal"> &nbsp;</p>
             </td>
             <td style="width:2.25in;padding:0in 0in 0in 2.9pt" width="216" valign="top">
             <p style="margin-bottom:0in; margin-bottom:.0001pt;line-height:normal"> &nbsp;</p>
             </td>
         </tr>
     </tbody>
</table><div>
</div><div>&nbsp;</div><div>Information on census tract and census tract certainty is required. Census Tract and Census Tract Certainty should be recorded in the year-appropriate data item fields in order to reflect demographic information at the time of diagnosis. Until the 2010 Census is completed and data are available for geocoding, tumors diagnosed in 2010 or later, should be coded to the 2000 census definitions and recorded in Census Tract 2000 [130] and Census Tr Certainty 2000 [365]. When the 2010 Census data are available for geocoding, tumors diagnosed in 2010 or later must be coded to the 2010 census tract definitions and recorded in Census Tract 2010 [135] and Census Tract Certainty 2010 [367]. For tumors diagnosed between January 1, 2008, and December 31, 2009, use of Census Tract 2010 [135] and Census Track Certainty 2010 [367] is recommended. </div></div><a name='145'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>CENSUS TR POVERTY INDICTR</strong></td><td style="text-align:right;font-weight:bold;"><strong>Revised</strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">145</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>NAACCR</a></td><td style="text-align:center;">2013</td><td style="text-align:center;">13</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">491 - 491</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>censusTrPovertyIndictr</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para mark-changed'>Assigns a code for neighborhood poverty level based on the census tract of diagnosis address. Cases diagnosed between 1995 and 2004 are assigned a code based on the 2000 U.S. Census, the last decennial census for which poverty level was collected. Cases diagnosed since 2005 are assigned a code based on the American Community Survey (ACS). <br /><br />The ACS publishes tract-level poverty data annually, on a rolling five-year window, with a two-year lag (e.g., poverty data for 2006-2010 will be available in 2012). Cases for a given diagnosis year are initially coded using the most recent file available when the cancer data are first released, and the item is subsequently coded using the ACS file centered on the year of diagnosis. For example, cases diagnosed in 2012 will initially be coded using the 2008-2012 ACS file, and two years later using the 2010-2014 ACS file. An exception to this rule is that cases diagnosed in 2005 and 2006 will be coded using the 2005-2009 ACS file, because this was the first such file released. Codes may be automatically assigned by running the Poverty and Census Tract Linkage Program available through the Data Analysis Tools section of the NAACCR website.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para mark-changed'>Many cancers are associated with socioeconomic status and it is useful to include a measure of this in analyses. A detailed rationale for this data item was published in 


<em>Journal of Registry Management </em>2010; 37(4): 148-151.</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>1</td><td class='code-desc'>0% - <5% poverty</td></tr><tr class='code-row'><td class='code-nbr'>2</td><td class='code-desc'>5% - <10% poverty</td></tr><tr class='code-row'><td class='code-nbr'>3</td><td class='code-desc'>10% - <20% poverty</td></tr><tr class='code-row'><td class='code-nbr'>4 </td><td class='code-desc'>20% - 100% poverty</td></tr><tr class='code-row'><td class='code-nbr'>9</td><td class='code-desc'>Unknown or not applicable</td></tr></table></div><a name='110'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>CENSUS TRACT 1970/80/90</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">110</td><td style="text-align:center;">6</td><td style="text-align:center;"><a href='#sources'>SEER</a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">158 - 163</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>Census Tract/Block Numbering Area (BNA) (SEER)<br />Census Tract<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>censusTract19708090</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Identifies the patient's census tract of residence at the time the tumor was diagnosed. Census Tract 70/80/90 is a derived (geocoded) variables based on the Census Boundary files from 1970, 1980, 1990 Decennial Census. See Census Tract 2000 [130]; Census Tract 2010 [135]; Census Tract 2020 [125]. Codes are those used by the U.S. Census Bureau for the Year 1970, 1980 or 1990 Census. Refer to Census Cod Sys 1970/80/90 [120] to ascertain the decade of reference. For consolidated records, the geocoded state should be based on the best address at diagnosis information identified.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Census tract codes allow central registries to calculate incidence rates for geographical areas having population estimates. This field allows a central registry to add Year 2020 Census tracts to tumors diagnosed in previous years, without losing the codes in data items Census Tract 2000 [130]; Census Tract 2010 [135]; Census Tract 2020 [125].<br /><br /><div>The Census Bureau provides population and other demographic data for census tracts. This allows for small area analysis for general surveillance or special geographical and socioeconomic analysis.</div><div>&nbsp;</div><div><strong>Instructions for Coding</strong></div><div><ul><li>This variable is generated through the process of geocoding either during abstracting or at the central registry level. </li><li>Census tract codes have a 4-digit basic number and also may have a 2-digit suffix. Census tract numbers range from 0001.00 to 9999.98, but the decimal should not be retained in the NAACCR layout.</li><li>At a minimum, all cases diagnosed through diagnosis year 1999 should have a Census Tract 1970/80/90. Cases diagnosed 1996-1999 must have both State at DX Geocode 1970/80/90 [81] and State at DX Geocode 2000 [82] codes for proper assignment of the Census Tr Poverty Indicatr [145]. </li><li>If the patient has multiple tumors, geocoded state at diagnosis may be different for each tumor. </li><li>Do not update this item if the patient's tract of residence changes. Store updated address information in the affiliated current address data items. Only update based on improved information on the residential address at time of diagnosis. For instance, it is appropriate to correct a tract during manual geocoding or a consolidation process.</li><li>PO Box address information should not be used to geocode this data item except in the infrequent case when no other address information is available.</li><li>Blank "Not geocoded" is allowable for cases diagnosed after 1999. However, it is recommended to have all cases geocoded to a Census Tract 1970/80/90 to allow for both retrospective and cross-sectional analyses.<br /></li></ul></div></div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>000100-999998</td><td class='code-desc'>Valid FIPS Codes</td></tr><tr class='code-row'><td class='code-nbr'>000000</td><td class='code-desc'>Area not census-tracted</td></tr><tr class='code-row'><td class='code-nbr'>999999</td><td class='code-desc'>Area census-tracted, but census tract is not available</td></tr><tr class='code-row'><td class='code-nbr'>Blank</td><td class='code-desc'>Census Tract 1970/80/90 not coded</td></tr><tr class='code-row'><td class='code-nbr'></td><td class='code-desc'> </td></tr></table></div><div class='content chap10-para'><em>Note:</em> For U.S. residents, historically, standard codes are those of the FIPS publication "Counties and Equivalent Entities of the United States, Its Possessions, and Associated Areas." These FIPS codes (FIPS 6-4) have been replaced by INCITS standard codes; however, there is no impact on this variable as the codes align with the system the Census used for each decennial census and changes will automatically be accounted for during geocoding. County codes issued by the Federal Information Processing Standards (FIPS) publication <em>Counties and Equivalent Entities of the United States, Its Possessions, and Associated Areas</em> is available in Appendix A.</div><a name='130'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>CENSUS TRACT 2000</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">130</td><td style="text-align:center;">6</td><td style="text-align:center;"><a href='#sources'>NAACCR</a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">172 - 177</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>Census Tract--Alternate (pre-2003)<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>censusTract2000</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Identifies the patient's census tract of residence at the time the tumor was diagnosed. Census Tract 2000 is a derived (geocoded) variables based on the Census Boundary files from 2000. See Census Tract 70/80/90 [110]; Census Tract 2010 [135]; Census Tract 2020 [125]. Codes are those used by the U.S. Census Bureau for the Year 2000 Census. For consolidated records, the geocoded state should be based on the best address at diagnosis information identified.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Census tract codes allow central registries to calculate incidence rates for geographical areas having population estimates. This field allows a central registry to add Year 2020 Census tracts to tumors diagnosed in previous years, without losing the codes in data items [110], [130] and [135].<br /><br /><div>The Census Bureau provides population and other demographic data for census tracts. This allows for small area analysis for general surveillance or special geographical and socioeconomic analysis.</div><div>&nbsp;</div><div><strong>Instructions for Coding </strong></div><div><ul><li>This variable is generated through the process of geocoding either during abstracting or at the central registry level. </li><li>Census tract codes have a 4-digit basic number and also may have a 2-digit suffix. Census tract numbers range from 0001.00 to 9999.98, but the decimal should not be retained in the NAACCR layout.</li><li>It is recommended that all cases diagnosed through 2009 should have a geocoded Census Tract 2000.</li><li>At a minimum, all cases diagnosed through 1996-2009 should have a geocoded Census Tract 2000. Cases diagnosed 1996-1999 must have both State at DX Geocode 70/80/90 [82] and State at DX 2000 Geocode [83] codes for proper assignment of the Census Tr Poverty Indicatr [145]. Cases diagnosed 2006-2009 must have both State at DX 2000 Geocode [83] and State at DX Geocode 2010 [84] codes for proper assignment of the Census Tr Poverty Indicatr [145].</li><li>If the patient has multiple tumors, geocoded state at diagnosis may be different for each tumor. </li><li>Do not update this item if the patient's tract of residence changes. Store updated address information in the affiliated current address data items. Only update based on improved information on the residential address at time of diagnosis. For instance, it is appropriate to correct a tract during manual geocoding or a consolidation process.</li><li>PO Box address information should not be used to geocode this data item except in the infrequent case when no other address information is available.</li><li>Blank "Not geocoded" is allowable for cases diagnosed before 1995 and after 2009. However, it is recommended to have all cases geocoded to a 2000 Census Tract to allow for both retrospective and cross-sectional analyses.<br /></li></ul></div></div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>000100-999998</td><td class='code-desc'>Valid FIPS code</td></tr><tr class='code-row'><td class='code-nbr'>000000</td><td class='code-desc'>Area not census tracted</td></tr><tr class='code-row'><td class='code-nbr'>999999</td><td class='code-desc'>Area census-tracted, but census tract is not available</td></tr><tr class='code-row'><td class='code-nbr'>Blank</td><td class='code-desc'>Census Tract 2000 not coded</td></tr><tr class='code-row'><td class='code-nbr'></td><td class='code-desc'> </td></tr></table></div><div class='content chap10-para'><em>Note</em>: For U.S. residents, historically, standard codes are those of the FIPS publication "Counties and Equivalent Entities of the United States, Its Possessions, and Associated Areas." These FIPS codes (FIPS 6-4) have been replaced by INCITS standard codes; however, there is no impact on this variable as the codes align with the system the Census used for each decennial census and changes will automatically be accounted for during geocoding. County codes issued by the Federal Information Processing Standards (FIPS) publication Counties and Equivalent Entities of the United States, Its Possessions, and Associated Areas is available in Appendix A.</div><a name='135'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>CENSUS TRACT 2010</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">135</td><td style="text-align:center;">6</td><td style="text-align:center;"><a href='#sources'>NAACCR</a></td><td style="text-align:center;">2011</td><td style="text-align:center;">12.1</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">185 - 190</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>censusTract2010</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Identifies the patient's census tract of residence at the time the tumor was diagnosed. Census Tract 2010 is a derived (geocoded) variables based on the Census Boundary files from 2010. See Census Tract 1970/80/90 [110]; Census Tract 2000 [130]; Census Tract 2020 [125]. Codes are those used by the U.S. Census Bureau for the Year 2010 Census. For consolidated records, the geocoded state should be based on the best address at diagnosis information identified.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Census tract codes allow central registries to calculate incidence rates for geographical areas having population estimates. This field allows a central registry to add Year 2020 Census tracts to tumors diagnosed in previous years, without losing the codes in data items [110], [130] and [135].<br /><br />The Census Bureau provides population and other demographic data for census tracts. This allows for small area analysis for general surveillance or special geographical and socioeconomic analysis.<br /><strong><br /></strong><div><strong>Instructions for Coding</strong></div><div><ul><li>This variable is generated through the process of geocoding either during abstracting or at the central registry level. </li><li>Census tract codes have a 4-digit basic number and also may have a 2-digit suffix. Census tract numbers range from 0001.00 to 9999.98, but the decimal should not be retained in the NAACCR layout.</li><li>It is recommended that all cases diagnosed through 2019 should have a geocoded Census Tract 2010.</li><li>At a minimum, all cases diagnosed through 2006-2019 should have a geocoded Census Tract 2010. Cases diagnosed 2006-2009 must have both State at DX Geocode 2000 [82] and State at DX Geocode 2010 [83] codes for proper assignment of the Census Tr Poverty Indicatr [145]. Cases diagnosed 2016-2019 must have both State at DX Geocode 2010 [83] and State at DX Geocode 2020 [84] codes for proper assignment of the Census Tr Poverty Indicatr [145]. </li><li>If the patient has multiple tumors, geocoded state at diagnosis may be different for each tumor. </li><li>Do not update this item if the patient's tract of residence changes. Store updated address information in the affiliated current address data items. Only update based on improved information on the residential address at time of diagnosis. For instance, it is appropriate to correct a tract during manual geocoding or a consolidation process.</li><li>PO Box address information should not be used to geocode this data item except in the infrequent case when no other address information is available.</li><li>Blank &#8220;Not geocoded&#8221; is allowable for cases diagnosed before 2005 and after 2019. However, it is preferred to have all cases geocoded to a 2010 Census Tract to allow for both retrospective and cross-sectional analyses.<br /></li></ul></div></div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>000100-999998</td><td class='code-desc'>Valid FIPS code</td></tr><tr class='code-row'><td class='code-nbr'>000000</td><td class='code-desc'>Area not census tracted</td></tr><tr class='code-row'><td class='code-nbr'>999999</td><td class='code-desc'>Area census tracted, but census tract is not available</td></tr><tr class='code-row'><td class='code-nbr'>Blank</td><td class='code-desc'>Census Tract 2010 not coded</td></tr><tr class='code-row'><td class='code-nbr'></td><td class='code-desc'> </td></tr></table></div><div class='content chap10-para'><em>Note</em>: For U.S. residents, historically, standard codes are those of the FIPS publication "Counties and Equivalent Entities of the United States, Its Possessions, and Associated Areas." These FIPS codes (FIPS 6-4) have been replaced by INCITS standard codes; however, there is no impact on this variable as the codes align with the system the Census used for each decennial census and changes will automatically be accounted for during geocoding. County codes issued by the Federal Information Processing Standards (FIPS) publication Counties and Equivalent Entities of the United States, Its Possessions, and Associated Areas is available in Appendix A.</div><a name='125'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>CENSUS TRACT 2020</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">125</td><td style="text-align:center;">6</td><td style="text-align:center;"><a href='#sources'>NAACCR</a></td><td style="text-align:center;">2018</td><td style="text-align:center;">18</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">198 - 203</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>censusTract2020</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Identifies the patient's census tract of residence at the time the tumor was diagnosed. Census Tract 2020 is a derived (geocoded) variables based on the Census Boundary files from 2020 See Census Tract 1970/80/90 [110]; Census Tract 2000 [130]; Census Tract 2010 [135]. Codes are those used by the U.S. Census Bureau for the Year 2020 Census. Census tract codes have a 4-digit basic number and also may have a 2-digit suffix. Census tract numbers range from 0001.00 to 9999.98, but the decimal should not be retained in the NAACCR layout.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Census tract codes allow central registries to calculate incidence rates for geographical areas having population estimates. This field allows a central registry to add Year 2020 Census tracts to tumors diagnosed in previous years, without losing the codes in data items [110], [130] and [135].<br /><br /><div>The Census Bureau provides population and other demographic data for census tracts. This allows for small area analysis for general surveillance or special geographical and socioeconomic analysis. </div><div>&nbsp;</div><div><strong>Instructions for Coding</strong></div><ul><li>This variable is generated through the process of geocoding either during abstracting or at the central registry level. </li><li>Census tract codes have a 4-digit basic number and also may have a 2-digit suffix. Census tract numbers range from 0001.00 to 9999.98, but the decimal should not be retained in the NAACCR layout.</li><li>It is recommended that all cases diagnosed through 2029 should have a geocoded Census Tract 2020.</li><li>At a minimum, all cases diagnosed through 2016-2029 should have a geocoded Census Tract 2020. Cases diagnosed 2016-2019 must have both Geocoded State at DX 2010 and Geocoded State at DX 2020 codes for proper assignment of the Census Tr Poverty Indicatr [145]. </li><li>If the patient has multiple tumors, geocoded state at diagnosis may be different for each tumor. </li><li>Do not update this item if the patient's tract of residence changes. Store updated address information in the affiliated current address data items. Only update based on improved information on the residential address at time of diagnosis. For instance, it is appropriate to correct a tract during manual geocoding or a consolidation process.</li><li>PO Box address information should not be used to geocode this data item except in the infrequent case when no other address information is available.</li><li>Blank "Not geocoded" is allowable for cases diagnosed before 2015 and after 2029. However, it is preferred to have all cases geocoded to a 2020 Census Tract to allow for both retrospective and cross-sectional analyses.</li></ul></div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>000000</td><td class='code-desc'>Area not census tracted</td></tr><tr class='code-row'><td class='code-nbr'>000100-999998</td><td class='code-desc'>Valid FIPS code</td></tr><tr class='code-row'><td class='code-nbr'>999999</td><td class='code-desc'>Area census tracted, but census tract is not available</td></tr><tr class='code-row'><td class='code-nbr'>Blank</td><td class='code-desc'>Census Tract 2020 not coded</td></tr><tr class='code-row'><td class='code-nbr' colspan='2'></td></tr></table></div><div class='content chap10-para'>Note: For U.S. residents, historically, standard codes are those of the FIPS publication "Counties and Equivalent Entities of the United States, Its Possessions, and Associated Areas." These FIPS codes (FIPS 6-4) have been replaced by INCITS standard codes; however, there is no impact on this variable as the codes align with the system the Census used for each decennial census and changes will automatically be accounted for during geocoding. County codes issued by the Federal Information Processing Standards (FIPS) publication 





<em>Counties and Equivalent Entities of the United States, Its Possessions, and Associated Areas</em> is available in Appendix A.</div><a name='369'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>CENSUS TRACT CERTAINTY 2020</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">369</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>NAACCR</a></td><td style="text-align:center;">2018</td><td style="text-align:center;">18</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">205 - 205</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>censusTractCertainty2020</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Code indicating basis of assignment of census tract for an individual record. Helpful in identifying cases geocoded from incomplete information or P.O. Box. This item is not coded by the hospital. Central registry staff assign the code based on the results of geocoding.</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>1</td><td class='code-desc'>Census tract based on complete and valid street address of residence</td></tr><tr class='code-row'><td class='code-nbr'>2</td><td class='code-desc'>Census tract based on residence ZIP + 4</td></tr><tr class='code-row'><td class='code-nbr'>3</td><td class='code-desc'>Census tract based on residence ZIP + 2</td></tr><tr class='code-row'><td class='code-nbr'>4</td><td class='code-desc'>Census tract based on residence ZIP code only</td></tr><tr class='code-row'><td class='code-nbr'>5</td><td class='code-desc'>Census tract based on ZIP code of P.O. Box</td></tr><tr class='code-row'><td class='code-nbr'>6</td><td class='code-desc'>Census tract/BNA based on residence city where city has only one census tract, or based on residence ZIP code where ZIP code has only one census tract</td></tr><tr class='code-row'><td class='code-nbr'>9</td><td class='code-desc'>Not assigned, geocoding attempted</td></tr><tr class='code-row'><td class='code-nbr'>Blank</td><td class='code-desc'>Not assigned, geocoding not attempted</td></tr><tr class='code-row'><td class='code-nbr' colspan='2'></td></tr></table></div><div class='content chap10-para'><strong>Clarification of NPCR Required Status
</strong><div>
<table style="border-collapse: collapse;" width="900" height="132" cellspacing="0" cellpadding="0" bordercolor="" border="0">
     <tbody>
         <tr>
             <td width="310" valign="top" height="20"> <u>Census-1990 data items:</u> </td>
             <td width="300" valign="top" height=""> <u>Census-2000 data items:</u> </td>
             <td style="2.25in;0in 0in 0in 2.9pt" width="300" valign="top" height=""> <u>Census-2010 data items:</u> </td>
             <td width="300" valign="top" height=""><u>Census-2020 data items:</u><br />
             </td>
         </tr>
         <tr>
             <td width="290" valign="top" height="10"> Census Tract 1970/80/90 [110] </td>
             <td width="222" valign="top"> Census Tract 2000 [130] </td>
             <td style="2.25in;0in 0in 0in 2.9pt" width="216" valign="top"> Census Tract 2010 [135] </td>
             <td valign="top">Census Tract 2020&nbsp; [371] <br />
             </td>
         </tr>
         <tr>
             <td style="211.5pt;0in 5.4pt 0in 5.4pt" width="282" valign="top" height="10"> Census Tr Cert 1970/80/90 [364] </td>
             <td width="290" valign="top"> Census Tr Certainty 2000 [365] </td>
             <td width="290" valign="top"> Census Tr Certainty 2010 [367] </td>
             <td width="290" valign="top">Census Tr Certainty 2010 [369] <br />
             </td>
         </tr>
         <tr>
             <td style="211.5pt;0in 5.4pt 0in 5.4pt" width="282" valign="top" height="10"> Census Tract Cod Sys--1970/80/90 [120] </td>
             <td style="166.5pt;0in 5.4pt 0in 5.4pt" width="222" valign="top">&nbsp;</td>
             <td style="2.25in;0in 0in 0in 2.9pt" width="216" valign="top">&nbsp;</td>
             <td valign="top"><br />
             </td>
         </tr>
     </tbody>
</table>
</div>
<div>Information on census tract and census tract certainty is required. Census Tract and Census Tract Certainty should be recorded in the year-appropriate data item fields in order to reflect demographic information at the time of diagnosis. Until the 2020 Census is completed and data are available for geocoding, tumors diagnosed in 2020 or later, should be coded to the 2010 census definitions and recorded in Census Tract 2010 [135] and Census Tr Certainty 2000 [367]. When the 2020 Census data are available for geocoding, tumors diagnosed in 2020 or later must be coded to the 2020 census tract definitions and recorded in Census Tract 2020 [371] and Census Tract Certainty 2020 [369]. For tumors diagnosed between January 1, 2018, and December 31, 2019, use of Census Tract 2020 [371] and Census Track Certainty 2020 [369] is recommended. </div></div><a name='140'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>CENSUS TRACT COD SYS--ALT</strong></td><td style="text-align:right;font-weight:bold;"><strong>Retired</strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">140</td><td style="text-align:center;"></td><td style="text-align:center;"><a href='#sources'></a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;">2003</td><td style="text-align:center;">10</td><td class="cross-out" style="text-align:center;"></td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td></td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td></td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>This data item was retired for Version 10 because Census Tract--2000 [130] is expected to contain only Census 2000 codes.</div><a name='1600'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>CHEMOTHERAPY FIELD 1</strong></td><td style="text-align:right;font-weight:bold;"><strong>Retired</strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">1600</td><td style="text-align:center;"></td><td style="text-align:center;"><a href='#sources'></a></td><td style="text-align:center;">1996</td><td style="text-align:center;">5</td><td style="text-align:center;">2004</td><td style="text-align:center;">10.1</td><td class="cross-out" style="text-align:center;"></td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td></td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td></td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>This field has been listed as in development since 1996. The NAACCR UDSC retired this data item in Version 10.1, as of January 1, 2004.</div><a name='1610'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>CHEMOTHERAPY FIELD 2</strong></td><td style="text-align:right;font-weight:bold;"><strong>Retired</strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">1610</td><td style="text-align:center;"></td><td style="text-align:center;"><a href='#sources'></a></td><td style="text-align:center;">1996</td><td style="text-align:center;">5</td><td style="text-align:center;">2004</td><td style="text-align:center;">10.1</td><td class="cross-out" style="text-align:center;"></td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td></td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td></td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>This field has been listed as in development since 1996. The NAACCR UDSC retired this data item in Version 10.1, as of January 1, 2004.</div><a name='1620'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>CHEMOTHERAPY FIELD 3</strong></td><td style="text-align:right;font-weight:bold;"><strong>Retired</strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">1620</td><td style="text-align:center;"></td><td style="text-align:center;"><a href='#sources'></a></td><td style="text-align:center;">1996</td><td style="text-align:center;">5</td><td style="text-align:center;">2004</td><td style="text-align:center;">10.1</td><td class="cross-out" style="text-align:center;"></td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td></td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td></td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>This field has been listed as in development since 1996. The NAACCR UDSC retired this data item in Version 10.1, as of January 1, 2004.</div><a name='1630'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>CHEMOTHERAPY FIELD 4</strong></td><td style="text-align:right;font-weight:bold;"><strong>Retired</strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">1630</td><td style="text-align:center;"></td><td style="text-align:center;"><a href='#sources'></a></td><td style="text-align:center;">1996</td><td style="text-align:center;">5</td><td style="text-align:center;">2004</td><td style="text-align:center;">10.1</td><td class="cross-out" style="text-align:center;"></td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td></td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td></td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>This field has been listed as in development since 1996. The NAACCR UDSC retired this data item in Version 10.1, as of January 1, 2004.</div><a name='3802'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>CHROMOSOME 19Q: LOSS OF HETEROZYGOSITY (LOH)</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">3802</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>NAACCR</a></td><td style="text-align:center;">2018</td><td style="text-align:center;">18</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1741 - 1741</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>chromosome19qLossHeterozygosity</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Chromosome 19q: Loss of Heterozygosity (LOH) refers to the loss of genetic material normally found on the long arm of one of the patient's two copies of chromosome 19. Codeletion of Chromosome 1p and 19q is a diagnostic, prognostic and predictive marker for gliomas and is strongly associated with the oligodendroglioma phenotype.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Chromosome 19q: Loss of Heterozygosity (LOH) is a Registry Data Collection Variable in AJCC. It was previously collected as Brain, CS SSF #6.</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>0</td><td class='code-desc'>Chromosome 19q deletion/LOH not identified/not present</td></tr><tr class='code-row'><td class='code-nbr'>1</td><td class='code-desc'>Chromosome 19q deletion/LOH present</td></tr><tr class='code-row'><td class='code-nbr'>6</td><td class='code-desc'>Benign or borderline tumor</td></tr><tr class='code-row'><td class='code-nbr'>7</td><td class='code-desc'>Test ordered, results not in chart</td></tr><tr class='code-row'><td class='code-nbr'>8</td><td class='code-desc'>Not applicable: Information not collected for this case<br/>
(If this item is required by your standard setter, use of code 8 will result in an edit error.)
</td></tr><tr class='code-row'><td class='code-nbr'>9</td><td class='code-desc'>Not documented in patient record<br/>
Cannot be determined by the pathologist<br/>
Chromosome 19q: LOH not assessed or unknown if assessed
</td></tr><tr class='code-row'><td class='code-nbr'></td><td class='code-desc'> </td></tr></table></div><div class='content chap10-para'>Each Site-Specific Data Item (SSDI) applies only to selected primary sites, histologies, and years of diagnosis. Depending on applicability and standard-setter requirements, SSDIs may be left blank. </div><a name='3801'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>CHROMOSOME 1P: LOSS OF HETEROZYGOSITY (LOH)</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">3801</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>NAACCR</a></td><td style="text-align:center;">2018</td><td style="text-align:center;">18</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1740 - 1740</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>chromosome1pLossHeterozygosity</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Chromosome 1p: Loss of Heterozygosity (LOH) refers to the loss of genetic material normally found on the short arm of one of the patient's two copies of chromosome 1. Codeletion of Chromosome 1p and 19q is a diagnostic, prognostic and predictive marker for gliomas and is strongly associated with the oligodendroglioma phenotype.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Chromosome 1p: Loss of Heterozygosity (LOH) is a Registry Data Collection Variable in AJCC. It was previously collected as Brain, CS SSF #5.</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>0</td><td class='code-desc'>Chromosome 1p deletion/LOH not identified/not present</td></tr><tr class='code-row'><td class='code-nbr'>1</td><td class='code-desc'>Chromosome 1p deletion/LOH identified/present</td></tr><tr class='code-row'><td class='code-nbr'>6</td><td class='code-desc'>Benign or borderline tumor</td></tr><tr class='code-row'><td class='code-nbr'>7</td><td class='code-desc'>Test ordered, results not in chart</td></tr><tr class='code-row'><td class='code-nbr'>8</td><td class='code-desc'>Not applicable: Information not collected for this case<br/>
(If this item is required by your standard setter, use of code 8 will result in an edit error.)
</td></tr><tr class='code-row'><td class='code-nbr'>9</td><td class='code-desc'>Not documented in patient record<br/>
Cannot be determined by the pathologist<br/>
Chromosome 1p deletion/LOH not assessed or unknown if assessed
</td></tr><tr class='code-row'><td class='code-nbr'></td><td class='code-desc'> </td></tr></table></div><div class='content chap10-para'>Each Site-Specific Data Item (SSDI) applies only to selected primary sites, histologies, and years of diagnosis. Depending on applicability and standard-setter requirements, SSDIs may be left blank. </div><a name='3821'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>CHROMOSOME 3 STATUS</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">3821</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>NAACCR</a></td><td style="text-align:center;">2018</td><td style="text-align:center;">18</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1874 - 1874</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>chromosome3Status</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Chromosome 3 Status refers to the partial or total loss of Chromosome 3, which is a prognostic factor for uveal melanoma.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Chromosome 3 Status is a Registry Data Collection Variable in AJCC. This data item was previously collected as Uveal Melanoma, CS SSF# 5.</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>0</td><td class='code-desc'>No loss of chromosome 3 </td></tr><tr class='code-row'><td class='code-nbr'>1</td><td class='code-desc'>Partial loss of chromosome 3</td></tr><tr class='code-row'><td class='code-nbr'>2</td><td class='code-desc'>Complete loss of chromosome 3</td></tr><tr class='code-row'><td class='code-nbr'>3</td><td class='code-desc'>Loss of chromosome 3, NOS</td></tr><tr class='code-row'><td class='code-nbr'>7</td><td class='code-desc'>Test ordered, results not in chart</td></tr><tr class='code-row'><td class='code-nbr'>8</td><td class='code-desc'>Not applicable: Information not collected for this case<br/>
(If this information is required by your standard setter, use of code 8 may result in an edit error.)
</td></tr><tr class='code-row'><td class='code-nbr'>9</td><td class='code-desc'>Not documented in medical record<br/>
Chromosome 3 status not assessed or unknown if assessed
</td></tr><tr class='code-row'><td class='code-nbr'></td><td class='code-desc'> </td></tr></table></div><div class='content chap10-para'>Each Site-Specific Data Item (SSDI) applies only to selected primary sites, histologies, and years of diagnosis. Depending on applicability and standard-setter requirements, SSDIs may be left blank.</div><a name='3822'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>CHROMOSOME 8Q STATUS</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">3822</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>NAACCR</a></td><td style="text-align:center;">2018</td><td style="text-align:center;">18</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1875 - 1875</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>chromosome8qStatus</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Chromosome 8q Status refers to gain in Chromosome 8q, which is a prognostic factor for uveal melanoma.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'><!--[if gte mso 10]>  <![endif]-->Chromosome 8q Status is a Registry Data Collection Variable in AJCC.  This data item was previously collected as Uveal Melanoma, CS SSF# 7.</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>0</td><td class='code-desc'>No gain in chromosome 8q </td></tr><tr class='code-row'><td class='code-nbr'>1</td><td class='code-desc'>Gain in chromosome 8q</td></tr><tr class='code-row'><td class='code-nbr'>7</td><td class='code-desc'>Test ordered, results not in chart</td></tr><tr class='code-row'><td class='code-nbr'>8</td><td class='code-desc'>Not applicable: Information not collected for this case<br/>
(If this information is required by your standard setter, use of code 8 may result in an edit error.)
</td></tr><tr class='code-row'><td class='code-nbr'>9</td><td class='code-desc'>Not documented in medical record<br/>
Chromosome 8q status not assessed or unknown if assessed
</td></tr><tr class='code-row'><td class='code-nbr'></td><td class='code-desc'> </td></tr></table></div><div class='content chap10-para'>Each Site-Specific Data Item (SSDI) applies only to selected primary sites, histologies, and years of diagnosis. Depending on applicability and standard-setter requirements, SSDIs may be left blank.</div><a name='3823'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>CIRCUMFERENTIAL RESECTION MARGIN (CRM)</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">3823</td><td style="text-align:center;">4</td><td style="text-align:center;"><a href='#sources'>NAACCR</a></td><td style="text-align:center;">2018</td><td style="text-align:center;">18</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1796 - 1799</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>circumferentialResectionMargin</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Circumferential or Radial Resection Margin, the distance in millimeters between the leading edge of the tumor and the surgically dissected margin as recorded on the pathology report, is a prognostic indicator for colon and rectal cancer.  This may also be referred to as the Radial Resection Margin or surgical clearance.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Circumferential or Radial Resection Margin is a Registry Data Collection Variable in AJCC.  It was previously collected as Colon and Rectum CS SSF# 6.</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>0.0</td><td class='code-desc'>Circumferential resection margin (CRM) positive<br/>
Margin IS involved with tumor<br/>
Described as "less than 1 millimeter (mm)"
</td></tr><tr class='code-row'><td class='code-nbr'>0.1-99.9</td><td class='code-desc'>Distance of tumor from margin: 0.1- 99.9 millimeters (mm)<br/>
(Exact size to nearest tenth of millimeter)
</td></tr><tr class='code-row'><td class='code-nbr'>XX.0</td><td class='code-desc'>100 mm or greater</td></tr><tr class='code-row'><td class='code-nbr'>XX.1</td><td class='code-desc'>Margins clear, distance from tumor not stated<br/>
Circumferential or radial resection margin negative, NOS<br/>
No residual tumor identified on specimen
</td></tr><tr class='code-row'><td class='code-nbr'>XX.2</td><td class='code-desc'>Margins cannot be assessed </td></tr><tr class='code-row'><td class='code-nbr'>XX.3</td><td class='code-desc'>Described as "at least" 1 mm</td></tr><tr class='code-row'><td class='code-nbr'>XX.4</td><td class='code-desc'>Described as "at least" 2 mm</td></tr><tr class='code-row'><td class='code-nbr'>XX.5</td><td class='code-desc'>Described as "at least" 3 mm</td></tr><tr class='code-row'><td class='code-nbr'>XX.6</td><td class='code-desc'>Described as "greater than" 3 mm</td></tr><tr class='code-row'><td class='code-nbr'>XX.7</td><td class='code-desc'>No resection of primary site<br/> 
Surgical procedure did not remove enough tissue to measure the circumferential or radial resection margin<br/>
(Examples include: polypectomy only, endoscopic mucosal resection (EMR), excisional biopsy only, transanal disk excision)
</td></tr><tr class='code-row'><td class='code-nbr'>XX.8</td><td class='code-desc'>Not applicable: Information not collected for this case<br/>
(If this information is required by your standard setter, use of code XX.8 may result in an edit error.)
</td></tr><tr class='code-row'><td class='code-nbr'>XX.9</td><td class='code-desc'>Not documented in medical record<br/>
Circumferential or radial resection margin not assessed or unknown if assessed
</td></tr><tr class='code-row'><td class='code-nbr'></td><td class='code-desc'> </td></tr></table></div><div class='content chap10-para'>Each Site-Specific Data Item (SSDI) applies only to selected primary sites, histologies, and years of diagnosis. Depending on applicability and standard-setter requirements, SSDIs may be left blank. </div><a name='610'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>CLASS OF CASE</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">610</td><td style="text-align:center;">2</td><td style="text-align:center;"><a href='#sources'>CoC</a></td><td style="text-align:center;">1990</td><td style="text-align:center;">pre V4</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">790 - 791</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>classOfCase</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Class of Case divides cases into two groups. Analytic cases (codes 00-22) are those that are required by CoC to be abstracted because of the program&#8217;s primary responsibility in managing the cancer. Analytic cases are grouped according to the location of diagnosis and treatment. Treatment and outcome reports may be limited to analytic cases. Nonanalytic cases (codes 30-49 and 99) may be abstracted by the facility to meet central registry requirements or because of a request by the facility&#8217;s cancer program. Nonanalytic cases are grouped according to the reason a patient who received care at the facility is nonanalytic, or the reason a patient who never received care at the facility may have been abstracted. <br /><br />Class of Case can be used in conjunction with Type of Reporting Source [500]. Type of Reporting Source is designed to document the source of documents used to abstract the cancer being reported.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Class of Case reflects the facility's role in managing the cancer, whether the cancer is required to be reported by CoC, and whether the case was diagnosed after the program's Reference Date.</div><div class='content chap10-para'><em>Note:</em> This expanded list of coded values is effective with Version 12. *Indicates Class of Case codes appropriate for abstracting cases from non-hospital sources such as physician offices, ambulatory surgery centers, freestanding pathology laboratories, radiation therapy centers. When applied to these types of facilities, the non-hospital source is the reporting facility. The codes are applied the same way as if the case were reported from a hospital.   By using Class of Case codes in this manner for non-hospital sources, the central cancer registry is able to retain information reflecting the facility&#8217;s role in managing the cancer consistent with the way it is reported from hospitals. Using Class of Case in conjunction with Type of Reporting Source [500] which identifies the source documents used to abstract the cancer being reported, the central cancer registry has two distinct types of information to use in making consolidation decisions</div><div class='content chap10-para'><strong>
  <span style="font-size:11.0pt;font-family:&quot;Times New Roman&quot;,&quot;serif&quot;;">Codes<br />Analytic Classes of Case (Required by CoC to be abstracted by accredited cancer programs; refer to <a target="_blank" href="http://www.facs.org/cancer/coc/fordsmanual.html"><em>STORE </em></a>for additional instructions)</span>
</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr' colspan='2'><b>INITIAL DIAGNOSIS AT REPORTING FACILITY</b></td></tr><tr class='code-row'><td class='code-nbr'>00*</td><td class='code-desc'>Initial diagnosis at the reporting facility AND all treatment or a decision not to treat was done ELSEWHERE</td></tr><tr class='code-row'><td class='code-nbr'>10*</td><td class='code-desc'>Initial diagnosis at the reporting facility or in a staff physician's office AND PART OR ALL of first course treatment or a decision not to treat was at the reporting facility, NOS</td></tr><tr class='code-row'><td class='code-nbr'>11</td><td class='code-desc'>Initial diagnosis in staff physician's office AND PART of first course treatment was done at the reporting facility </td></tr><tr class='code-row'><td class='code-nbr'>12</td><td class='code-desc'>Initial diagnosis in staff physician's office AND ALL first course treatment or a decision not to treat was done at the reporting facility</td></tr><tr class='code-row'><td class='code-nbr'>13*</td><td class='code-desc'>Initial diagnosis at the reporting facility AND PART of first course treatment was done at the reporting facility</td></tr><tr class='code-row'><td class='code-nbr'>14*</td><td class='code-desc'>Initial diagnosis at the reporting facility AND ALL first course treatment or a decision not to treat was done at the reporting facility</td></tr><tr class='code-row'><td class='code-nbr' colspan='2'><b>INITIAL DIAGNOSIS ELSEWHERE, FACILITY INVOLVED IN FIRST COURSE TREATMENT</b></td></tr><tr class='code-row'><td class='code-nbr'>20*</td><td class='code-desc'>Initial diagnosis elsewhere AND PART OR ALL of first course treatment was done at the reporting facility, NOS</td></tr><tr class='code-row'><td class='code-nbr'>21*</td><td class='code-desc'>Initial diagnosis elsewhere AND PART of treatment was done at the reporting facility</td></tr><tr class='code-row'><td class='code-nbr'>22*</td><td class='code-desc'>Initial diagnosis elsewhere AND ALL first course treatment was done at the reporting facility</td></tr><tr class='code-row'><td class='code-nbr' colspan='2'><b>Classes of Case not required by CoC to be abstracted (May be required by Cancer Committee, state or regional registry, or other entity)</b></td></tr><tr class='code-row'><td class='code-nbr' colspan='2'><b>PATIENT APPEARS IN PERSON AT REPORTING FACILITY; BOTH INITIAL DIAGNOSIS AND TREATMENT ELSEWHERE</b></td></tr><tr class='code-row'><td class='code-nbr'>30*</td><td class='code-desc'>Initial diagnosis and all first course treatment elsewhere AND reporting facility participated in DIAGNOSTIC WORKUP (for example, consult only, staging workup after initial diagnosis elsewhere)</td></tr><tr class='code-row'><td class='code-nbr'>31*</td><td class='code-desc'>Initial diagnosis and all first course treatment elsewhere AND reporting facility provided IN-TRANSIT care</td></tr><tr class='code-row'><td class='code-nbr'>32*</td><td class='code-desc'>Diagnosis AND all first course treatment provided elsewhere AND patient presents at reporting facility with disease RECURRENCE OR PERSISTENCE</td></tr><tr class='code-row'><td class='code-nbr'>33*</td><td class='code-desc'>Diagnosis AND all first course treatment provided elsewhere AND patient presents at reporting facility with disease HISTORY ONLY</td></tr><tr class='code-row'><td class='code-nbr'>34</td><td class='code-desc'>Type of case not required by CoC to be accessioned (for example, a benign colon tumor) AND initial diagnosis AND part or all of first course treatment by reporting facility</td></tr><tr class='code-row'><td class='code-nbr'>35</td><td class='code-desc'>Case diagnosed before program's Reference Date AND initial diagnosis AND PART OR ALL of first course treatment by reporting facility</td></tr><tr class='code-row'><td class='code-nbr'>36</td><td class='code-desc'>Type of case not required by CoC to be accessioned (for example, a benign colon tumor) AND initial diagnosis elsewhere AND part or all of first course treatment by reporting facility</td></tr><tr class='code-row'><td class='code-nbr'>37</td><td class='code-desc'>Case diagnosed before program's Reference Date AND initial diagnosis elsewhere AND all or part of first course treatment by reporting facility</td></tr><tr class='code-row'><td class='code-nbr'>38*</td><td class='code-desc'>Initial diagnosis established by AUTOPSY at the reporting facility, cancer not suspected prior to death</td></tr><tr class='code-row'><td class='code-nbr' colspan='2'><b>PATIENT DOES NOT APPEAR IN PERSON AT REPORTING FACILITY</b></td></tr><tr class='code-row'><td class='code-nbr'>40</td><td class='code-desc'>Diagnosis AND all first course treatment given at the same staff physician's office</td></tr><tr class='code-row'><td class='code-nbr'>41</td><td class='code-desc'>Diagnosis and all first course treatment given in two or more different staff physician offices</td></tr><tr class='code-row'><td class='code-nbr'>42</td><td class='code-desc'>Non-staff physician or non-CoC accredited clinic or other facility, not part of reporting facility, accessioned by reporting facility for diagnosis and/or treatment by that entity (for example, hospital abstracts cases from an independent radiation facility)</td></tr><tr class='code-row'><td class='code-nbr'>43*</td><td class='code-desc'>PATHOLOGY or other lab specimens ONLY</td></tr><tr class='code-row'><td class='code-nbr'>49*</td><td class='code-desc'>DEATH CERTIFICATE ONLY</td></tr><tr class='code-row'><td class='code-nbr' colspan='2'><b>UNKNOWN RELATIONSHIP TO REPORTING FACILITY</b></td></tr><tr class='code-row'><td class='code-nbr'>99*</td><td class='code-desc'>Nonanalytic case of unknown relationship to facility (not for use by CoC accredited cancer programs for analytic cases.); UNKNOWN</td></tr><tr class='code-row'><td class='code-nbr'></td><td class='code-desc'> </td></tr></table></div><div class='content chap10-para'><em>Note: </em>This expanded list of coded values is effective with  Version 12.   <br /><br />*Indicates Class of Case codes appropriate for abstracting cases from  non-hospital sources such as physician offices, ambulatory surgery  centers, freestanding pathology laboratories, radiation therapy centers.  When applied to these types of facilities, the non-hospital source is  the reporting facility. The codes are applied the same way as if the  case were reported from a hospital.     <br /><br />By using Class of Case codes in this manner for non-hospital sources,  the central cancer registry is able to retain information reflecting the  facility's role in managing the cancer consistent with the way it is  reported from hospitals. Using Class of Case in conjunction with Type of  Reporting Source [500] which identifies the source documents used to  abstract the cancer being reported, the central cancer registry has two  distinct types of information to use in making consolidation decisions</div><a name='2152'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>COC ACCREDITED FLAG</strong></td><td style="text-align:right;font-weight:bold;"><strong>Revised</strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">2152</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>NPCR</a></td><td style="text-align:center;">2018</td><td style="text-align:center;">18</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">2624 - 2624</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>cocAccreditedFlag</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>CoC Accredited Flag is assigned at the point and time of data abstraction to label an abstract being prepared for an analytic cancer case at a facility accredited by the Commission on Cancer (CoC). The flag may be assigned manually or can be defaulted by the registry&#8217;s software.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para mark-changed'>CoC-accredited facilities are required to collect certain data items including TNM staging.  It is burdensome for central registries to maintain a list of accredited facilities, and the list changes frequently. The flag is a means of incorporating the accredited status into abstracts at the time of abstraction by someone who has knowledge of the status. The flag thus simplifies validating that required items have been abstracted by CoC-accredited facilities. The flag also allows cases to be stratified during analyses to identify those never seen at a CoC-accredited facility; e.g., percentage of all cases seen in at least one CoC-accredited facility, evaluation of outcomes by facility status. NPCR will use this flag for facility status stratification.</div><div class='content chap10-para'><strong>Codes &nbsp;&nbsp; </strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>0</td><td class='code-desc'>Abstract prepared at a facility WITHOUT CoC accreditation of its cancer program

 </td></tr><tr class='code-row'><td class='code-nbr'>1</td><td class='code-desc'>ANALYTIC abstract prepared at facility WITH CoC accreditation of its cancer program (Includes Class of Case codes 10-22)</td></tr><tr class='code-row'><td class='code-nbr'>2</td><td class='code-desc'>NON-ANALYTIC abstract prepared at facility WITH CoC accreditation of its cancer program (Includes Class of Case codes 30-43 and 99, plus code 00 which CoC considers analytic but does not require to be staged)
 </td></tr><tr class='code-row'><td class='code-nbr'>Blank</td><td class='code-desc'>Not applicable; DCO</td></tr><tr class='code-row'><td class='code-nbr'></td><td class='code-desc'> </td></tr></table></div><a name='2140'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>COC CODING SYS--CURRENT</strong></td><td style="text-align:right;font-weight:bold;"><strong>Revised</strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">2140</td><td style="text-align:center;">2</td><td style="text-align:center;"><a href='#sources'>CoC</a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">2619 - 2620</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>Commission on Cancer Coding System-Current (CoC)<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>cocCodingSysCurrent</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para mark-changed'>Code the ACoS CoC coding system currently used in the record. CoC codes may be converted from an earlier version.</div><div class='content chap10-para mark-changed'>This item is no longer required by CoC.</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para mark-changed'><table><tr class='code-row'><td class='code-nbr'>00</td><td class='code-desc'>No CoC coding system used</td></tr><tr class='code-row'><td class='code-nbr'>01</td><td class='code-desc'>Pre-1988 (Cancer Program Manual Supplement)</td></tr><tr class='code-row'><td class='code-nbr'>02</td><td class='code-desc'>1988 <i>Data Acquisition Manual</i></td></tr><tr class='code-row'><td class='code-nbr'>03</td><td class='code-desc'>1989 <i>Data Acquisition Manual</i> Revisions</td></tr><tr class='code-row'><td class='code-nbr'>04</td><td class='code-desc'>1990 <i>Data Acquisition Manual</i> Revisions</td></tr><tr class='code-row'><td class='code-nbr'>05</td><td class='code-desc'>1994 <i>Data Acquisition Manual</i> (Interim/Revised)</td></tr><tr class='code-row'><td class='code-nbr'>06</td><td class='code-desc'>ROADS (effective with cases diagnosed 1996-1997)</td></tr><tr class='code-row'><td class='code-nbr'>07</td><td class='code-desc'>ROADS and 1998 Supplement (effective with cases diagnosed 1998-2002)</td></tr><tr class='code-row'><td class='code-nbr'>08</td><td class='code-desc'><i>FORDS</i> (effective with cases diagnosed 2003-2017)</td></tr><tr class='code-row'><td class='code-nbr'>09</td><td class='code-desc'><i>STORE</i> (effective with cases diagnosed 2018-2020)</td></tr><tr class='code-row'><td class='code-nbr'>99</td><td class='code-desc'>Unknown coding system</td></tr><tr class='code-row'><td class='code-nbr'></td><td class='code-desc'> </td></tr></table></div><a name='2150'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>COC CODING SYS--ORIGINAL</strong></td><td style="text-align:right;font-weight:bold;"><strong>Revised</strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">2150</td><td style="text-align:center;">2</td><td style="text-align:center;"><a href='#sources'>CoC</a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">2621 - 2622</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>cocCodingSysOriginal</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para mark-changed'>Code for the ACoS CoC coding system originally used to code the record.</div><div class='content chap10-para mark-changed'>This item is no longer required by CoC.</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para mark-changed'><table><tr class='code-row'><td class='code-nbr'>00</td><td class='code-desc'>No CoC coding system used</td></tr><tr class='code-row'><td class='code-nbr'>01</td><td class='code-desc'>Pre-1988 (Cancer Program Manual Supplement)</td></tr><tr class='code-row'><td class='code-nbr'>02</td><td class='code-desc'>1988 <i>Data Acquisition Manual</i></td></tr><tr class='code-row'><td class='code-nbr'>03</td><td class='code-desc'>1989 <i>Data Acquisition Manual</i> Revisions</td></tr><tr class='code-row'><td class='code-nbr'>04</td><td class='code-desc'>1990 <i>Data Acquisition Manual</i> Revisions</td></tr><tr class='code-row'><td class='code-nbr'>05</td><td class='code-desc'>1994 <i>Data Acquisition Manual</i> (Interim/Revised)</td></tr><tr class='code-row'><td class='code-nbr'>06</td><td class='code-desc'>ROADS (effective with cases diagnosed 1996-1997)</td></tr><tr class='code-row'><td class='code-nbr'>07</td><td class='code-desc'>ROADS and 1998 Supplement (effective with cases diagnosed 1998-2002)</td></tr><tr class='code-row'><td class='code-nbr'>08</td><td class='code-desc'><i>FORDS</i> (effective with cases diagnosed 2003-2017)</td></tr><tr class='code-row'><td class='code-nbr'>09</td><td class='code-desc'><i>STORE</i> (effective with cases diagnosed 2018-2020) </td></tr><tr class='code-row'><td class='code-nbr'>99</td><td class='code-desc'>Original CoC coding system is not known</td></tr><tr class='code-row'><td class='code-nbr'></td><td class='code-desc'> </td></tr></table></div><a name='870'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>CODING SYSTEM FOR EOD</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">870</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>SEER</a></td><td style="text-align:center;">1995</td><td style="text-align:center;">5</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1045 - 1045</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>Coding System for Extent of Disease (SEER)<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>codingSystemForEod</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Indicates the type of SEER EOD code applied to the tumor. Should be used whenever EOD coding is applied. </div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Used in data editing and analysis. </div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>0</td><td class='code-desc'>2-Digit Nonspecific Extent of Disease (1973-82)</td></tr><tr class='code-row'><td class='code-nbr'>1</td><td class='code-desc'>2-Digit Site-Specific Extent of Disease (1973-82)</td></tr><tr class='code-row'><td class='code-nbr'>2</td><td class='code-desc'>13-Digit (expanded) Site-Specific Extent of Disease (1973-1982)</td></tr><tr class='code-row'><td class='code-nbr'>3</td><td class='code-desc'>4-Digit Extent of Disease (1983-87)</td></tr><tr class='code-row'><td class='code-nbr'>4</td><td class='code-desc'>10-Digit Extent of Disease, 1988 (1988-2003)</td></tr><tr class='code-row'><td class='code-nbr'>Blank</td><td class='code-desc'>Cases diagnosed 2004+; or the item is not collected</td></tr></table></div><a name='3110'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>COMORBID/COMPLICATION 1</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">3110</td><td style="text-align:center;">5</td><td style="text-align:center;"><a href='#sources'>CoC</a></td><td style="text-align:center;">2003</td><td style="text-align:center;">10</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1527 - 1531</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>Comorbidities and Complications #1<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>comorbidComplication1</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Records the patient&#8217;s pre-existing medical conditions, factors influencing health status, and/or complications during the patient&#8217;s hospital stay for the treatment of this cancer using ICD-9-CM codes. All are considered secondary diagnoses</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Pre-existing medical conditions, factors influencing health status, and/or complications may affect treatment decisions and influence patient outcomes. Information on comorbidities is used to adjust outcome statistics when evaluating patient survival and other outcomes. Complications may be related to the quality of care.</div><div class='content chap10-para'><strong>Codes (Refer to the most recent version  of <a target="_blank" href="http://www.facs.org/cancer/coc/fordsmanual.html"><em>STORE</em> </a>for additional instructions.)</strong>  <br />ICD-9-CM Codes 00100-13980, 24000-99990, E8700-E8799, E9300-E9499, V0720-V0739, V1000-V1590, V2220- V2310, V2540, V4400-V4589, and V5041-V5049.</div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>00000</td><td class='code-desc'>No secondary diagnoses documented</td></tr></table></div><div class='content chap10-para'><em>Note: </em>For comorbid conditions (ICD-9-CM codes 00100-13980 and  24000-99990), there is an assumed decimal point between the third and  fourth characters. For complications (ICD-9-CM codes E8700-E8799 and  E9300-E9499), there is an assumed decimal point between the fourth and  fifth characters. For conditions influencing health status and contact  with health services (ICD-9-CM codes V0720-V0739, V1000-V1590, V2220-  V2310, V2540, V4400-V4589, and V5041-V5049), there is an assumed decimal  point between the third and fourth characters.</div><a name='3164'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>COMORBID/COMPLICATION 10</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">3164</td><td style="text-align:center;">5</td><td style="text-align:center;"><a href='#sources'>CoC</a></td><td style="text-align:center;">2006</td><td style="text-align:center;">11</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1572 - 1576</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>Comorbidities and Complications #10<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>comorbidComplication10</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Records the patient&#8217;s pre-existing medical conditions, factors influencing health status, and/or complications for the treatment of this cancer using ICD-9-CM codes. All are considered secondary diagnoses.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Pre-existing medical conditions, factors influencing health status, and/or complications may affect treatment decisions and influence patient outcomes. Information on comorbidities is used to adjust outcome statistics when evaluating patient survival and other outcomes. Complications may be related to the quality of care.</div><div class='content chap10-para'><strong>Codes (Refer to the most recent version of <a target="_blank" href="http://www.facs.org/cancer/coc/fordsmanual.html"><em>STORE</em></a> for additional instructions.)<br /></strong>ICD-9-CM Codes 00100-13980, 24000-99990, E8700-E8799, E9300-E9499, V0720-V0739, V1000-V1590, V2220- V2310, V2540, V4400-V4589, and V5041-V5049.</div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr' colspan='2'>Leave blank if no further secondary diagnosis.</td></tr></table></div><div class='content chap10-para'><em>Note:</em> For comorbid conditions (ICD-9-CM codes 00100-13980 and  24000-99990), there is an assumed decimal point between the third and  fourth characters. For complications (ICD-9-CM codes E8700-E8799 and  E9300-E9499), there is an assumed decimal point between the fourth and  fifth characters. For conditions influencing health status and contact  with health services (ICD-9-CM codes V0720-V0739, V1000-V1590,  V2220-V2310, V2540, V4400-V4589, and V5041-V5049), there is an assumed  decimal point between the third and fourth characters.</div><a name='3120'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>COMORBID/COMPLICATION 2</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">3120</td><td style="text-align:center;">5</td><td style="text-align:center;"><a href='#sources'>CoC</a></td><td style="text-align:center;">2003</td><td style="text-align:center;">10</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1532 - 1536</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>Comorbidities and Complications #2<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>comorbidComplication2</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Records the patient&#8217;s pre-existing medical conditions, factors influencing health status, and/or complications during the patient&#8217;s hospital stay for the treatment of this cancer using ICD-9-CM codes. All are considered secondary diagnoses.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Pre-existing medical conditions, factors influencing health status, and/or complications may affect treatment decisions and influence patient outcomes. Information on comorbidities is used to adjust outcome statistics when evaluating patient survival and other outcomes. Complications may be related to the quality of care.</div><div class='content chap10-para'><strong>Codes (Refer to the most recent version of <a target="_blank" href="http://www.facs.org/cancer/coc/fordsmanual.html"><em>STORE</em> </a>for additional instructions.)</strong>  <br /><div>ICD-9-CM Codes 00100-13980, 24000-99990, E8700-E8799, E9300-E9499, V0720-V0739, V1000-V1590, V2220- V2310, V2540, V4400-V4589, and V5041-V5049. </div><div> &nbsp;</div>Leave blank if no further secondary diagnosis.</div><div class='content chap10-para'><em>Note: </em>For comorbid conditions (ICD-9-CM codes 00100-13980 and  24000-99990), there is an assumed decimal point between the third and  fourth characters. For complications (ICD-9-CM codes E8700-E8799 and  E9300-E9499), there is an assumed decimal point between the fourth and  fifth characters. For conditions influencing health status and contact  with health services (ICD-9-CM codes V0720-V0739, V1000-V1590,  V2220-V2310, V2540, V4400-V4589, and V5041-V5049), there is an assumed  decimal point between the third and fourth characters.</div><a name='3130'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>COMORBID/COMPLICATION 3</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">3130</td><td style="text-align:center;">5</td><td style="text-align:center;"><a href='#sources'>CoC</a></td><td style="text-align:center;">2003</td><td style="text-align:center;">10</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1537 - 1541</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>Comorbidities and Complications #3<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>comorbidComplication3</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Records the patient&#8217;s pre-existing medical conditions, factors influencing health status, and/or complications during the patient&#8217;s hospital stay for the treatment of this cancer using ICD-9-CM codes. All are considered secondary diagnoses.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Pre-existing medical conditions, factors influencing health status, and/or complications may affect treatment decisions and influence patient outcomes. Information on comorbidities is used to adjust outcome statistics when evaluating patient survival and other outcomes. Complications may be related to the quality of care.</div><div class='content chap10-para'><strong>Codes (Refer to the most recent version of <a target="_blank" href="http://www.facs.org/cancer/coc/fordsmanual.html"><em>STORE</em> </a>for additional instructions.)</strong>  <br />ICD-9-CM Codes 00100-13980, 24000-99990, E8700-E8799, E9300-E9499, V0720-V0739, V1000-V1590, V2220- V2310, V2540, V4400-V4589, and V5041-V5049. <br /><br />Leave blank if no further secondary diagnoses.</div><div class='content chap10-para'><em>Note: </em>For comorbid conditions (ICD-9-CM codes 00100-13980 and  24000-99990), there is an assumed decimal point between the third and  fourth characters. For complications (ICD-9-CM codes E8700-E8799 and  E9300-E9499), there is an assumed decimal point between the fourth and  fifth characters. For conditions influencing health status and contact  with health services (ICD-9-CM codes V0720-V0739, V1000-V1590,  V2220-V2310, V2540, V4400-V4589, and V5041-V5049), there is an assumed  decimal point between the third and fourth characters.</div><a name='3140'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>COMORBID/COMPLICATION 4</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">3140</td><td style="text-align:center;">5</td><td style="text-align:center;"><a href='#sources'>CoC</a></td><td style="text-align:center;">2003</td><td style="text-align:center;">10</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1542 - 1546</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>Comorbidities and Complications #4<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>comorbidComplication4</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Records the patient&#8217;s pre-existing medical conditions, factors influencing health status, and/or complications during the patient&#8217;s hospital stay for the treatment of this cancer using ICD-9-CM codes. All are considered secondary diagnoses.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Pre-existing medical conditions, factors influencing health status, and/or complications may affect treatment decisions and influence patient outcomes. Information on comorbidities is used to adjust outcome statistics when evaluating patient survival and other outcomes. Complications may be related to the quality of care.</div><div class='content chap10-para'><strong>Codes (Refer to the most recent version of <a target="_blank" href="http://www.facs.org/cancer/coc/fordsmanual.html"><em>STORE</em> </a>for additional instructions.)</strong>  <br />ICD-9-CM Codes 00100-13980, 24000-99990, E8700-E8799, E9300-E9499, V0720-V0739, V1000-V1590, V2220- V2310, V2540, V4400-V4589, and V5041-V5049.<br /><br />Leave blank if no further secondary diagnoses.</div><div class='content chap10-para'><em>Note:</em> For comorbid conditions (ICD-9-CM codes 00100-13980 and  24000-99990), there is an assumed decimal point between the third and  fourth characters. For complications (ICD-9-CM codes E8700-E8799 and  E9300-E9499), there is an assumed decimal point between the fourth and  fifth characters. For conditions influencing health status and contact  with health services (ICD-9-CM codes V0720-V0739, V1000-V1590,  V2220-V2310, V2540, V4400-V4589, and V5041-V5049), there is an assumed  decimal point between the third and fourth characters.</div><a name='3150'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>COMORBID/COMPLICATION 5</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">3150</td><td style="text-align:center;">5</td><td style="text-align:center;"><a href='#sources'>CoC</a></td><td style="text-align:center;">2003</td><td style="text-align:center;">10</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1547 - 1551</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>Comorbidities and Complications #5<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>comorbidComplication5</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Records the patient&#8217;s pre-existing medical conditions, factors influencing health status, and/or complications during the patient&#8217;s hospital stay for the treatment of this cancer using ICD-9-CM codes. All are considered secondary diagnoses.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Pre-existing medical conditions, factors influencing health status, and/or complications may affect treatment decisions and influence patient outcomes. Information on comorbidities is used to adjust outcome statistics when evaluating patient survival and other outcomes. Complications may be related to the quality of care.</div><div class='content chap10-para'><strong>Codes (Refer to the most recent version of <a target="_blank" href="http://www.facs.org/cancer/coc/fordsmanual.html"><em>STORE</em> </a>for additional instructions.)</strong>  <br />ICD-9-CM Codes 00100-13980, 24000-99990, E8700-E8799, E9300-E9499, V0720-V0739, V1000-V1590, V2220- V2310, V2540, V4400-V4589, and V5041-V5049. <br /><br />Leave blank if no further secondary diagnoses.</div><div class='content chap10-para'><em>Note: </em>For comorbid conditions (ICD-9-CM codes 00100-13980 and  24000-99990), there is an assumed decimal point between the third and  fourth characters. For complications (ICD-9-CM codes E8700-E8799 and  E9300-E9499), there is an assumed decimal point between the fourth and  fifth characters. For conditions influencing health status and contact  with health services (ICD-9-CM codes V0720-V0739, V1000-V1590,  V2220-V2310, V2540, V4400-V4589, and V5041-V5049), there is an assumed  decimal point between the third and fourth characters.</div><a name='3160'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>COMORBID/COMPLICATION 6</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">3160</td><td style="text-align:center;">5</td><td style="text-align:center;"><a href='#sources'>CoC</a></td><td style="text-align:center;">2003</td><td style="text-align:center;">10</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1552 - 1556</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>Comorbidities and Complications #6<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>comorbidComplication6</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Records the patient&#8217;s pre-existing medical conditions, factors influencing health status, and/or complications during the patient&#8217;s hospital stay for the treatment of this cancer using ICD-9-CM codes. All are considered secondary diagnoses.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Pre-existing medical conditions, factors influencing health status, and/or complications may affect treatment decisions and influence patient outcomes. Information on comorbidities is used to adjust outcome statistics when evaluating patient survival and other outcomes. Complications may be related to the quality of care.</div><div class='content chap10-para'><strong>Codes (Refer to the most recent version of <a target="_blank" href="http://www.facs.org/cancer/coc/fordsmanual.html"><em>STORE</em> </a>for additional instructions.)</strong>  <br />ICD-9-CM Codes 00100-13980, 24000-99990, E8700-E8799, E9300-E9499, V0720-V0739, V1000-V1590, V2220- V2310, V2540, V4400-V4589, and V5041-V5049. <br /><br />Leave blank if no further secondary diagnoses.</div><div class='content chap10-para'><em>Note: </em>For comorbid conditions (ICD-9-CM codes 00100-13980 and  24000-99990), there is an assumed decimal point between the third and  fourth characters. For complications (ICD-9-CM codes E8700-E8799 and  E9300-E9499), there is an assumed decimal point between the fourth and  fifth characters. For conditions influencing health status and contact  with health services (ICD-9-CM codes V0720-V0739, V1000-V1590,  V2220-V2310, V2540, V4400-V4589, and V5041-V5049), there is an assumed  decimal point between the third and fourth characters.</div><a name='3161'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>COMORBID/COMPLICATION 7</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">3161</td><td style="text-align:center;">5</td><td style="text-align:center;"><a href='#sources'>CoC</a></td><td style="text-align:center;">2006</td><td style="text-align:center;">11</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1557 - 1561</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>Comorbidities and Complications #7<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>comorbidComplication7</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Records the patient&#8217;s pre-existing medical conditions, factors influencing health status, and/or complications during the patient&#8217;s hospital stay for the treatment of this cancer using ICD-9-CM codes. All are considered secondary diagnoses.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Pre-existing medical conditions, factors influencing health status, and/or complications may affect treatment decisions and influence patient outcomes. Information on comorbidities is used to adjust outcome statistics when evaluating patient survival and other outcomes. Complications may be related to the quality of care.</div><div class='content chap10-para'><strong>Codes (Refer to the most recent version of <a target="_blank" href="http://www.facs.org/cancer/coc/fordsmanual.html"><em>STORE</em> </a>for additional instructions.)</strong>  <br />ICD-9-CM Codes 00100-13980, 24000-99990, E8700-E8799, E9300-E9499, V0720-V0739, V1000-V1590, V2220- V2310, V2540, V4400-V4589, and V5041-V5049. <br /><br />Leave blank if no further secondary diagnosis.</div><div class='content chap10-para'><em>Note:</em> For comorbid conditions (ICD-9-CM codes 00100-13980 and  24000-99990), there is an assumed decimal point between the third and  fourth characters. For complications (ICD-9-CM codes E8700-E8799 and  E9300-E9499), there is an assumed decimal point between the fourth and  fifth characters. For conditions influencing health status and contact  with health services (ICD-9-CM codes V0720-V0739, V1000-V1590,  V2220-V2310, V2540, V4400-V4589, and V5041-V5049), there is an assumed  decimal point between the third and fourth characters.</div><a name='3162'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>COMORBID/COMPLICATION 8</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">3162</td><td style="text-align:center;">5</td><td style="text-align:center;"><a href='#sources'>CoC</a></td><td style="text-align:center;">2006</td><td style="text-align:center;">11</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1562 - 1566</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>Comorbidities and Complications #8<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>comorbidComplication8</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Records the patient&#8217;s pre-existing medical conditions, factors influencing health status, and/or complications during the patient&#8217;s hospital stay for the treatment of this cancer using ICD-9-CM codes. All are considered secondary diagnoses.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Pre-existing medical conditions, factors influencing health status, and/or complications may affect treatment decisions and influence patient outcomes. Information on comorbidities is used to adjust outcome statistics when evaluating patient survival and other outcomes. Complications may be related to the quality of care.</div><div class='content chap10-para'><strong>Codes (Refer to the most recent version of <a target="_blank" href="http://www.facs.org/cancer/coc/fordsmanual.html"><em>STORE</em> </a>for additional instructions.)</strong>  <br />ICD-9-CM Codes 00100-13980, 24000-99990, E8700-E8799, E9300-E9499, V0720-V0739, V1000-V1590, V2220- V2310, V2540, V4400-V4589, and V5041-V5049. <br /><br />Leave blank if no further secondary diagnosis.</div><div class='content chap10-para'><em>Note:</em> For comorbid conditions (ICD-9-CM codes 00100-13980 and  24000-99990), there is an assumed decimal point between the third and  fourth characters. For complications (ICD-9-CM codes E8700-E8799 and  E9300-E9499), there is an assumed decimal point between the fourth and  fifth characters. For conditions influencing health status and contact  with health services (ICD-9-CM codes V0720-V0739, V1000-V1590,  V2220-V2310, V2540, V4400-V4589, and V5041-V5049), there is an assumed  decimal point between the third and fourth characters.</div><a name='3163'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>COMORBID/COMPLICATION 9</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">3163</td><td style="text-align:center;">5</td><td style="text-align:center;"><a href='#sources'>CoC</a></td><td style="text-align:center;">2006</td><td style="text-align:center;">11</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1567 - 1571</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>Comorbidities and Complications #9<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>comorbidComplication9</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Records the patient&#8217;s pre-existing medical conditions, factors influencing health status, and/or complications during the patient&#8217;s hospital stay for the treatment of this cancer using ICD-9-CM codes. All are considered secondary diagnoses.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Pre-existing medical conditions, factors influencing health status, and/or complications may affect treatment decisions and influence patient outcomes. Information on comorbidities is used to adjust outcome statistics when evaluating patient survival and other outcomes. Complications may be related to the quality of care.</div><div class='content chap10-para'><strong>Codes (Refer to the most recent version of <a target="_blank" href="http://www.facs.org/cancer/coc/fordsmanual.html"><em>STORE</em> </a>for additional instructions.)</strong>  <br />ICD-9-CM Codes 00100-13980, 24000-99990, E8700-E8799, E9300-E9499, V0720-V0739, V1000-V1590, V2220- V2310, V2540, V4400-V4589, and V5041-V5049.</div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr' colspan='2'>Leave blank if no further secondary diagnosis.</td></tr></table></div><div class='content chap10-para'>Note: For comorbid conditions (ICD-9-CM codes 00100-13980 and 24000-99990), there is an assumed decimal point between the third and fourth characters. For complications (ICD-9-CM codes E8700-E8799 and E9300-E9499), there is an assumed decimal point between the fourth and fifth characters. For conditions influencing health status and contact with health services (ICD-9-CM codes V0720-V0739, V1000-V1590, V2220-V2310, V2540, V4400-V4589, and V5041-V5049), there is an assumed decimal point between the third and fourth characters.</div><a name='200'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>COMPUTED ETHNICITY</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">200</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>SEER</a></td><td style="text-align:center;">1995</td><td style="text-align:center;">4</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">220 - 220</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>computedEthnicity</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Patient</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Code identifying those cases for which ethnicity was determined by matching Name--Last [2230] and Name--Maiden [2390] to a computer list of Spanish/Hispanic names or by a software algorithm. This field was adopted for use for tumors diagnosed 1994 forward. See also Computed Ethnicity Source [210].</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>One method of identifying persons of Hispanic origin is to apply a standard computer list or algorithm to items 2230 and 2390, the patient&#8217;s surname and/or maiden name. This has advantages across large populations of being reproducible and facilitating comparisons between areas using identical methods. It may sometimes be possible to identify population denominators in which the same method was used to identify Hispanics. Generally, only central registries will have this capability.<br /><br />This field provides coding to indicate both that such a computerized name-based method was applied and the results of the method. Coding is independent of that in Spanish/Hispanic Origin [190]. The computer-derived ethnicity may be different from the ethnicity reported by registries in Spanish/Hispanic Origin [190] as code 7 (Spanish Surname Only), because that field may include manual review. This field shows the results of computer-derived ethnicity only.</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>0</td><td class='code-desc'>No match was run (for 1994 and later tumors)</td></tr><tr class='code-row'><td class='code-nbr'>1</td><td class='code-desc'>Non-Hispanic last name and non-Hispanic maiden name</td></tr><tr class='code-row'><td class='code-nbr'>2</td><td class='code-desc'>Non-Hispanic last name, did not check maiden name or patient was male</td></tr><tr class='code-row'><td class='code-nbr'>3</td><td class='code-desc'>Non-Hispanic last name, missing maiden name</td></tr><tr class='code-row'><td class='code-nbr'>4</td><td class='code-desc'>Hispanic last name, non-Hispanic maiden name</td></tr><tr class='code-row'><td class='code-nbr'>5</td><td class='code-desc'>Hispanic last name, did not check maiden name or patient was male</td></tr><tr class='code-row'><td class='code-nbr'>6</td><td class='code-desc'>Hispanic last name, missing maiden name</td></tr><tr class='code-row'><td class='code-nbr'>7</td><td class='code-desc'>Hispanic Maiden name (females only) (regardless of last name)</td></tr><tr class='code-row'><td class='code-nbr'>Blank</td><td class='code-desc'>1993 and earlier tumors, no match was run</td></tr></table></div><div class='content chap10-para'><em>    <br />Note: </em>For SEER, blanks are required for all cases diagnosed before 1994 and blanks are not allowed for any case diagnosed 1994 and after. Other registries may have computed this item for earlier years.<em><br /><br />Note:</em> NAACCR recognizes that available definitions and abstracting instructions for the data items Name--Last and Name--Maiden may be inadequate for describing names used in some cultures, including Hispanic cultures. Explicit instructions have not been provided for entering compound names, with or without hyphens or &#8220;De.&#8221; Order of names, use of maternal and paternal names, and use of hyphens can vary across cultures. It is likely, too, that abstracting and coding practice for these items varies across registries. Limitations inherent in these definitions should be kept in mind in any use of the data.</div><a name='210'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>COMPUTED ETHNICITY SOURCE</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">210</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>SEER</a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">221 - 221</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>computedEthnicitySource</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Patient</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Code identifying the method used to determine ethnicity as recorded in Computed Ethnicity [200].</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>0</td><td class='code-desc'>No match was run, for 1994 and later tumors</td></tr><tr class='code-row'><td class='code-nbr'>1</td><td class='code-desc'>Census Bureau list of Spanish surnames, NOS</td></tr><tr class='code-row'><td class='code-nbr'>2</td><td class='code-desc'>1980 Census Bureau list of Spanish surnames</td></tr><tr class='code-row'><td class='code-nbr'>3</td><td class='code-desc'>1990 Census Bureau list of Spanish surnames</td></tr><tr class='code-row'><td class='code-nbr'>4</td><td class='code-desc'>GUESS Program</td></tr><tr class='code-row'><td class='code-nbr'>5</td><td class='code-desc'>Combination list including South Florida names</td></tr><tr class='code-row'><td class='code-nbr'>6</td><td class='code-desc'>Combination of Census and other locally generated list</td></tr><tr class='code-row'><td class='code-nbr'>7</td><td class='code-desc'>Combination of Census and GUESS, with or without other lists</td></tr><tr class='code-row'><td class='code-nbr'>8</td><td class='code-desc'>Other type of match</td></tr><tr class='code-row'><td class='code-nbr'>9</td><td class='code-desc'>Unknown type of match</td></tr><tr class='code-row'><td class='code-nbr'>Blank</td><td class='code-desc'>1993 and earlier tumors, no match was run</td></tr></table></div><div class='content chap10-para'><em>Note: </em>For SEER, blanks are required for all cases diagnosed  before 1994 and blanks are not allowed for any case diagnosed 1994 and  after. Other registries may have computed this item for earlier years.</div><a name='89'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>COUNTY AT DX ANALYSIS</strong></td><td style="text-align:right;font-weight:bold;"><strong>Revised</strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">89</td><td style="text-align:center;">3</td><td style="text-align:center;"><a href='#sources'>NAACCR</a></td><td style="text-align:center;">2018</td><td style="text-align:center;">18</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">150 - 152</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>countyAtDxAnalysis</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>County at Diagnosis Analysis Code for the county of the patient's residence at the time the tumor was diagnosed is a derived variable to be used for county and county-based (such as CHSDA) rates and analysis for all cases regardless of year of diagnosis.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para mark-changed'>Historically, we had a single County at DX [90]. However, counties change over time (which impacts our derived variables such as poverty code indicator which don&#8217;t directly align with year of diagnosis), and the county reported by the facility does not always match the geocoded county. In the vast majority of cases where geocoded county and reported county differ, the geocoded county is correct. Including additional geocoded county codes for each census year addresses the accuracy of geocoded fields, however, it is cumbersome to pull data from different variables in order to generate county-level rates. Use of this variable ensures the most accurate and appropriate county data is used for calculating county-level rates. <br /><br /><div><strong>Instructions for Coding</strong></div><ul><li>This variable can be generated using a standard, NAACCR supplied SAS code (or the logic below). At a minimum, this field should be derived prior to release of data for county-level analysis or rates. Ideally, the variable should be updated whenever there is a change to any county field.</li><li>If the County At DX Reported [90] AND the County At DX Geocoded associated with the year of diagnosis are the same, the County At DX Analysis county can be pulled from either field. </li><li>If the County At DX Reported [90] is "999" or NULL AND County At DX Geocoded associated with the year of diagnosis is geocoded (Census Tr Cert [364] for cases diagnosed through 1999, [365] for cases diagnosed 2000-2009, or [367] for cases diagnosed 2010-2019] = is not null and less than 9), pull the County At DX Geocode associated with the year of diagnosis. Cases diagnosed 1990-1999, pull from County At DX Geocode 1990. Cases diagnosed 2000-2009, pull from County At DX Geocode 2000. Cases diagnosed 2010-2019, pull from County At DX Geocode 2010. Cases diagnosed 2020-2029, pull from County At DX Geocode 2020. </li><li>If the County At DX Geocoded associated with the year of diagnosis does not equal County At DX Reported [90] AND is a high quality geocode (Census Tr Cert [364 ]for cases diagnosed through 1999, [365] for cases diagnosed 2000-2009, or [367] for cases diagnosed 2010-2019] =  1), pull the County At DX Geocode associated with the year of diagnosis. Cases diagnosed 1990-1999, pull from County At DX Geocode 1990. Cases diagnosed 2000-2009, pull from County At DX Geocode 2000. Cases diagnosed 2010-2019, pull from County At DX Geocode 2010. Cases diagnosed 2020-2029, pull from County At DX Geocode 2020. </li><li>If the County At DX Geocoded associated with the year of diagnosis does not equal County At DX Reported [90] AND is based on a PO Box address (Census Tr Cert [364 ]for cases diagnosed through 1999, [365] for cases diagnosed 2000-2009, or [367] for cases diagnosed 2010-2019] = 5), the derived county equals the County At DX Reported [90].</li><li>If the County At DX Geocoded associated with the year of diagnosis is ungeocoded (Census Tr Cert [364] for cases diagnosed through 1999, #365 for cases diagnosed 2000-2009, or [367] for cases diagnosed 2010-2019] = blank or 9), the derived county equals the County At DX Reported [90].</li><li>If the County At DX Geocoded associated with the year of diagnosis does not match County At DX Reported [90] AND a geocode is based on residential addresses but geocoded to the centroid of a zip code (Census Tr Cert [364] for cases diagnosed through 1999, [365] for cases diagnosed 2000-2009, or [367] for cases diagnosed 2010-2019] = 2-4), manual review is required to resolve the discrepancy. Until manual review can be done, use the County At DX Reported [90]. </li><li>If the patient has multiple tumors, the county codes may be different for each tumor.</li><li>Detailed standards have not been set for Canadian provinces/territories. Use code 998 for Canadian residents.</li></ul></div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>001-997</td><td class='code-desc'>Valid FIPS code </td></tr><tr class='code-row'><td class='code-nbr'>998</td><td class='code-desc'>Known town, city, state, or country of residence but county code not known AND a resident outside of the state of reporting institution (must meet all criteria). Use for Canadian residents.</td></tr><tr class='code-row'><td class='code-nbr'>999</td><td class='code-desc'>The county of the patient is unknown, or the patient is not a United States resident. County is not documented in the patient's medical record. </td></tr><tr class='code-row'><td class='code-nbr' colspan='2'></td></tr></table></div><div class='content chap10-para'><em>Note</em>: For U.S. residents, historically, standard codes are those of the FIPS publication <em>Counties and Equivalent Entities of the United States, Its Possessions, and Associated Areas.</em> These FIPS codes (FIPS 6-4) have been replaced by INCITS standard codes; however, there is no impact on this variable as the codes align with the system the Census used for each decennial census and changes will automatically be accounted for during geocoding. County codes issued by the Federal Information Processing Standards (FIPS) publication, <em>Counties and Equivalent Entities of the United States, Its Possessions, and Associated Areas</em> is available in Appendix A.</div><a name='94'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>COUNTY AT DX GEOCODE 1970/80/90</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">94</td><td style="text-align:center;">3</td><td style="text-align:center;"><a href='#sources'>NAACCR</a></td><td style="text-align:center;">2016</td><td style="text-align:center;">16</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">155 - 157</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>County at DX Geocode1990<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>countyAtDxGeocode1990</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>County at Diagnosis 1990 Code for the county of the patient&#8217;s residence at the time the tumor was diagnosed is a derived (geocoded) variable based on Census Boundary files from 1990 Decennial Census. This code should be used for county and county-based (such as CHSDA) rates and analysis for all cases diagnosed prior to 2000.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Census tracts are areas geographically nested within counties and designated with a 6-digit number code. This 6-digit code is commonly repeated within a state in different counties. Census tract numbers are only unique when paired with the state and the county. Therefore, a tract cannot be accurately identified without knowing the county. Example from Massachusetts: Rural Franklin County contains a tract 040600 with 2010 population 4,612 people. Urban Suffolk County contains a tract 040600 with 2,444 people. The county must be known in order to distinguish between the two tract codes. Because we historically used a single variable for county at diagnosis [90] correct tract codes were frequently paired with the wrong county due to incorrect county assignment during abstracting or a change of county over time. Also, some variables, such as the Census Tr Poverty Indicatr [145] require the use of the decennial Census County codes closest to year of diagnosis and not the decade of year of diagnosis. Using a single county at diagnosis, and using the reported versus geocoded data, may result in erroneous assignment of geographic location as well as invalid links with census data (i.e., population, poverty category, urban/rural designation). <br /><br /><div><strong>Instructions for Coding</strong></div><ul><li>This variable is generated through the process of geocoding either during abstracting or at the central registry level. </li><li>At a minimum, all cases diagnosed through diagnosis year 1999 should have a geocoded County at Diagnosis 1990. Cases diagnosed 1996-1999 must have both County at Diagnosis 1990 and County at Diagnosis 2000 codes for proper assignment of the Census Tract Poverty Indicator [145]. </li><li>If the patient has multiple tumors, geocoded county may be different for each tumor. </li><li>Do not update this item if the patient's residential county changes. Store updated address information in the affiliated current address data items. Only update based on improved information on the residential address at time of diagnosis. For instance, it is appropriate to correct a county during manual geocoding or a consolidation process. </li><li>Refer to FORDS for residency rules.</li><li>PO Box address information should not be used to geocode this data item except in the infrequent case when no other address information is available.</li><li>Detailed standards have not been set for Canadian provinces/territories. Use code 998 for Canadian residents. </li><li>Blank "Not geocoded" is allowable for cases diagnosed after 1999. However, it is recommended to have all cases geocoded to a 1990 Census County to allow for both retrospective and cross-sectional analyses.</li></ul></div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>001-997</td><td class='code-desc'>County at diagnosis. Valid FIPS code </td></tr><tr class='code-row'><td class='code-nbr'>998</td><td class='code-desc'>Known town, city, state, or country of residence but county code not known AND a resident outside of the state of reporting institution (must meet all criteria). Use this code for Canadian residents.</td></tr><tr class='code-row'><td class='code-nbr'>999</td><td class='code-desc'>County unknown. The county of the patient is unknown, or the patient is not a United States resident. County is not documented in the patient's medical record.  </td></tr><tr class='code-row'><td class='code-nbr'></td><td class='code-desc'> </td></tr></table></div><div class='content chap10-para'><!--[if gte mso 10]>  <![endif]-->
<!--[if gte mso 10]>  <![endif]-->
<em></em><!--[if gte mso 10]>  <![endif]--><em>Note</em>: For U.S. residents, historically, standard codes are those of the FIPS publication "Counties and Equivalent Entities of the United States, Its Possessions, and Associated Areas." These FIPS codes (FIPS 6-4) have been replaced by INCITS standard codes; however, there is no impact on this variable as the codes align with the system the Census used for each decennial census and changes will automatically be accounted for during geocoding. County codes issued by the Federal Information Processing Standards (FIPS) publication <em>Counties and Equivalent Entities of the United States, Its Possessions, and Associated Areas</em> is available in Appendix A.</div><a name='95'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>COUNTY AT DX GEOCODE2000</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">95</td><td style="text-align:center;">3</td><td style="text-align:center;"><a href='#sources'>NAACCR</a></td><td style="text-align:center;">2016</td><td style="text-align:center;">16</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">169 - 171</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>countyAtDxGeocode2000</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Code for the county of the patient's residence at the time the tumor was diagnosed is a derived (geocoded) variable based on Census Boundary files from 2000 Decennial Census. 

















<strong>This code should be used for county and county-based (such as CHSDA) rates and analysis for all cases diagnosed in 2000-2009. </strong></div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'><div>Census tracts are areas geographically nested within counties and designated with a 6-digit number code. This 6-digit code is commonly repeated within a state in different counties. Census tract numbers are only unique when paired with the state and the county. Therefore, a tract cannot be accurately identified without knowing the county. Example from Massachusetts: Rural Franklin County contains a tract 040600 with 2010 population 4,612 people. Urban Suffolk County contains a tract 040600 with 2,444 people. The county must be known in order to distinguish between the two tract codes. Because we historically used a single variable for county at diagnosis [90], correct tract codes were frequently paired with the wrong county due to incorrect county assignment during abstracting or a change of county over time. Also, some variables, such as the Census Tr Poverty Indicatr [145] require the use of the decennial Census County codes closest to year of diagnosis and not the decade of year of diagnosis. Using a single county at diagnosis, and using the reported versus geocoded data, may result in erroneous assignment of geographic location as well as invalid links with census data (i.e., population, poverty category, urban/rural designation).   </div><div>&nbsp;</div><div><strong>Instructions for Coding</strong></div><div><ul><li>This variable is generated through the process of geocoding either during abstracting or at the central registry level. </li><li>It is recommended that all cases diagnosed through 2009 have a geocoded County at Diagnosis 2000.</li><li>At a minimum, all cases diagnosed through 1996-2009 should have a geocoded County at Diagnosis 2000. Cases diagnosed 1996-1999 must have both County at Diagnosis 1990 and County at Diagnosis 2000 codes for proper assignment of the Census Tract Poverty Indicator [145]. Cases diagnosed 2006-2009 must have both County at Diagnosis 2000 and County at Diagnosis 2010 codes for proper assignment of the Census Tract Poverty Indicator [145].</li><li>If the patient has multiple tumors, geocoded county may be different for each tumor. </li><li>Do not update this item if the patient&#8217;s county of residence changes. Store updated address information in the affiliated current address data items. Only update based on improved information on the residential address at time of diagnosis. For instance, it is appropriate to correct a county during manual geocoding or a consolidation process. </li><li>PO Box address information should not be used to geocode this data item except in the infrequent case when no other address information is available.</li><li>Detailed standards have not been set for Canadian provinces/territories. Use code 998 for Canadian residents. </li><li>Blank "Not geocoded" is allowable for cases diagnosed before 1995 and after 2009. However, it is recommended to have all cases geocoded to a 2000 Census County to allow for both retrospective and cross-sectional analyses. <br /></li></ul></div></div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>001-997</td><td class='code-desc'>County at diagnosis. Valid FIPS code.</td></tr><tr class='code-row'><td class='code-nbr'>998</td><td class='code-desc'>Known town, city, state, or country of residence but county code not known AND a resident outside of the state of reporting institution (must meet all criteria). Use this code for Canadian residents.</td></tr><tr class='code-row'><td class='code-nbr'>999</td><td class='code-desc'>County unknown. The county of the patient is unknown, or the patient is not a United States resident. County is not documented in the patient's medical record.  </td></tr><tr class='code-row'><td class='code-nbr'></td><td class='code-desc'> </td></tr></table></div><div class='content chap10-para'><em>Note</em>: For U.S. residents, historically, standard codes are those of the FIPS publication "Counties and Equivalent Entities of the United States, Its Possessions, and Associated Areas." These FIPS codes (FIPS 6-4) have been replaced by INCITS standard codes; however, there is no impact on this variable as the codes align with the system the Census used for each decennial census and changes will automatically be accounted for during geocoding. County codes issued by the Federal Information Processing Standards (FIPS) publication <em>Counties and Equivalent Entities of the United States, Its Possessions, and Associated Areas</em> is available in Appendix A.</div><a name='96'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>COUNTY AT DX GEOCODE2010</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">96</td><td style="text-align:center;">3</td><td style="text-align:center;"><a href='#sources'>NAACCR</a></td><td style="text-align:center;">2016</td><td style="text-align:center;">16</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">182 - 184</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>countyAtDxGeocode2010</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>County at Diagnosis 2010 Code for the county of the patient's residence at the time the tumor was diagnosed is a derived (geocoded) variable based on Census Boundary files from 2010 Decennial Census. This code should be used for county and county-based (such as CHSDA) rates and analysis for all cases diagnosed in 2010-2019.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Census tracts are areas geographically nested within counties and designated with a 6-digit number code. This 6-digit code is commonly repeated within a state in different counties. Census tract numbers are only unique when paired with the state and the county. Therefore, a tract cannot be accurately identified without knowing the county. Example from Massachusetts: Rural Franklin County contains a tract 040600 with 2010 population 4,612 people. Urban Suffolk County contains a tract 040600 with 2,444 people. The county must be known in order to distinguish between the two tract codes. Because we historically used a single variable for county at diagnosis [90], correct tract codes were frequently paired with the wrong county due to incorrect county assignment during abstracting or a change of county over time. Also, some variables, such as the Census Tr Poverty Indicatr [145] require the use of the decennial Census County codes closest to year of diagnosis and not the decade of year of diagnosis. Using a single county at diagnosis, and using the reported versus geocoded data, may result in erroneous assignment of geographic location as well as invalid links with census data (i.e., population, poverty category, urban/rural designation). <br /><br /><div><strong>Instructions for Coding</strong></div><ul><li>This variable is generated through the process of geocoding either during abstracting or at the central registry level. </li><li>It is recommended that all cases diagnosed through 2019 should have a geocoded County at Diagnosis 2010.</li><li>At a minimum, all cases diagnosed through 2006-2019 should have a geocoded County at Diagnosis 2010. Cases diagnosed 2006-2009 must have both County at Diagnosis 2000 and County at Diagnosis 2010 codes for proper assignment of the Census Tract Poverty Indicator [145]. Cases diagnosed 2016-2019 must have both County at Diagnosis 2010 and County at Diagnosis 2020 codes for proper assignment of the Census Tract Poverty Indicator [145].</li><li>If the patient has multiple tumors, geocoded county may be different for each tumor. </li><li>Do not update this item if the patient's county of residence changes. Store updated address information in the affiliated current address data items. Only update based on improved information on the residential address at time of diagnosis. For instance, it is appropriate to correct a county during manual geocoding or a consolidation process.</li><li>PO Box address information should not be used to geocode this data item except in the infrequent case when no other address information is available.</li><li>Detailed standards have not been set for Canadian provinces/territories. Use code 998 for Canadian residents. </li><li>Blank "Not geocoded" is allowable for cases diagnosed before 2005 and after 2019. However, it is preferred to have all cases geocoded to a 2010 Census County to allow for both retrospective and cross-sectional analyses.</li></ul></div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>001-997</td><td class='code-desc'>County at diagnosis. Valid FIPS code. </td></tr><tr class='code-row'><td class='code-nbr'>998</td><td class='code-desc'>Known town, city, state, or country of residence but county code not known AND a resident outside of the state of reporting institution (must meet all criteria). Use this code for Canadian residents.</td></tr><tr class='code-row'><td class='code-nbr'>999</td><td class='code-desc'>County unknown. The county of the patient is unknown, or the patient is not a United States resident. County is not documented in the patient's medical record. </td></tr><tr class='code-row'><td class='code-nbr'></td><td class='code-desc'> </td></tr></table></div><div class='content chap10-para'><em>Note</em>: For U.S. residents, historically, standard codes are those of the FIPS publication &#8220;Counties and Equivalent Entities of the United States, Its Possessions, and Associated Areas.&#8221; These FIPS codes (FIPS 6-4) have been replaced by INCITS standard codes; however, there is no impact on this variable as the codes align with the system the Census used for each decennial census and changes will automatically be accounted for during geocoding. County codes issued by the Federal Information Processing Standards (FIPS) publication <em>Counties and Equivalent Entities of the United States, Its Possessions, and Associated Areas</em> is available in Appendix A.</div><a name='97'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>COUNTY AT DX GEOCODE2020</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">97</td><td style="text-align:center;">3</td><td style="text-align:center;"><a href='#sources'>NAACCR</a></td><td style="text-align:center;">2016</td><td style="text-align:center;">16</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">195 - 197</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>countyAtDxGeocode2020</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Code for the county of the patient's residence at the time the tumor was diagnosed is a derived (geocoded) variable based on Census Boundary files from 2020 Decennial Census. 




















<strong>This code should be used for county and county-based (such as CHSDA) rates and analysis for all cases diagnosed in 2020-2029. </strong></div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Census tracts are areas geographically nested within counties and designated with a 6-digit number code. This 6-digit code is commonly repeated within a state in different counties. Census tract numbers are only unique when paired with the state and the county. Therefore, a tract cannot be accurately identified without knowing the county.  Example from Massachusetts:  Rural Franklin County contains a tract 040600 with 2010 population 4,612 people.  Urban Suffolk County contains a tract 040600 with 2,444 people.  The county must be known in order to distinguish between the two tract codes. Because we historically used a single variable for County at DX [90], correct tract codes were frequently paired with the wrong county due to incorrect county assignment during abstracting or a change of county over time. Also, some variables, such as the Census Tr Poverty Indicatr [145] require the use of the decennial Census County codes closest to year of diagnosis and not the decade of year of diagnosis. Using a single county at diagnosis, and using the reported versus geocoded data, may result in erroneous assignment of geographic location as well as invalid links with census data (i.e., population, poverty category, urban/rural designation). <br /><br /><strong>Instructions for Coding</strong><br /><ul><li>This variable is generated through the process of geocoding either during abstracting or at the central registry level. </li><li>It is recommended that all cases diagnosed through 2029 should have a geocoded County at Diagnosis 2020.</li><li>At a minimum, all cases diagnosed through 2016-2029 should have a geocoded County at Diagnosis 2020. Cases diagnosed in 2016-2019, must have both County at Diagnosis 2010 and County at Diagnosis 2020 codes for proper assignment of the Census Tr Poverty Indicatr [145]. </li><li>If the patient has multiple tumors, geocoded county may be different for each tumor. </li><li>Do not update this item if the patient's county of residence changes. Store updated address information in the affiliated current address data items. Only update based on improved information on the residential address at time of diagnosis. For instance, it is appropriate to correct a county during manual geocoding or a consolidation process.</li><li>PO Box address information should not be used to geocode this data item except in the infrequent case when no other address information is available.</li><li>If the patient has multiple tumors, the county codes may be different for each tumor.</li><li>Detailed standards have not been set for Canadian provinces/territories. Use code 998 for Canadian residents. </li><li>Blank "Not geocoded" is allowable for cases diagnosed before 2015 and after 2029. However, it is preferred to have all cases geocoded to a 2020 Census County to allow for both retrospective and cross-sectional analyses.<br /></li></ul></div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>001-997</td><td class='code-desc'>County at diagnosis. Valid FIPS code.</td></tr><tr class='code-row'><td class='code-nbr'>998</td><td class='code-desc'>Outside state/county code unknown. Known town, city, state, or country of residence but county code not known AND a resident outside of the state of reporting institution (must meet all criteria). Use this code for Canadian residents.</td></tr><tr class='code-row'><td class='code-nbr'>999</td><td class='code-desc'>County unknown. The county of the patient is unknown, or the patient is not a United States resident. County is not documented in the patient's medical record. </td></tr><tr class='code-row'><td class='code-nbr'></td><td class='code-desc'> </td></tr></table></div><div class='content chap10-para'><em></em><!--[if gte mso 10]>  <![endif]--><em>Note</em>: For U.S. residents, historically, standard codes are those of the FIPS publication "Counties and Equivalent Entities of the United States, Its Possessions, and Associated Areas." These FIPS codes (FIPS 6-4) have been replaced by INCITS standard codes; however, there is no impact on this variable as the codes align with the system the Census used for each decennial census and changes will automatically be accounted for during geocoding. County codes issued by the Federal Information Processing Standards (FIPS) publication <em>Counties and Equivalent Entities of the United States, Its Possessions, and Associated Areas</em> is available in Appendix A.</div><a name='90'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>COUNTY AT DX REPORTED</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">90</td><td style="text-align:center;">3</td><td style="text-align:center;"><a href='#sources'>FIPS/SEER</a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">135 - 137</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>County (pre-96 SEER/CoC)<br />County at Diagnosis (CoC)<br />County at DX<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>countyAtDx</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Code for the county of the patients residence at the time of diagnosis as identified by the Reporting Source. For U.S. residents, standard codes are those of the FIPS publication <em>Counties and Equivalent Entities of the United States, Its Possessions, and Associated Areas</em> or their equivalent INCITS codes.<br /><br />Calculating county and county-based variable rates using this item is <strong>not</strong> recommended. The more specific, geocoded county items should be used when available.<br />&nbsp;</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>This data item may be used for epidemiological purposes. For example, to measure cancer incidence in a particular geographic area. <br /><br /><strong>Instructions for Coding</strong><br /><ul><li>This field is intended to store address information for the patient's physical, residential address. All efforts should be made to find the patient's true street address and postal code, including reviewing relevant sources outside the medical record if available. The county for a PO Box mailing address should only be recorded when no other address information is available in the medical record and no other information sources are available.</li><li>If the patient has multiple tumors, county at diagnosis may be different for each tumor. </li><li>Do not update this item if the patient's county of residence changes. Store updated address information in the affiliated current address data items. Only update based on improved information on the residential address at time of diagnosis. For instance, it is appropriate to correct county during a consolidation process.</li><li>This variable is coded at time of abstracting and is considered less accurate than the derived, geocoded county at diagnosis variables: County at Diagnosis 1990, 2000, 2010, &amp; 2020. </li><li>Detailed standards have not been set for Canadian provinces/territories. Use code 998 for Canadian residents.</li></ul></div><div class='content chap10-para'><em>Note: </em>See Appendix A for standard FIPS county codes. See EDITS Table BPLACE.DBF in Appendix B for geocodes used by CoC.<em><br /><br />Note:</em> SEER does not use code 998. CoC uses country geocodes for  nonresidents of the United States (see Appendix B) and 998 for residents  of other states.</div><div class='content chap10-para'><strong>Codes (in addition to FIPS and Geocodes) </strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>001-997</td><td class='code-desc'>Valid FIPS code </td></tr><tr class='code-row'><td class='code-nbr'>998</td><td class='code-desc'>Known town, city, state, or country of residence but county code not known AND a resident outside of the state of reporting institution (must meet all criteria). Use this code for Canadian residents.</td></tr><tr class='code-row'><td class='code-nbr'>999</td><td class='code-desc'>The county of the patient is unknown, or the patient is not a United States resident. County is not documented in the patient's medical record. </td></tr><tr class='code-row'><td class='code-nbr' colspan='2'></td></tr></table></div><div class='content chap10-para'><em>Note</em>: For U.S. residents, historically, standard codes are those of the FIPS publication <em>Counties and Equivalent Entities of the United States, Its Possessions, and Associated Areas</em>. These FIPS codes (FIPS 6-4) have been replaced by INCITS standard codes; however, there is no impact on this variable as the codes align with the system the Census used for each decennial census and changes will automatically be accounted for during geocoding. County codes issued by the Federal Information Processing Standards (FIPS) publication <em>Counties and Equivalent Entities of the United States, Its Possessions, and Associated Areas</em> is available in Appendix A.</div><a name='1840'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>COUNTY--CURRENT</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">1840</td><td style="text-align:center;">3</td><td style="text-align:center;"><a href='#sources'>NAACCR</a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">2864 - 2866</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>countyCurrent</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Patient</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Code for county of patient&#8217;s current residence. See Chapter V, Unresolved Issues, for further discussion.<em><br /><br />Note:</em> This item was used by CoC only. CoC recommended use of FIPS codes (see Appendix A). The <em>ROADS Manual</em> also provided for use of geocodes for countries of residence outside the United States and Canada to be used in the county fields. </div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>This item may be used in administrative reports to define a referral area. </div><div class='content chap10-para'><strong>Codes (in addition to FIPS and geocodes) </strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>998</td><td class='code-desc'>Known town, city, state, or country of residence but county code not known AND a resident outside of the state of reporting institution (must meet all criteria)</td></tr><tr class='code-row'><td class='code-nbr'>999</td><td class='code-desc'>County unknown</td></tr></table></div><div class='content chap10-para'><em>Note:</em> This data item is no longer supported by CoC (as of January 1, 2003).</div><a name='2081'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>CRC CHECKSUM</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">2081</td><td style="text-align:center;">10</td><td style="text-align:center;"><a href='#sources'>NAACCR</a></td><td style="text-align:center;">1998</td><td style="text-align:center;">6</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">2607 - 2616</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>crcChecksum</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Cyclic Redundancy Code (CRC) CHECKSUM for the NAACCR record in which it resides. A unique value is calculated for each unique record in a NAACCR file. The value is calculated by applying a CRC algorithm to all data fields of the NAACCR record (excluding the CRC CHECKSUM field). Following a transmission, the CRC CHECKSUM can be recalculated and compared with the transmitted CHECKSUM. Identical values indicate an error-free transmission; differing values indicate an error in transmission.<br /><br />The algorithm recommended by NAACCR is on the NAACCR website at: <a href="http://www.naaccr.org">http://www.naaccr.org</a>. Users must provide recipients of the data with the algorithm used to create the data transmission file. Otherwise, the item should be left blank. </div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>The CHECKSUM can be used to determine if a record-level error occurred during transmission and can also be used to correct any such errors. Record-level CRC CHECKSUMs also allow portions of a NAACCR file to be salvaged in the event of a transmission error. </div><a name='3824'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>CREATININE PRETREATMENT LAB VALUE</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">3824</td><td style="text-align:center;">4</td><td style="text-align:center;"><a href='#sources'>NAACCR</a></td><td style="text-align:center;">2018</td><td style="text-align:center;">18</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1857 - 1860</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>creatininePretreatmentLabValue</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Creatinine Pretreatment Lab Value, an indicator of kidney function is required to calculate the Model for End-Stage Liver Disease (MELD) score, which is used to assign priority for liver transplant.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Creatinine Pretreatment Lab Value is a Registry Data Collection Variable in AJCC. This data item was previously collected for Liver, CS SSF# 4.</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>0.0</td><td class='code-desc'>0.0 milligram/deciliter (mg/dl)<br/>
0.0 micromole/liter (umol/L)
</td></tr><tr class='code-row'><td class='code-nbr'>0.1-99.9</td><td class='code-desc'>0.1-99.9 milligram/deciliter (mg/dl)<br/>
0.1-99.9 micromole/liter (umol/L)<br/>
(Exact value to nearest tenth of mg/dl or umol/L)
</td></tr><tr class='code-row'><td class='code-nbr'>XX.1</td><td class='code-desc'>100 mg/dl or greater<br/>
100 umol/L or greater
</td></tr><tr class='code-row'><td class='code-nbr'>XX.7</td><td class='code-desc'>Test ordered, results not in chart</td></tr><tr class='code-row'><td class='code-nbr'>XX.8</td><td class='code-desc'>Not applicable: Information not collected for this case<br/>
(If this item is required by your standard setter, use of code XX.8 will result in an edit error.)
</td></tr><tr class='code-row'><td class='code-nbr'>XX.9</td><td class='code-desc'>Not documented in medical record<br/>
Creatinine Pretreatment Lab Value not assessed or unknown if assessed
</td></tr><tr class='code-row'><td class='code-nbr'></td><td class='code-desc'> </td></tr></table></div><div class='content chap10-para'>Each Site-Specific Data Item (SSDI) applies only to selected primary sites, histologies, and years of diagnosis. Depending on applicability and standard-setter requirements, SSDIs may be left blank. </div><a name='3825'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>CREATININE PRETREATMENT UNIT OF MEASURE</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">3825</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>NAACCR</a></td><td style="text-align:center;">2018</td><td style="text-align:center;">18</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1861 - 1861</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>creatininePretxUnitOfMeasure</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Creatinine Pretreatment Unit of Measure identifies the unit of measure for the creatinine value measured in blood or serum prior to treatment. Creatinine is commonly measured in units of Milligrams/deciliter (mg/dL) in the United States and Micromoles/liter (umol/L) in Canada and Europe.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Creatinine Pretreatment is a Registry Data Collection Variable in AJCC. Creatinine Pretreatment Unit of Measure is needed to identify the unit in which creatinine is measured and was previously collected as Liver, CS SSF# 5.</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>1</td><td class='code-desc'>Milligrams/deciliter (mg/dL)</td></tr><tr class='code-row'><td class='code-nbr'>2</td><td class='code-desc'>Micromoles/liter (umol/L)</td></tr><tr class='code-row'><td class='code-nbr'>7</td><td class='code-desc'>Test ordered, results not in chart </td></tr><tr class='code-row'><td class='code-nbr'>8</td><td class='code-desc'>Not applicable: Information not collected for this case<br/>
(If this item is required by your standard setter, use of code 8 will result in an edit error.)
</td></tr><tr class='code-row'><td class='code-nbr'>9</td><td class='code-desc'>Not documented in medical record<br/>
Creatinine unit of measure not assessed or unknown if assessed
</td></tr><tr class='code-row'><td class='code-nbr'></td><td class='code-desc'> </td></tr></table></div><div class='content chap10-para'>Each Site-Specific Data Item (SSDI) applies only to selected primary sites, histologies, and years of diagnosis. Depending on applicability and standard-setter requirements, SSDIs may be left blank.</div><a name='2810'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>CS EXTENSION</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">2810</td><td style="text-align:center;">3</td><td style="text-align:center;"><a href='#sources'>AJCC</a></td><td style="text-align:center;">2003</td><td style="text-align:center;">10</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1301 - 1303</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>csExtension</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Identifies contiguous growth (extension) of the primary tumor within the organ of origin or its direct extension into neighboring organs. For certain sites such as ovary, discontinuous metastasis is coded in CS Extension.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Tumor extension at diagnosis is a prognostic indicator used by Collaborative Staging to derive some TNM-T codes and some SEER Summary Stage codes.</div><div class='content chap10-para'><strong>Codes (See the most current version of the <em>Collaborative Stage Data Collection System</em> (<a href="http://cancerstaging.org">http://cancerstaging.org</a>),<sup>13</sup> for rules and site-specific codes and coding structures.) </strong></div><div class='content chap10-para'><em>Note:</em> For cases diagnosed prior to 2010, this was a 2 character  field in CS version 1 which was converted to a 3 character field in CS  version 2. Most 2 character codes were converted by adding a zero as the  third character. For example, code 05 was usually converted to 050, 10  to 100, 11 to 110, etc. Special codes such as 88 and 99 were usually  converted to 888 and 999, respectively.</div><a name='2830'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>CS LYMPH NODES</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">2830</td><td style="text-align:center;">3</td><td style="text-align:center;"><a href='#sources'>AJCC</a></td><td style="text-align:center;">2003</td><td style="text-align:center;">10</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1305 - 1307</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>CS Lymph Nodes (SEER EOD)<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>csLymphNodes</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Identifies the regional lymph nodes involved with cancer at the time of diagnosis.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>The involvement of specific regional lymph nodes is a prognostic indicator used by Collaborative Staging to derive some TNM-N codes and SEER Summary Stage codes.</div><div class='content chap10-para'><strong>Codes (See the most current version of the <em>Collaborative Stage Data Collection System </em><a href="http://cancerstaging.org"></a>(<a target="_blank" href="http://cancerstaging.org">http://cancerstaging.org</a>),<sup>13</sup> for rules and site-specific codes and coding structures.) </strong></div><div class='content chap10-para'><em>Note: </em>For cases prior to 2010, this was a 2 character field in CS  version 1 which was converted to a 3 character field in CS version 2.  Most 2 character codes were converted by adding a zero as the third  character. For example, code 05 was usually converted to 050, 10 to 100,  11 to 110, etc. Special codes such as 88 and 99 were usually converted  to 888 and 999 respectively.</div><a name='2840'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>CS LYMPH NODES EVAL</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">2840</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>AJCC</a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1308 - 1308</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>CS Regional Nodes Evaluation<br />CS Reg Nodes Eval<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>csLymphNodesEval</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Records how the code for CS Lymph Nodes [2830] was determined, based on the diagnostic methods employed.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>This data item is used by Collaborative Staging to describe whether the staging basis for the TNM-N code is clinical or pathological and to record applicable prefix and suffix descriptors used with TNM staging.</div><div class='content chap10-para'><strong>Codes (See the most current version of the <em>Collaborative Stage Data Collection System</em> (<a href="http://cancerstaging.org"><strong>http://cancerstaging.org</strong></a><strong></strong>),<sup>13</sup> for rules and site-specific codes and coding structures.) </strong></div><a name='2850'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>CS METS AT DX</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">2850</td><td style="text-align:center;">2</td><td style="text-align:center;"><a href='#sources'>AJCC</a></td><td style="text-align:center;">2003</td><td style="text-align:center;">10</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1309 - 1310</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>CS Metastasis at Diagnosis<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>csMetsAtDx</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Identifies the distant site(s) of metastatic involvement at time of diagnosis.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>The presence of metastatic disease at diagnosis is an independent prognostic indicator, and it is used by Collaborative Staging to derive TNM-M codes and SEER Summary Stage codes.</div><div class='content chap10-para'><strong>Codes (See the most current version of the <em>Collaborative Stage Data Collection System</em> (<a href="http://cancerstaging.org">http://cancerstaging.org</a>),<sup>13</sup> for rules and site-specific codes and coding structures.) </strong></div><a name='2851'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>CS METS AT DX-BONE</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">2851</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>AJCC</a></td><td style="text-align:center;">2010</td><td style="text-align:center;">12</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1312 - 1312</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>csMetsAtDxBone</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Identifies the presence of distant metastatic involvement of bone at time of diagnosis.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>The presence of metastatic bone disease at diagnosis is an independent prognostic indicator, and it is used by Collaborative Staging to derive TNM-M codes and SEER Summary Stage codes for some sites.</div><div class='content chap10-para'><strong>Codes (See the most current version of the <em>Collaborative Stage Data Collection System</em> (<a href="http://cancerstaging.org">http://cancerstaging.org</a>),<sup>13</sup> for rules and site-specific codes and coding structures.) </strong></div><div class='content chap10-para'><em>Note: </em>This includes only the bone, not the bone marrow.</div><a name='2852'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>CS METS AT DX-BRAIN</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">2852</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>AJCC</a></td><td style="text-align:center;">2010</td><td style="text-align:center;">12</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1313 - 1313</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>csMetsAtDxBrain</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>The presence of metastatic brain disease at diagnosis is an independent prognostic indicator, and it is used by Collaborative Staging to derive TNM-M codes and SEER Summary Stage codes for some sites.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>The presence of metastatic brain disease at diagnosis is an independent prognostic indicator, and it is used by Collaborative Staging to derive TNM-M codes and SEER Summary Stage codes for some sites.</div><div class='content chap10-para'><strong>Codes (See the most current version of the <em>Collaborative Stage Data Collection System</em> (<a href="http://cancerstaging.org">http://cancerstaging.org</a>),<sup>13</sup> for rules and site-specific codes and coding structures.) </strong></div><div class='content chap10-para'><em>Note:</em> This includes only the brain, not spinal cord or other parts of the central nervous system.</div><a name='2853'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>CS METS AT DX-LIVER</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">2853</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>AJCC</a></td><td style="text-align:center;">2010</td><td style="text-align:center;">12</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1314 - 1314</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>csMetsAtDxLiver</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Identifies the presence of distant metastatic involvement of the liver at time of diagnosis.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>The presence of metastatic liver disease at diagnosis is an independent prognostic indicator, and it is used by Collaborative Staging to derive TNM-M codes and SEER Summary Stage codes for some sites.</div><div class='content chap10-para'><strong>Codes (See the most current version of the <em>Collaborative Stage Data Collection System</em> (<a href="http://cancerstaging.org">http://cancerstaging.org</a>),<sup>13</sup> for rules and site-specific codes and coding structures.) </strong></div><div class='content chap10-para'><em>Note:</em> This includes only the liver.</div><a name='2854'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>CS METS AT DX-LUNG</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">2854</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>AJCC</a></td><td style="text-align:center;">2010</td><td style="text-align:center;">12</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1315 - 1315</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>csMetsAtDxLung</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Identifies the presence of distant metastatic involvement of the lung at time of diagnosis.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>The presence of metastatic lung disease at diagnosis is an independent prognostic indicator, and it is used by Collaborative Staging to derive TNM-M codes and SEER Summary Stage codes for some sites.</div><div class='content chap10-para'><strong>Codes (See the most current version of the <em>Collaborative Stage Data Collection System</em> (<a href="http://cancerstaging.org">http://cancerstaging.org</a>),<sup>13</sup> for rules and site-specific codes and coding structures.) </strong></div><div class='content chap10-para'><em>Note:</em> This includes only the lung, not pleura or pleural fluid.</div><a name='2860'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>CS METS EVAL</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">2860</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>AJCC</a></td><td style="text-align:center;">2003</td><td style="text-align:center;">10</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1311 - 1311</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>CS Metastasis Evaluation<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>csMetsEval</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Records how the code for CS Mets at Dx [2850] was determined based on the diagnostic methods employed.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>This data item is used by Collaborative Staging to describe whether the staging basis for the TNM-M code is clinical or pathological and to record applicable prefix and suffix descriptors used with TNM staging.</div><div class='content chap10-para'><strong>Codes (See the most current version of the <em>Collaborative Stage Data Collection System</em> (<a href="http://cancerstaging.org">http://cancerstaging.org</a>),<sup>13</sup> for rules and site-specific codes and coding structures.) </strong></div><a name='2775'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>CS POSTRX EXTENSION</strong></td><td style="text-align:right;font-weight:bold;"><strong>Retired</strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">2775</td><td style="text-align:center;"></td><td style="text-align:center;"><a href='#sources'></a></td><td style="text-align:center;">2010</td><td style="text-align:center;">12</td><td style="text-align:center;">2018</td><td style="text-align:center;">18</td><td class="cross-out" style="text-align:center;"></td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td></td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td></td>
	</tr>
</table><a name='2780'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>CS POSTRX LYMPH NODES</strong></td><td style="text-align:right;font-weight:bold;"><strong>Retired</strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">2780</td><td style="text-align:center;"></td><td style="text-align:center;"><a href='#sources'></a></td><td style="text-align:center;">2010</td><td style="text-align:center;">12</td><td style="text-align:center;">2018</td><td style="text-align:center;">18</td><td class="cross-out" style="text-align:center;"></td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td></td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td></td>
	</tr>
</table><a name='2785'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>CS POSTRX METS AT DX</strong></td><td style="text-align:right;font-weight:bold;"><strong>Retired</strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">2785</td><td style="text-align:center;"></td><td style="text-align:center;"><a href='#sources'></a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;">2018</td><td style="text-align:center;">18</td><td class="cross-out" style="text-align:center;"></td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td></td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td></td>
	</tr>
</table><a name='2770'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>CS POSTRX TUMOR SIZE</strong></td><td style="text-align:right;font-weight:bold;"><strong>Retired</strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">2770</td><td style="text-align:center;"></td><td style="text-align:center;"><a href='#sources'></a></td><td style="text-align:center;">2010</td><td style="text-align:center;">12</td><td style="text-align:center;">2018</td><td style="text-align:center;">18</td><td class="cross-out" style="text-align:center;"></td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td></td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td></td>
	</tr>
</table><a name='2735'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>CS PRERX EXTENSION</strong></td><td style="text-align:right;font-weight:bold;"><strong>Retired</strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">2735</td><td style="text-align:center;"></td><td style="text-align:center;"><a href='#sources'></a></td><td style="text-align:center;">2010</td><td style="text-align:center;">12</td><td style="text-align:center;">2018</td><td style="text-align:center;">18</td><td class="cross-out" style="text-align:center;"></td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td></td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td></td>
	</tr>
</table><a name='2750'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>CS PRERX LYMPH NODES</strong></td><td style="text-align:right;font-weight:bold;"><strong>Retired</strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">2750</td><td style="text-align:center;"></td><td style="text-align:center;"><a href='#sources'></a></td><td style="text-align:center;">2010</td><td style="text-align:center;">12</td><td style="text-align:center;">2018</td><td style="text-align:center;">18</td><td class="cross-out" style="text-align:center;"></td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td></td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td></td>
	</tr>
</table><a name='2760'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>CS PRERX METS AT DX</strong></td><td style="text-align:right;font-weight:bold;"><strong>Retired</strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">2760</td><td style="text-align:center;"></td><td style="text-align:center;"><a href='#sources'></a></td><td style="text-align:center;">2010</td><td style="text-align:center;">12</td><td style="text-align:center;">2018</td><td style="text-align:center;">18</td><td class="cross-out" style="text-align:center;"></td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td></td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td></td>
	</tr>
</table><a name='2765'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>CS PRERX METS EVAL</strong></td><td style="text-align:right;font-weight:bold;"><strong>Retired</strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">2765</td><td style="text-align:center;"></td><td style="text-align:center;"><a href='#sources'></a></td><td style="text-align:center;">2010</td><td style="text-align:center;">12</td><td style="text-align:center;">2018</td><td style="text-align:center;">18</td><td class="cross-out" style="text-align:center;"></td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td></td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td></td>
	</tr>
</table><a name='2755'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>CS PRERX REG NODES EVAL</strong></td><td style="text-align:right;font-weight:bold;"><strong>Retired</strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">2755</td><td style="text-align:center;"></td><td style="text-align:center;"><a href='#sources'></a></td><td style="text-align:center;">2010</td><td style="text-align:center;">12</td><td style="text-align:center;">2018</td><td style="text-align:center;">18</td><td class="cross-out" style="text-align:center;"></td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td></td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td></td>
	</tr>
</table><a name='2740'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>CS PRERX TUM SZ/EXT EVAL</strong></td><td style="text-align:right;font-weight:bold;"><strong>Retired</strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">2740</td><td style="text-align:center;"></td><td style="text-align:center;"><a href='#sources'></a></td><td style="text-align:center;">2010</td><td style="text-align:center;">12</td><td style="text-align:center;">2018</td><td style="text-align:center;">18</td><td class="cross-out" style="text-align:center;"></td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td></td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td></td>
	</tr>
</table><a name='2730'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>CS PRERX TUMOR SIZE</strong></td><td style="text-align:right;font-weight:bold;"><strong>Retired</strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">2730</td><td style="text-align:center;"></td><td style="text-align:center;"><a href='#sources'></a></td><td style="text-align:center;">2010</td><td style="text-align:center;">12</td><td style="text-align:center;">2018</td><td style="text-align:center;">18</td><td class="cross-out" style="text-align:center;"></td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td></td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td></td>
	</tr>
</table><a name='2880'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>CS SITE-SPECIFIC FACTOR 1</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">2880</td><td style="text-align:center;">3</td><td style="text-align:center;"><a href='#sources'>AJCC</a></td><td style="text-align:center;">2003</td><td style="text-align:center;">10</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1316 - 1318</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>csSiteSpecificFactor1</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Identifies additional information needed to generate stage, or prognostic factors that have an effect on stage or survival.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Site-specific factors are used to record additional staging information needed by Collaborative Staging to derive TNM and/or SEER Summary Stage codes for particular site-histology schema.</div><div class='content chap10-para'><strong>Codes (The information recorded in CS Site-Specific Factor 1 differs for each anatomic site. See the most current version of the <em>Collaborative Stage Data Collection System</em> (<a target="_blank" href="http://cancerstaging.org">http://cancerstaging.org</a>),<sup>13</sup> for rules and site-specific codes and coding structures.) </strong></div><a name='2890'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>CS SITE-SPECIFIC FACTOR 2</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">2890</td><td style="text-align:center;">3</td><td style="text-align:center;"><a href='#sources'>AJCC</a></td><td style="text-align:center;">2003</td><td style="text-align:center;">10</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1319 - 1321</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>csSiteSpecificFactor2</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Identifies additional information needed to generate stage, or prognostic factors that have an effect on stage or survival.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Site-specific factors are used to record additional staging information needed by Collaborative Staging to derive TNM and/or SEER Summary Stage codes for particular site-histology schema.</div><div class='content chap10-para'><strong>Codes (The information recorded in CS Site-Specific Factor 2 differs for each anatomic site. See the most current version of the <em>Collaborative Stage Data Collection System</em> (<a target="_blank" href="http://cancerstaging.org">http://cancerstaging.org</a>),<sup>13</sup> for rules and site-specific codes and coding structures.) </strong></div><a name='2900'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>CS SITE-SPECIFIC FACTOR 3</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">2900</td><td style="text-align:center;">3</td><td style="text-align:center;"><a href='#sources'>AJCC</a></td><td style="text-align:center;">2003</td><td style="text-align:center;">10</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1322 - 1324</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>csSiteSpecificFactor3</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Identifies additional information needed to generate stage, or prognostic factors that have an effect on stage or survival.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Site-specific factors are used to record additional staging information needed by Collaborative Staging to derive TNM and/or SEER Summary Stage codes for particular site-histology schema.</div><div class='content chap10-para'><strong>Codes (The information recorded in CS Site-Specific Factor 3 differs for each anatomic site. See the most current version of the <em>Collaborative Stage Data Collection System</em> (<a target="_blank" href="http://cancerstaging.org">http://cancerstaging.org</a>),<sup>13</sup> for rules and site-specific codes and coding structures.) </strong></div><a name='2910'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>CS SITE-SPECIFIC FACTOR 4</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">2910</td><td style="text-align:center;">3</td><td style="text-align:center;"><a href='#sources'>AJCC</a></td><td style="text-align:center;">2003</td><td style="text-align:center;">10</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1325 - 1327</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>csSiteSpecificFactor4</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Identifies additional information needed to generate stage, or prognostic factors that have an effect on stage or survival.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Site-specific factors are used to record additional staging information needed by Collaborative Staging to derive TNM and/or SEER Summary Stage codes for particular site-histology schema.</div><div class='content chap10-para'><strong>Codes (The information recorded in CS Site-Specific Factor 4 differs for each anatomic site. See the most current version of the <em>Collaborative Stage Data Collection System</em> (<a target="_blank" href="http://cancerstaging.org">http://cancerstaging.org</a>),<sup>13</sup> for rules and site-specific codes and coding structures.) </strong></div><a name='2920'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>CS SITE-SPECIFIC FACTOR 5</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">2920</td><td style="text-align:center;">3</td><td style="text-align:center;"><a href='#sources'>AJCC</a></td><td style="text-align:center;">2003</td><td style="text-align:center;">10</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1328 - 1330</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>csSiteSpecificFactor5</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Identifies additional information needed to generate stage, or prognostic factors that have an effect on stage or survival.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Site-specific factors are used to record additional staging information needed by Collaborative Staging to derive TNM and/or SEER Summary Stage codes for particular site-histology schema.</div><div class='content chap10-para'><strong>Codes (The information recorded in CS Site-Specific Factor 5 differs for each anatomic site. See the most current version of the <em>Collaborative Stage Data Collection System</em> (<a target="_blank" href="http://cancerstaging.org">http://cancerstaging.org</a>),<sup>13</sup> for rules and site-specific codes and coding structures.) </strong></div><a name='2930'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>CS SITE-SPECIFIC FACTOR 6</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">2930</td><td style="text-align:center;">3</td><td style="text-align:center;"><a href='#sources'>AJCC</a></td><td style="text-align:center;">2003</td><td style="text-align:center;">10</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1331 - 1333</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>csSiteSpecificFactor6</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Identifies additional information needed to generate stage, or prognostic factors that have an effect on stage or survival.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Site-specific factors are used to record additional staging information needed by Collaborative Staging to derive TNM and/or SEER Summary Stage codes for particular site-histology schema.</div><div class='content chap10-para'><strong>Codes (The information recorded in CS Site-Specific Factor 6 differs for each anatomic site. See the most current version of the <em>Collaborative Stage Data Collection System</em> (<a target="_blank" href="http://cancerstaging.org">http://cancerstaging.org</a>),<sup>13</sup> for rules and site-specific codes and coding structures.) </strong></div><a name='2861'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>CS SITE-SPECIFIC FACTOR 7</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">2861</td><td style="text-align:center;">3</td><td style="text-align:center;"><a href='#sources'>AJCC</a></td><td style="text-align:center;">2010</td><td style="text-align:center;">12</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1334 - 1336</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>csSiteSpecificFactor7</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Identifies additional information needed to generate stage, or prognostic factors that have an effect on stage or survival.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Site-specific factors are used to record additional staging information needed by Collaborative Staging to derive TNM and/or SEER Summary Stage codes for particular site-histology schema.</div><div class='content chap10-para'><strong>Codes (The information recorded in CS Site-Specific Factor 7 differs for each anatomic site. See the most current version of the <em>Collaborative Stage Data Collection System</em> (<a href="http://cancerstaging.org">http://cancerstaging.org</a>),<sup>13</sup> for rules and site-specific codes and coding structures.) </strong></div><a name='2862'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>CS SITE-SPECIFIC FACTOR 8</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">2862</td><td style="text-align:center;">3</td><td style="text-align:center;"><a href='#sources'>AJCC</a></td><td style="text-align:center;">2010</td><td style="text-align:center;">12</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1337 - 1339</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>csSiteSpecificFactor8</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Identifies additional information needed to generate stage, or prognostic factors that have an effect on stage or survival.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Site-specific factors are used to record additional staging information needed by Collaborative Staging to derive TNM and/or SEER Summary Stage codes for particular site-histology schema.</div><div class='content chap10-para'><strong>Codes (The information recorded in CS Site-Specific Factor 8 differs for each anatomic site. See the most current version of the <em>Collaborative Stage Data Collection System</em> (<a target="_blank" href="http://cancerstaging.org">http://cancerstaging.org</a>),<sup>13</sup> for rules and site-specific codes and coding structures.) </strong></div><a name='2863'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>CS SITE-SPECIFIC FACTOR 9</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">2863</td><td style="text-align:center;">3</td><td style="text-align:center;"><a href='#sources'>AJCC</a></td><td style="text-align:center;">2010</td><td style="text-align:center;">12</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1340 - 1342</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>csSiteSpecificFactor9</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Identifies additional information needed to generate stage, or prognostic factors that have an effect on stage or survival.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Site-specific factors are used to record additional staging information needed by Collaborative Staging to derive TNM and/or SEER Summary Stage codes for particular site-histology schema.</div><div class='content chap10-para'><strong>Codes (The information recorded in CS Site-Specific Factor 9 differs for each anatomic site. See the most current version of the <em>Collaborative Stage Data Collection System</em> (<a href="http://cancerstaging.org">http://cancerstaging.org</a>),<sup>13</sup> for rules and site-specific codes and coding structures.) </strong></div><a name='2864'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>CS SITE-SPECIFIC FACTOR10</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">2864</td><td style="text-align:center;">3</td><td style="text-align:center;"><a href='#sources'>AJCC</a></td><td style="text-align:center;">2010</td><td style="text-align:center;">12</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1343 - 1345</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>csSiteSpecificFactor10</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Identifies additional information needed to generate stage, or prognostic factors that have an effect on stage or survival.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Site-specific factors are used to record additional staging information needed by Collaborative Staging to derive TNM and/or SEER Summary Stage codes for particular site-histology schema.</div><div class='content chap10-para'><strong>Codes (The information recorded in CS Site-Specific Factor10 differs for each anatomic site. See the most current version of the <em>Collaborative Stage Data Collection System</em> (<a href="http://cancerstaging.org">http://cancerstaging.org</a>),<sup>13</sup> for rules and site-specific codes and coding structures.) </strong></div><a name='2865'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>CS SITE-SPECIFIC FACTOR11</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">2865</td><td style="text-align:center;">3</td><td style="text-align:center;"><a href='#sources'>AJCC</a></td><td style="text-align:center;">2010</td><td style="text-align:center;">12</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1346 - 1348</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>csSiteSpecificFactor11</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Identifies additional information needed to generate stage, or prognostic factors that have an effect on stage or survival.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Site-specific factors are used to record additional staging information needed by Collaborative Staging to derive TNM and/or SEER Summary Stage codes for particular site-histology schema.</div><div class='content chap10-para'><strong>Codes (The information recorded in CS Site-Specific Factor11 differs for each anatomic site. See the most current version of the <em>Collaborative Stage Data Collection System</em> (<a href="http://cancerstaging.org">http://cancerstaging.org</a>),<sup>13</sup> for rules and site-specific codes and coding structures.) </strong></div><a name='2866'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>CS SITE-SPECIFIC FACTOR12</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">2866</td><td style="text-align:center;">3</td><td style="text-align:center;"><a href='#sources'>AJCC</a></td><td style="text-align:center;">2010</td><td style="text-align:center;">12</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1349 - 1351</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>csSiteSpecificFactor12</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Identifies additional information needed to generate stage, or prognostic factors that have an effect on stage or survival.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Site-specific factors are used to record additional staging information needed by Collaborative Staging to derive TNM and/or SEER Summary Stage codes for particular site-histology schema.</div><div class='content chap10-para'><strong>Codes (The information recorded in CS Site-Specific Factor12 differs for each anatomic site. See the most current version of the <em>Collaborative Stage Data Collection System</em> (<a href="http://cancerstaging.org">http://cancerstaging.org</a>),<sup>13</sup> for rules and site-specific codes and coding structures.) </strong></div><a name='2867'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>CS SITE-SPECIFIC FACTOR13</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">2867</td><td style="text-align:center;">3</td><td style="text-align:center;"><a href='#sources'>AJCC</a></td><td style="text-align:center;">2010</td><td style="text-align:center;">12</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1352 - 1354</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>csSiteSpecificFactor13</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Identifies additional information needed to generate stage, or prognostic factors that have an effect on stage or survival.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Site-specific factors are used to record additional staging information needed by Collaborative Staging to derive TNM and/or SEER Summary Stage codes for particular site-histology schema.</div><div class='content chap10-para'><strong>Codes (The information recorded in CS Site-Specific Factor13 differs for each anatomic site. See the most current version of the <em>Collaborative Stage Data Collection System</em> (<a href="http://cancerstaging.org">http://cancerstaging.org</a>),<sup>13</sup> for rules and site-specific codes and coding structures.) </strong></div><a name='2868'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>CS SITE-SPECIFIC FACTOR14</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">2868</td><td style="text-align:center;">3</td><td style="text-align:center;"><a href='#sources'>AJCC</a></td><td style="text-align:center;">2010</td><td style="text-align:center;">12</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1355 - 1357</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>csSiteSpecificFactor14</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Identifies additional information needed to generate stage, or prognostic factors that have an effect on stage or survival.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Site-specific factors are used to record additional staging information needed by Collaborative Staging to derive TNM and/or SEER Summary Stage codes for particular site-histology schema.</div><div class='content chap10-para'><strong>Codes (The information recorded in CS Site-Specific Factor14 differs for each anatomic site. See the most current version of the <em>Collaborative Stage Data Collection System</em> (<a href="http://cancerstaging.org">http://cancerstaging.org</a>),<sup>13</sup> for rules and site-specific codes and coding structures.) </strong></div><a name='2869'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>CS SITE-SPECIFIC FACTOR15</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">2869</td><td style="text-align:center;">3</td><td style="text-align:center;"><a href='#sources'>AJCC</a></td><td style="text-align:center;">2010</td><td style="text-align:center;">12</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1358 - 1360</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>csSiteSpecificFactor15</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Identifies additional information needed to generate stage, or prognostic factors that have an effect on stage or survival.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Site-specific factors are used to record additional staging information needed by Collaborative Staging to derive TNM and/or SEER Summary Stage codes for particular site-histology schema.</div><div class='content chap10-para'><strong>Codes (The information recorded in CS Site-Specific Factor15 differs for each anatomic site. See the most current version of the <em>Collaborative Stage Data Collection System</em> (<a href="http://cancerstaging.org">http://cancerstaging.org</a>),<sup>13</sup> for rules and site-specific codes and coding structures.) </strong></div><a name='2870'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>CS SITE-SPECIFIC FACTOR16</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">2870</td><td style="text-align:center;">3</td><td style="text-align:center;"><a href='#sources'>AJCC</a></td><td style="text-align:center;">2010</td><td style="text-align:center;">12</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1361 - 1363</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>csSiteSpecificFactor16</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Identifies additional information needed to generate stage, or prognostic factors that have an effect on stage or survival.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Site-specific factors are used to record additional staging information needed by Collaborative Staging to derive TNM and/or SEER Summary Stage codes for particular site-histology schema.</div><div class='content chap10-para'><strong>Codes (The information recorded in CS Site-Specific Factor16 differs for each anatomic site. See the most current version of the <em>Collaborative Stage Data Collection System</em> (<a href="http://cancerstaging.org">http://cancerstaging.org</a>),<sup>13</sup> for rules and site-specific codes and coding structures.) </strong></div><a name='2871'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>CS SITE-SPECIFIC FACTOR17</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">2871</td><td style="text-align:center;">3</td><td style="text-align:center;"><a href='#sources'>AJCC</a></td><td style="text-align:center;">2010</td><td style="text-align:center;">12</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1364 - 1366</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>csSiteSpecificFactor17</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Identifies additional information needed to generate stage, or prognostic factors that have an effect on stage or survival.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Site-specific factors are used to record additional staging information needed by Collaborative Staging to derive TNM and/or SEER Summary Stage codes for particular site-histology schema.</div><div class='content chap10-para'><strong>Codes (The information recorded in CS Site-Specific Factor17 differs for each anatomic site. See the most current version of the <em>Collaborative Stage Data Collection System</em> (<a href="http://cancerstaging.org">http://cancerstaging.org</a>),<sup>13</sup> for rules and site-specific codes and coding structures.) </strong></div><a name='2872'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>CS SITE-SPECIFIC FACTOR18</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">2872</td><td style="text-align:center;">3</td><td style="text-align:center;"><a href='#sources'>AJCC</a></td><td style="text-align:center;">2010</td><td style="text-align:center;">12</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1367 - 1369</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>csSiteSpecificFactor18</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Identifies additional information needed to generate stage, or prognostic factors that have an effect on stage or survival.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Site-specific factors are used to record additional staging information needed by Collaborative Staging to derive TNM and/or SEER Summary Stage codes for particular site-histology schema.</div><div class='content chap10-para'><strong>Codes (The information recorded in CS Site-Specific Factor18 differs for each anatomic site. See the most current version of the <em>Collaborative Stage Data Collection System</em> (<a href="http://cancerstaging.org">http://cancerstaging.org</a>),<sup>13</sup> for rules and site-specific codes and coding structures.) </strong></div><a name='2873'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>CS SITE-SPECIFIC FACTOR19</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">2873</td><td style="text-align:center;">3</td><td style="text-align:center;"><a href='#sources'>AJCC</a></td><td style="text-align:center;">2010</td><td style="text-align:center;">12</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1370 - 1372</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>csSiteSpecificFactor19</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Identifies additional information needed to generate stage, or prognostic factors that have an effect on stage or survival.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Site-specific factors are used to record additional staging information needed by Collaborative Staging to derive TNM and/or SEER Summary Stage codes for particular site-histology schema.</div><div class='content chap10-para'><strong>Codes (The information recorded in CS Site-Specific Factor19 differs for each anatomic site. See the most current version of the <em>Collaborative Stage Data Collection System</em> (<a href="http://cancerstaging.org">http://cancerstaging.org</a>),<sup>13</sup> for rules and site-specific codes and coding structures.) </strong></div><a name='2874'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>CS SITE-SPECIFIC FACTOR20</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">2874</td><td style="text-align:center;">3</td><td style="text-align:center;"><a href='#sources'>AJCC</a></td><td style="text-align:center;">2010</td><td style="text-align:center;">12</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1373 - 1375</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>csSiteSpecificFactor20</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Identifies additional information needed to generate stage, or prognostic factors that have an effect on stage or survival.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Site-specific factors are used to record additional staging information needed by Collaborative Staging to derive TNM and/or SEER Summary Stage codes for particular site-histology schema.</div><div class='content chap10-para'><strong>Codes (The information recorded in CS Site-Specific Factor20 differs for each anatomic site. See the most current version of the <em>Collaborative Stage Data Collection System</em> (<a href="http://cancerstaging.org">http://cancerstaging.org</a>),<sup>13</sup> for rules and site-specific codes and coding structures.) </strong></div><a name='2875'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>CS SITE-SPECIFIC FACTOR21</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">2875</td><td style="text-align:center;">3</td><td style="text-align:center;"><a href='#sources'>AJCC</a></td><td style="text-align:center;">2010</td><td style="text-align:center;">12</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1376 - 1378</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>csSiteSpecificFactor21</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Identifies additional information needed to generate stage, or prognostic factors that have an effect on stage or survival.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Site-specific factors are used to record additional staging information needed by Collaborative Staging to derive TNM and/or SEER Summary Stage codes for particular site-histology schema.</div><div class='content chap10-para'><strong>Codes (The information recorded in CS Site-Specific Factor21 differs for each anatomic site. See the most current version of the <em>Collaborative Stage Data Collection System</em> (<a target="_blank" href="http://cancerstaging.org">http://cancerstaging.org</a>),<sup>13</sup> for rules and site-specific codes and coding structures.) </strong></div><a name='2876'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>CS SITE-SPECIFIC FACTOR22</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">2876</td><td style="text-align:center;">3</td><td style="text-align:center;"><a href='#sources'>AJCC</a></td><td style="text-align:center;">2010</td><td style="text-align:center;">12</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1379 - 1381</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>csSiteSpecificFactor22</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Identifies additional information needed to generate stage, or prognostic factors that have an effect on stage or survival.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Site-specific factors are used to record additional staging information needed by Collaborative Staging to derive TNM and/or SEER Summary Stage codes for particular site-histology schema.</div><div class='content chap10-para'><strong>Codes (The information recorded in CS Site-Specific Factor22 differs for each anatomic site. See the most current version of the <em>Collaborative Stage Data Collection System</em> (<a target="_blank" href="http://cancerstaging.org">http://cancerstaging.org</a>),<sup>13</sup> for rules and site-specific codes and coding structures.) </strong></div><a name='2877'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>CS SITE-SPECIFIC FACTOR23</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">2877</td><td style="text-align:center;">3</td><td style="text-align:center;"><a href='#sources'>AJCC</a></td><td style="text-align:center;">2010</td><td style="text-align:center;">12</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1382 - 1384</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>csSiteSpecificFactor23</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Identifies additional information needed to generate stage, or prognostic factors that have an effect on stage or survival.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Site-specific factors are used to record additional staging information needed by Collaborative Staging to derive TNM and/or SEER Summary Stage codes for particular site-histology schema.</div><div class='content chap10-para'><strong>Codes (The information recorded in CS Site-Specific Factor23 differs for each anatomic site. See the most current version of the <em>Collaborative Stage Data Collection System</em> (<a target="_blank" href="http://cancerstaging.org">http://cancerstaging.org</a>),<sup>13</sup> for rules and site-specific codes and coding structures.) </strong></div><a name='2878'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>CS SITE-SPECIFIC FACTOR24</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">2878</td><td style="text-align:center;">3</td><td style="text-align:center;"><a href='#sources'>AJCC</a></td><td style="text-align:center;">2010</td><td style="text-align:center;">12</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1385 - 1387</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>csSiteSpecificFactor24</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Identifies additional information needed to generate stage, or prognostic factors that have an effect on stage or survival.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Site-specific factors are used to record additional staging information needed by Collaborative Staging to derive TNM and/or SEER Summary Stage codes for particular site-histology schema.</div><div class='content chap10-para'><strong>Codes (The information recorded in CS Site-Specific Factor24 differs for each anatomic site. See the most current version of the <em>Collaborative Stage Data Collection System</em> (<a target="_blank" href="http://cancerstaging.org">http://cancerstaging.org</a>),<sup>13</sup> for rules and site-specific codes and coding structures.) </strong></div><a name='2879'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>CS SITE-SPECIFIC FACTOR25</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">2879</td><td style="text-align:center;">3</td><td style="text-align:center;"><a href='#sources'>AJCC</a></td><td style="text-align:center;">2010</td><td style="text-align:center;">12</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1388 - 1390</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>csSiteSpecificFactor25</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Identifies additional information needed to generate stage, or prognostic factors that have an effect on stage or survival.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>CS Site-Specific Factor25 is used to discriminate between CS staging schema or between AJCC chapters where site and histology alone are insufficient to identify the tumor type or location to identify the applicable staging method.</div><div class='content chap10-para'><strong>Codes (The information recorded in CS Site-Specific Factor25 differs for each anatomic site. See the most current version of the <em>Collaborative Stage Data Collection System</em> (<a target="_blank" href="http://cancerstaging.org">http://cancerstaging.org</a>),<sup>13</sup> for rules and site-specific codes and coding structures.) </strong></div><a name='2800'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>CS TUMOR SIZE</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">2800</td><td style="text-align:center;">3</td><td style="text-align:center;"><a href='#sources'>AJCC</a></td><td style="text-align:center;">2003</td><td style="text-align:center;">10</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1298 - 1300</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>csTumorSize</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Records the largest dimension or diameter of the 









<strong>primary tumor</strong> in millimeters.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Tumor size at diagnosis is an independent prognostic indicator for many tumors and it is used by Collaborative Staging to derive some TNM-T codes.</div><div class='content chap10-para'><strong>Codes (See the most current version of the <em>Collaborative Stage Data Collection System</em> (<a target="_blank" href="http://cancerstaging.org">http://cancerstaging.org</a>),<sup>13</sup> for rules and site-specific codes and coding structures.) </strong></div><a name='2820'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>CS TUMOR SIZE/EXT EVAL</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">2820</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>AJCC</a></td><td style="text-align:center;">2003</td><td style="text-align:center;">10</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1304 - 1304</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>CS Tumor Size/Extension Evaluation<br />CS TS/Ext-Eval<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>csTumorSizeExtEval</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Records how the codes for the two items CS Tumor Size [2800] and CS Extension [2810] were determined, based on the diagnostic methods employed.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>This item is used by Collaborative Staging to describe whether the staging basis for the TNM-T code is clinical or pathological and to record applicable prefix and suffix descriptors used with TNM staging.</div><div class='content chap10-para'><strong>Codes (See the most current version of the <em>Collaborative Stage Data Collection System</em> (<a href="http://cancerstaging.org">http://cancerstaging.org</a>),<sup>13</sup> for rules and site-specific codes and coding structures.) </strong></div><a name='2936'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>CS VERSION DERIVED</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">2936</td><td style="text-align:center;">6</td><td style="text-align:center;"><a href='#sources'>AJCC</a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1514 - 1519</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>CS Version Latest<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>csVersionDerived</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>This data item is recorded the first time the CS output fields are derived and should be updated each time the CS Derived items are recomputed. The CS version number is returned as part of the output of the CS algorithm.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>The CS algorithm may be re-applied to compute the CS Derived items; for example, when the data are to be used for a special study, transmitted, or when an updated CS algorithm is produced. This item identifies the specific algorithm used to obtain the CS Derived values in the data record.</div><div class='content chap10-para'><strong>Codes (See the most current version of the <em>Collaborative Stage Data Collection System</em> (<a target="_blank" href="http://cancerstaging.org">http://cancerstaging.org</a>),<sup>13</sup> for rules and site-specific codes and coding structures.) </strong></div><div class='content chap10-para'>CS Version Derived is a 6-digit code (e.g., 010100). The first two  digits represent the major version number; the second two digits  represent minor version changes; and, the last two digits represent even  less significant changes, such as corrections of typographical errors  that do not affect coding or derivation results. <br /><br /> This item should not be blank if the CS Derived items contain values. It  should be blank if the CS Derived items are empty or the CS algorithm  has not been applied.</div><a name='2937'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>CS VERSION INPUT CURRENT</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">2937</td><td style="text-align:center;">6</td><td style="text-align:center;"><a href='#sources'>AJCC</a></td><td style="text-align:center;">2010</td><td style="text-align:center;">12</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1502 - 1507</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>csVersionInputCurrent</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>This item indicates the version of CS input fields after they have been updated or recoded. This data item is recorded the first time the CS input fields are entered and should be updated each time the CS input fields are modified.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Over time, the input codes and instructions for CS items may change. This item identifies the correct interpretation of input CS items.</div><div class='content chap10-para'><strong>Codes (See the most current version of the <em>Collaborative Stage Data Collection System</em> (<a target="_blank" href="http://cancerstaging.org">http://cancerstaging.org</a>),<sup>13</sup> for rules and site-specific codes and coding structures.) </strong></div><div class='content chap10-para'>CS Version Input Current is a 6-digit code (e.g., 020100). The first two  digits represent the major version number; the second two digits  represent minor version changes; and, the last two digits represent even  less significant changes, such as corrections of typographical errors  that do not affect coding or derivation of results.</div><a name='2935'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>CS VERSION INPUT ORIGINAL</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">2935</td><td style="text-align:center;">6</td><td style="text-align:center;"><a href='#sources'>AJCC</a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1508 - 1513</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>CS Version 1ST<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>csVersionInputOriginal</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>This item indicates the number of the version initially used to code Collaborative Staging (CS) fields. The CS version number is returned as part of the output of the CS algorithm.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Over time, the input codes and instructions for CS items may change. This item identifies the correct interpretation of input CS items.</div><div class='content chap10-para'><strong>Codes (See the most current version of the <em>Collaborative Stage Data Collection System</em> (<a target="_blank" href="http://cancerstaging.org">http://cancerstaging.org</a>),<sup>13</sup> for rules and site-specific codes and coding structures.) </strong></div><div class='content chap10-para'>CS Version Input Original is a 6-digit code (e.g., 010100). The first  two digits represent the major version number; the second two digits  represent minor version changes; and, the last two digits represent even  less significant changes, such as corrections of typographical errors  that do not affect coding or derivation of results.</div><a name='1270'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>DATE 1ST CRS RX COC</strong></td><td style="text-align:right;font-weight:bold;"><strong>Revised</strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">1270</td><td style="text-align:center;">8</td><td style="text-align:center;"><a href='#sources'>CoC</a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">2104 - 2111</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>Date Started (pre 96 CoC)<br />Date of First Course Treatment (CoC)<br />Date of 1st Crs RX--CoC<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>date1stCrsRxCoc</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para mark-changed'><div>Date of initiation of the first therapy for the cancer being reported, using the CoC definition of first course. The date of first treatment includes the date a decision was made not to treat the patient. See <em>STORE</em> for details. See Chapter V, Unresolved Issues for further discussion of the difference between SEER and CoC items. See Chapter X for date format. Use Date 1st Crs RX CoC Flag [1271] if there is no appropriate or known date for this item. </div>  <div> &nbsp;</div>  <div>Formerly Date of 1st Crs RX--CoC.</div></div><div class='content chap10-para mark-changed'><strong>Clarification of NPCR Required Status <br /></strong>Central registries funded by NPCR are required to collect either Date Initial RX SEER [1260] or Date 1st Crs RX CoC [1270].</div><a name='1271'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>DATE 1ST CRS RX COC FLAG</strong></td><td style="text-align:right;font-weight:bold;"><strong>Revised</strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">1271</td><td style="text-align:center;">2</td><td style="text-align:center;"><a href='#sources'>NAACCR</a></td><td style="text-align:center;">2010</td><td style="text-align:center;">12</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">2112 - 2113</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>Date of 1st Crs Rx Flag<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>date1stCrsRxCocFlag</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para mark-changed'><div>This flag explains why no appropriate value is in the field, Date 1st Crs RX CoC [1270].</div>  <div>&nbsp;</div>  <div>Formerly Date of 1st Crs Rx Flag.</div></div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para mark-changed'>Before Version 12 (through 2009 diagnosis), date fields included codes that provided information other than dates. As part of an initiative to standardize date fields, new fields were introduced to accommodate non-date information that had previously been transmitted in date fields.</div><div class='content chap10-para'><strong>Codes (See Appendix H for the complete Flavors of Null table, which includes the NAACCR codes, HL7 codes and definitions.)</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>10</td><td class='code-desc'>No information whatsoever can be inferred from this exceptional value (e.g, unknown whether treatment was administered)</td></tr><tr class='code-row'><td class='code-nbr'>11</td><td class='code-desc'>No proper value is applicable in this context (Autopsy only)</td></tr><tr class='code-row'><td class='code-nbr'>12</td><td class='code-desc'>A proper value is applicable but not known (e.g., treatment administered but date is unknown)</td></tr><tr class='code-row'><td class='code-nbr'>Blank</td><td class='code-desc'>A valid date value is provided in item Date 1st Crs RX CoC [1270], or the date was not expected to have been transmitted</td></tr></table></div><div class='content chap10-para'>Comment: This is part of the initiative of the transformation from the old NAACCR date standards to interoperable dates.</div><a name='2090'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>DATE CASE COMPLETED</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">2090</td><td style="text-align:center;">8</td><td style="text-align:center;"><a href='#sources'>NAACCR</a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">2648 - 2655</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>dateCaseCompleted</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>The date that: (1) the abstractor decided that the tumor report was complete and (2) the case passed all edits that were applied. Definitions may vary among registries and software providers. This field is locally used by central registries. See Chapter X for date format. Standard edits check that no dates are later than the current date. These specifications will not necessarily be the same as those used for Date Case Completed--CoC [2092]. </div><a name='2092'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>DATE CASE COMPLETED--COC</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">2092</td><td style="text-align:center;">8</td><td style="text-align:center;"><a href='#sources'>CoC</a></td><td style="text-align:center;">2010</td><td style="text-align:center;">12</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">2656 - 2663</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>dateCaseCompletedCoc</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Identifies the date that specified items are completed, based on the Class of Case, where those items pass the relevant edits. Follow-up information, including delayed treatment received elsewhere, may be coded after the Date Case Completed--CoC. See the current 

<em><a target="_blank" href="http://www.facs.org/cancer/coc/fordsmanual.html">STORE</a></em> for details. This item should be autocoded by the registry software; specifications may be obtained from NCDB. The CoC specifications will not necessarily be the same as those used for Date Case Completed [2090]. See Chapter X for date format. </div><a name='2085'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>DATE CASE INITIATED</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">2085</td><td style="text-align:center;">8</td><td style="text-align:center;"><a href='#sources'>NAACCR</a></td><td style="text-align:center;">2010</td><td style="text-align:center;">12</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">2640 - 2647</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>dateCaseInitiated</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Date the electronic abstract is initiated in the reporting facility's cancer registry database. See Chapter X for date format. Standard edits check that no dates are later than the current date or the date completed.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>This item is used to assess and monitor the timeliness of reporting. Timeliness of abstracting (and reporting) is a concern for all standard-setting organizations and consequently, timeliness standards have been established. Examples of use are as follows:<br /><blockquote><tab></tab></blockquote><ul><li><span style="font-family:Symbol;"><span style="Times New Roman&quot;"></span></span>This item can be used with the Date of 1<sup>st</sup>Contact&nbsp;[580] to measure timeliness of abstracting by individual reporting facilities.</li><li><span style="font-family:Symbol;"><span style="Times New Roman&quot;"></span></span>This item can be used with Date Case Report Exported&nbsp;[2110] to determine the "residency time" of a case report within a reporting facility's database prior to data transmission to a central cancer registry.</li><li><span style="font-family:Symbol;"><span style="Times New Roman&quot;"></span></span>This item can be used with Date Case Report Received&nbsp;[2111] to monitor central registry timeliness in entering case reports (for case reports abstracted in-house from hardcopy provided by a reporting facility).</li><li><span style="font-family:Symbol;"><span style="Times New Roman&quot;"></span></span>This item can be used with Date Case Completed&nbsp;[2090] to monitor timeliness of case report completion.</li></ul><blockquote><tab><tab><tab><tab></tab></tab></tab></tab></blockquote></div><a name='2100'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>DATE CASE LAST CHANGED</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">2100</td><td style="text-align:center;">8</td><td style="text-align:center;"><a href='#sources'>NAACCR</a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">2664 - 2671</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>dateCaseLastChanged</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Date the case was last changed or updated. See Chapter X for date format. Standard edits check that no dates are later than the current date. </div><a name='2110'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>DATE CASE REPORT EXPORTED</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">2110</td><td style="text-align:center;">8</td><td style="text-align:center;"><a href='#sources'>NPCR</a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">2672 - 2679</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>Date Case Transmitted (pre-98 NAACCR)<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>dateCaseReportExported</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Date the reporting facility exports the electronic abstract to a file for transmission to the central registry. See Chapter X for date format. Standard edits check that no dates are later than the current date. Definitions may vary among registries and software providers. </div><a name='2112'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>DATE CASE REPORT LOADED</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">2112</td><td style="text-align:center;">8</td><td style="text-align:center;"><a href='#sources'>NPCR</a></td><td style="text-align:center;">1997</td><td style="text-align:center;">5.1</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">2688 - 2695</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>dateCaseReportLoaded</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Date the tumor report is loaded into a central registry computerized processing file for initiation of quality control activities (e.g., visual editing, application of computerized edits, etc.). See Chapter X for date format. </div><a name='2111'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>DATE CASE REPORT RECEIVED</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">2111</td><td style="text-align:center;">8</td><td style="text-align:center;"><a href='#sources'>NPCR</a></td><td style="text-align:center;">1997</td><td style="text-align:center;">5.1</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">2680 - 2687</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>dateCaseReportReceived</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Date the abstract (or source record) is received by the central cancer registry for the respective tumor. If multiple reports are received from two or more sources and if a single date is needed, use the date the first abstract (or source record) was received from any source. See Chapter X for date format. </div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>This item is used to assess and monitor the timeliness of reporting. Timeliness of abstracting (and reporting) is a concern for all standard-setting organizations. This item can be used with the Date of 1st Contact [580] or the Path--Date of Specimen Collection [7320] to measure timeliness of reporting to central cancer registries by individual reporting facilities. This data item also can be used with the Date Tumor Record Availbl [2113] to measure timeliness of processing within the central cancer registry. </div><a name='443'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>DATE CONCLUSIVE DX</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">443</td><td style="text-align:center;">8</td><td style="text-align:center;"><a href='#sources'>SEER</a></td><td style="text-align:center;">2006</td><td style="text-align:center;">11</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">581 - 588</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>Date of Conclusive Diagnosis<br />Date of Conclusive Terminology<br />Date of Conclusive DX<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>dateConclusiveDx</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'><div>Documents the date when a conclusive cancer diagnosis (definite statement of malignancy) is made following an initial diagnosis that was based only on ambiguous terminology. See Chapter X for date format. Use DATE CONCLUSIVE DX FLAG [448] if there is no appropriate or known date for this item. </div>  <div> &nbsp;</div>  <div>Formerly Date of Conclusive DX. </div> </div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>This date will allow analysis of the primary site locations and frequency of cases that were originally diagnosed by ambiguous terminology and later confirmed by other conclusive method.<br /><br />This date will also allow for analysis of the time interval between cancer diagnosis based on ambiguous terminology and confirmation of the cancer diagnosis by conclusive means. </div><div class='content chap10-para'><strong>Codes (refer to <a target="_blank" href="http://seer.cancer.gov/tools/mphrules/index.html">http://seer.cancer.gov/tools/mphrules/index.html</a> for additional instructions). </strong></div><a name='448'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>DATE CONCLUSIVE DX FLAG</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">448</td><td style="text-align:center;">2</td><td style="text-align:center;"><a href='#sources'>NAACCR</a></td><td style="text-align:center;">2010</td><td style="text-align:center;">12</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">589 - 590</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>dateConclusiveDxFlag</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>This flag explains why no appropriate value is in the field, Date Conclusive DX [443]. This data item was first available in Volume II Version 12. </div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Before Version 12, date fields included codes that provided information other than dates. As part of an initiative to standardize date fields, new fields were introduced to accommodate non-date information that had previously been transmitted in date fields. </div><div class='content chap10-para'><strong>Codes (See Appendix H for the complete Flavors of Null table, which includes the NAACCR codes, HL7 codes and definitions.)</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>10</td><td class='code-desc'>No information whatsoever can be inferred from this exceptional (non-date) value. (e.g., unknown if the diagnosis was initially based on ambiguous terminology).</td></tr><tr class='code-row'><td class='code-nbr'>11</td><td class='code-desc'>No proper value is applicable in this context. (e.g., not applicable, initial diagnosis made by unambiguous terminology (Code 0 in data item Ambiguous Terminology DX [442]).</td></tr><tr class='code-row'><td class='code-nbr'>12</td><td class='code-desc'>A proper value is applicable but not known (e.g., the initial ambiguous diagnosis was followed by a conclusive term, but the date of the conclusive term is unknown).</td></tr><tr class='code-row'><td class='code-nbr'>15</td><td class='code-desc'>Information is not available at this time, but it is expected that it will be available later (e.g., accessioned based on ambiguous terminology only (Code 1 in data item Ambiguous Terminology DX [442]).</td></tr><tr class='code-row'><td class='code-nbr'>Blank</td><td class='code-desc'>A valid date value is provided in item Date Conclusive DX [443], or the date was not expected to have been transmitted.</td></tr></table></div><div class='content chap10-para'>Comment: This is part of the initiative of the transformation from the old NAACCR date standards to interoperable dates.</div><a name='1260'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>DATE INITIAL RX SEER</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">1260</td><td style="text-align:center;">8</td><td style="text-align:center;"><a href='#sources'>SEER</a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">2094 - 2101</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>Date Therapy Initiated (SEER)<br />Date Started (SEER)<br />Date of Initial RX--SEER<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>dateInitialRxSeer</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'><div>Date of initiation of the first course therapy for the tumor being reported, using the SEER definition of first course. See also Date 1st Crs RX CoC [1270]. See Chapter V, Unresolved Issues, for further discussion of the difference between SEER and CoC items. See Chapter X for date format. Use Date Initial RX SEER Flag [1261] if there is no appropriate or known date for this item. </div>  <div>&nbsp;</div>  <div>Formerly Date of Initial RX--SEER.</div></div><div class='content chap10-para'><strong>Clarification of NPCR Required Status<br /></strong>Central registries funded by NPCR are required to collect either Date Initial RX SEER [1260] or Date 1st Crs RX CoC [1270].</div><a name='1261'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>DATE INITIAL RX SEER FLAG</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">1261</td><td style="text-align:center;">2</td><td style="text-align:center;"><a href='#sources'>NAACCR</a></td><td style="text-align:center;">2010</td><td style="text-align:center;">12</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">2102 - 2103</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>Date of Initial RX Flag<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>dateInitialRxSeerFlag</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'><div>This flag explains why no appropriate value is in the field, Date Initial RX SEER [1260].</div>  <div>&nbsp;</div>  <div>Formerly Date of Initial RX Flag.</div> </div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Before Version 12 (through 2009 diagnosis), date fields included codes that provided information other than dates. As part of an initiative to standardize date fields, new fields were introduced to accommodate non-date information that had previously been transmitted in date fields. </div><div class='content chap10-para'><strong>Codes (See Appendix H for the complete Flavors of Null table, which includes the NAACCR codes, HL7 codes and definitions.)</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>10</td><td class='code-desc'>No information whatsoever can be inferred from this exceptional value (e.g, unknown if therapy was administered)</td></tr><tr class='code-row'><td class='code-nbr'>11</td><td class='code-desc'>No proper value is applicable in this context (e.g., therapy was not administered)</td></tr><tr class='code-row'><td class='code-nbr'>12</td><td class='code-desc'>A proper value is applicable but not known (e.g., therapy was administered and date is unknown)</td></tr><tr class='code-row'><td class='code-nbr'>Blank</td><td class='code-desc'>A valid date value is provided in item Date Initial RX SEER [1260], or the date was not expected to have been transmitted</td></tr></table></div><div class='content chap10-para'>Comment: This is part of the initiative of the transformation from the old NAACCR date standards to interoperable dates.</div><a name='580'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>DATE OF 1ST CONTACT</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">580</td><td style="text-align:center;">8</td><td style="text-align:center;"><a href='#sources'>CoC</a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">759 - 766</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>Date of Adm/First Contact<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>dateOf1stContact</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Date of first patient contact, as inpatient or outpatient, with the reporting facility for the diagnosis and/or treatment of the tumor. The date may represent the date of an outpatient visit for a biopsy, x-ray, scan, or laboratory test. See Chapter X for date format.<br /><br />When pathology-specimen-only tumors are collected (Class of Case 43, Type of Reporting Source 3), the date of specimen collection from the pathology report should be used as the Date of 1st Contact. If a pathology-specimen-only case is followed by patient contact with a facility for diagnosis and/or treatment of the respective tumor, ACoS coding rules require the hospital registry to change the Date of 1st Contact to reflect the date the patient first registered at that facility. Central registries, however, should retain the earlier date in their consolidated files, as that shows the patient&#8217;s first recorded contact with the healthcare system for this disease. <br /><br />When death certificate only (Class of Case 49, Type of Reporting Source 7) tumors are collected, the date of death should be used as the Date of 1st Contact. When Autopsy Only (Class of Case 38, Type of Reporting Source 6) tumors are collected, the date of death should be used as the Date of 1st Contact. </div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Timeliness of abstracting (and reporting) is a concern for all standard-setting organizations. Date of 1st Contact is one of several data items that can be used to measure timeliness of reporting to central cancer registries by individual facilities. For tumors that are not diagnosed at the reporting facility following its Reference Date (Class of Case 20-22, 30-37), the Date of 1st Contact [580] can be used in conjunction with the Date Case Report Received [2111] to measure timeliness of reporting by individual facilities. </div><div class='content chap10-para'><em>Comment</em>: To accurately measure the timeliness of data collection and submission of abstracts that are first diagnosed at autopsy (Class of Case 38, Type of Reporting Source 6) the date of death should be used as the Date of 1st Contact since the diagnosis was not determined until the autopsy was performed. Death Certificate Only cases (Class of Case 49, Type of Reporting Source 7) are created only by the central registry. For these cases, Date of 1st Contact should be filled with the date of death, and timeliness for DCO cases should be measured by different criteria. </div><a name='581'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>DATE OF 1ST CONTACT FLAG</strong></td><td style="text-align:right;font-weight:bold;"><strong>Revised</strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">581</td><td style="text-align:center;">2</td><td style="text-align:center;"><a href='#sources'>NAACCR</a></td><td style="text-align:center;">2010</td><td style="text-align:center;">12</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">767 - 768</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>Date of First Contact Flag<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>dateOf1stContactFlag</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para mark-changed'>This flag explains why no appropriate value is in the field Date of 1st Contact [580]. This data item was first available in Volume II Version 12.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para mark-changed'>Before Version 12 (through 2009 diagnosis), date fields included codes that provided information other than dates. As part of an initiative to standardize date fields, new fields were introduced to accommodate non-date information that had previously been transmitted in date fields.</div><div class='content chap10-para'><strong>Codes (See Appendix H for the complete Flavors of Null table, which includes the NAACCR codes, HL7 codes and definitions.)</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>12</td><td class='code-desc'>A proper value is applicable but not known (e.g., date of 1st contact is unknown)</td></tr><tr class='code-row'><td class='code-nbr'>Blank</td><td class='code-desc'>A valid date value is provided in item Date of 1st Contact [580], or the date was not expected to have been transmitted</td></tr></table></div><div class='content chap10-para'><em>Comment</em>: This is part of the initiative of the transformation from the old NAACCR date standards to interoperable dates.</div><a name='1080'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>DATE OF 1ST POSITIVE BX</strong></td><td style="text-align:right;font-weight:bold;"><strong>Retired</strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">1080</td><td style="text-align:center;"></td><td style="text-align:center;"><a href='#sources'></a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;">2010</td><td style="text-align:center;">12</td><td class="cross-out" style="text-align:center;"></td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td></td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td></td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>The NAACCR UDSC retired this data item in Version 12, as of January 1, 2010.</div><a name='240'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>DATE OF BIRTH</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">240</td><td style="text-align:center;">8</td><td style="text-align:center;"><a href='#sources'>SEER/CoC</a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">226 - 233</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>Birth Date(SEER/CoC/CCCR)<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>dateOfBirth</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Patient</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Date of birth of the patient. See Chapter X for date format. If age at diagnosis and year of diagnosis are known, but year of birth is unknown, then year of birth should be calculated and so coded. Only the year should be entered, left-justified. Estimate date of birth when information is not available. It is better to estimate than to leave birth date unknown. </div><a name='241'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>DATE OF BIRTH FLAG</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">241</td><td style="text-align:center;">2</td><td style="text-align:center;"><a href='#sources'>NAACCR</a></td><td style="text-align:center;">2010</td><td style="text-align:center;">12</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">234 - 235</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>dateOfBirthFlag</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Patient</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>This flag explains why no appropriate value is in the field, Date of Birth [240]. This data item was first available in Volume II Version 12.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Before Version 12 (through 2009 diagnosis), date fields included codes that provided information other than dates. As part of an initiative to standardize date fields, new fields were introduced to accommodate non-date information that had previously been transmitted in date fields.</div><div class='content chap10-para'><strong>Codes (See Appendix H for the complete Flavors of Null table, which includes the NAACCR codes, HL7 codes and definitions. Use code 12 when date of birth is unknown.)</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>12</td><td class='code-desc'>A proper value is applicable but not known (i.e., birth date is unknown)</td></tr><tr class='code-row'><td class='code-nbr'>Blank</td><td class='code-desc'>A valid date value is provided in item Date of Birth [240], or the date was not expected to have been transmitted</td></tr></table></div><div class='content chap10-para'>Comment: This is part of the initiative of the transformation from the old NAACCR date standards to interoperable dates.</div><a name='660'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>DATE OF CA CONFERENCE</strong></td><td style="text-align:right;font-weight:bold;"><strong>Retired</strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">660</td><td style="text-align:center;"></td><td style="text-align:center;"><a href='#sources'></a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;">2006</td><td style="text-align:center;">11</td><td class="cross-out" style="text-align:center;"></td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td></td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td></td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>The NAACCR UDSC retired this data item in Version 11, as of January 1, 2006.</div><a name='1755'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>DATE OF DEATH--CANADA</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">1755</td><td style="text-align:center;">8</td><td style="text-align:center;"><a href='#sources'>CCCR</a></td><td style="text-align:center;">2009</td><td style="text-align:center;">11.3</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">2953 - 2960</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>dateOfDeathCanada</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Patient</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>This field is used by the Canadian provinces/territories to record the patient's date of death. See Chapter X for date format. </div><a name='1756'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>DATE OF DEATH--CANADAFLAG</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">1756</td><td style="text-align:center;">2</td><td style="text-align:center;"><a href='#sources'>NAACCR</a></td><td style="text-align:center;">2010</td><td style="text-align:center;">12</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">2961 - 2962</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>dateOfDeathCanadaFlag</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Patient</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>This flag explains why no appropriate value is in the field, Date of Death--Canada [1755]. This data item was first available in Volume II Version 12.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Before Version 12 (through 2009 diagnosis), date fields included codes that provided information other than dates. As part of an initiative to standardize date fields, new fields were introduced to accommodate non-date information that had previously been transmitted in date fields.</div><div class='content chap10-para'><strong>Codes (See Appendix H for the complete Flavors of Null table, which includes the NAACCR codes, HL7 codes and definitions.) </strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>10</td><td class='code-desc'>No information whatsoever can be inferred from this exceptional value (e.g, patient is not known to be deceased)</td></tr><tr class='code-row'><td class='code-nbr'>11</td><td class='code-desc'>No proper value is applicable in this context (e.g. patient is alive)</td></tr><tr class='code-row'><td class='code-nbr'>12</td><td class='code-desc'>A proper value is applicable but not known (e.g., date of death is unknown)</td></tr><tr class='code-row'><td class='code-nbr'>Blank</td><td class='code-desc'>A valid date value is provided in item Date of Death--Canada [1755], or the date was not expected to have been transmitted</td></tr></table></div><div class='content chap10-para'>Comment: This is part of the initiative of the transformation from the old NAACCR date standards to interoperable dates.</div><a name='390'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>DATE OF DIAGNOSIS</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">390</td><td style="text-align:center;">8</td><td style="text-align:center;"><a href='#sources'>SEER/CoC</a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">544 - 551</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>Date of Initial Diagnosis (CoC)<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>dateOfDiagnosis</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Date of initial diagnosis by a recognized medical practitioner for the tumor being reported whether clinically or microscopically confirmed. See Chapter X for date format. <br /><br />For more discussion on determining date of diagnosis, consult the <a target="_blank" href="http://seer.cancer.gov/tools/codingmanuals/"><em>SEER Program Coding and Staging Manual</em></a> or CoC <em><a target="_blank" href="http://www.facs.org/cancer/coc/fordsmanual.html">STORE</a></em> manual. </div><a name='391'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>DATE OF DIAGNOSIS FLAG</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">391</td><td style="text-align:center;">2</td><td style="text-align:center;"><a href='#sources'>NAACCR</a></td><td style="text-align:center;">2010</td><td style="text-align:center;">12</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">552 - 553</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>dateOfDiagnosisFlag</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>This flag explains why no appropriate value in in the field, Date of Diagnosis [390]. This data item was first available in Volume II Version 12. </div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Before Version 12 (through 2009 diagnosis), date fields included codes that provided information other than dates. As part of an initiative to standardize date fields, new fields were introduced to accommodate non-date information that had previously been transmitted in date fields. </div><div class='content chap10-para'><strong>Codes (See Appendix H for the complete Flavors of Null table, which includes the NAACCR codes, HL7 codes and definitions.)</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>12</td><td class='code-desc'>A proper value is applicable but not known. (e.g., date of diagnosis is unknown)</td></tr><tr class='code-row'><td class='code-nbr'>Blank</td><td class='code-desc'>A valid date value is provided in item Date of Diagnosis [390], or the date was not expected to have been transmitted</td></tr></table></div><div class='content chap10-para'>Comment: This is part of the initiative of the transformation from the old NAACCR date standards to interoperable dates.</div><a name='590'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>DATE OF INPT ADM</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">590</td><td style="text-align:center;">8</td><td style="text-align:center;"><a href='#sources'>NAACCR</a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">769 - 776</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>Date of Inpatient Admission (CoC)<br />Date of Inpatient Adm<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>dateOfInptAdm</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'><div>Date of the inpatient admission to the reporting facility for the most definitive surgery. In the absence of surgery, use date of inpatient admission for any other therapy. In the absence of therapy, use date of inpatient admission for diagnostic evaluation. See Chapter X for date format. Use DATE OF INPT ADM FLAG [591] if there is no appropriate or known date for this item. </div>  <div>&nbsp;</div>  <div>Formerly Date of Inpatient Adm. </div> </div><div class='content chap10-para'><em>Note:</em> This data item is no longer supported by CoC (as of January 1, 2003). </div><a name='591'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>DATE OF INPT ADM FLAG</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">591</td><td style="text-align:center;">2</td><td style="text-align:center;"><a href='#sources'>NAACCR</a></td><td style="text-align:center;">2010</td><td style="text-align:center;">12</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">777 - 778</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>dateOfInptAdmFlag</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>This flag explains why no appropriate value is in the field, Date of Inpt Adm [590].&nbsp; </div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Before Version 12 (through 2009 diagnosis), date fields included codes that provided information other than dates. As part of an initiative to standardize date fields, new fields were introduced to accommodate non-date information that had previously been transmitted in date fields. </div><div class='content chap10-para'><strong>Codes (See Appendix H for the complete Flavors of Null table, which includes the NAACCR codes, HL7 codes and definitions.) </strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>10</td><td class='code-desc'>No information whatsoever can be inferred from this exceptional value (e.g, unknown if patient was an inpatient).</td></tr><tr class='code-row'><td class='code-nbr'>11</td><td class='code-desc'>No proper value is applicable in this context (e.g., patient was never an inpatient at the reporting facility).</td></tr><tr class='code-row'><td class='code-nbr'>12</td><td class='code-desc'>A proper value is applicable but not known. This event occurred, but the date is unknown (e.g., the patient was an inpatient but the date is unknown).</td></tr><tr class='code-row'><td class='code-nbr'>Blank</td><td class='code-desc'>A valid date value is provided in item Date of Inpt Adm [590], or the date was not expected to have been transmitted.</td></tr></table></div><div class='content chap10-para'>Comment: This is part of the initiative of the transformation from the old NAACCR date standards to interoperable dates.</div><a name='600'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>DATE OF INPT DISCH</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">600</td><td style="text-align:center;">8</td><td style="text-align:center;"><a href='#sources'>NAACCR</a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">779 - 786</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>Date of Inpatient Discharge (CoC)<br />Date of Inpatient Disch<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>dateOfInptDisch</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'><div>Date of the inpatient discharge from the reporting facility after the most definitive surgery. In the absence of surgery, use date of inpatient discharge for other therapy. In the absence of therapy, use date of inpatient discharge for diagnostic evaluation. This discharge date corresponds to the admission date described by Date of Inpt Adm [590]. See Chapter X for date format. Use DATE OF INPT DISCH FLAG [601] if there is no appropriate or known date for this item.&nbsp;<em>Note:</em> This item is not the same as the old NAACCR item, Date of Discharge, which has been deleted from the NAACCR layout. </div>  <div>&nbsp;</div>  <div>Formerly Date of Inpatient Disch. </div> </div><div class='content chap10-para'><em>Note:</em> This data item is no longer supported by CoC (as of January 1, 2003). </div><a name='601'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>DATE OF INPT DISCH FLAG</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">601</td><td style="text-align:center;">2</td><td style="text-align:center;"><a href='#sources'>NAACCR</a></td><td style="text-align:center;">2010</td><td style="text-align:center;">12</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">787 - 788</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>dateOfInptDischFlag</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>This flag explains why no appropriate value is in the field, Date of Inpt Disch [600]. This data item was first available in Volume II Version 12. </div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Before Version 12 (through 2009 diagnosis), date fields included codes that provided information other than dates. As part of an initiative to standardize date fields, new fields were introduced to accommodate non-date information that had previously been transmitted in date fields. </div><div class='content chap10-para'><strong>Codes (See Appendix H for the complete Flavors of Null table, which includes the NAACCR codes, HL7 codes and definitions.) </strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>10</td><td class='code-desc'>No information whatsoever can be inferred from this exceptional value (e.g, unknown if patient was an inpatient).</td></tr><tr class='code-row'><td class='code-nbr'>11</td><td class='code-desc'>No proper value is applicable in this context (e.g., patient was never an inpatient at the reporting facility).</td></tr><tr class='code-row'><td class='code-nbr'>12</td><td class='code-desc'>A proper value is applicable but not known. This event occurred, but the date is unknown (e.g., the patient was an inpatient but the date is unknown).</td></tr><tr class='code-row'><td class='code-nbr'>Blank</td><td class='code-desc'>A valid date value is provided in item Date of Inpt Disch [600], or the date was not expected to have been transmitted.</td></tr></table></div><div class='content chap10-para'>Comment: This is part of the initiative of the transformation from the old NAACCR date standards to interoperable dates.</div><a name='1772'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>DATE OF LAST CANCER (TUMOR) STATUS </strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">1772</td><td style="text-align:center;">8</td><td style="text-align:center;"><a href='#sources'>CoC</a></td><td style="text-align:center;">2018</td><td style="text-align:center;">18</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">2788 - 2795</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>dateOfLastCancerStatus</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'><!--[if gte mso 10]>  <![endif]-->This data item documents the date of last cancer (tumor status) of the patient&#8217;s malignant or non-malignant tumor. Record in CCYYMMDD form, where blank spaces are used for unknown trailing portions of the date or where a date is not applicable. This data item is required for CoC-accredited facilities as of cases diagnosed 01/01/2018 and later.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>This information is used for patient follow-up and outcomes studies.</div><a name='1773'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>DATE OF LAST CANCER (TUMOR) STATUS FLAG</strong></td><td style="text-align:right;font-weight:bold;"><strong>Revised</strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">1773</td><td style="text-align:center;">2</td><td title="V: 22: NAACCR
V: 18: CoC
" class=" HighlightToolTip" style="text-align:center;"><a href='#sources'>NAACCR</a></td><td style="text-align:center;">2018</td><td style="text-align:center;">18</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">2796 - 2797</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>dateOfLastCancerStatusFlag</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>This flag explains why there is no appropriate value in the corresponding date field, Date of Last Cancer (tumor) Status [1772]. This data item is required for CoC-accredited facilities as of cases diagnosed 01/01/2018 and later.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>This information is used for patient follow-up and outcomes studies. As part of an initiative to standardize date fields, date flag fields were introduced to accommodate non-date information that had previously been transmitted in date fields.</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>12</td><td class='code-desc'>A proper value is applicable but not known. This event occurred, but the date is unknown (that is, the Date of Last Cancer (tumor) Status is unknown). </td></tr><tr class='code-row'><td class='code-nbr'>Blank</td><td class='code-desc'>A valid date value is provided in item Date of Last Cancer (tumor) Status [1772].</td></tr><tr class='code-row'><td class='code-nbr' colspan='2'></td></tr></table></div><a name='1750'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>DATE OF LAST CONTACT</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">1750</td><td style="text-align:center;">8</td><td style="text-align:center;"><a href='#sources'>SEER/CoC</a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">2775 - 2782</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>Date of Last Contact or Death (CoC)<br />Date of Last Follow-Up or of Death (SEER)<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>dateOfLastContact</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Patient</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Date of last contact with the patient, or date of death. If the patient has multiple tumors, Date of Last Contact should be the same for all tumors. See Chapter X for date format. </div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Used for recording Date of Last Contact from active or passive follow-up. Used to record date of death and to calculate survival. </div><a name='1751'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>DATE OF LAST CONTACT FLAG</strong></td><td style="text-align:right;font-weight:bold;"><strong>Revised</strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">1751</td><td style="text-align:center;">2</td><td style="text-align:center;"><a href='#sources'>NAACCR</a></td><td style="text-align:center;">2010</td><td style="text-align:center;">12</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">2783 - 2784</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>dateOfLastContactFlag</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Patient</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para mark-changed'>This flag explains why no appropriate value is in the field, Date of Last Contact [1750].</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para mark-changed'>Before Version 12 (through 2009 diagnosis), date fields included codes that provided information other than dates. As part of an initiative to standardize date fields, new fields were introduced to accommodate non-date information that had previously been transmitted in date fields.</div><div class='content chap10-para'><strong>Codes (See Appendix H for the complete Flavors of Null table, which includes the NAACCR codes, HL7 codes and definitions.)</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>12</td><td class='code-desc'>A proper value is applicable but not known. This event occurred, but the date is unknown (e.g., date of last contact is unknown).</td></tr><tr class='code-row'><td class='code-nbr'>Blank</td><td class='code-desc'>A valid date value is provided in item Date of Last Contact [1750], or the date was not expected to have been transmitted.</td></tr></table></div><div class='content chap10-para'>Comment: This is part of the initiative of the transformation from the old NAACCR date standards to interoperable dates.</div><a name='445'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>DATE OF MULT TUMORS</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">445</td><td style="text-align:center;">8</td><td style="text-align:center;"><a href='#sources'>SEER</a></td><td style="text-align:center;">2006</td><td style="text-align:center;">11</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">593 - 600</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>Date of Multiple Tumors<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>dateOfMultTumors</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'><div>    <span style="font-size:11.0pt;font-family:&quot;Times New Roman&quot;,&quot;serif&quot;;">This data item is used to identify the month, day and year the patient is diagnosed with multiple tumors reported as a single primary using the SEER, IARC, or Canadian Cancer Registry</span>    <span style="font-size: 11.0pt;font-family:&quot;Times New Roman&quot;,&quot;serif&quot;;">multiple primary rules. See Chapter X for date format. <span style="color:black">Use DATE OF MULT TUMORS FLAG</span></span>    <span style="font-size:11.0pt;font-family:&quot;Times New Roman&quot;,&quot;serif&quot;; color:black;">[439] if there is no appropriate or known date for this item.</span>  </div>  <div> &nbsp;</div>  <div>Formerly Date of Multiple Tumors. </div> </div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Patients with multiple tumors may have a worse prognosis or more extensive treatment than patients with a single tumor. This data item will make it possible to identify important information about these cases for data analysis. The Date of Multiple Tumors will allow separation of cases with multiple tumors present at the time of initial diagnosis from cases with subsequent tumors abstracted as the same primary. The date will allow tracking of the time interval between the date of original diagnosis and the first date of subsequent tumor(s) for specific primary sites and tumor histologies. </div><div class='content chap10-para'><strong>Codes (refer to <a target="_blank" href="http://seer.cancer.gov/tools/mphrules/index.html">http://seer.cancer.gov/tools/mphrules/index.html</a> for additional instructions). </strong></div><a name='439'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>DATE OF MULT TUMORS FLAG</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">439</td><td style="text-align:center;">2</td><td style="text-align:center;"><a href='#sources'>NAACCR</a></td><td style="text-align:center;">2010</td><td style="text-align:center;">12</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">601 - 602</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>dateOfMultTumorsFlag</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>This flag explains why no appropriate value is in the field, Date of Mult Tumors [445]. This data item was first available in Volume II Version 12. </div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Before Version 12 (through 2009 diagnosis), date fields included codes that provided information other than dates. As part of an initiative to standardize date fields, new fields were introduced to accommodate non-date information that had previously been transmitted in date fields. </div><div class='content chap10-para'><strong>Codes (See Appendix H for the complete Flavors of Null table, which includes the NAACCR codes, HL7 codes and definitions.) </strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>11</td><td class='code-desc'>No proper value is applicable in this context (e.g., information on multiple tumors not collected/not applicable for this site).</td></tr><tr class='code-row'><td class='code-nbr'>12</td><td class='code-desc'>A proper value is applicable but not known. This event occurred, but the date is unknown (e.g., patient was diagnosed with multiple tumors and the date is unknown).</td></tr><tr class='code-row'><td class='code-nbr'>15</td><td class='code-desc'>Information is not available at this time, but it is expected that it will be available later (e.g., single tumor).</td></tr><tr class='code-row'><td class='code-nbr'>Blank</td><td class='code-desc'>A valid date value is provided in item Date of Mult Tumors [445], or the date was not expected to have been transmitted.</td></tr></table></div><div class='content chap10-para'>Comment: This is part of the initiative of the transformation from the old NAACCR date standards to interoperable dates.</div><a name='832'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>DATE OF SENTINEL LYMPH NODE BIOPSY</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">832</td><td style="text-align:center;">8</td><td style="text-align:center;"><a href='#sources'>CoC</a></td><td style="text-align:center;">2018</td><td style="text-align:center;">18</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1016 - 1023</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>dateSentinelLymphNodeBiopsy</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Records the date of the sentinel lymph node(s) biopsy procedure. This data item is required for CoC-accredited facilities as of cases diagnosed 01/01/2018 and later. 














<strong>This data item is required for breast and melanoma cases only. </strong></div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>It is a known fact that sentinel lymph node biopsies have been under-reported.  Additionally, the timing and results of sentinel lymph node biopsy procedures are used in quality of care measures. This data item can be used to more accurately assess the date of the sentinel lymph node biopsy procedure separate from the date of a subsequent regional node dissection procedure, if performed.</div><a name='833'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>DATE OF SENTINEL LYMPH NODE BIOPSY FLAG</strong></td><td style="text-align:right;font-weight:bold;"><strong>Revised</strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">833</td><td style="text-align:center;">2</td><td title="V: 22: SEER
V: 18: CoC
" class=" HighlightToolTip" style="text-align:center;"><a href='#sources'>SEER</a></td><td style="text-align:center;">2018</td><td style="text-align:center;">18</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1024 - 1025</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>dateSentinelLymphNodeBiopsyFlag</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para mark-changed'>This flag explains why there is no appropriate value in the corresponding date data item, Date of Sentinel Lymph Node Biopsy [832]. This data item is required for CoC-accredited facilities as of cases diagnosed 01/01/2018 and later. 









<strong>This data item is required for breast and melanoma cases only. </strong></div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>As part of an initiative to standardize date fields, date flag fields were introduced to accommodate non-date information that had previously been transmitted in date fields.</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>10</td><td class='code-desc'>No information whatsoever can be inferred from this exceptional value (that is, unknown if any sentinel lymph node biopsy was performed) </td></tr><tr class='code-row'><td class='code-nbr'>11</td><td class='code-desc'>No proper value is applicable in this context (for example, no sentinel lymph node biopsy performed; autopsy only cases)</td></tr><tr class='code-row'><td class='code-nbr'>12</td><td class='code-desc'>A proper value is applicable but not known. This event occurred, but the date is unknown (for example, sentinel lymph node biopsy performed but date is unknown)</td></tr><tr class='code-row'><td class='code-nbr'>Blank</td><td class='code-desc'>A valid date value is provided in item Date of Sentinel Lymph Node Biopsy [832]. Case was diagnosed prior to January 1, 2018. </td></tr><tr class='code-row'><td class='code-nbr'></td><td class='code-desc'> </td></tr></table></div><a name='682'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>DATE REGIONAL LYMPH NODE DISSECTION</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">682</td><td style="text-align:center;">8</td><td style="text-align:center;"><a href='#sources'>NAACCR</a></td><td style="text-align:center;">2018</td><td style="text-align:center;">18</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1002 - 1009</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>dateRegionalLNDissection</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Records the date non-sentinel regional node dissection was performed. This data item is required for CoC-accredited facilities as of cases diagnosed 01/01/2018 and later.&nbsp;</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>It is a known fact that sentinel lymph node biopsies have been under-reported. Additionally, the timing and results of sentinel lymph node biopsy procedures are used in quality of care measures. This data item can be used to more accurately assess the date of regional node dissection separate from the date of sentinel lymph node biopsy if performed.</div><a name='683'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>DATE REGIONAL LYMPH NODE DISSECTION FLAG</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">683</td><td style="text-align:center;">2</td><td style="text-align:center;"><a href='#sources'>NAACCR</a></td><td style="text-align:center;">2018</td><td style="text-align:center;">18</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1010 - 1011</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>dateRegionalLNDissectionFlag</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>This flag explains why there is no appropriate value in the corresponding date data item, Date of Regional Lymph Node Dissection [682]. This data item is required for CoC-accredited facilities as of cases diagnosed 01/01/2018 and later.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>As part of an initiative to standardize date fields, date flag fields were introduced to accommodate non-date information that had previously been transmitted in date fields.</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>10</td><td class='code-desc'>No information whatsoever can be inferred from this exceptional value (that is, unknown if any regional lymph node dissection was performed) </td></tr><tr class='code-row'><td class='code-nbr'>11</td><td class='code-desc'>No proper value is applicable in this context (for example, no regional lymph node dissection was performed; autopsy only cases)</td></tr><tr class='code-row'><td class='code-nbr'>12</td><td class='code-desc'>A proper value is applicable but not known. This event occurred, but the date is unknown (for example, regional lymph node dissection was performed but date is unknown)</td></tr><tr class='code-row'><td class='code-nbr'>Blank</td><td class='code-desc'>A valid date value is provided in item Date of Regional Lymph Node Dissection [682]. Case was diagnosed prior to January 1, 2018. </td></tr><tr class='code-row'><td class='code-nbr' colspan='2'></td></tr></table></div><a name='2113'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>DATE TUMOR RECORD AVAILBL</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">2113</td><td style="text-align:center;">8</td><td style="text-align:center;"><a href='#sources'>NPCR</a></td><td style="text-align:center;">1997</td><td style="text-align:center;">5.1</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">2696 - 2703</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>dateTumorRecordAvailbl</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Date the demographic and tumor identification information on a primary/reportable neoplasm, compiled from one or more source records, from one or more facilities, is available in the central cancer registry database to be counted as an incident tumor. Cancer identification information includes, at a minimum, site, histology, laterality, behavior, and date of diagnosis. See Chapter X for date format. </div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>This item is used to assess and monitor the timeliness of reporting. Timeliness of abstracting (and reporting) is a concern for all standard-setting organizations. This data item can be used with the Date Case Report Received [2111] to measure timeliness of processing within the central cancer registry. This item also can be used with the Date of 1st Contact [580] or the Path--Date of Specimen Collection [7320] to measure overall timeliness. </div><a name='2370'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>DC STATE</strong></td><td style="text-align:right;font-weight:bold;"><strong>Retired</strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">2370</td><td style="text-align:center;"></td><td style="text-align:center;"><a href='#sources'></a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;">1998</td><td style="text-align:center;">6</td><td class="cross-out" style="text-align:center;"></td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td></td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td></td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>The NAACCR UDSC retired this data item in Version 6, effective January 1, 1998. See Place of Death [1940].</div><a name='2380'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>DC STATE FILE NUMBER</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">2380</td><td style="text-align:center;">6</td><td style="text-align:center;"><a href='#sources'>State</a></td><td style="text-align:center;">2011</td><td style="text-align:center;">12.2</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">4598 - 4603</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>dcStateFileNumber</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Patient</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Death certificate identification number as assigned by the vital statistics office in the place recorded in Place of Death [1940]. </div><a name='2980'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>DERIVED AJCC-6 M</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">2980</td><td style="text-align:center;">2</td><td style="text-align:center;"><a href='#sources'>AJCC</a></td><td style="text-align:center;">2003</td><td style="text-align:center;">10</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1397 - 1398</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>Derived 6 M Storage Code<br />Derived AJCC M<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>derivedAjcc6M</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>This data item belongs to the Collaborative Stage (CS) Data Collection System which is based on the AJCC Cancer Staging Manual, 6th and 7th editions. AJCC T, N, M plus descriptors and AJCC staging components are composed of combinations of characters, numbers, and/or special characters and can be of varying lengths. To more easily handle these components a numeric code was assigned to each unique category for each T, N, M plus descriptors and AJCC stage for 6th and 7th editions. This field contains the numeric representation for AJCC 6th edition &#8220;M&#8221; and is derived from CS coded fields using the CS algorithm. This numeric representation is referred to as the &#8220;storage&#8221; code and its associated label is referred to as the &#8220;display&#8221; code. Explanations of the &#8220;storage&#8221; codes and their corresponding &#8220;display&#8221; codes can be found in the most current version of the Collaborative Stage Data Collection System (<a href="https://cancerstaging.org/cstage/Pages/default.aspx" target="_blank">https://cancerstaging.org/cstage/Pages/default.aspx</a>).<sup>13</sup> The display code should be used for display on the screen and in reports.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>The Collaborative Stage Data Collection System was designed by a joint task force including representatives from SEER, ACoS, CDC, NAACCR, NCRA, CCCR, CPAC, and AJCC, to provide a single uniform set of codes and rules for coding extent of disease (EOD) and stage information to meet the needs of all of the participating standard setters. When CS data items are coded, a computer algorithm provides the derivation of T, N, M, and stage-based on AJCC Cancer Staging Manual 6th &amp; 7th Editions, SEER Summary Stage 1977, and SEER Summary Stage 2000. There are separate derived CS fields in the NAACCR record based on AJCC 6th Edition for 2004+ cases and AJCC 7th Edition for 2010+ cases.</div><div class='content chap10-para'><strong>Codes (See the most current version of the <em>Collaborative Stage Data Collection System</em> (<a href="https://cancerstaging.org/cstage/Pages/default.aspx" target="_blank">https://cancerstaging.org/cstage/Pages/default.aspx</a>),<sup>13</sup> for rules and site-specific codes and coding structures.) </strong></div><a name='2990'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>DERIVED AJCC-6 M DESCRIPT</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">2990</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>AJCC</a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1399 - 1399</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>Derived AJCC M Descriptor<br />Derived  6 M Descriptor Storage Code<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>derivedAjcc6MDescript</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>This data item belongs to the Collaborative Stage (CS) Data Collection System which is based on the <em>AJCC Cancer Staging Manual</em>, 6th and 7th editions. AJCC T, N, M plus descriptors and AJCC staging components are composed of combinations of characters, numbers, and/or special characters and can be of varying lengths. To more easily handle these components a numeric code was assigned to each unique category for each T, N, M plus descriptors and AJCC stage for 6th and 7th editions. This field contains the numeric representation for AJCC 6th edition &#8220;M Descriptor&#8221; and is derived from CS coded fields using the CS algorithm. This numeric representation is referred to as the &#8220;storage&#8221; code and its associated label is referred to as the &#8220;display&#8221; code. Explanations of the &#8220;storage&#8221; codes and their corresponding &#8220;display&#8221; codes can be found in the most current version of the <em>Collaborative Stage Data Collection System</em> (<a href="https://cancerstaging.org/cstage/Pages/default.aspx" target="_blank">https://cancerstaging.org/cstage/Pages/default.aspx</a>).<sup>13</sup> The display code should be used for display on the screen and in reports.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>The Collaborative Stage Data Collection System was designed by a joint task force including representatives from SEER, ACoS, CDC, NAACCR, NCRA, CCCR, CPAC, and AJCC, to provide a single uniform set of codes and rules for coding extent of disease (EOD) and stage information to meet the needs of all of the participating standard setters. When CS data items are coded, a computer algorithm provides the derivation of T, N, M, and stage-based on AJCC Cancer Staging Manual 6th &amp; 7th Editions, SEER Summary Stage 1977, and SEER Summary Stage 2000. There are separate derived CS fields in the NAACCR record based on AJCC 6th Edition for 2004+ cases and AJCC 7th Edition for 2010+ cases.</div><div class='content chap10-para'><strong>Codes (See the most current version of the <em>Collaborative Stage Data Collection System</em> (<a href="https://cancerstaging.org/cstage/Pages/default.aspx" target="_blank">https://cancerstaging.org/cstage/Pages/default.aspx</a>),<sup>13</sup> for rules and site-specific codes and coding structures.) </strong></div><a name='2960'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>DERIVED AJCC-6 N</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">2960</td><td style="text-align:center;">2</td><td style="text-align:center;"><a href='#sources'>AJCC</a></td><td style="text-align:center;">2003</td><td style="text-align:center;">10</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1394 - 1395</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>Derived 6 N Descriptor Storage Code<br />Derived AJCC N<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>derivedAjcc6N</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>This data item belongs to the Collaborative Stage (CS) Data Collection System which is based on the <em>AJCC Cancer Staging Manual</em>, 6th and 7th editions. AJCC T, N, M plus descriptors and AJCC staging components are composed of combinations of characters, numbers, and/or special characters and can be of varying lengths. To more easily handle these components a numeric code was assigned to each unique category for each T, N, M plus descriptors and AJCC stage for 6th and 7th editions. This field contains the numeric representation for AJCC 6th edition &#8220;N&#8221; and is derived from CS coded fields using the CS algorithm. This numeric representation is referred to as the &#8220;storage&#8221; code and its associated label is referred to as the &#8220;display&#8221; code. Explanations of the &#8220;storage&#8221; codes and their corresponding &#8220;display&#8221; codes can be found in the most current version of the <em>Collaborative Stage Data Collection System</em> (<a href="https://cancerstaging.org/cstage/Pages/default.aspx" target="_blank">https://cancerstaging.org/cstage/Pages/default.aspx</a>).<sup>13</sup> The display code should be used for display on the screen and in reports.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>The Collaborative Stage Data Collection System was designed by a joint task force including representatives from SEER, ACoS, CDC, NAACCR, NCRA, CCCR, CPAC, and AJCC, to provide a single uniform set of codes and rules for coding extent of disease (EOD) and stage information to meet the needs of all of the participating standard setters. When CS data items are coded, a computer algorithm provides the derivation of T, N, M, and stage-based on AJCC Cancer Staging Manual 6th &amp; 7th Editions, SEER Summary Stage 1977, and SEER Summary Stage 2000. There are separate derived CS fields in the NAACCR record based on AJCC 6th Edition for 2004+ cases and AJCC 7th Edition for 2010+ cases.</div><div class='content chap10-para'><strong>Codes (See the most current version of the <em>Collaborative Stage Data Collection System</em> (<a href="https://cancerstaging.org/cstage/Pages/default.aspx" target="_blank">https://cancerstaging.org/cstage/Pages/default.aspx</a>),<sup>13</sup> for rules and site-specific codes and coding structures.) </strong></div><a name='2970'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>DERIVED AJCC-6 N DESCRIPT</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">2970</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>AJCC</a></td><td style="text-align:center;">2003</td><td style="text-align:center;">10</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1396 - 1396</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>Derived AJCC N Descriptor<br />Derived  6 N Descriptor Storage Code<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>derivedAjcc6NDescript</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>This data item belongs to the Collaborative Stage (CS) Data Collection System which is based on the <em>AJCC Cancer Staging Manual</em>, 6th and 7th editions. AJCC T, N, M plus descriptors and AJCC staging components are composed of combinations of characters, numbers, and/or special characters and can be of varying lengths. To more easily handle these components a numeric code was assigned to each unique category for each T, N, M plus descriptors and AJCC stage for 6th and 7th editions. This field contains the numeric representation for AJCC 6th edition &#8220;N Descriptor&#8221; and is derived from CS coded fields using the CS algorithm. This numeric representation is referred to as the &#8220;storage&#8221; code and its associated label is referred to as the &#8220;display&#8221; code. Explanations of the &#8220;storage&#8221; codes and their corresponding &#8220;display&#8221; codes can be found in the most current version of the <em>Collaborative Stage Data Collection System</em> (<a href="https://cancerstaging.org/cstage/Pages/default.aspx" target="_blank">https://cancerstaging.org/cstage/Pages/default.aspx</a>).<sup>13</sup> The display code should be used for display on the screen and in reports.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>The Collaborative Stage Data Collection System was designed by a joint task force including representatives from SEER, ACoS, CDC, NAACCR, NCRA, CCCR, CPAC, and AJCC, to provide a single uniform set of codes and rules for coding extent of disease (EOD) and stage information to meet the needs of all of the participating standard setters. When CS data items are coded, a computer algorithm provides the derivation of T, N, M, and stage-based on AJCC Cancer Staging Manual 6th &amp; 7th Editions, SEER Summary Stage 1977, and SEER Summary Stage 2000. There are separate derived CS fields in the NAACCR record based on AJCC 6th Edition for 2004+ cases and AJCC 7th Edition for 2010+ cases.</div><div class='content chap10-para'><strong>Codes (See the most current version of the <em>Collaborative Stage Data Collection System</em> (<a href="https://cancerstaging.org/cstage/Pages/default.aspx" target="_blank">https://cancerstaging.org/cstage/Pages/default.aspx</a>),<sup>13</sup> for rules and site-specific codes and coding structures.) </strong></div><a name='3000'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>DERIVED AJCC-6 STAGE GRP</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">3000</td><td style="text-align:center;">2</td><td style="text-align:center;"><a href='#sources'>AJCC</a></td><td style="text-align:center;">2003</td><td style="text-align:center;">10</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1400 - 1401</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>Derived 6 Stage Group Storage Code<br />Derived AJCC Stage Group<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>derivedAjcc6StageGrp</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>This data item belongs to the Collaborative Stage (CS) Data Collection System which is based on the <em>AJCC Cancer Staging Manual</em>, 6th and 7th editions. AJCC T, N, M plus descriptors and AJCC staging components are composed of combinations of characters, numbers, and/or special characters and can be of varying lengths. To more easily handle these components a numeric code was assigned to each unique category for each T, N, M plus descriptors and AJCC stage for 6th and 7th editions. This field contains the numeric representation for the AJCC 6th edition &#8220;Stage Group&#8221; and is derived from CS coded fields using the CS algorithm. This numeric representation is referred to as the &#8220;storage&#8221; code and its associated label is referred to as the &#8220;display&#8221; code. Explanations of the &#8220;storage&#8221; codes and their corresponding &#8220;display&#8221; codes can be found in the most current version of the <em>Collaborative Stage Data Collection System</em> (<a href="https://cancerstaging.org/cstage/Pages/default.aspx" target="_blank">https://cancerstaging.org/cstage/Pages/default.aspx</a>).<sup>13</sup> The display code should be used for display on the screen and in reports.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>The Collaborative Stage Data Collection System was designed by a joint task force including representatives from SEER, ACoS, CDC, NAACCR, NCRA, CCCR, CPAC, and AJCC, to provide a single uniform set of codes and rules for coding extent of disease (EOD) and stage information to meet the needs of all of the participating standard setters. When CS data items are coded, a computer algorithm provides the derivation of T, N, M, and stage-based on AJCC Cancer Staging Manual 6th &amp; 7th Editions, SEER Summary Stage 1977, and SEER Summary Stage 2000. There are separate derived CS fields in the NAACCR record based on AJCC 6th Edition for 2004+ cases and AJCC 7th Edition for 2010+ cases.</div><div class='content chap10-para'><strong>Codes (See the most current version of the <em>Collaborative Stage Data Collection System</em> (<a href="https://cancerstaging.org/cstage/Pages/default.aspx" target="_blank">https://cancerstaging.org/cstage/Pages/default.aspx</a>),<sup>13</sup> for rules and site-specific codes and coding structures.) </strong></div><a name='2940'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>DERIVED AJCC-6 T</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">2940</td><td style="text-align:center;">2</td><td style="text-align:center;"><a href='#sources'>AJCC</a></td><td style="text-align:center;">2003</td><td style="text-align:center;">10</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1391 - 1392</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>Derived T<br />Derived AJCC T<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>derivedAjcc6T</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>This data item belongs to the Collaborative Stage (CS) Data Collection System which is based on the <em>AJCC Cancer Staging Manual</em>, 6th and 7th editions. AJCC T, N, M plus descriptors and AJCC staging components are composed of combinations of characters, numbers, and/or special characters and can be of varying lengths. To more easily handle these components a numeric code was assigned to each unique category for each T, N, M plus descriptors and AJCC stage for 6th and 7th editions. This field contains the numeric representation for the AJCC 6th edition &#8220;T&#8221; and is derived from CS coded fields using the CS algorithm. This numeric representation is referred to as the &#8220;storage&#8221; code and its associated label is referred to as the &#8220;display&#8221; code. Explanations of the &#8220;storage&#8221; codes and their corresponding &#8220;display&#8221; codes can be found in the most current version of the <em>Collaborative Stage Data Collection System</em> (<a href="https://cancerstaging.org/cstage/Pages/default.aspx" target="_blank">https://cancerstaging.org/cstage/Pages/default.aspx</a>).<sup>13</sup> The display code should be used for display on the screen and in reports.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>The Collaborative Stage Data Collection System was designed by a joint task force including representatives from SEER, ACoS, CDC, NAACCR, NCRA, CCCR, CPAC, and AJCC, to provide a single uniform set of codes and rules for coding extent of disease (EOD) and stage information to meet the needs of all of the participating standard setters. When CS data items are coded, a computer algorithm provides the derivation of T, N, M, and stage-based on AJCC Cancer Staging Manual 6th &amp; 7th Editions, SEER Summary Stage 1977, and SEER Summary Stage 2000. There are separate derived CS fields in the NAACCR record based on AJCC 6th Edition for 2004+ cases and AJCC 7th Edition for 2010+ cases.</div><div class='content chap10-para'><strong>Codes (See the most current version of the <em>Collaborative Stage Data Collection System</em> (<a href="https://cancerstaging.org/cstage/Pages/default.aspx" target="_blank">https://cancerstaging.org/cstage/Pages/default.aspx</a>),<sup>13</sup> for rules and site-specific codes and coding structures.) </strong></div><a name='2950'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>DERIVED AJCC-6 T DESCRIPT</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">2950</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>AJCC</a></td><td style="text-align:center;">2003</td><td style="text-align:center;">10</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1393 - 1393</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>Derived AJCC T Descriptor<br />Derived 6 T Descriptor Storage Code<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>derivedAjcc6TDescript</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>This data item belongs to the Collaborative Stage (CS) Data Collection System which is based on the <em>AJCC Cancer Staging Manual</em>, 6th and 7th editions. AJCC T, N, M plus descriptors and AJCC staging components are composed of combinations of characters, numbers, and/or special characters and can be of varying lengths. To more easily handle these components a numeric code was assigned to each unique category for each T, N, M plus descriptors and AJCC stage for 6th and 7th editions. This field contains the numeric representation for the AJCC 6th edition &#8220;T Descriptor&#8221; and is derived from CS coded fields using the CS algorithm. This numeric representation is referred to as the &#8220;storage&#8221; code and its associated label is referred to as the &#8220;display&#8221; code. Explanations of the &#8220;storage&#8221; codes and their corresponding &#8220;display&#8221; codes can be found in the most current version of the <em>Collaborative Stage Data Collection System</em> (<a href="https://cancerstaging.org/cstage/Pages/default.aspx" target="_blank">https://cancerstaging.org/cstage/Pages/default.aspx</a>).<sup>13</sup> The display code should be used for display on the screen and in reports.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>The Collaborative Stage Data Collection System was designed by a joint task force including representatives from SEER, ACoS, CDC, NAACCR, NCRA, CCCR, CPAC, and AJCC, to provide a single uniform set of codes and rules for coding extent of disease (EOD) and stage information to meet the needs of all of the participating standard setters. When CS data items are coded, a computer algorithm provides the derivation of T, N, M, and stage-based on AJCC Cancer Staging Manual 6th &amp; 7th Editions, SEER Summary Stage 1977, and SEER Summary Stage 2000. There are separate derived CS fields in the NAACCR record based on AJCC 6th Edition for 2004+ cases and AJCC 7th Edition for 2010+ cases.</div><div class='content chap10-para'><strong>Codes (See the most current version of the <em>Collaborative Stage Data Collection System</em> (<a href="https://cancerstaging.org/cstage/Pages/default.aspx" target="_blank">https://cancerstaging.org/cstage/Pages/default.aspx</a>),<sup>13</sup> for rules and site-specific codes and coding structures.) </strong></div><a name='3420'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>DERIVED AJCC-7 M</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">3420</td><td style="text-align:center;">3</td><td style="text-align:center;"><a href='#sources'>AJCC</a></td><td style="text-align:center;">2010</td><td style="text-align:center;">12</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1410 - 1412</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>Derived 7 M Storage Code<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>derivedAjcc7M</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>This item is the derived AJCC &#8220;M&#8221; staging element from coded fields using the CS algorithm. Effective for cases diagnosed 2010+.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Derived AJCC-7 M can be used to evaluate disease spread at diagnosis, plan and track treatment patterns, and analyze outcomes.</div><div class='content chap10-para'><strong>Codes (See the most current version of the <em>Collaborative Stage Data Collection System</em> (<a href="https://cancerstaging.org/cstage/Pages/default.aspx" target="_blank">https://cancerstaging.org/cstage/Pages/default.aspx</a>),<sup>13</sup> for rules and site-specific codes and coding structures.) </strong></div><a name='3422'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>DERIVED AJCC-7 M DESCRIPT</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">3422</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>AJCC</a></td><td style="text-align:center;">2010</td><td style="text-align:center;">12</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1413 - 1413</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>Derived 7 M Descript Storage Code<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>derivedAjcc7MDescript</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>This item is the derived AJCC &#8220;M Descriptor&#8221; from coded fields using the CS algorithm. Effective for cases diagnosed 2010+.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Derived AJCC-7 M Descript can be used in analysis to differentiate the timing of staging with respect to the treatment process.</div><div class='content chap10-para'><strong>Codes (See the most current version of the <em>Collaborative Stage Data Collection System</em> (<a href="https://cancerstaging.org/cstage/Pages/default.aspx" target="_blank">https://cancerstaging.org/cstage/Pages/default.aspx</a>),<sup>13</sup> for rules and site-specific codes and coding structures.) </strong></div><a name='3410'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>DERIVED AJCC-7 N</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">3410</td><td style="text-align:center;">3</td><td style="text-align:center;"><a href='#sources'>AJCC</a></td><td style="text-align:center;">2010</td><td style="text-align:center;">12</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1406 - 1408</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>Derived 7 N Storage Code<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>derivedAjcc7N</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>This item is the derived AJCC &#8220;N&#8221; staging element from coded fields using the CS algorithm. Effective for cases diagnosed 2010+.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>The CS Derived AJCC-7 N can be used to evaluate disease spread at diagnosis, plan and track treatment patterns, and analyze outcomes.</div><div class='content chap10-para'><strong>Codes (See the most current version of the <em>Collaborative Stage Data Collection System</em> (<a href="https://cancerstaging.org/cstage/Pages/default.aspx" target="_blank">https://cancerstaging.org/cstage/Pages/default.aspx</a>),<sup>13</sup> for rules and site-specific codes and coding structures.) </strong></div><a name='3412'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>DERIVED AJCC-7 N DESCRIPT</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">3412</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>AJCC</a></td><td style="text-align:center;">2010</td><td style="text-align:center;">12</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1409 - 1409</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>Derived 7 N Descript Storage Code<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>derivedAjcc7NDescript</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>This item is the derived AJCC &#8220;N Descriptor&#8221; from coded fields using the CS algorithm. Effective for cases diagnosed 2010+.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Derived AJCC-7 N Descript can be used in analysis to differentiate the timing of staging with respect to the treatment process.</div><div class='content chap10-para'><strong>Codes (See the most current version of the <em>Collaborative Stage Data Collection System</em> (<a href="https://cancerstaging.org/cstage/Pages/default.aspx" target="_blank">https://cancerstaging.org/cstage/Pages/default.aspx</a>),<sup>13</sup> for rules and site-specific codes and coding structures.) </strong></div><a name='3430'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>DERIVED AJCC-7 STAGE GRP</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">3430</td><td style="text-align:center;">3</td><td style="text-align:center;"><a href='#sources'>AJCC</a></td><td style="text-align:center;">2010</td><td style="text-align:center;">12</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1414 - 1416</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>Derived 7 Stage Grp Storage Code<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>derivedAjcc7StageGrp</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>This item is the derived AJCC &#8220;Stage Group&#8221; from coded fields using the CS algorithm. Effective for cases diagnosed 2010+.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>The CS Derived AJCC-7 Stage Group can be used to evaluate disease spread at diagnosis, plan and track treatment patterns, and analyze outcomes.</div><div class='content chap10-para'><strong>Codes (See the most current version of the <em>Collaborative Stage Data Collection System</em> (<a href="https://cancerstaging.org/cstage/Pages/default.aspx" target="_blank">https://cancerstaging.org/cstage/Pages/default.aspx</a>),<sup>13</sup> for rules and site-specific codes and coding structures.) </strong></div><a name='3400'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>DERIVED AJCC-7 T</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">3400</td><td style="text-align:center;">3</td><td style="text-align:center;"><a href='#sources'>AJCC</a></td><td style="text-align:center;">2010</td><td style="text-align:center;">12</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1402 - 1404</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>Derived 7 T Storage Code<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>derivedAjcc7T</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>This item is the derived AJCC &#8220;T&#8221; staging element from coded fields using the CS algorithm. Effective for cases diagnosed 2010+.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Derived AJCC-7 T can be used to evaluate disease spread at diagnosis, plan and track treatment patterns, and analyze outcomes.</div><div class='content chap10-para'><strong>Codes (See the most current version of the <em>Collaborative Stage Data Collection System</em> (<a href="https://cancerstaging.org/cstage/Pages/default.aspx" target="_blank">https://cancerstaging.org/cstage/Pages/default.aspx</a>),<sup>13</sup> for rules and site-specific codes and coding structures.) </strong></div><a name='3402'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>DERIVED AJCC-7 T DESCRIPT</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">3402</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>AJCC</a></td><td style="text-align:center;">2010</td><td style="text-align:center;">12</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1405 - 1405</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>Derived 7 T Descript Storage Code<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>derivedAjcc7TDescript</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>This item is the derived AJCC &#8220;T Descriptor&#8221; from coded fields using the CS algorithm. Effective for cases diagnosed 2010+.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Derived AJCC-7 T Descript can be used in analysis to differentiate the timing of staging with respect to the treatment process.</div><div class='content chap10-para'><strong>Codes (See the most current version of the <em>Collaborative Stage Data Collection System</em> (<a href="https://cancerstaging.org/cstage/Pages/default.aspx" target="_blank">https://cancerstaging.org/cstage/Pages/default.aspx</a>),<sup>13</sup> for rules and site-specific codes and coding structures.) </strong></div><a name='3030'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>DERIVED AJCC--FLAG</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">3030</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>AJCC</a></td><td style="text-align:center;">2003</td><td style="text-align:center;">10</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1446 - 1446</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>AJCC Conversion Flag<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>derivedAjccFlag</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Flag to indicate whether the derived AJCC stage was derived from CS or EOD codes.</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>blank</td><td class='code-desc'>Not derived</td></tr><tr class='code-row'><td class='code-nbr'>1</td><td class='code-desc'>AJCC fields derived from Collaborative Stage</td></tr><tr class='code-row'><td class='code-nbr'>2</td><td class='code-desc'>AJCC fields derived from EOD (prior to 2004)</td></tr></table></div><a name='795'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>DERIVED EOD 2018 M</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">795</td><td style="text-align:center;">15</td><td style="text-align:center;"><a href='#sources'>SEER</a></td><td style="text-align:center;">2018</td><td style="text-align:center;">18</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">956 - 970</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>derivedEod2018M</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>This item stores the derived EOD 2018 M staging element from coded fields using the EOD algorithm. Effective for cases diagnosed 1/1/2018+.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'><div> Derived EOD 2018 M can be used to evaluate disease spread at diagnosis, treatment patterns and outcomes over time.</div><div>&nbsp;</div>Derived EOD 2018 M is only available at the central registry level.</div><div class='content chap10-para'><strong>Codes: See the most current version of EOD (<a href="https://staging.seer.cancer.gov/">https://staging.seer.cancer.gov/</a>) for rules and site-specific codes and coding structures.</strong></div><a name='815'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>DERIVED EOD 2018 N</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">815</td><td style="text-align:center;">15</td><td style="text-align:center;"><a href='#sources'>SEER</a></td><td style="text-align:center;">2018</td><td style="text-align:center;">18</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">941 - 955</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>derivedEod2018N</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>This item stores the derived EOD 2018 N staging element from coded fields using the EOD algorithm. Effective for cases diagnosed 1/1/2018+.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'><div> Derived EOD 2018 N can be used to evaluate disease spread at diagnosis, treatment patterns and outcomes over time.</div><div>&nbsp;</div>Derived EOD 2018 N is only available at the central registry level.</div><div class='content chap10-para'><strong>Codes: See the most current version of EOD (<a href="https://staging.seer.cancer.gov/">https://staging.seer.cancer.gov/</a>) for rules and site-specific codes and coding structures.</strong></div><a name='818'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>DERIVED EOD 2018 STAGE GROUP</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">818</td><td style="text-align:center;">15</td><td style="text-align:center;"><a href='#sources'>SEER</a></td><td style="text-align:center;">2018</td><td style="text-align:center;">18</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">971 - 985</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>derivedEod2018StageGroup</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Derived EOD 2018 Stage Group is derived using the EOD data collection system (EOD Primary Tumor [772], EOD Regional Nodes [774] and EOD Mets [776]) algorithm. Other data items may be included in the derivation process. Effective for cases diagnosed 1/1/2018+.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'><div> Derived EOD 2018 Stage Group can be used to evaluate disease spread at diagnosis, treatment patterns and outcomes over time.</div><div>&nbsp;</div>Derived EOD 2018 Stage group is only available at the central registry level.</div><div class='content chap10-para'><strong>Codes: See the most current version of EOD (<a href="https://staging.seer.cancer.gov/">https://staging.seer.cancer.gov/</a>) for rules and site-specific codes and coding structures.</strong></div><a name='785'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>DERIVED EOD 2018 T</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">785</td><td style="text-align:center;">15</td><td style="text-align:center;"><a href='#sources'>SEER</a></td><td style="text-align:center;">2018</td><td style="text-align:center;">18</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">926 - 940</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>derivedEod2018T</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>This item stores the derived EOD 2018 T value derived from coded fields using the EOD algorithm. Effective for cases diagnosed 1/1/2018+.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'><div> Derived EOD 2018 T can be used to evaluate disease spread at diagnosis, treatment patterns and outcomes over time.</div><div>&nbsp;</div>Derived EOD 2018 T is only available at the central registry level.</div><div class='content chap10-para'><strong>Codes: See the most current version of EOD (<a href="https://staging.seer.cancer.gov/">https://staging.seer.cancer.gov/</a>) for rules and site-specific codes and coding structures. </strong></div><a name='3600'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>DERIVED NEOADJUV RX FLAG</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">3600</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>AJCC</a></td><td style="text-align:center;">2010</td><td style="text-align:center;">12</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1445 - 1445</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>derivedNeoadjuvRxFlag</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>This data item belongs to the Collaborative Stage (CS) Data Collection System which is based on the 



<em>AJCC Cancer Staging Manual</em>, 6th and 7th editions. This field indicates whether the patient received neoadjuvant therapy (systemic therapy or radiation therapy prior to first course surgical treatment) as part of first course of treatment. </div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>The Collaborative Stage Data Collection System was designed by a joint task force including representatives from SEER, ACoS, CDC, NAACCR, NCRA, CCCR, CPAC, and AJCC, to provide a single uniform set of codes and rules for coding extent of disease (EOD) and stage information to meet the needs of all of the participating standard setters. When CS data items are coded, a computer algorithm provides the derivation of T, N, M, and stage-based on AJCC Cancer Staging Manual 6th &amp; 7th Editions, SEER Summary Stage 1977, and SEER Summary Stage 2000. There are separate derived CS fields in the NAACCR record based on AJCC 6th Edition for 2004+ cases and AJCC 7th Edition for 2010+ cases. </div><div class='content chap10-para'><strong>Codes (See the most current version of the <em>Collaborative Stage Data Collection System</em> (<a href="https://cancerstaging.org/cstage/Pages/default.aspx" target="_blank">https://cancerstaging.org/cstage/Pages/default.aspx</a>),<sup>13</sup> for rules and site-specific codes and coding structures.) </strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>0</td><td class='code-desc'>Neoadjuvant therapy was not administered as part of the first course of therapy</td></tr><tr class='code-row'><td class='code-nbr'>1</td><td class='code-desc'>Neoadjuvant therapy was administered as part of the first course of therapy</td></tr><tr class='code-row'><td class='code-nbr'>9</td><td class='code-desc'>Unknown</td></tr></table></div><div class='content chap10-para'>This data item will record whether neoadjuvant therapy was administered.  This will be a derived field based on RX SUMM--SYTEMIC/SUR SEQ [1639]  &amp; RX SUMM--SURG/RAD SEQ [1380].<br /><p>Comments:</p><blockquote><p>1.  This data field is used to record that neoadjuvant therapy was administered as part of the first course of treatment.<br />2.  This item is derived based on whether systemic therapy and/or  radiation therapy was administered prior to surgical treatment.<br />3.  If the initial surgical therapy is not performed following the  systemic therapy or radiation therapy, then this will be derived as 0,  i.e., it is not considered neoadjuvant therapy.</p></blockquote></div><a name='3490'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>DERIVED POSTRX-7 M</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">3490</td><td style="text-align:center;">2</td><td style="text-align:center;"><a href='#sources'>AJCC</a></td><td style="text-align:center;">2010</td><td style="text-align:center;">12</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1438 - 1439</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>Derived PostRX 7 M Storage Code<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>derivedPostrx7M</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>This data item belongs to the Collaborative Stage (CS) Data Collection System which is based on the <em>AJCC Cancer Staging Manual</em>, 6th and 7th editions. AJCC T, N, M plus descriptors and AJCC staging components are composed of combinations of characters, numbers, and/or special characters and can be of varying lengths. To more easily handle these components a numeric code was assigned to each unique category for each T, N, M plus descriptors and AJCC stage for 6th and 7th editions. This field contains the numeric representation for the post-treatment AJCC 7th edition &#8220;M&#8221; and is derived from CS coded fields using the CS algorithm. This numeric representation is referred to as the &#8220;storage&#8221; code and its associated label is referred to as the &#8220;display&#8221; code. Explanations of the &#8220;storage&#8221; codes and their corresponding &#8220;display&#8221; codes can be found in the most current version of the <em>Collaborative Stage Data Collection System</em> <a target="_blank" href="http://cancerstaging.org/cstage/manuals.html">(</a><a href="https://cancerstaging.org/cstage/Pages/default.aspx" target="_blank"></a><a target="_blank" href="http://cancerstaging.org/cstage/manuals.html">https://cancerstaging.org/cstage/Pages/default.aspx</a>).<sup>13</sup><br /><br />The display code should be used for display on the screen and in reports.The implementation of this data item has been deferred indefinitely. </div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>The Collaborative Stage Data Collection System was designed by a joint task force including representatives from SEER, ACoS, CDC, NAACCR, NCRA, CCCR, CPAC, and AJCC, to provide a single uniform set of codes and rules for coding extent of disease (EOD) and stage information to meet the needs of all of the participating standard setters. When CS data items are coded, a computer algorithm provides the derivation of T, N, M, and stage-based on AJCC Cancer Staging Manual 6th &amp; 7th Editions, SEER Summary Stage 1977, and SEER Summary Stage 2000. There are separate derived CS fields in the NAACCR record based on AJCC 6th Edition for 2004+ cases and AJCC 7th Edition for 2010+ cases. </div><div class='content chap10-para'><strong>Codes (See the most current version of the <em>Collaborative Stage Data Collection System</em> (<a href="https://cancerstaging.org/cstage/Pages/default.aspx" target="_blank">https://cancerstaging.org/cstage/Pages/default.aspx</a>),<sup>13</sup> for rules and site-specific codes and coding structures.) </strong></div><a name='3482'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>DERIVED POSTRX-7 N</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">3482</td><td style="text-align:center;">3</td><td style="text-align:center;"><a href='#sources'>AJCC</a></td><td style="text-align:center;">2010</td><td style="text-align:center;">12</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1435 - 1437</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>Derived PostRX 7 N Storage Code<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>derivedPostrx7N</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>This data item belongs to the Collaborative Stage (CS) Data Collection System which is based on the <em>AJCC Cancer Staging Manual</em>, 6th and 7th editions. AJCC T, N, M plus descriptors and AJCC staging components are composed of combinations of characters, numbers, and/or special characters and can be of varying lengths. To more easily handle these components a numeric code was assigned to each unique category for each T, N, M plus descriptors and AJCC stage for 6th and 7th editions. This field contains the numeric representation for the post-treatment AJCC 7th edition &#8220;N&#8221; and is derived from CS coded fields using the CS algorithm. This numeric representation is referred to as the &#8220;storage&#8221; code and its associated label is referred to as the &#8220;display&#8221; code. Explanations of the &#8220;storage&#8221; codes and their corresponding &#8220;display&#8221; codes can be found in the most current version of the <em>Collaborative Stage Data Collection System</em> (<a href="https://cancerstaging.org/cstage/Pages/default.aspx" target="_blank">https://cancerstaging.org/cstage/Pages/default.aspx</a>).<sup>13</sup><br /><br />The display code should be used for display on the screen and in reports.The implementation of this data item has been deferred indefinitely. </div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>The Collaborative Stage Data Collection System was designed by a joint task force including representatives from SEER, ACoS, CDC, NAACCR, NCRA, CCCR, CPAC, and AJCC, to provide a single uniform set of codes and rules for coding extent of disease (EOD) and stage information to meet the needs of all of the participating standard setters. When CS data items are coded, a computer algorithm provides the derivation of T, N, M, and stage-based on AJCC Cancer Staging Manual 6th &amp; 7th Editions, SEER Summary Stage 1977, and SEER Summary Stage 2000. There are separate derived CS fields in the NAACCR record based on AJCC 6th Edition for 2004+ cases and AJCC 7th Edition for 2010+ cases. </div><div class='content chap10-para'><strong>Codes (See the most current version of the <em>Collaborative Stage Data Collection System</em> (<a href="https://cancerstaging.org/cstage/Pages/default.aspx" target="_blank">https://cancerstaging.org/cstage/Pages/default.aspx</a>),<sup>13</sup> for rules and site-specific codes and coding structures.) </strong></div><a name='3492'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>DERIVED POSTRX-7 STGE GRP</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">3492</td><td style="text-align:center;">3</td><td style="text-align:center;"><a href='#sources'>AJCC</a></td><td style="text-align:center;">2010</td><td style="text-align:center;">12</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1440 - 1442</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>Derived PostRX 7 Stge Grp Storage Code<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>derivedPostrx7StgeGrp</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>This data item belongs to the Collaborative Stage (CS) Data Collection System which is based on the AJCC Cancer Staging Manual, 6th and 7th editions. AJCC T, N, M plus descriptors and AJCC staging components are composed of combinations of characters, numbers, and/or special characters and can be of varying lengths. To more easily handle these components a numeric code was assigned to each unique category for each T, N, M plus descriptors and AJCC stage for 6th and 7th editions. This field contains the numeric representation for the post-treatment AJCC 7th edition &#8220;Stage Group&#8221;and is derived from CS coded fields using the CS algorithm. This numeric representation is referred to as the &#8220;storage&#8221; code and its associated label is referred to as the &#8220;display&#8221; code. Explanations of the &#8220;storage&#8221; codes and their corresponding &#8220;display&#8221; codes can be found in the most current version of the Collaborative Stage Data Collection System (<a href="https://cancerstaging.org/cstage/Pages/default.aspx" target="_blank">https://cancerstaging.org/cstage/Pages/default.aspx</a>).<sup>13</sup><br /><br />The display code should be used for display on the screen and in reports. The implementation of this data item has been deferred indefinitely. </div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>The Collaborative Stage Data Collection System was designed by a joint task force including representatives from SEER, ACoS, CDC, NAACCR, NCRA, CCCR, CPAC, and AJCC, to provide a single uniform set of codes and rules for coding extent of disease (EOD) and stage information to meet the needs of all of the participating standard setters. When CS data items are coded, a computer algorithm provides the derivation of T, N, M, and stage-based on AJCC Cancer Staging Manual 6th &amp; 7th Editions, SEER Summary Stage 1977, and SEER Summary Stage 2000. There are separate derived CS fields in the NAACCR record based on AJCC 6th Edition for 2004+ cases and AJCC 7th Edition for 2010+ cases. </div><div class='content chap10-para'><strong>Codes (See the most current version of the <em>Collaborative Stage Data Collection System</em> (<a href="https://cancerstaging.org/cstage/Pages/default.aspx" target="_blank">https://cancerstaging.org/cstage/Pages/default.aspx</a>),<sup>13</sup> for rules and site-specific codes and coding structures.) </strong></div><a name='3480'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>DERIVED POSTRX-7 T</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">3480</td><td style="text-align:center;">3</td><td style="text-align:center;"><a href='#sources'>AJCC</a></td><td style="text-align:center;">2010</td><td style="text-align:center;">12</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1432 - 1434</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>Derived PostRX 7 T Storage Code<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>derivedPostrx7T</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>This data item belongs to the Collaborative Stage (CS) Data Collection System which is based on the <em>AJCC Cancer Staging Manual</em>, 6th and 7th editions. AJCC T, N, M plus descriptors and AJCC staging components are composed of combinations of characters, numbers, and/or special characters and can be of varying lengths. To more easily handle these components a numeric code was assigned to each unique category for each T, N, M plus the post-treatment AJCC 7th edition &#8220;T&#8221; and is derived from CS coded fields using the CS algorithm. This numeric representation is referred to as the &#8220;storage&#8221; code and its associated label is referred to as the &#8220;display&#8221; code. Explanations of the &#8220;storage&#8221; codes and their corresponding &#8220;display&#8221; codes can be found in the most current version of the <em>Collaborative Stage Data Collection System</em> (<a href="https://cancerstaging.org/cstage/Pages/default.aspx" target="_blank">https://cancerstaging.org/cstage/Pages/default.aspx</a>).<sup>13</sup><br /><br />The display code should be used for display on the screen and in reports.The implementation of this data item has been deferred indefinitely. </div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>The Collaborative Stage Data Collection System was designed by a joint task force including representatives from SEER, ACoS, CDC, NAACCR, NCRA, CCCR, CPAC, and AJCC, to provide a single uniform set of codes and rules for coding extent of disease (EOD) and stage information to meet the needs of all of the participating standard setters. When CS data items are coded, a computer algorithm provides the derivation of T, N, M, and stage-based on AJCC Cancer Staging Manual 6th &amp; 7th Editions, SEER Summary Stage 1977, and SEER Summary Stage 2000. There are separate derived CS fields in the NAACCR record based on AJCC 6th Edition for 2004+ cases and AJCC 7th Edition for 2010+ cases. </div><div class='content chap10-para'><strong>Codes (See the most current version of the <em>Collaborative Stage Data Collection System</em> (<a href="https://cancerstaging.org/cstage/Pages/default.aspx" target="_blank">https://cancerstaging.org/cstage/Pages/default.aspx</a>),<sup>13</sup> for rules and site-specific codes and coding structures.) </strong></div><a name='3460'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>DERIVED PRERX-7 M</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">3460</td><td style="text-align:center;">3</td><td style="text-align:center;"><a href='#sources'>AJCC</a></td><td style="text-align:center;">2010</td><td style="text-align:center;">12</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1425 - 1427</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>Derived PreRX 7 M Storage Code<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>derivedPrerx7M</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>This data item belongs to the Collaborative Stage (CS) Data Collection System which is based on the <em>AJCC Cancer Staging Manual</em>, 6th and 7th editions. AJCC T, N, M plus descriptors and AJCC staging components are composed of combinations of characters, numbers, and/or special characters and can be of varying lengths. To more easily handle these components a numeric code was assigned to each unique category for each T, N, M plus descriptors and AJCC stage for 6th and 7th editions. This field contains the numeric representation for the pre-treatment AJCC 7th edition &#8220;M&#8221; and is derived from CS coded fields using the CS algorithm. This numeric representation is referred to as the &#8220;storage&#8221; code and its associated label is referred to as the &#8220;display&#8221; code. Explanations of the &#8220;storage&#8221; codes and their corresponding &#8220;display&#8221; codes can be found in the most current version of the <em>Collaborative Stage Data Collection System</em> (<a href="https://cancerstaging.org/cstage/Pages/default.aspx" target="_blank">https://cancerstaging.org/cstage/Pages/default.aspx</a>).<sup>13</sup><br /><br />The display code should be used for display on the screen and in reports. The implementation of this data item has been deferred indefinitely. </div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>The Collaborative Stage Data Collection System was designed by a joint task force including representatives from SEER, ACoS, CDC, NAACCR, NCRA, CCCR, CPAC, and AJCC, to provide a single uniform set of codes and rules for coding extent of disease (EOD) and stage information to meet the needs of all of the participating standard setters. When CS data items are coded, a computer algorithm provides the derivation of T, N, M, and stage-based on AJCC Cancer Staging Manual 6th &amp; 7th Editions, SEER Summary Stage 1977, and SEER Summary Stage 2000. There are separate derived CS fields in the NAACCR record based on AJCC 6th Edition for 2004+ cases and AJCC 7th Edition for 2010+ cases. </div><div class='content chap10-para'><strong>Codes (See the most current version of the <em>Collaborative Stage Data Collection System</em> (<a href="https://cancerstaging.org/cstage/Pages/default.aspx" target="_blank">https://cancerstaging.org/cstage/Pages/default.aspx</a>),<sup>13</sup> for rules and site-specific codes and coding structures.) </strong></div><a name='3462'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>DERIVED PRERX-7 M DESCRIP</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">3462</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>AJCC</a></td><td style="text-align:center;">2010</td><td style="text-align:center;">12</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1428 - 1428</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>Derived  PreRX 7 M Descrip Storage Code<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>derivedPrerx7MDescrip</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>This data item belongs to the Collaborative Stage (CS) Data Collection System which is based on the <em>AJCC Cancer Staging Manual</em>, 6th and 7th editions. AJCC T, N, M plus descriptors and AJCC staging components are composed of combinations of characters, numbers, and/or special characters and can be of varying lengths. To more easily handle these components a numeric code was assigned to each unique category for each T, N, M plus descriptors and AJCC stage for 6th and 7th editions. This field contains the numeric representation for pre-treatment AJCC 7th edition &#8220;M Descriptor&#8221; and is derived from CS coded fields using the CS algorithm. This numeric representation is referred to as the &#8220;storage&#8221; code and its associated label is referred to as the &#8220;display&#8221; code. Explanations of the &#8220;storage&#8221; codes and their corresponding &#8220;display&#8221; codes can be found in the most current version of the <em>Collaborative Stage Data Collection System</em> (<a href="https://cancerstaging.org/cstage/Pages/default.aspx" target="_blank">https://cancerstaging.org/cstage/Pages/default.aspx</a>).<sup>13</sup><br /><br />The display code should be used for display on the screen and in reports. The implementation of this data item has been deferred indefinitely. </div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>The Collaborative Stage Data Collection System was designed by a joint task force including representatives from SEER, ACoS, CDC, NAACCR, NCRA, CCCR, CPAC, and AJCC, to provide a single uniform set of codes and rules for coding extent of disease (EOD) and stage information to meet the needs of all of the participating standard setters. When CS data items are coded, a computer algorithm provides the derivation of T, N, M, and stage-based on AJCC Cancer Staging Manual 6th &amp; 7th Editions, SEER Summary Stage 1977, and SEER Summary Stage 2000. There are separate derived CS fields in the NAACCR record based on AJCC 6th Edition for 2004+ cases and AJCC 7th Edition for 2010+ cases. </div><div class='content chap10-para'><strong>Codes (See the most current version of the <em>Collaborative Stage Data Collection System</em> (<a href="https://cancerstaging.org/cstage/Pages/default.aspx" target="_blank">https://cancerstaging.org/cstage/Pages/default.aspx</a>),<sup>13</sup> for rules and site-specific codes and coding structures.) </strong></div><a name='3450'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>DERIVED PRERX-7 N</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">3450</td><td style="text-align:center;">3</td><td style="text-align:center;"><a href='#sources'>AJCC</a></td><td style="text-align:center;">2010</td><td style="text-align:center;">12</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1421 - 1423</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>Derived PreRX 7 N Storage Code<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>derivedPrerx7N</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>This data item belongs to the Collaborative Stage (CS) Data Collection System which is based on the <em>AJCC Cancer Staging Manual</em>, 6th and 7th editions. AJCC T, N, M plus descriptors and AJCC staging components are composed of combinations of characters, numbers, and/or special characters and can be of varying lengths. To more easily handle these components a numeric code was assigned to each unique category for each T, N, M plus descriptors and AJCC stage for 6th and 7th editions. This field contains the numeric representation for the pre-treatment AJCC 7th edition &#8220;N&#8221; and is derived from CS coded fields using the CS algorithm. This numeric representation is referred to as the &#8220;storage&#8221; code and its associated label is referred to as the &#8220;display&#8221; code. Explanations of the &#8220;storage&#8221; codes and their corresponding &#8220;display&#8221; codes can be found in the most current version of the <em>Collaborative Stage Data Collection System</em> (<a href="https://cancerstaging.org/cstage/Pages/default.aspx" target="_blank">https://cancerstaging.org/cstage/Pages/default.aspx</a>).<sup>13</sup><br /><br />The display code should be used for display on the screen and in reports. The implementation of this data item has been deferred indefinitely. </div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>The Collaborative Stage Data Collection System was designed by a joint task force including representatives from SEER, ACoS, CDC, NAACCR, NCRA, CCCR, CPAC, and AJCC, to provide a single uniform set of codes and rules for coding extent of disease (EOD) and stage information to meet the needs of all of the participating standard setters. When CS data items are coded, a computer algorithm provides the derivation of T, N, M, and stage-based on AJCC Cancer Staging Manual 6th &amp; 7th Editions, SEER Summary Stage 1977, and SEER Summary Stage 2000. There are separate derived CS fields in the NAACCR record based on AJCC 6th Edition for 2004+ cases and AJCC 7th Edition for 2010+ cases. </div><div class='content chap10-para'><strong>Codes (See the most current version of the <em>Collaborative Stage Data Collection System</em> (<a href="https://cancerstaging.org/cstage/Pages/default.aspx" target="_blank">https://cancerstaging.org/cstage/Pages/default.aspx</a>),<sup>13</sup> for rules and site-specific codes and coding structures.) </strong></div><a name='3452'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>DERIVED PRERX-7 N DESCRIP</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">3452</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>AJCC</a></td><td style="text-align:center;">2010</td><td style="text-align:center;">12</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1424 - 1424</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>Derived PreRX 7 N Descrip Storage Code<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>derivedPrerx7NDescrip</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>This data item belongs to the Collaborative Stage (CS) Data Collection System which is based on the <em>AJCC Cancer Staging Manual</em>, 6th and 7th editions. AJCC T, N, M plus descriptors and AJCC staging components are composed of combinations of characters, numbers, and/or special characters and can be of varying lengths. To more easily handle these components a numeric code was assigned to each unique category for each T, N, M plus descriptors and AJCC stage for 6th and 7th editions. This field contains the numeric representation for the pre-treatment AJCC 7th edition &#8220;N Descriptor&#8221; and is derived from CS coded fields using the CS algorithm. This numeric representation is referred to as the &#8220;storage&#8221; code and its associated label is referred to as the &#8220;display&#8221; code. Explanations of the &#8220;storage&#8221; codes and their corresponding &#8220;display&#8221; codes can be found in the most current version of the <em>Collaborative Stage Data Collection System</em> (<a href="https://cancerstaging.org/cstage/Pages/default.aspx">https://cancerstaging.org/cstage/Pages/default.aspx</a>).<sup>13</sup><br /><br />The display code should be used for display on the screen and in reports. The implementation of this data item has been deferred indefinitely. </div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>The Collaborative Stage Data Collection System was designed by a joint task force including representatives from SEER, ACoS, CDC, NAACCR, NCRA, CCCR, CPAC, and AJCC, to provide a single uniform set of codes and rules for coding extent of disease (EOD) and stage information to meet the needs of all of the participating standard setters. When CS data items are coded, a computer algorithm provides the derivation of T, N, M, and stage-based on AJCC Cancer Staging Manual 6th &amp; 7th Editions, SEER Summary Stage 1977, and SEER Summary Stage 2000. There are separate derived CS fields in the NAACCR record based on AJCC 6th Edition for 2004+ cases and AJCC 7th Edition for 2010+ cases. </div><div class='content chap10-para'><strong>Codes (See the most current version of the <em>Collaborative Stage Data Collection System</em> (<a href="https://cancerstaging.org/cstage/Pages/default.aspx" target="_blank">https://cancerstaging.org/cstage/Pages/default.aspx</a>),<sup>13</sup> for rules and site-specific codes and coding structures.) </strong></div><a name='3470'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>DERIVED PRERX-7 STAGE GRP</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">3470</td><td style="text-align:center;">3</td><td style="text-align:center;"><a href='#sources'>AJCC</a></td><td style="text-align:center;">2010</td><td style="text-align:center;">12</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1429 - 1431</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>Derived PreRX 7 Stge Grp Storage Code<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>derivedPrerx7StageGrp</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>This data item belongs to the Collaborative Stage (CS) Data Collection System which is based on the <em>AJCC Cancer Staging Manual</em>, 6th and 7th editions. AJCC T, N, M plus descriptors and AJCC staging components are composed of combinations of characters, numbers, and/or special characters and can be of varying lengths. To more easily handle these components a numeric code was assigned to each unique category for each T, N, M plus descriptors and AJCC stage for 6th and 7th editions. This field contains the numeric representation for the pre-treatment AJCC 7th edition &#8220;Stage Group&#8221; and is derived from CS coded fields using the CS algorithm. This numeric representation is referred to as the &#8220;storage&#8221; code and its associated label is referred to as the &#8220;display&#8221; code. Explanations of the &#8220;storage&#8221; codes and their corresponding &#8220;display&#8221; codes can be found in the most current version of the <em>Collaborative Stage Data Collection System</em> (<a href="https://cancerstaging.org/cstage/Pages/default.aspx" target="_blank">https://cancerstaging.org/cstage/Pages/default.aspx</a>).<sup>13</sup><br /><br />The display code should be used for display on the screen and in reports. The implementation of this data item has been deferred indefinitely. </div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>The Collaborative Stage Data Collection System was designed by a joint task force including representatives from SEER, ACoS, CDC, NAACCR, NCRA, CCCR, CPAC, and AJCC, to provide a single uniform set of codes and rules for coding extent of disease (EOD) and stage information to meet the needs of all of the participating standard setters. When CS data items are coded, a computer algorithm provides the derivation of T, N, M, and stage-based on AJCC Cancer Staging Manual 6th &amp; 7th Editions, SEER Summary Stage 1977, and SEER Summary Stage 2000. There are separate derived CS fields in the NAACCR record based on AJCC 6th Edition for 2004+ cases and AJCC 7th Edition for 2010+ cases. </div><div class='content chap10-para'><strong>Codes (See the most current version of the <em>Collaborative Stage Data Collection System</em> (<a href="https://cancerstaging.org/cstage/Pages/default.aspx" target="_blank">https://cancerstaging.org/cstage/Pages/default.aspx</a>),<sup>13</sup> for rules and site-specific codes and coding structures.) </strong></div><a name='3440'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>DERIVED PRERX-7 T</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">3440</td><td style="text-align:center;">3</td><td style="text-align:center;"><a href='#sources'>AJCC</a></td><td style="text-align:center;">2010</td><td style="text-align:center;">12</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1417 - 1419</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>Derived PreRX 7 T Storage Code<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>derivedPrerx7T</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>This data item belongs to the Collaborative Stage (CS) Data Collection System which is based on the <em>AJCC Cancer Staging Manual</em>, 6th and 7th editions. AJCC T, N, M plus descriptors and AJCC staging components are composed of combinations of characters, numbers, and/or special characters and can be of varying lengths. To more easily handle these components a numeric code was assigned to each unique category for each T, N, M plus descriptors and AJCC stage for 6th and 7th editions. This field contains the numeric representation for the pre-treatment AJCC 7th edition &#8220;T&#8221; and is derived from CS coded fields using the CS algorithm. This numeric representation is referred to as the &#8220;storage&#8221; code and its associated label is referred to as the &#8220;display&#8221; code. Explanations of the &#8220;storage&#8221; codes and their corresponding &#8220;display&#8221; codes can be found in the the most current version of the <em>Collaborative Stage Data Collection System</em> (<a href="https://cancerstaging.org/cstage/Pages/default.aspx" target="_blank"></a><a href="https://cancerstaging.org/cstage/Pages/default.aspx">https://cancerstaging.org/cstage/Pages/default.aspx</a>).<sup>13</sup><br /><br />The display code should be used for display on the screen and in reports. The implementation of this data item has been deferred indefinitely. </div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>The Collaborative Stage Data Collection System was designed by a joint task force including representatives from SEER, ACoS, CDC, NAACCR, NCRA, CCCR, CPAC, and AJCC, to provide a single uniform set of codes and rules for coding extent of disease (EOD) and stage information to meet the needs of all of the participating standard setters. When CS data items are coded, a computer algorithm provides the derivation of T, N, M, and stage-based on AJCC Cancer Staging Manual 6th &amp; 7th Editions, SEER Summary Stage 1977, and SEER Summary Stage 2000. There are separate derived CS fields in the NAACCR record based on AJCC 6th Edition for 2004+ cases and AJCC 7th Edition for 2010+ cases. </div><div class='content chap10-para'><strong>Codes (See the most current version of the <em>Collaborative Stage Data Collection System</em> (<a href="https://cancerstaging.org/cstage/Pages/default.aspx" target="_blank">https://cancerstaging.org/cstage/Pages/default.aspx</a>),<sup>13</sup> for rules and site-specific codes and coding structures.) </strong></div><a name='3442'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>DERIVED PRERX-7 T DESCRIP</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">3442</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>AJCC</a></td><td style="text-align:center;">2010</td><td style="text-align:center;">12</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1420 - 1420</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>Derived PreRX 7 T Descrip Storage Code<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>derivedPrerx7TDescrip</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>This data item belongs to the Collaborative Stage (CS) Data Collection System which is based on the <em>AJCC Cancer Staging Manual</em>, 6th and 7th editions. AJCC T, N, M plus descriptors and AJCC staging components are composed of combinations of characters, numbers, and/or special characters and can be of varying lengths. To more easily handle these components a numeric code was assigned to each unique category for each T, N, M plus descriptors and AJCC stage for 6th and 7th editions. This field contains the numeric representation for the pre-treatment AJCC 7th edition &#8220;T Descriptor&#8221; and is derived from CS coded fields using the CS algorithm. This numeric representation is referred to as the &#8220;storage&#8221; code and its associated label is referred to as the &#8220;display&#8221; code. Explanations of the &#8220;storage&#8221; codes and their corresponding &#8220;display&#8221; codes can be found in the most current version of the <em>Collaborative Stage Data Collection System</em> (<a href="https://cancerstaging.org/cstage/Pages/default.aspx" target="_blank">https://cancerstaging.org/cstage/Pages/default.aspx</a>).<sup>13</sup><br /><br />The display code should be used for display on the screen and in reports. The implementation of this data item has been deferred indefinitely. </div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>The Collaborative Stage Data Collection System was designed by a joint task force including representatives from SEER, ACoS, CDC, NAACCR, NCRA, CCCR, CPAC, and AJCC, to provide a single uniform set of codes and rules for coding extent of disease (EOD) and stage information to meet the needs of all of the participating standard setters. When CS data items are coded, a computer algorithm provides the derivation of T, N, M, and stage-based on AJCC Cancer Staging Manual 6th &amp; 7th Editions, SEER Summary Stage 1977, and SEER Summary Stage 2000. There are separate derived CS fields in the NAACCR record based on AJCC 6th Edition for 2004+ cases and AJCC 7th Edition for 2010+ cases. </div><div class='content chap10-para'><strong>Codes (See the most current version of the <em>Collaborative Stage Data Collection System</em> (<a href="https://cancerstaging.org/cstage/Pages/default.aspx" target="_blank">https://cancerstaging.org/cstage/Pages/default.aspx</a>),<sup>13</sup> for rules and site-specific codes and coding structures.) </strong></div><a name='3610'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>DERIVED SEER CLIN STG GRP</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">3610</td><td style="text-align:center;">5</td><td style="text-align:center;"><a href='#sources'>SEER</a></td><td style="text-align:center;">2016</td><td style="text-align:center;">16</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">890 - 894</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>derivedSeerClinStgGrp</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>This data item is needed to store the results of the derived algorithmic calculation of Derived SEER Clinical Stage Group.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>The SEER Program is developing an algorithm to calculate clinical and pathologic stage group based on their T, N, and M components and additional information as needed to calculate stage. For example, for thyroid, additional information is needed on histology and age to calculate stage. Once the T, N, and M are known an algorithm can assign the stage group instead of a registrar having to look up the stage. There are also provisions for a separate field for directly assigned stage group if the registrar prefers entering it.</div><div class='content chap10-para'><strong>&nbsp; Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>0</td><td class='code-desc'>Stage 0
</td></tr><tr class='code-row'><td class='code-nbr'>0A</td><td class='code-desc'>Stage 0A </td></tr><tr class='code-row'><td class='code-nbr'>01S</td><td class='code-desc'>Stage 0is</td></tr><tr class='code-row'><td class='code-nbr'>1</td><td class='code-desc'>Stage I</td></tr><tr class='code-row'><td class='code-nbr'>1A</td><td class='code-desc'>Stage IA</td></tr><tr class='code-row'><td class='code-nbr'>1A1</td><td class='code-desc'>Stage IA1</td></tr><tr class='code-row'><td class='code-nbr'>1A2</td><td class='code-desc'>Stage IA2</td></tr><tr class='code-row'><td class='code-nbr'>1B</td><td class='code-desc'>Stage IB</td></tr><tr class='code-row'><td class='code-nbr'>1B1</td><td class='code-desc'>Stage IB1</td></tr><tr class='code-row'><td class='code-nbr'>1C</td><td class='code-desc'>Stage IC</td></tr><tr class='code-row'><td class='code-nbr'>1S</td><td class='code-desc'>Stage IS</td></tr><tr class='code-row'><td class='code-nbr'>2</td><td class='code-desc'>Stage 2</td></tr><tr class='code-row'><td class='code-nbr'>2A</td><td class='code-desc'>Stage 2A</td></tr><tr class='code-row'><td class='code-nbr'>2A1</td><td class='code-desc'>Stage 2A1</td></tr><tr class='code-row'><td class='code-nbr'>2A2</td><td class='code-desc'>Stage 2A2</td></tr><tr class='code-row'><td class='code-nbr'>2B</td><td class='code-desc'>Stage 2B</td></tr><tr class='code-row'><td class='code-nbr'>2C</td><td class='code-desc'>Stage 2C</td></tr><tr class='code-row'><td class='code-nbr'>3</td><td class='code-desc'>Stage 3</td></tr><tr class='code-row'><td class='code-nbr'>3A</td><td class='code-desc'>Stage 3A</td></tr><tr class='code-row'><td class='code-nbr'>3B</td><td class='code-desc'>Stage 3B</td></tr><tr class='code-row'><td class='code-nbr'>3C</td><td class='code-desc'>Stage 3C</td></tr><tr class='code-row'><td class='code-nbr'>3C1</td><td class='code-desc'>Stage 3C1</td></tr><tr class='code-row'><td class='code-nbr'>3C2</td><td class='code-desc'>Stage 3C2</td></tr><tr class='code-row'><td class='code-nbr'>4</td><td class='code-desc'>Stage 4</td></tr><tr class='code-row'><td class='code-nbr'>4A</td><td class='code-desc'>Stage 4A</td></tr><tr class='code-row'><td class='code-nbr'>4A1</td><td class='code-desc'>Stage 4A1</td></tr><tr class='code-row'><td class='code-nbr'>4A2</td><td class='code-desc'>Stage 4A2</td></tr><tr class='code-row'><td class='code-nbr'>4B</td><td class='code-desc'>Stage 4B</td></tr><tr class='code-row'><td class='code-nbr'>4C</td><td class='code-desc'>Stage 4C</td></tr><tr class='code-row'><td class='code-nbr'>OC</td><td class='code-desc'>Stage OC</td></tr><tr class='code-row'><td class='code-nbr'>88</td><td class='code-desc'>Not applicable</td></tr><tr class='code-row'><td class='code-nbr'>99</td><td class='code-desc'>Unknown</td></tr><tr class='code-row'><td class='code-nbr'>Blank</td><td class='code-desc'>The algorithm has not been run</td></tr><tr class='code-row'><td class='code-nbr'></td><td class='code-desc'> </td></tr></table></div><a name='3626'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>DERIVED SEER CMB M SRC</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">3626</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>SEER</a></td><td style="text-align:center;">2016</td><td style="text-align:center;">16</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">917 - 917</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>Derived SEER Combined M Source<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>derivedSeerCmbMSrc</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>This item is needed to store the results of the source information selected for the derived algorithmic calculation of Derived SEER Combined M [3620].</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>1</td><td class='code-desc'>Clinical </td></tr><tr class='code-row'><td class='code-nbr'>2</td><td class='code-desc'>Pathologic</td></tr><tr class='code-row'><td class='code-nbr'>3</td><td class='code-desc'>Clinical and pathologic information used </td></tr><tr class='code-row'><td class='code-nbr'>9</td><td class='code-desc'>Unknown</td></tr><tr class='code-row'><td class='code-nbr' colspan='2'></td></tr></table></div><a name='3624'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>DERIVED SEER CMB N SRC</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">3624</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>SEER</a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">916 - 916</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>Derived SEER Combined N Source<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>derivedSeerCmbNSrc</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>This item is needed to store the results of the source information selected for the derived algorithmic calculation of Derived SEER Combined N [3618].</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>1</td><td class='code-desc'>Clinical</td></tr><tr class='code-row'><td class='code-nbr'>2</td><td class='code-desc'>Pathologic</td></tr><tr class='code-row'><td class='code-nbr'>3</td><td class='code-desc'>Clinical and pathologic information used</td></tr><tr class='code-row'><td class='code-nbr'>9</td><td class='code-desc'>Unknown</td></tr><tr class='code-row'><td class='code-nbr' colspan='2'></td></tr></table></div><a name='3614'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>DERIVED SEER CMB STG GRP</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">3614</td><td style="text-align:center;">5</td><td style="text-align:center;"><a href='#sources'>SEER</a></td><td style="text-align:center;">2016</td><td style="text-align:center;">16</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">895 - 899</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>derivedSeerCmbStgGrp</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>This data item is needed to store the results of the derived algorithmic calculation of  SEER Combined Stage Group.
<!--[if gte mso 10]>  <![endif]--></div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Rationale for change proposal (potential benefits of change): The SEER Program is developing an algorithm to calculate clinical and pathologic stage group based on their T, N, and M components and additional information as needed to calculate stage. For example, for thyroid, additional information is needed on histology and age to calculate stage. Once the T, N, and M are known an algorithm can assign the stage group instead of a registrar having to look up the stage. There are also provisions for a separate field for directly assigned stage group if the registrar prefers entering it.</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>0A</td><td class='code-desc'>Stage 0</td></tr><tr class='code-row'><td class='code-nbr'>0IS</td><td class='code-desc'>Stage 0is</td></tr><tr class='code-row'><td class='code-nbr'>1</td><td class='code-desc'>Stage I</td></tr><tr class='code-row'><td class='code-nbr'>1A</td><td class='code-desc'>Stage IA</td></tr><tr class='code-row'><td class='code-nbr'>1A2</td><td class='code-desc'>Stage IA2</td></tr><tr class='code-row'><td class='code-nbr'>1B</td><td class='code-desc'>Stage IB</td></tr><tr class='code-row'><td class='code-nbr'>1B1</td><td class='code-desc'>Stage IB1</td></tr><tr class='code-row'><td class='code-nbr'>1B2</td><td class='code-desc'>Stage IB2</td></tr><tr class='code-row'><td class='code-nbr'>1C</td><td class='code-desc'>Stage IC</td></tr><tr class='code-row'><td class='code-nbr'>1S</td><td class='code-desc'>Stage IS</td></tr><tr class='code-row'><td class='code-nbr'>2</td><td class='code-desc'>Stage 2</td></tr><tr class='code-row'><td class='code-nbr'>2A</td><td class='code-desc'>Stage 2A</td></tr><tr class='code-row'><td class='code-nbr'>2A1</td><td class='code-desc'>Stage </td></tr><tr class='code-row'><td class='code-nbr'>2A2</td><td class='code-desc'>Stage IIA2</td></tr><tr class='code-row'><td class='code-nbr'>2B</td><td class='code-desc'>Stage IIB</td></tr><tr class='code-row'><td class='code-nbr'>2C</td><td class='code-desc'>Stage IIC</td></tr><tr class='code-row'><td class='code-nbr'>3</td><td class='code-desc'>Stage III</td></tr><tr class='code-row'><td class='code-nbr'>3A</td><td class='code-desc'>Stage IIIA</td></tr><tr class='code-row'><td class='code-nbr'>3B</td><td class='code-desc'>Stage IIIB</td></tr><tr class='code-row'><td class='code-nbr'>3C</td><td class='code-desc'>Stage IIIC</td></tr><tr class='code-row'><td class='code-nbr'>3C1</td><td class='code-desc'>Stage IIIC1</td></tr><tr class='code-row'><td class='code-nbr'>3C2</td><td class='code-desc'>Stage IIIC2</td></tr><tr class='code-row'><td class='code-nbr'>4</td><td class='code-desc'>Stage IV</td></tr><tr class='code-row'><td class='code-nbr'>4A</td><td class='code-desc'>Stage IVA</td></tr><tr class='code-row'><td class='code-nbr'>4A1</td><td class='code-desc'>Stage IVA1</td></tr><tr class='code-row'><td class='code-nbr'>4A2</td><td class='code-desc'>Stage IV42</td></tr><tr class='code-row'><td class='code-nbr'>4B</td><td class='code-desc'>Stage IVB</td></tr><tr class='code-row'><td class='code-nbr'>4C</td><td class='code-desc'>Stage IV4C</td></tr><tr class='code-row'><td class='code-nbr'>OC</td><td class='code-desc'>Occult</td></tr><tr class='code-row'><td class='code-nbr'>88</td><td class='code-desc'>Not applicable</td></tr><tr class='code-row'><td class='code-nbr'>99</td><td class='code-desc'>Unknown</td></tr><tr class='code-row'><td class='code-nbr'>Blank</td><td class='code-desc'>The algorithm has not been run</td></tr><tr class='code-row'><td class='code-nbr'></td><td class='code-desc'> </td></tr></table></div><a name='3622'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>DERIVED SEER CMB T SRC</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">3622</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>SEER</a></td><td style="text-align:center;">2016</td><td style="text-align:center;">16</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">915 - 915</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>Derived SEER Combined T Source<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>derivedSeerCmbTSrc</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>This item is needed to store the results of the source information selected for the derived algorithmic calculation of Derived SEER Combined T [3616].</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>1</td><td class='code-desc'>Clinical </td></tr><tr class='code-row'><td class='code-nbr'>2</td><td class='code-desc'>Pathologic</td></tr><tr class='code-row'><td class='code-nbr'>3</td><td class='code-desc'>Clinical and pathologic information used</td></tr><tr class='code-row'><td class='code-nbr'>9</td><td class='code-desc'>Unknown</td></tr><tr class='code-row'><td class='code-nbr'></td><td class='code-desc'> </td></tr></table></div><a name='3620'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>DERIVED SEER COMBINED M</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">3620</td><td style="text-align:center;">5</td><td style="text-align:center;"><a href='#sources'>SEER</a></td><td style="text-align:center;">2016</td><td style="text-align:center;">16</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">910 - 914</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>derivedSeerCombinedM</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>This item is used to store the results of the source information selected for the derived algorithmic calculation of Combined T, N, and M.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>The SEER Program has collected data from 2004 on AJCC 6th T, N, M and stage and from 2010 on AJCC 7th T, N, M and stage based on algorithmic derivation from Collaborative Stage (CS) data. These data were based on combining information from both the clinical and pathologic into a combined (or &#8216;best&#8217;) derived T, N, M and stage group. SEER would like to continue to be able to derive a combined T, N, M and stage group in order to evaluate time trends in cancer incidence by stage. SEER is designing an algorithm to combine the clinical and pathologic information for T, N, and M into a derived combined T, N and M and then the combined T, N, and M and additional information as needed are used to derive a combined stage. These derived combined T, N, M and stage items need to be new data items.</div><div class='content chap10-para'><strong>Codes (See the most recent versions of the <em>AJCC Cancer Staging Manual</em> and <em>STORE </em>manual)</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>88</td><td class='code-desc'>Not applicable </td></tr><tr class='code-row'><td class='code-nbr'>Blank</td><td class='code-desc'>Not derived</td></tr><tr class='code-row'><td class='code-nbr'></td><td class='code-desc'> </td></tr></table></div><a name='3618'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>DERIVED SEER COMBINED N</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">3618</td><td style="text-align:center;">5</td><td style="text-align:center;"><a href='#sources'>SEER</a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">905 - 909</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>derivedSeerCombinedN</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>This item is used to store the results of the source information  selected for the derived algorithmic calculation of Combined T, N, and  M.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>The SEER Program has collected data from 2004 on AJCC 6th T, N, M and stage and from 2010 on AJCC 7th T, N, M and stage based on algorithmic derivation from Collaborative Stage (CS) data. These data were based on combining information from both the clinical and pathologic into a combined (or &#8216;best&#8217;) derived T, N, M and stage group. SEER would like to continue to be able to derive a combined T, N, M and stage group in order to evaluate time trends in cancer incidence by stage. SEER is designing an algorithm to combine the clinical and pathologic information for T, N, and M into a derived combined T, N and M and then the combined T, N, and M and additional information as needed are used to derive a combined stage. These derived combined T, N, M and stage items need to be new data items.</div><div class='content chap10-para'><strong>Codes (See the most recent versions of the <em>AJCC Cancer Staging Manual</em> and <em>STORE </em>manual)</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>88</td><td class='code-desc'>Not applicable </td></tr><tr class='code-row'><td class='code-nbr'>Blank</td><td class='code-desc'>Not derived</td></tr><tr class='code-row'><td class='code-nbr'></td><td class='code-desc'> </td></tr></table></div><a name='3616'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>DERIVED SEER COMBINED T</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">3616</td><td style="text-align:center;">5</td><td style="text-align:center;"><a href='#sources'>SEER</a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">900 - 904</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>derivedSeerCombinedT</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>This new data item is needed to store the results of the derived algorithmic calculation of Derived SEER Combined T.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>The SEER Program has collected data from 2004 on AJCC 6th T, N, M and stage and from 2010 on AJCC 7th T, N, M and stage based on algorithmic derivation from Collaborative Stage (CS) data. These data were based on combining information from both the clinical and pathologic into a combined (or &#8216;best&#8217;) derived T, N, M and stage group. SEER would like to continue to be able to derive a combined T, N, M and stage group in order to evaluate time trends in cancer incidence by stage. SEER is designing an algorithm to combine the clinical and pathologic information for T, N, and M into a derived combined T, N and M and then the combined T, N, and M and additional information as needed are used to derive a combined stage.</div><div class='content chap10-para'><strong>Codes (See the most recent versions of the <em>AJCC Cancer Staging Manual </em>and <em>STORE </em>manual)</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>88</td><td class='code-desc'>Not applicable </td></tr><tr class='code-row'><td class='code-nbr'>Blank</td><td class='code-desc'>Not derived</td></tr><tr class='code-row'><td class='code-nbr'></td><td class='code-desc'> </td></tr></table></div><a name='3605'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>DERIVED SEER PATH STG GRP</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">3605</td><td style="text-align:center;">5</td><td style="text-align:center;"><a href='#sources'>SEER</a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">885 - 889</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>derivedSeerPathStgGrp</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>This data item is needed to store the results of the derived algorithmic calculation of Derived SEER Pathologic Stage Group.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>The SEER Program is developing an algorithm to calculate clinical and pathologic stage group based on their T, N, and M components and additional information as needed to calculate stage.  For example, for thyroid, additional information is needed on histology and age to calculate stage.  Once the T, N, and M are known an algorithm can assign the stage group instead of a registrar having to look up the stage.  There are also provisions for a separate field for directly assigned stage group if the registrar prefers entering it.</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>0</td><td class='code-desc'>Stage 0</td></tr><tr class='code-row'><td class='code-nbr'>0A</td><td class='code-desc'>Stage 0A</td></tr><tr class='code-row'><td class='code-nbr'>0IS</td><td class='code-desc'>Stage 0is</td></tr><tr class='code-row'><td class='code-nbr'>1</td><td class='code-desc'>Stage I</td></tr><tr class='code-row'><td class='code-nbr'>1A</td><td class='code-desc'>Stage IA</td></tr><tr class='code-row'><td class='code-nbr'>1A1</td><td class='code-desc'>Stage IA1</td></tr><tr class='code-row'><td class='code-nbr'>1A2</td><td class='code-desc'>Stage IA2</td></tr><tr class='code-row'><td class='code-nbr'>1B</td><td class='code-desc'>Stage IB</td></tr><tr class='code-row'><td class='code-nbr'>1B1</td><td class='code-desc'>Stage IB1</td></tr><tr class='code-row'><td class='code-nbr'>1B2</td><td class='code-desc'>Stage IB2</td></tr><tr class='code-row'><td class='code-nbr'>1C</td><td class='code-desc'>Stage IC</td></tr><tr class='code-row'><td class='code-nbr'>1S</td><td class='code-desc'>Stage IS</td></tr><tr class='code-row'><td class='code-nbr'>2</td><td class='code-desc'>Stage II</td></tr><tr class='code-row'><td class='code-nbr'>2A</td><td class='code-desc'>Stage IIA</td></tr><tr class='code-row'><td class='code-nbr'>2A1</td><td class='code-desc'>Stage IIA1</td></tr><tr class='code-row'><td class='code-nbr'>2A2</td><td class='code-desc'>Stage IIA2</td></tr><tr class='code-row'><td class='code-nbr'>2B</td><td class='code-desc'>Stage IIB</td></tr><tr class='code-row'><td class='code-nbr'>2C</td><td class='code-desc'>Stage IIC</td></tr><tr class='code-row'><td class='code-nbr'>3</td><td class='code-desc'>Stage III</td></tr><tr class='code-row'><td class='code-nbr'>3A</td><td class='code-desc'>Stage IIIA</td></tr><tr class='code-row'><td class='code-nbr'>3B</td><td class='code-desc'>Stage IIIB</td></tr><tr class='code-row'><td class='code-nbr'>3C</td><td class='code-desc'>Stage IIIC</td></tr><tr class='code-row'><td class='code-nbr'>3C1</td><td class='code-desc'>Stage IIIC1</td></tr><tr class='code-row'><td class='code-nbr'>3C2</td><td class='code-desc'>Stage IIIC2</td></tr><tr class='code-row'><td class='code-nbr'>4</td><td class='code-desc'>Stage IV</td></tr><tr class='code-row'><td class='code-nbr'>4A</td><td class='code-desc'>Stage IVA</td></tr><tr class='code-row'><td class='code-nbr'>4A1</td><td class='code-desc'>Stage IVA1</td></tr><tr class='code-row'><td class='code-nbr'>4A2</td><td class='code-desc'>Stage IVA2</td></tr><tr class='code-row'><td class='code-nbr'>4B</td><td class='code-desc'>Stage IVB</td></tr><tr class='code-row'><td class='code-nbr'>4C</td><td class='code-desc'>Stage IVC</td></tr><tr class='code-row'><td class='code-nbr'>OC</td><td class='code-desc'>Occult</td></tr><tr class='code-row'><td class='code-nbr'>88</td><td class='code-desc'>Not applicable</td></tr><tr class='code-row'><td class='code-nbr'>99</td><td class='code-desc'>Unknown</td></tr><tr class='code-row'><td class='code-nbr'>Blank</td><td class='code-desc'>Algorithm has not been run</td></tr><tr class='code-row'><td class='code-nbr'></td><td class='code-desc'> </td></tr></table></div><a name='3010'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>DERIVED SS1977</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">3010</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>AJCC</a></td><td style="text-align:center;">2003</td><td style="text-align:center;">10</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1443 - 1443</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>Derived SEER Summary Stage 1977<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>derivedSs1977</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>This item is the derived &#8220;SEER Summary Stage 1977&#8221; from the CS algorithm (or EOD codes) effective with 2004 diagnosis.  </div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>The Collaborative Stage Data Collection System was designed by a joint task force including representatives from SEER, ACoS, CDC, NAACCR, NCRA, CCCR, CPAC, and AJCC, to provide a single uniform set of codes and rules for coding extent of disease (EOD) and stage information to meet the needs of all of the participating standard setters. When CS data items are coded, a computer algorithm provides the derivation of T, N, M, and stage-based on AJCC Cancer Staging Manual 6th &amp; 7th Editions, SEER Summary Stage 1977, and SEER Summary Stage 2000. There are separate derived CS fields in the NAACCR record based on AJCC 6th Edition for 2004+ cases and AJCC 7th Edition for 2010+ cases.  </div><div class='content chap10-para'><strong>Codes (See the most current version of the <em>Collaborative Stage Data Collection System</em> (<a href="https://cancerstaging.org/cstage/Pages/default.aspx" target="_blank">https://cancerstaging.org/cstage/Pages/default.aspx</a>),<sup>13</sup> for rules and site-specific codes and coding structures.) </strong></div><a name='3040'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>DERIVED SS1977--FLAG</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">3040</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>AJCC</a></td><td style="text-align:center;">2003</td><td style="text-align:center;">10</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1447 - 1447</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>SS1977 Conversion Flag<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>derivedSs1977Flag</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Flag to indicate whether the derived SEER Summary Stage 1977 was derived from CS or EOD codes. </div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>The Collaborative Stage Data Collection System was designed by a joint task force including representatives from SEER, ACoS, CDC, NAACCR, NCRA, CCCR, CPAC, and AJCC, to provide a single uniform set of codes and rules for coding extent of disease (EOD) and stage information to meet the needs of all of the participating standard setters. When CS data items are coded, a computer algorithm provides the derivation of T, N, M, and stage-based on AJCC Cancer Staging Manual 6th &amp; 7th Editions, SEER Summary Stage 1977, and SEER Summary Stage 2000. There are separate derived CS fields in the NAACCR record based on AJCC 6th Edition for 2004+ cases and AJCC 7th Edition for 2010+ cases. </div><div class='content chap10-para'><strong>Codes (See the most current version of the <em>Collaborative Stage Data Collection System</em> (<a href="https://cancerstaging.org/cstage/Pages/default.aspx" target="_blank">https://cancerstaging.org/cstage/Pages/default.aspx</a>),<sup>13</sup> for rules and site-specific codes and coding structures.) </strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>Blank</td><td class='code-desc'>Not derived</td></tr><tr class='code-row'><td class='code-nbr'>1</td><td class='code-desc'>SS1977 derived from Collaborative Stage</td></tr><tr class='code-row'><td class='code-nbr'>2</td><td class='code-desc'>SS1977 derived from EOD (prior to 2004)</td></tr></table></div><a name='3020'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>DERIVED SS2000</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">3020</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>AJCC</a></td><td style="text-align:center;">2003</td><td style="text-align:center;">10</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1444 - 1444</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>Derived SEER Summary Stage 2000<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>derivedSs2000</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>This item is the derived &#8220;SEER Summary Stage 2000&#8221; from the CS algorithm (or EOD codes) effective with 2004 diagnosis.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>The Collaborative Stage Data Collection System was designed by a joint task force including representatives from SEER, ACoS, CDC, NAACCR, NCRA, CCCR, CPAC, and AJCC, to provide a single uniform set of codes and rules for coding extent of disease (EOD) and stage information to meet the needs of all of the participating standard setters. When CS data items are coded, a computer algorithm provides the derivation of T, N, M, and stage-based on AJCC Cancer Staging Manual 6th &amp; 7th Editions, SEER Summary Stage 1977, and SEER Summary Stage 2000. There are separate derived CS fields in the NAACCR record based on AJCC 6th Edition for 2004+ cases and AJCC 7th Edition for 2010+ cases.</div><div class='content chap10-para'><strong>Codes (See the most current version of the <em>Collaborative Stage Data Collection System</em> (<a href="https://cancerstaging.org/cstage/Pages/default.aspx" target="_blank">https://cancerstaging.org/cstage/Pages/default.aspx</a>),<sup>13</sup> for rules and site-specific codes and coding structures.) </strong></div><a name='3050'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>DERIVED SS2000--FLAG</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">3050</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>AJCC</a></td><td style="text-align:center;">2003</td><td style="text-align:center;">10</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1448 - 1448</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>SS2000 Conversion Flag<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>derivedSs2000Flag</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Flag to indicate whether the derived SEER Summary Stage 2000 was derived from CS or EOD codes.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>The Collaborative Stage Data Collection System was designed by a joint task force including representatives from SEER, ACoS, CDC, NAACCR, NCRA, CCCR, CPAC, and AJCC, to provide a single uniform set of codes and rules for coding extent of disease (EOD) and stage information to meet the needs of all of the participating standard setters. When CS data items are coded, a computer algorithm provides the derivation of T, N, M, and stage-based on AJCC Cancer Staging Manual 6th &amp; 7th Editions, SEER Summary Stage 1977, and SEER Summary Stage 2000. There are separate derived CS fields in the NAACCR record based on AJCC 6th Edition for 2004+ cases and AJCC 7th Edition for 2010+ cases.</div><div class='content chap10-para'><strong>Codes (See the most current version of the <em>Collaborative Stage Data Collection System</em> (<a href="https://cancerstaging.org/cstage/Pages/default.aspx" target="_blank">https://cancerstaging.org/cstage/Pages/default.aspx</a>),<sup>13</sup> for rules and site-specific codes and coding structures.) </strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>1</td><td class='code-desc'>SS2000 derived from Collaborative Stage</td></tr><tr class='code-row'><td class='code-nbr'>2</td><td class='code-desc'>SS2000 derived from EOD (prior to 2004)</td></tr><tr class='code-row'><td class='code-nbr'>Blank</td><td class='code-desc'>Not derived</td></tr></table></div><a name='762'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>DERIVED SUMMARY STAGE 2018</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">762</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>SEER</a></td><td style="text-align:center;">2018</td><td style="text-align:center;">16</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">986 - 986</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>Derived SS2018<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>derivedSummaryStage2018</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'><!--[if gte mso 10]>  <![endif]-->Derived Summary Stage 2018 is derived using the EOD data collection system (EOD Primary Tumor [772], EOD Regional Nodes [774] and EOD Mets [776]) algorithm. Other data items may be included in the derivation process. Effective for cases diagnosed 1/1/2018+.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'><div>The SEER program has collected staging information on cases since its inception in 1973. Summary Stage groups cases into broad categories of in situ, local, regional, and distant. Summary Stage can be used to evaluate disease spread at diagnosis, treatment patterns and outcomes over time.</div><div>&nbsp;</div>Derived Summary Stage 2018 [762] is only available at the central registry level.</div><div class='content chap10-para'><em>Note</em>: This data item was included in Standards Volume II, Version 16; however, it was not implemented until 2018.</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>0</td><td class='code-desc'>In situ </td></tr><tr class='code-row'><td class='code-nbr'>1</td><td class='code-desc'>Localized</td></tr><tr class='code-row'><td class='code-nbr'>2</td><td class='code-desc'>Regional, direct extension only</td></tr><tr class='code-row'><td class='code-nbr'>3</td><td class='code-desc'>Regional, regional lymph nodes only</td></tr><tr class='code-row'><td class='code-nbr'>4</td><td class='code-desc'>Regional, direct extension and regional lymph nodes</td></tr><tr class='code-row'><td class='code-nbr'>7</td><td class='code-desc'>Distant</td></tr><tr class='code-row'><td class='code-nbr'>8</td><td class='code-desc'>Benign, borderline</td></tr><tr class='code-row'><td class='code-nbr'>9</td><td class='code-desc'>Unknown if extension or metastasis (unstaged, unknown, or unspecified)<br/>
Death certificate only case
</td></tr><tr class='code-row'><td class='code-nbr'></td><td class='code-desc'> </td></tr></table></div><a name='490'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>DIAGNOSTIC CONFIRMATION</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">490</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>SEER/CoC</a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">576 - 576</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>diagnosticConfirmation</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Code for the best method of diagnostic confirmation of the cancer being reported at any time in the patient&#8217;s history. </div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Diagnostic confirmation is useful to calculate rates based on microscopically confirmed cancers. Full incidence calculations must also include tumors that are only confirmed clinically. The percentage of tumors that not micropscopically confirmed is an indication of whether case finding is including sources outside of pathology reports. </div><div class='content chap10-para'><strong>Codes </strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>1</td><td class='code-desc'>Positive histology</td></tr><tr class='code-row'><td class='code-nbr'>2</td><td class='code-desc'>Positive cytology</td></tr><tr class='code-row'><td class='code-nbr'>3</td><td class='code-desc'>Positive histology PLUS - positive immunophenotyping AND/OR positive genetic studies (Used only for hematopoietic and lymphoid neoplasms M-9590/3-9992/3)</td></tr><tr class='code-row'><td class='code-nbr'>4</td><td class='code-desc'>Positive microscopic confirmation, method not specified</td></tr><tr class='code-row'><td class='code-nbr'>5</td><td class='code-desc'>Positive laboratory test/marker study</td></tr><tr class='code-row'><td class='code-nbr'>6</td><td class='code-desc'>Direct visualization without microscopic confirmation</td></tr><tr class='code-row'><td class='code-nbr'>7</td><td class='code-desc'>Radiography and/or other imaging techniques without microscopic confirmation</td></tr><tr class='code-row'><td class='code-nbr'>8</td><td class='code-desc'>Clinical diagnosis only (other than 5, 6, or 7)</td></tr><tr class='code-row'><td class='code-nbr'>9</td><td class='code-desc'>Unknown whether or not microscopically confirmed; death certificate only</td></tr></table></div><div class='content chap10-para'><em>Note:</em> Code 3 (used only for hematopoietic and lymphoid neoplasms M-9590/3-9992/3) was adopted for use effective with 2010 diagnoses.</div><a name='2200'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>DIAGNOSTIC PROC 73-87</strong></td><td style="text-align:right;font-weight:bold;"><strong>Revised</strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">2200</td><td style="text-align:center;">2</td><td style="text-align:center;"><a href='#sources'>SEER</a></td><td style="text-align:center;">1995</td><td style="text-align:center;">5</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">2638 - 2639</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>Diagnostic Procedures (1973-87 SEER)<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>diagnosticProc7387</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para mark-changed'>Data item required by SEER for tumors of certain sites for the years 1973-87. This item is no longer collected. See Appendix D of the 


<em>SEER Program Code Manual</em> for details.</div><a name='3939'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>EGFR MUTATIONAL ANALYSIS</strong></td><td style="text-align:right;font-weight:bold;"><strong>New</strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">3939</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>NAACCR</a></td><td style="text-align:center;">2021</td><td style="text-align:center;">21</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1 - 1</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>egfrMutationalAnalysis</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Epidermal growth factor receptor (EGFR) mutational analysis is performed for patients with advanced non-small cell lung cancer (NSCLC) to identify patients with certain activating mutations in the EGFR gene which are sensitive to tyrosine kinase inhibitors.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>EGFR mutational analysis is recommended by treatment guidelines for patients with advanced lung cancer as a prognostic marker and factor in determining appropriate therapy. It is a new data item for cases diagnosed 01/01/2021+.</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>0</td><td class='code-desc'>Normal<br/> 
EGFR negative, EGFR wild type<br/>
Negative for mutations, no alterations, no mutations (somatic) identified, not present, not detected
 </td></tr><tr class='code-row'><td class='code-nbr'>1</td><td class='code-desc'>Abnormal (mutated)/detected in exon(s) 18, 19, 20, and/or 21 </td></tr><tr class='code-row'><td class='code-nbr'>2</td><td class='code-desc'>Abnormal (mutated)/detected but not in exon(s) 18, 19, 20, and/or 21</td></tr><tr class='code-row'><td class='code-nbr'>4</td><td class='code-desc'>Abnormal (mutated)/detected, NOS, exon(s) not specified</td></tr><tr class='code-row'><td class='code-nbr'>7</td><td class='code-desc'>Test ordered, results not in chart</td></tr><tr class='code-row'><td class='code-nbr'>8</td><td class='code-desc'>Not applicable: Information not collected for this case<br/>
If this information is required by your standard setter, use of code 8 may result in an edit error.
</td></tr><tr class='code-row'><td class='code-nbr'>9</td><td class='code-desc'>Not documented in medical record<br/>
EGFR not assessed or unknown if assessed
</td></tr><tr class='code-row'><td class='code-nbr'></td><td class='code-desc'> </td></tr></table></div><div class='content chap10-para'>Each Site-Specific Data Item (SSDI) applies only to selected primary 
sites, histologies, and years of diagnosis. Depending on applicability 
and standard-setter requirements, SSDIs may be left blank.</div><a name='2508'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>EHR REPORTING</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">2508</td><td style="text-align:center;">1000</td><td style="text-align:center;"><a href='#sources'>NAACCR</a></td><td style="text-align:center;">2018</td><td style="text-align:center;">18</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">5105 - 6104</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>ehrReporting</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Cancer case reports transmitted from electronic health records (EHR) in the HL7 CDA (Clinical Document Architecture) format must adhere to specifications and requirements as defined by the Implementation Guide (IG) which has been adopted by the Office of the National Coordinator of for Health Information Technology. The IG specifies collection and transmission of cancer diagnosis fields including (but not limited to) primary site, histology, behavior, diagnosis date, and staging elements. The IG also specifies transmission of other data documented in the EHR as part of the care of the patient which are also standardized, but are not routinely collected by cancer registries in the same way or as discrete items. Examples of these are procedures, medications, smoking, and vital signs (i.e., height, weight, BMI). Currently, software tools such as CDC&#8217;s eMaRC Plus parse some EHR elements and map or translate these fields to NAACCR items. However, some data are not able to be mapped to discrete items. This new proposed field will allow central cancer registries to collect information from the EHR and map these data in the NAACCR record layout so that they can be included in the central registry database and be available to enhance surveillance data.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Central cancer registries may wish to integrate EHR data, which are not already in the NAACCR record layout, into their databases. The EHR Reporting Field will allow central cancer registries to capture data that are received from EHR systems as discrete items. Collection of these data in this field will allow central cancer registries to assess ways in which the EHR data can be standardized in the NAACCR record layout in the future.</div><div class='content chap10-para'><strong>Examples of data to be collected in this field:</strong><br />Family history<br />Practice OID<br />Smoking Status<br />Tobacco Use<br />Vital sign: height<br />Vital sign: weight<br />Vital sign: BMI<br />Provider First Name<br />Provider Last Name<br />Provider Specialty<br />Medication name, code<br />Cancer-direct Procedures name, code, code system, date of procedure<br />Care Plan: planned encounter<br />EHR Vendor name, software and version</div><a name='776'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>EOD METS</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">776</td><td style="text-align:center;">2</td><td style="text-align:center;"><a href='#sources'>SEER</a></td><td style="text-align:center;">2018</td><td style="text-align:center;">16</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">924 - 925</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>SEER Mets<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>eodMets</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>EOD Mets is part of the EOD 2018 data collection system and is used to classify the distant site(s) of metastatic involvement at time of diagnosis. See also EOD Primary Tumor [772] and EOD Regional Nodes [774]. Effective for cases diagnosed 1/1/2018+.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'><!--[if gte mso 10]>  <![endif]-->
<!--[if gte mso 10]>  <![endif]-->EOD Mets is used to calculate Derived EOD 2018 M [795] (when applicable) and Derived Summary Stage 2018 [762]. Derivation will occur at the level of the central registry.</div><div class='content chap10-para'><em>Note</em>: This data item was included in Standards Volume II, Version 16; however, it was not implemented until 2018.</div><div class='content chap10-para'><strong>Codes (in addition to valid schema-specific codes)</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>00</td><td class='code-desc'>None<br/>
No distant metastasis<br/>
Unknown if distant metastasis
</td></tr><tr class='code-row'><td class='code-nbr'>88</td><td class='code-desc'>Not applicable: Information not collected for this schema<br/>
Use for these sites only: HemeRetic; <br/>Ill Defined Other (includes unknown primary site); <br/>Kaposi Sarcoma; <br/>Lymphoma; <br/>Lymphoma-CLL/SLL; <br/>Myeloma Plasma Cell Disorder
</td></tr><tr class='code-row'><td class='code-nbr'>99</td><td class='code-desc'>Death certificate only (DCO)</td></tr><tr class='code-row'><td class='code-nbr'></td><td class='code-desc'> </td></tr></table></div><div class='content chap10-para'><em>Note</em>: See the most current version of EOD (<a href="https://staging.seer.cancer.gov/">https://staging.seer.cancer.gov/</a>) for rules and site-specific codes and coding structures.</div><a name='772'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>EOD PRIMARY TUMOR</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">772</td><td style="text-align:center;">3</td><td style="text-align:center;"><a href='#sources'>SEER</a></td><td style="text-align:center;">2018</td><td style="text-align:center;">16</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">918 - 920</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>SEER Primary Tumor<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>eodPrimaryTumor</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>EOD Primary Tumor is part of the EOD 2018 data collection system and is used to classify contiguous growth (extension) of the primary tumor within the organ of origin or its direct extension into neighboring organs. See also EOD Regional Nodes [774] and EOD Mets [776]. Effective for cases diagnosed 1/1/2018+.






















<!--[if gte mso 10]>  <![endif]--></div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>EOD Primary Tumor is used to calculate Derived EOD 2018 T [785] (when applicable) and Derived Summary Stage 2018 [762]. Derivation will occur at the level of the central registry.</div><div class='content chap10-para'><em>Note</em>: This data item was included in Standards Volume II, Version 16; however, it was not implemented until 2018.</div><div class='content chap10-para'><strong>Codes (In addition to schema-specific codes where needed)</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>000</td><td class='code-desc'>In situ, intraepithelial, noninvasive</td></tr><tr class='code-row'><td class='code-nbr'>800</td><td class='code-desc'>No evidence of primary tumor</td></tr><tr class='code-row'><td class='code-nbr'>999</td><td class='code-desc'>Unknown; primary tumor not stated<br/>
Primary tumor cannot be assessed<br/>
Not documented in patient record<br/>
Death certificate only (DCO)
 </td></tr><tr class='code-row'><td class='code-nbr'></td><td class='code-desc'> </td></tr></table></div><div class='content chap10-para'><em>Note</em>: (See the most current version of EOD (<a href="https://staging.seer.cancer.gov/">https://staging.seer.cancer.gov/</a>) for rules and site-specific codes and coding structures.)</div><a name='3919'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>EOD PROSTATE PATHOLOGIC EXTENSION</strong></td><td style="text-align:right;font-weight:bold;"><strong>Revised</strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">3919</td><td style="text-align:center;">3</td><td title="V: 22: SEER
V: 18: NAACCR
" class=" HighlightToolTip" style="text-align:center;"><a href='#sources'>SEER</a></td><td style="text-align:center;">2018</td><td style="text-align:center;">18</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1941 - 1943</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td title="V: 22: Prostate, CS SSF# 3&lt;br />Prostate Pathological Extension&lt;br />
V: 18: 
" class=" HighlightToolTip">Prostate, CS SSF# 3<br />Prostate Pathological Extension<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>prostatePathologicalExtension</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para mark-changed'><span>
  <span id="lblItemName">EOD Prostate Pathologic </span></span><span><span id="lblItemName"></span></span><span><span id="lblItemName">Extension</span>
</span> is used to assign pT category for prostate cancer based on radical prostatectomy specimens.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para mark-changed'><span>
  <span id="lblItemName">EOD Prostate Pathologic Extension</span>
</span> is used in EOD.  It was previously collected as Prostate Pathological Extension, and Prostate, CS SSF# 3.</div><div class='content chap10-para'><strong>Codes (See the most current version of EOD (Prostate) (<a href="https://staging.seer.cancer.gov/">https://staging.seer.cancer.gov/</a>) for rules and site-specific codes and coding structures.) </strong></div><a name='774'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>EOD REGIONAL NODES</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">774</td><td style="text-align:center;">3</td><td style="text-align:center;"><a href='#sources'>SEER</a></td><td style="text-align:center;">2018</td><td style="text-align:center;">16</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">921 - 923</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>SEER Regional Nodes<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>eodRegionalNodes</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>EOD Regional Nodes is part of the EOD 2018 data collection system and is used to classify the regional lymph nodes involved with cancer at the time of diagnosis. See also EOD Primary Tumor [772] and EOD Mets [776]. Effective for cases diagnosed 1/1/2018+.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>EOD Regional Nodes is used to calculate Derived EOD 2018 N [815] (when applicable) and Derived Summary Stage 2018 [762]. Derivation will occur at the level of the central registry.</div><div class='content chap10-para'><em>Note</em>: This data item was included in Standards Volume II, Version 16; however, it was not implemented until 2018.</div><div class='content chap10-para'><strong>Codes (in addition to valid schema-specific codes)</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>000</td><td class='code-desc'>None</td></tr><tr class='code-row'><td class='code-nbr'>800</td><td class='code-desc'>Regional lymph node(s), NOS<br/>
Lymph node(s), NOS
</td></tr><tr class='code-row'><td class='code-nbr'>888</td><td class='code-desc'>Not applicablee.g., CNS, hematopoietic</td></tr><tr class='code-row'><td class='code-nbr'>999</td><td class='code-desc'>Unknown</td></tr><tr class='code-row'><td class='code-nbr'></td><td class='code-desc'> </td></tr></table></div><div class='content chap10-para'><em>Note</em>: See the most current version of EOD (<a href="https://staging.seer.cancer.gov/">https://staging.seer.cancer.gov/</a>) for rules and site-specific codes and coding structures.</div><a name='790'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>EOD--EXTENSION</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">790</td><td style="text-align:center;">2</td><td style="text-align:center;"><a href='#sources'>SEER</a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">993 - 994</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>Extension (SEER EOD) (96 CoC)<br />Extension (pre-96 SEER/CoC)<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>eodExtension</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Part of the 10-digit EOD [779]. Detailed site-specific codes for anatomic EOD used by SEER for tumors diagnosed from January 1, 1988, through December 31, 2003.<br /><br />Codes were revised effective January 1, 1998, to reflect changes in the <em>AJCC Cancer Staging Manual</em>, Fifth Edition.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Site-specific EOD codes provide extensive detail describing disease extent. The EOD codes can be grouped into different stage categories for analysis (e.g., historical summary stage categories consistent with those used in published SEER data since 1973, or more recently, AJCC stage groupings). The codes are updated as needed, but updates are usually backward compatible with old categories. See <em>Comparative Staging Guide for Cancer</em><sup>6</sup>.</div><div class='content chap10-para'><strong>Codes (See <em></em><a target="_blank" href="http://seer.cancer.gov/manuals/EOD10Dig.3rd.pdf"><em>SEER Extent of Disease, 1988: Codes and Coding Instructions</em>, Third Edition</a><sup>8</sup> for site-specific codes and coding rules for all EOD fields.) </strong></div><a name='800'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>EOD--EXTENSION PROST PATH</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">800</td><td style="text-align:center;">2</td><td style="text-align:center;"><a href='#sources'>SEER</a></td><td style="text-align:center;">1995</td><td style="text-align:center;">4</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">995 - 996</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>eodExtensionProstPath</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Part of the 10-digit EOD [779]. Detailed site-specific codes for anatomic EOD used by SEER for tumors diagnosed from January 1, 1988, through December 31, 2003. <br /><br />Codes were revised effective January 1, 1998, to reflect changes in the <em>AJCC Cancer Staging Manual</em>, Fifth Edition.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Site-specific EOD codes provide extensive detail describing disease extent. The EOD codes can be grouped into different stage categories for analysis (e.g., historical summary stage categories consistent with those used in published SEER data since 1973, or more recently, AJCC stage groupings). The codes are updated as needed, but updates are usually backward compatible with old categories. See <em>Comparative Staging Guide for Cancer</em>. <br /><br />EOD--Extension Prost Path is an additional field for prostate cancer only to reflect information from radical prostatectomy, effective for January 1, 1995, through December 31, 2003, diagnoses. The field is left blank for all other primaries.</div><div class='content chap10-para'><strong>Codes (See <em></em><a target="_blank" href="http://seer.cancer.gov/manuals/EOD10Dig.3rd.pdf"><em>SEER Extent of Disease, 1988: Codes and Coding Instructions</em>, Third Edition</a><sup>8</sup> for site-specific codes and coding rules for all EOD fields.) </strong></div><a name='810'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>EOD--LYMPH NODE INVOLV</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">810</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>SEER</a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">997 - 997</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>Lymph Nodes (pre 96-SEER/CoC)<br />Lymph Nodes (SEER EOD) (96 CoC)<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>eodLymphNodeInvolv</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Part of the 10-digit EOD [779]. Detailed site-specific codes for anatomic EOD used by SEER for tumors diagnosed from January 1, 1988, through December 31, 2003.<br /><br />Codes were revised effective January 1, 1998, to reflect changes in the <em>AJCC Cancer Staging Manual</em>, Fifth Edition. </div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Site-specific EOD codes provide extensive detail describing disease extent. The EOD codes can be grouped into different stage categories for analysis (e.g., historical summary stage categories consistent with those used in published SEER data since 1973, or more recently, AJCC stage groupings). The codes are updated as needed, but updates are usually backward compatible with old categories. See




<em><a target="_blank" href="http://seer.cancer.gov/tools/codingmanuals/historical.html">Comparative Staging Guide for Cancer</a></em>. </div><div class='content chap10-para'><strong>Codes (See <em></em><a target="_blank" href="http://seer.cancer.gov/manuals/EOD10Dig.3rd.pdf"><em>SEER Extent of Disease, 1988: Codes and Coding Instructions</em>, Third Edition<sup></sup></a><sup>8</sup> for site-specific codes and coding rules for all EOD fields.) </strong></div><a name='840'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>EOD--OLD 13 DIGIT</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">840</td><td style="text-align:center;">13</td><td style="text-align:center;"><a href='#sources'>SEER</a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1026 - 1038</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>SEER EEOD (SEER)<br />13-Digit (Expanded) Site-Specific Extent of Disease (SEER)<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>eodOld13Digit</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Detailed site-specific codes for EOD used by SEER for selected sites of cancer for tumors diagnosed 1973-1982, except death-certificate-only cases. </div><div class='content chap10-para'><strong>Codes (See <em>Extent of Disease: Codes and Coding Instructions (SEER 1977)</em><sup>10</sup> for codes.) </strong></div><a name='850'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>EOD--OLD 2 DIGIT</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">850</td><td style="text-align:center;">2</td><td style="text-align:center;"><a href='#sources'>SEER</a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1039 - 1040</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>2-Digit Nonspecific and 2-Digit Site-Specific Extent of Disease (1973-1982 SEER)<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>eodOld2Digit</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Site-specific codes for EOD used by SEER for tumors diagnosed from January 1, 1973, to December 31, 1982, for cancer sites that did not have a 13-digit scheme see EOD--Old 13 Digit [840]. </div><div class='content chap10-para'><strong>Codes (See <em>Extent of Disease: Codes and Coding Instructions (SEER 1977)</em><sup>10</sup> for codes.) </strong></div><a name='860'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>EOD--OLD 4 DIGIT</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">860</td><td style="text-align:center;">4</td><td style="text-align:center;"><a href='#sources'>SEER</a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1041 - 1044</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>4-Digit Extent of Disease (1983-1987 SEER)<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>eodOld4Digit</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Codes for site-specific EOD used by SEER for tumors diagnosed from January 1, 1983, to December 31, 1987, for all cancer sites. </div><div class='content chap10-para'><strong>Codes (See <em>SEER Extent of Disease: New 4-Digit Schemes: Codes and Coding Instructions</em><sup>9</sup> for codes.) </strong></div><a name='780'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>EOD--TUMOR SIZE</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">780</td><td style="text-align:center;">3</td><td style="text-align:center;"><a href='#sources'>SEER/CoC</a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">990 - 992</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>Size of Primary Tumor (SEER)<br />Size of Tumor (CoC)<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>eodTumorSize</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Part of the 10-digit EOD [779]. Detailed site-specific codes for anatomic EOD used by SEER for tumors diagnosed from January 1, 1988, through December 31, 2003.<br /><br />This field was included in the CoC dataset, separate from EOD.<br /><br />Codes were revised effective January 1, 1998, to reflect changes in the <em>AJCC Cancer Staging Manual</em>, Fifth Edition.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Site-specific EOD codes provide extensive detail describing disease extent. The EOD codes can be grouped into different stage categories for analysis (e.g., historical summary stage categories consistent with those used in published SEER data since 1973, or more recently, AJCC stage groupings). The codes are updated as needed, but updates are usually backward compatible with old categories. See
<em>Comparative Staging Guide for Cancer</em>.<sup>6</sup></div><div class='content chap10-para'><strong>Codes (</strong><strong>See <u><em>S</em></u><a target="_blank" href="seer.cancer.gov/manuals/EOD10Dig.pub.pdf"><em>EER Extent of Disease</em><em>, 1988: Codes and Coding Instructions</em>, Third Edition</a>, for site-specific codes and coding rules for all EOD fields. The CoC codes for Tumor Size are in the<em> <a target="_blank" href="http://www.facs.org/cancer/coc/fordsmanual.html">STORE</a></em> manual.)</strong></div><div class='content chap10-para'><p>
  <em>Note: </em>See Chapter V, Unresolved Issues, for a discussion of coding differences between CoC and SEER.</p></div><a name='3829'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>ESOPHAGUS AND EGJ TUMOR EPICENTER</strong></td><td style="text-align:right;font-weight:bold;"><strong>Revised</strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">3829</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>NAACCR</a></td><td style="text-align:center;">2018</td><td style="text-align:center;">18</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1814 - 1814</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>esophagusAndEgjTumorEpicenter</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Esophagus and Esophagogastric Junction (EGJ), Squamous Cell (including adenosquamous), Tumor Location refers to the position of the epicenter of the tumor in the esophagus.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para mark-changed'>This data item is required for prognostic stage grouping for squamous and adenosquamous carcinoma in AJCC 8th edition, Chapter 16 










<em>Esophagus and Esophagogastric Junction</em>. It is a new data item for cases diagnosed 1/1/2018+.</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>0</td><td class='code-desc'>U: Upper (Cervical/Proximal esophagus to lower border of azygos vein)</td></tr><tr class='code-row'><td class='code-nbr'>1</td><td class='code-desc'>M: Middle (Lower border of azygos vein to lower border of inferior pulmonary vein)</td></tr><tr class='code-row'><td class='code-nbr'>2</td><td class='code-desc'>L: Lower (Lower border of inferior pulmonary vein to stomach, including gastroesophageal junction)</td></tr><tr class='code-row'><td class='code-nbr'>9</td><td class='code-desc'>X: Esophagus, NOS<br/>
Specific location of epicenter not documented in medical record<br/>
Specific location of epicenter not assessed or unknown if assessed
</td></tr><tr class='code-row'><td class='code-nbr'></td><td class='code-desc'> </td></tr></table></div><div class='content chap10-para'>Each Site-Specific Data Item (SSDI) applies only to selected primary sites, histologies, and years of diagnosis. Depending on applicability and standard-setter requirements, SSDIs may be left blank. </div><a name='3826'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>ESTROGEN RECEPTOR PERCENT POSITIVE OR RANGE </strong></td><td style="text-align:right;font-weight:bold;"><strong>Revised</strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">3826</td><td style="text-align:center;">3</td><td style="text-align:center;"><a href='#sources'>NAACCR</a></td><td style="text-align:center;">2018</td><td style="text-align:center;">18</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1752 - 1754</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>estrogenReceptorPercntPosOrRange</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Estrogen Receptor, Percent Positive Range is the percent of cells staining estrogen receptor positive by IHC.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Estrogen Receptor, Percent Positive Range is a Registry Data Collection Variable in AJCC. It is a new data item for cases diagnosed 1/1/2018+.</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para mark-changed'><table><tr class='code-row'><td class='code-nbr'>000</td><td class='code-desc'>ER negative, or stated as less than 1% </td></tr><tr class='code-row'><td class='code-nbr'>001-100</td><td class='code-desc'>1-100 percent</td></tr><tr class='code-row'><td class='code-nbr'>R10</td><td class='code-desc'>Stated as 1-10%</td></tr><tr class='code-row'><td class='code-nbr'>R20</td><td class='code-desc'>Stated as 11-20%</td></tr><tr class='code-row'><td class='code-nbr'>R30</td><td class='code-desc'>Stated as 21-30%</td></tr><tr class='code-row'><td class='code-nbr'>R40</td><td class='code-desc'>Stated as 31-40%</td></tr><tr class='code-row'><td class='code-nbr'>R50</td><td class='code-desc'>Stated as 41-50%</td></tr><tr class='code-row'><td class='code-nbr'>R60</td><td class='code-desc'>Stated as 51-60%</td></tr><tr class='code-row'><td class='code-nbr'>R70</td><td class='code-desc'>Stated as 61-70%</td></tr><tr class='code-row'><td class='code-nbr'>R80</td><td class='code-desc'>Stated as 71-80%</td></tr><tr class='code-row'><td class='code-nbr'>R90</td><td class='code-desc'>Stated as 81-90%</td></tr><tr class='code-row'><td class='code-nbr'>R99</td><td class='code-desc'>Stated as 91-100%</td></tr><tr class='code-row'><td class='code-nbr'>XX7</td><td class='code-desc'>Test done, results not in chart </td></tr><tr class='code-row'><td class='code-nbr'>XX8</td><td class='code-desc'>Not applicable: Information not collected for this case<br/>
(If this item is required by your standard setter, use of code XX8 will result in an edit error.)
</td></tr><tr class='code-row'><td class='code-nbr'>XX9</td><td class='code-desc'>Not documented in medical record<br/>
Estrogen Receptor, Percent Positive Range not assessed or unknown if assessed
</td></tr><tr class='code-row'><td class='code-nbr' colspan='2'></td></tr></table></div><div class='content chap10-para mark-changed'>Each Site-Specific Data Item (SSDI) applies only to selected primary sites, histologies, and years of diagnosis. Depending on applicability and standard-setter requirements, SSDIs may be left blank.</div><a name='3827'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>ESTROGEN RECEPTOR SUMMARY</strong></td><td style="text-align:right;font-weight:bold;"><strong>Revised</strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">3827</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>NAACCR</a></td><td style="text-align:center;">2018</td><td style="text-align:center;">18</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1743 - 1743</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>estrogenReceptorSummary</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>ER (Estrogen Receptor) Summary is a summary of results of the estrogen receptor (ER) assay.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para mark-changed'>This data item is required for prognostic stage grouping in AJCC 8th edition, Chapter 48, 







<em>Breast</em>. It was previously collected as Breast CS SSF # 1.</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para mark-changed'><table><tr class='code-row'><td class='code-nbr'>0</td><td class='code-desc'>ER negative (0.0% or less than 1%)</td></tr><tr class='code-row'><td class='code-nbr'>1</td><td class='code-desc'>ER positive</td></tr><tr class='code-row'><td class='code-nbr'>7</td><td class='code-desc'>Test ordered, results not in chart</td></tr><tr class='code-row'><td class='code-nbr'>9</td><td class='code-desc'>Not documented in medical record<br/>
Cannot be determined (indeterminate)<br/>
ER (Estrogen Receptor) Summary status not assessed or unknown if assessed
</td></tr><tr class='code-row'><td class='code-nbr'></td><td class='code-desc'> </td></tr></table></div><div class='content chap10-para'>Each Site-Specific Data Item (SSDI) applies only to selected primary sites, histologies, and years of diagnosis. Depending on applicability and standard-setter requirements, SSDIs may be left blank.</div><a name='3828'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>ESTROGEN RECEPTOR TOTAL ALLRED SCORE </strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">3828</td><td style="text-align:center;">2</td><td style="text-align:center;"><a href='#sources'>NAACCR</a></td><td style="text-align:center;">2018</td><td style="text-align:center;">18</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1755 - 1756</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>estrogenReceptorTotalAllredScore</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Estrogen Receptor, Total Allred Score is based on the percentage of cells that stain positive by IHC for estrogen receptor (ER) and the intensity of that staining.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Estrogen Receptor, Total Allred Score is a Registry Data Collection Variable in AJCC. It is a new data item for cases diagnosed 1/1/2018+.</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>00</td><td class='code-desc'>Total ER Allred score of 0 </td></tr><tr class='code-row'><td class='code-nbr'>01</td><td class='code-desc'>Total ER Allred score of 1</td></tr><tr class='code-row'><td class='code-nbr'>02</td><td class='code-desc'>Total ER Allred score of 2</td></tr><tr class='code-row'><td class='code-nbr'>03</td><td class='code-desc'>Total ER Allred score of 3</td></tr><tr class='code-row'><td class='code-nbr'>04</td><td class='code-desc'>Total ER Allred score of 4</td></tr><tr class='code-row'><td class='code-nbr'>05</td><td class='code-desc'>Total ER Allred score of 5</td></tr><tr class='code-row'><td class='code-nbr'>06</td><td class='code-desc'>Total ER Allred score of 6</td></tr><tr class='code-row'><td class='code-nbr'>07</td><td class='code-desc'>Total ER Allred score of 7</td></tr><tr class='code-row'><td class='code-nbr'>08</td><td class='code-desc'>Total ER Allred score of 8</td></tr><tr class='code-row'><td class='code-nbr'>X8</td><td class='code-desc'>Not applicable: Information not collected for this case<br/>
(If this item is required by your standard setter, use of code X8 will result in an edit error.)
</td></tr><tr class='code-row'><td class='code-nbr'>X9</td><td class='code-desc'>Not documented in medical record<br/>
Estrogen Receptor, Total Allred Score not assessed, or unknown if assessed
</td></tr><tr class='code-row'><td class='code-nbr'></td><td class='code-desc'> </td></tr></table></div><div class='content chap10-para'>Each Site-Specific Data Item (SSDI) applies only to selected primary sites, histologies, and years of diagnosis. Depending on applicability and standard-setter requirements, SSDIs may be left blank. </div><a name='779'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>EXTENT OF DISEASE 10-DIG</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">779</td><td style="text-align:center;">12</td><td style="text-align:center;"><a href='#sources'></a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">990 - 1001</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>extentOfDisease10Dig</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>The name for a group of subfields that contain detailed site-specific codes for the anatomic EOD. SEER uses the subfields for tumors diagnosed from January 1, 1988, through December 31, 2003.<br /><br />Group names appear only in the data dictionary and in Appendix E.<strong><br /><br />Subfields</strong><br /><blockquote>EOD--Tumor Size [780]<br />EOD--Extension [790]<br />EOD--Extension Prost Path [800]<br />EOD--Lymph Node Involv [810]<br />Regional Nodes Positive [820]<br />Regional Nodes Examined [830] </blockquote></div><a name='3830'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>EXTRANODAL EXTENSION CLIN (NON-HEAD AND NECK)</strong></td><td style="text-align:right;font-weight:bold;"><strong>Revised</strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">3830</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>NAACCR</a></td><td style="text-align:center;">2018</td><td style="text-align:center;">18</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1922 - 1922</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>extranodalExtensionClin</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Extranodal Extension (ENE) Clinical is defined as "the extension of a nodal metastasis through the lymph node capsule into adjacent tissue" during the diagnostic workup. This data item defines clinical ENE for sites other than Head and Neck.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Extranodal Extension Clinical (non-Head and Neck) is a Registry Data Collection Variable for AJCC. This data item was previously collected for Penis, SSF# 17.</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para mark-changed'><table><tr class='code-row'><td class='code-nbr'>0</td><td class='code-desc'>Regional lymph nodes involved, ENE not present/not identified during diagnostic workup</td></tr><tr class='code-row'><td class='code-nbr'>1</td><td class='code-desc'>Regional lymph nodes involved, ENE present/identified during diagnostic workup, based on physical exam WITH or WITHOUT imaging</td></tr><tr class='code-row'><td class='code-nbr'>2</td><td class='code-desc'>Regional lymph nodes involved, ENE present/identified during diagnostic workup, based on microscopic confirmation</td></tr><tr class='code-row'><td class='code-nbr'>4</td><td class='code-desc'>Regional lymph nodes involved, ENE present/identified, unknown how identified </td></tr><tr class='code-row'><td class='code-nbr'>7</td><td class='code-desc'>No lymph node involvement during diagnostic workup (cN0)</td></tr><tr class='code-row'><td class='code-nbr'>8</td><td class='code-desc'>Not applicable: Information not collected for this case<br/>
(If this information is required by your standard setter, use of code 8 may result in an edit error)
</td></tr><tr class='code-row'><td class='code-nbr'>9</td><td class='code-desc'>Not documented in medical record<br/> 
Clinical ENE not assessed or unknown if assessed during diagnostic workup<br/>
Clinical assessment of lymph nodes not done, or unknown if done
</td></tr><tr class='code-row'><td class='code-nbr' colspan='2'></td></tr></table></div><div class='content chap10-para'>Each Site-Specific Data Item (SSDI) applies only to selected primary sites, histologies, and years of diagnosis. Depending on applicability and standard-setter requirements, SSDIs may be left blank.</div><a name='3831'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>EXTRANODAL EXTENSION HEAD AND NECK CLINICAL</strong></td><td style="text-align:right;font-weight:bold;"><strong>Revised</strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">3831</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>NAACCR</a></td><td style="text-align:center;">2018</td><td style="text-align:center;">18</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1818 - 1818</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>extranodalExtensionHeadNeckClin</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Extranodal extension (ENE) is defined as "the extension of a nodal metastasis through the lymph node capsule into adjacent tissue" and is a prognostic factor for most head and neck tumors. This data item pertains to clinical staging extension.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Extranodal Extension Head and Neck Clinical is a Registry Data Collection Variable in AJCC. It was previously collected as Head and Neck SSF# 8 (Common SSF).</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para mark-changed'><table><tr class='code-row'><td class='code-nbr'>0</td><td class='code-desc'>Regional lymph nodes involved, ENE not present/not identified during diagnostic workup</td></tr><tr class='code-row'><td class='code-nbr'>1</td><td class='code-desc'>Regional lymph nodes involved, ENE present/identified during diagnostic workup, based on physical exam WITH or WITHOUT imaging </td></tr><tr class='code-row'><td class='code-nbr'>2</td><td class='code-desc'>Regional lymph nodes involved, ENE present/identified during diagnostic workup, based on microscopic confirmation</td></tr><tr class='code-row'><td class='code-nbr'>4</td><td class='code-desc'>Regional lymph nodes involved, ENE present/identified, unknown how identified </td></tr><tr class='code-row'><td class='code-nbr'>7</td><td class='code-desc'>No lymph node involvement during diagnostic workup (cN0)</td></tr><tr class='code-row'><td class='code-nbr'>8</td><td class='code-desc'>Not applicable: Information not collected for this case<br/>
(If this information is required by your standard setter, use of code 8 may result in an edit error)
</td></tr><tr class='code-row'><td class='code-nbr'>9</td><td class='code-desc'>Not documented in medical record<br/>
ENE not assessed during diagnostic workup, or unknown if assessed<br/>
Clinical assessment of lymph nodes not done, or unknown if done
</td></tr><tr class='code-row'><td class='code-nbr' colspan='2'></td></tr></table></div><div class='content chap10-para mark-changed'>Each Site-Specific Data Item (SSDI) applies only to selected primary sites, histologies, and years of diagnosis. Depending on applicability and standard-setter requirements, SSDIs may be left blank.</div><a name='3832'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>EXTRANODAL EXTENSION HEAD AND NECK PATHOLOGICAL</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">3832</td><td style="text-align:center;">3</td><td style="text-align:center;"><a href='#sources'>NAACCR</a></td><td style="text-align:center;">2018</td><td style="text-align:center;">18</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1819 - 1821</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>extranodalExtensionHeadNeckPath</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Extranodal extension (ENE) is defined as "the extension of a nodal metastasis through the lymph node capsule into adjacent tissue" and is a prognostic factor for most head and neck tumors. This data item pertains to pathological staging extension.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Extranodal Extension Head and Neck Pathological is a Registry Data Collection Variable in AJCC. It was previously collected as Head and Neck SSF# 9 (Common SSF).</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>0.0</td><td class='code-desc'>Lymph nodes positive for cancer but ENE not identified or negative </td></tr><tr class='code-row'><td class='code-nbr'>0.1-9.9</td><td class='code-desc'>ENE 0.1 to 9.9 mm </td></tr><tr class='code-row'><td class='code-nbr'>X.1</td><td class='code-desc'>ENE 10 mm or greater </td></tr><tr class='code-row'><td class='code-nbr'>X.2</td><td class='code-desc'>ENE microscopic, size unknown<br/>
Stated as ENE (mi)
</td></tr><tr class='code-row'><td class='code-nbr'>X.3</td><td class='code-desc'>ENE major, size unknown<br/>
Stated as ENE (ma)
</td></tr><tr class='code-row'><td class='code-nbr'>X.4</td><td class='code-desc'>ENE present, microscopic or major unknown, size unknown</td></tr><tr class='code-row'><td class='code-nbr'>X.7</td><td class='code-desc'>Surgically resected regional lymph nodes negative for cancer (pN0)</td></tr><tr class='code-row'><td class='code-nbr'>X.8</td><td class='code-desc'>Not applicable: Information not collected for this case<br/>
(If this information is required by your standard setter, use of code X.8 may result in an edit error)
</td></tr><tr class='code-row'><td class='code-nbr'>X.9</td><td class='code-desc'>Not documented in medical record<br/>
No surgical resection of regional lymph nodes<br/>
ENE not assessed pathologically, or unknown if assessed<br/>
Pathological assessment of lymph nodes not done, or unknown if done

</td></tr><tr class='code-row'><td class='code-nbr'></td><td class='code-desc'> </td></tr></table></div><div class='content chap10-para'>Each Site-Specific Data Item (SSDI) applies only to selected primary sites, histologies, and years of diagnosis. Depending on applicability and standard-setter requirements, SSDIs may be left blank. </div><a name='3833'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>EXTRANODAL EXTENSION PATH (NON-HEAD AND NECK)</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">3833</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>NAACCR</a></td><td style="text-align:center;">2018</td><td style="text-align:center;">18</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1923 - 1923</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>extranodalExtensionPath</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'><div> Extranodal Extension Pathological is defined as "the extension of a nodal metastasis through the lymph node capsule into adjacent tissue" identified as part of the surgical resection. This data item defines pathological ENE for sites other than Head and Neck. </div></div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Extranodal Extension Pathological (non-Head and Neck) is a Registry Data Collection Variable for AJCC. This data item was previously collected for Penis, SSF# 17.</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>0</td><td class='code-desc'>Regional lymph nodes involved, ENE not present/not identified from surgical resection</td></tr><tr class='code-row'><td class='code-nbr'>1</td><td class='code-desc'>Regional lymph nodes involved, ENE present/identified from surgical resection</td></tr><tr class='code-row'><td class='code-nbr'>7</td><td class='code-desc'>No lymph node involvement from surgical resection (pN0)</td></tr><tr class='code-row'><td class='code-nbr'>8</td><td class='code-desc'>Not applicable: Information not collected for this case<br/>
(If this information is required by your standard setter, use of code 8 may result in an edit error)
</td></tr><tr class='code-row'><td class='code-nbr'>9</td><td class='code-desc'>Not documented in medical record<br/>
No surgical resection of regional lymph nodes<br/>
Cannot be determined<br/>
Pathological assessment of lymph nodes not done, or unknown if done<br/>
Extranodal Extension Pathological not assessed or unknown if assessed
</td></tr><tr class='code-row'><td class='code-nbr'></td><td class='code-desc'> </td></tr></table></div><div class='content chap10-para'>Each Site-Specific Data Item (SSDI) applies only to selected primary sites, histologies, and years of diagnosis. Depending on applicability and standard-setter requirements, SSDIs may be left blank. </div><a name='3834'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>EXTRAVASCULAR MATRIX PATTERNS </strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">3834</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>NAACCR</a></td><td style="text-align:center;">2018</td><td style="text-align:center;">18</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1876 - 1876</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>extravascularMatrixPatterns</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Extravascular Matrix Patterns, the presence of loops and networks in extracellular matrix patterns, is a prognostic factor for uveal melanoma.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Extravascular Matrix Pattern is a Registry Data Collection Variable in AJCC 8. This data item was previously collected as Uveal Melanoma, CS SSF #11 and CS SSF# 12. These two data items were combined and simplified into one data for cases diagnosed 1/1/2018+.</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>0</td><td class='code-desc'>Extravascular matrix pattern not present/not identified </td></tr><tr class='code-row'><td class='code-nbr'>1</td><td class='code-desc'>Extravascular matrix pattern present/identified</td></tr><tr class='code-row'><td class='code-nbr'>8</td><td class='code-desc'>Not applicable: Information not collected for this case<br/>
(If this information is required by your standard setter, use of code 8 may result in an edit error.)
</td></tr><tr class='code-row'><td class='code-nbr'>9</td><td class='code-desc'>Not documented in medical record<br/>
Extravascular Matrix Pattern not assessed or unknown if assessed
</td></tr><tr class='code-row'><td class='code-nbr'></td><td class='code-desc'> </td></tr></table></div><div class='content chap10-para'>Each Site-Specific Data Item (SSDI) applies only to selected primary sites, histologies, and years of diagnosis. Depending on applicability and standard-setter requirements, SSDIs may be left blank. </div><a name='360'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>FAMILY HISTORY OF CANCER</strong></td><td style="text-align:right;font-weight:bold;"><strong>Retired</strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">360</td><td style="text-align:center;"></td><td style="text-align:center;"><a href='#sources'></a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;">2010</td><td style="text-align:center;">12</td><td class="cross-out" style="text-align:center;"></td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td></td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td></td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>The NAACCR UDSC retired this data item in Version 12, as of January 1, 2010.</div><a name='3835'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>FIBROSIS SCORE</strong></td><td style="text-align:right;font-weight:bold;"><strong>Revised</strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">3835</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>NAACCR</a></td><td style="text-align:center;">2018</td><td style="text-align:center;">18</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1862 - 1862</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>fibrosisScore</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Fibrosis Score, the degree of fibrosis of the liver based on pathological examination, is a prognostic factor for liver cancer.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Fibrosis Score is a Registry Data Collection Variable in AJCC. This data item was previously collected for Liver, CS SSF# 2.</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para mark-changed'><table><tr class='code-row'><td class='code-nbr'>0</td><td class='code-desc'>Any of the following histologically confirmed<br/> 
<br/>
No to moderate fibrosis<br/>
<br/>
Ishak fibrosis score 0-4<br/>
METAVIR score F0-F3<br/>
Batt-Ludwig score 0-3</td></tr><tr class='code-row'><td class='code-nbr'>1</td><td class='code-desc'>Any of the following histologically confirmed<br/>
<br/>
Advanced/severe fibrosis<br/>
Developing cirrhosis<br/>
Incomplete cirrhosis<br/>
Transition to cirrhosis<br/>
Cirrhosis, probable or definite<br/>
Cirrhosis, NOS<br/>
<br/>
Ishak fibrosis score 5-6><br/>
METAVIR score F4<br/>
Batt-Ludwig score 4</td></tr><tr class='code-row'><td class='code-nbr'>7</td><td class='code-desc'>Clinical statement of advanced/severe fibrosis or cirrhosis, AND<br/>
Not histologically confirmed or unknown if histologically confirmed</td></tr><tr class='code-row'><td class='code-nbr'>8</td><td class='code-desc'>Not applicable: Information not collected for this case<br/>
(If this item is required by your standard setter, use of code 8 will result in an edit error.)
</td></tr><tr class='code-row'><td class='code-nbr'>9</td><td class='code-desc'>Not documented in medical record<br/>
Stated in medical record that patient does not have advanced cirrhosis/advanced fibrosis, not histologically confirmed or unknown if histologically confirmed<br/>
Fibrosis score stated but cannot be assigned to codes 0 or 1<br/>
Fibrosis score stated but scoring system not recorded<br/>
Fibrosis Score not assessed or unknown if assessed<br/>
</td></tr><tr class='code-row'><td class='code-nbr'></td><td class='code-desc'> </td></tr></table></div><div class='content chap10-para mark-changed'>Each Site-Specific Data Item (SSDI) applies only to selected primary sites, histologies, and years of diagnosis. Depending on applicability and standard-setter requirements, SSDIs may be left blank.</div><a name='3836'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>FIGO STAGE</strong></td><td style="text-align:right;font-weight:bold;"><strong>Revised</strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">3836</td><td title="V: 22: 5
V: 18: 2
" class=" HighlightToolTip" style="text-align:center;">5</td><td style="text-align:center;"><a href='#sources'>NAACCR</a></td><td style="text-align:center;">2018</td><td style="text-align:center;">18</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td title="V: 22: 1 - 5
V: 18: 1816 - 1817
" class="cross-out HighlightToolTip" style="text-align:center;">1 - 5</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>figoStage</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Federation Internationale de Gynecologie et d'Obstetrique (FIGO) is a staging system for female reproductive cancers.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'><!--[if gte mso 10]>  <![endif]-->FIGO stage is a Registry Data Collection Variable in AJCC for the female genital cancers. This data item was previously collected for the female genital cancers as: Vulva SSF #10, Vagina SSF #1, Cervix SSF #1, Corpus Carcinoma SSF #1, Corpus Sarcoma SSF #1, Ovary SSF #2, Fallopian Tube SSF #1, Peritoneum Female Genital SSF #1, and Placenta SSF #2.</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para mark-changed'><table><tr class='code-row'><td class='code-nbr'>1</td><td class='code-desc'>FIGO Stage I </td></tr><tr class='code-row'><td class='code-nbr'>1A</td><td class='code-desc'>FIGO Stage IA </td></tr><tr class='code-row'><td class='code-nbr'>1A1</td><td class='code-desc'>FIGO Stage IA1</td></tr><tr class='code-row'><td class='code-nbr'>1A2</td><td class='code-desc'>FIGO Stage IA2</td></tr><tr class='code-row'><td class='code-nbr'>1B</td><td class='code-desc'>FIGO Stage IB</td></tr><tr class='code-row'><td class='code-nbr'>1B1</td><td class='code-desc'>FIGO Stage IB1</td></tr><tr class='code-row'><td class='code-nbr'>1B2</td><td class='code-desc'>FIGO Stage IB2</td></tr><tr class='code-row'><td class='code-nbr'>1B3</td><td class='code-desc'>FIGO Stage IB3 </td></tr><tr class='code-row'><td class='code-nbr'>1C</td><td class='code-desc'>FIGO Stage IC</td></tr><tr class='code-row'><td class='code-nbr'>1C1</td><td class='code-desc'>FIGO Stage IC1</td></tr><tr class='code-row'><td class='code-nbr'>IC2</td><td class='code-desc'>FIGO Stage IC2</td></tr><tr class='code-row'><td class='code-nbr'>1C3</td><td class='code-desc'>FIGO Stage IC3</td></tr><tr class='code-row'><td class='code-nbr'>2</td><td class='code-desc'>FIGO Stage II</td></tr><tr class='code-row'><td class='code-nbr'>2A</td><td class='code-desc'>FIGO Stage IIA</td></tr><tr class='code-row'><td class='code-nbr'>2A1</td><td class='code-desc'>FIGO Stage IIA1</td></tr><tr class='code-row'><td class='code-nbr'>2A2</td><td class='code-desc'>FIGO Stage IIA2</td></tr><tr class='code-row'><td class='code-nbr'>2B</td><td class='code-desc'>FIGO Stage IIB</td></tr><tr class='code-row'><td class='code-nbr'>3</td><td class='code-desc'>FIGO Stage III</td></tr><tr class='code-row'><td class='code-nbr'>3A</td><td class='code-desc'>FIGO Stage IIIA</td></tr><tr class='code-row'><td class='code-nbr'>3A1</td><td class='code-desc'>FIGO Stage IIIA1</td></tr><tr class='code-row'><td class='code-nbr'>3A11</td><td class='code-desc'>FIGO Stage IIIAi</td></tr><tr class='code-row'><td class='code-nbr'>3A12</td><td class='code-desc'>FIGO Stage IIIAii</td></tr><tr class='code-row'><td class='code-nbr'>3A2</td><td class='code-desc'>FIGO Stage IIIA2</td></tr><tr class='code-row'><td class='code-nbr'>3B</td><td class='code-desc'>FIGO Stage IIIB</td></tr><tr class='code-row'><td class='code-nbr'>3C</td><td class='code-desc'>FIGO Stage IIIC</td></tr><tr class='code-row'><td class='code-nbr'>3C1</td><td class='code-desc'>FIGO Stage IIIC1</td></tr><tr class='code-row'><td class='code-nbr'>3C2</td><td class='code-desc'>FIGO Stage IIIC2</td></tr><tr class='code-row'><td class='code-nbr'>4</td><td class='code-desc'>FIGO Stage IV</td></tr><tr class='code-row'><td class='code-nbr'>4A</td><td class='code-desc'>FIGO Stage IVA</td></tr><tr class='code-row'><td class='code-nbr'>4B</td><td class='code-desc'>FIGO Stage IVB</td></tr><tr class='code-row'><td class='code-nbr'>97</td><td class='code-desc'>Not applicable: Carcinoma in situ (intraepithelial, noninvasive, preinvasive) </td></tr><tr class='code-row'><td class='code-nbr'>98</td><td class='code-desc'>Not applicable: Information not collected for this case<br/>
If this item is required by your standard setter, use of code 98 will result in an edit error.)
</td></tr><tr class='code-row'><td class='code-nbr'>99</td><td class='code-desc'>Not documented in medical record<br/>
FIGO stage unknown, not assessed or unknown if assessed
</td></tr><tr class='code-row'><td class='code-nbr'></td><td class='code-desc'> </td></tr></table></div><div class='content chap10-para'>Each Site-Specific Data Item (SSDI) applies only to selected primary sites, histologies, and years of diagnosis. Depending on applicability and standard-setter requirements, SSDIs may be left blank.</div><a name='35'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>FIN CODING SYSTEM</strong></td><td style="text-align:right;font-weight:bold;"><strong>Retired</strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">35</td><td style="text-align:center;"></td><td style="text-align:center;"><a href='#sources'></a></td><td style="text-align:center;">2001</td><td style="text-align:center;">7</td><td style="text-align:center;">2012</td><td style="text-align:center;">12.2</td><td class="cross-out" style="text-align:center;"></td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td></td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td></td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>The NAACCR UDSC retired this data item in Version 12.2, as of January 1, 2012.</div><a name='1500'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>FIRST COURSE CALC METHOD</strong></td><td style="text-align:right;font-weight:bold;"><strong>Retired</strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">1500</td><td style="text-align:center;"></td><td style="text-align:center;"><a href='#sources'></a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;">2013</td><td style="text-align:center;">13</td><td class="cross-out" style="text-align:center;"></td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td></td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td></td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>The NAACCR UDSC retired this data item in Version 13, as of January 1, 2013.</div><a name='2440'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>FOLLOWING REGISTRY</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">2440</td><td style="text-align:center;">10</td><td style="text-align:center;"><a href='#sources'>CoC</a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">4915 - 4924</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>followingRegistry</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Records the FIN of the registry responsible for following the patient. </div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'><div>The number is essential to NCDB for monitoring data submissions, ensuring the accuracy of data, and identifying areas for special studies. </div><div> &nbsp;</div><div><strong>Instructions for Coding</strong><br />CoC maintains the codes, including those for non-hospital sources of reporting.<br /><br />For facilities with 7-digit FINs, consisting of a constant &#8220;6&#8221; followed by 6-digit facility-specific codes in the range of 6020009-6953290 that were assigned by CoC before January 1, 2001: Enter all FIN codes of this type as 3 zeroes, followed by the constant &#8220;6&#8221; and the 6-digit facility-specific codes.<br /><br />For facilities with FINs greater than or equal to 10000000 that were assigned by CoC after January 1, 2001: Enter FIN codes of this type as 2 zeroes followed by the full 8-digit code. These sometimes are called CoC FIN 10-digit codes. &nbsp;</div> </div><div class='content chap10-para'><!--[if gte mso 10]>  <![endif]-->
<!--[if gte mso 10]>  <![endif]-->
<em>Note</em>: This item is not supported by CoC as of January 1, 2010, (the respective NPI item is required). </div><div class='content chap10-para'><strong>Codes (in addition to CoC assigned codes) </strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>0000000000</td><td class='code-desc'>Case not reported by a facility</td></tr><tr class='code-row'><td class='code-nbr'>0099999999</td><td class='code-desc'>Case reported, but facility number is unknown</td></tr></table></div><a name='1842'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>FOLLOW-UP CONTACT--CITY</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">1842</td><td style="text-align:center;">50</td><td style="text-align:center;"><a href='#sources'>SEER</a></td><td style="text-align:center;">1997</td><td style="text-align:center;">5.1</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">2879 - 2928</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>followUpContactCity</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Name of the city of the follow-up contact&#8217;s current usual residence. If the patient has multiple tumors, the follow-up contact city of residence should be the same for all tumors. </div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Sometimes registries carry out follow-up by contacting the patient and other contacts by a letter or phone call to ascertain their vital status. When a patient's current address is unknown or the patient is for some reason not to be contacted (e.g., patient is a minor child), the most current name, address and phone number of another contact, such as a relative or neighbor are needed. This information may also be useful for conducting research studies. </div><a name='1847'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>FOLLOWUP CONTACT--COUNTRY</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">1847</td><td style="text-align:center;">3</td><td style="text-align:center;"><a href='#sources'>NAACCR</a></td><td style="text-align:center;">2013</td><td style="text-align:center;">13</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">475 - 477</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>followupContactCountry</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Country code for the address of follow-up contact&#8217;s current usual residence. If the patient has multiple tumors, the country of follow-up contact residence should be the same for all tumors. This data item became part of the NAACCR transmission record effective with Volume II, Version 13 in order to include country and state for each geographic item and to use interoperable codes.  It supplements the item FOLLOW UP CONTACT--STATE [1844]. </div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Country of patient&#8217;s residence at follow-up is an important element of patient&#8217;s residential history profile and is useful for understanding risk factors, assessment of patient prognosis, and chances for survival. </div><div class='content chap10-para'><strong>Codes </strong>  <br />Use the International Standards Organization (ISO) 3166-1 Country Three Character Codes, whenever possible, augmented by custom codes. See Appendix B for complete list of country names and corresponding three character alpha codes.</div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr' colspan='2'>Custom codes for historic use only</td></tr><tr class='code-row'><td class='code-nbr'>ZZN</td><td class='code-desc'>North America NOS</td></tr><tr class='code-row'><td class='code-nbr'>ZZC</td><td class='code-desc'>Central America NOS</td></tr><tr class='code-row'><td class='code-nbr'>ZZS</td><td class='code-desc'>South America NOS</td></tr><tr class='code-row'><td class='code-nbr'>ZZP</td><td class='code-desc'>Pacific NOS</td></tr><tr class='code-row'><td class='code-nbr'>ZZE</td><td class='code-desc'>Europe NOS</td></tr><tr class='code-row'><td class='code-nbr'>ZZF</td><td class='code-desc'>Africa NOS</td></tr><tr class='code-row'><td class='code-nbr'>ZZA</td><td class='code-desc'>Asia NOS</td></tr><tr class='code-row'><td class='code-nbr'>ZZX</td><td class='code-desc'>Non-US NOS</td></tr><tr class='code-row'><td class='code-nbr'>ZZU</td><td class='code-desc'>Unknown
</td></tr><tr class='code-row'><td class='code-nbr' colspan='2'>Custom codes for historic use only</td></tr><tr class='code-row'><td class='code-nbr'>XNI</td><td class='code-desc'>North American Islands
</td></tr><tr class='code-row'><td class='code-nbr'>XCB</td><td class='code-desc'>Other Caribbean Islands</td></tr><tr class='code-row'><td class='code-nbr'>XEN</td><td class='code-desc'>England, Channel Islands, Isle of Man
</td></tr><tr class='code-row'><td class='code-nbr'>XSC</td><td class='code-desc'>Scandinavia
</td></tr><tr class='code-row'><td class='code-nbr'>XGR</td><td class='code-desc'>Germanic Countries
</td></tr><tr class='code-row'><td class='code-nbr'>XSL</td><td class='code-desc'>Slavic Countries</td></tr><tr class='code-row'><td class='code-nbr'>CSK</td><td class='code-desc'>Czechoslovakia (former)
</td></tr><tr class='code-row'><td class='code-nbr'>YUG</td><td class='code-desc'>Yugoslavia (former)</td></tr><tr class='code-row'><td class='code-nbr'>XUM</td><td class='code-desc'>Ukraine and Moldova</td></tr><tr class='code-row'><td class='code-nbr'>XNF</td><td class='code-desc'>North Africa</td></tr><tr class='code-row'><td class='code-nbr'>XSD</td><td class='code-desc'>Sudanese Countries</td></tr><tr class='code-row'><td class='code-nbr'>XWF</td><td class='code-desc'>West Africa</td></tr><tr class='code-row'><td class='code-nbr'>XSF</td><td class='code-desc'>South Africa</td></tr><tr class='code-row'><td class='code-nbr'>XEF</td><td class='code-desc'>East Africa</td></tr><tr class='code-row'><td class='code-nbr'>XIF</td><td class='code-desc'>African Islands</td></tr><tr class='code-row'><td class='code-nbr'>XET</td><td class='code-desc'>Ethiopia and Eritrea</td></tr><tr class='code-row'><td class='code-nbr'>XAP</td><td class='code-desc'>Arabian Peninsula</td></tr><tr class='code-row'><td class='code-nbr'>XIS</td><td class='code-desc'>Israel and Palestine</td></tr><tr class='code-row'><td class='code-nbr'>XCR</td><td class='code-desc'>Caucasian Republics of former USSR</td></tr><tr class='code-row'><td class='code-nbr'>XOR</td><td class='code-desc'>Other Asian Republics of former USSR</td></tr><tr class='code-row'><td class='code-nbr'>XSE</td><td class='code-desc'>Southeast Asia</td></tr><tr class='code-row'><td class='code-nbr'>XMS</td><td class='code-desc'>Malaysia, Singapore, Brunei</td></tr><tr class='code-row'><td class='code-nbr'>XCH</td><td class='code-desc'>China, NOS</td></tr><tr class='code-row'><td class='code-nbr'>XML</td><td class='code-desc'>Melanesian Islands</td></tr><tr class='code-row'><td class='code-nbr'>XMC</td><td class='code-desc'>Micronesian Islands</td></tr><tr class='code-row'><td class='code-nbr'>XPL</td><td class='code-desc'>Polynesian Islands</td></tr><tr class='code-row'><td class='code-nbr'></td><td class='code-desc'> </td></tr></table></div><a name='2394'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>FOLLOW-UP CONTACT--NAME</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">2394</td><td style="text-align:center;">60</td><td style="text-align:center;"><a href='#sources'>SEER</a></td><td style="text-align:center;">1997</td><td style="text-align:center;">5.1</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">4604 - 4663</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>followUpContactName</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>First and last name, in natural order, of a person, other than the patient or a physician, who can be contacted to obtain follow-up information for the patient. If the patient has multiple tumors, Follow-up Contact-Name should be the same for all tumors. </div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Sometimes registries carry out follow-up by contacting the patient and other contacts by a letter or phone call to ascertain their vital status. When a patient's current address is unknown or the patient is for some reason not to be contacted (e.g., patient is a minor child), the most current name, address and phone number of another contact, such as a relative or neighbor are needed. This information may also be useful for conducting research studies. </div><a name='2392'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>FOLLOW-UP CONTACT--NO&ST</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">2392</td><td style="text-align:center;">60</td><td style="text-align:center;"><a href='#sources'>SEER</a></td><td style="text-align:center;">1997</td><td style="text-align:center;">5.1</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">4664 - 4723</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>followUpContactNost</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>The number and street address or the rural mailing address of the follow-up contact&#8217;s current usual residence. This can be used to generate a follow-up inquiry, and must correspond to the other fields in the follow-up contact address. If the patient has multiple tumors, Follow-Up Contact--No&amp;St should be the same for all tumors.<br /><br />U.S. addresses should conform to the USPS <em>Postal Addressing Standards</em>. These standards are referenced in USPS Pub. 28, November 2000, <em>Postal Addressing Standards</em>. The current USPS Pub. 28 may be found and downloaded from the following website: <a href="http://pe.usps.gov/cpim/ftp/pubs/Pub28/pub28.pdf">http://pe.usps.gov/cpim/ftp/pubs/Pub28/pub28.pdf</a>.<br /><br />Canadian addresses should conform to the <em>Canada Postal Guide</em>. The current Canadian Postal Address standards may be found at the following website: <a target="_blank" href="http://www.canadapost.ca">http://www.canadapost.ca</a>. </div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Sometimes registries carry out follow-up by contacting the patient and other contacts by a letter or phone call to ascertain their vital status. When a patient's current address is unknown or the patient is for some reason not to be contacted (e.g., patient is a minor child), the most current name, address and phone number of another contact, such as a relative or neighbor are needed. This information may also be useful for conducting research studies. </div><div class='content chap10-para'><em>Note:</em> Prior to Version 5, Follow-Up Contact fields may have been used for patient current address in the NAACCR record layout. </div><a name='1846'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>FOLLOW-UP CONTACT--POSTAL</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">1846</td><td style="text-align:center;">9</td><td style="text-align:center;"><a href='#sources'>SEER</a></td><td style="text-align:center;">1997</td><td style="text-align:center;">5.1</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">2931 - 2939</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>followUpContactPostal</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Postal code for the address of the follow-up contact&#8217;s current usual residence. If the patient has multiple tumors, the Follow-up Contact-Postal should be the same for all tumors. For U.S. residents, use either the 5-digit or the extended 9-digit ZIP code. Blanks follow the 5-digit code. For Canadian residents, use the 6-character, alphanumeric postal code. Blanks follow the 6-character code. When available, enter postal code for other countries. </div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Sometimes registries carry out follow-up by contacting the patient and other contacts by a letter or phone call to ascertain their vital status. When a patient's current address is unknown or the patient is for some reason not to be contacted (e.g., patient is a minor child), the most current name, address and phone number of another contact, such as a relative or neighbor are needed. This information may also be useful for conducting research studies. </div><div class='content chap10-para'><strong>Codes (in addition to U.S., Canadian, and foreign postal codes) </strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>888888888</td><td class='code-desc'>Resident of country other than the United States (including its possessions, etc.) or Canada, and postal code unknown</td></tr><tr class='code-row'><td class='code-nbr'>999999999</td><td class='code-desc'>Resident of the United States (including its possessions, etc.) or Canada, and postal code unknown</td></tr></table></div><a name='1844'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>FOLLOW-UP CONTACT--STATE</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">1844</td><td style="text-align:center;">2</td><td style="text-align:center;"><a href='#sources'>SEER</a></td><td style="text-align:center;">1997</td><td style="text-align:center;">5.1</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">2929 - 2930</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>followUpContactState</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>USPS abbreviation for the state (including U.S. territories, commonwealths, or possessions), or Canada Post abbreviation for the Canadian province/territory of the follow-up contact&#8217;s current usual residence. If the patient has multiple tumors, the follow-up contact state should be the same for all tumors. Effective with NAACCR Volume II, Version 13, a new data item, FollowUp Contact--Country [1847] was added to the standard transmission record layout. The UDS Committee expects the new item to supplement the use of Follow-Up Contact--State [1844]. </div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Sometimes registries carry out follow-up by contacting the patient and other contacts by a letter or phone call to ascertain their vital status. When a patient's current address is unknown or the patient is for some reason not to be contacted (e.g., patient is a minor child), the most current name, address and phone number of another contact, such as a relative or neighbor are needed. This information may also be useful for conducting research studies. </div><div class='content chap10-para'><strong>Codes (in addition to USPS and Canadian Postal Service abbreviations) </strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>CD</td><td class='code-desc'>Resident of Canada, NOS (province/territory unknown)</td></tr><tr class='code-row'><td class='code-nbr'>US</td><td class='code-desc'>Resident of United States, NOS (state/commonwealth/territory/possession unknown)</td></tr><tr class='code-row'><td class='code-nbr'>XX</td><td class='code-desc'>Resident of country other than the United States (including its territories, commonwealths, or possessions) or Canada, and country is known</td></tr><tr class='code-row'><td class='code-nbr'>YY</td><td class='code-desc'>Resident of country other than the United States (including its territories, commonwealths, or possessions) or Canada, and country is unknown</td></tr><tr class='code-row'><td class='code-nbr'>ZZ</td><td class='code-desc'>Residence unknown</td></tr></table></div><a name='2393'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>FOLLOW-UP CONTACT--SUPPL</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">2393</td><td style="text-align:center;">60</td><td style="text-align:center;"><a href='#sources'>SEER</a></td><td style="text-align:center;">2003</td><td style="text-align:center;">10</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">4724 - 4783</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>followUpContactSuppl</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>This data item provides the ability to store additional address information such as the name of a place or facility, a nursing home, or the name of an apartment complex. It can be used to generate a follow-up inquiry, and must correspond to the other fields in the follow-up contact address. If the patient has multiple tumors, Follow-Up Contact--Suppl should be the same for all tumors. </div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Sometimes registries carry out follow-up by contacting the patient and other contacts by a letter or phone call to ascertain their vital status. When a patient's current address is unknown or the patient is for some reason not to be contacted (e.g., patient is a minor child), the most current name, address and phone number of another contact, such as a relative or neighbor are needed. This information may also be useful for conducting research studies. </div><a name='1790'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>FOLLOW-UP SOURCE</strong></td><td style="text-align:right;font-weight:bold;"><strong>Revised</strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">1790</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>CoC</a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">2801 - 2801</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>Follow-Up Method (pre-96 CoC)<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>followUpSource</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para mark-changed'>Records the source from which the latest follow-up information was obtained.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para mark-changed'>For registries performing follow-up, this field helps evaluate the success rates of various methods of follow-up. It also can be used to report to institutions the source of follow-up information that is sent to them. When there is a conflict in follow-up information, knowing the source can help resolve the inconsistency.</div><div class='content chap10-para'><strong>Codes </strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>0</td><td class='code-desc'>Reported hospitalization</td></tr><tr class='code-row'><td class='code-nbr'>1</td><td class='code-desc'>Readmission</td></tr><tr class='code-row'><td class='code-nbr'>2</td><td class='code-desc'>Physician</td></tr><tr class='code-row'><td class='code-nbr'>3</td><td class='code-desc'>Patient</td></tr><tr class='code-row'><td class='code-nbr'>4</td><td class='code-desc'>Department of Motor Vehicles</td></tr><tr class='code-row'><td class='code-nbr'>5</td><td class='code-desc'>Medicare/Medicaid file</td></tr><tr class='code-row'><td class='code-nbr'>7</td><td class='code-desc'>Death certificate</td></tr><tr class='code-row'><td class='code-nbr'>8</td><td class='code-desc'>Other</td></tr><tr class='code-row'><td class='code-nbr'>9</td><td class='code-desc'>Unknown, not stated in patient record</td></tr></table></div><a name='1791'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>FOLLOW-UP SOURCE CENTRAL</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">1791</td><td style="text-align:center;">2</td><td style="text-align:center;"><a href='#sources'>NAACCR</a></td><td style="text-align:center;">2006</td><td style="text-align:center;">11</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">2951 - 2952</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>followUpSourceCentral</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>This field is created by the central registry. It records the source from which the consolidated information was obtained on a patient's vital status and date of last contact. Follow-up Source Central would be updated when new or more reliable information becomes available. However, when the existing date of last contact/vital status is deemed to be more reliable than newly obtained information, then neither the date of last contact/vital status nor the follow-up source central would be changed. </div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>For central registries performing follow-up, this field could help evaluate the success rates of various methods of follow-up. When new follow-up information conflicts with the existing information, knowing the follow-up source can help resolve any discrepancies. </div><div class='content chap10-para'><strong>&#160;Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>00</td><td class='code-desc'>Follow-up not performed for this patient</td></tr><tr class='code-row'><td class='code-nbr'>(01-29)</td><td class='code-desc'>File Linkages</td></tr><tr class='code-row'><td class='code-nbr'>01</td><td class='code-desc'>Medicare/Medicaid File</td></tr><tr class='code-row'><td class='code-nbr'>02</td><td class='code-desc'>Center for Medicare and Medicaid Services (CMS, formerly HCFA)</td></tr><tr class='code-row'><td class='code-nbr'>03</td><td class='code-desc'>Department of Motor Vehicle Registration</td></tr><tr class='code-row'><td class='code-nbr'>04</td><td class='code-desc'>National Death Index (NDI)</td></tr><tr class='code-row'><td class='code-nbr'>05</td><td class='code-desc'>State Death Tape/Death Certificate File</td></tr><tr class='code-row'><td class='code-nbr'>06</td><td class='code-desc'>County/Municipality Death Tape/ Death Certificate File</td></tr><tr class='code-row'><td class='code-nbr'>07</td><td class='code-desc'>Social Security Administration Death Master File</td></tr><tr class='code-row'><td class='code-nbr'>08</td><td class='code-desc'>Hospital Discharge Data</td></tr><tr class='code-row'><td class='code-nbr'>09</td><td class='code-desc'>Health Maintenance Organization (HMO) file</td></tr><tr class='code-row'><td class='code-nbr'>10</td><td class='code-desc'>Social Security Epidemiological Vital Status Data</td></tr><tr class='code-row'><td class='code-nbr'>11</td><td class='code-desc'>Voter Registration File</td></tr><tr class='code-row'><td class='code-nbr'>12</td><td class='code-desc'>Research/Study Related Linkage</td></tr><tr class='code-row'><td class='code-nbr'>29</td><td class='code-desc'>Linkages, NOS</td></tr><tr class='code-row'><td class='code-nbr'>(30-39)</td><td class='code-desc'>Hospitals and Treatment Facilities</td></tr><tr class='code-row'><td class='code-nbr'>30</td><td class='code-desc'>Hospital in-patient/outpatient</td></tr><tr class='code-row'><td class='code-nbr'>31</td><td class='code-desc'>Casefinding</td></tr><tr class='code-row'><td class='code-nbr'>32</td><td class='code-desc'>Hospital cancer registry</td></tr><tr class='code-row'><td class='code-nbr'>33</td><td class='code-desc'>Radiation treatment center</td></tr><tr class='code-row'><td class='code-nbr'>34</td><td class='code-desc'>Oncology clinic</td></tr><tr class='code-row'><td class='code-nbr'>35</td><td class='code-desc'>Ambulatory surgical center</td></tr><tr class='code-row'><td class='code-nbr'>39</td><td class='code-desc'>Clinic/facility, NOS</td></tr><tr class='code-row'><td class='code-nbr'>(40-49)</td><td class='code-desc'>Physicians</td></tr><tr class='code-row'><td class='code-nbr'>40</td><td class='code-desc'>Attending physician</td></tr><tr class='code-row'><td class='code-nbr'>41</td><td class='code-desc'>Medical oncologist</td></tr><tr class='code-row'><td class='code-nbr'>42</td><td class='code-desc'>Radiation oncologist</td></tr><tr class='code-row'><td class='code-nbr'>43</td><td class='code-desc'>Surgeon</td></tr><tr class='code-row'><td class='code-nbr'>48</td><td class='code-desc'>Other specialist</td></tr><tr class='code-row'><td class='code-nbr'>49</td><td class='code-desc'>Physician, NOS</td></tr><tr class='code-row'><td class='code-nbr'>(50-59)</td><td class='code-desc'>Patient</td></tr><tr class='code-row'><td class='code-nbr'>50</td><td class='code-desc'>Patient contact</td></tr><tr class='code-row'><td class='code-nbr'>51</td><td class='code-desc'>Relative contact</td></tr><tr class='code-row'><td class='code-nbr'>59</td><td class='code-desc'>Patient, NOS</td></tr><tr class='code-row'><td class='code-nbr'>(60-98)</td><td class='code-desc'>Other</td></tr><tr class='code-row'><td class='code-nbr'>60</td><td class='code-desc'>Central or Regional cancer registry</td></tr><tr class='code-row'><td class='code-nbr'>61</td><td class='code-desc'>Internet sources</td></tr><tr class='code-row'><td class='code-nbr'>62</td><td class='code-desc'>Hospice</td></tr><tr class='code-row'><td class='code-nbr'>63</td><td class='code-desc'>Nursing homes</td></tr><tr class='code-row'><td class='code-nbr'>64</td><td class='code-desc'>Obituary</td></tr><tr class='code-row'><td class='code-nbr'>65</td><td class='code-desc'>Other research/study related sources</td></tr><tr class='code-row'><td class='code-nbr'>98</td><td class='code-desc'>Other, NOS</td></tr><tr class='code-row'><td class='code-nbr'>99</td><td class='code-desc'>Unknown source</td></tr></table></div><a name='2114'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>FUTURE USE TIMELINESS 1</strong></td><td style="text-align:right;font-weight:bold;"><strong>Retired</strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">2114</td><td style="text-align:center;"></td><td style="text-align:center;"><a href='#sources'></a></td><td style="text-align:center;">1998</td><td style="text-align:center;">6</td><td style="text-align:center;">2004</td><td style="text-align:center;">10.1</td><td class="cross-out" style="text-align:center;"></td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td></td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td></td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Reserved for future use for storing date of a central registry processing milestone. No standards have been adopted for this item. The NAACCR UDSC retired this data item in Version 10.1, as of January 1, 2004.</div><a name='2115'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>FUTURE USE TIMELINESS 2</strong></td><td style="text-align:right;font-weight:bold;"><strong>Retired</strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">2115</td><td style="text-align:center;"></td><td style="text-align:center;"><a href='#sources'></a></td><td style="text-align:center;">1998</td><td style="text-align:center;">6</td><td style="text-align:center;">2004</td><td style="text-align:center;">10.1</td><td class="cross-out" style="text-align:center;"></td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td></td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td></td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Reserved for future use for storing date of a central registry processing milestone. No standards have been adopted for this item. The NAACCR UDSC retired this data item in Version 10.1, as of January 1, 2004.</div><a name='351'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>GEOLOCATIONID - 1970/80/90</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">351</td><td style="text-align:center;">12</td><td style="text-align:center;"><a href='#sources'>NAACCR</a></td><td style="text-align:center;">2018</td><td style="text-align:center;">18</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">153 - 164</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>geolocationid19708090</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'><div>This is a 12 character concatenation of state, county, tract and block group. This data item may be used for epidemiological purposes. For example, to measure cancer incidence in a particular geographic area. Components of this code are used to derive area-based social measures such as poverty or urban/rural codes at the county or tract-level. The codes are primarily derived through the geocoding process.</div><div>&nbsp;</div><div><strong>Subfields</strong><br />State at DX Geocode 1970/80/90 [81]<br />County at DX Geocode 1970/80/90 [94]<br />Census Tract 1970/80/90 [110]<br />Census Block Grp 1970/80/90 [368]</div></div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>The concatenation of these variables into the full 12 character code is primarily a bookkeeping improvement over collecting the components separately. This format aligns with how the U.S census describes geographic entities in its many files and will enable direct linkage with census data over time. This format is also compatible with how the NAACCR geocoder returns information and will remove problems related to the leading zeros in census tracts. And because geocoded county codes are embedded in this field, it is less likely they will be confused with the NAACCR Item [90], County at DX Reported, which is often not associated with the geocoded census tract resulting in an edit failure for county-tract accuracy.<br /><br /><strong>Instructions for coding</strong><br />A 12 character string, with a maximum of one leading zero, left aligned. The code is generated by geocoding. Only numbers or blanks allowed. No decimal points or other characters allowed. <br /><br />The codes, with the exception of four 2-character alpha character codes for the State, are the Census Bureau ANSI/FIPS codes. Lists of geographic FIPS codes in census products can be found on the <a href="https://www.census.gov/geo/reference/ansi.html" target="_blank">ANSI/FIPS Codes</a> page.<br /><br />ANSI/FIPS codes follow census boundaries and are only unique when the smallest census boundary code is associated with the larger boundaries. For example, county at diagnosis is essential for investigating epidemiologic pattern at both the county and the census tract level. Census tracts are nested within counties and designated with a 6-digit number code. A given census tract code is commonly repeated within a state in different counties, making census tract numbers unique only when paired with the state and the county. Example from Massachusetts: Rural Franklin County contains a tract 040600 with 2010 population 4,612 people, and urban Suffolk County contains a tract 040600 with 2,444 people.</div><a name='352'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>GEOLOCATIONID - 2000</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">352</td><td style="text-align:center;">12</td><td style="text-align:center;"><a href='#sources'>NAACCR</a></td><td style="text-align:center;">2018</td><td style="text-align:center;">18</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">167 - 178</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>geolocationid2000</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>This is a 12 character concatenation of state, county, tract and block group. This data item may be used for epidemiological purposes. For example, to measure cancer incidence in a particular geographic area. Components of this code are used to derive area-based social measures such as poverty or urban/rural codes at the county or tract-level. The codes are primarily derived through the geocoding process. <div>&nbsp;</div><div><strong>Subfields</strong></div><div>State at DX Geocode 2000 [82]<br />County at DX Geocode2000 [95]<br />Census Tract 2000 [130]<br />Census Block Group 2000 [362]</div></div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>The concatenation of these variables into the full 12 character code is primarily a bookkeeping improvement over collecting the components separately. This format aligns with how the U.S census describes geographic entities in its many files and will enable direct linkage with census data over time. This format is also compatible with how the NAACCR geocoder returns information and will remove problems related to the leading zeros in census tracts. And because geocoded county codes are embedded in this field, it is less likely they will be confused with the NAACCR Item [90], County at DX Reported, which is often not associated with the geocoded census tract resulting in an edit failure for county-tract accuracy.<br /><br /><strong>Instructions for coding</strong><br />A 12 character string, with a maximum of one leading zero, left aligned. The code is generated by geocoding. Only numbers or blanks allowed. No decimal points or other characters allowed. <br /><br />The codes, with the exception of four 2-character alpha character codes for the State, are the Census Bureau ANSI/FIPS codes. Lists of geographic FIPS codes in census products can be found on the <a href="https://www.census.gov/geo/reference/ansi.html" target="_blank">ANSI/FIPS Codes</a> page.<br /><br />ANSI/FIPS codes follow census boundaries and are only unique when the smallest census boundary code is associated with the larger boundaries. For example, county at diagnosis is essential for investigating epidemiologic pattern at both the county and the census tract level. Census tracts are nested within counties and designated with a 6-digit number code. A given census tract code is commonly repeated within a state in different counties, making census tract numbers unique only when paired with the state and the county. Example from Massachusetts: Rural Franklin County contains a tract 040600 with 2010 population 4,612 people, and urban Suffolk County contains a tract 040600 with 2,444 people.</div><a name='353'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>GEOLOCATIONID - 2010</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">353</td><td style="text-align:center;">12</td><td style="text-align:center;"><a href='#sources'>NAACCR</a></td><td style="text-align:center;">2018</td><td style="text-align:center;">18</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">180 - 191</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>geolocationid2010</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>This is a 12 character concatenation of state, county, tract and block group. This data item may be used for epidemiological purposes. For example, to measure cancer incidence in a particular geographic area. Components of this code are used to derive area-based social measures such as poverty or urban/rural codes at the county or tract-level. The codes are primarily derived through the geocoding process.<br /> <br /><strong>Subfields</strong><br />State at DX Geocode 2010 [83]<br />County at DX Geocode2010 [96]<br />Census Tract 2010 [135]<br />Census Block Group 2010 [363]</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>The concatenation of these variables into the full 12 character code is primarily a bookkeeping improvement over collecting the components separately. This format aligns with how the U.S census describes geographic entities in its many files and will enable direct linkage with census data over time. This format is also compatible with how the NAACCR geocoder returns information and will remove problems related to the leading zeros in census tracts. And because geocoded county codes are embedded in this field, it is less likely they will be confused with the NAACCR Item [90], County at DX Reported, which is often not associated with the geocoded census tract resulting in an edit failure for county-tract accuracy.<br /><br /><strong>Instructions for coding</strong><br />A 12 character string, with a maximum of one leading zero, left aligned. The code is generated by geocoding. Only numbers or blanks allowed. No decimal points or other characters allowed. <br /><br />The codes, with the exception of four 2-character alpha character codes for the State, are the Census Bureau ANSI/FIPS codes. Lists of geographic FIPS codes in census products can be found on the <a href="https://www.census.gov/geo/reference/ansi.html" target="_blank">ANSI/FIPS Codes</a> page.<br /><br />ANSI/FIPS codes follow census boundaries and are only unique when the smallest census boundary code is associated with the larger boundaries. For example, county at diagnosis is essential for investigating epidemiologic pattern at both the county and the census tract level. Census tracts are nested within counties and designated with a 6-digit number code. A given census tract code is commonly repeated within a state in different counties, making census tract numbers unique only when paired with the state and the county. Example from Massachusetts: Rural Franklin County contains a tract 040600 with 2010 population 4,612 people, and urban Suffolk County contains a tract 040600 with 2,444 people.</div><div class='content chap10-para'>Codes:</div><a name='354'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>GEOLOCATIONID - 2020</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">354</td><td style="text-align:center;">12</td><td style="text-align:center;"><a href='#sources'>NAACCR</a></td><td style="text-align:center;">2018</td><td style="text-align:center;">18</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">193 - 204</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>geolocationid2020</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>This is a 12 character concatenation of state, county, tract and block group. This data item may be used for epidemiological purposes. For example, to measure cancer incidence in a particular geographic area. Components of this code are used to derive area-based social measures such as poverty or urban/rural codes at the county or tract-level. The codes are primarily derived through the geocoding process.<br /><br /><strong>Subfields</strong><br />State at DX Geocode 2020 [84]<br />County at DX Geocode2020 [97]<br />Census Tract 2020 [125]<br />Census Block Group 2020 [361]</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>The concatenation of these variables into the full 12 character code is primarily a bookkeeping improvement over collecting the components separately. This format aligns with how the U.S census describes geographic entities in its many files and will enable direct linkage with census data over time. This format is also compatible with how the NAACCR geocoder returns information and will remove problems related to the leading zeros in census tracts. And because geocoded county codes are embedded in this field, it is less likely they will be confused with the NAACCR Item [90], County at DX Reported, which is often not associated with the geocoded census tract resulting in an edit failure for county-tract accuracy.<br /><br /><strong>Instructions for coding</strong><br />A 12 character string, with a maximum of one leading zero, left aligned. The code is generated by geocoding. Only numbers or blanks allowed. No decimal points or other characters allowed. <br /><br />The codes, with the exception of four 2-character alpha character codes for the State, are the Census Bureau ANSI/FIPS codes. Lists of geographic FIPS codes in census products can be found on the <a href="https://www.census.gov/geo/reference/ansi.html" target="_blank">ANSI/FIPS Codes</a> page.<br /><br />ANSI/FIPS codes follow census boundaries and are only unique when the smallest census boundary code is associated with the larger boundaries. For example, county at diagnosis is essential for investigating epidemiologic pattern at both the county and the census tract level. Census tracts are nested within counties and designated with a 6-digit number code. A given census tract code is commonly repeated within a state in different counties, making census tract numbers unique only when paired with the state and the county. Example from Massachusetts: Rural Franklin County contains a tract 040600 with 2010 population 4,612 people, and urban Suffolk County contains a tract 040600 with 2,444 people.</div><a name='3837'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>GESTATIONAL TROPHOBLASTIC PROGNOSTIC SCORING INDEX</strong></td><td style="text-align:right;font-weight:bold;"><strong>Revised</strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">3837</td><td style="text-align:center;">2</td><td style="text-align:center;"><a href='#sources'>NAACCR</a></td><td style="text-align:center;">2018</td><td style="text-align:center;">18</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1924 - 1925</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>gestationalTrophoblasticPxIndex</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Gestational Trophoblastic Prognostic Scoring Index, a score based on the FIGO-modified World Health Organization (WHO) Prognostic Scoring Index, is used to stratify women with gestational trophoblastic neoplasia in addition to the anatomical stage group.  The risk score is appended to the anatomic stage.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para mark-changed'>This data item is required for prognostic stage grouping in AJCC 8th edition, Chapter 56 













<em>Gestational Trophoblastic Neoplasms</em>. It was previously collected as Placenta, CS SSF # 1.</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>00-25</td><td class='code-desc'>Risk factor score </td></tr><tr class='code-row'><td class='code-nbr'>X9</td><td class='code-desc'>Not documented in medical record<br/>
Prognostic scoring index not assessed, or unknown if assessed
</td></tr><tr class='code-row'><td class='code-nbr'></td><td class='code-desc'> </td></tr></table></div><div class='content chap10-para'>Each Site-Specific Data Item (SSDI) applies only to selected primary sites, histologies, and years of diagnosis. Depending on applicability and standard-setter requirements, SSDIs may be left blank. </div><a name='366'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>GIS COORDINATE QUALITY</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">366</td><td style="text-align:center;">2</td><td style="text-align:center;"><a href='#sources'>NAACCR</a></td><td style="text-align:center;">366</td><td style="text-align:center;">11</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">452 - 453</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>gisCoordinateQuality</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Code indicating the basis of assignment of latitude and longitude coordinates for an individual record from an address. This data item is helpful in identifying cases that were assigned coordinates based on incomplete information, post office boxes, or rural routes. This item is coded at the central registry, not by the reporting facility. Most of the time, this information is provided by geocoding software. Alternatively, a central registry staff member manually assigns the code. Codes are hierarchical, with lower numbers having priority.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Spatial analysis of cancer data often requires identifying data records with a high degree of geographic precision. Researchers can use this code as a basis for selecting records with a degree of precision that is appropriate to the study.</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>00</td><td class='code-desc'>Coordinates derived from local government-maintained address points, which are based on property parcel locations, not interpolation over a street segment's address range</td></tr><tr class='code-row'><td class='code-nbr'>01</td><td class='code-desc'>Coordinates assigned by Global Positioning System (GPS)</td></tr><tr class='code-row'><td class='code-nbr'>02</td><td class='code-desc'>Coordinates are match of house number and street, and based on property parcel location</td></tr><tr class='code-row'><td class='code-nbr'>03</td><td class='code-desc'>Coordinates are match of house number and street, interpolated over the matching street segment's address range</td></tr><tr class='code-row'><td class='code-nbr'>04</td><td class='code-desc'>Coordinates are street intersections</td></tr><tr class='code-row'><td class='code-nbr'>05</td><td class='code-desc'>Coordinates are at mid-point of street segment (missing or invalid building number)</td></tr><tr class='code-row'><td class='code-nbr'>06</td><td class='code-desc'>Coordinates are address ZIP code+4 centroid</td></tr><tr class='code-row'><td class='code-nbr'>07</td><td class='code-desc'>Coordinates are address ZIP code+2 centroid</td></tr><tr class='code-row'><td class='code-nbr'>08</td><td class='code-desc'>Coordinates were obtained manually by looking up a location on a paper or electronic map</td></tr><tr class='code-row'><td class='code-nbr'>09</td><td class='code-desc'>Coordinates are address 5-digit ZIP code centroid</td></tr><tr class='code-row'><td class='code-nbr'>10</td><td class='code-desc'>Coordinates are point ZIP code of Post Office Box or Rural Route</td></tr><tr class='code-row'><td class='code-nbr'>11</td><td class='code-desc'>Coordinates are centroid of address city (when address ZIP code is unknown or invalid, and there are multiple ZIP codes for the city)</td></tr><tr class='code-row'><td class='code-nbr'>12</td><td class='code-desc'>Coordinates are centroid of county</td></tr><tr class='code-row'><td class='code-nbr'>98</td><td class='code-desc'>Latitude and longitude are assigned, but coordinate quality is unknown</td></tr><tr class='code-row'><td class='code-nbr'>99</td><td class='code-desc'>Latitude and longitude are not assigned, but geocoding was attempted; unable to assign coordinates based on available information</td></tr><tr class='code-row'><td class='code-nbr'>Blank</td><td class='code-desc'>GIS Coordinate Quality not coded</td></tr></table></div><div class='content chap10-para'><em>Instructions for Coding:</em> Where multiple codes are applicable, use  the lower code value.  Note: This data item is similar in function to Census Tract Certainty  1970/80/90 [364] and Census Tract Certainty 2000 [365]. The codes for  this data item and the two census tract data items all describe how  location information was assigned based on the patient's resident  address at the time of diagnosis.  <br /><br />This data item must be populated if Latitude [2352] and Longitude [2354]  are also populated.</div><a name='3838'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>GLEASON PATTERNS CLINICAL</strong></td><td style="text-align:right;font-weight:bold;"><strong>Revised</strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">3838</td><td style="text-align:center;">2</td><td style="text-align:center;"><a href='#sources'>NAACCR</a></td><td style="text-align:center;">2018</td><td style="text-align:center;">18</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1927 - 1928</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>gleasonPatternsClinical</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Prostate cancers are graded using Gleason score or pattern. This data item represents the Gleason primary and secondary patterns from needle core biopsy or TURP.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'><!--[if gte mso 10]>  <![endif]-->Gleason Patterns Clinical is a Registry Data Collection Variable for Clinical Stage for AJCC. This data item was previously collected as Prostate, CS SSF# 7.</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para mark-changed'><table><tr class='code-row'><td class='code-nbr'>11</td><td class='code-desc'>Primary pattern 1, secondary pattern 1  </td></tr><tr class='code-row'><td class='code-nbr'>12</td><td class='code-desc'>Primary pattern 1, secondary pattern 2 </td></tr><tr class='code-row'><td class='code-nbr'>13</td><td class='code-desc'>Primary pattern 1, secondary pattern 3</td></tr><tr class='code-row'><td class='code-nbr'>14</td><td class='code-desc'>Primary pattern 1, secondary pattern 4</td></tr><tr class='code-row'><td class='code-nbr'>15</td><td class='code-desc'>Primary pattern 1, secondary pattern 5</td></tr><tr class='code-row'><td class='code-nbr'>19</td><td class='code-desc'>Primary pattern 1, secondary pattern unknown</td></tr><tr class='code-row'><td class='code-nbr'>21</td><td class='code-desc'>Primary pattern 2, secondary pattern 1</td></tr><tr class='code-row'><td class='code-nbr'>22</td><td class='code-desc'>Primary pattern 2, secondary pattern 2</td></tr><tr class='code-row'><td class='code-nbr'>23</td><td class='code-desc'>Primary pattern 2, secondary pattern 3</td></tr><tr class='code-row'><td class='code-nbr'>24</td><td class='code-desc'>Primary pattern 2, secondary pattern 4</td></tr><tr class='code-row'><td class='code-nbr'>25</td><td class='code-desc'>Primary pattern 2, secondary pattern 5</td></tr><tr class='code-row'><td class='code-nbr'>29</td><td class='code-desc'>Primary pattern 2, secondary pattern unknown</td></tr><tr class='code-row'><td class='code-nbr'>31</td><td class='code-desc'>Primary pattern 3, secondary pattern 1</td></tr><tr class='code-row'><td class='code-nbr'>32</td><td class='code-desc'>Primary pattern 3, secondary pattern 2</td></tr><tr class='code-row'><td class='code-nbr'>33</td><td class='code-desc'>Primary pattern 3, secondary pattern 3</td></tr><tr class='code-row'><td class='code-nbr'>34</td><td class='code-desc'>Primary pattern 3, secondary pattern 4</td></tr><tr class='code-row'><td class='code-nbr'>35</td><td class='code-desc'>Primary pattern 3, secondary pattern 5</td></tr><tr class='code-row'><td class='code-nbr'>39</td><td class='code-desc'>Primary pattern 3, secondary pattern unknown</td></tr><tr class='code-row'><td class='code-nbr'>41</td><td class='code-desc'>Primary pattern 4, secondary pattern 1</td></tr><tr class='code-row'><td class='code-nbr'>42</td><td class='code-desc'>Primary pattern 4, secondary pattern 2</td></tr><tr class='code-row'><td class='code-nbr'>43</td><td class='code-desc'>Primary pattern 4, secondary pattern 3</td></tr><tr class='code-row'><td class='code-nbr'>44</td><td class='code-desc'>Primary pattern 4, secondary pattern 4</td></tr><tr class='code-row'><td class='code-nbr'>45</td><td class='code-desc'>Primary pattern 4, secondary pattern 5</td></tr><tr class='code-row'><td class='code-nbr'>49</td><td class='code-desc'>Primary pattern 4, secondary pattern unknown</td></tr><tr class='code-row'><td class='code-nbr'>51</td><td class='code-desc'>Primary pattern 5, secondary pattern 1</td></tr><tr class='code-row'><td class='code-nbr'>52</td><td class='code-desc'>Primary pattern 5, secondary pattern 2</td></tr><tr class='code-row'><td class='code-nbr'>53</td><td class='code-desc'>Primary pattern 5, secondary pattern 3</td></tr><tr class='code-row'><td class='code-nbr'>54</td><td class='code-desc'>Primary pattern 5, secondary pattern 4</td></tr><tr class='code-row'><td class='code-nbr'>55</td><td class='code-desc'>Primary pattern 5, secondary pattern 5</td></tr><tr class='code-row'><td class='code-nbr'>59</td><td class='code-desc'>Primary pattern 5, secondary pattern unknown</td></tr><tr class='code-row'><td class='code-nbr'>X6</td><td class='code-desc'>TURP and/or Biopsy done, primary pattern unknown, secondary pattern unknown</td></tr><tr class='code-row'><td class='code-nbr'>X7</td><td class='code-desc'>No needle core biopsy/TURP performed</td></tr><tr class='code-row'><td class='code-nbr'>X8</td><td class='code-desc'>Not applicable: Information not collected for this case<br/>
(If this information is required by your standard setter, use of code X8 may result in an edit error.)
</td></tr><tr class='code-row'><td class='code-nbr'>X9</td><td class='code-desc'>Not documented in medical record<br/>
Gleason Patterns Clinical not assessed or unknown if assessed
Unknown whether TURP and/or Biopsy done

</td></tr><tr class='code-row'><td class='code-nbr'></td><td class='code-desc'> </td></tr></table></div><div class='content chap10-para mark-changed'>Each Site-Specific Data Item (SSDI) applies only to selected primary sites, histologies, and years of diagnosis. Depending on applicability and standard-setter requirements, SSDIs may be left blank.</div><a name='3839'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>GLEASON PATTERNS PATHOLOGICAL</strong></td><td style="text-align:right;font-weight:bold;"><strong>Revised</strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">3839</td><td style="text-align:center;">2</td><td style="text-align:center;"><a href='#sources'>NAACCR</a></td><td style="text-align:center;">2018</td><td style="text-align:center;">18</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1929 - 1930</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>gleasonPatternsPathological</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Prostate cancers are graded using Gleason score or pattern. This data item represents the Gleason primary and secondary patterns from prostatectomy or autopsy.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Gleason Patterns Pathological is a Registry Data Collection Variable for AJCC. This data item was previously collected as Prostate, CS SSF# 9.</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para mark-changed'><table><tr class='code-row'><td class='code-nbr'>11</td><td class='code-desc'>Primary pattern 1, secondary pattern 1  </td></tr><tr class='code-row'><td class='code-nbr'>12</td><td class='code-desc'>Primary pattern 1, secondary pattern 2</td></tr><tr class='code-row'><td class='code-nbr'>13</td><td class='code-desc'>Primary pattern 1, secondary pattern 3</td></tr><tr class='code-row'><td class='code-nbr'>14</td><td class='code-desc'>Primary pattern 1, secondary pattern 4</td></tr><tr class='code-row'><td class='code-nbr'>15</td><td class='code-desc'>Primary pattern 1, secondary pattern 5</td></tr><tr class='code-row'><td class='code-nbr'>19</td><td class='code-desc'>Primary pattern 1, secondary pattern unknown</td></tr><tr class='code-row'><td class='code-nbr'>21</td><td class='code-desc'>Primary pattern 2, secondary pattern 1</td></tr><tr class='code-row'><td class='code-nbr'>22</td><td class='code-desc'>Primary pattern 2, secondary pattern 2</td></tr><tr class='code-row'><td class='code-nbr'>23</td><td class='code-desc'>Primary pattern 2, secondary pattern 3</td></tr><tr class='code-row'><td class='code-nbr'>24</td><td class='code-desc'>Primary pattern 2, secondary pattern 4</td></tr><tr class='code-row'><td class='code-nbr'>25</td><td class='code-desc'>Primary pattern 2, secondary pattern 5</td></tr><tr class='code-row'><td class='code-nbr'>29</td><td class='code-desc'>Primary pattern 2, secondary pattern unknown</td></tr><tr class='code-row'><td class='code-nbr'>31</td><td class='code-desc'>Primary pattern 3, secondary pattern 1</td></tr><tr class='code-row'><td class='code-nbr'>32</td><td class='code-desc'>Primary pattern 3, secondary pattern 2</td></tr><tr class='code-row'><td class='code-nbr'>33</td><td class='code-desc'>Primary pattern 3, secondary pattern 3</td></tr><tr class='code-row'><td class='code-nbr'>34</td><td class='code-desc'>Primary pattern 3, secondary pattern 4</td></tr><tr class='code-row'><td class='code-nbr'>35</td><td class='code-desc'>Primary pattern 3, secondary pattern 5</td></tr><tr class='code-row'><td class='code-nbr'>39</td><td class='code-desc'>Primary pattern 3, secondary pattern unknown</td></tr><tr class='code-row'><td class='code-nbr'>41</td><td class='code-desc'>Primary pattern 4, secondary pattern 1</td></tr><tr class='code-row'><td class='code-nbr'>42</td><td class='code-desc'>Primary pattern 4, secondary pattern 2</td></tr><tr class='code-row'><td class='code-nbr'>43</td><td class='code-desc'>Primary pattern 4, secondary pattern 3</td></tr><tr class='code-row'><td class='code-nbr'>44</td><td class='code-desc'>Primary pattern 4, secondary pattern 4</td></tr><tr class='code-row'><td class='code-nbr'>45</td><td class='code-desc'>Primary pattern 4, secondary pattern 5</td></tr><tr class='code-row'><td class='code-nbr'>49</td><td class='code-desc'>Primary pattern 4, secondary pattern unknown</td></tr><tr class='code-row'><td class='code-nbr'>51</td><td class='code-desc'>Primary pattern 5, secondary pattern 1</td></tr><tr class='code-row'><td class='code-nbr'>52</td><td class='code-desc'>Primary pattern 5, secondary pattern 2</td></tr><tr class='code-row'><td class='code-nbr'>53</td><td class='code-desc'>Primary pattern 5, secondary pattern 3</td></tr><tr class='code-row'><td class='code-nbr'>54</td><td class='code-desc'>Primary pattern 5, secondary pattern 4</td></tr><tr class='code-row'><td class='code-nbr'>55</td><td class='code-desc'>Primary pattern 5, secondary pattern 5</td></tr><tr class='code-row'><td class='code-nbr'>59</td><td class='code-desc'>Primary pattern 5, secondary pattern unknown</td></tr><tr class='code-row'><td class='code-nbr'>X6</td><td class='code-desc'>Prostatectomy done, primary pattern unknown, secondary pattern unknown</td></tr><tr class='code-row'><td class='code-nbr'>X7</td><td class='code-desc'>No prostatectomy/autopsy performed</td></tr><tr class='code-row'><td class='code-nbr'>X8</td><td class='code-desc'>Not applicable: Information not collected for this case<br/>
(If this information is required by your standard setter, use of code X8 may result in an edit error.)
</td></tr><tr class='code-row'><td class='code-nbr'>X9</td><td class='code-desc'>Not documented in medical record<br/>
Gleason Patterns Pathological not assessed or unknown if assessed<br/>
Unknown if prostatectomy done

</td></tr><tr class='code-row'><td class='code-nbr'></td><td class='code-desc'> </td></tr></table></div><div class='content chap10-para mark-changed'>Each Site-Specific Data Item (SSDI) applies only to selected primary sites, histologies, and years of diagnosis. Depending on applicability and standard-setter requirements, SSDIs may be left blank.</div><a name='3840'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>GLEASON SCORE CLINICAL</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">3840</td><td style="text-align:center;">2</td><td style="text-align:center;"><a href='#sources'>NAACCR</a></td><td style="text-align:center;">2018</td><td style="text-align:center;">18</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1931 - 1932</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>gleasonScoreClinical</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>This data item records the Gleason score based on adding the values for primary and secondary patterns in Needle Core Biopsy or TURP.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Gleason Score Clinical is a Registry Data Collection Variable for AJCC. This data item was previously collected as Prostate, CS SSF# 8.</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>02</td><td class='code-desc'>Gleason score 2 </td></tr><tr class='code-row'><td class='code-nbr'>03</td><td class='code-desc'>Gleason score 3</td></tr><tr class='code-row'><td class='code-nbr'>04</td><td class='code-desc'>Gleason score 4</td></tr><tr class='code-row'><td class='code-nbr'>05</td><td class='code-desc'>Gleason score 5</td></tr><tr class='code-row'><td class='code-nbr'>06</td><td class='code-desc'>Gleason score 6</td></tr><tr class='code-row'><td class='code-nbr'>07</td><td class='code-desc'>Gleason score 7</td></tr><tr class='code-row'><td class='code-nbr'>08</td><td class='code-desc'>Gleason score 8</td></tr><tr class='code-row'><td class='code-nbr'>09</td><td class='code-desc'>Gleason score 9</td></tr><tr class='code-row'><td class='code-nbr'>10</td><td class='code-desc'>Gleason score 10</td></tr><tr class='code-row'><td class='code-nbr'>X7</td><td class='code-desc'>No needle core biopsy/TURP performed</td></tr><tr class='code-row'><td class='code-nbr'>X8</td><td class='code-desc'>Not applicable: Information not collected for this case<br/>
(If this information is required by your standard setter, use of code X8 may result in an edit error.)
</td></tr><tr class='code-row'><td class='code-nbr'>X9</td><td class='code-desc'>Not documented in medical record<br/>
Gleason Score Clinical not assessed or unknown if assessed 
</td></tr><tr class='code-row'><td class='code-nbr'></td><td class='code-desc'> </td></tr></table></div><div class='content chap10-para'>Each Site-Specific Data Item (SSDI) applies only to selected primary sites, histologies, and years of diagnosis. Depending on applicability and standard-setter requirements, SSDIs may be left blank. </div><a name='3841'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>GLEASON SCORE PATHOLOGICAL</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">3841</td><td style="text-align:center;">2</td><td style="text-align:center;"><a href='#sources'>NAACCR</a></td><td style="text-align:center;">2018</td><td style="text-align:center;">18</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1933 - 1934</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>gleasonScorePathological</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>This data item records the Gleason score based on adding the values for primary and secondary patterns from prostatectomy or autopsy.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Gleason Score Pathological is a Registry Data Collection Variable for AJCC. This data item was previously collected as Prostate, CS SSF# 10.</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>02</td><td class='code-desc'>Gleason score 2 </td></tr><tr class='code-row'><td class='code-nbr'>03</td><td class='code-desc'>Gleason score 3</td></tr><tr class='code-row'><td class='code-nbr'>04</td><td class='code-desc'>Gleason score 4</td></tr><tr class='code-row'><td class='code-nbr'>05</td><td class='code-desc'>Gleason score 5</td></tr><tr class='code-row'><td class='code-nbr'>06</td><td class='code-desc'>Gleason score 6</td></tr><tr class='code-row'><td class='code-nbr'>07</td><td class='code-desc'>Gleason score 7</td></tr><tr class='code-row'><td class='code-nbr'>08</td><td class='code-desc'>Gleason score 8</td></tr><tr class='code-row'><td class='code-nbr'>09</td><td class='code-desc'>Gleason score 9</td></tr><tr class='code-row'><td class='code-nbr'>10</td><td class='code-desc'>Gleason score 10</td></tr><tr class='code-row'><td class='code-nbr'>X7</td><td class='code-desc'>No prostatectomy done</td></tr><tr class='code-row'><td class='code-nbr'>X8</td><td class='code-desc'>Not applicable: Information not collected for this case<br/>
(If this information is required by your standard setter, use of code X8 may result in an edit error.)
</td></tr><tr class='code-row'><td class='code-nbr'>X9</td><td class='code-desc'>Not documented in medical record<br/>
Gleason Score Pathological not assessed or unknown if assessed 
</td></tr><tr class='code-row'><td class='code-nbr'></td><td class='code-desc'> </td></tr></table></div><div class='content chap10-para'>Each Site-Specific Data Item (SSDI) applies only to selected primary sites, histologies, and years of diagnosis. Depending on applicability and standard-setter requirements, SSDIs may be left blank. </div><a name='3842'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>GLEASON TERTIARY PATTERN</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">3842</td><td style="text-align:center;">2</td><td style="text-align:center;"><a href='#sources'>NAACCR</a></td><td style="text-align:center;">2018</td><td style="text-align:center;">18</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1935 - 1936</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>gleasonTertiaryPattern</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Prostate cancers are graded using Gleason score or pattern.  This data item represents the tertiary pattern value from prostatectomy or autopsy.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'><!--[if gte mso 10]>  <![endif]-->Tertiary Gleason pattern on prostatectomy is a Registry Data Collection Variable for AJCC. This data item was previously collected as Prostate, CS SSF# 11.</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>10</td><td class='code-desc'>Tertiary pattern 1 </td></tr><tr class='code-row'><td class='code-nbr'>20</td><td class='code-desc'>Tertiary pattern 2</td></tr><tr class='code-row'><td class='code-nbr'>30</td><td class='code-desc'>Tertiary pattern 3</td></tr><tr class='code-row'><td class='code-nbr'>40</td><td class='code-desc'>Tertiary pattern 4</td></tr><tr class='code-row'><td class='code-nbr'>50</td><td class='code-desc'>Tertiary pattern 5</td></tr><tr class='code-row'><td class='code-nbr'>X7</td><td class='code-desc'>No prostatectomy/autopsy performed</td></tr><tr class='code-row'><td class='code-nbr'>X8</td><td class='code-desc'>Not applicable: Information not collected for this case<br/>
(If this information is required by your standard setter, use of code X8 may result in an edit error.)
</td></tr><tr class='code-row'><td class='code-nbr'>X9</td><td class='code-desc'>Not documented in medical record<br/>
Gleason Tertiary Pattern not assessed or unknown if assessed
</td></tr><tr class='code-row'><td class='code-nbr'></td><td class='code-desc'> </td></tr></table></div><div class='content chap10-para'>Each Site-Specific Data Item (SSDI) applies only to selected primary sites, histologies, and years of diagnosis. Depending on applicability and standard-setter requirements, SSDIs may be left blank. </div><a name='440'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>GRADE</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">440</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>SEER/CoC</a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">569 - 569</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>Grade, Differentiation, or Cell Lineage Indicator (SEER/CCCR)<br />Grade/Differentiation (CoC)<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>grade</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Code for the grade or degree of differentiation of the reportable tumor. For lymphomas and leukemias, field also is used to indicate T-, B-, Null-, or NK-cell origin.<br /><br /><em>Note:</em> Code 8 was adopted for use with lymphoma cases diagnosed in 1995 and later.</div><div class='content chap10-para'><strong>Codes &nbsp;</strong>  <p style="margin-left: 0in; text-indent: 0in;">See the grade tables on page 67 of <a target="_blank" href="http://www.who.int/classifications/icd/adaptations/oncology/en/">ICD-O-3</a>.<sup>16</sup> See also the most recent <a target="_blank" href="http://www.facs.org/cancer/coc/fordsmanual.html">CoC<em> STORE</em></a><em> </em>manual and<em> </em><a target="_blank" href="http://seer.cancer.gov/tools/codingmanuals/"><em>SEER Program Code Manual</em></a>, for site specific coding rules and conversions.</p></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>1</td><td class='code-desc'>Grade I</td></tr><tr class='code-row'><td class='code-nbr'>2</td><td class='code-desc'>Grade II</td></tr><tr class='code-row'><td class='code-nbr'>3</td><td class='code-desc'>Grade III</td></tr><tr class='code-row'><td class='code-nbr'>4</td><td class='code-desc'>Grade IV</td></tr><tr class='code-row'><td class='code-nbr'>5</td><td class='code-desc'>T-cell</td></tr><tr class='code-row'><td class='code-nbr'>6</td><td class='code-desc'>B-cell</td></tr><tr class='code-row'><td class='code-nbr'>7</td><td class='code-desc'>Null cell</td></tr><tr class='code-row'><td class='code-nbr'>8</td><td class='code-desc'>NK (natural killer) cell</td></tr><tr class='code-row'><td class='code-nbr'>9</td><td class='code-desc'>Grade/differentiation unknown, not stated, or not applicable</td></tr></table></div><div class='content chap10-para'><em>Comment:</em> Use the most recent Hematopoietic and Lymphoid rules for assigning grades 5-8.</div><a name='1973'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>GRADE (73-91) ICD-O-1</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">1973</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>SEER</a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">2605 - 2605</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>gradeIcdO1</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Area for retaining the grade portion (1 digit) of the ICD-O-1 or field trial grade code entered before a conversion to ICD-O-2. See grouped data item Morph (73-91) ICD-O-1 [1970] in Appendix E. The item name includes years 1973-91. However, some states may have used the codes for cases before 1973. </div><div class='content chap10-para'><p style="margin-left:0in;text-indent:0in;">    <strong>Codes</strong>    <br />For cases diagnosed before 1992, contains the ICD-O-1&#160;or field trial 1-digit grade code as originally coded, if available.<sup>18, 19</sup></p>  <p>&#160;</p></div><a name='3843'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>GRADE CLINICAL</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">3843</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>NAACCR</a></td><td style="text-align:center;">2018</td><td style="text-align:center;">18</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1286 - 1286</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>gradeClinical</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>This data item records the grade of a solid primary tumor before any treatment (surgical resection or initiation of any treatment including neoadjuvant). <br /><br />For cases diagnosed January 1, 2018, and later, this data item, along with Grade Pathological and Grade Post-Neoadjuvant, replaces NAACCR Data Item Grade [440] as well as SSF&#8217;s for cancer sites with alternative grading systems (e.g., breast [Bloom-Richardson], prostate [Gleason]).</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Grade is a measure of the aggressiveness of the tumor. Grade and cell type are important prognostic indicators for many cancers. For some sites, grade is required to assign the clinical stage group. <br /><br />For those cases that are eligible AJCC staging, the recommended grading system is specified in the AJCC Chapter. The AJCC Chapter-specific grading systems (codes 1-5) take priority over the generic grade definitions (codes A-E, L, H, 9). For those cases that are not eligible for AJCC staging, if the recommended grading system is not documented, the generic grade definitions would apply.</div><div class='content chap10-para'><strong>Codes (</strong><!--[if gte mso 10]>  <![endif]--><strong>Refer to the most recent version of the SSDI Manual for additional site-specific instructions)</strong></div><div class='content chap10-para'>Each Site-Specific Data Item (SSDI) applies only to selected primary sites, histologies, and years of diagnosis. Depending on applicability and standard-setter requirements, SSDIs may be left blank. Leave blank for cases diagnosed prior to 2018.</div><a name='449'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>GRADE PATH SYSTEM</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">449</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>AJCC</a></td><td style="text-align:center;">2010</td><td style="text-align:center;">12</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">571 - 571</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>gradePathSystem</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Indicates whether a two, three or four grade system is used.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>This item is used to show whether a two, three or four grade system is used. This is the grade system stated in the path report; it is not converted. This item is used in conjunction with Grade Path Value [441] and is abstracted in addition to Grade Differentiation [440].</div><div class='content chap10-para'><strong>Codes (Refer to the most recent version of <em><a target="_blank" href="http://www.facs.org/cancer/coc/fordsmanual.html">STORE </a></em><fords>for additional instructions.) </fords></strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>2</td><td class='code-desc'>Two-Grade System</td></tr><tr class='code-row'><td class='code-nbr'>3</td><td class='code-desc'>Three-Grade System</td></tr><tr class='code-row'><td class='code-nbr'>4</td><td class='code-desc'>Four-Grade System</td></tr><tr class='code-row'><td class='code-nbr'>Blank</td><td class='code-desc'>Not a two, three or four grade system; unknown</td></tr></table></div><a name='441'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>GRADE PATH VALUE</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">441</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>AJCC</a></td><td style="text-align:center;">2010</td><td style="text-align:center;">12</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">570 - 570</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>gradePathValue</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Describes the actual grade according to the grading system in Grade Path System [449].</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>This data item will record grade specified in Grade Path System. This does not replace Grade [440].</div><div class='content chap10-para'><strong>Codes (Refer to the most recent version </strong>  <strong>of <fords></fords></strong>&nbsp;<strong><em><a target="_blank" href="http://www.facs.org/cancer/coc/fordsmanual.html">STORE</a> </em>    <fords>for additional instructions.) </fords>  </strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>1</td><td class='code-desc'>Recorded as Grade I or 1</td></tr><tr class='code-row'><td class='code-nbr'>2</td><td class='code-desc'>Recorded as Grade II or 2</td></tr><tr class='code-row'><td class='code-nbr'>3</td><td class='code-desc'>Recorded as Grade III or 3</td></tr><tr class='code-row'><td class='code-nbr'>4</td><td class='code-desc'>Recorded as Grade IV or 4</td></tr><tr class='code-row'><td class='code-nbr'>Blank</td><td class='code-desc'>No Two, Three or Four System Grade is available; unknown</td></tr></table></div><a name='3844'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>GRADE PATHOLOGICAL</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">3844</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>NAACCR</a></td><td style="text-align:center;">2018</td><td style="text-align:center;">18</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1287 - 1287</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>gradePathological</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>This data item records the grade of a solid primary tumor that has been resected and for which no neoadjuvant therapy was administered. If AJCC staging is being assigned, the tumor must have met the surgical resection requirements in the AJCC manual. This may include the grade from the clinical workup. <br /><br />Record the highest grade documented from any microscopic specimen of the primary site whether from the clinical workup or the surgical resection. <br /><br />For cases diagnosed January 1, 2018, and later, this data item, along with Grade Clinical and Grade Post-Neoadjuvant, replaces NAACCR Data Item Grade [440] as well as SSF&#8217;s for cancer sites with alternative grading systems (e.g., breast [Bloom-Richardson], prostate [Gleason]).</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Grade is a measure of the aggressiveness of the tumor. Grade and cell type are important prognostic indicators for many cancers. For some sites, grade is required to assign the pathological stage group. <br /><br />For those cases that are eligible AJCC staging, the recommended grading system is specified in the AJCC Chapter. The AJCC Chapter-specific grading systems (codes 1-5) take priority over the generic grade definitions (codes A-E, L, H, 9). For those cases that are not eligible for AJCC staging, if the recommended grading system is not documented, the generic grade definitions would apply.</div><div class='content chap10-para'><strong>Codes (Refer to the most recent version of the SSDI Manual for additional site-specific instructions)</strong></div><div class='content chap10-para'>Each Site-Specific Data Item (SSDI) applies only to selected primary sites, histologies, and years of diagnosis. Depending on applicability and standard-setter requirements, SSDIs may be left blank. Leave blank for cases diagnosed prior to 2018.</div><a name='1068'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>GRADE POST THERAPY CLIN (YC)</strong></td><td style="text-align:right;font-weight:bold;"><strong>New</strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">1068</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>NAACCR</a></td><td style="text-align:center;">2021</td><td style="text-align:center;">21</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1 - 1</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>gradePostTherapyClin</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>This data item records the grade of a solid primary tumor that has been microscopically sampled following neoadjuvant therapy or primary systemic/radiation therapy. If AJCC staging is being assigned, the tumor must have met the neoadjuvant therapy or primary systemic/radiation therapy requirements in the AJCC manual or according to national treatment guidelines. <br /><br />Record the highest grade documented from the microscopically sampled specimen of the primary site following neoadjuvant therapy or primary systemic/radiation therapy. <br /><br />For cases diagnosed January 1, 2020, and later, this data item, along with Grade Clinical, Grade Pathological, and Grade Post Therapy Path (yp), replaces NAACCR Data Item Grade [440] as well as SSF&#8217;s for cancer sites with alternative grading systems (e.g., breast [Bloom-Richardson], prostate [Gleason]).</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Grade is a measure of the aggressiveness of the tumor. Grade and cell type are important prognostic indicators for many cancers. For some sites, grade is required to assign the post therapy stage group.<br /><br />For those cases that are eligible for AJCC staging, the recommended grading system is specified in the AJCC Chapter. The AJCC Chapter-specific grading systems (codes 1-5, L, H, M, S) take priority over the generic grade definitions (codes A-E, 9). For those cases that are not eligible for AJCC staging, if the recommended grading system is not documented, the generic grade definitions would apply.</div><div class='content chap10-para'><strong>Codes (Refer to the most recent version of the SSDI Manual for additional site-specific instructions)</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>Blank</td><td class='code-desc'> </td></tr><tr class='code-row'><td class='code-nbr' colspan='2'></td></tr></table></div><div class='content chap10-para'>Each Site-Specific Data Item (SSDI) applies only to selected primary sites, histologies, and years of diagnosis. Depending on applicability and standard-setter requirements, SSDIs may be left blank.</div><a name='3845'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>GRADE POST THERAPY PATH (YP)</strong></td><td style="text-align:right;font-weight:bold;"><strong>Revised</strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">3845</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>NAACCR</a></td><td style="text-align:center;">2018</td><td style="text-align:center;">18</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1288 - 1288</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>gradePostTherapy</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para mark-changed'>This data item records the grade of a solid primary tumor that has been resected following neoadjuvant therapy. If AJCC staging is being assigned, the tumor must have met the surgical resection requirements in the AJCC manual. <br />
<br />
Record the highest grade documented from the surgical treatment resection specimen of the primary site following neoadjuvant therapy. <br />
<br />
For cases diagnosed January 1, 2018, and later, this data item, along with Grade Clinical and Grade Pathological, replaces NAACCR Data Item Grade [440] as well as SSF&#8217;s for cancer sites with alternative grading systems (e.g., breast [Bloom-Richardson], prostate [Gleason]).</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Grade is a measure of the aggressiveness of the tumor. Grade and cell type are important prognostic indicators for many cancers. For some sites, grade is required to assign the post-neoadjuvant stage group.<br /><br />For those cases that are eligible AJCC staging, the recommended grading system is specified in the AJCC Chapter. The AJCC Chapter-specific grading systems (codes 1-5) take priority over the generic grade definitions (codes A-E, L, H, 9). For those cases that are not eligible for AJCC staging, if the recommended grading system is not documented, the generic grade definitions would apply.</div><div class='content chap10-para'><strong>Codes (Refer to the most recent version of the SSDI Manual for additional site-specific instructions)</strong></div><div class='content chap10-para mark-changed'>Each Site-Specific Data Item (SSDI) applies only to selected primary sites, histologies, and years of diagnosis. Depending on applicability and standard-setter requirements, SSDIs may be left blank.</div><a name='3846'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>HCG POST-ORCHIECTOMY LAB VALUE</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">3846</td><td style="text-align:center;">7</td><td style="text-align:center;"><a href='#sources'>NAACCR</a></td><td style="text-align:center;">2018</td><td style="text-align:center;">18</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1975 - 1981</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>hcgPostOrchiectomyLabValue</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>hCG (Human Chorionic Gonadotropin) Post-orchiectomy Lab Value refers to the lowest hCG value measured post-orchiectomy. hCG is a serum tumor marker that is often elevated in patients with nonseminomatous germ cell tumors of the testis. The Post-Orchiectomy lab value is used to monitor response to therapy.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>hCG (Human Chorionic Gonadotropin) Post-orchiectomy Lab Value is a Registry Data Collection Variable in AJCC. It was previously collected as Testis CS SSF# 14.</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>0.0</td><td class='code-desc'>0.0 milli-International Units/milliliter (mIU/mL)</td></tr><tr class='code-row'><td class='code-nbr'>0.1-99999.9</td><td class='code-desc'>0.199,999.9 mIU/mL</td></tr><tr class='code-row'><td class='code-nbr'>XXXXX.1</td><td class='code-desc'>100,000 mIU/mL or greater</td></tr><tr class='code-row'><td class='code-nbr'>XXXXX.7</td><td class='code-desc'>Test ordered, results not in chart</td></tr><tr class='code-row'><td class='code-nbr'>XXXXX.8</td><td class='code-desc'>Not applicable: Information not collected for this case<br/>
(If this information is required by your standard setter, use of code XXXXX.8 may result in an edit error.)
</td></tr><tr class='code-row'><td class='code-nbr'>XXXXX.9</td><td class='code-desc'>Not documented in medical record<br/>
No orchiectomy performed<br/>
hCG (Human Chorionic Gonadotropin) Post-orchiectomy Lab Value not assessed or unknown if assessed
</td></tr><tr class='code-row'><td class='code-nbr'></td><td class='code-desc'> </td></tr></table></div><div class='content chap10-para'>Each Site-Specific Data Item (SSDI) applies only to selected primary sites, histologies, and years of diagnosis. Depending on applicability and standard-setter requirements, SSDIs may be left blank. </div><a name='3847'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>HCG POST-ORCHIECTOMY RANGE</strong></td><td style="text-align:right;font-weight:bold;"><strong>Revised</strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">3847</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>NAACCR</a></td><td style="text-align:center;">2018</td><td style="text-align:center;">18</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1982 - 1982</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>hcgPostOrchiectomyRange</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Human Chorionic Gonadotropin (hCG) Post-orchiectomy Range identifies the range category of the lowest hCG value measured post-orchiectomy. hCG is a serum tumor marker that is often elevated in patients with nonseminomatous germ cell tumors of the testis. The Post-Orchiectomy lab value is used to monitor response to therapy.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>hCG (Human Chorionic Gonadotropin) is a Registry Data Collection Variable in AJCC. hCG (Human Chorionic Gonadotropin) Post-orchiectomy Range is used to assign the S Category Pathological and was previously collected as Testis CS SSF# 15.</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para mark-changed'><table><tr class='code-row'><td class='code-nbr'>0</td><td class='code-desc'>Within normal limits</td></tr><tr class='code-row'><td class='code-nbr'>1</td><td class='code-desc'>Above normal and less than 5,000 milli-International Units/milliliter (mIU/mL)</td></tr><tr class='code-row'><td class='code-nbr'>2</td><td class='code-desc'>5,000-50,000 mIU/mL </td></tr><tr class='code-row'><td class='code-nbr'>3</td><td class='code-desc'>Greater than 50,000 mIU/mL</td></tr><tr class='code-row'><td class='code-nbr'>4</td><td class='code-desc'>Post-orchiectomy human chorionic gonadotropin (hCG) stated to be elevated</td></tr><tr class='code-row'><td class='code-nbr'>5</td><td class='code-desc'>Post-Orchiectomy human chorionic gonadotropin (hCG) unknown or not done but pre-orchiectomy hCG was normal </td></tr><tr class='code-row'><td class='code-nbr'>7</td><td class='code-desc'>Test ordered, results not in chart</td></tr><tr class='code-row'><td class='code-nbr'>8</td><td class='code-desc'>Not applicable: Information not collected for this case<br/>
(If this information is required by your standard setter, use of code 8 may result in an edit error.)
</td></tr><tr class='code-row'><td class='code-nbr'>9</td><td class='code-desc'>Not documented in medical record<br/>
No orchiectomy performed<br/>
hCG (Human Chorionic Gonadotropin) Post-orchiectomy Range not assessed or unknown if assessed 
</td></tr><tr class='code-row'><td class='code-nbr' colspan='2'></td></tr></table></div><div class='content chap10-para mark-changed'>Each Site-Specific Data Item (SSDI) applies only to selected primary sites, histologies, and years of diagnosis. Depending on applicability and standard-setter requirements, SSDIs may be left blank.</div><a name='3848'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>HCG PRE-ORCHIECTOMY LAB VALUE</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">3848</td><td style="text-align:center;">7</td><td style="text-align:center;"><a href='#sources'>NAACCR</a></td><td style="text-align:center;">2018</td><td style="text-align:center;">18</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1967 - 1973</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>hcgPreOrchiectomyLabValue</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>hCG (Human Chorionic Gonadotropin) Pre-orchiectomy Lab Value refers to the hCG value measured prior to treatment. hCG is a serum tumor marker that is often elevated in patients with nonseminomatous germ cell tumors of the testis.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>hCG (Human Chorionic Gonadotropin) Pre-orchiectomy Lab Value is a Registry Data Collection Variable in AJCC. It was previously collected as Testis CS SSF# 8.</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>0.0</td><td class='code-desc'>0.0 milli-International Units/milliliter (mIU/mL)</td></tr><tr class='code-row'><td class='code-nbr'>0.1-99999.9</td><td class='code-desc'>0.199,999.9 mIU/mL</td></tr><tr class='code-row'><td class='code-nbr'>XXXXX.1</td><td class='code-desc'>100,000 mIU/mL or greater</td></tr><tr class='code-row'><td class='code-nbr'>XXXXX.7</td><td class='code-desc'>Test ordered, results not in chart</td></tr><tr class='code-row'><td class='code-nbr'>XXXXX.8</td><td class='code-desc'>Not applicable: Information not collected for this case<br/>
(If this information is required by your standard setter, use of code XXXXX.8 may result in an edit error.)
</td></tr><tr class='code-row'><td class='code-nbr'>XXXXX.9</td><td class='code-desc'>Not documented in medical record<br/>
hCG (Human Chorionic Gonadotropin) Pre-orchiectomy Lab Value not assessed or unknown if assessed
</td></tr><tr class='code-row'><td class='code-nbr'></td><td class='code-desc'> </td></tr></table></div><div class='content chap10-para'>Each Site-Specific Data Item (SSDI) applies only to selected primary sites, histologies, and years of diagnosis. Depending on applicability and standard-setter requirements, SSDIs may be left blank. </div><a name='3849'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>HCG PRE-ORCHIECTOMY RANGE</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">3849</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>NAACCR</a></td><td style="text-align:center;">2018</td><td style="text-align:center;">18</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1974 - 1974</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>hcgPreOrchiectomyRange</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Human Chorionic Gonadotropin (hCG) Pre-orchiectomy Range identifies the range category of the highest hCG value measured prior to treatment. hCG is a serum tumor marker that is often elevated in patients with nonseminomatous germ cell tumors of the testis.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>hCG (Human Chorionic Gonadotropin) is a Registry Data Collection Variable in AJCC. hCG (Human Chorionic Gonadotropin) Pre-orchiectomy Range is used to assign the S Category Clinical and was previously collected as Testis CS SSF# 9.</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>0</td><td class='code-desc'>Within normal limits </td></tr><tr class='code-row'><td class='code-nbr'>1</td><td class='code-desc'>Above normal and less than 5,000 milli-International Units/milliliter (mIU/mL)</td></tr><tr class='code-row'><td class='code-nbr'>2</td><td class='code-desc'>5,000 - 50,000 mIU/mL </td></tr><tr class='code-row'><td class='code-nbr'>3</td><td class='code-desc'>Greater than 50,000 mIU/mL</td></tr><tr class='code-row'><td class='code-nbr'>4</td><td class='code-desc'>Pre-orchiectomy human chorionic gonadotropin (hCG) stated to be elevated</td></tr><tr class='code-row'><td class='code-nbr'>7</td><td class='code-desc'>Test ordered, results not in chart</td></tr><tr class='code-row'><td class='code-nbr'>8</td><td class='code-desc'>Not applicable: Information not collected for this case<br/>
(If this information is required by your standard setter, use of code 8 may result in an edit error.)
</td></tr><tr class='code-row'><td class='code-nbr'>9</td><td class='code-desc'>Not documented in medical record<br/>
hCG pre-orchiectomy range not assessed or unknown if assessed 
</td></tr><tr class='code-row'><td class='code-nbr'></td><td class='code-desc'> </td></tr></table></div><div class='content chap10-para'>Each Site-Specific Data Item (SSDI) applies only to selected primary sites, histologies, and years of diagnosis. Depending on applicability and standard-setter requirements, SSDIs may be left blank. </div><a name='3850'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>HER2 IHC SUMMARY </strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">3850</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>NAACCR</a></td><td style="text-align:center;">2018</td><td style="text-align:center;">18</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1757 - 1757</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>her2IhcSummary</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>HER2 IHC Summary is the summary score for HER2 testing by IHC.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>HER2 IHC Summary is a Registry Data Collection Variable in AJCC. It is a new data item for cases diagnosed 1/1/2018+.</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>0</td><td class='code-desc'>Negative (Score 0) </td></tr><tr class='code-row'><td class='code-nbr'>1</td><td class='code-desc'>Negative (Score 1+)</td></tr><tr class='code-row'><td class='code-nbr'>2</td><td class='code-desc'>Equivocal (Score 2+)<br/>
Stated as equivocal
</td></tr><tr class='code-row'><td class='code-nbr'>3</td><td class='code-desc'>Positive (Score 3+)<br/>
Stated as positive
</td></tr><tr class='code-row'><td class='code-nbr'>4</td><td class='code-desc'>Stated as negative, but score not stated</td></tr><tr class='code-row'><td class='code-nbr'>7</td><td class='code-desc'>Test ordered, results not in chart</td></tr><tr class='code-row'><td class='code-nbr'>8</td><td class='code-desc'>Not applicable: Information not collected for this case<br/>
(If this item is required by your standard setter, use of code 8 will result in an edit error.)
</td></tr><tr class='code-row'><td class='code-nbr'>9</td><td class='code-desc'>Not documented in medical record<br/>
Cannot be determined (indeterminate)<br/>
HER2 IHC Summary not assessed or unknown if assessed
</td></tr><tr class='code-row'><td class='code-nbr'></td><td class='code-desc'> </td></tr></table></div><div class='content chap10-para'>Each Site-Specific Data Item (SSDI) applies only to selected primary sites, histologies, and years of diagnosis. Depending on applicability and standard-setter requirements, SSDIs may be left blank.</div><a name='3851'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>HER2 ISH DUAL PROBE COPY NUMBER</strong></td><td style="text-align:right;font-weight:bold;"><strong>Revised</strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">3851</td><td style="text-align:center;">4</td><td style="text-align:center;"><a href='#sources'>NAACCR</a></td><td style="text-align:center;">2018</td><td style="text-align:center;">18</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1758 - 1761</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>her2IshDualProbeCopyNumber</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>HER2 in situ hybridization (ISH) Dual Probe Copy Number is the HER2 copy number based on a dual probe test.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>HER2 ISH Dual Probe Copy Number is a Registry Data Collection Variable in AJCC. It is a new data item for cases diagnosed 1/1/2018+.</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para mark-changed'><table><tr class='code-row'><td class='code-nbr'>0.0-99.9</td><td class='code-desc'>Reported HER2 copy number of 0.0-99.9</td></tr><tr class='code-row'><td class='code-nbr'>XX.1</td><td class='code-desc'>Reported HER2 copy number of 100 or greater</td></tr><tr class='code-row'><td class='code-nbr'>XX.7</td><td class='code-desc'>Test ordered, results not in chart</td></tr><tr class='code-row'><td class='code-nbr'>XX.8</td><td class='code-desc'>Not applicable: Information not collected for this case<br/>
(If this item is required by your standard setter, use of code XX.8 will result in an edit error.)
</td></tr><tr class='code-row'><td class='code-nbr'>XX.9</td><td class='code-desc'>Not documented in medical record<br/>
Cannot be determined (indeterminate)<br/>
Dual probe test not done; only single probe test performed<br/>
HER2 ISH Dual Probe Copy Number not assessed or unknown if assessed
</td></tr><tr class='code-row'><td class='code-nbr'></td><td class='code-desc'> </td></tr></table></div><div class='content chap10-para'><div>This data item may be left blank. 
<div>&nbsp;</div><div>Each Site-Specific Data Item (SSDI) applies only to selected primary sites, histologies, and years of diagnosis. Depending on applicability and standard-setter requirements, SSDIs may be left blank.&nbsp;</div></div></div><a name='3852'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>HER2 ISH DUAL PROBE RATIO</strong></td><td style="text-align:right;font-weight:bold;"><strong>Revised</strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">3852</td><td style="text-align:center;">4</td><td style="text-align:center;"><a href='#sources'>NAACCR</a></td><td style="text-align:center;">2018</td><td style="text-align:center;">18</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1762 - 1765</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>her2IshDualProbeRatio</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>HER2 in situ hybridization (ISH) Dual Probe Ratio is the summary score for HER2 testing using a dual probe.  The test will report results for both HER2 and CEP17, the latter used as a control.  The HER2/CEP17 ratio is reported.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>HER2 ISH Dual Probe Ratio is a Registry Data Collection Variable in AJCC. It is a new data item for cases diagnosed 1/1/2018+.</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para mark-changed'><table><tr class='code-row'><td class='code-nbr'>0.0-99.9</td><td class='code-desc'>Ratio of 0.0 to 99.9 </td></tr><tr class='code-row'><td class='code-nbr'>XX.2</td><td class='code-desc'>Less than 2.0</td></tr><tr class='code-row'><td class='code-nbr'>XX.3</td><td class='code-desc'>Greater than or equal to 2.0</td></tr><tr class='code-row'><td class='code-nbr'>XX.7</td><td class='code-desc'>Test ordered, results not in chart</td></tr><tr class='code-row'><td class='code-nbr'>XX.8</td><td class='code-desc'>Not applicable: Information not collected for this case<br/>
(If this item is required by your standard setter, use of code XX.8 will result in an edit error.)
</td></tr><tr class='code-row'><td class='code-nbr'>XX.9</td><td class='code-desc'>Not documented in medical record<br/>
Results cannot be determined (indeterminate)<br/>
Dual probe test not done; only single probe test performed<br/>
HER2 ISH Dual Probe Ratio not assessed or unknown if assessed
</td></tr><tr class='code-row'><td class='code-nbr'></td><td class='code-desc'> </td></tr></table></div><div class='content chap10-para'>Each Site-Specific Data Item (SSDI) applies only to selected primary sites, histologies, and years of diagnosis. Depending on applicability and standard-setter requirements, SSDIs may be left blank.</div><a name='3853'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>HER2 ISH SINGLE PROBE COPY NUMBER</strong></td><td style="text-align:right;font-weight:bold;"><strong>Revised</strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">3853</td><td style="text-align:center;">4</td><td style="text-align:center;"><a href='#sources'>NAACCR</a></td><td style="text-align:center;">2018</td><td style="text-align:center;">18</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1766 - 1769</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>her2IshSingleProbeCopyNumber</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>HER2 in situ hybridization (ISH) Single Probe Copy Number is the HER2 copy number based on a single probe test.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>HER2 ISH Single Probe Copy Number is a Registry Data Collection Variable in AJCC. It is a new data item for cases diagnosed 1/1/2018+.</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para mark-changed'><table><tr class='code-row'><td class='code-nbr'>0.0-99.9</td><td class='code-desc'>Reported HER2 copy number of 0.0-99.9</td></tr><tr class='code-row'><td class='code-nbr'>XX.1</td><td class='code-desc'>Reported HER2 copy number of 100 or greater</td></tr><tr class='code-row'><td class='code-nbr'>XX.7</td><td class='code-desc'>Test ordered, results not in chart</td></tr><tr class='code-row'><td class='code-nbr'>XX.8</td><td class='code-desc'>Not applicable: Information not collected for this case<br/>
(If this item is required by your standard setter, use of code XX.8 will result in an edit error.)
</td></tr><tr class='code-row'><td class='code-nbr'>XX.9</td><td class='code-desc'>Not documented in medical record<br/>
Cannot be determined (indeterminate)<br/>
Single probe test not done; only dual probe test performed<br/>
HER2 ISH Single Probe Copy Number not assessed or unknown if assessed
</td></tr><tr class='code-row'><td class='code-nbr'></td><td class='code-desc'> </td></tr></table></div><div class='content chap10-para'>Each Site-Specific Data Item (SSDI) applies only to selected primary sites, histologies, and years of diagnosis. Depending on applicability and standard-setter requirements, SSDIs may be left blank.</div><a name='3854'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>HER2 ISH SUMMARY</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">3854</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>NAACCR</a></td><td style="text-align:center;">2018</td><td style="text-align:center;">18</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1770 - 1770</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>her2IshSummary</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>HER2 in situ hybridization (ISH) Summary is the summary score for results of testing for ERBB2 gene copy number by any ISH method.  An immunohistochemistry (IHC) test identifies the protein expressed by the gene (ERBB2), and an ISH test identifies the number of copies of the gene (ERBB2) itself.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>HER2 ISH Summary is a Registry Data Collection Variable in AJCC. It is a new data item for cases diagnosed 1/1/2018+.</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>0</td><td class='code-desc'>Negative [not amplified] </td></tr><tr class='code-row'><td class='code-nbr'>2</td><td class='code-desc'>Equivocal </td></tr><tr class='code-row'><td class='code-nbr'>3</td><td class='code-desc'>Positive [amplified]</td></tr><tr class='code-row'><td class='code-nbr'>7</td><td class='code-desc'>Test ordered, results not in chart</td></tr><tr class='code-row'><td class='code-nbr'>8</td><td class='code-desc'>Not applicable: Information not collected for this case<br/>
(If this item is required by your standard setter, use of code 8 will result in an edit error.)
</td></tr><tr class='code-row'><td class='code-nbr'>9</td><td class='code-desc'>Not documented in medical record<br/>
Results cannot be determined (indeterminate)<br/>
HER2 ISH Summary not assessed or unknown if assessed
</td></tr><tr class='code-row'><td class='code-nbr'></td><td class='code-desc'> </td></tr></table></div><div class='content chap10-para'>Each Site-Specific Data Item (SSDI) applies only to selected primary sites, histologies, and years of diagnosis. Depending on applicability and standard-setter requirements, SSDIs may be left blank.</div><a name='3855'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>HER2 OVERALL SUMMARY </strong></td><td style="text-align:right;font-weight:bold;"><strong>Revised</strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">3855</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>NAACCR</a></td><td style="text-align:center;">2018</td><td style="text-align:center;">18</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1744 - 1744</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>her2OverallSummary</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>HER2 Overall Summary is a summary of results from HER2 testing.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para mark-changed'><div>This data item is required for prognostic stage grouping in AJCC 8th edition, Chapter 48, 





<em>Breast</em>. It was previously collected as Breast, CS SSF # 15.Experts recommend that every invasive breast cancer be tested for the presence of HER2 because anti-HER2 treatments are highly effective for these tumors.</div><div>&nbsp;</div>HER2 overall summary It will be collected for Esophagus and Esophagogastric Junction and Stomach for cases diagnosed 1/1/21+ because NCCN guidelines recommend HER2 testing at time of diagnosis if patients are documented or suspected of having metastatic disease. HER2 monoclonal antibodies may be added to chemotherapy for patients with HER2 positive disease.</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>0</td><td class='code-desc'>HER2 negative; equivocal </td></tr><tr class='code-row'><td class='code-nbr'>1</td><td class='code-desc'>HER2 positive</td></tr><tr class='code-row'><td class='code-nbr'>7</td><td class='code-desc'>Test ordered, results not in chart</td></tr><tr class='code-row'><td class='code-nbr'>9</td><td class='code-desc'>Not documented in medical record<br/>
Cannot be determined (indeterminate)<br/>
HER2 Overall Summary status not assessed or unknown if assessed
</td></tr><tr class='code-row'><td class='code-nbr'></td><td class='code-desc'> </td></tr></table></div><div class='content chap10-para'>Each Site-Specific Data Item (SSDI) applies only to selected primary sites, histologies, and years of diagnosis. Depending on applicability and standard-setter requirements, SSDIs may be left blank.</div><a name='3856'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>HERITABLE TRAIT</strong></td><td style="text-align:right;font-weight:bold;"><strong>Revised</strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">3856</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>NAACCR</a></td><td style="text-align:center;">2018</td><td style="text-align:center;">18</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1909 - 1909</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>heritableTrait</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Heritable trait pertains to evidence that a tumor is associated with a heritable mutation. In retinoblastoma, the heritable trait is a germline mutation in the RB1 gene, which is associated with bilateral disease, family history of retinoblastoma, presence of concomitant CNS midline embryonic tumor (commonly in pineal region), or retinoblastoma with an intracranial primitive neuroectodermal tumor (i.e., trilateral retinoblastoma). Children with any of these features may be assigned the H1 status without molecular testing.  High quality molecular testing for RB1 mutation is required to determine the presence or absence of RB1 mutation for children without clinical features of a heritable mutation.</div><div class='content chap10-para mark-changed'>Heritable trait is required for prognostic stage grouping in AJCC 8th edition, Chapter 68 











<em>Retinoblastoma</em>. It is a new data item for cases diagnosed 1/1/2018+.</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>0</td><td class='code-desc'>H0: Normal RB1 alleles<br/>
No clinical evidence of mutation
 </td></tr><tr class='code-row'><td class='code-nbr'>1</td><td class='code-desc'>H1: RB1 gene mutation OR<br/> 
Clinical evidence of mutation
</td></tr><tr class='code-row'><td class='code-nbr'>7</td><td class='code-desc'>Test ordered, results not in chart</td></tr><tr class='code-row'><td class='code-nbr'>9</td><td class='code-desc'>HX: Not documented in medical record<br/>
Test not done, or unknown if done<br/>
Insufficient evidence of a constitutional RB1 gene mutation
</td></tr><tr class='code-row'><td class='code-nbr'></td><td class='code-desc'> </td></tr></table></div><div class='content chap10-para'>Each Site-Specific Data Item (SSDI) applies only to selected primary sites, histologies, and years of diagnosis. Depending on applicability and standard-setter requirements, SSDIs may be left blank.</div><a name='3857'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>HIGH RISK CYTOGENETICS</strong></td><td style="text-align:right;font-weight:bold;"><strong>Revised</strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">3857</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>NAACCR</a></td><td style="text-align:center;">2018</td><td style="text-align:center;">18</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1915 - 1915</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>highRiskCytogenetics</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>High Risk Cytogenetics is defined as one or more of t(4;14), t(14;16), or  del 17p identified from FISH test results and is part of the staging criteria for plasma cell myeloma.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para mark-changed'>High Risk Cytogenetics is a prognostic factor required in AJCC 8th edition, Chapter 82 











<em>Plasma Cell Myeloma and Plasma Cell Disorders</em>, for staging of plasma cell myeloma. It is a new data item for cases diagnosed 1/1/2018+.</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>0</td><td class='code-desc'>High-risk cytogenetics not identified/not present </td></tr><tr class='code-row'><td class='code-nbr'>1</td><td class='code-desc'>High-risk cytogenetics present</td></tr><tr class='code-row'><td class='code-nbr'>7</td><td class='code-desc'>Test ordered, results not in chart</td></tr><tr class='code-row'><td class='code-nbr'>9</td><td class='code-desc'>Not documented in medical record<br/>
High Risk Cytogenetics not assessed or unknown if assessed
</td></tr><tr class='code-row'><td class='code-nbr'></td><td class='code-desc'> </td></tr></table></div><div class='content chap10-para'>Each Site-Specific Data Item (SSDI) applies only to selected primary sites, histologies, and years of diagnosis. Depending on applicability and standard-setter requirements, SSDIs may be left blank.</div><a name='3858'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>HIGH RISK HISTOLOGIC FEATURES</strong></td><td style="text-align:right;font-weight:bold;"><strong>Revised</strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">3858</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>NAACCR</a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1949 - 1949</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>highRiskHistologicFeatures</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para mark-changed'>High Risk Histologic Features are defined in AJCC 8 Chapter 15 to include the terms "poor differentiation, desmoplasia, sarcomatoid differentiation, undifferentiated." High risk histologic features are a prognostic factor for cutaneous cell carcinomas of the head and neck.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>High Risk Histologic Features is a Registry Data Collection Variable in AJCC. It was previously collected as Skin, CS SSF # 12.</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>0</td><td class='code-desc'>No high risk histologic features</td></tr><tr class='code-row'><td class='code-nbr'>1</td><td class='code-desc'>Desmoplasia</td></tr><tr class='code-row'><td class='code-nbr'>2</td><td class='code-desc'>Poor differentiation (grade 3)</td></tr><tr class='code-row'><td class='code-nbr'>3</td><td class='code-desc'>Sarcomatoid differentiation</td></tr><tr class='code-row'><td class='code-nbr'>4</td><td class='code-desc'>Undifferentiated (grade 4)</td></tr><tr class='code-row'><td class='code-nbr'>5</td><td class='code-desc'>Multiple high risk histologic features</td></tr><tr class='code-row'><td class='code-nbr'>6</td><td class='code-desc'>Histologic features, NOS (type of high risk histologic feature not specified)</td></tr><tr class='code-row'><td class='code-nbr'>8</td><td class='code-desc'>Not applicable: Information not collected for this case<br/>
(If this information is required by your standard setter, use of code 8 may result in an edit error)
</td></tr><tr class='code-row'><td class='code-nbr'>9</td><td class='code-desc'>Not documented in medical record<br/>
High risk histologic features not assessed or unknown if assessed
</td></tr><tr class='code-row'><td class='code-nbr'></td><td class='code-desc'> </td></tr></table></div><div class='content chap10-para mark-changed'>Each Site-Specific Data Item (SSDI) applies only to selected primary sites, histologies, and years of diagnosis. Depending on applicability and standard-setter requirements, SSDIs may be left blank.</div><a name='522'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>HISTOLOGIC TYPE ICD-O-3</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">522</td><td style="text-align:center;">4</td><td style="text-align:center;"><a href='#sources'>SEER/CoC</a></td><td style="text-align:center;">2001</td><td style="text-align:center;">9</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">564 - 567</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>ICD-O-3 Histology (CCCR)<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>histologicTypeIcdO3</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Codes for the histologic type of the tumor being reported using ICD-O-3. NAACCR adopted ICD-O-3 as the standard coding system for tumors diagnosed in 2001 and later, and recommended that prior tumors be converted from ICD-O-2. Effective with 2010 diagnoses, this item also includes histology codes as per the 2008 WHO Hematopoietic/Lymphoid publication<sup>39</sup>, which are listed on pages 3-5 of the NAACCR 2010 Implementation Guidelines. <a href="http://www.naaccr.org/StandardsandRegistryOperations/ImplementationGuidelines.aspx">http://www.naaccr.org/StandardsandRegistryOperations/ImplementationGuidelines.aspx</a>.<br />
<br />
Note: See Histology (92-00) ICD-O-2 [420] for ICD-O-2 codes. Effective with 2010 diagnoses, this item also includes histology codes as per the 2008 WHO Hematopoietic/Lymphoid publication <sup>39</sup>, which are listed on pages 3-5 of the NAACCR 2010 Implementation Guidelines. <a href="http://www.naaccr.org/LinkClick.aspx?fileticket=U-3o31G2Lik%3d&amp;tabid=126&amp;mid=466%20">http://www.naaccr.org/LinkClick.aspx?fileticket=U-3o31G2Lik%3d&amp;tabid=126&amp;mid=466 </a> </div><div class='content chap10-para'><strong>Codes <br /></strong>See ICD-O-3,<sup>14 </sup>Morphology Section and the SEER Hematopoietic database.</div><div class='content chap10-para'><strong>Clarification of Required Status</strong>  <br />This data item is required by all standard-setting organizations for  tumors diagnosed on or after January 1, 2001, and recommended (by  conversion from ICD-O-2 codes when conversion algorithms and tables are  available) for tumors diagnosed before 2001.  <br /><br />When the histologic type is coded according to ICD-O-3, the histology  code must be reported in Histologic Type ICD-O-3 [522], with behavior  coded in Behavior Code ICD-O-3 [523].  <br /><br />For information on required status for related data items for histologic  type and behavior when coded according to ICD-O-2, see Histology  (92-00) ICD-O-2 [420] and Behavior (92-00) ICD-O-2 [430].</div><a name='1971'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>HISTOLOGY (73-91) ICD-O-1</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">1971</td><td style="text-align:center;">4</td><td style="text-align:center;"><a href='#sources'>SEER</a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">2600 - 2603</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>histologyIcdO1</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Area for retaining the histology portion (4 digits) of the ICD-O-1 or field trial morphology codes entered before a conversion to ICD-O-2. See grouped data item Morph (73-91) ICD-O-1 [1970], in Appendix E. The item name includes years 1973-91. However, some states may have used the codes for cases before 1973. </div><div class='content chap10-para'><strong>Codes </strong>For cases diagnosed before 1992, contains the ICD-O-1 or field trial 4-digit histology code as originally coded, if available. Blank for tumors coded directly into ICD-O-2 or ICD-O-3 (i.e., 1992 and later cases).</div><a name='420'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>HISTOLOGY (92-00) ICD-O-2</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">420</td><td style="text-align:center;">4</td><td style="text-align:center;"><a href='#sources'>SEER/CoC</a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">559 - 562</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>Histology (CoC)<br />ICD-O-2 Histology (CCCR)<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>histologyIcdO2</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Codes for the histologic type of the tumor being reported using ICD-O-2. NAACCR adopted ICD-O-2 as the standard coding system for tumors diagnosed in 1992 and later and recommended that prior cases be converted to ICD-O-2.<br /><br /><em>Note:</em> See Histology (73-91) ICD-O-1 [1971] for ICD-O-1 and field trial codes. </div><div class='content chap10-para'><p>    <strong>Codes </strong>See ICD-O-2,<sup>15</sup> Morphology Section.</p>  <p>&#160;</p></div><div class='content chap10-para'><strong>Clarification of Required Status</strong>  <br />This data item is required by all standard-setting organizations for  tumors diagnosed from January 1, 1992, through December 31, 2000, and  recommended for tumors diagnosed before 1992.  <br /><br />When the histologic type is coded according to ICD-O-2, the histology  code must be reported in Histology (92-00) ICD-O-2 [420], with behavior  coded in Behavior (92-00) ICD-O-2 [430].  <br /><br />For information on required status for related data items for histologic  type and behavior when coded according to ICD-O-3, see Histologic Type  ICD-O-3 [522] and Behavior Code ICD-O-3 [523].</div><a name='3859'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>HIV STATUS</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">3859</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>NAACCR</a></td><td style="text-align:center;">2018</td><td style="text-align:center;">18</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1869 - 1869</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>hivStatus</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>HIV status refers to infection with the Human Immunodeficiency Virus which causes Acquired Immune Deficiency Syndrome (AIDS). AIDS is associated with increased risk of developing some lymphomas.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>HIV status may be collected by the surveillance community for neoplasms (e.g., Kaposi Sarcoma, Lymphomas) that are closely related to HIV/AIDS. Prior to 2018, Lymphoma SSF#1 and Kaposi Sarcoma SSF# 1, were used for HIV Status.</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>0</td><td class='code-desc'>Not associated with Human Immunodeficiency Virus (HIV)/Acquired Immune Deficiency Syndrome(AIDS)<br/>
HIV negative
 </td></tr><tr class='code-row'><td class='code-nbr'>1</td><td class='code-desc'>Associated with HIV/AIDS<br/>
HIV positive
</td></tr><tr class='code-row'><td class='code-nbr'>7</td><td class='code-desc'>Test ordered, results not in chart</td></tr><tr class='code-row'><td class='code-nbr'>8</td><td class='code-desc'>Not applicable: Information not collected for this case<br/>
(If this item is required by your standard setter, use of code 8 will result in an edit error.)
</td></tr><tr class='code-row'><td class='code-nbr'>9</td><td class='code-desc'>Not documented in medical record<br/>
HIV status not assessed or unknown if assessed
</td></tr><tr class='code-row'><td class='code-nbr'></td><td class='code-desc'> </td></tr></table></div><div class='content chap10-para'>Each Site-Specific Data Item (SSDI) applies only to selected primary sites, histologies, and years of diagnosis. Depending on applicability and standard-setter requirements, SSDIs may be left blank.</div><a name='3165'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>ICD REVISION COMORBID</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">3165</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>CoC</a></td><td style="text-align:center;">2006</td><td style="text-align:center;">11</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1526 - 1526</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>ICD Revision Comorbidities<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>icdRevisionComorbid</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>This item indicates the coding system in which the Comorbidities and Complications (secondary diagnoses) codes are provided. </div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>The CoC currently requires the collection and reporting of up to 10 ICD-9-CM codes describing secondary diagnoses for patients hospitalized for cancer treatment. Currently the use of ICD-10-CM is not mandatory in U.S. hospitals, though it may become so in the future. In the event this occurs cancer registries that maintain or collect this information will need to differentiate between ICD-9-CM and ICD-10-CM code use. The code values and definitions for this item would be expanded as necessary. Allowable codes reported in the Comorbidity and Complications items in 

<em><a target="_blank" href="http://www.facs.org/cancer/coc/fordsmanual.html">STORE</a></em> would be re-assessed at the same time. </div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>0</td><td class='code-desc'>No comorbidities or complications recorded in patient's record</td></tr><tr class='code-row'><td class='code-nbr'>1</td><td class='code-desc'>ICD-10-CM</td></tr><tr class='code-row'><td class='code-nbr'>9</td><td class='code-desc'>ICD-9-CM</td></tr><tr class='code-row'><td class='code-nbr'>Blank</td><td class='code-desc'>Comorbidities and Complications not collected</td></tr></table></div><a name='1920'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>ICD REVISION NUMBER</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">1920</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>SEER</a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">2946 - 2946</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>ICD Code Revision Used for Cause of Death (SEER)<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>icdRevisionNumber</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Patient</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Indicator for the coding scheme used to code the cause of death. </div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>0</td><td class='code-desc'>Patient alive at last follow-up</td></tr><tr class='code-row'><td class='code-nbr'>1</td><td class='code-desc'>ICD-10</td></tr><tr class='code-row'><td class='code-nbr'>7</td><td class='code-desc'>ICD-7</td></tr><tr class='code-row'><td class='code-nbr'>8</td><td class='code-desc'>ICDA-8</td></tr><tr class='code-row'><td class='code-nbr'>9</td><td class='code-desc'>ICD-9</td></tr></table></div><a name='1980'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>ICD-O-2 CONVERSION FLAG</strong></td><td style="text-align:right;font-weight:bold;"><strong>Revised</strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">1980</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>SEER</a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">2606 - 2606</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>Review Flag for 1973-91 Cases (SEER)<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>icdO2ConversionFlag</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para mark-changed'>Code specifying how the conversion of site and morphology codes from ICD-O-1 and the field trial editions to ICD-O-2 was accomplished. The item names include years 1973-91. However, some states may have used the codes for tumors before 1973. The code also covers morphology conversions from ICD-O-3 to ICD-O-2.</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>0</td><td class='code-desc'>Primary site and morphology originally coded in ICD-O-2</td></tr><tr class='code-row'><td class='code-nbr'>1</td><td class='code-desc'>Primary site and morphology converted without review</td></tr><tr class='code-row'><td class='code-nbr'>2</td><td class='code-desc'>Primary site converted with review; morphology machine-converted without review</td></tr><tr class='code-row'><td class='code-nbr'>3</td><td class='code-desc'>Primary site machine-converted without review, morphology converted with review</td></tr><tr class='code-row'><td class='code-nbr'>4</td><td class='code-desc'>Primary site and morphology converted with review</td></tr><tr class='code-row'><td class='code-nbr'>5</td><td class='code-desc'>Morphology converted from ICD-O-3 without review</td></tr><tr class='code-row'><td class='code-nbr'>6</td><td class='code-desc'>Morphology converted from ICD-O-3 with review</td></tr><tr class='code-row'><td class='code-nbr'>Blank</td><td class='code-desc'>Not converted</td></tr></table></div><a name='2116'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>ICD-O-3 CONVERSION FLAG</strong></td><td style="text-align:right;font-weight:bold;"><strong>Revised</strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">2116</td><td style="text-align:center;">1</td><td title="V: 22: SEER
V: 18: SEER/CoC
V: 16: SEER/CoC
V: 15: SEER/CoC
" class=" HighlightToolTip" style="text-align:center;"><a href='#sources'>SEER</a></td><td style="text-align:center;">2001</td><td style="text-align:center;">9</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">2704 - 2704</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>icdO3ConversionFlag</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para mark-changed'>Code specifying how the conversion of site and morphology codes from ICD-O-2 to ICD-O-3 was accomplished.</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>0</td><td class='code-desc'>Morphology (Morph--Type&Behav ICD-O-3 [521]) originally coded in ICD-O-3</td></tr><tr class='code-row'><td class='code-nbr'>1</td><td class='code-desc'>Morphology (Morph--Type&Behav ICD-O-3 [521]) converted from (Morph--Type&Behav ICD-O-2 [419]) without review</td></tr><tr class='code-row'><td class='code-nbr'>3</td><td class='code-desc'>Morphology (Morph--Type&Behav ICD-O-3 [521]) converted from (Morph--Type&Behav ICD-O-2 [419]) with review</td></tr><tr class='code-row'><td class='code-nbr'>Blank</td><td class='code-desc'>Not converted (clarification for cases diagnosed as of January 1, 2007: cases coded in prior ICD-O version and not converted to ICD-O-3)</td></tr></table></div><a name='192'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>IHS LINK</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">192</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>NPCR</a></td><td style="text-align:center;">2006</td><td style="text-align:center;">11</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">451 - 451</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>Indian Health Service Linkage<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>ihsLink</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Patient</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>This variable captures the results of the linkage of the registry database with the Indian Health Service patient registration database.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>The IHS linkage identifies cancer cases among American Indians who were misclassified as non-Indian in the registry database in order to improve the quality of cancer surveillance data on American Indians in individual registries and in all registries as a whole. The goal is to include cancer incidence data for American Indians in the United States Cancer Statistics by use of this variable as well as the race variable.</div><div class='content chap10-para'>Codes</div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>0</td><td class='code-desc'>Record sent for linkage, no IHS match</td></tr><tr class='code-row'><td class='code-nbr'>1</td><td class='code-desc'>Record sent for linkage, IHS match</td></tr><tr class='code-row'><td class='code-nbr'>Blank</td><td class='code-desc'>Record not sent for linkage or linkage result pending</td></tr></table></div><a name='300'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>INDUSTRY SOURCE</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">300</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>NPCR</a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">246 - 246</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>industrySource</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Code that best describes the source of industry information provided on this patient. This is a central cancer registry data item (i.e., codes should be applied by a central or regional registry rather than collected from reporting facilities).</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Industry information may come from a variety of sources. The most valid and reliable source of industry information for patients has not yet been determined.</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>0</td><td class='code-desc'>Unknown industry/no industry available</td></tr><tr class='code-row'><td class='code-nbr'>1</td><td class='code-desc'>Reporting facility records</td></tr><tr class='code-row'><td class='code-nbr'>2</td><td class='code-desc'>Death certificate</td></tr><tr class='code-row'><td class='code-nbr'>3</td><td class='code-desc'>Interview</td></tr><tr class='code-row'><td class='code-nbr'>7</td><td class='code-desc'>Other source</td></tr><tr class='code-row'><td class='code-nbr'>8</td><td class='code-desc'>Not applicable, patient less than 14 years of age at diagnosis</td></tr><tr class='code-row'><td class='code-nbr'>9</td><td class='code-desc'>Unknown source</td></tr><tr class='code-row'><td class='code-nbr'>Blank</td><td class='code-desc'>Not collected</td></tr></table></div><a name='605'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>INPATIENT STATUS</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">605</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>NAACCR</a></td><td style="text-align:center;">2010</td><td style="text-align:center;">12</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">789 - 789</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>inpatientStatus</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>This data item records whether there was an inpatient admission for the most definitive therapy, or in the absence of therapy, for diagnostic evaluation. This data item was first available in Volume II Version 12 (effective January 2010). </div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Before Version 12 (through 2009 diagnosis), date fields included information in addition to dates. This data item incorporates the non-date meanings for the Date of Inpt Adm [590] and Date of Inpt Disch [600] in order to retain the non-date information with the transition to interoperable dates. </div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>0</td><td class='code-desc'>Patient was never an inpatient</td></tr><tr class='code-row'><td class='code-nbr'>1</td><td class='code-desc'>Patient was inpatient</td></tr><tr class='code-row'><td class='code-nbr'>9</td><td class='code-desc'>Unknown if patient was an inpatient (only used for consolidated cases)</td></tr><tr class='code-row'><td class='code-nbr'>Blank</td><td class='code-desc'>Not collected</td></tr></table></div><div class='content chap10-para'>Comment: This is part of the initiative of the transformation from the old NAACCR date standards to interoperable dates.</div><a name='640'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>INPATIENT/OUTPT STATUS</strong></td><td style="text-align:right;font-weight:bold;"><strong>Retired</strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">640</td><td style="text-align:center;"></td><td style="text-align:center;"><a href='#sources'></a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;">2006</td><td style="text-align:center;">11</td><td class="cross-out" style="text-align:center;"></td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td></td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td></td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>The NAACCR UDSC retired this data item in Version 11, as of January 1, 2006.</div><a name='2410'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>INSTITUTION REFERRED FROM</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">2410</td><td style="text-align:center;">10</td><td style="text-align:center;"><a href='#sources'>CoC</a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">4935 - 4944</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>Facility Referred From<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>institutionReferredFrom</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Identifies the facility that referred the patient to the reporting facility. </div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>This number is used to document and monitor referral patterns.<strong><br /><br />Instructions for Coding</strong><br />CoC maintains the codes, including those for non-hospital sources of reporting. <br /><br />For facilities with 7-digit FINs, consisting of a constant &#8220;6&#8221; followed by 6-digit facility-specific codes in the range of 6020009-6953290 that were assigned by CoC before January 1, 2001: Enter all FIN codes of this type as 3 zeroes, followed by the constant &#8220;6&#8221; and the 6-digit facility-specific codes.<br /><br />For facilities with FINs greater than or equal to 10000000 that were assigned by CoC after January 1, 2001: Enter FIN codes of this type as 2 zeroes followed by the full 8-digit code. These sometimes are called CoC FIN 10-digit codes. </div><div class='content chap10-para'><em>Note</em>: This item is not supported by CoC as of January 1, 2010, (the respective NPI item is required). </div><div class='content chap10-para'><strong>Codes (in addition to CoC assigned codes) </strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>0000000000</td><td class='code-desc'>Case not referred from a facility</td></tr><tr class='code-row'><td class='code-nbr'>0099999999</td><td class='code-desc'>Case referred from a facility, but facility number is unknown</td></tr></table></div><a name='2420'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>INSTITUTION REFERRED TO</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">2420</td><td style="text-align:center;">10</td><td style="text-align:center;"><a href='#sources'>CoC</a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">4955 - 4964</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>Facility Referred To<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>institutionReferredTo</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Identifies the facility to which the patient was referred for further care. </div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'><div>This number is used to document and monitor referral patterns.</div><div> &nbsp;</div><strong>Instructions for Coding</strong><br />CoC maintains the codes, including those for non-hospital sources of reporting. <br /><br />For facilities with 7-digit FINs, consisting of a constant &#8220;6&#8221; followed by 6-digit facility-specific codes in the range of 6020009-6953290 that were assigned by CoC before January 1, 2001: Enter all FIN codes of this type as 3 zeroes, followed by the constant &#8220;6&#8221; and the 6-digit facility-specific codes.<br /><br />For facilities with FINs greater than or equal to 10000000 that were assigned by CoC after January 1, 2001: Enter FIN codes of this type as 2 zeroes followed by the full 8-digit code. These sometimes are called CoC FIN 10-digit codes. </div><div class='content chap10-para'><em>Note</em>: This item is not supported by CoC as of January 1, 2010, (the respective NPI item is required). </div><div class='content chap10-para'><strong>Codes (in addition to CoC assigned codes) </strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>0000000000</td><td class='code-desc'>Case not referred to a facility</td></tr><tr class='code-row'><td class='code-nbr'>0099999999</td><td class='code-desc'>Case referred to a facility, but facility number is unknown</td></tr></table></div><a name='3860'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>INTERNATIONAL NORMALIZED RATIO PROTHROMBIN TIME</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">3860</td><td style="text-align:center;">3</td><td style="text-align:center;"><a href='#sources'>NAACCR</a></td><td style="text-align:center;">2018</td><td style="text-align:center;">18</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1863 - 1865</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>iNRProthrombinTime</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>International Normalized Ratio for Prothrombin Time (INR), an indicator of the liver&#8217;s ability to make clotting factors, is required to calculate the Model for End-Stage Liver Disease (MELD) score, which is used to assign priority for liver transplant.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>International Normalized Ratio for Prothrombin Time (INR) is a Registry Data Collection Variable in AJCC. This data item was previously collected for Liver, CS SSF# 8.</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>0.0</td><td class='code-desc'>0.0 </td></tr><tr class='code-row'><td class='code-nbr'>0.1</td><td class='code-desc'>0.1 or less </td></tr><tr class='code-row'><td class='code-nbr'>0.2-9.9</td><td class='code-desc'>0.2 - 9.9<br/>
(Exact ratio to nearest tenth)
</td></tr><tr class='code-row'><td class='code-nbr'>X.1</td><td class='code-desc'>10 or greater</td></tr><tr class='code-row'><td class='code-nbr'>X.7</td><td class='code-desc'>Test ordered, results not in chart</td></tr><tr class='code-row'><td class='code-nbr'>X.8</td><td class='code-desc'>Not applicable: Information not collected for this case<br/>
(If this information is required by your standard setter, use of code X.8 may result in an edit error.)
</td></tr><tr class='code-row'><td class='code-nbr'>X.9</td><td class='code-desc'>Not documented in medical record<br/>
INR (International Normalized Ratio for Prothrombin Time) not assessed or unknown if assessed
</td></tr><tr class='code-row'><td class='code-nbr'></td><td class='code-desc'> </td></tr></table></div><div class='content chap10-para'>Each Site-Specific Data Item (SSDI) applies only to selected primary sites, histologies, and years of diagnosis. Depending on applicability and standard-setter requirements, SSDIs may be left blank. </div><a name='3864'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>INVASION BEYOND CAPSULE</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">3864</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>NAACCR</a></td><td style="text-align:center;">2018</td><td style="text-align:center;">18</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1834 - 1834</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>invasionBeyondCapsule</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Invasion beyond capsule pertains to the pathologically confirmed invasion of the tumor beyond the fibrous capsule in which the kidney is enclosed.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Invasion beyond capsule into specific tissues for Kidney is a Registry Data Collection Variable in AJCC.  It was previously collected as Kidney, CS SSF #1.</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>0</td><td class='code-desc'>Invasion beyond capsule not identified </td></tr><tr class='code-row'><td class='code-nbr'>1</td><td class='code-desc'>Perinephric (beyond renal capsule) fat or tissue</td></tr><tr class='code-row'><td class='code-nbr'>2</td><td class='code-desc'>Renal sinus</td></tr><tr class='code-row'><td class='code-nbr'>3</td><td class='code-desc'>Gerotas fascia</td></tr><tr class='code-row'><td class='code-nbr'>4</td><td class='code-desc'>Any combination of codes 1-3</td></tr><tr class='code-row'><td class='code-nbr'>5</td><td class='code-desc'>Invasion beyond capsule, NOS</td></tr><tr class='code-row'><td class='code-nbr'>8</td><td class='code-desc'>Not applicable: Information not collected for this case<br/>
(If this information is required by your standard setter, use of code 8 may result in an edit error.)
</td></tr><tr class='code-row'><td class='code-nbr'>9</td><td class='code-desc'>Not documented in medical record<br/>
Invasion beyond capsule not assessed or unknown if assessed<br/>
No surgical resection of primary site is performed
</td></tr><tr class='code-row'><td class='code-nbr'></td><td class='code-desc'> </td></tr></table></div><div class='content chap10-para'>Each Site-Specific Data Item (SSDI) applies only to selected primary sites, histologies, and years of diagnosis. Depending on applicability and standard-setter requirements, SSDIs may be left blank. </div><a name='3861'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>IPSILATERAL ADRENAL GLAND INVOLVEMENT</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">3861</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>NAACCR</a></td><td style="text-align:center;">2018</td><td style="text-align:center;">18</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1833 - 1833</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>ipsilateralAdrenalGlandInvolve</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Ipsilateral adrenal gland involvement pertains to direct extension of the tumor into the ipsilateral adrenal gland (continuous) or ipsilateral adrenal gland involvement by a separate nodule (noncontiguous).</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'><!--[if gte mso 10]>  <![endif]-->Ipsilateral adrenal gland involvement for Kidney is a Registry Data Collection Variable in AJCC.  It was previously collected as Kidney, CS SSF #3.</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>0</td><td class='code-desc'>Ipsilateral adrenal gland involvement not present/not identified </td></tr><tr class='code-row'><td class='code-nbr'>1</td><td class='code-desc'>Adrenal gland involvement by direct involvement (contiguous involvement)</td></tr><tr class='code-row'><td class='code-nbr'>2</td><td class='code-desc'>Adrenal gland involvement by separate nodule (noncontiguous involvement)</td></tr><tr class='code-row'><td class='code-nbr'>3</td><td class='code-desc'>Combination of code 1-2</td></tr><tr class='code-row'><td class='code-nbr'>4</td><td class='code-desc'>Ipsilateral adrenal gland involvement, unknown if direct involvement or separate nodule</td></tr><tr class='code-row'><td class='code-nbr'>8</td><td class='code-desc'>Not applicable: Information not collected for this case<br/>
(If this information is required by your standard setter, use of code 8 may result in an edit error.)
</td></tr><tr class='code-row'><td class='code-nbr'>9</td><td class='code-desc'>Not documented in medical record<br/>
Ipsilateral adrenal gland not resected<br/>
Ipsilateral adrenal gland involvement not assessed or unknown if assessed<br/>
No surgical resection of primary site is performed
</td></tr><tr class='code-row'><td class='code-nbr'></td><td class='code-desc'> </td></tr></table></div><div class='content chap10-para'>Each Site-Specific Data Item (SSDI) applies only to selected primary sites, histologies, and years of diagnosis. Depending on applicability and standard-setter requirements, SSDIs may be left blank. </div><a name='3862'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>JAK2</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">3862</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>NAACCR</a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1830 - 1830</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>jak2</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Janus Kinase 2 (JAK2, JAK 2) is a gene mutation that increases susceptibility to several myeloproliferative neoplasms (MPNs). Testing for the JAK2 mutation is done on whole blood. Nearly all people with polycythemia vera, and about half of those with primary myelofibrosis and essential thrombocythemia, have the mutation. JAK2 analysis continues to increase in use for hematopoietic neoplasms.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>JAK2 can be collected by the surveillance community for myeloproliferative neoplasms. Prior to 2018, HemeRetic SSF#1 was used for JAK2.</div><div class='content chap10-para'>Codes </div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>0</td><td class='code-desc'>JAK2 result stated as negative</td></tr><tr class='code-row'><td class='code-nbr'>1</td><td class='code-desc'>JAK2 positive for mutation V617F WITH or WITHOUT other mutations</td></tr><tr class='code-row'><td class='code-nbr'>2</td><td class='code-desc'>JAK2 positive for exon 12 mutation </td></tr><tr class='code-row'><td class='code-nbr'>3</td><td class='code-desc'>JAK2 positive for other specified mutation</td></tr><tr class='code-row'><td class='code-nbr'>4</td><td class='code-desc'>JAK2 positive for more than one mutation other than V617F</td></tr><tr class='code-row'><td class='code-nbr'>5</td><td class='code-desc'>JAK2 positive NOS<br/> 
Specific mutation(s) not stated
</td></tr><tr class='code-row'><td class='code-nbr'>7</td><td class='code-desc'>Test ordered, results not in chart</td></tr><tr class='code-row'><td class='code-nbr'>8</td><td class='code-desc'>Not applicable: Information not collected for this case<br/> 
(If this item is required by your standard setter, use of code 8 will result in an edit error.)
</td></tr><tr class='code-row'><td class='code-nbr'>9</td><td class='code-desc'>Not documented in medical record<br/>
JAK2 not assessed or unknown if assessed 
</td></tr><tr class='code-row'><td class='code-nbr'></td><td class='code-desc'> </td></tr></table></div><div class='content chap10-para'>Each Site-Specific Data Item (SSDI) applies only to selected primary sites, histologies, and years of diagnosis. Depending on applicability and standard-setter requirements, SSDIs may be left blank. </div><a name='3863'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>KI-67</strong></td><td style="text-align:right;font-weight:bold;"><strong>Revised</strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">3863</td><td style="text-align:center;">5</td><td style="text-align:center;"><a href='#sources'>NAACCR</a></td><td style="text-align:center;">2018</td><td style="text-align:center;">18</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1771 - 1775</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>ki67</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para mark-changed'>Ki-67 (MIB-1) (Proliferative Index) is a marker of cell proliferation. A high value indicates a tumor that is proliferating more rapidly. Codes and coding instructions for this data item are site-specific.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para mark-changed'>Ki-67 (MIB-1) (Proliferative Index) is a Registry Data Collection Variable in AJCC. It was a new data item for breast cases diagnosed 1/1/2018+. It will apply to neuroendocrine tumors (NET) of the gastrointestinal tract (AJCC Chapters 29 &#8211; 34) for cases diagnosed 1/1/2021+. High Ki-67 is an adverse prognostic factor and Ki-67 is a component of grade for these tumors. NCCN guidelines recommend that tumor differentiation, mitotic rate and Ki-67 should be recorded in the pathology report for these tumors.</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para mark-changed'><table><tr class='code-row'><td class='code-nbr'>0.0-100.0</td><td class='code-desc'>0.0 to 100.0 percent positive: enter percent positive </td></tr><tr class='code-row'><td class='code-nbr'>XXX.4</td><td class='code-desc'>Ki-67 stated as less than 3% </td></tr><tr class='code-row'><td class='code-nbr'>XXX.5</td><td class='code-desc'>Ki-67 stated as 3%-20%</td></tr><tr class='code-row'><td class='code-nbr'>XXX.6</td><td class='code-desc'>Ki-67 stated as greater than 20%</td></tr><tr class='code-row'><td class='code-nbr'>XXX.7</td><td class='code-desc'>Test done, actual percentage not stated</td></tr><tr class='code-row'><td class='code-nbr'>XXX.8</td><td class='code-desc'>Not applicable: Information not collected for this case<br/>
(If this item is required by your standard setter, use of code XXX.8 will result in an edit error.)
</td></tr><tr class='code-row'><td class='code-nbr'>XXX.9</td><td class='code-desc'>Not documented in medical record<br/>
Ki-67 (MIB-1) not assessed or unknown if assessed
</td></tr><tr class='code-row'><td class='code-nbr' colspan='2'></td></tr></table></div><div class='content chap10-para mark-changed'>Each Site-Specific Data Item (SSDI) applies only to selected primary sites, histologies, and years of diagnosis. Depending on applicability and standard-setter requirements, SSDIs may be left blank.</div><a name='3865'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>KIT GENE IMMUNOHISTOCHEMISTRY </strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">3865</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>NAACCR</a></td><td style="text-align:center;">2018</td><td style="text-align:center;">18</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1815 - 1815</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>kitGeneImmunohistochemistry</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>KIT Gene Immunohistochemistry (IHC) is the expression of the KIT gene in tumor tissue specimens based on immunohistochemical (IHC) stains. A positive test is a diagnostic and predictive marker for GIST tumors.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>KIT Gene Immunohistochemistry (IHC) is a Registry Data Collection Variable in AJCC. This data item was previously collected for GIST schemas in CS (different SSF&#8217;s).</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>0</td><td class='code-desc'>KIT negative/normal; within normal limits </td></tr><tr class='code-row'><td class='code-nbr'>1</td><td class='code-desc'>KIT positive</td></tr><tr class='code-row'><td class='code-nbr'>7</td><td class='code-desc'>Test ordered, results not in chart</td></tr><tr class='code-row'><td class='code-nbr'>8</td><td class='code-desc'>Not applicable: Information not collected for this case<br/>
(If this information is required by your standard setter, use of code 8 may result in an edit error.)
</td></tr><tr class='code-row'><td class='code-nbr'>9</td><td class='code-desc'>Not documented in medical record<br/>
Cannot be determined by pathologist<br/>
KIT not assessed or unknown if assessed
</td></tr><tr class='code-row'><td class='code-nbr'></td><td class='code-desc'> </td></tr></table></div><div class='content chap10-para'>Each Site-Specific Data Item (SSDI) applies only to selected primary sites, histologies, and years of diagnosis. Depending on applicability and standard-setter requirements, SSDIs may be left blank. </div><a name='3866'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>KRAS</strong></td><td style="text-align:right;font-weight:bold;"><strong>Revised</strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">3866</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>NAACCR</a></td><td style="text-align:center;">2018</td><td style="text-align:center;">18</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1800 - 1800</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>kras</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>KRAS is an important signaling intermediate in the growth receptor pathway which controls cell proliferation and survival. KRAS is a protein with production controlled by the K-ras gene. When the K-ras gene is activated through mutation during colorectal carcinogenesis, production of KRAS continuously stimulates cell proliferation and prevents cell deaths. Activating mutations in KRAS are an adverse prognostic factor for colorectal carcinoma and predict a poor response to monoclonal anti-EGFR antibody therapy in advanced colorectal carcinoma.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>KRAS is a Registry Data Collection Variable in AJCC. It was previously collected as Colon and Rectum CS SSF# 9.</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para mark-changed'><table><tr class='code-row'><td class='code-nbr'>0</td><td class='code-desc'>Normal<br/>
KRAS negative, KRAS wild type<br/>
Negative for (somatic) mutations, no alterations, no (somatic) mutations identified, not present, not detected

</td></tr><tr class='code-row'><td class='code-nbr'>1</td><td class='code-desc'>Abnormal (mutated) in codon(s) 12, 13 and/or 61</td></tr><tr class='code-row'><td class='code-nbr'>2</td><td class='code-desc'>Abnormal (mutated) in codon 146 only</td></tr><tr class='code-row'><td class='code-nbr'>3</td><td class='code-desc'>Abnormal (mutated), but not in codon(s) 12, 13, 61, or 146</td></tr><tr class='code-row'><td class='code-nbr'>4</td><td class='code-desc'>Abnormal (mutated), NOS, codon(s) not specified</td></tr><tr class='code-row'><td class='code-nbr'>7</td><td class='code-desc'>Test ordered, results not in chart</td></tr><tr class='code-row'><td class='code-nbr'>8</td><td class='code-desc'>Not applicable: Information not collected for this case<br/>
(If this information is required by your standard setter, use of code 8 may result in an edit error.)
</td></tr><tr class='code-row'><td class='code-nbr'>9</td><td class='code-desc'>Not documented in medical record<br/>
KRAS not assessed or unknown if assessed
</td></tr><tr class='code-row'><td class='code-nbr'></td><td class='code-desc'> </td></tr></table></div><div class='content chap10-para mark-changed'>Each Site-Specific Data Item (SSDI) applies only to selected primary sites, histologies, and years of diagnosis. Depending on applicability and standard-setter requirements, SSDIs may be left blank.</div><a name='2430'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>LAST FOLLOW-UP HOSPITAL</strong></td><td style="text-align:right;font-weight:bold;"><strong>Retired</strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">2430</td><td style="text-align:center;"></td><td style="text-align:center;"><a href='#sources'></a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;">2006</td><td style="text-align:center;">11</td><td class="cross-out" style="text-align:center;"></td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td></td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td></td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>The NAACCR UDSC retired this data item in Version 11, as of January 1, 2006.</div><a name='410'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>LATERALITY</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">410</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>SEER/CoC</a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">558 - 558</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>Laterality at Diagnosis (SEER)<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>laterality</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Code for the side of a paired organ, or the side of the body on which the reportable tumor originated. This applies to the primary site only.  </div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>0</td><td class='code-desc'>Not a paired site</td></tr><tr class='code-row'><td class='code-nbr'>1</td><td class='code-desc'>Right: origin of primary</td></tr><tr class='code-row'><td class='code-nbr'>2</td><td class='code-desc'>Left: origin of primary</td></tr><tr class='code-row'><td class='code-nbr'>3</td><td class='code-desc'>Only one side involved, right or left origin unspecified</td></tr><tr class='code-row'><td class='code-nbr'>4</td><td class='code-desc'>Bilateral involvement at time of diagnosis, lateral origin unknown for a single primary; or both ovaries involved simultaneously, single histology; bilateral retinoblastomas; bilateral Wilms' tumors</td></tr><tr class='code-row'><td class='code-nbr'>5</td><td class='code-desc'>Paired site: midline tumor</td></tr><tr class='code-row'><td class='code-nbr'>9</td><td class='code-desc'>Paired site, but no information concerning laterality</td></tr></table></div><a name='2352'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>LATITUDE</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">2352</td><td style="text-align:center;">10</td><td style="text-align:center;"><a href='#sources'>NAACCR</a></td><td style="text-align:center;">2003</td><td style="text-align:center;">10</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">4784 - 4793</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>latitude</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Paired with Longitude [2354], this represents the point location of the individual&#8217;s residence on the earth&#8217;s surface. It is typically determined by matching an address to a reference file or by identifying the residence using satellite imagery. This item is coded at the central registry, not by the reporting facility. </div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Latitude and Longitude comprise the universal standard for designating location on the earth&#8217;s surface.  Geographic Information Systems software can be used to convert these values into projected coordinates for map display.<strong><br /><br />Allowable values and format</strong><br />Latitude is a 10- digit numeric field, right justified, with up to six decimal places and an explicit decimal point.  The format is x12.345678, where &#8220;x&#8221; is reserved for a negative sign for locations south of the equator. Latitude north of the equator is positive. The datum of the decimal degree data shall be North American Datum of 1983 (NAD 83).<br /><br />Values are in decimal degrees, not degrees/minutes/seconds.<tab></tab><blockquote><p><tab>Correct: <tab>Latitude: 41. 890833<tab></tab></tab></tab></p></blockquote><blockquote><tab><tab><tab></tab></tab></tab><tab><tab><tab>Not this: <tab>Latitude: 41 deg 53' 27" </tab></tab></tab></tab></blockquote> </div><a name='3932'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>LDH LAB VALUE</strong></td><td style="text-align:right;font-weight:bold;"><strong>Revised</strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">3932</td><td style="text-align:center;">7</td><td style="text-align:center;"><a href='#sources'>NAACCR</a></td><td style="text-align:center;">2018</td><td style="text-align:center;">18</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1898 - 1904</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>ldhPretreatmentLabValue</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para mark-changed'>LDH (Lactate Dehydrogenase) Lab Value, measured in serum, is a predictor of treatment response, progression-free survival and overall survival for patients with Stage IV melanoma of the skin.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para mark-changed'>LDH (Lactate Dehydrogenase) Lab Value is a Registry Data Collection Variable in AJCC. It was previously collected as LDH Pretreatment Lab Value and Melanoma Skin, CS SSF# 5.</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>0.0</td><td class='code-desc'>0.0 (U/L) </td></tr><tr class='code-row'><td class='code-nbr'>0.1-99999.9</td><td class='code-desc'>0.199,999.9 U/L</td></tr><tr class='code-row'><td class='code-nbr'>XXXXX.1</td><td class='code-desc'>100,000 U/L or greater</td></tr><tr class='code-row'><td class='code-nbr'>XXXXX.7</td><td class='code-desc'>Test ordered, results not in chart</td></tr><tr class='code-row'><td class='code-nbr'>XXXXX.8</td><td class='code-desc'>Not applicable: Information not collected for this case<br/>
(If this item is required by your standard setter, use of code XXXXX.8 will result in an edit error.)
</td></tr><tr class='code-row'><td class='code-nbr'>XXXXX.9</td><td class='code-desc'>Not documented in medical record<br/>
LDH (Lactate Dehydrogenase) Pretreatment Lab Value not assessed or unknown if assessed
</td></tr><tr class='code-row'><td class='code-nbr'></td><td class='code-desc'> </td></tr></table></div><div class='content chap10-para'>Each Site-Specific Data Item (SSDI) applies only to selected primary sites, histologies, and years of diagnosis. Depending on applicability and standard-setter requirements, SSDIs may be left blank. </div><a name='3869'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>LDH LEVEL</strong></td><td style="text-align:right;font-weight:bold;"><strong>Revised</strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">3869</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>NAACCR</a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1916 - 1916</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>ldhPretreatmentLevel</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>LDH (Lactate Dehydrogenase) is an enzyme involved in conversion of sugars to energy and present in most cells in the body. Elevated pretreatment LDH is an adverse prognostic factor for plasma cell myeloma and melanoma of the skin.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para mark-changed'><span style="color:black">LDH (Lactate Dehydrogenase) Level is a prognostic factor required in AJCC 8<sup>th</sup> edition for Chapter 83 <em>Plasma Cell Myeloma and Plasma Cell Disorders</em> and Chapter 47 <em>Melanoma Skin</em>. For Plasma Cell Myeloma, LDH is part of the RISS Stage and is new for cases diagnosed 1/1/2018+. For Melanoma Skin, LDH is used to define the M subcategories and was previously collected as LDH Pretreatment Level and Melanoma Skin, SSF #4.</span></div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>0</td><td class='code-desc'>Normal LDH level<br/>
Low, below normal
 </td></tr><tr class='code-row'><td class='code-nbr'>1</td><td class='code-desc'>Above normal LDH level; High</td></tr><tr class='code-row'><td class='code-nbr'>7</td><td class='code-desc'>Test ordered, results not in chart</td></tr><tr class='code-row'><td class='code-nbr'>9</td><td class='code-desc'>Not documented in medical record<br/>
LDH (Lactate Dehydrogenase) Pretreatment Level not assessed or unknown if assessed
</td></tr><tr class='code-row'><td class='code-nbr'></td><td class='code-desc'> </td></tr></table></div><div class='content chap10-para'>Each Site-Specific Data Item (SSDI) applies only to selected primary sites, histologies, and years of diagnosis. Depending on applicability and standard-setter requirements, SSDIs may be left blank.</div><a name='3867'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>LDH POST-ORCHIECTOMY RANGE</strong></td><td style="text-align:right;font-weight:bold;"><strong>Revised</strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">3867</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>NAACCR</a></td><td style="text-align:center;">2018</td><td style="text-align:center;">18</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1984 - 1984</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>ldhPostOrchiectomyRange</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>LDH (Lactate Dehydrogenase) Post-Orchiectomy Range identifies the range category of the lowest LDH value measured post-orchiectomy. LDH is a nonspecific marker for testicular cancer that is elevated in some germ cell tumors. The Post-Orchiectomy lab value is used to monitor response to therapy.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>LDH (Lactate Dehydrogenase) is a Registry Data Collection Variable in AJCC. LDH (Lactate Dehydrogenase) Post-Orchiectomy Range is used to assign the S Category Pathological and was previously collected as Testis CS SSF# 16.</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para mark-changed'><table><tr class='code-row'><td class='code-nbr'>0</td><td class='code-desc'>Within normal limits</td></tr><tr class='code-row'><td class='code-nbr'>1</td><td class='code-desc'>Less than 1.5 x N<br/>
(Less than 1.5 times the upper limit of normal for LDH)
</td></tr><tr class='code-row'><td class='code-nbr'>2</td><td class='code-desc'>1.5 to 10 x N<br/> 
(Between 1.5 and 10 times the upper limit of normal for LDH)
</td></tr><tr class='code-row'><td class='code-nbr'>3</td><td class='code-desc'>Greater than 10 x N<br/> 
(Greater than 10 times the upper limit of normal for LDH)
</td></tr><tr class='code-row'><td class='code-nbr'>4</td><td class='code-desc'>Post-Orchiectomy lactate dehydrogenase (LDH) range stated to be elevated</td></tr><tr class='code-row'><td class='code-nbr'>5</td><td class='code-desc'>Post-Orchiectomy lactate dehydrogenase (LDH) unknown or not done but pre-orchiectomy LDH was normal </td></tr><tr class='code-row'><td class='code-nbr'>7</td><td class='code-desc'>Test ordered, results not in chart</td></tr><tr class='code-row'><td class='code-nbr'>8</td><td class='code-desc'>Not applicable: Information not collected for this case<br/>
(If this information is required by your standard setter, use of code 8 may result in an edit error.)
</td></tr><tr class='code-row'><td class='code-nbr'>9</td><td class='code-desc'>Not documented in medical record<br/>
No orchiectomy performed<br/>
LDH (Lactate Dehydrogenase) Post-Orchiectomy Range not assessed or unknown if assessed 
</td></tr><tr class='code-row'><td class='code-nbr' colspan='2'></td></tr></table></div><div class='content chap10-para'>Each Site-Specific Data Item (SSDI) applies only to selected primary sites, histologies, and years of diagnosis. Depending on applicability and standard-setter requirements, SSDIs may be left blank.</div><a name='3868'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>LDH PRE-ORCHIECTOMY RANGE</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">3868</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>NAACCR</a></td><td style="text-align:center;">2018</td><td style="text-align:center;">18</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1983 - 1983</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>ldhPreOrchiectomyRange</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Lactate Dehydrogenase (LDH) Range identifies the range category of the highest LDH value measured prior to treatment. LDH is a nonspecific marker for testicular cancer that is elevated in some germ cell tumors. This data item refers to the Pre-Orchiectomy range.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>LDH (Lactate Dehydrogenase) is a Registry Data Collection Variable in AJCC. LDH (Lactate Dehydrogenase) Pre-Orchiectomy Range is used to assign the S Category Clinical and was previously collected as Testis CS SSF# 10.</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>0</td><td class='code-desc'>Within normal limits</td></tr><tr class='code-row'><td class='code-nbr'>1</td><td class='code-desc'>Less than 1.5 x N<br/> 
(Less than 1.5 times the upper limit of normal for LDH)
</td></tr><tr class='code-row'><td class='code-nbr'>2</td><td class='code-desc'>1.5 to 10 x N<br/> 
(Between 1.5 and 10 times the upper limit of normal for LDH)
</td></tr><tr class='code-row'><td class='code-nbr'>3</td><td class='code-desc'>Greater than 10 x N<br/> 
(Greater than 10 times the upper limit of normal for LDH)
</td></tr><tr class='code-row'><td class='code-nbr'>4</td><td class='code-desc'>Pre-Orchiectomy lactate dehydrogenase (LDH) range stated to be elevated</td></tr><tr class='code-row'><td class='code-nbr'>7</td><td class='code-desc'>Test ordered, results not in chart</td></tr><tr class='code-row'><td class='code-nbr'>8</td><td class='code-desc'>Not applicable: Information not collected for this case<br/>
(If this information is required by your standard setter, use of code 8 may result in an edit error.)
</td></tr><tr class='code-row'><td class='code-nbr'>9</td><td class='code-desc'>Not documented in medical record<br/>
LDH (Lactate Dehydrogenase) Pre-Orchiectomy Range not assessed or unknown if assessed 
</td></tr><tr class='code-row'><td class='code-nbr'></td><td class='code-desc'> </td></tr></table></div><div class='content chap10-para'>Each Site-Specific Data Item (SSDI) applies only to selected primary sites, histologies, and years of diagnosis. Depending on applicability and standard-setter requirements, SSDIs may be left blank.</div><a name='3870'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>LDH UPPER LIMITS OF NORMAL</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">3870</td><td style="text-align:center;">3</td><td style="text-align:center;"><a href='#sources'>NAACCR</a></td><td style="text-align:center;">2018</td><td style="text-align:center;">18</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1895 - 1897</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>ldhUpperLimitsOfNormal</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>LDH (Lactate Dehydrogenase), an enzyme involved in converting sugars to energy in the body, is elevated in some malignancies.  LDH level is a prognostic factor for patients with Stage IV melanoma.  This data Item refers to the Upper Limit of Normal in the laboratory test used to interpret the Serum LDH result.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>LDH (Lactate Dehydrogenase) Upper Limits of Normal is a Registry Data Collection Variable in AJCC.  It was previously collected as Melanoma Skin, CS SSF# 6.</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>001-999</td><td class='code-desc'>001 - 999 upper limit of normal<br/> 
(Exact upper limit of normal)
 </td></tr><tr class='code-row'><td class='code-nbr'>XX8</td><td class='code-desc'>Not applicable: Information not collected for this case<br/>
(If this information is required by your standard setter, use of code XX8 may result in an edit error.)
</td></tr><tr class='code-row'><td class='code-nbr'>XX9</td><td class='code-desc'>Not documented in medical record<br/>
LDH Upper Limit not assessed or unknown if assessed
</td></tr><tr class='code-row'><td class='code-nbr'></td><td class='code-desc'> </td></tr></table></div><div class='content chap10-para'>Each Site-Specific Data Item (SSDI) applies only to selected primary sites, histologies, and years of diagnosis. Depending on applicability and standard-setter requirements, SSDIs may be left blank.</div><a name='3871'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>LN ASSESSMENT METHOD FEMORAL-INGUINAL</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">3871</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>NAACCR</a></td><td style="text-align:center;">2018</td><td style="text-align:center;">18</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1992 - 1992</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>lnAssessMethodFemoralInguinal</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>This data item describes the method used to assess involvement of femoral-inguinal lymph nodes associated with certain female genital cancers.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Method of assessment of regional nodal status is listed as a Registry Data Collection Variable in the AJCC GYN chapters. This data item was previously collected as Vulva, SSF# 15.</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>0</td><td class='code-desc'>Radiography, imaging<br/> 
(Ultrasound (US), computed tomography scan (CT), magnetic resonance imaging (MRI), positron emission tomography scan (PET))<br/><br/>

Physical exam only
</td></tr><tr class='code-row'><td class='code-nbr'>1</td><td class='code-desc'>Incisional biopsy; fine needle aspiration (FNA)</td></tr><tr class='code-row'><td class='code-nbr'>2</td><td class='code-desc'>Lymphadenectomy<br/>
Excisional biopsy or resection with microscopic confirmation
</td></tr><tr class='code-row'><td class='code-nbr'>7</td><td class='code-desc'>Regional lymph node(s) assessed, unknown assessment method</td></tr><tr class='code-row'><td class='code-nbr'>8</td><td class='code-desc'>Not applicable: Information not collected for this case<br/>
(If this item is required by your standard setter, use of code 8 will result in an edit error.)
</td></tr><tr class='code-row'><td class='code-nbr'>9</td><td class='code-desc'>Not documented in medical record<br/>
Regional lymph nodes not assessed or unknown if assessed 
</td></tr><tr class='code-row'><td class='code-nbr'></td><td class='code-desc'> </td></tr></table></div><div class='content chap10-para'>Each Site-Specific Data Item (SSDI) applies only to selected primary sites, histologies, and years of diagnosis. Depending on applicability and standard-setter requirements, SSDIs may be left blank.</div><a name='3872'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>LN ASSESSMENT METHOD PARA-AORTIC</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">3872</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>NAACCR</a></td><td style="text-align:center;">2018</td><td style="text-align:center;">18</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1987 - 1987</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>lnAssessMethodParaaortic</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>This data item describes the method used to assess involvement of para-aortic lymph nodes associated with certain female genital cancers.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Method of assessment of regional nodal status is listed as a Registry Data Collection Variable in the AJCC GYN chapters. This data item was previously collected as Vagina, CS SSF# 5.</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>0</td><td class='code-desc'>Radiography, imaging<br/> 
(Ultrasound (US), computed tomography scan (CT), magnetic resonance imaging (MRI), positron emission tomography scan (PET))<br/><br/>

Physical exam only
</td></tr><tr class='code-row'><td class='code-nbr'>1</td><td class='code-desc'>Incisional biopsy; fine needle aspiration (FNA)</td></tr><tr class='code-row'><td class='code-nbr'>2</td><td class='code-desc'>Lymphadenectomy<br/>
Excisional biopsy or resection with microscopic confirmation
</td></tr><tr class='code-row'><td class='code-nbr'>7</td><td class='code-desc'>Regional lymph node(s) assessed, unknown assessment method</td></tr><tr class='code-row'><td class='code-nbr'>8</td><td class='code-desc'>Not applicable: Information not collected for this case<br/>
(If this item is required by your standard setter, use of code 8 will result in an edit error.)
</td></tr><tr class='code-row'><td class='code-nbr'>9</td><td class='code-desc'>Not documented in medical record<br/>
Regional lymph nodes not assessed or unknown if assessed 
</td></tr><tr class='code-row'><td class='code-nbr'></td><td class='code-desc'> </td></tr></table></div><div class='content chap10-para'>Each Site-Specific Data Item (SSDI) applies only to selected primary sites, histologies, and years of diagnosis. Depending on applicability and standard-setter requirements, SSDIs may be left blank.</div><a name='3873'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>LN ASSESSMENT METHOD PELVIC</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">3873</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>NAACCR</a></td><td style="text-align:center;">2018</td><td style="text-align:center;">18</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1988 - 1988</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>lnAssessMethodPelvic</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>This data item describes the method used to assess involvement of pelvic lymph nodes associated with certain female genital cancers.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Method of assessment of regional nodal status is listed as a Registry Data Collection Variable in the AJCC GYN chapters. This data item was previously collected as Vagina, CS SSF# 3.</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>0</td><td class='code-desc'>Ultrasound (US), computed tomography scan (CT), magnetic resonance imaging (MRI), positron emission tomography scan (PET))<br/><br/>

Physical exam only
</td></tr><tr class='code-row'><td class='code-nbr'>1</td><td class='code-desc'>Incisional biopsy; fine needle aspiration (FNA)</td></tr><tr class='code-row'><td class='code-nbr'>2</td><td class='code-desc'>Lymphadenectomy<br/>
Excisional biopsy or resection with microscopic confirmation
</td></tr><tr class='code-row'><td class='code-nbr'>7</td><td class='code-desc'>Regional lymph node(s) assessed, unknown assessment method</td></tr><tr class='code-row'><td class='code-nbr'>8</td><td class='code-desc'>Not applicable: Information not collected for this case<br/>
(If this item is required by your standard setter, use of code 8 will result in an edit error.)
</td></tr><tr class='code-row'><td class='code-nbr'>9</td><td class='code-desc'>Not documented in medical record<br/>
Regional lymph nodes not assessed or unknown if assessed 
</td></tr><tr class='code-row'><td class='code-nbr'></td><td class='code-desc'> </td></tr></table></div><div class='content chap10-para'>Each Site-Specific Data Item (SSDI) applies only to selected primary sites, histologies, and years of diagnosis. Depending on applicability and standard-setter requirements, SSDIs may be left blank.</div><a name='3874'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>LN DISTANT ASSESSMENT METHOD</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">3874</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>NAACCR</a></td><td style="text-align:center;">2018</td><td style="text-align:center;">18</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1989 - 1989</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>lnDistantAssessMethod</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>This data item describes the method used to assess involvement of Distant (mediastinal, scalene) nodes associated with certain female genital cancers.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Method of assessment of distant nodal status is listed as a Registry Data Collection Variable in the AJCC GYN chapters. This data item was previously collected as Vagina, CS SSF# 7.</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>0</td><td class='code-desc'>Radiography, imaging<br/> 
(Ultrasound (US), computed tomography scan (CT), magnetic resonance imaging (MRI), positron emission tomography scan (PET))<br/><br/>

Physical exam only
</td></tr><tr class='code-row'><td class='code-nbr'>1</td><td class='code-desc'>Incisional biopsy; fine needle aspiration (FNA)</td></tr><tr class='code-row'><td class='code-nbr'>2</td><td class='code-desc'>Lymphadenectomy<br/>
Excisional biopsy or resection with microscopic confirmation
</td></tr><tr class='code-row'><td class='code-nbr'>7</td><td class='code-desc'>Distant lymph node(s) assessed, unknown assessment method</td></tr><tr class='code-row'><td class='code-nbr'>8</td><td class='code-desc'>Not applicable: Information not collected for this case<br/>
(If this item is required by your standard setter, use of code 8 will result in an edit error.)
</td></tr><tr class='code-row'><td class='code-nbr'>9</td><td class='code-desc'>Not documented in medical record<br/>
Distant lymph nodes not assessed or unknown if assessed 
</td></tr><tr class='code-row'><td class='code-nbr'></td><td class='code-desc'> </td></tr></table></div><div class='content chap10-para'>Each Site-Specific Data Item (SSDI) applies only to selected primary sites, histologies, and years of diagnosis. Depending on applicability and standard-setter requirements, SSDIs may be left blank.</div><a name='3875'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>LN DISTANT: MEDIASTINAL, SCALENE</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">3875</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>NAACCR</a></td><td style="text-align:center;">2018</td><td style="text-align:center;">18</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1990 - 1990</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>lnDistantMediastinalScalene</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>This data item describes the status of Distant (mediastinal, scalene) nodes associated with certain female genital cancers.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Specific distant lymph node involvement is listed as a Registry Data Collection Variable in the AJCC. This data was previously collected as Vagina, CS SSF# 6.</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>0</td><td class='code-desc'>Negative mediastinal and scalene lymph nodes</td></tr><tr class='code-row'><td class='code-nbr'>1</td><td class='code-desc'>Positive mediastinal lymph nodes</td></tr><tr class='code-row'><td class='code-nbr'>2</td><td class='code-desc'>Positive scalene lymph nodes</td></tr><tr class='code-row'><td class='code-nbr'>3</td><td class='code-desc'>Positive mediastinal and scalene lymph nodes</td></tr><tr class='code-row'><td class='code-nbr'>8</td><td class='code-desc'>Not applicable: Information not collected for this case<br/>
(If this item is required by your standard setter, use of code 8 will result in an edit error.)
</td></tr><tr class='code-row'><td class='code-nbr'>9</td><td class='code-desc'>Not documented in medical record<br/>
Mediastinal and scalene lymph nodes not assessed or unknown if assessed
</td></tr><tr class='code-row'><td class='code-nbr'></td><td class='code-desc'> </td></tr></table></div><div class='content chap10-para'>Each Site-Specific Data Item (SSDI) applies only to selected primary sites, histologies, and years of diagnosis. Depending on applicability and standard-setter requirements, SSDIs may be left blank.</div><a name='3876'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>LN HEAD AND NECK LEVELS I-III</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">3876</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>NAACCR</a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1822 - 1822</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>lnHeadAndNeckLevels1To3</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Lymph Nodes for Head and Neck, Levels I-III records the involvement of Levels I-III lymph nodes.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Level of nodal involvement is a Registry Data Collection Variable in AJCC for several head and neck chapters. This data item was previously collected as Head and Neck SSF# 3 (common SSF).</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>0</td><td class='code-desc'>No involvement in Levels I, II, or III lymph nodes </td></tr><tr class='code-row'><td class='code-nbr'>1</td><td class='code-desc'>Level I lymph node(s) involved</td></tr><tr class='code-row'><td class='code-nbr'>2</td><td class='code-desc'>Level II lymph node(s) involved</td></tr><tr class='code-row'><td class='code-nbr'>3</td><td class='code-desc'>Level III lymph node(s) involved</td></tr><tr class='code-row'><td class='code-nbr'>4</td><td class='code-desc'>Levels I and II lymph nodes involved</td></tr><tr class='code-row'><td class='code-nbr'>5</td><td class='code-desc'>Levels I and III lymph nodes involved</td></tr><tr class='code-row'><td class='code-nbr'>6</td><td class='code-desc'>Levels II and III lymph nodes involved</td></tr><tr class='code-row'><td class='code-nbr'>7</td><td class='code-desc'>Levels I, II and III lymph nodes involved</td></tr><tr class='code-row'><td class='code-nbr'>8</td><td class='code-desc'>Not applicable: Information not collected for this case<br/>
(If this item is required by your standard setter, use of code 8 will result in an edit error)
</td></tr><tr class='code-row'><td class='code-nbr'>9</td><td class='code-desc'>Not documented in medical record<br/>
Positive nodes, but level of positive node(s) unknown<br/>
Lymph node levels I-III not assessed, or unknown if assessed
</td></tr><tr class='code-row'><td class='code-nbr'></td><td class='code-desc'> </td></tr></table></div><div class='content chap10-para'>Each Site-Specific Data Item (SSDI) applies only to selected primary sites, histologies, and years of diagnosis. Depending on applicability and standard-setter requirements, SSDIs may be left blank.</div><a name='3877'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>LN HEAD AND NECK LEVELS IV-V</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">3877</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>NAACCR</a></td><td style="text-align:center;">2018</td><td style="text-align:center;">18</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1823 - 1823</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>lnHeadAndNeckLevels4To5</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Lymph Nodes for Head and Neck, Levels IV-V records the involvement of Levels IV-V lymph nodes.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Level of nodal involvement is a Registry Data Collection Variable in AJCC. This data item was previously collected as Head and Neck SSF# 4 (common SSF).</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>0</td><td class='code-desc'>No involvement in Levels IV or V lymph nodes
 </td></tr><tr class='code-row'><td class='code-nbr'>1</td><td class='code-desc'>Level IV lymph node(s) involved</td></tr><tr class='code-row'><td class='code-nbr'>2</td><td class='code-desc'>Level V lymph node(s) involved</td></tr><tr class='code-row'><td class='code-nbr'>3</td><td class='code-desc'>Levels IV and V lymph node(s) involved</td></tr><tr class='code-row'><td class='code-nbr'>8</td><td class='code-desc'>Not applicable: Information not collected for this case<br/>
(If this item is required by your standard setter, use of code 8 will result in an edit error)
</td></tr><tr class='code-row'><td class='code-nbr'>9</td><td class='code-desc'>Not documented in medical record<br/>
Positive nodes, but level of positive node(s) unknown<br/>
Lymph node levels IV-V not assessed, or unknown if assessed
</td></tr><tr class='code-row'><td class='code-nbr'></td><td class='code-desc'> </td></tr></table></div><div class='content chap10-para'>Each Site-Specific Data Item (SSDI) applies only to selected primary sites, histologies, and years of diagnosis. Depending on applicability and standard-setter requirements, SSDIs may be left blank.</div><a name='3878'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>LN HEAD AND NECK LEVELS VI-VII</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">3878</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>NAACCR</a></td><td style="text-align:center;">2018</td><td style="text-align:center;">18</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1824 - 1824</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>lnHeadAndNeckLevels6To7</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Lymph Nodes for Head and Neck, Levels VI-VII records the involvement of Levels VI-VII lymph nodes.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Level of nodal involvement is a Registry Data Collection Variable in AJCC. This data item was previously collected as Head and Neck SSF# 5 (common SSF).</div><div class='content chap10-para'>Level of nodal involvement is a Registry Data Collection Variable in AJCC. This data item was previously collected as Head and Neck SSF# 5 (common SSF).</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>0</td><td class='code-desc'>No involvement in Levels VI or VII lymph nodes</td></tr><tr class='code-row'><td class='code-nbr'>1</td><td class='code-desc'>Level VI lymph node(s) involved</td></tr><tr class='code-row'><td class='code-nbr'>2</td><td class='code-desc'>Level VII lymph node(s) involved</td></tr><tr class='code-row'><td class='code-nbr'>3</td><td class='code-desc'>Levels VI and VII lymph node(s) involved</td></tr><tr class='code-row'><td class='code-nbr'>8</td><td class='code-desc'>Not applicable: Information not collected for this case<br/>
(If this item is required by your standard setter, use of code 8 will result in an edit error)
</td></tr><tr class='code-row'><td class='code-nbr'>9</td><td class='code-desc'>Not documented in medical record<br/>
Positive nodes, but level of positive node(s) unknown<br/>
Lymph nodes levels VI-VII not assessed, or unknown if assessed
</td></tr><tr class='code-row'><td class='code-nbr'></td><td class='code-desc'> </td></tr></table></div><div class='content chap10-para'>Each Site-Specific Data Item (SSDI) applies only to selected primary sites, histologies, and years of diagnosis. Depending on applicability and standard-setter requirements, SSDIs may be left blank.</div><a name='3879'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>LN HEAD AND NECK OTHER</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">3879</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>NAACCR</a></td><td style="text-align:center;">2018</td><td style="text-align:center;">18</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1825 - 1825</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>lnHeadAndNeckOther</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Lymph Nodes for Head and Neck, Other records the involvement of lymph nodes other than Levels I-III, IV-V, and VI-VII.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Level of nodal involvement is a Registry Data Collection Variable in AJCC. This data item was previously collected as Head and Neck SSF# 6 (common SSF).</div><div class='content chap10-para'>Codes</div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>0</td><td class='code-desc'>No involvement in other head and neck lymph node regions </td></tr><tr class='code-row'><td class='code-nbr'>1</td><td class='code-desc'>Buccinator (facial) lymph node(s) involved</td></tr><tr class='code-row'><td class='code-nbr'>2</td><td class='code-desc'>Parapharyngeal lymph node(s) involved</td></tr><tr class='code-row'><td class='code-nbr'>3</td><td class='code-desc'>Periparotid and intraparotid lymph node(s) involved</td></tr><tr class='code-row'><td class='code-nbr'>4</td><td class='code-desc'>Preauricular lymph node(s) involved</td></tr><tr class='code-row'><td class='code-nbr'>5</td><td class='code-desc'>Retropharyngeal lymph node(s) involved</td></tr><tr class='code-row'><td class='code-nbr'>6</td><td class='code-desc'>Suboccipital/retroauricular lymph node(s) involved</td></tr><tr class='code-row'><td class='code-nbr'>7</td><td class='code-desc'>Any combination of codes 1-6</td></tr><tr class='code-row'><td class='code-nbr'>8</td><td class='code-desc'>Not applicable: Information not collected for this case<br/>
(If this item is required by your standard setter, use of code 8 will result in an edit error.)
</td></tr><tr class='code-row'><td class='code-nbr'>9</td><td class='code-desc'>Not documented in medical record<br/>
Positive nodes, but level of positive node(s) unknown<br/>
Other Head and Neck lymph nodes not assessed, or unknown if assessed
</td></tr><tr class='code-row'><td class='code-nbr'></td><td class='code-desc'> </td></tr></table></div><div class='content chap10-para'>Each Site-Specific Data Item (SSDI) applies only to selected primary sites, histologies, and years of diagnosis. Depending on applicability and standard-setter requirements, SSDIs may be left blank.</div><a name='3880'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>LN ISOLATED TUMOR CELLS (ITC)</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">3880</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>NAACCR</a></td><td style="text-align:center;">2018</td><td style="text-align:center;">18</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1906 - 1906</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>lnIsolatedTumorCells</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Lymph Nodes Isolated Tumor Cells (ITC), the presence of isolated tumor cells in regional lymph node(s) that may be detected by hematoxylin and eosin or by immunohistochemical staining, is a potential prognostic factor for Merkel Cell Carcinoma.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Regional lymph nodes positive for ITCs 







<br />(Tumor cell clusters not greater than 0.2 millimeter (mm))</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>0</td><td class='code-desc'>Regional lymph nodes negative for ITCs </td></tr><tr class='code-row'><td class='code-nbr'>1</td><td class='code-desc'>Regional lymph nodes positive for ITCs<br/> 
(Tumor cell clusters not greater than 0.2 millimeter (mm))
</td></tr><tr class='code-row'><td class='code-nbr'>8</td><td class='code-desc'>Not applicable: Information not collected for this case<br/>
(If this information is required by your standard setter, use of code 8 may result in an edit error.)
</td></tr><tr class='code-row'><td class='code-nbr'>9</td><td class='code-desc'>Not documented in medical record<br/>
ITCs not assessed or unknown if assessed
</td></tr><tr class='code-row'><td class='code-nbr'></td><td class='code-desc'> </td></tr></table></div><div class='content chap10-para'>Each Site-Specific Data Item (SSDI) applies only to selected primary sites, histologies, and years of diagnosis. Depending on applicability and standard-setter requirements, SSDIs may be left blank.</div><a name='3881'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>LN LATERALITY</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">3881</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>NAACCR</a></td><td style="text-align:center;">2018</td><td style="text-align:center;">18</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1993 - 1993</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>lnLaterality</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>This data item describes whether positive regional lymph nodes are unilateral or bilateral.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Laterality of regional node metastasis is a Registry Data Collection Variable in AJCC.  This data item was previously collected as Vulva, CS SSF# 11.</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>0</td><td class='code-desc'>No regional lymph node involvement </td></tr><tr class='code-row'><td class='code-nbr'>1</td><td class='code-desc'>Unilateral - all positive regional nodes with same laterality
OR only one regional node positive
</td></tr><tr class='code-row'><td class='code-nbr'>2</td><td class='code-desc'>Bilateral - positive bilateral regional lymph nodes</td></tr><tr class='code-row'><td class='code-nbr'>3</td><td class='code-desc'>Laterality unknown - positive regional lymph nodes with unknown laterality</td></tr><tr class='code-row'><td class='code-nbr'>8</td><td class='code-desc'>Not applicable: Information not collected for this case<br/>
(If this information is required by your standard setter, use of code 8 may result in an edit error.)
</td></tr><tr class='code-row'><td class='code-nbr'>9</td><td class='code-desc'>Not documented in medical record<br/>
Lymph node laterality not assessed or unknown if assessed
</td></tr><tr class='code-row'><td class='code-nbr'></td><td class='code-desc'> </td></tr></table></div><div class='content chap10-para'>Each Site-Specific Data Item (SSDI) applies only to selected primary sites, histologies, and years of diagnosis. Depending on applicability and standard-setter requirements, SSDIs may be left blank.</div><a name='3882'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>LN POSITIVE AXILLARY LEVEL I-II</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">3882</td><td style="text-align:center;">2</td><td style="text-align:center;"><a href='#sources'>NAACCR</a></td><td style="text-align:center;">2018</td><td style="text-align:center;">18</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1745 - 1746</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>lnPositiveAxillaryLevel1To2</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>This data item pertains to the number of positive ipsilateral level I and II axillary lymph nodes and intramammary lymph nodes based on pathological information.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Lymph Nodes Positive Axillary Level I-II can be collected by the surveillance community for breast cancers. Prior to 2018, Breast SSF#3 was used for Lymph Nodes Positive Axillary Level I-II.</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>00</td><td class='code-desc'>All ipsilateral axillary nodes examined negative </td></tr><tr class='code-row'><td class='code-nbr'>01-99</td><td class='code-desc'>1 - 99 nodes positive<br/> 
(Exact number of nodes positive)
</td></tr><tr class='code-row'><td class='code-nbr'>X1</td><td class='code-desc'>100 or more nodes positive</td></tr><tr class='code-row'><td class='code-nbr'>X5</td><td class='code-desc'>Positive nodes, number unspecified</td></tr><tr class='code-row'><td class='code-nbr'>X6</td><td class='code-desc'>Positive aspiration or needle core biopsy of lymph node(s) </td></tr><tr class='code-row'><td class='code-nbr'>X8</td><td class='code-desc'>Not applicable: Information not collected for this case<br/>
(If this item is required by your standard setter, use of code X8 will result in an edit error.)
</td></tr><tr class='code-row'><td class='code-nbr'>X9</td><td class='code-desc'>Not documented in medical record<br/>
Level I-II axillary nodes not assessed or unknown if assessed
</td></tr><tr class='code-row'><td class='code-nbr'></td><td class='code-desc'> </td></tr></table></div><div class='content chap10-para'>Each Site-Specific Data Item (SSDI) applies only to selected primary sites, histologies, and years of diagnosis. Depending on applicability and standard-setter requirements, SSDIs may be left blank.</div><a name='3883'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>LN SIZE</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">3883</td><td style="text-align:center;">4</td><td style="text-align:center;"><a href='#sources'>NAACCR</a></td><td style="text-align:center;">2018</td><td style="text-align:center;">18</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1826 - 1829</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>lnSize</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Lymph Nodes Size records diameter of the involved regional lymph node(s) with the largest diameter of any involved regional lymph node(s). Pathological measurement takes precedence over a clinical measurement for the same node.</div><div class='content chap10-para'>Lymph Nodes Size is a Registry Data Collection Variable in AJCC for several chapters. It was previously collected in the Head and Neck chapters as Size of Lymph Nodes, SSF# 1</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>0.0</td><td class='code-desc'>No involved regional nodes</td></tr><tr class='code-row'><td class='code-nbr'>0.1-99.9</td><td class='code-desc'>0.199.9 millimeters (mm)<br/>
(Exact size of lymph node to nearest tenth of a mm)
</td></tr><tr class='code-row'><td class='code-nbr'>XX.1</td><td class='code-desc'>100 millimeters (mm) or greater</td></tr><tr class='code-row'><td class='code-nbr'>XX.2</td><td class='code-desc'>Microscopic focus or foci only and no size of focus given</td></tr><tr class='code-row'><td class='code-nbr'>XX.3</td><td class='code-desc'>Described as "less than 1 centimeter (cm)"</td></tr><tr class='code-row'><td class='code-nbr'>XX.4</td><td class='code-desc'>Described as "at least" 2 cm</td></tr><tr class='code-row'><td class='code-nbr'>XX.5</td><td class='code-desc'>Described as "at least" 3 cm</td></tr><tr class='code-row'><td class='code-nbr'>XX.6</td><td class='code-desc'>Described as "at least" 4 cm</td></tr><tr class='code-row'><td class='code-nbr'>XX.7</td><td class='code-desc'>Described as greater than 5 cm
</td></tr><tr class='code-row'><td class='code-nbr'>XX.8</td><td class='code-desc'>Not applicable: Information not collected for this case<br/>
(If this item is required by your standard setter, use of code XX.8 will result in an edit error)
</td></tr><tr class='code-row'><td class='code-nbr'>XX.9</td><td class='code-desc'>Not documented in medical record<br/>
Regional lymph node(s) involved, size not stated<br/>
Lymph Nodes Size not assessed, or unknown if assessed
</td></tr><tr class='code-row'><td class='code-nbr'></td><td class='code-desc'> </td></tr></table></div><div class='content chap10-para'>Each Site-Specific Data Item (SSDI) applies only to selected primary sites, histologies, and years of diagnosis. Depending on applicability and standard-setter requirements, SSDIs may be left blank. </div><a name='3884'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>LN STATUS FEMORAL-INGUINAL, PARA-AORTIC, PELVIC</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">3884</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>NAACCR</a></td><td style="text-align:center;">2018</td><td style="text-align:center;">18</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1991 - 1991</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>lnStatusFemorInguinParaaortPelv</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>This data item describes the status of femoral-inguinal, para-aortic and pelvic lymph nodes associated with certain female genital cancers.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Specific regional lymph node involvement is listed as a Registry Data Collection Variable in AJCC. This information was previously collected as Vagina, CS SSF# 2 and CS SSF# 4</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>0</td><td class='code-desc'>Negative femoral-inguinal, para-aortic and pelvic lymph nodes</td></tr><tr class='code-row'><td class='code-nbr'>1</td><td class='code-desc'>Positive femoral-inguinal lymph nodes</td></tr><tr class='code-row'><td class='code-nbr'>2</td><td class='code-desc'>Positive para-aortic lymph nodes</td></tr><tr class='code-row'><td class='code-nbr'>3</td><td class='code-desc'>Positive pelvic lymph nodes</td></tr><tr class='code-row'><td class='code-nbr'>4</td><td class='code-desc'>Positive femoral-inguinal and para-aortic lymph nodes</td></tr><tr class='code-row'><td class='code-nbr'>5</td><td class='code-desc'>Positive femoral-inguinal and pelvic lymph nodes</td></tr><tr class='code-row'><td class='code-nbr'>6</td><td class='code-desc'>Positive para-aortic and pelvic lymph nodes</td></tr><tr class='code-row'><td class='code-nbr'>7</td><td class='code-desc'>Positive para-aortic, pelvic, and femoral-inguinal lymph nodes</td></tr><tr class='code-row'><td class='code-nbr'>8</td><td class='code-desc'>Not applicable: Information not collected for this case<br/>
(If this information is required by your standard setter, use of code 8 may result in an edit error.)
</td></tr><tr class='code-row'><td class='code-nbr'>9</td><td class='code-desc'>Not documented in medical record<br/>
Femoral-Inguinal, Para-aortic and Pelvic lymph nodes not assessed or unknown if assessed
</td></tr><tr class='code-row'><td class='code-nbr'></td><td class='code-desc'> </td></tr></table></div><div class='content chap10-para'>Each Site-Specific Data Item (SSDI) applies only to selected primary sites, histologies, and years of diagnosis. Depending on applicability and standard-setter requirements, SSDIs may be left blank. </div><a name='770'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>LOC/REG/DISTANT STAGE</strong></td><td style="text-align:right;font-weight:bold;"><strong>Retired</strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">770</td><td style="text-align:center;"></td><td style="text-align:center;"><a href='#sources'></a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;">2006</td><td style="text-align:center;">11</td><td class="cross-out" style="text-align:center;"></td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td></td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td></td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>The NAACCR UDSC retired this data item in Version 11, as of January 1, 2006.</div><a name='2354'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>LONGITUDE</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">2354</td><td style="text-align:center;">11</td><td style="text-align:center;"><a href='#sources'>NAACCR</a></td><td style="text-align:center;">2003</td><td style="text-align:center;">10</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">4794 - 4804</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>longitude</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Paired with Latitude [2352], this represents the point location of the individual&#8217;s residence on the earth&#8217;s surface. It is typically determined by matching an address to a reference file or by identifying the residence using satellite imagery. This item is coded at the central registry, not by the reporting facility. </div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Latitude and Longitude comprise the universal standard for designating location on the earth&#8217;s surface.  Geographic Information Systems software can be used to convert these values into projected coordinates for map display.<strong><br /><br />Allowable values and format</strong><br />Longitude is an 11 digit numeric field, right justified, with up to six decimal places and an explicit decimal point.  The format is x123.456789, where &#8220;x&#8221; is reserved for a negative sign for locations west of the Prime Meridian (0 degrees) and east of 180 degrees. The datum of the decimal degree data shall be North American Datum of 1983 (NAD 83).<br /><br />Values are in decimal degrees, not degrees/minutes/seconds.<tab><tab></tab></tab><tab><tab></tab></tab><tab><tab><br /></tab></tab><blockquote><tab><tab>Longitude: -123.128943<tab><tab></tab></tab></tab></tab><br /></blockquote><blockquote><tab><tab><tab><tab></tab></tab></tab></tab><tab><tab><tab><tab>Longitude: -71 deg 7' 44" </tab></tab></tab></tab></blockquote> </div><a name='3885'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>LYMPHOCYTOSIS</strong></td><td style="text-align:right;font-weight:bold;"><strong>Revised</strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">3885</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>NAACCR</a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1912 - 1912</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>lymphocytosis</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Lymphocytosis is defined by an excess of lymphocytes in the blood. In staging of Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL), lymphocytosis is defined as an absolute lymphocyte count (ALC) greater than 5,000 cells/&#181;L.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para mark-changed'>Lymphocytosis is a prognostic factor required for staging of Chronic Lymphocytic Leukemia/Small Lymphocytic Leukemia (CLL/SLL) in AJCC 8th edition, Chapter 79 















<em>Hodgkin and Non-Hodgkin Lymphomas</em>.  It is a new data item for cases diagnosed 1/1/2018+.</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>0</td><td class='code-desc'>Lymphocytosis not present<br/>
Absolute lymphocyte count = 5,000 cells/ L
 </td></tr><tr class='code-row'><td class='code-nbr'>1</td><td class='code-desc'>Lymphocytosis present<br/> 
Absolute lymphocyte count > 5,000 cells/L
</td></tr><tr class='code-row'><td class='code-nbr'>6</td><td class='code-desc'>Lab value unknown, physician states lymphocytosis is present</td></tr><tr class='code-row'><td class='code-nbr'>7</td><td class='code-desc'>Test ordered, results not in chart</td></tr><tr class='code-row'><td class='code-nbr'>9</td><td class='code-desc'>Not documented in medical record<br/>
Lymphocytosis not assessed or unknown if assessed
</td></tr><tr class='code-row'><td class='code-nbr'></td><td class='code-desc'> </td></tr></table></div><div class='content chap10-para'>Each Site-Specific Data Item (SSDI) applies only to selected primary sites, histologies, and years of diagnosis. Depending on applicability and standard-setter requirements, SSDIs may be left blank.</div><a name='1182'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>LYMPHOVASCULAR INVASION</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">1182</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>AJCC</a></td><td style="text-align:center;">2010</td><td style="text-align:center;">12</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1297 - 1297</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>Lymph-vascular Invasion<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>lymphVascularInvasion</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Lymphovascular invasion (LVI) indicates the presence or absence of tumor cells in lymphatic channels (not lymph nodes) or blood vessels within the primary tumor as noted microscopically by the pathologist.  LVI includes lymphatic invasion, vascular invasion, and lymphovascular invasion.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Presence or absence of cancer cells in the lymphatic ducts or blood vessels is useful for prognosis. CAP Protocols for some disease sites will be expanded to distinguish between lymphatic and small vessel invasion only, venous (large vessel) invasion only, and BOTH lymphatic and small vessel AND venous (large vessel) invasion.</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>0</td><td class='code-desc'>Lymphovascular Invasion stated as Not Present</td></tr><tr class='code-row'><td class='code-nbr'>1</td><td class='code-desc'>Lymphovascular Invasion Present/Identified</td></tr><tr class='code-row'><td class='code-nbr'>2</td><td class='code-desc'>Lymphatic and small vessel invasion only (L) </td></tr><tr class='code-row'><td class='code-nbr'>3</td><td class='code-desc'>Venous (large vessel) invasion only (V)</td></tr><tr class='code-row'><td class='code-nbr'>4</td><td class='code-desc'>BOTH lymphatic and small vessel AND venous (large vessel) invasion</td></tr><tr class='code-row'><td class='code-nbr'>8</td><td class='code-desc'>Not Applicable</td></tr><tr class='code-row'><td class='code-nbr'>9</td><td class='code-desc'>Unknown/Indeterminate/not mentioned in path report</td></tr><tr class='code-row'><td class='code-nbr'></td><td class='code-desc'> </td></tr></table></div><a name='3886'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>MAJOR VEIN INVOLVEMENT</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">3886</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>NAACCR</a></td><td style="text-align:center;">2018</td><td style="text-align:center;">18</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1835 - 1835</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>majorVeinInvolvement</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Major vein involvement pertains to the invasion of the kidney tumor into major veins.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Involvement of major veins for Kidney is a Registry Data Collection Variable in AJCC.  It was previously collected as Kidney, CS SSF #2.</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>0</td><td class='code-desc'>Major vein involvement not present/not identified </td></tr><tr class='code-row'><td class='code-nbr'>1</td><td class='code-desc'>Renal vein or its segmental branches</td></tr><tr class='code-row'><td class='code-nbr'>2</td><td class='code-desc'>Inferior vena cava (IVC)</td></tr><tr class='code-row'><td class='code-nbr'>3</td><td class='code-desc'>Major vein invasion, NOS</td></tr><tr class='code-row'><td class='code-nbr'>4</td><td class='code-desc'>Any combination of codes 1-3</td></tr><tr class='code-row'><td class='code-nbr'>8</td><td class='code-desc'>Not applicable: Information not collected for this case<br/>
(If this information is required by your standard setter, use of code 8 may result in an edit error.)
</td></tr><tr class='code-row'><td class='code-nbr'>9</td><td class='code-desc'>Not documented in medical record<br/>
Vein involvement not assessed or unknown if assessed
No surgical resection of primary site is performed
</td></tr><tr class='code-row'><td class='code-nbr'></td><td class='code-desc'> </td></tr></table></div><div class='content chap10-para'>Each Site-Specific Data Item (SSDI) applies only to selected primary sites, histologies, and years of diagnosis. Depending on applicability and standard-setter requirements, SSDIs may be left blank. </div><a name='150'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>MARITAL STATUS AT DX</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">150</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>SEER</a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">206 - 206</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>Marital Status at Diagnosis (SEER/CoC)<br />Marital Status at Initial Diagnosis (pre-96 CoC)<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>maritalStatusAtDx</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Code for the patient&#8217;s marital status at the time of diagnosis for the reportable tumor. If the patient has multiple tumors, marital status may be different for each tumor.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Incidence and survival with certain cancers vary by marital status. The item also helps in patient identification.</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>1</td><td class='code-desc'>Single (never married)</td></tr><tr class='code-row'><td class='code-nbr'>2</td><td class='code-desc'>Married (including common law)</td></tr><tr class='code-row'><td class='code-nbr'>3</td><td class='code-desc'>Separated</td></tr><tr class='code-row'><td class='code-nbr'>4</td><td class='code-desc'>Divorced</td></tr><tr class='code-row'><td class='code-nbr'>5</td><td class='code-desc'>Widowed</td></tr><tr class='code-row'><td class='code-nbr'>6</td><td class='code-desc'>Unmarried or Domestic Partner (same sex or opposite sex, registered or unregistered, other than common law marriage)</td></tr><tr class='code-row'><td class='code-nbr'>9</td><td class='code-desc'>Unknown</td></tr></table></div><a name='3887'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>MEASURED BASAL DIAMETER</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">3887</td><td style="text-align:center;">4</td><td style="text-align:center;"><a href='#sources'>NAACCR</a></td><td style="text-align:center;">2018</td><td style="text-align:center;">18</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1877 - 1880</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>measuredBasalDiameter</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Measured Basal Diameter, the largest basal diameter of a uveal melanoma, is a prognostic indicator for this tumor.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Measured Basal Diameter is listed as a Registry Data Collection Variable in AJCC. It was previously collected as Uveal Melanoma, CS SSF# 2.</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>0.0</td><td class='code-desc'>No mass/tumor found </td></tr><tr class='code-row'><td class='code-nbr'>0.1-99.9</td><td class='code-desc'>0.199.9 millimeters (mm)<br/>
(Exact measurement to nearest tenth of mm) 
</td></tr><tr class='code-row'><td class='code-nbr'>XX.0</td><td class='code-desc'>100 millimeters (mm) or larger</td></tr><tr class='code-row'><td class='code-nbr'>XX.1</td><td class='code-desc'>Described as "less than 3 mm"</td></tr><tr class='code-row'><td class='code-nbr'>XX.2</td><td class='code-desc'>Described as at least 3 mm</td></tr><tr class='code-row'><td class='code-nbr'>XX.3</td><td class='code-desc'>Described as at least 6 mm</td></tr><tr class='code-row'><td class='code-nbr'>XX.4</td><td class='code-desc'>Described as at least 9 mm</td></tr><tr class='code-row'><td class='code-nbr'>XX.5</td><td class='code-desc'>Described as at least 12 mm</td></tr><tr class='code-row'><td class='code-nbr'>XX.6</td><td class='code-desc'>Described as at least 15 mm</td></tr><tr class='code-row'><td class='code-nbr'>XX.8</td><td class='code-desc'>Not applicable: Information not collected for this case<br/>
(If this information is required by your standard setter, use of code XX.8 may result in an edit error.)
</td></tr><tr class='code-row'><td class='code-nbr'>XX.9</td><td class='code-desc'>Not documented in medical record<br/>
Cannot be determined by pathologist<br/>
Measured Basal Diameter not assessed or unknown if assessed
</td></tr><tr class='code-row'><td class='code-nbr'></td><td class='code-desc'> </td></tr></table></div><div class='content chap10-para'>Each Site-Specific Data Item (SSDI) applies only to selected primary sites, histologies, and years of diagnosis. Depending on applicability and standard-setter requirements, SSDIs may be left blank. </div><a name='3888'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>MEASURED THICKNESS</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">3888</td><td style="text-align:center;">4</td><td style="text-align:center;"><a href='#sources'>NAACCR</a></td><td style="text-align:center;">2018</td><td style="text-align:center;">18</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1881 - 1884</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>measuredThickness</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Measured Thickness, or height, of a uveal melanoma, is a prognostic indicator for this tumor.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Measured Thickness is listed as a Registry Data Collection Variable in AJCC. It was previously collected as Uveal Melanoma, CS SSF# 3.</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>0.0</td><td class='code-desc'>No mass/tumor found </td></tr><tr class='code-row'><td class='code-nbr'>0.1-99.9</td><td class='code-desc'>0.199.9 millimeters (mm)<br/>
(Exact measurement to nearest tenth of mm) 
</td></tr><tr class='code-row'><td class='code-nbr'>XX.0</td><td class='code-desc'>100 millimeters (mm) or larger</td></tr><tr class='code-row'><td class='code-nbr'>XX.1</td><td class='code-desc'>Described as "less than 3 mm"</td></tr><tr class='code-row'><td class='code-nbr'>XX.2</td><td class='code-desc'>Described as "at least" 3 mm </td></tr><tr class='code-row'><td class='code-nbr'>XX.3</td><td class='code-desc'>Described as "at least" 6 mm</td></tr><tr class='code-row'><td class='code-nbr'>XX.4</td><td class='code-desc'>Described as "at least" 9 mm</td></tr><tr class='code-row'><td class='code-nbr'>XX.5</td><td class='code-desc'>Described as "at least" 12 mm</td></tr><tr class='code-row'><td class='code-nbr'>XX.6</td><td class='code-desc'>Described as "greater than" 15 mm</td></tr><tr class='code-row'><td class='code-nbr'>XX.8</td><td class='code-desc'>Not applicable: Information not collected for this case<br/>
(If this information is required by your standard setter, use of code XX.8 may result in an edit error.)
</td></tr><tr class='code-row'><td class='code-nbr'>XX.9</td><td class='code-desc'>Not documented in medical record<br/>
Cannot be determined <br/>
Measured Thickness not assessed or unknown if assessed
</td></tr><tr class='code-row'><td class='code-nbr'></td><td class='code-desc'> </td></tr></table></div><div class='content chap10-para'>Each Site-Specific Data Item (SSDI) applies only to selected primary sites, histologies, and years of diagnosis. Depending on applicability and standard-setter requirements, SSDIs may be left blank. </div><a name='2300'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>MEDICAL RECORD NUMBER</strong></td><td style="text-align:right;font-weight:bold;"><strong>Revised</strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">2300</td><td title="V: 22: 15
V: 18: 11
V: 16: 11
" class=" HighlightToolTip" style="text-align:center;">15</td><td title="V: 22: NAACCR
V: 18: CoC
V: 16: CoC
V: 15: CoC
" class=" HighlightToolTip" style="text-align:center;"><a href='#sources'>NAACCR</a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td title="V: 22: 4315 - 4329
V: 18: 4315 - 4325
V: 16: 3606 - 3616
" class="cross-out HighlightToolTip" style="text-align:center;">4315 - 4329</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>medicalRecordNumber</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para mark-changed'>Records medical record number used by the facility to identify the patient.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para mark-changed'>This number identifies the patient in a facility. It can be used by a central registry to point back to the patient record, and it helps identify multiple reports on the same patient.</div><div class='content chap10-para'><strong>Codes (in addition to the medical record number) </strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>UNK</td><td class='code-desc'>Medical record number unknown</td></tr><tr class='code-row'><td class='code-nbr'>RT</td><td class='code-desc'>Radiation therapy department patient without HIM number</td></tr><tr class='code-row'><td class='code-nbr'>SU</td><td class='code-desc'>1-day surgery clinic patient without HIM number</td></tr></table></div><div class='content chap10-para'><em>Note: </em>Other standard abbreviations may be used to indicate  departments within the facility for patients without HIM numbers  assigned.</div><a name='2315'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>MEDICARE BENEFICIARY IDENTIFIER</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">2315</td><td style="text-align:center;">11</td><td style="text-align:center;"><a href='#sources'>NAACCR</a></td><td style="text-align:center;">2018</td><td style="text-align:center;">18</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">4337 - 4347</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>medicareBeneficiaryIdentifier</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Patient</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'><div>Congress passed the Medicare Access and CHIP Reauthorization ACT to remove Social Security Number (SSN) from Medicare ID card and replace the existing Medicare Health Insurance Claim Numbers with a Medicare Beneficiary Identifier (MBI). The MBI will be a randomly generated identifier that will not include a SSN or any personal identifiable information.</div></div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>The MBI is a step to minimize the risk of identity theft for Medicare beneficiaries and reduce opportunities for fraud. In early 2018, CMB plans to issue new Medicare cards with an MBI. A Health Insurance Claim Number will still be assigned to each Medicare beneficiary and will still be used for internal data exchanges between CMS and the states, but the new MBI must be used in all interactions with the beneficiary, the provider community and all external partners. The collection of the MBI should not change how registries currently collect SSN.</div><div class='content chap10-para'><strong>Codes (in addition to MBI)</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>Blank</td><td class='code-desc'>Not Available, Non-Medicare Patient, Not Applicable, or Unknown</td></tr><tr class='code-row'><td class='code-nbr'></td><td class='code-desc'> </td></tr></table></div><div class='content chap10-para'><div> </div><div><em>Note</em>: The Medicare Beneficiary Identifier (MBI) is randomly  generated and has 11 characters, consisting of numbers and letters,  entered without dashes. The MBI format: <a href="https://www.cms.gov/Medicare/New-Medicare-Card/Understanding-the-MBI-with-Format.pdf">https://www.cms.gov/Medicare/New-Medicare-Card/Understanding-the-MBI-with-Format.pdf</a></div></div><a name='3889'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>METHYLATION OF O6-METHYLGUANINE-METHYLTRANSFERASE</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">3889</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>NAACCR</a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1742 - 1742</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>methylationOfO6MGMT</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>O6-Methylguanine-Methyltransferase (MGMT) is an enzyme in cells that repairs DNA. Methylation of the MGMT gene reduces production of MGMT enzyme and the ability of tumor cells to repair damage caused by chemotherapy. Methylation of MGMT is a prognostic and predictive factor for high grade gliomas.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Methylation of O6-Methylguanine-Methyltransferase (MGMT) is a Registry Data Collection Variable in AJCC. It was previously collected as Brain, CS SSF #4.</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>0</td><td class='code-desc'>MGMT methylation absent/not present, unmethylated MGMT</td></tr><tr class='code-row'><td class='code-nbr'>1</td><td class='code-desc'>MGMT methylation present, low level<br/>
Hypomethylated<br/>
Partial methylated
</td></tr><tr class='code-row'><td class='code-nbr'>2</td><td class='code-desc'>MGMT methylation present, high level<br/>
Hypermethylated
</td></tr><tr class='code-row'><td class='code-nbr'>3</td><td class='code-desc'>MGMT Methylation present, level unspecified</td></tr><tr class='code-row'><td class='code-nbr'>6</td><td class='code-desc'>Benign or borderline tumor</td></tr><tr class='code-row'><td class='code-nbr'>7</td><td class='code-desc'>Test ordered, results not in chart</td></tr><tr class='code-row'><td class='code-nbr'>8</td><td class='code-desc'>Not applicable: Information not collected for this case<br/>
(If this item is required by your standard setter, use of code 8 will result in an edit error.)
</td></tr><tr class='code-row'><td class='code-nbr'>9</td><td class='code-desc'>Not documented in patient record<br/>
Cannot be determined by the pathologist<br/>
MGMT not assessed or unknown if assessed
</td></tr><tr class='code-row'><td class='code-nbr'></td><td class='code-desc'> </td></tr></table></div><div class='content chap10-para'>Each Site-Specific Data Item (SSDI) applies only to selected primary sites, histologies, and years of diagnosis. Depending on applicability and standard-setter requirements, SSDIs may be left blank.</div><a name='1112'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>METS AT DX-BONE</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">1112</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>SEER</a></td><td style="text-align:center;">2016</td><td style="text-align:center;">16</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">870 - 870</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>metsAtDxBone</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>This field identifies whether bone is an involved metastatic site. The six Mets at Dx-Metastatic Sites fields provide information on specific metastatic sites for data analysis.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Information on site of metastatic disease at diagnosis has prognostic implications to survival among patients with initial late stage disease. Capturing data on where the patient&#8217;s metastatic lesions (including the number of locations) will be an important variable to include when looking at survival. Survival among metastatic patients is becoming increasingly important for cancer survivors.</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>0</td><td class='code-desc'>None; no bone metastases</td></tr><tr class='code-row'><td class='code-nbr'>1</td><td class='code-desc'>Yes; distant bone metastases</td></tr><tr class='code-row'><td class='code-nbr'>8</td><td class='code-desc'>Not applicable</td></tr><tr class='code-row'><td class='code-nbr'>9</td><td class='code-desc'>Unknown whether bone is an involved metastatic site. Not documented in patient record.</td></tr><tr class='code-row'><td class='code-nbr' colspan='2'></td></tr></table></div><a name='1113'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>METS AT DX-BRAIN</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">1113</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>SEER</a></td><td style="text-align:center;">2016</td><td style="text-align:center;">16</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">871 - 871</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>metsAtDxBrain</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>This field identifies whether brain is an involved metastatic site. The six Mets at Dx-Metastatic Sites fields provide information on specific metastatic sites for data analysis.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Information on site of metastatic disease at diagnosis has prognostic implications to survival among patients with initial late stage disease. Capturing data on where the patient&#8217;s metastatic lesions (including the number of locations) will be an important variable to include when looking at survival. Survival among metastatic patients is becoming increasingly important for cancer survivors.</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>0</td><td class='code-desc'>None; no brain metastses </td></tr><tr class='code-row'><td class='code-nbr'>1</td><td class='code-desc'>Yes; distant brain metastases</td></tr><tr class='code-row'><td class='code-nbr'>8</td><td class='code-desc'>Not applicable</td></tr><tr class='code-row'><td class='code-nbr'>9</td><td class='code-desc'>Unknown whether brain is involved metastatic site. Not documented in patient record.
</td></tr><tr class='code-row'><td class='code-nbr'></td><td class='code-desc'> </td></tr></table></div><a name='1114'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>METS AT DX-DISTANT LN</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">1114</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>SEER</a></td><td style="text-align:center;">2016</td><td style="text-align:center;">16</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">872 - 872</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>metsAtDxDistantLn</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>This field identifies whether distant lymph node(s) are an involved metastatic site. The six Mets at Dx-Metastatic Sites fields provide information on specific metastatic sites for data analysis.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Information on site of metastatic disease at diagnosis has prognostic implications to survival among patients with initial late stage disease. Capturing data on where the patient&#8217;s metastatic lesions (including the number of locations) will be an important variable to include when looking at survival. Survival among metastatic patients is becoming increasingly important for cancer survivors.</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>0</td><td class='code-desc'>None; no distant lymph node metastases
 </td></tr><tr class='code-row'><td class='code-nbr'>1</td><td class='code-desc'>Yes; distant lymph node metastases</td></tr><tr class='code-row'><td class='code-nbr'>8</td><td class='code-desc'>Not applicable</td></tr><tr class='code-row'><td class='code-nbr'>9</td><td class='code-desc'>Unknown whether distant lymph node(s) are involved metastatic site. Not documented in patient record.
</td></tr><tr class='code-row'><td class='code-nbr' colspan='2'></td></tr></table></div><a name='1115'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>METS AT DX-LIVER</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">1115</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>SEER</a></td><td style="text-align:center;">2016</td><td style="text-align:center;">16</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">873 - 873</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>metsAtDxLiver</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>This field identifies whether liver is an involved metastatic site. The six Mets at Dx-Metastatic Sites fields provide information on specific metastatic sites for data analysis.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Information on site of metastatic disease at diagnosis has prognostic implications to survival among patients with initial late stage disease. Capturing data on where the patient&#8217;s metastatic lesions (including the number of locations) will be an important variable to include when looking at survival. Survival among metastatic patients is becoming increasingly important for cancer survivors.</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>0</td><td class='code-desc'>None; no liver metastases </td></tr><tr class='code-row'><td class='code-nbr'>1</td><td class='code-desc'>Yes; distant liver metastases</td></tr><tr class='code-row'><td class='code-nbr'>8</td><td class='code-desc'>Not applicable</td></tr><tr class='code-row'><td class='code-nbr'>9</td><td class='code-desc'>Unknown whether liver is involved metastatic site. Not documented in patient record.
</td></tr><tr class='code-row'><td class='code-nbr' colspan='2'></td></tr></table></div><a name='1116'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>METS AT DX-LUNG</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">1116</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>SEER</a></td><td style="text-align:center;">2016</td><td style="text-align:center;">16</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">874 - 874</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>metsAtDxLung</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'><!--[if gte mso 10]>  <![endif]-->This field identifies whether lung is an involved metastatic site. The six Mets at Dx-Metastatic Sites fields provide information on specific metastatic sites for data analysis.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Information on site of metastatic disease at diagnosis has prognostic implications to survival among patients with initial late stage disease. Capturing data on where the patient&#8217;s metastatic lesions (including the number of locations) will be an important variable to include when looking at survival. Survival among metastatic patients is becoming increasingly important for cancer survivors.</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>0</td><td class='code-desc'>None; no lung metastases</td></tr><tr class='code-row'><td class='code-nbr'>1</td><td class='code-desc'>Yes; distant lung metastases</td></tr><tr class='code-row'><td class='code-nbr'>8</td><td class='code-desc'>Not applicable</td></tr><tr class='code-row'><td class='code-nbr'>9</td><td class='code-desc'>Unknown whether lung is involved metastatic site. Not documented in patient record.
</td></tr><tr class='code-row'><td class='code-nbr' colspan='2'></td></tr></table></div><a name='1117'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>METS AT DX-OTHER</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">1117</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>SEER</a></td><td style="text-align:center;">2016</td><td style="text-align:center;">16</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">875 - 875</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>metsAtDxOther</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>The six Mets at Dx-Metastatic Sites fields provide information on metastases for data analysis.  This field identifies any type of distant involvement not captured in the Mets at Dx-Bone [1112], Mets at Dx-Brain [1113], Mets at Dx-Liver [1115], Mets at Dx-Lung [1116], and Mets at Dx-Distant LN [1114] fields.  It includes involvement of other specific sites and more generalized metastases such as carcinomatosis.  Some examples include but are not limited to the adrenal gland, bone marrow, pleura, malignant pleural effusion, peritoneum, and skin.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Information on site of metastatic disease at diagnosis has prognostic implications to survival among patients with initial late stage disease. Capturing data on where the patient&#8217;s metastatic lesions (including the number of locations) will be an important variable to include when looking at survival. Survival among metastatic patients is becoming increasingly important for cancer survivors.</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>0</td><td class='code-desc'>None; no other metastases</td></tr><tr class='code-row'><td class='code-nbr'>1</td><td class='code-desc'>Yes; distant metastases in known site(s) other than bone, brain, liver, lung or distant lymph nodes (Note: includes bone marrow involvement for lymphomas) </td></tr><tr class='code-row'><td class='code-nbr'>2</td><td class='code-desc'>Generalized metastases such as carcinomatosis </td></tr><tr class='code-row'><td class='code-nbr'>8</td><td class='code-desc'>Not applicable</td></tr><tr class='code-row'><td class='code-nbr'>9</td><td class='code-desc'>Unknown whether any other metastatic site or generalized metastases. Not documented in patient record.
</td></tr><tr class='code-row'><td class='code-nbr'></td><td class='code-desc'> </td></tr></table></div><a name='3890'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>MICROSATELLITE INSTABILITY (MSI)</strong></td><td style="text-align:right;font-weight:bold;"><strong>Revised</strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">3890</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>NAACCR</a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1801 - 1801</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>microsatelliteInstability</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Microsatellite Instability (MSI) is a form of genetic instability manifested by changes in the length of repeated single- to six-nucleotide sequences (known as DNA microsatellite sequences). High MSI, found in about 15% of colorectal carcinomas, is an adverse prognostic factor for colorectal carcinomas and predicts poor response to 5-FU chemotherapy (although the addition of oxaliplatin in FOLFOX regimens negates the adverse effects [page 266 AJCC manual]). High MSI is a hallmark of hereditary nonpolyposis colorectal carcinoma, also known as Lynch syndrome.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Microsatellite Instability (MSI) is a Registry Data Collection Variable in AJCC. It was previously collected as Colon and Rectum, CS SSF# 7.</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para mark-changed'><table><tr class='code-row'><td class='code-nbr'>0</td><td class='code-desc'>Microsatellite instability (MSI) stable; microsatellite stable (MSS); negative, NOS<br/>
AND/OR<br/>
Mismatch repair (MMR) intact, no loss of nuclear expression of MMR proteins<br/>
MMR proficient (pMMR or MMR-P)</td></tr><tr class='code-row'><td class='code-nbr'>1</td><td class='code-desc'>MSI unstable low (MSI-L)</td></tr><tr class='code-row'><td class='code-nbr'>2</td><td class='code-desc'>MSI unstable high (MSI-H)<br/>
AND/OR<br/>
MMR deficient (dMMR or MMR-D), loss of nuclear expression of one or more MMR proteins
</td></tr><tr class='code-row'><td class='code-nbr'>8</td><td class='code-desc'>Not applicable: Information not collected for this case<br/>
(If this information is required by your standard setter, use of code 8 may result in an edit error.)
</td></tr><tr class='code-row'><td class='code-nbr'>9</td><td class='code-desc'>Not documented in medical record<br/>
MSI-indeterminate<br/> 
Microsatellite instability not assessed or unknown if assessed
</td></tr><tr class='code-row'><td class='code-nbr'></td><td class='code-desc'> </td></tr></table></div><div class='content chap10-para mark-changed'>Each Site-Specific Data Item (SSDI) applies only to selected primary sites, histologies, and years of diagnosis. Depending on applicability and standard-setter requirements, SSDIs may be left blank.</div><a name='3891'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>MICROVASCULAR DENSITY </strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">3891</td><td style="text-align:center;">2</td><td style="text-align:center;"><a href='#sources'>NAACCR</a></td><td style="text-align:center;">2018</td><td style="text-align:center;">18</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1885 - 1886</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>microvascularDensity</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Microvascular Density (MVD), a quantitative measure of tumor vascularity, is a prognostic factor for uveal melanoma.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Microvascular Density (MVD), is a Registry Data Collection Variable in AJCC. This data item was previously collected as Uveal Melanoma, CS SSF# 13.</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>00</td><td class='code-desc'>No vessels involved </td></tr><tr class='code-row'><td class='code-nbr'>01-99</td><td class='code-desc'>01-99 vessels per 0.3 square millimeter (mm2)</td></tr><tr class='code-row'><td class='code-nbr'>X1</td><td class='code-desc'>Greater than or equal to 100 vessels per 0.3 square millimeter (mm2)</td></tr><tr class='code-row'><td class='code-nbr'>X2</td><td class='code-desc'>Lowest quartile for laboratory</td></tr><tr class='code-row'><td class='code-nbr'>X3</td><td class='code-desc'>Second quartile for laboratory</td></tr><tr class='code-row'><td class='code-nbr'>X4</td><td class='code-desc'>Third quartile for laboratory</td></tr><tr class='code-row'><td class='code-nbr'>X5</td><td class='code-desc'>Highest quartile for laboratory</td></tr><tr class='code-row'><td class='code-nbr'>X7</td><td class='code-desc'>Test ordered, results not in chart</td></tr><tr class='code-row'><td class='code-nbr'>X8</td><td class='code-desc'>Not applicable: Information not collected for this case<br/>
(If this information is required by your standard setter, use of code 8 may result in an edit error.)
</td></tr><tr class='code-row'><td class='code-nbr'>X9</td><td class='code-desc'>Not documented in medical record<br/>
Microvascular Density (MVD) not assessed or unknown if assessed
</td></tr><tr class='code-row'><td class='code-nbr'></td><td class='code-desc'> </td></tr></table></div><div class='content chap10-para'>Each Site-Specific Data Item (SSDI) applies only to selected primary sites, histologies, and years of diagnosis. Depending on applicability and standard-setter requirements, SSDIs may be left blank.</div><a name='2310'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>MILITARY RECORD NO SUFFIX</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">2310</td><td style="text-align:center;">2</td><td style="text-align:center;"><a href='#sources'>CoC</a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">4326 - 4327</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>Military Medical Record Number Suffix (CoC)<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>militaryRecordNoSuffix</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Patient identifier used by military hospitals to record relationship of the patient to the sponsor. </div><div class='content chap10-para'><strong>Codes </strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>01-19</td><td class='code-desc'>Child</td></tr><tr class='code-row'><td class='code-nbr'>20</td><td class='code-desc'>Sponsor</td></tr><tr class='code-row'><td class='code-nbr'>30-39</td><td class='code-desc'>Spouse</td></tr><tr class='code-row'><td class='code-nbr'>40-44</td><td class='code-desc'>Mother</td></tr><tr class='code-row'><td class='code-nbr'>45-49</td><td class='code-desc'>Father</td></tr><tr class='code-row'><td class='code-nbr'>50-54</td><td class='code-desc'>Mother-in-law</td></tr><tr class='code-row'><td class='code-nbr'>55-59</td><td class='code-desc'>Father-in-law</td></tr><tr class='code-row'><td class='code-nbr'>60-69</td><td class='code-desc'>Other eligible dependents</td></tr><tr class='code-row'><td class='code-nbr'>98</td><td class='code-desc'>Civilian emergency (Air Force/Navy)</td></tr><tr class='code-row'><td class='code-nbr'>99</td><td class='code-desc'>Not classified elsewhere/stillborn</td></tr><tr class='code-row'><td class='code-nbr'>Blank</td><td class='code-desc'>Not a military facility</td></tr></table></div><a name='3892'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>MITOTIC COUNT UVEAL MELANOMA</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">3892</td><td style="text-align:center;">4</td><td style="text-align:center;"><a href='#sources'>NAACCR</a></td><td style="text-align:center;">2018</td><td style="text-align:center;">18</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1887 - 1890</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>mitoticCountUvealMelanoma</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Mitotic Count Uveal Melanoma, the number of mitoses per 40 high-power fields (HPF) based on pathological evaluation, is a prognostic factor for uveal melanoma.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Mitotic Count Uveal Melanoma is listed as a Registry Data Collection Variable in AJCC.  It was previously collected as Uveal Melanoma, CS SSF# 9.</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>0.0</td><td class='code-desc'>0 mitoses per 40 high-power fields (HPF)<br/> 
Mitoses absent, no mitoses present, no mitotic activity
 </td></tr><tr class='code-row'><td class='code-nbr'>0.1-99.9</td><td class='code-desc'>0.1-99.9 mitosis per 40 HPF </td></tr><tr class='code-row'><td class='code-nbr'>XX.1</td><td class='code-desc'>100 or more mitoses per 40 HPF </td></tr><tr class='code-row'><td class='code-nbr'>XX.2</td><td class='code-desc'>Stated as low mitotic count or rate with no specific number</td></tr><tr class='code-row'><td class='code-nbr'>XX.3</td><td class='code-desc'>Stated as high mitotic count or rate with no specific number</td></tr><tr class='code-row'><td class='code-nbr'>XX.4</td><td class='code-desc'>Mitotic count described with denominator other than 40 HPF </td></tr><tr class='code-row'><td class='code-nbr'>XX.7</td><td class='code-desc'>Test ordered, results not in chart</td></tr><tr class='code-row'><td class='code-nbr'>XX.8</td><td class='code-desc'>Not applicable: Information not collected for this case<br/>
(If this information is required by your standard setter, use of code XX.8 may result in an edit error.)
</td></tr><tr class='code-row'><td class='code-nbr'>XX.9</td><td class='code-desc'>Not documented in medical record<br/>
Mitotic Count Uveal Melanoma not assessed or unknown if assessed
</td></tr><tr class='code-row'><td class='code-nbr'></td><td class='code-desc'> </td></tr></table></div><div class='content chap10-para'>Each Site-Specific Data Item (SSDI) applies only to selected primary sites, histologies, and years of diagnosis. Depending on applicability and standard-setter requirements, SSDIs may be left blank.</div><a name='3893'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>MITOTIC RATE MELANOMA</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">3893</td><td style="text-align:center;">2</td><td style="text-align:center;"><a href='#sources'>NAACCR</a></td><td style="text-align:center;">2018</td><td style="text-align:center;">18</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1872 - 1873</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>mitoticRateMelanoma</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Mitotic Rate Melanoma, the number of mitoses per square millimeter based on pathological evaluation, is a prognostic factor for melanoma of the skin.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'><!--[if gte mso 10]>  <![endif]-->Mitotic Rate Melanoma is a Registry Data Collection Variable in AJCC.  It was previously collected as Melanoma Skin, CS SSF# 7.</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>00</td><td class='code-desc'>0 mitoses per square millimeter (mm)<br/>
Mitoses absent<br/>
No mitoses present
 </td></tr><tr class='code-row'><td class='code-nbr'>01-99</td><td class='code-desc'>1 - 99 mitoses/square mm<br/>
(Exact measurement in mitoses/square mm) 
</td></tr><tr class='code-row'><td class='code-nbr'>X1</td><td class='code-desc'>100 mitoses/square mm or more</td></tr><tr class='code-row'><td class='code-nbr'>X2</td><td class='code-desc'>Stated as "less than 1 mitosis/square mm"<br/>
Stated as "nonmitogenic" 
</td></tr><tr class='code-row'><td class='code-nbr'>X3</td><td class='code-desc'>Stated as "at least 1 mitosis/square mm"<br/>
Stated as "mitogenic"
</td></tr><tr class='code-row'><td class='code-nbr'>X4</td><td class='code-desc'>Mitotic rate described with denominator other than square millimeter (mm)</td></tr><tr class='code-row'><td class='code-nbr'>X7</td><td class='code-desc'>Test ordered, results not in chart</td></tr><tr class='code-row'><td class='code-nbr'>X8</td><td class='code-desc'>Not applicable: Information not collected for this case<br/>
(If this information is required by your standard setter, use of code X8 may result in an edit error.)
</td></tr><tr class='code-row'><td class='code-nbr'>X9</td><td class='code-desc'>Not documented in medical record<br/>
Mitotic Rate Melanoma not assessed or unknown if assessed
</td></tr><tr class='code-row'><td class='code-nbr'></td><td class='code-desc'> </td></tr></table></div><div class='content chap10-para'>Each Site-Specific Data Item (SSDI) applies only to selected primary sites, histologies, and years of diagnosis. Depending on applicability and standard-setter requirements, SSDIs may be left blank.</div><a name='1970'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>MORPH (73-91) ICD-O-1</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">1970</td><td style="text-align:center;">6</td><td style="text-align:center;"><a href='#sources'></a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">2600 - 2605</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>morphIcdO1</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>The name for a group of subfields describing the type and behavior of the tumor being reported using ICD-O-1 codes.<br /><br />Group names appear only in the data dictionary and Appendix E.<br /><br /><strong>Subfields</strong><br />Histology (73-91) ICD-O-1 [1971]<br />Behavior (73-91) ICD-O-1 [1972]<br />Grade (73-91) ICD-O-1 [1973]</div><a name='470'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>MORPH CODING SYS--CURRENT</strong></td><td style="text-align:right;font-weight:bold;"><strong>Revised</strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">470</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>NAACCR</a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">574 - 574</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>morphCodingSysCurrent</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Code that best describes how morphology is currently coded. If converted, this field shows the system it is converted to. An update or new Morphology Coding System code incorporates all previous coding updates.</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para mark-changed'><table><tr class='code-row'><td class='code-nbr'>1</td><td class='code-desc'>ICD-O, First Edition</td></tr><tr class='code-row'><td class='code-nbr'>2</td><td class='code-desc'>ICD-O, 1986 Field Trial</td></tr><tr class='code-row'><td class='code-nbr'>3</td><td class='code-desc'>ICD-O, 1988 Field Trial</td></tr><tr class='code-row'><td class='code-nbr'>4</td><td class='code-desc'>ICD-O, Second Edition</td></tr><tr class='code-row'><td class='code-nbr'>5</td><td class='code-desc'>ICD-O, Second Edition, plus REAL lymphoma codes effective 1/1/1995</td></tr><tr class='code-row'><td class='code-nbr'>6</td><td class='code-desc'>ICD-O, Second Edition, plus FAB codes effective 1/1/1998</td></tr><tr class='code-row'><td class='code-nbr'>7</td><td class='code-desc'>ICD-O, Third Edition</td></tr><tr class='code-row'><td class='code-nbr'>8</td><td class='code-desc'>ICD-O, Third Edition, plus 2008 WHO hematopoietic/lymphoid new terms used for conditions diagnosed 1/1/2010*</td></tr><tr class='code-row'><td class='code-nbr'>9</td><td class='code-desc'>Other</td></tr><tr class='code-row'><td class='code-nbr'>A</td><td class='code-desc'>ICD-O, Third Edition, plus WHO new terms used for conditions, effective 1/1/2018** </td></tr><tr class='code-row'><td class='code-nbr'>B</td><td class='code-desc'>ICD-O 3.2, effective 1/1/2021  </td></tr><tr class='code-row'><td class='code-nbr'></td><td class='code-desc'> </td></tr></table></div><div class='content chap10-para'><div><em>Note:</em></div><div>&nbsp;</div><div>* These changes were based on the terms of the World Health Organization&#8217;s (WHO) fourth edition of the following publications: <br /><br />WHO Classification of Hematopoietic and Lymphoid Neoplasms (2007)<br />WHO Classification of Tumors of the Central Nervous System (2008)<br />WHO Classification of Tumors of the Digestive System (2010)<br /><br />For details including the list of terms included, refer to the link to the NAACCR ICD-O-3 Implementation Guidelines document, effective for 2014 cases: <a href=" https://20tqtx36s1la18rvn82wcmpn-wpengine.netdna-ssl.com/wp-content/uploads/2016/11/ICD-O-3-Implementation-Guide-FINAL.pdf" target="_blank">https://20tqtx36s1la18rvn82wcmpn-wpengine.netdna-ssl.com/wp-content/uploads/2016/11/ICD-O-3-Implementation-Guide-FINAL.pdf</a>.<br /> <br />**These changes are based on the terms of the World Health Organization&#8217;s (WHO) fourth edition of the following publications:</div><div>&nbsp;</div><div>WHO Classification of Tumors of the Breast (2012)</div><div>WHO Classification of Tumors of the Female Reproductive Organs (2013)<br />WHO Classification of Tumors of Soft Tissue and Bone (2013)<br />WHO Classification of Tumors of the Lung, Pleura, Thymus, and Heart (2015)<br />WHO Classification of Tumors of the Urinary System and Male Genital Organs (2016)<br />WHO Classifications of Tumors of the Central Nervous System, Revised 4th Ed (2016)<br />WHO Classifications of Tumors of the Head and Neck, Revised 4th Edition (2017) <br />WHO Classifications of Tumors of Endocrine Organs, Revised 4th Edition (2017)<br /><br />For details including the list of terms included, refer to the link to the NAACCR ICD-O-3 Implementation Guidelines document, effective for 2018 cases: <a href="https://20tqtx36s1la18rvn82wcmpn-wpengine.netdna-ssl.com/wp-content/uploads/2018/01/Updated-Jan-10-2018-ICD-O-3-Guidelines-v2.pdf" target="_blank">https://20tqtx36s1la18rvn82wcmpn-wpengine.netdna-ssl.com/wp-content/uploads/2018/01/Updated-Jan-10-2018-ICD-O-3-Guidelines-v2.pdf</a>.</div></div><a name='480'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>MORPH CODING SYS--ORIGINL</strong></td><td style="text-align:right;font-weight:bold;"><strong>Revised</strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">480</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>NAACCR</a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">575 - 575</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>morphCodingSysOriginl</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Code that best describes how morphology was originally coded. If later converted, this field shows the original codes used. An update or new Morphology Coding System code incorporates all previous coding updates.</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para mark-changed'><table><tr class='code-row'><td class='code-nbr'>1</td><td class='code-desc'>ICD-O, First Edition</td></tr><tr class='code-row'><td class='code-nbr'>2</td><td class='code-desc'>ICD-O, 1986 Field Trial</td></tr><tr class='code-row'><td class='code-nbr'>3</td><td class='code-desc'>ICD-O, 1988 Field Trial</td></tr><tr class='code-row'><td class='code-nbr'>4</td><td class='code-desc'>ICD-O, Second Edition</td></tr><tr class='code-row'><td class='code-nbr'>5</td><td class='code-desc'>ICD-O, Second Edition, plus REAL lymphoma codes effective 1/1/1995</td></tr><tr class='code-row'><td class='code-nbr'>6</td><td class='code-desc'>ICD-O, Second Edition, plus FAB codes effective 1/1/1998</td></tr><tr class='code-row'><td class='code-nbr'>7</td><td class='code-desc'>ICD-O, Third Edition</td></tr><tr class='code-row'><td class='code-nbr'>8</td><td class='code-desc'>ICD-O, Third Edition, plus 2008 WHO hematopoietic/lymphoid new terms used for conditions diagnosed 1/1/2010*</td></tr><tr class='code-row'><td class='code-nbr'>9</td><td class='code-desc'>Other</td></tr><tr class='code-row'><td class='code-nbr'>A</td><td class='code-desc'>ICD-O, Third Edition, plus WHO new terms used for conditions, effective 1/1/2018** </td></tr><tr class='code-row'><td class='code-nbr'>B</td><td class='code-desc'>ICD-O 3.2, effective 1/1/2021 </td></tr><tr class='code-row'><td class='code-nbr'></td><td class='code-desc'> </td></tr></table></div><div class='content chap10-para'><div><em>Notes</em>:</div><div>&nbsp;</div><div>*These changes were based on the terms of the World Health Organization&#8217;s (WHO) fourth edition of the following publications: <br />WHO Classification of Hematopoietic and Lymphoid Neoplasms (2007)<br />WHO Classification of Tumors of the Central Nervous System (2008)<br />WHO Classification of Tumors of the Digestive System (2010)<br /><br />For details including the list of terms included, here is the link to the NAACCR ICD-O-3  Implementation Guidelines document, effective for 2014 cases: <a href="https://20tqtx36s1la18rvn82wcmpn-wpengine.netdna-ssl.com/wp-content/uploads/2016/11/ICD-O-3-Implementation-Guide-FINAL.pdf" target="_blank">https://20tqtx36s1la18rvn82wcmpn-wpengine.netdna-ssl.com/wp-content/uploads/2016/11/ICD-O-3-Implementation-Guide-FINAL.pdf</a>.</div><div>**These changes are based on the terms of the World Health Organization&#8217;s (WHO) fourth edition of the following publications:<br /> <br />WHO Classification of Tumors of the Breast (2012)<br />WHO Classification of Tumors of the Female Reproductive Organs (2013)<br />WHO Classification of Tumors of Soft Tissue and Bone (2013)<br />WHO Classification of Tumors of the Lung, Pleura, Thymus, and Heart (2015)<br />WHO Classification of Tumors of the Urinary System and Male Genital Organs (2016)<br />WHO Classifications of Tumors of the Central Nervous System, Revised 4th Ed (2016)<br />WHO Classifications of Tumors of the Head and Neck, Revised 4th Edition (2017) <br />WHO Classifications of Tumors of Endocrine Organs, Revised 4th Edition (2017)<br /><br />For details including the list of terms included, here is the link to the NAACCR ICD-O-3 Implementation Guidelines document, effective for 2018 cases: <a href="https://20tqtx36s1la18rvn82wcmpn-wpengine.netdna-ssl.com/wp-content/uploads/2018/01/Updated-Jan-10-2018-ICD-O-3-Guidelines-v2.pdf" target="_blank">https://20tqtx36s1la18rvn82wcmpn-wpengine.netdna-ssl.com/wp-content/uploads/2018/01/Updated-Jan-10-2018-ICD-O-3-Guidelines-v2.pdf</a>.</div></div><a name='419'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>MORPH--TYPE&BEHAV ICD-O-2</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">419</td><td style="text-align:center;">5</td><td style="text-align:center;"><a href='#sources'></a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">559 - 563</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>morphTypebehavIcdO2</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>The name for a group of subfields describing the type and behavior of the tumor being reported using ICD-O-2 codes.<br /><br />Group names appear only in the data dictionary and Appendix E.<strong><br /><br />Subfields</strong><br />Histology (92-00) ICD-O-2 [420]<br />Behavior (92-00) ICD-O-2 [430]</div><a name='521'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>MORPH--TYPE&BEHAV ICD-O-3</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">521</td><td style="text-align:center;">5</td><td style="text-align:center;"><a href='#sources'></a></td><td style="text-align:center;">2001</td><td style="text-align:center;">9</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">564 - 568</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>morphTypebehavIcdO3</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>The name for a group of subfields describing the type and behavior of the tumor being reported using ICD-O-3 codes.<br /><br />Group names appear only in the data dictionary and Appendix E.<br /><br /><strong>Subfields</strong><br />Histologic Type ICD-O-3 [522]<br />Behavior Code ICD-O-3 [523]</div><a name='444'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>MULT TUM RPT AS ONE PRIM</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">444</td><td style="text-align:center;">2</td><td style="text-align:center;"><a href='#sources'>SEER</a></td><td style="text-align:center;">2006</td><td style="text-align:center;">11</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">591 - 592</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>Multiple Tumors Reported as Single Primary<br />Type of Multiple Tumors Reported As One Primary<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>multTumRptAsOnePrim</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>This data item is used to identify the type of multiple tumors in cases with multiple tumors that are abstracted and reported as a single primary using the SEER, IARC, or Canadian Cancer Registry multiple primary rules. Multiple tumors may individually exhibit <em>in situ</em>, invasive, or a combination of <em>in situ</em> and invasive behaviors. Multiple intracranial and central nervous system tumors may individually exhibit benign, borderline, malignant, or a combination of these behaviors. Multiple tumors found in the same organ or in a single primary site may occur at the time of initial diagnosis or later. </div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Patients with multiple tumors that are currently reported as a single primary may have a worse prognosis or more extensive treatment than patients with a single tumor. This data item will make it possible to identify important information about these cases for data analysis, and to compare individually reported cancer cases with historical data if the rules are changed. </div><div class='content chap10-para'><strong>Codes (refer to <a target="_blank" href="http://seer.cancer.gov/tools/mphrules/index.html">http://seer.cancer.gov/tools/mphrules/index.html</a> for additional instructions). </strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>00</td><td class='code-desc'>Single tumor</td></tr><tr class='code-row'><td class='code-nbr'>10</td><td class='code-desc'>Multiple benign</td></tr><tr class='code-row'><td class='code-nbr'>11</td><td class='code-desc'>Multiple borderline</td></tr><tr class='code-row'><td class='code-nbr'>12</td><td class='code-desc'>Benign and borderline</td></tr><tr class='code-row'><td class='code-nbr'>20</td><td class='code-desc'>Multiple <i>in situ</i></td></tr><tr class='code-row'><td class='code-nbr'>30</td><td class='code-desc'><i>In situ</i> and invasive</td></tr><tr class='code-row'><td class='code-nbr'>31</td><td class='code-desc'>Polyp and adenocarcinoma</td></tr><tr class='code-row'><td class='code-nbr'>32</td><td class='code-desc'>FAP with carcinoma</td></tr><tr class='code-row'><td class='code-nbr'>40</td><td class='code-desc'>Multiple invasive</td></tr><tr class='code-row'><td class='code-nbr'>80</td><td class='code-desc'>Unknown <i>in situ</i> or invasive</td></tr><tr class='code-row'><td class='code-nbr'>88</td><td class='code-desc'>NA</td></tr><tr class='code-row'><td class='code-nbr'>99</td><td class='code-desc'>Unknown</td></tr></table></div><a name='3894'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>MULTIGENE SIGNATURE METHOD</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">3894</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>NAACCR</a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1747 - 1747</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>multigeneSignatureMethod</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Multigene signatures or classifiers are assays of a panel of genes from a tumor specimen, intended to provide a quantitative assessment of the likelihood of response to chemotherapy and to evaluate prognosis or the likelihood of future metastasis. This data item identifies the multigene signature method used. Oncotype Dx is coded elsewhere. </div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Multigene Signature Method is a Registry Data Collection Variable in AJCC. It was previously collected as Breast, CS SSF #22. See also Multigene Signature Results. </div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>1</td><td class='code-desc'>Mammaprint </td></tr><tr class='code-row'><td class='code-nbr'>2</td><td class='code-desc'>PAM50 (Prosigna)</td></tr><tr class='code-row'><td class='code-nbr'>3</td><td class='code-desc'>Breast Cancer Index</td></tr><tr class='code-row'><td class='code-nbr'>4</td><td class='code-desc'>EndoPredict</td></tr><tr class='code-row'><td class='code-nbr'>5</td><td class='code-desc'>Test performed, type of test unknown</td></tr><tr class='code-row'><td class='code-nbr'>6</td><td class='code-desc'>Multiple tests, any tests in codes 1-4</td></tr><tr class='code-row'><td class='code-nbr'>7</td><td class='code-desc'>Test ordered, results not in chart</td></tr><tr class='code-row'><td class='code-nbr'>8</td><td class='code-desc'>Not applicable: Information not collected for this case<br/>
(If this item is required by your standard setter, use of code 8 will result in an edit error.)
</td></tr><tr class='code-row'><td class='code-nbr'>9</td><td class='code-desc'>Not documented in medical record<br/>
Multigene Signature Method not assessed or unknown if assessed
</td></tr><tr class='code-row'><td class='code-nbr'></td><td class='code-desc'> </td></tr></table></div><div class='content chap10-para'>Each Site-Specific Data Item (SSDI) applies only to selected primary sites, histologies, and years of diagnosis. Depending on applicability and standard-setter requirements, SSDIs may be left blank.</div><a name='3895'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>MULTIGENE SIGNATURE RESULTS</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">3895</td><td style="text-align:center;">2</td><td style="text-align:center;"><a href='#sources'>NAACCR</a></td><td style="text-align:center;">2018</td><td style="text-align:center;">18</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1748 - 1749</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>multigeneSignatureResults</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Multigene signatures or classifiers are assays of a panel of genes from a tumor specimen, intended to provide a quantitative assessment of the likelihood of response to chemotherapy and to evaluate prognosis or the likelihood of future metastasis. This data item identified the multigene signature result. Oncotype Dx is coded elsewhere.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'><!--[if gte mso 10]>  <![endif]-->Multigene Signature Results is a Registry Data Collection Variable in AJCC. It was previously collected as Breast, CS SSF #23. See also Multigene Signature Method.</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>00-99</td><td class='code-desc'>Enter actual recurrence score<br/> 
<i>Note</i>: Depending on the test, the range of values may be different
 </td></tr><tr class='code-row'><td class='code-nbr'>X1</td><td class='code-desc'>Score 100</td></tr><tr class='code-row'><td class='code-nbr'>X2</td><td class='code-desc'>Low risk</td></tr><tr class='code-row'><td class='code-nbr'>X3</td><td class='code-desc'>Moderate [intermediate] risk</td></tr><tr class='code-row'><td class='code-nbr'>X4</td><td class='code-desc'>High risk</td></tr><tr class='code-row'><td class='code-nbr'>X7</td><td class='code-desc'>Test ordered, results not in chart</td></tr><tr class='code-row'><td class='code-nbr'>X8</td><td class='code-desc'>Not applicable: Information not collected for this case<br/>
(If this item is required by your standard setter, use of code X8 will result in an edit error.)
</td></tr><tr class='code-row'><td class='code-nbr'>X9</td><td class='code-desc'>Not documented in medical record<br/>
Multigene Signature Results not assessed or unknown if assessed
</td></tr><tr class='code-row'><td class='code-nbr'></td><td class='code-desc'> </td></tr></table></div><div class='content chap10-para'>Each Site-Specific Data Item (SSDI) applies only to selected primary sites, histologies, and years of diagnosis. Depending on applicability and standard-setter requirements, SSDIs may be left blank.</div><a name='446'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>MULTIPLICITY COUNTER</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">446</td><td style="text-align:center;">2</td><td style="text-align:center;"><a href='#sources'>SEER</a></td><td style="text-align:center;">2006</td><td style="text-align:center;">11</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">603 - 604</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>multiplicityCounter</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>This data item is used to count the number of tumors (multiplicity) that are reported as a single primary, when present at the time of diagnosis or occurring later. </div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Patients with multiple tumors reported as a single primary for surveillance purposes may have a worse prognosis or more extensive treatment than patients with a single tumor. This data item will make it possible to identify important information about these cases for data analysis. </div><div class='content chap10-para'><strong>Codes (refer to <a target="_blank" href="http://seer.cancer.gov/tools/mphrules/index.html">http://seer.cancer.gov/tools/mphrules/index.html</a> for additional instructions).</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>00</td><td class='code-desc'>No primary tumor identified</td></tr><tr class='code-row'><td class='code-nbr'>01</td><td class='code-desc'>One tumor only</td></tr><tr class='code-row'><td class='code-nbr'>02</td><td class='code-desc'>Two tumors present; bilateral ovaries involved with cystic carcinoma</td></tr><tr class='code-row'><td class='code-nbr'>03</td><td class='code-desc'>Three tumors present</td></tr><tr class='code-row'><td class='code-nbr' colspan='2'>..</td></tr><tr class='code-row'><td class='code-nbr' colspan='2'>..</td></tr><tr class='code-row'><td class='code-nbr'>88</td><td class='code-desc'>Information on multiple tumors not collected/not applicable for this site</td></tr><tr class='code-row'><td class='code-nbr'>89</td><td class='code-desc'>Multicentric, multifocal, number unknown</td></tr><tr class='code-row'><td class='code-nbr'>99</td><td class='code-desc'>Unknown if multiple tumors; not documented</td></tr><tr class='code-row'><td class='code-nbr'>Blank</td><td class='code-desc'>Information not collected for this diagnosis date (e.g., all cases diagnosed prior to 2007)</td></tr><tr class='code-row'><td class='code-nbr'></td><td class='code-desc'> </td></tr></table></div><div class='content chap10-para'><em>Note</em>: Codes 00 and 89 were added effective for 2011.</div><a name='50'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>NAACCR RECORD VERSION</strong></td><td style="text-align:right;font-weight:bold;"><strong>Revised</strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">50</td><td style="text-align:center;">3</td><td style="text-align:center;"><a href='#sources'>NAACCR</a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">17 - 19</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>naaccrRecordVersion</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>NaaccrData</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>This item applies only to record types I, C, A, and M. Code the NAACCR record version used to create the record. The correction record (U) has its own record version data item.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>The NAACCR Layout version is necessary to communicate to the recipient of data in NAACCR form where the various items are found and how they are coded. It should be added to the record when the recorded is created.</div><div class='content chap10-para'><strong>Codes </strong></div><div class='content chap10-para mark-changed'><table><tr class='code-row'><td class='code-nbr'>120</td><td class='code-desc'>2010 Version 12</td></tr><tr class='code-row'><td class='code-nbr'>121</td><td class='code-desc'>2011 Version 12.1</td></tr><tr class='code-row'><td class='code-nbr'>122</td><td class='code-desc'>2012 Version 12.2</td></tr><tr class='code-row'><td class='code-nbr'>130</td><td class='code-desc'>2013 Version 13 </td></tr><tr class='code-row'><td class='code-nbr'>140</td><td class='code-desc'>2014 Version 14 </td></tr><tr class='code-row'><td class='code-nbr'>150</td><td class='code-desc'>2015 Version 15</td></tr><tr class='code-row'><td class='code-nbr'>160</td><td class='code-desc'>2016 Version 16</td></tr><tr class='code-row'><td class='code-nbr'>180</td><td class='code-desc'>2018 Version 18</td></tr><tr class='code-row'><td class='code-nbr'>210</td><td class='code-desc'>2021 Version 21</td></tr><tr class='code-row'><td class='code-nbr'></td><td class='code-desc'> </td></tr></table></div><div class='content chap10-para'>Historically (before 2010), this was a 1-character field with the following codes in column 19:<br /><br />1	 &nbsp; &nbsp;  &nbsp; &nbsp;  &nbsp; &nbsp; 1992-1994 Version 2 and Version 3<br />4	 &nbsp; &nbsp;  &nbsp; &nbsp;  &nbsp; &nbsp; 1995 Version 4.0<br />5	 &nbsp; &nbsp;  &nbsp; &nbsp;  &nbsp; &nbsp; 1996 and 1997 Version 5.0 or Version 5.1<br />6	 &nbsp; &nbsp;  &nbsp; &nbsp;  &nbsp; &nbsp; 1998 Version 6<br />7	 &nbsp; &nbsp;  &nbsp; &nbsp;  &nbsp; &nbsp; 1999 Version 7<br />8	 &nbsp; &nbsp;  &nbsp; &nbsp;  &nbsp; &nbsp; 2000 Version 8<br />9	 &nbsp; &nbsp;  &nbsp; &nbsp;  &nbsp; &nbsp; 2001 and 2002 Version 9 and 9.1<br />A	 &nbsp; &nbsp;  &nbsp; &nbsp;  &nbsp; &nbsp; 2003, 2004, and 2005 Version 10, 10.1, and 10.2<br />B	 &nbsp; &nbsp;  &nbsp; &nbsp;  &nbsp; &nbsp; 2006, 2007, and 2008 Version 11, 11.1, 11.2, and 11.3<br />Blank	 &nbsp; &nbsp; September 1989 Version<br /><br /><em>Note</em>: Code 4 was assigned to the 1995 Version to synchronize the document version and the layout version numbers. Layout document Versions 2 and 3 are coded as 1.</div><a name='2280'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>NAME--ALIAS</strong></td><td style="text-align:right;font-weight:bold;"><strong>Revised</strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">2280</td><td style="text-align:center;">40</td><td style="text-align:center;"><a href='#sources'>NAACCR</a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">4175 - 4214</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>Alias (CoC)<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>nameAlias</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Patient</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para mark-changed'>Records an alternate name or &#8220;AKA&#8221; (also known as) used by the patient, if known. Note that the birth surname (AKA maiden name) is entered in Name--Birth Surname [2232].</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para mark-changed'>The update is needed to reflect that Maiden Name is no longer going to be used as of 2021.</div><div class='content chap10-para mark-changed'><em>Note</em>: This data item is no longer supported by CoC (as of January 1, 2003), but is maintained by NAACCR.</div><a name='2232'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>NAME--BIRTH SURNAME</strong></td><td style="text-align:right;font-weight:bold;"><strong>New</strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">2232</td><td style="text-align:center;">40</td><td style="text-align:center;"><a href='#sources'>NAACCR</a></td><td style="text-align:center;">2021</td><td style="text-align:center;">21</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1 - 40</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>nameBirthSurname</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Patient</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Last name (surname) of patient at birth, regardless of gender or marital status.&nbsp; 












<br />Other alternate names should be recorded in the data item, Name--Alias [2280].</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>This can be used to link reports on a person whose surname might be different on different documents. It is also useful when using a Spanish surname algorithm to categorize ethnicity.</div><div class='content chap10-para'>Codes</div><div class='content chap10-para'>The field should be left blank if the birth surname is not known or not applicable. Since a value in this field may be used by linkage software or other computer algorithms, only legitimate surnames are allowable, and any variation of &#8220;unknown&#8221; or &#8220;not applicable&#8221; is not allowable.<br /><br /><em>Note:</em> This data item was introduced to be a gender-neutral birth-surname data item, analogous to Name--Maiden [2390].  It is to have been populated in the 2021 conversion by values in [2390]. The original (Name--Maiden) data item had been supported by CoC until January 1, 2003.</div><a name='2240'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>NAME--FIRST</strong></td><td style="text-align:right;font-weight:bold;"><strong>Revised</strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">2240</td><td style="text-align:center;">40</td><td title="V: 22: SEER
V: 18: CoC
V: 16: CoC
V: 15: CoC
" class=" HighlightToolTip" style="text-align:center;"><a href='#sources'>SEER</a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">4089 - 4128</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>First Name (CoC)<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>nameFirst</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Patient</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para mark-changed'>First name of the patient.</div><div class='content chap10-para mark-changed'><em>Note:</em> The CoC <em><a target="_blank" href="http://www.facs.org/cancer/coc/fordsmanual.html">STORE</a></em> manual allows this field to be blank. If facilities with CoC-approved cancer programs submit blanks to the central registry, it is suggested that the central registry devise procedures for completing the last and first name with text, such as UNKNOWN, after verifying with the hospital that the field was left intentionally blank.<br /><br /><em>Note</em>: See the most recent <em><a target="_blank" href="http://www.facs.org/cancer/coc/fordsmanual.html">STORE</a> </em>for CoC allowable values.</div><a name='2230'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>NAME--LAST</strong></td><td style="text-align:right;font-weight:bold;"><strong>Revised</strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">2230</td><td style="text-align:center;">40</td><td title="V: 22: SEER
V: 18: CoC
V: 16: CoC
V: 15: CoC
" class=" HighlightToolTip" style="text-align:center;"><a href='#sources'>SEER</a></td><td style="text-align:center;">2011</td><td style="text-align:center;">12.2</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">4049 - 4088</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>Last Name (CoC)<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>nameLast</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Patient</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Last name of the patient.</div><div class='content chap10-para'><em>Note:</em> See the most recent <em>STORE</em> for CoC allowable values.</div><a name='2390'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>NAME--MAIDEN</strong></td><td style="text-align:right;font-weight:bold;"><strong>Revised</strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">2390</td><td style="text-align:center;">40</td><td style="text-align:center;"><a href='#sources'>NAACCR</a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">4215 - 4254</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>Maiden Name (CoC)<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>nameMaiden</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Patient</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para mark-changed'>Maiden name of female patients who are or have been married.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para mark-changed'>This is used to link reports on a woman who changed her name between reports. It also is critical when using Spanish surname algorithms to categorize ethnicity.<br /><br />The field should be left blank if the maiden name is not known or not applicable. Since a value in this field may be used by linkage software or other computer algorithms, only legitimate surnames are allowable, and any variation of "unknown" or "not applicable" is not allowable.</div><div class='content chap10-para mark-changed'><em>Note</em>: This data item is no longer supported by CoC (as of January 1, 2003).</div><a name='2250'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>NAME--MIDDLE</strong></td><td style="text-align:right;font-weight:bold;"><strong>Revised</strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">2250</td><td style="text-align:center;">40</td><td title="V: 22: SEER
V: 18: CoC
V: 16: CoC
V: 15: CoC
" class=" HighlightToolTip" style="text-align:center;"><a href='#sources'>SEER</a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">4129 - 4168</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>Middle Name (CoC)<br />Middle Initial (pre-96 CoC)<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>nameMiddle</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Patient</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para mark-changed'>Middle name or, if middle name is unavailable, middle initial of the patient.<br /><br /><em>Note</em>: See the most recent <em><a target="_blank" href="http://www.facs.org/cancer/coc/fordsmanual.html">STORE</a> </em>for CoC allowable values.</div><a name='2260'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>NAME--PREFIX</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">2260</td><td style="text-align:center;">3</td><td style="text-align:center;"><a href='#sources'>NAACCR</a></td><td style="text-align:center;">2011</td><td style="text-align:center;">12.2</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">4169 - 4171</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>Name Prefix (CoC)<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>namePrefix</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Patient</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Abbreviated title that precedes name in a letter (e.g., "Rev," "Ms"). </div><div class='content chap10-para'><i>Note</i>: This data item is no longer supported by CoC (as of January 1, 2003). </div><a name='2290'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>NAME--SPOUSE/PARENT</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">2290</td><td style="text-align:center;">60</td><td style="text-align:center;"><a href='#sources'>NAACCR</a></td><td style="text-align:center;">2011</td><td style="text-align:center;">12.2</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">4255 - 4314</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>nameSpouseParent</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>NAACCR has not adopted standards for this item. Use varies by area. </div><a name='2270'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>NAME--SUFFIX</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">2270</td><td style="text-align:center;">3</td><td style="text-align:center;"><a href='#sources'>NAACCR</a></td><td style="text-align:center;">2011</td><td style="text-align:center;">12.2</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">4172 - 4174</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>Name Suffix (CoC)<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>nameSuffix</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Patient</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Title that follows a patient's last name, such as a generation order or credential status (e.g., "MD," "Jr.").
 </div><div class='content chap10-para'><em>Note</em>: This data item is no longer supported by CoC (as of January 1, 2003). </div><a name='3896'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>NCCN INTERNATIONAL PROGNOSTIC INDEX (IPI)</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">3896</td><td style="text-align:center;">2</td><td style="text-align:center;"><a href='#sources'>NAACCR</a></td><td style="text-align:center;">2018</td><td style="text-align:center;">18</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1870 - 1871</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>nccnInternationalPrognosticIndex</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'><div> The NCCN International Prognostic Index (IPI) (previously only "IPI") is used to define risk groups for specific lymphomas using a 0-5 score range, based on age, stage, number of extranodal sites of involvement, patient's performance status and pretreatment LDH level.  </div></div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>NCCN International Prognostic Index (IPI) is a Registry Data Collection Variable in AJCC. It was previously collected for Lymphomas, SSF# 3.</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>00-08</td><td class='code-desc'>0-8 points</td></tr><tr class='code-row'><td class='code-nbr'>X1</td><td class='code-desc'>Stated as low risk (0-1 point)</td></tr><tr class='code-row'><td class='code-nbr'>X2</td><td class='code-desc'>Stated as low intermediate risk (2-3 points)</td></tr><tr class='code-row'><td class='code-nbr'>X3</td><td class='code-desc'>Stated as intermediate risk (4-5 points)</td></tr><tr class='code-row'><td class='code-nbr'>X4</td><td class='code-desc'>Stated as high risk (6-8 points)</td></tr><tr class='code-row'><td class='code-nbr'>X8</td><td class='code-desc'>Not applicable: Information not collected for this case<br/> 
(If this item is required by your standard setter, use of code X8 will result in an edit error.)
</td></tr><tr class='code-row'><td class='code-nbr'>X9</td><td class='code-desc'>Not documented in medical record<br/>
NCCN International Prognostic Index (IPI) not assessed or unknown if assessed
</td></tr><tr class='code-row'><td class='code-nbr'></td><td class='code-desc'> </td></tr></table></div><div class='content chap10-para'>Each Site-Specific Data Item (SSDI) applies only to selected primary sites, histologies, and years of diagnosis. Depending on applicability and standard-setter requirements, SSDIs may be left blank. </div><a name='3946'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>NCDB--COVID19--TX IMPACT</strong></td><td style="text-align:right;font-weight:bold;"><strong>New</strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">3946</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>CoC</a></td><td style="text-align:center;">2021</td><td style="text-align:center;">21</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1 - 1</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>ncdbCovid19TxImpact</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Was the first course of treatment (diagnosis, staging, treatment or other cancer management events) impacted by hospital availability (limited access to facilities or postponement of non-essential procedures) due to COVID-19 pandemic? (No; First Course Delayed; First Course Altered; First Course Cancelled). Collection based on diagnosis years 2020 and 2021.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>To evaluate the impact of COVID-19 pandemic on cancer patients.</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>1</td><td class='code-desc'>Treatment not affected; active surveillance, no change</td></tr><tr class='code-row'><td class='code-nbr'>2</td><td class='code-desc'>First Course of Treatment timeline delayed</td></tr><tr class='code-row'><td class='code-nbr'>3</td><td class='code-desc'>First Course of Treatment plan altered</td></tr><tr class='code-row'><td class='code-nbr'>4</td><td class='code-desc'>Cancelled First Course of Treatment</td></tr><tr class='code-row'><td class='code-nbr'>5</td><td class='code-desc'>Patient refused treatment due to COVID-19 </td></tr><tr class='code-row'><td class='code-nbr'>9</td><td class='code-desc'>Not known if treatment affected</td></tr><tr class='code-row'><td class='code-nbr'></td><td class='code-desc'> </td></tr></table></div><div class='content chap10-para'><em>Note</em>: This item may be left blank.</div><a name='3944'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>NCDB--SARSCOV2--POS</strong></td><td style="text-align:right;font-weight:bold;"><strong>New</strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">3944</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>CoC</a></td><td style="text-align:center;">2021</td><td style="text-align:center;">21</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1 - 1</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>ncdbSarsCov2Pos</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Patient</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'><!--[if gte mso 9]><xml>
 <o:OfficeDocumentSettings>
  <o:AllowPNG/>
 </o:OfficeDocumentSettings>
</xml><![endif]-->
<!--[if gte mso 9]><xml>
 <w:WordDocument>
  <w:View>Normal</w:View>
  <w:Zoom>0</w:Zoom>
  <w:TrackMoves/>
  <w:TrackFormatting/>
  <w:DoNotShowComments/>
  <w:DoNotShowPropertyChanges/>
  <w:PunctuationKerning/>
  <w:ValidateAgainstSchemas/>
  <w:SaveIfXMLInvalid>false</w:SaveIfXMLInvalid>
  <w:IgnoreMixedContent>false</w:IgnoreMixedContent>
  <w:AlwaysShowPlaceholderText>false</w:AlwaysShowPlaceholderText>
  <w:DoNotPromoteQF/>
  <w:LidThemeOther>EN-US</w:LidThemeOther>
  <w:LidThemeAsian>X-NONE</w:LidThemeAsian>
  <w:LidThemeComplexScript>X-NONE</w:LidThemeComplexScript>
  <w:Compatibility>
   <w:BreakWrappedTables/>
   <w:SnapToGridInCell/>
   <w:WrapTextWithPunct/>
   <w:UseAsianBreakRules/>
   <w:DontGrowAutofit/>
   <w:SplitPgBreakAndParaMark/>
   <w:EnableOpenTypeKerning/>
   <w:DontFlipMirrorIndents/>
   <w:OverrideTableStyleHps/>
  </w:Compatibility>
  <m:mathPr>
   <m:mathFont m:val="Cambria Math" />
   <m:brkBin m:val="before" />
   <m:brkBinSub m:val="&#45;-" />
   <m:smallFrac m:val="off" />
   <m:dispDef/>
   <m:lMargin m:val="0" />
   <m:rMargin m:val="0" />
   <m:defJc m:val="centerGroup" />
   <m:wrapIndent m:val="1440" />
   <m:intLim m:val="subSup" />
   <m:naryLim m:val="undOvr" />
  </m:mathPr></w:WordDocument>
</xml><![endif]-->
<!--[if gte mso 9]><xml>
 <w:LatentStyles deflockedstate="false" defunhidewhenused="false" defsemihidden="false" defqformat="false" defpriority="99" latentstylecount="371">
  <w:LsdException locked="false" priority="0" qformat="true" name="Normal" />
  <w:LsdException locked="false" priority="9" qformat="true" name="heading 1" />
  <w:LsdException locked="false" priority="9" semihidden="true" unhidewhenused="true" qformat="true" name="heading 2" />
  <w:LsdException locked="false" priority="9" semihidden="true" unhidewhenused="true" qformat="true" name="heading 3" />
  <w:LsdException locked="false" priority="9" semihidden="true" unhidewhenused="true" qformat="true" name="heading 4" />
  <w:LsdException locked="false" priority="9" semihidden="true" unhidewhenused="true" qformat="true" name="heading 5" />
  <w:LsdException locked="false" priority="9" semihidden="true" unhidewhenused="true" qformat="true" name="heading 6" />
  <w:LsdException locked="false" priority="9" semihidden="true" unhidewhenused="true" qformat="true" name="heading 7" />
  <w:LsdException locked="false" priority="9" semihidden="true" unhidewhenused="true" qformat="true" name="heading 8" />
  <w:LsdException locked="false" priority="9" semihidden="true" unhidewhenused="true" qformat="true" name="heading 9" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="index 1" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="index 2" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="index 3" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="index 4" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="index 5" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="index 6" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="index 7" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="index 8" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="index 9" />
  <w:LsdException locked="false" priority="39" semihidden="true" unhidewhenused="true" name="toc 1" />
  <w:LsdException locked="false" priority="39" semihidden="true" unhidewhenused="true" name="toc 2" />
  <w:LsdException locked="false" priority="39" semihidden="true" unhidewhenused="true" name="toc 3" />
  <w:LsdException locked="false" priority="39" semihidden="true" unhidewhenused="true" name="toc 4" />
  <w:LsdException locked="false" priority="39" semihidden="true" unhidewhenused="true" name="toc 5" />
  <w:LsdException locked="false" priority="39" semihidden="true" unhidewhenused="true" name="toc 6" />
  <w:LsdException locked="false" priority="39" semihidden="true" unhidewhenused="true" name="toc 7" />
  <w:LsdException locked="false" priority="39" semihidden="true" unhidewhenused="true" name="toc 8" />
  <w:LsdException locked="false" priority="39" semihidden="true" unhidewhenused="true" name="toc 9" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="Normal Indent" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="footnote text" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="annotation text" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="header" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="footer" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="index heading" />
  <w:LsdException locked="false" priority="35" semihidden="true" unhidewhenused="true" qformat="true" name="caption" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="table of figures" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="envelope address" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="envelope return" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="footnote reference" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="annotation reference" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="line number" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="page number" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="endnote reference" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="endnote text" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="table of authorities" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="macro" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="toa heading" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="List" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="List Bullet" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="List Number" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="List 2" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="List 3" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="List 4" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="List 5" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="List Bullet 2" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="List Bullet 3" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="List Bullet 4" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="List Bullet 5" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="List Number 2" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="List Number 3" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="List Number 4" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="List Number 5" />
  <w:LsdException locked="false" priority="10" qformat="true" name="Title" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="Closing" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="Signature" />
  <w:LsdException locked="false" priority="1" semihidden="true" unhidewhenused="true" name="Default Paragraph Font" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="Body Text" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="Body Text Indent" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="List Continue" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="List Continue 2" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="List Continue 3" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="List Continue 4" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="List Continue 5" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="Message Header" />
  <w:LsdException locked="false" priority="11" qformat="true" name="Subtitle" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="Salutation" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="Date" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="Body Text First Indent" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="Body Text First Indent 2" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="Note Heading" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="Body Text 2" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="Body Text 3" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="Body Text Indent 2" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="Body Text Indent 3" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="Block Text" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="Hyperlink" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="FollowedHyperlink" />
  <w:LsdException locked="false" priority="22" qformat="true" name="Strong" />
  <w:LsdException locked="false" priority="20" qformat="true" name="Emphasis" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="Document Map" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="Plain Text" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="E-mail Signature" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="HTML Top of Form" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="HTML Bottom of Form" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="Normal (Web)" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="HTML Acronym" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="HTML Address" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="HTML Cite" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="HTML Code" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="HTML Definition" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="HTML Keyboard" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="HTML Preformatted" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="HTML Sample" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="HTML Typewriter" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="HTML Variable" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="Normal Table" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="annotation subject" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="No List" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="Outline List 1" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="Outline List 2" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="Outline List 3" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="Table Simple 1" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="Table Simple 2" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="Table Simple 3" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="Table Classic 1" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="Table Classic 2" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="Table Classic 3" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="Table Classic 4" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="Table Colorful 1" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="Table Colorful 2" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="Table Colorful 3" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="Table Columns 1" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="Table Columns 2" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="Table Columns 3" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="Table Columns 4" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="Table Columns 5" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="Table Grid 1" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="Table Grid 2" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="Table Grid 3" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="Table Grid 4" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="Table Grid 5" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="Table Grid 6" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="Table Grid 7" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="Table Grid 8" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="Table List 1" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="Table List 2" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="Table List 3" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="Table List 4" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="Table List 5" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="Table List 6" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="Table List 7" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="Table List 8" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="Table 3D effects 1" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="Table 3D effects 2" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="Table 3D effects 3" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="Table Contemporary" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="Table Elegant" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="Table Professional" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="Table Subtle 1" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="Table Subtle 2" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="Table Web 1" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="Table Web 2" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="Table Web 3" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="Balloon Text" />
  <w:LsdException locked="false" priority="39" name="Table Grid" />
  <w:LsdException locked="false" semihidden="true" unhidewhenused="true" name="Table Theme" />
  <w:LsdException locked="false" semihidden="true" name="Placeholder Text" />
  <w:LsdException locked="false" priority="1" qformat="true" name="No Spacing" />
  <w:LsdException locked="false" priority="60" name="Light Shading" />
  <w:LsdException locked="false" priority="61" name="Light List" />
  <w:LsdException locked="false" priority="62" name="Light Grid" />
  <w:LsdException locked="false" priority="63" name="Medium Shading 1" />
  <w:LsdException locked="false" priority="64" name="Medium Shading 2" />
  <w:LsdException locked="false" priority="65" name="Medium List 1" />
  <w:LsdException locked="false" priority="66" name="Medium List 2" />
  <w:LsdException locked="false" priority="67" name="Medium Grid 1" />
  <w:LsdException locked="false" priority="68" name="Medium Grid 2" />
  <w:LsdException locked="false" priority="69" name="Medium Grid 3" />
  <w:LsdException locked="false" priority="70" name="Dark List" />
  <w:LsdException locked="false" priority="71" name="Colorful Shading" />
  <w:LsdException locked="false" priority="72" name="Colorful List" />
  <w:LsdException locked="false" priority="73" name="Colorful Grid" />
  <w:LsdException locked="false" priority="60" name="Light Shading Accent 1" />
  <w:LsdException locked="false" priority="61" name="Light List Accent 1" />
  <w:LsdException locked="false" priority="62" name="Light Grid Accent 1" />
  <w:LsdException locked="false" priority="63" name="Medium Shading 1 Accent 1" />
  <w:LsdException locked="false" priority="64" name="Medium Shading 2 Accent 1" />
  <w:LsdException locked="false" priority="65" name="Medium List 1 Accent 1" />
  <w:LsdException locked="false" semihidden="true" name="Revision" />
  <w:LsdException locked="false" priority="34" qformat="true" name="List Paragraph" />
  <w:LsdException locked="false" priority="29" qformat="true" name="Quote" />
  <w:LsdException locked="false" priority="30" qformat="true" name="Intense Quote" />
  <w:LsdException locked="false" priority="66" name="Medium List 2 Accent 1" />
  <w:LsdException locked="false" priority="67" name="Medium Grid 1 Accent 1" />
  <w:LsdException locked="false" priority="68" name="Medium Grid 2 Accent 1" />
  <w:LsdException locked="false" priority="69" name="Medium Grid 3 Accent 1" />
  <w:LsdException locked="false" priority="70" name="Dark List Accent 1" />
  <w:LsdException locked="false" priority="71" name="Colorful Shading Accent 1" />
  <w:LsdException locked="false" priority="72" name="Colorful List Accent 1" />
  <w:LsdException locked="false" priority="73" name="Colorful Grid Accent 1" />
  <w:LsdException locked="false" priority="60" name="Light Shading Accent 2" />
  <w:LsdException locked="false" priority="61" name="Light List Accent 2" />
  <w:LsdException locked="false" priority="62" name="Light Grid Accent 2" />
  <w:LsdException locked="false" priority="63" name="Medium Shading 1 Accent 2" />
  <w:LsdException locked="false" priority="64" name="Medium Shading 2 Accent 2" />
  <w:LsdException locked="false" priority="65" name="Medium List 1 Accent 2" />
  <w:LsdException locked="false" priority="66" name="Medium List 2 Accent 2" />
  <w:LsdException locked="false" priority="67" name="Medium Grid 1 Accent 2" />
  <w:LsdException locked="false" priority="68" name="Medium Grid 2 Accent 2" />
  <w:LsdException locked="false" priority="69" name="Medium Grid 3 Accent 2" />
  <w:LsdException locked="false" priority="70" name="Dark List Accent 2" />
  <w:LsdException locked="false" priority="71" name="Colorful Shading Accent 2" />
  <w:LsdException locked="false" priority="72" name="Colorful List Accent 2" />
  <w:LsdException locked="false" priority="73" name="Colorful Grid Accent 2" />
  <w:LsdException locked="false" priority="60" name="Light Shading Accent 3" />
  <w:LsdException locked="false" priority="61" name="Light List Accent 3" />
  <w:LsdException locked="false" priority="62" name="Light Grid Accent 3" />
  <w:LsdException locked="false" priority="63" name="Medium Shading 1 Accent 3" />
  <w:LsdException locked="false" priority="64" name="Medium Shading 2 Accent 3" />
  <w:LsdException locked="false" priority="65" name="Medium List 1 Accent 3" />
  <w:LsdException locked="false" priority="66" name="Medium List 2 Accent 3" />
  <w:LsdException locked="false" priority="67" name="Medium Grid 1 Accent 3" />
  <w:LsdException locked="false" priority="68" name="Medium Grid 2 Accent 3" />
  <w:LsdException locked="false" priority="69" name="Medium Grid 3 Accent 3" />
  <w:LsdException locked="false" priority="70" name="Dark List Accent 3" />
  <w:LsdException locked="false" priority="71" name="Colorful Shading Accent 3" />
  <w:LsdException locked="false" priority="72" name="Colorful List Accent 3" />
  <w:LsdException locked="false" priority="73" name="Colorful Grid Accent 3" />
  <w:LsdException locked="false" priority="60" name="Light Shading Accent 4" />
  <w:LsdException locked="false" priority="61" name="Light List Accent 4" />
  <w:LsdException locked="false" priority="62" name="Light Grid Accent 4" />
  <w:LsdException locked="false" priority="63" name="Medium Shading 1 Accent 4" />
  <w:LsdException locked="false" priority="64" name="Medium Shading 2 Accent 4" />
  <w:LsdException locked="false" priority="65" name="Medium List 1 Accent 4" />
  <w:LsdException locked="false" priority="66" name="Medium List 2 Accent 4" />
  <w:LsdException locked="false" priority="67" name="Medium Grid 1 Accent 4" />
  <w:LsdException locked="false" priority="68" name="Medium Grid 2 Accent 4" />
  <w:LsdException locked="false" priority="69" name="Medium Grid 3 Accent 4" />
  <w:LsdException locked="false" priority="70" name="Dark List Accent 4" />
  <w:LsdException locked="false" priority="71" name="Colorful Shading Accent 4" />
  <w:LsdException locked="false" priority="72" name="Colorful List Accent 4" />
  <w:LsdException locked="false" priority="73" name="Colorful Grid Accent 4" />
  <w:LsdException locked="false" priority="60" name="Light Shading Accent 5" />
  <w:LsdException locked="false" priority="61" name="Light List Accent 5" />
  <w:LsdException locked="false" priority="62" name="Light Grid Accent 5" />
  <w:LsdException locked="false" priority="63" name="Medium Shading 1 Accent 5" />
  <w:LsdException locked="false" priority="64" name="Medium Shading 2 Accent 5" />
  <w:LsdException locked="false" priority="65" name="Medium List 1 Accent 5" />
  <w:LsdException locked="false" priority="66" name="Medium List 2 Accent 5" />
  <w:LsdException locked="false" priority="67" name="Medium Grid 1 Accent 5" />
  <w:LsdException locked="false" priority="68" name="Medium Grid 2 Accent 5" />
  <w:LsdException locked="false" priority="69" name="Medium Grid 3 Accent 5" />
  <w:LsdException locked="false" priority="70" name="Dark List Accent 5" />
  <w:LsdException locked="false" priority="71" name="Colorful Shading Accent 5" />
  <w:LsdException locked="false" priority="72" name="Colorful List Accent 5" />
  <w:LsdException locked="false" priority="73" name="Colorful Grid Accent 5" />
  <w:LsdException locked="false" priority="60" name="Light Shading Accent 6" />
  <w:LsdException locked="false" priority="61" name="Light List Accent 6" />
  <w:LsdException locked="false" priority="62" name="Light Grid Accent 6" />
  <w:LsdException locked="false" priority="63" name="Medium Shading 1 Accent 6" />
  <w:LsdException locked="false" priority="64" name="Medium Shading 2 Accent 6" />
  <w:LsdException locked="false" priority="65" name="Medium List 1 Accent 6" />
  <w:LsdException locked="false" priority="66" name="Medium List 2 Accent 6" />
  <w:LsdException locked="false" priority="67" name="Medium Grid 1 Accent 6" />
  <w:LsdException locked="false" priority="68" name="Medium Grid 2 Accent 6" />
  <w:LsdException locked="false" priority="69" name="Medium Grid 3 Accent 6" />
  <w:LsdException locked="false" priority="70" name="Dark List Accent 6" />
  <w:LsdException locked="false" priority="71" name="Colorful Shading Accent 6" />
  <w:LsdException locked="false" priority="72" name="Colorful List Accent 6" />
  <w:LsdException locked="false" priority="73" name="Colorful Grid Accent 6" />
  <w:LsdException locked="false" priority="19" qformat="true" name="Subtle Emphasis" />
  <w:LsdException locked="false" priority="21" qformat="true" name="Intense Emphasis" />
  <w:LsdException locked="false" priority="31" qformat="true" name="Subtle Reference" />
  <w:LsdException locked="false" priority="32" qformat="true" name="Intense Reference" />
  <w:LsdException locked="false" priority="33" qformat="true" name="Book Title" />
  <w:LsdException locked="false" priority="37" semihidden="true" unhidewhenused="true" name="Bibliography" />
  <w:LsdException locked="false" priority="39" semihidden="true" unhidewhenused="true" qformat="true" name="TOC Heading" />
  <w:LsdException locked="false" priority="41" name="Plain Table 1" />
  <w:LsdException locked="false" priority="42" name="Plain Table 2" />
  <w:LsdException locked="false" priority="43" name="Plain Table 3" />
  <w:LsdException locked="false" priority="44" name="Plain Table 4" />
  <w:LsdException locked="false" priority="45" name="Plain Table 5" />
  <w:LsdException locked="false" priority="40" name="Grid Table Light" />
  <w:LsdException locked="false" priority="46" name="Grid Table 1 Light" />
  <w:LsdException locked="false" priority="47" name="Grid Table 2" />
  <w:LsdException locked="false" priority="48" name="Grid Table 3" />
  <w:LsdException locked="false" priority="49" name="Grid Table 4" />
  <w:LsdException locked="false" priority="50" name="Grid Table 5 Dark" />
  <w:LsdException locked="false" priority="51" name="Grid Table 6 Colorful" />
  <w:LsdException locked="false" priority="52" name="Grid Table 7 Colorful" />
  <w:LsdException locked="false" priority="46" name="Grid Table 1 Light Accent 1" />
  <w:LsdException locked="false" priority="47" name="Grid Table 2 Accent 1" />
  <w:LsdException locked="false" priority="48" name="Grid Table 3 Accent 1" />
  <w:LsdException locked="false" priority="49" name="Grid Table 4 Accent 1" />
  <w:LsdException locked="false" priority="50" name="Grid Table 5 Dark Accent 1" />
  <w:LsdException locked="false" priority="51" name="Grid Table 6 Colorful Accent 1" />
  <w:LsdException locked="false" priority="52" name="Grid Table 7 Colorful Accent 1" />
  <w:LsdException locked="false" priority="46" name="Grid Table 1 Light Accent 2" />
  <w:LsdException locked="false" priority="47" name="Grid Table 2 Accent 2" />
  <w:LsdException locked="false" priority="48" name="Grid Table 3 Accent 2" />
  <w:LsdException locked="false" priority="49" name="Grid Table 4 Accent 2" />
  <w:LsdException locked="false" priority="50" name="Grid Table 5 Dark Accent 2" />
  <w:LsdException locked="false" priority="51" name="Grid Table 6 Colorful Accent 2" />
  <w:LsdException locked="false" priority="52" name="Grid Table 7 Colorful Accent 2" />
  <w:LsdException locked="false" priority="46" name="Grid Table 1 Light Accent 3" />
  <w:LsdException locked="false" priority="47" name="Grid Table 2 Accent 3" />
  <w:LsdException locked="false" priority="48" name="Grid Table 3 Accent 3" />
  <w:LsdException locked="false" priority="49" name="Grid Table 4 Accent 3" />
  <w:LsdException locked="false" priority="50" name="Grid Table 5 Dark Accent 3" />
  <w:LsdException locked="false" priority="51" name="Grid Table 6 Colorful Accent 3" />
  <w:LsdException locked="false" priority="52" name="Grid Table 7 Colorful Accent 3" />
  <w:LsdException locked="false" priority="46" name="Grid Table 1 Light Accent 4" />
  <w:LsdException locked="false" priority="47" name="Grid Table 2 Accent 4" />
  <w:LsdException locked="false" priority="48" name="Grid Table 3 Accent 4" />
  <w:LsdException locked="false" priority="49" name="Grid Table 4 Accent 4" />
  <w:LsdException locked="false" priority="50" name="Grid Table 5 Dark Accent 4" />
  <w:LsdException locked="false" priority="51" name="Grid Table 6 Colorful Accent 4" />
  <w:LsdException locked="false" priority="52" name="Grid Table 7 Colorful Accent 4" />
  <w:LsdException locked="false" priority="46" name="Grid Table 1 Light Accent 5" />
  <w:LsdException locked="false" priority="47" name="Grid Table 2 Accent 5" />
  <w:LsdException locked="false" priority="48" name="Grid Table 3 Accent 5" />
  <w:LsdException locked="false" priority="49" name="Grid Table 4 Accent 5" />
  <w:LsdException locked="false" priority="50" name="Grid Table 5 Dark Accent 5" />
  <w:LsdException locked="false" priority="51" name="Grid Table 6 Colorful Accent 5" />
  <w:LsdException locked="false" priority="52" name="Grid Table 7 Colorful Accent 5" />
  <w:LsdException locked="false" priority="46" name="Grid Table 1 Light Accent 6" />
  <w:LsdException locked="false" priority="47" name="Grid Table 2 Accent 6" />
  <w:LsdException locked="false" priority="48" name="Grid Table 3 Accent 6" />
  <w:LsdException locked="false" priority="49" name="Grid Table 4 Accent 6" />
  <w:LsdException locked="false" priority="50" name="Grid Table 5 Dark Accent 6" />
  <w:LsdException locked="false" priority="51" name="Grid Table 6 Colorful Accent 6" />
  <w:LsdException locked="false" priority="52" name="Grid Table 7 Colorful Accent 6" />
  <w:LsdException locked="false" priority="46" name="List Table 1 Light" />
  <w:LsdException locked="false" priority="47" name="List Table 2" />
  <w:LsdException locked="false" priority="48" name="List Table 3" />
  <w:LsdException locked="false" priority="49" name="List Table 4" />
  <w:LsdException locked="false" priority="50" name="List Table 5 Dark" />
  <w:LsdException locked="false" priority="51" name="List Table 6 Colorful" />
  <w:LsdException locked="false" priority="52" name="List Table 7 Colorful" />
  <w:LsdException locked="false" priority="46" name="List Table 1 Light Accent 1" />
  <w:LsdException locked="false" priority="47" name="List Table 2 Accent 1" />
  <w:LsdException locked="false" priority="48" name="List Table 3 Accent 1" />
  <w:LsdException locked="false" priority="49" name="List Table 4 Accent 1" />
  <w:LsdException locked="false" priority="50" name="List Table 5 Dark Accent 1" />
  <w:LsdException locked="false" priority="51" name="List Table 6 Colorful Accent 1" />
  <w:LsdException locked="false" priority="52" name="List Table 7 Colorful Accent 1" />
  <w:LsdException locked="false" priority="46" name="List Table 1 Light Accent 2" />
  <w:LsdException locked="false" priority="47" name="List Table 2 Accent 2" />
  <w:LsdException locked="false" priority="48" name="List Table 3 Accent 2" />
  <w:LsdException locked="false" priority="49" name="List Table 4 Accent 2" />
  <w:LsdException locked="false" priority="50" name="List Table 5 Dark Accent 2" />
  <w:LsdException locked="false" priority="51" name="List Table 6 Colorful Accent 2" />
  <w:LsdException locked="false" priority="52" name="List Table 7 Colorful Accent 2" />
  <w:LsdException locked="false" priority="46" name="List Table 1 Light Accent 3" />
  <w:LsdException locked="false" priority="47" name="List Table 2 Accent 3" />
  <w:LsdException locked="false" priority="48" name="List Table 3 Accent 3" />
  <w:LsdException locked="false" priority="49" name="List Table 4 Accent 3" />
  <w:LsdException locked="false" priority="50" name="List Table 5 Dark Accent 3" />
  <w:LsdException locked="false" priority="51" name="List Table 6 Colorful Accent 3" />
  <w:LsdException locked="false" priority="52" name="List Table 7 Colorful Accent 3" />
  <w:LsdException locked="false" priority="46" name="List Table 1 Light Accent 4" />
  <w:LsdException locked="false" priority="47" name="List Table 2 Accent 4" />
  <w:LsdException locked="false" priority="48" name="List Table 3 Accent 4" />
  <w:LsdException locked="false" priority="49" name="List Table 4 Accent 4" />
  <w:LsdException locked="false" priority="50" name="List Table 5 Dark Accent 4" />
  <w:LsdException locked="false" priority="51" name="List Table 6 Colorful Accent 4" />
  <w:LsdException locked="false" priority="52" name="List Table 7 Colorful Accent 4" />
  <w:LsdException locked="false" priority="46" name="List Table 1 Light Accent 5" />
  <w:LsdException locked="false" priority="47" name="List Table 2 Accent 5" />
  <w:LsdException locked="false" priority="48" name="List Table 3 Accent 5" />
  <w:LsdException locked="false" priority="49" name="List Table 4 Accent 5" />
  <w:LsdException locked="false" priority="50" name="List Table 5 Dark Accent 5" />
  <w:LsdException locked="false" priority="51" name="List Table 6 Colorful Accent 5" />
  <w:LsdException locked="false" priority="52" name="List Table 7 Colorful Accent 5" />
  <w:LsdException locked="false" priority="46" name="List Table 1 Light Accent 6" />
  <w:LsdException locked="false" priority="47" name="List Table 2 Accent 6" />
  <w:LsdException locked="false" priority="48" name="List Table 3 Accent 6" />
  <w:LsdException locked="false" priority="49" name="List Table 4 Accent 6" />
  <w:LsdException locked="false" priority="50" name="List Table 5 Dark Accent 6" />
  <w:LsdException locked="false" priority="51" name="List Table 6 Colorful Accent 6" />
  <w:LsdException locked="false" priority="52" name="List Table 7 Colorful Accent 6" />
 </w:LatentStyles>
</xml><![endif]-->
<!--[if gte mso 10]>

 /* Style Definitions */
 table.MsoNormalTable
	{mso-style-name:"Table Normal";
	mso-tstyle-rowband-size:0;
	mso-tstyle-colband-size:0;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-parent:"";
	mso-padding-alt:0in 5.4pt 0in 5.4pt;
	mso-para-margin-top:0in;
	mso-para-margin-right:0in;
	mso-para-margin-bottom:10.0pt;
	mso-para-margin-left:0in;
	line-height:115%;
	mso-pagination:widow-orphan;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:minor-latin;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:minor-bidi;}

<![endif]-->
Data item is designed to track whether patient received a
POSITIVE SARS-CoV-2 test or not. Collection based on diagnosis years 2020 and 2021.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>To evaluate the impact of COVID-19 diagnosis on cancer patients.</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>0</td><td class='code-desc'>Patient did not test positive for active SARS-CoV-2: No positive test </td></tr><tr class='code-row'><td class='code-nbr'>1</td><td class='code-desc'>Patient tested positive for active SARS-CoV-2: test positive on at least one test </td></tr><tr class='code-row'><td class='code-nbr'>9</td><td class='code-desc'>Unknown if tested; test done, results unknown </td></tr><tr class='code-row'><td class='code-nbr'></td><td class='code-desc'> </td></tr></table></div><div class='content chap10-para'><em>Note</em>: This item may be left blank.</div><a name='3945'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>NCDB--SARSCOV2--POS DATE</strong></td><td style="text-align:right;font-weight:bold;"><strong>New</strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">3945</td><td style="text-align:center;">8</td><td style="text-align:center;"><a href='#sources'>CoC</a></td><td style="text-align:center;">2021</td><td style="text-align:center;">21</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1 - 8</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>ncdbSarsCov2PosDate</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Patient</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>What was the date of the first positive test? Collection based on diagnosis years 2020 and 2021.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>To evaluate the impact of COVID-19 diagnosis on cancer patients.</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>YYYYMMDD</td><td class='code-desc'>Date the patient had a positive test for SARS-CoV-2, the virus that causes the 2019 novel coronavirus disease (COVID-19), as documented by a medical provider </td></tr><tr class='code-row'><td class='code-nbr'>Blank</td><td class='code-desc'>Date of the test is unknown or the date of a positive (diagnostic or serologic) test is unknown for SARS-CoV-2</td></tr><tr class='code-row'><td class='code-nbr' colspan='2'></td></tr></table></div><a name='3943'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>NCDB--SARSCOV2--TEST</strong></td><td style="text-align:right;font-weight:bold;"><strong>New</strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">3943</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>CoC</a></td><td style="text-align:center;">2021</td><td style="text-align:center;">21</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1 - 1</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>ncdbSarsCov2Test</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Patient</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Data item is designed to track whether patient received a SARS-CoV-2 test or not. Collection based on diagnosis years 2020 and 2021.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>To evaluate the impact of COVID-19 diagnosis on cancer patients.</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>0</td><td class='code-desc'>Patient not tested for SARS-CoV-2: facility records support that patient did not undergo pre-admit or in-hospital testing</td></tr><tr class='code-row'><td class='code-nbr'>1</td><td class='code-desc'>Patient tested for Active SARS-CoV2</td></tr><tr class='code-row'><td class='code-nbr'>9</td><td class='code-desc'>Unknown if patient tested for SARS-CoV-2/No facility record of preadmit hospital testing of SARS-CoV-2  </td></tr><tr class='code-row'><td class='code-nbr'></td><td class='code-desc'> </td></tr></table></div><div class='content chap10-para'><em>Note</em>: This item may be left blank.</div><a name='1632'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>NEOADJUVANT THERAPY</strong></td><td style="text-align:right;font-weight:bold;"><strong>New</strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">1632</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>SEER</a></td><td style="text-align:center;">2021</td><td style="text-align:center;">21</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1 - 1</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>neoadjuvantTherapy</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>This data item records whether the patient had neoadjuvant therapy prior to planned definitive surgical resection of the primary site.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>This data items provides information related to the quality of care and describes whether a patient had neoadjuvant therapy. <br /><br />For the purposes of this data item, neoadjuvant therapy is defined as systemic treatment (chemotherapy, endocrine / hormone therapy, targeted therapy, immunotherapy, or biological therapy) and/or radiation therapy before intended or performed surgical resection to improve local therapy and long term outcomes.</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>0</td><td class='code-desc'>No neoadjuvant therapy, no treatment before surgery, surgical resection not part of first course of treatment plan<br/>
Autopsy only
 </td></tr><tr class='code-row'><td class='code-nbr'>1</td><td class='code-desc'>Neoadjuvant therapy completed according to treatment plan and guidelines</td></tr><tr class='code-row'><td class='code-nbr'>2</td><td class='code-desc'>Neoadjuvant therapy started, but not completed OR unknown if completed</td></tr><tr class='code-row'><td class='code-nbr'>3</td><td class='code-desc'>Limited systemic exposure when the intent was not neoadjuvant; treatment did not meet the definition of neoadjuvant therapy</td></tr><tr class='code-row'><td class='code-nbr'>9</td><td class='code-desc'>Unknown if neoadjuvant therapy performed<br/>
Death Certificate only (DCO)
</td></tr><tr class='code-row'><td class='code-nbr'></td><td class='code-desc'> </td></tr></table></div><a name='1633'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>NEOADJUVANT THERAPY-CLINICAL RESPONSE</strong></td><td style="text-align:right;font-weight:bold;"><strong>New</strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">1633</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>SEER</a></td><td style="text-align:center;">2021</td><td style="text-align:center;">21</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1 - 1</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>neoadjuvTherapyClinicalResponse</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>This data item records the clinical outcomes of neoadjuvant therapy prior to planned surgical resection.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>This data items provides information related to the quality of care and describes the clinical outcomes after neoadjuvant therapy. This data item provides prognostically relevant information by quantifying the extent of therapy-induced tumor regression. Therefore, this item can provide a better risk stratification for patients who received neoadjuvant therapy. In addition, this data item can contribute to assessments of cancer care quality.<br /><br />This data item records the clinical outcomes of neoadjuvant therapy as determined by the managing physician (oncologic surgeon, radiation oncologist or medical oncologist).<br /><br />For the purposes of this data item, neoadjuvant therapy is defined as systemic treatment (chemotherapy, endocrine / hormone therapy, targeted therapy, immunotherapy, or biological therapy) and/or radiation therapy given to shrink a tumor before surgical resection.</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>0</td><td class='code-desc'>Neoadjuvant therapy not given </td></tr><tr class='code-row'><td class='code-nbr'>1</td><td class='code-desc'>Complete clinical response (CR)(per managing/treating physician statement)</td></tr><tr class='code-row'><td class='code-nbr'>2</td><td class='code-desc'>Partial clinical response (PR) (per managing/treating physician statement)</td></tr><tr class='code-row'><td class='code-nbr'>3</td><td class='code-desc'>Progressive disease (PD)(per managing/treating physician statement)</td></tr><tr class='code-row'><td class='code-nbr'>4</td><td class='code-desc'>Stable disease (SD)(per managing/treating physician statement)</td></tr><tr class='code-row'><td class='code-nbr'>5</td><td class='code-desc'>No response (NR) (per managing/treating physician statement<br/>
Not stated as progressive disease (PD) or stable disease (SD)
</td></tr><tr class='code-row'><td class='code-nbr'>6</td><td class='code-desc'>Neoadjuvant therapy done, managing/treating physician interpretation not available, treatment response inferred from imaging, biomarkers, or yc stage</td></tr><tr class='code-row'><td class='code-nbr'>7</td><td class='code-desc'>Complete clinical response based on pathology report (per pathologist assessment)</td></tr><tr class='code-row'><td class='code-nbr'>8</td><td class='code-desc'>Neoadjuvant therapy done, response not documented or unknown</td></tr><tr class='code-row'><td class='code-nbr'>9</td><td class='code-desc'>Unknown if neoadjuvant therapy performed<br/> 
Death Certificate only (DCO)
</td></tr><tr class='code-row'><td class='code-nbr' colspan='2'></td></tr></table></div><a name='1634'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>NEOADJUVANT THERAPY-TREATMENT EFFECT</strong></td><td style="text-align:right;font-weight:bold;"><strong>New</strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">1634</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>SEER</a></td><td style="text-align:center;">2021</td><td style="text-align:center;">21</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1 - 1</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>neoadjuvTherapyTreatmentEffect</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>This data item records the pathologist&#8217;s statement of neoadjuvant treatment effect on the primary tumor from the surgical pathology report. Whenever treatment effect definitions are recommended by or available in CAP Cancer Protocols, this data item follows the CAP definitions indicating absent or present effect. When specific CAP definitions are not available, registrars should use treatment effect general use categories.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>This data item provides information related to the quality of care and describes the pathological outcomes after neoadjuvant therapy. This data item provides prognostically relevant information by quantifying the extent of therapy-induced tumor regression. Therefore, this item can provide a better risk stratification for patients who received neoadjuvant therapy. In addition, this data item can contribute to assessments of cancer care quality.</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>0</td><td class='code-desc'>Neoadjuvant therapy not given/no known presurgical therapy </td></tr><tr class='code-row'><td class='code-nbr'>1-4</td><td class='code-desc'>Site-specific code; type of response</td></tr><tr class='code-row'><td class='code-nbr'>6</td><td class='code-desc'>Neoadjuvant therapy completed and surgical resection performed, response not documented or unknown<br/> 
Cannot be determined
</td></tr><tr class='code-row'><td class='code-nbr'>7</td><td class='code-desc'>Neoadjuvant therapy completed and planned surgical resection not performed</td></tr><tr class='code-row'><td class='code-nbr'>9</td><td class='code-desc'>Unknown if neoadjuvant therapy performed<br/>
Unknown if planned surgical procedure performed after completion of neoadjuvant therapy<br/>
Death Certificate only (DCO)
</td></tr><tr class='code-row'><td class='code-nbr'></td><td class='code-desc'> </td></tr></table></div><a name='1800'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>NEXT FOLLOW-UP SOURCE</strong></td><td style="text-align:right;font-weight:bold;"><strong>Revised</strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">1800</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>CoC</a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">2802 - 2802</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>Next Follow-Up Method (pre-96 CoC)<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>nextFollowUpSource</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para mark-changed'>Identifies the method planned for the next follow-up.</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>0</td><td class='code-desc'>Chart requisition</td></tr><tr class='code-row'><td class='code-nbr'>1</td><td class='code-desc'>Physician letter</td></tr><tr class='code-row'><td class='code-nbr'>2</td><td class='code-desc'>Contact letter</td></tr><tr class='code-row'><td class='code-nbr'>3</td><td class='code-desc'>Phone call</td></tr><tr class='code-row'><td class='code-nbr'>4</td><td class='code-desc'>Other hospital contact</td></tr><tr class='code-row'><td class='code-nbr'>5</td><td class='code-desc'>Other, NOS</td></tr><tr class='code-row'><td class='code-nbr'>8</td><td class='code-desc'>Foreign residents (not followed)</td></tr><tr class='code-row'><td class='code-nbr'>9</td><td class='code-desc'>Not followed, other cases for which follow-up is not required</td></tr></table></div><a name='191'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>NHIA DERIVED HISP ORIGIN</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">191</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>NAACCR</a></td><td style="text-align:center;">2005</td><td style="text-align:center;">10.2</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">448 - 448</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>nhiaDerivedHispOrigin</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Patient</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>The NAACCR Hispanic Identification Algorithm (NHIA) uses a combination of standard variables to directly or indirectly classify cases as Hispanic for analytic purposes. It is possible to separate Hispanic ancestral subgroups (e.g., Mexican) when indirect assignment results from birthplace information but not from surname match. The algorithm uses the following standard variables: Spanish/Hispanic Origin [190], Name--Last [2230], Name--Maiden [2390], Birthplace [250], Race 1 [160], IHS Link [192], and Sex [220].<br /><br />Code 7 (Spanish surname only) of the Spanish/Hispanic Origin [190] data item became effective with 1994 diagnoses. It is recommended that NHIA should be run on 1995 and later diagnoses. However, a central registry may run it on their data for prior years. For greater detail, please refer to the technical documentation: <a href="http://www.naaccr.org/LinkClick.aspx?fileticket=6E20OT41TcA%3d&amp;tabid=118&amp;mid=458">http://www.naaccr.org/LinkClick.aspx?fileticket=6E20OT41TcA%3d&amp;tabid=118&amp;mid=458</a>.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Sometimes despite best efforts to obtain complete information directly from the medical record, information is not available and is reported to the cancer registry as a missing data item. With regard to Hispanic ethnicity, some cancer registries have found it necessary to rely on indirect methods to populate this data element. Registries often have significant numbers or proportions of Hispanic populations in their jurisdiction.</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>0</td><td class='code-desc'>Non-Hispanic</td></tr><tr class='code-row'><td class='code-nbr'>1</td><td class='code-desc'>Mexican, by birthplace or other specific identifier</td></tr><tr class='code-row'><td class='code-nbr'>2</td><td class='code-desc'>Puerto Rican, by birthplace or other specific identifier</td></tr><tr class='code-row'><td class='code-nbr'>3</td><td class='code-desc'>Cuban, by birthplace or other specific identifier</td></tr><tr class='code-row'><td class='code-nbr'>4</td><td class='code-desc'>South or Central American (except Brazil), by birthplace or other specific identifier</td></tr><tr class='code-row'><td class='code-nbr'>5</td><td class='code-desc'>Other specified Spanish/Hispanic origin (includes European; excludes Dominican Republic), by birthplace or other specific identifier</td></tr><tr class='code-row'><td class='code-nbr'>6</td><td class='code-desc'>Spanish, NOS; Hispanic, NOS; Latino, NOS</td></tr><tr class='code-row'><td class='code-nbr'>7</td><td class='code-desc'>NHIA surname match only</td></tr><tr class='code-row'><td class='code-nbr'>8</td><td class='code-desc'>Dominican Republic</td></tr><tr class='code-row'><td class='code-nbr'>Blank</td><td class='code-desc'>Algorithm has not been run</td></tr></table></div><div class='content chap10-para'><em>Note:</em> Code 8 was added in Standards Volume II Version 10.2 effective January 2005.</div><a name='3645'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>NPCR DERIVED AJCC 8 TNM CLIN STG GRP</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">3645</td><td style="text-align:center;">15</td><td style="text-align:center;"><a href='#sources'>NPCR</a></td><td style="text-align:center;">2018</td><td style="text-align:center;">18</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1457 - 1471</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>npcrDerivedAjcc8TnmClinStgGrp</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>This item stores the results of NPCR's derived algorithmic calculation of clinical stage group based on AJCC T, N, and M and relevant biomarkers and prognostic factors. The algorithm derives AJCC 8th ed. stage group for 2018, however, updates to future AJCC editions are anticipated. The derived values for 7th ed. were stored in NPCR Derived Clin Stg Grp [3650].</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>The purpose of the derived stage fields is to segregate data values for AJCC stage groups derived from the NPCR algorithm from values directly entered from the medical record or by the registrar. NPCR's primary interest is in the directly-entered values, but derived values will have a purpose primarily at the central registry. It is important to not mix data values from the two sources in the same data items. This item was added in 2018 because the required length to hold AJCC stage group values increased from 4 columns to 15.</div><div class='content chap10-para'><strong>Codes (in addition to those published in the <em>AJCC Cancer Staging Manual</em>)</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>88</td><td class='code-desc'>Not applicable</td></tr><tr class='code-row'><td class='code-nbr'>99</td><td class='code-desc'>Unknown</td></tr><tr class='code-row'><td class='code-nbr'>Blank</td><td class='code-desc'>Not staged</td></tr><tr class='code-row'><td class='code-nbr' colspan='2'></td></tr></table></div><a name='3646'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>NPCR DERIVED AJCC 8 TNM PATH STG GRP</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">3646</td><td style="text-align:center;">15</td><td style="text-align:center;"><a href='#sources'>NPCR</a></td><td style="text-align:center;">2018</td><td style="text-align:center;">18</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1472 - 1486</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>npcrDerivedAjcc8TnmPathStgGrp</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>This item stores the results of NPCR's derived algorithmic calculation of pathologic stage group based on AJCC T, N, and M and relevant biomarkers and prognostic factors. The algorithm derives AJCC 8th ed. stage group for 2018, however, updates to future AJCC editions are anticipated. The derived values for 7th ed. were stored in NPCR Derived Path Stg Grp [3655].</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>The purpose of the derived stage fields is to segregate data values for AJCC stage groups derived from the NPCR algorithm from values directly entered from the medical record or by the registrar. NPCR's primary interest is in the directly-entered values, but derived values will have a purpose primarily at the central registry. It is important to not mix data values from the two sources in the same data items. This item was added in 2018 because the required length to hold AJCC stage group values increased from 4 columns to 15.</div><div class='content chap10-para'><strong>Codes (in addition to those published in the <em>AJCC Cancer Staging Manual</em>)</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>88</td><td class='code-desc'>Not applicable </td></tr><tr class='code-row'><td class='code-nbr'>99</td><td class='code-desc'>Unknown</td></tr><tr class='code-row'><td class='code-nbr'>Blank</td><td class='code-desc'>Not staged</td></tr><tr class='code-row'><td class='code-nbr' colspan='2'></td></tr></table></div><a name='3647'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>NPCR DERIVED AJCC 8 TNM POST THERAPY STG GRP</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">3647</td><td style="text-align:center;">15</td><td style="text-align:center;"><a href='#sources'>NPCR</a></td><td style="text-align:center;">2018</td><td style="text-align:center;">18</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1487 - 1501</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>npcrDerivedAjcc8TnmPostStgGrp</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>This item stores the results of NPCR's derived algorithmic calculation of post neoadjuvant stage group based on AJCC T, N, and M and relevant biomarkers and prognostic factors. The algorithm derives AJCC 8th ed. stage group for 2018, however, updates to future AJCC editions are anticipated. NPCR did not derive post neoadjuvant stage group for 7th ed.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>The purpose of the derived stage fields is to segregate data values for AJCC stage groups derived from the NPCR algorithm from values directly entered from the medical record or by the registrar. NPCR's primary interest is in the directly-entered values, but derived values will have a purpose primarily at the central registry. It is important to not mix data values from the two sources in the same data items. <br /><br />NPCR does not collect post neoadjuvant stage information, but the NPCR derivation algorithm supports collection by CoC accredited facilities and other registries.</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>88</td><td class='code-desc'>Not applicable</td></tr><tr class='code-row'><td class='code-nbr'>99</td><td class='code-desc'>Unknown</td></tr><tr class='code-row'><td class='code-nbr'>Blank</td><td class='code-desc'>Not staged</td></tr><tr class='code-row'><td class='code-nbr' colspan='2'></td></tr></table></div><div class='content chap10-para'><strong>Codes (in addition to those published in the <em>AJCC Cancer Staging Manual</em>) </strong></div><a name='3650'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>NPCR DERIVED CLIN STG GRP</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">3650</td><td style="text-align:center;">4</td><td style="text-align:center;"><a href='#sources'>NPCR</a></td><td style="text-align:center;">2016</td><td style="text-align:center;">16</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1449 - 1452</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>npcrDerivedClinStgGrp</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'><!--[if gte mso 10]>  <![endif]-->This item is needed to store the results of NPCR&#8217;s derived algorithmic calculation of clinical stage group based on AJCC T, N, and M and relevant biomarkers and prognostic factors. At this time the algorithm derives AJCC 7th ed. Stage group only; however, updates to future AJCC editions are anticipated.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>The purpose of the derived stage fields is to segregate the data values for AJCC clinical and pathological stage groups derived from the NPCR algorithm from the values directly entered from the medical record or by the registrar. NPCR&#8217;s primary interest is in the directly-entered values, but derived values will have a purpose primarily at the central registry. It is important to not mix data values from the two sources in the same data items.</div><div class='content chap10-para'><strong>Codes:  (Refer to the most recent version of <em>STORE </em>for additional coding instructions)</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>88</td><td class='code-desc'>Not applicable </td></tr><tr class='code-row'><td class='code-nbr'>99</td><td class='code-desc'>Unknown</td></tr><tr class='code-row'><td class='code-nbr'>Blank</td><td class='code-desc'>Not staged </td></tr><tr class='code-row'><td class='code-nbr'></td><td class='code-desc'> </td></tr></table></div><a name='3655'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>NPCR DERIVED PATH STG GRP</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">3655</td><td style="text-align:center;">4</td><td style="text-align:center;"><a href='#sources'>NPCR</a></td><td style="text-align:center;">2016</td><td style="text-align:center;">16</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1453 - 1456</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>npcrDerivedPathStgGrp</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>This new item is needed to store the results of NPCR&#8217;s derived algorithmic calculation of pathological stage group based on AJCC T, N, and M and relevant biomarkers and prognostic factors.  At this time the algorithm derives AJCC 7th ed. Stage group only; however, updates to future AJCC editions is anticipated.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>The purpose of the derived stage fields is to segregate the data values for AJCC clinical and pathological stage groups derived from the NPCR algorithm from the values directly entered from the medical record or by the registrar. NPCR&#8217;s primary interest is in the directly-entered values, but derived values will have a purpose primarily at the central registry. It is important to not mix data values from the two sources in the same data items.</div><div class='content chap10-para'><strong>Codes:&nbsp; (Refer to the most recent version of <em>STORE </em>for additional coding instructions)</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>88</td><td class='code-desc'>Not applicable</td></tr><tr class='code-row'><td class='code-nbr'>99</td><td class='code-desc'>Unknown</td></tr><tr class='code-row'><td class='code-nbr'>Blank</td><td class='code-desc'>Not staged </td></tr><tr class='code-row'><td class='code-nbr'></td><td class='code-desc'> </td></tr></table></div><a name='3720'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>NPCR SPECIFIC FIELD</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">3720</td><td style="text-align:center;">75</td><td style="text-align:center;"><a href='#sources'>NPCR</a></td><td style="text-align:center;">2013</td><td style="text-align:center;">13</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1647 - 1721</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>npcrSpecificField</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>A 75 character field to be used when information for a particular primary site needs to be collected by NPCR. </div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>This field allows NPCR to retain data collected through the CER project and is a place holder when additional site-specific information is needed. </div><div class='content chap10-para'><p>
  <strong>Codes <br /></strong>To be determined for each site where needed.<br /></p></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>Blank</td><td class='code-desc'>Field not coded </td></tr></table></div><a name='3105'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>NPI--ARCHIVE FIN</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">3105</td><td style="text-align:center;">10</td><td style="text-align:center;"><a href='#sources'>CMS</a></td><td style="text-align:center;">2007</td><td style="text-align:center;">11.1</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">725 - 734</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>npiArchiveFin</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>This field identifies the NPI number (National Provider Identifier) of the facility at the time it initially accessioned the tumor.<br /><br />NPI, a unique identification number for US health care providers, was scheduled for 2007-2008 implementation by the Centers for Medicare &amp; Medicaid Services (CMS) as part of the Health Insurance Portability and Accountability Act of 1996 (HIPAA). For billing purposes, large practices and large group providers were required to use NPI codes by May 2007; small health plans were required to use NPI codes by May 2008. </div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>The NPI-Archive FIN is the functional equivalent of Archive FIN [3100]. </div><div class='content chap10-para'><strong>Codes </strong>  <strong>[only valid NPI assigned 10-digit numeric codes (9-digit number plus 1 check digit). The check digit algorithm is available at: <a href="https://nppes.cms.hhs.gov/NPPES/NPIRegistryHome.do">https://nppes.cms.hhs.gov/NPPES/NPIRegistryHome.do</a>]</strong></div><a name='2445'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>NPI--FOLLOWING REGISTRY</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">2445</td><td style="text-align:center;">10</td><td style="text-align:center;"><a href='#sources'>CMS</a></td><td style="text-align:center;">2007</td><td style="text-align:center;">11.1</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">4905 - 4914</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>npiFollowingRegistry</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>The NPI (National Provider Identifier) code that records the registry responsible for following the patient.<br />
<br />
NPI, a unique identification number for US health care providers, was scheduled for 2007-2008 implementation by the Centers for Medicare &amp; Medicaid Services (CMS) as part of the Health Insurance Portability and Accountability Act of 1996 (HIPAA). For billing purposes, large practices and large group providers were required to use NPI codes by May 2007; small health plans were required to use NPI codes by May 2008. </div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>The number is essential to NCDB for monitoring data submissions, ensuring the accuracy of data, and identifying areas for special studies. </div><div class='content chap10-para'><strong>Codes [only valid NPI assigned 10-digit numeric codes (9-digit number plus 1 check digit). The check digit algorithm is available at: <a target="_blank" href="https://nppes.cms.hhs.gov/NPPES/NPIRegistryHome.do">https://nppes.cms.hhs.gov/NPPES/NPIRegistryHome.do</a>] </strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>Blank</td><td class='code-desc'> </td></tr></table></div><a name='2415'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>NPI--INST REFERRED FROM</strong></td><td style="text-align:right;font-weight:bold;"><strong>Revised</strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">2415</td><td style="text-align:center;">10</td><td style="text-align:center;"><a href='#sources'>CMS</a></td><td style="text-align:center;">2007</td><td style="text-align:center;">11.1</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">4925 - 4934</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>npiInstReferredFrom</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para mark-changed'>The NPI (National Provider Identifier) code that identifies the facility that referred the patient to the reporting facility. <br /><br />NPI, a unique identification number for US health care providers, was scheduled for 2007-2008 implementation by the Centers for Medicare &amp; Medicaid Services (CMS) as part of the Health Insurance Portability and Accountability Act of 1996 (HIPAA). For billing purposes, large practices and large group providers were required to use NPI codes by May 2007; small health plans were required to use NPI codes by May 2008.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para mark-changed'>This number is used to document and monitor referral patterns.</div><div class='content chap10-para'><strong>Codes [only valid NPI assigned 10-digit numeric codes (9-digit number plus 1 check digit). The check digit algorithm is available at: <a target="_blank" href="https://nppes.cms.hhs.gov/NPPES/NPIRegistryHome.do">https://nppes.cms.hhs.gov/NPPES/NPIRegistryHome.do</a>]</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr' colspan='2'>Blank</td></tr></table></div><a name='2425'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>NPI--INST REFERRED TO</strong></td><td style="text-align:right;font-weight:bold;"><strong>Revised</strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">2425</td><td style="text-align:center;">10</td><td style="text-align:center;"><a href='#sources'>CMS</a></td><td style="text-align:center;">2007</td><td style="text-align:center;">11.1</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">4945 - 4954</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>npiInstReferredTo</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para mark-changed'>The NPI (National Provider Identifier) code that identifies the facility to which the patient was referred for further care.<br /><br />NPI, a unique identification number for US health care providers, was scheduled for 2007-2008 implementation by the Centers for Medicare &amp; Medicaid Services (CMS) as part of the Health Insurance Portability and Accountability Act of 1996 (HIPAA). For billing purposes, large practices and large group providers were required to use NPI codes by May 2007; small health plans were required to use NPI codes by May 2008.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para mark-changed'>This number is used to document and monitor referral patterns.</div><div class='content chap10-para'><strong>Codes [only valid NPI assigned 10-digit numeric codes (9-digit number plus 1 check digit). The check digit algorithm is available at: <a target="_blank" href="https://nppes.cms.hhs.gov/NPPES/NPIRegistryHome.do">https://nppes.cms.hhs.gov/NPPES/NPIRegistryHome.do</a>]</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr' colspan='2'>Blank</td></tr></table></div><a name='2495'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>NPI--PHYSICIAN 3</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">2495</td><td style="text-align:center;">10</td><td style="text-align:center;"><a href='#sources'>CMS</a></td><td style="text-align:center;">2007</td><td style="text-align:center;">11.1</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">5069 - 5078</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>Radiation Oncologist (CoC)<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>npiPhysician3</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>The NPI (National Provider Identifier) code for another physician involved in the care of the patient. NPI, a unique identification number for US health care providers, was scheduled for 2007-2008 implementation by the Centers for Medicare &amp; Medicaid Services (CMS) as part of the Health Insurance Portability and Accountability Act of 1996 (HIPAA). For billing purposes, large practices and large group providers were required to use NPI codes by May 2007; small health plans were required to use NPI codes by May 2008. </div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Used to monitor patient radiotherapy care. </div><div class='content chap10-para'><strong>Codes [only valid NPI assigned 10-digit numeric codes (9-digit number plus 1 check digit). The check digit algorithm is available at: <a target="_blank" href="https://nppes.cms.hhs.gov/NPPES/NPIRegistryHome.do">https://nppes.cms.hhs.gov/NPPES/NPIRegistryHome.do</a>]</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr' colspan='2'>Blank</td></tr></table></div><a name='2505'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>NPI--PHYSICIAN 4</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">2505</td><td style="text-align:center;">10</td><td style="text-align:center;"><a href='#sources'>CMS</a></td><td style="text-align:center;">2007</td><td style="text-align:center;">11.1</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">5087 - 5096</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>Medical Oncologist (CoC)<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>npiPhysician4</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>The NPI (National Provider Identifier) code for another physician involved in the care of the patient. <br /><br />NPI, a unique identification number for US health care providers, was scheduled for 2007-2008 implementation by the Centers for Medicare &amp; Medicaid Services (CMS) as part of the Health Insurance Portability and Accountability Act of 1996 (HIPAA). For billing purposes, large practices and large group providers were required to use NPI codes by May 2007; small health plans were required to use NPI codes by May 2008. </div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Used to monitor patient medical oncology care. </div><div class='content chap10-para'><strong>Codes [only valid NPI assigned 10-digit numeric codes (9-digit number plus 1 check digit). The check digit algorithm is available at: <a target="_blank" href="https://nppes.cms.hhs.gov/NPPES/NPIRegistryHome.do">https://nppes.cms.hhs.gov/NPPES/NPIRegistryHome.do</a>]</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr' colspan='2'>Blank</td></tr></table></div><a name='2475'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>NPI--PHYSICIAN--FOLLOW-UP</strong></td><td style="text-align:right;font-weight:bold;"><strong>Revised</strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">2475</td><td style="text-align:center;">10</td><td style="text-align:center;"><a href='#sources'>CMS</a></td><td style="text-align:center;">2007</td><td style="text-align:center;">11.1</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">5033 - 5042</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>npiPhysicianFollowUp</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para mark-changed'>The NPI (National Provider Identifier) code for the physician currently responsible for the patient's medical care. <br /><br />NPI, a unique identification number for US health care providers, was scheduled for 2007-2008 implementation by the Centers for Medicare &amp; Medicaid Services (CMS) as part of the Health Insurance Portability and Accountability Act of 1996 (HIPAA). For billing purposes, large practices and large group providers were required to use NPI codes by May 2007; small health plans were required to use NPI codes by May 2008.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para mark-changed'>Used to monitor post-treatment patient care.</div><div class='content chap10-para'><strong>Codes [only valid NPI assigned 10-digit numeric codes (9-digit number plus 1 check digit). The check digit algorithm is available at: <a target="_blank" href="https://nppes.cms.hhs.gov/NPPES/NPIRegistryHome.do">https://nppes.cms.hhs.gov/NPPES/NPIRegistryHome.do</a>]</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr' colspan='2'>Blank</td></tr></table></div><a name='2465'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>NPI--PHYSICIAN--MANAGING</strong></td><td style="text-align:right;font-weight:bold;"><strong>Revised</strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">2465</td><td style="text-align:center;">10</td><td style="text-align:center;"><a href='#sources'>CMS</a></td><td style="text-align:center;">2007</td><td style="text-align:center;">11.1</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">5015 - 5024</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>npiPhysicianManaging</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para mark-changed'>The NPI (National Provider Identifier) code that identifies the physician who is responsible for the overall management of the patient during diagnosis and/or treatment for this cancer.<br /><br />NPI, a unique identification number for US health care providers, was scheduled for 2007-2008 implementation by the Centers for Medicare &amp; Medicaid Services (CMS) as part of the Health Insurance Portability and Accountability Act of 1996 (HIPAA). For billing purposes, large practices and large group providers were required to use NPI codes by May 2007; small health plans were required to use NPI codes by May 2008.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para mark-changed'>Used to monitor patient care.</div><div class='content chap10-para'><strong>Codes [only valid NPI assigned 10-digit numeric codes (9-digit number plus 1 check digit). The check digit algorithm is available at: <a target="_blank" href="https://nppes.cms.hhs.gov/NPPES/NPIRegistryHome.do">https://nppes.cms.hhs.gov/NPPES/NPIRegistryHome.do</a>]</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr' colspan='2'>Blank</td></tr></table></div><a name='2485'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>NPI--PHYSICIAN--PRIMARY SURG</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">2485</td><td style="text-align:center;">10</td><td style="text-align:center;"><a href='#sources'>CMS</a></td><td style="text-align:center;">2007</td><td style="text-align:center;">11.1</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">5051 - 5060</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>npiPhysicianPrimarySurg</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>The NPI (National Provider Identifier) code for the physician who performed the most definitive surgical procedure. <br /><br />NPI, a unique identification number for US health care providers, was scheduled for 2007-2008 implementation by the Centers for Medicare &amp; Medicaid Services (CMS) as part of the Health Insurance Portability and Accountability Act of 1996 (HIPAA). For billing purposes, large practices and large group providers were required to use NPI codes by May 2007; small health plans were required to use NPI codes by May 2008. </div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Used to monitor patient surgical care. </div><div class='content chap10-para'><strong>Codes [only valid NPI assigned 10-digit numeric codes (9-digit number plus 1 check digit). The check digit algorithm is available at: <a target="_blank" href="https://nppes.cms.hhs.gov/NPPES/NPIRegistryHome.do">https://nppes.cms.hhs.gov/NPPES/NPIRegistryHome.do</a>]</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr' colspan='2'>Blank</td></tr></table></div><a name='45'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>NPI--REGISTRY ID</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">45</td><td style="text-align:center;">10</td><td style="text-align:center;"><a href='#sources'>CMS</a></td><td style="text-align:center;">2007</td><td style="text-align:center;">11.1</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">20 - 29</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>npiRegistryId</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>NaaccrData</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>The NPI (National Provider Identifier) code that represents the data transmission source. This item stores the NPI of the facility registry that transmits the record.<br /><br />NPI, a unique identification number for US health care providers, was scheduled for 2007-2008 implementation by the Centers for Medicare &amp; Medicaid Services (CMS) as part of the Health Insurance Portability and Accountability Act of 1996 (HIPAA). For billing purposes, large practices and large group providers were required to use NPI codes by May 2007; small health plans were required to use NPI codes by May 2008.<br /><br />If the transmission source is not a health care provider or a covered entity, this item will be blank and the item Registry ID [40] should be used to identify the transmission source.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>The NPI equivalent of Registry ID [40].</div><div class='content chap10-para'><strong>Codes [only valid NPI assigned 10-digit numeric codes (9-digit number plus 1 check digit). The check digit algorithm is available at: <a target="_blank" href="https://nppes.cms.hhs.gov/NPPES/NPIRegistryHome.do">https://nppes.cms.hhs.gov/NPPES/NPIRegistryHome.do</a>]</strong></div><a name='545'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>NPI--REPORTING FACILITY</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">545</td><td style="text-align:center;">10</td><td style="text-align:center;"><a href='#sources'>CMS</a></td><td style="text-align:center;">2007</td><td style="text-align:center;">11.1</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">705 - 714</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>npiReportingFacility</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>The NPI (National Provider Identifier) code for the facility submitting the data in the record.<br /><br />NPI, a unique identification number for US health care providers, was scheduled for 2007-2008 implementation by the Centers for Medicare &amp; Medicaid Services (CMS) as part of the Health Insurance Portability and Accountability Act of 1996 (HIPAA). For billing purposes, large practices and large group providers were required to use NPI codes by May 2007; small health plans were required to use NPI codes by May 2008. </div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>The NPI equivalent of Reporting Facility [540]. </div><div class='content chap10-para'><strong> Codes [only valid NPI assigned 10-digit numeric codes (9-digit number plus 1 check digit). The check digit algorithm is available at: <a target="_blank" href="https://nppes.cms.hhs.gov/NPPES/NPIRegistryHome.do">https://nppes.cms.hhs.gov/NPPES/NPIRegistryHome.do</a>] </strong></div><a name='3941'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>NRAS MUTATIONAL ANALYSIS</strong></td><td style="text-align:right;font-weight:bold;"><strong>New</strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">3941</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>NAACCR</a></td><td style="text-align:center;">2021</td><td style="text-align:center;">21</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1 - 1</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>nrasMutationalAnalysis</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>NRAS is a signaling intermediate in the growth receptor pathway. Certain NRAS mutations predict poor response to anti-EGFR therapy in patients with metastatic colorectal cancer.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>NRAS mutational analysis is recommended in clinical guidelines for patients with metastatic colon cancer who are being considered for anti-EGFR therapy. It is a new data item for cases diagnosed 01/01/2021+.</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>0</td><td class='code-desc'>Normal<br/>
NRAS negative; NRAS wild type<br/>
Negative for (somatic) mutations, no alterations, no (somatic) mutations identified, not present, not detected
</td></tr><tr class='code-row'><td class='code-nbr'>1</td><td class='code-desc'>Abnormal (mutated)/detected in codon(s) 12, 13, and/or 61</td></tr><tr class='code-row'><td class='code-nbr'>2</td><td class='code-desc'>Abnormal (mutated)/detected, codon(s) specified but not in codon(s) 12, 13, or 61</td></tr><tr class='code-row'><td class='code-nbr'>4</td><td class='code-desc'>Abnormal (mutated), NOS, codon(s) not specified</td></tr><tr class='code-row'><td class='code-nbr'>7</td><td class='code-desc'>Test ordered, results not in chart</td></tr><tr class='code-row'><td class='code-nbr'>8</td><td class='code-desc'>Not applicable: Information not collected for this case<br/>
If this information is required by your standard setter, use of code 8 may result in an edit error.
</td></tr><tr class='code-row'><td class='code-nbr'>9</td><td class='code-desc'>Not documented in medical record<br/>
NRAS not assessed or unknown if assessed
</td></tr><tr class='code-row'><td class='code-nbr'></td><td class='code-desc'> </td></tr></table></div><div class='content chap10-para'>Each Site-Specific Data Item (SSDI) applies only to selected primary 
sites, histologies, and years of diagnosis. Depending on applicability 
and standard-setter requirements, SSDIs may be left blank.</div><a name='3897'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>NUMBER OF CORES EXAMINED</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">3897</td><td style="text-align:center;">2</td><td style="text-align:center;"><a href='#sources'>NAACCR</a></td><td style="text-align:center;">2018</td><td style="text-align:center;">18</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1937 - 1938</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>numberOfCoresExamined</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>This data item represents the number of cores examined as documented in the pathology report from needle biopsy of the prostate gland.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Number of Cores Examined is a Registry Data Collection Variable for AJCC. This data item was previously collected as Prostate, CS SSF# 13.</div><div class='content chap10-para'><strong>Codes:&nbsp;</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>01-99</td><td class='code-desc'>1 - 99 cores examined<br/>
(Exact number of cores examined)
</td></tr><tr class='code-row'><td class='code-nbr'>X1</td><td class='code-desc'>100 or more cores examined</td></tr><tr class='code-row'><td class='code-nbr'>X6</td><td class='code-desc'>Biopsy cores examined, number unknown</td></tr><tr class='code-row'><td class='code-nbr'>X7</td><td class='code-desc'>No needle core biopsy performed</td></tr><tr class='code-row'><td class='code-nbr'>X8</td><td class='code-desc'>Not applicable: Information not collected for this case<br/>
(If this information is required by your standard setter, use of code X8 may result in an edit error.)</td></tr><tr class='code-row'><td class='code-nbr'>X9</td><td class='code-desc'>Not documented in medical record<br/>
Number of cores examined not assessed or unknown if assessed
</td></tr><tr class='code-row'><td class='code-nbr'></td><td class='code-desc'> </td></tr></table></div><div class='content chap10-para'>Each Site-Specific Data Item (SSDI) applies only to selected primary sites, histologies, and years of diagnosis. Depending on applicability and standard-setter requirements, SSDIs may be left blank. </div><a name='3898'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>NUMBER OF CORES POSITIVE</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">3898</td><td style="text-align:center;">2</td><td style="text-align:center;"><a href='#sources'>NAACCR</a></td><td style="text-align:center;">2018</td><td style="text-align:center;">18</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1939 - 1940</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>numberOfCoresPositive</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>This data item represents the number of positive cores documented in the pathology report from needle biopsy of the prostate gland.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Number of Cores Positive is a Registry Data Collection Variable for AJCC. This data item was previously collected as Prostate, CS SSF# 12.</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>00</td><td class='code-desc'>All examined cores negative 
 </td></tr><tr class='code-row'><td class='code-nbr'>01-99</td><td class='code-desc'>1 - 99 cores positive<br/> 
(Exact number of cores positive)
</td></tr><tr class='code-row'><td class='code-nbr'>X1</td><td class='code-desc'>100 or more cores positive</td></tr><tr class='code-row'><td class='code-nbr'>X6</td><td class='code-desc'>Biopsy cores positive, number unknown</td></tr><tr class='code-row'><td class='code-nbr'>X7</td><td class='code-desc'>No needle core biopsy performed</td></tr><tr class='code-row'><td class='code-nbr'>X8</td><td class='code-desc'>Not applicable: Information not collected for this case<br/>
(If this information is required by your standard setter, use of code X8 may result in an edit error.)
</td></tr><tr class='code-row'><td class='code-nbr'>X9</td><td class='code-desc'>Not documented in medical record<br/>
Number of Cores Positive not assessed or unknown if assessed
</td></tr><tr class='code-row'><td class='code-nbr'></td><td class='code-desc'> </td></tr></table></div><div class='content chap10-para'>Each Site-Specific Data Item (SSDI) applies only to selected primary sites, histologies, and years of diagnosis. Depending on applicability and standard-setter requirements, SSDIs may be left blank. </div><a name='3899'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>NUMBER OF EXAMINED PARA-AORTIC NODES</strong></td><td style="text-align:right;font-weight:bold;"><strong>Revised</strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">3899</td><td style="text-align:center;">2</td><td style="text-align:center;"><a href='#sources'>NAACCR</a></td><td style="text-align:center;">2018</td><td style="text-align:center;">18</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1807 - 1808</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>numberOfExaminedParaAorticNodes</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Number of examined para-aortic nodes is the number of nodes examined based on para-aortic nodal dissection.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Number of Examined Para-aortic Nodes is listed as a Registry Data Collection Variable in AJCC. This data item was previously collected as Corpus, CS SSF# 6.</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para mark-changed'><table><tr class='code-row'><td class='code-nbr'>00</td><td class='code-desc'>No para-aortic nodes examined </td></tr><tr class='code-row'><td class='code-nbr'>01-99</td><td class='code-desc'>1 - 99 para-aortic nodes examined<br/> 
(Exact number of para-aortic lymph nodes examined)
</td></tr><tr class='code-row'><td class='code-nbr'>X1</td><td class='code-desc'>100 or more para-aortic nodes examined</td></tr><tr class='code-row'><td class='code-nbr'>X2</td><td class='code-desc'>Para-aortic nodes examined, number unknown</td></tr><tr class='code-row'><td class='code-nbr'>X6</td><td class='code-desc'>No para-aortic lymph nodes removed, but aspiration or core biopsy of para-aortic node(s) only</td></tr><tr class='code-row'><td class='code-nbr'>X8</td><td class='code-desc'>Not applicable: Information not collected for this case<br/>
(If this item is required by your standard setter, use of code X8 will result in an edit error.)
</td></tr><tr class='code-row'><td class='code-nbr'>X9</td><td class='code-desc'>Not documented in patient record<br/>
Cannot be determined, indeterminate if para-aortic nodes present<br/>
No lymph node dissection performed<br/>
Para-aortic lymph nodes not assessed or unknown if assessed
</td></tr><tr class='code-row'><td class='code-nbr'></td><td class='code-desc'> </td></tr></table></div><div class='content chap10-para mark-changed'>Each Site-Specific Data Item (SSDI) applies only to selected primary sites, histologies, and years of diagnosis. Depending on applicability and standard-setter requirements, SSDIs may be left blank.</div><a name='3900'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>NUMBER OF EXAMINED PELVIC NODES</strong></td><td style="text-align:right;font-weight:bold;"><strong>Revised</strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">3900</td><td style="text-align:center;">2</td><td style="text-align:center;"><a href='#sources'>NAACCR</a></td><td style="text-align:center;">2018</td><td style="text-align:center;">18</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1811 - 1812</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>numberOfExaminedPelvicNodes</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Number of examined pelvic nodes is the number of nodes examined based on pelvic nodal dissection.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Number of Examined Pelvic Nodes is listed as a Registry Data Collection Variable in AJCC. This data item was previously collected as Corpus, CS SSF# 4.</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para mark-changed'><table><tr class='code-row'><td class='code-nbr'>00</td><td class='code-desc'>No pelvic lymph nodes examined </td></tr><tr class='code-row'><td class='code-nbr'>01-99</td><td class='code-desc'>1 - 99 pelvic lymph nodes examined<br/> 
(Exact number of pelvic lymph nodes examined)
</td></tr><tr class='code-row'><td class='code-nbr'>X1</td><td class='code-desc'>100 or more pelvic nodes examined</td></tr><tr class='code-row'><td class='code-nbr'>X2</td><td class='code-desc'>Pelvic nodes examined, number unknown</td></tr><tr class='code-row'><td class='code-nbr'>X6</td><td class='code-desc'>No pelvic lymph nodes removed, but aspiration or core biopsy of pelvic node(s) only</td></tr><tr class='code-row'><td class='code-nbr'>X8</td><td class='code-desc'>Not applicable: Information not collected for this case<br/>
(If this item is required by your standard setter, use of code X8 will result in an edit error.)
</td></tr><tr class='code-row'><td class='code-nbr'>X9</td><td class='code-desc'>Not documented in patient record<br/>
Cannot be determined, indeterminate if positive pelvic nodes present
No lymph node dissection performed<br/>
Pelvic lymph nodes not assessed or unknown if assessed
</td></tr><tr class='code-row'><td class='code-nbr'></td><td class='code-desc'> </td></tr></table></div><div class='content chap10-para mark-changed'>Each Site-Specific Data Item (SSDI) applies only to selected primary sites, histologies, and years of diagnosis. Depending on applicability and standard-setter requirements, SSDIs may be left blank.</div><a name='1532'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>NUMBER OF PHASES OF RAD TREATMENT TO THIS VOLUME</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">1532</td><td style="text-align:center;">2</td><td style="text-align:center;"><a href='#sources'>CoC</a></td><td style="text-align:center;">2018</td><td style="text-align:center;">18</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">2347 - 2348</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>numberPhasesOfRadTxToVolume</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Identifies the total number of phases administered to the patient during the first course of treatment. A &#8220;phase&#8221; consists of one or more consecutive treatments delivered to the same anatomic volume with no change in the treatment technique. Although the majority of courses of radiation therapy are completed in one or two phases (historically, the &#8220;regional&#8221; and &#8220;boost&#8221; treatments) there are occasions in which three or more phases are used, most typically with head and neck malignancies. This data item is required for CoC-accredited facilities as of cases diagnosed 01/01/2018 and later.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>The number of phases of radiation treatment is used to evaluate patterns of radiation therapy and the treatment schedule.</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>00</td><td class='code-desc'>No radiation treatment </td></tr><tr class='code-row'><td class='code-nbr'>01</td><td class='code-desc'>1 phase</td></tr><tr class='code-row'><td class='code-nbr'>02</td><td class='code-desc'>2 phases</td></tr><tr class='code-row'><td class='code-nbr'>03</td><td class='code-desc'>3 phases</td></tr><tr class='code-row'><td class='code-nbr'>04</td><td class='code-desc'>4 or more phases</td></tr><tr class='code-row'><td class='code-nbr'>99</td><td class='code-desc'>Unknown number of phases; Unknown if radiation therapy administered</td></tr><tr class='code-row'><td class='code-nbr' colspan='2'></td></tr></table></div><a name='3901'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>NUMBER OF POSITIVE PARA-AORTIC NODES</strong></td><td style="text-align:right;font-weight:bold;"><strong>Revised</strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">3901</td><td style="text-align:center;">2</td><td style="text-align:center;"><a href='#sources'>NAACCR</a></td><td style="text-align:center;">2018</td><td style="text-align:center;">18</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1805 - 1806</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>numberOfPositiveParaAorticNodes</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Number of Positive Para-Aortic Nodes is the number of positive nodes based on para-aortic nodal dissection</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Number of Positive Para-aortic Nodes is listed as a Registry Data Collection Variable in AJCC. This data item was previously collected as Corpus, CS SSF# 5.</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para mark-changed'><table><tr class='code-row'><td class='code-nbr'>00</td><td class='code-desc'>All para-aortic lymph nodes examined negative </td></tr><tr class='code-row'><td class='code-nbr'>01-99</td><td class='code-desc'>1-99 para-aortic lymph nodes positive<br/>
(Exact number of nodes positive)
</td></tr><tr class='code-row'><td class='code-nbr'>X1</td><td class='code-desc'>100 or more para-aortic nodes positive</td></tr><tr class='code-row'><td class='code-nbr'>X2</td><td class='code-desc'>Positive para-aortic nodes identified, number unknown</td></tr><tr class='code-row'><td class='code-nbr'>X6</td><td class='code-desc'>Positive aspiration or core biopsy of para-aortic lymph node(s)</td></tr><tr class='code-row'><td class='code-nbr'>X8</td><td class='code-desc'>Not applicable: Information not collected for this case<br/>
(If this item is required by your standard setter, use of code X8 will result in an edit error.)
</td></tr><tr class='code-row'><td class='code-nbr'>X9</td><td class='code-desc'>Not documented in patient record<br/>
Cannot be determined, indeterminate if positive para-aortic nodes present<br/>
No lymph node dissection performed<br/>
Para-aortic lymph nodes not assessed or unknown if assessed
</td></tr><tr class='code-row'><td class='code-nbr'></td><td class='code-desc'> </td></tr></table></div><div class='content chap10-para mark-changed'>Each Site-Specific Data Item (SSDI) applies only to selected primary sites, histologies, and years of diagnosis. Depending on applicability and standard-setter requirements, SSDIs may be left blank.</div><a name='3902'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>NUMBER OF POSITIVE PELVIC NODES</strong></td><td style="text-align:right;font-weight:bold;"><strong>Revised</strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">3902</td><td style="text-align:center;">2</td><td style="text-align:center;"><a href='#sources'>NAACCR</a></td><td style="text-align:center;">2018</td><td style="text-align:center;">18</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1809 - 1810</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>numberOfPositivePelvicNodes</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Number of Positive Pelvic Nodes is the number of positive nodes based on pelvic nodal dissection.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Number of Positive Pelvic Nodes is listed as a Registry Data Collection Variable in AJCC. This data item was previously collected as Corpus, CS SSF# 3.</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para mark-changed'><table><tr class='code-row'><td class='code-nbr'>00</td><td class='code-desc'>All pelvic nodes examined negative </td></tr><tr class='code-row'><td class='code-nbr'>01-99</td><td class='code-desc'>1 - 99 pelvic nodes positive<br/> 
(Exact number of nodes positive)
</td></tr><tr class='code-row'><td class='code-nbr'>X1</td><td class='code-desc'>100 or more pelvic nodes positive</td></tr><tr class='code-row'><td class='code-nbr'>X2</td><td class='code-desc'>Positive pelvic nodes identified, number unknown</td></tr><tr class='code-row'><td class='code-nbr'>X6</td><td class='code-desc'>Positive aspiration or core biopsy of pelvic lymph node(s)</td></tr><tr class='code-row'><td class='code-nbr'>X8</td><td class='code-desc'>Not applicable: Information not collected for this case<br/>
(If this item is required by your standard setter, use of code X8 will result in an edit error.)
</td></tr><tr class='code-row'><td class='code-nbr'>X9</td><td class='code-desc'>Not documented in patient record<br/>
Cannot be determined, indeterminate if positive pelvic nodes present<br/>
No lymph node dissection performed<br/>
Pelvic lymph nodes not assessed or unknown if assessed
</td></tr><tr class='code-row'><td class='code-nbr'></td><td class='code-desc'> </td></tr></table></div><div class='content chap10-para mark-changed'>Each Site-Specific Data Item (SSDI) applies only to selected primary sites, histologies, and years of diagnosis. Depending on applicability and standard-setter requirements, SSDIs may be left blank.</div><a name='447'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>NUMBER OF TUMORS/HIST</strong></td><td style="text-align:right;font-weight:bold;"><strong>Retired</strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">447</td><td style="text-align:center;"></td><td style="text-align:center;"><a href='#sources'></a></td><td style="text-align:center;">2006</td><td style="text-align:center;">11</td><td style="text-align:center;">2008</td><td style="text-align:center;">11.2</td><td class="cross-out" style="text-align:center;"></td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td></td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td></td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>The NAACCR UDSC retired this data item in Version 11.2, effective January 1, 2008.</div><a name='290'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>OCCUPATION SOURCE</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">290</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>NPCR</a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">245 - 245</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>occupationSource</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Code that best describes the source of occupation information provided on this patient. This is a central cancer registry data item (i.e., codes should be applied by a central or regional registry rather than collected from reporting facilities).</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Occupation information may come from a variety of sources. The most valid and reliable source of occupation information for patients has not yet been determined.</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>0</td><td class='code-desc'>Unknown occupation/no occupation available</td></tr><tr class='code-row'><td class='code-nbr'>1</td><td class='code-desc'>Reporting facility records</td></tr><tr class='code-row'><td class='code-nbr'>2</td><td class='code-desc'>Death certificate</td></tr><tr class='code-row'><td class='code-nbr'>3</td><td class='code-desc'>Interview</td></tr><tr class='code-row'><td class='code-nbr'>7</td><td class='code-desc'>Other source</td></tr><tr class='code-row'><td class='code-nbr'>8</td><td class='code-desc'>Not applicable, patient less than 14 years of age at diagnosis</td></tr><tr class='code-row'><td class='code-nbr'>9</td><td class='code-desc'>Unknown source</td></tr><tr class='code-row'><td class='code-nbr'>Blank</td><td class='code-desc'>Not collected</td></tr></table></div><a name='3903'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>ONCOTYPE DX RECURRENCE SCORE-DCIS</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">3903</td><td style="text-align:center;">3</td><td style="text-align:center;"><a href='#sources'>NAACCR</a></td><td style="text-align:center;">2018</td><td style="text-align:center;">18</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1776 - 1778</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>oncotypeDxRecurrenceScoreDcis</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Oncotype Dx Recurrence Score-DCIS is a numeric score of a genomic test to predict the risk of local recurrence of breast cancer based on the assessment of 21 genes.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Oncotype Dx Recurrence Score-DCIS is a Registry Data Collection Variable in AJCC. It is a new data item for cases diagnosed 1/1/2018+.</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>0-100</td><td class='code-desc'>Enter actual recurrence score between 0 and 100 </td></tr><tr class='code-row'><td class='code-nbr'>XX6</td><td class='code-desc'>Not applicable: invasive case</td></tr><tr class='code-row'><td class='code-nbr'>XX7</td><td class='code-desc'>Test ordered, results not in chart</td></tr><tr class='code-row'><td class='code-nbr'>XX8</td><td class='code-desc'>Not applicable: Information not collected for this case<br/>
(If this item is required by your standard setter, use of code XX8 will result in an edit error.)
</td></tr><tr class='code-row'><td class='code-nbr'>XX9</td><td class='code-desc'>Not documented in medical record<br/>
Oncotype Dx Recurrence Score-DCIS not assessed or unknown if assessed
</td></tr><tr class='code-row'><td class='code-nbr'></td><td class='code-desc'> </td></tr></table></div><div class='content chap10-para'>Each Site-Specific Data Item (SSDI) applies only to selected primary sites, histologies, and years of diagnosis. Depending on applicability and standard-setter requirements, SSDIs may be left blank.</div><a name='3904'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>ONCOTYPE DX RECURRENCE SCORE-INVASIVE</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">3904</td><td style="text-align:center;">3</td><td style="text-align:center;"><a href='#sources'>NAACCR</a></td><td style="text-align:center;">2018</td><td style="text-align:center;">18</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1779 - 1781</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>oncotypeDxRecurrenceScoreInvasiv</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Oncotype Dx Recurrence Score-Invasive is a numeric score of a genomic test to predict the likelihood of distant recurrence of invasive breast cancer based on the assessment of 21 genes.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Oncotype Dx Recurrence Score-Invasive is a Registry Data Collection Variable in AJCC. It is a new data item for cases diagnosed 1/1/2018+.</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>0-100</td><td class='code-desc'>Enter actual recurrence score between 0 and 100 </td></tr><tr class='code-row'><td class='code-nbr'>XX4</td><td class='code-desc'>Stated as less than 11</td></tr><tr class='code-row'><td class='code-nbr'>XX5</td><td class='code-desc'>Stated as equal to or greater than 11</td></tr><tr class='code-row'><td class='code-nbr'>XX6</td><td class='code-desc'>Not applicable: in situ case</td></tr><tr class='code-row'><td class='code-nbr'>XX7</td><td class='code-desc'>Test ordered, results not in chart</td></tr><tr class='code-row'><td class='code-nbr'>XX9</td><td class='code-desc'>Not documented in medical record<br/>
Oncotype Dx Recurrence Score-Invasive not assessed or unknown if assessed
</td></tr><tr class='code-row'><td class='code-nbr'></td><td class='code-desc'> </td></tr></table></div><div class='content chap10-para'>Each Site-Specific Data Item (SSDI) applies only to selected primary sites, histologies, and years of diagnosis. Depending on applicability and standard-setter requirements, SSDIs may be left blank.</div><a name='3905'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>ONCOTYPE DX RISK LEVEL-DCIS</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">3905</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>NAACCR</a></td><td style="text-align:center;">2018</td><td style="text-align:center;">18</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1782 - 1782</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>oncotypeDxRiskLevelDcis</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Oncotype Dx Risk Level-DCIS stratifies Oncotype Dx recurrence scores into low, intermediate, and high risk of local recurrence.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Oncotype Dx Risk Level-DCIS is a Registry Data Collection Variable in AJCC. It is a new data item for cases diagnosed 1/1/2018+.</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>0</td><td class='code-desc'>Low risk (recurrence score 0-38) </td></tr><tr class='code-row'><td class='code-nbr'>1</td><td class='code-desc'>Intermediate risk (recurrence score 39-54)</td></tr><tr class='code-row'><td class='code-nbr'>2</td><td class='code-desc'>High risk (recurrence score greater than or equal to 55)</td></tr><tr class='code-row'><td class='code-nbr'>6</td><td class='code-desc'>Not applicable: invasive case</td></tr><tr class='code-row'><td class='code-nbr'>7</td><td class='code-desc'>Test ordered, results not in chart
</td></tr><tr class='code-row'><td class='code-nbr'>8</td><td class='code-desc'>Not applicable: Information not collected for this case<br/>
(If this item is required by your standard setter, use of code 8 will result in an edit error.)
</td></tr><tr class='code-row'><td class='code-nbr'>9</td><td class='code-desc'>Not documented in medical record<br/>
Oncotype Dx Risk Level-DCIS not assessed or unknown if assessed
</td></tr><tr class='code-row'><td class='code-nbr'></td><td class='code-desc'> </td></tr></table></div><div class='content chap10-para'>Each Site-Specific Data Item (SSDI) applies only to selected primary sites, histologies, and years of diagnosis. Depending on applicability and standard-setter requirements, SSDIs may be left blank.</div><a name='3906'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>ONCOTYPE DX RISK LEVEL-INVASIVE</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">3906</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>NAACCR</a></td><td style="text-align:center;">2018</td><td style="text-align:center;">18</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1783 - 1783</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>oncotypeDxRiskLevelInvasive</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Oncotype Dx Risk Level-Invasive stratifies Oncotype Dx recurrence scores into low, intermediate, and high risk of distant recurrence.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Oncotype Dx Risk Level-Invasive is a Registry Data Collection Variable in AJCC. It is a new data item for cases diagnosed 1/1/2018+.</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>0</td><td class='code-desc'>Low risk (recurrence score 0-17) </td></tr><tr class='code-row'><td class='code-nbr'>1</td><td class='code-desc'>Intermediate risk (recurrence score 18-30)</td></tr><tr class='code-row'><td class='code-nbr'>2</td><td class='code-desc'>High risk (recurrence score greater than or equal to 31)</td></tr><tr class='code-row'><td class='code-nbr'>6</td><td class='code-desc'>Not applicable: DCIS case</td></tr><tr class='code-row'><td class='code-nbr'>7</td><td class='code-desc'>Test done, results not in chart</td></tr><tr class='code-row'><td class='code-nbr'>8</td><td class='code-desc'>Not applicable: Information not collected for this case<br/>
(If this item is required by your standard setter, use of code 8 will result in an edit error.)
</td></tr><tr class='code-row'><td class='code-nbr'>9</td><td class='code-desc'>Not documented in medical record<br/>
Oncotype Dx Risk Level-Invasive not assessed or unknown if assessed
</td></tr><tr class='code-row'><td class='code-nbr'></td><td class='code-desc'> </td></tr></table></div><div class='content chap10-para'>Each Site-Specific Data Item (SSDI) applies only to selected primary sites, histologies, and years of diagnosis. Depending on applicability and standard-setter requirements, SSDIs may be left blank. </div><a name='3907'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>ORGANOMEGALY</strong></td><td style="text-align:right;font-weight:bold;"><strong>Revised</strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">3907</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>NAACCR</a></td><td style="text-align:center;">2018</td><td style="text-align:center;">18</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1913 - 1913</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>organomegaly</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Organomegaly is defined as presence of enlarged liver and/or spleen on physical examination and is part of the staging criteria for Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL).</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para mark-changed'>Organomegaly is a prognostic factor required for staging of CLL/SLL in AJCC 8th edition, Chapter 79 












<em>Hodgkin and Non-Hodgkin Lymphomas</em>. It is a new data item for cases diagnosed 1/1/2018+.</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para mark-changed'><table><tr class='code-row'><td class='code-nbr'>0</td><td class='code-desc'>Neither hepatomegaly (liver) nor splenomegaly (spleen) present</td></tr><tr class='code-row'><td class='code-nbr'>1</td><td class='code-desc'>Hepatomegaly (liver) and/or splenomegaly (spleen) present</td></tr><tr class='code-row'><td class='code-nbr'>9</td><td class='code-desc'>Not documented in medical record<br/>
Organomegaly (hepatomegaly and/or splenomegaly) not assessed or unknown if assessed
</td></tr><tr class='code-row'><td class='code-nbr'></td><td class='code-desc'> </td></tr></table></div><div class='content chap10-para mark-changed'>Each Site-Specific Data Item (SSDI) applies only to selected primary sites, histologies, and years of diagnosis. Depending on applicability and standard-setter requirements, SSDIs may be left blank.</div><a name='1070'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>OTHER STAGING SYSTEM</strong></td><td style="text-align:right;font-weight:bold;"><strong>Retired</strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">1070</td><td style="text-align:center;"></td><td style="text-align:center;"><a href='#sources'></a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;">2006</td><td style="text-align:center;">11</td><td class="cross-out" style="text-align:center;"></td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td></td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td></td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>The NAACCR UDSC retired this data item in Version 11, as of January 1, 2006.</div><a name='1985'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>OVER-RIDE ACSN/CLASS/SEQ</strong></td><td style="text-align:right;font-weight:bold;"><strong>Revised</strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">1985</td><td style="text-align:center;">1</td><td title="V: 22: NAACCR
V: 18: CoC
V: 16: CoC
V: 15: CoC
" class=" HighlightToolTip" style="text-align:center;"><a href='#sources'>NAACCR</a></td><td style="text-align:center;">2001</td><td style="text-align:center;">9</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">2574 - 2574</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>Over-ride Accession/Class of Case/Sequence<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>overRideAcsnClassSeq</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Some computer edits identify errors. Others indicate possible errors that require manual review for resolution. To eliminate the need to review the same cases repeatedly, over-ride flags have been developed to indicate that data in a record (or records) have been reviewed and, while unusual, are correct. <br /><br />This over-ride is used with the following edit in the NAACCR Metafile of the EDITS software: <tab>Accession Number, Class of Case, Seq Number (CoC). </tab></div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Some edits check for code combinations that are possible, but quite rare. If the code combination generates an error message and review of the case indicates that the codes are correct for the case, then the over-ride flag is used to skip the edit in the future. See Chapter IV, Recommended Data Edits and Software Coordination of Standards.<br /><br /><strong>Over-ride Flag as Used in the EDITS Software Package</strong><br />The edit, Accession Number, Class of Case, Seq Number (CoC), checks the following:<br /><ol><li>If the case is the only case or the first of multiple cases diagnosed at the facility (Sequence Number--Hospital = 00, 01, 60, or 61, and Class of Case = 00, 10-14, or 40), then the first 4 characters of the Accession Number--Hosp must equal the year of the Date of 1st Contact.</li><li>If the case is first diagnosed at autopsy (Class of Case = 38) and the case is the only case or the first of multiple cases for a patient (Sequence Number--Hospital = 00, 01, 60, or 61), then the first 4 characters of the Accession Number--Hosp must equal the year of the Date of Last Contact AND must equal the year of the Date of 1st Contact.</li><li>If the case is first diagnosed at autopsy (Class of Case = 38) and the case is not the first case for a patient (Sequence Number--Hospital) greater than 01 or greater than 61), then the year of the Date of 1st Contact must equal the year of Date of Last Contact.</li></ol>There are some exceptions to the above rules. Over-ride Acsn/Class/Seq may be used to override the edit when the circumstances fit the following situation or one similar to it:<br /><blockquote><blockquote>The case may be the only or the first of multiple malignant cases for a patient (Sequence Number--Hospital = 00 or 01), but there is an earlier benign case (with an earlier year of the Date of 1st Contact) to which the Accession Number--Hosp applies.<br /></blockquote></blockquote><strong><br />Instructions for Coding</strong><br /><ol><li>If edit generates an error or warning message, verify that the Accession Number--Hosp, Sequence Number--Hospital, and Class of Case are correct.</li><li>Leave blank if the program does not generate an error message for the edit Accession Number, Class of Case, Seq Number (CoC).</li><li>Leave blank and correct any errors for the case if an item is discovered to be incorrect.</li><li>Code 1 if review of accession number, sequence number and class of case verifies that they have been coded correctly and there is an unusual combination of these data items.</li></ol></div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>Blank</td><td class='code-desc'>Not reviewed or reviewed and corrected</td></tr><tr class='code-row'><td class='code-nbr'>1</td><td class='code-desc'>Reviewed and confirmed as reported</td></tr></table></div><a name='1990'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>OVER-RIDE AGE/SITE/MORPH</strong></td><td style="text-align:right;font-weight:bold;"><strong>Revised</strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">1990</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>SEER</a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">2579 - 2579</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>Age/Site/Histology Interfield Review (Interfield Edit 15) (SEER #3)<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>overRideAgeSiteMorph</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para mark-changed'>Some computer edits identify errors. Others indicate possible errors that require manual review for resolution. To eliminate the need to review the same cases repeatedly, over-ride flags have been developed to indicate that data in a record (or records) have been reviewed and, while unusual, are correct. <br />This over-ride is used with the following edits in the NAACCR Metafile of the EDITS software: <br /><blockquote><tab>Age, Primary Site, Morphology ICDO2 (SEER IF15)</tab><br /><tab><tab>Age, Primary Site, Morphology ICDO3 (SEER IF15)<tab></tab></tab></tab><br /><tab><tab><tab>Age, Primary Site, Morph ICDO3--Adult (SEER) </tab></tab></tab><br /><tab><tab><tab><tab>Age, Primary Site, Morph ICDO3--Pediatric (NPCR) </tab></tab></tab></tab></blockquote></div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para mark-changed'>Some edits check for code combinations that are possible, but quite rare. If the code combination generates an error message and review of the case indicates that the codes are correct for the case, then the over-ride flag is used to skip the edit in the future. See Chapter IV, Recommended Data Edits and Software Coordination of Standards.<br /><br /><strong>Over-ride Flag as Used in the EDITS Software Package</strong><br />Some cancers occur almost exclusively in certain age groups.<br /><br />Edits of the type Age, Primary Site, Morphology require review if a site/morphology combination occurs in an age group for which it is extremely rare. The edit Age, Primary Site, Morph ICDO3--Adult (SEER) edits cases with an Age at Diagnosis of 15 and older. The edit Age, Primary Site, Morph ICDO3--Pediatric (NPCR) edits cases with an Age at Diagnosis of less than 15. The edits Age, Primary Site, Morphology ICDO2 (SEER IF15) and Age, Primary Site, Morphology ICDO3 (SEER IF15) contain logic for all ages.<strong><br /><br />Instructions for Coding</strong><ol><li>Leave blank if the program does not generate an error message (and if the case was not diagnosed <em>in utero</em>) for the edits of the type Age, Primary Site, Morphology.</li><li>Correct any errors for the case if an item is discovered to be incorrect. <br /></li><li>Code 1 or 3 as indicated if review of items in the error or warning message confirms that all are correct. </li></ol></div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>1</td><td class='code-desc'>Reviewed and confirmed that age/site/histology combination is correct as reported</td></tr><tr class='code-row'><td class='code-nbr'>2</td><td class='code-desc'>Reviewed and confirmed that case was diagnosed <i>in utero</i></td></tr><tr class='code-row'><td class='code-nbr'>3</td><td class='code-desc'>Reviewed and confirmed that conditions 1 and 2 both apply</td></tr><tr class='code-row'><td class='code-nbr'>Blank</td><td class='code-desc'>Not reviewed or reviewed and corrected.</td></tr></table></div><a name='1987'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>OVER-RIDE COC-SITE/TYPE</strong></td><td style="text-align:right;font-weight:bold;"><strong>Revised</strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">1987</td><td style="text-align:center;">1</td><td title="V: 22: NAACCR
V: 18: CoC
V: 16: CoC
V: 15: CoC
" class=" HighlightToolTip" style="text-align:center;"><a href='#sources'>NAACCR</a></td><td style="text-align:center;">2001</td><td style="text-align:center;">9</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">2576 - 2576</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>overRideCocSiteType</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para mark-changed'>Some computer edits identify errors. Others indicate possible errors that require manual review for resolution. To eliminate the need to review the same cases repeatedly, over-ride flags have been developed to indicate that data in a record (or records) have been reviewed and, while unusual, are correct. <br /><br />This over-ride is used with the following edits in the NAACCR Metafile of the EDITS software:<tab><br /></tab>&nbsp;&nbsp; &nbsp;&nbsp; <tab>P</tab><tab>rimary Site, Morphology-Type ICDO2 (CoC) <br /><tab></tab></tab>&nbsp;&nbsp; &nbsp;&nbsp; <tab><tab>Primary Site, Morphology-Type ICDO3 (CoC)<br /><tab></tab></tab></tab>&nbsp;&nbsp; &nbsp;&nbsp; <tab><tab><tab>Primary Site, Morphology-Type, Behavior ICDO3 (CoC) </tab></tab></tab></div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para mark-changed'>Some edits check for code combinations that are possible, but quite rare. If the code combination generates an error message and review of the case indicates that the codes are correct for the case, then the over-ride flag is used to skip the edit in the future. See Chapter IV, Recommended Data Edits and Software Coordination of Standards.<strong><br /><br />Over-ride Flag as Used in the EDITS Software Package</strong><br />Multiple versions of edits of the type Primary Site, Morphology-Type check for "usual" combinations of site and ICD-O-2 or ICD-O-3 histology. The SEER version of the edit is more restrictive than the CoC edit, and thus, uses a different over-ride flag. The CoC version of the edit will accept Over-ride CoC Site/Type or Over-ride Site/Type (the SEER edit) as equivalent.<tab><br /><br />The Site/Histology validation list (available on the SEER web site) contains those histologies commonly found in the specified primary site. Histologies that occur only rarely or never are not included. These edits require review of all combinations not listed.<br /><br />Since basal and squamous cell carcinomas of non-genital skin sites are not reportable to SEER, these site/histology combinations do not appear on the SEER validation list. For the CoC version of the edit, if primary site is in the range C440-C449 (skin), and ICD-O-2 histology is in the range 8000-8004 (neoplasms, malignant, NOS), 8010-8045 (epithielial carcinomas), 8050-8082 (papillary and squamous cell carcinomas), or 8090-8110 (basal cell carcinomas), or ICD-O-3 histology is in the range 8000-8005 (neoplasms, malignant, NOS), 8010-8046 (epithelial carcinomas), 8050-8084 (papillary and squamous cell carcinomas), or 8090-8110 (basal cell carcinomas), no further editing is done. No over-ride is necessary for these cases in the CoC version of the edit.<br /><br />Review of these cases requires investigating whether the combination is biologically plausible or whether cancer registry coding conventions would allow different codes for the diagnosis. Review of these rare combinations often results in a change to either the site or histology.<strong><br /><br />Instructions for Coding</strong></tab><br /><ol><li><tab>Leave blank if the program does not generate an error message for the CoC edits of the type Primary Site, Morphology-Type.</tab></li><li>Leave blank and correct any errors for the case if an item is discovered to be incorrect.<tab></tab></li><li><tab>Code 1 if review of all items in the error or warning message confirms they are correct and coded in conformance with coding rules. </tab></li></ol></div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>Blank</td><td class='code-desc'>Not reviewed or reviewed and corrected</td></tr><tr class='code-row'><td class='code-nbr'>1</td><td class='code-desc'>Reviewed and confirmed as reported</td></tr></table></div><a name='3750'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>OVER-RIDE CS 1</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">3750</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>AJCC</a></td><td style="text-align:center;">2011</td><td style="text-align:center;">12.1</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">2705 - 2705</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>overRideCs1</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Some computer edits identify errors. Others indicate possible errors that require manual review for resolution. To eliminate the need to review the same cases repeatedly, over-ride flags have been developed to indicate that data in a record (or records) have been reviewed and, while unusual, are correct.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Some edits check for code combinations that are possible, but quite rare. If the code combination generates an error message and review of the case indicates that the codes are correct for the case, then the over-ride flag is used to skip the edit in the future.</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>1</td><td class='code-desc'>Reviewed and confirmed as reported</td></tr><tr class='code-row'><td class='code-nbr'>Blank</td><td class='code-desc'>Not reviewed or reviewed and corrected</td></tr></table></div><a name='3759'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>OVER-RIDE CS 10</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">3759</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>AJCC</a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">2714 - 2714</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>overRideCs10</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Some computer edits identify errors. Others indicate possible errors that require manual review for resolution. To eliminate the need to review the same cases repeatedly, over-ride flags have been developed to indicate that data in a record (or records) have been reviewed and, while unusual, are correct.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Some edits check for code combinations that are possible, but quite rare. If the code combination generates an error message and review of the case indicates that the codes are correct for the case, then the over-ride flag is used to skip the edit in the future.   </div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>1</td><td class='code-desc'>Reviewed and confirmed as reported</td></tr><tr class='code-row'><td class='code-nbr'>Blank</td><td class='code-desc'>Not reviewed or reviewed and corrected</td></tr></table></div><a name='3760'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>OVER-RIDE CS 11</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">3760</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>AJCC</a></td><td style="text-align:center;">2011</td><td style="text-align:center;">12.1</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">2715 - 2715</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>overRideCs11</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Some computer edits identify errors. Others indicate possible errors that require manual review for resolution. To eliminate the need to review the same cases repeatedly, over-ride flags have been developed to indicate that data in a record (or records) have been reviewed and, while unusual, are correct.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Some edits check for code combinations that are possible, but quite rare. If the code combination generates an error message and review of the case indicates that the codes are correct for the case, then the over-ride flag is used to skip the edit in the future.</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>1</td><td class='code-desc'>Reviewed and confirmed as reported</td></tr><tr class='code-row'><td class='code-nbr'>Blank</td><td class='code-desc'>Not reviewed or reviewed and corrected</td></tr></table></div><a name='3761'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>OVER-RIDE CS 12</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">3761</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>AJCC</a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">2716 - 2716</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>overRideCs12</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Some computer edits identify errors. Others indicate possible errors that require manual review for resolution. To eliminate the need to review the same cases repeatedly, over-ride flags have been developed to indicate that data in a record (or records) have been reviewed and, while unusual, are correct.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Some edits check for code combinations that are possible, but quite rare. If the code combination generates an error message and review of the case indicates that the codes are correct for the case, then the over-ride flag is used to skip the edit in the future.</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>1</td><td class='code-desc'>Reviewed and confirmed as reported</td></tr><tr class='code-row'><td class='code-nbr'>Blank</td><td class='code-desc'>Not reviewed or reviewed and corrected</td></tr></table></div><a name='3762'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>OVER-RIDE CS 13</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">3762</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>AJCC</a></td><td style="text-align:center;">2011</td><td style="text-align:center;">12.1</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">2717 - 2717</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>overRideCs13</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Some computer edits identify errors. Others indicate possible errors that require manual review for resolution. To eliminate the need to review the same cases repeatedly, over-ride flags have been developed to indicate that data in a record (or records) have been reviewed and, while unusual, are correct.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Some edits check for code combinations that are possible, but quite rare. If the code combination generates an error message and review of the case indicates that the codes are correct for the case, then the over-ride flag is used to skip the edit in the future.</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>1</td><td class='code-desc'>Reviewed and confirmed as reported</td></tr><tr class='code-row'><td class='code-nbr'>Blank</td><td class='code-desc'>Not reviewed or reviewed and corrected</td></tr></table></div><a name='3763'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>OVER-RIDE CS 14</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">3763</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>AJCC</a></td><td style="text-align:center;">2011</td><td style="text-align:center;">12.1</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">2718 - 2718</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>overRideCs14</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Some computer edits identify errors. Others indicate possible errors that require manual review for resolution. To eliminate the need to review the same cases repeatedly, over-ride flags have been developed to indicate that data in a record (or records) have been reviewed and, while unusual, are correct.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Some edits check for code combinations that are possible, but quite rare. If the code combination generates an error message and review of the case indicates that the codes are correct for the case, then the over-ride flag is used to skip the edit in the future.</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>1</td><td class='code-desc'>Reviewed and confirmed as reported</td></tr><tr class='code-row'><td class='code-nbr'>Blank</td><td class='code-desc'>Not reviewed or reviewed and corrected</td></tr></table></div><a name='3764'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>OVER-RIDE CS 15</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">3764</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>AJCC</a></td><td style="text-align:center;">2011</td><td style="text-align:center;">12.1</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">2719 - 2719</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>overRideCs15</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Some computer edits identify errors. Others indicate possible errors that require manual review for resolution. To eliminate the need to review the same cases repeatedly, over-ride flags have been developed to indicate that data in a record (or records) have been reviewed and, while unusual, are correct.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Some edits check for code combinations that are possible, but quite rare. If the code combination generates an error message and review of the case indicates that the codes are correct for the case, then the over-ride flag is used to skip the edit in the future.</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>1</td><td class='code-desc'>Reviewed and confirmed as reported</td></tr><tr class='code-row'><td class='code-nbr'>Blank</td><td class='code-desc'>Not reviewed or reviewed and corrected</td></tr></table></div><a name='3765'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>OVER-RIDE CS 16</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">3765</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>AJCC</a></td><td style="text-align:center;">2011</td><td style="text-align:center;">12.1</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">2720 - 2720</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>overRideCs16</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Some computer edits identify errors. Others indicate possible errors that require manual review for resolution. To eliminate the need to review the same cases repeatedly, over-ride flags have been developed to indicate that data in a record (or records) have been reviewed and, while unusual, are correct.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Some edits check for code combinations that are possible, but quite rare. If the code combination generates an error message and review of the case indicates that the codes are correct for the case, then the over-ride flag is used to skip the edit in the future.</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>1</td><td class='code-desc'>Reviewed and confirmed as reported</td></tr><tr class='code-row'><td class='code-nbr'>Blank</td><td class='code-desc'>Not reviewed or reviewed and corrected</td></tr></table></div><a name='3766'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>OVER-RIDE CS 17</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">3766</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>AJCC</a></td><td style="text-align:center;">2011</td><td style="text-align:center;">12.1</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">2721 - 2721</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>overRideCs17</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Some computer edits identify errors. Others indicate possible errors that require manual review for resolution. To eliminate the need to review the same cases repeatedly, over-ride flags have been developed to indicate that data in a record (or records) have been reviewed and, while unusual, are correct.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Some edits check for code combinations that are possible, but quite rare. If the code combination generates an error message and review of the case indicates that the codes are correct for the case, then the over-ride flag is used to skip the edit in the future.</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>1</td><td class='code-desc'>Reviewed and confirmed as reported</td></tr><tr class='code-row'><td class='code-nbr'>Blank</td><td class='code-desc'>Not reviewed or reviewed and corrected</td></tr></table></div><a name='3767'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>OVER-RIDE CS 18</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">3767</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>AJCC</a></td><td style="text-align:center;">2011</td><td style="text-align:center;">12.1</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">2722 - 2722</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>overRideCs18</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Some computer edits identify errors. Others indicate possible errors that require manual review for resolution. To eliminate the need to review the same cases repeatedly, over-ride flags have been developed to indicate that data in a record (or records) have been reviewed and, while unusual, are correct.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Some edits check for code combinations that are possible, but quite rare. If the code combination generates an error message and review of the case indicates that the codes are correct for the case, then the over-ride flag is used to skip the edit in the future.</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>1</td><td class='code-desc'>Reviewed and confirmed as reported</td></tr><tr class='code-row'><td class='code-nbr'>Blank</td><td class='code-desc'>Not reviewed or reviewed and corrected</td></tr></table></div><a name='3768'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>OVER-RIDE CS 19</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">3768</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>AJCC</a></td><td style="text-align:center;">2011</td><td style="text-align:center;">12.1</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">2723 - 2723</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>overRideCs19</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Some computer edits identify errors. Others indicate possible errors that require manual review for resolution. To eliminate the need to review the same cases repeatedly, over-ride flags have been developed to indicate that data in a record (or records) have been reviewed and, while unusual, are correct.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Some edits check for code combinations that are possible, but quite rare. If the code combination generates an error message and review of the case indicates that the codes are correct for the case, then the over-ride flag is used to skip the edit in the future.</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>1</td><td class='code-desc'>Reviewed and confirmed as reported</td></tr><tr class='code-row'><td class='code-nbr'>Blank</td><td class='code-desc'>Not reviewed or reviewed and corrected</td></tr></table></div><a name='3751'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>OVER-RIDE CS 2</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">3751</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>AJCC</a></td><td style="text-align:center;">2011</td><td style="text-align:center;">12.1</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">2706 - 2706</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>overRideCs2</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Some computer edits identify errors. Others indicate possible errors that require manual review for resolution. To eliminate the need to review the same cases repeatedly, over-ride flags have been developed to indicate that data in a record (or records) have been reviewed and, while unusual, are correct.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Some edits check for code combinations that are possible, but quite rare. If the code combination generates an error message and review of the case indicates that the codes are correct for the case, then the over-ride flag is used to skip the edit in the future.</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>1</td><td class='code-desc'>Reviewed and confirmed as reported</td></tr><tr class='code-row'><td class='code-nbr'>Blank</td><td class='code-desc'>Not reviewed or reviewed and corrected</td></tr></table></div><a name='3769'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>OVER-RIDE CS 20</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">3769</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>AJCC/NPCR</a></td><td style="text-align:center;">2011</td><td style="text-align:center;">12.1</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">2724 - 2724</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>Direct Summary Stage 2000 Flag<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>overRideCs20</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Some computer edits identify errors. Others indicate possible errors that require manual review for resolution. To eliminate the need to review the same cases repeatedly, over-ride flags have been developed to indicate that data in a record (or records) have been reviewed and, while unusual, are correct.<br /><br />Over-ride CS 20 has been designated as a flag for directly coded SEER Summary Stage 2000 [759] to support CDC's National Program of Cancer Registries (NPCR) requirements.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Some edits check for code combinations that are possible, but quite rare. If the code combination generates an error message and review of the case indicates that the codes are correct for the case, then the over-ride flag is used to skip the edit in the future. For diagnosis years 2012 and later, NPCR permits the use of SEER Summary Stage 2000 [759] in those cases where collection of Collaborative Stage version 2 data items is not feasible due to a lack of data or staffing and time constraints at the local or central cancer registry.  Over-ride CS 20 has been designated as a special-purpose flag to identify cases where SEER Summary Stage 2000 [759] is directly coded and reported in lieu of Derived SS2000 [3020], in accordance with NPCR reporting requirements.<br /><br />The Over-ride CS 20 value of "1", set by the user, identifies a record with NAACCR data item 759 used to report Summary Stage 2000 as permitted by NPCR requirements only; Over-ride CS 20 is left blank for all other cases.</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>1</td><td class='code-desc'>Directly coded SEER Summary Stage 2000 [759] used to report Summary Stage; Derived Summary Stage 2000 [3020] must be blank.</td></tr><tr class='code-row'><td class='code-nbr'>Blank</td><td class='code-desc'>Derived Summary Stage 2000 [3020] reported using Collaborative Stage Data Collection System or case diagnosed prior to 2012.</td></tr></table></div><a name='3752'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>OVER-RIDE CS 3</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">3752</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>AJCC</a></td><td style="text-align:center;">2011</td><td style="text-align:center;">12.1</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">2707 - 2707</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>overRideCs3</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Some computer edits identify errors. Others indicate possible errors that require manual review for resolution. To eliminate the need to review the same cases repeatedly, over-ride flags have been developed to indicate that data in a record (or records) have been reviewed and, while unusual, are correct.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Some edits check for code combinations that are possible, but quite rare. If the code combination generates an error message and review of the case indicates that the codes are correct for the case, then the over-ride flag is used to skip the edit in the future.</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>1</td><td class='code-desc'>Reviewed and confirmed as reported</td></tr><tr class='code-row'><td class='code-nbr'>Blank</td><td class='code-desc'>Not reviewed or reviewed and corrected</td></tr></table></div><a name='3753'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>OVER-RIDE CS 4</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">3753</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>AJCC</a></td><td style="text-align:center;">2011</td><td style="text-align:center;">12.1</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">2708 - 2708</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>overRideCs4</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Some computer edits identify errors. Others indicate possible errors that require manual review for resolution. To eliminate the need to review the same cases repeatedly, over-ride flags have been developed to indicate that data in a record (or records) have been reviewed and, while unusual, are correct.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Some edits check for code combinations that are possible, but quite rare. If the code combination generates an error message and review of the case indicates that the codes are correct for the case, then the over-ride flag is used to skip the edit in the future.</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>1</td><td class='code-desc'>Reviewed and confirmed as reported</td></tr><tr class='code-row'><td class='code-nbr'>Blank</td><td class='code-desc'>Not reviewed or reviewed and corrected</td></tr></table></div><a name='3754'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>OVER-RIDE CS 5</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">3754</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>AJCC</a></td><td style="text-align:center;">2011</td><td style="text-align:center;">12.1</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">2709 - 2709</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>overRideCs5</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Some computer edits identify errors. Others indicate possible errors that require manual review for resolution. To eliminate the need to review the same cases repeatedly, over-ride flags have been developed to indicate that data in a record (or records) have been reviewed and, while unusual, are correct.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Some edits check for code combinations that are possible, but quite rare. If the code combination generates an error message and review of the case indicates that the codes are correct for the case, then the over-ride flag is used to skip the edit in the future.</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>1</td><td class='code-desc'>Reviewed and confirmed as reported</td></tr><tr class='code-row'><td class='code-nbr'>Blank</td><td class='code-desc'>Not reviewed or reviewed and corrected</td></tr></table></div><a name='3755'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>OVER-RIDE CS 6</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">3755</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>AJCC</a></td><td style="text-align:center;">2011</td><td style="text-align:center;">12.1</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">2710 - 2710</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>overRideCs6</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Some computer edits identify errors. Others indicate possible errors that require manual review for resolution. To eliminate the need to review the same cases repeatedly, over-ride flags have been developed to indicate that data in a record (or records) have been reviewed and, while unusual, are correct.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Some edits check for code combinations that are possible, but quite rare. If the code combination generates an error message and review of the case indicates that the codes are correct for the case, then the over-ride flag is used to skip the edit in the future.</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>1</td><td class='code-desc'>Reviewed and confirmed as reported</td></tr><tr class='code-row'><td class='code-nbr'>Blank</td><td class='code-desc'>Not reviewed or reviewed and corrected</td></tr></table></div><a name='3756'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>OVER-RIDE CS 7</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">3756</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>AJCC</a></td><td style="text-align:center;">2011</td><td style="text-align:center;">12.1</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">2711 - 2711</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>overRideCs7</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Some computer edits identify errors. Others indicate possible errors that require manual review for resolution. To eliminate the need to review the same cases repeatedly, over-ride flags have been developed to indicate that data in a record (or records) have been reviewed and, while unusual, are correct.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Some edits check for code combinations that are possible, but quite rare. If the code combination generates an error message and review of the case indicates that the codes are correct for the case, then the over-ride flag is used to skip the edit in the future.</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>1</td><td class='code-desc'>Reviewed and confirmed as reported</td></tr><tr class='code-row'><td class='code-nbr'>Blank</td><td class='code-desc'>Not reviewed or reviewed and corrected</td></tr></table></div><a name='3757'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>OVER-RIDE CS 8</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">3757</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>AJCC</a></td><td style="text-align:center;">2011</td><td style="text-align:center;">12.1</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">2712 - 2712</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>overRideCs8</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Some computer edits identify errors. Others indicate possible errors that require manual review for resolution. To eliminate the need to review the same cases repeatedly, over-ride flags have been developed to indicate that data in a record (or records) have been reviewed and, while unusual, are correct.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Some edits check for code combinations that are possible, but quite rare. If the code combination generates an error message and review of the case indicates that the codes are correct for the case, then the over-ride flag is used to skip the edit in the future.</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>1</td><td class='code-desc'>Reviewed and confirmed as reported</td></tr><tr class='code-row'><td class='code-nbr'>Blank</td><td class='code-desc'>Not reviewed or reviewed and corrected</td></tr></table></div><a name='3758'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>OVER-RIDE CS 9</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">3758</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>AJCC</a></td><td style="text-align:center;">2011</td><td style="text-align:center;">12.1</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">2713 - 2713</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>overRideCs9</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Some computer edits identify errors. Others indicate possible errors that require manual review for resolution. To eliminate the need to review the same cases repeatedly, over-ride flags have been developed to indicate that data in a record (or records) have been reviewed and, while unusual, are correct.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Some edits check for code combinations that are possible, but quite rare. If the code combination generates an error message and review of the case indicates that the codes are correct for the case, then the over-ride flag is used to skip the edit in the future.</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>1</td><td class='code-desc'>Reviewed and confirmed as reported</td></tr><tr class='code-row'><td class='code-nbr'>Blank</td><td class='code-desc'>Not reviewed or reviewed and corrected</td></tr></table></div><a name='2040'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>OVER-RIDE HISTOLOGY</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">2040</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>SEER</a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">2587 - 2587</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>Histology/Behavior Interfield Review (Field Item Edit Morph)<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>overRideHistology</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Some computer edits identify errors. Others indicate possible errors that require manual review for resolution. To eliminate the need to review the same cases repeatedly, over-ride flags have been developed to indicate that data in a record (or records) have been reviewed and, while unusual, are correct. <br />This over-ride is used with the following edits in the NAACCR Metafile of the EDITS software:<br /> &nbsp;&nbsp; &nbsp;&nbsp; <tab>Diagnostic Confirmation, Behavior ICDO2 (SEER IF31)<br /><tab></tab></tab>&nbsp;&nbsp; &nbsp;&nbsp; <tab><tab>Diagnostic Confirmation, Behavior ICDO3 (SEER IF31)<br /><tab></tab></tab></tab>&nbsp;&nbsp; &nbsp;&nbsp; <tab><tab><tab>Morph (1973-91) ICD-O-1 (SEER MORPH)<br /><tab></tab></tab></tab></tab>&nbsp;&nbsp; &nbsp;&nbsp; <tab><tab><tab><tab>Morphology--Type/Behavior ICDO2 (SEER MORPH)<tab><br /></tab></tab></tab></tab></tab>&nbsp;&nbsp; &nbsp;&nbsp; <tab><tab><tab><tab><tab>Morphology--Type/Behavior ICDO3 (SEER MORPH) </tab></tab></tab></tab></tab></div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Some edits check for code combinations that are possible, but quite rare. If the code combination generates an error message and review of the case indicates that the codes are correct for the case, then the over-ride flag is used to skip the edit in the future. See Chapter IV, Recommended Data Edits and Software Coordination of Standards.<strong><br />
<br />
Over-ride Flags as Used in the EDITS Software Package</strong><br />
Edits of the type Diagnostic Confirmation, Behavior differ in the use of ICD-O-2 or ICD-O-3 and check that, for <em>in situ</em> cases (Behavior = 2), Diagnostic Confirmation specifies microscopic confirmation (1, 2, or 4).<br />
<br />
The distinction between <em>in situ</em> and invasive is very important to a registry, since prognosis is so different. Since the determination that a neoplasm has not invaded surrounding tissues, i.e., <em>in situ</em>, is made microscopically, cases coded <em>in situ</em> in behavior should have a microscopic confirmation code. However, very rarely, a physician will designate a case noninvasive or <em>in situ</em> without microscopic evidence.<br />
<br />
<tab>If an edit of the type, Diagnostic Confirmation, Behavior, gives an error message or warning, check that Behavior and Diagnostic Confirmation have been coded correctly. Check carefully for any cytologic or histologic evidence that may have been missed in coding.</tab><br />
<blockquote>
<tab></tab></blockquote><tab>Edits of the type, Morphology--Type/Behavior, perform the following check: <br />
</tab>
<ol>
     <li><tab>Codes listed in ICD-O-2 or ICD-O-3 with behavior codes of only 0 or 1 are considered valid, since the behavior matrix of ICD-O-2 and ICD-O-3 allows for the elevation of the behavior of such histologies when the tumor is <em>in situ </em>or malignant. This edit forces review of these rare cases to verify that they are indeed <em>in situ </em>or malignant.<br />
     <br />
     </tab></li>
     <li><tab>The following histologies are generally not accepted as <em>in situ</em>: ICD-O-2 histologies 8000-8004, 8020, 8021, 8331, 8332, 8800-9054, 9062, 9082, 9083, 9110-9491, 9501-9989, ICD-O-3 histologies 8000-8005, 8020, 8021, 8331, 8332, 8800-9055, 9062, 9082, 9083, 9110-9493, 9501-9989. This edit forces review of these cases.<br />
     <br />
     </tab></li>
     <li><tab>If a Morphology-Type/Behavior edit produces an error or warning message and the case is one in which the 4-digit morphology code is one that appears in ICD-O-2 or ICD-O-3 only with behavior codes of 0 or 1, or the case is one in which the 4-digit morphology code is not generally accepted with a behavior code of 2, verify the coding of morphology and that the behavior should be coded malignant or <em>in situ</em>. The registrar may need to consult a pathologist or medical advisor in problem cases.<br />
     <br />
     </tab><tab>
     Exceptions:</tab><br />
     <tab>
     If year of Date of Diagnosis &amp;gt; 2000, then a behavior code of 1 is valid for the following ICD-O-2 histologies and no over-ride flag is needed: 8931, 9393, 9538, 9950, 9960-9962, 9980-9984, and 9989. Similarly, the following ICD-O-3 histologies are valid with a behavior code of 1: 8442, 8451, 8462, 8472, and 8473. If year of Date of Diagnosis &amp;gt; 2003, the following ICD-O-3 benign histologies will pass without review: 8146, 8271, 8861, 8897, 9121, 9122, 9131, 9161, 9350, 9351, 9352, 9360, 9361, 9383, 9384, 9394, 9412, 9413, 9444, 9492, 9493, 9506, 9531, 9532, 9533, 9534, 9537, 9541, 9550, 9562, and 9570.</tab><br />
     <tab></tab><tab>
     <br />
     </tab></li>
     <li><tab>Grade 5-8 with histologies not in the range of 9590-9948 is impossible.<br />
     <br />
     </tab></li>
     <li><tab>Some terms in ICD-O-2 and ICD-O-3 carry an implied statement of grade. These histologies must be reported with the correct grade as stated below. An error of this type cannot be over-ridden.<br />
     &nbsp; <br />
     <tab><strong>ICD-O-2</strong><tab><br />
     8020/34 Carcinoma, undifferentiated<tab><br />
     8021/34 Carcinoma, anaplastic<br />
     <tab>8331/31 Follicular adenocarcinoma, well differentiated<tab><br />
     8851/31 Liposarcoma, well differentiated<tab><br />
     9062/34 Seminoma, anaplastic<br />
     <tab>9082/34 Malignant teratoma, undifferentiated<tab><br />
     9083/32 Malignant teratoma, intermediate type<tab><br />
     9401/34 Astrocytoma, anaplastic<tab><br />
     9451/34 Oligodendroglioma, anaplastic<br />
     <tab>9511/31 Retinoblastoma, differentiated<tab><br />
     9512/34 Retinoblastoma, undifferentiated<br />
     <tab><u><br />
     </u><strong>ICD-O-3</strong><tab><br />
     8020/34 Carcinoma, undifferentiated<tab><br />
     8021/34 Carcinoma, anaplastic<tab><br />
     8331/31 Follicular adenocarcinoma, well differentiated<br />
     <tab>9082/34 Malignant teratoma, undifferentiated<tab><br />
     9083/32 Malignant teratoma, intermediate type<tab><br />
     9401/34 Astrocytoma, anaplastic<tab><br />
     9451/34 Oligodendroglioma, anaplastic<tab><br />
     9511/31 Retinoblastoma, differentiated<tab><br />
     9512/34 Retinoblastoma, undifferentiated</tab></tab></tab></tab></tab></tab></tab></tab></tab></tab></tab></tab></tab></tab></tab></tab></tab></tab></tab></tab></tab></tab></tab></li>
</ol>
<strong>Instructions for Coding<br />
</strong>
<ol>
     <li>Leave blank if the program does not generate an error message for the edits of the types, Diagnostic Confirmation, Behav Code or Morphology--Type/Behavior. </li>
     <li>Leave blank and correct any errors for the case if an item is discovered to be incorrect. </li>
     <li><leave blank="" and="" correct="" any="" errors="" for="" the="" case="" if="" an="" item="" is="" discovered="" to="" be=""  incorrect.<="" tab=""><tab><tab><tab><tab><tab><tab><tab><tab><tab><tab><tab>Code 1, 2, or 3 as indicated if review of all items in the error or warning message confirms that all are correct.</tab></tab></tab></tab></tab></tab></tab></tab></tab></tab></tab></leave></li>
</ol></div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>1</td><td class='code-desc'>Reviewed and confirmed that the pathologist states the primary to be "<i>in situ</i>" or "malignant" although the behavior code of the histology is designated as "benign" or "uncertain" in ICD-O-2 or ICD-O-3</td></tr><tr class='code-row'><td class='code-nbr'>2</td><td class='code-desc'>Reviewed and confirmed that the behavior code is "<i>in situ,</i>" but the case is not microscopically confirmed</td></tr><tr class='code-row'><td class='code-nbr'>3</td><td class='code-desc'>Reviewed and confirmed that conditions 1 and 2 both apply</td></tr><tr class='code-row'><td class='code-nbr'>Blank</td><td class='code-desc'>Not reviewed or reviewed and corrected</td></tr></table></div><a name='1986'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>OVER-RIDE HOSPSEQ/DXCONF</strong></td><td style="text-align:right;font-weight:bold;"><strong>Revised</strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">1986</td><td style="text-align:center;">1</td><td title="V: 22: NAACCR
V: 18: CoC
V: 16: CoC
V: 15: CoC
" class=" HighlightToolTip" style="text-align:center;"><a href='#sources'>NAACCR</a></td><td style="text-align:center;">2001</td><td style="text-align:center;">9</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">2575 - 2575</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>Over-ride Hospital Sequence/Diagnostic Confirmation<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>overRideHospseqDxconf</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para mark-changed'>Some computer edits identify errors. Others indicate possible errors that require manual review for resolution. To eliminate the need to review the same cases repeatedly, over-ride flags have been developed to indicate that data in a record (or records) have been reviewed and, while unusual, are correct. <br /><br />This over-ride is used with the following edit in the NAACCR Metafile of the EDITS software:<br />&nbsp;&nbsp; &nbsp;&nbsp; <tab>Diagnostic Confirm, Seq Num--Hosp (CoC) </tab></div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para mark-changed'>Some edits check for code combinations that are possible, but quite rare. If the code combination generates an error message and review of the case indicates that the codes are correct for the case, then the over-ride flag is used to skip the edit in the future. See Chapter IV, Recommended Data Edits and Software Coordination of Standards.<strong><br /><br />Over-ride Flag as Used in the EDITS Software Package</strong><br />The edit, Diagnostic Confirm, Seq Num--Hosp (CoC), does the following:<br /><ol><li>If any case is one of multiple primaries and is not microscopically confirmed or lacks a positive lab test/marker study, i.e., Diagnostic Confirmation &amp;gt; 5 and Sequence Number--Hospital &amp;gt; 00 (more than one primary), review is required. <br /></li><li>If Primary Site specifies an ill-defined or unknown primary (C760-C768, C809), no further checking is done.</li><li>If Sequence Number--Hospital is in the range of 60-88, this edit is skipped.</li></ol><p>It is important to verify that the non-microscopically confirmed case is indeed a separate primary from any others that may have been reported. This edit forces review of multiple primary cancers when one of the primaries is coded to a site other than ill-defined or unknown and is not microscopically confirmed or confirmed by a positive lab test/marker study.</p><ol><li>If the suspect case is confirmed accurate as coded and if the number of primaries is correct, set the Over-ride HospSeq/DxConf to 1. Do not set the over-ride flag on the patient's other primary cancers.</li><li>If it turns out that the non-microscopically confirmed cancer is considered a manifestation of one of the patient's other cancers, delete the non-microscopically confirmed case. Check the sequence numbers of remaining cases, correcting them if necessary. Also check for other data items on the remaining cases that may need to be changed as a result of the corrections, such as stage and treatment.</li></ol><p><strong>Instructions for Coding</strong></p><ul><li>Leave blank if the program does not generate an error message for the edit Diagnostic Confirm, Seq Num--Hosp (CoC).</li><li>Leave blank and correct any errors for the case if an item is discovered to be incorrect.</li><li>Code 1 if review of all items in the error or warning message confirms that all are correct.</li></ul></div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>1</td><td class='code-desc'>Reviewed and confirmed as reported</td></tr><tr class='code-row'><td class='code-nbr'>Blank</td><td class='code-desc'>Not reviewed or reviewed and corrected</td></tr></table></div><a name='1988'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>OVER-RIDE HOSPSEQ/SITE</strong></td><td style="text-align:right;font-weight:bold;"><strong>Revised</strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">1988</td><td style="text-align:center;">1</td><td title="V: 22: NAACCR
V: 18: CoC
V: 16: CoC
V: 15: CoC
" class=" HighlightToolTip" style="text-align:center;"><a href='#sources'>NAACCR</a></td><td style="text-align:center;">2001</td><td style="text-align:center;">9</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">2577 - 2577</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>Over-ride Hospital Sequence/Site<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>overRideHospseqSite</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Some computer edits identify errors. Others indicate possible errors that require manual review for resolution. To eliminate the need to review the same cases repeatedly, over-ride flags have been developed to indicate that data in a record (or records) have been reviewed and, while unusual, are correct. <br /><br />This over-ride is used with the following edits in the NAACCR Metafile of the EDITS software:<tab><br /></tab>&nbsp;&nbsp; &nbsp;&nbsp; <tab>Seq Num--Hosp, Primary Site, Morph ICDO2 (CoC)<tab><br /></tab></tab>&nbsp;&nbsp; &nbsp;&nbsp; <tab><tab>Seq Num--Hosp, Primary Site, Morph ICDO3 (CoC) </tab></tab></div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Some edits check for code combinations that are possible, but quite rare. If the code combination generates an error message and review of the case indicates that the codes are correct for the case, then the over-ride flag is used to skip the edit in the future. See Chapter IV, Recommended Data Edits and Software Coordination of Standards.<br />
<br />
<strong>Over-ride Flag as Used in the EDITS Software Package</strong><br />
Edits of the type Seq Num--Hosp, Primary Site, Morph differ in use of ICD-O-2 or ICD-O-3 morphology. They force review of multiple primary cancers when one of the primaries is coded to a site/morphology combination that could indicate a metastatic site rather than a primary site. <br />
<ol>
     <li>If Sequence Number--Hospital indicates the person has had more than one primary, then any case with one of the following site/histology combinations requires review:
     <ul>
         <li><span style="font-family:Symbol;"><span><span style="font:7.0pt &quot;Times New Roman&quot;"></span></span></span>C760-C768 (ill-defined sites) or C809 (unknown primary) and ICD-O-2&nbsp;or ICD-O-3&nbsp;histology less than 9590. Look for evidence that the unknown or ill-defined primary is a secondary site from one of the patient's other cancers. For example, a clinical discharge diagnosis of "abdominal carcinomatosis" may be attributable to the patient&#8217;s primary ovarian cystadenocarcinoma already in the registry, and should not be entered as a second primary.</li>
         <li><span style="font-family:Symbol;"><span><span style="font:7.0pt &quot;Times New Roman&quot;"></span></span></span>C770-C779 (lymph nodes) and ICD-O-2&nbsp;histology not in range 9590-9717 or ICD-O-3&nbsp;histology not in the range 9590-9729; or C420-C424 and ICD-O-2 histology not in range 9590-9941 or ICD-O-3 histology not in the range 9590-9989. That combination is most likely a metastatic lesion. Check whether the lesion could be a manifestation of one of the patient&#8217;s other cancers.</li>
         <li><span style="font-family:Symbol;"><span><span style="font:7.0pt &quot;Times New Roman&quot;">&nbsp;</span></span></span>Any site and ICD-O-2&nbsp;histology in the range 9720-9723, 9740-9741 or ICD-O-3&nbsp;histology in the range 9740-9758. Verify that these diagnoses are coded correctly and are indeed separate primaries from the others.</li>
     </ul>
     </li>
     <li>If it turns out that the suspect tumor is a manifestation of one of the patient's other cancers, delete the metastatic or secondary case, re-sequence remaining cases, and correct the coding on the original case as necessary.</li>
</ol>
<strong>Instructions for Coding</strong>
<ul>
     <li>Leave blank if the program does not generate an error message for an edit of the type Seq Num--Hosp, Primary Site, Morph.</li>
     <li>Leave blank and correct any errors for the case if an item is discovered to be incorrect.</li>
     <li>Code 1 if review of all items in the error or warning message confirms that hospital sequence number and site are both correct.</li>
</ul></div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>1</td><td class='code-desc'>Reviewed and confirmed as reported</td></tr><tr class='code-row'><td class='code-nbr'>Blank</td><td class='code-desc'>Not reviewed or reviewed and corrected</td></tr></table></div><a name='2060'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>OVER-RIDE ILL-DEFINE SITE</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">2060</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>SEER</a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">2589 - 2589</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>Sequence Number/Ill-defined Site Interfield Review (Interfield Edit 22)<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>overRideIllDefineSite</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Some computer edits identify errors. Others indicate possible errors that require manual review for resolution. To eliminate the need to review the same cases repeatedly, over-ride flags have been developed to indicate that data in a record (or records) have been reviewed and, while unusual, are correct. <br /><br />This over-ride is used with the following edits in the NAACCR Metafile of the EDITS software: <tab><br /></tab>&nbsp;&nbsp; &nbsp;&nbsp; <tab>Seq Num--Central, Prim Site, Morph ICDO2 (SEER IF22)<tab><br /></tab></tab>&nbsp;&nbsp; &nbsp;&nbsp; <tab><tab>Seq Num--Central, Prim Site, Morph ICDO3 (SEER IF22) </tab></tab> </div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Some edits check for code combinations that are possible, but quite rare. If the code combination generates an error message and review of the case indicates that the codes are correct for the case, then the over-ride flag is used to skip the edit in the future. See Chapter IV, Recommended Data Edits and Software Coordination of Standards.<strong><br /><br />Over-ride Flag as Used in the EDITS Software Package</strong><br />Edits of the type Seq Num--Central, Primary Site, Morph differ in use of ICD-O-2 or ICD-O-3 morphology. They force review of multiple primary cancers when one of the primaries is coded to a site/morphology combination that could indicate a metastatic site rather than a primary site.<ol><li>If Sequence Number-Central indicates the person has had more than one primary, then any case with one of the following site/histology combinations requires review:<span style="font-family: Symbol;"></span></li><ul><li><span style="font-family:Symbol;"><span style="Times New Roman&quot;"></span></span>C760-C768 (ill-defined sites) or C809 (unknown primary) and ICD-O-2&nbsp;or ICD-O-3&nbsp;histology &amp;lt; 9590. Look for evidence that the unknown or ill-defined primary is a secondary site from one of the patient&#8217;s other cancers. For example, a clinical discharge diagnosis of &#8220;abdominal carcinomatosis&#8221; may be attributable to the patient&#8217;s primary ovarian cystadenocarcinoma already in the registry, and should not be entered as a second primary.</li><li><span style="font-family:Symbol;"><span style="Times New Roman&quot;"></span></span>C770-C779 (lymph nodes) and ICD-O-2&nbsp;histology not in the range 9590-9717 or ICD-O-3&nbsp;histology not in the range 9590-9729; or C420-C424 and ICD-O-2 histology not in the range 9590-9941 or ICD-O-3 histology not in the range 9590-9989. That combination is most likely a metastatic lesion. Check whether the lesion could be a manifestation of one of the patient&#8217;s other cancers.</li><li><span style="font-family:Symbol;"><span style="Times New Roman&quot;"></span></span>Any site and ICD-O-2&nbsp;histology in the range 9720-9723, 9740-9741 or ICD-O-3&nbsp;histology in the range 9740-9758. Verify that these diagnoses are coded correctly and are indeed separate primaries from the others.</li></ul><li>If it turns out that the suspect tumor is a manifestation of one of the patient's other cancers, delete the metastatic or secondary case, re-sequence remaining cases, and correct the coding on the original case as necessary.</li></ol><strong>Instructions for Coding</strong><ul><li>Code 1 can be used if a second or subsequent primary reporting with an ill-defined primary site has been reviewed and is indeed an independent primary.</li><li>Leave blank and correct any errors for the case if an item is discovered to be incorrect.</li></ul> </div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>1</td><td class='code-desc'>Reviewed and confirmed as reported: a second or subsequent primary reported with an ill-defined primary site (C76.0-C76.8, C80.9) has been reviewed and is an independent primary</td></tr><tr class='code-row'><td class='code-nbr'>Blank</td><td class='code-desc'>Not reviewed or reviewed and corrected</td></tr></table></div><a name='2070'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>OVER-RIDE LEUK, LYMPHOMA</strong></td><td style="text-align:right;font-weight:bold;"><strong>Revised</strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">2070</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>SEER</a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">2590 - 2590</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>Leukemia or Lymphoma/Diagnostic Confirmation Interfield Review (Interfield Edit 48)<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>overRideLeukLymphoma</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para mark-changed'>Some computer edits identify errors. Others indicate possible errors that require manual review for resolution. To eliminate the need to review the same cases repeatedly, over-ride flags have been developed to indicate that data in a record (or records) have been reviewed and, while unusual, are correct. <br /><br />This over-ride is used with the following edits in the NAACCR Metafile of the EDITS software:<br />&nbsp;&nbsp; &nbsp;&nbsp; <tab>Diagnostic Confirmation, Histology ICDO2 (SEER IF48)<br /><tab></tab></tab>&nbsp;&nbsp; &nbsp;&nbsp; <tab><tab>Diagnostic Confirmation, Histology ICDO3 (SEER IF48) </tab></tab></div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para mark-changed'>Some edits check for code combinations that are possible, but quite rare. If the code combination generates an error message and review of the case indicates that the codes are correct for the case, then the over-ride flag is used to skip the edit in the future. See Chapter IV, Recommended Data Edits and Software Coordination of Standards.<strong><br /><br />Over-ride Flag as Used in the EDITS Software Package</strong><br />Edits of the type Diagnostic Confirmation, Histology differ in use of ICD-O-2 or ICD-O-3 and check the following:<br /><ol><li>Since lymphoma and leukemia are almost exclusively microscopic diagnoses, this edit forces review of any cases of lymphoma that have diagnostic confirmation of direct visualization or clinical, and any leukemia with a diagnostic confirmation of direct visualization.</li><li>If histology = 9590-9717 for ICD-O-2 or 9590-9729 for ICD-O-3 (lymphoma) then Diagnostic Confirmation cannot be 6 (direct visualization) or 8 (clinical).</li><li>If histology = 9720-9941 for ICD-O-2 or 9731-9948 for ICD-O-3 (leukemia and other) then Diagnostic Confirmation cannot be 6 (direct visualization).</li></ol><strong>Instructions for Coding</strong><ul><li>Leave blank if the program does not generate an error message for the edits of the type Diagnostic Confirmation, Histology.</li><li>Leave blank and correct any errors for the case if an item is discovered to be incorrect.</li><li>If the edit produces an error or warning message, verify that the ICD-O-2 or ICD-O-3 histology and diagnostic confirmation are correctly coded. Remember that positive hematologic findings and bone marrow specimens are included as histologic confirmation (code 1 in Diagnostic Confirmation) for leukemia. Code 1 indicates that a review has taken place and histologic type and diagnostic confirmation are correctly coded.</li></ul></div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>Blank</td><td class='code-desc'>Not reviewed or reviewed and corrected</td></tr><tr class='code-row'><td class='code-nbr'>1</td><td class='code-desc'>Reviewed and confirmed as reported</td></tr></table></div><a name='2078'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>OVER-RIDE NAME/SEX</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">2078</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>NAACCR</a></td><td style="text-align:center;">2018</td><td style="text-align:center;">18</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">2595 - 2595</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>overRideNameSex</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Patient</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Some computer edits identify errors. Others indicate possible errors that require manual review for resolution. To eliminate the need to review the same cases repeatedly, over-ride flags have been developed to indicate that data in a record (or records) have been reviewed and, while unusual, are correct.<br /><br />This over-ride is used with the following edit in the NAACCR Metafile of the EDITS software:<br /><br />Sex, Name-First, Date of Birth (NAACCR)</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Some edits check for code combinations that are possible, but quite rare. If the code combination generates an error message and review of the case indicates that the codes are correct for the case, then the over-ride flag is used to skip the edit in the future. See Chapter IV, Recommended Data Edits and Software Coordination of Standards. Over-ride flag as used in the EDITS Software Package Edits of the type Sex, Name does not allow extremely rare or nonexistent combinations of first name and sex, such as John/female.</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>1</td><td class='code-desc'>Reviewed and confirmed as reported  </td></tr><tr class='code-row'><td class='code-nbr'>Blank</td><td class='code-desc'>Not reviewed or reviewed and corrected</td></tr><tr class='code-row'><td class='code-nbr' colspan='2'></td></tr></table></div><div class='content chap10-para'><em>Note</em>:  






<!--[if gte mso 10]>  <![endif]-->Leave blank if the program does not generate an error message for the edit Sex, Name-First, Date of Birth (NAACCR)</div><a name='2050'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>OVER-RIDE REPORT SOURCE</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">2050</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>SEER</a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">2588 - 2588</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>Type of Reporting Source/Sequence Number Interfield Review (Interfield Edit 04) (Seer #7)<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>overRideReportSource</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Some computer edits identify errors. Others indicate possible errors that require manual review for resolution. To eliminate the need to review the same cases repeatedly, over-ride flags have been developed to indicate that data in a record (or records) have been reviewed and, while unusual, are correct. <br /><br />This over-ride is used with the following edits in the NAACCR Metafile of the EDITS software: <tab></tab><br />&nbsp;&nbsp; &nbsp;&nbsp; Type of Rep Srce(DC), Seq Num--Cent, ICDO2 (SEER IF04)<tab><tab><br /></tab></tab>&nbsp;&nbsp; &nbsp;&nbsp; <tab><tab>Type of Rep Srce(DC), Seq Num--Cent, ICDO3 (SEER IF04) </tab></tab><p><br />&nbsp;</p> </div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Some edits check for code combinations that are possible, but quite rare. If the code combination generates an error message and review of the case indicates that the codes are correct for the case, then the over-ride flag is used to skip the edit in the future. See Chapter IV, Recommended Date Edits and Software Coordination of Standards.<strong><br /><br />Over-ride Flag as Used in the EDITS Software Package</strong><br />Edits of the type 'Type of Rep Srce(DC), Seq Num--Cent' checks that if the case is a death-certificate-only case and the histology is not a lymphoma, leukemia, immunoproliferative or myeloproliferative disease (ICD-O-2 or ICD-O-3 histology is less than 9590), then the tumor sequence number must specify one primary only (sequence '00').<strong><br /><br />Instructions for Coding</strong><ul><li>Leave blank if the program does not generate an error message for the report source edit.</li><li>Code 1 if review of type of reporting source, histologic type and tumor sequence number verified that a second or subsequent primary with a reporting source of death-certificate-only has been reviewed and is indeed an independent primary.</li></ul> </div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>Blank</td><td class='code-desc'>Not reviewed or reviewed and corrected</td></tr><tr class='code-row'><td class='code-nbr'>1</td><td class='code-desc'>Reviewed and confirmed as reported</td></tr></table></div><a name='2000'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>OVER-RIDE SEQNO/DXCONF</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">2000</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>SEER</a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">2583 - 2583</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>Sequence Number/Diagnostic Confirmation Interfield Review (Interfield Edit 23)<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>overRideSeqnoDxconf</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Some computer edits identify errors. Others indicate possible errors that require manual review for resolution. To eliminate the need to review the same cases repeatedly, over-ride flags have been developed to indicate that data in a record (or records) have been reviewed and, while unusual, are correct. <br /><br />This over-ride is used with the following edits in the NAACCR Metafile of the EDITS software:<tab><br /></tab>&nbsp;&nbsp; &nbsp;&nbsp; <tab>Diagnostic Confirm, Seq Num--Central (SEER IF23) </tab></div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Some edits check for code combinations that are impossible, but quite rare. If the code combination generates an error message and review of the case indicates that the codes are correct for the case, then the over-ride flag is used to skip the edit in the future. See Chapter IV, Recommended Data Edits and Software Coordination of Standards.<strong><br /><br />Over-ride Flag as Used in the EDITS Software Package</strong><ul><li>The edit checks if the case is one of multiple primaries and is not microscopically confirmed or has only positive lab test/marker studies (i.e., Diagnostic Confirmation &amp;gt;5) and tumor sequence number &amp;gt;00 (more than one primary). </li><li>The edit is skipped if the Sequence Number--Central is in the range of 60-99.</li></ul><strong>Instructions for Coding</strong><ul><li>Leave blank if the program does not generate an error message for the Diagnostic Confirmation and Sequence Number Central edit.</li><li>Code 1 if the cases have been reviewed and it is verified that there are multiple primaries of specific sites in which at least one diagnosis has not been microscopically confirmed.</li></ul></div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>Blank</td><td class='code-desc'>Not reviewed or reviewed and corrected</td></tr><tr class='code-row'><td class='code-nbr'>1</td><td class='code-desc'>Reviewed and confirmed as reported</td></tr></table></div><a name='2071'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>OVER-RIDE SITE/BEHAVIOR</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">2071</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>SEER</a></td><td style="text-align:center;">1997</td><td style="text-align:center;">5.1</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">2591 - 2591</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>Over-ride Flag for Site/Behavior (IF39)<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>overRideSiteBehavior</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Some computer edits identify errors. Others indicate possible errors that require manual review for resolution. To eliminate the need to review the same cases repeatedly, over-ride flags have been developed to indicate that data in a record (or records) have been reviewed and, while unusual, are correct. <br /><br />This over-ride is used with the following edits in the NAACCR Metafile of the EDITS software:<tab><br /></tab>&nbsp;&nbsp; &nbsp;&nbsp; <tab>Primary Site, Behavior Code ICDO2 (SEER IF39)<tab><br /></tab></tab>&nbsp;&nbsp; &nbsp;&nbsp; <tab><tab>Primary Site, Behavior Code ICDO3 (SEER IF39) </tab></tab></div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Some edits check for code combinations that are possible, but quite rare. If the code combination generates an error message and review of the case indicates that the codes are correct for the case, then the over-ride flag is used to skip the edit in the future. See Chapter IV, Recommended Data Edits and Software Coordination of Standards.<strong><br /><br />Over-ride Flag as Used in the EDITS Software Package</strong><br />Edits of the type, Primary Site, Behavior Code, require review of the following primary sites with a behavior of <em>in situ</em> (ICD-O-2 or ICD-O-3 behavior = 2):<br /><tab><br /></tab>&nbsp;&nbsp; &nbsp;&nbsp; <tab>C269             </tab>&nbsp;&nbsp; &nbsp;&nbsp; &nbsp;&nbsp; &nbsp;&nbsp; &nbsp;&nbsp; <tab>Gastrointestinal tract, NOS<tab><br /></tab></tab>&nbsp;&nbsp; &nbsp;&nbsp; <tab><tab>C399             </tab></tab>&nbsp;&nbsp; &nbsp;&nbsp; &nbsp;&nbsp; &nbsp;&nbsp; &nbsp;&nbsp; <tab><tab>Ill-defined sites within respiratory system<tab><br /></tab></tab></tab>&nbsp;&nbsp; &nbsp;&nbsp; <tab><tab><tab>C559             </tab></tab></tab>&nbsp;&nbsp; &nbsp;&nbsp; &nbsp;&nbsp; &nbsp;&nbsp; &nbsp;&nbsp; <tab><tab><tab>Uterus, NOS<br /><tab></tab></tab></tab></tab>&nbsp;&nbsp; &nbsp;&nbsp; <tab><tab><tab><tab>C579             </tab></tab></tab></tab>&nbsp;&nbsp; &nbsp;&nbsp; &nbsp;&nbsp; &nbsp;&nbsp; &nbsp;&nbsp; <tab><tab><tab><tab>Female genital tract, NOS<tab><br /></tab></tab></tab></tab></tab>&nbsp;&nbsp; &nbsp;&nbsp; <tab><tab><tab><tab><tab>C639             </tab></tab></tab></tab></tab>&nbsp;&nbsp; &nbsp;&nbsp; &nbsp;&nbsp; &nbsp;&nbsp; &nbsp;&nbsp; <tab><tab><tab><tab><tab>Male genital organs, NOS<tab><br /></tab></tab></tab></tab></tab></tab>&nbsp;&nbsp; &nbsp;&nbsp; <tab><tab><tab><tab><tab><tab>C689             </tab></tab></tab></tab></tab></tab>&nbsp;&nbsp; &nbsp;&nbsp; &nbsp;&nbsp; &nbsp;&nbsp; &nbsp;&nbsp; <tab><tab><tab><tab><tab><tab>Urinary system, NOS<br /><tab></tab></tab></tab></tab></tab></tab></tab>&nbsp;&nbsp; &nbsp;&nbsp; <tab><tab><tab><tab><tab><tab><tab>C729 </tab></tab></tab></tab></tab></tab></tab>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <tab><tab><tab><tab><tab><tab><tab>Nervous system, NOS<tab><br /></tab></tab></tab></tab></tab></tab></tab></tab>&nbsp;&nbsp; &nbsp;&nbsp; <tab><tab><tab><tab><tab><tab><tab><tab>C759 </tab></tab></tab></tab></tab></tab></tab></tab>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <tab><tab><tab><tab><tab><tab><tab><tab>Endocrine gland, NOS<tab><br /></tab></tab></tab></tab></tab></tab></tab></tab></tab>&nbsp;&nbsp; &nbsp;&nbsp; <tab><tab><tab><tab><tab><tab><tab><tab><tab>C760-C768     </tab></tab></tab></tab></tab></tab></tab></tab></tab>&nbsp;&nbsp; &nbsp; <tab><tab><tab><tab><tab><tab><tab><tab><tab>Ill-defined sites<tab><br /></tab></tab></tab></tab></tab></tab></tab></tab></tab></tab>&nbsp;&nbsp; &nbsp;&nbsp; <tab><tab><tab><tab><tab><tab><tab><tab><tab><tab>C809             </tab></tab></tab></tab></tab></tab></tab></tab></tab></tab>&nbsp;&nbsp; &nbsp;&nbsp; &nbsp;&nbsp; &nbsp;&nbsp; &nbsp;&nbsp; <tab><tab><tab><tab><tab><tab><tab><tab><tab><tab>Unknown primary site<br /><br />Since the designation of <em>in situ</em> is very specific and almost always requires microscopic confirmation, ordinarily specific information should also be available regarding the primary site. Conversely, if inadequate information is available to determine a specific primary site, it is unlikely that information about a cancer being <em>in situ</em> is reliable.<br /></tab></tab></tab></tab></tab></tab></tab></tab></tab></tab><blockquote><tab><tab><tab><tab><tab><tab><tab><tab><tab><tab><tab>If an <em>in situ</em> diagnosis is stated, try to obtain a more specific primary site. A primary site within an organ system can sometimes be identified based on the diagnostic procedure or treatment given or on the histologic type. If no more specific site can be determined, it is usually preferable to code a behavior code of 3. In the exceedingly rare situation in which it is certain that the behavior is <em>in situ</em> and no more specific site code is applicable, set Over-ride Site/Behavior to 1.</tab></tab></tab></tab></tab></tab></tab></tab></tab></tab></tab><br /><tab><tab><tab><tab><tab><tab><tab><tab><tab><tab><tab></tab></tab></tab></tab></tab></tab></tab></tab></tab></tab></tab></blockquote><tab><tab><tab><tab><tab><tab><tab><tab><tab><tab><tab><strong>Instructions for Coding</strong><ul><li>Leave blank if the program does not generate an error message for the edit Primary Site, Behavior Code ICDO2 (SEER IF39) and/or the edit Primary Site, Behavior Code ICDO3 (SEER IF39).</li><li>Leave blank and correct any errors for the case if an item is discovered to be incorrect. </li><li>Code 1 if review of site and behavior verifies that the patient has an <em>in situ</em> cancer of a nonspecific site and no further information about the primary site is available. </li></ul></tab></tab></tab></tab></tab></tab></tab></tab></tab></tab></tab></div><div class='content chap10-para'><strong>Codes </strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>1</td><td class='code-desc'>Reviewed and confirmed as reported</td></tr><tr class='code-row'><td class='code-nbr'>Blank</td><td class='code-desc'>Not reviewed or reviewed and corrected</td></tr></table></div><div class='content chap10-para'><em>Note: </em>The IF 39 edit does not allow<em> in situ </em>cases of  nonspecific sites, such as gastrointestinal tract, NOS; uterus, NOS;  female genital tract, NOS; male genital organs, NOS; and others. The  over-ride indicates that the conflict has been reviewed.</div><a name='2072'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>OVER-RIDE SITE/EOD/DX DT</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">2072</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>SEER</a></td><td style="text-align:center;">1997</td><td style="text-align:center;">5.1</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">2592 - 2592</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>Over-ride Flag for Site/EOD/Diagnosis Date (IF40) (SEER #13)<br />Over-ride Flag for Site/CS Extension/Diagnosis Date (IF176)<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>overRideSiteEodDxDt</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Some computer edits identify errors. Others indicate possible errors that require manual review for resolution. To eliminate the need to review the same cases repeatedly, over-ride flags have been developed to indicate that data in a record (or records) have been reviewed and, while unusual, are correct. <br /><br />This over-ride is used with the following edits in the NAACCR Metafile of the EDITS software:<tab><br /></tab>&nbsp;&nbsp; &nbsp;&nbsp; <tab>Primary Site, EOD, ICDO2 (SEER IF40) <br /><tab></tab></tab>&nbsp;&nbsp; &nbsp;&nbsp; <tab><tab>Primary Site, EOD, ICDO3 (SEER IF40)<tab><br /></tab></tab></tab>&nbsp;&nbsp; &nbsp;&nbsp; <tab><tab><tab>Primary Site, CS Extension (SEER IF 176) </tab></tab></tab> </div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Some edits check for code combinations that are possible, but quite rare. If the code combination generates an error message and review of the case indicates that the codes are correct for the case, then the over-ride flag is used to skip the edit in the future. See Chapter IV, Recommended Data Edits and Software Coordination of Standards.<strong><br /><br />Over-ride Flag as Used in the EDITS Software Package</strong><br />Edits of this type Primary Site, EOD do not allow &#8220;localized&#8221; disease with nonspecific sites, such as mouth, NOS; colon, NOS (except ICD-O-2 or ICD-O-3 histology 8210, 8220, 8261, or 8263); bone, NOS; female genital system, NOS; male genital organs, NOS; and others.<strong><br /><br />Instructions for Coding</strong><ul><li>Leave blank if the program does not generate an error message for the edit Primary Site, EOD, ICDO2 (SEER IF40) and/or the edit Primary Site, EOD, ICDO3 (SEER IF40).</li><li>Code 1 if the case has been reviewed and it has been verified that the patient had &#8220;localized&#8221; disease with a nonspecific site and no further information about the primary site is available.</li></ul> </div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>Blank</td><td class='code-desc'>Not reviewed or reviewed and corrected</td></tr><tr class='code-row'><td class='code-nbr'>1</td><td class='code-desc'>Reviewed and confirmed as reported</td></tr></table></div><a name='2073'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>OVER-RIDE SITE/LAT/EOD</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">2073</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>SEER</a></td><td style="text-align:center;">1997</td><td style="text-align:center;">5.1</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">2593 - 2593</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>Over-ride Flag for Site/Laterality/CS Extension (IF177)<br />Over-ride Flag for Site/Laterality/EOD (IF41)<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>overRideSiteLatEod</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'><p>Some computer edits identify errors. Others indicate possible errors that require manual review for resolution. To eliminate the need to review the same cases repeatedly, over-ride flags have been developed to indicate that data in a record (or records) have been reviewed and, while unusual, are correct. </p>  <p>This over-ride is used with the following edits in the NAACCR Metafile of the EDITS software:<tab><br /></tab>&nbsp;&nbsp; &nbsp;&nbsp; <tab>Primary Site, Laterality, EOD, ICDO2 (SEER IF41) <br /><tab></tab></tab>&nbsp;&nbsp; &nbsp;&nbsp; <tab><tab>Primary Site, Laterality, EOD, ICDO3 (SEER IF41)<tab><br /></tab></tab></tab>&nbsp;&nbsp; &nbsp;&nbsp; <tab><tab><tab>Primary Site, Laterality, CS Extension (SEER IF177) </tab></tab></tab></p> </div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Some edits check for code combinations that are possible, but quite rare. If the code combination generates an error message and review of the case indicates that the codes are correct for the case, then the over-ride flag is used to skip the edit in the future. See Chapter IV, Recommended Data Edits and Software Coordination of Standards.<strong><br /><br />Over-ride Flag as Used in the EDITS Software Package</strong><br />Edits of this type Primary Site, Laterality, EOD apply to paired organs and do not allow EOD to be specified as <em>in situ</em>, localized, or regional by direct extension if laterality is coded as &#8220;bilateral, site unknown,&#8221; or &#8220;laterality unknown.&#8221;<strong><br /><br />Instructions for Coding</strong><ul><li>Leave blank if the program does not generate an error message for the edit Primary Site, Laterality, EOD, ICDO2 (SEER IF41) and/or Primary Site, Laterality, EOD, ICDO3 (SEER IF41).</li><li>Code 1 if the case has been reviewed and it has been verified that the patient had laterality coded nonspecifically and EOD coded specifically.</li></ul> </div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>1</td><td class='code-desc'>Reviewed and confirmed as reported</td></tr><tr class='code-row'><td class='code-nbr'>Blank</td><td class='code-desc'>Not reviewed or reviewed and corrected</td></tr></table></div><a name='2074'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>OVER-RIDE SITE/LAT/MORPH</strong></td><td style="text-align:right;font-weight:bold;"><strong>Revised</strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">2074</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>SEER</a></td><td style="text-align:center;">1997</td><td style="text-align:center;">5.1</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">2594 - 2594</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>Over-ride Flag for Site/Laterality/Morphology (IF42)<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>overRideSiteLatMorph</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para mark-changed'>Some computer edits identify errors. Others indicate possible errors that require manual review for resolution. To eliminate the need to review the same cases repeatedly, over-ride flags have been developed to indicate that data in a record (or records) have been reviewed and, while unusual, are correct. <br /><br />This over-ride is used with the following edits in the NAACCR Metafile of the EDITS software:<br />&nbsp;&nbsp; &nbsp;&nbsp; <tab>Laterality, Primary Site, Morph ICDO2 (SEER IF42)<tab><br /></tab></tab>&nbsp;&nbsp; &nbsp;&nbsp; <tab><tab>Laterality, Primary Site, Morph ICDO3 (SEER IF42) </tab></tab></div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para mark-changed'>Some edits check for code combinations that are possible, but quite rare. If the code combination generates an error message and review of the case indicates that the codes are correct for the case, then the over-ride flag is used to skip the edit in the future. See Chapter IV, Recommended Data Edits and Software Coordination of Standards.<strong><br /><br />Over-ride Flag as Used in the EDITS Software Package</strong><br />Edits of the type Laterality, Primary Site, Morph differ in use of ICD-O-2 or ICD-O-3 morphology and do the following:<br /><ol><li>If the Primary Site is a paired organ and ICD-O-2 or ICD-O-3 behavior is <em>in situ</em> (2), then laterality must be 1, 2, or 3.</li><li>If diagnosis year less than 1988 and ICD-O-2 or ICD-O-3 histology = 9590, no further editing is performed.</li><li>If diagnosis year greater than 1987 and ICD-O-2 or ICD-O-3 histology = 9140, 9700, 9701, 9590-9980, no further editing is performed.</li></ol>The intent of this edit is to force review of <em>in situ</em> cases for which laterality is coded 4 (bilateral) or 9 (unknown laterality) as to origin.<tab>In rare instances when the tumor is truly midline (9) or the rare combination is otherwise confirmed correct, enter a code 1 for Override Site/Lat/Morph.<br /><br /><strong>Instructions for Coding</strong><ul><li>Leave blank if the program does not generate an error message for the edit Laterality, Primary site, Morph ICDO2 (SEER IF 42) and/or the edit Laterality, Primary site, Morph ICDO3 (SEER IF42).</li><li>Leave blank and correct any errors for the case if an item is discovered to be incorrect.</li><li>Code 1 if review of site, laterality and morphology verifies that the case had behavior code of &#8220;<em>in situ</em>&#8221; and laterality is not stated as &#8220;right: origin of primary;&#8221; &#8220;left: origin of primary;&#8221; or &#8220;only one side involved, right or left origin not specified&#8221;.</li></ul></tab></div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>Blank</td><td class='code-desc'>Not reviewed or reviewed and corrected</td></tr><tr class='code-row'><td class='code-nbr'>1</td><td class='code-desc'>Reviewed and confirmed as reported</td></tr></table></div><a name='2010'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>OVER-RIDE SITE/LAT/SEQNO</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">2010</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>SEER</a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">2584 - 2584</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>Site/Histology/Laterality/Sequence Number Interrecord Review (Interrecord Edit 09)<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>overRideSiteLatSeqno</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Some computer edits identify errors. Others indicate possible errors that require manual review for resolution. To eliminate the need to review the same cases repeatedly, over-ride flags have been developed to indicate that data in a record (or records) have been reviewed and, while unusual, are correct. <br /><br />This over-ride is used with the following Interrecord Edit from the SEER Program:&nbsp;&nbsp;&nbsp; &nbsp;&nbsp; &nbsp;&nbsp; <tab>Verify Same Primary Not Reported Twice for a Person (SEER IR09)</tab><p><tab>Presently, documentation on interrecord edits is not included in the EDITS software. </tab></p></div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Some edits check for code combinations that are possible, but quite rare. If the code combination generates an error message and review of the case indicates that the codes are correct for the case, then the over-ride flag is used to skip the edit in the future. See Chapter IV, Recommended Data Edits and Software Coordination of Standards.<strong><br />
<br />
Over-ride Flag as Used in the EDITS Software Package</strong><br />
Verify Same Primary Not Reported Twice for a Person (SEER IR09) applies to paired organs and does not allow two cases with the same primary site group, laterality and three digit histology code. This edit verifies that the same primary is not reported twice for a person.<strong><br />
<br />
Instructions for Coding</strong>
<ul>
     <li>Leave blank if the program does not generate an error message for the edit Verify Same Primary Not Reported Twice for a Person (SEER IR09).</li>
     <li>Code 1 if the case has been reviewed and it has been verified that the patient had multiple primaries of the same histology (3 digit) in the same primary site group.</li>
</ul></div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>1</td><td class='code-desc'>Reviewed and confirmed as reported</td></tr><tr class='code-row'><td class='code-nbr'>Blank</td><td class='code-desc'>Not reviewed or reviewed and corrected</td></tr></table></div><a name='1989'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>OVER-RIDE SITE/TNM-STGGRP</strong></td><td style="text-align:right;font-weight:bold;"><strong>Revised</strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">1989</td><td style="text-align:center;">1</td><td title="V: 22: NAACCR
V: 18: CoC
V: 16: CoC
V: 15: CoC
" class=" HighlightToolTip" style="text-align:center;"><a href='#sources'>NAACCR</a></td><td style="text-align:center;">2001</td><td style="text-align:center;">9</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">2578 - 2578</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>overRideSiteTnmStggrp</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Some computer edits identify errors. Others indicate possible errors that require manual review for resolution. To eliminate the need to review the same cases repeatedly, over-ride flags have been developed to indicate that data in a record (or records) have been reviewed and, while unusual, are correct. <br /><br /><div>This over-ride is used with the following edits in the NAACCR Metafile of the EDITS software:<tab></tab></div><div><tab></tab></div><div> &nbsp; &nbsp;  &nbsp; &nbsp; <tab>Primary Site, AJCC Stage Group - Ed 6, (NAACCR)</tab></div><div> &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; Primary Site, AJCC Stage Group - Ed 6, ICDO3 (CoC)</div><div> &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; Primary Site, AJCC Stage Group - Ed 7, ICDO3 (CoC)</div><div> &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; Primary Site, AJCC Stage Group - Ed 7, ICDO3 (NPCR) </div><div><tab></tab> </div></div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Some edits check for code combinations that are possible, but quite rare. If the code combination generates an error message and review of the case indicates that the codes are correct for the case, then the override flag is used to skip the edit in the future. See Chapter IV, Recommended Data Edits and Software Coordination of Standards.<strong><br /><br />Over-ride Flag as Used in the EDITS Software Package</strong><br />Edits of the type Primary Site, AJCC Stage Group - Ed 6 and Primary Site, AJCC Stage Group - Ed 7 check that the pathologic and clinical AJCC stage group codes are valid for the site and histology group according to the AJCC Cancer Staging Manual Sixth Edition and AJCC Cancer Staging Manual Seventh Edition, using the codes described for the items TNM Clin Stage Group [970] and TNM Path Stage Group [910]. Combinations of site and histology not represented in any AJCC schema must be coded 88. Unknown stage groups must be coded 99. Blanks are not permitted.<br /><br />Since pediatric cancers whose sites and histologies have an AJCC scheme may be coded according to a pediatric scheme instead, Override Site/TNM-Stage Group is used to indicate pediatric cases not coded according to the AJCC manual. Pediatric Stage groups should not be recorded in the TNM Clin Stage Group or TNM Path Stage Group items. When neither clinical nor pathologic AJCC staging is used for pediatric cases, code all AJCC items 88. When any components of either is used to stage a pediatric case, follow the instructions for coding AJCC items and leave Override Site/TNM-Stage Group blank.<br /><br /><strong>Instructions for Coding</strong><ul><li>Leave blank if the program does not generate an error message for the edits of the type Primary Site, AJCC Stage Group - Ed 6 and Primary Site, AJCC Stage Group - Ed 7.</li><li>Leave blank and correct any errors for the case if an item is discovered to be incorrect.</li><li>Code 1 if the case is confirmed to be a pediatric case that was coded using a pediatric coding system.</li></ul></div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>Blank</td><td class='code-desc'>Not reviewed or reviewed and corrected</td></tr><tr class='code-row'><td class='code-nbr'>1</td><td class='code-desc'>Reviewed and confirmed as reported</td></tr></table></div><a name='2030'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>OVER-RIDE SITE/TYPE</strong></td><td style="text-align:right;font-weight:bold;"><strong>Revised</strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">2030</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>SEER</a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">2586 - 2586</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>Site/Type Interfield Review (Interfield Edit 25)<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>overRideSiteType</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para mark-changed'>Some computer edits identify errors. Others indicate possible errors that require manual review for resolution. To eliminate the need to review the same cases repeatedly, over-ride flags have been developed to indicate that data in a record (or records) have been reviewed and, while unusual, are correct. <br /><br />This over-ride is used with the following edits in the NAACCR Metafile of the EDITS software:<tab><br /></tab>&nbsp;&nbsp; &nbsp;&nbsp; <tab>Primary Site, Morphology-Type ICDO2 (CoC)<br /><tab></tab></tab>&nbsp;&nbsp; &nbsp;&nbsp; <tab><tab>Primary Site, Morphology-Type ICDO3 (CoC)<br /><tab></tab></tab></tab>&nbsp;&nbsp; &nbsp;&nbsp; <tab><tab><tab>Primary Site, Morphology-Type ICDO2 (SEER IF25)<tab><br /></tab></tab></tab></tab>&nbsp;&nbsp; &nbsp;&nbsp; <tab><tab><tab><tab>Primary Site, Morphology-Type ICDO3 (SEER IF25)<tab><br /></tab></tab></tab></tab></tab>&nbsp;&nbsp; &nbsp;&nbsp; <tab><tab><tab><tab><tab>Primary Site, Morphology-Type, Behavior ICDO3 (SEER IF25)<tab><br /></tab></tab></tab></tab></tab></tab>&nbsp;&nbsp; &nbsp;&nbsp; <tab><tab><tab><tab><tab><tab>Primary Site, Morphology-Type, Behavior ICDO3 (CoC) </tab></tab></tab></tab></tab></tab></div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para mark-changed'>Some edits check for code combinations that are possible, but quite rare. If the code combination generates an error message and review of the case indicates that the codes are correct for the case then the over-ride flag is used to skip the edit in the future. See Chapter IV, Recommended Data Edits and Software Coordination of Standards.<strong><br /><br />Over-ride Flag as Used in the EDITS Software Package</strong><br />Multiple versions of edits of the type Primary site, Morphology-Type check for "usual" combinations of site and ICD-O-2 or ICD-O-3 histology. The SEER version of the edit is more restrictive than the CoC edit, and thus uses a different over-ride flag. The CoC version of the edit will accept Over-ride CoC-Site/Type or Over-ride Site/Type as equivalent.<br /><ol><li>The Site/Histology validation list (available on the SEER web site) contains those histologies commonly found in the specified primary site. Histologies that occur only rarely or never are not included. These edits require review of all combinations not listed.</li><li>Since basal and squamous cell carcinomas of non-genital skin sites are not reportable to SEER, these site/histology combinations do not appear on the SEER validation list. For the CoC version of the edit, if Primary Site is in the range C440-C449 (skin), and ICD-O-2 histology is in the range 8000-8004 (neoplasms, malignant, NOS), 8010-8045 (epithelial carcinomas), 8050-8082 (papillary and squamous cell carcinomas), or 8090-8110 (basal cell carcinomas), or ICD-O-3 histology is in the range 8000-8005 (neoplasms, malignant, NOS), 8010-8046 (epithelial carcinomas), 8050-8084 (papillary and squamous cell carcinomas), or 8090-8110 (basal cell carcinomas), no further editing is done. No over-ride is necessary for these cases in the CoC version of the edit.</li></ol>Review of these cases requires investigating whether a) the combination is biologically implausible, or b) there are cancer registry coding conventions that would dictate different codes for the diagnosis. Review of these rare combinations often results in changes to the primary site and/or morphology, rather than a decision that the combination is correct.<br /><br /><strong>Instructions for Coding</strong><ul><li>Leave blank if the program does not generate an error message for the edits of the type Primary Site, Morphology-Type.</li><li>Leave blank and correct any errors for the case if an item is discovered to be incorrect.</li><li>Code 1 if the case has been reviewed and both the site and histology are correct.</li></ul></div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>1</td><td class='code-desc'>Reviewed and confirmed as reported</td></tr><tr class='code-row'><td class='code-nbr'>Blank</td><td class='code-desc'>Not reviewed or reviewed and corrected</td></tr></table></div><a name='1984'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>OVER-RIDE SS/DISMET1</strong></td><td style="text-align:right;font-weight:bold;"><strong>Retired</strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">1984</td><td style="text-align:center;"></td><td style="text-align:center;"><a href='#sources'></a></td><td style="text-align:center;">2001</td><td style="text-align:center;">9</td><td style="text-align:center;">2010</td><td style="text-align:center;">12</td><td class="cross-out" style="text-align:center;"></td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td></td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td></td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>The NAACCR UDSC retired this data item in Version 12, as of January 1, 2010.</div><a name='1981'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>OVER-RIDE SS/NODESPOS</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">1981</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>NAACCR</a></td><td style="text-align:center;">2001</td><td style="text-align:center;">9</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">2571 - 2571</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>Over-ride Summary Stage/Nodes Positive<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>overRideSsNodespos</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Some computer edits identify errors. Others indicate possible errors that require manual review for resolution. To eliminate the need to review the same cases repeatedly, over-ride flags have been developed to indicate that data in a record (or records) have been reviewed and, while unusual, are correct. <br /><br />This over-ride is used with the following edits in the NAACCR Metafile of the EDITS software:<tab><br /></tab>&nbsp;&nbsp; &nbsp;&nbsp; <tab>Summary Stage 1977, Regional Nodes Pos (NAACCR)<br /></tab>&nbsp;&nbsp; &nbsp;&nbsp; <tab><tab>Summary Stage 2000, Regional Nodes Pos (NAACCR) </tab></tab></div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Some edits check for code combinations that are possible, but quite rare. If the code combination generates an error or warning message and review of the case indicates that the codes are correct for the case, then the over-ride flag is used to skip the edit in the future. See Chapter IV, Recommended Data Edits and Software Coordination of Standards.<strong><br /><br />Over-ride Flag as Used in the EDITS Software Package</strong><br />The edit Summary Stage 1977, Regional Nodes Pos (NAACCR) checks SEER Summary Stage 1977 against Regional Nodes Positive and generates an error or warning if there is an incompatibility between the two data items. The edit Summary Stage 2000, Regional Nodes Pos (NAACCR) checks SEER Summary Stage 2000 against Regional Nodes Positive and generates an error or warning if there is an incompatibility between the two data items.<strong><br /><br />Instructions for Coding</strong><ul><li>Leave blank if the program does not generate an error message for the edit Summary Stage 1977, Regional Nodes Pos (NAACCR) or the edit Summary Stage 2000, Regional Nodes Pos (NAACCR).</li><li>Leave blank and correct any errors for the case if an item is discovered to be incorrect.</li><li>Code 1 if the case has been reviewed and it has been verified that the case has both SEER Summary Stage 1977 and Nodes Positive coded correctly or SEER Summary Stage 2000 and Nodes Positive coded correctly.</li></ul></div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>1</td><td class='code-desc'>Reviewed and confirmed as reported</td></tr><tr class='code-row'><td class='code-nbr'>Blank</td><td class='code-desc'>Not reviewed or reviewed and corrected</td></tr></table></div><a name='1983'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>OVER-RIDE SS/TNM-M</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">1983</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>NAACCR</a></td><td style="text-align:center;">2001</td><td style="text-align:center;">9</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">2573 - 2573</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>Over-ride Summary Stage/TNM-M<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>overRideSsTnmM</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Some computer edits identify errors. Others indicate possible errors that require manual review for resolution. To eliminate the need to review the same cases repeatedly, over-ride flags have been developed to indicate that data in a record (or records) have been reviewed and, while unusual, are correct. <br /><br />This over-ride is used with the following edits in the NAACCR Metafile of the EDITS software:<br />&nbsp;&nbsp; &nbsp;&nbsp; <tab>Summary Stage 1977, TNM-M (NAACCR) <br /><tab></tab></tab>&nbsp;&nbsp; &nbsp;&nbsp; <tab><tab>Summary Stage 2000, TNM-M (NAACCR) </tab></tab></div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Some edits check for code combinations that are possible, but quite rare. If the code combination generates an error or warning message and review of the case indicates that the codes are correct for the case, then the over-ride flag is used to skip the edit in the future. See Chapter IV, Recommended Data Edits and Software Coordination of Standards.<strong><br /><br />Over-ride Flag as Used in the EDITS Software Package</strong><br />The edit Summary Stage 1977, TNM-M (NAACCR) checks the SEER Summary Stage 1977 against the TNM-M and generates a warning if the SEER Summary Stage 1977 is &#8216;distant&#8217; and the TNM-M is &#8216;0&#8217;. (TNM-M is derived from TNM Path M and TNM Clin M, with TNM Path M having precedence.) It also checks if the SEER Summary Stage 1977 is not &#8216;distant&#8217; and the TNM-M is greater than or equal to &#8216;1&#8217; and generates an error or a warning. The edit Summary Stage 2000, TNM-M (NAACCR) checks the SEER Summary Stage 2000 against the TNM-M and generates a warning if the SEER Summary Stage 2000 is &#8216;distant&#8217; and the TNM-M is &#8216;0&#8217;. It also checks if the SEER Summary Stage 2000 is not &#8216;distant&#8217; and the TNM-M is greater than or equal to &#8216;1&#8217; and generates an error or a warning.<strong><br /><br />Instructions for Coding</strong><ul><li>Leave blank if the program does not generate an error message for the edit Summary Stage 1977, TNM-M (NAACCR) or the edit Summary Stage 2000, TNM-M (NAACCR).</li><li>Leave blank and correct any errors for the case if an item is discovered to be incorrect.</li><li>Code 1 if the case has been reviewed and it has been verified that both SEER Summary Stage 1977 and TNM-M have been coded correctly or that SEER Summary Stage 2000 and TNM-M have been coded correctly.</li></ul></div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>1</td><td class='code-desc'>Reviewed and confirmed as reported</td></tr><tr class='code-row'><td class='code-nbr'>Blank</td><td class='code-desc'>Not reviewed or reviewed and corrected</td></tr></table></div><a name='1982'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>OVER-RIDE SS/TNM-N</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">1982</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>NAACCR</a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">2572 - 2572</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>Over-ride Summary Stage/TNM-N<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>overRideSsTnmN</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Some computer edits identify errors. Others indicate possible errors that require manual review for resolution. To eliminate the need to review the same cases repeatedly, over-ride flags have been developed to indicate that data in a record (or records) have been reviewed and, while unusual, are correct. <br /><br />This over-ride is used with the following edits in the NAACCR Metafile of the EDITS software:<br />&nbsp;&nbsp; &nbsp;&nbsp; <tab>Summary Stage 1977, TNM-N (NAACCR) <br /><tab></tab></tab>&nbsp;&nbsp; &nbsp;&nbsp; <tab><tab>Summary Stage 2000, TNM-N (NAACCR) </tab></tab></div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Some edits check for code combinations that are possible, but quite rare. If the code combination generates an error message and review of the case indicates that the codes are correct for the case, then the over-ride flag is used to skip the edit in the future. See Chapter IV, Recommended Data Edits and Software Coordination of Standards.<strong><br /><br />Over-ride Flag as Used in the EDITS Software Package</strong><br />The edit Summary Stage 1977, TNM-N (NAACCR) checks SEER Summary Stage 1977 against the TNM-N and generates an error if the SEER Summary Stage 1977 indicates regional nodal involvement and the TNM-N does not. (TNM-N is derived from TNM Path N and TNM Clin N, with TNM Path N having precedence.) It also generates an error if the SEER Summary Stage 1977 is &#8216;<em>in situ</em>&#8217; or &#8216;localized&#8217; and the TNM-N is greater than or equal to &#8216;1&#8217;. The edit Summary Stage 2000, TNM-N (NAACCR) checks SEER Summary Stage 2000 against the TNM-N and generates an error if the SEER Summary Stage 2000 indicates regional nodal involvement and the TNM-N does not. It also generates an error if the SEER Summary Stage 2000 is &#8216;<em>in situ</em>&#8217; or &#8216;localized&#8217; and the TNM-N is greater than or equal to &#8216;1&#8217;.<br /><br /><strong>Instructions for Coding</strong><ul><li>Leave blank if the program does not generate an error message for the edit Summary Stage 1977, TNM-N (NAACCR) or the edit Summary Stage 2000, TNM-N (NAACCR).</li><li>Leave blank and correct any errors for the case if an item is discovered to be incorrect.</li><li>Code 1 if the case has been reviewed and it has been verified that both SEER Summary Stage 1977 and TNM-N or both SEER Summary Stage 2000 and TNM-N have been coded correctly.</li></ul></div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>Blank</td><td class='code-desc'>Not reviewed or reviewed and corrected</td></tr><tr class='code-row'><td class='code-nbr'>1</td><td class='code-desc'>Reviewed and confirmed as reported</td></tr></table></div><a name='2020'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>OVER-RIDE SURG/DXCONF</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">2020</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>SEER</a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">2585 - 2585</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>Surgery/Diagnostic Confirmation Interfield Review (Interfield Edit 46)<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>overRideSurgDxconf</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Some computer edits identify errors. Others indicate possible errors that require manual review for resolution. To eliminate the need to review the same cases repeatedly, over-ride flags have been developed to indicate that data in a record (or records) have been reviewed and, while unusual, are correct. <br /><br />This over-ride is used with the following edits in the NAACCR Metafile of the EDITS software:<br />&nbsp;&nbsp; &nbsp;&nbsp; <tab>RX Summ--Surg Prim Site, Diag Conf (SEER IF76)<tab><br /></tab></tab>&nbsp;&nbsp; &nbsp;&nbsp; <tab><tab>RX Summ--Surg Site 98-02, Diag Conf (SEER IF106)<tab><br /></tab></tab></tab>&nbsp;&nbsp; &nbsp;&nbsp; <tab><tab><tab>RX Summ--Surgery Type, Diag Conf (SEER IF46) </tab></tab></tab></div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Some edits check for code combinations that are possible, but quite rare. If the code combination generates an error message and review of the case indicates that the codes are correct for the case, then the over-ride flag is used to skip the edit in the future. See Chapter IV, Recommended Data Edits and Software Coordination of Standards.<br /><br /><strong>Over-ride Flag as Used in the EDITS Software Package</strong><br />Edits of the type RX Summ--Surg Prim Site, Diag Conf check that cases with a primary site surgical procedure coded 20-90 are histologically confirmed. <tab>If the patient had a surgical procedure, most likely there was a microscopic examination of the cancer. Verify the surgery and diagnostic confirmation codes, and correct any errors. Sometimes there are valid reasons why no microscopic confirmation is achieved with the surgery; for example, the tissue removed may be inadequate for evaluation.<br /><br /><strong>Instructions for Coding</strong><ul><li>Leave blank if the program does not generate an error message for edits of the type, RX Summ--Surg Prim Site, Diag Conf.</li><li>Leave blank and correct any errors for the case if an item is discovered to be incorrect.</li><li>Code 1 if review confirms that they are correct. The patient had surgery, but the tissue removed was not sufficient for microscopic confirmation.</li></ul></tab></div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>Blank</td><td class='code-desc'>Not reviewed or reviewed and corrected</td></tr><tr class='code-row'><td class='code-nbr'>1</td><td class='code-desc'>Reviewed and confirmed as reported</td></tr></table></div><a name='1994'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>OVER-RIDE TNM 3</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">1994</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>NAACCR</a></td><td style="text-align:center;">2018</td><td style="text-align:center;">18</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">2582 - 2582</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>overRideTnm3</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Some computer edits identify errors. Others indicate possible errors that require manual review for resolution. To eliminate the need to review the same cases repeatedly, over-ride flags have been developed to indicate that data in a record (or records) have been reviewed and, while unusual, are correct.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Some edits check for code combinations that are possible, but quite rare. If the code combination generates an error message and review of the case indicates that the codes are correct for the case, then the over-ride flag is used to skip the edit in the future.</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>1</td><td class='code-desc'>Reviewed and confirmed as reported </td></tr><tr class='code-row'><td class='code-nbr'>Blank</td><td class='code-desc'>Not reviewed or reviewed and corrected</td></tr><tr class='code-row'><td class='code-nbr' colspan='2'></td></tr></table></div><a name='1992'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>OVER-RIDE TNM STAGE</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">1992</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>NAACCR</a></td><td style="text-align:center;">2018</td><td style="text-align:center;">18</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">2580 - 2580</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>overRideTnmStage</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Some computer edits identify errors. Others indicate possible errors that require manual review for resolution. To eliminate the need to review the same cases repeatedly, over-ride flags have been developed to indicate that data in a record (or records) have been reviewed and, while unusual, are correct.<br /><br /><div>This over-ride is used with the following edits in the NAACCR Metafile of the EDITS software:</div><div><ul><li>Primary Site, TNM Clin Stage Valid A- Ed 7 (CoC)</li><li>Primary Site, TNM Clin Stage Valid B- Ed 7 (CoC)</li><li>Primary Site, TNM Path Stage Valid A- Ed 7 (CoC)</li><li>Primary Site, TNM Path Stage Valid B- Ed 7 (CoC)</li></ul>These edits check T, N, and M combinations against stage group. Adding this over-ride allows the edit to pass when combinations of T, N, and M are entered that are not included in the stage tables used with the edits.&nbsp;</div><div>&nbsp;</div></div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>This over-ride will allow registrars to enter combination of T, N, and M with a stage group that differs from the combinations documented in the AJCC Staging Manual.</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>1</td><td class='code-desc'>Reviewed and confirmed as reported </td></tr><tr class='code-row'><td class='code-nbr'>Blank</td><td class='code-desc'>Not reviewed or reviewed and corrected</td></tr><tr class='code-row'><td class='code-nbr' colspan='2'></td></tr></table></div><a name='1993'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>OVER-RIDE TNM TIS</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">1993</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>NAACCR</a></td><td style="text-align:center;">2018</td><td style="text-align:center;">18</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">2581 - 2581</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>overRideTnmTis</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Some computer edits identify errors. Others indicate possible errors that require manual review for resolution. To eliminate the need to review the same cases repeatedly, over-ride flags have been developed to indicate that data in a record (or records) have been reviewed and, while unusual, are correct.<br /><br /><div>This over-ride is used with the following edits in the NAACCR Metafile of the EDITS software:</div><div><ul><li>TNM Clin T, N, M, In Situ (CoC)</li><li>TNM Path T, N, M, In Situ (CoC)</li></ul>If the patient has a T value indicating in situ/ noninvasive, this edit verifies that the N, M, and stage group reflect in situ/noninvasive disease. However, there are certain circumstances where AJCC does allow a T value indicating in situ/noninvasive and N, M, and/or stage group that indicates invasive disease. An over-ride is required to accommodate these situations.</div><div>&nbsp;</div></div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>This over-ride will allow registrars to enter combination of T, N, and M with a stage group that differs from the combinations documented in the AJCC Staging Manual.</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>1</td><td class='code-desc'>Reviewed and confirmed as reported </td></tr><tr class='code-row'><td class='code-nbr'>Blank</td><td class='code-desc'>Not reviewed or reviewed and corrected</td></tr><tr class='code-row'><td class='code-nbr' colspan='2'></td></tr></table></div><a name='3260'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>PAIN ASSESSMENT</strong></td><td style="text-align:right;font-weight:bold;"><strong>Retired</strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">3260</td><td style="text-align:center;"></td><td style="text-align:center;"><a href='#sources'></a></td><td style="text-align:center;">2003</td><td style="text-align:center;">10</td><td style="text-align:center;">2004</td><td style="text-align:center;">10.1</td><td class="cross-out" style="text-align:center;"></td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td></td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td></td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>This data item was published in 
<em>FORDS</em> but later withdrawn by CoC and never implemented. The NAACCR UDSC retired this data item in Version 10.1, as of January 1, 2004.</div><a name='7320'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>PATH DATE SPEC COLLECT 1</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">7320</td><td style="text-align:center;">14</td><td style="text-align:center;"><a href='#sources'>HL7</a></td><td style="text-align:center;">2010</td><td style="text-align:center;">12</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">6200 - 6213</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>OBR-7 Observation Date/Time #00241 (HL7)<br />Path--Date Spec Collection<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>pathDateSpecCollect1</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'><div>Records the date and time the specimen for the report on the cancer &nbsp;was collected, not the date read, interpreted or typed.<div> &nbsp;</div><div>This is a field to record when specimens are collected; can be used as approximate date of diagnosis in absence of other information. HL7 OBR-7 records the date and time (YYYYMMDDHHMMSS). NAACCR records the date (YYYYMMDD).</div><div> &nbsp;</div><div>This data item accommodates only one path report. If additional reports were prepared, enter the date specimen collected in Path Date Spec Collect 2 through Path Date Spec Collect 5 [7321 - 7324]. Information in this data item should refer to the path report described in data items 7010, 7090, 7100, 7190 and 7480.</div></div></div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Cancer registries collect cancer information from various sources including pathology laboratories. Pathology reports of different types may be sent via HL7 messages. Included here are data items coming from such a message to be included in the cancer registry database to aid in consolidating a cancer case when there is information from multiple sources. Traditionally, these data items were not part of the NAACCR Standards Volume II record layout and therefore provide a link to NAACCR Standards Volume V. 


<a href="http://www.naaccr.org/standardsandregistryoperations/volumev.aspx">http://www.naaccr.org/standardsandregistryoperations/volumev.aspx</a></div><a name='7321'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>PATH DATE SPEC COLLECT 2</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">7321</td><td style="text-align:center;">14</td><td style="text-align:center;"><a href='#sources'>HL7</a></td><td style="text-align:center;">2010</td><td style="text-align:center;">12</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">6306 - 6319</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>Path--Date Spec Collection<br />OBR-7 Observation Date/Time #00241 (HL7)<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>pathDateSpecCollect2</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'><div>Records the date and time the specimen for the report on the cancer was collected, not the date read, interpreted or typed.<br /><br /><div> </div><div> </div></div><div><div>This data item accommodates only one path report; if additional path reports were prepared, enter the date the specimen was collected in Path Date Spec Collect No 3 through Path Date Spec Collect No 5 [7322-7324]. Information in this data item should refer to the path report described in data items 7011, 7091, 7101, 7191, and 7481.</div><div> &nbsp;</div></div><div><div>This is a field to record when specimens are collected; can be used as approximate date of diagnosis in absence of other information. HL7 OBR-7 records the date and time (YYYYMMDDHHMMSS). NAACCR records the date (YYYYMMDD).</div></div>  <div>  </div> </div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Cancer registries collect cancer information from various sources including pathology laboratories. Pathology reports of different types may be sent via HL7 messages. Included here are data items coming from such a message to be included in the cancer registry database to aid in consolidating a cancer case when there is information from multiple sources. Traditionally, these data items were not part of the NAACCR Standards Volume II record layout and therefore provide a link to NAACCR Standards Volume V. 



<a href="http://www.naaccr.org/standardsandregistryoperations/volumev.aspx">http://www.naaccr.org/standardsandregistryoperations/volumev.aspx</a></div><a name='7322'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>PATH DATE SPEC COLLECT 3</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">7322</td><td style="text-align:center;">14</td><td style="text-align:center;"><a href='#sources'>HL7</a></td><td style="text-align:center;">2010</td><td style="text-align:center;">12</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">6412 - 6425</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>OBR-7 Observation Date/Time #00241 (HL7)<br />Path--Date Spec Collection<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>pathDateSpecCollect3</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'><div>Records the date and time the specimen for the report on the cancer was collected, not the date read, interpreted or typed.<div> </div></div><div> &nbsp;</div><div><div>This is a field to record when specimens are collected; can be used as approximate date of diagnosis in absence of other information. HL7 OBR-7 records the date and time (YYYYMMDDHHMMSS). NAACCR records the date (YYYYMMDD).</div></div>  <div>    <p>This data item accommodates only one path report; if additional path reports were prepared, enter the date the specimen was collected in Path Date Spec Collect No 4 through Path Date Spec Collect No 5 [7323-7324]. Information in this data item should refer to the path report described in data items 7012, 7092, 7102, 7192, and 7482.<br /></p></div> </div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Cancer registries collect cancer information from various sources including pathology laboratories. Pathology reports of different types may be sent via HL7 messages. Included here are data items coming from such a message to be included in the cancer registry database to aid in consolidating a cancer case when there is information from multiple sources. Traditionally, these data items were not part of the NAACCR Standards Volume II record layout and therefore provide a link to NAACCR Standards Volume V. 



<a href="http://www.naaccr.org/standardsandregistryoperations/volumev.aspx">http://www.naaccr.org/standardsandregistryoperations/volumev.aspx</a></div><a name='7323'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>PATH DATE SPEC COLLECT 4</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">7323</td><td style="text-align:center;">14</td><td style="text-align:center;"><a href='#sources'>HL7</a></td><td style="text-align:center;">2010</td><td style="text-align:center;">12</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">6518 - 6531</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>Path--Date Spec Collection<br />OBR-7 Observation Date/Time #00241 (HL7)<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>pathDateSpecCollect4</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'><div>Records the date and time the specimen for the report on the cancer was collected, not the date read, interpreted or typed.<div> </div></div><div> &nbsp;</div><div><div>This is a field to record when specimens are collected; can be used as approximate date of diagnosis in absence of other information. HL7 OBR-7 records the date and time (YYYYMMDDHHMMSS). NAACCR records the date (YYYYMMDD).</div></div>  <div> &nbsp;</div>  <div>    <div>This data item accommodates only one path report; if additional path reports were prepared, enter the date the specimen was collected in Path Date Spec Collect No 5 [7324]. Information in this data item should refer to the path report described in data items 7013, 7093, 7103, 7193, and 7483.</div></div> </div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Cancer registries collect cancer information from various sources including pathology laboratories. Pathology reports of different types may be sent via HL7 messages. Included here are data items coming from such a message to be included in the cancer registry database to aid in consolidating a cancer case when there is information from multiple sources. Traditionally, these data items were not part of the NAACCR Standards Volume II record layout and therefore provide a link to NAACCR Standards Volume V. 


<a href="http://www.naaccr.org/standardsandregistryoperations/volumev.aspx">http://www.naaccr.org/standardsandregistryoperations/volumev.aspx</a></div><a name='7324'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>PATH DATE SPEC COLLECT 5</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">7324</td><td style="text-align:center;">14</td><td style="text-align:center;"><a href='#sources'>HL7</a></td><td style="text-align:center;">2010</td><td style="text-align:center;">12</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">6624 - 6637</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>OBR-7 Observation Date/Time #00241 (HL7)<br />Path--Date Spec Collection<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>pathDateSpecCollect5</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'><div>Records the date and time the specimen for the report on the cancer was collected, not the date read, interpreted or typed.<div> </div></div><div> &nbsp;</div><div><div>This is a field to record when specimens are collected; can be used as approximate date of diagnosis in absence of other information. HL7 OBR-7 records the date and time (YYYYMMDDHHMMSS). NAACCR records the date (YYYYMMDD).</div></div>  <div>    <p>This data item accommodates only one path report. Information in this data item should refer to the path report described in data items 7014, 7094, 7104, 7194, and 7484.<br /></p></div> </div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Cancer registries collect cancer information from various sources including pathology laboratories. Pathology reports of different types may be sent via HL7 messages. Included here are data items coming from such a message to be included in the cancer registry database to aid in consolidating a cancer case when there is information from multiple sources. Traditionally, these data items were not part of the NAACCR Standards Volume II record layout and therefore provide a link to NAACCR Standards Volume V. 


<a href="http://www.naaccr.org/standardsandregistryoperations/volumev.aspx">http://www.naaccr.org/standardsandregistryoperations/volumev.aspx</a></div><a name='7100'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>PATH ORDER PHYS LIC NO 1</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">7100</td><td style="text-align:center;">20</td><td style="text-align:center;"><a href='#sources'>HL7</a></td><td style="text-align:center;">2010</td><td style="text-align:center;">12</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">6241 - 6260</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>OBR-16 Ordering Provider (License Number) #00226<br />Path Ordering Client/Phys--Lic No.<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>pathOrderPhysLicNo1</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>License number of physician submitting specimens for the first path report. <br /><br />This data item accommodates only one path report. If additional reports were prepared, enter the license number of physician in Path Order Phys Lic No 2 through Path Order Phys Lic No 5 [7101-7104]. Information in this data item should refer to the path report described in data items 7010, 7090, 7190, 7320, and 7480. </div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Cancer registries collect cancer information from various sources including pathology laboratories. Pathology reports of different types may be sent via HL7 messages. Included here are data items coming from such a message to be included in the cancer registry database to aid in consolidating a cancer case when there is information from multiple sources. Traditionally, these data items were not part of the NAACCR Standards Volume II record layout and therefore provide a link to NAACCR Standards Volume V. 

<a href="http://www.naaccr.org/standardsandregistryoperations/volumev.aspx">http://www.naaccr.org/standardsandregistryoperations/volumev.aspx</a></div><a name='7101'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>PATH ORDER PHYS LIC NO 2</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">7101</td><td style="text-align:center;">20</td><td style="text-align:center;"><a href='#sources'>HL7</a></td><td style="text-align:center;">2010</td><td style="text-align:center;">12</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">6347 - 6366</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>Path Ordering Client/Phys--Lic No.<br />OBR-16 Ordering Provider (License Number) #00226<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>pathOrderPhysLicNo2</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>License number of physician submitting specimens for the second path report. <br /><br />This data item accommodates only one path report; if additional path reports were prepared, enter the license number of physician in Path Order Phys Lic No 3 through Path Order Phys Lic No 5 [7102-7104]. Information in this data item should refer to the path report described in data items 7011, 7091, 7191, 7321, and 7481. </div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Cancer registries collect cancer information from various sources including pathology laboratories. Pathology reports of different types may be sent via HL7 messages. Included here are data items coming from such a message to be included in the cancer registry database to aid in consolidating a cancer case when there is information from multiple sources. Traditionally, these data items were not part of the NAACCR Standards Volume II record layout and therefore provide a link to NAACCR Standards Volume V. 

<a href="http://www.naaccr.org/standardsandregistryoperations/volumev.aspx">http://www.naaccr.org/standardsandregistryoperations/volumev.aspx</a></div><a name='7102'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>PATH ORDER PHYS LIC NO 3</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">7102</td><td style="text-align:center;">20</td><td style="text-align:center;"><a href='#sources'>HL7</a></td><td style="text-align:center;">2010</td><td style="text-align:center;">12</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">6453 - 6472</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>OBR-16 Ordering Provider (License Number) #00226<br />Path Ordering Client/Phys--Lic No.<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>pathOrderPhysLicNo3</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>License number of physician submitting specimens for the third path report. <br /><br />This item accommodates only one path report; if additional path reports were prepared, enter the license number of physician in Path Order Phys Lic No 4 through Path Order Phys Lic No 5 [7103-7104]. Information in this data item should refer to the path report described in data items 7012, 7022, 7192, 7322, and 7482. </div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Cancer registries collect cancer information from various sources including pathology laboratories. Pathology reports of different types may be sent via HL7 messages. Included here are data items coming from such a message to be included in the cancer registry database to aid in consolidating a cancer case when there is information from multiple sources. Traditionally, these data items were not part of the NAACCR Standards Volume II record layout and therefore provide a link to NAACCR Standards Volume V. 

<a href="http://www.naaccr.org/standardsandregistryoperations/volumev.aspx">http://www.naaccr.org/standardsandregistryoperations/volumev.aspx</a></div><a name='7103'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>PATH ORDER PHYS LIC NO 4</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">7103</td><td style="text-align:center;">20</td><td style="text-align:center;"><a href='#sources'>HL7</a></td><td style="text-align:center;">2010</td><td style="text-align:center;">12</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">6559 - 6578</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>Path Ordering Client/Phys--Lic No.<br />OBR-16 Ordering Provider (License Number) #00226<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>pathOrderPhysLicNo4</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>License number of physician submitting specimens for the fourth path report. <br /><br />This data item accommodates only one path report; if an additional path report was prepared, enter the license number of physician in Path Order Phys Lic No 5 [7104]. Information in this data item should refer to the path report described in data items 7013, 7023, 7193, 7323, and 7483. </div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Cancer registries collect cancer information from various sources including pathology laboratories. Pathology reports of different types may be sent via HL7 messages. Included here are data items coming from such a message to be included in the cancer registry database to aid in consolidating a cancer case when there is information from multiple sources. Traditionally, these data items were not part of the NAACCR Standards Volume II record layout and therefore provide a link to NAACCR Standards Volume V. 

<a href="http://www.naaccr.org/standardsandregistryoperations/volumev.aspx">http://www.naaccr.org/standardsandregistryoperations/volumev.aspx</a></div><a name='7104'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>PATH ORDER PHYS LIC NO 5</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">7104</td><td style="text-align:center;">20</td><td style="text-align:center;"><a href='#sources'>HL7</a></td><td style="text-align:center;">2010</td><td style="text-align:center;">12</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">6665 - 6684</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>pathOrderPhysLicNo5</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>License number of physician submitting specimens for the fifth path report. <br /><br />Information in this data item should refer to the path report described in data items 7014, 7024, 7194, 7324, and 7484. </div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Cancer registries collect cancer information from various sources including pathology laboratories. Pathology reports of different types may be sent via HL7 messages. Included here are data items coming from such a message to be included in the cancer registry database to aid in consolidating a cancer case when there is information from multiple sources. Traditionally, these data items were not part of the NAACCR Standards Volume II record layout and therefore provide a link to NAACCR Standards Volume V. 

<a href="http://www.naaccr.org/standardsandregistryoperations/volumev.aspx">http://www.naaccr.org/standardsandregistryoperations/volumev.aspx</a></div><a name='7190'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>PATH ORDERING FAC NO 1</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">7190</td><td style="text-align:center;">25</td><td style="text-align:center;"><a href='#sources'>HL7</a></td><td style="text-align:center;">2010</td><td style="text-align:center;">12</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">6216 - 6240</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>ORC-21 Ordering Facility Name #01311 (HL7)<br />Path Ordering Facility Number (AHA Number)<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>pathOrderingFacNo1</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Facility ID number of the facility where the specimen described in the first path report was removed/collected. <br /><br />Use the National Provider Identifier (NPI) if possible. Otherwise, use a number defined by the American Hospital Association (AHA), or some other standard-setting organization such as the American College of Surgeons (ACoS) or Clinical Laboratory Improvement Amendments (CLIA). <br /><br />This item accommodates only one path report; if additional path reports were prepared, enter the facility ID number(s) in Path Ordering Fac No 2 through Path Ordering Fac No 5 [7191-7194]. Information in this data item should refer to the path report described in data items 7010, 7090, 7100, 7320, and 7480. </div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'><div> The facility where the specimen was obtained is most likely the location of the medical record for the patient as well as any residual tissue. </div><div><br />Cancer registries collect cancer information from various sources including pathology laboratories. Pathology reports of different types may be sent via HL7 messages. Included here are data items coming from such a message to be included in the cancer registry database to aid in consolidating a cancer case when there is information from multiple sources. Traditionally, these data items were not part of the NAACCR Standards Volume II record layout and therefore provide a link to NAACCR Standards Volume V. <a href="http://www.naaccr.org/standardsandregistryoperations/volumev.aspx">http://www.naaccr.org/standardsandregistryoperations/volumev.aspx</a> </div> </div><a name='7191'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>PATH ORDERING FAC NO 2</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">7191</td><td style="text-align:center;">25</td><td style="text-align:center;"><a href='#sources'>HL7</a></td><td style="text-align:center;">2010</td><td style="text-align:center;">12</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">6322 - 6346</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>Path Ordering Facility Number (AHA Number)<br />ORC-21 Ordering Facility Name #01311 (HL7)<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>pathOrderingFacNo2</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Facility ID number of the facility where the specimen described in the second path report was removed/collected. Use the National Provider Identifier (NPI) if possible. Otherwise, use a number defined by the American Hospital Association (AHA), or some other standard-setting organization such as the American College of Surgeons (ACoS) or Clinical Laboratory Improvement Amendments (CLIA).This item accommodates only one path report; if additional path reports were prepared, enter the facility ID number(s) in Path Ordering Fac No 3 through Path Ordering Fac No 5 [7192-7194]. Information in this data item should refer to the path report described in data items 7011, 7091, 7101, 7321, and 7481. </div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>The facility where the specimen was obtained is most likely the location of the medical record for the patient as well as any residual tissue. 

<div><br />Cancer registries collect cancer information from various sources including pathology laboratories. Pathology reports of different types may be sent via HL7 messages. Included here are data items coming from such a message to be included in the cancer registry database to aid in consolidating a cancer case when there is information from multiple sources. Traditionally, these data items were not part of the NAACCR Standards Volume II record layout and therefore provide a link to NAACCR Standards Volume V. <a href="http://www.naaccr.org/standardsandregistryoperations/volumev.aspx">http://www.naaccr.org/standardsandregistryoperations/volumev.aspx</a></div></div><a name='7192'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>PATH ORDERING FAC NO 3</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">7192</td><td style="text-align:center;">25</td><td style="text-align:center;"><a href='#sources'>HL7</a></td><td style="text-align:center;">2010</td><td style="text-align:center;">12</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">6428 - 6452</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>ORC-21 Ordering Facility Name #01311 (HL7)<br />Path Ordering Facility Number (AHA Number)<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>pathOrderingFacNo3</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Facility ID number of the facility where the specimen described in the third path report was removed/collected.<br /><br />Use the National Provider Identifier (NPI) if possible. Otherwise, use a number defined by the American Hospital Association (AHA), or some other standard-setting organization such as the American College of Surgeons (ACoS) or Clinical Laboratory Improvement Amendments (CLIA).<br /><br />This item accommodates only one path report; if additional path reports were prepared, enter the facility ID number(s) in Path Ordering Fac No 4 through Path Ordering Fac No 5 [7193-7194]. Information in this data item should refer to the path report described in data items 7012, 7092, 7102, 7322, and 7482. </div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>The facility where the specimen was obtained is most likely the location of the medical record for the patient as well as any residual tissue. 

<div><br />Cancer registries collect cancer information from various sources including pathology laboratories. Pathology reports of different types may be sent via HL7 messages. Included here are data items coming from such a message to be included in the cancer registry database to aid in consolidating a cancer case when there is information from multiple sources. Traditionally, these data items were not part of the NAACCR Standards Volume II record layout and therefore provide a link to NAACCR Standards Volume V. <a href="http://www.naaccr.org/standardsandregistryoperations/volumev.aspx">http://www.naaccr.org/standardsandregistryoperations/volumev.aspx</a></div></div><a name='7193'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>PATH ORDERING FAC NO 4</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">7193</td><td style="text-align:center;">25</td><td style="text-align:center;"><a href='#sources'>HL7</a></td><td style="text-align:center;">2010</td><td style="text-align:center;">12</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">6534 - 6558</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>Path Ordering Facility Number (AHA Number)<br />ORC-21 Ordering Facility Name #01311 (HL7)<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>pathOrderingFacNo4</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Facility ID number of the facility where the specimen described in the fourth path report was removed/collected. <br /><br />Use the National Provider Identifier (NPI) if possible. Otherwise, use a number defined by the American Hospital Association (AHA), or some other standard-setting organization such as the American College of Surgeons (ACoS) or Clinical Laboratory Improvement Amendments (CLIA).<br /><br />This item accommodates only one path report; if an additional path report was prepared, enter the facility ID number in Path Ordering Fac No 5 [7194]. Information in this data item should refer to the path report described in data items 7013, 7093, 7103, 7323, and 7483.  </div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>The facility where the specimen was obtained is most likely the location of the medical record for the patient as well as any residual tissue. 


<div><br />Cancer registries collect cancer information from various sources including pathology laboratories. Pathology reports of different types may be sent via HL7 messages. Included here are data items coming from such a message to be included in the cancer registry database to aid in consolidating a cancer case when there is information from multiple sources. Traditionally, these data items were not part of the NAACCR Standards Volume II record layout and therefore provide a link to NAACCR Standards Volume V. <a href="http://www.naaccr.org/standardsandregistryoperations/volumev.aspx">http://www.naaccr.org/standardsandregistryoperations/volumev.aspx</a></div></div><a name='7194'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>PATH ORDERING FAC NO 5</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">7194</td><td style="text-align:center;">25</td><td style="text-align:center;"><a href='#sources'>HL7</a></td><td style="text-align:center;">2010</td><td style="text-align:center;">12</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">6640 - 6664</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>ORC-21 Ordering Facility Name #01311 (HL7)<br />Path Ordering Facility Number (AHA Number)<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>pathOrderingFacNo5</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Facility ID number of the facility where the specimen described in the fifth path report was removed/collected. <br /><br />Use the National Provider Identifier (NPI) if possible. Otherwise, use a number defined by the American Hospital Association (AHA), or some other standard-setting organization such as the American College of Surgeons (ACoS) or Clinical Laboratory Improvement Amendments (CLIA).<br /><br />This item accommodates only one path report. Information in this data item should refer to the path report described in data items 7014, 7094, 7104, 7324, and 7484. </div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>The facility where the specimen was obtained is most likely the location of the medical record for the patient as well as any residual tissue. 

<div><br />Cancer registries collect cancer information from various sources including pathology laboratories. Pathology reports of different types may be sent via HL7 messages. Included here are data items coming from such a message to be included in the cancer registry database to aid in consolidating a cancer case when there is information from multiple sources. Traditionally, these data items were not part of the NAACCR Standards Volume II record layout and therefore provide a link to NAACCR Standards Volume V. <a href="http://www.naaccr.org/standardsandregistryoperations/volumev.aspx">http://www.naaccr.org/standardsandregistryoperations/volumev.aspx</a></div></div><a name='7090'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>PATH REPORT NUMBER 1</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">7090</td><td style="text-align:center;">20</td><td style="text-align:center;"><a href='#sources'>HL7</a></td><td style="text-align:center;">2010</td><td style="text-align:center;">12</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">6180 - 6199</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>Path Report Number<br />OBR-3 Filler Order Number #00217 (HL7)<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>pathReportNumber1</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'><div>Unique sequential number assigned by a laboratory to the first report for this case.<br /><br />This item accommodates only one path report. When information is available for more than one path report, enter the path report number(s) in Path Report No 2 through Path Report No 5 [7091-7094]. Information in this data item should refer to the path report described in data items 7010, 7100, 7190, 7320, and 7480. </div><div> &nbsp;</div><div>Note: In some cases the HL7 field length as sent by the laboratory may be longer than 20.</div> </div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'><div>The pathology report number provides a cross reference that identifies the specimen at the pathology facility. It may be useful for follow back with the pathology facility.</div><div> &nbsp;</div><div>Cancer registries collect cancer information from various sources including pathology laboratories. Pathology reports of different types may be sent via HL7 messages. Included here are data items coming from such a message to be included in the cancer registry database to aid in consolidating a cancer case when there is information from multiple sources. Traditionally, these data items were not part of the NAACCR Standards Volume II record layout and therefore provide a link to NAACCR Standards Volume V. <a href="http://www.naaccr.org/standardsandregistryoperations/volumev.aspx">http://www.naaccr.org/standardsandregistryoperations/volumev.aspx</a></div> </div><a name='7091'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>PATH REPORT NUMBER 2</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">7091</td><td style="text-align:center;">20</td><td style="text-align:center;"><a href='#sources'>HL7</a></td><td style="text-align:center;">2010</td><td style="text-align:center;">12</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">6286 - 6305</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>OBR-3 Filler Order Number #00217 (HL7)<br />Path Report Number<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>pathReportNumber2</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'><div>Unique sequential number assigned by a laboratory to the second report for this case.<br /><br />This item accommodates only one path report. When information is available for more than two path reports, enter the path report number(s) in Path Report No 3 through Path Report No 5 [7092-7094]. Information in this data item should refer to the path report described in data items 7011, 7101, 7191, 7321, and 7481. </div><div> &nbsp;</div><div>Note: In some cases the HL7 field length as sent by the laboratory may be longer than 20.</div> </div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>The pathology report number provides a cross reference that identifies the specimen at the pathology facility. It may be useful for follow back with the pathology facility.<div> </div><div>Cancer registries collect cancer information from various sources including pathology laboratories. Pathology reports of different types may be sent via HL7 messages. Included here are data items coming from such a message to be included in the cancer registry database to aid in consolidating a cancer case when there is information from multiple sources. Traditionally, these data items were not part of the NAACCR Standards Volume II record layout and therefore provide a link to NAACCR Standards Volume V. <a href="http://www.naaccr.org/standardsandregistryoperations/volumev.aspx">http://www.naaccr.org/standardsandregistryoperations/volumev.aspx</a></div> </div><a name='7092'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>PATH REPORT NUMBER 3</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">7092</td><td style="text-align:center;">20</td><td style="text-align:center;"><a href='#sources'>HL7</a></td><td style="text-align:center;">2010</td><td style="text-align:center;">12</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">6392 - 6411</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>Path Report Number<br />OBR-3 Filler Order Number #00217 (HL7)<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>pathReportNumber3</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'><div>Unique sequential number assigned by a laboratory to the third report for this case.<br /><br />This item accommodates only one path report. When information is available for more than three path reports, enter the path report number(s) in Path Report No 4 through Path Report No 5 [7093-7094]. Information in this data item should refer to the path report described in data items 7012, 7102, 7192, 7322, and 7482. </div><div> &nbsp;</div><div>Note: In some cases the HL7 field length as sent by the laboratory may be longer than 20.</div> </div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>The pathology report number provides a cross reference that identifies the specimen at the pathology facility. It may be useful for follow back with the pathology facility.<div> </div><div>Cancer registries collect cancer information from various sources including pathology laboratories. Pathology reports of different types may be sent via HL7 messages. Included here are data items coming from such a message to be included in the cancer registry database to aid in consolidating a cancer case when there is information from multiple sources. Traditionally, these data items were not part of the NAACCR Standards Volume II record layout and therefore provide a link to NAACCR Standards Volume V. <a href="http://www.naaccr.org/standardsandregistryoperations/volumev.aspx">http://www.naaccr.org/standardsandregistryoperations/volumev.aspx</a></div> </div><a name='7093'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>PATH REPORT NUMBER 4</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">7093</td><td style="text-align:center;">20</td><td style="text-align:center;"><a href='#sources'>HL7</a></td><td style="text-align:center;">2010</td><td style="text-align:center;">12</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">6498 - 6517</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>OBR-3 Filler Order Number #00217 (HL7)<br />Path Report Number<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>pathReportNumber4</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'><div>Unique sequential number assigned by a laboratory to the fourth report for this case.<br /><br />This item accommodates only one path report. When information is available for more than four path reports, enter the path report number in Path Report No 5 [7094]. Information in this data item should refer to the path report described in data items 7013, 7103, 7193, 7323, and 7483. </div><div> &nbsp;</div><div>Note: In some cases the HL7 field length as sent by the laboratory may be longer than 20.</div> </div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>The pathology report number provides a cross reference that identifies the specimen at the pathology facility. It may be useful for follow back with the pathology facility.<div> </div><div>Cancer registries collect cancer information from various sources including pathology laboratories. Pathology reports of different types may be sent via HL7 messages. Included here are data items coming from such a message to be included in the cancer registry database to aid in consolidating a cancer case when there is information from multiple sources. Traditionally, these data items were not part of the NAACCR Standards Volume II record layout and therefore provide a link to NAACCR Standards Volume V. <a href="http://www.naaccr.org/standardsandregistryoperations/volumev.aspx">http://www.naaccr.org/standardsandregistryoperations/volumev.aspx</a></div> </div><a name='7094'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>PATH REPORT NUMBER 5</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">7094</td><td style="text-align:center;">20</td><td style="text-align:center;"><a href='#sources'>HL7</a></td><td style="text-align:center;">2010</td><td style="text-align:center;">12</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">6604 - 6623</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>Path Report Number<br />OBR-3 Filler Order Number #00217 (HL7)<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>pathReportNumber5</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'><div>Unique sequential number assigned by a laboratory to the fifth report for this case.<br /><br />This item accommodates only one path report. Information in this data item should refer to the path report described in data items 7014, 7104, 7194, 7324, and 7484. </div><div> &nbsp;</div><div>Note: In some cases the HL7 field length as sent by the laboratory may be longer than 20.</div> </div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>The pathology report number provides a cross reference that identifies the specimen at the pathology facility. It may be useful for follow back with the pathology facility.<div> </div><div>Cancer registries collect cancer information from various sources including pathology laboratories. Pathology reports of different types may be sent via HL7 messages. Included here are data items coming from such a message to be included in the cancer registry database to aid in consolidating a cancer case when there is information from multiple sources. Traditionally, these data items were not part of the NAACCR Standards Volume II record layout and therefore provide a link to NAACCR Standards Volume V. <a href="http://www.naaccr.org/standardsandregistryoperations/volumev.aspx">http://www.naaccr.org/standardsandregistryoperations/volumev.aspx</a></div> </div><a name='7480'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>PATH REPORT TYPE 1</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">7480</td><td style="text-align:center;">2</td><td style="text-align:center;"><a href='#sources'>HL7</a></td><td style="text-align:center;">2010</td><td style="text-align:center;">12</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">6214 - 6215</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>Path--Report Type<br />OBR-4 Universal Service ID #00238 (HL7)<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>pathReportType1</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>This field reflects the type of report transmitted to the cancer registry and may need to be classified at the central cancer registry.<br /><br />This data item accommodates information for only one path report. If additional path reports were prepared, enter the path report type(s) in Path Report Type 2 through Path Report Type 5 [7481-7484]. Information in this data item should refer to the path report described in data items 7010, 7100, 7090, 7190, and 7320. </div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'><div> This variable is primarily used for administrative purposes at the cancer registry.<br /> &nbsp; </div><div><div>Cancer registries collect cancer information from various sources including pathology laboratories. Pathology reports of different types may be sent via HL7 messages. Included here are data items coming from such a message to be included in the cancer registry database to aid in consolidating a cancer case when there is information from multiple sources. Traditionally, these data items were not part of the NAACCR Standards Volume II record layout and therefore provide a link to NAACCR Standards Volume V. <a href="http://www.naaccr.org/standardsandregistryoperations/volumev.aspx">http://www.naaccr.org/standardsandregistryoperations/volumev.aspx</a></div></div> </div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>01</td><td class='code-desc'>Pathology (includes pathology report, addendum, synoptic reports, etc.)</td></tr><tr class='code-row'><td class='code-nbr'>02</td><td class='code-desc'>Cytology</td></tr><tr class='code-row'><td class='code-nbr'>03</td><td class='code-desc'>Gyn Cytology</td></tr><tr class='code-row'><td class='code-nbr'>04</td><td class='code-desc'>Bone Marrow (biopsy/aspirate)</td></tr><tr class='code-row'><td class='code-nbr'>05</td><td class='code-desc'>Autopsy</td></tr><tr class='code-row'><td class='code-nbr'>06</td><td class='code-desc'>Clinical Laboratory Blood Work, NOS</td></tr><tr class='code-row'><td class='code-nbr'>07</td><td class='code-desc'>Tumor Marker (p53, CD's Ki, CEA, Her2/Neu, etc.)</td></tr><tr class='code-row'><td class='code-nbr'>08</td><td class='code-desc'>Cytogenetics</td></tr><tr class='code-row'><td class='code-nbr'>09</td><td class='code-desc'>Immunohistochemical Stains</td></tr><tr class='code-row'><td class='code-nbr'>10</td><td class='code-desc'>Molecular Studies</td></tr><tr class='code-row'><td class='code-nbr'>11</td><td class='code-desc'>Flow Cytometry, Immunophenotype</td></tr><tr class='code-row'><td class='code-nbr'>98</td><td class='code-desc'>Other</td></tr><tr class='code-row'><td class='code-nbr'>99</td><td class='code-desc'>Unknown</td></tr></table></div><a name='7481'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>PATH REPORT TYPE 2</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">7481</td><td style="text-align:center;">2</td><td style="text-align:center;"><a href='#sources'>HL7</a></td><td style="text-align:center;">2010</td><td style="text-align:center;">12</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">6320 - 6321</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>OBR-4 Universal Service ID #00238 (HL7)<br />Path--Report Type<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>pathReportType2</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>This field reflects the type of report transmitted to the cancer registry and may need to be classified at the central cancer registry.<br /><br />This data item accommodates information for only one path report. If additional path reports were prepared, enter the path report type(s) in Path Report Type 3 through Path Report Type 5 [7482-7484]. Information in this data item should refer to the path report described in data items 7011, 7101, 7091, 7191, and 7321. </div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>This variable is primarily used for administrative purposes at the cancer registry.<br /> <div><div>Cancer registries collect cancer information from various sources including pathology laboratories. Pathology reports of different types may be sent via HL7 messages. Included here are data items coming from such a message to be included in the cancer registry database to aid in consolidating a cancer case when there is information from multiple sources. Traditionally, these data items were not part of the NAACCR Standards Volume II record layout and therefore provide a link to NAACCR Standards Volume V. <a href="http://www.naaccr.org/standardsandregistryoperations/volumev.aspx">http://www.naaccr.org/standardsandregistryoperations/volumev.aspx</a></div></div> </div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>01</td><td class='code-desc'>Pathology (includes pathology report, addendum, synoptic reports, etc.)</td></tr><tr class='code-row'><td class='code-nbr'>02</td><td class='code-desc'>Cytology</td></tr><tr class='code-row'><td class='code-nbr'>03</td><td class='code-desc'>Gyn Cytology</td></tr><tr class='code-row'><td class='code-nbr'>04</td><td class='code-desc'>Bone Marrow (biopsy/aspirate)</td></tr><tr class='code-row'><td class='code-nbr'>05</td><td class='code-desc'>Autopsy</td></tr><tr class='code-row'><td class='code-nbr'>06</td><td class='code-desc'>Clinical Laboratory Blood Work, NOS</td></tr><tr class='code-row'><td class='code-nbr'>07</td><td class='code-desc'>Tumor Marker (p53, CD's Ki, CEA, Her2/Neu, etc.)</td></tr><tr class='code-row'><td class='code-nbr'>08</td><td class='code-desc'>Cytogenetics</td></tr><tr class='code-row'><td class='code-nbr'>09</td><td class='code-desc'>Immunohistochemical Stains</td></tr><tr class='code-row'><td class='code-nbr'>10</td><td class='code-desc'>Molecular Studies</td></tr><tr class='code-row'><td class='code-nbr'>11</td><td class='code-desc'>Flow Cytometry, Immunophenotype</td></tr><tr class='code-row'><td class='code-nbr'>98</td><td class='code-desc'>Other</td></tr><tr class='code-row'><td class='code-nbr'>99</td><td class='code-desc'>Unknown</td></tr></table></div><a name='7482'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>PATH REPORT TYPE 3</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">7482</td><td style="text-align:center;">2</td><td style="text-align:center;"><a href='#sources'>HL7</a></td><td style="text-align:center;">2010</td><td style="text-align:center;">12</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">6426 - 6427</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>Path--Report Type<br />OBR-4 Universal Service ID #00238 (HL7)<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>pathReportType3</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>This field reflects the type of report transmitted to the cancer registry and may need to be classified at the central cancer registry.<br /><br />This data item accommodates information for only one path report. If additional path reports were prepared, enter the path report type(s) in Path Report Type 4 through Path Report Type 5 [7433-7484]. Information in this data item should refer to the path report described in data items 7012, 7102, 7092, 7192, and 7322. </div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>This variable is primarily used for administrative purposes at the cancer registry.<br /> <div><div>Cancer registries collect cancer information from various sources including pathology laboratories. Pathology reports of different types may be sent via HL7 messages. Included here are data items coming from such a message to be included in the cancer registry database to aid in consolidating a cancer case when there is information from multiple sources. Traditionally, these data items were not part of the NAACCR Standards Volume II record layout and therefore provide a link to NAACCR Standards Volume V. <a href="http://www.naaccr.org/standardsandregistryoperations/volumev.aspx">http://www.naaccr.org/standardsandregistryoperations/volumev.aspx</a></div></div> </div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>01</td><td class='code-desc'>Pathology (includes pathology report, addendum, synoptic reports, etc.)</td></tr><tr class='code-row'><td class='code-nbr'>02</td><td class='code-desc'>Cytology</td></tr><tr class='code-row'><td class='code-nbr'>03</td><td class='code-desc'>Gyn Cytology</td></tr><tr class='code-row'><td class='code-nbr'>04</td><td class='code-desc'>Bone Marrow (biopsy/aspirate)</td></tr><tr class='code-row'><td class='code-nbr'>05</td><td class='code-desc'>Autopsy</td></tr><tr class='code-row'><td class='code-nbr'>06</td><td class='code-desc'>Clinical Laboratory Blood Work, NOS</td></tr><tr class='code-row'><td class='code-nbr'>07</td><td class='code-desc'>Tumor Marker (p53, CD's Ki, CEA, Her2/Neu, etc.)</td></tr><tr class='code-row'><td class='code-nbr'>08</td><td class='code-desc'>Cytogenetics</td></tr><tr class='code-row'><td class='code-nbr'>09</td><td class='code-desc'>Immunohistochemical Stains</td></tr><tr class='code-row'><td class='code-nbr'>10</td><td class='code-desc'>Molecular Studies</td></tr><tr class='code-row'><td class='code-nbr'>11</td><td class='code-desc'>Flow Cytometry, Immunophenotype</td></tr><tr class='code-row'><td class='code-nbr'>98</td><td class='code-desc'>Other</td></tr><tr class='code-row'><td class='code-nbr'>99</td><td class='code-desc'>Unknown</td></tr></table></div><a name='7483'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>PATH REPORT TYPE 4</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">7483</td><td style="text-align:center;">2</td><td style="text-align:center;"><a href='#sources'>HL7</a></td><td style="text-align:center;">2010</td><td style="text-align:center;">12</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">6532 - 6533</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>OBR-4 Universal Service ID #00238 (HL7)<br />Path--Report Type<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>pathReportType4</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>This field reflects the type of report transmitted to the cancer registry and may need to be classified at the central cancer registry.<br /><br />This data item accommodates information for only one path report. If an additional path report was prepared, enter the path report type in Path Report Path Report Type 5 [7484]. Information in this data item should refer to the path report described in data items 7013, 7103, 7093, 7193, and 7323. </div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>This variable is primarily used for administrative purposes at the cancer registry.<br /> <div><div>Cancer registries collect cancer information from various sources including pathology laboratories. Pathology reports of different types may be sent via HL7 messages. Included here are data items coming from such a message to be included in the cancer registry database to aid in consolidating a cancer case when there is information from multiple sources. Traditionally, these data items were not part of the NAACCR Standards Volume II record layout and therefore provide a link to NAACCR Standards Volume V. <a href="http://www.naaccr.org/standardsandregistryoperations/volumev.aspx">http://www.naaccr.org/standardsandregistryoperations/volumev.aspx</a></div></div> </div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>01</td><td class='code-desc'>Pathology (includes pathology report, addendum, synoptic reports, etc.)</td></tr><tr class='code-row'><td class='code-nbr'>02</td><td class='code-desc'>Cytology</td></tr><tr class='code-row'><td class='code-nbr'>03</td><td class='code-desc'>Gyn Cytology</td></tr><tr class='code-row'><td class='code-nbr'>04</td><td class='code-desc'>Bone Marrow (biopsy/aspirate)</td></tr><tr class='code-row'><td class='code-nbr'>05</td><td class='code-desc'>Autopsy</td></tr><tr class='code-row'><td class='code-nbr'>06</td><td class='code-desc'>Clinical Laboratory Blood Work, NOS</td></tr><tr class='code-row'><td class='code-nbr'>07</td><td class='code-desc'>Tumor Marker (p53, CD's Ki, CEA, Her2/Neu, etc.)</td></tr><tr class='code-row'><td class='code-nbr'>08</td><td class='code-desc'>Cytogenetics</td></tr><tr class='code-row'><td class='code-nbr'>09</td><td class='code-desc'>Immunohistochemical Stains</td></tr><tr class='code-row'><td class='code-nbr'>10</td><td class='code-desc'>Molecular Studies</td></tr><tr class='code-row'><td class='code-nbr'>11</td><td class='code-desc'>Flow Cytometry, Immunophenotype</td></tr><tr class='code-row'><td class='code-nbr'>98</td><td class='code-desc'>Other</td></tr><tr class='code-row'><td class='code-nbr'>99</td><td class='code-desc'>Unknown</td></tr></table></div><a name='7484'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>PATH REPORT TYPE 5</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">7484</td><td style="text-align:center;">2</td><td style="text-align:center;"><a href='#sources'>HL7</a></td><td style="text-align:center;">2010</td><td style="text-align:center;">12</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">6638 - 6639</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>Path--Report Type<br />OBR-4 Universal Service ID #00238 (HL7)<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>pathReportType5</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>This field reflects the type of report transmitted to the cancer registry and may need to be classified at the central cancer registry.<br /><br />This data item accommodates information for only one path report. Information in this data item should refer to the path report described in data items 7014, 7104, 7094, 7194, and 7324. </div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>This variable is primarily used for administrative purposes at the cancer registry.<br /> <div><div>Cancer registries collect cancer information from various sources including pathology laboratories. Pathology reports of different types may be sent via HL7 messages. Included here are data items coming from such a message to be included in the cancer registry database to aid in consolidating a cancer case when there is information from multiple sources. Traditionally, these data items were not part of the NAACCR Standards Volume II record layout and therefore provide a link to NAACCR Standards Volume V. <a href="http://www.naaccr.org/standardsandregistryoperations/volumev.aspx">http://www.naaccr.org/standardsandregistryoperations/volumev.aspx</a></div></div> </div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>01</td><td class='code-desc'>Pathology (includes pathology report, addendum, synoptic reports, etc.)</td></tr><tr class='code-row'><td class='code-nbr'>02</td><td class='code-desc'>Cytology</td></tr><tr class='code-row'><td class='code-nbr'>03</td><td class='code-desc'>Gyn Cytology</td></tr><tr class='code-row'><td class='code-nbr'>04</td><td class='code-desc'>Bone Marrow (biopsy/aspirate)</td></tr><tr class='code-row'><td class='code-nbr'>05</td><td class='code-desc'>Autopsy</td></tr><tr class='code-row'><td class='code-nbr'>06</td><td class='code-desc'>Clinical Laboratory Blood Work, NOS</td></tr><tr class='code-row'><td class='code-nbr'>07</td><td class='code-desc'>Tumor Marker (p53, CD's Ki, CEA, Her2/Neu, etc.)</td></tr><tr class='code-row'><td class='code-nbr'>08</td><td class='code-desc'>Cytogenetics</td></tr><tr class='code-row'><td class='code-nbr'>09</td><td class='code-desc'>Immunohistochemical Stains</td></tr><tr class='code-row'><td class='code-nbr'>10</td><td class='code-desc'>Molecular Studies</td></tr><tr class='code-row'><td class='code-nbr'>11</td><td class='code-desc'>Flow Cytometry, Immunophenotype</td></tr><tr class='code-row'><td class='code-nbr'>98</td><td class='code-desc'>Other</td></tr><tr class='code-row'><td class='code-nbr'>99</td><td class='code-desc'>Unknown</td></tr></table></div><a name='7010'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>PATH REPORTING FAC ID 1</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">7010</td><td style="text-align:center;">25</td><td style="text-align:center;"><a href='#sources'>HL7</a></td><td style="text-align:center;">2010</td><td style="text-align:center;">12</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">6155 - 6179</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>MSH-4 Sending Facility (Name) #00004 (HL7)<br />BHS-4 Batch Sending Facility #0084<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>pathReportingFacId1</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>An identifying code (for example, a CLIA number) that uniquely identifies the pathology facility sending the first report of the case.<br /><br />This data item accommodates information for only one path report. If additional path reports were prepared, enter the identifying code of pathology facility sending the report in Path Reporting Fac ID 2 through Path Reporting Fac ID 5 [7011-7014]. Information in this data item should refer to the path report described in data items 7100, 7090, 7190, 7320, and 7480. </div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'><div> Clinical Laboratory Improvement Act Identification Numbers (CLIAs) are used for laboratory reporting.<br /> &nbsp;</div><div><div><div>Cancer registries collect cancer information from various sources including pathology laboratories. Pathology reports of different types may be sent via HL7 messages. Included here are data items coming from such a message to be included in the cancer registry database to aid in consolidating a cancer case when there is information from multiple sources. Traditionally, these data items were not part of the NAACCR Standards Volume II record layout and therefore provide a link to NAACCR Standards Volume V. <a href="http://www.naaccr.org/standardsandregistryoperations/volumev.aspx">http://www.naaccr.org/standardsandregistryoperations/volumev.aspx</a></div></div></div> </div><a name='7011'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>PATH REPORTING FAC ID 2</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">7011</td><td style="text-align:center;">25</td><td style="text-align:center;"><a href='#sources'>HL7</a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">6261 - 6285</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>BHS-4 Batch Sending Facility #0084<br />MSH-4 Sending Facility (Name) #00004 (HL7)<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>pathReportingFacId2</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>An identifying code (for example, a CLIA number) that uniquely identifies the pathology facility sending the second report of the case.<br /><br />This data item accommodates information for only one path report. If additional path reports were prepared, enter the identifying code of pathology facility sending the report in Path Reporting Fac ID 3 through Path Reporting Fac ID 5 [7012-7014]. Information in this data item should refer to the path report described in data items 7101, 7091, 7191, 7321, and 7481. </div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Clinical Laboratory Improvement Act Identification Numbers (CLIAs) are used for laboratory reporting.<br /> <div><div><div>Cancer registries collect cancer information from various sources including pathology laboratories. Pathology reports of different types may be sent via HL7 messages. Included here are data items coming from such a message to be included in the cancer registry database to aid in consolidating a cancer case when there is information from multiple sources. Traditionally, these data items were not part of the NAACCR Standards Volume II record layout and therefore provide a link to NAACCR Standards Volume V. <a href="http://www.naaccr.org/standardsandregistryoperations/volumev.aspx">http://www.naaccr.org/standardsandregistryoperations/volumev.aspx</a></div></div></div> </div><a name='7012'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>PATH REPORTING FAC ID 3</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">7012</td><td style="text-align:center;">25</td><td style="text-align:center;"><a href='#sources'>HL7</a></td><td style="text-align:center;">2010</td><td style="text-align:center;">12</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">6367 - 6391</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>MSH-4 Sending Facility (Name) #00004 (HL7)<br />BHS-4 Batch Sending Facility #0084<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>pathReportingFacId3</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>An identifying code (for example, a CLIA number) that uniquely identifies the pathology facility sending the third report of the case.<br /><br />This data item accommodates information for only one path report. If additional path reports were prepared, enter the identifying code of pathology facility sending the report in Path Reporting Fac ID 4 through Path Reporting Fac ID 5 [7013-7014]. Information in this data item should refer to the path report described in data items 7102, 7092, 7192, 7322, and 7482. </div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Clinical Laboratory Improvement Act Identification Numbers (CLIAs) are used for laboratory reporting.<br /> <div><div><div>Cancer registries collect cancer information from various sources including pathology laboratories. Pathology reports of different types may be sent via HL7 messages. Included here are data items coming from such a message to be included in the cancer registry database to aid in consolidating a cancer case when there is information from multiple sources. Traditionally, these data items were not part of the NAACCR Standards Volume II record layout and therefore provide a link to NAACCR Standards Volume V. <a href="http://www.naaccr.org/standardsandregistryoperations/volumev.aspx">http://www.naaccr.org/standardsandregistryoperations/volumev.aspx</a></div></div></div> </div><a name='7013'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>PATH REPORTING FAC ID 4</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">7013</td><td style="text-align:center;">25</td><td style="text-align:center;"><a href='#sources'>HL7</a></td><td style="text-align:center;">2010</td><td style="text-align:center;">12</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">6473 - 6497</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>BHS-4 Batch Sending Facility #0084<br />MSH-4 Sending Facility (Name) #00004 (HL7)<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>pathReportingFacId4</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>An identifying code (for example, a CLIA number) that uniquely identifies the pathology facility sending the fourth report of the case.<br /><br />This data item accommodates information for only one path report. If an additional path report was prepared, enter the identifying code of pathology facility sending the report in Path Reporting Fac ID 5 [7014]. Information in this data item should refer to the path report described in data items 7103, 7093, 7193, 7323, and 7483. </div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Clinical Laboratory Improvement Act Identification Numbers (CLIAs) are used for laboratory reporting.<br /> <div><div><div>Cancer registries collect cancer information from various sources including pathology laboratories. Pathology reports of different types may be sent via HL7 messages. Included here are data items coming from such a message to be included in the cancer registry database to aid in consolidating a cancer case when there is information from multiple sources. Traditionally, these data items were not part of the NAACCR Standards Volume II record layout and therefore provide a link to NAACCR Standards Volume V. <a href="http://www.naaccr.org/standardsandregistryoperations/volumev.aspx">http://www.naaccr.org/standardsandregistryoperations/volumev.aspx</a></div></div></div> </div><a name='7014'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>PATH REPORTING FAC ID 5</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">7014</td><td style="text-align:center;">25</td><td style="text-align:center;"><a href='#sources'>HL7</a></td><td style="text-align:center;">2010</td><td style="text-align:center;">12</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">6579 - 6603</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>MSH-4 Sending Facility (Name) #00004 (HL7)<br />BHS-4 Batch Sending Facility #0084<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>pathReportingFacId5</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>An identifying code (for example, a CLIA number) that uniquely identifies the pathology facility sending the fifth report of the case.<br /><br />Information in this data item should refer to the path report described in data items 7104, 7094, 7194, 7324, and 7484. </div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Clinical Laboratory Improvement Act Identification Numbers (CLIAs) are used for laboratory reporting.<br /> <div><div><div>Cancer registries collect cancer information from various sources including pathology laboratories. Pathology reports of different types may be sent via HL7 messages. Included here are data items coming from such a message to be included in the cancer registry database to aid in consolidating a cancer case when there is information from multiple sources. Traditionally, these data items were not part of the NAACCR Standards Volume II record layout and therefore provide a link to NAACCR Standards Volume V. <a href="http://www.naaccr.org/standardsandregistryoperations/volumev.aspx">http://www.naaccr.org/standardsandregistryoperations/volumev.aspx</a></div></div></div> </div><a name='20'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>PATIENT ID NUMBER</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">20</td><td style="text-align:center;">8</td><td style="text-align:center;"><a href='#sources'>Reporting Registry</a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">42 - 49</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>patientIdNumber</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Patient</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Unique number assigned to an individual patient by the central registry. The central registry will assign this same number to all of the patient&#8217;s subsequent tumors (records). <br /><br />Patient ID Number will only differ when multiple central registries accession the same patient. Each central registry will assign their unique Patient ID Number.<br /><br />NAACCR recommends that the registry should not reissue or reuse this number when a patient&#8217;s record is deleted from the files.<br /><br />In the transmit file (data exchange) this number will be the Patient ID Number assigned by the sending registry as defined in Registry ID [40].</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Provides the central registry with a unique identification number that will link all records (multiple tumors) for the same patient. The unique number also allows the central registry to identify the patient when there are multiple reports from different hospitals.</div><a name='21'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>PATIENT SYSTEM ID-HOSP</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">21</td><td style="text-align:center;">8</td><td style="text-align:center;"><a href='#sources'>NAACCR</a></td><td style="text-align:center;">2006</td><td style="text-align:center;">11</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">50 - 57</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>patientSystemIdHosp</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>The unique, non-repeating number automatically assigned to patients by the hospital tumor registry software system. The same number is used for all the patient's subsequent tumors. This Patient System ID-Hosp number should not be reused when a patient is deleted.<br /><br />This number is different from Accession Number-Hosp [550]. While Accession Number-Hosp [550] is subject to change, the Patient System ID-Hosp number is created and maintained by the hospital tumor registry&#8217;s software system, and requires no key entry. Because the Patient System ID-Hosp number is unchanging, it affords an absolute linkage between a hospital patient record and a central registry&#8217;s patient record.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>This provides a stable identifier to link back to all reported tumors for a patient. It also serves as a reliable linking identifier; useful when central registries send follow-up information back to hospitals. Other identifiers such as social security number and medical record number, while useful, are subject to change and are thus less useful for this type of record linkage.</div><a name='1120'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>PEDIATRIC STAGE</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">1120</td><td style="text-align:center;">2</td><td style="text-align:center;"><a href='#sources'>CoC</a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1289 - 1290</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>pediatricStage</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Code for stage of pediatric tumor in an AJCC stage scheme, a pediatric intergroup study scheme, or a pediatric cooperative group scheme. </div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Staging of pediatric tumors requires very different schemes from those used to stage adult tumors. </div><div class='content chap10-para'><strong>Codes<br /></strong>See the <em>ROADS </em>manual for allowable codes for this field.</div><div class='content chap10-para'><em>Note:</em> This data item is no longer supported by CoC (as of January 1, 2003).</div><a name='1140'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>PEDIATRIC STAGED BY</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">1140</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>CoC</a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1293 - 1293</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>Staged By (Pediatric Stage) (CoC)<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>pediatricStagedBy</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Code for person who documented the pediatric staging system and stage. </div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>0</td><td class='code-desc'>Not staged</td></tr><tr class='code-row'><td class='code-nbr'>1</td><td class='code-desc'>Managing physician</td></tr><tr class='code-row'><td class='code-nbr'>2</td><td class='code-desc'>Pathologist</td></tr><tr class='code-row'><td class='code-nbr'>3</td><td class='code-desc'>Other physician</td></tr><tr class='code-row'><td class='code-nbr'>4</td><td class='code-desc'>Any combination of 1, 2, or 3</td></tr><tr class='code-row'><td class='code-nbr'>5</td><td class='code-desc'>Registrar</td></tr><tr class='code-row'><td class='code-nbr'>6</td><td class='code-desc'>Any combination of 5 with 1, 2, or 3</td></tr><tr class='code-row'><td class='code-nbr'>7</td><td class='code-desc'>Other</td></tr><tr class='code-row'><td class='code-nbr'>8</td><td class='code-desc'>Staged, individual not specified</td></tr><tr class='code-row'><td class='code-nbr'>9</td><td class='code-desc'>Unknown if staged</td></tr></table></div><div class='content chap10-para'><em>Note:</em> This data item is no longer supported by CoC (as of January 1, 2003).</div><a name='1130'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>PEDIATRIC STAGING SYSTEM</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">1130</td><td style="text-align:center;">2</td><td style="text-align:center;"><a href='#sources'>CoC</a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1291 - 1292</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>Type of Staging System (Pediatric) (CoC)<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>pediatricStagingSystem</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Staging system used to assign the Pediatric Stage. </div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Staging of pediatric tumors requires very different schemes from those used to stage adult tumors. </div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>00</td><td class='code-desc'>None</td></tr><tr class='code-row'><td class='code-nbr'>01</td><td class='code-desc'>AJCC</td></tr><tr class='code-row'><td class='code-nbr'>02</td><td class='code-desc'>Ann Arbor</td></tr><tr class='code-row'><td class='code-nbr'>03</td><td class='code-desc'>Children's Cancer Group (CCG)</td></tr><tr class='code-row'><td class='code-nbr'>04</td><td class='code-desc'>Evans</td></tr><tr class='code-row'><td class='code-nbr'>05</td><td class='code-desc'>General Summary</td></tr><tr class='code-row'><td class='code-nbr'>06</td><td class='code-desc'>Intergroup Ewings</td></tr><tr class='code-row'><td class='code-nbr'>07</td><td class='code-desc'>Intergroup Hepatoblastoma</td></tr><tr class='code-row'><td class='code-nbr'>08</td><td class='code-desc'>Intergroup Rhabdomyosarcoma</td></tr><tr class='code-row'><td class='code-nbr'>09</td><td class='code-desc'>International System</td></tr><tr class='code-row'><td class='code-nbr'>10</td><td class='code-desc'>Murphy</td></tr><tr class='code-row'><td class='code-nbr'>11</td><td class='code-desc'>NCI (pediatric oncology)</td></tr><tr class='code-row'><td class='code-nbr'>12</td><td class='code-desc'>National Wilms's Tumor Study</td></tr><tr class='code-row'><td class='code-nbr'>13</td><td class='code-desc'>Pediatric Oncology Group (POG)</td></tr><tr class='code-row'><td class='code-nbr'>14</td><td class='code-desc'>Reese-Ellsworth</td></tr><tr class='code-row'><td class='code-nbr'>15</td><td class='code-desc'>SEER Extent of Disease</td></tr><tr class='code-row'><td class='code-nbr'>88</td><td class='code-desc'>Not applicable (not pediatric case)</td></tr><tr class='code-row'><td class='code-nbr'>97</td><td class='code-desc'>Other</td></tr><tr class='code-row'><td class='code-nbr'>99</td><td class='code-desc'>Unknown</td></tr></table></div><div class='content chap10-para'><em>Note:</em> This data item is no longer supported by CoC (as of January 1, 2003).</div><a name='3908'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>PERCENT NECROSIS POST NEOADJUVANT</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">3908</td><td style="text-align:center;">5</td><td style="text-align:center;"><a href='#sources'>NAACCR</a></td><td style="text-align:center;">2018</td><td style="text-align:center;">18</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1734 - 1738</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>percentNecrosisPostNeoadjuvant</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Percent Necrosis Post Neoadjuvant is a prognostic factor for bone sarcomas.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Percent Necrosis Post Neoadjuvant is a Registry Data Collection Variable for AJCC. It was previously collected as Bone, CS SSF# 3.</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>0.0</td><td class='code-desc'>Tumor necrosis not identified/not present</td></tr><tr class='code-row'><td class='code-nbr'>0.1-100.0</td><td class='code-desc'>0.1100.0 percent tumor necrosis<br/>
(Percentage of tumor necrosis to nearest tenth of a percent)

</td></tr><tr class='code-row'><td class='code-nbr'>XXX.2</td><td class='code-desc'>Tumor necrosis present, percent not stated</td></tr><tr class='code-row'><td class='code-nbr'>XXX.8</td><td class='code-desc'>Not applicable: Information not collected for this case<br/>
(If this item is required by your standard setter, use of code XXX.8 will result in an edit error.)
</td></tr><tr class='code-row'><td class='code-nbr'>XXX.9</td><td class='code-desc'>Not documented in medical record<br/>
No histologic examined of primary site<br/>
No neoadjuvant therapy<br/>
No surgical resection of primary site is performed
</td></tr><tr class='code-row'><td class='code-nbr'></td><td class='code-desc'> </td></tr></table></div><div class='content chap10-para'>Each Site-Specific Data Item (SSDI) applies only to selected primary sites, histologies, and years of diagnosis. Depending on applicability and standard-setter requirements, SSDIs may be left blank. </div><a name='3909'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>PERINEURAL INVASION</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">3909</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>NAACCR</a></td><td style="text-align:center;">2018</td><td style="text-align:center;">18</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1802 - 1802</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>perineuralInvasion</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Perineural Invasion, within or adjacent to the primary tumor, is a negative prognostic factor for cutaneous squamous cell carcinomas of the head and neck and carcinomas of the colon and rectum, eyelid and lacrimal gland.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Perineural Invasion is a Registry Data Collection Variable in AJCC.  It was previously collected as Colon and Rectum CS SSF# 8 and Lacrimal Gland CS SSF# 4.</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>0</td><td class='code-desc'>Perineural invasion not identified/not present</td></tr><tr class='code-row'><td class='code-nbr'>1</td><td class='code-desc'>Perineural invasion identified/present</td></tr><tr class='code-row'><td class='code-nbr'>8</td><td class='code-desc'>Not applicable: Information not collected for this case<br/>
(If this information is required by your standard setter, use of code 8 may result in an edit error.)
</td></tr><tr class='code-row'><td class='code-nbr'>9</td><td class='code-desc'>Not documented in medical record<br/>
Pathology report does not mention perineural invasion<br/>
Cannot be determined by the pathologist<br/>
Perineural invasion not assessed or unknown if assessed
</td></tr><tr class='code-row'><td class='code-nbr'></td><td class='code-desc'> </td></tr></table></div><div class='content chap10-para'>Each Site-Specific Data Item (SSDI) applies only to selected primary sites, histologies, and years of diagnosis. Depending on applicability and standard-setter requirements, SSDIs may be left blank. </div><a name='3910'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>PERIPHERAL BLOOD INVOLVEMENT</strong></td><td style="text-align:right;font-weight:bold;"><strong>Revised</strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">3910</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>NAACCR</a></td><td style="text-align:center;">2018</td><td style="text-align:center;">18</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1908 - 1908</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>peripheralBloodInvolvement</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Peripheral blood involvement, summarized in "B category", refers to the percentage of peripheral blood lymphocytes that are atypical (Sezary) cells and whether they are "Clone negative" or "Clone positive".</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para mark-changed'>Peripheral blood involvement is a prognostic factor required in AJCC 8th edition, Chapter 81 
















<em>Primary Cutaneous Lymphomas</em>, for staging of Mycosis Fungoides and Sezary Syndrome. It was previously collected as Mycosis Fungoides, CS SSF #1.</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>0</td><td class='code-desc'>Absence of significant blood involvement<br/>
5% or less of peripheral blood lymphocytes are atypical (Sezary) cells<br/> 
Clone unknown<br/>
Stated as B0</td></tr><tr class='code-row'><td class='code-nbr'>1</td><td class='code-desc'>Absence of significant blood involvement<br/>
5% or less of peripheral blood lymphocytes are atypical (Sezary) cells<br/> 
Clone negative<br/>
Stated as B0a</td></tr><tr class='code-row'><td class='code-nbr'>2</td><td class='code-desc'>Absence of significant blood involvement:<br/> 
5% or less of peripheral blood lymphocytes are atypical (Sezary) cells<br/> 
Clone positive<br/>
Stated as B0b</td></tr><tr class='code-row'><td class='code-nbr'>3</td><td class='code-desc'>Low blood tumor burden<br/>
More than 5% of peripheral blood lymphocytes are atypical (Sezary) cells but does not meet the criteria of B2<br/> 
Clone unknown<br/>
Stated as B1</td></tr><tr class='code-row'><td class='code-nbr'>4</td><td class='code-desc'>Low blood tumor burden<br/>
More than 5% of peripheral blood lymphocytes are atypical (Sezary) cells but does not meet the criteria of B2<br/> 
Clone negative<br/>
Stated as B1a</td></tr><tr class='code-row'><td class='code-nbr'>5</td><td class='code-desc'>Low blood tumor burden<br/>
More than 5% of peripheral blood lymphocytes are atypical (Sezary) cells but does not meet the criteria of B2<br/> 
Clone positive<br/>
Stated as B1b</td></tr><tr class='code-row'><td class='code-nbr'>6</td><td class='code-desc'>High blood tumor burden<br/>
Greater than or equal to 1000 Sezary cells per microliter (uL)<br/> 
Clone positive<br/>
Stated as B2</td></tr><tr class='code-row'><td class='code-nbr'>7</td><td class='code-desc'>Test ordered, results not in chart</td></tr><tr class='code-row'><td class='code-nbr'>9</td><td class='code-desc'>Not documented in medical record<br/>
Peripheral Blood Involvement not assessed or unknown if assessed
</td></tr><tr class='code-row'><td class='code-nbr'></td><td class='code-desc'> </td></tr></table></div><div class='content chap10-para'>Each Site-Specific Data Item (SSDI) applies only to selected primary sites, histologies, and years of diagnosis. Depending on applicability and standard-setter requirements, SSDIs may be left blank.</div><a name='3911'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>PERITONEAL CYTOLOGY</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">3911</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>NAACCR</a></td><td style="text-align:center;">2018</td><td style="text-align:center;">18</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1813 - 1813</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>peritonealCytology</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Peritoneal cytology pertains to the results of cytologic examination for malignant cells performed on fluid that is obtained from the peritoneal cavity.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Peritoneal Cytology is listed as a Registry Data Collection Variable in AJCC. This data item was previously collected as Corpus, CS SSF# 2.</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>0</td><td class='code-desc'>Peritoneal cytology/washing negative for malignancy </td></tr><tr class='code-row'><td class='code-nbr'>1</td><td class='code-desc'>Peritoneal cytology/washing atypical and/or suspicious</td></tr><tr class='code-row'><td class='code-nbr'>2</td><td class='code-desc'>Peritoneal cytology/washing malignant (positive for malignancy)</td></tr><tr class='code-row'><td class='code-nbr'>3</td><td class='code-desc'>Unsatisfactory/nondiagnostic</td></tr><tr class='code-row'><td class='code-nbr'>7</td><td class='code-desc'>Test ordered, results not in chart</td></tr><tr class='code-row'><td class='code-nbr'>8</td><td class='code-desc'>Not applicable: Information not collected for this case<br/>
(If this item is required by your standard setter, use of code 8 will result in an edit error.)
</td></tr><tr class='code-row'><td class='code-nbr'>9</td><td class='code-desc'>Not documented in medical record<br/>
Peritoneal cytology not assessed or unknown if assessed
</td></tr><tr class='code-row'><td class='code-nbr'></td><td class='code-desc'> </td></tr></table></div><div class='content chap10-para'>Each Site-Specific Data Item (SSDI) applies only to selected primary sites, histologies, and years of diagnosis. Depending on applicability and standard-setter requirements, SSDIs may be left blank.</div><a name='1501'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>PHASE I DOSE PER FRACTION</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">1501</td><td style="text-align:center;">5</td><td style="text-align:center;"><a href='#sources'>CoC</a></td><td style="text-align:center;">2018</td><td style="text-align:center;">18</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">2289 - 2293</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>phase1DosePerFraction</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Records the dose per fraction (treatment session) delivered to the patient in the first phase of radiation during the first course of treatment. The unit of measure is centiGray (cGy). This data item is required for CoC-accredited facilities as of&nbsp; 01/01/2018.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Radiation therapy is delivered in one or more phases with identified dose per fraction. It is necessary to capture information describing the dose per fraction to evaluate patterns of radiation oncology care. Outcomes are strongly related to the dose delivered.</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>00000</td><td class='code-desc'>Radiation therapy was not administered</td></tr><tr class='code-row'><td class='code-nbr'>00001-99997</td><td class='code-desc'>Record the actual Phase I dose delivered in cGy</td></tr><tr class='code-row'><td class='code-nbr'>99998</td><td class='code-desc'>Not applicable, brachytherapy or radioisotopes administered to the patient</td></tr><tr class='code-row'><td class='code-nbr'>99999</td><td class='code-desc'>Regional radiation therapy was administered but dose is unknown, it is unknown whether radiation therapy was administered. Death Certificate only. </td></tr><tr class='code-row'><td class='code-nbr' colspan='2'></td></tr></table></div><a name='1503'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>PHASE I NUMBER OF FRACTIONS</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">1503</td><td style="text-align:center;">3</td><td style="text-align:center;"><a href='#sources'>CoC</a></td><td style="text-align:center;">2018</td><td style="text-align:center;">18</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">2294 - 2296</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>phase1NumberOfFractions</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Records the total number of fractions (treatment sessions) delivered to the patient in the first phase of radiation during the first course of treatment. This data item is required for CoC-accredited facilities as of 01/01/2018.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'><br /> Radiation therapy is delivered in one or more phases with each phase spread out over a number of fractions (treatment sessions). It is necessary to capture information describing the number of fraction(s) to evaluate patterns of radiation oncology care.</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>000</td><td class='code-desc'>Radiation therapy was not administered to the patient. </td></tr><tr class='code-row'><td class='code-nbr'>001-998</td><td class='code-desc'>Number of fractions administered to the patient during the first phase of radiation therapy. </td></tr><tr class='code-row'><td class='code-nbr'>999</td><td class='code-desc'>Phase I Radiation therapy was administered, but the number of fractions is unknown; It is unknown whether radiation therapy was administered. </td></tr><tr class='code-row'><td class='code-nbr' colspan='2'></td></tr></table></div><a name='1502'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>PHASE I RADIATION EXTERNAL BEAM PLANNING TECH</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">1502</td><td style="text-align:center;">2</td><td style="text-align:center;"><a href='#sources'>CoC</a></td><td style="text-align:center;">2018</td><td style="text-align:center;">18</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">2287 - 2288</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>phase1RadiationExternalBeamTech</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Identifies the external beam radiation planning technique used to administer the first phase of radiation treatment during the first course of treatment. This data item is required for CoC-accredited facilities as of 01/01/2018.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>External beam radiation is the most commonly-used radiation modality in North America. In this data item we specified the planning technique for external beam treatment. Identifying the radiation technique is of interest for patterns of care and comparative effectiveness studies.<br /><br />Historically, the previously-named Regional Treatment Modality data item [1570] utilized codes that were not mutually exclusive. Rather, it included codes describing a mix of modalities, treatment planning techniques, and delivery techniques that are commonly utilized by radiation oncologists. However, every phase of radiation treatment will include a specified modality, planning technique, and delivery technique. The goal of the 2018 implementation of separate phase-specific data items for the recording of Phase I Radiation Treatment Modality [1506] and Phase I Radiation External Beam Planning Tech [1502] is to clarify this information and implement mutually exclusive categories.  A separate data item for delivery technique has not been implemented because this information is not consistently reported in end treatment summaries.</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>00</td><td class='code-desc'>No radiation treatment</td></tr><tr class='code-row'><td class='code-nbr'>01</td><td class='code-desc'>External beam, NOS</td></tr><tr class='code-row'><td class='code-nbr'>02</td><td class='code-desc'>Low energy x-ray/photon therapy</td></tr><tr class='code-row'><td class='code-nbr'>03</td><td class='code-desc'>2-D therapy</td></tr><tr class='code-row'><td class='code-nbr'>04</td><td class='code-desc'>Conformal or 3-D conformal therapy</td></tr><tr class='code-row'><td class='code-nbr'>05</td><td class='code-desc'>Intensity modulated therapy </td></tr><tr class='code-row'><td class='code-nbr'>06</td><td class='code-desc'>Stereotactic radiotherapy or radiosurgery, NOS</td></tr><tr class='code-row'><td class='code-nbr'>07</td><td class='code-desc'>Stereotactic radiotherapy or radiosurgery, robotic.</td></tr><tr class='code-row'><td class='code-nbr'>08</td><td class='code-desc'>Stereotactic radiotherapy or radiosurgery, Gamma Knife</td></tr><tr class='code-row'><td class='code-nbr'>09</td><td class='code-desc'>CT-guided online adaptive therapy</td></tr><tr class='code-row'><td class='code-nbr'>10</td><td class='code-desc'>MR-guided online adaptive therapy</td></tr><tr class='code-row'><td class='code-nbr'>88</td><td class='code-desc'>Not Applicable</td></tr><tr class='code-row'><td class='code-nbr'>98</td><td class='code-desc'>Other, NOS</td></tr><tr class='code-row'><td class='code-nbr'>99</td><td class='code-desc'>Unknown</td></tr><tr class='code-row'><td class='code-nbr' colspan='2'></td></tr></table></div><a name='1504'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>PHASE I RADIATION PRIMARY TREATMENT VOLUME</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">1504</td><td style="text-align:center;">2</td><td style="text-align:center;"><a href='#sources'>CoC</a></td><td style="text-align:center;">2018</td><td style="text-align:center;">18</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">2281 - 2282</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>phase1RadiationPrimaryTxVolume</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Identifies the primary treatment volume or primary anatomic target treated during the first phase of radiation therapy during the first course of treatment. This data item is required for CoC-accredited facilities as of 01/01/2018.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Radiation treatment is commonly delivered in one or more phases. Typically, in each phase, the primary tumor or tumor bed is treated. This data item should be used to indicate the primary target volume, which might include the primary tumor or tumor bed. If the primary tumor was not targeted, record the other regional or distant site that was targeted. Draining lymph nodes may also be targeted during the first phase. These will be identified in a separate data item Phase I Radiation to Draining Lymph Nodes [1505].<br /><div>&nbsp;</div><div>This data item provides information describing the anatomical structure targeted by radiation therapy during the first phase of radiation treatment and can be used to determine whether the site of the primary diseases was treated with radiation or if other regional or distant sites were targeted. This information is useful in evaluating the patterns of care within a facility and on a regional or national basis. The breakdown and reorganization of the sites will allow for concise reporting. </div></div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>00</td><td class='code-desc'>No radiation treatment</td></tr><tr class='code-row'><td class='code-nbr'>01</td><td class='code-desc'>Neck lymph node regions</td></tr><tr class='code-row'><td class='code-nbr'>02</td><td class='code-desc'>Thoracic lymph node regions</td></tr><tr class='code-row'><td class='code-nbr'>03</td><td class='code-desc'>Neck and thoracic lymph node regions</td></tr><tr class='code-row'><td class='code-nbr'>04</td><td class='code-desc'>Breast/ Chestwall lymph node regions</td></tr><tr class='code-row'><td class='code-nbr'>05</td><td class='code-desc'>Abdominal lymph nodes</td></tr><tr class='code-row'><td class='code-nbr'>06</td><td class='code-desc'>Pelvic lymph nodes</td></tr><tr class='code-row'><td class='code-nbr'>07</td><td class='code-desc'>Abdominal and pelvic lymph nodes</td></tr><tr class='code-row'><td class='code-nbr'>09</td><td class='code-desc'>Lymph node region, NOS</td></tr><tr class='code-row'><td class='code-nbr'>10</td><td class='code-desc'>Eye/orbit/optic nerve</td></tr><tr class='code-row'><td class='code-nbr'>11</td><td class='code-desc'>Pituitary</td></tr><tr class='code-row'><td class='code-nbr'>12</td><td class='code-desc'>Brain</td></tr><tr class='code-row'><td class='code-nbr'>13</td><td class='code-desc'>Brain (Limited) </td></tr><tr class='code-row'><td class='code-nbr'>14</td><td class='code-desc'>Spinal cord</td></tr><tr class='code-row'><td class='code-nbr'>20</td><td class='code-desc'>Nasopharynx</td></tr><tr class='code-row'><td class='code-nbr'>21</td><td class='code-desc'>Oral Cavity</td></tr><tr class='code-row'><td class='code-nbr'>22</td><td class='code-desc'>Oropharynx</td></tr><tr class='code-row'><td class='code-nbr'>23</td><td class='code-desc'>Larynx (glottis) or hypopharynx</td></tr><tr class='code-row'><td class='code-nbr'>24</td><td class='code-desc'>Sinuses/Nasal tract</td></tr><tr class='code-row'><td class='code-nbr'>25</td><td class='code-desc'>Parotid or other salivary glands</td></tr><tr class='code-row'><td class='code-nbr'>26</td><td class='code-desc'>Thyroid</td></tr><tr class='code-row'><td class='code-nbr'>29</td><td class='code-desc'>Head and neck (NOS)</td></tr><tr class='code-row'><td class='code-nbr'>30</td><td class='code-desc'>Lung or bronchus</td></tr><tr class='code-row'><td class='code-nbr'>31</td><td class='code-desc'>Mesothelium</td></tr><tr class='code-row'><td class='code-nbr'>32</td><td class='code-desc'>Thymus</td></tr><tr class='code-row'><td class='code-nbr'>39</td><td class='code-desc'>Chest/lung (NOS)</td></tr><tr class='code-row'><td class='code-nbr'>40</td><td class='code-desc'>Breast - whole</td></tr><tr class='code-row'><td class='code-nbr'>41</td><td class='code-desc'>Breast - partial</td></tr><tr class='code-row'><td class='code-nbr'>42</td><td class='code-desc'>Chest wall</td></tr><tr class='code-row'><td class='code-nbr'>50</td><td class='code-desc'>Esophagus</td></tr><tr class='code-row'><td class='code-nbr'>51</td><td class='code-desc'>Stomach</td></tr><tr class='code-row'><td class='code-nbr'>52</td><td class='code-desc'>Small bowel</td></tr><tr class='code-row'><td class='code-nbr'>53</td><td class='code-desc'>Colon</td></tr><tr class='code-row'><td class='code-nbr'>54</td><td class='code-desc'>Rectum</td></tr><tr class='code-row'><td class='code-nbr'>55</td><td class='code-desc'>Anus</td></tr><tr class='code-row'><td class='code-nbr'>56</td><td class='code-desc'>Liver</td></tr><tr class='code-row'><td class='code-nbr'>57</td><td class='code-desc'>Biliary tree or gallbladder</td></tr><tr class='code-row'><td class='code-nbr'>58</td><td class='code-desc'>Pancreas or hepatopancreatic ampulla</td></tr><tr class='code-row'><td class='code-nbr'>59</td><td class='code-desc'>Abdomen (NOS)</td></tr><tr class='code-row'><td class='code-nbr'>60</td><td class='code-desc'>Bladder - whole</td></tr><tr class='code-row'><td class='code-nbr'>61</td><td class='code-desc'>Bladder - partial</td></tr><tr class='code-row'><td class='code-nbr'>62</td><td class='code-desc'>Kidney</td></tr><tr class='code-row'><td class='code-nbr'>63</td><td class='code-desc'>Ureter</td></tr><tr class='code-row'><td class='code-nbr'>64</td><td class='code-desc'>Prostate - whole</td></tr><tr class='code-row'><td class='code-nbr'>65</td><td class='code-desc'>Prostate - partial</td></tr><tr class='code-row'><td class='code-nbr'>66</td><td class='code-desc'>Urethra</td></tr><tr class='code-row'><td class='code-nbr'>67</td><td class='code-desc'>Penis</td></tr><tr class='code-row'><td class='code-nbr'>68</td><td class='code-desc'>Testicle or scrotum</td></tr><tr class='code-row'><td class='code-nbr'>70</td><td class='code-desc'>Ovaries or fallopian tubes</td></tr><tr class='code-row'><td class='code-nbr'>71</td><td class='code-desc'>Uterus or Cervix</td></tr><tr class='code-row'><td class='code-nbr'>72</td><td class='code-desc'>Vagina</td></tr><tr class='code-row'><td class='code-nbr'>73</td><td class='code-desc'>Vulva</td></tr><tr class='code-row'><td class='code-nbr'>80</td><td class='code-desc'>Skull</td></tr><tr class='code-row'><td class='code-nbr'>81</td><td class='code-desc'>Spine/vertebral bodies</td></tr><tr class='code-row'><td class='code-nbr'>82</td><td class='code-desc'>Shoulder</td></tr><tr class='code-row'><td class='code-nbr'>83</td><td class='code-desc'>Ribs</td></tr><tr class='code-row'><td class='code-nbr'>84</td><td class='code-desc'>Hip</td></tr><tr class='code-row'><td class='code-nbr'>85</td><td class='code-desc'>Pelvic bones</td></tr><tr class='code-row'><td class='code-nbr'>86</td><td class='code-desc'>Pelvis (NOS, non-visceral)</td></tr><tr class='code-row'><td class='code-nbr'>88</td><td class='code-desc'>Extremity bone, NOS</td></tr><tr class='code-row'><td class='code-nbr'>90</td><td class='code-desc'>Skin</td></tr><tr class='code-row'><td class='code-nbr'>91</td><td class='code-desc'>Soft tissue</td></tr><tr class='code-row'><td class='code-nbr'>92</td><td class='code-desc'>Hemibody</td></tr><tr class='code-row'><td class='code-nbr'>93</td><td class='code-desc'>Whole body</td></tr><tr class='code-row'><td class='code-nbr'>94</td><td class='code-desc'>Mantle, mini-mantle (obsolete after 2017)</td></tr><tr class='code-row'><td class='code-nbr'>95</td><td class='code-desc'>Lower extended field (obsolete after 2017)</td></tr><tr class='code-row'><td class='code-nbr'>96</td><td class='code-desc'>Inverted Y (obsolete after 2017)</td></tr><tr class='code-row'><td class='code-nbr'>97</td><td class='code-desc'>Invalid historical FORDS value</td></tr><tr class='code-row'><td class='code-nbr'>98</td><td class='code-desc'>Other</td></tr><tr class='code-row'><td class='code-nbr'>99</td><td class='code-desc'>Unknown</td></tr><tr class='code-row'><td class='code-nbr'></td><td class='code-desc'> </td></tr></table></div><a name='1505'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>PHASE I RADIATION TO DRAINING LYMPH NODES</strong></td><td style="text-align:right;font-weight:bold;"><strong>Revised</strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">1505</td><td style="text-align:center;">2</td><td style="text-align:center;"><a href='#sources'>CoC</a></td><td style="text-align:center;">2018</td><td style="text-align:center;">18</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">2283 - 2284</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td title="V: 22: phase1RadiationToDrainingLN
V: 18: phase1RadiationToDrainingLymphNodes
" class=" HighlightToolTip">phase1RadiationToDrainingLN</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Identifies the draining lymph nodes treated (if any) during the first phase of radiation therapy delivered to the patient during the first course of treatment. This data item is required for CoC-accredited facilities as of 01/01/2018.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>The first phase of radiation treatment commonly targets both the primary tumor (or tumor bed) and draining lymph nodes as a secondary site. This data item should be used to indicate the draining regional lymph nodes, if any, that were irradiated during the first phase of radiation.</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>00</td><td class='code-desc'>No radiation treatment </td></tr><tr class='code-row'><td class='code-nbr'>01</td><td class='code-desc'>Neck lymph node regions</td></tr><tr class='code-row'><td class='code-nbr'>02</td><td class='code-desc'>Thoracic lymph node regions</td></tr><tr class='code-row'><td class='code-nbr'>03</td><td class='code-desc'>Neck and thoracic lymph node regions</td></tr><tr class='code-row'><td class='code-nbr'>04</td><td class='code-desc'>Breast/Chest wall lymph node regions</td></tr><tr class='code-row'><td class='code-nbr'>05</td><td class='code-desc'>Abdominal lymph nodes </td></tr><tr class='code-row'><td class='code-nbr'>06</td><td class='code-desc'>Pelvic lymph nodes</td></tr><tr class='code-row'><td class='code-nbr'>07</td><td class='code-desc'>Abdominal and pelvic lymph nodes </td></tr><tr class='code-row'><td class='code-nbr'>08</td><td class='code-desc'>Lymph node region, NOS</td></tr><tr class='code-row'><td class='code-nbr'>88</td><td class='code-desc'>Not applicable; Phase I Radiation Primary Treatment Volume is lymph nodes</td></tr><tr class='code-row'><td class='code-nbr'>99</td><td class='code-desc'>Unknown if any radiation treatment to draining lymph nodes; Unknown if radiation treatment administered</td></tr><tr class='code-row'><td class='code-nbr'></td><td class='code-desc'> </td></tr></table></div><a name='1506'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>PHASE I RADIATION TREATMENT MODALITY</strong></td><td style="text-align:right;font-weight:bold;"><strong>Revised</strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">1506</td><td style="text-align:center;">2</td><td style="text-align:center;"><a href='#sources'>CoC</a></td><td style="text-align:center;">2018</td><td style="text-align:center;">18</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">2285 - 2286</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>phase1RadiationTreatmentModality</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Identifies the radiation modality administered during the first phase of radiation treatment delivered as part of the first course of treatment. This data item is required for CoC-accredited facilities as of 01/01/2018.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Radiation modality reflects whether a treatment was external beam, brachytherapy, a radioisotope as well as their major subtypes, or a combination of modalities. This data item should be used to indicate the radiation modality administered during the first phase of radiation. <br /><br />Historically, the previously-named Regional Treatment Modality data item [1570] utilized codes that were not mutually exclusive. Rather, it included codes describing a mix of modalities, treatment planning techniques, and delivery techniques that are commonly utilized by radiation oncologists. However, every phase of radiation treatment will include a specific modality, planning technique, and delivery technique. The goal of the 2018 implementation of separate phase-specific data items for the recording of radiation modality and radiation treatment planning techniques is to clarify this information and implement mutually exclusive categories.  A separate data item for delivery technique has not been implemented because this information is not consistently reported in end treatment summaries.</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para mark-changed'><table><tr class='code-row'><td class='code-nbr'>00</td><td class='code-desc'>No radiation treatment </td></tr><tr class='code-row'><td class='code-nbr'>01</td><td class='code-desc'>External beam, NOS</td></tr><tr class='code-row'><td class='code-nbr'>02</td><td class='code-desc'>External beam, photons</td></tr><tr class='code-row'><td class='code-nbr'>03</td><td class='code-desc'>External beam, protons</td></tr><tr class='code-row'><td class='code-nbr'>04</td><td class='code-desc'>External beam, electrons</td></tr><tr class='code-row'><td class='code-nbr'>05</td><td class='code-desc'>External beam, neutrons</td></tr><tr class='code-row'><td class='code-nbr'>06</td><td class='code-desc'>External beam, carbon ions</td></tr><tr class='code-row'><td class='code-nbr'>07</td><td class='code-desc'>Brachytherapy, NOS</td></tr><tr class='code-row'><td class='code-nbr'>08</td><td class='code-desc'>Brachytherapy, intracavitary, LDR</td></tr><tr class='code-row'><td class='code-nbr'>09</td><td class='code-desc'>Brachytherapy, intracavitary, HDR</td></tr><tr class='code-row'><td class='code-nbr'>10</td><td class='code-desc'>Brachytherapy, interstitial, LDR</td></tr><tr class='code-row'><td class='code-nbr'>11</td><td class='code-desc'>Brachytherapy, interstitial, HDR</td></tr><tr class='code-row'><td class='code-nbr'>12</td><td class='code-desc'>Brachytherapy, electronic</td></tr><tr class='code-row'><td class='code-nbr'>13</td><td class='code-desc'>Radioisotopes, NOS</td></tr><tr class='code-row'><td class='code-nbr'>14</td><td class='code-desc'>Radioisotopes, radium-223</td></tr><tr class='code-row'><td class='code-nbr'>15</td><td class='code-desc'>Radioisotopes, strontium-89</td></tr><tr class='code-row'><td class='code-nbr'>16</td><td class='code-desc'>Radioisotopes, strontium-90</td></tr><tr class='code-row'><td class='code-nbr'>98</td><td class='code-desc'>Radiation therapy administered but treatment modality is not specified or unknown </td></tr><tr class='code-row'><td class='code-nbr'>99</td><td class='code-desc'>Unknown if radiation treatment administered</td></tr><tr class='code-row'><td class='code-nbr'></td><td class='code-desc'> </td></tr></table></div><a name='1507'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>PHASE I TOTAL DOSE</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">1507</td><td style="text-align:center;">6</td><td style="text-align:center;"><a href='#sources'>CoC</a></td><td style="text-align:center;">2018</td><td style="text-align:center;">18</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">2297 - 2302</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>phase1TotalDose</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'><!--[if gte mso 10]>  <![endif]-->Identifies the total radiation dose delivered to the patient in the first phase of radiation treatment during the first course of treatment. The unit of measure is centiGray (cGy). This data item is required for CoC-accredited facilities as of 01/01/2018.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>To evaluate the patterns of radiation care, it is necessary to capture information describing the prescribed dose of Phase I radiation to the patient during the first course of treatment. Outcomes are strongly related to the total dose delivered.</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>000000</td><td class='code-desc'>No therapy administered</td></tr><tr class='code-row'><td class='code-nbr'>000001-999997</td><td class='code-desc'>Record the actual total dose delivered in cGy</td></tr><tr class='code-row'><td class='code-nbr'>999998</td><td class='code-desc'>Not applicable, radioisotopes administered to the patient</td></tr><tr class='code-row'><td class='code-nbr'>999999</td><td class='code-desc'>Radiation therapy was administered, but the dose is unknown; it is unknown whether radiation therapy was administered</td></tr><tr class='code-row'><td class='code-nbr'></td><td class='code-desc'> </td></tr></table></div><a name='1511'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>PHASE II DOSE PER FRACTION</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">1511</td><td style="text-align:center;">5</td><td style="text-align:center;"><a href='#sources'>CoC</a></td><td style="text-align:center;">2018</td><td style="text-align:center;">18</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">2311 - 2315</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>phase2DosePerFraction</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Records the dose per fraction (treatment session) delivered to the patient in the second phase of radiation during the first course of treatment. The unit of measure is centiGray (cGy). This data item is required for CoC-accredited facilities for cases diagnosed as of 01/01/2018.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Radiation therapy is delivered in one or more phases with identified dose per fraction. It is necessary to capture information describing the dose per fraction to evaluate patterns of radiation oncology care. Outcomes are strongly related to the dose delivered.</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>00000</td><td class='code-desc'>Radiation therapy was not administered</td></tr><tr class='code-row'><td class='code-nbr'>00001-99997</td><td class='code-desc'>Record the actual Phase II dose delivered in cGy</td></tr><tr class='code-row'><td class='code-nbr'>99998</td><td class='code-desc'>Not applicable, brachytherapy or radioisotopes administered to the patient</td></tr><tr class='code-row'><td class='code-nbr'>99999</td><td class='code-desc'>Phase II (Boost) radiation therapy was administered but dose is unknown, it is unknown whether Phase II radiation therapy was administered. Death Certificate only. </td></tr><tr class='code-row'><td class='code-nbr'></td><td class='code-desc'> </td></tr></table></div><div class='content chap10-para'>Blanks allowed if no Phase II radiation treatment administered.</div><a name='1513'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>PHASE II NUMBER OF FRACTIONS</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">1513</td><td style="text-align:center;">3</td><td style="text-align:center;"><a href='#sources'>CoC</a></td><td style="text-align:center;">2018</td><td style="text-align:center;">18</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">2316 - 2318</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>phase2NumberOfFractions</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Records the total number of fractions (treatment sessions) administered to the patient in the second phase of radiation during the first course of treatment. This data item is required for CoC-accredited facilities for cases diagnosed as of 01/01/2018.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Radiation therapy is delivered in one or more phases with each phase spread out over a number of fractions (treatment sessions). It is necessary to capture information describing the number of fraction(s) to evaluate patterns of radiation oncology care.</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>000</td><td class='code-desc'>Radiation therapy was not administered to the patient</td></tr><tr class='code-row'><td class='code-nbr'>001-998</td><td class='code-desc'>Number of fractions administered to the patient during the second phase of radiation therapy</td></tr><tr class='code-row'><td class='code-nbr'>999</td><td class='code-desc'>Phase II Radiation therapy was administered, but the number of fractions is unknown; It is unknown whether radiation therapy was administered</td></tr><tr class='code-row'><td class='code-nbr' colspan='2'></td></tr></table></div><div class='content chap10-para'>Blanks allowed if no Phase II radiation treatment administered.</div><a name='1512'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>PHASE II RADIATION EXTERNAL BEAM PLANNING TECH</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">1512</td><td style="text-align:center;">2</td><td style="text-align:center;"><a href='#sources'>CoC</a></td><td style="text-align:center;">2018</td><td style="text-align:center;">18</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">2309 - 2310</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>phase2RadiationExternalBeamTech</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Identifies the external beam radiation planning technique used to administer the second phase of radiation treatment during the first course of treatment. This data item is required for CoC-accredited facilities for cases diagnosed as of 01/01/2018.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>External beam radiation is the most commonly-used radiation modality in North America. In this data item we specified the planning technique for external beam treatment. Identifying the radiation technique is of interest for patterns of care and comparative effectiveness studies.<br /><br />Historically, the previously-named Rad--Boost RX Modality [3200] utilized codes that were not mutually exclusive. Rather, it included codes describing a mix of modalities, treatment planning techniques, and delivery techniques that are commonly utilized by radiation oncologists. However, every phase of radiation treatment will include a specified modality, planning technique, and delivery technique. The goal of the 2018 implementation of separate phase-specific data items for the recording of Phase II Radiation Treatment Modality [1516] and Phase II Radiation External Beam Planning Tech [1512] is to clarify this information and implement mutually exclusive categories.  A separate data item for delivery technique has not been implemented because this information is not consistently reported in end treatment summaries.</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>00</td><td class='code-desc'>No radiation treatment</td></tr><tr class='code-row'><td class='code-nbr'>01</td><td class='code-desc'>External beam, NOS</td></tr><tr class='code-row'><td class='code-nbr'>02</td><td class='code-desc'>Low energy x-ray/photon therapy</td></tr><tr class='code-row'><td class='code-nbr'>03</td><td class='code-desc'>2-D therapy</td></tr><tr class='code-row'><td class='code-nbr'>04</td><td class='code-desc'>Conformal or 3-D conformal therapy</td></tr><tr class='code-row'><td class='code-nbr'>05</td><td class='code-desc'>Intensity modulated therapy </td></tr><tr class='code-row'><td class='code-nbr'>06</td><td class='code-desc'>Stereotactic radiotherapy or radiosurgery, NOS</td></tr><tr class='code-row'><td class='code-nbr'>07</td><td class='code-desc'>Stereotactic radiotherapy or radiosurgery, robotic</td></tr><tr class='code-row'><td class='code-nbr'>08</td><td class='code-desc'>Stereotactic radiotherapy or radiosurgery, Gamma Knife</td></tr><tr class='code-row'><td class='code-nbr'>09</td><td class='code-desc'>CT-guided online adaptive therapy</td></tr><tr class='code-row'><td class='code-nbr'>10</td><td class='code-desc'>MR-guided online adaptive therapy</td></tr><tr class='code-row'><td class='code-nbr'>88</td><td class='code-desc'>Not applicable</td></tr><tr class='code-row'><td class='code-nbr'>98</td><td class='code-desc'>Other, NOS</td></tr><tr class='code-row'><td class='code-nbr'>99</td><td class='code-desc'>Unknown</td></tr><tr class='code-row'><td class='code-nbr'></td><td class='code-desc'> </td></tr></table></div><div class='content chap10-para'>Blanks allowed if no Phase II radiation treatment administered.</div><a name='1514'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>PHASE II RADIATION PRIMARY TREATMENT VOLUME</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">1514</td><td style="text-align:center;">2</td><td style="text-align:center;"><a href='#sources'>CoC</a></td><td style="text-align:center;">2018</td><td style="text-align:center;">18</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">2303 - 2304</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>phase2RadiationPrimaryTxVolume</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Identifies the primary treatment volume or primary anatomic target treated during the second phase of radiation therapy during the first course of treatment. This data item is required for CoC-accredited facilities as of cases diagnosed 01/01/2018.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Radiation treatment is commonly delivered in one or more phases. Typically, in each phase, the primary tumor or tumor bed is treated. This data item should be used to indicate the primary target volume, which might include the primary tumor or tumor bed. If the primary tumor was not targeted, record the other regional or distant site that was targeted. Draining lymph nodes may also be targeted during the second phase. These will be identified in a separate data item Phase II Radiation to Draining Lymph Nodes [1515].<br /><br />This data item provides information describing the anatomical structure targeted by radiation therapy during the second phase of radiation treatment and can be used to determine whether the site of the primary diseases was treated with radiation or if other regional or distant sites were targeted. This information is useful in evaluating the patterns of care within a facility and on a regional or national basis. The breakdown and reorganization of the sites will allow for concise reporting.</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>00</td><td class='code-desc'>No phase II radiation treatment</td></tr><tr class='code-row'><td class='code-nbr'>01</td><td class='code-desc'>Neck lymph node regions</td></tr><tr class='code-row'><td class='code-nbr'>02</td><td class='code-desc'>Thoracic lymph node regions</td></tr><tr class='code-row'><td class='code-nbr'>03</td><td class='code-desc'>Neck and thoracic lymph node regions</td></tr><tr class='code-row'><td class='code-nbr'>04</td><td class='code-desc'>Breast/ Chestwall lymph node regions</td></tr><tr class='code-row'><td class='code-nbr'>05</td><td class='code-desc'>Abdominal lymph nodes</td></tr><tr class='code-row'><td class='code-nbr'>06</td><td class='code-desc'>Pelvic lymph nodes</td></tr><tr class='code-row'><td class='code-nbr'>07</td><td class='code-desc'>Abdominal and pelvic lymph nodes</td></tr><tr class='code-row'><td class='code-nbr'>09</td><td class='code-desc'>Lymph node region, NOS</td></tr><tr class='code-row'><td class='code-nbr'>10</td><td class='code-desc'>Eye/orbit/optic nerve</td></tr><tr class='code-row'><td class='code-nbr'>11</td><td class='code-desc'>Pituitary</td></tr><tr class='code-row'><td class='code-nbr'>12</td><td class='code-desc'>Brain</td></tr><tr class='code-row'><td class='code-nbr'>13</td><td class='code-desc'>Brain (Limited) </td></tr><tr class='code-row'><td class='code-nbr'>14</td><td class='code-desc'>Spinal cord</td></tr><tr class='code-row'><td class='code-nbr'>20</td><td class='code-desc'>Nasopharynx</td></tr><tr class='code-row'><td class='code-nbr'>21</td><td class='code-desc'>Oral Cavity</td></tr><tr class='code-row'><td class='code-nbr'>22</td><td class='code-desc'>Oropharynx</td></tr><tr class='code-row'><td class='code-nbr'>23</td><td class='code-desc'>Larynx (glottis) or hypopharynx</td></tr><tr class='code-row'><td class='code-nbr'>24</td><td class='code-desc'>Sinuses/Nasal tract</td></tr><tr class='code-row'><td class='code-nbr'>25</td><td class='code-desc'>Parotid or other salivary glands</td></tr><tr class='code-row'><td class='code-nbr'>26</td><td class='code-desc'>Thyroid</td></tr><tr class='code-row'><td class='code-nbr'>29</td><td class='code-desc'>Head and neck (NOS)</td></tr><tr class='code-row'><td class='code-nbr'>30</td><td class='code-desc'>Lung or bronchus</td></tr><tr class='code-row'><td class='code-nbr'>31</td><td class='code-desc'>Mesothelium</td></tr><tr class='code-row'><td class='code-nbr'>32</td><td class='code-desc'>Thymus</td></tr><tr class='code-row'><td class='code-nbr'>39</td><td class='code-desc'>Chest/lung (NOS)</td></tr><tr class='code-row'><td class='code-nbr'>40</td><td class='code-desc'>Breast - whole</td></tr><tr class='code-row'><td class='code-nbr'>41</td><td class='code-desc'>Breast - partial</td></tr><tr class='code-row'><td class='code-nbr'>42</td><td class='code-desc'>Chest wall</td></tr><tr class='code-row'><td class='code-nbr'>50</td><td class='code-desc'>Esophagus</td></tr><tr class='code-row'><td class='code-nbr'>51</td><td class='code-desc'>Stomach</td></tr><tr class='code-row'><td class='code-nbr'>52</td><td class='code-desc'>Small bowel</td></tr><tr class='code-row'><td class='code-nbr'>53</td><td class='code-desc'>Colon</td></tr><tr class='code-row'><td class='code-nbr'>54</td><td class='code-desc'>Rectum</td></tr><tr class='code-row'><td class='code-nbr'>55</td><td class='code-desc'>Anus</td></tr><tr class='code-row'><td class='code-nbr'>56</td><td class='code-desc'>Liver</td></tr><tr class='code-row'><td class='code-nbr'>57</td><td class='code-desc'>Biliary tree or gallbladder</td></tr><tr class='code-row'><td class='code-nbr'>58</td><td class='code-desc'>Pancreas or hepatopancreatic ampulla</td></tr><tr class='code-row'><td class='code-nbr'>59</td><td class='code-desc'>Abdomen (NOS)</td></tr><tr class='code-row'><td class='code-nbr'>60</td><td class='code-desc'>Bladder - whole</td></tr><tr class='code-row'><td class='code-nbr'>61</td><td class='code-desc'>Bladder - partial</td></tr><tr class='code-row'><td class='code-nbr'>62</td><td class='code-desc'>Kidney</td></tr><tr class='code-row'><td class='code-nbr'>63</td><td class='code-desc'>Ureter</td></tr><tr class='code-row'><td class='code-nbr'>64</td><td class='code-desc'>Prostate - whole</td></tr><tr class='code-row'><td class='code-nbr'>65</td><td class='code-desc'>Prostate - partial</td></tr><tr class='code-row'><td class='code-nbr'>66</td><td class='code-desc'>Urethra</td></tr><tr class='code-row'><td class='code-nbr'>67</td><td class='code-desc'>Penis</td></tr><tr class='code-row'><td class='code-nbr'>68</td><td class='code-desc'>Testicle or scrotum</td></tr><tr class='code-row'><td class='code-nbr'>70</td><td class='code-desc'>Ovaries or fallopian tubes</td></tr><tr class='code-row'><td class='code-nbr'>71</td><td class='code-desc'>Uterus or Cervix</td></tr><tr class='code-row'><td class='code-nbr'>72</td><td class='code-desc'>Vagina</td></tr><tr class='code-row'><td class='code-nbr'>73</td><td class='code-desc'>Vulva</td></tr><tr class='code-row'><td class='code-nbr'>80</td><td class='code-desc'>Skull</td></tr><tr class='code-row'><td class='code-nbr'>81</td><td class='code-desc'>Spine/vertebral bodies</td></tr><tr class='code-row'><td class='code-nbr'>82</td><td class='code-desc'>Shoulder</td></tr><tr class='code-row'><td class='code-nbr'>83</td><td class='code-desc'>Ribs</td></tr><tr class='code-row'><td class='code-nbr'>84</td><td class='code-desc'>Hip</td></tr><tr class='code-row'><td class='code-nbr'>85</td><td class='code-desc'>Pelvic bones</td></tr><tr class='code-row'><td class='code-nbr'>86</td><td class='code-desc'>Pelvis (NOS, non-visceral)</td></tr><tr class='code-row'><td class='code-nbr'>88</td><td class='code-desc'>Extremity bone, NOS</td></tr><tr class='code-row'><td class='code-nbr'>90</td><td class='code-desc'>Skin</td></tr><tr class='code-row'><td class='code-nbr'>91</td><td class='code-desc'>Soft tissue</td></tr><tr class='code-row'><td class='code-nbr'>92</td><td class='code-desc'>Hemibody</td></tr><tr class='code-row'><td class='code-nbr'>93</td><td class='code-desc'>Whole body</td></tr><tr class='code-row'><td class='code-nbr'>94</td><td class='code-desc'>Mantle, mini-mantle (obsolete after 2017)</td></tr><tr class='code-row'><td class='code-nbr'>95</td><td class='code-desc'>Lower extended field (obsolete after 2017)</td></tr><tr class='code-row'><td class='code-nbr'>96</td><td class='code-desc'>Inverted Y (obsolete after 2017)</td></tr><tr class='code-row'><td class='code-nbr'>97</td><td class='code-desc'>Invalid historical FORDS value </td></tr><tr class='code-row'><td class='code-nbr'>98</td><td class='code-desc'>Other</td></tr><tr class='code-row'><td class='code-nbr'>99</td><td class='code-desc'>Unknown</td></tr><tr class='code-row'><td class='code-nbr'></td><td class='code-desc'> </td></tr></table></div><a name='1515'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>PHASE II RADIATION TO DRAINING LYMPH NODES</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">1515</td><td style="text-align:center;">2</td><td style="text-align:center;"><a href='#sources'>CoC</a></td><td style="text-align:center;">2018</td><td style="text-align:center;">18</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">2305 - 2306</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>phase2RadiationToDrainingLN</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Identifies the draining lymph nodes treated (if any) during the second phase of radiation therapy delivered to the patient during the first course of treatment. This data item is required for CoC-accredited facilities as of cases diagnosed 01/01/2018.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>The second phase of radiation treatment commonly targets both the primary tumor (or tumor bed) and draining lymph nodes as a secondary site. This data item should be used to indicate the draining regional lymph nodes, if any, that were irradiated during the second phase of radiation.</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>00</td><td class='code-desc'>No radiation treatment to draining lymph nodes </td></tr><tr class='code-row'><td class='code-nbr'>01</td><td class='code-desc'>Neck lymph node regions</td></tr><tr class='code-row'><td class='code-nbr'>02</td><td class='code-desc'>Thoracic lymph node regions</td></tr><tr class='code-row'><td class='code-nbr'>03</td><td class='code-desc'>Neck and thoracic lymph node regions</td></tr><tr class='code-row'><td class='code-nbr'>04</td><td class='code-desc'>Breast/Chest wall lymph node regions</td></tr><tr class='code-row'><td class='code-nbr'>05</td><td class='code-desc'>Abdominal lymph nodes </td></tr><tr class='code-row'><td class='code-nbr'>06</td><td class='code-desc'>Pelvic lymph nodes</td></tr><tr class='code-row'><td class='code-nbr'>07</td><td class='code-desc'>Abdominal and pelvic lymph nodes </td></tr><tr class='code-row'><td class='code-nbr'>08</td><td class='code-desc'>Lymph node region, NOS</td></tr><tr class='code-row'><td class='code-nbr'>88</td><td class='code-desc'>Not Applicable; Phase II Radiation Primary Treatment Volume is lymph nodes</td></tr><tr class='code-row'><td class='code-nbr'>99</td><td class='code-desc'>Unknown if any radiation treatment to draining lymph nodes; Unknown if radiation treatment administered</td></tr><tr class='code-row'><td class='code-nbr'></td><td class='code-desc'> </td></tr></table></div><div class='content chap10-para'>Blanks allowed if no Phase II radiation treatment administered.</div><a name='1516'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>PHASE II RADIATION TREATMENT MODALITY</strong></td><td style="text-align:right;font-weight:bold;"><strong>Revised</strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">1516</td><td style="text-align:center;">2</td><td style="text-align:center;"><a href='#sources'>CoC</a></td><td style="text-align:center;">2018</td><td style="text-align:center;">18</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">2307 - 2308</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>phase2RadiationTreatmentModality</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Identifies the radiation modality administered during the second phase of radiation treatment delivered during the first course of treatment. This data item is required for CoC-accredited facilities as of 01/01/2018.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Radiation modality reflects whether a treatment was external beam, brachytherapy, a radioisotope as well as their major subtypes, or a combination of modalities. This data item should be used to indicate the radiation modality administered during the second phase of radiation. <br /><br />Historically, the previously-named Radiation Treatment Modality data item [1570] utilized codes that were not mutually exclusive. Rather, it included codes describing a mix of modalities, treatment planning techniques, and delivery techniques that are commonly utilized by radiation oncologists. However, every phase of radiation treatment will include a specified modality, planning technique, and delivery technique. The goal of the 2018 implementation of separate phase-specific data items for the recording of radiation modality and radiation treatment planning techniques is to clarify this information and implement mutually exclusive categories.  A separate data item for delivery technique has not been implemented because this information is not consistently reported in end treatment summaries.</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para mark-changed'><table><tr class='code-row'><td class='code-nbr'>00</td><td class='code-desc'>No radiation treatment</td></tr><tr class='code-row'><td class='code-nbr'>01</td><td class='code-desc'>External beam, NOS</td></tr><tr class='code-row'><td class='code-nbr'>02</td><td class='code-desc'>External beam, photons</td></tr><tr class='code-row'><td class='code-nbr'>03</td><td class='code-desc'>External beam, protons</td></tr><tr class='code-row'><td class='code-nbr'>04</td><td class='code-desc'>External beam, electrons</td></tr><tr class='code-row'><td class='code-nbr'>05</td><td class='code-desc'>External beam, neutrons</td></tr><tr class='code-row'><td class='code-nbr'>06</td><td class='code-desc'>External beam, carbon ions</td></tr><tr class='code-row'><td class='code-nbr'>07</td><td class='code-desc'>Brachytherapy, NOS</td></tr><tr class='code-row'><td class='code-nbr'>08</td><td class='code-desc'>Brachytherapy, intracavitary, LDR</td></tr><tr class='code-row'><td class='code-nbr'>09</td><td class='code-desc'>Brachytherapy, intracavitary, HDR</td></tr><tr class='code-row'><td class='code-nbr'>10</td><td class='code-desc'>Brachytherapy, Interstitial, LDR</td></tr><tr class='code-row'><td class='code-nbr'>11</td><td class='code-desc'>Brachytherapy, Interstitial, HDR</td></tr><tr class='code-row'><td class='code-nbr'>12</td><td class='code-desc'>Brachytherapy, electronic</td></tr><tr class='code-row'><td class='code-nbr'>13</td><td class='code-desc'>Radioisotopes, NOS</td></tr><tr class='code-row'><td class='code-nbr'>14</td><td class='code-desc'>Radioisotopes, Radium-232</td></tr><tr class='code-row'><td class='code-nbr'>15</td><td class='code-desc'>Radioisotopes, Strontium-89</td></tr><tr class='code-row'><td class='code-nbr'>16</td><td class='code-desc'>Radioisotopes, Strontium-90</td></tr><tr class='code-row'><td class='code-nbr'>98</td><td class='code-desc'>Radiation therapy administered but treatment modality is not specified or unknown  </td></tr><tr class='code-row'><td class='code-nbr'>99</td><td class='code-desc'>Treatment radiation modality unknown; Unknown if radiation treatment administered</td></tr><tr class='code-row'><td class='code-nbr'></td><td class='code-desc'> </td></tr></table></div><div class='content chap10-para'>Blanks allowed if no Phase II radiation treatment administered.</div><a name='1517'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>PHASE II TOTAL DOSE</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">1517</td><td style="text-align:center;">6</td><td style="text-align:center;"><a href='#sources'>CoC</a></td><td style="text-align:center;">2018</td><td style="text-align:center;">18</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">2319 - 2324</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>phase2TotalDose</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Identifies the total radiation dose administered in the second phase of radiation treatment delivered to the patient during the first course of treatment. The unit of measure is centiGray (cGy). This data item is required for CoC-accredited facilities for cases diagnosed as of 01/01/2018.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>To evaluate the patterns of radiation care, it is necessary to capture information describing the prescribed dose of Phase II radiation to the patient during the first course of treatment. Outcomes are strongly related to the total dose delivered.</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>000000</td><td class='code-desc'>No radiation treatment</td></tr><tr class='code-row'><td class='code-nbr'>000001-999997</td><td class='code-desc'>Record the actual total dose delivered in cGy</td></tr><tr class='code-row'><td class='code-nbr'>999998</td><td class='code-desc'>Not applicable, brachytherapy or radioisotopes administered to the patient</td></tr><tr class='code-row'><td class='code-nbr'>999999</td><td class='code-desc'>Radiation therapy was administered, but the dose is unknown; it is unknown whether radiation therapy was administered</td></tr><tr class='code-row'><td class='code-nbr'></td><td class='code-desc'> </td></tr></table></div><div class='content chap10-para'>Blanks allowed if no Phase II radiation treatment administered.</div><a name='1521'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>PHASE III DOSE PER FRACTION</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">1521</td><td style="text-align:center;">5</td><td style="text-align:center;"><a href='#sources'>CoC</a></td><td style="text-align:center;">2018</td><td style="text-align:center;">18</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">2333 - 2337</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>phase3DosePerFraction</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Records the dose per fraction (treatment session) delivered to the patient in the third phase of radiation during the first course of treatment. The unit of measure is centiGray (cGy). This data item is required for CoC-accredited facilities for cases diagnosed as of 01/01/2018.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'><!--[if gte mso 10]>  <![endif]-->Radiation therapy is delivered in one or more phases with identified dose per fraction. It is necessary to capture information describing the dose per fraction to evaluate patterns of radiation oncology care. Outcomes are strongly related to the dose delivered.</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>00000 </td><td class='code-desc'>No radiation treatment</td></tr><tr class='code-row'><td class='code-nbr'>00001-99997</td><td class='code-desc'>Record the actual Phase III dose delivered in cGy</td></tr><tr class='code-row'><td class='code-nbr'>99998 </td><td class='code-desc'>Not applicable, radioisotopes administered to the patient</td></tr><tr class='code-row'><td class='code-nbr'>99999 </td><td class='code-desc'>Phase III radiation therapy was administered but dose is unknown, it is unknown whether Phase III radiation therapy was administered. Death Certificate only.</td></tr><tr class='code-row'><td class='code-nbr'></td><td class='code-desc'> </td></tr></table></div><div class='content chap10-para'>Blanks allowed if no Phase III radiation treatment administered.</div><a name='1523'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>PHASE III NUMBER OF FRACTIONS</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">1523</td><td style="text-align:center;">3</td><td style="text-align:center;"><a href='#sources'>CoC</a></td><td style="text-align:center;">2018</td><td style="text-align:center;">18</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">2338 - 2340</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>phase3NumberOfFractions</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Records the total number of fractions (treatment sessions) delivered to the patient in the third phase of radiation during the first course of treatment. This data item is required for CoC-accredited facilities for cases diagnosed as of 01/01/2018.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'><!--[if gte mso 10]>  <![endif]-->Radiation therapy is delivered in one or more phases with each phase spread out over a number of fractions (treatment sessions). It is necessary to capture information describing the number of fraction(s) to evaluate patterns of radiation oncology care.</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>000</td><td class='code-desc'>No radiation treatment</td></tr><tr class='code-row'><td class='code-nbr'>001-998</td><td class='code-desc'>Number of fractions administered to the patient during the third phase of radiation therapy.</td></tr><tr class='code-row'><td class='code-nbr'>999</td><td class='code-desc'>Phase III Radiation therapy was administered, but the number of fractions is unknown; It is unknown whether radiation therapy was administered.</td></tr><tr class='code-row'><td class='code-nbr'></td><td class='code-desc'> </td></tr></table></div><div class='content chap10-para'>Blanks allowed if no Phase III radiation treatment administered.</div><a name='1522'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>PHASE III RADIATION EXTERNAL BEAM PLANNING TECH</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">1522</td><td style="text-align:center;">2</td><td style="text-align:center;"><a href='#sources'>CoC</a></td><td style="text-align:center;">2018</td><td style="text-align:center;">18</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">2331 - 2332</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>phase3RadiationExternalBeamTech</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Identifies the external beam radiation planning technique used to administer the third phase of radiation treatment during the first course of treatment. This data item is required for CoC-accredited facilities for cases diagnosed as of 01/01/2018.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>External beam radiation is the most commonly-used radiation modality in North America. In this data item we specified the planning technique for external beam treatment. Identifying the radiation technique is of interest for patterns of care and comparative effectiveness studies.<br /><br />Historically, the previously-name Regional Treatment Modality data item [1570] utilized codes that were not mutually exclusive. Rather, it included codes describing a mix of modalities, treatment planning techniques, and delivery techniques that are commonly utilized by radiation oncologists. However, every phase of radiation treatment will include a specified modality, planning technique, and delivery technique. The goal of the 2018 implementation of separate phase-specific data items for the recording of Phase III Radiation Treatment Modality [1526] and Phase III Radiation External Beam Planning Tech [1522] is to clarify this information and implement mutually exclusive categories. A separate data item for delivery technique has not been implemented because this information is not consistently reported in end treatment summaries.</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>00</td><td class='code-desc'>No radiation treatment</td></tr><tr class='code-row'><td class='code-nbr'>01</td><td class='code-desc'>External beam, NOS</td></tr><tr class='code-row'><td class='code-nbr'>02</td><td class='code-desc'>Low energy x-ray/photon therapy</td></tr><tr class='code-row'><td class='code-nbr'>03</td><td class='code-desc'>2-D therapy</td></tr><tr class='code-row'><td class='code-nbr'>04</td><td class='code-desc'>Conformal or 3-D conformal therapy</td></tr><tr class='code-row'><td class='code-nbr'>05</td><td class='code-desc'>Intensity modulated therapy </td></tr><tr class='code-row'><td class='code-nbr'>06</td><td class='code-desc'>Stereotactic radiotherapy or radiosurgery, NOS</td></tr><tr class='code-row'><td class='code-nbr'>07</td><td class='code-desc'>Stereotactic radiotherapy or radiosurgery, robotic.</td></tr><tr class='code-row'><td class='code-nbr'>08</td><td class='code-desc'>Stereotactic radiotherapy or radiosurgery, Gamma Knife</td></tr><tr class='code-row'><td class='code-nbr'>09</td><td class='code-desc'>CT-guided online adaptive therapy</td></tr><tr class='code-row'><td class='code-nbr'>10</td><td class='code-desc'>MR-guided online adaptive therapy</td></tr><tr class='code-row'><td class='code-nbr'>88</td><td class='code-desc'>Not Applicable</td></tr><tr class='code-row'><td class='code-nbr'>98</td><td class='code-desc'>Other, NOS</td></tr><tr class='code-row'><td class='code-nbr'>99</td><td class='code-desc'>Unknown</td></tr><tr class='code-row'><td class='code-nbr' colspan='2'></td></tr></table></div><div class='content chap10-para'>Blanks allowed if no Phase III radiation treatment administered.</div><a name='1524'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>PHASE III RADIATION PRIMARY TREATMENT VOLUME</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">1524</td><td style="text-align:center;">2</td><td style="text-align:center;"><a href='#sources'>CoC</a></td><td style="text-align:center;">2018</td><td style="text-align:center;">18</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">2325 - 2326</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>phase3RadiationPrimaryTxVolume</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Identifies the primary treatment volume or primary anatomic target treated during the third phase of radiation therapy during the first course of treatment. This data item is required for CoC-accredited facilities for cases diagnosed as of 01/01/2018.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Radiation treatment is commonly delivered in one or more phases. Typically, in each phase, the primary tumor or tumor bed is treated. This data item should be used to indicate the primary target volume, which might include the primary tumor or tumor bed. If the primary tumor was not targeted, record the other regional or distant site that was targeted. Draining lymph nodes may also be targeted during the first phase. These will be identified in a separate data item Phase III Radiation to Draining Lymph Nodes [1525].








<div>&nbsp;</div>This data item provides information describing the anatomical structure targeted by radiation therapy during the third phase of radiation treatment and can be used to determine whether the site of the primary diseases was treated with radiation or if other regional or distant sites were targeted. This information is useful in evaluating the patterns of care within a facility and on a regional or national basis. The breakdown and reorganization of the sites will allow for concise reporting.</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>00</td><td class='code-desc'>No phase III radiation treatment</td></tr><tr class='code-row'><td class='code-nbr'>01</td><td class='code-desc'>Neck lymph node regions</td></tr><tr class='code-row'><td class='code-nbr'>02</td><td class='code-desc'>Thoracic lymph node regions</td></tr><tr class='code-row'><td class='code-nbr'>03</td><td class='code-desc'>Neck and thoracic lymph node regions</td></tr><tr class='code-row'><td class='code-nbr'>04</td><td class='code-desc'>Breast/ Chestwall lymph node regions</td></tr><tr class='code-row'><td class='code-nbr'>05</td><td class='code-desc'>Abdominal lymph nodes</td></tr><tr class='code-row'><td class='code-nbr'>06</td><td class='code-desc'>Pelvic lymph nodes</td></tr><tr class='code-row'><td class='code-nbr'>07</td><td class='code-desc'>Abdominal and pelvic lymph nodes</td></tr><tr class='code-row'><td class='code-nbr'>09</td><td class='code-desc'>Lymph node region, NOS</td></tr><tr class='code-row'><td class='code-nbr'>10</td><td class='code-desc'>Eye/orbit/optic nerve</td></tr><tr class='code-row'><td class='code-nbr'>11</td><td class='code-desc'>Pituitary</td></tr><tr class='code-row'><td class='code-nbr'>12</td><td class='code-desc'>Brain</td></tr><tr class='code-row'><td class='code-nbr'>13</td><td class='code-desc'>Brain (Limited) </td></tr><tr class='code-row'><td class='code-nbr'>14</td><td class='code-desc'>Spinal cord</td></tr><tr class='code-row'><td class='code-nbr'>20</td><td class='code-desc'>Nasopharynx</td></tr><tr class='code-row'><td class='code-nbr'>21</td><td class='code-desc'>Oral Cavity</td></tr><tr class='code-row'><td class='code-nbr'>22</td><td class='code-desc'>Oropharynx</td></tr><tr class='code-row'><td class='code-nbr'>23</td><td class='code-desc'>Larynx (glottis) or hypopharynx</td></tr><tr class='code-row'><td class='code-nbr'>24</td><td class='code-desc'>Sinuses/Nasal tract</td></tr><tr class='code-row'><td class='code-nbr'>25</td><td class='code-desc'>Parotid or other salivary glands</td></tr><tr class='code-row'><td class='code-nbr'>26</td><td class='code-desc'>Thyroid</td></tr><tr class='code-row'><td class='code-nbr'>29</td><td class='code-desc'>Head and neck (NOS)</td></tr><tr class='code-row'><td class='code-nbr'>30</td><td class='code-desc'>Lung or bronchus</td></tr><tr class='code-row'><td class='code-nbr'>31</td><td class='code-desc'>Mesothelium</td></tr><tr class='code-row'><td class='code-nbr'>32</td><td class='code-desc'>Thymus</td></tr><tr class='code-row'><td class='code-nbr'>39</td><td class='code-desc'>Chest/lung (NOS)</td></tr><tr class='code-row'><td class='code-nbr'>40</td><td class='code-desc'>Breast - whole</td></tr><tr class='code-row'><td class='code-nbr'>41</td><td class='code-desc'>Breast - partial</td></tr><tr class='code-row'><td class='code-nbr'>42</td><td class='code-desc'>Chest wall</td></tr><tr class='code-row'><td class='code-nbr'>50</td><td class='code-desc'>Esophagus</td></tr><tr class='code-row'><td class='code-nbr'>51</td><td class='code-desc'>Stomach</td></tr><tr class='code-row'><td class='code-nbr'>52</td><td class='code-desc'>Small bowel</td></tr><tr class='code-row'><td class='code-nbr'>53</td><td class='code-desc'>Colon</td></tr><tr class='code-row'><td class='code-nbr'>54</td><td class='code-desc'>Rectum</td></tr><tr class='code-row'><td class='code-nbr'>55</td><td class='code-desc'>Anus</td></tr><tr class='code-row'><td class='code-nbr'>56</td><td class='code-desc'>Liver</td></tr><tr class='code-row'><td class='code-nbr'>57</td><td class='code-desc'>Biliary tree or gallbladder</td></tr><tr class='code-row'><td class='code-nbr'>58</td><td class='code-desc'>Pancreas or hepatopancreatic ampulla</td></tr><tr class='code-row'><td class='code-nbr'>59</td><td class='code-desc'>Abdomen (NOS)</td></tr><tr class='code-row'><td class='code-nbr'>60</td><td class='code-desc'>Bladder - whole</td></tr><tr class='code-row'><td class='code-nbr'>61</td><td class='code-desc'>Bladder - partial</td></tr><tr class='code-row'><td class='code-nbr'>62</td><td class='code-desc'>Kidney</td></tr><tr class='code-row'><td class='code-nbr'>63</td><td class='code-desc'>Ureter</td></tr><tr class='code-row'><td class='code-nbr'>64</td><td class='code-desc'>Prostate - whole</td></tr><tr class='code-row'><td class='code-nbr'>65</td><td class='code-desc'>Prostate - partial</td></tr><tr class='code-row'><td class='code-nbr'>66</td><td class='code-desc'>Urethra</td></tr><tr class='code-row'><td class='code-nbr'>67</td><td class='code-desc'>Penis</td></tr><tr class='code-row'><td class='code-nbr'>68</td><td class='code-desc'>Testicle or scrotum</td></tr><tr class='code-row'><td class='code-nbr'>70</td><td class='code-desc'>Ovaries or fallopian tubes</td></tr><tr class='code-row'><td class='code-nbr'>71</td><td class='code-desc'>Uterus or Cervix</td></tr><tr class='code-row'><td class='code-nbr'>72</td><td class='code-desc'>Vagina</td></tr><tr class='code-row'><td class='code-nbr'>73</td><td class='code-desc'>Vulva</td></tr><tr class='code-row'><td class='code-nbr'>80</td><td class='code-desc'>Skull</td></tr><tr class='code-row'><td class='code-nbr'>81</td><td class='code-desc'>Spine/vertebral bodies</td></tr><tr class='code-row'><td class='code-nbr'>82</td><td class='code-desc'>Shoulder</td></tr><tr class='code-row'><td class='code-nbr'>83</td><td class='code-desc'>Ribs</td></tr><tr class='code-row'><td class='code-nbr'>84</td><td class='code-desc'>Hip</td></tr><tr class='code-row'><td class='code-nbr'>85</td><td class='code-desc'>Pelvic bones</td></tr><tr class='code-row'><td class='code-nbr'>86</td><td class='code-desc'>Pelvis (NOS, non-visceral)</td></tr><tr class='code-row'><td class='code-nbr'>88</td><td class='code-desc'>Extremity bone, NOS</td></tr><tr class='code-row'><td class='code-nbr'>90</td><td class='code-desc'>Skin</td></tr><tr class='code-row'><td class='code-nbr'>91</td><td class='code-desc'>Soft tissue</td></tr><tr class='code-row'><td class='code-nbr'>92</td><td class='code-desc'>Hemibody</td></tr><tr class='code-row'><td class='code-nbr'>93</td><td class='code-desc'>Whole body</td></tr><tr class='code-row'><td class='code-nbr'>94</td><td class='code-desc'>Mantle, mini-mantle (obsolete after 2017)</td></tr><tr class='code-row'><td class='code-nbr'>95</td><td class='code-desc'>Lower extended field (obsolete after 2017)</td></tr><tr class='code-row'><td class='code-nbr'>96</td><td class='code-desc'>Inverted Y (obsolete after 2017)</td></tr><tr class='code-row'><td class='code-nbr'>98</td><td class='code-desc'>Other</td></tr><tr class='code-row'><td class='code-nbr'>99</td><td class='code-desc'>Unknown</td></tr><tr class='code-row'><td class='code-nbr'></td><td class='code-desc'> </td></tr></table></div><a name='1525'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>PHASE III RADIATION TO DRAINING LYMPH NODES</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">1525</td><td style="text-align:center;">2</td><td style="text-align:center;"><a href='#sources'>CoC</a></td><td style="text-align:center;">2018</td><td style="text-align:center;">18</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">2327 - 2328</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>phase3RadiationToDrainingLN</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Identifies the draining lymph nodes treated (if any) during the third phase of radiation therapy delivered to the patient during the first course of treatment. This data item is required for CoC-accredited facilities as of cases diagnosed 01/01/2018.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>The third phase of radiation treatment commonly targets both the primary tumor (or tumor bed) and draining lymph nodes as a secondary site. This data item should be used to indicate the draining regional lymph nodes, if any, that were irradiated during the third phase of radiation.</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>00</td><td class='code-desc'>No radiation treatment </td></tr><tr class='code-row'><td class='code-nbr'>01</td><td class='code-desc'>Neck tymph node regions</td></tr><tr class='code-row'><td class='code-nbr'>02</td><td class='code-desc'>Thoracic lymph node regions</td></tr><tr class='code-row'><td class='code-nbr'>03</td><td class='code-desc'>Neck and thoracic lymph node regions</td></tr><tr class='code-row'><td class='code-nbr'>04</td><td class='code-desc'>Breast/Chest wall lymph node regions</td></tr><tr class='code-row'><td class='code-nbr'>05</td><td class='code-desc'>Abdominal lymph nodes </td></tr><tr class='code-row'><td class='code-nbr'>06</td><td class='code-desc'>Pelvic lymph nodes</td></tr><tr class='code-row'><td class='code-nbr'>07</td><td class='code-desc'>Abdominal and pelvic lymph nodes </td></tr><tr class='code-row'><td class='code-nbr'>08</td><td class='code-desc'>Lymph node region, NOS</td></tr><tr class='code-row'><td class='code-nbr'>88</td><td class='code-desc'>Not Applicable; Phase III Radiation Primary Treatment Volume is lymph nodes</td></tr><tr class='code-row'><td class='code-nbr'>99</td><td class='code-desc'>Unknown if any radiation treatment to draining lymph nodes; Unknown if radiation treatment administered</td></tr><tr class='code-row'><td class='code-nbr'></td><td class='code-desc'> </td></tr></table></div><div class='content chap10-para'>Blanks allowed if no Phase III radiation treatment administered.</div><a name='1526'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>PHASE III RADIATION TREATMENT MODALITY</strong></td><td style="text-align:right;font-weight:bold;"><strong>Revised</strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">1526</td><td style="text-align:center;">2</td><td style="text-align:center;"><a href='#sources'>CoC</a></td><td style="text-align:center;">2018</td><td style="text-align:center;">18</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">2329 - 2330</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>phase3RadiationTreatmentModality</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Radiation modality reflects whether a treatment was external beam, brachytherapy, a radioisotope as well as their major subtypes, or a combination of modalities. This data item should be used to indicate the radiation modality administered during the third phase of radiation. This data item is required for CoC-accredited facilities for cases diagnosed as of 01/01/2018.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Radiation modality reflects whether a treatment was external beam, brachytherapy, a radioisotope as well as their major subtypes, or a combination of modalities. This data item should be used to indicate the radiation modality administered during the third phase of radiation. <br /><br />Historically, the previously-name Radiation Treatment Modality data item [1570] utilized codes that were not mutually exclusive. Rather, it included codes describing a mix of modalities, treatment planning techniques, and delivery techniques that are commonly utilized by radiation oncologists. However, every phase of radiation treatment will include a specified modality, planning technique, and delivery technique. The goal of the 2018 implementation of separate phase-specific data items for the recording of radiation modality and radiation treatment planning techniques is to clarify this information and implement mutually exclusive categories. A separate data item for delivery technique has not been implemented because this information is not consistently reported in end treatment summaries.</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para mark-changed'><table><tr class='code-row'><td class='code-nbr'>00</td><td class='code-desc'>No radiation treatment</td></tr><tr class='code-row'><td class='code-nbr'>01</td><td class='code-desc'>External beam, NOS</td></tr><tr class='code-row'><td class='code-nbr'>02</td><td class='code-desc'>External beam, photons</td></tr><tr class='code-row'><td class='code-nbr'>03</td><td class='code-desc'>External beam, protons</td></tr><tr class='code-row'><td class='code-nbr'>04</td><td class='code-desc'>External beam, electrons</td></tr><tr class='code-row'><td class='code-nbr'>05</td><td class='code-desc'>External beam, neutrons</td></tr><tr class='code-row'><td class='code-nbr'>06</td><td class='code-desc'>External beam, carbon ions</td></tr><tr class='code-row'><td class='code-nbr'>07</td><td class='code-desc'>Brachytherapy, NOS</td></tr><tr class='code-row'><td class='code-nbr'>08</td><td class='code-desc'>Brachytherapy, intracavitary, LDR</td></tr><tr class='code-row'><td class='code-nbr'>09</td><td class='code-desc'>Brachytherapy, intracavitary, HDR</td></tr><tr class='code-row'><td class='code-nbr'>10</td><td class='code-desc'>Brachytherapy, Interstitial, LDR</td></tr><tr class='code-row'><td class='code-nbr'>11</td><td class='code-desc'>Brachytherapy, Interstitial, HDR</td></tr><tr class='code-row'><td class='code-nbr'>12</td><td class='code-desc'>Brachytherapy, electronic</td></tr><tr class='code-row'><td class='code-nbr'>13</td><td class='code-desc'>Radioisotopes, NOS</td></tr><tr class='code-row'><td class='code-nbr'>14</td><td class='code-desc'>Radioisotopes, Radium-232</td></tr><tr class='code-row'><td class='code-nbr'>15</td><td class='code-desc'>Radioisotopes, Strontium-89</td></tr><tr class='code-row'><td class='code-nbr'>16</td><td class='code-desc'>Radioisotopes, Strontium-90</td></tr><tr class='code-row'><td class='code-nbr'>98</td><td class='code-desc'>Radiation therapy administered but treatment modality is not specified or unknown  </td></tr><tr class='code-row'><td class='code-nbr'>99</td><td class='code-desc'>Treatment radiation modality unknown; Unknown if radiation treatment administered</td></tr><tr class='code-row'><td class='code-nbr' colspan='2'></td></tr></table></div><div class='content chap10-para'>Blanks allowed if no Phase III radiation treatment administered.</div><a name='1527'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>PHASE III TOTAL DOSE</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">1527</td><td style="text-align:center;">6</td><td style="text-align:center;"><a href='#sources'>CoC</a></td><td style="text-align:center;">2018</td><td style="text-align:center;">18</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">2341 - 2346</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>phase3TotalDose</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Identifies the total radiation dose delivered during the third phase of radiation treatment delivered to the patient during the first course of treatment. The unit of measure is centiGray (cGy). This data item is required for CoC-accredited facilities for cases diagnosed as of 01/01/2018.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>To evaluate the patterns of radiation care, it is necessary to capture information describing the prescribed dose of Phase III radiation to the patient during the first course of treatment. Outcomes are strongly related to the total dose delivered.</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>000000</td><td class='code-desc'>No radiation treatment</td></tr><tr class='code-row'><td class='code-nbr'>000001-999997</td><td class='code-desc'>Record the actual total dose delivered in cGy</td></tr><tr class='code-row'><td class='code-nbr'>999998 </td><td class='code-desc'>Not applicable, radioisotopes administered to the patient</td></tr><tr class='code-row'><td class='code-nbr'>999999</td><td class='code-desc'>Radiation therapy was administered, but the dose is unknown; it is unknown whether radiation therapy was administered</td></tr><tr class='code-row'><td class='code-nbr'></td><td class='code-desc'> </td></tr></table></div><div class='content chap10-para'>Blanks allowed if no Phase III radiation treatment administered.</div><a name='2490'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>PHYSICIAN 3</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">2490</td><td style="text-align:center;">8</td><td style="text-align:center;"><a href='#sources'>CoC</a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">5079 - 5086</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>Physician #3 (CoC)<br />Other Physician (pre-96 CoC)<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>physician3</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Code for another physician involved in the care of the patient. Registry may use physicians&#8217; medical license numbers or may create individual numbering systems. </div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Used to monitor patient radiotherapy care. </div><div class='content chap10-para'><!--[if gte mso 10]>  <![endif]-->
<em>Note</em>: This item is not supported by CoC as of January 1, 2010, (the respective NPI item is required). </div><div class='content chap10-para'><strong>Codes in addition to medical license numbers or facility-generated codes </strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>00000000</td><td class='code-desc'>None, no additional physician</td></tr><tr class='code-row'><td class='code-nbr'>99999999</td><td class='code-desc'>Physician is unknown or an identification number is not assigned</td></tr></table></div><a name='2500'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>PHYSICIAN 4</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">2500</td><td style="text-align:center;">8</td><td style="text-align:center;"><a href='#sources'>CoC</a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">5097 - 5104</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>Other Physician (pre-96 CoC)<br />Physician #4 (CoC)<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>physician4</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Code for another physician involved in the care of the patient. Registry may use physicians&#8217; medical license numbers or may create individual numbering systems. </div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Used to monitor patient medical oncology care. </div><div class='content chap10-para'><em>Note</em>: This item is not supported by CoC as of January 1, 2010, (the respective NPI item is required). </div><div class='content chap10-para'><strong>Codes in addition to medical license numbers or facility-generated codes </strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>99999999</td><td class='code-desc'>Physician is unknown or an identification number is not assigned</td></tr><tr class='code-row'><td class='code-nbr'>00000000</td><td class='code-desc'>None, no additional physician</td></tr></table></div><a name='2470'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>PHYSICIAN--FOLLOW-UP</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">2470</td><td style="text-align:center;">8</td><td style="text-align:center;"><a href='#sources'>CoC</a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">5043 - 5050</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>Follow-Up Physician (pre-96 CoC)<br />Following Physician (CoC)<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>physicianFollowUp</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Code for the physician currently responsible for the patient&#8217;s medical care. Registry may use physicians&#8217; medical license numbers or may create individual numbering systems. </div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Used to monitor post-treatment patient care. </div><div class='content chap10-para'><em>Note</em>: This item is not supported by CoC as of January 1, 2010, (the respective NPI item is required). </div><div class='content chap10-para'><strong>Codes in addition to medical license numbers or facility-generated codes </strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>99999999</td><td class='code-desc'>Follow-up physician unknown or ID number not assigned</td></tr></table></div><a name='2460'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>PHYSICIAN--MANAGING</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">2460</td><td style="text-align:center;">8</td><td style="text-align:center;"><a href='#sources'>NAACCR</a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">5025 - 5032</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>Managing Physician (CoC)<br />Attending Physician (pre-96 CoC)<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>physicianManaging</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Code for the physician who is responsible for the overall management of the patient during diagnosis and/or treatment for this cancer. Registry may use physicians&#8217; medical license numbers or may create individual numbering systems. </div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Used to monitor patient care. </div><div class='content chap10-para'><em>Note</em>: This item is not supported by CoC as of January 1, 2010, (the respective NPI item is required). </div><div class='content chap10-para'><strong>Codes in addition to medical license numbers or facility-generated codes </strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>99999999</td><td class='code-desc'>Managing physician unknown or ID number not assigned</td></tr></table></div><a name='2480'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>PHYSICIAN--PRIMARY SURG</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">2480</td><td style="text-align:center;">8</td><td style="text-align:center;"><a href='#sources'>CoC</a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">5061 - 5068</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>Primary Surgeon (CoC)<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>physicianPrimarySurg</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Code for physician who performed the most definitive surgical procedure. Registry may use physician&#8217;s medical license numbers or may create individual numbering systems. </div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Used to monitor patient surgical care. </div><div class='content chap10-para'><em>Note</em>: This item is not supported by CoC as of January 1, 2010, (the respective NPI item is required). </div><div class='content chap10-para'><strong>Codes in addition to medical license numbers or facility-generated codes </strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>00000000</td><td class='code-desc'>Patient had no surgery and no surgical consultation</td></tr><tr class='code-row'><td class='code-nbr'>88888888</td><td class='code-desc'>Physician who performed a surgical procedure was not a surgeon (i.e., radiation oncologist, diagnostic radiologist, or general practitioner)</td></tr><tr class='code-row'><td class='code-nbr'>99999999</td><td class='code-desc'>Primary Surgeon unknown or ID number not assigned</td></tr></table></div><a name='1940'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>PLACE OF DEATH</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">1940</td><td style="text-align:center;">3</td><td style="text-align:center;"><a href='#sources'>NPCR</a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">2948 - 2950</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>placeOfDeath</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Patient</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>State or country where the patient died and where certificate of death is filed. Effective with NAACCR Volume II, Version 13 two new data items, Place of Death--State [1942] and Place of Death--Country [1944] were added to the standard transmission record layout. The UDS Committee expects the new items to replace the use of Place of Death [1940] since the new items use interoperable codes. </div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>This field also helps carry out death clearance. When a hospital reports a place of death, the information can help in death certificate matching. It can also signal an out-of-state death for which the death certificate is to be requested. </div><div class='content chap10-para'><strong>Codes in addition to geocodes </strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>997</td><td class='code-desc'>Not applicable, patient alive</td></tr><tr class='code-row'><td class='code-nbr'>999</td><td class='code-desc'>Place of death unknown</td></tr></table></div><div class='content chap10-para'><em>Note:</em> See Appendix B for geocodes.</div><a name='1944'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>PLACE OF DEATH--COUNTRY</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">1944</td><td style="text-align:center;">3</td><td style="text-align:center;"><a href='#sources'>NAACCR</a></td><td style="text-align:center;">2013</td><td style="text-align:center;">13</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">480 - 482</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>placeOfDeathCountry</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Patient</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Code for the country in which the patient died and where certificate of death is filed. If the patient has multiple tumors, all records should contain the same code. This data item became part of the NAACCR transmission record effective with Volume II, Version 13 in order to include country and state for each geographic item and to use interoperable codes.  It supplements the item Place of Death--State [1942]. It replaces the use of Place of Death [1940].</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Place of death is helpful for carrying out death clearance. When a reporting facility reports a place of death that is outside of the registry&#8217;s country, the information can signal a death for which the death certificate will not be available from another state or through the NDI linkage.</div><div class='content chap10-para'><strong>Codes<br /></strong>Use the International Standards Organization (ISO) 3166-1 Country Three Character Codes, whenever possible, augmented by custom codes. See Appendix B for complete list of country names and corresponding three character alpha codes.</div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'></td><td class='code-desc'> </td></tr><tr class='code-row'><td class='code-nbr'>ZZN</td><td class='code-desc'>North America NOS</td></tr><tr class='code-row'><td class='code-nbr'>ZZC</td><td class='code-desc'>Central America NOS</td></tr><tr class='code-row'><td class='code-nbr'>ZZS</td><td class='code-desc'>South America NOS</td></tr><tr class='code-row'><td class='code-nbr'>ZZP</td><td class='code-desc'>Pacific NOS</td></tr><tr class='code-row'><td class='code-nbr'>ZZE</td><td class='code-desc'>Europe NOS</td></tr><tr class='code-row'><td class='code-nbr'>ZZF</td><td class='code-desc'>Africa NOS</td></tr><tr class='code-row'><td class='code-nbr'>ZZA</td><td class='code-desc'>Asia NOS</td></tr><tr class='code-row'><td class='code-nbr'>ZZX</td><td class='code-desc'>Non-US NOS</td></tr><tr class='code-row'><td class='code-nbr'>ZZU</td><td class='code-desc'>Unknown</td></tr><tr class='code-row'><td class='code-nbr' colspan='2'>Custom codes for historic use only </td></tr><tr class='code-row'><td class='code-nbr'>XNI</td><td class='code-desc'>North American Islands</td></tr><tr class='code-row'><td class='code-nbr'>ZCB</td><td class='code-desc'>Other Caribbean Islands</td></tr><tr class='code-row'><td class='code-nbr'>XEN</td><td class='code-desc'>England, Channel Islands, Isle of Man</td></tr><tr class='code-row'><td class='code-nbr'>XSC</td><td class='code-desc'>Scandinavia</td></tr><tr class='code-row'><td class='code-nbr'>XGR</td><td class='code-desc'>Germanic Countries</td></tr><tr class='code-row'><td class='code-nbr'>XSL</td><td class='code-desc'>Slavic Countries</td></tr><tr class='code-row'><td class='code-nbr'>CSK</td><td class='code-desc'>Czechoslovakia (former)</td></tr><tr class='code-row'><td class='code-nbr'>YUG</td><td class='code-desc'>Yugoslavia (former)</td></tr><tr class='code-row'><td class='code-nbr'>XUM</td><td class='code-desc'>Ukraine and Moldova</td></tr><tr class='code-row'><td class='code-nbr'>XNF</td><td class='code-desc'>North Africa</td></tr><tr class='code-row'><td class='code-nbr'>XSD</td><td class='code-desc'>Sudanese Countries</td></tr><tr class='code-row'><td class='code-nbr'>XWF</td><td class='code-desc'>West Africa</td></tr><tr class='code-row'><td class='code-nbr'>XSF</td><td class='code-desc'>South Africa</td></tr><tr class='code-row'><td class='code-nbr'>XEF</td><td class='code-desc'>East Africa</td></tr><tr class='code-row'><td class='code-nbr'>XIF</td><td class='code-desc'>African Islands</td></tr><tr class='code-row'><td class='code-nbr'>XET</td><td class='code-desc'>Ethiopia and Eritrea</td></tr><tr class='code-row'><td class='code-nbr'>XAP</td><td class='code-desc'>Arabian Peninsula</td></tr><tr class='code-row'><td class='code-nbr'>XIS</td><td class='code-desc'>Israel and Palestine</td></tr><tr class='code-row'><td class='code-nbr'>XCR</td><td class='code-desc'>Caucasian Republics of former USSR</td></tr><tr class='code-row'><td class='code-nbr'>XOR</td><td class='code-desc'>Other Asian Republics of former USSR</td></tr><tr class='code-row'><td class='code-nbr'>XSE</td><td class='code-desc'>Southeast Asia</td></tr><tr class='code-row'><td class='code-nbr'>XMS </td><td class='code-desc'>Malaysia, Singapore, Brunei</td></tr><tr class='code-row'><td class='code-nbr'>XCH</td><td class='code-desc'>China, NOS</td></tr><tr class='code-row'><td class='code-nbr'>XML</td><td class='code-desc'>Melanesian Islands</td></tr><tr class='code-row'><td class='code-nbr'>XMC</td><td class='code-desc'>Micronesian Islands</td></tr><tr class='code-row'><td class='code-nbr'>XPL</td><td class='code-desc'>Polynesian Islands</td></tr><tr class='code-row'><td class='code-nbr'>Blank</td><td class='code-desc'>Not applicable, patient alive </td></tr><tr class='code-row'><td class='code-nbr'></td><td class='code-desc'> </td></tr></table></div><a name='1942'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>PLACE OF DEATH--STATE</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">1942</td><td style="text-align:center;">2</td><td style="text-align:center;"><a href='#sources'>NAACCR</a></td><td style="text-align:center;">2013</td><td style="text-align:center;">13</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">478 - 479</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>placeOfDeathState</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Patient</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>State or Province where the patient died and where certificate of death is filed. This data item became part of the NAACCR transmission record effective with Volume II, Version 13 in order to include country and state for each geographic item and to use interoperable codes. It supplements the item PLACE OF DEATH--COUNTRY [1944]. It replaces the use of PLACE OF DEATH [1940].</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>This field also helps carry out death clearance. When a reporting facility reports a place of death, the information can help in death certificate matching. It can also signal an out-of-state death for which the death certificate is to be requested.</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>Blank</td><td class='code-desc'>Not applicable, patient alive
 </td></tr></table></div><div class='content chap10-para'>See Appendix B for numeric and alphabetic lists of places and codes (also see Appendix B of the <em>SEER Program Code Manual</em> at <a href="http://seer.cancer.gov/tools/codingmanuals/index.html">seer.cancer.gov/tools/codingmanuals/index.html</a>).</div><a name='3913'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>PLEURAL EFFUSION</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">3913</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>NAACCR</a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1926 - 1926</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>pleuralEffusion</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Pleural effusion is the accumulation of fluid between the parietal pleura (the pleura covering the chest wall and diaphragm) and the visceral pleura (the pleura covering the lungs).</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Pleural Effusion is collected by the surveillance community for pleura cancers. Prior to 2018, Pleura SSF #1 was used for Pleural Effusion.</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>0</td><td class='code-desc'>Pleural effusion not identified/not present</td></tr><tr class='code-row'><td class='code-nbr'>1</td><td class='code-desc'>Pleural effusion present, non-malignant (negative)</td></tr><tr class='code-row'><td class='code-nbr'>2</td><td class='code-desc'>Pleural effusion present, malignant (positive)</td></tr><tr class='code-row'><td class='code-nbr'>3</td><td class='code-desc'>Pleural effusion, atypical/atypical mesothelial cells</td></tr><tr class='code-row'><td class='code-nbr'>4</td><td class='code-desc'>Pleural effusion, NOS</td></tr><tr class='code-row'><td class='code-nbr'>8</td><td class='code-desc'>Not applicable:  Information not collected for this case<br/>
(If this item is required by your standard setter, use of code 8 will result in an edit error.)
</td></tr><tr class='code-row'><td class='code-nbr'>9</td><td class='code-desc'>Not documented in medical record<br/>
Pleural Effusion not assessed or unknown if assessed
</td></tr><tr class='code-row'><td class='code-nbr'></td><td class='code-desc'> </td></tr></table></div><div class='content chap10-para'>Each Site-Specific Data Item (SSDI) applies only to selected primary sites, histologies, and years of diagnosis. Depending on applicability and standard-setter requirements, SSDIs may be left blank. </div><a name='650'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>PRESENTATION AT CA CONF</strong></td><td style="text-align:right;font-weight:bold;"><strong>Retired</strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">650</td><td style="text-align:center;"></td><td style="text-align:center;"><a href='#sources'></a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;">2006</td><td style="text-align:center;">11</td><td class="cross-out" style="text-align:center;"></td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td></td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td></td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>The NAACCR UDSC retired this data item in Version 11, as of January 1, 2006.</div><a name='630'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>PRIMARY PAYER AT DX</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">630</td><td style="text-align:center;">2</td><td style="text-align:center;"><a href='#sources'>CoC</a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">792 - 793</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>Primary Payer at Diagnosis (CoC)<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>primaryPayerAtDx</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Primary payer/insurance carrier at the time of initial diagnosis and/or treatment at the reporting facility. </div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>This item is used in financial analysis and as an indicator for quality and outcome analyses. </div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>01</td><td class='code-desc'>Not insured</td></tr><tr class='code-row'><td class='code-nbr'>02</td><td class='code-desc'>Not insured, self-pay</td></tr><tr class='code-row'><td class='code-nbr'>10</td><td class='code-desc'>Insurance, NOS</td></tr><tr class='code-row'><td class='code-nbr'>20</td><td class='code-desc'>Private Insurance: Managed care, HMO, or PPO</td></tr><tr class='code-row'><td class='code-nbr'>21</td><td class='code-desc'>Private Insurance: Fee-for-Service</td></tr><tr class='code-row'><td class='code-nbr'>31</td><td class='code-desc'>Medicaid</td></tr><tr class='code-row'><td class='code-nbr'>35</td><td class='code-desc'>Medicaid - Administered through a Managed Care plan</td></tr><tr class='code-row'><td class='code-nbr'>60</td><td class='code-desc'>Medicare/Medicare, NOS</td></tr><tr class='code-row'><td class='code-nbr'>61</td><td class='code-desc'>Medicare with supplement, NOS</td></tr><tr class='code-row'><td class='code-nbr'>62</td><td class='code-desc'>Medicare - Administered through a Managed Care plan</td></tr><tr class='code-row'><td class='code-nbr'>63</td><td class='code-desc'>Medicare with private supplement</td></tr><tr class='code-row'><td class='code-nbr'>64</td><td class='code-desc'>Medicare with Medicaid eligibility</td></tr><tr class='code-row'><td class='code-nbr'>65</td><td class='code-desc'>TRICARE</td></tr><tr class='code-row'><td class='code-nbr'>66</td><td class='code-desc'>Military</td></tr><tr class='code-row'><td class='code-nbr'>67</td><td class='code-desc'>Veterans Affairs</td></tr><tr class='code-row'><td class='code-nbr'>68</td><td class='code-desc'>Indian/Public Health Service</td></tr><tr class='code-row'><td class='code-nbr'>99</td><td class='code-desc'>Insurance status unknown</td></tr><tr class='code-row'><td class='code-nbr'></td><td class='code-desc'> </td></tr></table></div><a name='3917'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>PRIMARY SCLEROSING CHOLANGITIS </strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">3917</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>NAACCR</a></td><td style="text-align:center;">2018</td><td style="text-align:center;">18</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1831 - 1831</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>primarySclerosingCholangitis</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Primary sclerosing cholangitis denotes a chronic autoimmune inflammation of the bile ducts that leads to scar formation and narrowing of the ducts over time. It is a prognostic factor for intrahepatic bile duct cancer.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Primary Sclerosing Cholangitis is a Registry Data Collection Variable in AJCC. This data item was previously collected for Intrahepatic Bile Duct, SSF# 11.</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>0</td><td class='code-desc'>PSC not identified/not present</td></tr><tr class='code-row'><td class='code-nbr'>1</td><td class='code-desc'>PSC present</td></tr><tr class='code-row'><td class='code-nbr'>8</td><td class='code-desc'>Not applicable: Information not collected for this case<br/>
(If this information is required by your standard setter, use of code 8 may result in an edit error.)
</td></tr><tr class='code-row'><td class='code-nbr'>9</td><td class='code-desc'>Not documented in medical record<br/>
PSC not assessed or unknown if assessed
</td></tr><tr class='code-row'><td class='code-nbr'></td><td class='code-desc'> </td></tr></table></div><div class='content chap10-para'>Each Site-Specific Data Item (SSDI) applies only to selected primary sites, histologies, and years of diagnosis. Depending on applicability and standard-setter requirements, SSDIs may be left blank. </div><a name='400'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>PRIMARY SITE</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">400</td><td style="text-align:center;">4</td><td style="text-align:center;"><a href='#sources'>SEER/CoC</a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">554 - 557</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>IDC-O-2/3 Topography (CCCR)<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>primarySite</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Code for the primary site of the tumor being reported using either ICD-O-2 or ICD-O-3. NAACCR adopted ICD-O-2 as the standard coding system for tumors diagnosed beginning January 1, 1992. In addition, NAACCR recommended that tumors diagnosed prior to 1992 be converted to ICD-O-2. The topography (primary site) codes did not change between ICD-O-2 and ICD-O-3. </div><div class='content chap10-para'><strong>Codes <br /></strong>See ICD-O-2,<sup>14 </sup>or ICD-O-3,<sup>13 </sup>Topography Section, for the codes for primary site.<strong><br /></strong></div><div class='content chap10-para'><em>Note:</em> See data item Site (73-91) ICD-O-1 [1960] for ICD-O-1 cases.</div><a name='3918'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>PROFOUND IMMUNE SUPPRESSION</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">3918</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>NAACCR</a></td><td style="text-align:center;">2018</td><td style="text-align:center;">18</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1907 - 1907</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>profoundImmuneSuppression</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Profound Immune Suppression, suppressed immune status that may be associated with HIV/AIDs, solid organ transplant, chronic lymphocytic leukemia, non-Hodgkin lymphoma, multiple conditions or other conditions, increases the risk of developing Merkel Cell Carcinoma and is an adverse prognostic factor.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Profound Immune Suppression is a Registry Data Collection Variable in AJCC. It was previously collected as Merkel Cell Penis, SSF #22, Merkel Cell Scrotum SSF #22, Merkel Cell Skin, SSF# 22, and Merkel Cell Vulva, SSF# 22.</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>0</td><td class='code-desc'>No immune suppression condition(s) identified/not present</td></tr><tr class='code-row'><td class='code-nbr'>1</td><td class='code-desc'>Human Immunodeficiency Virus (HIV)/Acquired Immunodeficiency Syndrome (AIDS)</td></tr><tr class='code-row'><td class='code-nbr'>2</td><td class='code-desc'>Solid organ transplant recipient</td></tr><tr class='code-row'><td class='code-nbr'>3</td><td class='code-desc'>Chronic lymphocytic leukemia</td></tr><tr class='code-row'><td class='code-nbr'>4</td><td class='code-desc'>Non-Hodgkin lymphoma</td></tr><tr class='code-row'><td class='code-nbr'>5</td><td class='code-desc'>Multiple immune suppression conditions</td></tr><tr class='code-row'><td class='code-nbr'>6</td><td class='code-desc'>Profound immune suppression present</td></tr><tr class='code-row'><td class='code-nbr'>8</td><td class='code-desc'>Not applicable: Information not collected for this case<br/>
(If this information is required by your standard setter, use of code 8 may result in an edit error.)
</td></tr><tr class='code-row'><td class='code-nbr'>9</td><td class='code-desc'>Not documented in medical record<br/>
Profound immune suppression not assessed or unknown if assessed
</td></tr><tr class='code-row'><td class='code-nbr'></td><td class='code-desc'> </td></tr></table></div><div class='content chap10-para'>Each Site-Specific Data Item (SSDI) applies only to selected primary sites, histologies, and years of diagnosis. Depending on applicability and standard-setter requirements, SSDIs may be left blank. </div><a name='3914'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>PROGESTERONE RECEPTOR PERCENT POSITIVE OR RANGE</strong></td><td style="text-align:right;font-weight:bold;"><strong>Revised</strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">3914</td><td style="text-align:center;">3</td><td style="text-align:center;"><a href='#sources'>NAACCR</a></td><td style="text-align:center;">2018</td><td style="text-align:center;">18</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1784 - 1786</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>progesteroneRecepPrcntPosOrRange</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Progesterone Receptor, Percent Positive or Range is the percent of cells staining progesterone receptor positive measured by IHC.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Progesterone Receptor, Percent Positive or Range is a Registry Data Collection Variable in AJCC. It is a new data item for cases diagnosed 1/1/2018+.</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para mark-changed'><table><tr class='code-row'><td class='code-nbr'>000</td><td class='code-desc'>PR negative, or stated as less than 1%
 </td></tr><tr class='code-row'><td class='code-nbr'>001-100</td><td class='code-desc'>1-100 percent</td></tr><tr class='code-row'><td class='code-nbr'>R10</td><td class='code-desc'>Stated as 1-10%</td></tr><tr class='code-row'><td class='code-nbr'>R20</td><td class='code-desc'>Stated as 11-20%</td></tr><tr class='code-row'><td class='code-nbr'>R30</td><td class='code-desc'>Stated as 21-30%</td></tr><tr class='code-row'><td class='code-nbr'>R40</td><td class='code-desc'>Stated as 31-40%</td></tr><tr class='code-row'><td class='code-nbr'>R50</td><td class='code-desc'>Stated as 41-50%</td></tr><tr class='code-row'><td class='code-nbr'>R60</td><td class='code-desc'>Stated as 51-60%</td></tr><tr class='code-row'><td class='code-nbr'>R70</td><td class='code-desc'>Stated as 61-70%</td></tr><tr class='code-row'><td class='code-nbr'>R80</td><td class='code-desc'>Stated as 71-80%</td></tr><tr class='code-row'><td class='code-nbr'>R90</td><td class='code-desc'>Stated as 81-90%</td></tr><tr class='code-row'><td class='code-nbr'>R99</td><td class='code-desc'>Stated as 91-100%</td></tr><tr class='code-row'><td class='code-nbr'>XX7</td><td class='code-desc'>Test done, results not in chart </td></tr><tr class='code-row'><td class='code-nbr'>XX8</td><td class='code-desc'>Not applicable: Information not collected for this case<br/>
(If this item is required by your standard setter, use of code XX8 will result in an edit error.)

</td></tr><tr class='code-row'><td class='code-nbr'>XX9</td><td class='code-desc'>Not documented in medical record<br/>
PR (Progesterone Receptor) Percent Positive or Range not assessed or unknown if assessed

</td></tr><tr class='code-row'><td class='code-nbr' colspan='2'></td></tr></table></div><div class='content chap10-para'><div><em>Note</em>: </div>
<ul><li>Physician statement of PR (Progesterone Receptor) Percent Positive or Range can be used to code this data item.</li><li>Code this data item using the same report used to record PR Summary.</li><li>If PR negative, or percentage less than 1%, code 000.</li><li>The actual PR (1-100%) percent takes priority over the range codes.</li><li>If PR positive but percentage unknown, code XX9.</li></ul>
<p>Each Site-Specific Data Item (SSDI) applies only to selected primary sites, histologies, and years of diagnosis. Depending on applicability and standard-setter requirements, SSDIs may be left blank.</p></div><a name='3915'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>PROGESTERONE RECEPTOR SUMMARY</strong></td><td style="text-align:right;font-weight:bold;"><strong>Revised</strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">3915</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>NAACCR</a></td><td style="text-align:center;">2018</td><td style="text-align:center;">18</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1750 - 1750</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>progesteroneRecepSummary</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>PR (Progesterone Receptor) Summary is a summary of results from the progesterone receptor (PR) assay.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para mark-changed'>This data item is required for prognostic stage grouping in AJCC 8th edition, Chapter 48, 








<em>Breast</em>. It was previously collected as Breast CS SSF # 2.</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para mark-changed'><table><tr class='code-row'><td class='code-nbr'>0</td><td class='code-desc'>PR negative (0.0% or less than 1%)</td></tr><tr class='code-row'><td class='code-nbr'>1</td><td class='code-desc'>PR positive</td></tr><tr class='code-row'><td class='code-nbr'>7</td><td class='code-desc'>Test ordered, results not in chart</td></tr><tr class='code-row'><td class='code-nbr'>9</td><td class='code-desc'>Not documented in medical record<br/>
Cannot be determined (indeterminate)<br/>
PR (Progesterone Receptor) Summary  status not assessed or unknown if assessed
</td></tr><tr class='code-row'><td class='code-nbr'></td><td class='code-desc'> </td></tr></table></div><div class='content chap10-para'><div>
  <!--[if gte mso 10]>  <![endif]-->Note 1: Physician statement of PR (Progesterone Receptor) Summary status can be used to code this data item when no other information is available.<br /><br />Note 2: The result of the PR test performed on the primary breast tissue is to be recorded in this data item. <br /><br />Note 3: Results from nodal or metastatic tissue may be used ONLY when there is no evidence of primary tumor.<br /><br />Note 4: In cases where PR is reported on more than one breast tumor specimen, record the highest value. If any sample is positive, record as positive.<br />&nbsp; &#8226; Exception: If PR is positive on an in situ specimen and PR is negative on all tested invasive specimens, code PR as negative (code 0).<br /><br />Note 5: If neoadjuvant therapy is given, record the assay from tumor specimens prior to neoadjuvant therapy.<br />&nbsp; &#8226; If neoadjuvant therapy is given and there are no PR results from pre-treatment specimens, report the findings from post-treatment specimens. <br /><br />Note 6: If the patient is PR positive and node negative, a multigene test such as Oncotype Dx may be performed, in which case another PR test will be performed. Do not record the results of that test in this field. <br />&nbsp; &#8226; Record only the results of the test which made the patient eligible to be given the multigene test. 
<div>&nbsp;</div><div>&nbsp;Each Site-Specific Data Item (SSDI) applies only to selected primary sites, histologies, and years of diagnosis. Depending on applicability and standard-setter requirements, SSDIs may be left blank.</div></div></div><a name='3916'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>PROGESTERONE RECEPTOR TOTAL ALLRED SCORE</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">3916</td><td style="text-align:center;">2</td><td style="text-align:center;"><a href='#sources'>NAACCR</a></td><td style="text-align:center;">2018</td><td style="text-align:center;">18</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1787 - 1788</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>progesteroneRecepTotalAllredScor</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Progesterone Receptor, Total Allred Score is based on the percentage of cells that stain by IHC for progesterone receptor (PR) and the intensity of that staining.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'><!--[if gte mso 10]>  <![endif]-->Progesterone Receptor, Total Allred Score is a Registry Data Collection Variable in AJCC. It is a new data item for cases diagnosed 1/1/2018+.</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>00</td><td class='code-desc'>Total PR Allred score of 0 </td></tr><tr class='code-row'><td class='code-nbr'>01</td><td class='code-desc'>Total PR Allred score of 1</td></tr><tr class='code-row'><td class='code-nbr'>02</td><td class='code-desc'>Total PR Allred score of 2</td></tr><tr class='code-row'><td class='code-nbr'>03</td><td class='code-desc'>Total PR Allred score of 3</td></tr><tr class='code-row'><td class='code-nbr'>04</td><td class='code-desc'>Total PR Allred score of 4</td></tr><tr class='code-row'><td class='code-nbr'>05</td><td class='code-desc'>Total PR Allred score of 5</td></tr><tr class='code-row'><td class='code-nbr'>06</td><td class='code-desc'>Total PR Allred score of 6</td></tr><tr class='code-row'><td class='code-nbr'>07</td><td class='code-desc'>Total PR Allred score of 7</td></tr><tr class='code-row'><td class='code-nbr'>08</td><td class='code-desc'>Total PR Allred score of 8</td></tr><tr class='code-row'><td class='code-nbr'>X8</td><td class='code-desc'>Not applicable: Information not collected for this case<br/>
(If this item is required by your standard setter, use of code X8 will result in an edit error.)
</td></tr><tr class='code-row'><td class='code-nbr'>X9</td><td class='code-desc'>Not documented in medical record <br/>
PR (Progesterone Receptor) Total Allred Score not assessed, or unknown if assessed
</td></tr><tr class='code-row'><td class='code-nbr'></td><td class='code-desc'> </td></tr></table></div><div class='content chap10-para'>Each Site-Specific Data Item (SSDI) applies only to selected primary sites, histologies, and years of diagnosis. Depending on applicability and standard-setter requirements, SSDIs may be left blank. </div><a name='1470'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>PROTOCOL ELIGIBILITY STAT</strong></td><td style="text-align:right;font-weight:bold;"><strong>Retired</strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">1470</td><td style="text-align:center;"></td><td style="text-align:center;"><a href='#sources'></a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;">2006</td><td style="text-align:center;">11</td><td class="cross-out" style="text-align:center;"></td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td></td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td></td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>The NAACCR UDSC retired this data item in Version 11, as of January 1, 2006.</div><a name='1480'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>PROTOCOL PARTICIPATION</strong></td><td style="text-align:right;font-weight:bold;"><strong>Retired</strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">1480</td><td style="text-align:center;"></td><td style="text-align:center;"><a href='#sources'></a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;">2006</td><td style="text-align:center;">11</td><td class="cross-out" style="text-align:center;"></td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td></td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td></td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>The NAACCR UDSC retired this data item in Version 11, as of January 1, 2006.</div><a name='3920'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>PSA (PROSTATIC SPECIFIC ANTIGEN) LAB VALUE</strong></td><td style="text-align:right;font-weight:bold;"><strong>Revised</strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">3920</td><td style="text-align:center;">5</td><td style="text-align:center;"><a href='#sources'>NAACCR</a></td><td style="text-align:center;">2018</td><td style="text-align:center;">18</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1944 - 1948</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>psaLabValue</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>PSA (Prostatic Specific Antigen) is a protein produced by cells of the prostate gland and is elevated in patients with prostate cancer. This data item pertains to PSA lab value.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para mark-changed'>This data item is required for prognostic stage grouping in AJCC 8th edition, Chapter 58, 






<em>Prostate</em>. It was previously collected as Prostate, CS SSF# 1.</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>0.1</td><td class='code-desc'>0.1 or less nanograms/milliliter (ng/ml)<br/>
(Exact value to nearest tenth of ng/ml)
</td></tr><tr class='code-row'><td class='code-nbr'>0.2-999.9</td><td class='code-desc'>0.2999.9 ng/ml<br/>
(Exact value to nearest tenth of ng/ml)
</td></tr><tr class='code-row'><td class='code-nbr'>XXX.1</td><td class='code-desc'>1,000 ng/ml or greater</td></tr><tr class='code-row'><td class='code-nbr'>XXX.7</td><td class='code-desc'>Test ordered, results not in chart</td></tr><tr class='code-row'><td class='code-nbr'>XXX.9</td><td class='code-desc'>Not documented in medical record<br/>
PSA lab value not assessed or unknown if assessed 
</td></tr><tr class='code-row'><td class='code-nbr'></td><td class='code-desc'> </td></tr></table></div><div class='content chap10-para'>Each Site-Specific Data Item (SSDI) applies only to selected primary sites, histologies, and years of diagnosis. Depending on applicability and standard-setter requirements, SSDIs may be left blank. </div><a name='1780'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>QUALITY OF SURVIVAL</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">1780</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>CoC</a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">2800 - 2800</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>qualityOfSurvival</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Records patient&#8217;s ability to carry on the activities of daily living at the date of last contact. </div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>0</td><td class='code-desc'>Normal activity</td></tr><tr class='code-row'><td class='code-nbr'>1</td><td class='code-desc'>Symptomatic and ambulatory</td></tr><tr class='code-row'><td class='code-nbr'>2</td><td class='code-desc'>Ambulatory more than 50 percent of the time, occasionally needs assistance</td></tr><tr class='code-row'><td class='code-nbr'>3</td><td class='code-desc'>Ambulatory less than 50 percent of the time, nursing care needed</td></tr><tr class='code-row'><td class='code-nbr'>4</td><td class='code-desc'>Bedridden, may require hospitalization</td></tr><tr class='code-row'><td class='code-nbr'>8</td><td class='code-desc'>Not applicable, dead</td></tr><tr class='code-row'><td class='code-nbr'>9</td><td class='code-desc'>Unknown or unspecified</td></tr></table></div><div class='content chap10-para'><em>Note:</em> This data item is no longer supported by CoC (as of January 1, 2003).</div><a name='160'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>RACE 1</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">160</td><td style="text-align:center;">2</td><td style="text-align:center;"><a href='#sources'>SEER/CoC</a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">207 - 208</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>Race<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>race1</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Patient</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Code the patient&#8217;s race. Race is coded separately from Spanish/Hispanic Origin [190]. All tumors for the same patient should have the same race codes. If the patient is multiracial, code all races using RACE 2 through RACE 5 [161-164]. For coding instructions and race code history see the current <em>SEER Program Coding and Staging Manual</em><sup>3</sup>.<br /><br />Reference to Census 2000 definitions for ethnicity and race: <a target="_blank" href="http://www.census.gov/prod/cen2000/doc/sf2.pdf">http://www.census.gov/prod/cen2000/doc/sf2.pdf</a> (Appendix G).</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Because race has a significant association with cancer rates and outcomes, a comparison between areas with different racial distributions may require an analysis of race to interpret the findings. The race codes listed correspond closely to race categories used by the U.S. Census Bureau to allow calculation of race-specific incidence rates. The full coding system should be used to allow accurate national comparison and collaboration, even if the state population does not include many of the race categories.</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>01</td><td class='code-desc'>White</td></tr><tr class='code-row'><td class='code-nbr'>02</td><td class='code-desc'>Black</td></tr><tr class='code-row'><td class='code-nbr'>03</td><td class='code-desc'>American Indian, Aleutian, or Eskimo (includes all indigenous populations of the Western hemisphere)</td></tr><tr class='code-row'><td class='code-nbr'>04</td><td class='code-desc'>Chinese</td></tr><tr class='code-row'><td class='code-nbr'>05</td><td class='code-desc'>Japanese</td></tr><tr class='code-row'><td class='code-nbr'>06</td><td class='code-desc'>Filipino</td></tr><tr class='code-row'><td class='code-nbr'>07</td><td class='code-desc'>Hawaiian</td></tr><tr class='code-row'><td class='code-nbr'>08</td><td class='code-desc'>Korean</td></tr><tr class='code-row'><td class='code-nbr' colspan='2'>*</td></tr><tr class='code-row'><td class='code-nbr'>10</td><td class='code-desc'>Vietnamese</td></tr><tr class='code-row'><td class='code-nbr'>11</td><td class='code-desc'>Laotian</td></tr><tr class='code-row'><td class='code-nbr'>12</td><td class='code-desc'>Hmong</td></tr><tr class='code-row'><td class='code-nbr'>13</td><td class='code-desc'>Kampuchean (Cambodian)</td></tr><tr class='code-row'><td class='code-nbr'>14</td><td class='code-desc'>Thai</td></tr><tr class='code-row'><td class='code-nbr'>15</td><td class='code-desc'>Asian Indian or Pakistani, NOS (code 09 prior to Version 12)</td></tr><tr class='code-row'><td class='code-nbr'>16</td><td class='code-desc'>   Asian Indian </td></tr><tr class='code-row'><td class='code-nbr'>17</td><td class='code-desc'>   Pakistani</td></tr><tr class='code-row'><td class='code-nbr'>20</td><td class='code-desc'>Micronesian, NOS</td></tr><tr class='code-row'><td class='code-nbr'>21</td><td class='code-desc'>Chamorro/Chamoru</td></tr><tr class='code-row'><td class='code-nbr'>22</td><td class='code-desc'>Guamanian, NOS</td></tr><tr class='code-row'><td class='code-nbr'>25</td><td class='code-desc'>Polynesian, NOS</td></tr><tr class='code-row'><td class='code-nbr'>26</td><td class='code-desc'>Tahitian</td></tr><tr class='code-row'><td class='code-nbr'>27</td><td class='code-desc'>Samoan</td></tr><tr class='code-row'><td class='code-nbr'>28</td><td class='code-desc'>Tongan</td></tr><tr class='code-row'><td class='code-nbr'>30</td><td class='code-desc'>Melanesian, NOS</td></tr><tr class='code-row'><td class='code-nbr'>31</td><td class='code-desc'>Fiji Islander</td></tr><tr class='code-row'><td class='code-nbr'>32</td><td class='code-desc'>New Guinean</td></tr><tr class='code-row'><td class='code-nbr'>96</td><td class='code-desc'>Other Asian, including Asian, NOS and Oriental, NOS</td></tr><tr class='code-row'><td class='code-nbr'>97</td><td class='code-desc'>Pacific Islander, NOS</td></tr><tr class='code-row'><td class='code-nbr'>98</td><td class='code-desc'>Other</td></tr><tr class='code-row'><td class='code-nbr'>99</td><td class='code-desc'>Unknown</td></tr></table></div><div class='content chap10-para'>*Code 09 was retired effective with Version 12. See codes 15-17.</div><a name='161'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>RACE 2</strong></td><td style="text-align:right;font-weight:bold;"><strong>Revised</strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">161</td><td style="text-align:center;">2</td><td title="V: 22: SEER
V: 18: SEER/CoC
V: 16: SEER/CoC
V: 15: SEER/CoC
" class=" HighlightToolTip" style="text-align:center;"><a href='#sources'>SEER</a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">209 - 210</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>race2</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Patient</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Code the patient&#8217;s race. Race is coded separately from Spanish/Hispanic Origin [190]. All tumors for the same patient should have the same race codes. If the patient is multiracial, code all races using RACE 2 through RACE 5 [161-164]. For coding instructions and race code history see the current <em>SEER Program Coding and Staging Manual</em><sup>3</sup>.<br /><br />Reference to Census 2000 definitions for ethnicity and race: <a target="_blank" href="http://www.census.gov/prod/cen2000/doc/sf2.pdf">http://www.census.gov/prod/cen2000/doc/sf2.pdf</a> (Appendix G).</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Because race has a significant association with cancer rates and outcomes, a comparison between areas with different racial distributions may require an analysis of race to interpret the findings. The race codes listed correspond closely to race categories used by the U.S. Census Bureau to allow calculation of race-specific incidence rates. The full coding system should be used to allow accurate national comparison and collaboration, even if the state population does not include many of the race categories.</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>01</td><td class='code-desc'>White</td></tr><tr class='code-row'><td class='code-nbr'>02</td><td class='code-desc'>Black</td></tr><tr class='code-row'><td class='code-nbr'>03</td><td class='code-desc'>American Indian, Aleutian, or Eskimo (includes all indigenous populations of the Western hemisphere)</td></tr><tr class='code-row'><td class='code-nbr'>04</td><td class='code-desc'>Chinese</td></tr><tr class='code-row'><td class='code-nbr'>05</td><td class='code-desc'>Japanese</td></tr><tr class='code-row'><td class='code-nbr'>06</td><td class='code-desc'>Filipino</td></tr><tr class='code-row'><td class='code-nbr'>07</td><td class='code-desc'>Hawaiian</td></tr><tr class='code-row'><td class='code-nbr'>08</td><td class='code-desc'>Korean</td></tr><tr class='code-row'><td class='code-nbr' colspan='2'>*</td></tr><tr class='code-row'><td class='code-nbr'>10</td><td class='code-desc'>Vietnamese</td></tr><tr class='code-row'><td class='code-nbr'>11</td><td class='code-desc'>Laotian</td></tr><tr class='code-row'><td class='code-nbr'>12</td><td class='code-desc'>Hmong</td></tr><tr class='code-row'><td class='code-nbr'>13</td><td class='code-desc'>Kampuchean (Cambodian)</td></tr><tr class='code-row'><td class='code-nbr'>14</td><td class='code-desc'>Thai</td></tr><tr class='code-row'><td class='code-nbr'>15</td><td class='code-desc'>Asian Indian or Pakistani, NOS (code 09 prior to Version 12)</td></tr><tr class='code-row'><td class='code-nbr'>16</td><td class='code-desc'>   Asian Indian</td></tr><tr class='code-row'><td class='code-nbr'>17</td><td class='code-desc'>   Pakistani</td></tr><tr class='code-row'><td class='code-nbr'>20</td><td class='code-desc'>Micronesian, NOS</td></tr><tr class='code-row'><td class='code-nbr'>21</td><td class='code-desc'>Chamorro/Chamoru</td></tr><tr class='code-row'><td class='code-nbr'>22</td><td class='code-desc'>Guamanian, NOS</td></tr><tr class='code-row'><td class='code-nbr'>25</td><td class='code-desc'>Polynesian, NOS</td></tr><tr class='code-row'><td class='code-nbr'>26</td><td class='code-desc'>Tahitian</td></tr><tr class='code-row'><td class='code-nbr'>27</td><td class='code-desc'>Samoan</td></tr><tr class='code-row'><td class='code-nbr'>28</td><td class='code-desc'>Tongan</td></tr><tr class='code-row'><td class='code-nbr'>30</td><td class='code-desc'>Melanesian, NOS</td></tr><tr class='code-row'><td class='code-nbr'>31</td><td class='code-desc'>Fiji Islander</td></tr><tr class='code-row'><td class='code-nbr'>32</td><td class='code-desc'>New Guinean</td></tr><tr class='code-row'><td class='code-nbr'>88</td><td class='code-desc'>No further race documented</td></tr><tr class='code-row'><td class='code-nbr'>96</td><td class='code-desc'>Other Asian, including Asian, NOS and Oriental, NOS</td></tr><tr class='code-row'><td class='code-nbr'>97</td><td class='code-desc'>Pacific Islander, NOS</td></tr><tr class='code-row'><td class='code-nbr'>98</td><td class='code-desc'>Other</td></tr><tr class='code-row'><td class='code-nbr'>99</td><td class='code-desc'>Unknown</td></tr><tr class='code-row'><td class='code-nbr'>Blank</td><td class='code-desc'>Race 2-5 not coded</td></tr></table></div><div class='content chap10-para'><em>*Code 09 was retired effective with Version 12. See codes 15-17.<br /><br />Note:</em> If diagnosed prior to 2000 and any race code (Race 2, 3, 4,  or 5) is blank, all subsequent race codes must be blank. If diagnosed  after 1999 and any race code (for Race 2, 3, 4, and 5) is 88 (no further  race documented), then all subsequent race codes also must be 88. If  any race equals 99, then all race codes (Race 1, 2, 3, 4, and 5) must be  99.</div><a name='162'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>RACE 3</strong></td><td style="text-align:right;font-weight:bold;"><strong>Revised</strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">162</td><td style="text-align:center;">2</td><td title="V: 22: SEER
V: 18: SEER/CoC
V: 16: SEER/CoC
V: 15: SEER/CoC
" class=" HighlightToolTip" style="text-align:center;"><a href='#sources'>SEER</a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">211 - 212</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>race3</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Patient</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Code the patient&#8217;s race. Race is coded separately from Spanish/Hispanic Origin [190]. All tumors for the same patient should have the same race codes. If the patient is multiracial, code all races using RACE 2 through RACE 5 [161-164]. For coding instructions and race code history see the current <em>SEER Program Coding and Staging Manual</em><sup>3</sup>.<br /><br />Reference to Census 2000 definitions for ethnicity and race: <a target="_blank" href="http://www.census.gov/prod/cen2000/doc/sf2.pdf">http://www.census.gov/prod/cen2000/doc/sf2.pdf</a> (Appendix G).</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Because race has a significant association with cancer rates and outcomes, a comparison between areas with different racial distributions may require an analysis of race to interpret the findings. The race codes listed correspond closely to race categories used by the U.S. Census Bureau to allow calculation of race-specific incidence rates. The full coding system should be used to allow accurate national comparison and collaboration, even if the state population does not include many of the race categories.</div><div class='content chap10-para'><strong>Codes </strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>01</td><td class='code-desc'>White</td></tr><tr class='code-row'><td class='code-nbr'>02</td><td class='code-desc'>Black</td></tr><tr class='code-row'><td class='code-nbr'>03</td><td class='code-desc'>American Indian, Aleutian, or Eskimo (includes all indigenous populations of the Western hemisphere)</td></tr><tr class='code-row'><td class='code-nbr'>04</td><td class='code-desc'>Chinese</td></tr><tr class='code-row'><td class='code-nbr'>05</td><td class='code-desc'>Japanese</td></tr><tr class='code-row'><td class='code-nbr'>06</td><td class='code-desc'>Filipino</td></tr><tr class='code-row'><td class='code-nbr'>07</td><td class='code-desc'>Hawaiian</td></tr><tr class='code-row'><td class='code-nbr'>08</td><td class='code-desc'>Korean</td></tr><tr class='code-row'><td class='code-nbr' colspan='2'>*</td></tr><tr class='code-row'><td class='code-nbr'>10</td><td class='code-desc'>Vietnamese</td></tr><tr class='code-row'><td class='code-nbr'>11</td><td class='code-desc'>Laotian</td></tr><tr class='code-row'><td class='code-nbr'>12</td><td class='code-desc'>Hmong</td></tr><tr class='code-row'><td class='code-nbr'>13</td><td class='code-desc'>Kampuchean (Cambodian)</td></tr><tr class='code-row'><td class='code-nbr'>14</td><td class='code-desc'>Thai</td></tr><tr class='code-row'><td class='code-nbr'>15</td><td class='code-desc'>Asian Indian or Pakistani, NOS (code 09 prior to Version 12)</td></tr><tr class='code-row'><td class='code-nbr'>16</td><td class='code-desc'>   Asian Indian</td></tr><tr class='code-row'><td class='code-nbr'>17</td><td class='code-desc'>   Pakistani</td></tr><tr class='code-row'><td class='code-nbr'>20</td><td class='code-desc'>Micronesian, NOS</td></tr><tr class='code-row'><td class='code-nbr'>21</td><td class='code-desc'>Chamorro/Chamoru</td></tr><tr class='code-row'><td class='code-nbr'>22</td><td class='code-desc'>Guamanian, NOS</td></tr><tr class='code-row'><td class='code-nbr'>25</td><td class='code-desc'>Polynesian, NOS</td></tr><tr class='code-row'><td class='code-nbr'>26</td><td class='code-desc'>Tahitian</td></tr><tr class='code-row'><td class='code-nbr'>27</td><td class='code-desc'>Samoan</td></tr><tr class='code-row'><td class='code-nbr'>28</td><td class='code-desc'>Tongan</td></tr><tr class='code-row'><td class='code-nbr'>30</td><td class='code-desc'>Melanesian, NOS</td></tr><tr class='code-row'><td class='code-nbr'>31</td><td class='code-desc'>Fiji Islander</td></tr><tr class='code-row'><td class='code-nbr'>32</td><td class='code-desc'>New Guinean</td></tr><tr class='code-row'><td class='code-nbr'>88</td><td class='code-desc'>No further race documented</td></tr><tr class='code-row'><td class='code-nbr'>96</td><td class='code-desc'>Other Asian, including Asian, NOS and Oriental, NOS</td></tr><tr class='code-row'><td class='code-nbr'>97</td><td class='code-desc'>Pacific Islander, NOS</td></tr><tr class='code-row'><td class='code-nbr'>98</td><td class='code-desc'>Other</td></tr><tr class='code-row'><td class='code-nbr'>99</td><td class='code-desc'>Unknown</td></tr><tr class='code-row'><td class='code-nbr'>Blank</td><td class='code-desc'>Race 2-5 not coded</td></tr></table></div><div class='content chap10-para mark-changed'>*Code 09 was retired effective with Version 12. See codes 15-17.






<em><br /><br />Note:</em> If diagnosed prior to 2000 and any race code (Race 2, 3, 4,  or 5) is blank, all subsequent race codes must be blank. If diagnosed  after 1999 and any race code (for Race 2, 3, 4, and 5) is 88 (no further  race documented), then all subsequent race codes also must be 88. If  any race equals 99, then all race codes (Race 1, 2, 3, 4, and 5) must be  99.</div><a name='163'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>RACE 4</strong></td><td style="text-align:right;font-weight:bold;"><strong>Revised</strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">163</td><td style="text-align:center;">2</td><td title="V: 22: SEER
V: 18: SEER/CoC
V: 16: SEER/CoC
V: 15: SEER/CoC
" class=" HighlightToolTip" style="text-align:center;"><a href='#sources'>SEER</a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">213 - 214</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>race4</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Patient</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Code the patient&#8217;s race. Race is coded separately from Spanish/Hispanic Origin [190]. All tumors for the same patient should have the same race codes. If the patient is multiracial, code all races using RACE 2 through RACE 5 [161-164]. For coding instructions and race code history see the current <em>SEER Program Coding and Staging Manual</em><sup>3</sup>.<br /><br />Reference to Census 2000 definitions for ethnicity and race: <a target="_blank" href="http://www.census.gov/prod/cen2000/doc/sf2.pdf">http://www.census.gov/prod/cen2000/doc/sf2.pdf</a> (Appendix G).</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Because race has a significant association with cancer rates and outcomes, a comparison between areas with different racial distributions may require an analysis of race to interpret the findings. The race codes listed correspond closely to race categories used by the U.S. Census Bureau to allow calculation of race-specific incidence rates. The full coding system should be used to allow accurate national comparison and collaboration, even if the state population does not include many of the race categories.</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>01</td><td class='code-desc'>White</td></tr><tr class='code-row'><td class='code-nbr'>02</td><td class='code-desc'>Black</td></tr><tr class='code-row'><td class='code-nbr'>03</td><td class='code-desc'>American Indian, Aleutian, or Eskimo (includes all indigenous populations of the Western hemisphere).</td></tr><tr class='code-row'><td class='code-nbr'>04</td><td class='code-desc'>Chinese</td></tr><tr class='code-row'><td class='code-nbr'>05</td><td class='code-desc'>Japanese</td></tr><tr class='code-row'><td class='code-nbr'>06</td><td class='code-desc'>Filipino</td></tr><tr class='code-row'><td class='code-nbr'>07</td><td class='code-desc'>Hawaiian</td></tr><tr class='code-row'><td class='code-nbr'>08</td><td class='code-desc'>Korean</td></tr><tr class='code-row'><td class='code-nbr' colspan='2'>*</td></tr><tr class='code-row'><td class='code-nbr'>10</td><td class='code-desc'>Vietnamese</td></tr><tr class='code-row'><td class='code-nbr'>11</td><td class='code-desc'>Laotian</td></tr><tr class='code-row'><td class='code-nbr'>12</td><td class='code-desc'>Hmong</td></tr><tr class='code-row'><td class='code-nbr'>13</td><td class='code-desc'>Kampuchean (Cambodian)</td></tr><tr class='code-row'><td class='code-nbr'>14</td><td class='code-desc'>Thai</td></tr><tr class='code-row'><td class='code-nbr'>15</td><td class='code-desc'>Asian Indian or Pakistani, NOS (code 09 prior to Version 12)</td></tr><tr class='code-row'><td class='code-nbr'>16</td><td class='code-desc'>   Asian Indian</td></tr><tr class='code-row'><td class='code-nbr'>17</td><td class='code-desc'>   Pakistani</td></tr><tr class='code-row'><td class='code-nbr'>20</td><td class='code-desc'>Micronesian, NOS</td></tr><tr class='code-row'><td class='code-nbr'>21</td><td class='code-desc'>Chamorro/Chamoru</td></tr><tr class='code-row'><td class='code-nbr'>22</td><td class='code-desc'>Guamanian, NOS</td></tr><tr class='code-row'><td class='code-nbr'>25</td><td class='code-desc'>Polynesian, NOS</td></tr><tr class='code-row'><td class='code-nbr'>26</td><td class='code-desc'>Tahitian</td></tr><tr class='code-row'><td class='code-nbr'>27</td><td class='code-desc'>Samoan</td></tr><tr class='code-row'><td class='code-nbr'>28</td><td class='code-desc'>Tongan</td></tr><tr class='code-row'><td class='code-nbr'>30</td><td class='code-desc'>Melanesian, NOS</td></tr><tr class='code-row'><td class='code-nbr'>31</td><td class='code-desc'>Fiji Islander</td></tr><tr class='code-row'><td class='code-nbr'>32</td><td class='code-desc'>New Guinean</td></tr><tr class='code-row'><td class='code-nbr'>88</td><td class='code-desc'>No further race documented</td></tr><tr class='code-row'><td class='code-nbr'>96</td><td class='code-desc'>Other Asian, including Asian, NOS and Oriental, NOS</td></tr><tr class='code-row'><td class='code-nbr'>97</td><td class='code-desc'>Pacific Islander, NOS</td></tr><tr class='code-row'><td class='code-nbr'>98</td><td class='code-desc'>Other</td></tr><tr class='code-row'><td class='code-nbr'>99</td><td class='code-desc'>Unknown</td></tr><tr class='code-row'><td class='code-nbr'>Blank</td><td class='code-desc'>Race 2-5 not coded</td></tr></table></div><div class='content chap10-para'><em>* Code 09 was retired effective with Version 12. See codes 15-17., Codes <br /><br />Note:</em> If diagnosed prior to 2000 and any race code (Race 2, 3, 4,  or 5) is blank, all subsequent race codes must be blank. If diagnosed  after 1999 and any race code (for Race 2, 3, 4, and 5) is 88 (no further  race documented), then all subsequent race codes also must be 88. If  any race equals 99, then all race codes (Race 1, 2, 3, 4, and 5) must be  99.</div><a name='164'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>RACE 5</strong></td><td style="text-align:right;font-weight:bold;"><strong>Revised</strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">164</td><td style="text-align:center;">2</td><td title="V: 22: SEER
V: 18: SEER/CoC
V: 16: SEER/CoC
V: 15: SEER/CoC
" class=" HighlightToolTip" style="text-align:center;"><a href='#sources'>SEER</a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">215 - 216</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>race5</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Patient</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Code the patient&#8217;s race. Race is coded separately from Spanish/Hispanic Origin [190]. All tumors for the same patient should have the same race codes. If the patient is multiracial, code all races using RACE 2 through RACE 5 [161-164]. For coding instructions and race code history see the current <em>SEER Program Coding and Staging Manual</em><sup>3</sup>.<br /><br />Reference to Census 2000 definitions for ethnicity and race: <a target="_blank" href="http://www.census.gov/prod/cen2000/doc/sf2.pdf">http://www.census.gov/prod/cen2000/doc/sf2.pdf</a> (Appendix G).</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Because race has a significant association with cancer rates and outcomes, a comparison between areas with different racial distributions may require an analysis of race to interpret the findings. The race codes listed correspond closely to race categories used by the U.S. Census Bureau to allow calculation of race-specific incidence rates. The full coding system should be used to allow accurate national comparison and collaboration, even if the state population does not include many of the race categories.</div><div class='content chap10-para'>.</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>01</td><td class='code-desc'>White</td></tr><tr class='code-row'><td class='code-nbr'>02</td><td class='code-desc'>Black</td></tr><tr class='code-row'><td class='code-nbr'>03</td><td class='code-desc'>American Indian, Aleutian, or Eskimo (includes all indigenous populations of the Western hemisphere)</td></tr><tr class='code-row'><td class='code-nbr'>04</td><td class='code-desc'>Chinese</td></tr><tr class='code-row'><td class='code-nbr'>05</td><td class='code-desc'>Japanese</td></tr><tr class='code-row'><td class='code-nbr'>06</td><td class='code-desc'>Filipino</td></tr><tr class='code-row'><td class='code-nbr'>07</td><td class='code-desc'>Hawaiian</td></tr><tr class='code-row'><td class='code-nbr'>08</td><td class='code-desc'>Korean</td></tr><tr class='code-row'><td class='code-nbr' colspan='2'>*</td></tr><tr class='code-row'><td class='code-nbr'>10</td><td class='code-desc'>Vietnamese</td></tr><tr class='code-row'><td class='code-nbr'>11</td><td class='code-desc'>Laotian</td></tr><tr class='code-row'><td class='code-nbr'>12</td><td class='code-desc'>Hmong</td></tr><tr class='code-row'><td class='code-nbr'>13</td><td class='code-desc'>Kampuchean (Cambodian)</td></tr><tr class='code-row'><td class='code-nbr'>14</td><td class='code-desc'>Thai</td></tr><tr class='code-row'><td class='code-nbr'>15</td><td class='code-desc'>Asian Indian or Pakistani, NOS (code 09 prior to Version 12)</td></tr><tr class='code-row'><td class='code-nbr'>16</td><td class='code-desc'>   Asian Indian</td></tr><tr class='code-row'><td class='code-nbr'>17</td><td class='code-desc'>   Pakistani</td></tr><tr class='code-row'><td class='code-nbr'>20</td><td class='code-desc'>Micronesian, NOS</td></tr><tr class='code-row'><td class='code-nbr'>21</td><td class='code-desc'>Chamorro/Chamoru</td></tr><tr class='code-row'><td class='code-nbr'>22</td><td class='code-desc'>Guamanian, NOS</td></tr><tr class='code-row'><td class='code-nbr'>25</td><td class='code-desc'>Polynesian, NOS</td></tr><tr class='code-row'><td class='code-nbr'>26</td><td class='code-desc'>Tahitian</td></tr><tr class='code-row'><td class='code-nbr'>27</td><td class='code-desc'>Samoan</td></tr><tr class='code-row'><td class='code-nbr'>28</td><td class='code-desc'>Tongan</td></tr><tr class='code-row'><td class='code-nbr'>30</td><td class='code-desc'>Melanesian, NOS</td></tr><tr class='code-row'><td class='code-nbr'>31</td><td class='code-desc'>Fiji Islander</td></tr><tr class='code-row'><td class='code-nbr'>32</td><td class='code-desc'>New Guinean</td></tr><tr class='code-row'><td class='code-nbr'>88</td><td class='code-desc'>No further race documented</td></tr><tr class='code-row'><td class='code-nbr'>96</td><td class='code-desc'>Other Asian, including Asian, NOS and Oriental, NOS</td></tr><tr class='code-row'><td class='code-nbr'>97</td><td class='code-desc'>Pacific Islander, NOS</td></tr><tr class='code-row'><td class='code-nbr'>98</td><td class='code-desc'>Other</td></tr><tr class='code-row'><td class='code-nbr'>99</td><td class='code-desc'>Unknown</td></tr><tr class='code-row'><td class='code-nbr'>Blank</td><td class='code-desc'>Race 2-5 not coded</td></tr></table></div><div class='content chap10-para'>*Code 09 was retired effective with Version 12. See codes 15-17.<br /><em><br />Note: </em>If diagnosed prior to 2000 and any race code (Race 2, 3, 4,  or 5) is blank, all subsequent race codes must be blank. If diagnosed  after 1999 and any race code (for Race 2, 3, 4, and 5) is 88 (no further  race documented), then all subsequent race codes also must be 88. If  any race equals 99, then all race codes (Race 1, 2, 3, 4, and 5) must be  99</div><a name='170'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>RACE CODING SYS--CURRENT</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">170</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>NAACCR</a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">217 - 217</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>raceCodingSysCurrent</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Patient</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Code that best describes how Race [160] currently is coded. If the data have been converted, this field shows the system to which it has been converted.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Race 1 - 5 codes [160 - 164] have changed over time. To be able to accurately group and analyze the data, it is necessary to record the system used to record the race codes.</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>1</td><td class='code-desc'>4-value coding: 1 = White, 2 = Black, 3 = Other, 9 = Unknown</td></tr><tr class='code-row'><td class='code-nbr'>2</td><td class='code-desc'>SEER < 1988 (1-digit)</td></tr><tr class='code-row'><td class='code-nbr'>3</td><td class='code-desc'>1988-1990 SEER & CoC (2-digit)</td></tr><tr class='code-row'><td class='code-nbr'>4</td><td class='code-desc'>1991-1993 SEER & CoC (added codes 20-97, additional Asian and Pacific Islander codes)</td></tr><tr class='code-row'><td class='code-nbr'>5</td><td class='code-desc'>1994-1999 SEER & CoC (added code 14, Thai)</td></tr><tr class='code-row'><td class='code-nbr'>6</td><td class='code-desc'>2000+ SEER & CoC (added code 88 for Race 2, 3, 4, and 5)</td></tr><tr class='code-row'><td class='code-nbr'>7</td><td class='code-desc'>2010+ SEER & CoC (added codes 15, 16, and 17; removed 09)</td></tr><tr class='code-row'><td class='code-nbr'>9</td><td class='code-desc'>Other</td></tr></table></div><a name='180'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>RACE CODING SYS--ORIGINAL</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">180</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>NAACCR</a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">218 - 218</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>raceCodingSysOriginal</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Patient</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Code that best describes how Race [160] originally was coded. If data have been converted, this field identifies the coding system originally used to code the case.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Race 1 - 5 codes [160 - 164] have changed over time. Identifying both original and current coding systems used to code race promotes accurate data grouping and analysis.</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>9</td><td class='code-desc'>Other</td></tr><tr class='code-row'><td class='code-nbr'>1</td><td class='code-desc'>4-value coding: 1 = White, 2 = Black, 3 = Other, 9 = Unknown</td></tr><tr class='code-row'><td class='code-nbr'>2</td><td class='code-desc'>SEER < 1988 (1-digit)</td></tr><tr class='code-row'><td class='code-nbr'>3</td><td class='code-desc'>1988-1990 SEER & CoC (2-digit)</td></tr><tr class='code-row'><td class='code-nbr'>4</td><td class='code-desc'>1991-1993 SEER & CoC (added codes 20-97, additional Asian and Pacific Islander codes)</td></tr><tr class='code-row'><td class='code-nbr'>5</td><td class='code-desc'>1994-1999 SEER & CoC (added code 14, Thai)</td></tr><tr class='code-row'><td class='code-nbr'>6</td><td class='code-desc'>2000+ SEER & CoC (added code 88 for Race 2, 3, 4, and 5)</td></tr><tr class='code-row'><td class='code-nbr'>7</td><td class='code-desc'>2010+ SEER & CoC (added codes 15, 16, and 17; removed 09)</td></tr></table></div><a name='193'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>RACE--NAPIIA(DERIVED API)</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">193</td><td style="text-align:center;">2</td><td style="text-align:center;"><a href='#sources'>NAACCR</a></td><td style="text-align:center;">2009</td><td style="text-align:center;">11.3</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">449 - 450</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>Race--NAPIIA<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>raceNapiia</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Patient</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>NAPIIA is an acronym for NAACCR Asian and Pacific Islander Identification Algorithm. Race--NAPIIA(derived API) recodes some single-race cases with a Race 1 [160] code of 96 to a more specific Asian race category, based on an algorithm that makes use of the birthplace and name fields (first, last, and maiden names). For single-race cases with a Race 1 code other than 96, it returns the Race 1 code. Multiple-race cases (those with information in Race 2 through Race 5, [161-164]) are handled variously; for greater detail please refer to the technical documentation: <a href="http://www.naaccr.org/LinkClick.aspx?fileticket=3HnBhlmhkBs%3d&amp;tabid=118&amp;mid=458">http://www.naaccr.org/LinkClick.aspx?fileticket=3HnBhlmhkBs%3d&amp;tabid=118&amp;mid=458</a><br />
<br />
In Version 1.1 of the algorithm, birthplace can be used to indirectly assign a specific race to one of eight Asian race groups (Chinese, Japanese, Vietnamese, Korean, Asian Indian, Filipino, Thai, and Cambodian), and names can be used to indirectly assign a specific race to one of seven Asian groups (Chinese, Japanese, Vietnamese, Korean, Asian Indian, Filipino, and Hmong). Subsequent versions of NAPIIA may incorporate Pacific Islanders and may potentially incorporate name lists for Thai, Cambodian, and Laotians.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>The use of more specific Asian and Pacific Islander codes will enhance surveillance and research activities focused on specific API subgroups.</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>01</td><td class='code-desc'>White</td></tr><tr class='code-row'><td class='code-nbr'>02</td><td class='code-desc'>Black</td></tr><tr class='code-row'><td class='code-nbr'>03</td><td class='code-desc'>American Indian, Aleutian, or Eskimo (includes all indigenous populations of the Western Hemisphere)</td></tr><tr class='code-row'><td class='code-nbr'>04</td><td class='code-desc'>Chinese</td></tr><tr class='code-row'><td class='code-nbr'>05</td><td class='code-desc'>Japanese</td></tr><tr class='code-row'><td class='code-nbr'>06</td><td class='code-desc'>Filipino</td></tr><tr class='code-row'><td class='code-nbr'>07</td><td class='code-desc'>Hawaiian</td></tr><tr class='code-row'><td class='code-nbr'>08</td><td class='code-desc'>Korean</td></tr><tr class='code-row'><td class='code-nbr' colspan='2'>*</td></tr><tr class='code-row'><td class='code-nbr'>10</td><td class='code-desc'>Vietnamese</td></tr><tr class='code-row'><td class='code-nbr'>11</td><td class='code-desc'>Laotian</td></tr><tr class='code-row'><td class='code-nbr'>12</td><td class='code-desc'>Hmong</td></tr><tr class='code-row'><td class='code-nbr'>13</td><td class='code-desc'>Kampuchean (Cambodian)</td></tr><tr class='code-row'><td class='code-nbr'>14</td><td class='code-desc'>Thai</td></tr><tr class='code-row'><td class='code-nbr'>15</td><td class='code-desc'>Asian Indian or Pakistani, NOS (code 09 prior to Version 12)</td></tr><tr class='code-row'><td class='code-nbr'>16</td><td class='code-desc'>   Asian Indian</td></tr><tr class='code-row'><td class='code-nbr'>17</td><td class='code-desc'>   Pakistani</td></tr><tr class='code-row'><td class='code-nbr'>20</td><td class='code-desc'>Micronesian, NOS</td></tr><tr class='code-row'><td class='code-nbr'>21</td><td class='code-desc'>Chamorro/Chamoru</td></tr><tr class='code-row'><td class='code-nbr'>22</td><td class='code-desc'>Guamanian, NOS</td></tr><tr class='code-row'><td class='code-nbr'>25</td><td class='code-desc'>Polynesian, NOS</td></tr><tr class='code-row'><td class='code-nbr'>26</td><td class='code-desc'>Tahitian</td></tr><tr class='code-row'><td class='code-nbr'>27</td><td class='code-desc'>Samoan</td></tr><tr class='code-row'><td class='code-nbr'>28</td><td class='code-desc'>Tongan</td></tr><tr class='code-row'><td class='code-nbr'>30</td><td class='code-desc'>Melanesian, NOS</td></tr><tr class='code-row'><td class='code-nbr'>31</td><td class='code-desc'>Fiji Islander</td></tr><tr class='code-row'><td class='code-nbr'>32</td><td class='code-desc'>New Guinean</td></tr><tr class='code-row'><td class='code-nbr'>96</td><td class='code-desc'>Other Asian, including Asian, NOS and Oriental, NOS</td></tr><tr class='code-row'><td class='code-nbr'>97</td><td class='code-desc'>Pacific Islander, NOS</td></tr><tr class='code-row'><td class='code-nbr'>98</td><td class='code-desc'>Other</td></tr><tr class='code-row'><td class='code-nbr'>99</td><td class='code-desc'>Unknown</td></tr><tr class='code-row'><td class='code-nbr'>Blank</td><td class='code-desc'>Algorithm was not run</td></tr></table></div><div class='content chap10-para'>* Code 09 was retired effective with Version 12. See codes 15-17.</div><a name='3210'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>RAD--BOOST DOSE CGY</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">3210</td><td style="text-align:center;">5</td><td style="text-align:center;"><a href='#sources'>CoC</a></td><td style="text-align:center;">2003</td><td style="text-align:center;">10</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">2268 - 2272</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>Boost Radiation Dose: cGy<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>radBoostDoseCgy</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Records the additional dose delivered to that part of the treatment volume encompassed by the boost fields or devices. The unit of measure is centiGray (cGy).</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>To evaluate patterns of radiation oncology care, it is necessary to describe the boost radiation dose. A boost dose is administered to a volume within the regional volume. As in chemotherapy, outcomes are strongly related to the dose delivered.</div><div class='content chap10-para'><strong>Codes (In addition to value dose. Refer to the most recent version of <em>STORE </em>for additional instructions.) </strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>(Fill blanks)</td><td class='code-desc'>Record the actual boost dose delivered</td></tr><tr class='code-row'><td class='code-nbr'>00000</td><td class='code-desc'>Boost radiation therapy was not administered</td></tr><tr class='code-row'><td class='code-nbr'>88888</td><td class='code-desc'>Not applicable, brachytherapy or radioisotopes administered to the patient</td></tr><tr class='code-row'><td class='code-nbr'>99999</td><td class='code-desc'>Boost radiation therapy administered, boost dose unknown</td></tr></table></div><a name='3200'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>RAD--BOOST RX MODALITY</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">3200</td><td style="text-align:center;">2</td><td style="text-align:center;"><a href='#sources'>CoC</a></td><td style="text-align:center;">2003</td><td style="text-align:center;">10</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">2266 - 2267</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>Boost Radiation Treatment Modality<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>radBoostRxModality</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Records the dominant modality of radiation therapy used to deliver the most clinically significant boost dose to the primary volume of interest during the first course of treatment. This is accomplished with external beam fields of reduced size (relative to the regional treatment fields), implants, stereotactic radiosurgery, conformal therapy, or intensity-modulated radiation therapy. External beam boosts may consist of two or more successive phases with progressively smaller fields, and they are generally coded as a single entity. This field is used with Rad--Regional RX Modality [1570].</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Radiation treatment frequently is delivered in two or more phases that can be summarized as regional and boost treatments. A boost dose is administered to a volume within the regional volume. For outcomes analysis, the modalities used for each of these phases can be very important</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>00</td><td class='code-desc'>No boost treatment</td></tr><tr class='code-row'><td class='code-nbr'>20</td><td class='code-desc'>External beam, NOS</td></tr><tr class='code-row'><td class='code-nbr'>21</td><td class='code-desc'>Orthovoltage</td></tr><tr class='code-row'><td class='code-nbr'>22</td><td class='code-desc'>Cobalt-60, Cesium-137</td></tr><tr class='code-row'><td class='code-nbr'>23</td><td class='code-desc'>Photons (2-5 MV)</td></tr><tr class='code-row'><td class='code-nbr'>24</td><td class='code-desc'>Photons (6-10 MV)</td></tr><tr class='code-row'><td class='code-nbr'>25</td><td class='code-desc'>Photons (11-19 MV)</td></tr><tr class='code-row'><td class='code-nbr'>26</td><td class='code-desc'>Photons (> 19 MV)</td></tr><tr class='code-row'><td class='code-nbr'>27</td><td class='code-desc'>Photons (mixed energies)</td></tr><tr class='code-row'><td class='code-nbr'>28</td><td class='code-desc'>Electrons</td></tr><tr class='code-row'><td class='code-nbr'>29</td><td class='code-desc'>Photons and electrons mixed</td></tr><tr class='code-row'><td class='code-nbr'>30</td><td class='code-desc'>Neutrons, with or without photons/electrons</td></tr><tr class='code-row'><td class='code-nbr'>31</td><td class='code-desc'>IMRT</td></tr><tr class='code-row'><td class='code-nbr'>32</td><td class='code-desc'>Conformal or 3-D therapy</td></tr><tr class='code-row'><td class='code-nbr'>40</td><td class='code-desc'>Protons</td></tr><tr class='code-row'><td class='code-nbr'>41</td><td class='code-desc'>Stereotactic radiosurgery, NOS</td></tr><tr class='code-row'><td class='code-nbr'>42</td><td class='code-desc'>Linac radiosurgery</td></tr><tr class='code-row'><td class='code-nbr'>43</td><td class='code-desc'>Gamma Knife</td></tr><tr class='code-row'><td class='code-nbr'>50</td><td class='code-desc'>Brachytherapy, NOS</td></tr><tr class='code-row'><td class='code-nbr'>51</td><td class='code-desc'>Brachytherapy, Intracavitary, LDR</td></tr><tr class='code-row'><td class='code-nbr'>52</td><td class='code-desc'>Brachytherapy, Intracavitary, HDR</td></tr><tr class='code-row'><td class='code-nbr'>53</td><td class='code-desc'>Brachytherapy, Interstitial, LDR</td></tr><tr class='code-row'><td class='code-nbr'>54</td><td class='code-desc'>Brachytherapy, Interstitial, HDR</td></tr><tr class='code-row'><td class='code-nbr'>55</td><td class='code-desc'>Radium</td></tr><tr class='code-row'><td class='code-nbr'>60</td><td class='code-desc'>Radio-isotopes, NOS</td></tr><tr class='code-row'><td class='code-nbr'>61</td><td class='code-desc'>Strontium - 89</td></tr><tr class='code-row'><td class='code-nbr'>62</td><td class='code-desc'>Strontium - 90</td></tr><tr class='code-row'><td class='code-nbr'>98</td><td class='code-desc'>Other, NOS</td></tr><tr class='code-row'><td class='code-nbr'>99</td><td class='code-desc'>Unknown</td></tr></table></div><a name='1530'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>RAD--ELAPSED RX DAYS</strong></td><td style="text-align:right;font-weight:bold;"><strong>Retired</strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">1530</td><td style="text-align:center;"></td><td style="text-align:center;"><a href='#sources'></a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;">2006</td><td style="text-align:center;">11</td><td class="cross-out" style="text-align:center;"></td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td></td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td></td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>The NAACCR UDSC retired this data item in Version 11, as of January 1, 2006.</div><a name='1531'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>RADIATION TREATMENT DISCONTINUED EARLY</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">1531</td><td style="text-align:center;">2</td><td style="text-align:center;"><a href='#sources'>CoC</a></td><td style="text-align:center;">2018</td><td style="text-align:center;">18</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">2349 - 2350</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>radiationTxDiscontinuedEarly</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>This field is used to identify patients/tumors whose radiation treatment course was discontinued earlier than initially planned. That is the patients/tumors received fewer treatment fractions (sessions) than originally intended by the treating physician. This data item is required for CoC-accredited facilities as of cases diagnosed 01/01/2018 and later.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Currently, the total dose of radiation reflects what was actually delivered rather than what was intended. When a patient doesn&#8217;t complete a radiation course as initially intended this is typically commented on within the radiation end of treatment summary. By flagging these patients within the cancer registry database, these patients can be excluded from analyses attempting to describe adherence to radiation treatment guidelines or patterns of care analyses.</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>00</td><td class='code-desc'>No radiation treatment </td></tr><tr class='code-row'><td class='code-nbr'>01</td><td class='code-desc'>Radiation treatment completed as prescribed </td></tr><tr class='code-row'><td class='code-nbr'>02</td><td class='code-desc'>Radiation treatment discontinued early  toxicity</td></tr><tr class='code-row'><td class='code-nbr'>03</td><td class='code-desc'>Radiation treatment discontinued early - contraindicated due to other patient risk factors (comorbid conditions, advanced age, progression of tumor prior to planned radiation etc.)</td></tr><tr class='code-row'><td class='code-nbr'>04</td><td class='code-desc'>Radiation treatment discontinued early  patient decision</td></tr><tr class='code-row'><td class='code-nbr'>05</td><td class='code-desc'>Radiation discontinued early  family decision</td></tr><tr class='code-row'><td class='code-nbr'>06</td><td class='code-desc'>Radiation discontinued early  patient expired</td></tr><tr class='code-row'><td class='code-nbr'>07</td><td class='code-desc'>Radiation discontinued early  reason not documented</td></tr><tr class='code-row'><td class='code-nbr'>99</td><td class='code-desc'>Unknown if radiation treatment discontinued; Unknown whether radiation therapy administered</td></tr><tr class='code-row'><td class='code-nbr'></td><td class='code-desc'> </td></tr></table></div><a name='1560'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>RAD--INTENT OF TREATMENT</strong></td><td style="text-align:right;font-weight:bold;"><strong>Retired</strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">1560</td><td style="text-align:center;"></td><td style="text-align:center;"><a href='#sources'></a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;">2006</td><td style="text-align:center;">11</td><td class="cross-out" style="text-align:center;"></td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td></td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td></td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>The NAACCR UDSC retired this data item in Version 11, as of January 1, 2006.</div><a name='1590'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>RAD--LOCAL CONTROL STATUS</strong></td><td style="text-align:right;font-weight:bold;"><strong>Retired</strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">1590</td><td style="text-align:center;"></td><td style="text-align:center;"><a href='#sources'></a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;">2006</td><td style="text-align:center;">11</td><td class="cross-out" style="text-align:center;"></td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td></td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td></td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>The NAACCR UDSC retired this data item in Version 11, as of January 1, 2006.</div><a name='1550'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>RAD--LOCATION OF RX</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">1550</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>CoC</a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">2263 - 2263</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>Location of Radiation Treatment (CoC)<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>radLocationOfRx</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Identifies the location of the facility where radiation treatment was administered during first course of treatment. See also RX Summ--Radiation [1360].</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>0</td><td class='code-desc'>No radiation treatment</td></tr><tr class='code-row'><td class='code-nbr'>1</td><td class='code-desc'>All radiation treatment at this facility</td></tr><tr class='code-row'><td class='code-nbr'>2</td><td class='code-desc'>Regional treatment at this facility, boost elsewhere</td></tr><tr class='code-row'><td class='code-nbr'>3</td><td class='code-desc'>Boost radiation at this facility, regional elsewhere</td></tr><tr class='code-row'><td class='code-nbr'>4</td><td class='code-desc'>All radiation treatment elsewhere</td></tr><tr class='code-row'><td class='code-nbr'>8</td><td class='code-desc'>Other, NOS</td></tr><tr class='code-row'><td class='code-nbr'>9</td><td class='code-desc'>Unknown</td></tr></table></div><a name='1520'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>RAD--NO OF TREATMENT VOL</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">1520</td><td style="text-align:center;">3</td><td style="text-align:center;"><a href='#sources'>CoC</a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">2258 - 2260</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>Number of Treatments to this Volume (CoC)<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>radNoOfTreatmentVol</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Records the total number of treatment sessions (fractions) administered during the first course of therapy. See also RX--Treatment Volume [1540].</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>000</td><td class='code-desc'>None</td></tr><tr class='code-row'><td class='code-nbr'>001-998</td><td class='code-desc'>Number of treatments</td></tr><tr class='code-row'><td class='code-nbr'>999</td><td class='code-desc'>Unknown</td></tr></table></div><a name='1510'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>RAD--REGIONAL DOSE: CGY</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">1510</td><td style="text-align:center;">5</td><td style="text-align:center;"><a href='#sources'>CoC</a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">2253 - 2257</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>Regional Dose: cGy (CoC)<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>radRegionalDoseCgy</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>The dominant or most clinically significant total dose of regional radiation therapy delivered to the patient during the first course of treatment. The unit of measure is centiGray (cGy). See also Rad--Regional RX Modality [1570].</div><div class='content chap10-para'><strong>Codes (in addition to actual doses) </strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>(Fill spaces)</td><td class='code-desc'>Record the actual regional dose delivered</td></tr><tr class='code-row'><td class='code-nbr'>00000</td><td class='code-desc'>Radiation therapy was not administered</td></tr><tr class='code-row'><td class='code-nbr'>88888</td><td class='code-desc'>Not applicable, brachytherapy or radioisotopes administered to the patient</td></tr><tr class='code-row'><td class='code-nbr'>99999</td><td class='code-desc'>Regional radiation therapy was administered, but the dose is unknown</td></tr></table></div><a name='1570'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>RAD--REGIONAL RX MODALITY</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">1570</td><td style="text-align:center;">2</td><td style="text-align:center;"><a href='#sources'>CoC</a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">2264 - 2265</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>Regional Treatment Modality (CoC)<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>radRegionalRxModality</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Records the dominant modality of radiation therapy used to deliver the clinically most significant regional dose to the primary volume of interest during the first course of treatment.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Radiation treatment frequently is delivered in two or more phases that can be summarized as regional and boost treatments. To evaluate patterns of radiation oncology care, it is necessary to know which radiation resources were employed in the delivery of therapy. For outcomes analysis, the modalities used for each of these phases can be very important.</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>00</td><td class='code-desc'>No radiation treatment</td></tr><tr class='code-row'><td class='code-nbr'>20</td><td class='code-desc'>External beam, NOS</td></tr><tr class='code-row'><td class='code-nbr'>21</td><td class='code-desc'>Orthovoltage</td></tr><tr class='code-row'><td class='code-nbr'>22</td><td class='code-desc'>Cobalt-60, Cesium-137</td></tr><tr class='code-row'><td class='code-nbr'>23</td><td class='code-desc'>Photons (2-5 MV)</td></tr><tr class='code-row'><td class='code-nbr'>24</td><td class='code-desc'>Photons (6-10 MV)</td></tr><tr class='code-row'><td class='code-nbr'>25</td><td class='code-desc'>Photons (11-19 MV)</td></tr><tr class='code-row'><td class='code-nbr'>26</td><td class='code-desc'>Photons (> 19 MV)</td></tr><tr class='code-row'><td class='code-nbr'>27</td><td class='code-desc'>Photons (mixed energies)</td></tr><tr class='code-row'><td class='code-nbr'>28</td><td class='code-desc'>Electrons</td></tr><tr class='code-row'><td class='code-nbr'>29</td><td class='code-desc'>Photons and electrons mixed</td></tr><tr class='code-row'><td class='code-nbr'>30</td><td class='code-desc'>Neutrons, with or without photons/electrons</td></tr><tr class='code-row'><td class='code-nbr'>31</td><td class='code-desc'>IMRT</td></tr><tr class='code-row'><td class='code-nbr'>32</td><td class='code-desc'>Conformal or 3-D therapy</td></tr><tr class='code-row'><td class='code-nbr'>40</td><td class='code-desc'>Protons</td></tr><tr class='code-row'><td class='code-nbr'>41</td><td class='code-desc'>Stereotactic radiosurgery, NOS</td></tr><tr class='code-row'><td class='code-nbr'>42</td><td class='code-desc'>Linac radiosurgery</td></tr><tr class='code-row'><td class='code-nbr'>43</td><td class='code-desc'>Gamma Knife</td></tr><tr class='code-row'><td class='code-nbr'>50</td><td class='code-desc'>Brachytherapy, NOS</td></tr><tr class='code-row'><td class='code-nbr'>51</td><td class='code-desc'>Brachytherapy, Intracavitary, Low Dose Rate (LDR)</td></tr><tr class='code-row'><td class='code-nbr'>52</td><td class='code-desc'>Brachytherapy, Intracavitary, High Dose Rate (HDR)</td></tr><tr class='code-row'><td class='code-nbr'>53</td><td class='code-desc'>Brachytherapy, Interstitial, Low Dose Rate (LDR)</td></tr><tr class='code-row'><td class='code-nbr'>54</td><td class='code-desc'>Brachytherapy, Interstitial, High Dose Rate (HDR)</td></tr><tr class='code-row'><td class='code-nbr'>55</td><td class='code-desc'>Radium</td></tr><tr class='code-row'><td class='code-nbr'>60</td><td class='code-desc'>Radio-isotopes, NOS</td></tr><tr class='code-row'><td class='code-nbr'>61</td><td class='code-desc'>Strontium - 89</td></tr><tr class='code-row'><td class='code-nbr'>62</td><td class='code-desc'>Strontium - 90</td></tr><tr class='code-row'><td class='code-nbr'>80*</td><td class='code-desc'>Combination modality, specified</td></tr><tr class='code-row'><td class='code-nbr'>85*</td><td class='code-desc'>Combination modality, NOS</td></tr><tr class='code-row'><td class='code-nbr'>98</td><td class='code-desc'>Other, NOS</td></tr><tr class='code-row'><td class='code-nbr'>99</td><td class='code-desc'>Unknown</td></tr></table></div><div class='content chap10-para'><p>
  <em>Note: </em>For tumors diagnosed prior to January 1, 2003, the codes  reported in this data item describe any radiation administered to the  patient as part or all of the first course of therapy. <br /><br />  *Codes 80 and 85 describe specific converted descriptions of radiation  therapy coded according to <em>Volume II ROADS</em>, and<em> DAM </em>rules and should only be used to record regional radiation for tumors diagnosed prior to January 1, 2003. </p></div><a name='1580'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>RAD--RX COMPLETION STATUS</strong></td><td style="text-align:right;font-weight:bold;"><strong>Retired</strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">1580</td><td style="text-align:center;"></td><td style="text-align:center;"><a href='#sources'></a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;">2006</td><td style="text-align:center;">11</td><td class="cross-out" style="text-align:center;"></td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td></td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td></td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>The NAACCR UDSC retired this data item in Version 11, as of January 1, 2006.</div><a name='1540'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>RAD--TREATMENT VOLUME</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">1540</td><td style="text-align:center;">2</td><td style="text-align:center;"><a href='#sources'>CoC</a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">2261 - 2262</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>Radiation Treatment Volume (CoC)<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>radTreatmentVolume</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Identifies the volume or anatomic target of the most clinically significant regional radiation therapy delivered to the patient during the first course of therapy. See also Rad--Regional RX Modality [1570].</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>00</td><td class='code-desc'>No radiation therapy, not applicable</td></tr><tr class='code-row'><td class='code-nbr'>01</td><td class='code-desc'>Eye/orbit</td></tr><tr class='code-row'><td class='code-nbr'>02</td><td class='code-desc'>Pituitary</td></tr><tr class='code-row'><td class='code-nbr'>03</td><td class='code-desc'>Brain (NOS)</td></tr><tr class='code-row'><td class='code-nbr'>04</td><td class='code-desc'>Brain (limited)</td></tr><tr class='code-row'><td class='code-nbr'>05</td><td class='code-desc'>Head and neck (NOS)</td></tr><tr class='code-row'><td class='code-nbr'>06</td><td class='code-desc'>Head and neck (limited)</td></tr><tr class='code-row'><td class='code-nbr'>07</td><td class='code-desc'>Glottis</td></tr><tr class='code-row'><td class='code-nbr'>08</td><td class='code-desc'>Sinuses</td></tr><tr class='code-row'><td class='code-nbr'>09</td><td class='code-desc'>Parotid</td></tr><tr class='code-row'><td class='code-nbr'>10</td><td class='code-desc'>Chest/lung (NOS)</td></tr><tr class='code-row'><td class='code-nbr'>11</td><td class='code-desc'>Lung (limited)</td></tr><tr class='code-row'><td class='code-nbr'>12</td><td class='code-desc'>Esophagus</td></tr><tr class='code-row'><td class='code-nbr'>13</td><td class='code-desc'>Stomach</td></tr><tr class='code-row'><td class='code-nbr'>14</td><td class='code-desc'>Liver</td></tr><tr class='code-row'><td class='code-nbr'>15</td><td class='code-desc'>Pancreas</td></tr><tr class='code-row'><td class='code-nbr'>16</td><td class='code-desc'>Kidney</td></tr><tr class='code-row'><td class='code-nbr'>17</td><td class='code-desc'>Abdomen (NOS)</td></tr><tr class='code-row'><td class='code-nbr'>18</td><td class='code-desc'>Breast</td></tr><tr class='code-row'><td class='code-nbr'>19</td><td class='code-desc'>Breast/lymph nodes</td></tr><tr class='code-row'><td class='code-nbr'>20</td><td class='code-desc'>Chest wall</td></tr><tr class='code-row'><td class='code-nbr'>21</td><td class='code-desc'>Chest wall/lymph nodes</td></tr><tr class='code-row'><td class='code-nbr'>22</td><td class='code-desc'>Mantle, mini-mantle</td></tr><tr class='code-row'><td class='code-nbr'>23</td><td class='code-desc'>Lower extended field</td></tr><tr class='code-row'><td class='code-nbr'>24</td><td class='code-desc'>Spine</td></tr><tr class='code-row'><td class='code-nbr'>25</td><td class='code-desc'>Skull</td></tr><tr class='code-row'><td class='code-nbr'>26</td><td class='code-desc'>Ribs</td></tr><tr class='code-row'><td class='code-nbr'>27</td><td class='code-desc'>Hip</td></tr><tr class='code-row'><td class='code-nbr'>28</td><td class='code-desc'>Pelvic bones</td></tr><tr class='code-row'><td class='code-nbr'>29</td><td class='code-desc'>Pelvis (NOS)</td></tr><tr class='code-row'><td class='code-nbr'>30</td><td class='code-desc'>Skin</td></tr><tr class='code-row'><td class='code-nbr'>31</td><td class='code-desc'>Soft tissue</td></tr><tr class='code-row'><td class='code-nbr'>32</td><td class='code-desc'>Hemibody</td></tr><tr class='code-row'><td class='code-nbr'>33</td><td class='code-desc'>Whole body</td></tr><tr class='code-row'><td class='code-nbr'>34</td><td class='code-desc'>Bladder and pelvis</td></tr><tr class='code-row'><td class='code-nbr'>35</td><td class='code-desc'>Prostate and pelvis</td></tr><tr class='code-row'><td class='code-nbr'>36</td><td class='code-desc'>Uterus and Cervix</td></tr><tr class='code-row'><td class='code-nbr'>37</td><td class='code-desc'>Shoulder</td></tr><tr class='code-row'><td class='code-nbr'>38</td><td class='code-desc'>Extremities bone, NOS</td></tr><tr class='code-row'><td class='code-nbr'>39</td><td class='code-desc'>Inverted Y</td></tr><tr class='code-row'><td class='code-nbr'>40</td><td class='code-desc'>Spinal cord</td></tr><tr class='code-row'><td class='code-nbr'>41</td><td class='code-desc'>Prostate</td></tr><tr class='code-row'><td class='code-nbr'>50</td><td class='code-desc'>Thyroid</td></tr><tr class='code-row'><td class='code-nbr'>60</td><td class='code-desc'>Lymph node region, NOS</td></tr><tr class='code-row'><td class='code-nbr'>98</td><td class='code-desc'>Other</td></tr><tr class='code-row'><td class='code-nbr'>99</td><td class='code-desc'>Unknown</td></tr></table></div><a name='3190'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>READM SAME HOSP 30 DAYS</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">3190</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>CoC</a></td><td style="text-align:center;">2003</td><td style="text-align:center;">10</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">2276 - 2276</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>Readmission to the Same Hospital Within 30 Days of Surgical Discharge<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>readmSameHosp30Days</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Records a readmission to the same hospital within 30 days of discharge following hospitalization for surgical resection of the primary site for the same illness. </div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>This data item provides information related to the quality of care. A patient may have a readmission related to the primary diagnosis on discharge if the length of stay was too short, and then needed to return due to problems or complications. A patient may also need to be readmitted if discharge planning and/or follow-up instructions were ineffective. It is important to distinguish a planned from an unplanned readmission, since a planned readmission is not an indicator of quality of care problems. </div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>0</td><td class='code-desc'>No surgical procedure of the primary site was performed. Patient not readmitted to the same hospital within 30 days of discharge.</td></tr><tr class='code-row'><td class='code-nbr'>1</td><td class='code-desc'>Patient was surgically treated and was then readmitted to the same hospital within 30 days of being discharged. This readmission was unplanned.</td></tr><tr class='code-row'><td class='code-nbr'>2</td><td class='code-desc'>Patient was surgically treated and was then readmitted to the same hospital within 30 days of being discharged. This readmission was planned (chemotherapy port insertion, revision of colostomy, etc.).</td></tr><tr class='code-row'><td class='code-nbr'>3</td><td class='code-desc'>Patient was surgically treated and, within 30 days of being discharged, had both a planned and an unplanned readmission to the same hospital.</td></tr><tr class='code-row'><td class='code-nbr'>9</td><td class='code-desc'>It is unknown whether surgery of the primary site was recommended or performed. It is unknown whether the patient was readmitted to the same hospital within 30 days of discharge. Death certificate only.</td></tr></table></div><a name='1440'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>REASON FOR NO CHEMO</strong></td><td style="text-align:right;font-weight:bold;"><strong>Retired</strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">1440</td><td style="text-align:center;"></td><td style="text-align:center;"><a href='#sources'></a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;">2006</td><td style="text-align:center;">11</td><td class="cross-out" style="text-align:center;"></td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td></td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td></td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>The NAACCR UDSC retired this data item in Version 11, as of January 1, 2006.</div><a name='1450'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>REASON FOR NO HORMONE</strong></td><td style="text-align:right;font-weight:bold;"><strong>Retired</strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">1450</td><td style="text-align:center;"></td><td style="text-align:center;"><a href='#sources'></a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;">2006</td><td style="text-align:center;">11</td><td class="cross-out" style="text-align:center;"></td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td></td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td></td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>The NAACCR UDSC retired this data item in Version 11, as of January 1, 2006.</div><a name='1430'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>REASON FOR NO RADIATION</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">1430</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>CoC</a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">2250 - 2250</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>Reason for No Regional Radiation Therapy<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>reasonForNoRadiation</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Code the reason the patient did not receive radiation treatment as part of first course of therapy. See also RX--Regional RX Modality [1570].</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>0</td><td class='code-desc'>Radiation therapy was administered.</td></tr><tr class='code-row'><td class='code-nbr'>1</td><td class='code-desc'>Radiation therapy was not administered because it was not part of the planned first-course treatment. Diagnosed at autopsy.</td></tr><tr class='code-row'><td class='code-nbr'>2</td><td class='code-desc'>Radiation therapy was not administered because it was contraindicated due to patient risk factors (comorbid conditions, advanced age, etc).</td></tr><tr class='code-row'><td class='code-nbr'>5</td><td class='code-desc'>Radiation therapy was not administered because the patient died prior to planned or recommended treatment.</td></tr><tr class='code-row'><td class='code-nbr'>6</td><td class='code-desc'>Radiation therapy was not administered; it was recommended by the patient's physician, but was not administered as part of the first-course therapy. No reason was noted in the patient's record.</td></tr><tr class='code-row'><td class='code-nbr'>7</td><td class='code-desc'>Radiation therapy was not administered; it was recommended by the patient's physician, but this treatment was refused by the patient, the patient's family member, or the patient's guardian. The refusal was noted in the patient record.</td></tr><tr class='code-row'><td class='code-nbr'>8</td><td class='code-desc'>Radiation therapy was recommended, but it is unknown if it was administered.</td></tr><tr class='code-row'><td class='code-nbr'>9</td><td class='code-desc'>It is unknown if radiation therapy was recommended or administered. Death-certificate-only.</td></tr></table></div><a name='1340'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>REASON FOR NO SURGERY</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">1340</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>SEER/CoC</a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">2234 - 2234</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>Reason for No Cancer-Directed Surgery (SEER)<br />Reason for No CA Dir Surgery (CoC)<br />Reason for No Surgery to Primary Site<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>reasonForNoSurgery</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Records the reason that no surgery was performed on the primary site. </div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>This data item provides information related to the quality of care and describes why primary site surgery was not performed. </div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>0</td><td class='code-desc'>Surgery of the primary site was performed.</td></tr><tr class='code-row'><td class='code-nbr'>1</td><td class='code-desc'>Surgery of the primary site was not performed because it was not part of the planned first-course treatment.</td></tr><tr class='code-row'><td class='code-nbr'>2</td><td class='code-desc'>Surgery of the primary site was not recommended/performed because it was contraindicated due to patient risk factors (comorbid conditions, advanced age, etc.).</td></tr><tr class='code-row'><td class='code-nbr'>5</td><td class='code-desc'>Surgery of the primary site was not performed because the patient died prior to planned or recommended surgery.</td></tr><tr class='code-row'><td class='code-nbr'>6</td><td class='code-desc'>Surgery of the primary site was not performed; it was recommended by the patient's physician, but was not performed as part of the first-course therapy. No reason was noted in the patient's record.</td></tr><tr class='code-row'><td class='code-nbr'>7</td><td class='code-desc'>Surgery of the primary site was not performed; it was recommended by the patient's physician, but this treatment was refused by the patient, the patient's family member, or the patient's guardian. The refusal was noted in the patient record.</td></tr><tr class='code-row'><td class='code-nbr'>8</td><td class='code-desc'>Surgery of the primary site was recommended, but it is unknown if it was performed. Further follow-up is recommended.</td></tr><tr class='code-row'><td class='code-nbr'>9</td><td class='code-desc'>It is unknown if surgery of the primary site was recommended or performed. Death certificate-only cases and autopsy-only cases.</td></tr></table></div><a name='1775'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>RECORD NUMBER RECODE</strong></td><td style="text-align:right;font-weight:bold;"><strong>Revised</strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">1775</td><td style="text-align:center;">2</td><td style="text-align:center;"><a href='#sources'>NAACCR</a></td><td style="text-align:center;">2018</td><td style="text-align:center;">18</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">2798 - 2799</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>recordNumberRecode</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>This variable sequentially numbers a person's tumors within each dataset. The ordered values are based on date of diagnosis and then sequence number central. This variable is used as part of the algorithm for calculating the survival time recode variables (NAACCR items 1782-1788) and is used for survival, prevalence, and multiple primary &#8211; standardized incidence ratio analyses in SEER*Stat.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para mark-changed'>These changes will benefit the cancer surveillance community by facilitating the application of standard methods for survival analysis. Beginning with data collected in the November 2014 call for data, NAACCR has published 








<em>Cancer in North America Volume 4: Cancer Survival in the United States and Canada</em>, which provides cancer survival estimates on a wider population than was previously available. However, at present IMS must pre-process the datasets that are included in the NAACCR survival dataset to calculate the four new standard data items, SEER Cause Specific COD [1914], SEER Other COD [1915], Record Number Recode [1775], and Vital Status Recode [1762]. For registries that do not submit cause of death information to NAACCR, it is not possible to calculate the 'SEER cause-specific death classification' or 'SEER other cause of death classification' variables. The 4 new data items will assist individual registries in performing survival analyses using their own data.</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>01</td><td class='code-desc'>Record number 01 for patient in database </td></tr><tr class='code-row'><td class='code-nbr'>02</td><td class='code-desc'>Record number 02 for patient in database</td></tr><tr class='code-row'><td class='code-nbr' colspan='2'>...</td></tr><tr class='code-row'><td class='code-nbr'>99</td><td class='code-desc'>Record number 99 for patient in database</td></tr><tr class='code-row'><td class='code-nbr' colspan='2'></td></tr></table></div><a name='10'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>RECORD TYPE</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">10</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>NAACCR</a></td><td style="text-align:center;"></td><td style="text-align:center;">pre V4</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1 - 1</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>recordType</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>NaaccrData</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Generated field that identifies which of the six NAACCR data exchange record types is being used in a file of data exchange records. A file should have records of only one type.</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>I</td><td class='code-desc'><b>I</b>ncidence-only record type (nonconfidential coded data)
Length = 4048</td></tr><tr class='code-row'><td class='code-nbr'>C</td><td class='code-desc'><b>C</b>onfidential record type (incidence record plus confidential data)
Length = 6154</td></tr><tr class='code-row'><td class='code-nbr'>A</td><td class='code-desc'>Full case <b>A</b>bstract record type (incidence and confidential data plus text summaries; used for reporting to central registries)
Length = 24194</td></tr><tr class='code-row'><td class='code-nbr'>U</td><td class='code-desc'>Correction/ <b>U</b>pdate record type (short format record used to submit corrections to data already submitted)
Length = 1543</td></tr><tr class='code-row'><td class='code-nbr'>M</td><td class='code-desc'>Record <b>M</b>odified since previous submission to central registry (identical in format to the "A" record type; used to submit changes to data already submitted) 
Length = 24194</td></tr><tr class='code-row'><td class='code-nbr'>L</td><td class='code-desc'>Pathology <b>L</b>aboratory</td></tr><tr class='code-row'><td class='code-nbr'></td><td class='code-desc'> </td></tr></table></div><a name='1860'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>RECURRENCE DATE--1ST</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">1860</td><td style="text-align:center;">8</td><td style="text-align:center;"><a href='#sources'>CoC</a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">2867 - 2874</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>Date of First Recurrence (CoC)<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>recurrenceDate1st</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>The date of the first recurrence of this tumor. See Chapter X for date format. </div><a name='1861'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>RECURRENCE DATE--1ST FLAG</strong></td><td style="text-align:right;font-weight:bold;"><strong>Revised</strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">1861</td><td style="text-align:center;">2</td><td style="text-align:center;"><a href='#sources'>NAACCR</a></td><td style="text-align:center;">2010</td><td style="text-align:center;">12</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">2875 - 2876</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>recurrenceDate1stFlag</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para mark-changed'>This flag explains why no appropriate value is in the field, Recurrence Date--1st [1860].</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para mark-changed'>Before Version 12 (through 2009 diagnosis), date fields included codes that provided information other than dates. As part of an initiative to standardize date fields, new fields were introduced to accommodate non-date information that had previously been transmitted in date fields.</div><div class='content chap10-para'><strong>Codes (See Appendix H for the Flavors of Null table in its entirety which includes the NAACCR codes, HL7 codes and definitions.)</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>10</td><td class='code-desc'>No information whatsoever can be inferred from this exceptional value (e.g, unknown if the patient had a first recurrence)</td></tr><tr class='code-row'><td class='code-nbr'>11</td><td class='code-desc'>No proper value is applicable in this context (e.g., patient became disease-free after treatment; never had a recurrence; or patient was never disease-free; autopsy only case)</td></tr><tr class='code-row'><td class='code-nbr'>12</td><td class='code-desc'>A proper value is appicable but not known (i.e., there was a recurrence, but the date is unknown)</td></tr><tr class='code-row'><td class='code-nbr'>Blank</td><td class='code-desc'>A valid date value is provided in item Recurrence Date--1st [1860], or the date was not expected to have been transmitted</td></tr></table></div><div class='content chap10-para'>Comment: This is part of the initiative of the transformation from the old NAACCR date standards to interoperable dates.</div><a name='1871'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>RECURRENCE DISTANT SITE 1</strong></td><td style="text-align:right;font-weight:bold;"><strong>Retired</strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">1871</td><td style="text-align:center;"></td><td style="text-align:center;"><a href='#sources'></a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;">2010</td><td style="text-align:center;">12</td><td class="cross-out" style="text-align:center;"></td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td></td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td></td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>The NAACCR UDSC retired this data item in Version 12, as of January 1, 2010.</div><a name='1872'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>RECURRENCE DISTANT SITE 2</strong></td><td style="text-align:right;font-weight:bold;"><strong>Retired</strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">1872</td><td style="text-align:center;"></td><td style="text-align:center;"><a href='#sources'></a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;">2010</td><td style="text-align:center;">12</td><td class="cross-out" style="text-align:center;"></td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td></td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td></td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>The NAACCR UDSC retired this data item in Version 12, as of January 1, 2010.</div><a name='1873'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>RECURRENCE DISTANT SITE 3</strong></td><td style="text-align:right;font-weight:bold;"><strong>Retired</strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">1873</td><td style="text-align:center;"></td><td style="text-align:center;"><a href='#sources'></a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;">2010</td><td style="text-align:center;">12</td><td class="cross-out" style="text-align:center;"></td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td></td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td></td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>The NAACCR UDSC retired this data item in Version 12, as of January 1, 2010.</div><a name='1870'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>RECURRENCE DISTANT SITES</strong></td><td style="text-align:right;font-weight:bold;"><strong>Retired</strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">1870</td><td style="text-align:center;"></td><td style="text-align:center;"><a href='#sources'></a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;">2002</td><td style="text-align:center;">9.1</td><td class="cross-out" style="text-align:center;"></td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td></td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td></td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>The NAACCR UDSC retired this data item in Version 9.1, as of January 1, 2002.</div><a name='1880'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>RECURRENCE TYPE--1ST</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">1880</td><td style="text-align:center;">2</td><td style="text-align:center;"><a href='#sources'>CoC</a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">2877 - 2878</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>Type of First Recurrence (CoC)<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>recurrenceType1st</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Code for the type of first recurrence after a period of documented disease free intermission or remission.</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>00</td><td class='code-desc'>Patient became disease-free after treatment and has not had a recurrence; leukemia in remission.</td></tr><tr class='code-row'><td class='code-nbr'>04</td><td class='code-desc'><i>In situ</i> recurrence of an invasive tumor.</td></tr><tr class='code-row'><td class='code-nbr'>06</td><td class='code-desc'><i>In situ</i> recurrence of an <i>in situ</i> tumor.</td></tr><tr class='code-row'><td class='code-nbr'>10</td><td class='code-desc'>Local recurrence and there is insufficient information available to code to 13-17. Recurrence is confined to the remnant of the organ of origin; to the organ of origin; to the anastomosis; or to scar tissue where the organ previously existed.</td></tr><tr class='code-row'><td class='code-nbr'>13</td><td class='code-desc'>Local recurrence of an invasive tumor.</td></tr><tr class='code-row'><td class='code-nbr'>14</td><td class='code-desc'>Trocar recurrence of an invasive tumor. Includes recurrence in the trocar path or entrance site following prior surgery.</td></tr><tr class='code-row'><td class='code-nbr'>15</td><td class='code-desc'>Both local and trocar recurrence of an invasive tumor (both 13 and 14)</td></tr><tr class='code-row'><td class='code-nbr'>16</td><td class='code-desc'>Local recurrence of an <i>in situ</i> tumor.</td></tr><tr class='code-row'><td class='code-nbr'>17</td><td class='code-desc'>Both local and trocar recurrence of an <i>in situ</i> tumor.</td></tr><tr class='code-row'><td class='code-nbr'>20</td><td class='code-desc'>Regional recurrence, and there is insufficient information available to code to 21-27.</td></tr><tr class='code-row'><td class='code-nbr'>21</td><td class='code-desc'>Recurrence of an invasive tumor in adjacent tissue or organ(s) only.</td></tr><tr class='code-row'><td class='code-nbr'>22</td><td class='code-desc'>Recurrence of an invasive tumor in regional lymph nodes only.</td></tr><tr class='code-row'><td class='code-nbr'>25</td><td class='code-desc'>Recurrence of an invasive tumor in adjacent tissue or organ(s) and in regional lymph nodes (both 21 and 22) at the same time.</td></tr><tr class='code-row'><td class='code-nbr'>26</td><td class='code-desc'>Regional recurrence of an <i>in situ</i> tumor, NOS.</td></tr><tr class='code-row'><td class='code-nbr'>27</td><td class='code-desc'>Recurrence of an <i>in situ</i> tumor in adjacent tissue or organ(s) and in regional lymph nodes at the same time.</td></tr><tr class='code-row'><td class='code-nbr'>30</td><td class='code-desc'>Both regional recurrence of an invasive tumor in adjacent tissue or organ(s) and/or regional lymph nodes (20-25) and local and/or trocar recurrence (10, 13, 14, or 15).</td></tr><tr class='code-row'><td class='code-nbr'>36</td><td class='code-desc'>Both regional recurrence of an <i>in situ</i> tumor in adjacent tissue or organ(s) and/or regional lymph nodes (26 or 27) and local and/or trocar recurrence (16 or 17).</td></tr><tr class='code-row'><td class='code-nbr'>40</td><td class='code-desc'>Distant recurrence and there is insufficient information available to code to 46-62.</td></tr><tr class='code-row'><td class='code-nbr'>46</td><td class='code-desc'>Distant recurrence of an <i>in situ</i> tumor.</td></tr><tr class='code-row'><td class='code-nbr'>51</td><td class='code-desc'>Distant recurrence of an invasive tumor in the peritoneum only. Peritoneum includes peritoneal surfaces of all structures within the abdominal cavity and/or positive ascitic fluid.</td></tr><tr class='code-row'><td class='code-nbr'>52</td><td class='code-desc'>Distant recurrence of an invasive tumor in the lung only. Lung includes the visceral pleura.</td></tr><tr class='code-row'><td class='code-nbr'>53</td><td class='code-desc'>Distant recurrence of an invasive tumor in the pleura only. Pleura includes the pleural surface of all structures within the thoracic cavity and/or positive pleural fluid.</td></tr><tr class='code-row'><td class='code-nbr'>54</td><td class='code-desc'>Distant recurrence of an invasive tumor in the liver only.</td></tr><tr class='code-row'><td class='code-nbr'>55</td><td class='code-desc'>Distant recurrence of an invasive tumor in bone only. This includes bones other than the primary site.</td></tr><tr class='code-row'><td class='code-nbr'>56</td><td class='code-desc'>Distant recurrence of an invasive tumor in the CNS only. This includes the brain and spinal cord, but not the external eye.</td></tr><tr class='code-row'><td class='code-nbr'>57</td><td class='code-desc'>Distant recurrence of an invasive tumor in the skin only. This includes skin other than the primary site.</td></tr><tr class='code-row'><td class='code-nbr'>58</td><td class='code-desc'>Distant recurrence of an invasive tumor in lymph node only. Refer to the staging scheme for a description of lymph nodes that are distant for a particular site.</td></tr><tr class='code-row'><td class='code-nbr'>59</td><td class='code-desc'>Distant systemic recurrence of an invasive tumor only. This includes leukemia, bone marrow metastasis, carcinomatosis, and generalized disease.</td></tr><tr class='code-row'><td class='code-nbr'>60</td><td class='code-desc'>Distant recurrence of an invasive tumor in a single distant site (51-58) and local, trocar, and/or regional recurrence (10-15, 20-25, or 30).</td></tr><tr class='code-row'><td class='code-nbr'>62</td><td class='code-desc'>Distant recurrence of an invasive tumor in multiple sites (recurrences that can be coded to more than one category 51-59).</td></tr><tr class='code-row'><td class='code-nbr'>70</td><td class='code-desc'>Since diagnosis, patient has never been disease-free. This includes cases with distant metastasis at diagnosis, systemic disease, unknown primary, or minimal disease that is not treated.</td></tr><tr class='code-row'><td class='code-nbr'>88</td><td class='code-desc'>Disease has recurred, but the type of recurrence is unknown.</td></tr><tr class='code-row'><td class='code-nbr'>99</td><td class='code-desc'>It is unknown whether the disease has recurred or if the patient was ever disease-free.</td></tr></table></div><a name='1890'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>RECURRENCE TYPE--1ST--OTH</strong></td><td style="text-align:right;font-weight:bold;"><strong>Retired</strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">1890</td><td style="text-align:center;"></td><td style="text-align:center;"><a href='#sources'></a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;">2006</td><td style="text-align:center;">11</td><td class="cross-out" style="text-align:center;"></td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td></td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td></td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>The NAACCR UDSC retired this data item in Version 11, as of January 1, 2006.</div><a name='1490'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>REFERRAL TO SUPPORT SERV</strong></td><td style="text-align:right;font-weight:bold;"><strong>Retired</strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">1490</td><td style="text-align:center;"></td><td style="text-align:center;"><a href='#sources'></a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;">2006</td><td style="text-align:center;">11</td><td class="cross-out" style="text-align:center;"></td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td></td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td></td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>The NAACCR UDSC retired this data item in Version 11, as of January 1, 2006.</div><a name='830'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>REGIONAL NODES EXAMINED</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">830</td><td style="text-align:center;">2</td><td style="text-align:center;"><a href='#sources'>SEER/CoC</a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1000 - 1001</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>Number of Regional Lymph Nodes Examined (SEER)<br />Regional Lymph Nodes Examined<br />Pathologic Review of Regional Lymph Nodes (SEER)<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>regionalNodesExamined</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Records the total number of regional lymph nodes that were removed and examined by the pathologist. Beginning with tumors diagnosed on or after January 1, 2004, this item is a component of the Collaborative Stage system.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>This data item serves as a quality measure of the pathologic and surgical evaluation and treatment of the patient.</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>00</td><td class='code-desc'>No nodes were examined</td></tr><tr class='code-row'><td class='code-nbr'>01-89</td><td class='code-desc'>1-89 nodes were examined (code the exact number of regional lymph nodes examined)</td></tr><tr class='code-row'><td class='code-nbr'>90</td><td class='code-desc'>90 or more nodes were examined</td></tr><tr class='code-row'><td class='code-nbr'>95</td><td class='code-desc'>No regional nodes were removed, but aspiration of regional nodes was performed</td></tr><tr class='code-row'><td class='code-nbr'>96</td><td class='code-desc'>Regional lymph node removal was documented as a sampling, and the number of nodes is unknown/not stated</td></tr><tr class='code-row'><td class='code-nbr'>97</td><td class='code-desc'>Regional lymph node removal was documented as a dissection, and the number of nodes is unknown/not stated</td></tr><tr class='code-row'><td class='code-nbr'>98</td><td class='code-desc'>Regional lymph nodes were surgically removed, but the number of lymph nodes is unknown/not stated and not documented as a sampling or dissection; nodes were examined, but the number is unknown</td></tr><tr class='code-row'><td class='code-nbr'>99</td><td class='code-desc'>It is unknown whether nodes were examined; not stated in patient record</td></tr><tr class='code-row'><td class='code-nbr'></td><td class='code-desc'> </td></tr></table></div><a name='820'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>REGIONAL NODES POSITIVE</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">820</td><td style="text-align:center;">2</td><td style="text-align:center;"><a href='#sources'>SEER/CoC</a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">998 - 999</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>Pathologic Review of Regional Lymph Nodes (SEER)<br />Regional Lymph Nodes Positive<br />Number of Positive Regional Lymph Nodes (SEER)<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>regionalNodesPositive</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Records the exact number of regional nodes examined by the pathologist and found to contain metastases. Beginning with tumors diagnosed on or after January 1, 2004, this item is a component of the Collaborative Stage system. For tumors diagnosed from 1988 through 2003, this item was part of the 10-digit EOD [779], detailed site-specific codes for anatomic EOD. </div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>This data item is necessary for pathologic staging, and it serves as a quality measure for pathology reports and the extent of the surgical evaluation and treatment of the patient. </div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>00</td><td class='code-desc'>All nodes examined are negative</td></tr><tr class='code-row'><td class='code-nbr'>01-89</td><td class='code-desc'>1-89 nodes are positive (code exact number of nodes positive)</td></tr><tr class='code-row'><td class='code-nbr'>90</td><td class='code-desc'>90 or more nodes are positive</td></tr><tr class='code-row'><td class='code-nbr'>95</td><td class='code-desc'>Positive aspiration of lymph node(s) was performed</td></tr><tr class='code-row'><td class='code-nbr'>97</td><td class='code-desc'>Positive nodes are documented, but the number is unspecified</td></tr><tr class='code-row'><td class='code-nbr'>98</td><td class='code-desc'>No nodes were examined</td></tr><tr class='code-row'><td class='code-nbr'>99</td><td class='code-desc'>It is unknown whether nodes are positive; not applicable; not stated in patient record</td></tr></table></div><div class='content chap10-para'><em>Note:</em> See Chapter V, Unresolved Issues, for a discussion of coding differences between CoC and SEER.</div><a name='40'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>REGISTRY ID</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">40</td><td style="text-align:center;">10</td><td style="text-align:center;"><a href='#sources'>NAACCR</a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">30 - 39</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>registryId</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>NaaccrData</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'><p>A unique code that represents the data transmission source. This item should be used for central registries and non-US health care providers. Refer to Registry ID table in Appendix B.</p>  <p>For cases diagnosed on or after 2008, this item may be blank if NPI--Registry ID (item 45) is used to represent the data transmission source. </p></div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Used to track data submission flow and to resolve transmission issues.</div><div class='content chap10-para'><strong>Codes (in addition to CoC assigned codes or NAACCR assigned codes) </strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>0000000000</td><td class='code-desc'>Case not reported by a facility</td></tr><tr class='code-row'><td class='code-nbr'>0099999999</td><td class='code-desc'>Case reported, but facility number is unknown</td></tr></table></div><div class='content chap10-para'><em>Note: </em>Prior to 2008, this field may contain data from reporting facilities.</div><a name='30'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>REGISTRY TYPE</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">30</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>NAACCR</a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">2 - 2</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>registryType</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>NaaccrData</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>A computer-generated code that best describes the type of registry generating the record; used when cases are pooled from multiple registries (a hospital-based registry reporting to a state should have a &#8220;3&#8221; in this field).</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Facilitates tracking of data sources when data from multiple registries are pooled.</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>1</td><td class='code-desc'>Central registry (population-based)</td></tr><tr class='code-row'><td class='code-nbr'>2</td><td class='code-desc'>Central registry or hospital consortium (not population-based)</td></tr><tr class='code-row'><td class='code-nbr'>3</td><td class='code-desc'>Single hospital/freestanding center</td></tr></table></div><a name='260'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>RELIGION</strong></td><td style="text-align:right;font-weight:bold;"><strong>Retired</strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">260</td><td style="text-align:center;"></td><td style="text-align:center;"><a href='#sources'></a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;">2010</td><td style="text-align:center;">12</td><td class="cross-out" style="text-align:center;"></td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td></td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td></td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>The NAACCR UDSC retired this data item in Version 12, as of January 1, 2010.</div><a name='540'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>REPORTING FACILITY</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">540</td><td style="text-align:center;">10</td><td style="text-align:center;"><a href='#sources'>CoC</a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">715 - 724</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>Facility Identification Number (CoC)<br />Reporting Hospital<br />Institution ID Number (CoC)<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>reportingFacility</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>CoC code for the facility whose data are described in the record. </div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>The Reporting Facility identification number or FIN is used to identify a reporting facility in the central registry database and is useful for monitoring data submission, ensuring the accuracy of data and identifying areas for special studies. </div><div class='content chap10-para'><strong>Codes (in addition to CoC assigned codes) </strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>0000000000</td><td class='code-desc'>Case not reported by a facility</td></tr><tr class='code-row'><td class='code-nbr'>0099999999</td><td class='code-desc'>Case reported, but facility number is unknown</td></tr></table></div><div class='content chap10-para'>A listing of valid FINs can be found at <a target="_blank" href="http://www.facs.org/cancer/coc/fin.html">http://www.facs.org/cancer/coc/fin.html</a>.<em><br /><br />Note:</em>When this special code is being used, the length in 9s  should correspond to the length indicated by the code in FIN coding  system [35]. The 9s must be right justified in the field, and the  remaining spaces should be filled with leading zeroes to a total length  of 10.</div><a name='538'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>REPORTING HOSPITAL FAN</strong></td><td style="text-align:right;font-weight:bold;"><strong>Retired</strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">538</td><td style="text-align:center;"></td><td style="text-align:center;"><a href='#sources'></a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;">2006</td><td style="text-align:center;">11</td><td class="cross-out" style="text-align:center;"></td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td></td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td></td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>The NAACCR UDSC retired this data item in Version 11, as of January 1, 2006.</div><a name='37'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>RESERVED 00</strong></td><td style="text-align:right;font-weight:bold;"><strong>Retired</strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">37</td><td style="text-align:center;"></td><td style="text-align:center;"><a href='#sources'></a></td><td style="text-align:center;">2011</td><td style="text-align:center;">12.2</td><td style="text-align:center;">2021</td><td style="text-align:center;">21</td><td class="cross-out" style="text-align:center;"></td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>reserved00</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><a name='370'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>RESERVED 01</strong></td><td style="text-align:right;font-weight:bold;"><strong>Retired</strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">370</td><td style="text-align:center;"></td><td style="text-align:center;"><a href='#sources'></a></td><td style="text-align:center;">2011</td><td style="text-align:center;">12.2</td><td style="text-align:center;">2021</td><td style="text-align:center;">21</td><td class="cross-out" style="text-align:center;"></td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>reserved01</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><a name='530'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>RESERVED 02</strong></td><td style="text-align:right;font-weight:bold;"><strong>Retired</strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">530</td><td style="text-align:center;"></td><td style="text-align:center;"><a href='#sources'></a></td><td style="text-align:center;">2011</td><td style="text-align:center;">12.2</td><td style="text-align:center;">2021</td><td style="text-align:center;">21</td><td class="cross-out" style="text-align:center;"></td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>reserved02</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><a name='680'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>RESERVED 03</strong></td><td style="text-align:right;font-weight:bold;"><strong>Retired</strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">680</td><td style="text-align:center;"></td><td style="text-align:center;"><a href='#sources'></a></td><td style="text-align:center;">2011</td><td style="text-align:center;">12.2</td><td style="text-align:center;">2021</td><td style="text-align:center;">21</td><td class="cross-out" style="text-align:center;"></td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>reserved03</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><a name='750'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>RESERVED 04</strong></td><td style="text-align:right;font-weight:bold;"><strong>Retired</strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">750</td><td style="text-align:center;"></td><td style="text-align:center;"><a href='#sources'></a></td><td style="text-align:center;">2011</td><td style="text-align:center;">12.2</td><td style="text-align:center;">2021</td><td style="text-align:center;">21</td><td class="cross-out" style="text-align:center;"></td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>reserved04</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><a name='1180'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>RESERVED 05</strong></td><td style="text-align:right;font-weight:bold;"><strong>Retired</strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">1180</td><td style="text-align:center;"></td><td style="text-align:center;"><a href='#sources'></a></td><td style="text-align:center;">2011</td><td style="text-align:center;">12.2</td><td style="text-align:center;">2021</td><td style="text-align:center;">21</td><td class="cross-out" style="text-align:center;"></td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>reserved05</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><a name='1190'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>RESERVED 06</strong></td><td style="text-align:right;font-weight:bold;"><strong>Retired</strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">1190</td><td style="text-align:center;"></td><td style="text-align:center;"><a href='#sources'></a></td><td style="text-align:center;">2011</td><td style="text-align:center;">12.2</td><td style="text-align:center;">2021</td><td style="text-align:center;">21</td><td class="cross-out" style="text-align:center;"></td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>reserved06</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><a name='1300'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>RESERVED 07</strong></td><td style="text-align:right;font-weight:bold;"><strong>Retired</strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">1300</td><td style="text-align:center;"></td><td style="text-align:center;"><a href='#sources'></a></td><td style="text-align:center;">2011</td><td style="text-align:center;">12.2</td><td style="text-align:center;">2021</td><td style="text-align:center;">21</td><td class="cross-out" style="text-align:center;"></td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>reserved07</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><a name='1650'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>RESERVED 08</strong></td><td style="text-align:right;font-weight:bold;"><strong>Retired</strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">1650</td><td style="text-align:center;"></td><td style="text-align:center;"><a href='#sources'></a></td><td style="text-align:center;">2011</td><td style="text-align:center;">12.2</td><td style="text-align:center;">2021</td><td style="text-align:center;">21</td><td class="cross-out" style="text-align:center;"></td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>reserved08</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><a name='1740'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>RESERVED 09</strong></td><td style="text-align:right;font-weight:bold;"><strong>Retired</strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">1740</td><td style="text-align:center;"></td><td style="text-align:center;"><a href='#sources'></a></td><td style="text-align:center;">2011</td><td style="text-align:center;">12.2</td><td style="text-align:center;">2021</td><td style="text-align:center;">21</td><td class="cross-out" style="text-align:center;"></td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>reserved09</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><a name='1835'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>RESERVED 10</strong></td><td style="text-align:right;font-weight:bold;"><strong>Retired</strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">1835</td><td style="text-align:center;"></td><td style="text-align:center;"><a href='#sources'></a></td><td style="text-align:center;">2011</td><td style="text-align:center;">12.2</td><td style="text-align:center;">2021</td><td style="text-align:center;">21</td><td class="cross-out" style="text-align:center;"></td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>reserved10</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><a name='1900'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>RESERVED 11</strong></td><td style="text-align:right;font-weight:bold;"><strong>Retired</strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">1900</td><td style="text-align:center;"></td><td style="text-align:center;"><a href='#sources'></a></td><td style="text-align:center;">2011</td><td style="text-align:center;">12.2</td><td style="text-align:center;">2021</td><td style="text-align:center;">21</td><td class="cross-out" style="text-align:center;"></td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>reserved11</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><a name='2510'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>RESERVED 12</strong></td><td style="text-align:right;font-weight:bold;"><strong>Retired</strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">2510</td><td style="text-align:center;"></td><td style="text-align:center;"><a href='#sources'></a></td><td style="text-align:center;">2011</td><td style="text-align:center;">12.2</td><td style="text-align:center;">2021</td><td style="text-align:center;">21</td><td class="cross-out" style="text-align:center;"></td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>reserved12</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><a name='2080'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>RESERVED 13</strong></td><td style="text-align:right;font-weight:bold;"><strong>Retired</strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">2080</td><td style="text-align:center;"></td><td style="text-align:center;"><a href='#sources'></a></td><td style="text-align:center;">2011</td><td style="text-align:center;">12.2</td><td style="text-align:center;">2021</td><td style="text-align:center;">21</td><td class="cross-out" style="text-align:center;"></td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>reserved13</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><a name='2210'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>RESERVED 14</strong></td><td style="text-align:right;font-weight:bold;"><strong>Retired</strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">2210</td><td style="text-align:center;"></td><td style="text-align:center;"><a href='#sources'></a></td><td style="text-align:center;">2011</td><td style="text-align:center;">12.2</td><td style="text-align:center;">2021</td><td style="text-align:center;">21</td><td class="cross-out" style="text-align:center;"></td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>reserved14</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><a name='2400'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>RESERVED 15</strong></td><td style="text-align:right;font-weight:bold;"><strong>Retired</strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">2400</td><td style="text-align:center;"></td><td style="text-align:center;"><a href='#sources'></a></td><td style="text-align:center;">2011</td><td style="text-align:center;">12.2</td><td style="text-align:center;">2021</td><td style="text-align:center;">21</td><td class="cross-out" style="text-align:center;"></td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>reserved15</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><a name='2450'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>RESERVED 16</strong></td><td style="text-align:right;font-weight:bold;"><strong>Retired</strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">2450</td><td style="text-align:center;"></td><td style="text-align:center;"><a href='#sources'></a></td><td style="text-align:center;">2011</td><td style="text-align:center;">12.2</td><td style="text-align:center;">2021</td><td style="text-align:center;">21</td><td class="cross-out" style="text-align:center;"></td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>reserved16</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><a name='2700'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>RESERVED 17</strong></td><td style="text-align:right;font-weight:bold;"><strong>Retired</strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">2700</td><td style="text-align:center;"></td><td style="text-align:center;"><a href='#sources'></a></td><td style="text-align:center;">2013</td><td style="text-align:center;">13</td><td style="text-align:center;">2018</td><td style="text-align:center;">18</td><td class="cross-out" style="text-align:center;"></td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>reserved17</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><a name='2161'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>RESERVED 18</strong></td><td style="text-align:right;font-weight:bold;"><strong>Retired</strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">2161</td><td style="text-align:center;"></td><td style="text-align:center;"><a href='#sources'></a></td><td style="text-align:center;">2013</td><td style="text-align:center;">13</td><td style="text-align:center;">18</td><td style="text-align:center;">18</td><td class="cross-out" style="text-align:center;"></td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>reserved18</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><a name='2162'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>RESERVED 19</strong></td><td style="text-align:right;font-weight:bold;"><strong>Retired</strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">2162</td><td style="text-align:center;"></td><td style="text-align:center;"><a href='#sources'></a></td><td style="text-align:center;">2016</td><td style="text-align:center;">16</td><td style="text-align:center;">18</td><td style="text-align:center;">18</td><td class="cross-out" style="text-align:center;"></td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>reserved19</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><a name='2163'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>RESERVED 20</strong></td><td style="text-align:right;font-weight:bold;"><strong>Retired</strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">2163</td><td style="text-align:center;"></td><td style="text-align:center;"><a href='#sources'></a></td><td style="text-align:center;">2016</td><td style="text-align:center;">16</td><td style="text-align:center;">2018</td><td style="text-align:center;">18</td><td class="cross-out" style="text-align:center;"></td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>reserved20</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><a name='3921'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>RESIDUAL TUMOR VOLUME POST CYTOREDUCTION </strong></td><td style="text-align:right;font-weight:bold;"><strong>Revised</strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">3921</td><td style="text-align:center;">2</td><td style="text-align:center;"><a href='#sources'>NAACCR</a></td><td style="text-align:center;">2018</td><td style="text-align:center;">18</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1920 - 1921</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>residualTumVolPostCytoreduction</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Gross residual tumor after primary cytoreductive surgery is a prognostic factor for ovarian cancer and residual tumor volume after cytoreductive surgery is a prognostic factor for late stage ovarian cancers.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Residual Tumor Volume Post Cytoreduction is a Registry Data Collection Variable listed in AJCC. It was previously collected as Ovary, CS SSF # 3.</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para mark-changed'><table><tr class='code-row'><td class='code-nbr'>00</td><td class='code-desc'>No gross residual tumor nodules </td></tr><tr class='code-row'><td class='code-nbr'>50</td><td class='code-desc'>Residual tumor nodule(s) 1 centimeter (cm) or less </td></tr><tr class='code-row'><td class='code-nbr'>60</td><td class='code-desc'>Residual tumor nodule(s) greater than 1 cm</td></tr><tr class='code-row'><td class='code-nbr'>70</td><td class='code-desc'>Macroscopic residual tumor nodule(s), size not stated</td></tr><tr class='code-row'><td class='code-nbr'>80</td><td class='code-desc'>Procedure described as optimal debulking and size of residual tumor nodule(s) not given</td></tr><tr class='code-row'><td class='code-nbr'>97</td><td class='code-desc'>No cytoreductive surgery performed</td></tr><tr class='code-row'><td class='code-nbr'>98</td><td class='code-desc'>Not applicable: Information not collected for this case<br/>
(If this item is required by your standard setter, use of code 98 will result in an edit error.)
</td></tr><tr class='code-row'><td class='code-nbr'>99</td><td class='code-desc'>Not documented in medical record<br/>
Residual tumor status after cytoreductive surgery not assessed or unknown if assessed
</td></tr><tr class='code-row'><td class='code-nbr'></td><td class='code-desc'> </td></tr></table></div><div class='content chap10-para mark-changed'>Each Site-Specific Data Item (SSDI) applies only to selected primary sites, histologies, and years of diagnosis. Depending on applicability and standard-setter requirements, SSDIs may be left blank.</div><a name='3922'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>RESPONSE TO NEOADJUVANT THERAPY</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">3922</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>NAACCR</a></td><td style="text-align:center;">2018</td><td style="text-align:center;">18</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1751 - 1751</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>responseToNeoadjuvantTherapy</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>This data item records the physician's statement of response to neoadjuvant chemotherapy.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Response to Neoadjuvant Therapy is a Registry Data Collection Variable in AJCC. It was previously collected as Breast, CS SSF #21.</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>0</td><td class='code-desc'>Neoadjuvant therapy not given</td></tr><tr class='code-row'><td class='code-nbr'>1</td><td class='code-desc'>Stated as complete response (CR)</td></tr><tr class='code-row'><td class='code-nbr'>2</td><td class='code-desc'>Stated as partial response (PR)</td></tr><tr class='code-row'><td class='code-nbr'>3</td><td class='code-desc'>Stated as response to treatment, but not noted if complete or partial</td></tr><tr class='code-row'><td class='code-nbr'>4</td><td class='code-desc'>Stated as no response (NR)</td></tr><tr class='code-row'><td class='code-nbr'>8</td><td class='code-desc'>Not applicable: Information not collected for this case<br/>
(If this item is required by your standard setter, use of code 8 will result in an edit error.)
</td></tr><tr class='code-row'><td class='code-nbr'>9</td><td class='code-desc'>Not documented in medical record<br/>
Response to neoadjuvant therapy not assessed or unknown if assessed
</td></tr><tr class='code-row'><td class='code-nbr'></td><td class='code-desc'> </td></tr></table></div><div class='content chap10-para'>Each Site-Specific Data Item (SSDI) applies only to selected primary sites, histologies, and years of diagnosis. Depending on applicability and standard-setter requirements, SSDIs may be left blank. </div><a name='2155'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>RQRS NCDB SUBMISSION FLAG</strong></td><td style="text-align:right;font-weight:bold;"><strong>Revised</strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">2155</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>CoC</a></td><td style="text-align:center;">2018</td><td style="text-align:center;">18</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">2623 - 2623</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>rqrsNcdbSubmissionFlag</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para mark-changed'>This flag identifies the type of data submission from reporting facilities to the CoC National Cancer Database (NCDB). This data item is required for CoC-accredited facilities with submission starting 01/01/2018. Update: As of 01/01/2021, this item will no longer be required by CoC.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>CoC-accredited hospitals make multiple data submissions for various reasons:<br /><ul><li>Rapid Quality Reporting System (current, generally incomplete cases)</li><li>NCDB Call for Data (older, complete cases)</li></ul>The NCDB is moving to submission of data via a single data portal rather than the current separate data portals for RQRS and NCDB. This data item will facilitate identification of the purpose of the data submission at the receiving end.</div><div class='content chap10-para mark-changed'>This item is no longer required by CoC.</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>1</td><td class='code-desc'>Data Submission for RQRS </td></tr><tr class='code-row'><td class='code-nbr'>2</td><td class='code-desc'>Data Submission for NCDB Annual Call for Data</td></tr><tr class='code-row'><td class='code-nbr' colspan='2'></td></tr></table></div><a name='339'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>RUCA 2000</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">339</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>NAACCR</a></td><td style="text-align:center;">2018</td><td style="text-align:center;">18</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">460 - 460</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>Rural Urban Commuting Area-Tract-level 2000<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>ruca2000</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>A measure of how accessible to an urban center a cancer patient's census tract at diagnosis is based on the USDA identification of urban and rural commuting areas. The variable is a binomial-either in an urban commuting area or not. The measure indicates proximity to large urban centers and can be an indicator of access to oncology specialists and cancer treatment facilities. Collecting the variable with each decennial census allows for retrospective and cross-sectional epidemiologic analysis.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Studies have shown that residents of rural areas have lower screening rates, lower rates of follow-up of abnormal screening tests, higher late-stage diagnosis rates, and differences in cancer treatment patterns. Including tract-level indicators of rural-urban residence in the NAACCR data files will facilitate research in rural-urban disparities and allow researchers to control for rural-urban differences in model-based analysis of cancer risks and outcomes. Using these codes allows cancer registries to release the area-based measure instead of more sensitive information such as address or long/lat. The measure has been tested for uniqueness and the categories selected/aggregated so that identification of individual level census tracts is not possible as long as county is not known. Therefore, unless the researcher can scientifically defend the need for county, the county identifier will not be released in the same database.</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>1</td><td class='code-desc'>Urban commuting area-RUCA codes 1.0, 1.1, 2.0, 2.1, 3.0, 4.1, 5.1, 7.1, 8.1, and 10.1 </td></tr><tr class='code-row'><td class='code-nbr'>2</td><td class='code-desc'>Not an urban commuting area-All other RUCA codes except 99</td></tr><tr class='code-row'><td class='code-nbr'>9</td><td class='code-desc'>Unknown or not applicable-census tract not available or RUCA code = 99</td></tr><tr class='code-row'><td class='code-nbr' colspan='2'></td></tr></table></div><div class='content chap10-para'><em>Note</em>: This is a derived variable. Currently, the variable is derived during call for data. However, SAS code to derive the variable at the central registry variable for local use is available on the NAACCR website.</div><a name='341'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>RUCA 2010</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">341</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>NAACCR</a></td><td style="text-align:center;">2018</td><td style="text-align:center;">18</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">461 - 461</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>Rural Urban Commuting Area-Tract-level 2010<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>ruca2010</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>A measure of how accessible to an urban center a cancer patient's census tract at diagnosis is based on the USDA identification of urban and rural commuting areas. The variable is a binomial-either in an urban commuting area or not. The measure indicates proximity to large urban centers and can be an indicator of access to oncology specialists and cancer treatment facilities. Collecting the variable with each decennial census allows for retrospective and cross-sectional epidemiologic analysis.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Studies have shown that residents of rural areas have lower screening rates, lower rates of follow-up of abnormal screening tests, higher late-stage diagnosis rates, and differences in cancer treatment patterns. Including tract-level indicators of rural-urban residence in the NAACCR data files will facilitate research in rural-urban disparities and allow researchers to control for rural-urban differences in model-based analysis of cancer risks and outcomes. Using these codes allows cancer registries to release the area-based measure instead of more sensitive information such as address or long/lat. The measure has been tested for uniqueness and the categories selected/aggregated so that identification of individual level census tracts is not possible as long as county is not known. Therefore, unless the researcher can scientifically defend the need for county, the county identifier will not be released in the same database.</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>1</td><td class='code-desc'>Urban commuting area-RUCA codes 1.0, 1.1, 2.0, 2.1, 3.0, 4.1, 5.1, 7.1, 8.1, and 10.1 </td></tr><tr class='code-row'><td class='code-nbr'>2</td><td class='code-desc'>Not an urban commuting area-all other RUCA codes except 99</td></tr><tr class='code-row'><td class='code-nbr'>9</td><td class='code-desc'>Unknown or not applicable-census tract not available or RUCA code = 99</td></tr><tr class='code-row'><td class='code-nbr' colspan='2'></td></tr></table></div><div class='content chap10-para'><em>Note</em>: This is a derived variable. Currently, the variable is derived during call for data. However, SAS code to derive the variable at the central registry variable for local use is available on the NAACCR website.</div><a name='3300'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>RURALURBAN CONTINUUM 1993</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">3300</td><td style="text-align:center;">2</td><td style="text-align:center;"><a href='#sources'>NAACCR</a></td><td style="text-align:center;">2003</td><td style="text-align:center;">10</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">454 - 455</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>Beale Code<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>ruralurbanContinuum1993</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>The RuralUrban Continuum (1993) codes (usually known as the Beale Codes) separate counties into four metropolitan and six non-metropolitan categories, based on the size their populations and form a classification scheme that distinguishes metropolitan counties by size and non-metropolitan counties by degree of urbanization and proximity to metro areas.<br />
<br />
These codes can be derived electronically, using patients&#8217; state and county at diagnosis, so registrars do not need to provide them. FIPS state and county code mappings to Beale Codes can be obtained in an Excel file at&nbsp;<a target="_blank" href="http://www.ers.usda.gov/data-products/rural-urban-continuum-codes.aspx"><!--[if gte mso 10]> <![endif]-->http://www.ers.usda.gov/data-products/rural-urban-continuum-codes.aspx</a> <!--[if gte mso 10]> <![endif]-->.<br />
<br />
The code is a 10-point continuum, transmitted in standard NAACCR record form with a leading 0, (00-09). Abstractors do not enter these codes. Areas that are not included in the Rural-Urban Continuum code table, such as Canadian provinces/territories and U.S. territories (other than Puerto Rico) will be coded 98. Records for non-residents of the state of the reporting institution (County at DX = 998) also will be coded 98. If Addr at DX--State is XX, YY or ZZ, or if County at DX = 999, the Rural-Urban Continuum will be coded 99. </div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Categorizing counties by population size helps researchers investigate geographic correlates of the burden of cancer in the area of interest. </div><div class='content chap10-para'><strong>Codes&#160;</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'><b>Metropolitan Counties (00-03)</b> </td><td class='code-desc'> </td></tr><tr class='code-row'><td class='code-nbr'>00</td><td class='code-desc'>Central counties of metropolitan areas of 1 million population or more</td></tr><tr class='code-row'><td class='code-nbr'>01</td><td class='code-desc'>Fringe counties of metropolitan areas of 1 million population or more</td></tr><tr class='code-row'><td class='code-nbr'>02</td><td class='code-desc'>Counties in metropolitan areas of 250,000-1,000,000 population</td></tr><tr class='code-row'><td class='code-nbr'>03</td><td class='code-desc'>Counties in metropolitan areas of less than 250,000 population</td></tr><tr class='code-row'><td class='code-nbr' colspan='2'><b>Nonmetropolitan Counties (04-09)</b></td></tr><tr class='code-row'><td class='code-nbr'>04</td><td class='code-desc'>Urban population of 20,000 or more, adjacent to a metropolitan area</td></tr><tr class='code-row'><td class='code-nbr'>05</td><td class='code-desc'>Urban population of 20,000 or more, not adjacent to a metropolitan area</td></tr><tr class='code-row'><td class='code-nbr'>06</td><td class='code-desc'>Urban population of 2,500-19,999, adjacent to a metropolitan area</td></tr><tr class='code-row'><td class='code-nbr'>07</td><td class='code-desc'>Urban population of 2,500-19,999, not adjacent to a metropolitan area</td></tr><tr class='code-row'><td class='code-nbr'>08</td><td class='code-desc'>Completely rural (no places with a population of 2,500 or more) adjacent to a metropolitan area</td></tr><tr class='code-row'><td class='code-nbr'>09</td><td class='code-desc'>Completely rural (no places with a population of 2,500 or more) not adjacent to a metropolitan area</td></tr><tr class='code-row'><td class='code-nbr'>98</td><td class='code-desc'>Program run, but: (1) area is not included in Rural-Urban Continuum code table, or (2) record is for resident outside of state of reporting institution</td></tr><tr class='code-row'><td class='code-nbr'>99</td><td class='code-desc'>Unknown</td></tr><tr class='code-row'><td class='code-nbr'>Blank</td><td class='code-desc'>Program not run; record not coded</td></tr></table></div><a name='3310'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>RURALURBAN CONTINUUM 2003</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">3310</td><td style="text-align:center;">2</td><td style="text-align:center;"><a href='#sources'>NAACCR</a></td><td style="text-align:center;">2003</td><td style="text-align:center;">10</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">456 - 457</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>Beale Code<br />RuralUrban Continuum 2000<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>ruralurbanContinuum2003</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>The RuralUrban Continuum (2003) codes (usually known as the Beale Codes) separate counties into four metropolitan and six non-metropolitan categories, based on the size their populations and form a classification scheme that distinguishes metropolitan counties by size and non-metropolitan counties by degree of urbanization and proximity to metro areas.<br /><br />These codes can be derived electronically, using patients&#8217; state and county at diagnosis, so registrars do not need to provide them. FIPS state and county code mappings to Beale Codes can be obtained in an Excel file at <a target="_blank" href="http://www.ers.usda.gov/data-products/rural-urban-continuum-codes.aspx">http://www.ers.usda.gov/data-products/rural-urban-continuum-codes.aspx</a>.<br /><br />The code is a 9-point continuum, transmitted in standard NAACCR record form with a leading 0, (01-09). Abstractors do not enter these codes.	<br /><br />Areas that are not included in the Rural-Urban Continuum code table, such as Canadian provinces/territories and U.S. territories (other than Puerto Rico) will be coded 98. Records for non-residents of the state of the reporting institution (County at DX = 998) also will be coded 98. If Addr at DX--State is XX, YY or ZZ, or if County at DX = 999, the Rural-Urban Continuum will be coded 99. </div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Categorizing counties by population size helps researchers investigate geographic correlates of the burden of cancer in the area of interest. </div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'><b>Metropolitan Counties (01-03)</b></td><td class='code-desc'> </td></tr><tr class='code-row'><td class='code-nbr'>01</td><td class='code-desc'>Counties in metro areas of 1 million population or more</td></tr><tr class='code-row'><td class='code-nbr'>02</td><td class='code-desc'>Counties in metro areas of 250,000 to 1 million population</td></tr><tr class='code-row'><td class='code-nbr'>03</td><td class='code-desc'>Counties in metro areas of fewer than 250,000 population</td></tr><tr class='code-row'><td class='code-nbr'><b>Non-Metropolitan Counties (04-09)</b></td><td class='code-desc'> </td></tr><tr class='code-row'><td class='code-nbr'>04</td><td class='code-desc'>Urban population of 20,000 or more, adjacent to a metro area</td></tr><tr class='code-row'><td class='code-nbr'>05</td><td class='code-desc'>Urban population of 20,000 or more, not adjacent to a metro area</td></tr><tr class='code-row'><td class='code-nbr'>06</td><td class='code-desc'>Urban population of 2,500 to 19,999, adjacent to a metro area</td></tr><tr class='code-row'><td class='code-nbr'>07</td><td class='code-desc'>Urban population of 2,500 to 19,999, not adjacent to a metro area</td></tr><tr class='code-row'><td class='code-nbr'>08</td><td class='code-desc'>Completely rural or less than 2,500 urban population, adjacent to a metro area</td></tr><tr class='code-row'><td class='code-nbr'>09</td><td class='code-desc'>Completely rural or less than 2,500 urban population, not adjacent to a metro area</td></tr><tr class='code-row'><td class='code-nbr'>98</td><td class='code-desc'>Program run, but: (1) area is not included in Rural-Urban Continuum code table, or (2) record is for resident outside of state of reporting institution</td></tr><tr class='code-row'><td class='code-nbr'>99</td><td class='code-desc'>Unknown</td></tr><tr class='code-row'><td class='code-nbr'>Blank</td><td class='code-desc'>Program not run; record not coded</td></tr></table></div><a name='3312'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>RURALURBAN CONTINUUM 2013</strong></td><td style="text-align:right;font-weight:bold;"><strong>Revised</strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">3312</td><td style="text-align:center;">2</td><td style="text-align:center;"><a href='#sources'>NAACCR</a></td><td style="text-align:center;">2016</td><td style="text-align:center;">16</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">458 - 459</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td title="V: 22: Beale Code&lt;br />
V: 18: 
V: 16: 
" class=" HighlightToolTip">Beale Code<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>ruralurbanContinuum2013</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para mark-changed'>Comment: The RuralUrban Continuum (2013) codes separate counties into four metropolitan and six non-metropolitan categories, based on the size their populations and form a classification scheme that distinguishes metropolitan counties by size and non-metropolitan counties by degree of urbanization and proximity to metro areas.<br /><br />These codes can be derived electronically, using patients&#8217; state and county at diagnosis, so registrars do not need to provide them. FIPS state and county code mappings to Beale Codes can be obtained in an Excel file athttp://www.ers.usda.gov/Data/RuralUrbanContinuumCodes.<br /><br />The code is a 9-point continuum, transmitted in standard NAACCR record form with a leading 0, (01-09). Abstractors do not enter these codes. <br /><br />Areas that are not included in the Rural-Urban Continuum code table, such as Canadian provinces/territories and U.S. territories (other than Puerto Rico) will be coded 98. Records for non-residents of the state of the reporting institution (County at DX = 998) also will be coded 98. If Addr at DX&#8211;State is XX, YY or ZZ, or if County at DX = 999, the Rural-Urban Continuum will be coded 99.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para mark-changed'>Categorizing counties by population size helps researchers investigate geographic correlates of the burden of cancer in the area of interest.</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'><b>Metropolitan Counties (00-03)</b> </td><td class='code-desc'> </td></tr><tr class='code-row'><td class='code-nbr'>01</td><td class='code-desc'>Counties in metro areas of 1 million population or more</td></tr><tr class='code-row'><td class='code-nbr'>02</td><td class='code-desc'>Counties in metro areas of 250,000 to 1 million population</td></tr><tr class='code-row'><td class='code-nbr'>03</td><td class='code-desc'>Counties in metro areas of fewer than 250,000 population</td></tr><tr class='code-row'><td class='code-nbr' colspan='2'><b>Nonmetropolitan Counties (04-09)</b> </td></tr><tr class='code-row'><td class='code-nbr'>04</td><td class='code-desc'>Urban population of 20,000 or more, adjacent to a metro area</td></tr><tr class='code-row'><td class='code-nbr'>05</td><td class='code-desc'>Urban population of 20,000 or more, not adjacent to a metro area</td></tr><tr class='code-row'><td class='code-nbr'>06</td><td class='code-desc'>Urban population of 2,500 to 19,999, adjacent to a metro area</td></tr><tr class='code-row'><td class='code-nbr'>07</td><td class='code-desc'>Urban population of 2,500 to 19,999, not adjacent to a metro area</td></tr><tr class='code-row'><td class='code-nbr'>08</td><td class='code-desc'>Completely rural or less than 2,500 urban population, adjacent to a metro area</td></tr><tr class='code-row'><td class='code-nbr'>09</td><td class='code-desc'>Completely rural or less than 2,500 urban population, not adjacent to a metro area</td></tr><tr class='code-row'><td class='code-nbr'>98</td><td class='code-desc'>Program run, but: (1) area is not included in Rural-Urban Continuum code table, or (2) record is for resident outside of state of reporting institution</td></tr><tr class='code-row'><td class='code-nbr'>99</td><td class='code-desc'>Unknown</td></tr><tr class='code-row'><td class='code-nbr'>Blank</td><td class='code-desc'>Program not run; record not coded</td></tr><tr class='code-row'><td class='code-nbr' colspan='2'></td></tr></table></div><a name='1460'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>RX CODING SYSTEM--CURRENT</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">1460</td><td style="text-align:center;">2</td><td style="text-align:center;"><a href='#sources'>NAACCR</a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">2251 - 2252</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>rxCodingSystemCurrent</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Code describing how treatment for this tumor now is coded.</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>00</td><td class='code-desc'>Treatment data not coded/transmitted (i.e., all treatment fields [items 1200-1450 and 1500-1645] blank)</td></tr><tr class='code-row'><td class='code-nbr'>01</td><td class='code-desc'>Treatment data coded using 1-digit surgery codes (obsolete)</td></tr><tr class='code-row'><td class='code-nbr'>02</td><td class='code-desc'>Treatment data coded according to 1983-1992 SEER manuals and 1983-1995 CoC manuals</td></tr><tr class='code-row'><td class='code-nbr'>03</td><td class='code-desc'>Treatment data coded according to 1996 <i>ROADS Manual</i></td></tr><tr class='code-row'><td class='code-nbr'>04</td><td class='code-desc'>Treatment data coded according to 1998 <i>ROADS</i> Supplement</td></tr><tr class='code-row'><td class='code-nbr'>05</td><td class='code-desc'>Treatment data coded according to 1998 <i>SEER Manual</i></td></tr><tr class='code-row'><td class='code-nbr'>06</td><td class='code-desc'>Treatment data coded according to <i>FORDS</i> manual</td></tr><tr class='code-row'><td class='code-nbr'>07</td><td class='code-desc'>Treatment data coded according to 2010 SEER Coding Manual</td></tr><tr class='code-row'><td class='code-nbr'>08</td><td class='code-desc'>Treatment data coded according to <i>STORE</i> Manual and 2018 SEER Coding Manual</td></tr><tr class='code-row'><td class='code-nbr'>99</td><td class='code-desc'>Other coding, including partial or nonstandard coding</td></tr><tr class='code-row'><td class='code-nbr'></td><td class='code-desc'> </td></tr></table></div><a name='1240'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>RX DATE BRM</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">1240</td><td style="text-align:center;">8</td><td style="text-align:center;"><a href='#sources'>CoC</a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">2194 - 2201</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>Date Immunotherapy Started (CoC)<br />RX Date--BRM<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>rxDateBrm</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'><div>Date of initiation for immunotherapy (a.k.a. biological response modifier) that is part of the first course of treatment. See also RX Summ--BRM [1410]. See Chapter X for date format.<br /><br />Formerly RX Date--BRM.</div></div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>The dates on which different treatment modalities were started are used to evaluate whether the treatments were part of first course of therapy and to reconstruct the sequence of first-course treatment modes. </div><div class='content chap10-para'><em>Note: </em>CoC discontinued support of this item from 2003 through 2009. </div><a name='1241'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>RX DATE BRM FLAG</strong></td><td style="text-align:right;font-weight:bold;"><strong>Revised</strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">1241</td><td style="text-align:center;">2</td><td style="text-align:center;"><a href='#sources'>NAACCR</a></td><td style="text-align:center;">2010</td><td style="text-align:center;">12</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">2202 - 2203</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>RX Date--BRM Flag<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>rxDateBrmFlag</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'><div>This flag explains why no appropriate value is in the field, RX Date BRM [1240]. <br /><br />Formerly RX Date--BRM Flag.</div></div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para mark-changed'>Before Version 12 (through 2009 diagnosis), date fields included codes that provided information other than dates. As part of an initiative to standardize date fields, new fields were introduced to accommodate non-date information that had previously been transmitted in date fields.</div><div class='content chap10-para'><strong>Codes (See Appendix H for the complete Flavors of Null table, which includes the NAACCR codes, HL7 codes and definitions.)</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>10</td><td class='code-desc'>No information whatsoever can be inferred from this exceptional value (e.g, unknown if immunotherapy administered).</td></tr><tr class='code-row'><td class='code-nbr'>11</td><td class='code-desc'>No proper value is applicable in this context (e.g., no immunotherapy administered; autopsy only case).</td></tr><tr class='code-row'><td class='code-nbr'>12</td><td class='code-desc'>A proper value is applicable but not known. This event occurred, but the date is unknown (e.g., immunotherapy administered but date is unknown).</td></tr><tr class='code-row'><td class='code-nbr'>15</td><td class='code-desc'>Information is not available at this time, but it is expected that it will be available later (e.g., immune therapy is planned as part of the first course of therapy, but had not been started at the time of the most recent follow-up).</td></tr><tr class='code-row'><td class='code-nbr'>Blank</td><td class='code-desc'>A valid date value is provided in item RX Date BRM [1240], or the date was not expected to have been transmitted.</td></tr></table></div><div class='content chap10-para'><em>Comment</em>: This is part of the initiative of the transformation from the old NAACCR date standards to interoperable dates.</div><a name='1220'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>RX DATE CHEMO</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">1220</td><td style="text-align:center;">8</td><td style="text-align:center;"><a href='#sources'>CoC</a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">2174 - 2181</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>Date Chemotherapy Started (CoC)<br />RX Date--Chemo<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>rxDateChemo</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'><div>Date of initiation of chemotherapy that is part of the first course of treatment. See also RX Summ--Chemo [1390]. See Chapter X for date format.<br /><br />Formerly RX Date--Chemo. </div></div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>The dates on which different treatment modalities were started are used to evaluate whether the treatments were part of first-course therapy and to reconstruct the sequence of first-course treatment modes. </div><div class='content chap10-para'><em>Note:</em> CoC discontinued support of this item from 2003 through 2009. </div><a name='1221'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>RX DATE CHEMO FLAG</strong></td><td style="text-align:right;font-weight:bold;"><strong>Revised</strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">1221</td><td style="text-align:center;">2</td><td style="text-align:center;"><a href='#sources'>NAACCR</a></td><td style="text-align:center;">2010</td><td style="text-align:center;">12</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">2182 - 2183</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>RX Date--Chemo Flag<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>rxDateChemoFlag</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'><div>This flag explains why no appropriate value is in the field, RX Date Chemo [1220].<br /><br />Formerly RX Date--Chemo Flag </div></div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para mark-changed'>Before Version 12 (through 2009 diagnosis), date fields included codes that provided information other than dates. As part of an initiative to standardize date fields, new fields were introduced to accommodate non-date information that had previously been transmitted in date fields.</div><div class='content chap10-para'><strong>Codes (See Appendix H for the complete Flavors of Null table, which includes the NAACCR codes, HL7 codes and definitions.) </strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>10</td><td class='code-desc'>No information whatsoever can be inferred from this exceptional value (e.g., unknown if chemotherapy administered).</td></tr><tr class='code-row'><td class='code-nbr'>11</td><td class='code-desc'>No proper value is applicable in this context (e.g., no chemotherapy administered; autopsy only case).</td></tr><tr class='code-row'><td class='code-nbr'>12</td><td class='code-desc'>A proper value is applicable but not known. This event occurred, but the date is unknown (e.g., chemotherapy administered but date is unknown).</td></tr><tr class='code-row'><td class='code-nbr'>15</td><td class='code-desc'>Information is not available at this time, but it is expected that it will be available later (e.g., chemotherapy is planned as part of the first course of therapy, but had not been started at the time of the most recent follow-up).</td></tr><tr class='code-row'><td class='code-nbr'>Blank</td><td class='code-desc'>A valid date value is provided in item RX Date Chemo [1220], or the date was not expected to have been transmitted.</td></tr></table></div><div class='content chap10-para'><em>Comment</em>: This is part of the initiative of the transformation from the old NAACCR date standards to interoperable dates.</div><a name='1280'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>RX DATE DX/STG PROC</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">1280</td><td style="text-align:center;">8</td><td style="text-align:center;"><a href='#sources'>CoC</a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">2214 - 2221</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>Date of Non Cancer-Directed Surgery ( CoC)<br />Date of Diagnostic, Staging or Palliative Procedures (1996-2002)<br />Date of Surgical Diagnostic and Staging Procedure (CoC)<br />RX Date--DX/Stg/Pall Proc<br />RX Date--DX/Stg Proc<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>rxDateDxStgProc</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'><div>Records the date on which the surgical diagnostic and/or staging procedure was performed. See Surgical and Diagnostic Staging Procedure [1350]. See Chapter X for date format. </div>  <div>&nbsp;</div>  <div>Formerly RX Date--DX/Stg Proc. </div> </div><div class='content chap10-para'><em>Note:</em> This is a CoC item and for tumors diagnosed from January 1, 1996, through December 31, 2002, this may have been the date on which diagnostic, staging, and palliative procedures were performed. Beginning with tumors diagnosed on or after January 1, 2003, palliative procedures are collected in RX Summ--Palliative Proc [3270] and RX Hosp--Palliative Proc [3280]. </div><a name='1281'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>RX DATE DX/STG PROC FLAG</strong></td><td style="text-align:right;font-weight:bold;"><strong>Revised</strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">1281</td><td style="text-align:center;">2</td><td style="text-align:center;"><a href='#sources'>NAACCR</a></td><td style="text-align:center;">2010</td><td style="text-align:center;">12</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">2222 - 2223</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>RX Date--Dx/Stg Proc Flag<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>rxDateDxStgProcFlag</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para mark-changed'><div>This flag explains why no appropriate value is in the field, RX Date DX/Stg Proc [1280].</div>  <div>&nbsp;</div>  <div>Formerly RX Date--Dx/Stg Proc Flag. </div></div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para mark-changed'>Before Version 12 (through 2009 diagnosis), date fields included codes that provided information other than dates. As part of an initiative to standardize date fields, new fields were introduced to accommodate non-date information that had previously been transmitted in date fields.</div><div class='content chap10-para'><strong>Codes (See Appendix H for the complete Flavors of Null table, which includes the NAACCR codes, HL7 codes and definitions.) </strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>10</td><td class='code-desc'>No information whatsoever can be inferred from this exceptional value (e.g, unknown if any diagnostic or staging procedure performed).</td></tr><tr class='code-row'><td class='code-nbr'>11</td><td class='code-desc'>No proper value is applicable in this context (e.g., no diagnostic or staging procedure performed; autopsy only case).</td></tr><tr class='code-row'><td class='code-nbr'>12</td><td class='code-desc'>A proper value is applicable but not known. This event occurred, but the date is unknown (e.g., diagnostic or staging procedure performed but date is unknown).</td></tr><tr class='code-row'><td class='code-nbr'>Blank</td><td class='code-desc'>A valid date value is provided in item RX Date DX/Stg Proc [1280], or the date was not expected to have been transmitted.</td></tr></table></div><div class='content chap10-para'><em>Comment</em>: This is part of the initiative of the transformation from the old NAACCR date standards to interoperable dates.</div><a name='1230'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>RX DATE HORMONE</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">1230</td><td style="text-align:center;">8</td><td style="text-align:center;"><a href='#sources'>CoC</a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">2184 - 2191</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>Date Hormone Therapy Started (CoC)<br />RX Date--Hormone<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>rxDateHormone</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'><div>Date of initiation for hormone therapy that is part of the first course of treatment. See also RX Summ--Hormone [1400]. See Chapter X for date format.<br /><br />Formerly RX Date--Hormone. </div></div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>The dates on which different treatment modalities were started are used to evaluate whether the treatments were part of first-course therapy and to reconstruct the sequence of first-course treatment modes. </div><div class='content chap10-para'><em>Note:</em> CoC discontinued support of this item from 2003 through 2009. </div><a name='1231'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>RX DATE HORMONE FLAG</strong></td><td style="text-align:right;font-weight:bold;"><strong>Revised</strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">1231</td><td style="text-align:center;">2</td><td style="text-align:center;"><a href='#sources'>NAACCR</a></td><td style="text-align:center;">2010</td><td style="text-align:center;">12</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">2192 - 2193</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>RX Date--Hormone Flag<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>rxDateHormoneFlag</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'><div>This flag explains why no appropriate value is in the field, RX Date Hormone [1230].<br /><br />Formerly RX Date--Hormone Flag. </div></div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para mark-changed'>Before Version 12 (through 2009 diagnosis), date fields included codes that provided information other than dates. As part of an initiative to standardize date fields, new fields were introduced to accommodate non-date information that had previously been transmitted in date fields.</div><div class='content chap10-para'><strong>Codes (See Appendix H for the complete Flavors of Null table, which includes the NAACCR codes, HL7 codes and definitions.) </strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>10</td><td class='code-desc'>No information whatsoever can be inferred from this exceptional value (e.g., unknown if any hormone therapy administered).</td></tr><tr class='code-row'><td class='code-nbr'>11</td><td class='code-desc'>No proper value is applicable in this context (e.g., no hormone therapy administered; autopsy only cases).</td></tr><tr class='code-row'><td class='code-nbr'>12</td><td class='code-desc'>A proper value is applicable but not known. This event occurred, but the date is unknown (e.g., hormone therapy administered but date is unknown).</td></tr><tr class='code-row'><td class='code-nbr'>15</td><td class='code-desc'>Information is not available at this time, but it is expected that it will be available later (e.g., hormone therapy is planned as part of the first course of therapy, but had not been started at the time of the most recent follow-up).</td></tr><tr class='code-row'><td class='code-nbr'>Blank</td><td class='code-desc'>A valid date value is provided in item RX Date Hormone [1230], or the date was not expected to have been transmitted.</td></tr></table></div><div class='content chap10-para'><em>Comment</em>: This is part of the initiative of the transformation from the old NAACCR date standards to interoperable dates.</div><a name='3170'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>RX DATE MST DEFN SRG</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">3170</td><td style="text-align:center;">8</td><td style="text-align:center;"><a href='#sources'>CoC</a></td><td style="text-align:center;">2003</td><td style="text-align:center;">10</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">2124 - 2131</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>Date of Most Definitive Surgical Resection of the Primary Site<br />RX Date--Most Defin Surg<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>rxDateMostDefinSurg</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'><div>Date of most definitive surgical resection of the primary site performed as part of the first course of treatment. See Chapter X for date format. Use RX DATE MST DEFN SRG FLAG [3171] if there is no appropriate or known date for this item. </div>  <div>&nbsp;</div>  <div>Formerly RX Date--Most Defin Surg. </div></div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>This item is used to measure lag time between diagnosis and the most definitive surgery of the primary site or survival following the procedure. It also is used in conjunction with RX Date Surg Disch [3180] to calculate the duration of hospitalization following the most definitive primary site surgical procedure to evaluate treatment efficacy.</div><a name='3171'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>RX DATE MST DEFN SRG FLAG</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">3171</td><td style="text-align:center;">2</td><td style="text-align:center;"><a href='#sources'>NAACCR</a></td><td style="text-align:center;">2010</td><td style="text-align:center;">12</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">2132 - 2133</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>rxDateMostDefinSurgFlag</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'><div>This flag explains why no appropriate value is in the field, RX Date Mst Defn Srg [3170].</div>  <div>&nbsp;</div>  <div>    <br />  </div></div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Before Version 12 (through 2009 diagnosis), date fields included codes that provided information other than dates. As part of an initiative to standardize date fields, new fields were introduced to accommodate non-date information that had previously been transmitted in date fields.</div><div class='content chap10-para'><strong>Codes (See Appendix H for the complete Flavors of Null table, which includes the NAACCR codes, HL7 codes and definitions.)</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>10</td><td class='code-desc'>No information whatsoever can be inferred from this exceptional value. (e.g, unknown if any surgical procedure of the primary site was performed).</td></tr><tr class='code-row'><td class='code-nbr'>11</td><td class='code-desc'>No proper value is applicable in this context (e.g., no surgical resection of the primary site was performed and for cases diagnosed at autopsy).</td></tr><tr class='code-row'><td class='code-nbr'>12</td><td class='code-desc'>A proper value is applicable but not known. This event occurred, but the date is unknown (e.g., surgical procedure of the primary site was performed but the date is unknown).</td></tr><tr class='code-row'><td class='code-nbr'>Blank</td><td class='code-desc'>A valid date value is provided in item RX Date Mst Defn Srg [3170], or the date was not expected to have been transmitted.</td></tr></table></div><div class='content chap10-para'>Comment: This is part of the initiative of the transformation from the old NAACCR date standards to interoperable dates.</div><a name='1250'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>RX DATE OTHER</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">1250</td><td style="text-align:center;">8</td><td style="text-align:center;"><a href='#sources'>CoC</a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">2204 - 2211</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>Date Other Treatment Started (CoC)<br />RX Date--Other<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>rxDateOther</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'><div>Date of initiation for other treatment that is part of the first course of treatment at any facility. See RX Summ--Other [1420]. See Chapter X for date format.<br /><br />Formerly RX Date--Other. </div></div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>The dates on which different treatment modalities were started are used to evaluate whether the treatments were part of first-course therapy and to reconstruct the sequence of first-course treatment modes. </div><a name='1251'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>RX DATE OTHER FLAG</strong></td><td style="text-align:right;font-weight:bold;"><strong>Revised</strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">1251</td><td style="text-align:center;">2</td><td style="text-align:center;"><a href='#sources'>NAACCR</a></td><td style="text-align:center;">2010</td><td style="text-align:center;">12</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">2212 - 2213</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>RX Date--Other Flag<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>rxDateOtherFlag</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'><div>This flag explains why no appropriate value is in the field, RX Date Other [1250].<br /><br />Formerly RX Date--Other Flag. </div></div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para mark-changed'>Before Version 12 (through 2009 diagnosis), date fields included codes that provided information other than dates. As part of an initiative to standardize date fields, new fields were introduced to accommodate non-date information that had previously been transmitted in date fields.</div><div class='content chap10-para'><strong>Codes (See Appendix H for the complete Flavors of Null table, which includes the NAACCR codes, HL7 codes and definitions.) </strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>10</td><td class='code-desc'>No information whatsoever can be inferred from this exceptional value (e.g, unknown if other therapy administered).</td></tr><tr class='code-row'><td class='code-nbr'>11</td><td class='code-desc'>No proper value is applicable in this context (e.g., no other treatment administered; autopsy only case).</td></tr><tr class='code-row'><td class='code-nbr'>12</td><td class='code-desc'>A proper value is applicable but not known. This event occurred, but the date is unknown (e.g., other therapy administered but the date is unknown).</td></tr><tr class='code-row'><td class='code-nbr'>15</td><td class='code-desc'>Information is not available at this time, but it is expected that it will be available later (e.g., other therapy is planned as part of the first course of therapy, but had not been started at the time of the most recent follow-up). </td></tr><tr class='code-row'><td class='code-nbr'>Blank</td><td class='code-desc'>A valid date value is provided in item RX Date Other [1250], or the date was not expected to have been transmitted.</td></tr><tr class='code-row'><td class='code-nbr'></td><td class='code-desc'> </td></tr></table></div><div class='content chap10-para'><em>Comment</em>: This is part of the initiative of the transformation from the old NAACCR date standards to interoperable dates.</div><a name='3220'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>RX DATE RAD ENDED</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">3220</td><td style="text-align:center;">8</td><td style="text-align:center;"><a href='#sources'>CoC</a></td><td style="text-align:center;">2003</td><td style="text-align:center;">10</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">2154 - 2161</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>Date Radiation Ended<br />RX Date--Radiation Ended<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>rxDateRadiationEnded</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'><div>The date on which the patient completes or receives the last radiation treatment at any facility. See Chapter X for date format. Use RX DATE RAD ENDED FLAG [3221] if there is no appropriate or known date for this item. </div>  <div>&nbsp;</div>  <div>Formerly RX Date--Radiation Ended. </div>  </div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>The length of time over which radiation therapy is administered to a patient is a factor in tumor control and treatment morbidity. It is useful in evaluating the quality-of-care and the success of patient support programs designed to maintain continuity of treatment.  </div><a name='3221'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>RX DATE RAD ENDED FLAG</strong></td><td style="text-align:right;font-weight:bold;"><strong>Revised</strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">3221</td><td style="text-align:center;">2</td><td style="text-align:center;"><a href='#sources'>NAACCR</a></td><td style="text-align:center;">2010</td><td style="text-align:center;">12</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">2162 - 2163</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>rxDateRadiationEndedFlag</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para mark-changed'>This flag explains why no appropriate value is in the field, RX Date Rad Ended [3220].</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para mark-changed'>Before Version 12 (through 2009 diagnosis), date fields included codes that provided information other than dates. As part of an initiative to standardize date fields, new fields were introduced to accommodate non-date information that had previously been transmitted in date fields.</div><div class='content chap10-para'><strong>Codes (See Appendix H for the complete Flavors of Null table, which includes the NAACCR codes, HL7 codes and definitions.)</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>10</td><td class='code-desc'>No information whatsoever can be inferred from this exceptional value (e.g., unknown if radiation therapy administered).</td></tr><tr class='code-row'><td class='code-nbr'>11</td><td class='code-desc'>No proper value is applicable in this context (e.g., radiation therapy was not administered; diagnosed at autopsy).</td></tr><tr class='code-row'><td class='code-nbr'>12</td><td class='code-desc'>A proper value is applicable but not known. This event occurred, but the date is unknown (e.g., date radiation ended is unknown).</td></tr><tr class='code-row'><td class='code-nbr'>15</td><td class='code-desc'>Information is not available at this time, but it is expected that it will be available later (e.g., radiation was administered and was ongoing at the time of most recent follow-up).</td></tr><tr class='code-row'><td class='code-nbr'>Blank</td><td class='code-desc'>A valid date value is provided in item RX Date Rad Ended [3220], or the date was not expected to have been transmitted.</td></tr></table></div><div class='content chap10-para'>Comment: This is part of the initiative of the transformation from the old NAACCR date standards to interoperable dates.</div><a name='1210'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>RX DATE RADIATION</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">1210</td><td style="text-align:center;">8</td><td style="text-align:center;"><a href='#sources'>CoC</a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">2144 - 2151</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>Date Radiation Started (CoC)<br />RX Date--Radiation<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>rxDateRadiation</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'><div>Records the date on which radiation therapy began at any facility that is part of the first course of treatment. See Chapter X for date format. Use RX DATE RADIATION FLAG [1211] if there is no appropriate or known date for this item.<br /><br />Formerly RX Date--Radiation </div></div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>The dates on which different treatment modalities were started are used to evaluate whether the treatments were part of first-course therapy and to reconstruct the sequence of first-course treatment modes. </div><a name='1211'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>RX DATE RADIATION FLAG</strong></td><td style="text-align:right;font-weight:bold;"><strong>Revised</strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">1211</td><td style="text-align:center;">2</td><td style="text-align:center;"><a href='#sources'>NAACCR</a></td><td style="text-align:center;">2010</td><td style="text-align:center;">12</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">2152 - 2153</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>RX Date--Radiation Flag<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>rxDateRadiationFlag</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'><div>This flag explains why no appropriate value is in the field, RX Date Radiation [1210].<br /><br />Formerly RX Date--Radiation Flag. </div></div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para mark-changed'>Before Version 12 (through 2009 diagnosis), date fields included codes that provided information other than dates. As part of an initiative to standardize date fields, new fields were introduced to accommodate non-date information that had previously been transmitted in date fields.</div><div class='content chap10-para'><strong>Codes (See Appendix H for the complete Flavors of Null table, which includes the NAACCR codes, HL7 codes and definitions.) </strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>10</td><td class='code-desc'>No information whatsoever can be inferred from this exceptional value (e.g., unknown whether any radiation therapy administered).</td></tr><tr class='code-row'><td class='code-nbr'>11</td><td class='code-desc'>No proper value is applicable in this context (e.g., no radiation therapy administered; autopsy only case).</td></tr><tr class='code-row'><td class='code-nbr'>12</td><td class='code-desc'>A proper value is applicable but not known. This event occurred, but the date is unknown (e.g., radiation therapy administered but date is unknown).</td></tr><tr class='code-row'><td class='code-nbr'>15</td><td class='code-desc'>Information is not available at this time, but it is expected that it will be available later (e.g., radiation therapy is planned as part of the first course of therapy, but had not been started at the time of the most recent follow-up).</td></tr><tr class='code-row'><td class='code-nbr'>Blank</td><td class='code-desc'>A valid date value is provided in item RX Date Radiation [1210], or the date was not expected to have been transmitted.</td></tr></table></div><div class='content chap10-para'><em>Comment</em>: This is part of the initiative of the transformation from the old NAACCR date standards to interoperable dates.</div><a name='3180'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>RX DATE SURG DISCH</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">3180</td><td style="text-align:center;">8</td><td style="text-align:center;"><a href='#sources'>CoC</a></td><td style="text-align:center;">2003</td><td style="text-align:center;">10</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">2134 - 2141</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>Date of Surgical Discharge<br />RX Date--Surgical Disch<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>rxDateSurgicalDisch</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'><div>Records the date the patient was discharged following primary site surgery. The date corresponds to the event recorded in RX Date Mst Defn Srg [3170]. See Chapter X for date format. Use RX DATE SURG DISCH FLAG [3181] if there is no appropriate or known date for this item. </div>  <div>&nbsp;</div>  <div>Formerly RX Date--Surgical Disch. </div> </div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Length of stay is an important quality-of-care and financial measure among hospital administrations, those who fund public and private health care, and public health users. This date, in conjunction with the data item RX Date Mst Defn Srg [3170], will allow for the calculation of a patient&#8217;s length of hospitalization associated with primary site surgery. </div><a name='3181'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>RX DATE SURG DISCH FLAG</strong></td><td style="text-align:right;font-weight:bold;"><strong>Revised</strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">3181</td><td style="text-align:center;">2</td><td style="text-align:center;"><a href='#sources'>NAACCR</a></td><td style="text-align:center;">2010</td><td style="text-align:center;">12</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">2142 - 2143</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>rxDateSurgicalDischFlag</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para mark-changed'>This flag explains why no appropriate value is in the field, RX Date Surg Disch [3180].</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para mark-changed'>Before Version 12 (through 2009 diagnosis), date fields included codes that provided information other than dates. As part of an initiative to standardize date fields, new fields were introduced to accommodate non-date information that had previously been transmitted in date fields.</div><div class='content chap10-para'><strong>Codes (See Appendix H for the complete Flavors of Null table, which includes the NAACCR codes, HL7 codes and definitions.) </strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>10</td><td class='code-desc'>No information whatsoever can be inferred from this exceptional value (e.g., unknown whether surgical treatment was performed).</td></tr><tr class='code-row'><td class='code-nbr'>11</td><td class='code-desc'>No proper value is applicable in this context (e.g., no surgical treatment of the primary site was performed; autopsy only case).</td></tr><tr class='code-row'><td class='code-nbr'>12</td><td class='code-desc'>A proper value is applicable but not known. This event occurred, but the date is unknown (e.g., surgical treatment performed but the date of discharge is unknown).</td></tr><tr class='code-row'><td class='code-nbr'>Blank</td><td class='code-desc'>A valid date value is provided in item RX Date Surg Disch [3180], or the date was not expected to have been transmitted.</td></tr></table></div><div class='content chap10-para'><em>Comment</em>: This is part of the initiative of the transformation from the old NAACCR date standards to interoperable dates.</div><a name='1200'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>RX DATE SURGERY</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">1200</td><td style="text-align:center;">8</td><td style="text-align:center;"><a href='#sources'>CoC</a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">2114 - 2121</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>Date of Cancer-Directed Surgery (CoC)<br />Date of Surgery<br />Date of First Surgical Procedure (CoC)<br />RX Date--Surgery<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>rxDateSurgery</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'><div>Date the first surgery of the type described under Surgery of Primary Site, Scope of Regional Lymph Node Surgery, or Surgery of Other Regional Site(s), Distant Site(s) or Distant Lymph Nodes was performed. See also RX Summ--Surg Prim Site [1290], RX Summ--Scope Reg LN Sur [1292], and RX Summ--Surg Oth Reg/Dis [1294]. See Chapter X for date format. </div>  <div> &nbsp;</div>  <div>Formerly RX Date--Surgery.</div> </div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>The dates on which different treatment modalities were started are used to evaluate whether the treatments were part of first-course therapy and to reconstruct the sequence of first-course treatment modes. </div><a name='1201'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>RX DATE SURGERY FLAG</strong></td><td style="text-align:right;font-weight:bold;"><strong>Revised</strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">1201</td><td style="text-align:center;">2</td><td style="text-align:center;"><a href='#sources'>NAACCR</a></td><td style="text-align:center;">2010</td><td style="text-align:center;">12</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">2122 - 2123</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>RX Date--Surgery Flag<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>rxDateSurgeryFlag</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'><div>This flag explains why no appropriate value is in the field, RX Date Surgery [1200]. <br /><br />Formerly RX Date--Surgery Flag.</div></div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para mark-changed'>Before Version 12 (through 2009 diagnosis), date fields included codes that provided information other than dates. As part of an initiative to standardize date fields, new fields were introduced to accommodate non-date information that had previously been transmitted in date fields.</div><div class='content chap10-para'><strong>Codes (See Appendix H for the complete Flavors of Null table, which includes the NAACCR codes, HL7 codes and definitions.) </strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>10</td><td class='code-desc'>No information whatsoever can be inferred from this exceptional value (e.g., unknown if any surgical procedure site was performed).</td></tr><tr class='code-row'><td class='code-nbr'>11</td><td class='code-desc'>No proper value is applicable in this context (e.g., no surgical procedure was performed; autopsy only case).</td></tr><tr class='code-row'><td class='code-nbr'>12</td><td class='code-desc'>A proper value is applicable but not known. This event occurred, but the date is unknown (e.g., surgery was performed but the date is unknown).</td></tr><tr class='code-row'><td class='code-nbr'>Blank</td><td class='code-desc'>A valid date value is provided in item RX Date Surgery [1200], or the date was not expected to have been transmitted.</td></tr></table></div><div class='content chap10-para'><em>Comment</em>: This is part of the initiative of the transformation from the old NAACCR date standards to interoperable dates.</div><a name='3230'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>RX DATE SYSTEMIC</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">3230</td><td style="text-align:center;">8</td><td style="text-align:center;"><a href='#sources'>CoC</a></td><td style="text-align:center;">2003</td><td style="text-align:center;">10</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">2164 - 2171</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>Date Systemic Therapy Started<br />RX Date--Systemic<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>rxDateSystemic</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'><div>Date of initiation of systemic therapy that is part of the first course of treatment. Systemic therapy includes the administration of chemotherapy agents, hormone agents, biological response modifiers, bone marrow transplants, stem cell harvests, and surgical and/or radiation endocrine therapy. See Chapter X for date format. Use RX DATE SYSTEMIC FLAG [3231] if there is no appropriate or known date for this item. </div>  <div>&nbsp;</div>  <div>Formerly RX Date--Systemic. </div> </div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Collecting dates for each treatment modality allows the sequencing of multiple treatments and aids in the evaluation of time intervals from diagnosis to treatment and from treatment to recurrence. </div><a name='3231'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>RX DATE SYSTEMIC FLAG</strong></td><td style="text-align:right;font-weight:bold;"><strong>Revised</strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">3231</td><td style="text-align:center;">2</td><td style="text-align:center;"><a href='#sources'>NAACCR</a></td><td style="text-align:center;">2010</td><td style="text-align:center;">12</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">2172 - 2173</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>rxDateSystemicFlag</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para mark-changed'>This flag explains why no appropriate value is in the field, RX Date Systemic [3230].</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para mark-changed'>Before Version 12 (through 2009 diagnosis), date fields included codes that provided information other than dates. As part of an initiative to standardize date fields, new fields were introduced to accommodate non-date information that had previously been transmitted in date fields.</div><div class='content chap10-para'><strong>Codes (See Appendix H for the complete Flavors of Null table, which includes the NAACCR codes, HL7 codes and definitions.) </strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>10</td><td class='code-desc'>No information whatsoever can be inferred from this exceptional value (e.g., unknown if systemic therapy was administered).</td></tr><tr class='code-row'><td class='code-nbr'>11</td><td class='code-desc'>No proper value is applicable in this context (e.g., no systemic therapy was administered; autopsy only case).</td></tr><tr class='code-row'><td class='code-nbr'>12</td><td class='code-desc'>A proper value is applicable but not known. This event occurred, but the date is unknown (e.g., systemic therapy administered but date is unknown).</td></tr><tr class='code-row'><td class='code-nbr'>15</td><td class='code-desc'>Information is not available at this time, but it is expected that it will be available later (e.g., systemic therapy is planned as part of the first course of therapy, but had not been started at the time of the most recent follow-up).</td></tr><tr class='code-row'><td class='code-nbr'>Blank</td><td class='code-desc'>A valid date value is provided in item RX Date Systemic [3230], or the date was not expected to have been transmitted.</td></tr></table></div><div class='content chap10-para'><em>Comment</em>: This is part of the initiative of the transformation from the old NAACCR date standards to interoperable dates.</div><a name='665'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>RX HOSP--ASA CLASS</strong></td><td style="text-align:right;font-weight:bold;"><strong>Retired</strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">665</td><td style="text-align:center;"></td><td style="text-align:center;"><a href='#sources'></a></td><td style="text-align:center;">2010</td><td style="text-align:center;">12</td><td style="text-align:center;">2011</td><td style="text-align:center;">12.1</td><td class="cross-out" style="text-align:center;"></td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td></td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td></td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>This new data item was proposed for inclusion in Version 12 but the request was withdrawn prior to implementation of the standard. The data item was retired in Version 12.1, as of January 1, 2011.</div><a name='720'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>RX HOSP--BRM</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">720</td><td style="text-align:center;">2</td><td style="text-align:center;"><a href='#sources'>CoC</a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">806 - 807</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>Immunotherapy at this Facility (CoC)<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>rxHospBrm</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Records whether immunotherapeutic agents (biologic response modifiers) were administered as first-course treatment at this facility or the reason they were not given. Immunotherapy consists of biological or chemical agents that alter the immune system or change the host&#8217;s response to tumor cells. </div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Systemic therapy may involve the administration of one or a combination of agents. This data item allows for the evaluation of immunotherapeutic agents given as part of the first course of therapy. Furthermore, it is useful to know the reason immunotherapy was not administered when evaluating quality of care.<br /><br />If central registries wish to study the treatment given at particular facilities, the facility-level treatment fields must be used. The summary treatment fields, conversely, combine information for all facilities that provide first course of treatment for the tumor. Facility-specific fields allow studies of detailed referral patterns and treatment by type of healthcare setting. Knowing what part of the treatment was given at a particular facility also helps resolve consolidation issues. </div><div class='content chap10-para'><em>Note</em>: Prior to 2013, targeted therapies that invoke an immune response, such as Herceptin, had been coded as chemotherapy. Effective with cases diagnosed January 1, 2013, and forward these therapies are classified as biological response modifiers. Coding instructions for these changes have been added to the remarks field for the applicable drugs in the SEER*RX Interactive Drug Database (


<a target="_blank" href="http://seer.cancer.gov/tools/seerrx/">http://seer.cancer.gov/tools/seerrx/</a>). </div><div class='content chap10-para'><strong>Codes (Refer to the most recent <em>STORE </em>and SEER Rx for complete coding instructions.) </strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>00</td><td class='code-desc'>None, immunotherapy was not part of the planned first course of therapy; not customary therapy for this cancer. Diagnosed at autopsy.</td></tr><tr class='code-row'><td class='code-nbr'>01</td><td class='code-desc'>Immunotherapy administered as first course therapy.</td></tr><tr class='code-row'><td class='code-nbr'>82</td><td class='code-desc'>Immunotherapy was not recommended/administered because it was contraindicated due to patient risk factors (comorbid conditions, advanced age, etc.) or there was progression of disease prior to administration.</td></tr><tr class='code-row'><td class='code-nbr'>85</td><td class='code-desc'>Immunotherapy was not administered because the patient died prior to planned or recommended therapy.</td></tr><tr class='code-row'><td class='code-nbr'>86</td><td class='code-desc'>Immunotherapy was not administered. It was recommended by the patient's physician but was not administered as part of the first-course of therapy. No reason was noted in the patient record.</td></tr><tr class='code-row'><td class='code-nbr'>87</td><td class='code-desc'>Immunotherapy was not administered. It was recommended by the patient's physician but was refused by the patient or the patient's family or guardian. The refusal was noted in the patient record.</td></tr><tr class='code-row'><td class='code-nbr'>88</td><td class='code-desc'>Immunotherapy was recommended, but it is unknown if it was administered.</td></tr><tr class='code-row'><td class='code-nbr'>99</td><td class='code-desc'>It is unknown if immunotherapy was recommended or administered because it was not stated in the patient record. Death certificate-only case.</td></tr></table></div><div class='content chap10-para'><em>Note: </em>For tumors diagnosed on or after January 1, 2003,  information on bone marrow and stem cell transplants is no longer coded  under this item.<em> ROADS </em>codes 02-06 should not be used in this  field. For diagnosed on or after January 1, 2003, this information  should be coded in the new field RX SUMM--Transplnt/Endocr [3250].</div><a name='700'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>RX HOSP--CHEMO</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">700</td><td style="text-align:center;">2</td><td style="text-align:center;"><a href='#sources'>CoC</a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">802 - 803</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>Chemotherapy at this Facility (CoC)<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>rxHospChemo</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Records the type of chemotherapy administered at the reporting facility as a part of first course therapy or the reason chemotherapy was not given. </div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Systemic therapy may involve the administration of one or a combination of agents. This data item allows for the evaluation of chemotherapeutic agents given as part of the first course of therapy. Furthermore, it is useful to know the reason chemotherapy was not administered when evaluating quality of care. <br /><br />If central registries wish to study the treatment given at particular facilities, the facility-level treatment fields must be used. The summary treatment fields, conversely, combine information for all facilities that provide first course of treatment for the tumor. Facility-specific fields allow studies of detailed referral patterns and treatment by type of healthcare setting. Knowing what part of the treatment was given at a particular facility also helps resolve consolidation issues. </div><div class='content chap10-para'><em>Note</em>: Prior to 2013, targeted therapies that invoke an immune response, such as Herceptin, had been coded as chemotherapy. Effective with cases diagnosed January 1, 2013, and forward these therapies are classified as biological response modifiers. Coding instructions for these changes have been added to the remarks field for the applicable drugs in the SEER*RX Interactive Drug Database (

<a target="_blank" href="http://seer.cancer.gov/tools/seerrx/">http://seer.cancer.gov/tools/seerrx/</a>). </div><div class='content chap10-para'><strong>Codes (Refer to the most recent <em>STORE </em>and SEER RX for additional complete coding directions.) </strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>00</td><td class='code-desc'>None, chemotherapy was not part of the first course of therapy or there was progression of disease prior to administration; Not customary therapy for this cancer. Diagnosed at autopsy.</td></tr><tr class='code-row'><td class='code-nbr'>01</td><td class='code-desc'>Chemotherapy was administered, but type and number of agents is not documented in patient record.</td></tr><tr class='code-row'><td class='code-nbr'>02</td><td class='code-desc'>Chemotherapy, single agent.</td></tr><tr class='code-row'><td class='code-nbr'>03</td><td class='code-desc'>Chemotherapy, multiple agents.</td></tr><tr class='code-row'><td class='code-nbr'>82</td><td class='code-desc'>Chemotherapy was not recommended/administered because it was contraindicated due to patient risk factors (comorbid conditions, advanced age) or there was progression of disease prior to planned administration.</td></tr><tr class='code-row'><td class='code-nbr'>85</td><td class='code-desc'>Chemotherapy was not administered because the patient died prior to planned or recommended therapy.</td></tr><tr class='code-row'><td class='code-nbr'>86</td><td class='code-desc'>Chemotherapy was recommended by the patient's physician, but was not administered as part of first-course therapy. No reason was stated in the patient record.</td></tr><tr class='code-row'><td class='code-nbr'>87</td><td class='code-desc'>Chemotherapy was not administered; it was recommended by the patient's physician, but this treatment was refused by the patient, the patient's family member, or the patient's guardian. The refusal was noted in the patient record.</td></tr><tr class='code-row'><td class='code-nbr'>88</td><td class='code-desc'>Chemotherapy was recommended, but it is unknown if it was administered.</td></tr><tr class='code-row'><td class='code-nbr'>99</td><td class='code-desc'>It is unknown whether chemotherapy was recommended or administered because it is not stated in patient record. Death certificate-only case</td></tr></table></div><a name='740'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>RX HOSP--DX/STG PROC</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">740</td><td style="text-align:center;">2</td><td style="text-align:center;"><a href='#sources'>CoC</a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">809 - 810</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>Non Cancer-Directed Surgery at this Facility (CoC)<br />Surgical Diagnostic & Staging Procedure at this Facility (1996-2002)<br />RX Hosp--DX/Stg/Pall Proc<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>rxHospDxStgProc</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Identifies the surgical procedure(s) performed in an effort to diagnose and/or stage disease at this facility. </div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>This data item is used to track the use of surgical procedure resources that are not considered treatment.<br /><br />If central registries wish to study the procedures performed at particular facilities, the facility-level fields must be used. The summary fields, conversely, combine information for all facilities that provide first course of treatment for the tumor. Facility-specific fields allow studies of detailed referral patterns and diagnostic/staging procedures by type of healthcare setting. Knowing what part of the diagnostic or staging process was performed at a particular facility also helps resolve consolidation issues. </div><div class='content chap10-para'><strong>Codes (Refer to the most recent version  of <em>STORE </em>for additional instructions.) </strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>00</td><td class='code-desc'>No surgical diagnostic or staging procedure was performed.</td></tr><tr class='code-row'><td class='code-nbr'>01</td><td class='code-desc'>A biopsy (incisional, needle, or aspiration) was done to a site other than the primary site. No exploratory procedure was done.</td></tr><tr class='code-row'><td class='code-nbr'>02</td><td class='code-desc'>A biopsy (incisional, needle, or aspiration) was done of the primary site or biopsy of a lymph node was done to diagnose or stage lymphoma.</td></tr><tr class='code-row'><td class='code-nbr'>03</td><td class='code-desc'>A surgical exploration only. The patient was not biopsied or treated during the procedure.</td></tr><tr class='code-row'><td class='code-nbr'>04</td><td class='code-desc'>A surgical procedure with a bypass was performed, but no biopsy was done.</td></tr><tr class='code-row'><td class='code-nbr'>05</td><td class='code-desc'>An exploratory procedure was performed, and a biopsy of either the primary site or another site was done.</td></tr><tr class='code-row'><td class='code-nbr'>06</td><td class='code-desc'>A bypass procedure was performed, and a biopsy of either the primary site or another site was done.</td></tr><tr class='code-row'><td class='code-nbr'>07</td><td class='code-desc'>A procedure was done, but the type of procedure is unknown.</td></tr><tr class='code-row'><td class='code-nbr'>09</td><td class='code-desc'>No information about whether a diagnostic or staging procedure was performed.</td></tr></table></div><div class='content chap10-para'><em>Note</em>: This item has been used for tumors diagnosed in 1996 and  later. For cases diagnosed before 1996, this item may have been  converted from the <em>DAM</em>, and cases with surgery would have been  converted to 09 in this field. For cases diagnosed between 1996 and  2002, this field may have described palliative care according to coding  rules in<em> ROADS</em>. For tumors diagnosed on or after January 1, 2003, palliative care is coded in a new field RX Hosp--Palliative Proc [3280].</div><a name='710'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>RX HOSP--HORMONE</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">710</td><td style="text-align:center;">2</td><td style="text-align:center;"><a href='#sources'>CoC</a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">804 - 805</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>Hormone Therapy at this Facility (CoC)<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>rxHospHormone</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Records whether systemic hormonal agents were administered as first-course treatment at this facility or the reason they were not given. Hormone therapy consists of a group of drugs that may affect the long-term control of a cancer&#8217;s growth. It is not usually used as a curative measure. </div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Systemic therapy may involve the administration of one or a combination of agents. This data item allows for the evaluation of hormonal agents given as part of the first course of therapy. Furthermore, it is useful to know the reason hormone therapy was not administered when evaluating quality of care for certain tumors. <br /><br />If central registries wish to study the treatment given at particular facilities, the facility-level  treatment fields must be used. The summary treatment fields, conversely, combine information for all reporting facilities that provide first course of treatment for the tumor. Facility-specific fields allow studies of detailed referral patterns and treatment by type of healthcare setting. Knowing what part of the treatment was given at a particular facility also helps resolve consolidation issues. </div><div class='content chap10-para'><strong>Codes (Refer to the most recent version  of <em>STORE</em> for additional instructions.) </strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>00</td><td class='code-desc'>None, hormone therapy was not part of the planned first course of therapy. Diagnosed at autopsy.</td></tr><tr class='code-row'><td class='code-nbr'>01</td><td class='code-desc'>Hormone therapy was administered as first course therapy.</td></tr><tr class='code-row'><td class='code-nbr'>82</td><td class='code-desc'>Hormone therapy was not recommended/administered because it was contraindicated due to patient risk factors (comorbid conditions, advanced age) or there was progression of disease prior to administration.</td></tr><tr class='code-row'><td class='code-nbr'>85</td><td class='code-desc'>Hormone therapy was not administered because the patient died prior to planned or recommended therapy.</td></tr><tr class='code-row'><td class='code-nbr'>86</td><td class='code-desc'>Hormone therapy was not administered. It was recommended by the patient's physician, but was not administered as part of first-course therapy. No reason was stated in the patient record.</td></tr><tr class='code-row'><td class='code-nbr'>87</td><td class='code-desc'>Hormone therapy was not administered. It was recommended by the patient's physician, but was refused by the patient, or the patient's family member or guardian. The refusal was noted in the patient record.</td></tr><tr class='code-row'><td class='code-nbr'>88</td><td class='code-desc'>Hormone therapy was recommended, but it is unknown if it was administered.</td></tr><tr class='code-row'><td class='code-nbr'>99</td><td class='code-desc'>It is unknown whether hormone therapy was recommended or administered because it is not stated in the patient record; death certificate-only cases.</td></tr></table></div><div class='content chap10-para'><em>Note</em>: Codes 02-03 entered under the<em> ROADS </em>rules for tumors  diagnosed prior to January 1, 2003, should have been converted to the  appropriate code in the new field RX SUMM--Transplnt/Endocr [3250]  implemented with <em>FORDS</em>. Endocrine surgery and endocrine radiation  therapy are no longer coded as Hormone Therapy for tumors diagnosed on  or after January 1, 2003.</div><a name='730'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>RX HOSP--OTHER</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">730</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>CoC</a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">808 - 808</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>Other Treatment at this Facility (CoC)<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>rxHospOther</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Identifies treatment given at this facility that cannot be defined as surgery, radiation, or systemic therapy according to the defined data items in this manual. Treatment for reportable hematopoietic diseases can be supportive care, observation, or any treatment that does not meet the usual definition in which treatment modifies, controls, removes, or destroys proliferating cancer tissue. Supportive care such as phlebotomy, transfusions, or aspirin may be recorded for hematopoietic diseases ONLY. </div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Information on other therapy is used to describe treatment practices and evaluate quality of care. If central registries wish to study the treatment given at particular facilities, the facility-level treatment fields must be used. The summary treatment fields, conversely, combine information for all reporting facilities that provide first course of treatment for the tumor. Facility-specific fields allow studies of detailed referral patterns and treatment by type of healthcare setting. Knowing what part of the treatment was given at a particular facility also helps resolve consolidation issues. </div><div class='content chap10-para'><strong>Codes </strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>0</td><td class='code-desc'>None; all cancer treatment was coded in other treatment fields. Patient received no cancer treatment. Diagnosed at autopsy.</td></tr><tr class='code-row'><td class='code-nbr'>1</td><td class='code-desc'>Cancer treatment that cannot be assigned to specified treatment data items.</td></tr><tr class='code-row'><td class='code-nbr'>2</td><td class='code-desc'>Other-Experimental; this code is not defined. It may be used to record participation in institution-based clinical trials.</td></tr><tr class='code-row'><td class='code-nbr'>3</td><td class='code-desc'>Patient is involved in a double-blind clinical trial. Code the treatment actually administered when the double-blind trial code is broken.</td></tr><tr class='code-row'><td class='code-nbr'>6</td><td class='code-desc'>Other unproven; Cancer treatments administered by nonmedical personnel.</td></tr><tr class='code-row'><td class='code-nbr'>7</td><td class='code-desc'>Refusal; other treatment was not administered. Treatment listed in code 1, 2 or 3 was recommended by the patient's physician but was refused by the patient or the patient's family or guardian. The refusal was noted in the patient record.</td></tr><tr class='code-row'><td class='code-nbr'>8</td><td class='code-desc'>Recommended, unknown if administered; other treatment was recommended, but it is unknown whether it was administered.</td></tr><tr class='code-row'><td class='code-nbr'>9</td><td class='code-desc'>It is unknown whether other treatment was recommended or administered because it is not stated in the patient record. Death certificate only case.</td></tr></table></div><a name='3280'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>RX HOSP--PALLIATIVE PROC</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">3280</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>CoC</a></td><td style="text-align:center;">2003</td><td style="text-align:center;">10</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">811 - 811</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>Palliative Care at this Facility<br />Palliative Procedure at this Facility<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>rxHospPalliativeProc</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Identifies care provided at the reporting facility in an effort to palliate or alleviate symptoms. Palliative procedures may include surgery, radiation therapy, systemic therapy (chemotherapy, hormone therapy, or other systemic drugs), and/or pain management. </div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>This data item allows reporting facilities to track care that is considered palliative rather than diagnostic or curative in intent.  If central registries wish to study types of palliative care given at particular facilities, the facility-level fields must be used. Facility-specific fields allow studies of detailed referral patterns and treatment by type of healthcare setting. Knowing what palliative procedures and care was performed at a particular facility also helps resolve consolidation issues. </div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>0</td><td class='code-desc'>No palliative care provided. Diagnosed at autopsy</td></tr><tr class='code-row'><td class='code-nbr'>1</td><td class='code-desc'>Surgery (which may involve a bypass procedure) performed to alleviate symptoms, but no attempt to diagnose, stage, or treat the tumor is made.</td></tr><tr class='code-row'><td class='code-nbr'>2</td><td class='code-desc'>Radiation therapy given to alleviate symptoms, but no attempt to produce cure is made.</td></tr><tr class='code-row'><td class='code-nbr'>3</td><td class='code-desc'>Chemotherapy, hormone therapy, or other systemic drugs given to alleviate symptoms without curative intent.</td></tr><tr class='code-row'><td class='code-nbr'>4</td><td class='code-desc'>Patient received or was referred for pain management only.</td></tr><tr class='code-row'><td class='code-nbr'>5</td><td class='code-desc'>Any combination of codes 1, 2, and/or 3 <u>without</u> code 4.</td></tr><tr class='code-row'><td class='code-nbr'>6</td><td class='code-desc'>Any combination of codes 1, 2, and/or 3 <u>with</u> code 4.</td></tr><tr class='code-row'><td class='code-nbr'>7</td><td class='code-desc'>Palliative care was performed or recommended, but no information on the type of procedure is available in the patient record.</td></tr><tr class='code-row'><td class='code-nbr'>9</td><td class='code-desc'>Unknown if palliative care was performed or recommended. Not stated in patient record.</td></tr></table></div><a name='690'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>RX HOSP--RADIATION</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">690</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>SEER</a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">801 - 801</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>Radiation at this Facility (CoC)<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>rxHospRadiation</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Defines the type of radiation therapy the patient received at the reporting facility as a part of the first course of treatment.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>If central registries wish to study the treatment given at particular facilities, the facility-level treatment fields must be used. The summary treatment fields, conversely, combine information for all facilities that provide first course of treatment for the tumor. Facility-specific fields allow studies of detailed referral patterns and treatment by type of healthcare setting. Knowing what part of the treatment was given at a particular facility also helps resolve consolidation issues.</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>0</td><td class='code-desc'>None</td></tr><tr class='code-row'><td class='code-nbr'>1</td><td class='code-desc'>Beam radiation</td></tr><tr class='code-row'><td class='code-nbr'>2</td><td class='code-desc'>Radioactive implants</td></tr><tr class='code-row'><td class='code-nbr'>3</td><td class='code-desc'>Radioisotopes</td></tr><tr class='code-row'><td class='code-nbr'>4</td><td class='code-desc'>Combination of 1 with 2 or 3</td></tr><tr class='code-row'><td class='code-nbr'>5</td><td class='code-desc'>Radiation, NOS-method or source not specified</td></tr><tr class='code-row'><td class='code-nbr'>9</td><td class='code-desc'>Unknown if radiation therapy administered</td></tr></table></div><div class='content chap10-para'><em>Note</em>: CoC no longer requires this item effective January 1, 2002.  SEER continues to support it as a historically collected and currently  transmitted data item.</div><a name='676'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>RX HOSP--REG LN REMOVED</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">676</td><td style="text-align:center;">2</td><td style="text-align:center;"><a href='#sources'>CoC</a></td><td style="text-align:center;">1997</td><td style="text-align:center;">5.1</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">799 - 800</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>RX Hosp--Reg LN Examined<br />Number of Regional Lymph Nodes Examined at This Facility (CoC)<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>rxHospRegLnRemoved</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Describes number of regional lymph nodes removed at the reporting facility as part of the first course of treatment. </div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>If central registries wish to study the treatment given at particular facilities, the facility-level treatment fields must be used. The summary treatment fields, conversely, combine information for all reporting facilities that provide first course of treatment for the tumor. Facility-specific fields allow studies of detailed referral patterns and treatment by type of healthcare setting. Knowing the extent of treatment given at a particular facility also helps resolve consolidation issues. </div><div class='content chap10-para'><strong>Codes (Refer to ROADS for additional coding instructions.) </strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>00</td><td class='code-desc'>No regional lymph nodes removed</td></tr><tr class='code-row'><td class='code-nbr'>01</td><td class='code-desc'>One regional lymph node removed</td></tr><tr class='code-row'><td class='code-nbr'>02</td><td class='code-desc'>Two regional lymph nodes removed</td></tr><tr class='code-row'><td class='code-nbr' colspan='2'>..</td></tr><tr class='code-row'><td class='code-nbr' colspan='2'>..</td></tr><tr class='code-row'><td class='code-nbr'>90</td><td class='code-desc'>Ninety or more regional lymph nodes removed</td></tr><tr class='code-row'><td class='code-nbr'>95</td><td class='code-desc'>No regional lymph node(s) removed, but aspiration of regional lymph node(s) was performed</td></tr><tr class='code-row'><td class='code-nbr'>96</td><td class='code-desc'>Regional lymph node removal documented as a sampling and number of lymph nodes unknown/not stated</td></tr><tr class='code-row'><td class='code-nbr'>97</td><td class='code-desc'>Regional lymph node removal documented as a dissection and number of lymph nodes unknown/not stated</td></tr><tr class='code-row'><td class='code-nbr'>98</td><td class='code-desc'>Regional lymph nodes surgically removed, but number of lymph nodes unknown/not stated and not documented as sampling or dissection</td></tr><tr class='code-row'><td class='code-nbr'>99</td><td class='code-desc'>Unknown; not stated; death certificate-only</td></tr></table></div><div class='content chap10-para'><em>Note:</em> As of January 1, 2003, this data item is no longer required  or recommended by CoC. However, the item was collected in the past and  it is recommended that historic data be retained.</div><a name='747'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>RX HOSP--SCOPE REG 98-02</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">747</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>CoC</a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">814 - 814</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>Scope of Regional Lymph Node Surgery at this Facility (CoC)<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>rxHospScopeReg9802</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Describes the removal, biopsy, or aspiration of regional lymph node(s) at the time of surgery of the primary site or during a separate surgical event at the reporting facility. This field is to be used for <em>ROADS</em> codes after the <em>ROADS</em> to <em>FORDS</em> conversion. It is also to be used to code Scope of Regional Lymph Node Surgery at the reporting facility for all tumors diagnosed before January 1, 2003. </div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>In evaluating quality of care and treatment practices it is important to identify the removal, biopsy, or aspiration of regional lymph node(s) at the time of surgery of the primary site or during a separate surgical event.<br /><br />If central registries wish to study the treatment given at particular reporting facilities, the facility-level treatment fields must be used. The summary treatment fields, conversely, combine information across all reporting facilities that provide first course of treatment for the tumor. Reporting facility-specific fields allow studies of detailed referral patterns and treatment by type of hospital. Knowing the extent of treatment given at a particular reporting facility also helps resolve coding issues. </div><div class='content chap10-para'><strong>Codes (See the CoC <em>ROADS Manual 1998 Supplement</em> and the <em>SEER Program Code Manual</em> for site-specific codes.</strong></div><a name='672'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>RX HOSP--SCOPE REG LN SUR</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">672</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>CoC</a></td><td style="text-align:center;">1997</td><td style="text-align:center;">5.1</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">797 - 797</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>Scope of Regional Lymph Node Surgery at this Facility (CoC)<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>rxHospScopeRegLnSur</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Describes the removal, biopsy, or aspiration of regional lymph node(s) performed at the reporting facility for diagnosis and/or staging or as a part of the first course of therapy. </div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>This item is important for evaluating quality of care and treatment practices relating to initial diagnosis, staging and/or first course of therapy.  If central registries wish to study the treatment given at particular  facilities, the facility-level treatment fields must be used. The summary treatment fields, conversely, combine information for all reporting facilities that provide first course of treatment for the tumor. Facility-specific fields allow studies of detailed referral patterns and treatment by type of healthcare setting. Knowing the extent of treatment given at a particular facility also helps resolve consolidation issues. If central registries wish to study the treatment given at particular reporting facilities, the reporting facility-level treatment fields must be used. The summary treatment fields, conversely, combine information across all reporting facilities that provide first course of treatment for the tumor. Reporting facility-specific fields allow studies of detailed referral patterns and treatment by type of reporting facility. Knowing the extent of treatment given at a particular reporting facility also helps resolve coding issues. </div><div class='content chap10-para'><strong>Codes (Refer to the most recent version  of <em>STORE</em> for instructions that should be applied to all surgically treated cases for all types of cancers.) </strong>The treatment of breast and skin cancers are where the distinction between sentinel lymph node biopsies (SLNBx) and more extensive dissection of regional lymph nodes is most frequently encountered. For all other sites, non-sentinel regional node dissections are typical, and codes 2, 6 and 7 are infrequently used.</div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>0</td><td class='code-desc'>No regional lymph nodes removed. No lymph nodes found in the pathologic specimen. Diagnosed at autopsy.</td></tr><tr class='code-row'><td class='code-nbr'>1</td><td class='code-desc'>Biopsy or aspiration of regional lymph node, NOS.</td></tr><tr class='code-row'><td class='code-nbr'>2</td><td class='code-desc'>Sentinel lymph node biopsy.</td></tr><tr class='code-row'><td class='code-nbr'>3</td><td class='code-desc'>Regional lymph node(s) removed and the number of nodes removed is unknown or not stated; the procedure is not specified as sentinel node biopsy. Regional lymph nodes removed, NOS.</td></tr><tr class='code-row'><td class='code-nbr'>4</td><td class='code-desc'>1 to 3 regional lymph nodes removed.</td></tr><tr class='code-row'><td class='code-nbr'>5</td><td class='code-desc'>4 or more regional lymph nodes removed.</td></tr><tr class='code-row'><td class='code-nbr'>6</td><td class='code-desc'>Sentinel node biopsy and code 3, 4, or 5 at same time or timing not stated.</td></tr><tr class='code-row'><td class='code-nbr'>7</td><td class='code-desc'>Sentinel node biopsy and code 3, 4, or 5 at different times.</td></tr><tr class='code-row'><td class='code-nbr'>9</td><td class='code-desc'>Unknown or not applicable. It is unknown whether regional lymph node surgery was performed. Death certificate only case; unknown or ill-defined primary site; hematopoietic, reticuloendothelial, ummunoproliferative or  myeloproliferative disease.</td></tr></table></div><div class='content chap10-para'><em>Note:</em> One important use of registry data is the tracking of  treatment patterns over time. To compare contemporary treatment to previously published treatment based  on former codes, or to data unmodified from pre-1998 definitions, the  ability to differentiate surgeries in which four or more regional lymph  nodes are removed is desirable. However, it is very important to note  that the distinction between codes 4 and 5 is made to permit comparison  of current surgical procedures with procedures coded in the past when  the removal of fewer than 4 nodes was not reflected in surgery codes. It  is not intended to reflect clinical significance when applied to a  particular surgical procedure. It is important to avoid inferring, by  data presentation or other methods, that one category is preferable to  another within the intent of these items.</div><a name='742'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>RX HOSP--SCREEN/BX PROC1</strong></td><td style="text-align:right;font-weight:bold;"><strong>Retired</strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">742</td><td style="text-align:center;"></td><td style="text-align:center;"><a href='#sources'></a></td><td style="text-align:center;">1997</td><td style="text-align:center;">5</td><td style="text-align:center;">2006</td><td style="text-align:center;">11</td><td class="cross-out" style="text-align:center;"></td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td></td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td></td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>The NAACCR UDSC retired this data item in Version 11, as of January 1, 2006.</div><a name='743'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>RX HOSP--SCREEN/BX PROC2</strong></td><td style="text-align:right;font-weight:bold;"><strong>Retired</strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">743</td><td style="text-align:center;"></td><td style="text-align:center;"><a href='#sources'></a></td><td style="text-align:center;">1997</td><td style="text-align:center;">5.1</td><td style="text-align:center;">2006</td><td style="text-align:center;">11</td><td class="cross-out" style="text-align:center;"></td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td></td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td></td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>The NAACCR UDSC retired this data item in Version 11, as of January 1, 2006.</div><a name='744'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>RX HOSP--SCREEN/BX PROC3</strong></td><td style="text-align:right;font-weight:bold;"><strong>Retired</strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">744</td><td style="text-align:center;"></td><td style="text-align:center;"><a href='#sources'></a></td><td style="text-align:center;">1997</td><td style="text-align:center;">5.1</td><td style="text-align:center;">2006</td><td style="text-align:center;">11</td><td class="cross-out" style="text-align:center;"></td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td></td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td></td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>The NAACCR UDSC retired this data item in Version 11, as of January 1, 2006.</div><a name='745'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>RX HOSP--SCREEN/BX PROC4</strong></td><td style="text-align:right;font-weight:bold;"><strong>Retired</strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">745</td><td style="text-align:center;"></td><td style="text-align:center;"><a href='#sources'></a></td><td style="text-align:center;">1997</td><td style="text-align:center;">5.1</td><td style="text-align:center;">2006</td><td style="text-align:center;">11</td><td class="cross-out" style="text-align:center;"></td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td></td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td></td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>The NAACCR UDSC retired this data item in Version 11, as of January 1, 2006.</div><a name='668'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>RX HOSP--SURG APP 2010</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">668</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>CoC</a></td><td style="text-align:center;">2010</td><td style="text-align:center;">12</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">794 - 794</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>rxHospSurgApp2010</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>This item is used to describe the   method of surgical approach used for patients undergoing surgery of the primary site at the reporting facility. If the patient has multiple surgeries to the primary site, this item describes the approach used for the most invasive, definitive surgery </div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>This item is used to monitor patterns and trends in the adoption and use of minimally-invasive surgical techniques.<br /><br />If central registries wish to study the treatment given at particular facilities, the facility-level treatment fields must be used. Facility-specific fields allow studies of detailed referral patterns and treatment by type of healthcare setting. Knowing the extent of treatment given at a particular facility also helps resolve consolidation issues. </div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>0</td><td class='code-desc'>No surgical procedure of primary site at this facility. Diagnosed at autopsy.</td></tr><tr class='code-row'><td class='code-nbr'>1</td><td class='code-desc'>Robotic assisted.</td></tr><tr class='code-row'><td class='code-nbr'>2</td><td class='code-desc'>Robotic converted to open.</td></tr><tr class='code-row'><td class='code-nbr'>3</td><td class='code-desc'>Endoscopic or laparoscopic.</td></tr><tr class='code-row'><td class='code-nbr'>4</td><td class='code-desc'>Endoscopic or laparoscopic converted to open.</td></tr><tr class='code-row'><td class='code-nbr'>5</td><td class='code-desc'>Open. Approach not specified.</td></tr><tr class='code-row'><td class='code-nbr'>9</td><td class='code-desc'>Unknown whether surgery was performed; Patient record does not state whether a surgical procedure of the primary site was performed and no information is available. Death certificate only.</td></tr></table></div><a name='748'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>RX HOSP--SURG OTH 98-02</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">748</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>CoC</a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">815 - 815</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>Surgery of Other Regional Site(s), Distant Site(s), or Distant Lymph Node(s) at this Facility (CoC)<br />Surgical Procedure/Other Site at this Facility<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>rxHospSurgOth9802</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Records the surgical removal of distant lymph nodes or other tissue(s)/organ(s) beyond the primary site at this facility. This field is to be used for <em>ROADS</em> codes after the <em>ROADS</em> to <em>FORDS</em> conversion. It is also to be used to code Surgery Other Regional/Distant Sites at the reporting facility for all tumors diagnosed before January 1, 2003. </div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>The removal of non-primary tissue documents the extent of surgical treatment and is useful in evaluating the extent of metastatic involvement. <br /><br />If central registries wish to study the treatment given at particular facilities, the facility-level treatment fields must be used. The summary treatment fields, conversely, combine information for all reporting facilities that provide first course of treatment for the tumor. Facility-specific fields allow studies of detailed referral patterns and treatment by type of healthcare setting. Knowing what part of the treatment was given at a particular facility also helps resolve consolidation issues. </div><div class='content chap10-para'><strong>Codes (See the CoC <em>ROADS Manual</em> 1998 Supplement and the SEER Program Code Manual for site-specific codes.) </strong></div><a name='674'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>RX HOSP--SURG OTH REG/DIS</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">674</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>CoC</a></td><td style="text-align:center;">1997</td><td style="text-align:center;">5.1</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">798 - 798</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>Surgery of Other Regional Site(s), Distant Site(s), or Distant Lymph Node(s) at this Facility (CoC)<br />Surgical Procedure/Other Site at this Facility<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>rxHospSurgOthRegDis</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Records the surgical removal of distant lymph nodes or other tissue(s)/organ(s) beyond the primary site performed at this facility as a part of first course of treatment. </div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>The removal of non-primary tissue documents the extent of surgical treatment and is useful in evaluating the extent of metastatic involvement. <br /><br />If central registries wish to study the treatment given at particular facilities, the facility-level treatment fields must be used. The summary treatment fields, conversely, combine information for all reporting facilities that provide first course of treatment for the tumor. Facility-specific fields allow studies of detailed referral patterns and treatment by type of healthcare setting. Knowing what part of the treatment was given at a particular facility also helps resolve consolidation issues. </div><div class='content chap10-para'><strong>Codes (Refer to the most recent version  of <em>STORE</em> for additional instructions.) </strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>0</td><td class='code-desc'>None; no non-primary site resection was performed. Diagnosed at autopsy.</td></tr><tr class='code-row'><td class='code-nbr'>1</td><td class='code-desc'>Non-primary surgical procedure performed, unknown if whether site is regional or 	distant.</td></tr><tr class='code-row'><td class='code-nbr'>2</td><td class='code-desc'>Non-primary surgical procedure to other regional sites</td></tr><tr class='code-row'><td class='code-nbr'>3</td><td class='code-desc'>Non-primary surgical procedure to <i>distant lymph node(s)</i>.</td></tr><tr class='code-row'><td class='code-nbr'>4</td><td class='code-desc'>Non-primary surgical procedure to distant site.</td></tr><tr class='code-row'><td class='code-nbr'>5</td><td class='code-desc'>Any combination of codes 2, 3, or 4.</td></tr><tr class='code-row'><td class='code-nbr'>9</td><td class='code-desc'>Unknown; it is unknown whether any surgical procedure of a non-primary site was performed.
	Death certificate only.</td></tr></table></div><a name='670'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>RX HOSP--SURG PRIM SITE</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">670</td><td style="text-align:center;">2</td><td style="text-align:center;"><a href='#sources'>CoC</a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">795 - 796</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>Cancer-Directed Surgery at This Facility (pre-96 CoC)<br />Surgical Procedure of Primary Site<br />RX Hosp--CA Dir Surgery (pre-96 NAACCR)<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>rxHospSurgPrimSite</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Describes surgical procedures used to treat the primary site of the reportable tumor. This item records that portion of the first course of treatment given at the reporting facility. See Chapter V, Unresolved Issues, for a discussion of differences in treatment coding among groups and over time. </div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>This data item can be used to compare the efficacy of treatment options.<br /><br />If central registries wish to study the treatment given at particular facilities, the facility-level treatment fields must be used. The summary treatment fields, conversely, combine information for all reporting facilities that provide first course of treatment for the tumor. Facility-specific fields allow studies of detailed referral patterns and treatment by type of healthcare setting. Knowing what part of the treatment was given at a particular facility also helps resolve consolidation issues. </div><div class='content chap10-para'><strong>Codes in addition to the site-specific codes (Refer to the most recent version  of <em>STORE</em> for additional instructions.) </strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>00</td><td class='code-desc'>None. No surgical procedure of primary site. Diagnosed at autopsy.</td></tr><tr class='code-row'><td class='code-nbr'>10-19</td><td class='code-desc'>Site-specific codes. Tumor destruction; no pathologic specimen produced.</td></tr><tr class='code-row'><td class='code-nbr'>20-80</td><td class='code-desc'>Site-specific codes. Resection. Path specimen produced.</td></tr><tr class='code-row'><td class='code-nbr'>90</td><td class='code-desc'>Surgery, NOS; surgical treatment of the primary site was done, but no information on the type 	of procedure is provided.</td></tr><tr class='code-row'><td class='code-nbr'>98</td><td class='code-desc'>Site specific codes; special.</td></tr><tr class='code-row'><td class='code-nbr'>99</td><td class='code-desc'>Unknown. Patient record does not state whether surgical treatment of the primary site was 	performed, and no information is available. Death certificate-only.</td></tr></table></div><a name='746'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>RX HOSP--SURG SITE 98-02</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">746</td><td style="text-align:center;">2</td><td style="text-align:center;"><a href='#sources'>CoC</a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">812 - 813</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>RX Hosp--CA Dir Surgery (pre-96 NAACCR)<br />Surgical Procedure of Primary Site<br />Cancer-Directed Surgery at this Facility (pre-96 CoC)<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>rxHospSurgSite9802</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Describes surgical procedures used to treat the primary site of the reportable tumor. This item records that portion of the first course of treatment given at the reporting facility. This field is to be used for <em>ROADS</em> codes after the <em>ROADS</em> to <em>FORDS</em> conversion. It is also to be used to code Surgery Primary Site at the reporting facility for all tumors diagnosed before January 1, 2003. See Chapter V, Unresolved Issues, for a discussion of differences in treatment coding among groups and over time. </div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>This data item can be used to compare the efficacy of treatment options.<br /><br />If central registries wish to study the treatment given at particular facilities, the facility-level treatment fields must be used. The summary treatment fields, conversely, combine information for all reporting facilities that provide first course of treatment for the tumor. Facility-specific fields allow studies of detailed referral patterns and treatment by type of healthcare setting. Knowing what part of the treatment was given at a particular facility also helps resolve consolidation issues. </div><div class='content chap10-para'><strong>Codes (in addition to the site-specific codes)</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>00</td><td class='code-desc'>No surgery performed</td></tr><tr class='code-row'><td class='code-nbr'>99</td><td class='code-desc'>Unknown if surgery performed</td></tr></table></div><div class='content chap10-para'><em>Note</em>: See the CoC <em>ROADS </em>Manual 1998 Supplement and the <em>SEER Program Code Manual</em> for site-specific codes.</div><a name='678'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>RX HOSP--SURG TIMING</strong></td><td style="text-align:right;font-weight:bold;"><strong>Retired</strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">678</td><td style="text-align:center;"></td><td style="text-align:center;"><a href='#sources'></a></td><td style="text-align:center;">2010</td><td style="text-align:center;">12</td><td style="text-align:center;">2011</td><td style="text-align:center;">12.1</td><td class="cross-out" style="text-align:center;"></td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td></td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td></td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>This new data item was proposed for inclusion in Version 12 but the request was withdrawn prior to implementation of the standard. The data item was retired in Version 12.1, as of January 1, 2011.</div><a name='1410'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>RX SUMM--BRM</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">1410</td><td style="text-align:center;">2</td><td style="text-align:center;"><a href='#sources'>SEER/CoC</a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">2247 - 2248</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>Biological Response Modifiers (pre-96 SEER)<br />Immunotherapy (SEER/CoC)<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>rxSummBrm</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Records whether immunotherapeutic (biologic response modifiers) agents were administered as first-course treatment at all facilities or the reason they were not given. Immunotherapy consists of biological or chemical agents that alter the immune system or change the host&#8217;s response to tumor cells. </div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Systemic therapy may involve the administration of one or a combination of agents. This data item allows for the evaluation of the administration of immunotherapeutic agents as part of the first course of therapy. </div><div class='content chap10-para'><em>Note</em>: Prior to 2013, targeted therapies that invoke an immune response, such as Herceptin, had been coded as chemotherapy. Effective with cases diagnosed January 1, 2013, and forward these therapies are classified as biological response modifiers. Coding instructions for these changes have been added to the remarks field for the applicable drugs in the SEER*RX Interactive Drug Database (

<a target="_blank" href="http://seer.cancer.gov/tools/seerrx/">http://seer.cancer.gov/tools/seerrx/</a>). </div><div class='content chap10-para'><strong>Codes (Refer to the most recent version  of <em>STORE</em> and the <em>SEER Program Code Manual</em> for additional instructions.) </strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>00</td><td class='code-desc'>None, immunotherapy was not part of the planned first course of therapy.</td></tr><tr class='code-row'><td class='code-nbr'>01</td><td class='code-desc'>Immunotherapy administered as first course therapy.</td></tr><tr class='code-row'><td class='code-nbr'>82</td><td class='code-desc'>Immunotherapy was not recommended/administered because it was contraindicated due to patient risk factors (i.e., comorbid conditions, advanced age).</td></tr><tr class='code-row'><td class='code-nbr'>85</td><td class='code-desc'>Immunotherapy was not administered because the patient died prior to planned or recommended therapy.</td></tr><tr class='code-row'><td class='code-nbr'>86</td><td class='code-desc'>Immunotherapy was not administered. It was recommended by the patient's physician, but was not administered as part of first-course therapy. No reason was stated in the patient record.</td></tr><tr class='code-row'><td class='code-nbr'>87</td><td class='code-desc'>Immunotherapy was not administered. It was recommended by the patient's physician, but this treatment was refused by the patient, the patient's family member, or the patient's guardian. The refusal was noted in the patient record.</td></tr><tr class='code-row'><td class='code-nbr'>88</td><td class='code-desc'>Immunotherapy was recommended, but it is unknown if it was administered.</td></tr><tr class='code-row'><td class='code-nbr'>99</td><td class='code-desc'>It is unknown whether an immunotherapeutic agent(s) was recommended or administered because it is not stated in patient record; death certificate-only cases.</td></tr></table></div><div class='content chap10-para'><em>Note :</em>For tumors diagnosed on or after January 1, 2003,  information on bone marrow transplants and stem cell transplants should  be coded in the new field, RX SUMM--Transplnt/Endocr [3250]. The CoC  standards for hospitals do not allow use of codes 02-06 in tumors  diagnosed on or after January 1, 2003.</div><a name='1390'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>RX SUMM--CHEMO</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">1390</td><td style="text-align:center;">2</td><td style="text-align:center;"><a href='#sources'>SEER/CoC</a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">2243 - 2244</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>Chemotherapy (SEER/CoC)<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>rxSummChemo</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Codes for chemotherapy given as part of the first course of treatment or the reason chemotherapy was not given. Includes treatment given at all facilities as part of the first course. </div><div class='content chap10-para'><em>Note</em>: Prior to 2013, targeted therapies that invoke an immune response, such as Herceptin, had been coded as chemotherapy. Effective with cases diagnosed January 1, 2013, and forward these therapies are classified as biological response modifiers. Coding instructions for these changes have been added to the remarks field for the applicable drugs in the SEER*RX Interactive Drug Database (

<a target="_blank" href="http://seer.cancer.gov/tools/seerrx/">http://seer.cancer.gov/tools/seerrx/</a>). </div><div class='content chap10-para'><strong>Codes (Refer to the most recent version  of <em>STORE</em> for additional instructions.) </strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>00</td><td class='code-desc'>None, chemotherapy was not part of the planned first course of therapy.</td></tr><tr class='code-row'><td class='code-nbr'>01</td><td class='code-desc'>Chemotherapy, NOS.</td></tr><tr class='code-row'><td class='code-nbr'>02</td><td class='code-desc'>Chemotherapy, single agent.</td></tr><tr class='code-row'><td class='code-nbr'>03</td><td class='code-desc'>Chemotherapy, multiple agents.</td></tr><tr class='code-row'><td class='code-nbr'>82</td><td class='code-desc'>Chemotherapy was not recommended/administered because it was contraindicated due to patient risk factors (i.e., comorbid conditions, advanced age).</td></tr><tr class='code-row'><td class='code-nbr'>85</td><td class='code-desc'>Chemotherapy was not administered because the patient died prior to planned or recommended therapy.</td></tr><tr class='code-row'><td class='code-nbr'>86</td><td class='code-desc'>Chemotherapy was not administered. It was recommended by the patient's physician, but was not administered as part of first-course therapy. No reason was stated in the patient record.</td></tr><tr class='code-row'><td class='code-nbr'>87</td><td class='code-desc'>Chemotherapy was not administered; it was recommended by the patient's physician, but this treatment was refused by the patient, the patient's family member, or the patient's guardian. The refusal was noted in the patient record.</td></tr><tr class='code-row'><td class='code-nbr'>88</td><td class='code-desc'>Chemotherapy was recommended, but it is unknown if it was administered.</td></tr><tr class='code-row'><td class='code-nbr'>99</td><td class='code-desc'>It is unknown whether a chemotherapeutic agent(s) was recommended or administered because it is not stated in patient record; death certificate-only cases.</td></tr></table></div><a name='1350'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>RX SUMM--DX/STG PROC</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">1350</td><td style="text-align:center;">2</td><td style="text-align:center;"><a href='#sources'>CoC</a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">2235 - 2236</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>RX Summ--DX/Stg/Pall Proc<br />Surgical Diagnostic and Staging Procedure (1996-2002)<br />Non Cancer-Directed Surgery (CoC)<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>rxSummDxStgProc</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Identifies the surgical procedure(s) performed in an effort to diagnose and/or stage disease. </div><div class='content chap10-para'><strong>Codes (Refer to the most recent version  of <em>STORE</em> for additional instructions.) </strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>00</td><td class='code-desc'>No surgical diagnostic or staging procedure was performed.</td></tr><tr class='code-row'><td class='code-nbr'>01</td><td class='code-desc'>A biopsy (incisional, needle, or aspiration) was done to a site other than the primary site. No exploratory procedure was done.</td></tr><tr class='code-row'><td class='code-nbr'>02</td><td class='code-desc'>A biopsy (incisional, needle, or aspiration) was done of the primary site.</td></tr><tr class='code-row'><td class='code-nbr'>03</td><td class='code-desc'>A surgical exploratory only. The patient was not biopsied or treated.</td></tr><tr class='code-row'><td class='code-nbr'>04</td><td class='code-desc'>A surgical procedure with a bypass was performed, but no biopsy was done.</td></tr><tr class='code-row'><td class='code-nbr'>05</td><td class='code-desc'>An exploratory procedure was performed, and a biopsy of either the primary site or another site was done.</td></tr><tr class='code-row'><td class='code-nbr'>06</td><td class='code-desc'>A bypass procedure was performed, and a biopsy of either the primary site or another site was done.</td></tr><tr class='code-row'><td class='code-nbr'>07</td><td class='code-desc'>A procedure was done, but the type of procedure is unknown.</td></tr><tr class='code-row'><td class='code-nbr'>09</td><td class='code-desc'>No information about whether a diagnostic or staging procedure was performed.</td></tr></table></div><div class='content chap10-para'><em>Note: </em>CoC recommends this item for tumors diagnosed 1996 and  forward. For tumors diagnosed before 1996, this item may have been  converted, and tumors with surgery would have been converted to 09 in  this field. See also RX Summ--Surg Prim Site [1290] and RX  Summ--Reconstruct 1st [1330]. For SEER and pre-1996 CoC, see RX  Summ--Surgery Type [1640]. For tumors diagnosed between 1996 and 2002  this field may have described palliative care. For tumors diagnosed on  or after January 1, 2003, palliative care is coded in a new field RX  Summ--Palliative Proc [3270].</div><a name='1400'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>RX SUMM--HORMONE</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">1400</td><td style="text-align:center;">2</td><td style="text-align:center;"><a href='#sources'>SEER/CoC</a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">2245 - 2246</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>Hormone Therapy (SEER/CoC)<br />Endocrine (Hormone/Steroid) Therapy (pre-96 SEER)<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>rxSummHormone</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Records whether systemic hormonal agents were administered as first-course treatment at any facility, or the reason they were not given. Hormone therapy consists of a group of drugs that may affect the long-term control of a cancer&#8217;s growth. It is not usually used as a curative measure. </div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Systemic therapy may involve the administration of one or a combination of agents. This data item allows for the evaluation of the administration of hormonal agents as part of the first course of therapy. </div><div class='content chap10-para'><strong>Codes (Refer to the most recent version  of <em>STORE</em> and the <em>SEER Program Code Manual</em> for additional instructions.) </strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>00</td><td class='code-desc'>None, hormone therapy was not part of the planned first course of therapy.</td></tr><tr class='code-row'><td class='code-nbr'>01</td><td class='code-desc'>Hormone therapy administered as first course therapy.</td></tr><tr class='code-row'><td class='code-nbr'>82</td><td class='code-desc'>Hormone therapy was not recommended/administered because it was contraindicated due to patient risk factors (i.e., comorbid conditions, advanced age).</td></tr><tr class='code-row'><td class='code-nbr'>85</td><td class='code-desc'>Hormone therapy was not administered because the patient died prior to planned or recommended therapy.</td></tr><tr class='code-row'><td class='code-nbr'>86</td><td class='code-desc'>Hormone therapy was not administered. It was recommended by the patient's physician, but was not administered as part of first-course therapy. No reason was stated in the patient record.</td></tr><tr class='code-row'><td class='code-nbr'>87</td><td class='code-desc'>Hormone therapy was not administered. It was recommended by the patient's physician, but this treatment was refused by the patient, the patient's family member, or the patient's guardian. The refusal was noted in the patient record.</td></tr><tr class='code-row'><td class='code-nbr'>88</td><td class='code-desc'>Hormone therapy was recommended, but it is unknown if it was administered.</td></tr><tr class='code-row'><td class='code-nbr'>99</td><td class='code-desc'>It is unknown whether a hormonal agent(s) was recommended or administered because it is not stated in the patient record. Death certificate-only cases.</td></tr></table></div><div class='content chap10-para'><em>Note: </em>For tumors diagnosed on or after January 1, 2003,  information on endocrine surgery and/or endocrine radiation should be  coded in the new field, RX Summ--Transplnt/Endocr [3250]. The CoC  standards for hospitals do not allow use of codes 02-03 in tumors  diagnosed on or after January 1, 2003.</div><a name='1420'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>RX SUMM--OTHER</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">1420</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>SEER/CoC</a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">2249 - 2249</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>Other Treatment (CoC)<br />Other Cancer-Directed Therapy (SEER/pre-96 CoC)<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>rxSummOther</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Identifies other treatment given at all facilities that cannot be defined as surgery, radiation, or systemic therapy according to the defined data items in this manual. Treatment for reportable hematopoietic diseases can be supportive care, observation, or any treatment that does not meet the usual definition in which treatment modifies, controls, removes, or destroys proliferating cancer tissue. Such treatments include phlebotomy, transfusions, and aspirin. </div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Information on other therapy is used to describe and evaluate the quality-of-care and treatment practices. </div><div class='content chap10-para'><strong>Codes (Refer to the most recent version  of <em>STORE</em> for additional coding instructions) </strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>0</td><td class='code-desc'>None</td></tr><tr class='code-row'><td class='code-nbr'>1</td><td class='code-desc'>Other</td></tr><tr class='code-row'><td class='code-nbr'>2</td><td class='code-desc'>Other Experimental</td></tr><tr class='code-row'><td class='code-nbr'>3</td><td class='code-desc'>Other-Double Blind</td></tr><tr class='code-row'><td class='code-nbr'>6</td><td class='code-desc'>Other-Unproven</td></tr><tr class='code-row'><td class='code-nbr'>7</td><td class='code-desc'>Refusal</td></tr><tr class='code-row'><td class='code-nbr'>8</td><td class='code-desc'>Recommended</td></tr><tr class='code-row'><td class='code-nbr'>9</td><td class='code-desc'>Unknown; unknown if administered</td></tr></table></div><a name='3270'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>RX SUMM--PALLIATIVE PROC</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">3270</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>CoC</a></td><td style="text-align:center;">2003</td><td style="text-align:center;">10</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">2237 - 2237</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>Palliative Procedure<br />Palliative Care<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>rxSummPalliativeProc</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Identifies any care provided in an effort to palliate or alleviate symptoms. Palliative care is performed to relieve symptoms and may include surgery, radiation therapy, systemic therapy (chemotherapy, hormone therapy, or other systemic drugs), and/or pain management therapy. </div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>This data item allows reporting facilities to track care that is considered palliative rather than diagnostic or curative intent. </div><div class='content chap10-para'><strong>Codes </strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>0</td><td class='code-desc'>No palliative care provided; diagnosed at autopsy</td></tr><tr class='code-row'><td class='code-nbr'>1</td><td class='code-desc'>Surgery (which may involve a bypass procedure) to alleviate symptoms, but no attempt to diagnose, stage, or treat the primary tumor is made</td></tr><tr class='code-row'><td class='code-nbr'>2</td><td class='code-desc'>Radiation therapy to alleviate symptoms, but no attempt to diagnose, stage, or treat the primary tumor is made</td></tr><tr class='code-row'><td class='code-nbr'>3</td><td class='code-desc'>Chemotherapy, hormone therapy, or other systemic drugs to alleviate symptoms, but no attempt to diagnose, stage, or treat the primary tumor is made</td></tr><tr class='code-row'><td class='code-nbr'>4</td><td class='code-desc'>Patient received or was referred for pain management therapy with no other palliative care</td></tr><tr class='code-row'><td class='code-nbr'>5</td><td class='code-desc'>Any combination of codes 1, 2, and/or 3 without code 4</td></tr><tr class='code-row'><td class='code-nbr'>6</td><td class='code-desc'>Any combination of codes 1, 2, and/or 3 with code 4</td></tr><tr class='code-row'><td class='code-nbr'>7</td><td class='code-desc'>Palliative care was performed or referred, but no information on the type of procedure is available in the patient record</td></tr><tr class='code-row'><td class='code-nbr'>9</td><td class='code-desc'>Unknown if palliative care was performed or referred; not stated in patient record</td></tr></table></div><a name='1370'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>RX SUMM--RAD TO CNS</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">1370</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>SEER/CoC</a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">2239 - 2239</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>Radiation to the Brain and/or Central Nervous System (SEER)<br />Radiation Therapy to CNS (CoC)<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>rxSummRadToCns</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>For lung and leukemia cases only, codes for radiation given to the brain or central nervous system. Includes treatment given at all facilities as part of the first course. See Chapter V, Unresolved Issues, for more information.
<br /><br /><em>Note:</em> SEER does not collect this data item beginning with 1998 cases. They retain the codes for older cases in this field, and they have also recoded radiation coded here as radiation in RX Summ--Radiation [1360]. CoC does not collect this data item beginning with 1996 cases. </div><div class='content chap10-para'><strong>Codes <br />For Lung and Leukemia Cases only </strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>0</td><td class='code-desc'>No radiation to the brain and/or central nervous system</td></tr><tr class='code-row'><td class='code-nbr'>1</td><td class='code-desc'>Radiation</td></tr><tr class='code-row'><td class='code-nbr'>7</td><td class='code-desc'>Patient or patient's guardian refused</td></tr><tr class='code-row'><td class='code-nbr'>8</td><td class='code-desc'>Radiation recommended, unknown if administered</td></tr><tr class='code-row'><td class='code-nbr'>9</td><td class='code-desc'>Unknown<br />
<b>For all other cases (primaries other than lung or leukemia):</b><br /> 9     Not Applicable</td></tr></table></div><a name='1360'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>RX SUMM--RADIATION</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">1360</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>SEER</a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">2238 - 2238</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>Radiation (SEER/CoC)<br />Radiation Therapy (pre-96 CoC)<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>rxSummRadiation</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Codes for the type of radiation therapy performed as part of the first course of treatment.</div><div class='content chap10-para'><em>Note:</em> Radiation to brain and central nervous system for leukemia and lung cases is coded as radiation in this field.</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>0</td><td class='code-desc'>None</td></tr><tr class='code-row'><td class='code-nbr'>1</td><td class='code-desc'>Beam radiation</td></tr><tr class='code-row'><td class='code-nbr'>2</td><td class='code-desc'>Radioactive implants</td></tr><tr class='code-row'><td class='code-nbr'>3</td><td class='code-desc'>Radioisotopes</td></tr><tr class='code-row'><td class='code-nbr'>4</td><td class='code-desc'>Combination of 1 with 2 or 3</td></tr><tr class='code-row'><td class='code-nbr'>5</td><td class='code-desc'>Radiation, NOS-method or source not specified</td></tr><tr class='code-row'><td class='code-nbr'>6</td><td class='code-desc'>Currently allowable for historic cases only; see note below</td></tr><tr class='code-row'><td class='code-nbr'>7</td><td class='code-desc'>Patient or patient's guardian refused*</td></tr><tr class='code-row'><td class='code-nbr'>8</td><td class='code-desc'>Radiation recommended, unknown if administered*</td></tr><tr class='code-row'><td class='code-nbr'>9</td><td class='code-desc'>Unknown if radiation administered</td></tr></table></div><div class='content chap10-para'><em>Note</em>: CoC discontinued collection of this item in 2003 when FORDS was  implemented. For CoC, codes 7 and 8 were used for tumors diagnosed  before 1996, but should have been converted to 0 in this field and to  the appropriate code in the new field Reason for No Radiation [1430].  SEER continues to use codes 7 and 8 for all years. See Chapter V,  Unresolved Issues, for further discussion.  <br /><br />In the SEER program, a code 2 for other radiation was used between 1973  and 1987. When the radiation codes were expanded to add codes &#8216;2&#8217;  radioactive implants and &#8216;3&#8217; radioisotopes, all cases with a code &#8216;2&#8217;  and diagnosed in 1973-1987 were converted to a code &#8216;6&#8217; radiation other  than beam radiation.</div><a name='1330'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>RX SUMM--RECONSTRUCT 1ST</strong></td><td style="text-align:right;font-weight:bold;"><strong>Revised</strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">1330</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>SEER</a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">2233 - 2233</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>Reconstruction/Restoration-First Course (CoC)<br />Reconstruction--First Course (SEER)<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>rxSummReconstruct1st</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para mark-changed'>Codes for surgical procedures done to reconstruct, restore, or improve the shape and appearance or function of body structures that are missing, defective, damaged, or misshapen by cancer or therapies. Reconstructive/restorative procedures are coded here when started during the first course of therapy. <br /><br />CoC introduced site-specific codes for this item in the CoC <em>ROADS Manual</em> 1998 Supplement. RX Coding System--Current [1460] identifies which coding system applies.<br /><br />SEER collects reconstructive procedures for breast cancer tumors only.For reconstructive/restorative procedures performed later, see Subseq RX--Reconstruct Del [1741]. See also RX Summ--Surgery Type [1640].</div><div class='content chap10-para mark-changed'><em>Note:</em> This data item is no longer supported by CoC (as of January 1, 2003).</div><a name='1296'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>RX SUMM--REG LN EXAMINED</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">1296</td><td style="text-align:center;">2</td><td style="text-align:center;"><a href='#sources'>SEER/CoC</a></td><td style="text-align:center;">1997</td><td style="text-align:center;">5.1</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">2229 - 2230</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>Number of Regional Lymph Nodes Removed (CoC)<br />Number of Regional Lymph Nodes Examined (SEER/CoC)<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>rxSummRegLnExamined</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Codes for the number of regional lymph nodes examined in conjunction with surgery performed as part of the first-course treatment. This includes treatment given at all facilities as part of the first course of treatment. See also RX Summ--Scope Reg LN Sur [1292]. </div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>00</td><td class='code-desc'>No regional lymph nodes examined</td></tr><tr class='code-row'><td class='code-nbr'>01</td><td class='code-desc'>One regional lymph node examined</td></tr><tr class='code-row'><td class='code-nbr'>02</td><td class='code-desc'>Two regional lymph nodes examined</td></tr><tr class='code-row'><td class='code-nbr' colspan='2'>..</td></tr><tr class='code-row'><td class='code-nbr' colspan='2'>..</td></tr><tr class='code-row'><td class='code-nbr'>90</td><td class='code-desc'>90 or more regional lymph nodes examined</td></tr><tr class='code-row'><td class='code-nbr' colspan='2'>..</td></tr><tr class='code-row'><td class='code-nbr'>95</td><td class='code-desc'>No regional lymph node(s) removed, but aspiration of regional lymph node(s) was performed</td></tr><tr class='code-row'><td class='code-nbr'>96</td><td class='code-desc'>Regional lymph node removal documented as sampling, and number of lymph nodes unknown/not stated</td></tr><tr class='code-row'><td class='code-nbr'>97</td><td class='code-desc'>Regional lymph node removal documented as a dissection, and number of lymph nodes unknown/not stated</td></tr><tr class='code-row'><td class='code-nbr'>98</td><td class='code-desc'>Regional lymph nodes surgically removed, but number of lymph nodes unknown/not stated and not documented as sampling or dissection</td></tr><tr class='code-row'><td class='code-nbr'>99</td><td class='code-desc'>Unknown; not stated; death certificate-only</td></tr></table></div><div class='content chap10-para'><em>Note: </em>As of January 1, 2003, this data item is no longer required  or recommended by CoC. However, the item was collected in the past and  it is recommended that historic data be retained.</div><a name='1647'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>RX SUMM--SCOPE REG 98-02</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">1647</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>SEER/CoC</a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">2279 - 2279</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>Scope of Regional Lymph Node Surgery (SEER/CoC)<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>rxSummScopeReg9802</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Describes the removal, biopsy or aspiration of regional lymph node(s) at the time of surgery of the primary site or during a separate surgical event at all facilities. This field is to be used for <em>ROADS</em> codes after the <em>ROADS</em> to <em>FORDS</em> conversion. It is also to be used to code Scope of Regional Lymph Node Surgery at all facilities for all tumors diagnosed before January 1, 2003. </div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>In evaluating quality of care and treatment practices it is important to identify the removal, biopsy, or aspiration of regional lymph node(s) at the time of surgery of the primary site or during a separate surgical event. </div><div class='content chap10-para'><strong>Codes (See the CoC <em>ROADS </em>Manual 1998 Supplement and the <em>SEER Program Code Manual</em> for site-specific codes.) </strong></div><a name='1292'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>RX SUMM--SCOPE REG LN SUR</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">1292</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>SEER/CoC</a></td><td style="text-align:center;">1997</td><td style="text-align:center;">5.1</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">2227 - 2227</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>Scope of Regional Lymph Node Surgery (SEER/CoC)<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>rxSummScopeRegLnSur</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Describes the removal, biopsy or aspiration of regional lymph node(s) at the time of surgery of the primary site or during a separate surgical event at all facilities. </div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>In evaluating quality-of-care and treatment practices it is important to identify the removal, biopsy, or aspiration of regional lymph node(s) at the time of surgery of the primary site or during a separate surgical event. </div><div class='content chap10-para'><strong>Codes (Refer to the most recent versions  of <em>STORE</em> and the <em>SEER Program Code Manual</em> for instructions that should be applied to all surgically treated cases for all types of cancers.)</strong>  The treatment of breast and skin cancers are where the distinction between sentinel lymph node biopsies (SLNBx) and more extensive dissection of regional lymph nodes is most frequently encountered. For all other sites, non-sentinel regional node dissections are typical, and codes 2, 6 and 7 are infrequently used.</div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>0</td><td class='code-desc'>None</td></tr><tr class='code-row'><td class='code-nbr'>1</td><td class='code-desc'>Biopsy or aspiration of regional lymph node, NOS</td></tr><tr class='code-row'><td class='code-nbr'>2</td><td class='code-desc'>Sentinel lymph node biopsy</td></tr><tr class='code-row'><td class='code-nbr'>3</td><td class='code-desc'>Number of regional lymph nodes removed unknown, not stated; regional lymph nodes removed, NOS</td></tr><tr class='code-row'><td class='code-nbr'>4</td><td class='code-desc'>1 to 3 regional lymph nodes removed</td></tr><tr class='code-row'><td class='code-nbr'>5</td><td class='code-desc'>4 or more regional lymph nodes removed</td></tr><tr class='code-row'><td class='code-nbr'>6</td><td class='code-desc'>Sentinel node biopsy and code 3, 4, or 5 at same time or timing not noted</td></tr><tr class='code-row'><td class='code-nbr'>7</td><td class='code-desc'>Sentinel node biopsy and code 3, 4, or 5 at different times</td></tr><tr class='code-row'><td class='code-nbr'>9</td><td class='code-desc'>Unknown or not applicable</td></tr></table></div><div class='content chap10-para'><em>Note: </em>One important use of registry data is the tracking of  treatment patterns over time. To compare contemporary treatment to  previously published treatment based on former codes, or to data  unmodified from pre-1998 definitions, the ability to differentiate  surgeries in which four or more regional lymph nodes are removed is  desirable. However, it is very important to note that the distinction  between codes 4 and 5 is made to permit comparison of current surgical  procedures with procedures coded in the past when the removal of fewer  than 4 nodes was not reflected in surgery codes. It is not intended to  reflect clinical significance when applied to a particular surgical  procedure. It is important to avoid inferring, by data presentation or  other methods, that one category is preferable to another within the  intent of these items.</div><a name='1642'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>RX SUMM--SCREEN/BX PROC1</strong></td><td style="text-align:right;font-weight:bold;"><strong>Retired</strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">1642</td><td style="text-align:center;"></td><td style="text-align:center;"><a href='#sources'></a></td><td style="text-align:center;">1997</td><td style="text-align:center;">5.1</td><td style="text-align:center;">2006</td><td style="text-align:center;">11</td><td class="cross-out" style="text-align:center;"></td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td></td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td></td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>The NAACCR UDSC retired this data item in Version 11, as of January 1, 2006.</div><a name='1643'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>RX SUMM--SCREEN/BX PROC2</strong></td><td style="text-align:right;font-weight:bold;"><strong>Retired</strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">1643</td><td style="text-align:center;"></td><td style="text-align:center;"><a href='#sources'></a></td><td style="text-align:center;">1997</td><td style="text-align:center;">5.1</td><td style="text-align:center;">2006</td><td style="text-align:center;">11</td><td class="cross-out" style="text-align:center;"></td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td></td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td></td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>The NAACCR UDSC retired this data item in Version 11, as of January 1, 2006.</div><a name='1644'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>RX SUMM--SCREEN/BX PROC3</strong></td><td style="text-align:right;font-weight:bold;"><strong>Retired</strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">1644</td><td style="text-align:center;"></td><td style="text-align:center;"><a href='#sources'></a></td><td style="text-align:center;">1997</td><td style="text-align:center;">5.1</td><td style="text-align:center;">2006</td><td style="text-align:center;">11</td><td class="cross-out" style="text-align:center;"></td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td></td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td></td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>The NAACCR UDSC retired this data item in Version 11, as of January 1, 2006.</div><a name='1645'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>RX SUMM--SCREEN/BX PROC4</strong></td><td style="text-align:right;font-weight:bold;"><strong>Retired</strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">1645</td><td style="text-align:center;"></td><td style="text-align:center;"><a href='#sources'></a></td><td style="text-align:center;">1997</td><td style="text-align:center;">5.1</td><td style="text-align:center;">2006</td><td style="text-align:center;">11</td><td class="cross-out" style="text-align:center;"></td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td></td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td></td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>The NAACCR UDSC retired this data item in Version 11, as of January 1, 2006.</div><a name='1648'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>RX SUMM--SURG OTH 98-02</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">1648</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>SEER/CoC</a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">2280 - 2280</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>Surgery of Other Regional Site(s), Distant Site(s) or Distant Lymph Nodes (SEER/CoC)<br />Surgical Procedure/Other Site<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>rxSummSurgOth9802</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Records the surgical removal of distant lymph nodes or other tissue(s)/organ(s) beyond the primary site given at all facilities as part of the first course of treatment. This field is to be used for <em>ROADS</em> codes after the <em>ROADS</em> to <em>FORDS</em> conversion. It is also to be used to code Surgery Regional/Distant Sites at all facilities for all tumors diagnosed before January 1, 2003. </div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>The removal of non-primary tissue documents the extent of surgical treatment and is useful in evaluating the extent of metastatic involvement. </div><div class='content chap10-para'><strong>Codes (See the CoC ROADS Manual 1998 Supplement and the SEER Program Code Manual for site-specific codes.) </strong></div><a name='1294'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>RX SUMM--SURG OTH REG/DIS</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">1294</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>SEER/CoC</a></td><td style="text-align:center;">1997</td><td style="text-align:center;">5.1</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">2228 - 2228</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>Surgery of Other Regional Site(s), Distant Site(s) or Distant Lymph Nodes (SEER/CoC)<br />Surgical Procedure/Other Site<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>rxSummSurgOthRegDis</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Records the surgical removal of distant lymph nodes or other tissue(s)/organ(s) beyond the primary site. </div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>The removal of non-primary tissue documents the extent of surgical treatment and is useful in evaluating the extent of metastatic involvement. </div><div class='content chap10-para'><strong>Codes (Refer to the most recent version  of <em>STORE </em>and <em>SEER Program Code Manual</em> for additional instructions.) </strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>0</td><td class='code-desc'>None; diagnosed at autopsy</td></tr><tr class='code-row'><td class='code-nbr'>1</td><td class='code-desc'>Non-primary surgical procedure performed</td></tr><tr class='code-row'><td class='code-nbr'>2</td><td class='code-desc'>Non-primary surgical procedure to other regional sites</td></tr><tr class='code-row'><td class='code-nbr'>3</td><td class='code-desc'>Non-primary surgical procedure to distant lymph node(s)</td></tr><tr class='code-row'><td class='code-nbr'>4</td><td class='code-desc'>Non-primary surgical procedure to distant site</td></tr><tr class='code-row'><td class='code-nbr'>5</td><td class='code-desc'>Any combination of codes 2, 3, or 4</td></tr><tr class='code-row'><td class='code-nbr'>9</td><td class='code-desc'>Unknown; death certificate only</td></tr></table></div><a name='1290'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>RX SUMM--SURG PRIM SITE</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">1290</td><td style="text-align:center;">2</td><td style="text-align:center;"><a href='#sources'>SEER/CoC</a></td><td style="text-align:center;">1997</td><td style="text-align:center;">5.1</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">2225 - 2226</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>Surgery of Primary Site (SEER/CoC)<br />Cancer-Directed Surgery (pre-96 CoC)<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>rxSummSurgPrimSite</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Site-specific codes for the type of surgery to the primary site performed as part of the first course of treatment. This includes treatment given at all facilities as part of the first course of treatment. </div><div class='content chap10-para'><strong>Codes (in addition to the site-specific codes; Refer to the most recent version  of <em>STORE</em> and SEER Program Code manual for additional instructions.) </strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>00</td><td class='code-desc'>None</td></tr><tr class='code-row'><td class='code-nbr'>10-19</td><td class='code-desc'>Site-specific code; tumor destruction</td></tr><tr class='code-row'><td class='code-nbr'>20-80</td><td class='code-desc'>Site-specific codes; resection</td></tr><tr class='code-row'><td class='code-nbr'>90</td><td class='code-desc'>Surgery, NOS</td></tr><tr class='code-row'><td class='code-nbr'>98</td><td class='code-desc'>Site specific codes; special</td></tr><tr class='code-row'><td class='code-nbr'>99</td><td class='code-desc'>Unknown</td></tr></table></div><a name='1646'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>RX SUMM--SURG SITE 98-02</strong></td><td style="text-align:right;font-weight:bold;"><strong>Revised</strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">1646</td><td style="text-align:center;">2</td><td style="text-align:center;"><a href='#sources'>SEER/CoC</a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">2277 - 2278</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>Surgery of Primary Site (SEER/CoC)<br />Cancer-Directed Surgery (pre-96 CoC)<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>rxSummSurgSite9802</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para mark-changed'>Site-specific codes for the type of surgery to the primary site performed as part of the first course of treatment. This includes treatment given at all facilities as part of the first course of treatment. This field is to be used for <em>ROADS</em> codes after the <em>ROADS</em> to <em>FORDS</em> conversion. It is also to be used to code Surgery Primary Site at all facilities for all tumors diagnosed before January 1, 2003.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para mark-changed'>If central registries wish to study the treatment given at particular hospitals, the hospital-level treatment fields must be used.</div><div class='content chap10-para'><strong>Codes (in addition to the site-specific codes) </strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>00</td><td class='code-desc'>No primary site surgery performed</td></tr><tr class='code-row'><td class='code-nbr'>99</td><td class='code-desc'>Unknown if primary site surgery performed</td></tr></table></div><div class='content chap10-para'><em>Note:</em> See the CoC<em> ROADS Manual</em>, 1998 Supplement, CoC Coding System [2140] code 7, and the<em> SEER Program Code Manual</em>, RX Coding System [1460] code 5, 1998 for site-specific codes.</div><a name='1380'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>RX SUMM--SURG/RAD SEQ</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">1380</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>SEER/CoC</a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">2240 - 2240</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>Radiation Sequence with Surgery (pre-96 SEER/CoC)<br />Radiation/Surgery Sequence (CoC)<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>rxSummSurgRadSeq</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Codes for the sequencing of radiation and surgery given as part of the first course of treatment. See also RX Summ--Surg Prim Site [1290], RX Summ--Scope LN Surg [1292], RX Summ--Surg Oth Reg/Dis [1294], and RX Summ--Radiation [1360]. </div><div class='content chap10-para'><strong>Codes </strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>0</td><td class='code-desc'>No radiation and/or no surgery; unknown if surgery and/or radiation given</td></tr><tr class='code-row'><td class='code-nbr'>2</td><td class='code-desc'>Radiation before surgery</td></tr><tr class='code-row'><td class='code-nbr'>3</td><td class='code-desc'>Radiation after surgery</td></tr><tr class='code-row'><td class='code-nbr'>4</td><td class='code-desc'>Radiation both before and after surgery</td></tr><tr class='code-row'><td class='code-nbr'>5</td><td class='code-desc'>Intraoperative radiation</td></tr><tr class='code-row'><td class='code-nbr'>6</td><td class='code-desc'>Intraoperative radiation with other radiation given before and/or after surgery</td></tr><tr class='code-row'><td class='code-nbr'>7</td><td class='code-desc'>Surgery both before and after radiation</td></tr><tr class='code-row'><td class='code-nbr'>9</td><td class='code-desc'>Sequence unknown, but both surgery and radiation were given</td></tr></table></div><a name='1640'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>RX SUMM--SURGERY TYPE</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">1640</td><td style="text-align:center;">2</td><td style="text-align:center;"><a href='#sources'>SEER</a></td><td style="text-align:center;">2011</td><td style="text-align:center;">12.2</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">2274 - 2275</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>Site--Specific Surgery (pre-98 SEER)<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>rxSummSurgeryType</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Field for pre-1996 surgery codes for CoC and pre-1998 surgery codes for SEER. Surgery codes used 1998 and later can be backward converted into the older codes and the converted value can be stored in this field. See Chapter V, Unresolved Issues, for discussion of CoC/SEER differences in coding treatment. </div><a name='1310'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>RX SUMM--SURGICAL APPROCH</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">1310</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>CoC</a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">2231 - 2231</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>Surgical Approach (CoC)<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>rxSummSurgicalApproch</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Codes for method used to approach the surgical field for the primary site. </div><div class='content chap10-para'><em>Note:</em> As of January 1, 2003, this data item is no longer required or recommended by CoC. However, the item was collected in the past and it is recommended that historic data be retained. This former item should not be confused with NAACCR item [668] RX HOSP--SURG APP 2010 . </div><div class='content chap10-para'><strong>Codes (See the CoC <em>ROADS Manual</em>, 1998 Supplement, for site-specific codes.)</strong></div><a name='1320'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>RX SUMM--SURGICAL MARGINS</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">1320</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>CoC</a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">2232 - 2232</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>Surgical Margins (CoC)<br />Residual Primary Tumor Following Cancer-Directed Surgery (pre-96 CoC)<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>rxSummSurgicalMargins</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Codes describe the final status of surgical margins after resection of the primary tumor. See also RX Summ--Surg Prim Site [1290]. </div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>This item serves as a quality measure for pathology reports, is used for staging, and may be a prognostic factor in recurrence. This item is not limited to cases that have been staged. It applies to all cases that have a surgical procedure of the primary site. </div><div class='content chap10-para'><strong>Codes (Refer to the most recent version  of <em>STORE</em> for additional instructions.) </strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>0</td><td class='code-desc'>No residual tumor</td></tr><tr class='code-row'><td class='code-nbr'>1</td><td class='code-desc'>Residual tumor, NOS</td></tr><tr class='code-row'><td class='code-nbr'>2</td><td class='code-desc'>Microscopic residual tumor</td></tr><tr class='code-row'><td class='code-nbr'>3</td><td class='code-desc'>Macroscopic residual tumor</td></tr><tr class='code-row'><td class='code-nbr'>7</td><td class='code-desc'>Margins not evaluable</td></tr><tr class='code-row'><td class='code-nbr'>8</td><td class='code-desc'>No primary site surgery</td></tr><tr class='code-row'><td class='code-nbr'>9</td><td class='code-desc'>Unknown or not applicable</td></tr></table></div><div class='content chap10-para'><em>Note:</em> Codes were site specific (1998-2002), and have been changed to be generic across all disease sites.</div><a name='1639'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>RX SUMM--SYSTEMIC/SUR SEQ</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">1639</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>CoC</a></td><td style="text-align:center;">2006</td><td style="text-align:center;">11</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">2273 - 2273</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>Systemic/Surgery Sequence<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>rxSummSystemicSurSeq</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Records the sequencing of systemic therapy (RX Summ-Chemo [1390], RX Summ-Hormone [1400], RX Summ-BRM [1410], and RX Summ-Transplnt/Endocr [3250]) and surgical procedures given as part of the first course of treatment. See also RX Summ--Surg Prim Site [1290], RX Summ--Scope LN Surg [1292], and RX Summ--Surg Oth Reg/Dis [1294]. </div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>The sequence of systemic therapy and surgical procedures given as part of the first course of treatment cannot always be determined using the date on which each modality was started or performed. This data item can be used to more precisely evaluate the time of delivery of treatment to the patient. </div><div class='content chap10-para'><strong>Codes </strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>0</td><td class='code-desc'>No systemic therapy and/or surgical procedures; unknown if surgery and/or systemic therapy given</td></tr><tr class='code-row'><td class='code-nbr'>2</td><td class='code-desc'>Systemic therapy before surgery</td></tr><tr class='code-row'><td class='code-nbr'>3</td><td class='code-desc'>Systemic therapy after surgery</td></tr><tr class='code-row'><td class='code-nbr'>4</td><td class='code-desc'>Systemic therapy both before and after surgery</td></tr><tr class='code-row'><td class='code-nbr'>5</td><td class='code-desc'>Intraoperative systemic therapy</td></tr><tr class='code-row'><td class='code-nbr'>6</td><td class='code-desc'>Intraoperative systemic therapy with other therapy administered before and/or after surgery</td></tr><tr class='code-row'><td class='code-nbr'>7</td><td class='code-desc'>Surgery both before and after systemic therapy</td></tr><tr class='code-row'><td class='code-nbr'>9</td><td class='code-desc'>Sequence unknown, but both surgery and systemic therapy given</td></tr></table></div><a name='3250'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>RX SUMM--TRANSPLNT/ENDOCR</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">3250</td><td style="text-align:center;">2</td><td style="text-align:center;"><a href='#sources'>CoC</a></td><td style="text-align:center;">2003</td><td style="text-align:center;">10</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">2241 - 2242</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>Hematologic Transplant and Endocrine Procedures<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>rxSummTransplntEndocr</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Identifies systemic therapeutic procedures administered as part of the first course of treatment at this and all other facilities. If none of these procedures were administered then this item records the reason they were not performed. These include bone marrow transplants, stem cell harvests, surgical and/or radiation endocrine therapy. </div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>This data item allows the evaluation of patterns of treatment, which involve the alteration of the immune system or change the patient&#8217;s response to tumor cells but do not involve the administration of antineoplastic agents. </div><div class='content chap10-para'><strong>Codes (Refer to the most recent version  of <em>STORE</em> for additional instructions.) </strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>00</td><td class='code-desc'>No transplant procedure or endocrine therapy was administered as part of first course therapy; diagnosed at autopsy</td></tr><tr class='code-row'><td class='code-nbr'>10</td><td class='code-desc'>Bone marrow transplant procedure was administered, but the type was not specified.</td></tr><tr class='code-row'><td class='code-nbr'>11</td><td class='code-desc'>Bone marrow transplant-autologous</td></tr><tr class='code-row'><td class='code-nbr'>12</td><td class='code-desc'>Bone marrow transplant-allogeneic</td></tr><tr class='code-row'><td class='code-nbr'>20</td><td class='code-desc'>Stem cell harvest and infusion</td></tr><tr class='code-row'><td class='code-nbr'>30</td><td class='code-desc'>Endocrine surgery and/or endocrine radiation therapy.</td></tr><tr class='code-row'><td class='code-nbr'>40</td><td class='code-desc'>Combination of endocrine surgery and/or radiation with a transplant procedure. (combination of codes 30 and 10, 11, 12 or 20).</td></tr><tr class='code-row'><td class='code-nbr'>82</td><td class='code-desc'>Hematologic transplant and/or endocrine surgery/radiation was not recommended/administered because it was contraindicated due to patient risk factors (i.e., comorbid conditions, advanced age).</td></tr><tr class='code-row'><td class='code-nbr'>85</td><td class='code-desc'>Hematologic transplant and/or endocrine surgery/radiation was not administered because the patient died prior to planned or recommended therapy.</td></tr><tr class='code-row'><td class='code-nbr'>86</td><td class='code-desc'>Hematologic transplant and/or endocrine surgery/radiation was not administered. It was recommended by the patient's physician, but was not administered as part of first-course therapy. No reason was stated in the patient record.</td></tr><tr class='code-row'><td class='code-nbr'>87</td><td class='code-desc'>Hematologic transplant and/or endocrine surgery/radiation was not administered; it was recommended by the patient's physician, but this treatment was refused by the patient, the patient's family member, or the patient's guardian; refusal noted in patient record</td></tr><tr class='code-row'><td class='code-nbr'>88</td><td class='code-desc'>Hematologic transplant and/or endocrine surgery/radiation was recommended, but it is unknown if it was administered</td></tr><tr class='code-row'><td class='code-nbr'>99</td><td class='code-desc'>It is unknown whether hematologic transplant and/or endocrine surgery/radiation was recommended or administered because it is not stated in patient record; death certificate-only cases</td></tr></table></div><a name='1285'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>RX SUMM--TREATMENT STATUS</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">1285</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>SEER/CoC</a></td><td style="text-align:center;">2010</td><td style="text-align:center;">12</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">2224 - 2224</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>rxSummTreatmentStatus</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>This data item is a summary of the status for all treatment modalities. It is used in conjunction with Date Initial RX SEER [1260] and/or Date 1st Crs RX CoC [1270] and each modality of treatment with their respective date field to document whether treatment was given or not given, whether it is unknown if treatment was given, or whether treatment was given on an unknown date. Also indicates active surveillance (watchful waiting). This data item is effective for January 2010+ diagnoses. </div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>This field will document active surveillance (watchful waiting) and eliminate searching each treatment modality to determine whether treatment was given. </div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>0</td><td class='code-desc'>No treatment given</td></tr><tr class='code-row'><td class='code-nbr'>1</td><td class='code-desc'>Treatment given</td></tr><tr class='code-row'><td class='code-nbr'>2</td><td class='code-desc'>Active surveillance (watchful waiting)</td></tr><tr class='code-row'><td class='code-nbr'>9</td><td class='code-desc'>Unknown if treatment was given</td></tr></table></div><a name='2660'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>RX TEXT--BRM</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">2660</td><td style="text-align:center;">1000</td><td style="text-align:center;"><a href='#sources'>NPCR</a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">19135 - 20134</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>rxTextBrm</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Text area for manual documentation of information regarding the treatment of the tumor being reported with biological response modifiers or immunotherapy.  </div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Text documentation is an essential component of a complete electronic report and is heavily utilized for quality control and special studies. Text is needed to justify coded values and to document supplemental information not transmitted within coded values. High-quality text documentation facilitates consolidation of information from multiple reporting sources at the central registry.<br /><br />The text field must contain a description that has been entered by the reporter independently from the code(s). If software generates text automatically from codes, the text cannot be utilized to check coded values. Information documenting the disease process should be entered manually from the medical record <strong>and should not be generated electronically from coded values</strong>.<strong><br /><br />Instructions</strong><ul><li>Prioritize entered information in the order of the fields listed below.</li><li>Text automatically generated from coded data is not acceptable.</li><li>NAACCR-approved abbreviations should be utilized (see Appendix G).</li><li>Do not repeat information from other text fields.</li><li>Additional comments can be continued in empty text fields, including Remarks. For text documentation that is continued from one text field to another, use asterisks or other symbols to indicate the connection with preceding text.</li><li>If information is missing from the record, state that it is missing.</li><li>Do not include irrelevant information.</li><li>Do not include information that the registry is not authorized to collect.</li></ul><em>Note:</em> For software that allows unlimited text, NAACCR recommends that the software indicate to the reporter the portion of the text that will be transmitted to the central registry.<strong><br /><br />Suggestions for text:</strong><ul><li>Date treatment began</li><li>Where treatment was given, e.g., at this facility, at another facility </li><li>Type of BRM agent, e.g., Interferon, BCG</li><li>BRM procedures, e.g., bone marrow transplant, stem cell transplant</li><li>Other treatment information, e.g., treatment cycle incomplete; unknown if BRM was given</li></ul>  </div><div class='content chap10-para'><p> <strong>Data Item(s) to be verified/validated using the text entered in this field</strong> <br />
After manual entry of the text field, ensure that the text entered both agrees with the coded values and clearly justifies the selected codes in the following fields:<br />
</p>
<table style="margin-left:99.9pt;border-collapse:collapse;border:none;" border="1" cellpadding="0" cellspacing="0">
     <tbody>
         <tr>
             <td style="width:157.5pt;border:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="210">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal"> <strong>Item name</strong> </p>
             </td>
             <td style="width:76.5pt;border:solid windowtext 1.0pt; border-left:none;padding:0in 5.4pt 0in 5.4pt" valign="top" width="102">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal"> <strong>Item number</strong> </p>
             </td>
         </tr>
         <tr>
             <td style="width:157.5pt;border:solid windowtext 1.0pt; border-top:none; padding:0in 5.4pt 0in 5.4pt" valign="top" width="210">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal">Date Initial RX SEER</p>
             </td>
             <td style="width:76.5pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="102">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal">1260</p>
             </td>
         </tr>
         <tr>
             <td style="width:157.5pt;border:solid windowtext 1.0pt; border-top:none; padding:0in 5.4pt 0in 5.4pt" valign="top" width="210">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal">Date 1<sup>st </sup>Crs RX CoC</p>
             </td>
             <td style="width:76.5pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="102">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal">1270</p>
             </td>
         </tr>
         <tr>
             <td style="width:157.5pt;border:solid windowtext 1.0pt; border-top:none; padding:0in 5.4pt 0in 5.4pt" valign="top" width="210">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal">RX Hosp--BRM</p>
             </td>
             <td style="width:76.5pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="102">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal">720</p>
             </td>
         </tr>
         <tr>
             <td style="width:157.5pt;border:solid windowtext 1.0pt; border-top:none; padding:0in 5.4pt 0in 5.4pt" valign="top" width="210">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal">RX Date Systemic</p>
             </td>
             <td style="width:76.5pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="102">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal">3230</p>
             </td>
         </tr>
         <tr>
             <td style="width:157.5pt;border:solid windowtext 1.0pt; border-top:none; padding:0in 5.4pt 0in 5.4pt" valign="top" width="210">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal">RX Summ--Tranplnt/Endocr</p>
             </td>
             <td style="width:76.5pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="102">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal">3250</p>
             </td>
         </tr>
         <tr>
             <td style="width:157.5pt;border:solid windowtext 1.0pt; border-top:none; padding:0in 5.4pt 0in 5.4pt" valign="top" width="210">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal">RX Summ--BRM</p>
             </td>
             <td style="width:76.5pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="102">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal">1410</p>
             </td>
         </tr>
         <tr>
             <td style="width: 157.5pt; border-right: 1pt solid windowtext; border-width: medium 1pt 1pt; border-style: none solid solid; border-color: -moz-use-text-color windowtext windowtext; -moz-border-top-colors: none; -moz-border-right-colors: none; -moz-border-bottom-colors: none; -moz-border-left-colors: none; -moz-border-image: none; padding: 0in 5.4pt;" valign="top" width="210">
             <p style="margin-bottom: 0.0001pt; line-height: normal;">RX Date BRM</p>
             </td>
             <td style="width:76.5pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="102">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal">1240</p>
             </td>
         </tr>
         <tr>
             <td style="width:157.5pt;border:solid windowtext 1.0pt; border-top:none; padding:0in 5.4pt 0in 5.4pt" valign="top" width="210">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal">RX Summ--Systemic/Sur Seq</p>
             </td>
             <td style="width:76.5pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="102">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal">1639</p>
             </td>
         </tr>
     </tbody>
</table>  </div><a name='2640'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>RX TEXT--CHEMO</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">2640</td><td style="text-align:center;">1000</td><td style="text-align:center;"><a href='#sources'>NPCR</a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">17135 - 18134</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>rxTextChemo</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Text area for manual documentation of information regarding chemotherapy treatment of the reported tumor. </div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Text documentation is an essential component of a complete electronic report and is heavily utilized for quality control and special studies. Text is needed to justify coded values and to document supplemental information not transmitted within coded values. High-quality text documentation facilitates consolidation of information from multiple reporting sources at the central registry.<br /><br />The text field must contain a description that has been entered by the reporter independently from the code(s). If software generates text automatically from codes, the text cannot be utilized to check coded values. Information documenting the disease process should be entered manually from the medical record <strong>and should not be generated electronically from coded values</strong>.<strong><br /><br />Instructions</strong><ul><li>Prioritize entered information in the order of the fields listed below.</li><li>Text automatically generated from coded data is not acceptable.</li><li>NAACCR-approved abbreviations should be utilized (see Appendix G).</li><li>Do not repeat information from other text fields.</li><li>Additional comments can be continued in empty text fields, including Remarks. For text documentation that is continued from one text field to another, use asterisks or other symbols to indicate the connection with preceding text.</li><li>If information is missing from the record, state that it is missing.</li><li>Do not include irrelevant information.</li><li>Do not include information that the registry is not authorized to collect.</li></ul><em>Note:</em> For software that allows unlimited text, NAACCR recommends that the software indicate to the reporter the portion of the text that will be transmitted to the central registry.<strong><br /><br />Suggestions for text:</strong><ul><li>Date chemotherapy began</li><li>Where treatment was given, e.g., at this facility, at another facility</li><li>Type of chemotherapy, e.g., name of agent(s) or protocol</li><li>Other treatment information, e.g., treatment cycle incomplete, unknown if chemotherapy was given</li></ul> </div><div class='content chap10-para'><strong>Data Item(s) to be verified/validated using the text entered in this field</strong>  <br />After manual entry of the text field, ensure that the text entered both  agrees with the coded values and clearly justifies the selected codes in  the following fields:<br /><br /><table style="margin-left: 99.9pt; border-collapse: collapse; border: medium none;" border="0" cellpadding="0" cellspacing="0"><tbody><tr><td style="width:157.5pt;border:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="210"><p style="margin-bottom:0in;margin-bottom:.0001pt;line-height:   normal"><strong>Item name</strong></p></td><td style="width:76.5pt;border:solid windowtext 1.0pt;   border-left:none;padding:0in 5.4pt 0in 5.4pt" valign="top" width="102"><p style="margin-bottom:0in;margin-bottom:.0001pt;line-height:   normal"><strong>Item number</strong></p></td></tr><tr><td style="width:157.5pt;border:solid windowtext 1.0pt;   border-top:none;   padding:0in 5.4pt 0in 5.4pt" valign="top" width="210"><p style="margin-bottom:0in;margin-bottom:.0001pt;line-height:   normal">Date Initial RX SEER</p></td><td style="width:76.5pt;border-top:none;border-left:   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="102"><p style="margin-bottom:0in;margin-bottom:.0001pt;line-height:   normal">1260</p></td></tr><tr><td style="width:157.5pt;border:solid windowtext 1.0pt;   border-top:none;   padding:0in 5.4pt 0in 5.4pt" valign="top" width="210"><p style="margin-bottom:0in;margin-bottom:.0001pt;line-height:   normal">Date 1<sup>st </sup>Crs RX CoC</p></td><td style="width:76.5pt;border-top:none;border-left:   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="102"><p style="margin-bottom:0in;margin-bottom:.0001pt;line-height:   normal">1270</p></td></tr><tr><td style="width:157.5pt;border:solid windowtext 1.0pt;   border-top:none;   padding:0in 5.4pt 0in 5.4pt" valign="top" width="210"><p style="margin-bottom:0in;margin-bottom:.0001pt;line-height:   normal">RX Hosp--Chemo</p></td><td style="width:76.5pt;border-top:none;border-left:   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="102"><p style="margin-bottom:0in;margin-bottom:.0001pt;line-height:   normal">700</p></td></tr><tr><td style="width:157.5pt;border:solid windowtext 1.0pt;   border-top:none;   padding:0in 5.4pt 0in 5.4pt" valign="top" width="210"><p style="margin-bottom:0in;margin-bottom:.0001pt;line-height:   normal">RX Date Systemic</p></td><td style="width:76.5pt;border-top:none;border-left:   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="102"><p style="margin-bottom:0in;margin-bottom:.0001pt;line-height:   normal">3230</p></td></tr><tr><td style="width:157.5pt;border:solid windowtext 1.0pt;   border-top:none;   padding:0in 5.4pt 0in 5.4pt" valign="top" width="210"><p style="margin-bottom:0in;margin-bottom:.0001pt;line-height:   normal">RX Summ--Tranplnt/Endocr</p></td><td style="width:76.5pt;border-top:none;border-left:   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="102"><p style="margin-bottom:0in;margin-bottom:.0001pt;line-height:   normal">3250</p></td></tr><tr><td style="width:157.5pt;border:solid windowtext 1.0pt;   border-top:none;   padding:0in 5.4pt 0in 5.4pt" valign="top" width="210"><p style="margin-bottom:0in;margin-bottom:.0001pt;line-height:   normal">RX Summ--Chemo</p></td><td style="width: 76.5pt; border-width: medium 1pt 1pt medium; border-style: none solid solid none; border-color: -moz-use-text-color windowtext windowtext -moz-use-text-color; padding: 0in 5.4pt;" valign="top" width="102"><p style="margin-bottom: 0.0001pt; line-height: normal;">1390</p></td></tr><tr><td style="width: 157.5pt; border-right: 1pt solid windowtext; border-width: medium 1pt 1pt; border-style: none solid solid; border-color: -moz-use-text-color windowtext windowtext; -moz-border-top-colors: none; -moz-border-right-colors: none; -moz-border-bottom-colors: none; -moz-border-left-colors: none; -moz-border-image: none; padding: 0in 5.4pt;" valign="top" width="210"><p style="margin-bottom: 0.0001pt; line-height: normal;">RX Date Chemo</p></td><td style="width:76.5pt;border-top:none;border-left:   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="102"><p style="margin-bottom:0in;margin-bottom:.0001pt;line-height:   normal">1220</p></td></tr><tr><td style="width: 157.5pt; border-right: 1pt solid windowtext; border-width: medium 1pt 1pt; border-style: none solid solid; border-color: -moz-use-text-color windowtext windowtext; -moz-border-top-colors: none; -moz-border-right-colors: none; -moz-border-bottom-colors: none; -moz-border-left-colors: none; -moz-border-image: none; padding: 0in 5.4pt;" valign="top" width="210"><p style="margin-bottom:0in;margin-bottom:.0001pt;line-height:   normal">RX Summ--Systemic/Sur Seq</p></td><td style="width:76.5pt;border-top:none;border-left:   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="102"><p style="margin-bottom:0in;margin-bottom:.0001pt;line-height:   normal">1639</p></td></tr></tbody></table> </div><a name='2650'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>RX TEXT--HORMONE</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">2650</td><td style="text-align:center;">1000</td><td style="text-align:center;"><a href='#sources'>NPCR</a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">18135 - 19134</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>rxTextHormone</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Text area for information about hormonal treatment. </div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Text documentation is an essential component of a complete electronic report and is heavily utilized for quality control and special studies. Text is needed to justify coded values and to document supplemental information not transmitted within coded values. High-quality text documentation facilitates consolidation of information from multiple reporting sources at the central registry.<br /><br />The text field must contain a description that has been entered by the reporter independently from the code(s). If software generates text automatically from codes, the text cannot be utilized to check coded values. Information documenting the disease process should be entered manually from the medical record <strong>and should not be generated electronically from coded values</strong>.<strong><br /><br />Instructions</strong><ul><li>Prioritize entered information in the order of the fields listed below.</li><li>Text automatically generated from coded data is not acceptable.</li><li>NAACCR-approved abbreviations should be utilized (see Appendix G).</li><li>Do not repeat information from other text fields.</li><li>Additional comments can be continued in empty text fields, including Remarks. For text documentation that is continued from one text field to another, use asterisks or other symbols to indicate the connection with preceding text.</li><li>If information is missing from the record, state that it is missing.</li><li>Do not include irrelevant information.</li><li>Do not include information that the registry is not authorized to collect.</li></ul><em>Note:</em> For software that allows unlimited text, NAACCR recommends that the software indicate to the reporter the portion of the text that will be transmitted to the central registry. <br /><br /><strong>Suggestions for text:</strong><ul><li>Date treatment was started</li><li>Where treatment was given, e.g., at this facility, at another facility</li><li>Type of hormone or antihormone, e.g., Tamoxifen</li><li>Type of endocrine surgery or radiation, e.g., orchiectomy</li><li>Other treatment information, e.g., treatment cycle incomplete; unknown if hormones were given</li></ul> </div><div class='content chap10-para'><p>    <strong>Data Item(s) to be verified/validated using the text entered in this field</strong>    <br />After manual entry of the text field, ensure that the text entered both  agrees with the coded values and clearly justifies the selected codes in  the following fields: <br /></p>  <table style="margin-left: 99.9pt; border-collapse: collapse; border: medium none;" border="0" cellpadding="0" cellspacing="0">    <tbody>      <tr>        <td style="width:157.5pt;border:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="210">          <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height:   normal">            <strong>Item name</strong>          </p>        </td>        <td style="width:76.5pt;border:solid windowtext 1.0pt;   border-left:none;padding:0in 5.4pt 0in 5.4pt" valign="top" width="102">          <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height:   normal">            <strong>Item number</strong>          </p>        </td>      </tr>      <tr>        <td style="width:157.5pt;border:solid windowtext 1.0pt;   border-top:none;   padding:0in 5.4pt 0in 5.4pt" valign="top" width="210">          <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height:   normal">Date Initial RX SEER</p>        </td>        <td style="width:76.5pt;border-top:none;border-left:   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="102">          <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height:   normal">1260</p>        </td>      </tr>      <tr>        <td style="width:157.5pt;border:solid windowtext 1.0pt;   border-top:none;   padding:0in 5.4pt 0in 5.4pt" valign="top" width="210">          <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height:   normal">Date 1<sup>st </sup>Crs RX CoC</p>        </td>        <td style="width:76.5pt;border-top:none;border-left:   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="102">          <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height:   normal">1270</p>        </td>      </tr>      <tr>        <td style="width: 157.5pt; border-right: 1pt solid windowtext; border-width: medium 1pt 1pt; border-style: none solid solid; border-color: -moz-use-text-color windowtext windowtext; -moz-border-top-colors: none; -moz-border-right-colors: none; -moz-border-bottom-colors: none; -moz-border-left-colors: none; -moz-border-image: none; padding: 0in 5.4pt;" valign="top" width="210">          <p style="margin-bottom: 0.0001pt; line-height: normal;">RX Hosp--Hormone</p>        </td>        <td style="width:76.5pt;border-top:none;border-left:   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="102">          <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height:   normal">710</p>        </td>      </tr>      <tr>        <td style="width:157.5pt;border:solid windowtext 1.0pt;   border-top:none;   padding:0in 5.4pt 0in 5.4pt" valign="top" width="210">          <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height:   normal">RX Date Systemic</p>        </td>        <td style="width:76.5pt;border-top:none;border-left:   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="102">          <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height:   normal">3230</p>        </td>      </tr>      <tr>        <td style="width:157.5pt;border:solid windowtext 1.0pt;   border-top:none;   padding:0in 5.4pt 0in 5.4pt" valign="top" width="210">          <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height:   normal">RX Summ--Tranplnt/Endocr</p>        </td>        <td style="width:76.5pt;border-top:none;border-left:   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="102">          <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height:   normal">3250</p>        </td>      </tr>      <tr>        <td style="width:157.5pt;border:solid windowtext 1.0pt;   border-top:none;   padding:0in 5.4pt 0in 5.4pt" valign="top" width="210">          <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height:   normal">RX Summ--Hormone</p>        </td>        <td style="width:76.5pt;border-top:none;border-left:   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="102">          <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height:   normal">1400</p>        </td>      </tr>      <tr>        <td style="width: 157.5pt; border-right-color: windowtext; border-width: medium 1pt 1pt; border-style: none solid solid; padding: 0in 5.4pt;" valign="top" width="210">          <p style="margin-bottom: 0.0001pt; line-height: normal;">RX Date Hormone</p>        </td>        <td style="width:76.5pt;border-top:none;border-left:   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="102">          <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height:   normal">1230</p>        </td>      </tr>      <tr>        <td style="width:157.5pt;border:solid windowtext 1.0pt;   border-top:none;   padding:0in 5.4pt 0in 5.4pt" valign="top" width="210">          <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height:   normal">RX Summ--Systemic/Sur Seq</p>        </td>        <td style="width:76.5pt;border-top:none;border-left:   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="102">          <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height:   normal">1639</p>        </td>      </tr>    </tbody>  </table> </div><a name='2670'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>RX TEXT--OTHER</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">2670</td><td style="text-align:center;">1000</td><td style="text-align:center;"><a href='#sources'>NPCR</a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">20135 - 21134</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>rxTextOther</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Text area for manual documentation of information regarding the treatment of the tumor being reported with treatment that cannot be defined as surgery, radiation, or systemic therapy. This includes experimental treatments (when the mechanism of action for a drug is unknown), and blinded clinical trials. If the mechanism of action for the experimental drug is known, code to the appropriate treatment field. </div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Text documentation is an essential component of a complete electronic report and is heavily utilized for quality control and special studies. Text is needed to justify coded values and to document supplemental information not transmitted within coded values. High-quality text documentation facilitates consolidation of information from multiple reporting sources at the central registry.<br /><br />The text field must contain a description that has been entered by the reporter independently from the code(s). If software generates text automatically from codes, the text cannot be utilized to check coded values. Information documenting the disease process should be entered manually from the medical record <strong>and should not be generated electronically from coded values</strong>. <strong><br /><br />Instructions</strong><ul><li>Prioritize entered information in the order of the fields listed below.</li><li>Text automatically generated from coded data is not acceptable.</li><li>NAACCR-approved abbreviations should be utilized (see Appendix G).</li><li>Do not repeat information from other text fields.</li><li>Additional comments can be continued in empty text fields, including Remarks. For text documentation that is continued from one text field to another, use asterisks or other symbols to indicate the connection with preceding text.</li><li>If information is missing from the record, state that it is missing.</li><li>Do not include irrelevant information.</li><li>Do not include information that the registry is not authorized to collect.</li></ul><em>Note:</em> For software that allows unlimited text, NAACCR recommends that the software indicate to the reporter the portion of the text that will be transmitted to the central registry.<br /><br /><strong>Suggestions for text:</strong><ul><li>Date treatment was started</li><li>Where treatment was given, e.g., at this facility, at another facility</li><li>Type of other treatment, e.g., blinded clinical trial, hyperthermia</li><li>Other treatment information, e.g., treatment cycle incomplete; unknown if other treatment was given</li></ul> </div><div class='content chap10-para'><strong>Data Item(s) to be verified/validated using the text entered in this field</strong>  <br />After manual entry of the text field, ensure that the text entered both  agrees with the coded values and clearly justifies the selected codes in  the following fields:<br /><br /><table style="margin-left: 99.9pt; border-collapse: collapse; border: medium none;" border="0" cellpadding="0" cellspacing="0"><tbody><tr><td style="width:157.5pt;border:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="210"><p style="margin-bottom:0in;margin-bottom:.0001pt;line-height:   normal"><strong>Item name</strong></p></td><td style="width:76.5pt;border:solid windowtext 1.0pt;   border-left:none;padding:0in 5.4pt 0in 5.4pt" valign="top" width="102"><p style="margin-bottom:0in;margin-bottom:.0001pt;line-height:   normal"><strong>Item number</strong></p></td></tr><tr><td style="width:157.5pt;border:solid windowtext 1.0pt;   border-top:none;   padding:0in 5.4pt 0in 5.4pt" valign="top" width="210"><p style="margin-bottom:0in;margin-bottom:.0001pt;line-height:   normal">Date Initial RX SEER</p></td><td style="width:76.5pt;border-top:none;border-left:   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="102"><p style="margin-bottom:0in;margin-bottom:.0001pt;line-height:   normal">1260</p></td></tr><tr><td style="width: 157.5pt; border-right: 1pt solid windowtext; border-width: medium 1pt 1pt; border-style: none solid solid; border-color: -moz-use-text-color windowtext windowtext; -moz-border-top-colors: none; -moz-border-right-colors: none; -moz-border-bottom-colors: none; -moz-border-left-colors: none; -moz-border-image: none; padding: 0in 5.4pt;" valign="top" width="210"><p style="margin-bottom:0in;margin-bottom:.0001pt;line-height:   normal">Date 1<sup>st</sup> Crs RX CoC</p></td><td style="width:76.5pt;border-top:none;border-left:   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="102"><p style="margin-bottom:0in;margin-bottom:.0001pt;line-height:   normal">1270</p></td></tr><tr><td style="width:157.5pt;border:solid windowtext 1.0pt;   border-top:none;   padding:0in 5.4pt 0in 5.4pt" valign="top" width="210"><p style="margin-bottom:0in;margin-bottom:.0001pt;line-height:   normal">RX Summ--Other</p></td><td style="width:76.5pt;border-top:none;border-left:   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="102"><p style="margin-bottom:0in;margin-bottom:.0001pt;line-height:   normal">1420</p></td></tr><tr><td style="width:157.5pt;border:solid windowtext 1.0pt;   border-top:none;   padding:0in 5.4pt 0in 5.4pt" valign="top" width="210"><p style="margin-bottom: 0.0001pt; line-height: normal;">RX Date Other</p></td><td style="width:76.5pt;border-top:none;border-left:   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="102"><p style="margin-bottom:0in;margin-bottom:.0001pt;line-height:   normal">1250</p></td></tr><tr><td style="width:157.5pt;border:solid windowtext 1.0pt;   border-top:none;   padding:0in 5.4pt 0in 5.4pt" valign="top" width="210"><p style="margin-bottom:0in;margin-bottom:.0001pt;line-height:   normal">RX Hosp--Other</p></td><td style="width:76.5pt;border-top:none;border-left:   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="102"><p style="margin-bottom:0in;margin-bottom:.0001pt;line-height:   normal">730</p></td></tr></tbody></table> </div><a name='2620'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>RX TEXT--RADIATION (BEAM)</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">2620</td><td style="text-align:center;">1000</td><td style="text-align:center;"><a href='#sources'>NPCR</a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">15135 - 16134</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>rxTextRadiation</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Text area for manual documentation of information regarding treatment of the tumor being reported with beam radiation.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Text documentation is an essential component of a complete electronic report and is heavily utilized for quality control and special studies. Text is needed to justify coded values and to document supplemental information not transmitted within coded values. High-quality text documentation facilitates consolidation of information from multiple reporting sources at the central registry.<br /><br />The text field must contain a description that has been entered by the reporter independently from the code(s). If software generates text automatically from codes, the text cannot be utilized to check coded values. Information documenting the disease process should be entered manually from the medical record <strong>and should not be generated electronically from coded values</strong>.<strong><br /><br />Instructions</strong><ul><li>Prioritize entered information in the order of the fields listed below.</li><li>Text automatically generated from coded data is not acceptable.</li><li>NAACCR-approved abbreviations should be utilized (see Appendix G).</li><li>Do not repeat information from other text fields.</li><li>Additional comments can be continued in empty text fields, including Remarks. For text documentation that is continued from one text field to another, use asterisks or other symbols to indicate the connection with preceding text.</li><li>If information is missing from the record, state that it is missing.</li><li>Do not include irrelevant information.</li><li>Do not include information that the registry is not authorized to collect.</li></ul><em>Note:</em> For software that allows unlimited text, NAACCR recommends that the software indicate to the reporter the portion of the text that will be transmitted to the central registry.<br /><br /><strong>Suggestions for text:</strong><ul><li>Date radiation treatment began</li><li>Where treatment was given, e.g., at this facility, at another facility</li><li>Type(s) of beam radiation, e.g., Orthovoltage, Cobalt 60, MV X-rays, Electrons, Mixed modalities</li><li>Other treatment information, e.g., patient discontinued after 5 treatments; unknown if radiation was given</li></ul></div><div class='content chap10-para'><strong>Data Item(s) to be verified/validated using the text entered in this field</strong> <br />
After manual entry of the text field, ensure that the text entered both agrees with the coded values and clearly justifies the selected codes in the following fields: <br />
<br />
<table style="margin-left:99.9pt;border-collapse:collapse;border:none;" cellpadding="0" border="1" cellspacing="0">
     <tbody>
         <tr>
             <td style="width:157.5pt;border:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt" width="210" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal"><strong>Item name</strong></p>
             </td>
             <td style="width:76.5pt;border:solid windowtext 1.0pt; border-left:none;padding:0in 5.4pt 0in 5.4pt" width="102" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal"><strong>Item number</strong></p>
             </td>
         </tr>
         <tr>
             <td style="width:157.5pt;border:solid windowtext 1.0pt; border-top:none; padding:0in 5.4pt 0in 5.4pt" width="210" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;,&quot;sans-serif&quot;;Times New Roman&quot;;color:black">Date Initial RX SEER</span></p>
             </td>
             <td style="width:76.5pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt" width="102" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal">1260</p>
             </td>
         </tr>
         <tr>
             <td style="width:157.5pt;border:solid windowtext 1.0pt; border-top:none; padding:0in 5.4pt 0in 5.4pt" width="210" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;,&quot;sans-serif&quot;;Times New Roman&quot;;color:black">Date 1st Crs RX CoC</span></p>
             </td>
             <td style="width:76.5pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt" width="102" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal">1270</p>
             </td>
         </tr>
         <tr>
             <td style="width:157.5pt;border:solid windowtext 1.0pt; border-top:none; padding:0in 5.4pt 0in 5.4pt" width="210" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;,&quot;sans-serif&quot;;Times New Roman&quot;;color:black">RX Summ--Radiation</span></p>
             </td>
             <td style="width:76.5pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt" width="102" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal">1360</p>
             </td>
         </tr>
         <tr>
             <td style="width:157.5pt;border:solid windowtext 1.0pt; border-top:none; padding:0in 5.4pt 0in 5.4pt" width="210" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;,&quot;sans-serif&quot;;Times New Roman&quot;;color:black">RX Summ--Surg/Rad Seq</span></p>
             </td>
             <td style="width:76.5pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt" width="102" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal">1380</p>
             </td>
         </tr>
         <tr>
             <td style="width:157.5pt;border:solid windowtext 1.0pt; border-top:none; padding:0in 5.4pt 0in 5.4pt" width="210" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;,&quot;sans-serif&quot;;Times New Roman&quot;;color:black">Reason For No Radiation</span></p>
             </td>
             <td style="width:76.5pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt" width="102" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal">1430</p>
             </td>
         </tr>
         <tr>
             <td style="width:157.5pt;border:solid windowtext 1.0pt; border-top:none; padding:0in 5.4pt 0in 5.4pt" width="210" valign="top">
             <p style="margin-bottom: 0.0001pt; line-height: normal;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;,&quot;sans-serif&quot;;Times New Roman&quot;;color:black">RX Date Radiation</span></p>
             </td>
             <td style="width:76.5pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt" width="102" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal">1210</p>
             </td>
         </tr>
         <tr>
             <td style="width:157.5pt;border:solid windowtext 1.0pt; border-top:none; padding:0in 5.4pt 0in 5.4pt" width="210" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;,&quot;sans-serif&quot;;Times New Roman&quot;;color:black">Rad Regional RX Modality</span></p>
             </td>
             <td style="width:76.5pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt" width="102" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal">1570</p>
             </td>
         </tr>
         <tr>
             <td style="width:157.5pt;border:solid windowtext 1.0pt; border-top:none; padding:0in 5.4pt 0in 5.4pt" width="210" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;,&quot;sans-serif&quot;;Times New Roman&quot;;color:black">RX Hosp--Radiation</span></p>
             </td>
             <td style="width:76.5pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt" width="102" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal">690</p>
             </td>
         </tr>
         <tr>
             <td style="width: 157.5pt; border-right: 1pt solid windowtext; border-width: medium 1pt 1pt; border-style: none solid solid; border-color: -moz-use-text-color windowtext windowtext; -moz-border-top-colors: none; -moz-border-right-colors: none; -moz-border-bottom-colors: none; -moz-border-left-colors: none; -moz-border-image: none; padding: 0in 5.4pt;" width="210" valign="top">
             <p style="margin-bottom: 0.0001pt; line-height: normal;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;,&quot;sans-serif&quot;;Times New Roman&quot;;color:black">RX Date Rad Ended</span></p>
             </td>
             <td style="width:76.5pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt" width="102" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal">3220</p>
             </td>
         </tr>
         <tr>
             <td style="width:157.5pt;border:solid windowtext 1.0pt; border-top:none; padding:0in 5.4pt 0in 5.4pt" width="210" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;,&quot;sans-serif&quot;;Times New Roman&quot;;color:black">RX Summ--Rad to CNS</span></p>
             </td>
             <td style="width:76.5pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt" width="102" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal">1370</p>
             </td>
         </tr>
         <tr>
             <td style="width:157.5pt;border:solid windowtext 1.0pt; border-top:none; padding:0in 5.4pt 0in 5.4pt" width="210" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;,&quot;sans-serif&quot;;Times New Roman&quot;;color:black">Rad--No of Treatment Vol</span></p>
             </td>
             <td style="width:76.5pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt" width="102" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal">1520</p>
             </td>
         </tr>
         <tr>
             <td style="width:157.5pt;border:solid windowtext 1.0pt; border-top:none; padding:0in 5.4pt 0in 5.4pt" width="210" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;,&quot;sans-serif&quot;;Times New Roman&quot;;color:black">Rad--Regional Dose cGy</span></p>
             </td>
             <td style="width:76.5pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt" width="102" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal">1510</p>
             </td>
         </tr>
         <tr>
             <td style="width:157.5pt;border:solid windowtext 1.0pt; border-top:none; padding:0in 5.4pt 0in 5.4pt" width="210" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;,&quot;sans-serif&quot;;Times New Roman&quot;;color:black">Rad Treatment Volume</span></p>
             </td>
             <td style="width:76.5pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt" width="102" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal">1540</p>
             </td>
         </tr>
         <tr>
             <td style="width:157.5pt;border:solid windowtext 1.0pt; border-top:none; padding:0in 5.4pt 0in 5.4pt" width="210" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;,&quot;sans-serif&quot;;Times New Roman&quot;;color:black">Rad Location of RX</span></p>
             </td>
             <td style="width:76.5pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt" width="102" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal">1550</p>
             </td>
         </tr>
         <tr>
             <td style="width:157.5pt;border:solid windowtext 1.0pt; border-top:none; padding:0in 5.4pt 0in 5.4pt" width="210" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;,&quot;sans-serif&quot;;Times New Roman&quot;;color:black">Rad Boost RX Modality</span></p>
             </td>
             <td style="width:76.5pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt" width="102" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal">3200</p>
             </td>
         </tr>
         <tr>
             <td style="width:157.5pt;border:solid windowtext 1.0pt; border-top:none; padding:0in 5.4pt 0in 5.4pt" width="210" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;,&quot;sans-serif&quot;;Times New Roman&quot;;color:black">Rad Boost Dose cGy</span></p>
             </td>
             <td style="width:76.5pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt" width="102" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal">3210</p>
  </td>
         </tr>
         <tr>
             <td style="width:157.5pt;border:solid windowtext 1.0pt; border-top:none; padding:0in 5.4pt 0in 5.4pt" width="210" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal">Phase I dose per Fraction<br />
             </p>
             </td>
             <td style="width:76.5pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt" width="102" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal">1501</p>
             </td>
         </tr>
         <tr>
             <td style="width:157.5pt;border:solid windowtext 1.0pt; border-top:none; padding:0in 5.4pt 0in 5.4pt" width="210" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal">Phase II dose per Fraction</p>
             </td>
             <td style="width:76.5pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt" width="102" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal">1511</p>
             </td>
         </tr>
         <tr>
             <td style="width:157.5pt;border:solid windowtext 1.0pt; border-top:none; padding:0in 5.4pt 0in 5.4pt" width="210" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal">Phase III dose per Fraction</p>
             </td>
             <td style="width:76.5pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt" width="102" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal">1521</p>
             </td>
         </tr>
         <tr>
             <td style="width:157.5pt;border:solid windowtext 1.0pt; border-top:none; padding:0in 5.4pt 0in 5.4pt" width="210" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal">Phase I Number of Fractions</p>
             </td>
             <td style="width:76.5pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt" width="102" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal">1503</p>
             </td>
         </tr>
         <tr>
             <td style="width:157.5pt;border:solid windowtext 1.0pt; border-top:none; padding:0in 5.4pt 0in 5.4pt" width="210" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal">Phase II Number of Fractions</p>
             </td>
             <td style="width:76.5pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt" width="102" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal">1513</p>
             </td>
         </tr>
         <tr>
             <td style="width:157.5pt;border:solid windowtext 1.0pt; border-top:none; padding:0in 5.4pt 0in 5.4pt" width="210" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal">Phase III Number of Fractions</p>
             </td>
             <td style="width:76.5pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt" width="102" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal">1523</p>
             </td>
         </tr>
         <tr>
             <td style="width:157.5pt;border:solid windowtext 1.0pt; border-top:none; padding:0in 5.4pt 0in 5.4pt" width="210" valign="top">
             <p style="margin-bottom: 0.0001pt; line-height: normal;">Phase I Radiation Treatment Modality</p>
             </td>
             <td style="width:76.5pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt" width="102" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal">1506</p>
             </td>
         </tr>
         <tr>
             <td style="width:157.5pt;border:solid windowtext 1.0pt; border-top:none; padding:0in 5.4pt 0in 5.4pt" width="210" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal">Phase II Radiation Treatment Modality</p>
             </td>
             <td style="width:76.5pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt" width="102" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal">1516</p>
             </td>
         </tr>
         <tr>
             <td style="width: 157.5pt; border-color: currentcolor windowtext windowtext; border-style: none solid solid; border-width: medium 1pt 1pt; border-image: none 100% / 1 / 0 stretch; -moz-border-top-colors: none; -moz-border-left-colors: none; -moz-border-bottom-colors: none; -moz-border-right-colors: none; padding: 0in 5.4pt;" width="210" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal">Phase III Radiation Treatment Modality</p>
             </td>
             <td style="width:76.5pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt" width="102" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal">1526</p>
             </td>
         </tr>
     </tbody>
</table></div><a name='2630'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>RX TEXT--RADIATION OTHER</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">2630</td><td style="text-align:center;">1000</td><td style="text-align:center;"><a href='#sources'>NPCR</a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">16135 - 17134</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>rxTextRadiationOther</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Text area for manual documentation of information regarding treatment of the tumor being reported with radiation other than beam radiation. This includes brachytherapy and systemic radiation therapy.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Text documentation is an essential component of a complete electronic report and is heavily utilized for quality control and special studies. Text is needed to justify coded values and to document supplemental information not transmitted within coded values. High-quality text documentation facilitates consolidation of information from multiple reporting sources at the central registry.<br /><br />The text field must contain a description that has been entered by the reporter independently from the code(s). If software generates text automatically from codes, the text cannot be utilized to check coded values. Information documenting the disease process should be entered manually from the medical record <strong>and should not be generated electronically from coded values</strong>.<br /><br /><strong>Instructions</strong><ul><li>Prioritize entered information in the order of the fields listed below.</li><li>Text automatically generated from coded data is not acceptable.</li><li>NAACCR-approved abbreviations should be utilized (see Appendix G).</li><li>Do not repeat information from other text fields.</li><li>Additional comments can be continued in empty text fields, including Remarks. For text documentation that is continued from one text field to another, use asterisks or other symbols to indicate the connection with preceding text.</li><li>If information is missing from the record, state that it is missing.</li><li>Do not include irrelevant information.</li><li>Do not include information that the registry is not authorized to collect.</li></ul><em>Note:</em> For software that allows unlimited text, NAACCR recommends that the software indicate to the reporter the portion of the text that will be transmitted to the central registry.<strong><br /><br />Suggestions for text:</strong><ul><li>Date treatment was started</li><li>Where treatment was given, e.g., at this facility, at another facility</li><li>Type(s) of nonbeam radiation, e.g., High Dose rate brachytherapy, seed implant, Radioisotopes (I-131)</li><li>Other treatment information, e.g., unknown if radiation was given</li></ul></div><div class='content chap10-para'><strong>Data Item(s) to be verified/validated using the text entered in this field</strong> <br />
After manual entry of the text field, ensure that the text entered both agrees with the coded values and clearly justifies the selected codes in the following fields: <br />
<br />
<table style="margin-left:99.9pt;border-collapse:collapse;border:none;" cellpadding="0" border="1" cellspacing="0">
     <tbody>
         <tr>
             <td style="width:157.5pt;border:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt" width="210" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal"><strong>Item name</strong></p>
             </td>
             <td style="width:76.5pt;border:solid windowtext 1.0pt; border-left:none;padding:0in 5.4pt 0in 5.4pt" width="102" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal"><strong>Item number</strong></p>
             </td>
         </tr>
         <tr>
             <td style="width:157.5pt;border:solid windowtext 1.0pt; border-top:none; padding:0in 5.4pt 0in 5.4pt" width="210" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;,&quot;sans-serif&quot;;Times New Roman&quot;;color:black">Date Initial RX SEER</span></p>
             </td>
             <td style="width:76.5pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt" width="102" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal">1260</p>
             </td>
         </tr>
         <tr>
             <td style="width:157.5pt;border:solid windowtext 1.0pt; border-top:none; padding:0in 5.4pt 0in 5.4pt" width="210" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;,&quot;sans-serif&quot;;Times New Roman&quot;;color:black">Date 1st Crs RX CoC</span></p>
             </td>
             <td style="width:76.5pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt" width="102" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal">1270</p>
             </td>
         </tr>
         <tr>
             <td style="width:157.5pt;border:solid windowtext 1.0pt; border-top:none; padding:0in 5.4pt 0in 5.4pt" width="210" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;,&quot;sans-serif&quot;;Times New Roman&quot;;color:black">RX Summ--Radiation</span></p>
             </td>
             <td style="width:76.5pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt" width="102" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal">1360</p>
             </td>
         </tr>
         <tr>
             <td style="width:157.5pt;border:solid windowtext 1.0pt; border-top:none; padding:0in 5.4pt 0in 5.4pt" width="210" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;,&quot;sans-serif&quot;;Times New Roman&quot;;color:black">RX Summ--Surg/Rad Seq</span></p>
             </td>
             <td style="width:76.5pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt" width="102" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal">1380</p>
             </td>
         </tr>
         <tr>
             <td style="width:157.5pt;border:solid windowtext 1.0pt; border-top:none; padding:0in 5.4pt 0in 5.4pt" width="210" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;,&quot;sans-serif&quot;;Times New Roman&quot;;color:black">Reason For No Radiation</span></p>
             </td>
             <td style="width:76.5pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt" width="102" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal">1430</p>
             </td>
         </tr>
         <tr>
             <td style="width:157.5pt;border:solid windowtext 1.0pt; border-top:none; padding:0in 5.4pt 0in 5.4pt" width="210" valign="top">
             <p style="margin-bottom: 0.0001pt; line-height: normal;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;,&quot;sans-serif&quot;;Times New Roman&quot;;color:black">RX Date Radiation</span></p>
             </td>
             <td style="width:76.5pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt" width="102" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal">1210</p>
             </td>
         </tr>
         <tr>
             <td style="width:157.5pt;border:solid windowtext 1.0pt; border-top:none; padding:0in 5.4pt 0in 5.4pt" width="210" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;,&quot;sans-serif&quot;;Times New Roman&quot;;color:black">Rad Regional RX Modality</span></p>
             </td>
             <td style="width:76.5pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt" width="102" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal">1570</p>
             </td>
         </tr>
         <tr>
             <td style="width:157.5pt;border:solid windowtext 1.0pt; border-top:none; padding:0in 5.4pt 0in 5.4pt" width="210" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;,&quot;sans-serif&quot;;Times New Roman&quot;;color:black">RX Hosp--Radiation</span></p>
             </td>
             <td style="width:76.5pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt" width="102" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal">690</p>
             </td>
         </tr>
         <tr>
             <td style="width: 157.5pt; border-right: 1pt solid windowtext; border-width: medium 1pt 1pt; border-style: none solid solid; border-color: -moz-use-text-color windowtext windowtext; -moz-border-top-colors: none; -moz-border-right-colors: none; -moz-border-bottom-colors: none; -moz-border-left-colors: none; -moz-border-image: none; padding: 0in 5.4pt;" width="210" valign="top">
             <p style="margin-bottom: 0.0001pt; line-height: normal;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;,&quot;sans-serif&quot;;Times New Roman&quot;;color:black">RX Date Rad Ended</span></p>
             </td>
             <td style="width:76.5pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt" width="102" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal">3220</p>
             </td>
         </tr>
         <tr>
             <td style="width:157.5pt;border:solid windowtext 1.0pt; border-top:none; padding:0in 5.4pt 0in 5.4pt" width="210" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;,&quot;sans-serif&quot;;Times New Roman&quot;;color:black">RX Summ--Rad to CNS</span></p>
             </td>
             <td style="width:76.5pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt" width="102" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal">1370</p>
             </td>
         </tr>
         <tr>
             <td style="width:157.5pt;border:solid windowtext 1.0pt; border-top:none; padding:0in 5.4pt 0in 5.4pt" width="210" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;,&quot;sans-serif&quot;;Times New Roman&quot;;color:black">Rad--No of Treatment Vol</span></p>
             </td>
             <td style="width:76.5pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt" width="102" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal">1520</p>
             </td>
         </tr>
         <tr>
             <td style="width:157.5pt;border:solid windowtext 1.0pt; border-top:none; padding:0in 5.4pt 0in 5.4pt" width="210" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;,&quot;sans-serif&quot;;Times New Roman&quot;;color:black">Rad--Regional Dose cGy</span></p>
             </td>
             <td style="width:76.5pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt" width="102" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal">1510</p>
             </td>
         </tr>
         <tr>
             <td style="width:157.5pt;border:solid windowtext 1.0pt; border-top:none; padding:0in 5.4pt 0in 5.4pt" width="210" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;,&quot;sans-serif&quot;;Times New Roman&quot;;color:black">Rad Treatment Volume</span></p>
             </td>
             <td style="width:76.5pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt" width="102" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal">1540</p>
             </td>
         </tr>
         <tr>
             <td style="width:157.5pt;border:solid windowtext 1.0pt; border-top:none; padding:0in 5.4pt 0in 5.4pt" width="210" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;,&quot;sans-serif&quot;;Times New Roman&quot;;color:black">Rad Location of RX</span></p>
             </td>
             <td style="width:76.5pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt" width="102" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal">1550</p>
             </td>
         </tr>
         <tr>
             <td style="width:157.5pt;border:solid windowtext 1.0pt; border-top:none; padding:0in 5.4pt 0in 5.4pt" width="210" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;,&quot;sans-serif&quot;;Times New Roman&quot;;color:black">Rad Boost RX Modality</span></p>
             </td>
             <td style="width:76.5pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt" width="102" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal">3200</p>
             </td>
         </tr>
         <tr>
             <td style="width:157.5pt;border:solid windowtext 1.0pt; border-top:none; padding:0in 5.4pt 0in 5.4pt" width="210" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;,&quot;sans-serif&quot;;Times New Roman&quot;;color:black">Rad Boost Dose cGy</span></p>
             </td>
             <td style="width:76.5pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt" width="102" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal">3210</p>
  </td>
         </tr>
         <tr>
             <td style="width:157.5pt;border:solid windowtext 1.0pt; border-top:none; padding:0in 5.4pt 0in 5.4pt" width="210" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal">Phase I dose per Fraction<br />
             </p>
             </td>
             <td style="width:76.5pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt" width="102" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal">1501</p>
             </td>
         </tr>
         <tr>
             <td style="width:157.5pt;border:solid windowtext 1.0pt; border-top:none; padding:0in 5.4pt 0in 5.4pt" width="210" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal">Phase II dose per Fraction</p>
             </td>
             <td style="width:76.5pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt" width="102" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal">1511</p>
             </td>
         </tr>
         <tr>
             <td style="width:157.5pt;border:solid windowtext 1.0pt; border-top:none; padding:0in 5.4pt 0in 5.4pt" width="210" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal">Phase III dose per Fraction</p>
             </td>
             <td style="width:76.5pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt" width="102" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal">1521</p>
             </td>
         </tr>
         <tr>
             <td style="width:157.5pt;border:solid windowtext 1.0pt; border-top:none; padding:0in 5.4pt 0in 5.4pt" width="210" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal">Phase I Number of Fractions</p>
             </td>
             <td style="width:76.5pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt" width="102" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal">1503</p>
             </td>
         </tr>
         <tr>
             <td style="width:157.5pt;border:solid windowtext 1.0pt; border-top:none; padding:0in 5.4pt 0in 5.4pt" width="210" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal">Phase II Number of Fractions</p>
             </td>
             <td style="width:76.5pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt" width="102" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal">1513</p>
             </td>
         </tr>
         <tr>
             <td style="width:157.5pt;border:solid windowtext 1.0pt; border-top:none; padding:0in 5.4pt 0in 5.4pt" width="210" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal">Phase III Number of Fractions</p>
             </td>
             <td style="width:76.5pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt" width="102" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal">1523</p>
             </td>
         </tr>
         <tr>
             <td style="width:157.5pt;border:solid windowtext 1.0pt; border-top:none; padding:0in 5.4pt 0in 5.4pt" width="210" valign="top">
             <p style="margin-bottom: 0.0001pt; line-height: normal;">Phase I Radiation Treatment Modality</p>
             </td>
             <td style="width:76.5pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt" width="102" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal">1506</p>
             </td>
         </tr>
         <tr>
             <td style="width:157.5pt;border:solid windowtext 1.0pt; border-top:none; padding:0in 5.4pt 0in 5.4pt" width="210" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal">Phase II Radiation Treatment Modality</p>
             </td>
             <td style="width:76.5pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt" width="102" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal">1516</p>
             </td>
         </tr>
         <tr>
             <td style="width: 157.5pt; border-color: currentcolor windowtext windowtext; border-style: none solid solid; border-width: medium 1pt 1pt; border-image: none 100% / 1 / 0 stretch; -moz-border-top-colors: none; -moz-border-left-colors: none; -moz-border-bottom-colors: none; -moz-border-right-colors: none; padding: 0in 5.4pt;" width="210" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal">Phase III Radiation Treatment Modality</p>
             </td>
             <td style="width:76.5pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt" width="102" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal">1526</p>
             </td>
         </tr>
     </tbody>
</table></div><a name='2610'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>RX TEXT--SURGERY</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">2610</td><td style="text-align:center;">1000</td><td style="text-align:center;"><a href='#sources'>NPCR</a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">14135 - 15134</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>rxTextSurgery</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Text area for information describing all surgical procedures performed as part of treatment.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Text documentation is an essential component of a complete electronic report and is heavily utilized for quality control and special studies. Text is needed to justify coded values and to document supplemental information not transmitted within coded values. High-quality text documentation facilitates consolidation of information from multiple reporting sources at the central registry.<br /><br />The text field must contain a description that has been entered by the reporter independently from the code(s). If software generates text automatically from codes, the text cannot be utilized to check coded values. Information documenting the disease process should be entered manually from the medical record <strong>and should not be generated electronically from coded values</strong>.<strong><br /><br />Instructions</strong><ul><li>Prioritize entered information in the order of the fields listed below.</li><li>Text automatically generated from coded data is not acceptable.</li><li>NAACCR-approved abbreviations should be utilized (see Appendix G).</li><li>Do not repeat information from other text fields.</li><li>Additional comments can be continued in empty text fields, including Remarks. For text documentation that is continued from one text field to another, use asterisks or other symbols to indicate the connection with preceding text.</li><li>If information is missing from the record, state that it is missing.</li><li>Do not include irrelevant information.</li><li>Do not include information that the registry is not authorized to collect.</li></ul><em>Note:</em> For software that allows unlimited text, NAACCR recommends that the software indicate to the reporter the portion of the text that will be transmitted to the central registry.<strong><br /><br />Suggestions for text:</strong><ul><li>Date of each procedure.</li><li>Type(s) of surgical procedure(s), including excisional biopsies and surgery to other and distant sites.</li><li>Lymph nodes removed.</li><li>Regional tissues removed.</li><li>Metastatic sites.</li><li>Facility where each procedure was performed.</li><li>Record positive and negative findings. Record positive findings first.</li><li>Other treatment information, e.g., planned procedure aborted; unknown if surgery performed.</li></ul></div><div class='content chap10-para'><strong>Data Item(s) to be verified/validated using the text entered in this field</strong> After manual entry of the text field, ensure that the text entered both agrees with the coded values and clearly justifies the selected codes in the following fields:<br />
<br />
<table style="margin-left:99.9pt;border-collapse:collapse;border:none;" cellpadding="0" border="1" cellspacing="0">
     <tbody>
         <tr>
             <td style="width:157.5pt;border:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt" width="210" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal"><strong>Item name</strong></p>
             </td>
             <td style="width:76.5pt;border:solid windowtext 1.0pt; border-left:none;padding:0in 5.4pt 0in 5.4pt" width="102" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal"><strong>Item number</strong></p>
             </td>
         </tr>
         <tr>
             <td style="width:157.5pt;border:solid windowtext 1.0pt; border-top:none; padding:0in 5.4pt 0in 5.4pt" width="210" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal">Date Initial RX SEER</p>
             </td>
             <td style="width:76.5pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt" width="102" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal">1260</p>
             </td>
         </tr>
         <tr>
             <td style="width:157.5pt;border:solid windowtext 1.0pt; border-top:none; padding:0in 5.4pt 0in 5.4pt" width="210" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal">Date 1st Crs RX CoC</p>
             </td>
             <td style="width:76.5pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt" width="102" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal">1270</p>
             </td>
         </tr>
         <tr>
             <td style="width:157.5pt;border:solid windowtext 1.0pt; border-top:none; padding:0in 5.4pt 0in 5.4pt" width="210" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal">RX Date Surgery</p>
             </td>
             <td style="width:76.5pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt" width="102" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal">1200</p>
             </td>
         </tr>
         <tr>
             <td style="width:157.5pt;border:solid windowtext 1.0pt; border-top:none; padding:0in 5.4pt 0in 5.4pt" width="210" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal">RX Summ--Surg Prim Site</p>
             </td>
             <td style="width:76.5pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt" width="102" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal">1290</p>
             </td>
         </tr>
         <tr>
             <td style="width:157.5pt;border:solid windowtext 1.0pt; border-top:none; padding:0in 5.4pt 0in 5.4pt" width="210" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal">RX Hosp--Surg Prim Site</p>
             </td>
             <td style="width:76.5pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt" width="102" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal">670</p>
             </td>
         </tr>
         <tr>
             <td style="width:157.5pt;border:solid windowtext 1.0pt; border-top:none; padding:0in 5.4pt 0in 5.4pt" width="210" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal">RX Summ--Scope Reg LN Sur</p>
             </td>
             <td style="width:76.5pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt" width="102" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal">1292</p>
             </td>
         </tr>
         <tr>
             <td style="width:157.5pt;border:solid windowtext 1.0pt; border-top:none; padding:0in 5.4pt 0in 5.4pt" width="210" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal">RX Hosp--Scope Reg LN Sur</p>
             </td>
             <td style="width:76.5pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt" width="102" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal">672</p>
             </td>
         </tr>
         <tr>
             <td style="width:157.5pt;border:solid windowtext 1.0pt; border-top:none; padding:0in 5.4pt 0in 5.4pt" width="210" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal">RX Summ--Surg Oth Reg/Dis</p>
             </td>
             <td style="width:76.5pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt" width="102" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal">1294</p>
             </td>
         </tr>
         <tr>
             <td style="width:157.5pt;border:solid windowtext 1.0pt; border-top:none; padding:0in 5.4pt 0in 5.4pt" width="210" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal">RX Hosp--Surg Oth Reg/Dis</p>
             </td>
             <td style="width:76.5pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt" width="102" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal">674</p>
             </td>
         </tr>
         <tr>
             <td style="width:157.5pt;border:solid windowtext 1.0pt; border-top:none; padding:0in 5.4pt 0in 5.4pt" width="210" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal">Reason for No Surgery</p>
             </td>
             <td style="width:76.5pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt" width="102" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal">1340</p>
             </td>
         </tr>
         <tr>
             <td style="width:157.5pt;border:solid windowtext 1.0pt; border-top:none; padding:0in 5.4pt 0in 5.4pt" width="210" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal">RX Summ--Surgical Margins</p>
             </td>
             <td style="width:76.5pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt" width="102" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal">1320</p>
             </td>
         </tr>
         <tr>
             <td style="width:157.5pt;border:solid windowtext 1.0pt; border-top:none; padding:0in 5.4pt 0in 5.4pt" width="210" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal">RX Hosp--Palliative Proc</p>
             </td>
             <td style="width:76.5pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt" width="102" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal">3280</p>
             </td>
         </tr>
         <tr>
             <td style="width:157.5pt;border:solid windowtext 1.0pt; border-top:none; padding:0in 5.4pt 0in 5.4pt" width="210" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal">RX Summ--Palliative Proc</p>
             </td>
             <td style="width:76.5pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt" width="102" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal">3270</p>
             </td>
         </tr>
         <tr>
             <td style="width:157.5pt;border:solid windowtext 1.0pt; border-top:none; padding:0in 5.4pt 0in 5.4pt" width="210" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal">Text--Place of Diagnosis</p>
             </td>
             <td style="width:76.5pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt" width="102" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal">2690</p>
             </td>
         </tr>
         <tr>
             <td style="width:157.5pt;border:solid windowtext 1.0pt; border-top:none; padding:0in 5.4pt 0in 5.4pt" width="210" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal">RX Summ--Surg/Rad Seq</p>
             </td>
             <td style="width:76.5pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt" width="102" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal">1380</p>
             </td>
         </tr>
         <tr>
             <td style="width:157.5pt;border:solid windowtext 1.0pt; border-top:none; padding:0in 5.4pt 0in 5.4pt" width="210" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal">RX Summ--Systemic/Sur Seq&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>
             </td>
             <td style="width:76.5pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt" width="102" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal">1639</p>
                        </td>
         </tr>
     </tbody>
</table></div><a name='3923'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>S CATEGORY CLINICAL</strong></td><td style="text-align:right;font-weight:bold;"><strong>Revised</strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">3923</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>NAACCR</a></td><td style="text-align:center;">2018</td><td style="text-align:center;">18</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1985 - 1985</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>sCategoryClinical</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>S Category Clinical combines the results of pre-orchiectomy Alpha Fetoprotein (AFP), Human Chorionic Gonadotropin (hCG) and Lactate Dehydrogenase (LDH) into a summary S value.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para mark-changed'>S Category Clinical is required for prognostic stage grouping in AJCC 8th edition, Chapter 59 















<em>Testis</em>. It is a new data item for cases diagnosed 1/1/2018+.</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>0</td><td class='code-desc'>S0: Marker study levels within normal levels
 </td></tr><tr class='code-row'><td class='code-nbr'>1</td><td class='code-desc'>S1: At least one of these values is elevated AND<br/>
LDH less than 1.5 x N* AND<br/>
hCG (mIU/L) less than 5,000 AND<br/>
AFP (ng/mL) less than 1,000 
</td></tr><tr class='code-row'><td class='code-nbr'>2</td><td class='code-desc'>S2:<br/>
LDH 1.5 x N* to 10 x N* OR<br/> 
hCG (mIU/L) 5,000 to 50,000 OR<br/> 
AFP (ng/mL) 1,000 to 10,000
</td></tr><tr class='code-row'><td class='code-nbr'>3</td><td class='code-desc'>S3: Only one elevated test is needed<br/>
LDH greater than 10 x N* OR<br/> 
hcG (mIU/mL) greater than 50,000 OR<br/> 
AFP (ng/mL) greater than 10,000<br/>
 </td></tr><tr class='code-row'><td class='code-nbr'>9</td><td class='code-desc'>SX: Not documented in medical record<br/>
S Category Clinical not assessed or unknown if assessed
</td></tr><tr class='code-row'><td class='code-nbr' colspan='2'></td></tr></table></div><div class='content chap10-para'><div>
  <!--[if gte mso 10]>  <![endif]-->*N indicates the upper limit of normal for the LDH assay. 
<div>&nbsp;</div><div>Each Site-Specific Data Item (SSDI) applies only to selected primary sites, histologies, and years of diagnosis. Depending on applicability and standard-setter requirements, SSDIs may be left blank.&nbsp;</div></div></div><a name='3924'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>S CATEGORY PATHOLOGICAL</strong></td><td style="text-align:right;font-weight:bold;"><strong>Revised</strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">3924</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>NAACCR</a></td><td style="text-align:center;">2018</td><td style="text-align:center;">18</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1986 - 1986</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>sCategoryPathological</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>S Category Pathological combines the results of post-orchiectomy Alpha Fetoprotein (AFP), Human Chorionic Gonadotropin (hCG) and Lactate Dehydrogenase (LDH) into a summary S value.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para mark-changed'>S Category Pathological is required for prognostic stage grouping in AJCC 8th edition, Chapter 59, 










<em>Testis</em>. It is a new data item for cases diagnosed 1/1/2018+.</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para mark-changed'><table><tr class='code-row'><td class='code-nbr'>0</td><td class='code-desc'>S0: Marker study levels within normal levels </td></tr><tr class='code-row'><td class='code-nbr'>1</td><td class='code-desc'>S1: At least one of these values is elevated AND<br/>
  LDH less than 1.5 x N* AND<br/>
  hCG (mIU/L) less than 5,000 AND<br/> 
  AFP (ng/mL) less than 1,000 
</td></tr><tr class='code-row'><td class='code-nbr'>2</td><td class='code-desc'>S2<br/>
  LDH 1.5 x N* to 10 x N* OR<br/> 
  hCG (mIU/L) 5,000 to 50,000 OR<br/> 
  AFP (ng/mL) 1,000 to 10,000
</td></tr><tr class='code-row'><td class='code-nbr'>3</td><td class='code-desc'>S3: Only one elevated test is needed <br/>
  LDH greater than 10 x N* OR<br/> 
  hcG (mIU/mL) greater than 50,000 OR<br/> 
  AFP (ng/mL) greater than 10,000
</td></tr><tr class='code-row'><td class='code-nbr'>5</td><td class='code-desc'>Post orchiectomy serum tumor markers unknown or not done but pre orchiectomy serum tumor markers were normal </td></tr><tr class='code-row'><td class='code-nbr'>9</td><td class='code-desc'>SX: Not documented in medical record<br/>
S Category Pathological not assessed or unknown if assessed
</td></tr><tr class='code-row'><td class='code-nbr' colspan='2'></td></tr></table></div><div class='content chap10-para'><div>*N indicates the upper limit of normal for the LDH assay. 
<div>&nbsp;</div><div>Each Site-Specific Data Item (SSDI) applies only to selected primary sites, histologies, and years of diagnosis. Depending on applicability and standard-setter requirements, SSDIs may be left blank.&nbsp;</div></div></div><a name='3925'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>SARCOMATOID FEATURES</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">3925</td><td style="text-align:center;">3</td><td style="text-align:center;"><a href='#sources'>NAACCR</a></td><td style="text-align:center;">2018</td><td style="text-align:center;">18</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1836 - 1838</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>sarcomatoidFeatures</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Sarcomatoid features: present or absent and percentage refers to the observation of sheets and fascicles of malignant spindle cells in a kidney tumor which can occur across all histologic subtypes. The percentage of sarcomatoid component has been shown to correlate with cancer-specific mortality.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Sarcomatoid features for Kidney is a Registry Data Collection Variable in AJCC. It was previously collected as Kidney, CS SSF #4.</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>000</td><td class='code-desc'>Sarcomatoid features not present/not identified </td></tr><tr class='code-row'><td class='code-nbr'>000-100</td><td class='code-desc'>Sarcomatoid features 1-100%</td></tr><tr class='code-row'><td class='code-nbr'>R01</td><td class='code-desc'>Sarcomatoid features stated as less than 10%</td></tr><tr class='code-row'><td class='code-nbr'>R02</td><td class='code-desc'>Sarcomatoid features stated as range 10%-30% present</td></tr><tr class='code-row'><td class='code-nbr'>R03</td><td class='code-desc'>Sarcomatoid features stated as a range 31% to 50% present</td></tr><tr class='code-row'><td class='code-nbr'>R04</td><td class='code-desc'>Sarcomatoid features stated as a range 51% to 80% present</td></tr><tr class='code-row'><td class='code-nbr'>R05</td><td class='code-desc'>Sarcomatoid features stated as greater than 80%</td></tr><tr class='code-row'><td class='code-nbr'>XX6</td><td class='code-desc'>Sarcomatoid features present, percentage unknown</td></tr><tr class='code-row'><td class='code-nbr'>XX7</td><td class='code-desc'>Not applicable: Not a renal cell carcinoma morphology</td></tr><tr class='code-row'><td class='code-nbr'>XX8</td><td class='code-desc'>Not applicable: Information not collected for this case<br/>
(If this information is required by your standard setter, use of code XX8 may result in an edit error.)
</td></tr><tr class='code-row'><td class='code-nbr'>XX9</td><td class='code-desc'>Not documented in medical record<br/>
Sarcomatoid features not assessed or unknown if assessed<br/>
No surgical resection of primary site is performed
</td></tr><tr class='code-row'><td class='code-nbr'></td><td class='code-desc'> </td></tr></table></div><div class='content chap10-para'>Each Site-Specific Data Item (SSDI) applies only to selected primary sites, histologies, and years of diagnosis. Depending on applicability and standard-setter requirements, SSDIs may be left blank. </div><a name='3926'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>SCHEMA DISCRIMINATOR 1</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">3926</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>NAACCR</a></td><td style="text-align:center;">2018</td><td style="text-align:center;">18</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1731 - 1731</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>schemaDiscriminator1</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Captures additional information needed to generate AJCC ID [995] and Schema ID [3800] for some anatomic sites. Discriminators can be based on sub site, histology or other features which affect prognosis.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>A schema discriminator is used to assign AJCC ID [995] when site and histology alone are insufficient to identify the applicable AJCC staging method and to assign Schema ID [3800], which links each case to the appropriate SSDIs, Summary Stage and EOD data collection system.</div><div class='content chap10-para'><strong>Codes (The information recorded in Schema Discriminator differs for each anatomic site. See the SSDI manual for most current version of the site-specific codes and coding structures.)</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'></td><td class='code-desc'> </td></tr></table></div><div class='content chap10-para'>Each Site-Specific Data Item (SSDI) applies only to selected primary sites, histologies, and years of diagnosis. Depending on applicability and standard-setter requirements, SSDIs may be left blank. </div><a name='3927'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>SCHEMA DISCRIMINATOR 2</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">3927</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>NAACCR</a></td><td style="text-align:center;">2018</td><td style="text-align:center;">18</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1732 - 1732</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>schemaDiscriminator2</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Captures additional information needed to generate AJCC ID [995] and Schema ID [3800] for some anatomic sites. Discriminators can be based on sub site, histology or other features which affect prognosis.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>A schema discriminator is used to assign AJCC ID [995] when site and histology alone are insufficient to identify the applicable AJCC staging method and to assign Schema ID [3800], which links each case to the appropriate SSDIs, Summary Stage and EOD data collection system.</div><div class='content chap10-para'><strong>Codes (The information recorded in Schema Discriminator differs for each anatomic site. See the SSDI manual for most current version of the site-specific codes and coding structures.)</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'></td><td class='code-desc'> </td></tr></table></div><div class='content chap10-para'>Each Site-Specific Data Item (SSDI) applies only to selected primary sites, histologies, and years of diagnosis. Depending on applicability and standard-setter requirements, SSDIs may be left blank. </div><a name='3928'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>SCHEMA DISCRIMINATOR 3</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">3928</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>NAACCR</a></td><td style="text-align:center;">2018</td><td style="text-align:center;">18</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1733 - 1733</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>schemaDiscriminator3</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Captures additional information needed to generate AJCC ID [95] and Schema ID [3800] for some anatomic sites. Discriminators can be based on sub site, histology or other features which affect prognosis.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>A schema discriminator is used to assign AJCC ID [995] when site and histology alone are insufficient to identify the applicable AJCC staging method and to assign Schema ID [3800], which links each case to the appropriate SSDIs, Summary Stage and EOD data collection system.</div><div class='content chap10-para'><strong>Codes (The information recorded in Schema Discriminator differs for each anatomic site. See the SSDI manual for most current version of the site-specific codes and coding structures.)</strong></div><div class='content chap10-para'>Each Site-Specific Data Item (SSDI) applies only to selected primary sites, histologies, and years of diagnosis. Depending on applicability and standard-setter requirements, SSDIs may be left blank. </div><a name='3800'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>SCHEMA ID</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">3800</td><td style="text-align:center;">5</td><td style="text-align:center;"><a href='#sources'>NAACCR</a></td><td style="text-align:center;">2018</td><td style="text-align:center;">18</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1726 - 1730</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>schemaId</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>The derived values in this data item link Site-Specific Data Items (including grade data items) with the appropriate site/histology grouping and accounts for every combination of primary site and histology. The values for this data item are derived based on primary site, histology, and schema discriminator fields (when required). The derived values link Site-Specific Data Items with the appropriate site/histology grouping. <br /><br /><div>For example, the Schema ID for an adenocarcinoma of the lung is 00360. This value links the Site-Specific Data Items associated with adenocarcinoma of the lung: Separate Tumor Nodules [3929], Visceral and Parietal Pleural Invasion [3937], and Pleural Effusion [3913]. The Schema ID would also link to the appropriate grade data items an adenocarcinoma of the lung. The AJCC ID [995] code for Lung is 36. The AJCC ID [995] would link to the AJCC TNM Data items (Clin T, Clin N, Etc.) specific to Lung.</div><div>&nbsp;</div><div>AJCC ID [995] will not be assigned when a site/histology combination is not eligible for TNM staging.&nbsp;</div></div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>The purpose of the derived Schema ID is to link the appropriate Site-Specific Data Items with the patient&#8217;s primary site/histology. This data item is similar to AJCC ID [995], but includes additional site/histologies that may not be eligible for TNM staging using the current AJCC Staging Manual. AJCC ID [995] is left blank if a case is not eligible for TNM Staging using the current AJCC Staging Manual. Separating AJCC ID [995] and the Schema ID allows coding of Site-Specific Data Items for site/histology combinations that are not eligible for an AJCC Stage, but are eligible for Summary Stage.<br /><br />This data item will also be used to develop edits and could potentially be used for analysis.</div><div class='content chap10-para'><strong>Codes: See the&nbsp;<!--[if gte mso 10]>  <![endif]-->NAACCR Site-Specific Data Item webpage for codes.</strong></div><div class='content chap10-para'>Each Site-Specific Data Item (SSDI) applies only to selected primary sites, histologies, and years of diagnosis. Depending on applicability and standard-setter requirements, SSDIs may be left blank. </div><a name='2117'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>SCHEMA ID VERSION CURRENT</strong></td><td style="text-align:right;font-weight:bold;"><strong>New</strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">2117</td><td style="text-align:center;">5</td><td style="text-align:center;"><a href='#sources'>SEER</a></td><td style="text-align:center;">2021</td><td style="text-align:center;">21</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1 - 5</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>schemaIdVersionCurrent</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>This item indicates the version of EOD component of the SEER Staging API used to assign the 2018 and later staging fields of Schema ID, Grades, EOD input fields, SS2018, and SSDIs. This data item is recorded the first time the Schema ID is determined and should be updated each time the related input fields are modified.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Over time, the definitions for Schema ID and the input codes and instructions for Grades, EOD, SS2018, and SSDI items may change. This item identifies the correct interpretation of information recorded.</div><div class='content chap10-para'>Codes</div><div class='content chap10-para'>Schema ID Version Current is a code with up to 2 digits, a decimal and then up to 2 more digits. (e.g., 1.5, 10.12). The first two digits represent the major version number related to diagnosis year; the second two digits represent minor version changes with the diagnosis years. Minimum allowable value would be &#8220;1.0&#8221;. Maximum allowable value would be &#8220;99.99&#8221;.&nbsp; Blanks would not be allowed.<br /><br />Versions used for 2018-2019 diagnosis years<br />1.0&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 03/20/2018 release<br />1.1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 04/20/2018 release<br />1.2&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 05/17/2018 release<br />1.3&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 06/26/2018 release<br />1.4&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 09/06/2018 release <br />1.5&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 02/15/2019 release<br />1.6&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 04/03/2019 release<br />1.7&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 09/04/2019 release<br /><div>&nbsp;</div><div>Versions used for 2021 diagnosis years</div><div>2.0&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ??/??/2021 release</div><div>&nbsp;</div><div>This data item will be generated by registry software. No coding instructions are required.</div><div>&nbsp;</div><div>&nbsp;</div></div><a name='2118'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>SCHEMA ID VERSION ORIGINAL</strong></td><td style="text-align:right;font-weight:bold;"><strong>New</strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">2118</td><td style="text-align:center;">5</td><td style="text-align:center;"><a href='#sources'>SEER</a></td><td style="text-align:center;">2021</td><td style="text-align:center;">21</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1 - 5</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>schemaIdVersionOriginal</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>This item indicates the version of EOD component of the SEER Staging API used to assign the 2018 and later staging fields of Schema ID, Grades, EOD input fields, SS2018, and SSDIs. This data item is recorded the first time the Schema ID is determined. This data item should not be updated each time the related input fields are modified.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Over time, the definitions for Schema ID and the input codes and instructions for Grades, EOD, SS2018, and SSDI items may change. This item identifies the original instructions used to code these items.</div><div class='content chap10-para'>Codes</div><div class='content chap10-para'><div></div><div>Schema ID Version Original is a code with up to 2 digits, a decimal and then up to 2 more digits. (e.g., 1.5, 10.12). The first two digits represent the major version number related to diagnosis year; the second two digits represent minor version changes with the diagnosis years. Minimum allowable value would be &#8220;1.0&#8221;. Maximum allowable value would be &#8220;99.99&#8221;.&nbsp; Blanks would not be allowed.<br /><br />Versions used for 2018-2019 diagnosis years<br />1.0&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 03/20/2018 release<br />1.1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 04/20/2018 release<br />1.2&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 05/17/2018 release<br />1.3&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 06/26/2018 release<br />1.4&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 09/06/2018 release <br />1.5&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 02/15/2019 release<br />1.6&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 04/03/2019 release<br />1.7&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 09/04/2019 release<br /><br />1.99&nbsp;&nbsp; &nbsp;Case abstracted prior to implementation of this data item and a more specific version value cannot be assigned.<br /><br />Versions used for 2021 diagnosis years<br />2.0&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ??/??/2021 release</div><div>&nbsp;</div><div>This data item will be generated by registry software. No coding instructions are required.</div></div><a name='510'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>SCREENING DATE</strong></td><td style="text-align:right;font-weight:bold;"><strong>Retired</strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">510</td><td style="text-align:center;"></td><td style="text-align:center;"><a href='#sources'></a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;">2010</td><td style="text-align:center;">12</td><td class="cross-out" style="text-align:center;"></td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td></td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td></td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>The NAACCR UDSC retired this data item in Version 12, as of January 1, 2010.</div><a name='520'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>SCREENING RESULT</strong></td><td style="text-align:right;font-weight:bold;"><strong>Retired</strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">520</td><td style="text-align:center;"></td><td style="text-align:center;"><a href='#sources'></a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;">2010</td><td style="text-align:center;">12</td><td class="cross-out" style="text-align:center;"></td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td></td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td></td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>The NAACCR UDSC retired this data item in Version 12, as of January 1, 2010.</div><a name='3780'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>SECONDARY DIAGNOSIS 1</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">3780</td><td style="text-align:center;">7</td><td style="text-align:center;"><a href='#sources'>CoC</a></td><td style="text-align:center;">2013</td><td style="text-align:center;">13</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1577 - 1583</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>Secondary Dx ICD-10 1<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>secondaryDiagnosis1</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Records the patient&#8217;s preexisting medical conditions, factors influencing health status, and/or complications for the treatment of this cancer. Both are considered secondary diagnoses. Preexisting medical conditions, factors influencing health status, and/or complications may affect treatment decisions and influence patient outcomes. Information on comorbidities is used to adjust outcome statistics when evaluating patient survival and other outcomes. Complications may be related to the quality of care. ICD-10-CM codes are 7 characters long, where each character represents an aspect of the condition or procedure: the 7 characters indicate 'section', 'body system', 'root operation', 'body part', 'approach', 'device', and 'qualifier', respectively (see ICD-10-PCS Reference Manual for additional information).</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>The current Comorbidity and complication items are based on ICD-9-CM codes and only allow 5 characters, with the introduction of ICD-10-CM in to common use the NAACCR transmission record needs to be able to carry these new codes (that are longer in length and different in structure).</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>A00.0 - B99.9</td><td class='code-desc'>infectious and parasitic diseases </td></tr><tr class='code-row'><td class='code-nbr'>E00.0 - E89.89	</td><td class='code-desc'>endocrine and metabolic diseases</td></tr><tr class='code-row'><td class='code-nbr'>G00.0 - P96.9</td><td class='code-desc'>diseases of the nervous system, eye, ear, skin, circulatory, respiratory, and digestive , musculoskeletal, genitourinary systems, pregnancy, childbirth and perinatal conditions </td></tr><tr class='code-row'><td class='code-nbr'>R00.0 - S99.929</td><td class='code-desc'>symptoms, signs and abnormal clinical and lab findings</td></tr><tr class='code-row'><td class='code-nbr'>T36.0 - T50.996</td><td class='code-desc'>medical poisonings</td></tr><tr class='code-row'><td class='code-nbr'>Y62.0 - Y84.9	</td><td class='code-desc'>medical misadventures</td></tr><tr class='code-row'><td class='code-nbr'>Z14.0 - Z22.9	</td><td class='code-desc'>genetic susceptibility / infection disease carrier</td></tr><tr class='code-row'><td class='code-nbr'>Z68.1 - Z68.54</td><td class='code-desc'>BMI</td></tr><tr class='code-row'><td class='code-nbr'>Z80.0 - Z80.9</td><td class='code-desc'>family history of malignant neoplasms</td></tr><tr class='code-row'><td class='code-nbr'>Z85.0 - Z86.03</td><td class='code-desc'>personal history of malignant neoplasms</td></tr><tr class='code-row'><td class='code-nbr'>Z86.1 - Z99.89	</td><td class='code-desc'>other personal health status</td></tr></table></div><a name='3798'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>SECONDARY DIAGNOSIS 10</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">3798</td><td style="text-align:center;">7</td><td style="text-align:center;"><a href='#sources'>CoC</a></td><td style="text-align:center;">2013</td><td style="text-align:center;">13</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1640 - 1646</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>Secondary Dx ICD10 10<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>secondaryDiagnosis10</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Records the patient&#8217;s preexisting medical conditions, factors influencing health status, and/or complications for the treatment of this cancer. Both are considered secondary diagnoses. Preexisting medical conditions, factors influencing health status, and/or complications may affect treatment decisions and influence patient outcomes. Information on comorbidities is used to adjust outcome statistics when evaluating patient survival and other outcomes. Complications may be related to the quality of care. ICD-10-CM codes are 7 characters long, where each character represents an aspect of the condition or procedure: the 7 characters indicate 'section', 'body system', 'root operation', 'body part', 'approach', 'device', and 'qualifier', respectively (see ICD-10-PCS Reference Manual for additional information).</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>The current Comorbidity and complication items are based on ICD-9-CM codes and only allow 5 characters, with the introduction of ICD-10-CM in to common use the NAACCR transmission record needs to be able to carry these new codes (that are longer in length and different in structure).</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>A00.0 - B99.9</td><td class='code-desc'>infectious and parasitic diseases</td></tr><tr class='code-row'><td class='code-nbr'>E00.0 - E89.89	</td><td class='code-desc'>endocrine and metabolic diseases</td></tr><tr class='code-row'><td class='code-nbr'>G00.0 - P96.9</td><td class='code-desc'>diseases of the nervous system, eye, ear, skin, circulatory, respiratory, and digestive , musculoskeletal, genitourinary systems, pregnancy, childbirth and perinatal conditions </td></tr><tr class='code-row'><td class='code-nbr'>R00.0 - S99.929</td><td class='code-desc'>symptoms, signs and abnormal clinical and lab findings</td></tr><tr class='code-row'><td class='code-nbr'>T36.0 - T50.996</td><td class='code-desc'>medical poisonings</td></tr><tr class='code-row'><td class='code-nbr'>Y62.0 - Y84.9	</td><td class='code-desc'>medical misadventures</td></tr><tr class='code-row'><td class='code-nbr'>Z14.0 - Z22.9	</td><td class='code-desc'>genetic susceptibility / infection disease carrier</td></tr><tr class='code-row'><td class='code-nbr'>Z68.1 - Z68.54</td><td class='code-desc'>BMI</td></tr><tr class='code-row'><td class='code-nbr'>Z80.0 - Z80.9	</td><td class='code-desc'>family history of malignant neoplasms</td></tr><tr class='code-row'><td class='code-nbr'>Z85.0 - Z86.03</td><td class='code-desc'>personal history of malignant neoplasms</td></tr><tr class='code-row'><td class='code-nbr'>Z86.1 - Z99.89	</td><td class='code-desc'>other personal health status</td></tr></table></div><a name='3782'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>SECONDARY DIAGNOSIS 2</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">3782</td><td style="text-align:center;">7</td><td style="text-align:center;"><a href='#sources'>CoC</a></td><td style="text-align:center;">2013</td><td style="text-align:center;">13</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1584 - 1590</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>Secondary Dx ICD10 2<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>secondaryDiagnosis2</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Records the patient&#8217;s preexisting medical conditions, factors influencing health status, and/or complications for the treatment of this cancer. Both are considered secondary diagnoses. Preexisting medical conditions, factors influencing health status, and/or complications may affect treatment decisions and influence patient outcomes. Information on comorbidities is used to adjust outcome statistics when evaluating patient survival and other outcomes. Complications may be related to the quality of care. ICD-10-CM codes are 7 characters long, where each character represents an aspect of the condition or procedure: the 7 characters indicate 'section', 'body system', 'root operation', 'body part', 'approach', 'device', and 'qualifier', respectively (see ICD-10-PCS Reference Manual for additional information).</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>The current Comorbidity and complication items are based on ICD-9-CM codes and only allow 5 characters, with the introduction of ICD-10-CM in to common use the NAACCR transmission record needs to be able to carry these new codes (that are longer in length and different in structure).</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>A00.0 - B99.9</td><td class='code-desc'>infectious and parasitic diseases </td></tr><tr class='code-row'><td class='code-nbr'>E00.0 - E89.89	</td><td class='code-desc'>endocrine and metabolic diseases</td></tr><tr class='code-row'><td class='code-nbr'>G00.0 - P96.9</td><td class='code-desc'>diseases of the nervous system, eye, ear, skin, circulatory, respiratory, and digestive , musculoskeletal, genitourinary systems, pregnancy, childbirth and perinatal conditions </td></tr><tr class='code-row'><td class='code-nbr'>R00.0 - S99.929</td><td class='code-desc'>symptoms, signs and abnormal clinical and lab findings</td></tr><tr class='code-row'><td class='code-nbr'>T36.0 - T50.996</td><td class='code-desc'>medical poisonings</td></tr><tr class='code-row'><td class='code-nbr'>Y62.0 - Y84.9	</td><td class='code-desc'>medical misadventures</td></tr><tr class='code-row'><td class='code-nbr'>Z14.0 - Z22.9	</td><td class='code-desc'>genetic susceptibility / infection disease carrier</td></tr><tr class='code-row'><td class='code-nbr'>Z68.1 - Z68.54</td><td class='code-desc'>BMI</td></tr><tr class='code-row'><td class='code-nbr'>Z80.0 - Z80.9	</td><td class='code-desc'>family history of malignant neoplasms</td></tr><tr class='code-row'><td class='code-nbr'>Z85.0 - Z86.03</td><td class='code-desc'>personal history of malignant neoplasms</td></tr><tr class='code-row'><td class='code-nbr'>Z86.1 - Z99.89	</td><td class='code-desc'>other personal health status</td></tr></table></div><a name='3784'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>SECONDARY DIAGNOSIS 3</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">3784</td><td style="text-align:center;">7</td><td style="text-align:center;"><a href='#sources'>CoC</a></td><td style="text-align:center;">2013</td><td style="text-align:center;">13</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1591 - 1597</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>Secondary Dx ICD10 3<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>secondaryDiagnosis3</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'><div>Records the patient&#8217;s preexisting medical conditions, factors influencing health status, and/or complications for the treatment of this cancer. Both are considered secondary diagnoses. Preexisting medical conditions, factors influencing health status, and/or complications may affect treatment decisions and influence patient outcomes. Information on comorbidities is used to adjust outcome statistics when evaluating patient survival and other outcomes. Complications may be related to the quality of care. ICD-10-CM codes are 7 characters long, where each character represents an aspect of the condition or procedure: the 7 characters indicate 'section', 'body system', 'root operation', 'body part', 'approach', 'device', and 'qualifier', respectively (see ICD-10-PCS Reference Manual for additional information). </div></div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>The current Comorbidity and complication items are based on ICD-9-CM codes and only allow 5 characters, with the introduction of ICD-10-CM in to common use the NAACCR transmission record needs to be able to carry these new codes (that are longer in length and different in structure).</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>A00.0 - B99.9</td><td class='code-desc'>infectious and parasitic diseases </td></tr><tr class='code-row'><td class='code-nbr'>E00.0 - E89.89	</td><td class='code-desc'>endocrine and metabolic diseases</td></tr><tr class='code-row'><td class='code-nbr'>G00.0 - P96.9</td><td class='code-desc'>diseases of the nervous system, eye, ear, skin, circulatory, respiratory, and digestive , musculoskeletal, genitourinary systems, pregnancy, childbirth and perinatal conditions </td></tr><tr class='code-row'><td class='code-nbr'>R00.0 - S99.929</td><td class='code-desc'>symptoms, signs and abnormal clinical and lab findings</td></tr><tr class='code-row'><td class='code-nbr'>T36.0 - T50.996</td><td class='code-desc'>medical poisonings</td></tr><tr class='code-row'><td class='code-nbr'>Y62.0 - Y84.9	</td><td class='code-desc'>medical misadventures</td></tr><tr class='code-row'><td class='code-nbr'>Z14.0 - Z22.9	</td><td class='code-desc'>genetic susceptibility / infection disease carrier</td></tr><tr class='code-row'><td class='code-nbr'>Z68.1 - Z68.54</td><td class='code-desc'>BMI</td></tr><tr class='code-row'><td class='code-nbr'>Z80.0 - Z80.9	</td><td class='code-desc'>family history of malignant neoplasms</td></tr><tr class='code-row'><td class='code-nbr'>Z85.0 - Z86.03</td><td class='code-desc'>personal history of malignant neoplasms</td></tr><tr class='code-row'><td class='code-nbr'>Z86.1 - Z99.89	</td><td class='code-desc'>other personal health status</td></tr></table></div><a name='3786'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>SECONDARY DIAGNOSIS 4</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">3786</td><td style="text-align:center;">7</td><td style="text-align:center;"><a href='#sources'>CoC</a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1598 - 1604</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>Secondary Dx ICD10 4<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>secondaryDiagnosis4</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Records the patient&#8217;s preexisting medical conditions, factors influencing health status, and/or complications for the treatment of this cancer. Both are considered secondary diagnoses. Preexisting medical conditions, factors influencing health status, and/or complications may affect treatment decisions and influence patient outcomes. Information on comorbidities is used to adjust outcome statistics when evaluating patient survival and other outcomes. Complications may be related to the quality of care. ICD-10-CM codes are 7 characters long, where each character represents an aspect of the condition or procedure: the 7 characters indicate 'section', 'body system', 'root operation', 'body part', 'approach', 'device', and 'qualifier', respectively (see ICD-10-PCS Reference Manual for additional information).</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>The current Comorbidity and complication items are based on ICD-9-CM codes and only allow 5 characters, with the introduction of ICD-10-CM in to common use the NAACCR transmission record needs to be able to carry these new codes (that are longer in length and different in structure).</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>A00.0 - B99.9</td><td class='code-desc'>infectious and parasitic diseases</td></tr><tr class='code-row'><td class='code-nbr'>E00.0 - E89.89	</td><td class='code-desc'>endocrine and metabolic diseases</td></tr><tr class='code-row'><td class='code-nbr'>G00.0 - P96.9</td><td class='code-desc'>diseases of the nervous system, eye, ear, skin, circulatory, respiratory, and digestive , musculoskeletal, genitourinary systems, pregnancy, childbirth and perinatal conditions </td></tr><tr class='code-row'><td class='code-nbr'>R00.0 - S99.929</td><td class='code-desc'>symptoms, signs and abnormal clinical and lab findings</td></tr><tr class='code-row'><td class='code-nbr'>T36.0 - T50.996</td><td class='code-desc'>medical poisonings</td></tr><tr class='code-row'><td class='code-nbr'>Y62.0 - Y84.9	</td><td class='code-desc'>medical misadventures</td></tr><tr class='code-row'><td class='code-nbr'>Z14.0 - Z22.9	</td><td class='code-desc'>genetic susceptibility / infection disease carrier</td></tr><tr class='code-row'><td class='code-nbr'>Z68.1 - Z68.54</td><td class='code-desc'>BMI</td></tr><tr class='code-row'><td class='code-nbr'>Z80.0 - Z80.9	</td><td class='code-desc'>family history of malignant neoplasms</td></tr><tr class='code-row'><td class='code-nbr'>Z85.0 - Z86.03</td><td class='code-desc'>personal history of malignant neoplasms</td></tr><tr class='code-row'><td class='code-nbr'>Z86.1 - Z99.89	</td><td class='code-desc'>other personal health status</td></tr></table></div><a name='3788'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>SECONDARY DIAGNOSIS 5</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">3788</td><td style="text-align:center;">7</td><td style="text-align:center;"><a href='#sources'>CoC</a></td><td style="text-align:center;">2013</td><td style="text-align:center;">13</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1605 - 1611</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>Secondary Dx ICD10 5<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>secondaryDiagnosis5</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Records the patient&#8217;s preexisting medical conditions, factors influencing health status, and/or complications for the treatment of this cancer. Both are considered secondary diagnoses. Preexisting medical conditions, factors influencing health status, and/or complications may affect treatment decisions and influence patient outcomes. Information on comorbidities is used to adjust outcome statistics when evaluating patient survival and other outcomes. Complications may be related to the quality of care. ICD-10-CM codes are 7 characters long, where each character represents an aspect of the condition or procedure: the 7 characters indicate 'section', 'body system', 'root operation', 'body part', 'approach', 'device', and 'qualifier', respectively (see ICD-10-PCS Reference Manual for additional information).</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>The current Comorbidity and complication items are based on ICD-9-CM codes and only allow 5 characters, with the introduction of ICD-10-CM in to common use the NAACCR transmission record needs to be able to carry these new codes (that are longer in length and different in structure).</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>A00.0 - B99.9</td><td class='code-desc'>infectious and parasitic diseases </td></tr><tr class='code-row'><td class='code-nbr'>E00.0 - E89.89	</td><td class='code-desc'>endocrine and metabolic diseases</td></tr><tr class='code-row'><td class='code-nbr'>G00.0 - P96.9</td><td class='code-desc'>diseases of the nervous system, eye, ear, skin, circulatory, respiratory, and digestive , musculoskeletal, genitourinary systems, pregnancy, childbirth and perinatal conditions </td></tr><tr class='code-row'><td class='code-nbr'>R00.0 - S99.929</td><td class='code-desc'>symptoms, signs and abnormal clinical and lab findings</td></tr><tr class='code-row'><td class='code-nbr'>T36.0 - T50.996</td><td class='code-desc'>medical poisonings</td></tr><tr class='code-row'><td class='code-nbr'>Y62.0 - Y84.9	</td><td class='code-desc'>medical misadventures</td></tr><tr class='code-row'><td class='code-nbr'>Z14.0 - Z22.9	</td><td class='code-desc'>genetic susceptibility / infection disease carrier</td></tr><tr class='code-row'><td class='code-nbr'>Z68.1 - Z68.54</td><td class='code-desc'>BMI</td></tr><tr class='code-row'><td class='code-nbr'>Z80.0 - Z80.9	</td><td class='code-desc'>family history of malignant neoplasms</td></tr><tr class='code-row'><td class='code-nbr'>Z85.0 - Z86.03</td><td class='code-desc'>personal history of malignant neoplasms</td></tr><tr class='code-row'><td class='code-nbr'>Z86.1 - Z99.89	</td><td class='code-desc'>other personal health status</td></tr></table></div><a name='3790'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>SECONDARY DIAGNOSIS 6</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">3790</td><td style="text-align:center;">7</td><td style="text-align:center;"><a href='#sources'>CoC</a></td><td style="text-align:center;">2013</td><td style="text-align:center;">13</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1612 - 1618</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>Secondary Dx ICD10 6<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>secondaryDiagnosis6</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Records the patient&#8217;s preexisting medical conditions, factors influencing health status, and/or complications for the treatment of this cancer. Both are considered secondary diagnoses. Preexisting medical conditions, factors influencing health status, and/or complications may affect treatment decisions and influence patient outcomes. Information on comorbidities is used to adjust outcome statistics when evaluating patient survival and other outcomes. Complications may be related to the quality of care. ICD-10-CM codes are 7 characters long, where each character represents an aspect of the condition or procedure: the 7 characters indicate 'section', 'body system', 'root operation', 'body part', 'approach', 'device', and 'qualifier', respectively (see ICD-10-PCS Reference Manual for additional information).</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>The current Comorbidity and complication items are based on ICD-9-CM codes and only allow 5 characters, with the introduction of ICD-10-CM in to common use the NAACCR transmission record needs to be able to carry these new codes (that are longer in length and different in structure).</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>A00.0 - B99.9</td><td class='code-desc'>infectious and parasitic diseases </td></tr><tr class='code-row'><td class='code-nbr'>E00.0 - E89.89	</td><td class='code-desc'>endocrine and metabolic diseases</td></tr><tr class='code-row'><td class='code-nbr'>G00.0 - P96.9</td><td class='code-desc'>diseases of the nervous system, eye, ear, skin, circulatory, respiratory, and digestive , musculoskeletal, genitourinary systems, pregnancy, childbirth and perinatal conditions </td></tr><tr class='code-row'><td class='code-nbr'>R00.0 - S99.929</td><td class='code-desc'>symptoms, signs and abnormal clinical and lab findings</td></tr><tr class='code-row'><td class='code-nbr'>T36.0 - T50.996</td><td class='code-desc'>medical poisonings</td></tr><tr class='code-row'><td class='code-nbr'>Y62.0 - Y84.9	</td><td class='code-desc'>medical misadventures</td></tr><tr class='code-row'><td class='code-nbr'>Z14.0 - Z22.9	</td><td class='code-desc'>genetic susceptibility / infection disease carrier</td></tr><tr class='code-row'><td class='code-nbr'>Z68.1 - Z68.54</td><td class='code-desc'>BMI</td></tr><tr class='code-row'><td class='code-nbr'>Z80.0 - Z80.9	</td><td class='code-desc'>family history of malignant neoplasms</td></tr><tr class='code-row'><td class='code-nbr'>Z85.0 - Z86.03</td><td class='code-desc'>personal history of malignant neoplasms</td></tr><tr class='code-row'><td class='code-nbr'>Z86.1 - Z99.89	</td><td class='code-desc'>other personal health status</td></tr></table></div><a name='3792'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>SECONDARY DIAGNOSIS 7</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">3792</td><td style="text-align:center;">7</td><td style="text-align:center;"><a href='#sources'>CoC</a></td><td style="text-align:center;">2013</td><td style="text-align:center;">13</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1619 - 1625</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>Secondary Dx ICD10 7<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>secondaryDiagnosis7</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Records the patient&#8217;s preexisting medical conditions, factors influencing health status, and/or complications for the treatment of this cancer. Both are considered secondary diagnoses. Preexisting medical conditions, factors influencing health status, and/or complications may affect treatment decisions and influence patient outcomes. Information on comorbidities is used to adjust outcome statistics when evaluating patient survival and other outcomes. Complications may be related to the quality of care. ICD-10-CM codes are 7 characters long, where each character represents an aspect of the condition or procedure: the 7 characters indicate 'section', 'body system', 'root operation', 'body part', 'approach', 'device', and 'qualifier', respectively (see ICD-10-PCS Reference Manual for additional information).</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>The current Comorbidity and complication items are based on ICD-9-CM codes and only allow 5 characters, with the introduction of ICD-10-CM in to common use the NAACCR transmission record needs to be able to carry these new codes (that are longer in length and different in structure).</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>A00.0 - B99.9</td><td class='code-desc'>infectious and parasitic diseases</td></tr><tr class='code-row'><td class='code-nbr'>E00.0 - E89.89	</td><td class='code-desc'>endocrine and metabolic diseases</td></tr><tr class='code-row'><td class='code-nbr'>G00.0 - P96.9</td><td class='code-desc'>diseases of the nervous system, eye, ear, skin, circulatory, respiratory, and digestive , musculoskeletal, genitourinary systems, pregnancy, childbirth and perinatal conditions </td></tr><tr class='code-row'><td class='code-nbr'>R00.0 - S99.929</td><td class='code-desc'>symptoms, signs and abnormal clinical and lab findings</td></tr><tr class='code-row'><td class='code-nbr'>T36.0 - T50.996</td><td class='code-desc'>medical poisonings</td></tr><tr class='code-row'><td class='code-nbr'>Y62.0 - Y84.9	</td><td class='code-desc'>medical misadventures</td></tr><tr class='code-row'><td class='code-nbr'>Z14.0 - Z22.9	</td><td class='code-desc'>genetic susceptibility / infection disease carrier</td></tr><tr class='code-row'><td class='code-nbr'>Z68.1 - Z68.54</td><td class='code-desc'>BMI</td></tr><tr class='code-row'><td class='code-nbr'>Z80.0 - Z80.9	</td><td class='code-desc'>family history of malignant neoplasms</td></tr><tr class='code-row'><td class='code-nbr'>Z85.0 - Z86.03</td><td class='code-desc'>personal history of malignant neoplasms</td></tr><tr class='code-row'><td class='code-nbr'>Z86.1 - Z99.89	</td><td class='code-desc'>other personal health status</td></tr></table></div><a name='3794'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>SECONDARY DIAGNOSIS 8</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">3794</td><td style="text-align:center;">7</td><td style="text-align:center;"><a href='#sources'>CoC</a></td><td style="text-align:center;">2013</td><td style="text-align:center;">13</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1626 - 1632</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>Secondary Dx ICD10 8<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>secondaryDiagnosis8</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Records the patient&#8217;s preexisting medical conditions, factors influencing health status, and/or complications for the treatment of this cancer. Both are considered secondary diagnoses. Preexisting medical conditions, factors influencing health status, and/or complications may affect treatment decisions and influence patient outcomes. Information on comorbidities is used to adjust outcome statistics when evaluating patient survival and other outcomes. Complications may be related to the quality of care. ICD-10-CM codes are 7 characters long, where each character represents an aspect of the condition or procedure: the 7 characters indicate 'section', 'body system', 'root operation', 'body part', 'approach', 'device', and 'qualifier', respectively (see ICD-10-PCS Reference Manual for additional information).</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>The current Comorbidity and complication items are based on ICD-9-CM codes and only allow 5 characters, with the introduction of ICD-10-CM in to common use the NAACCR transmission record needs to be able to carry these new codes (that are longer in length and different in structure).</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>A00.0 - B99.9</td><td class='code-desc'>infectious and parasitic diseases</td></tr><tr class='code-row'><td class='code-nbr'>E00.0 - E89.89	</td><td class='code-desc'>endocrine and metabolic diseases</td></tr><tr class='code-row'><td class='code-nbr'>G00.0 - P96.9</td><td class='code-desc'>diseases of the nervous system, eye, ear, skin, circulatory, respiratory, and digestive , musculoskeletal, genitourinary systems, pregnancy, childbirth and perinatal conditions </td></tr><tr class='code-row'><td class='code-nbr'>R00.0 - S99.929</td><td class='code-desc'>symptoms, signs and abnormal clinical and lab findings</td></tr><tr class='code-row'><td class='code-nbr'>T36.0 - T50.996</td><td class='code-desc'>medical poisonings</td></tr><tr class='code-row'><td class='code-nbr'>Y62.0 - Y84.9	</td><td class='code-desc'>medical misadventures</td></tr><tr class='code-row'><td class='code-nbr'>Z14.0 - Z22.9	</td><td class='code-desc'>genetic susceptibility / infection disease carrier</td></tr><tr class='code-row'><td class='code-nbr'>Z68.1 - Z68.54</td><td class='code-desc'>BMI</td></tr><tr class='code-row'><td class='code-nbr'>Z80.0 - Z80.9	</td><td class='code-desc'>family history of malignant neoplasms</td></tr><tr class='code-row'><td class='code-nbr'>Z85.0 - Z86.03</td><td class='code-desc'>personal history of malignant neoplasms</td></tr><tr class='code-row'><td class='code-nbr'>Z86.1 - Z99.89	</td><td class='code-desc'>other personal health status</td></tr></table></div><a name='3796'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>SECONDARY DIAGNOSIS 9</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">3796</td><td style="text-align:center;">7</td><td style="text-align:center;"><a href='#sources'>CoC</a></td><td style="text-align:center;">2013</td><td style="text-align:center;">13</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1633 - 1639</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>Secondary Dx ICD10 9<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>secondaryDiagnosis9</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Records the patient&#8217;s preexisting medical conditions, factors influencing health status, and/or complications for the treatment of this cancer. Both are considered secondary diagnoses. Preexisting medical conditions, factors influencing health status, and/or complications may affect treatment decisions and influence patient outcomes. Information on comorbidities is used to adjust outcome statistics when evaluating patient survival and other outcomes. Complications may be related to the quality of care. ICD-10-CM codes are 7 characters long, where each character represents an aspect of the condition or procedure: the 7 characters indicate 'section', 'body system', 'root operation', 'body part', 'approach', 'device', and 'qualifier', respectively (see ICD-10-PCS Reference Manual for additional information).</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>The current Comorbidity and complication items are based on ICD-9-CM codes and only allow 5 characters, with the introduction of ICD-10-CM in to common use the NAACCR transmission record needs to be able to carry these new codes (that are longer in length and different in structure).</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>A00.0 - B99.9</td><td class='code-desc'>infectious and parasitic diseases</td></tr><tr class='code-row'><td class='code-nbr'>E00.0 - E89.89	</td><td class='code-desc'>endocrine and metabolic diseases</td></tr><tr class='code-row'><td class='code-nbr'>G00.0 - P96.9</td><td class='code-desc'>diseases of the nervous system, eye, ear, skin, circulatory, respiratory, and digestive , musculoskeletal, genitourinary systems, pregnancy, childbirth and perinatal conditions </td></tr><tr class='code-row'><td class='code-nbr'>R00.0 - S99.929</td><td class='code-desc'>symptoms, signs and abnormal clinical and lab findings</td></tr><tr class='code-row'><td class='code-nbr'>T36.0 - T50.996</td><td class='code-desc'>medical poisonings</td></tr><tr class='code-row'><td class='code-nbr'>Y62.0 - Y84.9	</td><td class='code-desc'>medical misadventures</td></tr><tr class='code-row'><td class='code-nbr'>Z14.0 - Z22.9	</td><td class='code-desc'>genetic susceptibility / infection disease carrier</td></tr><tr class='code-row'><td class='code-nbr'>Z68.1 - Z68.54</td><td class='code-desc'>BMI</td></tr><tr class='code-row'><td class='code-nbr'>Z80.0 - Z80.9	</td><td class='code-desc'>family history of malignant neoplasms</td></tr><tr class='code-row'><td class='code-nbr'>Z85.0 - Z86.03</td><td class='code-desc'>personal history of malignant neoplasms</td></tr><tr class='code-row'><td class='code-nbr'>Z86.1 - Z99.89	</td><td class='code-desc'>other personal health status</td></tr></table></div><a name='1914'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>SEER CAUSE SPECIFIC COD</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">1914</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>SEER</a></td><td style="text-align:center;">2018</td><td style="text-align:center;">18</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">2944 - 2944</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>seerCauseSpecificCod</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>This variable was created for use in cause-specific survival and designates that the person died of their cancer.<br /><br />Adapted from <a href="http://seer.cancer.gov/causespecific/">http://seer.cancer.gov/causespecific/</a>:<br />Cause-specific survival is a net survival measure representing survival of a specified cause of death in the absence of other causes of death. Estimates are calculated by specifying the cause of death. Individuals who die of causes other than the specified cause are considered to be censored. This requires a cause of death variable that accurately captures all causes related to the specific cause. Vital records offices use algorithms to process causes of death from death certificates in order to identify a single, disease-specific, underlying cause of death. In some cases, attribution of a single cause of death may be difficult and misattribution may occur. For example a death may be attributed to the site of metastasis instead of the primary site.<br /><br />To capture deaths related to the specific cancer but not coded as such, the SEER cause-specific death classification variables are defined by taking into account causes of deaths in conjunction with tumor sequence (i.e., only one tumor or the first of subsequent tumors), site of the original cancer diagnosis, and comorbidities (e.g., AIDS and/or site-related diseases).<br /><br />The 'SEER cause-specific death classification' variable is used to obtain cancer-specific survival probability for a given cohort of cancer patients. Deaths attributed to the cancer of interest are treated as events and deaths from other causes are treated as censored observation. This variable is used in SEER*Stat cause-specific survival and crude probability of death using cause of death information.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>These changes will benefit the cancer surveillance community by facilitating the application of standard methods for survival analysis. Beginning with data collected in the November 2014 call for data, NAACCR has published 








<em>Cancer in North America Volume 4: Cancer Survival in the United States and Canada</em>, which provides cancer survival estimates on a wider population than was previously available. However, at present IMS must pre-process the datasets that are included in the NAACCR survival dataset to calculate the four new standard data items, SEER Cause Specific COD [1914], SEER Other COD [1915], Record Number Recode [1775], and Vital Status Recode [1762]. For registries that do not submit cause of death information to NAACCR, it is not possible to calculate the 'SEER cause-specific death classification' or 'SEER other cause of death classification' variables. The 4 new data items will assist individual registries in performing survival analyses using their own data.</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>0</td><td class='code-desc'>Alive or dead of other cause </td></tr><tr class='code-row'><td class='code-nbr'>1</td><td class='code-desc'>Dead (attributable to this cancer dx)</td></tr><tr class='code-row'><td class='code-nbr'>8</td><td class='code-desc'>Missing/Unknown Cause of Death </td></tr><tr class='code-row'><td class='code-nbr'>9</td><td class='code-desc'>Not applicable / not first tumor</td></tr><tr class='code-row'><td class='code-nbr' colspan='2'></td></tr></table></div><a name='2120'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>SEER CODING SYS--CURRENT</strong></td><td style="text-align:right;font-weight:bold;"><strong>Revised</strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">2120</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>NAACCR</a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">2617 - 2617</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>seerCodingSysCurrent</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para mark-changed'>This shows the SEER coding system best describing the majority of SEER items as they are in the record (after conversion).</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para mark-changed'>Change the allowable values to alpha-numeric in order to accommodate SEER Program Manual editions.</div><div class='content chap10-para mark-changed'>This item is no longer required by SEER.</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para mark-changed'><table><tr class='code-row'><td class='code-nbr'>0</td><td class='code-desc'>No SEER coding</td></tr><tr class='code-row'><td class='code-nbr'>1</td><td class='code-desc'>Pre-<i>1988 SEER Coding Manuals</i></td></tr><tr class='code-row'><td class='code-nbr'>2</td><td class='code-desc'><i>1988 SEER Coding Manual</i></td></tr><tr class='code-row'><td class='code-nbr'>3</td><td class='code-desc'><i>1989 SEER Coding Manual</i></td></tr><tr class='code-row'><td class='code-nbr'>4</td><td class='code-desc'><i>1992 SEER Coding Manual</i></td></tr><tr class='code-row'><td class='code-nbr'>5</td><td class='code-desc'><i>1998 SEER Coding Manual</i></td></tr><tr class='code-row'><td class='code-nbr'>6</td><td class='code-desc'><i>2003 SEER Coding Manual</i></td></tr><tr class='code-row'><td class='code-nbr'>7</td><td class='code-desc'><i>2004 SEER Coding Manual</i></td></tr><tr class='code-row'><td class='code-nbr'>8</td><td class='code-desc'><i>2007 SEER Coding Manual</i></td></tr><tr class='code-row'><td class='code-nbr'>9</td><td class='code-desc'><i>2007 SEER Coding Manual</i> with 2008 changes</td></tr><tr class='code-row'><td class='code-nbr'>A</td><td class='code-desc'><i>2010 SEER Coding Manual</i></td></tr><tr class='code-row'><td class='code-nbr'>B</td><td class='code-desc'><i>2011 SEER Coding Manual</i></td></tr><tr class='code-row'><td class='code-nbr'>C</td><td class='code-desc'><i>2012 SEER Coding Manual</i></td></tr><tr class='code-row'><td class='code-nbr'>D</td><td class='code-desc'><i>2013 SEER Coding Manual</i> </td></tr><tr class='code-row'><td class='code-nbr'>E</td><td class='code-desc'><i>2014 SEER Coding Manual</i> </td></tr><tr class='code-row'><td class='code-nbr'>F</td><td class='code-desc'><i>2015 SEER Coding Manual</i>  </td></tr><tr class='code-row'><td class='code-nbr'>G</td><td class='code-desc'><i>2016 SEER Coding Manual</i> </td></tr><tr class='code-row'><td class='code-nbr'>H</td><td class='code-desc'><i>2018 SEER Coding Manual</i> </td></tr><tr class='code-row'><td class='code-nbr'>I</td><td class='code-desc'><i>2021 SEER Coding Manual</>  </td></tr><tr class='code-row'><td class='code-nbr'></td><td class='code-desc'> </td></tr></table></div><a name='2130'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>SEER CODING SYS--ORIGINAL</strong></td><td style="text-align:right;font-weight:bold;"><strong>Revised</strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">2130</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>NAACCR</a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">2618 - 2618</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>seerCodingSysOriginal</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para mark-changed'>This shows the SEER coding system best describing the way the majority of SEER items in the record were originally coded.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para mark-changed'>Change the allowable values to alpha-numeric in order to accommodate SEER Program Manual editions.</div><div class='content chap10-para mark-changed'>This item is no longer required by SEER.</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para mark-changed'><table><tr class='code-row'><td class='code-nbr'>0</td><td class='code-desc'>No SEER coding</td></tr><tr class='code-row'><td class='code-nbr'>1</td><td class='code-desc'>Pre-<i>1988 SEER Coding Manuals</i></td></tr><tr class='code-row'><td class='code-nbr'>2</td><td class='code-desc'><i>1988 SEER Coding Manual</i></td></tr><tr class='code-row'><td class='code-nbr'>3</td><td class='code-desc'><i>1989 SEER Coding Manual</i></td></tr><tr class='code-row'><td class='code-nbr'>4</td><td class='code-desc'><i>1992 SEER Coding Manual</i></td></tr><tr class='code-row'><td class='code-nbr'>5</td><td class='code-desc'><i>1998 SEER Coding Manual</i></td></tr><tr class='code-row'><td class='code-nbr'>6</td><td class='code-desc'><i>2003 SEER Coding Manual</i></td></tr><tr class='code-row'><td class='code-nbr'>7</td><td class='code-desc'><i>2004 SEER Coding Manual</i></td></tr><tr class='code-row'><td class='code-nbr'>8</td><td class='code-desc'><i>2007 SEER Coding Manual</i></td></tr><tr class='code-row'><td class='code-nbr'>9</td><td class='code-desc'><i>2007 SEER Coding Manual</i> with 2008 changes</td></tr><tr class='code-row'><td class='code-nbr'>A</td><td class='code-desc'><i>2010 SEER Coding Manual</i></td></tr><tr class='code-row'><td class='code-nbr'>B</td><td class='code-desc'><i>2011 SEER Coding Manual</i></td></tr><tr class='code-row'><td class='code-nbr'>C</td><td class='code-desc'><i>2012 SEER Coding Manual</i></td></tr><tr class='code-row'><td class='code-nbr'>D</td><td class='code-desc'><i>2013 SEER Coding Manual</i></td></tr><tr class='code-row'><td class='code-nbr'>E</td><td class='code-desc'><i>2014 SEER Coding Manual</i> </td></tr><tr class='code-row'><td class='code-nbr'>F</td><td class='code-desc'><i>2015 SEER Coding Manual</i>  </td></tr><tr class='code-row'><td class='code-nbr'>G</td><td class='code-desc'><i>2016 SEER Coding Manual</i>  </td></tr><tr class='code-row'><td class='code-nbr'>H</td><td class='code-desc'><i>2018 SEER Coding Manual</i>  </td></tr><tr class='code-row'><td class='code-nbr'>I</td><td class='code-desc'><i>2021 SEER coding Manual</> </td></tr><tr class='code-row'><td class='code-nbr'></td><td class='code-desc'> </td></tr></table></div><a name='1915'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>SEER OTHER COD</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">1915</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>SEER</a></td><td style="text-align:center;">2018</td><td style="text-align:center;">18</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">2945 - 2945</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>seerOtherCod</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Using the same recoding logic as the &#8216;SEER cause-specific death classification&#8217; variable, the &#8216;SEER other cause of death classification&#8217; variable designates that the person died of causes other than their cancer. <br /><br />Adapted from <a href="http://seer.cancer.gov/causespecific/">http://seer.cancer.gov/causespecific/</a>:<br />The 'SEER other cause of death classification' variable is used to obtain the other-cause survival probability for a cohort of patients. It is used when deaths attributed to causes other than cancer are treated as events and deaths from cancer are treated as censored observation. This variable is used in the SEER*Stat left-truncated life table session. -specific survival and crude probability of death using cause of death information.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>These changes will benefit the cancer surveillance community by facilitating the application of standard methods for survival analysis. Beginning with data collected in the November 2014 call for data, NAACCR has published 










<em>Cancer in North America Volume 4: Cancer Survival in the United States and Canada</em>, which provides cancer survival estimates on a wider population than was previously available. However, at present IMS must pre-process the datasets that are included in the NAACCR survival dataset to calculate the four new standard data items, SEER Cause Specific COD [1914], SEER Other COD [1915], Record Number Recode [1775], and Vital Status Recode [1762]. For registries that do not submit cause of death information to NAACCR, it is not possible to calculate the 'SEER cause-specific death classification' or 'SEER other cause of death classification' variables. The 4 new data items will assist individual registries in performing survival analyses using their own data.</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>0</td><td class='code-desc'>Alive or dead due to cancer </td></tr><tr class='code-row'><td class='code-nbr'>1</td><td class='code-desc'>Dead (attributable to causes other than this cancer diagnosis) </td></tr><tr class='code-row'><td class='code-nbr'>8</td><td class='code-desc'>Missing/Unknown Cause of Death </td></tr><tr class='code-row'><td class='code-nbr'>9</td><td class='code-desc'>Not applicable/not first tumor</td></tr><tr class='code-row'><td class='code-nbr'></td><td class='code-desc'> </td></tr></table></div><a name='2190'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>SEER RECORD NUMBER</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">2190</td><td style="text-align:center;">2</td><td style="text-align:center;"><a href='#sources'>SEER</a></td><td style="text-align:center;">1995</td><td style="text-align:center;">4</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">2636 - 2637</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>Record Number (SEER)<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>seerRecordNumber</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>A unique sequential number assigned by the SEER participant to each record for the person for each submission. The number may change from submission to submission. See also Tumor Record Number [60].</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>01</td><td class='code-desc'>One or first of more than one record for person</td></tr><tr class='code-row'><td class='code-nbr'>02</td><td class='code-desc'>Second record for person</td></tr><tr class='code-row'><td class='code-nbr' colspan='2'>..</td></tr><tr class='code-row'><td class='code-nbr' colspan='2'>..</td></tr><tr class='code-row'><td class='code-nbr'>nn</td><td class='code-desc'>Last of nn records for person</td></tr></table></div><a name='3700'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>SEER SITE-SPECIFIC FACT 1</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">3700</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>SEER</a></td><td style="text-align:center;">2010</td><td style="text-align:center;">12</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1520 - 1520</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>seerSiteSpecificFact1</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>A one character field to be used when information for a particular primary site needs to be collected by SEER.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>This field is a place holder when site-specific information is needed for SEER.</div><div class='content chap10-para'><strong>Codes (To be determined for each site where needed. Refer to the most current version of the <em></em><a target="_blank" href="http://seer.cancer.gov/tools/codingmanuals/"><em>SEER Program Coding and Staging </em><strong><em><span style="font-size:11.0pt;font-family: &quot;Times New Roman&quot;,&quot;serif&quot;;">Manual</span></em></strong></a><strong><em><span style="font-size:11.0pt;font-family: &quot;Times New Roman&quot;,&quot;serif&quot;;">,</span></em><sup><span style="font-size: 11.0pt;font-family:&quot;Times New Roman&quot;,&quot;serif&quot;;">3</span></sup></strong> for details.)</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>Blank</td><td class='code-desc'>Field not coded</td></tr></table></div><a name='3702'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>SEER SITE-SPECIFIC FACT 2</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">3702</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>SEER</a></td><td style="text-align:center;">2010</td><td style="text-align:center;">12</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1521 - 1521</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>seerSiteSpecificFact2</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>A one character field to be used when information for a particular primary site needs to be collected by SEER. </div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>This field is a place holder when site-specific information is needed for SEER. </div><div class='content chap10-para'><strong>Codes </strong>  <strong>(To be determined for each site where needed. Refer to the most current version of the<em> </em><a target="_blank" href="http://seer.cancer.gov/tools/codingmanuals/"><em>SEER Program Coding and Staging</em><strong><em><span style="font-size:11.0pt;font-family: &quot;Times New Roman&quot;,&quot;serif&quot;;"> Manual</span></em></strong></a><strong><em><span style="font-size:11.0pt;font-family: &quot;Times New Roman&quot;,&quot;serif&quot;;">,</span></em><sup><span style="font-size: 11.0pt;font-family:&quot;Times New Roman&quot;,&quot;serif&quot;;">3</span></sup></strong>for details.)</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>Blank</td><td class='code-desc'>Field not coded</td></tr></table></div><a name='3704'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>SEER SITE-SPECIFIC FACT 3</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">3704</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>SEER</a></td><td style="text-align:center;">2010</td><td style="text-align:center;">12</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1522 - 1522</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>seerSiteSpecificFact3</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>A one character field to be used when information for a particular primary site needs to be collected by SEER. </div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>This field is a place holder when site-specific information is needed for SEER. </div><div class='content chap10-para'><strong>Codes </strong>  <strong>(To be determined for each site where needed. Refer to the most current version of the<em> </em><a target="_blank" href="http://seer.cancer.gov/tools/codingmanuals/"><em>SEER Program Coding and Staging </em><strong><em><span style="font-size:11.0pt;font-family: &quot;Times New Roman&quot;,&quot;serif&quot;;">Manual</span></em></strong></a><strong><em><span style="font-size:11.0pt;font-family: &quot;Times New Roman&quot;,&quot;serif&quot;;">,</span></em><sup><span style="font-size: 11.0pt;font-family:&quot;Times New Roman&quot;,&quot;serif&quot;;">3</span></sup></strong>for details.)</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>Blank</td><td class='code-desc'>Field not coded.</td></tr></table></div><a name='3706'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>SEER SITE-SPECIFIC FACT 4</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">3706</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>SEER</a></td><td style="text-align:center;">2010</td><td style="text-align:center;">12</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1523 - 1523</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>seerSiteSpecificFact4</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>A one character field to be used when information for a particular primary site needs to be collected by SEER. </div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>This field is a place holder when site-specific information is needed for SEER. </div><div class='content chap10-para'><strong>Codes </strong>  <strong>(To be determined for each site where needed. Refer to the most current version of the<em> </em><a target="_blank" href="http://seer.cancer.gov/tools/codingmanuals/"><em>SEER Program Coding and Staging</em><strong><em><span style="font-size: 11pt; font-family: &quot;Times New Roman&quot;,&quot;serif&quot;;"> Manual</span></em></strong></a><strong><em><span style="font-size: 11pt; font-family: &quot;Times New Roman&quot;,&quot;serif&quot;;">,</span></em><sup><span style="font-size: 11.0pt;font-family:&quot;Times New Roman&quot;,&quot;serif&quot;;">3</span></sup></strong>for details.)</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>Blank</td><td class='code-desc'>Field not coded</td></tr></table></div><a name='3708'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>SEER SITE-SPECIFIC FACT 5</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">3708</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>SEER</a></td><td style="text-align:center;">2010</td><td style="text-align:center;">12</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1524 - 1524</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>seerSiteSpecificFact5</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>A one character field to be used when information for a particular primary site needs to be collected by SEER. </div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>This field is a place holder when site-specific information is needed for SEER. </div><div class='content chap10-para'><strong>Codes </strong>  <strong>(To be determined for each site where needed. Refer to the most current version of the<em> </em><a target="_blank" href="http://seer.cancer.gov/tools/codingmanuals/"><em>SEER Program Coding and Staging </em><strong><em><span style="font-size:11.0pt;font-family: &quot;Times New Roman&quot;,&quot;serif&quot;;">Manual</span></em></strong></a><strong><em><span style="font-size:11.0pt;font-family: &quot;Times New Roman&quot;,&quot;serif&quot;;">,</span></em><sup><span style="font-size: 11.0pt;font-family:&quot;Times New Roman&quot;,&quot;serif&quot;;">3</span></sup></strong>for details.)</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>Blank</td><td class='code-desc'>Field not coded</td></tr></table></div><a name='3710'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>SEER SITE-SPECIFIC FACT 6</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">3710</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>SEER</a></td><td style="text-align:center;">2010</td><td style="text-align:center;">12</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1525 - 1525</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>seerSiteSpecificFact6</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>A one character field to be used when information for a particular primary site needs to be collected by SEER. </div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>This field is a place holder when site-specific information is needed for SEER. </div><div class='content chap10-para'><strong>Codes &#160;<strong>(To be determined for each site where needed. Refer to the most current version of the <a target="_blank" href="http://seer.cancer.gov/tools/codingmanuals/"><em>SEER Program Coding and Staging </em><strong><em><span style="font-size:11.0pt;font-family: &quot;Times New Roman&quot;,&quot;serif&quot;;">Manual</span></em></strong></a><strong><em><span style="font-size:11.0pt;font-family: &quot;Times New Roman&quot;,&quot;serif&quot;;">,</span></em><sup><span style="font-size: 11.0pt;font-family:&quot;Times New Roman&quot;,&quot;serif&quot;;">3</span></sup></strong>for details.)</strong></strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>Blank</td><td class='code-desc'>Field not coded</td></tr></table></div><a name='760'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>SEER SUMMARY STAGE 1977</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">760</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>SEER</a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">989 - 989</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>General Summary Stage (SEER/CoC)<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>seerSummaryStage1977</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Code for summary stage at the initial diagnosis or treatment of the reportable tumor. This has traditionally been used by central registries to monitor time trends. For hospital registries, CoC requires its use in the absence of a defined AJCC classification. For site-specific definitions of categories, see the SEER Summary Staging Guide.<br /><br />SEER Summary Stage 1977 is limited to information available within 2 months of the date of diagnosis. NAACCR approved extension of this time period to 4 months for prostate tumors diagnosed beginning January 1, 1995.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Stage information is important when evaluating the effects of cancer control programs. It is crucial for understanding whether changes over time in incidence rates or outcomes are due to earlier detection of the cancers. In addition, cancer treatment cannot be studied without knowing the stage at diagnosis.<br /><br />To study historical trends in stage, the coding system must be relatively unchanged (stable) over time. AJCC&#8217;s TNM system is updated periodically to maintain clinical relevance with changes in diagnosis and treatment. The surveillance registries often rely on the Summary Stage, which they consider to be more &#8220;stable.&#8221; Summary Stage has been in widespread use, either as the primary staging scheme or a secondary scheme, in most central and hospital registries since 1977.</div><div class='content chap10-para'><strong>Codes </strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>9</td><td class='code-desc'>Unstaged</td></tr><tr class='code-row'><td class='code-nbr'>0</td><td class='code-desc'><i>In situ</i></td></tr><tr class='code-row'><td class='code-nbr'>1</td><td class='code-desc'>Localized</td></tr><tr class='code-row'><td class='code-nbr'>2</td><td class='code-desc'>Regional, direct extension only</td></tr><tr class='code-row'><td class='code-nbr'>3</td><td class='code-desc'>Regional, regional lymph nodes only</td></tr><tr class='code-row'><td class='code-nbr'>4</td><td class='code-desc'>Regional, direct extension and regional lymph nodes</td></tr><tr class='code-row'><td class='code-nbr'>5</td><td class='code-desc'>Regional, NOS</td></tr><tr class='code-row'><td class='code-nbr'>7</td><td class='code-desc'>Distant</td></tr><tr class='code-row'><td class='code-nbr'>8</td><td class='code-desc'>Not applicable</td></tr></table></div><div class='content chap10-para'><em>Note: </em>Code 8 has been added in Version 10.1 to be used when there  is not an applicable code to reflect stage (e.g., benign brain,  borderline ovarian).<em><br /><br />Note:</em> See also the item Derived SS1977 [3010] for the value of  SEER Summary Stage 1977 as generated by the Collaborative Staging  algorithm.<strong><br /><br />Clarification of NAACCR and NPCR Required Status</strong><br />Summary stage is required. The correct data item to use (and  corresponding code manual) is determined by the year in which the cancer  was diagnosed. Tumors diagnosed on or after January 1, 2004, should be  assigned a summary stage based upon the Collaborative Stage data item  algorithms and retained in Derived SS2000 [3020]. Tumors diagnosed on or  after January 1, 2001, should be assigned a summary stage according to  the SEER <em>Summary Staging Manual 2000</em>, and the code should be  reported in SEER Summary Stage 2000 [759]. Tumors diagnosed before  January 1, 2001, should be assigned a summary stage according to<em> SEER Summary Stage Guide 1977</em>, and the code should be reported in SEER Summary Stage 1977 [760].</div><a name='759'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>SEER SUMMARY STAGE 2000</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">759</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>SEER</a></td><td style="text-align:center;">2001</td><td style="text-align:center;">9</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">988 - 988</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>seerSummaryStage2000</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Code for summary stage at the initial diagnosis or treatment of the reportable tumor. For hospital registries, CoC requires its use in the absence of a defined AJCC classification. For site-specific definitions of categories, see SEER <em>Summary Staging Manual 2000</em>.<br /><br />Summary stage should include all information available through completion of surgery(ies) in the first course of treatment or within 4 months of diagnosis in the absence of disease progression, whichever is longer.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Stage information is important when evaluating the effects of cancer control programs. It is crucial in understanding whether changes over time in incidence rates or outcomes are due to earlier detection of the cancers. In addition, cancer treatment cannot be studied without knowing the stage at diagnosis.</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>0</td><td class='code-desc'><i>In situ</i></td></tr><tr class='code-row'><td class='code-nbr'>1</td><td class='code-desc'>Localized</td></tr><tr class='code-row'><td class='code-nbr'>2</td><td class='code-desc'>Regional, direct extension only</td></tr><tr class='code-row'><td class='code-nbr'>3</td><td class='code-desc'>Regional, regional lymph nodes only</td></tr><tr class='code-row'><td class='code-nbr'>4</td><td class='code-desc'>Regional, direct extension and regional lymph nodes</td></tr><tr class='code-row'><td class='code-nbr'>5</td><td class='code-desc'>Regional, NOS</td></tr><tr class='code-row'><td class='code-nbr'>7</td><td class='code-desc'>Distant</td></tr><tr class='code-row'><td class='code-nbr'>8</td><td class='code-desc'>Not applicable</td></tr><tr class='code-row'><td class='code-nbr'>9</td><td class='code-desc'>Unstaged</td></tr></table></div><div class='content chap10-para'><em>Note:</em> Code 8 has been added in Version 10.1 to be used when there  is not an applicable code to reflect stage (e.g., benign brain,  borderline ovarian).<em><br /><br />Note: </em>See also the item Derived SS2000 [3020] for the value of  SEER Summary Stage 2000 as generated by the collaborative Staging  algorithm.<br /><br /><strong>Clarification of NAACCR and NPCR Required Status</strong><br />Summary stage is required. The correct data item to use (and  corresponding code manual) is determined by the year in which the cancer  was diagnosed. Tumors diagnosed on or after January 1, 2004, should be  assigned a summary stage based upon the Collaborative Stage data item  algorithms and retained in Derived SS2000 [3020]. Tumors diagnosed on or  after January 1, 2001, should be assigned a summary stage according to  the SEER <em>Summary Staging Manual 2000</em>, and the code should be  reported in SEER Summary Stage 2000 [759]. Tumors diagnosed before  January 1, 2001, should be assigned a summary stage according to <em>SEER Summary Stage Guide 1977</em>, and the code should be reported in SEER Summary Stage 1977 [760].</div><a name='2180'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>SEER TYPE OF FOLLOW-UP</strong></td><td style="text-align:right;font-weight:bold;"><strong>Revised</strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">2180</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>SEER</a></td><td style="text-align:center;">1995</td><td style="text-align:center;">4</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">2635 - 2635</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>Type of Follow-Up (SEER)<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>seerTypeOfFollowUp</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para mark-changed'>Codes for the type of follow-up expected for a SEER case.</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>1</td><td class='code-desc'>"Autopsy-Only" or "Death Certificate-Only" case</td></tr><tr class='code-row'><td class='code-nbr'>2</td><td class='code-desc'>Active follow-up case</td></tr><tr class='code-row'><td class='code-nbr'>3</td><td class='code-desc'><i>In situ</i> cancer of the cervix uteri only</td></tr><tr class='code-row'><td class='code-nbr'>4</td><td class='code-desc'>Case not originally in active follow-up, but in active follow-up now (San Francisco-Oakland only)</td></tr></table></div><a name='834'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>SENTINEL LYMPH NODES EXAMINED</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">834</td><td style="text-align:center;">2</td><td style="text-align:center;"><a href='#sources'>CoC</a></td><td style="text-align:center;">2018</td><td style="text-align:center;">18</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1014 - 1015</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>sentinelLymphNodesExamined</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Records the total number of lymph nodes sampled during the sentinel node biopsy and examined by the pathologist. This data item is required for CoC-accredited facilities as of cases diagnosed 01/01/2018 and later. 








<strong>This data item is required for breast and melanoma cases only. </strong></div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>It is a known fact that sentinel lymph node biopsies have been under-reported. Additionally, the timing and results of sentinel lymph node biopsy procedures are used in quality of care measures. This data item can be used to more accurately assess the number of lymph nodes biopsied during the sentinel node biopsy procedure separate from the number of lymph nodes dissected during additional subsequent regional node procedures.</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>00</td><td class='code-desc'>No sentinel nodes were examined 
 </td></tr><tr class='code-row'><td class='code-nbr'>01-90</td><td class='code-desc'>Sentinel nodes were examined (code the exact number of sentinel lymph nodes examined)</td></tr><tr class='code-row'><td class='code-nbr'>95</td><td class='code-desc'>No sentinel nodes were removed, but aspiration of sentinel node(s) was performed </td></tr><tr class='code-row'><td class='code-nbr'>98</td><td class='code-desc'>Sentinel lymph nodes were biopsied, but the number is unknown </td></tr><tr class='code-row'><td class='code-nbr'>99</td><td class='code-desc'>It is unknown whether sentinel nodes were examined; not stated in patient record</td></tr><tr class='code-row'><td class='code-nbr'></td><td class='code-desc'> </td></tr></table></div><a name='835'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>SENTINEL LYMPH NODES POSITIVE</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">835</td><td style="text-align:center;">2</td><td style="text-align:center;"><a href='#sources'>CoC</a></td><td style="text-align:center;">2018</td><td style="text-align:center;">18</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1012 - 1013</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>sentinelLymphNodesPositive</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Records the exact number of sentinel lymph nodes biopsied by the pathologist and found to contain metastases. This data item is required for CoC-accredited facilities as of cases diagnosed 01/01/2018 and later. 








<strong>This data item is required for breast and melanoma cases only. </strong></div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>It is a known fact that sentinel lymph node biopsies have been under-reported. Additionally, the timing and results of sentinel lymph node biopsy procedures are used in quality of care measures. This data item can be used to more accurately assess the number of positive sentinel lymph nodes biopsied separate from the number of positive lymph nodes identified during additional subsequent regional node dissection procedures, if performed.</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>00</td><td class='code-desc'>All sentinel nodes examined are negative </td></tr><tr class='code-row'><td class='code-nbr'>01-90</td><td class='code-desc'>Sentinel nodes are positive (code exact number of nodes positive) </td></tr><tr class='code-row'><td class='code-nbr'>95</td><td class='code-desc'>Positive aspiration of sentinel lymph node(s) was performed </td></tr><tr class='code-row'><td class='code-nbr'>97</td><td class='code-desc'>Positive sentinel nodes are documented, but the number is unspecified; For breast ONLY: SLN and RLND occurred during the same procedure </td></tr><tr class='code-row'><td class='code-nbr'>98</td><td class='code-desc'>No sentinel nodes were biopsied </td></tr><tr class='code-row'><td class='code-nbr'>99</td><td class='code-desc'>It is unknown whether sentinel nodes are positive; not applicable; not stated in patient record</td></tr><tr class='code-row'><td class='code-nbr'></td><td class='code-desc'> </td></tr></table></div><a name='3929'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>SEPARATE TUMOR NODULES</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">3929</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>NAACCR</a></td><td style="text-align:center;">2018</td><td style="text-align:center;">18</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1866 - 1866</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>separateTumorNodules</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>"Separate tumor nodules" refers to what is conceptually a single tumor with intrapulmonary metastasis in the ipsilateral (same) lung. Their presence in the same or different lobes of lung from the primary tumor affects the T and M categories.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>This data item was previously collected for Lung, SSF# 1 and at least one standard setter is continuing to collect it.</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>0</td><td class='code-desc'>No separate tumor nodules; single tumor only<br/>
Separate tumor nodules of same histologic type not identified/not present<br/>
Intrapulmonary metastasis not identified/not present<br/>
Multiple nodules described as multiple foci of adenocarcinoma in situ or minimally invasive adenocarcinoma
</td></tr><tr class='code-row'><td class='code-nbr'>1</td><td class='code-desc'>Separate tumor nodules of same histologic type in ipsilateral lung, same lobe</td></tr><tr class='code-row'><td class='code-nbr'>2</td><td class='code-desc'>Separate tumor nodules of same histologic type in ipsilateral lung, different lobe</td></tr><tr class='code-row'><td class='code-nbr'>3</td><td class='code-desc'>Separate tumor nodules of same histologic type in ipsilateral lung, same AND different lobes</td></tr><tr class='code-row'><td class='code-nbr'>4</td><td class='code-desc'>Separate tumor nodules of same histologic type in ipsilateral lung, unknown if same or different lobe(s)</td></tr><tr class='code-row'><td class='code-nbr'>7</td><td class='code-desc'>Multiple nodules or foci of tumor present, not classifiable based on notes 3 and 4</td></tr><tr class='code-row'><td class='code-nbr'>8</td><td class='code-desc'>Not applicable: Information not collected for this case<br/> 
(If this item is required by your standard setter, use of code 8 will result in an edit error.)
</td></tr><tr class='code-row'><td class='code-nbr'>9</td><td class='code-desc'>Not documented in medical record<br/>
Primary tumor is in situ<br/> 
Separate Tumor Nodules not assessed or unknown if assessed
</td></tr><tr class='code-row'><td class='code-nbr'></td><td class='code-desc'> </td></tr></table></div><div class='content chap10-para'>Each Site-Specific Data Item (SSDI) applies only to selected primary sites, histologies, and years of diagnosis. Depending on applicability and standard-setter requirements, SSDIs may be left blank. </div><a name='380'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>SEQUENCE NUMBER--CENTRAL</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">380</td><td style="text-align:center;">2</td><td style="text-align:center;"><a href='#sources'>SEER</a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">542 - 543</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>Sequence Number (pre-96 SEER)<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>sequenceNumberCentral</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Code indicates the sequence of all reportable neoplasms over the lifetime of the person. This data item differs from Sequence Number-Hospital [560], because the definitions of reportable neoplasms often vary between a hospital and a central registry. Each neoplasm is assigned a different number. Sequence Number 00 indicates that the person has had only one <em>in situ</em> or one malignant neoplasm as defined by the Federal reportable list (regardless of central registry reference date). Sequence Number 01 indicates the first of two or more reportable neoplasms, but 02 indicates the second of two or more reportable neoplasms, and so on. Because the time period of Sequence Number is a person&#8217;s lifetime, reportable neoplasms not included in the central registry (those that occur outside the registry catchment area or before the reference date) also are allotted a sequence number. For example, a registry may contain a single record for a patient with a sequence number of 02 because the first reportable neoplasm preceded the central registry&#8217;s reference date.<strong><br /><br />Reporting Requirements: Federally Required and State/Province Defined<br /></strong> The Federal or SEER/NPCR standard defining the reportable neoplasms is described in Chapter III, Standards For Tumor Inclusion and Reportability. It is assumed that this shared standard is the &#8220;minimum&#8221; definition of reportability. Individual central cancer registries may define additional neoplasms as reportable.<br /><br />Numeric codes in the 00-59 range indicate the sequence of neoplasms of <em>in situ</em> or malignant behavior (2 or 3) at the time of diagnosis, which SEER/NPCR standards require to be reported. Codes 60 to 87 indicate the sequence of non-malignant tumors (as defined in Chapter III) and any other neoplasms that the central registry has defined as reportable. Neoplasms required by SEER/NPCR with an <em>in situ</em> or malignant behavior at the time of diagnosis are sequenced completely independently of this higher-numbered category. Sequence Number-Hospital does not affect Sequence Number-Central. The two notational systems are independent but central registries should take Sequence Number-Hospital [560] into account when coding Sequence Number Central. </div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>The purpose of sequencing based on the patient&#8217;s lifetime is to truly identify the 00s, the people who only had one malignant primary in their lifetimes for survival analysis. If a central registry sequences by just what is reported to them, then it will be unclear whether 00 means the person only had one malignant primary in his lifetime or the person had one malignant primary since the central registry started collecting data. The Federally required reportable list has changed throughout the years, so the registry must use the appropriate reportable list for the year of diagnosis. The central registry reference date will not affect Sequence Number-Central. </div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr' colspan='2'>....</td></tr><tr class='code-row'><td class='code-nbr'>00</td><td class='code-desc'>One primary in the patient's lifetime</td></tr><tr class='code-row'><td class='code-nbr'>01</td><td class='code-desc'>First of two or more primaries</td></tr><tr class='code-row'><td class='code-nbr'>02</td><td class='code-desc'>Second of two or more primaries</td></tr><tr class='code-row'><td class='code-nbr' colspan='2'>....</td></tr><tr class='code-row'><td class='code-nbr' colspan='2'>....</td></tr><tr class='code-row'><td class='code-nbr'>59</td><td class='code-desc'>Fifty-ninth or higher of fifty-nine or more primaries</td></tr><tr class='code-row'><td class='code-nbr'>99</td><td class='code-desc'>Unspecified or unknown sequence number of Federally required <i>in situ</i> or malignant tumors. Sequence number 99 can be used if there is a malignant tumor and its sequence number is unknown. If there is known to be more than one malignant tumor, then the tumors must be sequenced.)</td></tr><tr class='code-row'><td class='code-nbr' colspan='2'>....</td></tr><tr class='code-row'><td class='code-nbr'>60</td><td class='code-desc'>One non-malignant tumor or central registry-defined neoplasm</td></tr><tr class='code-row'><td class='code-nbr'>61</td><td class='code-desc'>First of two or more non-malignant tumor or central registry-defined neoplasms</td></tr><tr class='code-row'><td class='code-nbr'>62</td><td class='code-desc'>Second of two or more non-malignant tumor or central registry-defined neoplasms</td></tr><tr class='code-row'><td class='code-nbr' colspan='2'>....</td></tr><tr class='code-row'><td class='code-nbr'>88</td><td class='code-desc'>Unspecified or unknown sequence number for non-malignant tumor or central registry-defined neoplasms. (Sequence number 88 can be used if there is a non-malignant tumor and its sequence number is unknown. If there is known to be more than one non-malignant tumor, then the tumors must be sequenced.)</td></tr><tr class='code-row'><td class='code-nbr'>98</td><td class='code-desc'>Cervix carcinoma <i>in situ</i> (CIS)/CIN III, Diagnosis Years 1996-2002.</td></tr></table></div><div class='content chap10-para'><span style="font-size:11.0pt;font-family:&quot;Times New Roman&quot;,&quot;serif&quot;;">The table that follows shows which sequence number series to use by type of neoplasm.</span>  <br />  <br />  <em>    <table style="border-collapse: collapse; border: medium none;" border="1" bordercolor="" cellpadding="0" cellspacing="0" width="500">      <tbody>        <tr>          <td style="width: 375.1pt; border: 1pt solid windowtext; padding: 0in 5.75pt;" height="" valign="top" width="450">            <span style="font-size: 11pt;">            </span>            <p>              <strong style="font-size: 11pt;">Neoplasm</strong>            </p>          </td>          <td style="width:124.2pt;border:solid windowtext 1.0pt; border-left:none;padding:0in 5.75pt 0in 5.75pt" valign="top" width="166">            <p>              <strong>SeqNum-Central</strong>            </p>          </td>        </tr>        <tr>          <td style="width:375.1pt;border:solid windowtext 1.0pt; border-top:none;padding: 0in 5.75pt 0in 5.75pt" valign="top" width="500">            <p>              <strong>                <em>In Situ/</em>Malignant as Federally Required based on Diagnosis Year</strong>            </p>          </td>          <td style="width:124.2pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; padding:0in 5.75pt 0in 5.75pt" valign="top" width="166">            <p>              <strong>(Numeric Series)</strong>            </p>          </td>        </tr>        <tr>          <td style="width: 375.1pt; border-right: 1pt solid windowtext; border-width: medium 1pt 1pt; border-style: none solid solid; border-color: -moz-use-text-color windowtext windowtext; -moz-border-top-colors: none; -moz-border-right-colors: none; -moz-border-bottom-colors: none; -moz-border-left-colors: none; -moz-border-image: none; padding: 0in 5.75pt;" valign="top" width="500">            <p>              <em>In Situ </em>(behavior code = 2) (Cervix CIS/CIN III, Diagnosis Year before 1996) (includes VIN III, VAIN III, AIN III)</p>          </td>          <td style="width:124.2pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; padding:0in 5.75pt 0in 5.75pt" valign="top" width="166">            <p>00 -- 59</p>          </td>        </tr>        <tr>          <td style="width:375.1pt;border:solid windowtext 1.0pt; border-top:none;padding: 0in 5.75pt 0in 5.75pt" valign="top" width="500">            <p>Malignant (behavior code = 3)</p>          </td>          <td style="width:124.2pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; padding:0in 5.75pt 0in 5.75pt" valign="top" width="166">            <p>00 -- 59</p>          </td>        </tr>        <tr>          <td style="width:375.1pt;border:solid windowtext 1.0pt; border-top:none;padding: 0in 5.75pt 0in 5.75pt" valign="top" width="500">            <p>Juvenile Astrocytoma, Diagnosis Year 2001+ (*)</p>          </td>          <td style="width:124.2pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; padding:0in 5.75pt 0in 5.75pt" valign="top" width="166">            <p>00 -- 59</p>          </td>        </tr>        <tr>          <td style="width:375.1pt;border:solid windowtext 1.0pt; border-top:none;padding: 0in 5.75pt 0in 5.75pt" valign="top" width="500">            <p>Invasive following<em> In Situ</em>--New primary as defined by CoC</p>          </td>          <td style="width:124.2pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; padding:0in 5.75pt 0in 5.75pt" valign="top" width="166">            <p>00 -- 59</p>          </td>        </tr>        <tr>          <td style="width: 375.1pt; border-right: 1pt solid windowtext; border-width: medium 1pt 1pt; border-style: none solid solid; border-color: -moz-use-text-color windowtext windowtext; -moz-border-top-colors: none; -moz-border-right-colors: none; -moz-border-bottom-colors: none; -moz-border-left-colors: none; -moz-border-image: none; padding: 0in 5.75pt;" valign="top" width="500">            <p>Invasive following<em> In Situ</em>--New primary as defined by SEER</p>          </td>          <td style="width:124.2pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; padding:0in 5.75pt 0in 5.75pt" valign="top" width="166">            <p>00 -- 59</p>          </td>        </tr>        <tr>          <td style="width:375.1pt;border:solid windowtext 1.0pt; border-top:none;padding: 0in 5.75pt 0in 5.75pt" valign="top" width="500">            <p>Unspecified Federally Required Sequence Number &#160;or Unknown</p>          </td>          <td style="width:124.2pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; padding:0in 5.75pt 0in 5.75pt" valign="top" width="166">            <p>99</p>          </td>        </tr>        <tr>          <td style="width:375.1pt;border:solid windowtext 1.0pt; border-top:none;padding: 0in 5.75pt 0in 5.75pt" valign="top" width="500">            <p>              <strong>Non-malignant Tumor as Federally Required based on Diagnosis Year or State/Province Registry-Defined</strong>            </p>          </td>          <td style="width:124.2pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; padding:0in 5.75pt 0in 5.75pt" valign="top" width="166">            <p> &#160;</p>          </td>        </tr>        <tr>          <td style="width:375.1pt;border:solid windowtext 1.0pt; border-top:none;padding: 0in 5.75pt 0in 5.75pt" valign="top" width="500">            <p>Examples:</p>          </td>          <td style="width:124.2pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; padding:0in 5.75pt 0in 5.75pt" valign="top" width="166">            <p> &#160;</p>          </td>        </tr>        <tr>          <td style="width:375.1pt;border:solid windowtext 1.0pt; border-top:none;padding: 0in 5.75pt 0in 5.75pt" valign="top" width="500">            <p>Non-malignant Tumor/Benign Brain</p>          </td>          <td style="width:124.2pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; padding:0in 5.75pt 0in 5.75pt" valign="top" width="166">            <p>60 -- 87</p>          </td>        </tr>        <tr>          <td style="width:375.1pt;border:solid windowtext 1.0pt; border-top:none;padding: 0in 5.75pt 0in 5.75pt" valign="top" width="500">            <p>Borderline Ovarian, Diagnosis Year 2001+</p>          </td>          <td style="width:124.2pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; padding:0in 5.75pt 0in 5.75pt" valign="top" width="166">            <p>60 -- 87</p>          </td>        </tr>        <tr>          <td style="width:375.1pt;border:solid windowtext 1.0pt; border-top:none;padding: 0in 5.75pt 0in 5.75pt" valign="top" width="500">            <p>Other Borderline/Benign</p>          </td>          <td style="width:124.2pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; padding:0in 5.75pt 0in 5.75pt" valign="top" width="166">            <p>60 -- 87</p>          </td>        </tr>        <tr>          <td style="width:375.1pt;border:solid windowtext 1.0pt; border-top:none;padding: 0in 5.75pt 0in 5.75pt" valign="top" width="500">            <p>Skin SCC/BCC</p>          </td>          <td style="width:124.2pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; padding:0in 5.75pt 0in 5.75pt" valign="top" width="166">            <p>60 -- 87</p>          </td>        </tr>        <tr>          <td style="width:375.1pt;border:solid windowtext 1.0pt; border-top:none;padding: 0in 5.75pt 0in 5.75pt" valign="top" width="500">            <p>PIN III</p>          </td>          <td style="width:124.2pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; padding:0in 5.75pt 0in 5.75pt" valign="top" width="166">            <p>60 -- 87</p>          </td>        </tr>        <tr>          <td style="width:375.1pt;border:solid windowtext 1.0pt; border-top:none;padding: 0in 5.75pt 0in 5.75pt" valign="top" width="500">            <p>Cervix CIS/CIN III, Diagnosis Year 2003+</p>          </td>          <td style="width:124.2pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; padding:0in 5.75pt 0in 5.75pt" valign="top" width="166">            <p>60 -- 87</p>          </td>        </tr>        <tr>          <td style="width:375.1pt;border:solid windowtext 1.0pt; border-top:none;padding: 0in 5.75pt 0in 5.75pt" valign="top" width="500">            <p>Unspecified Non-malignant Tumor or Central Registry-Defined Sequence Number</p>          </td>          <td style="width:124.2pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; padding:0in 5.75pt 0in 5.75pt" valign="top" width="166">            <p>88</p>          </td>        </tr>        <tr>          <td style="width:375.1pt;border:solid windowtext 1.0pt; border-top:none;padding: 0in 5.75pt 0in 5.75pt" valign="top" width="500">            <p>Cervix CIS/CIN III, Diagnosis Year 1996-2002</p>          </td>          <td style="width:124.2pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt" valign="top" width="166">            <p>98</p>          </td>        </tr>      </tbody>    </table>    <br />Note:</em> See the section on Sequence Number--Central in The<em> SEER Program Code Manual</em>.<em><br /><br />Note: </em>Conversion Guidance: The sequence numbers for neoplasms whose histologies were associated with behavior codes that changed from<em> in situ</em>/malignant to benign/borderline or vice versa during the conversion from ICD-O-2 to ICD-O-3 should not be re-sequenced.</div><a name='560'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>SEQUENCE NUMBER--HOSPITAL</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">560</td><td style="text-align:center;">2</td><td style="text-align:center;"><a href='#sources'>CoC</a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">754 - 755</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>Sequence Number (CoC)<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>sequenceNumberHospital</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Item indicates the sequence of all malignant and non-malignant neoplasms over the lifetime of the patient. The code may differ from the Sequence Number--Central [380] because the definitions of reportable neoplasms often vary between a hospital and a central registry. The two items also handle some types of tumors differently. Each neoplasm is assigned a different number. Sequence Number 00 indicates that the person has only one malignant neoplasm in his lifetime (regardless of hospital registry reference date). Sequence Number 01 indicates the first of two or more malignant neoplasms, while 02 indicates the second of two or more malignant neoplasms, and so on. Because the time period of Sequence Number is a person&#8217;s lifetime, reportable neoplasms not included in the hospital registry are also allotted a sequence number. For example, a registry may contain a single record for a patient with a sequence number of 02 because the first reportable neoplasm occurred before the hospital registry&#8217;s reference date. Similarly, Sequence Number 60 indicates the patient has only one non-malignant neoplasm, and Sequence Number 61 represents the first of multiple non-malignant neoplasms. <br /><br />Sequence numbers should be reassigned if the facility subsequently learns of an unaccessioned tumor that affects sequencing. Sequence Number-Central [380] does not affect Sequence Number-Hospital. The two notational systems are independent.<strong><br /><br />Timing Rule</strong><br />If two or more malignant tumors are diagnosed at the same time, the lowest sequence number will be assigned to the diagnosis with the worst prognosis. Likewise, if two or more non-malignant tumors are diagnosed at the same time, the lowest sequence number is assigned to the diagnosis with the worse prognosis. If no difference in prognosis is evident, the decision is arbitrary. </div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr' colspan='2'>...</td></tr><tr class='code-row'><td class='code-nbr'>00</td><td class='code-desc'>One malignant primary only in the patient's lifetime</td></tr><tr class='code-row'><td class='code-nbr'>01</td><td class='code-desc'>First of two or more malignant primaries</td></tr><tr class='code-row'><td class='code-nbr'>02</td><td class='code-desc'>Second of two or more malignant primaries</td></tr><tr class='code-row'><td class='code-nbr'>..</td><td class='code-desc'>(Actual number of this malignant primary)</td></tr><tr class='code-row'><td class='code-nbr'>59</td><td class='code-desc'>Fifty-ninth or higher of fifty-nine or more malignant primaries</td></tr><tr class='code-row'><td class='code-nbr'>99</td><td class='code-desc'>Unspecified sequence number of a primary malignant tumor or unknown. When a patient has multiple tumors with unspecified/unknown sequence numbers code 99 should only be used once.)</td></tr><tr class='code-row'><td class='code-nbr' colspan='2'>...</td></tr><tr class='code-row'><td class='code-nbr'>60</td><td class='code-desc'>Only one non-malignant tumor in the patient's lifetime</td></tr><tr class='code-row'><td class='code-nbr'>61</td><td class='code-desc'>First of two or more non-malignant tumors</td></tr><tr class='code-row'><td class='code-nbr'>62</td><td class='code-desc'>Second of two or more non-malignant tumors</td></tr><tr class='code-row'><td class='code-nbr' colspan='2'>...</td></tr><tr class='code-row'><td class='code-nbr'>88</td><td class='code-desc'>Unspecified number of non-malignant tumors (When a patient has multiple unspecified neoplasms in this category code 88 should only be used once.)</td></tr></table></div><div class='content chap10-para'><p>    <strong>      <span style="font-size:11.0pt;font-family:&quot;Times New Roman&quot;,&quot;serif&quot;;">The table that follows shows which sequence number series to use by type of neoplasm</span>    </strong>    <em>.</em>  </p>  <p>  </p>  <table style="border-collapse: collapse; border: medium none;" width="500" cellspacing="0" cellpadding="0" bordercolor="" border="1">    <tbody>      <tr>        <td style="width: 375.1pt; border: 1pt solid windowtext; padding: 0in 5.75pt;" height="" width="450" valign="top">          <span style="font-size: 11pt;">          </span>          <p style="margin-left: 0in; text-indent: 0in;">            <strong style="font-size: 11pt;">Neoplasm</strong>          </p>        </td>        <td style="width:124.2pt;border:solid windowtext 1.0pt;   border-left:none;padding:0in 5.75pt 0in 5.75pt" width="166" valign="top">          <p style="margin-left:0in;text-indent:0in;">            <strong>SeqNum-Hospital</strong>          </p>        </td>      </tr>      <tr>        <td style="width:375.1pt;border:solid windowtext 1.0pt;   border-top:none;padding:   0in 5.75pt 0in 5.75pt" width="500" valign="top">          <p style="margin-left:0in;text-indent:0in;">            <strong>              <em>In situ</em>/Malignant</strong>          </p>        </td>        <td style="width:124.2pt;border-top:none;border-left:   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;   padding:0in 5.75pt 0in 5.75pt" width="166" valign="top">          <p style="margin-left:0in;text-indent:0in;">            <strong>(code   range)</strong>          </p>        </td>      </tr>      <tr>        <td style="width: 375.1pt; border-right: 1pt solid windowtext; border-width: medium 1pt 1pt; border-style: none solid solid; border-color: -moz-use-text-color windowtext windowtext; -moz-border-top-colors: none; -moz-border-right-colors: none; -moz-border-bottom-colors: none; -moz-border-left-colors: none; -moz-border-image: none; padding: 0in 5.75pt;" width="500" valign="top">          <p style="margin-left: 0in; text-indent: 0in;">One <em>in situ </em>(behavior code = 2) or   malignant (behavior code =3) primary tumor only in the patient&#8217;s lifetime</p>        </td>        <td style="width:124.2pt;border-top:none;border-left:   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;   padding:0in 5.75pt 0in 5.75pt" width="166" valign="top">          <p style="margin-left:0in;text-indent:0in;">00</p>        </td>      </tr>      <tr>        <td style="width:375.1pt;border:solid windowtext 1.0pt;   border-top:none;padding:   0in 5.75pt 0in 5.75pt" width="500" valign="top">          <p style="margin-left:0in;text-indent:0in;">First   of multiple <em>in situ</em> or malignant   primary tumors in the patient&#8217;s lifetime</p>        </td>        <td style="width:124.2pt;border-top:none;border-left:   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;   padding:0in 5.75pt 0in 5.75pt" width="166" valign="top">          <p style="margin-left:0in;text-indent:0in;">01</p>        </td>      </tr>      <tr>        <td style="width:375.1pt;border:solid windowtext 1.0pt;   border-top:none;padding:   0in 5.75pt 0in 5.75pt" width="500" valign="top">          <p style="margin-left:0in;text-indent:0in;">Actual   sequence of two or more <em>in situ </em>or   malignant primary tumors</p>        </td>        <td style="width:124.2pt;border-top:none;border-left:   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;   padding:0in 5.75pt 0in 5.75pt" width="166" valign="top">          <p style="margin-left:0in;text-indent:0in;">02   -- 59</p>        </td>      </tr>      <tr>        <td style="width:375.1pt;border:solid windowtext 1.0pt;   border-top:none;padding:   0in 5.75pt 0in 5.75pt" width="500" valign="top">          <p style="margin-left:0in;text-indent:0in;">Unspecified   malignant sequence number or unknown</p>        </td>        <td style="width:124.2pt;border-top:none;border-left:   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;   padding:0in 5.75pt 0in 5.75pt" width="166" valign="top">          <p style="margin-left:0in;text-indent:0in;">99</p>        </td>      </tr>      <tr>        <td style="width:375.1pt;border:solid windowtext 1.0pt;   border-top:none;padding:   0in 5.75pt 0in 5.75pt" width="500" valign="top">          <p style="margin-left:0in;text-indent:0in;">            <strong>Non-Malignant</strong>          </p>        </td>        <td style="width:124.2pt;border-top:none;border-left:   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;   padding:0in 5.75pt 0in 5.75pt" width="166" valign="top">          <p style="margin-left:0in;text-indent:0in;"> &nbsp;</p>        </td>      </tr>      <tr>        <td style="width:375.1pt;border:solid windowtext 1.0pt;   border-top:none;padding:   0in 5.75pt 0in 5.75pt" width="500" valign="top">          <p style="margin-left:0in;text-indent:0in;">One   benign (behavior code = 0) or borderline (behavior code = 1) primary tumor   only in the patient&#8217;s lifetime</p>        </td>        <td style="width:124.2pt;border-top:none;border-left:   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;   padding:0in 5.75pt 0in 5.75pt" width="166" valign="top">          <p style="margin-left:0in;text-indent:0in;">60</p>        </td>      </tr>      <tr>        <td style="width:375.1pt;border:solid windowtext 1.0pt;   border-top:none;padding:   0in 5.75pt 0in 5.75pt" width="500" valign="top">          <p style="margin-left:0in;text-indent:0in;">First   of two or more benign or borderline primary tumors in the patient&#8217;s lifetime</p>        </td>        <td style="width:124.2pt;border-top:none;border-left:   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;   padding:0in 5.75pt 0in 5.75pt" width="166" valign="top">          <p style="margin-left:0in;text-indent:0in;">61</p>        </td>      </tr>      <tr>        <td style="width:375.1pt;border:solid windowtext 1.0pt;   border-top:none;padding:   0in 5.75pt 0in 5.75pt" width="500" valign="top">          <p style="margin-left:0in;text-indent:0in;">Actual   sequence of two or more non-malignant primary tumors</p>        </td>        <td style="width:124.2pt;border-top:none;border-left:   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;   padding:0in 5.75pt 0in 5.75pt" width="166" valign="top">          <p style="margin-left:0in;text-indent:0in;">62   -- 87</p>        </td>      </tr>      <tr>        <td style="width:375.1pt;border:solid windowtext 1.0pt;   border-top:none;padding:   0in 5.75pt 0in 5.75pt" width="500" valign="top">          <p style="margin-left:0in;text-indent:0in;">Unspecified   non-malignant sequence number or unknown</p>        </td>        <td style="width:124.2pt;border-top:none;border-left:   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt" width="166" valign="top">          <p style="margin-left:0in;text-indent:0in;">88</p>        </td>      </tr>    </tbody>  </table>  <em>    <br />  </em>  <span style="font-size:11.0pt;font-family:&quot;Times New Roman&quot;,&quot;serif&quot;;">*Juvenile astrocytomas should be reported as 9421/3.</span>  <em>    <br />    <br />Note:</em> See the section on Sequence Number in CoC (<em>STORE</em>) manual.</div><a name='3930'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>SERUM ALBUMIN PRETREATMENT LEVEL</strong></td><td style="text-align:right;font-weight:bold;"><strong>Revised</strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">3930</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>NAACCR</a></td><td style="text-align:center;">2018</td><td style="text-align:center;">18</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1917 - 1917</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>serumAlbuminPretreatmentLevel</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Albumin is the most abundant protein in human blood plasma. Serum albumin pretreatment level is a prognostic factor for plasma cell myeloma.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para mark-changed'>Serum albumin pretreatment level is a prognostic factor required in AJCC 8th edition, Chapter 82 













<em>Plasma Cell Myeloma and Plasma Cell Disorders</em>, for the Revised International Staging System (RISS). It is a new data item for cases diagnosed 1/1/2018+.</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>0</td><td class='code-desc'>Serum albumin <3.5 g/dL </td></tr><tr class='code-row'><td class='code-nbr'>1</td><td class='code-desc'>Serum albumin =3.5 g/dL </td></tr><tr class='code-row'><td class='code-nbr'>7</td><td class='code-desc'>Test ordered, results not in chart</td></tr><tr class='code-row'><td class='code-nbr'>9</td><td class='code-desc'>Not documented in medical record<br/>
Serum Albumin Pretreatment Level not assessed or unknown if assessed
</td></tr><tr class='code-row'><td class='code-nbr'></td><td class='code-desc'> </td></tr></table></div><div class='content chap10-para'>Each Site-Specific Data Item (SSDI) applies only to selected primary sites, histologies, and years of diagnosis. Depending on applicability and standard-setter requirements, SSDIs may be left blank.</div><a name='3931'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>SERUM BETA-2 MICROGLOBULIN PRETREATMENT LEVEL</strong></td><td style="text-align:right;font-weight:bold;"><strong>Revised</strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">3931</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>NAACCR</a></td><td style="text-align:center;">2018</td><td style="text-align:center;">18</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1918 - 1918</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>serumBeta2MicroglobulinPretxLvl</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Serum Beta-2 Microglobulin is a protein that is found on the surface of many cells and plentiful on the surface of white blood cells. Increased production or destruction of these cells causes Serum &#946;2 (beta-2) Microglobulin level to increase. Elevated Serum &#946;2 (beta-2) Microglobulin level is a prognostic factor for plasma cell myeloma.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para mark-changed'>Serum Beta-2 Microglobulin Pretreatment Level is a prognostic factor required in AJCC 8th edition, Chapter 82 


















<em>Plasma Cell Myeloma and Plasma Cell Disorders</em>, for staging of plasma cell myeloma. It is a new data item for cases diagnosed 1/1/2018+.</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>0</td><td class='code-desc'>2-microglobulin <3.5 mg/L  </td></tr><tr class='code-row'><td class='code-nbr'>1</td><td class='code-desc'>2-microglobulin =3.5 mg/L <5.5 mg/L</td></tr><tr class='code-row'><td class='code-nbr'>2</td><td class='code-desc'>2-microglobulin =5.5 mg/L</td></tr><tr class='code-row'><td class='code-nbr'>7</td><td class='code-desc'>Test ordered, results not in chart</td></tr><tr class='code-row'><td class='code-nbr'>9</td><td class='code-desc'>Not documented in medical record<br/><br/>
Serum Beta-2 Microglobulin Pretreatment Level not assessed or unknown if assessed</td></tr><tr class='code-row'><td class='code-nbr'></td><td class='code-desc'> </td></tr></table></div><div class='content chap10-para'>Each Site-Specific Data Item (SSDI) applies only to selected primary sites, histologies, and years of diagnosis. Depending on applicability and standard-setter requirements, SSDIs may be left blank.</div><a name='220'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>SEX</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">220</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>SEER/CoC</a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">222 - 222</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>sex</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Patient</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Code for the sex of the patient.</div><div class='content chap10-para'><strong>Codes </strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>1</td><td class='code-desc'>Male</td></tr><tr class='code-row'><td class='code-nbr'>2</td><td class='code-desc'>Female</td></tr><tr class='code-row'><td class='code-nbr'>3</td><td class='code-desc'>Other (intersex, disorders of sexual development/DSD). The word hermaphrodite formerly classified under this code is an outdated term.</td></tr><tr class='code-row'><td class='code-nbr'>4</td><td class='code-desc'>Transsexual, NOS</td></tr><tr class='code-row'><td class='code-nbr'>5</td><td class='code-desc'>Transsexual, natal male </td></tr><tr class='code-row'><td class='code-nbr'>6</td><td class='code-desc'>Transsexual, natal female</td></tr><tr class='code-row'><td class='code-nbr'>9</td><td class='code-desc'>Not stated/Unknown</td></tr><tr class='code-row'><td class='code-nbr'></td><td class='code-desc'> </td></tr></table></div><a name='1960'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>SITE (73-91) ICD-O-1</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">1960</td><td style="text-align:center;">4</td><td style="text-align:center;"><a href='#sources'>SEER</a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">2596 - 2599</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>Primary Site (1973-91) (SEER)<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>siteIcdO1</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Area for retaining the ICD-O-1 primary site code entered before conversion to ICD-0-2. The item name includes years 1973-91. However, some states may have used the codes for cases before 1973. </div><div class='content chap10-para'><strong>Codes<br /></strong>For tumors diagnosed before 1992, contains the ICD-O-1 site code as originally coded, if available. Blank for tumors coded directly into ICD-O-2 (i.e., 1992 and later tumors).<strong><br /></strong></div><a name='450'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>SITE CODING SYS--CURRENT</strong></td><td style="text-align:right;font-weight:bold;"><strong>Revised</strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">450</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>NAACCR</a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">572 - 572</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>siteCodingSysCurrent</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para mark-changed'>Code that best describes how the primary site currently is coded. If converted, this field shows the system to which it is converted.</div><div class='content chap10-para'><strong>Codes </strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>1</td><td class='code-desc'>ICD-8 and MOTNAC</td></tr><tr class='code-row'><td class='code-nbr'>2</td><td class='code-desc'>ICD-9</td></tr><tr class='code-row'><td class='code-nbr'>3</td><td class='code-desc'>ICD-O, First Edition</td></tr><tr class='code-row'><td class='code-nbr'>4</td><td class='code-desc'>ICD-O, Second Edition</td></tr><tr class='code-row'><td class='code-nbr'>5</td><td class='code-desc'>ICD-O, Third Edition</td></tr><tr class='code-row'><td class='code-nbr'>6</td><td class='code-desc'>ICD-10</td></tr><tr class='code-row'><td class='code-nbr'>9</td><td class='code-desc'>Other</td></tr></table></div><a name='460'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>SITE CODING SYS--ORIGINAL</strong></td><td style="text-align:right;font-weight:bold;"><strong>Revised</strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">460</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>NAACCR</a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">573 - 573</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>siteCodingSysOriginal</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para mark-changed'>Code that best describes how primary site was originally coded. If converted, this field shows the original coding system used.</div><div class='content chap10-para'><strong>Codes </strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>1</td><td class='code-desc'>ICD-8 and MOTNAC</td></tr><tr class='code-row'><td class='code-nbr'>2</td><td class='code-desc'>ICD-9</td></tr><tr class='code-row'><td class='code-nbr'>3</td><td class='code-desc'>ICD-O, First Edition</td></tr><tr class='code-row'><td class='code-nbr'>4</td><td class='code-desc'>ICD-O, Second Edition</td></tr><tr class='code-row'><td class='code-nbr'>5</td><td class='code-desc'>ICD-O, Third Edition</td></tr><tr class='code-row'><td class='code-nbr'>6</td><td class='code-desc'>ICD-10</td></tr><tr class='code-row'><td class='code-nbr'>9</td><td class='code-desc'>Other</td></tr></table></div><a name='1090'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>SITE OF DISTANT MET 1</strong></td><td style="text-align:right;font-weight:bold;"><strong>Retired</strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">1090</td><td style="text-align:center;"></td><td style="text-align:center;"><a href='#sources'></a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;">2010</td><td style="text-align:center;">12</td><td class="cross-out" style="text-align:center;"></td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td></td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td></td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>The NAACCR UDSC retired this data item in Version 12, as of January 1, 2010.</div><a name='1100'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>SITE OF DISTANT MET 2</strong></td><td style="text-align:right;font-weight:bold;"><strong>Retired</strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">1100</td><td style="text-align:center;"></td><td style="text-align:center;"><a href='#sources'></a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;">2010</td><td style="text-align:center;">12</td><td class="cross-out" style="text-align:center;"></td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td></td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td></td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>The NAACCR UDSC retired this data item in Version 12, as of January 1, 2010.</div><a name='1110'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>SITE OF DISTANT MET 3</strong></td><td style="text-align:right;font-weight:bold;"><strong>Retired</strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">1110</td><td style="text-align:center;"></td><td style="text-align:center;"><a href='#sources'></a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;">2010</td><td style="text-align:center;">12</td><td class="cross-out" style="text-align:center;"></td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td></td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td></td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>The NAACCR UDSC retired this data item in Version 12, as of January 1, 2010.</div><a name='2320'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>SOCIAL SECURITY NUMBER</strong></td><td style="text-align:right;font-weight:bold;"><strong>Revised</strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">2320</td><td style="text-align:center;">9</td><td title="V: 22: SEER
V: 18: CoC
V: 16: CoC
V: 15: CoC
" class=" HighlightToolTip" style="text-align:center;"><a href='#sources'>SEER</a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">4328 - 4336</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>socialSecurityNumber</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Patient</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para mark-changed'>Records patient&#8217;s social security number. The number is entered without dashes and without any letter suffix. This is not always identical to the Medicare claim number.</div><div class='content chap10-para'><strong>Codes (in addition to social security number) </strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>999999999</td><td class='code-desc'>Unknown</td></tr></table></div><a name='190'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>SPANISH/HISPANIC ORIGIN</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">190</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>SEER/CoC</a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">219 - 219</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>Spanish Origin--All Sources (96 CoC)<br />Spanish Surname or Origin (SEER)<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>spanishHispanicOrigin</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Patient</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Code identifying persons of Spanish or Hispanic origin. This code is used by hospital and central registries to show the &#8220;best guess&#8221; as to whether or not the person should be classified as Hispanic for purposes of calculating cancer rates. If the patient has multiple tumors, all records should have the same code.<br /><br />Reference to Census 2000 definitions for ethnicity and race: <a target="_blank" href="http://www.census.gov/prod/cen2000/doc/sf2.pdf">http://www.census.gov/prod/cen2000/doc/sf2.pdf</a>. All information resources should be used to determine the correct code, including:<ul><li>Stated ethnicity in the medical record</li><li>Stated Hispanic origin on the death certificate</li><li>Birthplace</li><li>Information about life history and/or language spoken found during the abstracting process</li><li>Patient&#8217;s last name [2230] or maiden name [2390] found on a list of Hispanic names</li></ul>Some registries code the information from the medical record, others code ethnicity based on Spanish names, and others use a combination of methods.<br /><br />Persons of Spanish or Hispanic origin may be of any race, but these categories generally are not used for Native Americans, Filipinos, etc., who may have Spanish names. If a patient has an Hispanic name, but there is reason to believe they are not Hispanic (e.g., the patient is Filipino, or the patient is a woman known to be non-Hispanic who has a Hispanic married name), the code in this field should be 0 (non-Spanish, non-Hispanic). The code in item Computed Ethnicity [200], however, would reflect the Hispanic name.<br /><br />Assign code 7 if Hispanic ethnicity is based strictly on a computer list or algorithm (unless contrary evidence is available) and also code in Computed Ethnicity [200]. <br /><br />See also Computed Ethnicity [200].<em><br /><br />Note:</em> NAACCR recognizes that available definitions and abstracting instructions for Name--Last [2230] and Name--Maiden [2390] may be inadequate for describing names used in some cultures, including Hispanic cultures. Explicit instructions have not been provided for entering compound names, with or without hyphens or &#8220;De.&#8221; Order of names, use of maternal and paternal names, and use of hyphens can vary across cultures. It is likely that abstracting and coding practice for these items varies across registries. Limitations inherent in these definitions should be kept in mind when using the data.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>See the rationales for the Race 1-5 [160-164] and Computed Ethnicity [200]. Ethnic origin has a significant association with cancer rates and outcomes. Hispanic populations have different patterns of occurrence of cancer from other populations that may be included in the &#8220;white&#8221; category of Race [160].</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>0</td><td class='code-desc'>Non-Spanish; non-Hispanic</td></tr><tr class='code-row'><td class='code-nbr'>1</td><td class='code-desc'>Mexican (includes Chicano)</td></tr><tr class='code-row'><td class='code-nbr'>2</td><td class='code-desc'>Puerto Rican</td></tr><tr class='code-row'><td class='code-nbr'>3</td><td class='code-desc'>Cuban</td></tr><tr class='code-row'><td class='code-nbr'>4</td><td class='code-desc'>South or Central American (except Brazil)</td></tr><tr class='code-row'><td class='code-nbr'>5</td><td class='code-desc'>Other specified Spanish/Hispanic origin (includes European; excludes Dominican Republic)</td></tr><tr class='code-row'><td class='code-nbr'>6</td><td class='code-desc'>Spanish, NOS<br/>Hispanic, NOS<br/>Latino, NOS<br/>There is evidence, other than surname or maiden name, that the person is Hispanic, but he/she cannot be assigned to any of the other categories 1-5.</td></tr><tr class='code-row'><td class='code-nbr'>7</td><td class='code-desc'>Spanish surname only (Code 7 is ordinarily for central registry use only, hospital registrars may use code 7 if using a list of Hispanic surnames provided by their central registry; otherwise, code 9 'unknown whether Spanish or not' should be used.)  The only evidence of the person's Hispanic origin is the surname or maiden name and there is no contrary evidence that the person is not Hispanic.</td></tr><tr class='code-row'><td class='code-nbr'>8</td><td class='code-desc'>Dominican Republic</td></tr><tr class='code-row'><td class='code-nbr'>9</td><td class='code-desc'>Unknown whether Spanish or not</td></tr><tr class='code-row'><td class='code-nbr'></td><td class='code-desc'> </td></tr></table></div><div class='content chap10-para'><em>Note:</em> Code 7 was adopted for use effective with 1994 diagnosis and modified December 1994. <em>Note: </em>Code 8 was added in Standards Volume II Version 10.2,  effective January 2005, however, abstractors may assign code 8 to tumors  diagnosed prior to 2005. <strong><br /></strong></div><a name='81'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>STATE AT DX GEOCODE 1970/80/90</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">81</td><td style="text-align:center;">2</td><td style="text-align:center;"><a href='#sources'>NAACCR</a></td><td style="text-align:center;">2018</td><td style="text-align:center;">18</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">153 - 154</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>State at DX Geocode1990<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>stateAtDxGeocode19708090</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Code for the state of the patient's residence at the time the tumor was diagnosed is a derived (geocoded) variable based on Census Boundary files from 1970, 1980, or 1990 Decennial Census.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Populating the GeoLocationID 70/80/90 [351] correctly requires FIPS code for state and not the USPS abbreviations. Also, on rare occasions, the boundaries of states do change (North Carolina and South Carolina border, for example).</div><div class='content chap10-para'><div><strong> Instructions for Coding </strong></div><div><ul><li>This variable is generated through the process of geocoding either during abstracting or at the central registry level. For U.S. residents, this data item stores the county codes issued by the Federal Information Processing Standards (FIPS) publication Counties and Equivalent Entities of the United States, Its Possessions, and Associated Areas. The information in this publication is available in Appendix A.</li><li>It is recommended that geocoding be performed using the NAACCR geocoder.</li><li>It is recommended that all cases diagnosed through 1999 should have a State at DX Geocode 70/80/90 [81] based on 1990 Census.</li><li>At a minimum, all cases diagnosed through 1995-1999 should have a geocoded State at DX Geocode 1990 [81]. Some cases, such as those diagnosed in 1999, must have both State at DX Geocode 1990 [81] and State at DX Geocode 2000 [82] codes for proper assignment of the Census Tr Poverty Indicatr [145]. </li><li>Do not update this item if the patient's residence changes. Store address update information in the affiliated current address data items. Only update based on improved information on the residential address at time of diagnosis.</li><li>PO Box address information should not be used to geocode this data item except in the infrequent case when no other address information is available.</li><li>If the patient has multiple tumors, the county codes may be different for each tumor.</li></ul></div></div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>01-95</td><td class='code-desc'>Valid FIPS code </td></tr><tr class='code-row'><td class='code-nbr'>Blank</td><td class='code-desc'>Residence unknown, geocoding not performed, geocoding unsuccessful, residence outside US (including its territories, commonwealths, or possessions) residence US, NOS.</td></tr><tr class='code-row'><td class='code-nbr'></td><td class='code-desc'> </td></tr></table></div><div class='content chap10-para'><em>Note</em>: For U.S. residents, historically, standard codes are those of the FIPS publication "Counties and Equivalent Entities of the United States, Its Possessions, and Associated Areas." These FIPS codes (FIPS 6-4) have been replaced by INCITS standard codes, however, there is no impact on this variable as the codes align with the system the Census used for each decennial census and will automatically be accounted for during geocoding.</div><a name='82'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>STATE AT DX GEOCODE 2000</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">82</td><td style="text-align:center;">2</td><td style="text-align:center;"><a href='#sources'>NAACCR</a></td><td style="text-align:center;">2018</td><td style="text-align:center;">18</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">167 - 168</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>stateAtDxGeocode2000</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Code for the state of the patient's residence at the time the tumor was diagnosed is a derived (geocoded) variable based on Census Boundary files from 2000 Decennial Census.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'><!--[if gte mso 10]>  <![endif]-->Populating the GeoLocationID - 2000 [352] correctly requires FIPS code for state and not the USPS abbreviations. Also, on rare occasions, the boundaries of states do change (North Carolina and South Carolina border, for example).</div><div class='content chap10-para'><div><strong> Instructions for Coding</strong></div><div><ul><li>This variable is generated through the process of geocoding either during abstracting or at the central registry level. For U.S. residents, this data item stores the county codes issued by the Federal Information Processing Standards (FIPS) publication Counties and Equivalent Entities of the United States, Its Possessions, and Associated Areas. The information in this publication is available in Appendix A.</li><li>It is recommended that geocoding be performed using the NAACCR geocoder.</li><li>It is recommended that all cases diagnosed through 2009 should have a State at DX Geocode 2000 [82].</li><li>At a minimum, all cases diagnosed through 1995-2009 should have a State at DX Geocode 2000. Some cases, such as those diagnosed in 2009, must have both State at DX Geocode 2000 [82] and State at DX Geocode 2010 [353] codes for proper assignment of the Census Tr Poverty Indicatr [145]. </li><li>Do not update this item if the patient&#8217;s residence changes. Store address update information in the affiliated current address data items. Only update based on improved information on the residential address at time of diagnosis.</li><li>PO Box address information should not be used to geocode this data item except in the infrequent case when no other address information is available.</li><li>If the patient has multiple tumors, the county codes may be different for each tumor. <br /></li></ul></div></div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>01-95</td><td class='code-desc'>Valid FIPS Code </td></tr><tr class='code-row'><td class='code-nbr'>Blank</td><td class='code-desc'>Residence unknown, geocoding not performed, geocoding unsuccessful, residence outside US (including its territories, commonwealths, or possessions) residence US, NOS.</td></tr><tr class='code-row'><td class='code-nbr'></td><td class='code-desc'> </td></tr></table></div><div class='content chap10-para'><!--[if gte mso 10]>  <![endif]-->
<em>Note</em>: For U.S. residents, historically, standard codes are those of the FIPS publication "Counties and Equivalent Entities of the United States, Its Possessions, and Associated Areas." These FIPS codes (FIPS 6-4) have been replaced by INCITS standard codes, however, there is no impact on this variable as the codes align with the system the Census used for each decennial census and will automatically be accounted for during geocoding.</div><a name='83'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>STATE AT DX GEOCODE 2010</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">83</td><td style="text-align:center;">2</td><td style="text-align:center;"><a href='#sources'>NAACCR</a></td><td style="text-align:center;">2018</td><td style="text-align:center;">18</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">180 - 181</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>stateAtDxGeocode2010</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Code for the state of the patient's residence at the time the tumor was diagnosed is a derived (geocoded) variable based on Census Boundary files from 2010 Decennial Census.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'><div> Populating the GeoLocationID 2010 [353] correctly requires FIPS code for state and not the USPS abbreviations. Also, on rare occasions, the boundaries of states do change (North Carolina and South Carolina border, for example).</div><div>&nbsp;</div><div><strong>Instructions for Coding</strong></div><div>  </div><ul><li>This variable is generated through the process of geocoding either during abstracting or at the central registry level. For U.S. residents, this data item stores the county codes issued by the Federal Information Processing Standards (FIPS) publication Counties and Equivalent Entities of the United States, Its Possessions, and Associated Areas. The information in this publication is available in Appendix A.</li><li>It is recommended that geocoding be performed using the NAACCR geocoder.</li><li>It is recommended that all cases diagnosed through 2019 should have a State at DX Geocode 2010 [83].</li><li>At a minimum, all cases diagnosed through 2005-2019 should have a State at DX Geocode 2010 [83]. Some cases, such as those diagnosed 2015-2019, must have both State at DX Geocode 2010 [83] and State at DX Geocode 2020 [354] codes for proper assignment of the Census Tr Poverty Indicatr [145]. </li><li>Do not update this item if the patient's residence changes. Store address update information in the affiliated current address data items. Only update based on improved information on the residential address at time of diagnosis.</li><li>PO Box address information should not be used to geocode this data item except in the infrequent case when no other address information is available.</li><li>If the patient has multiple tumors, the county codes may be different for each tumor.</li></ul></div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>01-95</td><td class='code-desc'>Valid FIPS Codes </td></tr><tr class='code-row'><td class='code-nbr'>Blank</td><td class='code-desc'>Residence unknown, geocoding not performed, geocoding unsuccessful, residence outside US (including its territories, commonwealths, or possessions) residence US, NOS.</td></tr><tr class='code-row'><td class='code-nbr'></td><td class='code-desc'> </td></tr></table></div><a name='84'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>STATE AT DX GEOCODE 2020</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">84</td><td style="text-align:center;">2</td><td style="text-align:center;"><a href='#sources'>NAACCR</a></td><td style="text-align:center;">2018</td><td style="text-align:center;">18</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">193 - 194</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>stateAtDxGeocode2020</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Code for the state of the patient's residence at the time the tumor was diagnosed is a derived (geocoded) variable based on Census Boundary files from 2020 Decennial Census.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'><div> Populating the GeoLocationID 2020 [354] correctly requires FIPS code for state and not the USPS abbreviations. Also, on rare occasions, the boundaries of states do change (North Carolina and South Carolina border, for example). </div><div>&nbsp;</div><div><strong>Instruction for Coding</strong></div><div><ul><li>This variable is generated through the process of geocoding either during abstracting or at the central registry level. For U.S. residents, this data item stores the state codes issued by the Federal Information Processing Standards (FIPS) publication Counties and Equivalent Entities of the United States, Its Possessions, and Associated Areas. The information in this publication is available in Appendix A.</li><li>It is recommended that geocoding be performed using the NAACCR geocoder.</li><li>It is recommended that all cases diagnosed through 2029 should have a State at DX Geocode 2020 [84].</li><li>At a minimum, all cases diagnosed 2015-2029 should have a State at DX Geocode 2010 [83]. Some cases, such as those diagnosed in 2029, must have both State at DX Geocode 2020 [84] and State at DX 2030 codes for proper assignment of the Census Tr Poverty Indicatr [145]. </li><li>Do not update this item if the patient's residence changes. Store address update information in the affiliated current address data items. Only update based on improved information on the residential address at time of diagnosis.</li><li>PO Box address information should not be used to geocode this data item except in the infrequent case when no other address information is available.</li><li>If the patient has multiple tumors, the state codes may be different for each tumor. <br /></li></ul></div></div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>01-95</td><td class='code-desc'>Valid FIPS code </td></tr><tr class='code-row'><td class='code-nbr'>Blank</td><td class='code-desc'>Residence unknown, geocoding not performed, geocoding unsuccessful, residence outside US (including its territories, commonwealths, or possessions) residence US, NOS.</td></tr><tr class='code-row'><td class='code-nbr'></td><td class='code-desc'> </td></tr></table></div><div class='content chap10-para'><em>Note</em>: For U.S. residents, historically, standard codes are those of the FIPS publication "Counties and Equivalent Entities of the United States, Its Possessions, and Associated Areas." These FIPS codes (FIPS 6-4) have been replaced by INCITS standard codes, however, there is no impact on this variable as the codes align with the system the Census used for each decennial census and will automatically be accounted for during geocoding.</div><a name='2220'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>STATE/REQUESTOR ITEMS</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">2220</td><td style="text-align:center;">1000</td><td style="text-align:center;"><a href='#sources'>Varies</a></td><td style="text-align:center;">2011</td><td style="text-align:center;">12.2</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">3049 - 4048</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>stateRequestorItems</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Reserved for use by individual states or central registries, or for use by special studies. </div><a name='2160'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>SUBSQ REPORT FOR PRIMARY</strong></td><td style="text-align:right;font-weight:bold;"><strong>Retired</strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">2160</td><td style="text-align:center;"></td><td style="text-align:center;"><a href='#sources'></a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;">1998</td><td style="text-align:center;">6</td><td class="cross-out" style="text-align:center;"></td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td></td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td></td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>The NAACCR UDSC retired this data item in Version 6, effective January 1, 1998.</div><a name='1675'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>SUBSQ RX 2ND COURSE BRM</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">1675</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>CoC</a></td><td style="text-align:center;">2011</td><td style="text-align:center;">12.2</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">2476 - 2476</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>subsqRx2ndCourseBrm</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Codes for the type of biological response modifier therapy given as part of the second course of treatment. Central registries currently collecting this data item should follow the <em>1998 ROADS Manual</em> coding instructions. The codes are the same as those for Immunotherapy, <em>1998 ROADS Manual</em>, p. 243. </div><div class='content chap10-para'><em>Note:</em> This data item is no longer supported by CoC (as of January 1, 2003). </div><a name='1673'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>SUBSQ RX 2ND COURSE CHEMO</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">1673</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>CoC</a></td><td style="text-align:center;">2011</td><td style="text-align:center;">12.2</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">2474 - 2474</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>subsqRx2ndCourseChemo</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Codes for the type of chemotherapy given as part of the second course of treatment. Central registries currently collecting this data item should follow the <em>1998 ROADS Manual</em> coding instructions. The codes are the same as those for Chemotherapy, <em>1998 ROADS Manual</em>, p. 228. </div><div class='content chap10-para'><em>Note:</em> This data item is no longer supported by CoC (as of January 1, 2003). </div><a name='1670'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>SUBSQ RX 2ND COURSE CODES</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">1670</td><td style="text-align:center;">11</td><td style="text-align:center;"><a href='#sources'></a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">2467 - 2477</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>subsqRx2ndCourseCodes</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>The name for a group of subfields that describe the second course or set of subsequent therapy. As of January 1, 2003, CoC no longer supports Subsequent Therapy data items.<br /><br />Group names appear only in the data dictionary and Appendix E.<br /><strong><br />Subfields</strong><br />&nbsp;&nbsp; &nbsp;&nbsp; &nbsp;&nbsp; Subsq RX 2nd Course Surg [1671]<br />&nbsp;&nbsp; &nbsp;&nbsp; &nbsp;&nbsp; Subsq RX 2nd Course Rad [1672]<br />&nbsp;&nbsp; &nbsp;&nbsp; &nbsp;&nbsp; Subsq RX 2nd Course Chemo [1673]<br />&nbsp;&nbsp; &nbsp;&nbsp; &nbsp;&nbsp; Subsq RX 2nd Course Horm [1674]<br />&nbsp;&nbsp; &nbsp;&nbsp; &nbsp;&nbsp; Subsq RX 2nd Course BRM [1675]<br />&nbsp;&nbsp; &nbsp;&nbsp; &nbsp;&nbsp; Subsq RX 2nd Course Oth [1676]</div><a name='1660'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>SUBSQ RX 2ND COURSE DATE</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">1660</td><td style="text-align:center;">8</td><td style="text-align:center;"><a href='#sources'>CoC</a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">2457 - 2464</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>Second Course of Therapy-Date Started (pre-96 CoC)<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>subsqRx2ndCourseDate</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Date of initiation of second-course treatment. Central registries currently collecting this data item should follow the 

<em>1998 ROADS Manual</em> coding instructions. See Chapter X for date format. Use SUBSQ RX 2NDCRS DATE FLAG [1661] if there is no appropriate or known date for this item. </div><div class='content chap10-para'><em>Note:</em> This data item is no longer supported by CoC (as of January 1, 2003). </div><a name='1674'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>SUBSQ RX 2ND COURSE HORM</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">1674</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>CoC</a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">2475 - 2475</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>subsqRx2ndCourseHorm</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Codes for the type of hormonal therapy given as part of the second course of treatment. Central registries currently collecting this data item should follow the <em>1998 ROADS Manual</em> coding instructions. The codes are the same as those for Hormone Therapy, <em>1998 ROADS Manual</em>, p. 238. </div><div class='content chap10-para'><em>Note:</em> This data item is no longer supported by CoC (as of January 1, 2003). </div><a name='1676'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>SUBSQ RX 2ND COURSE OTH</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">1676</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>CoC</a></td><td style="text-align:center;">2011</td><td style="text-align:center;">12.2</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">2477 - 2477</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>subsqRx2ndCourseOth</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Codes for the type of other treatment given as part of the second course of treatment. Central registries currently collecting this data item should follow the <em>1998 ROADS Manual</em> coding instructions. The codes are the same as those for Other Treatment, <em>1998 ROADS Manual</em>, p. 246. </div><div class='content chap10-para'><em>Note:</em> This data item is no longer supported by CoC (as of January 1, 2003). </div><a name='1672'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>SUBSQ RX 2ND COURSE RAD</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">1672</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>CoC</a></td><td style="text-align:center;">2011</td><td style="text-align:center;">12.2</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">2473 - 2473</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>subsqRx2ndCourseRad</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Codes for the type of radiation given as part of the second course of treatment. Central registries currently collecting this data item should follow the <em>1998 ROADS Manual</em> coding instructions. The codes are the same as those for Radiation, <em>1998 ROADS Manual</em>, p. 199. </div><div class='content chap10-para'><em>Note:</em> This data item is no longer supported by CoC (as of January 1, 2003). </div><a name='1671'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>SUBSQ RX 2ND COURSE SURG</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">1671</td><td style="text-align:center;">2</td><td style="text-align:center;"><a href='#sources'>CoC</a></td><td style="text-align:center;">2011</td><td style="text-align:center;">12.2</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">2467 - 2468</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>subsqRx2ndCourseSurg</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Codes for the type of primary site surgery given as part of the second course of treatment. Central registries currently collecting this data item should follow the <em>1998 ROADS Manual</em> coding instructions. The codes are the same as those for Surgery of Primary Site, <em>1998 ROADS Manual</em>, p. 187. </div><div class='content chap10-para'><em>Note:</em> This data item is no longer supported by CoC (as of January 1, 2003). </div><a name='1661'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>SUBSQ RX 2NDCRS DATE FLAG</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">1661</td><td style="text-align:center;">2</td><td style="text-align:center;"><a href='#sources'>NAACCR</a></td><td style="text-align:center;">2010</td><td style="text-align:center;">12</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">2465 - 2466</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>subsqRx2ndcrsDateFlag</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>This flag explains why no appropriate value is in the field, Subsq RX 2nd Course Date [1660]. </div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Before Version 12 (through 2009 diagnosis), date fields included codes that provided information other than dates. As part of an initiative to standardize date fields, new fields were introduced to accommodate non-date information that had previously been transmitted in date fields. </div><div class='content chap10-para'><strong>Codes (See Appendix H for the Flavors of Null table in its entirety which includes the NAACCR codes, HL7 codes and definitions.)</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>10</td><td class='code-desc'>No information whatsoever can be inferred from this exceptional value (e.g., unknown if any subsequent therapy)</td></tr><tr class='code-row'><td class='code-nbr'>11</td><td class='code-desc'>No proper value is applicable in this context (e.g., no subsequent therapy)</td></tr><tr class='code-row'><td class='code-nbr'>Blank</td><td class='code-desc'>A valid date value is provided in item Subsq RX 2nd Course Date [1660], or the date was not expected to have been transmitted</td></tr></table></div><div class='content chap10-para'><em>Comment: </em>This is part of the initiative of the transformation from the old NAACCR date standards to interoperable dates.</div><a name='1679'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>SUBSQ RX 2ND--REG LN REM</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">1679</td><td style="text-align:center;">2</td><td style="text-align:center;"><a href='#sources'>CoC</a></td><td style="text-align:center;">1997</td><td style="text-align:center;">5.1</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">2471 - 2472</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>subsqRx2ndRegLnRem</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Codes for the number of regional lymph nodes removed as part of the second course of treatment. Central registries currently collecting this data item should follow the <em>1998 ROADS Manual</em> coding instructions. The codes are the same as those for Number of Regional Lymph Nodes Removed, <em>1998 ROADS Manual</em>, p. 193. </div><div class='content chap10-para'><em>Note:</em> This data item is no longer supported by CoC (as of January 1, 2003). </div><a name='1677'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>SUBSQ RX 2ND--SCOPE LN SU</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">1677</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>CoC</a></td><td style="text-align:center;">1997</td><td style="text-align:center;">5.1</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">2469 - 2469</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>subsqRx2ndScopeLnSu</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Codes for the type of surgery performed to remove regional lymph nodes as part of the second course of treatment. Central registries currently collecting this data item should follow the <em>1998 ROADS Manual</em> coding instructions. The codes are the same as those for Scope of Regional Lymph Node Surgery, <em>1998 ROADS Manual</em>, p. 192.&nbsp; </div><div class='content chap10-para'><em>Note:</em> This data item is no longer supported by CoC (as of January 1, 2003). </div><a name='1678'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>SUBSQ RX 2ND--SURG OTH</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">1678</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>CoC</a></td><td style="text-align:center;">1997</td><td style="text-align:center;">5.1</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">2470 - 2470</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>subsqRx2ndSurgOth</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Codes for the type of surgery performed on tissue or organs other than the primary site and regional lymph nodes as part of the second course of treatment. Central registries currently collecting this data item should follow the <em>1998 ROADS Manual</em> coding instructions. The codes are the same as those for Surgery of Other Regional Site(s), Distant Site(s) or Distant Lymph Node(s), <em>1998 ROADS Manual</em>, p. 194. </div><div class='content chap10-para'><em>Note:</em> This data item is no longer supported by CoC (as of January 1, 2003). </div><a name='1695'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>SUBSQ RX 3RD COURSE BRM</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">1695</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>CoC</a></td><td style="text-align:center;">2011</td><td style="text-align:center;">12.2</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">2497 - 2497</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>subsqRx3rdCourseBrm</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Codes for the type of biological response modifier therapy given as part of the second course of treatment. Central registries currently collecting this data item should follow the <i>1998 ROADS Manual</i> coding instructions. The codes are the same as those for Immunotherapy, <i>1998 ROADS Manual</i>, p. 243 </div><div class='content chap10-para'><i>Note:</i> This data item is no longer supported by CoC (as of January 1, 2003). </div><a name='1693'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>SUBSQ RX 3RD COURSE CHEMO</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">1693</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>CoC</a></td><td style="text-align:center;">2011</td><td style="text-align:center;">12.2</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">2495 - 2495</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>subsqRx3rdCourseChemo</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Codes for the type of chemotherapy given as part of the third course of treatment. Central registries currently collecting this data item should follow the <i>1998 ROADS Manual</i> coding instructions. The codes are the same as those for Chemotherapy, <i>1998 ROADS Manual</i>, p. 228. </div><div class='content chap10-para'><i>Note:</i> This data item is no longer supported by CoC (as of January 1, 2003). </div><a name='1690'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>SUBSQ RX 3RD COURSE CODES</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">1690</td><td style="text-align:center;">11</td><td style="text-align:center;"><a href='#sources'></a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">2488 - 2498</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>subsqRx3rdCourseCodes</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>The name for a group of subfields that describe the third course or set of subsequent therapy. As of January 1, 2003, CoC no longer supports Subsequent Therapy data items.<br /><br />Group names appear only in the data dictionary and Appendix E.<strong><br /><br />Subfields</strong><br />&nbsp;&nbsp; &nbsp;&nbsp; &nbsp;&nbsp; Subsq RX 3rd Course Surg [1691]<br />&nbsp;&nbsp; &nbsp;&nbsp; &nbsp;&nbsp; Subsq RX 3rd Course Rad [1692]<br />&nbsp;&nbsp; &nbsp;&nbsp; &nbsp;&nbsp; Subsq RX 3rd Course Chemo [1693]<br />&nbsp;&nbsp; &nbsp;&nbsp; &nbsp;&nbsp; Subsq RX 3rd Course Horm [1694]<br />&nbsp;&nbsp; &nbsp;&nbsp; &nbsp;&nbsp; Subsq RX 3rd Course BRM [1695]<br />&nbsp;&nbsp; &nbsp;&nbsp; &nbsp;&nbsp; Subsq RX 3rd Course Oth [1696]</div><a name='1680'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>SUBSQ RX 3RD COURSE DATE</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">1680</td><td style="text-align:center;">8</td><td style="text-align:center;"><a href='#sources'>CoC</a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">2478 - 2485</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>subsqRx3rdCourseDate</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Date of initiation of third course of treatment. Central registries currently collecting this data item should follow the 


<em>1998 ROADS Manual</em> coding instructions. See Chapter X for date format. Use SUBSQ RX 3RD CRS DATE FLAG [1681] if there is no appropriate or known date for this item. </div><a name='1694'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>SUBSQ RX 3RD COURSE HORM</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">1694</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>CoC</a></td><td style="text-align:center;">2011</td><td style="text-align:center;">12.2</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">2496 - 2496</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>subsqRx3rdCourseHorm</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Codes for the type of hormonal therapy given as part of the third course of treatment. Central registries currently collecting this data item should follow the <i>1998 ROADS Manual</i> coding instructions. The codes are the same as those for Hormone Therapy, <i>1998 ROADS Manual</i>, p. 238. </div><div class='content chap10-para'><i>Note:</i> This data item is no longer supported by CoC (as of January 1, 2003). </div><a name='1696'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>SUBSQ RX 3RD COURSE OTH</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">1696</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>CoC</a></td><td style="text-align:center;">2011</td><td style="text-align:center;">12.2</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">2498 - 2498</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>subsqRx3rdCourseOth</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Codes for the type of other treatment given as part of the third course of treatment. Central registries currently collecting this data item should follow the <i>1998 ROADS Manual</i> coding instructions. The codes are the same as those for Other Treatment, <i>1998 ROADS Manual</i>, p. 246. </div><div class='content chap10-para'><i>Note:</i> This data item is no longer supported by CoC (as of January 1, 2003). </div><a name='1692'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>SUBSQ RX 3RD COURSE RAD</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">1692</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>CoC</a></td><td style="text-align:center;">2011</td><td style="text-align:center;">12.2</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">2494 - 2494</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>subsqRx3rdCourseRad</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Codes for the type of radiation given as part of the third course of treatment. Central registries currently collecting this data item should follow the <i>1998 ROADS Manual</i> coding instructions. The codes are the same as those for Radiation, <i>1998 ROADS Manual</i>, p. 199. </div><div class='content chap10-para'><i>Note:</i> This data item is no longer supported by CoC (as of January 1, 2003). </div><a name='1691'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>SUBSQ RX 3RD COURSE SURG</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">1691</td><td style="text-align:center;">2</td><td style="text-align:center;"><a href='#sources'>CoC</a></td><td style="text-align:center;">2011</td><td style="text-align:center;">12.2</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">2488 - 2489</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>subsqRx3rdCourseSurg</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Codes for the type of primary site surgery given as part of the third course of treatment. Central registries currently collecting this data item should follow the <i>1998 ROADS Manual</i> coding instructions. The codes are the same as those for Surgery of Primary Site, <i>1998 ROADS Manual</i>, p. 187. </div><div class='content chap10-para'><i>Note:</i> This data item is no longer supported by CoC (as of January 1, 2003). </div><a name='1681'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>SUBSQ RX 3RDCRS DATE FLAG</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">1681</td><td style="text-align:center;">2</td><td style="text-align:center;"><a href='#sources'>NAACCR</a></td><td style="text-align:center;">2010</td><td style="text-align:center;">12</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">2486 - 2487</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>subsqRx3rdcrsDateFlag</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>This flag explains why no appropriate value is in the field, Subsq RX 3rd Course Date [1680]. </div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Before Version 12 (through 2009 diagnosis), date fields included codes that provided information other than dates. As part of an initiative to standardize date fields, new fields were introduced to accommodate non-date information that had previously been transmitted in date fields. </div><div class='content chap10-para'><strong>Codes (See Appendix H for the Flavors of Null table in its entirety which includes the NAACCR codes, HL7 codes and definitions.)</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>10</td><td class='code-desc'>No information whatsoever can be inferred from this exceptional value (e.g., unknown if any subsequent therapy)</td></tr><tr class='code-row'><td class='code-nbr'>11</td><td class='code-desc'>No proper value is applicable in this context (e.g., no subsequent therapy)</td></tr><tr class='code-row'><td class='code-nbr'>Blank</td><td class='code-desc'>A valid date value is provided in item Subsq RX 3rd Course Date [1680], or the date was not expected to have been transmitted</td></tr></table></div><div class='content chap10-para'><em>Comment:</em> This is part of the initiative of the transformation from the old NAACCR date standards to interoperable dates.</div><a name='1699'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>SUBSQ RX 3RD--REG LN REM</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">1699</td><td style="text-align:center;">2</td><td style="text-align:center;"><a href='#sources'>CoC</a></td><td style="text-align:center;">1997</td><td style="text-align:center;">5.1</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">2492 - 2493</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>subsqRx3rdRegLnRem</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Codes for the number of regional lymph nodes removed as part of the third course of treatment. Central registries currently collecting this data item should follow the <em>1998 ROADS Manual</em> coding instructions. The codes are the same as those for Number of Regional Lymph Nodes Removed, <em>1998 ROADS Manual</em>, p. 193. </div><div class='content chap10-para'><em>Note:</em> This data item is no longer supported by CoC (as of January 1, 2003). </div><a name='1697'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>SUBSQ RX 3RD--SCOPE LN SU</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">1697</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>CoC</a></td><td style="text-align:center;">1997</td><td style="text-align:center;">5.1</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">2490 - 2490</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>subsqRx3rdScopeLnSu</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Codes for the type of surgery performed to remove regional lymph nodes as part of the third course of treatment. Central registries currently collecting this data item should follow the <em>1998 ROADS Manual</em> coding instructions. The codes are the same as those for Scope of Regional Lymph Node Surgery, <em>1998 ROADS Manual</em>, p. 192. </div><div class='content chap10-para'><em>Note:</em> This data item is no longer supported by CoC (as of January 1, 2003). </div><a name='1698'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>SUBSQ RX 3RD--SURG OTH</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">1698</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>CoC</a></td><td style="text-align:center;">1997</td><td style="text-align:center;">5.1</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">2491 - 2491</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>subsqRx3rdSurgOth</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Codes for the type of surgery performed on tissue or organs other than the primary site and regional lymph nodes as part of the third course of treatment. Central registries currently collecting this data item should follow the <em>1998 ROADS Manual</em> coding instructions. The codes are the same as those for Surgery of Other Regional Site(s), Distant Site(s) or Distant Lymph Node(s), <em>1998 ROADS Manual</em>, p. 194. </div><div class='content chap10-para'><em>Note:</em> This data item is no longer supported by CoC (as of January 1, 2003). </div><a name='1715'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>SUBSQ RX 4TH COURSE BRM</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">1715</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>CoC</a></td><td style="text-align:center;">2011</td><td style="text-align:center;">12.2</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">2518 - 2518</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>subsqRx4thCourseBrm</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Codes for the type of biological response modifier therapy given as part of the second course of treatment. Central registries currently collecting this data item should follow the <i>1998 ROADS Manual</i> coding instructions. The codes are the same as those for Immunotherapy, <i>1998 ROADS Manual</i>, p. 243 </div><div class='content chap10-para'><i>Note:</i> This data item is no longer supported by CoC (as of January 1, 2003). </div><a name='1713'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>SUBSQ RX 4TH COURSE CHEMO</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">1713</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>CoC</a></td><td style="text-align:center;">2011</td><td style="text-align:center;">12.2</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">2516 - 2516</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>subsqRx4thCourseChemo</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Codes for the type of chemotherapy given as part of the fourth course of treatment. Central registries currently collecting this data item should follow the <i>1998 ROADS Manual</i> coding instructions. The codes are the same as those for Chemotherapy, <i>1998 ROADS Manual</i>, p. 228. </div><div class='content chap10-para'><i>Note:</i> This data item is no longer supported by CoC (as of January 1, 2003). </div><a name='1710'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>SUBSQ RX 4TH COURSE CODES</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">1710</td><td style="text-align:center;">11</td><td style="text-align:center;"><a href='#sources'></a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">2509 - 2519</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>subsqRx4thCourseCodes</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>The name for a group of subfields that describe the fourth course or set of subsequent therapy. As of January 1, 2003, CoC no longer support Subsequent Therapy data items.<br /><br />Group names appear only in the data dictionary and Appendix E.<br /><br /><strong>Subfields</strong><br />&nbsp;&nbsp; &nbsp;&nbsp; &nbsp;&nbsp; Subsq RX 4th Course Surg [1711]<br />&nbsp;&nbsp; &nbsp;&nbsp; &nbsp;&nbsp; Subsq RX 4th Course Rad [1712]<br />&nbsp;&nbsp; &nbsp;&nbsp; &nbsp;&nbsp; Subsq RX 4th Course Chemo [1713]<br />&nbsp;&nbsp; &nbsp;&nbsp; &nbsp;&nbsp; Subsq RX 4th Course Horm [1714]<br />&nbsp;&nbsp; &nbsp;&nbsp; &nbsp;&nbsp; Subsq RX 4th Course BRM [1715]<br />&nbsp;&nbsp; &nbsp;&nbsp; &nbsp;&nbsp; Subsq RX 4th Course Oth [1716]</div><a name='1700'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>SUBSQ RX 4TH COURSE DATE</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">1700</td><td style="text-align:center;">8</td><td style="text-align:center;"><a href='#sources'>CoC</a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">2499 - 2506</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>subsqRx4thCourseDate</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Date of initiation of the fourth course of treatment. Central registries currently collecting this data item should follow the 

<em>1998 ROADS Manual</em> coding instructions. See Chapter X for date format. Use SUBSQ RX 4THCRS DATE FLAG [1701] if there is no appropriate or known date for this item. </div><a name='1714'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>SUBSQ RX 4TH COURSE HORM</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">1714</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>CoC</a></td><td style="text-align:center;">2011</td><td style="text-align:center;">12.2</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">2517 - 2517</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>subsqRx4thCourseHorm</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Codes for the type of hormonal therapy given as part of the fourth course of treatment. Central registries currently collecting this data item should follow the <i>1998 ROADS Manual</i> coding instructions. The codes are the same as those for Hormone Therapy, <i>1998 ROADS Manual</i>, p. 238. </div><div class='content chap10-para'><i>Note:</i> This data item is no longer supported by CoC (as of January 1, 2003). </div><a name='1716'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>SUBSQ RX 4TH COURSE OTH</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">1716</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>CoC</a></td><td style="text-align:center;">2011</td><td style="text-align:center;">12.2</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">2519 - 2519</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>subsqRx4thCourseOth</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Codes for the type of other treatment given as part of the fourth course of treatment. Central registries currently collecting this data item should follow the <i>1998 ROADS Manual</i> coding instructions. The codes are the same as those for Other Treatment, <i>1998 ROADS Manual</i>, p. 246. </div><div class='content chap10-para'><i>Note:</i> This data item is no longer supported by CoC (as of January 1, 2003). </div><a name='1712'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>SUBSQ RX 4TH COURSE RAD</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">1712</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>CoC</a></td><td style="text-align:center;">2011</td><td style="text-align:center;">12.2</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">2515 - 2515</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>subsqRx4thCourseRad</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Codes for the type of radiation given as part of the fourth course of treatment. Central registries currently collecting this data item should follow the <i>1998 ROADS Manual</i> coding instructions. The codes are the same as those for Radiation, <i>1998 ROADS Manual</i>, p. 199. </div><div class='content chap10-para'><i>Note:</i> This data item is no longer supported by CoC (as of January 1, 2003). </div><a name='1711'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>SUBSQ RX 4TH COURSE SURG</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">1711</td><td style="text-align:center;">2</td><td style="text-align:center;"><a href='#sources'>CoC</a></td><td style="text-align:center;">2011</td><td style="text-align:center;">12.2</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">2509 - 2510</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>subsqRx4thCourseSurg</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Codes for the type of primary site surgery given as part of the fourth course of treatment. Central registries currently collecting this data item should follow the <i>1998 ROADS Manual</i> coding instructions. The codes are the same as those for Surgery of Primary Site, <i>1998 ROADS Manual</i>, p. 187. </div><div class='content chap10-para'><i>Note:</i> This data item is no longer supported by CoC (as of January 1, 2003). </div><a name='1701'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>SUBSQ RX 4THCRS DATE FLAG</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">1701</td><td style="text-align:center;">2</td><td style="text-align:center;"><a href='#sources'>NAACCR</a></td><td style="text-align:center;">2010</td><td style="text-align:center;">12</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">2507 - 2508</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>subsqRx4thcrsDateFlag</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>This flag explains why no appropriate value is in the field, Subsq RX 4th Course Date [1700]. </div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Before Version 12 (through 2009 diagnosis), date fields included codes that provided information other than dates. As part of an initiative to standardize date fields, new fields were introduced to accommodate non-date information that had previously been transmitted in date fields. </div><div class='content chap10-para'><strong>Codes (See Appendix H for the complete Flavors of Null table, which includes the NAACCR codes, HL7 codes and definitions.) </strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>10</td><td class='code-desc'>No information whatsoever can be inferred from this exceptional value (e.g., unknown if any subsequent therapy)</td></tr><tr class='code-row'><td class='code-nbr'>11</td><td class='code-desc'>No proper value is applicable in this context (e.g., no subsequent therapy)</td></tr><tr class='code-row'><td class='code-nbr'>Blank</td><td class='code-desc'>A valid date value is provided in item Subsq RX 4th Course Date [1700], or the date was not expected to have been transmitted</td></tr></table></div><div class='content chap10-para'><em>Comment:</em> This is part of the initiative of the transformation from the old NAACCR date standards to interoperable dates.</div><a name='1719'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>SUBSQ RX 4TH--REG LN REM</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">1719</td><td style="text-align:center;">2</td><td style="text-align:center;"><a href='#sources'>CoC</a></td><td style="text-align:center;">1997</td><td style="text-align:center;">5.1</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">2513 - 2514</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>subsqRx4thRegLnRem</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Codes for the number of regional lymph nodes removed as part of the fourth course of treatment. Central registries currently collecting this data item should follow the <em>1998 ROADS Manual</em> coding instructions. The codes are the same as those for Number of Regional Lymph Nodes Removed, <em>1998 ROADS Manual</em>, p. 193. </div><div class='content chap10-para'><em>Note:</em> This data item is no longer supported by CoC (as of January 1, 2003). </div><a name='1717'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>SUBSQ RX 4TH--SCOPE LN SU</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">1717</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>CoC</a></td><td style="text-align:center;">1997</td><td style="text-align:center;">5.1</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">2511 - 2511</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>subsqRx4thScopeLnSu</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Codes for the type of surgery performed to remove regional lymph nodes as part of the fourth course of treatment. Central registries currently collecting this data item should follow the <em>1998 ROADS Manual</em> coding instructions. The codes are the same as those for Scope of Regional Lymph Node Surgery, <em>1998 ROADS Manual</em>, p. 192. </div><div class='content chap10-para'><em>Note:</em> This data item is no longer supported by CoC (as of January 1, 2003). </div><a name='1718'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>SUBSQ RX 4TH--SURG OTH</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">1718</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>CoC</a></td><td style="text-align:center;">1997</td><td style="text-align:center;">5.1</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">2512 - 2512</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>subsqRx4thSurgOth</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Codes for the type of surgery performed on tissue or organs other than the primary site and regional lymph nodes as part of the fourth course of treatment. Central registries currently collecting this data item should follow the <em>1998 ROADS Manual</em> coding instructions. The codes are the same as those for Surgery of Other Regional Site(s), Distant Site(s) or Distant Lymph Node(s), <em>1998 ROADS Manual</em>, p. 194. </div><div class='content chap10-para'><em>Note:</em> This data item is no longer supported by CoC (as of January 1, 2003). </div><a name='1735'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>SUBSQ RX 5TH COURSE BRM</strong></td><td style="text-align:right;font-weight:bold;"><strong>Retired</strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">1735</td><td style="text-align:center;"></td><td style="text-align:center;"><a href='#sources'></a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;">2006</td><td style="text-align:center;">11</td><td class="cross-out" style="text-align:center;"></td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td></td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td></td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>The NAACCR UDSC retired this data item in Version 11, as of January 1, 2006.</div><a name='1733'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>SUBSQ RX 5TH COURSE CHEMO</strong></td><td style="text-align:right;font-weight:bold;"><strong>Retired</strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">1733</td><td style="text-align:center;"></td><td style="text-align:center;"><a href='#sources'></a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;">2006</td><td style="text-align:center;">11</td><td class="cross-out" style="text-align:center;"></td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td></td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td></td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>The NAACCR UDSC retired this data item in Version 11, as of January 1, 2006.</div><a name='1730'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>SUBSQ RX 5TH COURSE CODES</strong></td><td style="text-align:right;font-weight:bold;"><strong>Retired</strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">1730</td><td style="text-align:center;"></td><td style="text-align:center;"><a href='#sources'></a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;">2006</td><td style="text-align:center;">11</td><td class="cross-out" style="text-align:center;"></td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td></td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td></td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>The NAACCR UDSC retired this data item in Version 11, as of January 1, 2006.</div><a name='1720'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>SUBSQ RX 5TH COURSE DATE</strong></td><td style="text-align:right;font-weight:bold;"><strong>Retired</strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">1720</td><td style="text-align:center;"></td><td style="text-align:center;"><a href='#sources'></a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;">2006</td><td style="text-align:center;">11</td><td class="cross-out" style="text-align:center;"></td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td></td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td></td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>The NAACCR UDSC retired this data item in Version 11, as of January 1, 2006.</div><a name='1734'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>SUBSQ RX 5TH COURSE HORM</strong></td><td style="text-align:right;font-weight:bold;"><strong>Retired</strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">1734</td><td style="text-align:center;"></td><td style="text-align:center;"><a href='#sources'></a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;">2006</td><td style="text-align:center;">11</td><td class="cross-out" style="text-align:center;"></td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td></td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td></td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>The NAACCR UDSC retired this data item in Version 11, as of January 1, 2006.</div><a name='1736'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>SUBSQ RX 5TH COURSE OTH</strong></td><td style="text-align:right;font-weight:bold;"><strong>Retired</strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">1736</td><td style="text-align:center;"></td><td style="text-align:center;"><a href='#sources'></a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;">2006</td><td style="text-align:center;">11</td><td class="cross-out" style="text-align:center;"></td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td></td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td></td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>The NAACCR UDSC retired this data item in Version 11, as of January 1, 2006.</div><a name='1732'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>SUBSQ RX 5TH COURSE RAD</strong></td><td style="text-align:right;font-weight:bold;"><strong>Retired</strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">1732</td><td style="text-align:center;"></td><td style="text-align:center;"><a href='#sources'></a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;">2006</td><td style="text-align:center;">11</td><td class="cross-out" style="text-align:center;"></td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td></td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td></td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>The NAACCR UDSC retired this data item in Version 11, as of January 1, 2006.</div><a name='1731'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>SUBSQ RX 5TH COURSE SURG</strong></td><td style="text-align:right;font-weight:bold;"><strong>Retired</strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">1731</td><td style="text-align:center;"></td><td style="text-align:center;"><a href='#sources'></a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;">2006</td><td style="text-align:center;">11</td><td class="cross-out" style="text-align:center;"></td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td></td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td></td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>The NAACCR UDSC retired this data item in Version 11, as of January 1, 2006.</div><a name='1739'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>SUBSQ RX 5TH--REG LN REM</strong></td><td style="text-align:right;font-weight:bold;"><strong>Retired</strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">1739</td><td style="text-align:center;"></td><td style="text-align:center;"><a href='#sources'></a></td><td style="text-align:center;">1997</td><td style="text-align:center;">5.1</td><td style="text-align:center;">2006</td><td style="text-align:center;">11</td><td class="cross-out" style="text-align:center;"></td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td></td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td></td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>The NAACCR UDSC retired this data item in Version 11, as of January 1, 2006.</div><a name='1737'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>SUBSQ RX 5TH--SCOPE LN SU</strong></td><td style="text-align:right;font-weight:bold;"><strong>Retired</strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">1737</td><td style="text-align:center;"></td><td style="text-align:center;"><a href='#sources'></a></td><td style="text-align:center;">1997</td><td style="text-align:center;">5.1</td><td style="text-align:center;">2006</td><td style="text-align:center;">11</td><td class="cross-out" style="text-align:center;"></td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td></td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td></td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>The NAACCR UDSC retired this data item in Version 11, as of January 1, 2006.</div><a name='1738'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>SUBSQ RX 5TH--SURG OTH</strong></td><td style="text-align:right;font-weight:bold;"><strong>Retired</strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">1738</td><td style="text-align:center;"></td><td style="text-align:center;"><a href='#sources'></a></td><td style="text-align:center;">1997</td><td style="text-align:center;">5.1</td><td style="text-align:center;">2006</td><td style="text-align:center;">11</td><td class="cross-out" style="text-align:center;"></td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td></td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td></td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>The NAACCR UDSC retired this data item in Version 11, as of January 1, 2006.</div><a name='1741'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>SUBSQ RX--RECONSTRUCT DEL</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">1741</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>CoC</a></td><td style="text-align:center;">1997</td><td style="text-align:center;">5.1</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">2520 - 2520</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>Reconstruction/Restoration--Delayed (CoC)<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>subsqRxReconstructDel</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Code for surgical procedure done to reconstruct, restore, or improve shape and appearance or function of body structures that are missing, defective, damaged, or misshapen by cancer or therapies. Reconstructive/restorative procedures are coded here when started after the first course of therapy. Central registries currently collecting this data item should follow the 


<em>1998 ROADS Manual</em> coding instructions. For reconstructive/restorative procedures started during the first course of therapy, see RX Summ--Reconstruct 1st [1330]. See also RX Summ--Surgery Type [1640]. </div><div class='content chap10-para'><strong>Codes </strong>  <br />See the CoC <em>ROADS</em> Manual, 1998 Supplement, for site-specific codes.</div><div class='content chap10-para'><em>Note:</em> This data item is no longer supported by CoC (as of January 1, 2003).</div><a name='764'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>SUMMARY STAGE 2018</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">764</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>SEER</a></td><td style="text-align:center;">2018</td><td style="text-align:center;">16</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">987 - 987</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>Directly Assigned SS2018<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>summaryStage2018</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'><div>This item stores the directly assigned Summary Stage 2018. Effective for cases diagnosed 1/1/2018+. </div></div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>The SEER program has collected staging information on cases since its inception in 1973. Summary Stage groups cases into broad categories of in situ, local, regional, and distant. Summary Stage can be used to evaluate disease spread at diagnosis, treatment patterns and outcomes over time.</div><div class='content chap10-para'><em>Note</em>: This data item was included in Standards Volume II, Version 16; however, it was not implemented until 2018.</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>0</td><td class='code-desc'>In situ </td></tr><tr class='code-row'><td class='code-nbr'>1</td><td class='code-desc'>Localized only</td></tr><tr class='code-row'><td class='code-nbr'>2</td><td class='code-desc'>Regional by direct extension only</td></tr><tr class='code-row'><td class='code-nbr'>3</td><td class='code-desc'>Regional lymph nodes only</td></tr><tr class='code-row'><td class='code-nbr'>4</td><td class='code-desc'>Regional by BOTH direct extension AND lymph node involvement</td></tr><tr class='code-row'><td class='code-nbr'>7</td><td class='code-desc'>Distant site(s)/node(s) involved</td></tr><tr class='code-row'><td class='code-nbr'>8</td><td class='code-desc'>Benign/borderline*</td></tr><tr class='code-row'><td class='code-nbr'>9</td><td class='code-desc'>Unknown if extension or metastasis (unstaged, unknown, or unspecified)<br/>
Death certificate only case
</td></tr><tr class='code-row'><td class='code-nbr'></td><td class='code-desc'> </td></tr></table></div><div class='content chap10-para'><div>*Applicable for the following SS2018 chapters: Brain, CNS Other, Intracranial Gland.</div><div>&nbsp;</div><div><em>Note</em>: For SS2018, code 5 for &#8220;Regional, NOS&#8221; can no longer be coded. Code 5 (Regional, NOS) is still applicable.</div></div><a name='1782'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>SURV-DATE ACTIVE FOLLOWUP</strong></td><td style="text-align:right;font-weight:bold;"><strong>Revised</strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">1782</td><td style="text-align:center;">8</td><td style="text-align:center;"><a href='#sources'>NAACCR</a></td><td style="text-align:center;">2015</td><td style="text-align:center;">15</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">2965 - 2972</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>survDateActiveFollowup</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para mark-changed'>The Surv-Date Active Followup is defined as the earlier of the Date of Last Contact [1750] and a study cutoff date. The study cut-off date is a pre-determined date based on the year of data submission and is set in the survival program used to derive the seven survival variables. If the Date of Last Contact [1750] is earlier than the study cut-off date and either the day or month is unknown or not available, the values are imputed by the survival program. The survival program is available from your standard setter or NAACCR.   <br /><br />Example 1   <br />Date of Last Contact: 20111120 <br /><div>Study Cut-off Date: 20111231</div><div> </div>Surv-Date Active Followup: 20111120 <br />Note: The date of last contact is earlier than the study cut-off date, and the date of last contact is complete, so the date of last contact is used in Surv-Date Active Followup. <br /><br />Example 2 <br />Date of Last Contact: 201111<br />Study Cut-off Date: 20111231 <br />Surv-Date Active Followup: 20111115 <br />Note: Rationale is to take mid-point of possible values. For Nov (30 days) it would be FLOOR((1+30)/2) = 15, where FLOOR is a function that rounds a decimal down to an integer.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para mark-changed'>The Surv-Date Active Followup is needed to be able to recalculate survival months if a different study cut-off date is used and provides flexibility to recalculate survival without needing to rerun the survival program on the original data.</div><div class='content chap10-para mark-changed'>Additional information about the survival algorithm and what specific values are assigned in given missing date situations are available here: 















<a href="http://seer.cancer.gov/survivaltime/" target="_blank">http://seer.cancer.gov/survivaltime/</a>.</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'>If Date of Last Contact [1750] is blank, Surv-Date Active Followup will also be blank.</div><a name='1788'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>SURV-DATE DX RECODE</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">1788</td><td style="text-align:center;">8</td><td style="text-align:center;"><a href='#sources'>NAACCR</a></td><td style="text-align:center;">2015</td><td style="text-align:center;">15</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">2991 - 2998</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>survDateDxRecode</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>The survival date of diagnosis recode is calculated using the month, day, and year of the Date of Diagnosis [390]. If the Date of Diagnosis [390] has complete month and day information, the Surv-Date Dx Recode will be the same as the Date of Diagnosis [390]. If the day or month is unknown or not available, the values are imputed by the survival program used to derive the seven survival variables. The survival program is available from your standard setter or NAACCR.  <br /><br />Example 1   <br />Date of diagnosis: 20111199 <br />Date of Last Contact: 20111120 <br />Surv-Date of DX Recode: 20111110 <br />Note: The recoded value is the mid-point between 11/1 and 11/20.<br /><br />Example 2 <br />Date of diagnosis: 2011<br />Date of Last Contact: 20111120 <br />Surv-Date of DX Recode: 20110611 <br />Note: The recoded value is the mid-point between 20110101 and 20111120.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>The Surv-Date DX Recode is needed to be able to match to a lifetable entry to obtain expected survival. If a case is diagnosed in January 2000, the first 12 months of expected survival will be from the 2000 life table. If a case is diagnosed in December 2000, only one month will be from the 2000 life table and then the 2001 life table is used.</div><div class='content chap10-para'>Additional information about the survival algorithm and what specific values are assigned in given missing date situations are available here: 








<a target="_blank" href=" http://seer.cancer.gov/survivaltime/">http://seer.cancer.gov/survivaltime/</a>.</div><a name='1785'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>SURV-DATE PRESUMED ALIVE</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">1785</td><td style="text-align:center;">8</td><td style="text-align:center;"><a href='#sources'>NAACCR</a></td><td style="text-align:center;">2015</td><td style="text-align:center;">15</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">2978 - 2985</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>survDatePresumedAlive</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>The Surv-Date Presumed Alive is the last date for which complete death ascertainment is available from the registry at the time a file is transmitted. Because not all central cancer registries conduct active patient follow-up, it is necessary to have an option for calculating survival times based on the assumption that the registry has ascertained all available deaths (state/province and national), and persons not known to be deceased are presumed to be alive as of the last date for which complete death ascertainment is available. This variable is set in the survival program used to derive the seven survival variables. The survival program is available from your standard setter or NAACCR.   <br /><br />Example 1   <br />Vital Status: Alive <br />Date of Last Contact: 20111120 <br />Study Cut-off Date: 20111231 <br />Latest date for complete death ascertainment: 20111231 <br />Surv-Date Presumed Alive: 20111231</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>The Surv-Date Presumed Alive is needed to be able to recalculate survival months if a different study cut-off date is used and provides flexibility to recalculate survival without needing to rerun the survival program on the original data.</div><div class='content chap10-para'>Additional information about the survival algorithm and what specific values are assigned in given missing date situations are available here: 










<a target="_blank" href=" http://seer.cancer.gov/survivaltime/">http://seer.cancer.gov/survivaltime/</a>.</div><a name='1783'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>SURV-FLAG ACTIVE FOLLOWUP</strong></td><td style="text-align:right;font-weight:bold;"><strong>Revised</strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">1783</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>NAACCR</a></td><td style="text-align:center;">2015</td><td style="text-align:center;">15</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">2973 - 2973</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>survFlagActiveFollowup</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para mark-changed'>This flag is generated by the program that creates Surv-Mos Active Followup [1784] and describes how complete the date information is that was used to calculate survival months. This item is one of seven survival variables designed to facilitate a common approach to survival analysis by NAACCR registries.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para mark-changed'>The flag will enable analysts to easily select a subset of cases.</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>0</td><td class='code-desc'>Complete dates are available and there are 0 days of survival (i.e., date last contact = date of diagnosis)  </td></tr><tr class='code-row'><td class='code-nbr'>1</td><td class='code-desc'>Complete dates are available and there are more than 0 days of survival (i.e., date last contact > date diagnosis)</td></tr><tr class='code-row'><td class='code-nbr'>2</td><td class='code-desc'>Incomplete dates are available and there could be zero days of follow-up (i.e., known components are equal, e.g., 2006 and 20061002) </td></tr><tr class='code-row'><td class='code-nbr'>3</td><td class='code-desc'>Incomplete dates are available and there cannot be zero days of follow-up (i.e., any difference in known date components, e.g., 200602 and 200603)  </td></tr><tr class='code-row'><td class='code-nbr'>8</td><td class='code-desc'>Not calculated because a Death Certificate Only or Autopsy Only case </td></tr><tr class='code-row'><td class='code-nbr'>9</td><td class='code-desc'>Unknown</td></tr><tr class='code-row'><td class='code-nbr'>Blank</td><td class='code-desc'>Not coded</td></tr><tr class='code-row'><td class='code-nbr'></td><td class='code-desc'> </td></tr></table></div><a name='1786'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>SURV-FLAG PRESUMED ALIVE</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">1786</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>NAACCR</a></td><td style="text-align:center;">2015</td><td style="text-align:center;">15</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">2986 - 2986</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>survFlagPresumedAlive</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>This flag is generated by the program that creates Surv-Mos Presumed Alive [1787] and describes how complete the date information is that was used to calculate survival months. This item is one of seven survival variables designed to facilitate a common approach to survival analysis by NAACCR registries.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>The flag will enable analysts to easily select a subset of cases.</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>0</td><td class='code-desc'>Complete dates are available and there are 0 days of survival (i.e., presumed alive date last contact = date of diagnosis)  </td></tr><tr class='code-row'><td class='code-nbr'>1</td><td class='code-desc'>Complete dates are available and there are more than 0 days of survival (i.e., presumed alive date last contact > date diagnosis) </td></tr><tr class='code-row'><td class='code-nbr'>2</td><td class='code-desc'>Incomplete dates are available and there could be zero days of follow-up (i.e., known components are equal, e.g., 2006 and 20061002) </td></tr><tr class='code-row'><td class='code-nbr'>3</td><td class='code-desc'>Incomplete dates are available and there cannot be zero days of follow-up (i.e., any difference in known date components, e.g., 200602 and 200603)</td></tr><tr class='code-row'><td class='code-nbr'>8</td><td class='code-desc'>Not calculated because a Death Certificate Only or Autopsy Only case </td></tr><tr class='code-row'><td class='code-nbr'>9</td><td class='code-desc'>Unknown</td></tr><tr class='code-row'><td class='code-nbr'>Blank</td><td class='code-desc'>Not coded</td></tr><tr class='code-row'><td class='code-nbr'></td><td class='code-desc'> </td></tr></table></div><a name='1784'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>SURV-MOS ACTIVE FOLLOWUP</strong></td><td style="text-align:right;font-weight:bold;"><strong>Revised</strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">1784</td><td style="text-align:center;">4</td><td style="text-align:center;"><a href='#sources'>NAACCR</a></td><td style="text-align:center;">2015</td><td style="text-align:center;">15</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">2974 - 2977</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>survMosActiveFollowup</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para mark-changed'>The survival interval in months is calculated using the month, day, and year of the Surv-Date DX Recode [1788] and the month, day, and year of the Surv-Date Active Followup [1782]. The survival interval is calculated by a program available from your standard setter or NAACCR.  <br /><br />Example of a case diagnosed in 2011 and submitted in 2013.  <br />Date of submission: 20131101 <br />Date of diagnosis: 20110915<br />Date of last contact: 20111017 <br />Vital status: Alive <br />Study cutoff date: 20111231 <br />20111017 would be used as the date of last contact for the survival calculation. The survival time would be 1 month.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para mark-changed'>Accurate survival estimates are crucial for monitoring trends in population-based cancer survival and assessing the effectiveness of healthcare delivery to cancer patients. With the aim of obtaining the most precise estimates of survival, it is necessary to use complete dates (month, day, and year components) in the calculation of the survival interval. The survival interval in months is calculated using complete dates, and the algorithm imputes missing components of dates when they are not available in central registry records.</div><div class='content chap10-para mark-changed'>Additional information about the algorithm and what specific values are assigned in given missing date situations are available here: 













<a href="http://seer.cancer.gov/survivaltime/" target="_blank">http://seer.cancer.gov/survivaltime/</a>.</div><div class='content chap10-para'><strong>Codes<br /></strong>A value of 9999 is for missing and matches the Surv- Flag Active Followup value of 9 or blank. Leading zeros will be used when needed to left fill the field.  <strong><br /></strong></div><div class='content chap10-para'><strong>Calculation </strong><br />Survival months = FLOOR((endpoint &#8211; date of diagnosis) / days in a month) <br /><br />The FLOOR function rounds a decimal down to an integer, e.g., FLOOR(1.68) = 1.  Days in a month is assigned as 365.24/12.</div><a name='1787'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>SURV-MOS PRESUMED ALIVE</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">1787</td><td style="text-align:center;">4</td><td style="text-align:center;"><a href='#sources'>NAACCR</a></td><td style="text-align:center;">2015</td><td style="text-align:center;">15</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">2987 - 2990</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>survMosPresumedAlive</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'><div> Because not all central cancer registries conduct active patient follow-up, it is necessary to have an option for calculating survival times based on the assumption that the registry has ascertained all available deaths (state/province and national), and persons not known to be deceased are presumed to be alive as of the last date for which complete death ascertainment is available. The survival interval in months is calculated using the month, day, and year of the Surv-Date DX Recode [1788] and the month, day, and year of the Surv-Date Presumed Alive [1785]. The survival program is available from your standard setter or NAACCR.   </div><div>&nbsp;</div><div>Example of a case diagnosed in 2011 and submitted in 2013.  <br />Date of submission: 20131101 <br />Date of diagnosis: 20110915 <br />Date of last contact: 20111017 <br />Latest date for complete death ascertainment: 20111231 <br />Vital status: Alive <br />Study cutoff date: 20111231 <br />Under the "presumed alive" scenario, 20111231 would be used as the endpoint for the survival calculation. The presumed alive survival time would be 3 months, while the survival time using the date of last contact (assuming active follow-up) would be 1 month.&nbsp;</div></div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Accurate survival estimates are crucial for monitoring trends in population-based cancer survival and assessing the effectiveness of healthcare delivery to cancer patients. With the aim of obtaining the most precise estimates of survival, it is necessary to use complete dates (month, day, and year components) in the calculation of the survival interval. The survival interval in months is calculated using complete dates, and the algorithm imputes missing components of dates when they are not available in central registry records.</div><div class='content chap10-para'>Additional information about the algorithm and what specific values are assigned in given missing date situations are available here: 











<a target="_blank" href=" http://seer.cancer.gov/survivaltime/">http://seer.cancer.gov/survivaltime/</a>.</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'>A value of 9999 is for missing and matches the Surv-Flag Presumed Alive [1786] value of 9 or blank. Leading zeros will be used when needed to left fill the field.</div><a name='2360'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>TELEPHONE</strong></td><td style="text-align:right;font-weight:bold;"><strong>Revised</strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">2360</td><td style="text-align:center;">10</td><td title="V: 22: SEER
V: 18: CoC
V: 16: CoC
V: 15: CoC
" class=" HighlightToolTip" style="text-align:center;"><a href='#sources'>SEER</a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">4588 - 4597</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>telephone</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Patient</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para mark-changed'>Current telephone number with area code for the patient. Number is entered without dashes.</div><div class='content chap10-para'><strong>Codes (in addition to valid telephone number) </strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>0000000000</td><td class='code-desc'>Patient does not have a telephone</td></tr><tr class='code-row'><td class='code-nbr'>9999999999</td><td class='code-desc'>Telephone number unavailable or unknown</td></tr></table></div><div class='content chap10-para'><em>Note:</em> Prior to Version 5, Follow-Up Contact fields may have been used for patient current telephone in the NAACCR record layout.</div><a name='2550'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>TEXT--DX PROC--LAB TESTS</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">2550</td><td style="text-align:center;">1000</td><td style="text-align:center;"><a href='#sources'>NPCR</a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">9935 - 10934</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>textDxProcLabTests</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Text area for manual documentation of information from laboratory examinations other than cytology or histopathology.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Text documentation is an essential component of a complete electronic report and is heavily utilized for quality control and special studies. Text is needed to justify coded values and to document supplemental information not transmitted within coded values. High-quality text documentation facilitates consolidation of information from multiple reporting sources at the central registry.<br /><br />The text field must contain a description that has been entered by the reporter independently from the code(s). If software generates text automatically from codes, the text cannot be utilized to check coded values. Information documenting the disease process should be entered manually from the medical record <strong>and should not be generated electronically from coded values</strong>.<strong><br /><br />Instructions</strong><ul><li>Prioritize entered information in the order of the fields listed below.</li><li>Text automatically generated from coded data is not acceptable.</li><li>NAACCR-approved abbreviations should be utilized (see Appendix G).</li><li>Do not repeat information from other text fields.</li><li>Additional comments can be continued in empty text fields, including Remarks. For text documentation that is continued from one text field to another, use asterisks or other symbols to indicate the connection with preceding text.</li><li>If information is missing from the record, state that it is missing.</li><li>Do not include irrelevant information.</li><li>Do not include information that the registry is not authorized to collect.</li></ul><em>Note:</em> For software that allows unlimited text, NAACCR recommends that the software indicate to the reporter the portion of the text that will be transmitted to the central registry.<strong><br /><br />Suggestions for text:</strong><ul><li>Type of lab test/tissue specimen(s)</li><li>Record both positive and negative findings. Record positive test results first.</li><li>Information can include tumor markers, serum and urine electrophoresis, special studies, etc.</li><li>Date(s) of lab test(s)</li><li>Tumor markers included, but are not limited to:</li><ul><li>Breast Cancer &#8211; Estrogen Receptor Assay (ERA), Progesterone Receptor Assay (PRA), Her2/neu.</li><li>   Prostate Cancer &#8211; Prostatic Specific Antigen (PSA)</li><li>   Testicular Cancer &#8211; Human Chorionic Gonadotropin (hCG), Alpha Fetoprotein (AFP), Lactate Dehydrogenase (LDH) </li></ul></ul></div><div class='content chap10-para'><strong> </strong> <strong>Data Item(s) to be verified/validated using the text entered in this field:</strong> <br />
After manual entry of the text field, ensure that the text entered both agrees with the coded values and clearly justifies the selected codes in the following fields: <br />
<br />
<table style="margin-left:95.4pt;border-collapse:collapse;border:none;" border="1" cellspacing="0" cellpadding="0">
     <tbody>
         <tr>
             <td style="width:2.0in;border:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt" width="192" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal"><strong>Item name</strong></p>
             </td>
             <td style="width:76.5pt;border:solid windowtext 1.0pt; border-left:none;padding:0in 5.4pt 0in 5.4pt" width="102" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal"><strong>Item number</strong></p>
             </td>
         </tr>
         <tr>
             <td style="width:2.0in;border:solid windowtext 1.0pt; border-top:none; padding:0in 5.4pt 0in 5.4pt" width="192" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal">Primary Site</p>
             </td>
             <td style="width:76.5pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt" width="102" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal">400</p>
             </td>
         </tr>
         <tr>
             <td style="width:2.0in;border:solid windowtext 1.0pt; border-top:none; padding:0in 5.4pt 0in 5.4pt" width="192" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal">Grade</p>
             </td>
             <td style="width:76.5pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt" width="102" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal">440</p>
             </td>
         </tr>
         <tr>
             <td style="width:2.0in;border:solid windowtext 1.0pt; border-top:none; padding:0in 5.4pt 0in 5.4pt" width="192" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal">Diagnostic Confirmation</p>
             </td>
             <td style="width:76.5pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt" width="102" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal">490</p>
             </td>
         </tr>
         <tr>
             <td style="width:2.0in;border:solid windowtext 1.0pt; border-top:none; padding:0in 5.4pt 0in 5.4pt" width="192" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal">Collaborative Stage&nbsp;variables</p>
             </td>
             <td style="width:76.5pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt" width="102" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal">2800-2930</p>
             </td>
         </tr>
         <tr>
             <td style="width:2.0in;border:solid windowtext 1.0pt; border-top:none; padding:0in 5.4pt 0in 5.4pt" width="192" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal">Date of Diagnosis</p>
             </td>
             <td style="width:76.5pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt" width="102" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal">390</p>
              </td>
         </tr>
         <tr>
             <td style="width:2.0in;border:solid windowtext 1.0pt; border-top:none; padding:0in 5.4pt 0in 5.4pt" width="192" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal">Summary Stage 2018<br /></p>
             </td>
             <td style="width:76.5pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt" width="102" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal">764</p>
 </td>
         </tr>
         <tr>
             <td style="width:2.0in;border:solid windowtext 1.0pt; border-top:none; padding:0in 5.4pt 0in 5.4pt" width="192" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal">AJCC TNM Data Items<br /></p>
             </td>
             <td style="width:76.5pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt" width="102" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal">1001-1036</p>
 </td>
         </tr>
         <tr>
             <td style="width:2.0in;border:solid windowtext 1.0pt; border-top:none; padding:0in 5.4pt 0in 5.4pt" width="192" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal">EOD Data Items<br /></p>
             </td>
             <td style="width:76.5pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt" width="102" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal">772-776</p>
 </td>
         </tr>
         <tr>
             <td style="width:2.0in;border:solid windowtext 1.0pt; border-top:none; padding:0in 5.4pt 0in 5.4pt" width="192" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal">Site-specific SSDI Data Items<br /></p>
             </td>
             <td style="width:76.5pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt" width="102" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal">3801-3937</p></td>
         </tr>
     </tbody>
</table></div><a name='2560'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>TEXT--DX PROC--OP</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">2560</td><td style="text-align:center;">1000</td><td style="text-align:center;"><a href='#sources'>NPCR</a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">10935 - 11934</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>textDxProcOp</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Text area for manual documentation of all surgical procedures that provide information for staging.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Text documentation is an essential component of a complete electronic report and is heavily utilized for quality control and special studies. Text is needed to justify coded values and to document supplemental information not transmitted within coded values. High-quality text documentation facilitates consolidation of information from multiple reporting sources at the central registry.<br /><br />The text field must contain a description that has been entered by the reporter independently from the code(s). If software generates text automatically from codes, the text cannot be utilized to check coded values. Information documenting the disease process should be entered manually from the medical record <strong>and should not be generated electronically from coded values</strong>.<strong><br /><br />Instructions</strong><ul><li>Prioritize entered information in the order of the fields listed below.</li><li>Text automatically generated from coded data is not acceptable.</li><li>NAACCR-approved abbreviations should be utilized (see Appendix G).</li><li>Do not repeat information from other text fields.</li><li>Additional comments can be continued in empty text fields, including Remarks. For text documentation that is continued from one text field to another, use asterisks or other symbols to indicate the connection with preceding text.</li><li>If information is missing from the record, state that it is missing.</li><li>Do not include irrelevant information.</li><li>Do not include information that the registry is not authorized to collect.</li></ul><em>Note:</em> For software that allows unlimited text, NAACCR recommends that the software indicate to the reporter the portion of the text that will be transmitted to the central registry.<strong><br /><br />Suggestions for text:</strong><ul><li>Dates and descriptions of biopsies and all other surgical procedures from which staging information was derived</li><li>Number of lymph nodes removed</li><li>Size of tumor removed</li><li>Documentation of residual tumor</li><li>Evidence of invasion of surrounding areas</li><li>Reason primary site surgery could not be completed</li></ul></div><div class='content chap10-para'><strong> <strong>Data Item(s) to be verified/validated using the text entered in this field</strong> <br />
</strong>After manual entry of the text field, ensure that the text entered both agrees with the coded values and clearly justifies the selected codes in the following fields: <br />
<br />
<table style="margin-left:95.4pt;border-collapse:collapse;border:none;" border="1" cellspacing="0" cellpadding="0">
     <tbody>
         <tr>
             <td style="width:2.0in;border:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt" width="192" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal"><strong>Item name</strong></p>
             </td>
             <td style="width:76.5pt;border:solid windowtext 1.0pt; border-left:none;padding:0in 5.4pt 0in 5.4pt" width="102" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal"><strong>Item number</strong></p>
             </td>
         </tr>
         <tr>
             <td style="width:2.0in;border:solid windowtext 1.0pt; border-top:none; padding:0in 5.4pt 0in 5.4pt" width="192" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal">Date of Diagnosis</p>
             </td>
             <td style="width:76.5pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt" width="102" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal">390</p>
             </td>
         </tr>
         <tr>
             <td style="width:2.0in;border:solid windowtext 1.0pt; border-top:none; padding:0in 5.4pt 0in 5.4pt" width="192" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal">RX Summ--Dx/Stg Proc</p>
             </td>
             <td style="width:76.5pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt" width="102" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal">1350</p>
             </td>
         </tr>
         <tr>
             <td style="width:2.0in;border:solid windowtext 1.0pt; border-top:none; padding:0in 5.4pt 0in 5.4pt" width="192" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal">Diagnostic Confirmation</p>
             </td>
             <td style="width:76.5pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt" width="102" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal">490</p>
             </td>
         </tr>
         <tr>
             <td style="width:2.0in;border:solid windowtext 1.0pt; border-top:none; padding:0in 5.4pt 0in 5.4pt" width="192" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal">Primary Site</p>
             </td>
             <td style="width:76.5pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt" width="102" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal">400</p>
             </td>
         </tr>
         <tr>
             <td style="width:2.0in;border:solid windowtext 1.0pt; border-top:none; padding:0in 5.4pt 0in 5.4pt" width="192" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal">RX Hosp--Dx/Stg Proc</p>
             </td>
             <td style="width:76.5pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt" width="102" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal">740</p>
             </td>
         </tr>
         <tr>
             <td style="width:2.0in;border:solid windowtext 1.0pt; border-top:none; padding:0in 5.4pt 0in 5.4pt" width="192" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal">RX Summ--Surg Prim Site</p>
             </td>
             <td style="width:76.5pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt" width="102" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal">1290</p>
             </td>
         </tr>
         <tr>
             <td style="width:2.0in;border:solid windowtext 1.0pt; border-top:none; padding:0in 5.4pt 0in 5.4pt" width="192" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal">Collaborative Stage&nbsp;variables</p>
             </td>
             <td style="width:76.5pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt" width="102" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal">2800-2930</p>
             </td>
         </tr>
         <tr>
             <td style="width:2.0in;border:solid windowtext 1.0pt; border-top:none; padding:0in 5.4pt 0in 5.4pt" width="192" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal">SEER Summary Stage 1977</p>
             </td>
             <td style="width:76.5pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt" width="102" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal">760</p>
             </td>
         </tr>
         <tr>
             <td style="width:2.0in;border:solid windowtext 1.0pt; border-top:none; padding:0in 5.4pt 0in 5.4pt" width="192" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal">SEER Summary Stage 2000</p>
             </td>
             <td style="width:76.5pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt" width="102" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal">759</p>
             </td>
         </tr>
         <tr>
             <td style="width:2.0in;border:solid windowtext 1.0pt; border-top:none; padding:0in 5.4pt 0in 5.4pt" width="192" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal">Reason for No Surgery</p>
             </td>
             <td style="width:76.5pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt" width="102" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal">1340</p>
              </td>
         </tr>
         <tr>
             <td style="width:2.0in;border:solid windowtext 1.0pt; border-top:none; padding:0in 5.4pt 0in 5.4pt" width="192" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal">Summary Stage 2018<br /></p>
             </td>
             <td style="width:76.5pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt" width="102" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal">764</p>
 </td>
         </tr>
         <tr>
             <td style="width:2.0in;border:solid windowtext 1.0pt; border-top:none; padding:0in 5.4pt 0in 5.4pt" width="192" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal">AJCC TNM Data Items<br /></p>
             </td>
             <td style="width:76.5pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt" width="102" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal">1001-1036</p>
 </td>
         </tr>
         <tr>
             <td style="width:2.0in;border:solid windowtext 1.0pt; border-top:none; padding:0in 5.4pt 0in 5.4pt" width="192" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal">EOD Data Items<br /></p>
             </td>
             <td style="width:76.5pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt" width="102" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal">772-776</p>
 </td>
         </tr>
         <tr>
             <td style="width:2.0in;border:solid windowtext 1.0pt; border-top:none; padding:0in 5.4pt 0in 5.4pt" width="192" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal">Site-specific SSDI Data Items<br /></p>
             </td>
             <td style="width:76.5pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt" width="102" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal">3801-3937</p></td>
         </tr>
     </tbody>
</table></div><a name='2570'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>TEXT--DX PROC--PATH</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">2570</td><td style="text-align:center;">1000</td><td style="text-align:center;"><a href='#sources'>NPCR</a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">11935 - 12934</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>textDxProcPath</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Text area for manual documentation of information from cytology and histopathology reports.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Text documentation is an essential component of a complete electronic report and is heavily utilized for quality control and special studies. Text is needed to justify coded values and to document supplemental information not transmitted within coded values. High-quality text documentation facilitates consolidation of information from multiple reporting sources at the central registry.<br /><br />The text field must contain a description that has been entered by the reporter independently from the code(s). If software generates text automatically from codes, the text cannot be utilized to check coded values. Information documenting the disease process should be entered manually from the medical record <strong>and should not be generated electronically from coded values</strong>. <strong><br /><br />Instructions</strong><ul><li>Prioritize entered information in the order of the fields listed below.</li><li>Text automatically generated from coded data is not acceptable.</li><li>NAACCR-approved abbreviations should be utilized (see Appendix G).</li><li>Do not repeat information from other text fields.</li><li>Additional comments can be continued in empty text fields, including Remarks. For text documentation that is continued from one text field to another, use asterisks or other symbols to indicate the connection with preceding text.</li><li>If information is missing from the record, state that it is missing.</li><li>Do not include irrelevant information.</li><li>Do not include information that the registry is not authorized to collect.</li></ul><em>Note:</em> For software that allows unlimited text, NAACCR recommends that the software indicate to the reporter the portion of the text that will be transmitted to the central registry.<strong><br /><br />Suggestions for text:</strong><ul><li>Date(s) of procedure(s)</li><li>Anatomic source of specimen</li><li>Type of tissue specimen(s)</li><li>Tumor type and grade (include all modifying adjectives, i.e., predominantly, with features of, with foci of, elements of, etc.)</li><li>Gross tumor size</li><li>Extent of tumor spread</li><li>Involvement of resection margins</li><li>Number of lymph nodes involved and examined</li><li>Record both positive and negative findings. Record positive test results first.</li><li>Note if pathology report is a slide review or a second opinion from an outside source, i.e., AFIP, Mayo, etc.</li><li>Record any additional comments from the pathologist, including differential diagnoses considered and any ruled out or favored</li></ul></div><div class='content chap10-para'><strong>Data Item(s) to be verified/validated using the text entered in this field</strong> <br />
<p>After manual entry of the text field, ensure that the text entered both agrees with the coded values and clearly justifies the selected codes in the following fields:</p>
<p> </p>
<table style="margin-left:95.4pt;border-collapse:collapse;" border="0" cellspacing="0" cellpadding="0">
     <tbody>
         <tr>
             <td style="width:169.0pt;border:solid windowtext 1.0pt; padding:0in 5.4pt 0in 5.4pt" width="225" valign="top">
             <p style="margin-bottom:0in; margin-bottom:.0001pt;line-height:normal"> <strong> <span style="font-size:12.0pt; font-family:&quot;Times New Roman&quot;,&quot;serif&quot;;Times New Roman&quot;">Item name</span> </strong> </p>
             </td>
             <td style="width:83.0pt;border:solid windowtext 1.0pt; border-left:none;padding:0in 5.4pt 0in 5.4pt" width="111" valign="top">
             <p style="margin-bottom:0in; margin-bottom:.0001pt;line-height:normal"> <strong> <span style="font-size:12.0pt; font-family:&quot;Times New Roman&quot;,&quot;serif&quot;;Times New Roman&quot;">Item number</span> </strong> </p>
             </td>
         </tr>
         <tr>
             <td style="width:169.0pt;border:solid windowtext 1.0pt; border-top:none;padding:0in 5.4pt 0in 5.4pt" width="225" valign="top">
             <p style="margin-bottom:0in; margin-bottom:.0001pt;line-height:normal"> <span style="font-size:12.0pt; font-family:&quot;Times New Roman&quot;,&quot;serif&quot;;Times New Roman&quot;">Date of Diagnosis</span> </p>
             </td>
             <td style="width:83.0pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; padding:0in 5.4pt 0in 5.4pt" width="111" valign="top">
             <p style="margin-bottom:0in; margin-bottom:.0001pt;line-height:normal"> <span style="font-size:12.0pt; font-family:&quot;Times New Roman&quot;,&quot;serif&quot;;Times New Roman&quot;">390</span> </p>
             </td>
         </tr>
         <tr>
             <td style="width:169.0pt;border:solid windowtext 1.0pt; border-top:none;padding:0in 5.4pt 0in 5.4pt" width="225" valign="top">
             <p style="margin-bottom:0in; margin-bottom:.0001pt;line-height:normal"> <span style="font-size:12.0pt; font-family:&quot;Times New Roman&quot;,&quot;serif&quot;;Times New Roman&quot;">Primary Site</span> </p>
             </td>
             <td style="width:83.0pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; padding:0in 5.4pt 0in 5.4pt" width="111" valign="top">
             <p style="margin-bottom:0in; margin-bottom:.0001pt;line-height:normal"> <span style="font-size:12.0pt; font-family:&quot;Times New Roman&quot;,&quot;serif&quot;;Times New Roman&quot;">400</span> </p>
             </td>
         </tr>
         <tr>
             <td style="width:169.0pt;border:solid windowtext 1.0pt; border-top:none;padding:0in 5.4pt 0in 5.4pt" width="225" valign="top">
             <p style="margin-bottom:0in; margin-bottom:.0001pt;line-height:normal"> <span style="font-size:12.0pt; font-family:&quot;Times New Roman&quot;,&quot;serif&quot;;Times New Roman&quot;">Laterality</span> </p>
             </td>
             <td style="width:83.0pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; padding:0in 5.4pt 0in 5.4pt" width="111" valign="top">
             <p style="margin-bottom:0in; margin-bottom:.0001pt;line-height:normal"> <span style="font-size:12.0pt; font-family:&quot;Times New Roman&quot;,&quot;serif&quot;;Times New Roman&quot;">410</span> </p>
             </td>
         </tr>
         <tr>
             <td style="width:169.0pt;border:solid windowtext 1.0pt; border-top:none;padding:0in 5.4pt 0in 5.4pt" width="225" valign="top">
             <p style="margin-bottom:0in; margin-bottom:.0001pt;line-height:normal"> <span style="font-size:12.0pt; font-family:&quot;Times New Roman&quot;,&quot;serif&quot;;Times New Roman&quot;">Histologic Type ICD-O-3</span> </p>
             </td>
             <td style="width:83.0pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; padding:0in 5.4pt 0in 5.4pt" width="111" valign="top">
             <p style="margin-bottom:0in; margin-bottom:.0001pt;line-height:normal"> <span style="font-size:12.0pt; font-family:&quot;Times New Roman&quot;,&quot;serif&quot;;Times New Roman&quot;">522</span> </p>
             </td>
         </tr>
         <tr>
             <td style="width:169.0pt;border:solid windowtext 1.0pt; border-top:none;padding:0in 5.4pt 0in 5.4pt" width="225" valign="top">
             <p style="margin-bottom:0in; margin-bottom:.0001pt;line-height:normal"> <span style="font-size:12.0pt; font-family:&quot;Times New Roman&quot;,&quot;serif&quot;;Times New Roman&quot;">Grade</span> </p>
             </td>
             <td style="width:83.0pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; padding:0in 5.4pt 0in 5.4pt" width="111" valign="top">
             <p style="margin-bottom:0in; margin-bottom:.0001pt;line-height:normal"> <span style="font-size:12.0pt; font-family:&quot;Times New Roman&quot;,&quot;serif&quot;;Times New Roman&quot;">440</span> </p>
             </td>
         </tr>
         <tr>
             <td style="width:169.0pt;border:solid windowtext 1.0pt; border-top:none;padding:0in 5.4pt 0in 5.4pt" width="225" valign="top">
             <p style="margin-bottom:0in; margin-bottom:.0001pt;line-height:normal"> <span style="font-size:12.0pt; font-family:&quot;Times New Roman&quot;,&quot;serif&quot;;Times New Roman&quot;">Collaborative Stage&nbsp;variables</span> </p>
             </td>
             <td style="width:83.0pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; padding:0in 5.4pt 0in 5.4pt" width="111" valign="top">
             <p style="margin-bottom:0in; margin-bottom:.0001pt;line-height:normal"> <span style="font-size:12.0pt; font-family:&quot;Times New Roman&quot;,&quot;serif&quot;;Times New Roman&quot;">2800-2930</span> </p>
             </td>
         </tr>
         <tr>
             <td style="width:169.0pt;border:solid windowtext 1.0pt; border-top:none;padding:0in 5.4pt 0in 5.4pt" width="225" valign="top">
             <p style="margin-bottom:0in; margin-bottom:.0001pt;line-height:normal"> <span style="font-size:12.0pt; font-family:&quot;Times New Roman&quot;,&quot;serif&quot;;Times New Roman&quot;">Diagnostic confirmation</span> </p>
             </td>
             <td style="width:83.0pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; padding:0in 5.4pt 0in 5.4pt" width="111" valign="top">
             <p style="margin-bottom:0in; margin-bottom:.0001pt;line-height:normal"> <span style="font-size:12.0pt; font-family:&quot;Times New Roman&quot;,&quot;serif&quot;;Times New Roman&quot;">490</span> </p>
             </td>
         </tr>
         <tr>
             <td style="width:169.0pt;border:solid windowtext 1.0pt; border-top:none;padding:0in 5.4pt 0in 5.4pt" width="225" valign="top">
             <p style="margin-bottom:0in; margin-bottom:.0001pt;line-height:normal"> <span style="font-size:12.0pt; font-family:&quot;Times New Roman&quot;,&quot;serif&quot;;Times New Roman&quot;">RX Hosp--Surg Prim Site</span> </p>
             </td>
             <td style="width:83.0pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; padding:0in 5.4pt 0in 5.4pt" width="111" valign="top">
             <p style="margin-bottom:0in; margin-bottom:.0001pt;line-height:normal"> <span style="font-size:12.0pt; font-family:&quot;Times New Roman&quot;,&quot;serif&quot;;Times New Roman&quot;">670</span> </p>
             </td>
         </tr>
         <tr>
             <td style="width:169.0pt;border:solid windowtext 1.0pt; border-top:none;padding:0in 5.4pt 0in 5.4pt" width="225" valign="top">
             <p style="margin-bottom:0in; margin-bottom:.0001pt;line-height:normal"> <span style="font-size:12.0pt; font-family:&quot;Times New Roman&quot;,&quot;serif&quot;;Times New Roman&quot;">RX Hosp--Scope Reg LN Sur</span> </p>
             </td>
             <td style="width:83.0pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; padding:0in 5.4pt 0in 5.4pt" width="111" valign="top">
             <p style="margin-bottom:0in; margin-bottom:.0001pt;line-height:normal"> <span style="font-size:12.0pt; font-family:&quot;Times New Roman&quot;,&quot;serif&quot;;Times New Roman&quot;">672</span> </p>
             </td>
         </tr>
         <tr>
             <td style="width:169.0pt;border:solid windowtext 1.0pt; border-top:none;padding:0in 5.4pt 0in 5.4pt" width="225" valign="top">
             <p style="margin-bottom:0in; margin-bottom:.0001pt;line-height:normal"> <span style="font-size:12.0pt; font-family:&quot;Times New Roman&quot;,&quot;serif&quot;;Times New Roman&quot;">RX Hosp--Surg Oth Rg/Dis</span> </p>
             </td>
             <td style="width:83.0pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; padding:0in 5.4pt 0in 5.4pt" width="111" valign="top">
             <p style="margin-bottom:0in; margin-bottom:.0001pt;line-height:normal"> <span style="font-size:12.0pt; font-family:&quot;Times New Roman&quot;,&quot;serif&quot;;Times New Roman&quot;">674</span> </p>
             </td>
         </tr>
         <tr>
             <td style="width:169.0pt;border:solid windowtext 1.0pt; border-top:none;padding:0in 5.4pt 0in 5.4pt" width="225" valign="top">
             <p style="margin-bottom:0in; margin-bottom:.0001pt;line-height:normal"> <span style="font-size:12.0pt; font-family:&quot;Times New Roman&quot;,&quot;serif&quot;;Times New Roman&quot;">RX Summ--Surg Prim Site</span> </p>
             </td>
             <td style="width:83.0pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; padding:0in 5.4pt 0in 5.4pt" width="111" valign="top">
             <p style="margin-bottom:0in; margin-bottom:.0001pt;line-height:normal"> <span style="font-size:12.0pt; font-family:&quot;Times New Roman&quot;,&quot;serif&quot;;Times New Roman&quot;">1290</span> </p>
             </td>
         </tr>
         <tr>
             <td style="width:169.0pt;border:solid windowtext 1.0pt; border-top:none;padding:0in 5.4pt 0in 5.4pt" width="225" valign="top">
             <p style="margin-bottom:0in; margin-bottom:.0001pt;line-height:normal"> <span style="font-size:12.0pt; font-family:&quot;Times New Roman&quot;,&quot;serif&quot;;Times New Roman&quot;">RX Summ--Scope Reg LN Sur</span> </p>
             </td>
             <td style="width:83.0pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; padding:0in 5.4pt 0in 5.4pt" width="111" valign="top">
             <p style="margin-bottom:0in; margin-bottom:.0001pt;line-height:normal"> <span style="font-size:12.0pt; font-family:&quot;Times New Roman&quot;,&quot;serif&quot;;Times New Roman&quot;">1292</span> </p>
             </td>
         </tr>
         <tr>
             <td style="width:169.0pt;border:solid windowtext 1.0pt; border-top:none;padding:0in 5.4pt 0in 5.4pt" width="225" valign="top">
             <p style="margin-bottom:0in; margin-bottom:.0001pt;line-height:normal"> <span style="font-size:12.0pt; font-family:&quot;Times New Roman&quot;,&quot;serif&quot;;Times New Roman&quot;">RX Summ--Surg Oth Reg/Dis</span> </p>
             </td>
             <td style="width:83.0pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; padding:0in 5.4pt 0in 5.4pt" width="111" valign="top">
             <p style="margin-bottom:0in; margin-bottom:.0001pt;line-height:normal"> <span style="font-size:12.0pt; font-family:&quot;Times New Roman&quot;,&quot;serif&quot;;Times New Roman&quot;">1294</span> </p>
             </td>
         </tr>
         <tr>
             <td style="width:169.0pt;border:solid windowtext 1.0pt; border-top:none;padding:0in 5.4pt 0in 5.4pt" width="225" valign="top">
             <p style="margin-bottom:0in; margin-bottom:.0001pt;line-height:normal"> <span style="font-size:12.0pt; font-family:&quot;Times New Roman&quot;,&quot;serif&quot;;Times New Roman&quot;">SEER Summary Stage 2000</span> </p>
             </td>
             <td style="width:83.0pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; padding:0in 5.4pt 0in 5.4pt" width="111" valign="top">
             <p style="margin-bottom:0in; margin-bottom:.0001pt;line-height:normal"> <span style="font-size:12.0pt; font-family:&quot;Times New Roman&quot;,&quot;serif&quot;;Times New Roman&quot;">759</span> </p>
             </td>
         </tr>
         <tr>
             <td style="width:169.0pt;border:solid windowtext 1.0pt; border-top:none;padding:0in 5.4pt 0in 5.4pt" width="225" valign="top">
             <p style="margin-bottom:0in; margin-bottom:.0001pt;line-height:normal"> <span style="font-size:12.0pt; font-family:&quot;Times New Roman&quot;,&quot;serif&quot;;Times New Roman&quot;">SEER Summary Stage 1977</span> </p>
             </td>
             <td style="width:83.0pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; padding:0in 5.4pt 0in 5.4pt" width="111" valign="top">
             <p style="margin-bottom:0in; margin-bottom:.0001pt;line-height:normal"> <span style="font-size:12.0pt; font-family:&quot;Times New Roman&quot;,&quot;serif&quot;;Times New Roman&quot;">760</span> </p>
             </td>
         </tr>
         <tr>
             <td style="width:169.0pt;border:solid windowtext 1.0pt; border-top:none;padding:0in 5.4pt 0in 5.4pt" width="225" valign="top">
             <p style="margin-bottom:0in; margin-bottom:.0001pt;line-height:normal"> <span style="font-size:12.0pt; font-family:&quot;Times New Roman&quot;,&quot;serif&quot;;Times New Roman&quot;">Regional Nodes Positive</span> </p>
             </td>
             <td style="width:83.0pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; padding:0in 5.4pt 0in 5.4pt" width="111" valign="top">
             <p style="margin-bottom:0in; margin-bottom:.0001pt;line-height:normal"> <span style="font-size:12.0pt; font-family:&quot;Times New Roman&quot;,&quot;serif&quot;;Times New Roman&quot;">820</span> </p>
             </td>
         </tr>
         <tr>
             <td style="width:169.0pt;border:solid windowtext 1.0pt; border-top:none;padding:0in 5.4pt 0in 5.4pt" width="225" valign="top">
             <p style="margin-bottom:0in; margin-bottom:.0001pt;line-height:normal"> <span style="font-size:12.0pt; font-family:&quot;Times New Roman&quot;,&quot;serif&quot;;Times New Roman&quot;">Regional Nodes Examined</span> </p>
             </td>
             <td style="width:83.0pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; padding:0in 5.4pt 0in 5.4pt" width="111" valign="top">
             <p style="margin-bottom:0in; margin-bottom:.0001pt;line-height:normal"> <span style="font-size:12.0pt; font-family:&quot;Times New Roman&quot;,&quot;serif&quot;;Times New Roman&quot;">830</span> </p>
             </td>
         </tr>
         <tr>
             <td style="width:169.0pt;border:solid windowtext 1.0pt; border-top:none;padding:0in 5.4pt 0in 5.4pt" width="225" valign="top">
             <p style="margin-bottom:0in; margin-bottom:.0001pt;line-height:normal"> <span style="font-size:12.0pt; font-family:&quot;Times New Roman&quot;,&quot;serif&quot;;Times New Roman&quot;">RX Date Surgery</span> </p>
             </td>
             <td style="width:83.0pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; padding:0in 5.4pt 0in 5.4pt" width="111" valign="top">
             <p style="margin-bottom:0in; margin-bottom:.0001pt;line-height:normal"> <span style="font-size:12.0pt; font-family:&quot;Times New Roman&quot;,&quot;serif&quot;;Times New Roman&quot;">1200</span> </p>
             </td>
         </tr>
         <tr>
             <td style="width:169.0pt;border:solid windowtext 1.0pt; border-top:none;padding:0in 5.4pt 0in 5.4pt" width="225" valign="top">
             <p style="margin-bottom:0in; margin-bottom:.0001pt;line-height:normal"> <span style="font-size:12.0pt; font-family:&quot;Times New Roman&quot;,&quot;serif&quot;;Times New Roman&quot;">Reason for No Surgery</span> </p>
             </td>
             <td style="width:83.0pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; padding:0in 5.4pt 0in 5.4pt" width="111" valign="top">
             <p style="margin-bottom:0in; margin-bottom:.0001pt;line-height:normal"> <span style="font-size:12.0pt; font-family:&quot;Times New Roman&quot;,&quot;serif&quot;;Times New Roman&quot;">1340</span> </p>
             </td>
         </tr>
         <tr>
             <td style="width:169.0pt;border:solid windowtext 1.0pt; border-top:none;padding:0in 5.4pt 0in 5.4pt" width="225" valign="top">
             <p style="margin-bottom:0in; margin-bottom:.0001pt;line-height:normal"> <span style="font-size:12.0pt; font-family:&quot;Times New Roman&quot;,&quot;serif&quot;;Times New Roman&quot;">RX Summ--Surg/Rad Seq</span> </p>
             </td>
             <td style="width:83.0pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; padding:0in 5.4pt 0in 5.4pt" width="111" valign="top">
             <p style="margin-bottom:0in; margin-bottom:.0001pt;line-height:normal"> <span style="font-size:12.0pt; font-family:&quot;Times New Roman&quot;,&quot;serif&quot;;Times New Roman&quot;">1380</span> </p>
             </td>
         </tr>
         <tr>
             <td style="width:169.0pt;border:solid windowtext 1.0pt; border-top:none;padding:0in 5.4pt 0in 5.4pt" width="225" valign="top">
             <p style="margin-bottom:0in; margin-bottom:.0001pt;line-height:normal"> <span style="font-size:12.0pt; font-family:&quot;Times New Roman&quot;,&quot;serif&quot;;Times New Roman&quot;">RX Summ--Systemic/Sur Seq</span> </p>
             </td>
             <td style="width:83.0pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; padding:0in 5.4pt 0in 5.4pt" width="111" valign="top">
             <p style="margin-bottom:0in; margin-bottom:.0001pt;line-height:normal"> <span style="font-size:12.0pt; font-family:&quot;Times New Roman&quot;,&quot;serif&quot;;Times New Roman&quot;">1639</span> </p>
             </td>
         </tr>
         <tr>
             <td style="width:2.0in;border:solid windowtext 1.0pt; border-top:none; padding:0in 5.4pt 0in 5.4pt" width="192" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal">Summary Stage 2018<br /></p>
             </td>
             <td style="width:76.5pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt" width="102" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal">764</p>
              </td>
         </tr>
         <tr>
             <td style="width:2.0in;border:solid windowtext 1.0pt; border-top:none; padding:0in 5.4pt 0in 5.4pt" width="192" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal">AJCC TNM Data Items<br /></p>
             </td>
             <td style="width:76.5pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt" width="102" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal">1001-1036</p>
 </td>
         </tr>
         <tr>
             <td style="width:2.0in;border:solid windowtext 1.0pt; border-top:none; padding:0in 5.4pt 0in 5.4pt" width="192" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal">Directly-assigned EOD Data Items<br /></p>
             </td>
             <td style="width: 76.5pt; border-color: currentcolor windowtext windowtext currentcolor; border-style: none solid solid none; border-width: medium 1pt 1pt medium; padding: 0in 5.4pt;" width="102" valign="top">
             <p style="margin-bottom: 0.0001pt; line-height: normal;">772-776</p>
 </td>
         </tr>
         <tr>
             <td style="width: 2in; border-color: currentcolor windowtext windowtext; border-style: none solid solid; border-width: medium 1pt 1pt; border-image: none 100% / 1 / 0 stretch; -moz-border-top-colors: none; -moz-border-left-colors: none; -moz-border-bottom-colors: none; -moz-border-right-colors: none; padding: 0in 5.4pt;" width="192" valign="top">
             <p style="margin-bottom: 0.0001pt; line-height: normal;">Site-specific SSDI Data Items<br /></p>
             </td>
             <td style="width:76.5pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt" width="102" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal">3801-3937</p>
</td>
         </tr>
     </tbody>
</table></div><a name='2520'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>TEXT--DX PROC--PE</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">2520</td><td style="text-align:center;">1000</td><td style="text-align:center;"><a href='#sources'>NPCR</a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">6935 - 7934</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>textDxProcPe</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Text area for manual documentation from the history and physical examination about the history of the current tumor and the clinical description of the tumor.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Text documentation is an essential component of a complete electronic report and is heavily utilized for quality control and special studies. Text is needed to justify coded values and to document supplemental information not transmitted within coded values. High-quality text documentation facilitates consolidation of information from multiple reporting sources at the central registry.<br /><br />The text field must contain a description that has been entered by the reporter independently from the code(s). If software generates text automatically from codes, the text cannot be utilized to check coded values. Information documenting the disease process should be entered manually from the medical record <strong>and should not be generated electronically from coded values</strong>.<strong><br /><br />Instructions</strong><ul><li>Prioritize entered information in the order of the fields listed below.</li><li>Text automatically generated from coded data is not acceptable.</li><li>NAACCR-approved abbreviations should be utilized (see Appendix G).</li><li>Do not repeat information from other text fields.</li><li>Additional comments can be continued in empty text fields, including Remarks. For text documentation that is continued from one text field to another, use asterisks or other symbols to indicate the connection with preceding text.</li><li>If information is missing from the record, state that it is missing.</li><li>Do not include irrelevant information.</li><li>Do not include information that the registry is not authorized to collect.</li></ul><em>Note:</em> For software that allows unlimited text, NAACCR recommends that the software indicate to the reporter the portion of the text that will be transmitted to the central registry.<strong><br /><br />Suggestions for text:</strong><ul><li>Date of physical exam</li><li>Age, sex, race/ethnicity</li><li>History that relates to cancer diagnosis</li><li>Primary site</li><li>Histology (if diagnosis prior to this admission)</li><li>Tumor location</li><li>Tumor size</li><li>Palpable lymph nodes</li><li>Record positive and negative clinical findings. Record positive results first</li><li>Impression (when stated and pertains to cancer diagnosis)</li><li>Treatment plan</li></ul></div><div class='content chap10-para'><strong> </strong> <strong>Data Item(s) to be verified/validated using the text entered in this field<br />
</strong>After manual entry of the text field, ensure that the text entered both agrees with the coded values and clearly justifies the selected codes in the following fields:<br />
<br />
<table style="margin-left: 95.4pt; border-collapse: collapse; border: medium none;" border="1" cellspacing="0" cellpadding="0">
     <tbody>
         <tr>
             <td style="width:2.0in;border:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt" width="192" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal"><strong>Item name</strong></p>
             </td>
             <td style="width:76.5pt;border:solid windowtext 1.0pt; border-left:none;padding:0in 5.4pt 0in 5.4pt" width="102" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal"><strong>Item number</strong></p>
             </td>
         </tr>
         <tr>
             <td style="width:2.0in;border:solid windowtext 1.0pt; border-top:none; padding:0in 5.4pt 0in 5.4pt" width="192" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal">Date of Diagnosis</p>
             </td>
             <td style="width:76.5pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt" width="102" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal">390</p>
             </td>
         </tr>
         <tr>
             <td style="width:2.0in;border:solid windowtext 1.0pt; border-top:none; padding:0in 5.4pt 0in 5.4pt" width="192" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal">Primary Site</p>
             </td>
             <td style="width:76.5pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt" width="102" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal">400</p>
             </td>
         </tr>
         <tr>
             <td style="width:2.0in;border:solid windowtext 1.0pt; border-top:none; padding:0in 5.4pt 0in 5.4pt" width="192" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal">Laterality</p>
             </td>
             <td style="width:76.5pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt" width="102" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal">410</p>
             </td>
         </tr>
         <tr>
             <td style="width:2.0in;border:solid windowtext 1.0pt; border-top:none; padding:0in 5.4pt 0in 5.4pt" width="192" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal">Histologic Type ICD-O-3</p>
             </td>
             <td style="width:76.5pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt" width="102" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal">522</p>
             </td>
         </tr>
         <tr>
             <td style="width:2.0in;border:solid windowtext 1.0pt; border-top:none; padding:0in 5.4pt 0in 5.4pt" width="192" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal">Grade</p>
             </td>
             <td style="width:76.5pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt" width="102" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal">440</p>
             </td>
         </tr>
         <tr>
             <td style="width:2.0in;border:solid windowtext 1.0pt; border-top:none; padding:0in 5.4pt 0in 5.4pt" width="192" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal">Collaborative Stage&nbsp;variables</p>
             </td>
             <td style="width:76.5pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt" width="102" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal">2800-2930</p>
             </td>
         </tr>
         <tr>
             <td style="width:2.0in;border:solid windowtext 1.0pt; border-top:none; padding:0in 5.4pt 0in 5.4pt" width="192" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal">Diagnostic confirmation</p>
             </td>
             <td style="width:76.5pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt" width="102" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal">490</p>
             </td>
         </tr>
         <tr>
             <td style="width:2.0in;border:solid windowtext 1.0pt; border-top:none; padding:0in 5.4pt 0in 5.4pt" width="192" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal">RX Hosp--Surg Prim Site</p>
             </td>
             <td style="width:76.5pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt" width="102" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal">670</p>
             </td>
         </tr>
         <tr>
             <td style="width:2.0in;border:solid windowtext 1.0pt; border-top:none; padding:0in 5.4pt 0in 5.4pt" width="192" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal">RX Hosp--Scope Reg LN Sur</p>
             </td>
             <td style="width:76.5pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt" width="102" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal">672</p>
             </td>
         </tr>
         <tr>
             <td style="width:2.0in;border:solid windowtext 1.0pt; border-top:none; padding:0in 5.4pt 0in 5.4pt" width="192" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal">RX Hosp--Surg Oth Rg/Dis</p>
             </td>
             <td style="width:76.5pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt" width="102" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal">674</p>
             </td>
         </tr>
         <tr>
             <td style="width:2.0in;border:solid windowtext 1.0pt; border-top:none; padding:0in 5.4pt 0in 5.4pt" width="192" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal">RX Summ--Surg Prim Site</p>
             </td>
             <td style="width:76.5pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt" width="102" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal">1290</p>
             </td>
         </tr>
         <tr>
             <td style="width:2.0in;border:solid windowtext 1.0pt; border-top:none; padding:0in 5.4pt 0in 5.4pt" width="192" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal">RX Summ--Scope Reg LN Sur</p>
             </td>
             <td style="width:76.5pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt" width="102" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal">1292</p>
             </td>
         </tr>
         <tr>
             <td style="width:2.0in;border:solid windowtext 1.0pt; border-top:none; padding:0in 5.4pt 0in 5.4pt" width="192" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal">RX Summ--Surg Oth Reg/Dis</p>
             </td>
             <td style="width:76.5pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt" width="102" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal">1294</p>
             </td>
         </tr>
         <tr>
             <td style="width:2.0in;border:solid windowtext 1.0pt; border-top:none; padding:0in 5.4pt 0in 5.4pt" width="192" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal">SEER Summary Stage 2000</p>
             </td>
             <td style="width:76.5pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt" width="102" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal">759</p>
             </td>
         </tr>
         <tr>
             <td style="width:2.0in;border:solid windowtext 1.0pt; border-top:none; padding:0in 5.4pt 0in 5.4pt" width="192" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal">SEER Summary Stage 1977</p>
             </td>
             <td style="width:76.5pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt" width="102" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal">760</p>
             </td>
         </tr>
         <tr>
             <td style="width:2.0in;border:solid windowtext 1.0pt; border-top:none; padding:0in 5.4pt 0in 5.4pt" width="192" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal">Regional Nodes Positive</p>
             </td>
             <td style="width:76.5pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt" width="102" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal">820</p>
             </td>
         </tr>
         <tr>
             <td style="width:2.0in;border:solid windowtext 1.0pt; border-top:none; padding:0in 5.4pt 0in 5.4pt" width="192" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal">Regional Nodes Examined</p>
             </td>
             <td style="width:76.5pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt" width="102" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal">830</p>
             </td>
         </tr>
         <tr>
             <td style="width:2.0in;border:solid windowtext 1.0pt; border-top:none; padding:0in 5.4pt 0in 5.4pt" width="192" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal">RX Date Surgery</p>
             </td>
             <td style="width:76.5pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt" width="102" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal">1200</p>
             </td>
         </tr>
         <tr>
             <td style="width: 2in; border-color: currentcolor windowtext windowtext; border-style: none solid solid; border-width: medium 1pt 1pt; border-image: none 100% / 1 / 0 stretch; -moz-border-top-colors: none; -moz-border-left-colors: none; -moz-border-bottom-colors: none; -moz-border-right-colors: none; padding: 0in 5.4pt;" width="192" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal">Reason for No Surgery</p>
             </td>
             <td style="width:76.5pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt" width="102" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal">1340</p>
             </td>
         </tr>
         <tr>
             <td style="width:2.0in;border:solid windowtext 1.0pt; border-top:none; padding:0in 5.4pt 0in 5.4pt" width="192" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal">RX Summ--Surg/Rad Seq</p>
             </td>
             <td style="width:76.5pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt" width="102" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal">1380</p>
             </td>
         </tr>
         <tr>
             <td style="width:2.0in;border:solid windowtext 1.0pt; border-top:none; padding:0in 5.4pt 0in 5.4pt" width="192" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal">RX Summ--Systemic/Sur Seq</p>
             </td>
             <td style="width:76.5pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt" width="102" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal">1639</p>
             </td>
         </tr>
         <tr>
             <td style="width:2.0in;border:solid windowtext 1.0pt; border-top:none; padding:0in 5.4pt 0in 5.4pt" width="192" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal">Summary Stage 2018<br /></p>
             </td>
             <td style="width:76.5pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt" width="102" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal">764</p> </td>
         
         </tr>
         <tr>
             <td style="width:2.0in;border:solid windowtext 1.0pt; border-top:none; padding:0in 5.4pt 0in 5.4pt" width="192" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal">AJCC TNM Data Items<br /></p>
             </td>
             <td style="width:76.5pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt" width="102" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal">1001-1036</p>
 </td>
         </tr>
         <tr>
             <td style="width:2.0in;border:solid windowtext 1.0pt; border-top:none; padding:0in 5.4pt 0in 5.4pt" width="192" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal">EOD Data Items<br /></p>
             </td>
             <td style="width:76.5pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt" width="102" valign="top">
             <p style="margin-bottom: 0.0001pt; line-height: normal;">772-776</p>
 </td>
         </tr>
         <tr>
             <td style="width:2.0in;border:solid windowtext 1.0pt; border-top:none; padding:0in 5.4pt 0in 5.4pt" width="192" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal">Site-specific SSDI Data Items<br /></p>
             </td>
             <td style="width:76.5pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt" width="102" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal">3801-3937</p> </td></tr>
     </tbody>
</table></div><a name='2540'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>TEXT--DX PROC--SCOPES</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">2540</td><td style="text-align:center;">1000</td><td style="text-align:center;"><a href='#sources'>NPCR</a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">8935 - 9934</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>textDxProcScopes</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Text area for manual documentation from endoscopic examinations that provide information for staging and treatment.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Text documentation is an essential component of a complete electronic report and is heavily utilized for quality control and special studies. Text is needed to justify coded values and to document supplemental information not transmitted within coded values. High-quality text documentation facilitates consolidation of information from multiple reporting sources at the central registry.<br /><br />The text field must contain a description that has been entered by the reporter independently from the code(s). If software generates text automatically from codes, the text cannot be utilized to check coded values. Information documenting the disease process should be entered manually from the medical record <strong>and should not be generated electronically from coded values</strong>. <strong><br /><br />Instructions</strong><ul><li>Prioritize entered information in the order of the fields listed below.</li><li>Text automatically generated from coded data is not acceptable.</li><li>NAACCR-approved abbreviations should be utilized (see Appendix G).</li><li>Do not repeat information from other text fields.</li><li>Additional comments can be continued in empty text fields, including Remarks. For text documentation that is continued from one text field to another, use asterisks or other symbols to indicate the connection with preceding text.</li><li>If information is missing from the record, state that it is missing.</li><li>Do not include irrelevant information.</li><li>Do not include information that the registry is not authorized to collect.</li></ul><em>Note:</em> For software that allows unlimited text, NAACCR recommends that the software indicate to the reporter the portion of the text that will be transmitted to the central registry.<br /><br /><strong>Suggestions for text:</strong><ul><li>Date(s) of endoscopic exam(s)</li><li>Primary site</li><li>Histology (if given)</li><li>Tumor location</li><li>Tumor size</li><li>Record site and type of endoscopic biopsy </li><li>Record positive and negative clinical findings. Record positive results first</li></ul></div><div class='content chap10-para'><strong>Data Item(s) to be verified/validated using the text entered in this field</strong> <br />
After manual entry of the text field, ensure that the text entered both agrees with the coded values and clearly justifies the selected codes in the following fields:<br />
<br />
<table style="margin-left:95.4pt;border-collapse:collapse;border:none;" border="1" cellspacing="0" cellpadding="0">
     <tbody>
         <tr>
             <td style="width:2.0in;border:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt" width="192" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal"><strong>Item name</strong></p>
             </td>
             <td style="width:76.5pt;border:solid windowtext 1.0pt; border-left:none;padding:0in 5.4pt 0in 5.4pt" width="102" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal"><strong>Item number</strong></p>
             </td>
         </tr>
         <tr>
             <td style="width:2.0in;border:solid windowtext 1.0pt; border-top:none; padding:0in 5.4pt 0in 5.4pt" width="192" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal">Date of Diagnosis</p>
             </td>
             <td style="width:76.5pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt" width="102" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal">390</p>
             </td>
         </tr>
         <tr>
             <td style="width:2.0in;border:solid windowtext 1.0pt; border-top:none; padding:0in 5.4pt 0in 5.4pt" width="192" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal">RX Summ--Dx/Stg Proc</p>
             </td>
             <td style="width:76.5pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt" width="102" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal">1350</p>
             </td>
         </tr>
         <tr>
             <td style="width:2.0in;border:solid windowtext 1.0pt; border-top:none; padding:0in 5.4pt 0in 5.4pt" width="192" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal">Diagnostic Confirmation</p>
             </td>
             <td style="width:76.5pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt" width="102" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal">490</p>
             </td>
         </tr>
         <tr>
             <td style="width:2.0in;border:solid windowtext 1.0pt; border-top:none; padding:0in 5.4pt 0in 5.4pt" width="192" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal">Primary Site</p>
             </td>
             <td style="width:76.5pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt" width="102" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal">400</p>
             </td>
         </tr>
         <tr>
             <td style="width:2.0in;border:solid windowtext 1.0pt; border-top:none; padding:0in 5.4pt 0in 5.4pt" width="192" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal">Laterality</p>
             </td>
             <td style="width:76.5pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt" width="102" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal">410</p>
             </td>
         </tr>
         <tr>
             <td style="width:2.0in;border:solid windowtext 1.0pt; border-top:none; padding:0in 5.4pt 0in 5.4pt" width="192" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal">Histology (92-00) ICD-O-2</p>
             </td>
             <td style="width:76.5pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt" width="102" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal">420</p>
             </td>
         </tr>
         <tr>
             <td style="width:2.0in;border:solid windowtext 1.0pt; border-top:none; padding:0in 5.4pt 0in 5.4pt" width="192" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal">Histologic Type ICD-O-3</p>
             </td>
             <td style="width:76.5pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt" width="102" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal">522</p>
             </td>
         </tr>
         <tr>
             <td style="width:2.0in;border:solid windowtext 1.0pt; border-top:none; padding:0in 5.4pt 0in 5.4pt" width="192" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal">Collaborative Stage&nbsp;variables</p>
             </td>
             <td style="width:76.5pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt" width="102" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal">2800-2930</p>
             </td>
         </tr>
         <tr>
             <td style="width:2.0in;border:solid windowtext 1.0pt; border-top:none; padding:0in 5.4pt 0in 5.4pt" width="192" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal">SEER Summary Stage 1977</p>
             </td>
             <td style="width:76.5pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt" width="102" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal">760</p>
             </td>
         </tr>
         <tr>
             <td style="width:2.0in;border:solid windowtext 1.0pt; border-top:none; padding:0in 5.4pt 0in 5.4pt" width="192" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal">SEER Summary Stage 2000</p>
             </td>
             <td style="width:76.5pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt" width="102" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal">759</p>
             </td>
         </tr>
         <tr>
             <td style="width:2.0in;border:solid windowtext 1.0pt; border-top:none; padding:0in 5.4pt 0in 5.4pt" width="192" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal">RX Hosp--Surg Prim Site</p>
             </td>
             <td style="width:76.5pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt" width="102" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal">670</p>
             </td>
         </tr>
         <tr>
             <td style="width:2.0in;border:solid windowtext 1.0pt; border-top:none; padding:0in 5.4pt 0in 5.4pt" width="192" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal">RX Date Surgery</p>
             </td>
             <td style="width:76.5pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt" width="102" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal">1200</p>
             </td>
         </tr>
         <tr>
             <td style="width:2.0in;border:solid windowtext 1.0pt; border-top:none; padding:0in 5.4pt 0in 5.4pt" width="192" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal">Summary Stage 2018<br /></p>
             </td>
             <td style="width:76.5pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt" width="102" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal">764</p>
 </td>
         </tr>
         <tr>
             <td style="width:2.0in;border:solid windowtext 1.0pt; border-top:none; padding:0in 5.4pt 0in 5.4pt" width="192" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal">Ajcc TNM Data Items<br /></p>
             </td>
             <td style="width:76.5pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt" width="102" valign="top">
             <p style="margin-bottom: 0.0001pt; line-height: normal;">1001-1036</p>
 </td>
         </tr>
         <tr>
             <td style="width:2.0in;border:solid windowtext 1.0pt; border-top:none; padding:0in 5.4pt 0in 5.4pt" width="192" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal">EOD Data Items<br /></p>
             </td>
             <td style="width:76.5pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt" width="102" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal">772-776</p>
 </td>
         </tr>
         <tr>
             <td style="width:2.0in;border:solid windowtext 1.0pt; border-top:none; padding:0in 5.4pt 0in 5.4pt" width="192" valign="top">
             <p style="margin-bottom: 0.0001pt; line-height: normal;">Site-specific SSDI Data Items<br /></p>
             </td>
             <td style="width:76.5pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt" width="102" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal">3801-3937</p>
 </td>
         </tr>
     </tbody>
</table></div><a name='2530'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>TEXT--DX PROC--X-RAY/SCAN</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">2530</td><td style="text-align:center;">1000</td><td style="text-align:center;"><a href='#sources'>NPCR</a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">7935 - 8934</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>textDxProcXRayScan</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Text area for manual documentation from all X-rays, scan, and/or other imaging examinations that provide information about staging.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Text documentation is an essential component of a complete electronic report and is heavily utilized for quality control and special studies. Text is needed to justify coded values and to document supplemental information not transmitted within coded values. High-quality text documentation facilitates consolidation of information from multiple reporting sources at the central registry.<br /><br />The text field must contain a description that has been entered by the reporter independently from the code(s). If software generates text automatically from codes, the text cannot be utilized to check coded values. Information documenting the disease process should be entered manually from the medical record <strong>and should not be generated electronically from coded values</strong>.<strong><br /><br />Instructions</strong><ul><li>Prioritize entered information in the order of the fields listed below.</li><li>Text automatically generated from coded data is not acceptable.</li><li>NAACCR-approved abbreviations should be utilized (see Appendix G).</li><li>Do not repeat information from other text fields.</li><li>Additional comments can be continued in empty text fields, including Remarks. For text documentation that is continued from one text field to another, use asterisks or other symbols to indicate the connection with preceding text.</li><li>If information is missing from the record, state that it is missing.</li><li>Do not include irrelevant information.</li><li>Do not include information that the registry is not authorized to collect.</li></ul><em>Note:</em> For software that allows unlimited text, NAACCR recommends that the software indicate to the reporter the portion of the text that will be transmitted to the central registry.<strong><br /><br />Suggestions for text:</strong><ul><li>Date(s) and type(s) of X-ray/Scan(s)</li><li>Primary site</li><li>Histology (if given)</li><li>Tumor location</li><li>Tumor size</li><li>Lymph nodes</li><li>Record positive and negative clinical findings. Record positive results first</li><li>Distant disease or metastasis</li></ul></div><div class='content chap10-para'><strong>Data Item(s) to be verified/validated using the text entered in this field</strong> <br />
After manual entry of the text field, ensure that the text entered both agrees with the coded values and clearly justifies the selected codes in the following fields:<br />
<br />
<table style="margin-left:95.4pt;border-collapse:collapse;border:none;" border="1" cellspacing="0" cellpadding="0">
     <tbody>
         <tr>
             <td style="width:2.0in;border:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt" width="192" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal"><strong>Item name</strong></p>
             </td>
             <td style="width:76.5pt;border:solid windowtext 1.0pt; border-left:none;padding:0in 5.4pt 0in 5.4pt" width="102" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal"><strong>Item number</strong></p>
             </td>
         </tr>
         <tr>
             <td style="width:2.0in;border:solid windowtext 1.0pt; border-top:none; padding:0in 5.4pt 0in 5.4pt" width="192" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal">Date of Diagnosis</p>
             </td>
             <td style="width:76.5pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt" width="102" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal">390</p>
             </td>
         </tr>
         <tr>
             <td style="width:2.0in;border:solid windowtext 1.0pt; border-top:none; padding:0in 5.4pt 0in 5.4pt" width="192" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal">RxSumm--Dx/Stg Proc</p>
             </td>
             <td style="width:76.5pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt" width="102" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal">1350</p>
             </td>
         </tr>
         <tr>
             <td style="width:2.0in;border:solid windowtext 1.0pt; border-top:none; padding:0in 5.4pt 0in 5.4pt" width="192" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal">Primary Site</p>
             </td>
             <td style="width:76.5pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt" width="102" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal">400</p>
             </td>
         </tr>
         <tr>
             <td style="width:2.0in;border:solid windowtext 1.0pt; border-top:none; padding:0in 5.4pt 0in 5.4pt" width="192" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal">Laterality</p>
             </td>
             <td style="width:76.5pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt" width="102" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal">410</p>
             </td>
         </tr>
         <tr>
             <td style="width:2.0in;border:solid windowtext 1.0pt; border-top:none; padding:0in 5.4pt 0in 5.4pt" width="192" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal">Histology (92-00) ICD-O-2</p>
             </td>
             <td style="width:76.5pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt" width="102" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal">420</p>
             </td>
         </tr>
         <tr>
             <td style="width:2.0in;border:solid windowtext 1.0pt; border-top:none; padding:0in 5.4pt 0in 5.4pt" width="192" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal">Histologic Type ICD-O-3</p>
             </td>
             <td style="width:76.5pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt" width="102" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal">522</p>
             </td>
         </tr>
         <tr>
             <td style="width:2.0in;border:solid windowtext 1.0pt; border-top:none; padding:0in 5.4pt 0in 5.4pt" width="192" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal">Collaborative Stage&nbsp;variables</p>
             </td>
             <td style="width:76.5pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt" width="102" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal">2800-2930</p>
             </td>
         </tr>
         <tr>
             <td style="width:2.0in;border:solid windowtext 1.0pt; border-top:none; padding:0in 5.4pt 0in 5.4pt" width="192" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal">SEER Summary Stage 2000</p>
             </td>
             <td style="width:76.5pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt" width="102" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal">759</p>
             </td>
         </tr>
         <tr>
             <td style="width:2.0in;border:solid windowtext 1.0pt; border-top:none; padding:0in 5.4pt 0in 5.4pt" width="192" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal">SEER Summary Stage 1977</p>
             </td>
             <td style="width:76.5pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt" width="102" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal">760</p>
              </td>
         </tr>
         <tr>
             <td style="width:2.0in;border:solid windowtext 1.0pt; border-top:none; padding:0in 5.4pt 0in 5.4pt" width="192" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal">Summary Stage 2018<br /></p>
             </td>
             <td style="width:76.5pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt" width="102" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal">764</p>
 </td>
         </tr>
         <tr>
             <td style="width:2.0in;border:solid windowtext 1.0pt; border-top:none; padding:0in 5.4pt 0in 5.4pt" width="192" valign="top">
             <p style="margin-bottom: 0.0001pt; line-height: normal;">AJCC TNM Data Items<br /></p>
             </td>
             <td style="width:76.5pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt" width="102" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal">1001-1036</p>
 </td>
         </tr>
         <tr>
             <td style="width:2.0in;border:solid windowtext 1.0pt; border-top:none; padding:0in 5.4pt 0in 5.4pt" width="192" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal">EOD Data Items<br /></p>
             </td>
             <td style="width:76.5pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt" width="102" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal">772-776</p>
 </td>
         </tr>
         <tr>
             <td style="width:2.0in;border:solid windowtext 1.0pt; border-top:none; padding:0in 5.4pt 0in 5.4pt" width="192" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal">Site-specific SSDI Data Items<br /></p>
             </td>
             <td style="width:76.5pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt" width="102" valign="top">
             <p style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal">3901-3937</p>
</td>
         </tr>
     </tbody>
</table></div><a name='2590'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>TEXT--HISTOLOGY TITLE</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">2590</td><td style="text-align:center;">100</td><td style="text-align:center;"><a href='#sources'>NPCR</a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">13035 - 13134</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>textHistologyTitle</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Text area for manual documentation of information regarding the histologic type, behavior, and grade (differentiation) of the tumor being reported. </div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Text documentation is an essential component of a complete electronic report and is heavily utilized for quality control and special studies. Text is needed to justify coded values and to document supplemental information not transmitted within coded values. High-quality text documentation facilitates consolidation of information from multiple reporting sources at the central registry.<br /><br />The text field must contain a description that has been entered by the reporter independently from the code(s). If software generates text automatically from codes, the text cannot be utilized to check coded values. Information documenting the disease process should be entered manually from the medical record <strong>and should not be generated electronically from coded values</strong>.<strong><br /><br />Instructions</strong><ul><li>Prioritize entered information in the order of the fields listed below.</li><li>Text automatically generated from coded data is not acceptable.</li><li>NAACCR-approved abbreviations should be utilized (see Appendix G).</li><li>Do not repeat information from other text fields.</li><li>Additional comments can be continued in empty text fields, including Remarks. For text documentation that is continued from one text field to another, use asterisks or other symbols to indicate the connection with preceding text.</li><li>If information is missing from the record, state that it is missing.</li><li>Do not include irrelevant information.</li><li>Do not include information that the registry is not authorized to collect.</li></ul><em>Note:</em> For software that allows unlimited text, NAACCR recommends that the software indicate to the reporter the portion of the text that will be transmitted to the central registry.<strong><br /><br />Suggestions for text:</strong><ul><li>Information on histologic type and behavior</li><li>Information on differentiation from scoring systems such as Gleason&#8217;s Score, Bloom-Richardson Grade, etc.</li></ul> </div><div class='content chap10-para'><strong>Data Item(s) to be verified/validated using the text entered in this field</strong>  <br />After manual entry of the text field, ensure that the text entered both  agrees with the coded values and clearly justifies the selected codes in  the following fields:<br /><br /><table style="margin-left:95.4pt;border-collapse:collapse;border:none;" border="1" cellpadding="0" cellspacing="0"><tbody><tr><td style="width:2.0in;border:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="192"><p style="margin-bottom:0in;margin-bottom:.0001pt;line-height:   normal"><strong>Item name</strong></p></td><td style="width:76.5pt;border:solid windowtext 1.0pt;   border-left:none;padding:0in 5.4pt 0in 5.4pt" valign="top" width="102"><p style="margin-bottom:0in;margin-bottom:.0001pt;line-height:   normal"><strong>Item number</strong></p></td></tr><tr><td style="width:2.0in;border:solid windowtext 1.0pt;   border-top:none;   padding:0in 5.4pt 0in 5.4pt" valign="top" width="192"><p style="margin-bottom:0in;margin-bottom:.0001pt;line-height:   normal">Histology (92-00) ICD-O-2</p></td><td style="width:76.5pt;border-top:none;border-left:   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="102"><p style="margin-bottom:0in;margin-bottom:.0001pt;line-height:   normal">420</p></td></tr><tr><td style="width:2.0in;border:solid windowtext 1.0pt;   border-top:none;   padding:0in 5.4pt 0in 5.4pt" valign="top" width="192"><p style="margin-bottom:0in;margin-bottom:.0001pt;line-height:   normal">Behavior (92-00) ICD-O-2</p></td><td style="width:76.5pt;border-top:none;border-left:   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="102"><p style="margin-bottom:0in;margin-bottom:.0001pt;line-height:   normal">430</p></td></tr><tr><td style="width:2.0in;border:solid windowtext 1.0pt;   border-top:none;   padding:0in 5.4pt 0in 5.4pt" valign="top" width="192"><p style="margin-bottom:0in;margin-bottom:.0001pt;line-height:   normal">Histologic Type ICD-O-3</p></td><td style="width:76.5pt;border-top:none;border-left:   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="102"><p style="margin-bottom:0in;margin-bottom:.0001pt;line-height:   normal">522</p></td></tr><tr><td style="width:2.0in;border:solid windowtext 1.0pt;   border-top:none;   padding:0in 5.4pt 0in 5.4pt" valign="top" width="192"><p style="margin-bottom:0in;margin-bottom:.0001pt;line-height:   normal">Behavior Code ICD-O-3</p></td><td style="width:76.5pt;border-top:none;border-left:   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="102"><p style="margin-bottom:0in;margin-bottom:.0001pt;line-height:   normal">523</p></td></tr><tr><td style="width:2.0in;border:solid windowtext 1.0pt;   border-top:none;   padding:0in 5.4pt 0in 5.4pt" valign="top" width="192"><p style="margin-bottom:0in;margin-bottom:.0001pt;line-height:   normal">Grade</p></td><td style="width:76.5pt;border-top:none;border-left:   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="102"><p style="margin-bottom:0in;margin-bottom:.0001pt;line-height:   normal">440</p></td></tr></tbody></table></div><a name='2690'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>TEXT--PLACE OF DIAGNOSIS</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">2690</td><td style="text-align:center;">60</td><td style="text-align:center;"><a href='#sources'>NPCR</a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">22135 - 22194</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>Place of Diagnosis<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>textPlaceOfDiagnosis</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Text area for manual documentation of the facility, physician office, city, state, or county where the diagnosis was made. </div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Text documentation is an essential component of a complete electronic report and is heavily utilized for quality control and special studies. Text is needed to justify coded values and to document supplemental information not transmitted within coded values. High-quality text documentation facilitates consolidation of information from multiple reporting sources at the central registry.<br />
<br />
<strong>Instructions</strong>
<ul>
     <li>Prioritize entered information in the order of the fields listed below.</li>
     <li>NAACCR-approved abbreviations should be utilized (see Appendix G).</li>
     <li>Do not repeat information from other text fields.</li>
     <li>Additional comments can be continued in empty text fields, including Remarks. For text documentation that is continued from one text field to another, use asterisks or other symbols to indicate the connection with preceding text.</li>
     <li>If information is missing from the record, state that it is missing.</li>
     <li>Do not include irrelevant information.</li>
     <li>Do not include information that the registry is not authorized to collect.</li>
</ul>
<em>Note:</em> For software that allows unlimited text, NAACCR recommends that the software indicate to the reporter the portion of the text that will be transmitted to the central registry.<br />
<br />
<strong>Suggestions for text:</strong>
<ul>
     <li>The complete name of the hospital or the physician office where diagnosis occurred. The initials of a hospital are not adequate.</li>
     <li>For out-of-state residents and facilities, include the city and the state where the medical facility is located.</li>
</ul>
<strong>Data Item(s) to be verified/validated using the text entered in this field</strong><br />
After manual entry of the text field, ensure that the text entered both agrees with the coded values and clearly justifies the selected codes in the following fields:<br />
<br />
<strong>Item Numbers: </strong>2410, 2420, 500, 540, 610, 670, 740 </div><a name='2580'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>TEXT--PRIMARY SITE TITLE</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">2580</td><td style="text-align:center;">100</td><td style="text-align:center;"><a href='#sources'>NPCR</a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">12935 - 13034</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>textPrimarySiteTitle</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Text area for manual documentation of information regarding the primary site and laterality of the tumor being reported. </div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Text documentation is an essential component of a complete electronic report and is heavily utilized for quality control and special studies. Text is needed to justify coded values and to document supplemental information not transmitted within coded values. High-quality text documentation facilitates consolidation of information from multiple reporting sources at the central registry.<br /><br />The text field must contain a description that has been entered by the reporter independently from the code(s). If software generates text automatically from codes, the text cannot be utilized to check coded values. Information documenting the disease process should be entered manually from the medical record <strong>and should not be generated electronically from coded values</strong>.<strong><br /><br />Instructions</strong><ul><li>Prioritize entered information in the order of the fields listed below.</li><li>Text automatically generated from coded data is not acceptable.</li><li>NAACCR-approved abbreviations should be utilized (see Appendix G).</li><li>Do not repeat information from other text fields.</li><li>Additional comments can be continued in empty text fields, including Remarks. For text documentation that is continued from one text field to another, use asterisks or other symbols to indicate the connection with preceding text.</li><li>If information is missing from the record, state that it is missing.</li><li>Do not include irrelevant information.</li><li>Do not include information that the registry is not authorized to collect.</li></ul><em>Note:</em> For software that allows unlimited text, NAACCR recommends that the software indicate to the reporter the portion of the text that will be transmitted to the central registry.<strong><br /><br />Suggestions for text:</strong><ul><li>State the specific location of the primary site, including subsite. </li><li>Include available information on tumor laterality</li></ul> </div><div class='content chap10-para'><strong>  </strong>  <strong>Data Item(s) to be verified/validated using the text entered in this field</strong>  <br />After manual entry of the text field, ensure that the text entered both  agrees with the coded values and clearly justifies the selected codes in  the following fields:<br /><br /><table style="margin-left: 95.4pt; border-collapse: collapse; border: medium none;" border="0" cellpadding="0" cellspacing="0"><tbody><tr><td style="width:2.0in;padding:0in 5.4pt 0in 5.4pt" valign="top" width="192"><p style="margin-bottom:0in;margin-bottom:.0001pt;line-height:   normal"><strong>Item name</strong></p></td><td style="width:76.5pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="102"><p style="margin-bottom:0in;margin-bottom:.0001pt;line-height:   normal"><strong>Item number</strong></p></td></tr><tr><td style="width:2.0in;padding:0in 5.4pt 0in 5.4pt" valign="top" width="192"><p style="margin-bottom:0in;margin-bottom:.0001pt;line-height:   normal">Primary site</p></td><td style="width:76.5pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="102"><p style="margin-bottom:0in;margin-bottom:.0001pt;line-height:   normal">400</p></td></tr><tr><td style="width:2.0in;padding:0in 5.4pt 0in 5.4pt" valign="top" width="192"><p style="margin-bottom:0in;margin-bottom:.0001pt;line-height:   normal">Laterality</p></td><td style="width: 76.5pt; padding: 0in 5.4pt;" valign="top" width="102"><p style="margin-bottom:0in;margin-bottom:.0001pt;line-height:   normal">410</p></td></tr></tbody></table></div><a name='2680'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>TEXT--REMARKS</strong></td><td style="text-align:right;font-weight:bold;"><strong>Revised</strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">2680</td><td style="text-align:center;">1000</td><td style="text-align:center;"><a href='#sources'>NPCR</a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">21135 - 22134</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>textRemarks</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para mark-changed'>Text area for information that is given only in coded form elsewhere or for which the abstract provides no other place. Overflow data can also be placed here. Problematic coding issues can also be discussed in this section.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para mark-changed'>Text documentation is an essential component of a complete electronic report and is heavily utilized for quality control and special studies. Text is needed to justify coded values and to document supplemental information not transmitted within coded values. High-quality text documentation facilitates consolidation of information from multiple reporting sources at the central registry.<strong><br /><br />Instructions</strong><ul><li>NAACCR-approved abbreviations should be utilized (see Appendix G).</li><li>Do not repeat information from other text fields.</li><li>Additional comments from other text fields can be continued in the Remarks field. For text documentation that is continued from one text field to another, use asterisks or other symbols to indicate the connection with preceding text.</li><li>If information is missing from the record, state that it is missing.</li><li>Do not include irrelevant information.</li><li>Do not include information that the registry is not authorized to collect.</li></ul><em>Note:</em> For software that allows unlimited text, NAACCR recommends that the software indicate to the reporter the portion of the text that will be transmitted to the central registry.<strong><br /><br />Suggestions for text:</strong><ul><li>Smoking history</li><li>Family and personal history of cancer</li><li>Comorbidities</li><li>Information on sequence numbers if a person was diagnosed with another primary out-of-state or before the registry&#8217;s reference date</li><li>Place of birth</li><li>Justification of over-ride flags</li><li>Information clarifying anything unusual such as reason for reporting a case seemingly not reportable for that facility or reason for coding numerous fields as &#8220;unknown.&#8221; </li></ul></div><a name='2600'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>TEXT--STAGING</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">2600</td><td style="text-align:center;">1000</td><td style="text-align:center;"><a href='#sources'>NPCR</a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">13135 - 14134</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>textStaging</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Additional text area for staging information not already entered in other Text fields.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Text documentation is an essential component of a complete electronic report and is heavily utilized for quality control and special studies. Text is needed to justify coded values and to document supplemental information not transmitted within coded values. High-quality text documentation facilitates consolidation of information from multiple reporting sources at the central registry.<br /><br />The text field must contain a description that has been entered by the reporter independently from the code(s). If software generates text automatically from codes, the text cannot be utilized to check coded values. Information documenting the disease process should be entered manually from the medical record <strong>and should not be generated electronically from coded values</strong>.<strong><br /><br />Instructions</strong><ul><li>Prioritize entered information in the order of the fields listed below.</li><li>Text automatically generated from coded data is not acceptable.</li><li>NAACCR-approved abbreviations should be utilized (see Appendix G).</li><li>Do not repeat information from other text fields.</li><li>Additional comments can be continued in empty text fields, including Remarks. For text documentation that is continued from one text field to another, use asterisks or other symbols to indicate the connection with preceding text.</li><li>If information is missing from the record, state that it is missing.</li><li>Do not include irrelevant information.</li><li>Do not include information that the registry is not authorized to collect.</li></ul><em>Note:</em> For software that allows unlimited text, NAACCR recommends that the software indicate to the reporter the portion of the text that will be transmitted to the central registry.<br /><br /><strong>Suggestions for text:</strong><ul><li>Date(s) of procedure(s), including clinical procedures, that provided information for assigning stage</li><li>Organs involved by direct extension</li><li>Size of tumor</li><li>Status of margins</li><li>Number and sites of positive lymph nodes</li><li>Site(s) of distant metastasis</li><li>Physician's specialty and comments</li></ul></div><div class='content chap10-para'><strong>Data Item(s) to be verified/validated using the text entered in this field</strong>  <br />After manual entry of the text field, ensure that the text entered both  agrees with the coded values and clearly justifies the selected codes in  the following fields:<br /><br /><table style="margin-left:95.4pt;border-collapse:collapse;border:none;" border="0" cellpadding="0" cellspacing="0"><tbody><tr><td style="width:2.0in;padding:0in 5.4pt 0in 5.4pt" valign="top" width="192"><p style="margin-bottom:0in;margin-bottom:.0001pt;line-height:   normal"><strong>Item name</strong></p></td><td style="width:76.5pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="102"><p style="margin-bottom:0in;margin-bottom:.0001pt;line-height:   normal"><strong>Item number</strong></p></td></tr><tr><td style="width:2.0in;padding:0in 5.4pt 0in 5.4pt" valign="top" width="192"><p style="margin-bottom:0in;margin-bottom:.0001pt;line-height:   normal">RxDate Dx/Stg Proc</p></td><td style="width:76.5pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="102"><p style="margin-bottom:0in;margin-bottom:.0001pt;line-height:   normal">1280</p></td></tr><tr><td style="width:2.0in;padding:0in 5.4pt 0in 5.4pt" valign="top" width="192"><p style="margin-bottom:0in;margin-bottom:.0001pt;line-height:   normal">Collaborative Stage&#160;variables</p></td><td style="width:76.5pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="102"><p style="margin-bottom:0in;margin-bottom:.0001pt;line-height:   normal">2800-2930</p></td></tr><tr><td style="width:2.0in;padding:0in 5.4pt 0in 5.4pt" valign="top" width="192"><p style="margin-bottom:0in;margin-bottom:.0001pt;line-height:   normal">SEER Summary Stage 1977</p></td><td style="width:76.5pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="102"><p style="margin-bottom:0in;margin-bottom:.0001pt;line-height:   normal">760</p></td></tr><tr><td style="width:2.0in;padding:0in 5.4pt 0in 5.4pt" valign="top" width="192"><p style="margin-bottom:0in;margin-bottom:.0001pt;line-height:   normal">SEER Summary Stage 2000</p></td><td style="width:76.5pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="102"><p style="margin-bottom:0in;margin-bottom:.0001pt;line-height:   normal">759</p></td></tr><tr><td style="width:2.0in;padding:0in 5.4pt 0in 5.4pt" valign="top" width="192"><p style="margin-bottom:0in;margin-bottom:.0001pt;line-height:   normal">Regional Nodes Positive</p></td><td style="width:76.5pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="102"><p style="margin-bottom:0in;margin-bottom:.0001pt;line-height:   normal">820</p></td></tr><tr><td style="width:2.0in;padding:0in 5.4pt 0in 5.4pt" valign="top" width="192"><p style="margin-bottom:0in;margin-bottom:.0001pt;line-height:   normal">Regional Nodes Examined</p></td><td style="width:76.5pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="102"><p style="margin-bottom:0in;margin-bottom:.0001pt;line-height:   normal">830</p></td></tr><tr><td style="width:2.0in;padding:0in 5.4pt 0in 5.4pt" valign="top" width="192"><p style="margin-bottom:0in;margin-bottom:.0001pt;line-height:   normal">RX Hosp--Surg Prim Site</p></td><td style="width:76.5pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="102"><p style="margin-bottom:0in;margin-bottom:.0001pt;line-height:   normal">670</p></td></tr><tr><td style="width:2.0in;padding:0in 5.4pt 0in 5.4pt" valign="top" width="192"><p style="margin-bottom:0in;margin-bottom:.0001pt;line-height:   normal">RX Summ--Surg Prim Site</p></td><td style="width:76.5pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="102"><p style="margin-bottom:0in;margin-bottom:.0001pt;line-height:   normal">1290</p></td></tr><tr><td style="width:2.0in;padding:0in 5.4pt 0in 5.4pt" valign="top" width="192"><p style="margin-bottom:0in;margin-bottom:.0001pt;line-height:   normal">RX Hosp--Scope Reg LN Sur</p></td><td style="width:76.5pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="102"><p style="margin-bottom:0in;margin-bottom:.0001pt;line-height:   normal">672</p></td></tr><tr><td style="width:2.0in;padding:0in 5.4pt 0in 5.4pt" valign="top" width="192"><p style="margin-bottom:0in;margin-bottom:.0001pt;line-height:   normal">RX Summ--Scope Reg LN Sur</p></td><td style="width:76.5pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="102"><p style="margin-bottom:0in;margin-bottom:.0001pt;line-height:   normal">1292</p></td></tr><tr><td style="width:2.0in;padding:0in 5.4pt 0in 5.4pt" valign="top" width="192"><p style="margin-bottom:0in;margin-bottom:.0001pt;line-height:   normal">RX Hosp--Surg Oth Rg/Dis</p></td><td style="width:76.5pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="102"><p style="margin-bottom:0in;margin-bottom:.0001pt;line-height:   normal">674</p></td></tr><tr><td style="width:2.0in;padding:0in 5.4pt 0in 5.4pt" valign="top" width="192"><p style="margin-bottom:0in;margin-bottom:.0001pt;line-height:   normal">RX Summ--Surg Oth Reg/Dis</p></td><td style="width:76.5pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="102"><p style="margin-bottom:0in;margin-bottom:.0001pt;line-height:   normal">1294</p></td></tr><tr><td style="width:2.0in;padding:0in 5.4pt 0in 5.4pt" valign="top" width="192"><p style="margin-bottom:0in;margin-bottom:.0001pt;line-height:   normal">Mult Tum Rpt as One Prim</p></td><td style="width:76.5pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="102"><p style="margin-bottom:0in;margin-bottom:.0001pt;line-height:   normal">444</p></td></tr><tr><td style="width:2.0in;padding:0in 5.4pt 0in 5.4pt" valign="top" width="192"><p style="margin-bottom:0in;margin-bottom:.0001pt;line-height:   normal">Lateraltiy</p></td><td style="width:76.5pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="102"><p style="margin-bottom:0in;margin-bottom:.0001pt;line-height:   normal">410</p></td></tr></tbody></table></div><a name='320'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>TEXT--USUAL INDUSTRY</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">320</td><td style="text-align:center;">100</td><td style="text-align:center;"><a href='#sources'>NPCR</a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">347 - 446</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>textUsualIndustry</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Text area for information about the patient&#8217;s usual industry, also known as usual kind of business/industry.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Used to identify new work-related health hazards; serves as an additional measure of socioeconomic status; identifies industrial groups or worksite-related groups in which cancer screening or prevention activities may be beneficial.<br /><br />The data item &#8220;usual industry&#8221; is defined identically as on death certificates and conforms to the 1989 revision of the U.S. Standard Certificate of Death.<sup>25</sup> See related materials in reference list, Chapter VII.<strong><br /><br />Abstracting Instructions</strong><br />Record the primary type of activity carried on by the business/industry at the location where the patient was employed for the most number of years before diagnosis of this tumor. Be sure to distinguish among &#8220;manufacturing,&#8221; &#8220;wholesale,&#8221; &#8220;retail,&#8221; and &#8220;service&#8221; components of an industry that performs more than one of these components.<br /><br />If the primary activity carried on at the location where the patient worked is unknown, it may be sufficient for facility registrars to record the name of the company (with city or town) in which the patient performed his/her usual industry. In these situations, if resources permit, a central or regional registry may be able to use the employer name and city/town to determine the type of activity conducted at that location.<br /><br />As noted in the Text--Usual Occupation [310] section, in those situations where the usual occupation is not available or is unknown, the patient&#8217;s current or most recent occupation is recorded, if available. The information for industry should be based upon the information in occupation. Therefore, if current or most recent occupation rather than usual occupation was recorded, record the patient&#8217;s current or most recent business/industry.<br /><br />If later documentation in the patient&#8217;s record provides an industry that is more likely to be the usual industry than what was originally recorded, facility registrars are encouraged to update the abstract with the new information. However, it is not the responsibility of the facility registrars to update abstracts with industry information provided on death certificates. Comparison with death certificate information should be the function of a central or regional registry. <br /><br />There should be an entry for Text--Usual Industry if any occupation is recorded. If no information is available regarding the industry in which the reported occupation was carried out, record &#8220;unknown.&#8221; If the patient was not a student or homemaker and had never worked, record &#8220;never worked&#8221; as the usual industry. This data item usually is collected only for patients who are age 14 years or older at the time of diagnosis.</div><a name='310'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>TEXT--USUAL OCCUPATION</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">310</td><td style="text-align:center;">100</td><td style="text-align:center;"><a href='#sources'>NPCR</a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">247 - 346</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>textUsualOccupation</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Text area for information about the patient&#8217;s usual occupation, also known as usual type of job or work.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Used to identify new work-related health hazards; serves as an additional measure of socioeconomic status; identifies occupational groups in which cancer screening or prevention activities may be beneficial.<br /><br />The data item &#8220;usual occupation&#8221; is defined identically as on death certificates and conforms to the 1989 revision of the U.S. Standard Certificate of Death.<sup>25</sup> See related materials in reference list, Chapter VII.<strong><br /><br />Abstracting Instructions</strong><br />Record the patient&#8217;s usual occupation (i.e., the kind of work performed during most of the patient&#8217;s working life before diagnosis of this tumor). Do not record &#8220;retired.&#8221; If usual occupation is not available or is unknown, record the patient&#8217;s current or most recent occupation, or any available occupation.<br /><br />If later documentation in the patient&#8217;s record provides an occupation that is more likely to be the usual occupation than what was originally recorded, facility registrars are encouraged to update the abstract with the new information. However, it is not the responsibility of the facility registrars to update abstracts with occupation information provided on death certificates. Comparison with death certificate information should be the function of a central or regional registry.<br /><br />If the patient was a homemaker and also worked outside the home during most of his/her adult life, record the usual occupation outside the home; if the patient was a homemaker and did not work outside the home for most of his/her adult life, record &#8220;homemaker.&#8221; If the patient was not a student or homemaker and had never worked, record &#8220;never worked&#8221; as the usual occupation.<br /><br />If no information is available, record &#8220;unknown.&#8221;<br /><br />This data item usually is collected only for patients who are age 14 years or older at the time of diagnosis.</div><a name='3933'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>THROMBOCYTOPENIA</strong></td><td style="text-align:right;font-weight:bold;"><strong>Revised</strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">3933</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>NAACCR</a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1914 - 1914</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>thrombocytopenia</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Thrombocytopenia is defined by a deficiency of platelets in the blood. In staging of Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL), thrombocytopenia is defined as Platelets (Plt) less than 100,000/&#956;L.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para mark-changed'>Thrombocytopenia is a prognostic factor required for staging of Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) in AJCC 8th edition, Chapter 79 





















<em>Hodgkin and Non-Hodgkin Lymphomas</em>. It is a new data item for cases diagnosed 1/1/2018+.</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>0</td><td class='code-desc'>Thrombocytopenia not present<br/> 
Platelets (Plt) = 100,000/L
 </td></tr><tr class='code-row'><td class='code-nbr'>1</td><td class='code-desc'>Thrombocytopenia present<br/> 
Platelets (Plt) < 100,000/L
</td></tr><tr class='code-row'><td class='code-nbr'>6</td><td class='code-desc'>Lab value unknown, physician states thrombocytopenia is present</td></tr><tr class='code-row'><td class='code-nbr'>7</td><td class='code-desc'>Test ordered, results not in chart</td></tr><tr class='code-row'><td class='code-nbr'>9</td><td class='code-desc'>Not documented in medical record<br/>
Thrombocytopenia not assessed or unknown if assessed
</td></tr><tr class='code-row'><td class='code-nbr'></td><td class='code-desc'> </td></tr></table></div><div class='content chap10-para'>Each Site-Specific Data Item (SSDI) applies only to selected primary sites, histologies, and years of diagnosis. Depending on applicability and standard-setter requirements, SSDIs may be left blank.</div><a name='980'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>TNM CLIN DESCRIPTOR</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">980</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>CoC</a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1081 - 1081</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>Clinical Stage (Prefix/Suffix) Descriptor (CoC)<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>tnmClinDescriptor</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Identifies the AJCC clinical stage (prefix/suffix) descriptor as recorded by the physician. AJCC stage descriptors identify special cases that need separate data analysis. The descriptors are adjuncts to and do not change the stage group.<br /><br />Pathologic and clinical stage data are given three separate areas in the NAACCR Data Exchange Record Layout. CoC defines a descriptor and &#8220;Staged By&#8221; item for each of these three areas.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>CoC requires that AJCC TNM staging be used in its approved cancer programs. AJCC developed its staging system for evaluating trends in the treatment and control of cancer. This staging is used by physicians to estimate prognosis, to plan treatment, to evaluate new types of therapy, to analyze outcome, to design follow-up strategies, and to assess early detection results.</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>0</td><td class='code-desc'>None</td></tr><tr class='code-row'><td class='code-nbr'>1</td><td class='code-desc'>E (Extranodal, lymphomas only)</td></tr><tr class='code-row'><td class='code-nbr'>2</td><td class='code-desc'>S (Spleen, lymphomas only)</td></tr><tr class='code-row'><td class='code-nbr'>3</td><td class='code-desc'>M (Multiple primary tumors in a single site)</td></tr><tr class='code-row'><td class='code-nbr'>5</td><td class='code-desc'>E & S (Extranodal and spleen, lymphomas only)</td></tr><tr class='code-row'><td class='code-nbr'>9</td><td class='code-desc'>Unknown, not stated in patient record</td></tr><tr class='code-row'><td class='code-nbr'>blank</td><td class='code-desc'>Field not coded </td></tr><tr class='code-row'><td class='code-nbr' colspan='2'></td></tr></table></div><a name='960'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>TNM CLIN M</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">960</td><td style="text-align:center;">4</td><td style="text-align:center;"><a href='#sources'>AJCC</a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1073 - 1076</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>Clinical M (CoC)<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>tnmClinM</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Detailed site-specific codes for the clinical metastases (M) as defined by AJCC and recorded by the physician.<br /><br />Pathologic and clinical stage data are given three separate areas in the NAACCR Data Exchange Record Layout.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>CoC requires that AJCC TNM staging be used in its approved cancer programs. AJCC developed its staging system for evaluating trends in the treatment and control of cancer. This staging is used by physicians to estimate prognosis, to plan treatment, to evaluate new types of therapy, to analyze outcome, to design follow-up strategies, and to assess early detection results.</div><div class='content chap10-para'><strong>Codes (in addition to those published in the <em>AJCC Cancer Staging Manual)</em></strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>88</td><td class='code-desc'>Not applicable, no code assigned for this case in the current AJCC Staging Manual.</td></tr><tr class='code-row'><td class='code-nbr' colspan='2'>This field is left blank if no information at all is available to code this item.</td></tr></table></div><div class='content chap10-para'><em>Note: </em>See the<em> AJCC Cancer Staging Manual</em>, current edition for site-specific categories for the TNM elements and stage groups. See the<em> STORE </em>manual for specifications for codes and data entry rules.</div><a name='950'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>TNM CLIN N</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">950</td><td style="text-align:center;">4</td><td style="text-align:center;"><a href='#sources'>AJCC</a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1069 - 1072</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>Clinical N (CoC)<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>tnmClinN</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Detailed site-specific codes for the clinical nodes (N) as defined by AJCC and recorded by the physician.<br /><br />Pathologic and clinical stage data are given three separate areas in the NAACCR Data Exchange Record Layout.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>CoC requires that AJCC TNM staging be used in its approved cancer programs. AJCC developed its staging system for evaluating trends in the treatment and control of cancer. This staging is used by physicians to estimate prognosis, to plan treatment, to evaluate new types of therapy, to analyze outcome, to design follow-up strategies, and to assess early detection results.</div><div class='content chap10-para'><strong>Codes (in addition to those published in the <em>AJCC Cancer Staging Manual)</em></strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>88</td><td class='code-desc'>Not applicable, no code assigned for this case in the current AJCC Staging Manual.</td></tr><tr class='code-row'><td class='code-nbr' colspan='2'>This field is left blank if no information at all is available to code this item.</td></tr></table></div><div class='content chap10-para'><em>Note: </em>See the <em>AJCC Cancer Staging Manual</em>, current edition for site-specific categories for the TNM elements and stage groups. See the <em>STORE </em>manual for specifications for codes and data entry rules.</div><a name='970'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>TNM CLIN STAGE GROUP</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">970</td><td style="text-align:center;">4</td><td style="text-align:center;"><a href='#sources'>AJCC</a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1077 - 1080</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>Clinical Stage Group (CoC)<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>tnmClinStageGroup</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Detailed site-specific codes for the clinical stage group as defined by AJCC and recorded by the physician.<br /><br />Pathologic and clinical stage data are given three separate areas in the NAACCR Data Exchange Record Layout.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>CoC requires that AJCC TNM staging be used in its approved cancer programs. AJCC developed its staging system for evaluating trends in the treatment and control of cancer. This staging is used by physicians to estimate prognosis, to plan treatment, to evaluate new types of therapy, to analyze outcome, to design follow-up strategies, and to assess early detection results.</div><div class='content chap10-para'><strong>Codes (in addition to those published in the <em>AJCC Cancer Staging Manual</em>) </strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>88</td><td class='code-desc'>Not applicable, no code assigned for this case in the current AJCC Staging Manual.</td></tr><tr class='code-row'><td class='code-nbr'>99</td><td class='code-desc'>Unknown, not staged</td></tr></table></div><div class='content chap10-para'><em>Note:</em> See the<em> AJCC Cancer Staging Manual</em>, current edition for site-specific categories for the TNM elements and stage groups. See the<em> STORE </em>manual for specifications for codes and data entry rules.</div><a name='990'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>TNM CLIN STAGED BY</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">990</td><td style="text-align:center;">2</td><td style="text-align:center;"><a href='#sources'>CoC</a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">868 - 869</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>Staged By (Clinical Stage) (CoC)<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>tnmClinStagedBy</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Identifies the person who recorded the clinical AJCC staging elements and the stage group in the patient&#8217;s medical record.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Data captured in this field can be used to evaluate the source of clinical staging and form the basis for quality management and improvement studies. This item can be used to monitor application of the CoC Staging Standard.</div><div class='content chap10-para'><strong>Codes (Refer to the most recent version  of <em>STORE</em> for additional coding instructions) </strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>00</td><td class='code-desc'>Not Staged</td></tr><tr class='code-row'><td class='code-nbr'>10</td><td class='code-desc'>Physician, NOS, or physician type not specified in codes 11-15</td></tr><tr class='code-row'><td class='code-nbr'>11</td><td class='code-desc'>Surgeon</td></tr><tr class='code-row'><td class='code-nbr'>12</td><td class='code-desc'>Radiation Oncologist</td></tr><tr class='code-row'><td class='code-nbr'>13</td><td class='code-desc'>Medical Oncologist</td></tr><tr class='code-row'><td class='code-nbr'>14</td><td class='code-desc'>Pathologist</td></tr><tr class='code-row'><td class='code-nbr'>15</td><td class='code-desc'>Multiple Physicians; tumor board, etc.</td></tr><tr class='code-row'><td class='code-nbr'>20</td><td class='code-desc'>Cancer registrar</td></tr><tr class='code-row'><td class='code-nbr'>30</td><td class='code-desc'>Cancer registrar and physician</td></tr><tr class='code-row'><td class='code-nbr'>40</td><td class='code-desc'>Nurse, physician assistant,  or other non-physician medical staff</td></tr><tr class='code-row'><td class='code-nbr'>50</td><td class='code-desc'>Staging assigned at another facility</td></tr><tr class='code-row'><td class='code-nbr'>60</td><td class='code-desc'>Staging by Central Registry </td></tr><tr class='code-row'><td class='code-nbr'>88</td><td class='code-desc'>Case is not eligible for staging</td></tr><tr class='code-row'><td class='code-nbr'>99</td><td class='code-desc'>Staged but unknown who assigned stage  </td></tr><tr class='code-row'><td class='code-nbr' colspan='2'></td></tr></table></div><a name='940'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>TNM CLIN T</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">940</td><td style="text-align:center;">4</td><td style="text-align:center;"><a href='#sources'>AJCC</a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1065 - 1068</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>Clinical T (CoC)<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>tnmClinT</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Detailed site-specific codes for the clinical tumor (T) as defined by AJCC and recorded by the physician.<br /><br />Pathologic and clinical stage data are given three separate areas in the NAACCR Data Exchange Record Layout.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>CoC requires that AJCC TNM staging be used in its approved cancer programs. AJCC developed its staging system for evaluating trends in the treatment and control of cancer. This staging is used by physicians to estimate prognosis, to plan treatment, to evaluate new types of therapy, to analyze outcome, to design follow-up strategies, and to assess early detection results.</div><div class='content chap10-para'><strong>Codes (in addition to those published in the <em>AJCC Cancer Staging Manual</em>)</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>88</td><td class='code-desc'>Not applicable, no code assigned for this case in the current AJCC Staging Manual.</td></tr><tr class='code-row'><td class='code-nbr' colspan='2'>This field is left blank if no information at all is available to code this item.</td></tr></table></div><div class='content chap10-para'><em>Note:</em> See the<em> AJCC Cancer Staging Manual</em>, current edition for site-specific categories for the TNM elements and stage groups. See the<em> STORE </em>manual for specifications for codes and data entry rules.</div><a name='1060'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>TNM EDITION NUMBER</strong></td><td style="text-align:right;font-weight:bold;"><strong>Revised</strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">1060</td><td style="text-align:center;">2</td><td style="text-align:center;"><a href='#sources'>CoC</a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1046 - 1047</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>tnmEditionNumber</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>A code that indicates the edition of the AJCC manual used to stage the case. This applies to the manually coded AJCC fields. It does not apply to the Derived AJCC T, N, M and AJCC Stage Group fields [2940, 2960, 2980, and 3000].</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>TNM codes have changed over time and conversion is not always simple. Therefore, a case-specific indicator is needed to allow grouping of cases for comparison.</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para mark-changed'><table><tr class='code-row'><td class='code-nbr'>00</td><td class='code-desc'>Not staged (cases that have AJCC staging scheme and staging was not done)</td></tr><tr class='code-row'><td class='code-nbr'>01</td><td class='code-desc'>First Edition</td></tr><tr class='code-row'><td class='code-nbr'>02</td><td class='code-desc'>Second Edition (published 1983)</td></tr><tr class='code-row'><td class='code-nbr'>03</td><td class='code-desc'>Third Edition (published 1988)</td></tr><tr class='code-row'><td class='code-nbr'>04</td><td class='code-desc'>Fourth Edition (published 1992), recommended for use for cases diagnosed 1993-1997</td></tr><tr class='code-row'><td class='code-nbr'>05</td><td class='code-desc'>Fifth Edition (published 1997), recommended for use for cases diagnosed 1998-2002</td></tr><tr class='code-row'><td class='code-nbr'>06</td><td class='code-desc'>Sixth Edition (published 2002), recommended for use for cases diagnosed 2003-2009</td></tr><tr class='code-row'><td class='code-nbr'>07</td><td class='code-desc'>Seventh Edition (published 2009), recommended for use with cases diagnosed 2010-2017</td></tr><tr class='code-row'><td class='code-nbr'>08</td><td class='code-desc'>Eighth Edition (published 2016), recommended for use with cases diagnosed 2018+ for which a later edition has not yet been released</td></tr><tr class='code-row'><td class='code-nbr'>09</td><td class='code-desc'>Ninth Edition (first chapter published 2020), recommended for use with chapter-specific cases diagnosed 2021+ </td></tr><tr class='code-row'><td class='code-nbr'>88</td><td class='code-desc'>Not applicable (cases that do not have an AJCC staging scheme)</td></tr><tr class='code-row'><td class='code-nbr'>99</td><td class='code-desc'>Edition Unknown</td></tr><tr class='code-row'><td class='code-nbr' colspan='2'></td></tr></table></div><a name='1050'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>TNM OTHER DESCRIPTOR</strong></td><td style="text-align:right;font-weight:bold;"><strong>Retired</strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">1050</td><td style="text-align:center;"></td><td style="text-align:center;"><a href='#sources'></a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;">2006</td><td style="text-align:center;">11</td><td class="cross-out" style="text-align:center;"></td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td></td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td></td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>The NAACCR UDSC retired this data item in Version 11, as of January 1, 2006.</div><a name='1020'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>TNM OTHER M</strong></td><td style="text-align:right;font-weight:bold;"><strong>Retired</strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">1020</td><td style="text-align:center;"></td><td style="text-align:center;"><a href='#sources'></a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;">2006</td><td style="text-align:center;">11</td><td class="cross-out" style="text-align:center;"></td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td></td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td></td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>The NAACCR UDSC retired this data item in Version 11, as of January 1, 2006.</div><a name='1010'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>TNM OTHER N</strong></td><td style="text-align:right;font-weight:bold;"><strong>Retired</strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">1010</td><td style="text-align:center;"></td><td style="text-align:center;"><a href='#sources'></a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;">2006</td><td style="text-align:center;">11</td><td class="cross-out" style="text-align:center;"></td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td></td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td></td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>The NAACCR UDSC retired this data item in Version 11, as of January 1, 2006.</div><a name='1030'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>TNM OTHER STAGE GROUP</strong></td><td style="text-align:right;font-weight:bold;"><strong>Retired</strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">1030</td><td style="text-align:center;"></td><td style="text-align:center;"><a href='#sources'></a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;">2006</td><td style="text-align:center;">11</td><td class="cross-out" style="text-align:center;"></td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td></td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td></td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>The NAACCR UDSC retired this data item in Version 11, as of January 1, 2006.</div><a name='1040'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>TNM OTHER STAGED BY</strong></td><td style="text-align:right;font-weight:bold;"><strong>Retired</strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">1040</td><td style="text-align:center;"></td><td style="text-align:center;"><a href='#sources'></a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;">2006</td><td style="text-align:center;">11</td><td class="cross-out" style="text-align:center;"></td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td></td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td></td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>The NAACCR UDSC retired this data item in Version 11, as of January 1, 2006.</div><a name='1000'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>TNM OTHER T</strong></td><td style="text-align:right;font-weight:bold;"><strong>Retired</strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">1000</td><td style="text-align:center;"></td><td style="text-align:center;"><a href='#sources'></a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;">2006</td><td style="text-align:center;">11</td><td class="cross-out" style="text-align:center;"></td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td></td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td></td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>The NAACCR UDSC retired this data item in Version 11, as of January 1, 2006.</div><a name='920'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>TNM PATH DESCRIPTOR</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">920</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>CoC</a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1064 - 1064</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>Pathologic Stage (Prefix/Suffix) Descriptor (CoC)<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>tnmPathDescriptor</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Identified the AJCC pathologic stage (prefix/suffix) descriptor as recorded by the physician. AJCC stage descriptors identify special cases that need separate data analysis. The descriptors are adjuncts to and do not change the stage group.<br /><br />Pathologic and clinical stage data are given three separate areas in the NAACCR Data Exchange Record Layout. CoC defines a descriptor and &#8220;Staged By&#8221; item for each of these three areas.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>CoC requires that AJCC TNM staging be used in its approved cancer programs. AJCC developed its staging system for evaluating trends in the treatment and control of cancer. This staging is used by physicians to estimate prognosis, to plan treatment, to evaluate new types of therapy, to analyze outcome, to design follow-up strategies, and to assess early detection results.</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>0</td><td class='code-desc'>None</td></tr><tr class='code-row'><td class='code-nbr'>1</td><td class='code-desc'>E (Extranodal, lymphomas only)</td></tr><tr class='code-row'><td class='code-nbr'>2</td><td class='code-desc'>S (Spleen, lymphomas only)</td></tr><tr class='code-row'><td class='code-nbr'>3</td><td class='code-desc'>M (Multiple primary tumors in a single site)</td></tr><tr class='code-row'><td class='code-nbr'>4</td><td class='code-desc'>Y (Classification during or after initial multimodality therapy)pathologic staging only</td></tr><tr class='code-row'><td class='code-nbr'>5</td><td class='code-desc'>E & S (Extranodal and spleen, lymphomas only)</td></tr><tr class='code-row'><td class='code-nbr'>6</td><td class='code-desc'>M & Y (Multiple primary tumors and initial multimodality therapy)</td></tr><tr class='code-row'><td class='code-nbr'>9</td><td class='code-desc'>Unknown, not stated in patient record</td></tr><tr class='code-row'><td class='code-nbr'>blank</td><td class='code-desc'>Field not coded </td></tr><tr class='code-row'><td class='code-nbr'></td><td class='code-desc'> </td></tr></table></div><a name='900'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>TNM PATH M</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">900</td><td style="text-align:center;">4</td><td style="text-align:center;"><a href='#sources'>AJCC</a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1056 - 1059</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>Pathologic M (CoC)<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>tnmPathM</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Detailed site-specific codes for the pathologic metastases (M) as defined by AJCC and recorded by the physician.<br /><br />Pathologic and clinical stage data are given three separate areas in the NAACCR Data Exchange Record Layout.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>CoC requires that AJCC TNM staging be used in its approved cancer programs. AJCC developed its staging system for evaluating trends in the treatment and control of cancer. This staging is used by physicians to estimate prognosis, to plan treatment, to evaluate new types of therapy, to analyze outcome, to design follow-up strategies, and to assess early detection results.</div><div class='content chap10-para'><strong>Codes (in addition to those published in the <em>AJCC Cancer Staging Manual</em>) </strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>88</td><td class='code-desc'>Not applicable, no code assigned for this case in the current AJCC Staging Manual.</td></tr><tr class='code-row'><td class='code-nbr' colspan='2'>This field is left blank if no information at all is available to code this item.</td></tr></table></div><div class='content chap10-para'><em>Note: </em>See the <em>AJCC Cancer Staging Manual</em>, current edition for site-specific categories for the TNM elements and stage groups. See the <em>STORE</em> manual for specifications for codes and data entry rules.</div><a name='890'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>TNM PATH N</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">890</td><td style="text-align:center;">4</td><td style="text-align:center;"><a href='#sources'>AJCC</a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1052 - 1055</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>Pathologic N (CoC)<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>tnmPathN</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Detailed site-specific codes for the pathologic nodes (N) as defined by AJCC and recorded by physician.<br /><br />Pathologic and clinical stage data are given three separate areas in the NAACCR Data Exchange Record Layout.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>CoC requires that AJCC TNM staging be used in its approved cancer programs. AJCC developed its staging system for evaluating trends in the treatment and control of cancer. This staging is used by physicians to estimate prognosis, to plan treatment, to evaluate new types of therapy, to analyze outcome, to design follow-up strategies, and to assess early detection results.</div><div class='content chap10-para'><strong>Codes (in addition to those published in the <em>AJCC Cancer Staging Manual</em>) </strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>88</td><td class='code-desc'>Not applicable, no code assigned for this case in the current AJCC Staging Manual.</td></tr><tr class='code-row'><td class='code-nbr' colspan='2'>This field is left blank if no information at all is available to code this item.</td></tr></table></div><div class='content chap10-para'><em>Note: </em>See the<em> AJCC Cancer Staging Manual</em>, current edition for site-specific categories for the TNM elements and stage groups. See the<em> STORE </em>manual for specifications for codes and data entry rules.</div><a name='910'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>TNM PATH STAGE GROUP</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">910</td><td style="text-align:center;">4</td><td style="text-align:center;"><a href='#sources'>AJCC</a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1060 - 1063</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>Pathologic Stage Group (CoC)<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>tnmPathStageGroup</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Detailed site-specific codes for the pathologic stage group as defined by AJCC and recorded by the physician.<br /><br />Pathologic and clinical stage data are given three separate areas in the NAACCR Data Exchange Record Layout.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>CoC requires that AJCC TNM staging be used in its approved cancer programs. AJCC developed its staging system for evaluating trends in the treatment and control of cancer. This staging is used by physicians to estimate prognosis, to plan treatment, to evaluate new types of therapy, to analyze outcome, to design follow-up strategies, and to assess early detection results.</div><div class='content chap10-para'><strong>Codes (in addition to those published in the <em>AJCC Cancer Staging Manual</em>) </strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>88</td><td class='code-desc'>Not applicable, no code assigned for this case in the current AJCC Staging Manual.</td></tr><tr class='code-row'><td class='code-nbr'>99</td><td class='code-desc'>Unknown, unstaged</td></tr></table></div><div class='content chap10-para'><em>Note:</em> See the<em> AJCC Cancer Staging Manual</em>, current edition for site-specific categories for the TNM elements and stage groups. See the<em> STORE </em>manual for specifications for codes and data entry rules.</div><a name='930'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>TNM PATH STAGED BY</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">930</td><td style="text-align:center;">2</td><td style="text-align:center;"><a href='#sources'>CoC</a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">866 - 867</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>Staged By (Pathologic Stage) (CoC)<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>tnmPathStagedBy</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Identifies the person who recorded the pathologic AJCC staging elements and the stage group in the patient&#8217;s medical record.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Data captured in this field can be used to evaluate the source of pathologic staging and form the basis for quality management and improvement studies.</div><div class='content chap10-para'><strong>Codes (Refer to the most recent version  of <em>STORE </em>for additional coding instructions) </strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>00</td><td class='code-desc'>Not staged</td></tr><tr class='code-row'><td class='code-nbr'>10</td><td class='code-desc'>Physician, NOS, or physician type not specified in codes 11-15</td></tr><tr class='code-row'><td class='code-nbr'>11</td><td class='code-desc'>Surgeon</td></tr><tr class='code-row'><td class='code-nbr'>12</td><td class='code-desc'>Radiation Oncologist</td></tr><tr class='code-row'><td class='code-nbr'>13</td><td class='code-desc'>Medical Oncologist</td></tr><tr class='code-row'><td class='code-nbr'>14</td><td class='code-desc'>Pathologist</td></tr><tr class='code-row'><td class='code-nbr'>15</td><td class='code-desc'>Multiple Physicians; tumor board, etc</td></tr><tr class='code-row'><td class='code-nbr'>20</td><td class='code-desc'>Cancer registrar</td></tr><tr class='code-row'><td class='code-nbr'>30</td><td class='code-desc'>Cancer registrar and physician</td></tr><tr class='code-row'><td class='code-nbr'>40</td><td class='code-desc'>Nurse, physician assistant,  or other non-physician medical staff</td></tr><tr class='code-row'><td class='code-nbr'>50</td><td class='code-desc'>Staging assigned at another facility</td></tr><tr class='code-row'><td class='code-nbr'>60</td><td class='code-desc'>Staging by Central Registry </td></tr><tr class='code-row'><td class='code-nbr'>88</td><td class='code-desc'>Case is not eligible for staging</td></tr><tr class='code-row'><td class='code-nbr'>99</td><td class='code-desc'>Staged but unknown who assigned stage </td></tr><tr class='code-row'><td class='code-nbr' colspan='2'></td></tr></table></div><a name='880'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>TNM PATH T</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">880</td><td style="text-align:center;">4</td><td style="text-align:center;"><a href='#sources'>AJCC</a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1048 - 1051</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>Pathologic T (CoC)<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>tnmPathT</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Detailed site-specific codes for the pathologic tumor (T) as defined by AJCC and recorded by the physician.<br /><br />Pathologic and clinical stage data are given three separate areas in the NAACCR Data Exchange Record Layout.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>CoC requires that AJCC TNM staging be used in its approved cancer programs. AJCC developed its staging system for evaluating trends in the treatment and control of cancer. This staging is used by physicians to estimate prognosis, to plan treatment, to evaluate new types of therapy, to analyze outcome, to design follow-up strategies, and to assess early detection results.</div><div class='content chap10-para'><strong>Codes (in addition to those published in the <em>AJCC Cancer Staging Manual</em>) </strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>88</td><td class='code-desc'>Not applicable, no code assigned for this case in the current AJCC Staging Manual.</td></tr><tr class='code-row'><td class='code-nbr' colspan='2'>This field is left blank if no information at all is available to code this item.</td></tr></table></div><div class='content chap10-para'><em>Note: </em>See the <em>AJCC Cancer Staging Manual</em>, current edition for site-specific categories for the TNM elements and stage groups. See the<em> STORE </em>manual for specifications for codes and data entry rules.</div><a name='340'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>TOBACCO HISTORY</strong></td><td style="text-align:right;font-weight:bold;"><strong>Retired</strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">340</td><td style="text-align:center;"></td><td style="text-align:center;"><a href='#sources'></a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;">2010</td><td style="text-align:center;">12</td><td class="cross-out" style="text-align:center;"></td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td></td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td></td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>The NAACCR UDSC retired this data item in Version 12, as of January 1, 2010.</div><a name='1533'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>TOTAL DOSE</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">1533</td><td style="text-align:center;">6</td><td style="text-align:center;"><a href='#sources'>CoC</a></td><td style="text-align:center;">2018</td><td style="text-align:center;">18</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">2351 - 2356</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>totalDose</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Identifies the total radiation dose administered to the patient across all phases during the first course of treatment. The unit of measure is centiGray (cGy). This data item is required for CoC-accredited facilities as of cases diagnosed 01/01/2018 and later.</div><div class='content chap10-para'>To evaluate the patterns of radiation care, it is necessary to capture information describing the prescribed total dose of radiation during the first course of treatment. Outcomes are strongly related to the dose delivered.</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>000000</td><td class='code-desc'>No radiation treatment</td></tr><tr class='code-row'><td class='code-nbr'>000001-999997 </td><td class='code-desc'>Record the actual dose delivered in cGy</td></tr><tr class='code-row'><td class='code-nbr'>999998 </td><td class='code-desc'>Not applicable, radioisotopes administered to the patient</td></tr><tr class='code-row'><td class='code-nbr'>999999 </td><td class='code-desc'>Radiation therapy was administered, but the dose is unknown; it is unknown whether radiation therapy was administered</td></tr><tr class='code-row'><td class='code-nbr'></td><td class='code-desc'> </td></tr></table></div><a name='3934'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>TUMOR DEPOSITS</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">3934</td><td style="text-align:center;">2</td><td style="text-align:center;"><a href='#sources'>NAACCR</a></td><td style="text-align:center;">2018</td><td style="text-align:center;">18</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1803 - 1804</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>tumorDeposits</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>A tumor deposit is defined as a discrete nodule of cancer in pericolic/perirectal fat or in adjacent mesentery (mesocolic or rectal fat) within the lymph drainage area of the primary carcinoma, without identifiable lymph node tissue or identifiable vascular structure.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>The presence of tumor deposits is a Registry Data Collection Variable in AJCC. It was previously collected as Colon and Rectum CS SSF# 4.</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>00</td><td class='code-desc'>No tumor deposits</td></tr><tr class='code-row'><td class='code-nbr'>01-99</td><td class='code-desc'>01-99 Tumor deposits<br/>
(Exact number of Tumor Deposits)
</td></tr><tr class='code-row'><td class='code-nbr'>X1</td><td class='code-desc'>100 or more Tumor Deposits</td></tr><tr class='code-row'><td class='code-nbr'>X2</td><td class='code-desc'>Tumor Deposits identified, number unknown</td></tr><tr class='code-row'><td class='code-nbr'>X8</td><td class='code-desc'>Not applicable: Information not collected for this case<br/>
(If this information is required by your standard setter, use of code X8 may result in an edit error.)
</td></tr><tr class='code-row'><td class='code-nbr'>X9</td><td class='code-desc'>Not documented in medical record<br/>
Cannot be determined by the pathologist<br/>
Pathology report does not mention tumor deposits<br/>
No surgical resection done<br/>
Tumor Deposits not assessed or unknown if assessed
</td></tr><tr class='code-row'><td class='code-nbr'></td><td class='code-desc'> </td></tr></table></div><div class='content chap10-para'>Each Site-Specific Data Item (SSDI) applies only to selected primary sites, histologies, and years of diagnosis. Depending on applicability and standard-setter requirements, SSDIs may be left blank. </div><a name='3935'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>TUMOR GROWTH PATTERN</strong></td><td style="text-align:right;font-weight:bold;"><strong>Revised</strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">3935</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>NAACCR</a></td><td style="text-align:center;">2018</td><td style="text-align:center;">18</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1832 - 1832</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>tumorGrowthPattern</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Tumor Growth Pattern refers to the growth pattern of intrahepatic cholangiocarcinoma.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Tumor Growth Pattern is a Registry Data Collection Variable in AJCC. This data item was previously collected for Intrahepatic Bile Duct, SSF# 10.</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para mark-changed'><table><tr class='code-row'><td class='code-nbr'>1</td><td class='code-desc'>Mass-forming</td></tr><tr class='code-row'><td class='code-nbr'>2</td><td class='code-desc'>Periductal infiltrating</td></tr><tr class='code-row'><td class='code-nbr'>3</td><td class='code-desc'>Mixed mass-forming and periductal infiltrating</td></tr><tr class='code-row'><td class='code-nbr'>8</td><td class='code-desc'>Not applicable: Information not collected for this case<br/>
(If this information is required by your standard setter, use of code 8 may result in an edit error.)
</td></tr><tr class='code-row'><td class='code-nbr'>9</td><td class='code-desc'>Not documented in medical record<br/>
Radiology and/or pathology report does not mention tumor growth pattern<br/>
Cannot be determined by the pathologist<br/>
Tumor growth pattern not assessed or unknown if assessed
</td></tr><tr class='code-row'><td class='code-nbr'></td><td class='code-desc'> </td></tr></table></div><div class='content chap10-para mark-changed'>Each Site-Specific Data Item (SSDI) applies only to selected primary sites, histologies, and years of diagnosis. Depending on applicability and standard-setter requirements, SSDIs may be left blank.</div><a name='1150'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>TUMOR MARKER 1</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">1150</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>SEER</a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1294 - 1294</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>Tumor Marker One (CoC)<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>tumorMarker1</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Records prognostic indicators for specific sites or histologies. CoC offered these items for optional use for cases diagnosed 1996 and forward. See the CoC <em>ROADS Manual</em>, 1998 Supplement, for a list of specific sites and histologies.<br /><br />For SEER requirements for the specific sites, histologies, and diagnosis years for which this item is coded, see the 1998 <em>SEER Program Code Manual</em>. </div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>0</td><td class='code-desc'>None done (SX)</td></tr><tr class='code-row'><td class='code-nbr'>1</td><td class='code-desc'>Positive/elevated</td></tr><tr class='code-row'><td class='code-nbr'>2</td><td class='code-desc'>Negative/normal; within normal limits (S0)</td></tr><tr class='code-row'><td class='code-nbr'>3</td><td class='code-desc'>Borderline; undetermined whether positive/elevated or negative/normal</td></tr><tr class='code-row'><td class='code-nbr' colspan='2'><b>Three-tiered system:</b> </td></tr><tr class='code-row'><td class='code-nbr'>4</td><td class='code-desc'>Range 1 (S1)</td></tr><tr class='code-row'><td class='code-nbr'>5</td><td class='code-desc'>Range 2 (S2)</td></tr><tr class='code-row'><td class='code-nbr'>6</td><td class='code-desc'>Range 3 (S3)</td></tr><tr class='code-row'><td class='code-nbr'>8</td><td class='code-desc'>Ordered, but results not in chart</td></tr><tr class='code-row'><td class='code-nbr'>9</td><td class='code-desc'>Not applicable</td></tr><tr class='code-row'><td class='code-nbr'><b>For sites for which Tumor Marker 1 is not collected</b></td><td class='code-desc'> </td></tr><tr class='code-row'><td class='code-nbr'>9</td><td class='code-desc'>Not applicable</td></tr></table></div><div class='content chap10-para'><p>
  <em>Note: </em>As of January 1, 2003, this data item is no longer required or recommended by CoC. However, the item was collected in the past and it is recommended that historic data be retained.</p></div><a name='1160'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>TUMOR MARKER 2</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">1160</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>SEER</a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1295 - 1295</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>Tumor Marker Two (CoC)<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>tumorMarker2</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Records prognostic indicators for specific sites or histologies. CoC offered these items for optional use for cases diagnosed 1996 and forward. See the CoC <em>ROADS Manual</em>, 1998 Supplement, for a list of specific sites and histologies.<br /><br />For SEER requirements for the specific sites, histologies, and diagnosis years for which this item is coded, see the 1998 <em>SEER Program Code Manual</em>. </div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>0</td><td class='code-desc'>None done (SX)</td></tr><tr class='code-row'><td class='code-nbr'>1</td><td class='code-desc'>Positive/elevated</td></tr><tr class='code-row'><td class='code-nbr'>2</td><td class='code-desc'>Negative/normal; within normal limits (S0)</td></tr><tr class='code-row'><td class='code-nbr'>3</td><td class='code-desc'>Borderline; undetermined whether positive/elevated or negative/normal</td></tr><tr class='code-row'><td class='code-nbr'> <b>Three-tiered system:</b> </td><td class='code-desc'> </td></tr><tr class='code-row'><td class='code-nbr'>4</td><td class='code-desc'>Range 1 (S1)</td></tr><tr class='code-row'><td class='code-nbr'>5</td><td class='code-desc'>Range 2 (S2)</td></tr><tr class='code-row'><td class='code-nbr'>6</td><td class='code-desc'>Range 3 (S3)</td></tr><tr class='code-row'><td class='code-nbr'>8</td><td class='code-desc'>Ordered, but results not in chart</td></tr><tr class='code-row'><td class='code-nbr'>9</td><td class='code-desc'>Not applicable</td></tr><tr class='code-row'><td class='code-nbr' colspan='2'><b>For sites for which Tumor Marker 2 is not collected:</b></td></tr><tr class='code-row'><td class='code-nbr'>9</td><td class='code-desc'>Not applicable</td></tr></table></div><div class='content chap10-para'><em>Note: </em>As of January 1, 2003, this data item is no longer required  or recommended by CoC. However, the item was collected in the past and  it is recommended that historic data be retained.</div><a name='1170'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>TUMOR MARKER 3</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">1170</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>SEER</a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1296 - 1296</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>Tumor Marker Three (CoC)<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>tumorMarker3</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Records prognostic indicators for specific sites or histologies. CoC offered these items for optional use for cases diagnosed 1996 and forward. See the CoC <em>ROADS Manual</em>, 1998 Supplement, for a list of specific sites and histologies.<br /><br />For SEER requirements for the specific sites, histologies, and diagnosis years for which this item is coded, see the 1998 <em>SEER Program Code Manual</em>. </div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>0</td><td class='code-desc'>None done (SX)</td></tr><tr class='code-row'><td class='code-nbr'>1</td><td class='code-desc'>Positive/elevated</td></tr><tr class='code-row'><td class='code-nbr'>2</td><td class='code-desc'>Negative/normal; within normal limits (S0)</td></tr><tr class='code-row'><td class='code-nbr'>3</td><td class='code-desc'>Borderline; undetermined whether positive/elevated or negative/normal</td></tr><tr class='code-row'><td class='code-nbr'><b>Three-tiered system:</b> </td><td class='code-desc'> </td></tr><tr class='code-row'><td class='code-nbr'>4</td><td class='code-desc'>Range 1 (S1)</td></tr><tr class='code-row'><td class='code-nbr'>5</td><td class='code-desc'>Range 2 (S2)</td></tr><tr class='code-row'><td class='code-nbr'>6</td><td class='code-desc'>Range 3 (S3)</td></tr><tr class='code-row'><td class='code-nbr'>8</td><td class='code-desc'>Ordered, but results not in chart</td></tr><tr class='code-row'><td class='code-nbr'>9</td><td class='code-desc'>Not applicable</td></tr><tr class='code-row'><td class='code-nbr' colspan='2'><b>For sites for which Tumor Marker 3 is not collected:For sites for which Tumor Marker 3 is not collected:</b></td></tr><tr class='code-row'><td class='code-nbr'>9</td><td class='code-desc'>Not applicable</td></tr></table></div><div class='content chap10-para'><em>Note:</em> As of January 1, 2003, this data item is no longer required  or recommended by CoC. However, the item was collected in the past and  it is recommended that historic data be retained.</div><a name='60'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>TUMOR RECORD NUMBER</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">60</td><td style="text-align:center;">2</td><td style="text-align:center;"><a href='#sources'>NAACCR</a></td><td style="text-align:center;">2011</td><td style="text-align:center;">12.2</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">40 - 41</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>tumorRecordNumber</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>A system-generated number assigned to each tumor. The number should never change even if the tumor sequence is changed or a record (tumor) is deleted.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>This is a unique number that identifies a specific tumor so data can be linked. "Sequence Number" cannot be used as a link because the number is changed if a report identifies an earlier tumor or if a tumor record is deleted.</div><a name='752'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>TUMOR SIZE CLINICAL</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">752</td><td style="text-align:center;">3</td><td style="text-align:center;"><a href='#sources'>SEER</a></td><td style="text-align:center;">2016</td><td style="text-align:center;">16</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">876 - 878</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>tumorSizeClinical</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>This data item records the size of a solid primary tumor 














<strong>before
any treatment</strong> (surgical resection or initiation of any treatment including neoadjuvant).</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Clinical tumor size (pre-treatment size) is essential for treatment decision making and prognosis determination for many types of cancer.</div><div class='content chap10-para'><strong>Codes&nbsp;<!--[if gte mso 10]>  <![endif]-->(Refer to the most recent version of <em><a target="_blank" href="http://seer.cancer.gov/tools/codingmanuals/">SEER Program Coding and Staging Manual</a></em> for additional instructions.)</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>000</td><td class='code-desc'>No mass/tumor found </td></tr><tr class='code-row'><td class='code-nbr'>001</td><td class='code-desc'>1 mm or described as <b>less than</b> 1 mm (0.1 cm or less than 0.1 cm)</td></tr><tr class='code-row'><td class='code-nbr'>002-988</td><td class='code-desc'>Exact size in millimeters (2 mm to 988 mm) (0.2 to 98.8 cm) </td></tr><tr class='code-row'><td class='code-nbr'>989</td><td class='code-desc'>989 millimeters or larger (98.9 cm or larger)</td></tr><tr class='code-row'><td class='code-nbr'>990</td><td class='code-desc'>Microscopic focus or foci only and no size of focus is given</td></tr><tr class='code-row'><td class='code-nbr'>998</td><td class='code-desc'>SITE-SPECIFIC CODES<br>
<br> 
Alternate descriptions of tumor size for specific sites:<br> 
<br>
Familial/multiple polyposis:<br>
-Rectosigmoid and rectum (C19.9, C20.9)<br> 
-Colon (C18.0, C18.2-C18.9)<br>
<br>
<b>If no size is documented:</b><br>
Circumferential:<br>
-Esophagus (C15.0-C15.5, C15.8, C15.9)<br> 
<br>
Diffuse; widespread: 3/4s or more; linitis plastica:<br>
-Stomach and Esophagus GE Junction (C16.0-C16.6, C16.8, C16.9)<br> 
<br>
Diffuse, entire lung or NOS:<br>
-Lung and main stem bronchus (C34.0-C34.3, C34.8, C34.9)<br>                                                  <br>                        
Diffuse:<br>
-Breast (C50.0-C50.6, C50.8, C50.9)
</td></tr><tr class='code-row'><td class='code-nbr'>999</td><td class='code-desc'>Unknown; size not stated; Not documented in patient record; Size of tumor cannot be assessed; The only measurement(s) describes pieces or chips; Not applicable
</td></tr><tr class='code-row'><td class='code-nbr'></td><td class='code-desc'> </td></tr></table></div><a name='754'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>TUMOR SIZE PATHOLOGIC</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">754</td><td style="text-align:center;">3</td><td style="text-align:center;"><a href='#sources'>SEER</a></td><td style="text-align:center;">2016</td><td style="text-align:center;">16</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">879 - 881</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>tumorSizePathologic</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>This data item records the size of a solid primary tumor that has been resected.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Pathologic tumor size is an important prognostic indicator and valuable for clinical practice and research on surgically treated patients for most cancers.</div><div class='content chap10-para'><strong>Codes (Refer to the most recent version of <em><a target="_blank" href="http://seer.cancer.gov/tools/codingmanuals/">SEER Program Coding and Staging Manual</a></em> for additional instructions.)</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>000</td><td class='code-desc'>No mass/tumor found </td></tr><tr class='code-row'><td class='code-nbr'>001</td><td class='code-desc'>1 mm or described as less than 1 mm (0.1 cm or less than 0.1 cm)
</td></tr><tr class='code-row'><td class='code-nbr'>002-988</td><td class='code-desc'>Exact size in millimeters (2 mm to 988 mm) (0.2 cm to 98.8 cm)
</td></tr><tr class='code-row'><td class='code-nbr'>989</td><td class='code-desc'>989 millimeters or larger (98.9 cm or larger)</td></tr><tr class='code-row'><td class='code-nbr'>990</td><td class='code-desc'>Microscopic focus or foci only and no size of focus is given</td></tr><tr class='code-row'><td class='code-nbr'>998</td><td class='code-desc'>Alternate descriptions of tumor size for specific sites:<br> 
<br>
Familial/multiple polyposis:<br>
-Rectosigmoid and rectum (C19.9, C20.9)<br> 
-Colon (C18.0, C18.2-C18.9)<br>
<br>
<b>If no size is documented:</b><br>
Circumferential:<br>
-Esophagus (C15.0-C15.5, C15.8, C15.9)<br> 
<br>
Diffuse; widespread: 3/4s or more; linitis plastica:<br>
-Stomach and Esophagus GE Junction (C16.0-C16.6, C16.8, C16.9)<br> 
<br>
Diffuse, entire lung or NOS:<br>
-Lung and main stem bronchus (C34.0-C34.3, C34.8, C34.9)<br>                                                  <br>                        
Diffuse:<br>
-Breast (C50.0-C50.6, C50.8, C50.9)</td></tr><tr class='code-row'><td class='code-nbr'>999</td><td class='code-desc'>Unknown; size not stated; Not documented in patient record; Size of tumor cannot be assessed; No excisional biopsy or tumor resection done; The only measurement(s) describes pieces or chips; Not applicable
</td></tr><tr class='code-row'><td class='code-nbr'></td><td class='code-desc'> </td></tr></table></div><a name='756'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>TUMOR SIZE SUMMARY</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">756</td><td style="text-align:center;">3</td><td style="text-align:center;"><a href='#sources'>NPCR/CoC</a></td><td style="text-align:center;">2016</td><td style="text-align:center;">16</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">882 - 884</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>tumorSizeSummary</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>This data item records the most accurate measurement of a solid primary tumor, usually measured on the surgical resection specimen.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Tumor size is one indication of the extent of disease. As such, it is used by both clinicians and researchers. Tumor size that is independent of stage is also useful for quality assurance efforts.</div><div class='content chap10-para'><strong>Codes: (See the most recent version of the <a target="_blank" href="https://www.facs.org/quality-programs/cancer/ncdb/registrymanuals/cocmanuals"><em>STORE </em></a>manual</strong> <strong>for additional instructions.) </strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>000</td><td class='code-desc'>No mass/tumor found </td></tr><tr class='code-row'><td class='code-nbr'>001</td><td class='code-desc'>1 mm or described as less than 1 mm (0.1 cm or less than 0.1 cm)</td></tr><tr class='code-row'><td class='code-nbr'>002-988</td><td class='code-desc'>Exact size in millimeters (2mm-988mm) (0.2 cm to 98.8 cm)</td></tr><tr class='code-row'><td class='code-nbr'>989</td><td class='code-desc'>989 millimeters or larger (98.9 cm or larger)</td></tr><tr class='code-row'><td class='code-nbr'>990</td><td class='code-desc'>Microscopic focus or foci only and no size of focus is given</td></tr><tr class='code-row'><td class='code-nbr'>998</td><td class='code-desc'>Alternate descriptions of tumor size for specific sites:<br> 
<br>
Familial/multiple polyposis:<br>
-Rectosigmoid and rectum (C19.9, C20.9)<br> 
-Colon (C18.0, C18.2-C18.9)<br>
<br>
<b>If no size is documented:</b><br>
Circumferential:<br>
-Esophagus (C15.0-C15.5, C15.8, C15.9)<br> 
<br>
Diffuse; widespread: 3/4s or more; linitis plastica:<br>
-Stomach and Esophagus GE Junction (C16.0-C16.6, C16.8, C16.9)<br> 
<br>
Diffuse, entire lung or NOS:<br>
-Lung and main stem bronchus (C34.0-C34.3, C34.8, C34.9)<br>                                                  <br>                        
Diffuse:<br>
-Breast (C50.0-C50.6, C50.8, C50.9)</td></tr><tr class='code-row'><td class='code-nbr'>999</td><td class='code-desc'>Unknown; size not stated; 
Not documented in patient record; 
Size of tumor cannot be assessed; 
No excisional biopsy or tumor resection done;
The only measurement(s) describes pieces or chips;
Not applicable</td></tr><tr class='code-row'><td class='code-nbr'></td><td class='code-desc'> </td></tr></table></div><a name='500'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>TYPE OF REPORTING SOURCE</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">500</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>SEER</a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">577 - 577</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>typeOfReportingSource</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>This variable codes the source documents used to abstract the majority of information on the tumor being reported. This may not be the source of original case finding (for example, if a case is identified through a pathology laboratory report review and all source documents used to abstract the case are from the physician&#8217;s office, code this item 4).</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>The code in this field can be used to explain why information may be incomplete on a tumor. For example, death certificate only cases have unknown values for many data items, so one may want to exclude them from some analyses. The field also is used to monitor the success of non-hospital case reporting and follow-back mechanisms. All population-based registries should have some death certificate-only cases where no hospital admission was involved, but too high a percentage can imply both shortcomings in case-finding and that follow-back to uncover missed hospital reports was not complete.<br /><br /><strong>Coding Instructions</strong><br />Code in the following priority order: 1, 2, 8, 4, 3, 5, 6, 7. This is a change to reflect the addition of codes 2 and 8 and to prioritize laboratory reports over nursing home reports. The source facilities included in the previous code 1 (hospital inpatient and outpatient) are split between codes 1, 2, and 8.<br /><br />This data item is intended to indicate the completeness of information available to the abstractor. Reports from health plans (e.g., Kaiser, Veterans Administration, military facilities) in which all diagnostic and treatment information is maintained centrally and is available to the abstractor are expected to be at least as complete as reports for hospital inpatients, which is why these sources are grouped with inpatients and given the code with the highest priority.<br /><br />Sources coded with '2' usually have complete information on the cancer diagnosis, staging, and treatment.<br /><br />Sources coded with '8' would include, but would not be limited to, outpatient surgery and nuclear medicine services. A physician's office that calls itself a surgery center should be coded as a physician's office. Surgery centers are equipped and staffed to perform surgical procedures under general anesthesia. If a physician's office calls itself a surgery center, but cannot perform surgical procedures under general anesthesia, code as a physician office.</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>1</td><td class='code-desc'>Hospital inpatient; Managed health plans with comprehensive, unified medical records</td></tr><tr class='code-row'><td class='code-nbr'>2</td><td class='code-desc'>Radiation Treatment Centers or Medical Oncology Centers (hospital-affiliated or independent)</td></tr><tr class='code-row'><td class='code-nbr'>3</td><td class='code-desc'>Laboratory only (hospital-affiliated or independent)</td></tr><tr class='code-row'><td class='code-nbr'>4</td><td class='code-desc'>Physician's office/private medical practitioner (LMD)</td></tr><tr class='code-row'><td class='code-nbr'>5</td><td class='code-desc'>Nursing/convalescent home/hospice</td></tr><tr class='code-row'><td class='code-nbr'>6</td><td class='code-desc'>Autopsy only</td></tr><tr class='code-row'><td class='code-nbr'>7</td><td class='code-desc'>Death certificate only</td></tr><tr class='code-row'><td class='code-nbr'>8</td><td class='code-desc'>Other hospital outpatient units/surgery centers</td></tr><tr class='code-row'><td class='code-nbr'></td><td class='code-desc'> </td></tr></table></div><a name='3936'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>ULCERATION</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">3936</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>NAACCR</a></td><td style="text-align:center;">2018</td><td style="text-align:center;">18</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1905 - 1905</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>ulceration</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Ulceration, the absence of an intact epidermis overlying the primary melanoma based upon histopathological examination, is a prognostic factor for melanoma of the skin.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Ulceration is a Registry Data Collection Variable in AJCC.  It was previously collected as Melanoma Skin, CS SSF# 2.</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>0</td><td class='code-desc'>Ulceration not identified/not present</td></tr><tr class='code-row'><td class='code-nbr'>1</td><td class='code-desc'>Ulceration present</td></tr><tr class='code-row'><td class='code-nbr'>8</td><td class='code-desc'>Not applicable: Information not collected for this case<br/>
(If this item is required by your standard setter, use of code 8 will result in an edit error.)

</td></tr><tr class='code-row'><td class='code-nbr'>9</td><td class='code-desc'>Not documented in medical record<br/>
Cannot be determined by the pathologist<br/>
Pathology report does not mention ulceration<br/>
Ulceration not assessed or unknown if assessed

</td></tr><tr class='code-row'><td class='code-nbr'></td><td class='code-desc'> </td></tr></table></div><div class='content chap10-para'>Each Site-Specific Data Item (SSDI) applies only to selected primary sites, histologies, and years of diagnosis. Depending on applicability and standard-setter requirements, SSDIs may be left blank. </div><a name='1850'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>UNUSUAL FOLLOW-UP METHOD</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">1850</td><td style="text-align:center;">2</td><td style="text-align:center;"><a href='#sources'>NAACCR</a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">2963 - 2964</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>unusualFollowUpMethod</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>User-defined numeric codes used to flag cases that need unusual follow-up methods. </div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr' colspan='2'>User-defined</td></tr></table></div><div class='content chap10-para'><em>Note:</em> This data item is no longer supported by CoC (as of January 1, 2003).</div><a name='345'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>URIC 2000</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">345</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>NAACCR</a></td><td style="text-align:center;">2018</td><td style="text-align:center;">18</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">462 - 462</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>Urban Rural Indicator Code-Tract-level 2000<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>uric2000</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>A measure of how urban a cancer patient's census tract at diagnosis is based on the Census Bureau's identification of urban and rural areas (already collect at county-level).  The variable is a 4 code continuum. The measure indicates of the rural nature of the place of residence and can be an indicator of access to recreation, access to food stores, exposures to pollutants, crime levels, social cohesion, etc. Collecting the variable with each decennial census allows for retrospective and cross-sectional epidemiologic analysis.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Studies have shown that residents of rural areas have lower screening rates, lower rates of follow-up of abnormal screening tests, higher late-stage diagnosis rates, and differences in cancer treatment patterns.  Including tract-level indicators of rural-urban residence in the NAACCR data files will facilitate research in rural-urban disparities and allow researchers to control for rural-urban differences in model-based analysis of cancer risks and outcomes. Using these codes allows cancer registries to release the area-based measure instead of more sensitive information such as address or long/lat. The measure has been tested for uniqueness and the categories selected/aggregated so that identification of individual level census tracts is not possible as long as county is not known. Therefore, unless the researcher can scientifically defend the need for county, the county identifier will not be released in the same database.</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>1</td><td class='code-desc'>All urban-the percent of the population in an urban area = 100%</td></tr><tr class='code-row'><td class='code-nbr'>2</td><td class='code-desc'>Mostly urban-the percent of the population in an urban area < 100% and  50% </td></tr><tr class='code-row'><td class='code-nbr'>3</td><td class='code-desc'>Mostly rural-the percent of the population in an urban area > 0% and < 50%</td></tr><tr class='code-row'><td class='code-nbr'>4</td><td class='code-desc'>All rural-the percent of the population in an urban area = 0%</td></tr><tr class='code-row'><td class='code-nbr'>9</td><td class='code-desc'>Unknown or not applicable-census tract not available or tract population was zero at the last decadal census</td></tr><tr class='code-row'><td class='code-nbr'></td><td class='code-desc'> </td></tr></table></div><div class='content chap10-para'><em>Note</em>: This is a derived variable. Currently, the variable is derived during call for data. However, SAS code to derive the variable at the central registry variable for local use is available on the NAACCR website.</div><a name='346'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>URIC 2010</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">346</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>NAACCR</a></td><td style="text-align:center;">2018</td><td style="text-align:center;">18</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">463 - 463</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td>Urban Rural Indicator Code-Tract-level 2010<br /></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>uric2010</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>A measure of how urban a cancer patient's census tract at diagnosis is based on the Census Bureau's identification of urban and rural areas (already collect at county-level).  The variable is a 4 code continuum. The measure indicates of the rural nature of the place of residence and can be an indicator of access to recreation, access to food stores, exposures to pollutants, crime levels, social cohesion, etc. Collecting the variable with each decennial census allows for retrospective and cross-sectional epidemiologic analysis.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Studies have shown that residents of rural areas have lower screening rates, lower rates of follow-up of abnormal screening tests, higher late-stage diagnosis rates, and differences in cancer treatment patterns. Including tract-level indicators of rural-urban residence in the NAACCR data files will facilitate research in rural-urban disparities and allow researchers to control for rural-urban differences in model-based analysis of cancer risks and outcomes. Using these codes allows cancer registries to release the area-based measure instead of more sensitive information such as address or long/lat. The measure has been tested for uniqueness and the categories selected/aggregated so that identification of individual level census tracts is not possible as long as county is not known. Therefore, unless the researcher can scientifically defend the need for county, the county identifier will not be released in the same database.</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>1</td><td class='code-desc'>All urban-the percent of the population in an urban area = 100%</td></tr><tr class='code-row'><td class='code-nbr'>2</td><td class='code-desc'>Mostly urban-the percent of the population in an urban area < 100% and  50%</td></tr><tr class='code-row'><td class='code-nbr'>3</td><td class='code-desc'>Mosty rural-the percent of the population in an urban area > 0% and < 50%</td></tr><tr class='code-row'><td class='code-nbr'>4</td><td class='code-desc'>All rural-the percent of the population in an urban area = 0%</td></tr><tr class='code-row'><td class='code-nbr'>9</td><td class='code-desc'>Unknown or not applicable-census tract not available or tract population was zero at the last decadal census</td></tr><tr class='code-row'><td class='code-nbr'></td><td class='code-desc'> </td></tr></table></div><div class='content chap10-para'><em>Note</em>: This is a derived variable. Currently, the variable is derived during call for data. However, SAS code to derive the variable at the central registry variable for local use is available on the NAACCR website.</div><a name='2170'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>VENDOR NAME</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">2170</td><td style="text-align:center;">10</td><td style="text-align:center;"><a href='#sources'>NAACCR</a></td><td style="text-align:center;">2011</td><td style="text-align:center;">12.2</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">2625 - 2634</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>vendorName</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>System-generated. Name of the computer services vendor who programmed the system submitting the data. Abbreviate as necessary and keep a consistent name throughout all submissions. Include software version number where available. Code is self-assigned by vendor. </div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>This is used to track which vendor and which software version submitted the case. It helps define the source and extent of a problem discovered in data submitted by a software provider. </div><a name='3937'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>VISCERAL AND PARIETAL PLEURAL INVASION</strong></td><td style="text-align:right;font-weight:bold;"><strong>Revised</strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">3937</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>NAACCR</a></td><td style="text-align:center;">2018</td><td style="text-align:center;">18</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">1867 - 1867</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>visceralParietalPleuralInvasion</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Tumor</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Visceral and Parietal Pleural Invasion is defined as invasion beyond the elastic layer or to the surface of the visceral pleura.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>Visceral and Parietal Pleural Invasion (previously called "pleural/elastic layer invasion (PL)") is a Registry Data Collection Variable for AJCC. This data item was previously collected for Lung, SSF# 2.</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para mark-changed'><table><tr class='code-row'><td class='code-nbr'>0</td><td class='code-desc'>No evidence of visceral pleural invasion identified<br/>
Tumor does not completely traverse the elastic layer of the pleura<br/>
Stated as PL0
</td></tr><tr class='code-row'><td class='code-nbr'>4</td><td class='code-desc'>Invasion of visceral pleural present, NOS<br/>
Stated as PL1 or PL2
</td></tr><tr class='code-row'><td class='code-nbr'>5</td><td class='code-desc'>Tumor invades into or through the parietal pleural OR chest wall
<br/>
Stated as PL3<br/>
<br/>
Conversions that will be implemented:<br/>
<br/>
<b>Code 1 cases:</b> Now code 4<br/>
<b>Code 2 cases:</b> Now code 4<br/>
<b>Code 3 cases:</b> Now code 5<br/></td></tr><tr class='code-row'><td class='code-nbr'>6</td><td class='code-desc'>Tumor extends to pleura, NOS; not stated if visceral or parietal</td></tr><tr class='code-row'><td class='code-nbr'>8</td><td class='code-desc'>Not applicable: Information not collected for this case<br/>
If this item is required by your standard setter, use of code 8 will result in an edit error.)
</td></tr><tr class='code-row'><td class='code-nbr'>9</td><td class='code-desc'>Not documented in medical record<br/>
No surgical resection of primary site is performed<br/>
Visceral Pleural Invasion not assessed or unknown if assessed or cannot be determined
</td></tr><tr class='code-row'><td class='code-nbr'></td><td class='code-desc'> </td></tr></table></div><div class='content chap10-para mark-changed'>Each Site-Specific Data Item (SSDI) applies only to selected primary sites, histologies, and years of diagnosis. Depending on applicability and standard-setter requirements, SSDIs may be left blank.</div><a name='1760'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>VITAL STATUS</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">1760</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>SEER/CoC</a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">2785 - 2785</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>vitalStatus</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Patient</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>Vital status of the patient as of the date entered in Date of Last Contact [1750]. If the patient has multiple tumors, vital status should be the same for all tumors. </div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>0</td><td class='code-desc'>Dead</td></tr><tr class='code-row'><td class='code-nbr'>1</td><td class='code-desc'>Alive</td></tr><tr class='code-row'><td class='code-nbr'></td><td class='code-desc'> </td></tr></table></div><a name='1762'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>VITAL STATUS RECODE</strong></td><td style="text-align:right;font-weight:bold;"><strong></strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">1762</td><td style="text-align:center;">1</td><td style="text-align:center;"><a href='#sources'>NAACCR</a></td><td style="text-align:center;">2018</td><td style="text-align:center;">18</td><td style="text-align:center;"></td><td style="text-align:center;"></td><td class="cross-out" style="text-align:center;">2786 - 2786</td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td>vitalStatusRecode</td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td>Patient</td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>This variables is akin to Vital Status [1760], with the exception that any patient that dies after the follow-up cut-off date is recoded to alive as of the cut-off date. This variable is used as part of the algorithm for calculating the survival time recode variables (NAACCR items 1782-1788) and is used for survival, prevalence, and multiple primary &#8211; standardized incidence ratio analyses in SEER*Stat. This recode is necessary to conduct survival and prevalence analyses outside of SEER*Stat using other statistical software.</div><div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div><div class='content chap10-para'>These changes will benefit the cancer surveillance community by facilitating the application of standard methods for survival analysis. Beginning with data collected in the November 2014 call for data, NAACCR has published





<em> Cancer in North America Volume 4: Cancer Survival in the United States and Canada</em>, which provides cancer survival estimates on a wider population than was previously available. However, at present IMS must pre-process the datasets that are included in the NAACCR survival dataset to calculate the four&nbsp; standard data items, SEER Cause Specific COD [1914], SEER Other COD [1915], Record Number Recode [1775], and Vital Status Recode [1762]. For registries that do not submit cause of death information to NAACCR, it is not possible to calculate the 'SEER cause-specific death classification' or 'SEER other cause of death classification' variables. The 4 new data items will assist individual registries in performing survival analyses using their own data.</div><div class='content chap10-para'><strong>Codes</strong></div><div class='content chap10-para'><table><tr class='code-row'><td class='code-nbr'>0</td><td class='code-desc'>Dead as of study cutoff date </td></tr><tr class='code-row'><td class='code-nbr'>1</td><td class='code-desc'>Alive as of study cutoff date</td></tr><tr class='code-row'><td class='code-nbr' colspan='2'></td></tr></table></div><a name='620'></a><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr>
		<td colspan="7"><strong>YEAR FIRST SEEN THIS CA</strong></td><td style="text-align:right;font-weight:bold;"><strong>Retired</strong></td>
	</tr><tr class="tableColTitle">
		<td style="width:60px;">Item #</td><td style="width:60px;">Length</td><td style="width:160px;">Source of Standard</td><td style="width:60px;">Year Implemented</td><td style="width:60px;">Version Implemented</td><td style="width:60px;">Year Retired</td><td style="width:60px;">Version Retired</td><td class="cross-out" style="width:120px;">Column #</td>
	</tr><tr class="tableColData">
		<td style="text-align:center;">620</td><td style="text-align:center;"></td><td style="text-align:center;"><a href='#sources'></a></td><td style="text-align:center;"></td><td style="text-align:center;"></td><td style="text-align:center;">2006</td><td style="text-align:center;">11</td><td class="cross-out" style="text-align:center;"></td>
	</tr>
</table><table class="chap10-head-table" cellspacing="0" cellpadding="0">
	<tr class="tableColData">
		<td>Alternate Name:</td><td></td>
	</tr><tr class="tableColData">
		<td>XML NAACCR ID:</td><td></td>
	</tr><tr class="tableColData">
		<td>PARENT XML ELEMENT:</td><td></td>
	</tr>
</table><div class='content chap10-para-head'><strong><strong>Description</strong></strong></div><div class='content chap10-para'>The NAACCR UDSC retired this data item in Version 11, as of January 1, 2006.</div>
</div>

               
            
            <script type="text/javascript">

                var _gaq = _gaq || [];
                _gaq.push(['_setAccount', 'UA-7111251-1']);
                _gaq.push(['_setDomainName', 'naaccr.org']);
                _gaq.push(['_trackPageview']);

                (function () {
                    var ga = document.createElement('script'); ga.type = 'text/javascript'; ga.async = true;
                    ga.src = ('https:' == document.location.protocol ? 'https://ssl' : 'http://www') + '.google-analytics.com/ga.js';
                    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(ga, s);
                })();

            </script>
        </form>
    </body>
</html>
        
    